[
  {
    "id": 2,
    "user_query": "Is the protein Papilin secreted?",
    "vicuna-13b_response": "Papilin is a protein that is found in the saliva of some species of animals, including humans. It is produced by cells in the salivary glands and is secreted into the saliva, where it helps to protect the teeth from bacteria and other harmful microorganisms.\nIn general, proteins that are produced by cells in one part of the body and are secreted into the bloodstream or other bodily fluids are considered to be secreted proteins. Papilin is one such protein, as it is produced by cells in the salivary glands and is secreted into the saliva.\nIt is worth noting that the secretion of proteins like Papilin is a complex process that involves the transport of the protein through the cell and the secretory pathway, as well as the regulation of protein synthesis and secretion by various signaling pathways. The secretion of proteins like Papilin is an important part of the body's defense mechanisms, as it helps to protect against infection and disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Papilin is a protein found in the saliva of some species of animals, including humans.\n2. Papilin is produced by cells in the salivary glands.\n3. Papilin is secreted into the saliva.\n4. The secretion of proteins like Papilin involves the transport of the protein through the cell and the secretory pathway.\n5. The secretion of such proteins is a part of the body's defense mechanisms against infection and disease.",
    "vicuna-13b_fact": [
      "Papilin is a protein found in the saliva of some species of animals, including humans.",
      "Papilin is produced by cells in the salivary glands.",
      "Papilin is secreted into the saliva.",
      "The secretion of proteins like Papilin involves the transport of the protein through the cell and the secretory pathway.",
      "The secretion of such proteins is a part of the body's defense mechanisms against infection and disease."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Papilin is a protein found in numerous tissues, including the heart, skin, and cartilage. It is not specifically associated with saliva.\n2. FALSE [correction]: Papilin is not produced by cells in the salivary glands. It is produced in different tissues including lung, kidney, heart, and cartilage.\n3. FALSE [correction]: Papilin is not secreted into the saliva; it is typically associated with extracellular matrixes.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 8,
    "user_query": "Has Denosumab (Prolia) been approved by FDA?",
    "vicuna-13b_response": "Yes, Denosumab (trade name Prolia) is a medication that has been approved by the United States Food and Drug Administration (FDA) for the treatment of osteoporosis in postmenopausal women, and for the treatment of bone loss associated with hormone therapy in men with prostate cancer. It is also being studied for potential use in the treatment of other conditions, such as rheumatoid arthritis and cancer-related bone loss.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Denosumab, also known as Prolia, is a medication approved by the FDA.\n2. It is used for the treatment of osteoporosis in postmenopausal women.\n3. Denosumab is also used for the treatment of bone loss associated with hormone therapy in men with prostate cancer.\n4. This drug is being studied for potential use in the treatment of other conditions, like rheumatoid arthritis and cancer-related bone loss.",
    "vicuna-13b_fact": [
      "Denosumab, also known as Prolia, is a medication approved by the FDA.",
      "It is used for the treatment of osteoporosis in postmenopausal women.",
      "Denosumab is also used for the treatment of bone loss associated with hormone therapy in men with prostate cancer.",
      "This drug is being studied for potential use in the treatment of other conditions, like rheumatoid arthritis and cancer-related bone loss."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "vicuna-13b_response": "Acrokeratosis paraneoplastica is a medical condition characterized by the development of thick, scaly patches on the skin of the hands and feet. The condition is often seen in individuals with cancer, particularly those with lung, breast, or ovarian cancer.\nOne synonym for acrokeratosis paraneoplastica is \"acrokeratotic hyperplasia.\" This term refers to the thick, scaly patches that develop on the skin, as well as the increased cell growth that occurs in the affected areas.\nOther synonyms for acrokeratosis paraneoplastica include \"paraneoplastic acrokeratitis,\" \"acrokeratosis associated with malignancy,\" and \"neoplastic acrokeratosis.\" These terms all refer to the connection between the development of acrokeratosis paraneoplastica and the presence of cancer in the body.\nIt is important to note that while acrokeratosis paraneoplastica is often seen in individuals with cancer, it is not necessarily a direct result of the cancer itself. Rather, it is thought to be caused by a reaction to the cancer or its treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Acrokeratosis paraneoplastica is a medical condition characterized by thick, scaly patches on the skin of the hands and feet.\n2. Acrokeratosis paraneoplastica is often seen in individuals with cancer, particularly those with lung, breast, or ovarian cancer.\n3. One synonym for acrokeratosis paraneoplastica is \"acrokeratotic hyperplasia.\"\n4. Other synonyms for acrokeratosis paraneoplastica include \"paraneoplastic acrokeratitis,\" \"acrokeratosis associated with malignancy,\" and \"neoplastic acrokeratosis.\"\n5. The cause of acrokeratosis paraneoplastica is thought to be a reaction to cancer or its treatment.",
    "vicuna-13b_fact": [
      "Acrokeratosis paraneoplastica is a medical condition characterized by thick, scaly patches on the skin of the hands and feet.",
      "Acrokeratosis paraneoplastica is often seen in individuals with cancer, particularly those with lung, breast, or ovarian cancer.",
      "One synonym for acrokeratosis paraneoplastica is \"acrokeratotic hyperplasia.\"",
      "Other synonyms for acrokeratosis paraneoplastica include \"paraneoplastic acrokeratitis,\" \"acrokeratosis associated with malignancy,\" and \"neoplastic acrokeratosis.\"",
      "The cause of acrokeratosis paraneoplastica is thought to be a reaction to cancer or its treatment."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: One synonym for acrokeratosis paraneoplastica is \"Bazex syndrome.\"\n4. FALSE [correction]: Other synonyms for acrokeratosis paraneoplastica include \"Bazex's syndrome,\" \"acrokeratosis neoplastica,\" and \"Bazex syndrome.\"\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 11,
    "user_query": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?",
    "vicuna-13b_response": "The Vaughan-Williams classification system is a method for categorizing anti-arrhythmic drugs based on their mechanism of action. The classification system includes four classes:\nClass I: Drugs that prolong the duration of the cardiac action potential and increase the refractory period. These drugs are effective in controlling atrial fibrillation and atrial flutter, but can also cause adverse effects such as bradycardia and heart block. Examples of Class I drugs include disopyramide, procainamide, and sotalol.\nClass II: Drugs that increase the force of myocardial contraction and reduce the rate of depolarization. These drugs are effective in controlling atrial and ventricular arrhythmias, but can also cause adverse effects such as increased myocardial oxygen demand and the potential for cardiac failure. Examples of Class II drugs include digitalis glycosides, dipyridamole, and dobutamine.\nClass III: Drugs that increase the conduction of electrical impulses through the atrioventricular node and the His-Purkinje system. These drugs are effective in controlling atrial and ventricular arrhythmias, but can also cause adverse effects such as increased atrioventricular nodal conduction and the potential for asystole. Examples of Class III drugs include adenosine, ajmaline, and propranolol.\nClass IV: Drugs that have a variety of effects on the cardiovascular system, including anti-adrenergic, anti-tachycardia, and anti-dysrhythmic effects. These drugs are effective in controlling a wide range of arrhythmias, but can also cause adverse effects such as bradycardia, heart block, and hypotension. Examples of Class IV drugs include diltiazem, verapamil, and amiodarone.\nIt is important to note that the Vaughan-Williams classification system is not universally accepted and some drugs may be classified differently depending on the source. Additionally, some drugs may have effects that are not fully explained by a single classification and may have effects on multiple classes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Vaughan-Williams classification system categorizes anti-arrhythmic drugs based on their mechanism of action.\n2. The Vaughan-Williams classification system includes four classes.\n3. Class I of Vaughan-Williams classification includes drugs such as disopyramide, procainamide, and sotalol.\n4. Class II of Vaughan-Williams classification includes drugs such as digitalis glycosides, dipyridamole, and dobutamine.\n5. Class IV of Vaughan-Williams classification includes drugs such as diltiazem, verapamil, and amiodarone.",
    "vicuna-13b_fact": [
      "The Vaughan-Williams classification system categorizes anti-arrhythmic drugs based on their mechanism of action.",
      "The Vaughan-Williams classification system includes four classes.",
      "Class I of Vaughan-Williams classification includes drugs such as disopyramide, procainamide, and sotalol.",
      "Class II of Vaughan-Williams classification includes drugs such as digitalis glycosides, dipyridamole, and dobutamine.",
      "Class IV of Vaughan-Williams classification includes drugs such as diltiazem, verapamil, and amiodarone."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Vaughan-Williams classification system includes five classes.\n3. TRUE\n4. FALSE [correction]: Class II of Vaughan-Williams classification includes drugs such as Propranolol, Metoprolol, and Esmolol.\n5. FALSE [correction]: Class IV of Vaughan-Williams classification includes drugs such as diltiazem and verapamil, but does not include amiodarone.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 12,
    "user_query": "Which are the different isoforms of the mammalian Notch receptor?",
    "vicuna-13b_response": "The mammalian Notch receptor is a single-pass transmembrane protein that is widely expressed in various tissues and plays an important role in cell-cell communication during development and adult life. The Notch receptor has multiple isoforms, which are different forms of the protein that are produced by alternative splicing of the Notch gene.\nThe most common isoform of the Notch receptor is the Notch1 receptor, which is expressed in a wide range of tissues, including the brain, heart, kidney, and intestine. Other isoforms of the Notch receptor include Notch2, Notch3, and Notch4, which are expressed in specific tissues and have unique functions.\nFor example, Notch2 is expressed in the brain and is involved in the development of the nervous system, while Notch3 is expressed in the heart and is involved in cardiac development. Notch4 is expressed in the testis and is involved in sperm development.\nOverall, the different isoforms of the mammalian Notch receptor have specific functions in different tissues and cells, and their dysregulation has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The mammalian Notch receptor is a single-pass transmembrane protein.\n2. The Notch receptor has multiple isoforms produced by alternative splicing of the Notch gene.\n3. The most common isoform of the Notch receptor is the Notch1 receptor, which is expressed in various tissues including the brain, heart, kidney, and intestine.\n4. Other isoforms of the Notch receptor include Notch2, Notch3, and Notch4, which are expressed in specific tissues and have unique functions.\n5. The dysregulation of the mammalian Notch receptor has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact": [
      "The mammalian Notch receptor is a single-pass transmembrane protein.",
      "The Notch receptor has multiple isoforms produced by alternative splicing of the Notch gene.",
      "The most common isoform of the Notch receptor is the Notch1 receptor, which is expressed in various tissues including the brain, heart, kidney, and intestine.",
      "Other isoforms of the Notch receptor include Notch2, Notch3, and Notch4, which are expressed in specific tissues and have unique functions.",
      "The dysregulation of the mammalian Notch receptor has been implicated in various diseases, including cancer and neurodegenerative disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 15,
    "user_query": "Is the monoclonal antibody Trastuzumab (Herceptin) of potential use in the treatment of prostate cancer?",
    "vicuna-13b_response": "Trastuzumab (Herceptin) is a monoclonal antibody that is primarily used in the treatment of breast cancer and gastric cancer. Its use in the treatment of prostate cancer has been studied, but its efficacy in this context is still being evaluated.\nTrastuzumab works by targeting the HER2/neu gene, which is amplified in some breast cancers. The antibody binds to the HER2/neu protein and blocks its activity, leading to inhibition of cancer cell growth and survival.\nIn prostate cancer, HER2/neu amplification is less common than in breast cancer. However, some studies have suggested that a subset of prostate cancers may express HER2/neu and may be sensitive to Trastuzumab.\nClinical trials have been conducted to evaluate the use of Trastuzumab in prostate cancer, but the results have been mixed. Some studies have shown that Trastuzumab can improve overall survival in men with metastatic castration-resistant prostate cancer (mCRPC), while others have shown no benefit or even increased toxicity.\nThe FDA has approved Trastuzumab for the treatment of certain types of breast cancer and gastric cancer, but it is not approved for the treatment of prostate cancer. Further research is needed to determine the potential benefits and risks of Trastuzumab in the treatment of prostate cancer.\nIn conclusion, while Trastuzumab has shown some promise in the treatment of prostate cancer, its use in this context is still being evaluated and its efficacy is still being studied.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Trastuzumab (Herceptin) is primarily used in the treatment of breast cancer and gastric cancer.\n2. Trastuzumab works by targeting the HER2/neu gene and inhibiting cancer cell growth and survival.\n3. Some studies suggest a subset of prostate cancers may express HER2/neu and may be sensitive to Trastuzumab.\n4. The FDA has approved Trastuzumab for the treatment of certain types of breast cancer and gastric cancer, but not for the treatment of prostate cancer.\n5. Some clinical trials have shown variable results regarding the use of Trastuzumab in men with metastatic castration-resistant prostate cancer.",
    "vicuna-13b_fact": [
      "Trastuzumab (Herceptin) is primarily used in the treatment of breast cancer and gastric cancer.",
      "Trastuzumab works by targeting the HER2/neu gene and inhibiting cancer cell growth and survival.",
      "Some studies suggest a subset of prostate cancers may express HER2/neu and may be sensitive to Trastuzumab.",
      "The FDA has approved Trastuzumab for the treatment of certain types of breast cancer and gastric cancer, but not for the treatment of prostate cancer.",
      "Some clinical trials have shown variable results regarding the use of Trastuzumab in men with metastatic castration-resistant prostate cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 22,
    "user_query": "Are transcription and splicing connected?",
    "vicuna-13b_response": "Transcription and splicing are two distinct processes that occur in the nucleus of eukaryotic cells. Transcription is the process by which the genetic information stored in DNA is used to synthesize a complementary RNA molecule, known as messenger RNA (mRNA). This mRNA molecule then serves as a template for protein synthesis.\nSplicing, on the other hand, is the process by which introns (non-coding sequences within mRNA) are removed and exons (coding sequences within mRNA) are joined together to form a continuous, functional mRNA molecule. This process is necessary for the proper expression of genetic information and is critical for the proper functioning of cells.\nWhile transcription and splicing are distinct processes, they are closely linked and can influence each other. For example, the transcription process can affect the splicing of mRNA, and the splicing process can affect the stability of mRNA. Additionally, some transcription factors are also involved in the splicing process, and some splicing factors are also involved in the transcription process.\nIn summary, transcription and splicing are two distinct processes that are closely linked and can influence each other.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Transcription and splicing are two distinct processes that occur in the nucleus of eukaryotic cells.\n2. Transcription is the process by which the genetic information stored in DNA is used to synthesize a complementary RNA molecule, known as messenger RNA (mRNA).\n3. Splicing is the process by which introns (non-coding sequences within mRNA) are removed and exons (coding sequences within mRNA) are joined together to form a continuous, functional mRNA molecule.\n4. The transcription process can affect the splicing of mRNA, and the splicing process can affect the stability of mRNA.\n5. Some transcription factors are also involved in the splicing process, and some splicing factors are also involved in the transcription process.",
    "vicuna-13b_fact": [
      "Transcription and splicing are two distinct processes that occur in the nucleus of eukaryotic cells.",
      "Transcription is the process by which the genetic information stored in DNA is used to synthesize a complementary RNA molecule, known as messenger RNA (mRNA).",
      "Splicing is the process by which introns (non-coding sequences within mRNA) are removed and exons (coding sequences within mRNA) are joined together to form a continuous, functional mRNA molecule.",
      "The transcription process can affect the splicing of mRNA, and the splicing process can affect the stability of mRNA.",
      "Some transcription factors are also involved in the splicing process, and some splicing factors are also involved in the transcription process."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 23,
    "user_query": "What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?",
    "vicuna-13b_response": "Facioscapulohumeral muscular dystrophy (FSHD) is an inherited muscle disorder that is caused by a mutation in the DUX4 gene. The mode of inheritance of FSHD is believed to be autosomal dominant, which means that a person has a 50% chance of inheriting the gene from an affected parent. However, some cases of FSHD may be sporadic, meaning they occur in people without a family history of the condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Facioscapulohumeral muscular dystrophy (FSHD) is an inherited muscle disorder.\n2. This disorder is caused by a mutation in the DUX4 gene.\n3. The mode of inheritance of FSHD is assumed to be autosomal dominant.\n4. A person with an affected parent has a 50% chance of inheriting the gene.\n5. Some cases of FSHD may be sporadic, occurring in individuals without a family history of the condition.",
    "vicuna-13b_fact": [
      "Facioscapulohumeral muscular dystrophy (FSHD) is an inherited muscle disorder.",
      "This disorder is caused by a mutation in the DUX4 gene.",
      "The mode of inheritance of FSHD is assumed to be autosomal dominant.",
      "A person with an affected parent has a 50% chance of inheriting the gene.",
      "Some cases of FSHD may be sporadic, occurring in individuals without a family history of the condition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 25,
    "user_query": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?",
    "vicuna-13b_response": "The ryanodine receptor is a type of calcium channel found in the endoplasmic reticulum (ER) and sarcoplasmic reticulum (SR) of muscle cells. It is a complex quaternary macromolecular structure composed of four subunits (alpha1, alpha2, beta, and gamma) that form a heterotetrameric structure. The subunits are encoded by different genes and are synthesized as separate polypeptide chains that are then assembled into the mature receptor.\nThe subunits of the ryanodine receptor are:\n* Alpha1 subunit: This subunit is responsible for the high-affinity binding of ryanodine, a plant-derived alkaloid that acts as an antagonist of the receptor. It also has a role in the regulation of the receptor's gating.\n* Alpha2 subunit: This subunit is responsible for the low-affinity binding of ryanodine and is involved in the regulation of the receptor's gating.\n* Beta subunit: This subunit is responsible for the formation of the receptor's pore.\n* Gamma subunit: This subunit is responsible for the regulation of the receptor's gating.\nIn addition to the subunits, the ryanodine receptor also requires accessory proteins for its proper function. These include calsequestrin, which binds calcium ions and helps to regulate their release from the ER, and the regulatory protein calmodulin, which modulates the activity of the receptor.\nOverall, the ryanodine receptor is a complex quaternary macromolecular structure that is composed of four subunits and requires accessory proteins for its proper function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The ryanodine receptor is a type of calcium channel found in the endoplasmic reticulum (ER) and sarcoplasmic reticulum (SR) of muscle cells.\n2. The ryanodine receptor is composed of four subunits (alpha1, alpha2, beta, and gamma) that form a heterotetrameric structure.\n3. The subunits of the ryanodine receptor are synthesized as separate polypeptide chains that are then assembled into the mature receptor.\n4. Calsequestrin and calmodulin are accessory proteins required for the proper function of the ryanodine receptor.\n5. The alpha1 subunit of the ryanodine receptor is responsible for the high-affinity binding of ryanodine and has a role in the regulation of the receptor's gating.",
    "vicuna-13b_fact": [
      "The ryanodine receptor is a type of calcium channel found in the endoplasmic reticulum (ER) and sarcoplasmic reticulum (SR) of muscle cells.",
      "The ryanodine receptor is composed of four subunits (alpha1, alpha2, beta, and gamma) that form a heterotetrameric structure.",
      "The subunits of the ryanodine receptor are synthesized as separate polypeptide chains that are then assembled into the mature receptor.",
      "Calsequestrin and calmodulin are accessory proteins required for the proper function of the ryanodine receptor.",
      "The alpha1 subunit of the ryanodine receptor is responsible for the high-affinity binding of ryanodine and has a role in the regulation of the receptor's gating."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The ryanodine receptor is composed of four identical subunits, not alpha1, alpha2, beta, and gamma.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 26,
    "user_query": "What kind of chromatography is HILIC?",
    "vicuna-13b_response": "HILIC (Hydrophilic Interaction Chromatography) is a type of liquid chromatography that separates analytes based on their hydrophilic-hydrophobic interactions. In HILIC, the stationary phase is usually a silica gel or a polymer that has been modified to have a high concentration of hydrophilic functional groups, such as amino or sulfuric acid groups. The mobile phase is usually an organic solvent, such as acetonitrile or methanol.\nIn HILIC, the analytes are separated based on their ability to interact with the stationary phase. Hydrophilic analytes will interact more strongly with the hydrophilic stationary phase, while hydrophobic analytes will interact more strongly with the non-polar mobile phase. As a result, the analytes will separate based on their hydrophilic-hydrophobic properties.\nHILIC is commonly used for the separation of small molecules, such as drugs, metabolites, and pesticides, and is particularly useful for the analysis of compounds that contain polar functional groups. HILIC is also used in protein chromatography, where the stationary phase is modified to have a high concentration of hydrophilic groups, such as amino acids, to interact with the hydrophilic side chains of proteins.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. HILIC (Hydrophilic Interaction Chromatography) is a type of liquid chromatography that separates analytes based on their hydrophilic-hydrophobic interactions.\n2. In HILIC, the stationary phase is usually a silica gel or a polymer that has been modified to have a high concentration of hydrophilic functional groups.\n3. The mobile phase in HILIC is usually an organic solvent, such as acetonitrile or methanol.\n4. HILIC is commonly used for the separation of small molecules, such as drugs, metabolites, and pesticides.\n5. HILIC can be utilized in protein chromatography, where the stationary phase is modified to have a high concentration of hydrophilic groups to interact with the hydrophilic side chains of proteins.",
    "vicuna-13b_fact": [
      "HILIC (Hydrophilic Interaction Chromatography) is a type of liquid chromatography that separates analytes based on their hydrophilic-hydrophobic interactions.",
      "In HILIC, the stationary phase is usually a silica gel or a polymer that has been modified to have a high concentration of hydrophilic functional groups.",
      "The mobile phase in HILIC is usually an organic solvent, such as acetonitrile or methanol.",
      "HILIC is commonly used for the separation of small molecules, such as drugs, metabolites, and pesticides.",
      "HILIC can be utilized in protein chromatography, where the stationary phase is modified to have a high concentration of hydrophilic groups to interact with the hydrophilic side chains of proteins."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 27,
    "user_query": "What is the effect of TRH on myocardial contractility?",
    "vicuna-13b_response": "TRH, or thyrotropin-releasing hormone, is a hormone that stimulates the release of thyroid-stimulating hormone (TSH) from the pituitary gland. TSH, in turn, stimulates the production and release of thyroid hormones from the thyroid gland.\nThe effect of TRH on myocardial contractility, or the ability of the heart muscle to contract and pump blood, is complex and depends on various factors. In general, TRH can increase the contractility of the heart muscle by increasing the levels of catecholamines, such as norepinephrine, in the heart. This can lead to an increase in heart rate and cardiac output, which can be beneficial in some circumstances, such as during exercise or stress.\nHowever, chronically elevated levels of TRH and catecholamines can have detrimental effects on the heart, including increased oxygen demand, increased workload, and decreased coronary blood flow. This can lead to cardiac hypertrophy, or an enlargement and thickening of the heart muscle, which can increase the risk of heart failure and other cardiovascular diseases.\nIt is important to note that the effects of TRH on myocardial contractility can be influenced by various factors, including the levels of TRH and catecholamines, the presence of other hormones and medications, and the overall health and condition of the individual. Therefore, the effects of TRH on myocardial contractility should be carefully monitored in individuals receiving TRH therapy, especially those with preexisting heart conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TRH, or thyrotropin-releasing hormone, stimulates the release of thyroid-stimulating hormone (TSH) from the pituitary gland.\n2. TSH stimulates the production and release of thyroid hormones from the thyroid gland.\n3. TRH can increase the contractility of the heart muscle by increasing the levels of catecholamines, such as norepinephrine.\n4. Chronically elevated levels of TRH and catecholamines can lead to cardiac hypertrophy.\n5. The effects of TRH on myocardial contractility can be influenced by various factors including the levels of TRH and catecholamines, the presence of other hormones and medications, and the overall health and condition of the individual.",
    "vicuna-13b_fact": [
      "TRH, or thyrotropin-releasing hormone, stimulates the release of thyroid-stimulating hormone (TSH) from the pituitary gland.",
      "TSH stimulates the production and release of thyroid hormones from the thyroid gland.",
      "TRH can increase the contractility of the heart muscle by increasing the levels of catecholamines, such as norepinephrine.",
      "Chronically elevated levels of TRH and catecholamines can lead to cardiac hypertrophy.",
      "The effects of TRH on myocardial contractility can be influenced by various factors including the levels of TRH and catecholamines, the presence of other hormones and medications, and the overall health and condition of the individual."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 28,
    "user_query": "Proteomic analyses need prior knowledge of the organism complete genome. Is the complete genome of the bacteria of the genus Arthrobacter available?",
    "vicuna-13b_response": "Yes, the complete genome sequences of several Arthrobacter species are available in public databases. Arthrobacter is a genus of gram-positive bacteria that are commonly found in soil and the gastrointestinal tracts of animals.\nThe GenBank database at the National Center for Biotechnology Information (NCBI) provides access to a large collection of DNA sequences, including bacterial genomes. As of my knowledge cutoff date of September 2021, the complete genome sequences of several Arthrobacter species were available in GenBank, including:\n* Arthrobacter chlorophenolicus A6\n* Arthrobacter globiformis ATCC 23748\n* Arthrobacter nitroguajarensis K8\n* Arthrobacter oxidans ATCC 12478\n* Arthrobacter peroxydans ATCC 14868\n* Arthrobacter sp. strain A10\nThese genomes can be accessed and downloaded from the NCBI website, or through the use of tools such as the NCBI Genome Workbench, which allows users to view, analyze, and download genome data.\nIt is important to note that the availability of a complete genome sequence does not necessarily mean that all of the proteins encoded by the genome have been identified and characterized. Proteomic analyses can provide valuable information about the proteins expressed by an organism, but they typically require additional experimental work beyond the availability of a genome sequence.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The complete genome sequences of several Arthrobacter species are available in public databases.\n2. Arthrobacter is a genus of gram-positive bacteria that is commonly found in soil and the gastrointestinal tracts of animals.\n3. As of September 2021, the complete genome sequences of several Arthrobacter species were available in GenBank.\n4. The GenBank database at the National Center for Biotechnology Information (NCBI) provides access to a large collection of DNA sequences, including bacterial genomes.\n5. Availability of a complete genome sequence does not necessarily mean that all of the proteins encoded by the genome have been identified and characterized.",
    "vicuna-13b_fact": [
      "The complete genome sequences of several Arthrobacter species are available in public databases.",
      "Arthrobacter is a genus of gram-positive bacteria that is commonly found in soil and the gastrointestinal tracts of animals.",
      "As of September 2021, the complete genome sequences of several Arthrobacter species were available in GenBank.",
      "The GenBank database at the National Center for Biotechnology Information (NCBI) provides access to a large collection of DNA sequences, including bacterial genomes.",
      "Availability of a complete genome sequence does not necessarily mean that all of the proteins encoded by the genome have been identified and characterized."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Arthrobacter is a genus of gram-positive bacteria that is commonly found in soil, but it is not typically found in the gastrointestinal tracts of animals.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 29,
    "user_query": "What is the structural fold of bromodomain proteins?",
    "vicuna-13b_response": "Bromodomain proteins are a type of protein that contain a conserved structural motif called a bromodomain. The bromodomain is a protein domain that recognizes and binds to acetylated lysine residues on histone proteins, which are involved in the compaction of DNA into chromatin.\nThe structural fold of a bromodomain protein is characterized by a beta-sheet core with alpha-helical extensions on either side. The bromodomain is formed by the alpha-helical extensions, which contain the binding site for acetylated lysine residues. The bromodomain is typically around 100 amino acids in length and is composed of several beta-strands arranged in a beta-sheet structure, with the acetylated lysine residues binding in the grooves between the beta-strands.\nBromodomain proteins play important roles in regulating gene expression by controlling the access of transcription factors to the DNA template. They are also involved in other cellular processes, such as cell cycle progression and apoptosis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Bromodomain proteins contain a conserved structural motif called a bromodomain.\n2. The bromodomain is a protein domain that binds to acetylated lysine residues on histone proteins.\n3. The structural fold of a bromodomain protein is characterized by a beta-sheet core with alpha-helical extensions on either side. \n4. The bromodomain is typically around 100 amino acids in length and is composed of several beta-strands arranged in a beta-sheet structure. \n5. Bromodomain proteins play key roles in controlling the access of transcription factors to the DNA template, regulating gene expression, cell cycle progression, and apoptosis.",
    "vicuna-13b_fact": [
      "Bromodomain proteins contain a conserved structural motif called a bromodomain.",
      "The bromodomain is a protein domain that binds to acetylated lysine residues on histone proteins.",
      "The structural fold of a bromodomain protein is characterized by a beta-sheet core with alpha-helical extensions on either side.",
      "The bromodomain is typically around 100 amino acids in length and is composed of several beta-strands arranged in a beta-sheet structure.",
      "Bromodomain proteins play key roles in controlling the access of transcription factors to the DNA template, regulating gene expression, cell cycle progression, and apoptosis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 32,
    "user_query": "Which MAP kinase phosphorylates the transcription factor c-jun?",
    "vicuna-13b_response": "The MAP kinase that phosphorylates the transcription factor c-Jun is called JNK (Jun N-terminal kinase). JNK is a member of the MAP kinase family of signaling proteins, which are involved in a variety of cellular processes, including cell proliferation, differentiation, and apoptosis. JNK is activated in response to a variety of stimuli, including inflammation, oxidative stress, and UV radiation, and it phosphorylates a number of downstream targets, including c-Jun, which is a component of the AP-1 transcription factor complex. Phosphorylation of c-Jun by JNK leads to its translocation to the nucleus, where it participates in the regulation of gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. JNK (Jun N-terminal kinase) is the MAP kinase that phosphorylates the transcription factor c-Jun.  \n2. JNK is a member of the MAP kinase family of signaling proteins.\n3. JNK is involved in cellular processes such as cell proliferation, differentiation, and apoptosis.\n4. JNK is activated by a variety of stimuli including inflammation, oxidative stress, and UV radiation.\n5. The phosphorylation of c-Jun by JNK leads to its translocation to the nucleus, where it regulates gene expression.",
    "vicuna-13b_fact": [
      "JNK (Jun N-terminal kinase) is the MAP kinase that phosphorylates the transcription factor c-Jun.",
      "JNK is a member of the MAP kinase family of signaling proteins.",
      "JNK is involved in cellular processes such as cell proliferation, differentiation, and apoptosis.",
      "JNK is activated by a variety of stimuli including inflammation, oxidative stress, and UV radiation.",
      "The phosphorylation of c-Jun by JNK leads to its translocation to the nucleus, where it regulates gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 36,
    "user_query": "Which fusion protein is involved in the development of Ewing sarcoma?",
    "vicuna-13b_response": "Ewing sarcoma is a type of cancer that affects bone and soft tissue. It is caused by the fusion of two genes, EWSR1 and FLI1, which results in the formation of an oncogenic fusion protein known as EWS-FLI. This fusion protein disrupts normal cellular signaling pathways and leads to the uncontrolled growth and division of cancer cells. The EWS-FLI fusion protein is specific to Ewing sarcoma and is not found in normal cells, making it an attractive target for cancer therapy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ewing sarcoma is a type of cancer that affects bone and soft tissue.\n2. Ewing sarcoma is caused by the fusion of two genes, EWSR1 and FLI1.\n3. The fusion of EWSR1 and FLI1 genes results in the formation of an oncogenic fusion protein known as EWS-FLI.\n4. The EWS-FLI fusion protein disrupts normal cellular signaling pathways leading to uncontrolled growth and division of cancer cells.\n5. The EWS-FLI fusion protein is specific to Ewing sarcoma and is not found in normal cells.",
    "vicuna-13b_fact": [
      "Ewing sarcoma is a type of cancer that affects bone and soft tissue.",
      "Ewing sarcoma is caused by the fusion of two genes, EWSR1 and FLI1.",
      "The fusion of EWSR1 and FLI1 genes results in the formation of an oncogenic fusion protein known as EWS-FLI.",
      "The EWS-FLI fusion protein disrupts normal cellular signaling pathways leading to uncontrolled growth and division of cancer cells.",
      "The EWS-FLI fusion protein is specific to Ewing sarcoma and is not found in normal cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 40,
    "user_query": "Treatment of which disease was investigated in the MR CLEAN study?",
    "vicuna-13b_response": "The MR CLEAN study was a clinical trial that investigated the treatment of multiple sclerosis (MS). MS is a chronic autoimmune disease that affects the central nervous system, including the brain and spinal cord. In MS, the immune system attacks the myelin sheath that surrounds and protects the nerve fibers, leading to damage and inflammation. The MR CLEAN study was designed to evaluate the safety and efficacy of an investigational medication called ocrelizumab for the treatment of relapsing-remitting MS, which is the most common form of MS.\nThe MR CLEAN study was a phase III clinical trial that involved over 1,200 people with relapsing-remitting MS who were randomly assigned to receive either ocrelizumab or a commonly used MS medication called interferon beta-1a. The study found that ocrelizumab was more effective than interferon beta-1a at reducing the number of MS relapses and the risk of disability progression. The results of the MR CLEAN study were published in the New England Journal of Medicine in 2017 and have been widely cited as a significant advance in the treatment of MS.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The MR CLEAN study investigated the treatment of multiple sclerosis (MS).\n2. MS is a chronic autoimmune disease that affects the central nervous system, including the brain and spinal cord.\n3. The MR CLEAN study evaluated the safety and efficacy of an investigational medication called ocrelizumab for the treatment of relapsing-remitting MS.\n4. The MR CLEAN study involved over 1,200 people with relapsing-remitting MS.\n5. The results of the MR CLEAN study were published in the New England Journal of Medicine in 2017.",
    "vicuna-13b_fact": [
      "The MR CLEAN study investigated the treatment of multiple sclerosis (MS).",
      "MS is a chronic autoimmune disease that affects the central nervous system, including the brain and spinal cord.",
      "The MR CLEAN study evaluated the safety and efficacy of an investigational medication called ocrelizumab for the treatment of relapsing-remitting MS.",
      "The MR CLEAN study involved over 1,200 people with relapsing-remitting MS.",
      "The results of the MR CLEAN study were published in the New England Journal of Medicine in 2017."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The MR CLEAN trial investigated treatment for acute ischemic stroke, not multiple sclerosis.\n2. TRUE\n3. FALSE [correction]: The OPERA I and II studies, not the MR CLEAN study, evaluated the safety and efficacy of ocrelizumab for the treatment of relapsing-remitting MS.\n4. UNKNOWN\n5. FALSE [correction]: The results of the MR CLEAN study were published in the New England Journal of Medicine in 2015.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 44,
    "user_query": "Does BNP increase after intensive exercise in athletes?",
    "vicuna-13b_response": "BNP (B-type natriuretic peptide) is a hormone that is produced by the heart in response to stress, such as intense exercise. BNP levels can increase after intensive exercise in athletes, as well as in non-athletes. However, the increase in BNP levels after exercise is typically more pronounced in athletes due to their higher levels of physical activity and cardiovascular fitness.\nBNP is primarily produced by the ventricular myocytes (cardiac muscle cells) in the heart, and its release is stimulated by factors such as increased workload, hypertension, and heart failure. BNP acts on the kidneys to increase sodium and water excretion, which helps to reduce the workload on the heart and maintain blood pressure.\nIn athletes, BNP levels may increase after intense exercise due to the increased workload on the heart, as well as the increased demand for oxygen and nutrients during exercise. However, it is important to note that BNP levels can also be influenced by other factors such as age, sex, and underlying medical conditions.\nOverall, while BNP levels may increase after intensive exercise in athletes, it is important to interpret these findings in the context of an individual's overall health and fitness level. Additionally, further testing and evaluation may be necessary to determine the cause of any changes in BNP levels.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BNP (B-type natriuretic peptide) is a hormone produced by the heart in response to stress, such as intense exercise.\n2. BNP levels can increase after intensive exercise in athletes and non-athletes.\n3. The increase in BNP levels after exercise is typically more pronounced in athletes.\n4. BNP is primarily produced by the ventricular myocytes (cardiac muscle cells) in the heart.\n5. BNP helps to reduce the workload on the heart and maintain blood pressure by acting on the kidneys to increase sodium and water excretion.",
    "vicuna-13b_fact": [
      "BNP (B-type natriuretic peptide) is a hormone produced by the heart in response to stress, such as intense exercise.",
      "BNP levels can increase after intensive exercise in athletes and non-athletes.",
      "The increase in BNP levels after exercise is typically more pronounced in athletes.",
      "BNP is primarily produced by the ventricular myocytes (cardiac muscle cells) in the heart.",
      "BNP helps to reduce the workload on the heart and maintain blood pressure by acting on the kidneys to increase sodium and water excretion."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "vicuna-13b_response": "Weaver syndrome and Sotos syndrome are both genetic disorders that can affect a person's physical development and growth. However, they are different conditions with different characteristics.\nWeaver syndrome, also known as mesomelic dwarfism with normal intelligence, is a rare genetic disorder that affects bone growth and development. People with Weaver syndrome typically have short stature, with an average height of around 4 feet, and normal intelligence. They may also have other features such as a broad chest, short arms and legs, and a large head.\nSotos syndrome, on the other hand, is a genetic disorder that affects growth and development in several areas of the body. People with Sotos syndrome tend to be tall, with an average height of around 6 feet, and they may have a high degree of intelligence. However, they may also have other features such as a broad forehead, long arms and legs, and a large hands and feet.\nWhile both Weaver syndrome and Sotos syndrome can affect a person's physical development and growth, they are distinct conditions with different characteristics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Weaver syndrome and Sotos syndrome are both genetic disorders that can affect a person's physical development and growth.\n2. Weaver syndrome, also known as mesomelic dwarfism with normal intelligence, is a rare genetic disorder that affects bone growth and development.\n3. People with Weaver syndrome typically have short stature, with an average height of around 4 feet, and normal intelligence. \n4. Sotos syndrome is a genetic disorder that affects growth and development in several areas of the body.\n5. People with Sotos syndrome tend to be tall, with an average height of around 6 feet, and they may have a high degree of intelligence.",
    "vicuna-13b_fact": [
      "Weaver syndrome and Sotos syndrome are both genetic disorders that can affect a person's physical development and growth.",
      "Weaver syndrome, also known as mesomelic dwarfism with normal intelligence, is a rare genetic disorder that affects bone growth and development.",
      "People with Weaver syndrome typically have short stature, with an average height of around 4 feet, and normal intelligence.",
      "Sotos syndrome is a genetic disorder that affects growth and development in several areas of the body.",
      "People with Sotos syndrome tend to be tall, with an average height of around 6 feet, and they may have a high degree of intelligence."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Weaver syndrome is not also known as mesomelic dwarfism with normal intelligence, it is a rare genetic disorder that can cause rapid growth.\n3. FALSE [correction]: People with Weaver syndrome typically have accelerated growth, leading to a large physique, not a short stature.\n4. TRUE\n5. FALSE [correction]: People with Sotos syndrome often do grow to be tall, however, they typically face learning disabilities or have intellectual impairment and do not usually have a high degree of intelligence.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 49,
    "user_query": "Are ultraconserved elements often transcribed?",
    "vicuna-13b_response": "Ultraconserved elements (UCEs) are DNA sequences that are highly conserved across multiple species, meaning they do not change as much as other DNA sequences over time. UCEs are often found near genes and have been shown to play important roles in gene regulation.\nWhether or not UCEs are transcribed, or converted from DNA to RNA, can vary. Some UCEs are transcribed, meaning they are used as a template for the synthesis of RNA molecules. These RNA molecules can then be used for various cellular processes, such as protein synthesis.\nHowever, not all UCEs are transcribed. Some UCEs are located in regions of DNA that are not accessible to the transcription machinery, or they may be in a \"closed\" conformation that prevents transcription. Additionally, some UCEs may act as binding sites for proteins or other molecules, and their transcription may be regulated by these interactions.\nOverall, the transcription of UCEs can be influenced by a variety of factors, including their location in the genome, the presence of regulatory elements, and the overall structure of the DNA.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ultraconserved elements (UCEs) are DNA sequences that are highly conserved across multiple species.\n2. UCEs are often found near genes.\n3. UCEs have roles in gene regulation.\n4. Some UCEs are transcribed and used as a template for the synthesis of RNA molecules.\n5. The transcription of UCEs can be influenced by a variety of factors, including their location in the genome, the presence of regulatory elements, and the overall structure of the DNA.",
    "vicuna-13b_fact": [
      "Ultraconserved elements (UCEs) are DNA sequences that are highly conserved across multiple species.",
      "UCEs are often found near genes.",
      "UCEs have roles in gene regulation.",
      "Some UCEs are transcribed and used as a template for the synthesis of RNA molecules.",
      "The transcription of UCEs can be influenced by a variety of factors, including their location in the genome, the presence of regulatory elements, and the overall structure of the DNA."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 54,
    "user_query": "Which DNA sequences are more prone for the formation of R-loops?",
    "vicuna-13b_response": "R-loops are a type of DNA structure that can form when a single-stranded region of DNA is exposed to nucleases, which are enzymes that can cut DNA. R-loops are formed when a single-stranded region of DNA is ligated to a complementary single-stranded region, creating a loop structure. R-loops can be harmful to the cell because they can disrupt gene expression and cause genome instability.\nThere are several factors that can influence the formation of R-loops, including the length and composition of the single-stranded regions, as well as the presence of proteins that can protect the DNA from nucleases. Some DNA sequences are more prone to the formation of R-loops than others, including:\n1. Short, single-stranded regions: Short, single-stranded regions of DNA are more prone to the formation of R-loops because they are more accessible to nucleases. These regions are often found in the promoter and enhancer regions of genes, as well as in intronic regions.\n2. G/C-rich regions: DNA sequences that are rich in G/C nucleotides are more prone to the formation of R-loops because they are more stable than A/T-rich sequences. G/C-rich regions are often found in the intronic regions of genes, as well as in the non-coding regions of the genome.\n3. Repetitive DNA sequences: Repetitive DNA sequences, such as satellite repeats and microsatellites, are more prone to the formation of R-loops because they are highly conserved and have a high degree of sequence similarity.\nOverall, the formation of R-loops is a complex process that is influenced by a variety of factors, including the length and composition of the single-stranded regions, as well as the presence of proteins that can protect the DNA from nucleases. Some DNA sequences are more prone to the formation of R-loops than others, including short, single-stranded regions, G/C-rich regions, and repetitive DNA sequences.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. R-loops are a type of DNA structure that form when a single-stranded region of DNA is ligated to a complementary single-stranded region.\n2. R-loops can disrupt gene expression and cause genome instability.\n3. Short, single-stranded regions of DNA are more prone to the formation of R-loops.\n4. DNA sequences that are rich in G/C nucleotides are more prone to the formation of R-loops.\n5. Repetitive DNA sequences, such as satellite repeats and microsatellites, are more prone to the formation of R-loops.",
    "vicuna-13b_fact": [
      "R-loops are a type of DNA structure that form when a single-stranded region of DNA is ligated to a complementary single-stranded region.",
      "R-loops can disrupt gene expression and cause genome instability.",
      "Short, single-stranded regions of DNA are more prone to the formation of R-loops.",
      "DNA sequences that are rich in G/C nucleotides are more prone to the formation of R-loops.",
      "Repetitive DNA sequences, such as satellite repeats and microsatellites, are more prone to the formation of R-loops."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: R-loops are a type of DNA structure that form when an RNA strand invades the DNA duplex and hybridizes with the DNA strand, displacing the other DNA strand.\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 55,
    "user_query": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?",
    "vicuna-13b_response": "Familial isolated pituitary adenoma (FIPA) is a rare condition characterized by the development of one or more pituitary adenomas in multiple family members, in the absence of other pituitary hormone deficiencies or other neurological symptoms. The genetic basis of FIPA is not well understood, but several genes have been implicated in its development.\nOne of the genes that has been identified as being implicated in the development of FIPA is the PRAD1 gene. The PRAD1 gene provides instructions for making a protein called proteinase-activated receptor 1 (PAR-1), which is involved in regulating cell growth and division. Mutations in the PRAD1 gene have been found to cause FIPA, as well as other conditions such as Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.\nAnother gene that has been implicated in the development of FIPA is the SDHB gene. The SDHB gene provides instructions for making an enzyme called succinate dehydrogenase complex subunit B (SDHB), which is involved in producing energy for cells. Mutations in the SDHB gene have been found to cause FIPA, as well as other conditions such as paraganglioma and pheochromocytoma.\nIt is important to note that the genetic basis of FIPA is complex and multifactorial, and the exact genetic cause of the condition is not yet fully understood. Further research is needed to identify the specific genetic mutations that are responsible for FIPA and to develop effective treatments for this condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Familial isolated pituitary adenoma (FIPA) is a rare condition characterized by the development of one or more pituitary adenomas in multiple family members, without other pituitary hormone deficiencies or neurological symptoms.\n2. The PRAD1 gene is one of the genes identified as being implicated in the development of FIPA.\n3. The PRAD1 gene provides instructions for making a protein called proteinase-activated receptor 1 (PAR-1).\n4. Mutations in the PRAD1 gene have been found to cause FIPA, Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.\n5. Another gene, the SDHB gene, implicated in FIPA's development, provides instructions for making an enzyme called succinate dehydrogenase complex subunit B (SDHB).",
    "vicuna-13b_fact": [
      "Familial isolated pituitary adenoma (FIPA) is a rare condition characterized by the development of one or more pituitary adenomas in multiple family members, without other pituitary hormone deficiencies or neurological symptoms.",
      "The PRAD1 gene is one of the genes identified as being implicated in the development of FIPA.",
      "The PRAD1 gene provides instructions for making a protein called proteinase-activated receptor 1 (PAR-1).",
      "Mutations in the PRAD1 gene have been found to cause FIPA, Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.",
      "Another gene, the SDHB gene, implicated in FIPA's development, provides instructions for making an enzyme called succinate dehydrogenase complex subunit B (SDHB)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: The PRAD1 gene provides instructions for making a protein called Cyclin D1.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 56,
    "user_query": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?",
    "vicuna-13b_response": "Hypertrophic cardiomyopathy (HCM) is a genetic disorder that affects the heart muscle and is characterized by thickening of the heart muscle, particularly in the left ventricle. The mutations in the troponin C gene have been found to cause HCM. Troponin C is a protein that plays a crucial role in the contraction of heart muscle. Mutations in the troponin C gene can lead to abnormalities in the function of the protein, which can result in the thickening of heart muscle and the development of HCM. Some of the mutations that have been identified in the troponin C gene include the S34T mutation, the R127C mutation, and the D111G mutation. These mutations can be inherited from one's parents or can occur spontaneously. It is important to note that not all mutations in the troponin C gene lead to the development of HCM, and the severity of the condition can vary among individuals with the same mutation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle and is characterized by thickening of the heart muscle, particularly in the left ventricle.\n2. Mutations in the troponin C gene can cause hypertrophic cardiomyopathy.\n3. Troponin C is a protein that plays a crucial role in the contraction of heart muscle.\n4. Some of the mutations identified in the troponin C gene include the S34T mutation, the R127C mutation, and the D111G mutation.\n5. These mutations can be inherited from one's parents or can occur spontaneously.",
    "vicuna-13b_fact": [
      "Hypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle and is characterized by thickening of the heart muscle, particularly in the left ventricle.",
      "Mutations in the troponin C gene can cause hypertrophic cardiomyopathy.",
      "Troponin C is a protein that plays a crucial role in the contraction of heart muscle.",
      "Some of the mutations identified in the troponin C gene include the S34T mutation, the R127C mutation, and the D111G mutation.",
      "These mutations can be inherited from one's parents or can occur spontaneously."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 58,
    "user_query": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?",
    "vicuna-13b_response": "Constitutive heterochromatin is a region of the genome that is compacted and repressed, and it is characterized by a specific set of post-translational histone modifications. These modifications include:\n1. H3K9me3 (trimethylation of lysine 9 on histone H3): This modification is one of the most well-known markers of constitutive heterochromatin and is often referred to as \"tri-methyl-histone H3.\" It is thought to recruit proteins that help compact the chromatin and repress gene expression.\n2. H3K27me3 (trimethylation of lysine 27 on histone H3): This modification is also found in constitutive heterochromatin and is thought to work in conjunction with H3K9me3 to compact the chromatin and repress gene expression.\n3. H3K9me2 (dimethylation of lysine 9 on histone H3): This modification is also found in constitutive heterochromatin and is thought to be a intermediate step in the formation of H3K9me3.\n4. H3K27me1 (dimethylation of lysine 27 on histone H3): This modification is also found in constitutive heterochromatin and is thought to be a intermediate step in the formation of H3K27me3.\n5. H3S10ph (phosphorylation of serine 10 on histone H3): This modification is found in constitutive heterochromatin and is thought to be involved in the recruitment of proteins that help compact the chromatin and repress gene expression.\nThese modifications work together to compact the chromatin and repress gene expression, leading to the silencing of the genes located in the constitutive heterochromatin regions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. H3K9me3 (trimethylation of lysine 9 on histone H3) is a post-translational modification that is characteristic of constitutive heterochromatin.\n2. H3K27me3 (trimethylation of lysine 27 on histone H3) is another modification found in constitutive heterochromatin.\n3. H3K9me2 (dimethylation of lysine 9 on histone H3) is found in constitutive heterochromatin.\n4. H3K27me1 (dimethylation of lysine 27 on histone H3) is a post-translational histone modification found in constitutive heterochromatin.\n5. H3S10ph (phosphorylation of serine 10 on histone H3) is a modification found in constitutive heterochromatin.",
    "vicuna-13b_fact": [
      "H3K9me3 (trimethylation of lysine 9 on histone H3) is a post-translational modification that is characteristic of constitutive heterochromatin.",
      "H3K27me3 (trimethylation of lysine 27 on histone H3) is another modification found in constitutive heterochromatin.",
      "H3K9me2 (dimethylation of lysine 9 on histone H3) is found in constitutive heterochromatin.",
      "H3K27me1 (dimethylation of lysine 27 on histone H3) is a post-translational histone modification found in constitutive heterochromatin.",
      "H3S10ph (phosphorylation of serine 10 on histone H3) is a modification found in constitutive heterochromatin."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: H3K27me3 (trimethylation of lysine 27 on histone H3) is a modification found in facultative heterochromatin, not constitutive heterochromatin.\n3. TRUE\n4. FALSE [correction]: H3K27me1 (monomethylation of lysine 27 on histone H3) is frequently associated with gene activation, not constitutive heterochromatin.\n5. FALSE [correction]: H3S10ph (phosphorylation of serine 10 on histone H3) is associated with chromosome condensation during mitosis and is not typically found in constitutive heterochromatin.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 63,
    "user_query": "Are long non coding RNAs as conserved in sequence as protein coding genes?",
    "vicuna-13b_response": "Long non-coding RNAs (lncRNAs) are RNA molecules that are typically longer than 200 nucleotides and do not code for proteins. They have been shown to play important roles in various cellular processes, such as gene regulation, chromatin modification, and translation regulation.\nThe conservation of lncRNAs in sequence compared to protein-coding genes can vary depending on the specific lncRNA and protein-coding gene. In general, lncRNAs are less conserved in sequence compared to protein-coding genes because they do not have a direct role in protein synthesis, which is considered to be a more conserved process. However, some lncRNAs have been shown to be highly conserved in sequence, particularly those that have been evolutionarily conserved and have been implicated in important cellular processes.\nIt is also important to note that the conservation of lncRNAs can be influenced by various factors, such as the specific cell type, developmental stage, and environmental conditions. Therefore, the conservation of lncRNAs can vary depending on the context in which they are studied.\nIn summary, while some lncRNAs may be highly conserved in sequence, the conservation of lncRNAs compared to protein-coding genes is generally lower. However, the conservation of lncRNAs can vary depending on various factors, and some lncRNAs have been shown to be highly conserved in sequence.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Long non-coding RNAs (lncRNAs) are RNA molecules that are typically longer than 200 nucleotides and do not code for proteins.\n2. lncRNAs play important roles in various cellular processes, such as gene regulation, chromatin modification, and translation regulation.\n3. In general, lncRNAs are less conserved in sequence compared to protein-coding genes.\n4. Some lncRNAs have been shown to be highly conserved in sequence, particularly those that have been evolutionarily conserved and have been implicated in important cellular processes.\n5. The conservation of lncRNAs can be influenced by various factors, such as the specific cell type, developmental stage, and environmental conditions.",
    "vicuna-13b_fact": [
      "Long non-coding RNAs (lncRNAs) are RNA molecules that are typically longer than 200 nucleotides and do not code for proteins.",
      "lncRNAs play important roles in various cellular processes, such as gene regulation, chromatin modification, and translation regulation.",
      "In general, lncRNAs are less conserved in sequence compared to protein-coding genes.",
      "Some lncRNAs have been shown to be highly conserved in sequence, particularly those that have been evolutionarily conserved and have been implicated in important cellular processes.",
      "The conservation of lncRNAs can be influenced by various factors, such as the specific cell type, developmental stage, and environmental conditions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 65,
    "user_query": "What is clathrin?",
    "vicuna-13b_response": "Clathrin is a type of protein that plays a crucial role in the process of endocytosis, which is the process by which cells absorb molecules and other substances from their surroundings. Clathrin is a component of the coated pits, which are small invaginations of the cell membrane that form during endocytosis.\nClathrin is a large, triskelion-shaped protein that is composed of three identical subunits. Each subunit has a \"leg\" that extends into the cell and an \"arm\" that extends outward into the extracellular space. The three subunits are held together by a hinge region, which allows them to move relative to each other.\nDuring endocytosis, clathrin and other proteins form a coat around the plasma membrane, creating a pit that invaginates into the cell. This pit then deepens, eventually forming a vesicle that can internalize various substances from the extracellular space. Once the vesicle has formed, it can fuse with the endoplasmic reticulum or another organelle, releasing its contents into the cell.\nClathrin is also involved in other cellular processes, including exocytosis (the process by which cells release substances into their surroundings), the recycling of cell surface receptors, and the formation of transport vesicles.\nOverall, clathrin is a crucial component of the endocytic pathway, and its function is essential for the proper functioning of cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Clathrin is a type of protein that plays a crucial role in endocytosis.\n2. Clathrin is a component of the coated pits, which are small invaginations of the cell membrane that form during endocytosis.\n3. Clathrin is a large, triskelion-shaped protein composed of three identical subunits.\n4. During endocytosis, clathrin and other proteins form a coat around the plasma membrane, which then invaginates into the cell forming a vesicle that can internalize various substances.\n5. Clathrin is also involved in exocytosis, the recycling of cell surface receptors, and the formation of transport vesicles.",
    "vicuna-13b_fact": [
      "Clathrin is a type of protein that plays a crucial role in endocytosis.",
      "Clathrin is a component of the coated pits, which are small invaginations of the cell membrane that form during endocytosis.",
      "Clathrin is a large, triskelion-shaped protein composed of three identical subunits.",
      "During endocytosis, clathrin and other proteins form a coat around the plasma membrane, which then invaginates into the cell forming a vesicle that can internalize various substances.",
      "Clathrin is also involved in exocytosis, the recycling of cell surface receptors, and the formation of transport vesicles."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Clathrin is a large, triskelion-shaped protein composed of three heavy chains and three light chains.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 66,
    "user_query": "What are the main results of PRKAR1A Knockdown?",
    "vicuna-13b_response": "PRKAR1A is a protein kinase that plays a role in regulating cellular metabolism and energy homeostasis. Knockdown of PRKAR1A has been shown to have various effects in different cellular and animal models. Here are some of the main results of PRKAR1A knockdown:\n1. Increased glucose uptake and glycolysis: PRKAR1A knockdown has been shown to increase glucose uptake and glycolysis in various cell types, including cancer cells and hepatocytes. This suggests that PRKAR1A knockdown may lead to increased energy production in these cells.\n2. Increased fatty acid oxidation: PRKAR1A knockdown has been shown to increase fatty acid oxidation in liver cells, which may lead to increased energy production and decreased fat storage.\n3. Increased insulin sensitivity: PRKAR1A knockdown has been shown to increase insulin sensitivity in muscle cells and adipocytes, suggesting that PRKAR1A knockdown may be beneficial for treating insulin resistance.\n4. Decreased cell proliferation and survival: PRKAR1A knockdown has been shown to decrease cell proliferation and survival in various cell types, including cancer cells and fibroblasts.\n5. Decreased protein synthesis: PRKAR1A knockdown has been shown to decrease protein synthesis in muscle cells, suggesting that PRKAR1A knockdown may be beneficial for treating muscle wasting.\nOverall, PRKAR1A knockdown has been shown to have various effects on cellular metabolism and energy homeostasis, and further research is needed to fully understand its role in these processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PRKAR1A is a protein kinase that plays a role in regulating cellular metabolism and energy homeostasis.\n2. PRKAR1A knockdown increases glucose uptake and glycolysis in various cell types, including cancer cells and hepatocytes.\n3. PRKAR1A knockdown leads to increased fatty acid oxidation in liver cells.\n4. PRKAR1A knockdown boosts insulin sensitivity in muscle cells and adipocytes.\n5. PRKAR1A knockdown decreases cell proliferation and survival in various cell types, including cancer cells and fibroblasts.\n6. PRKAR1A knockdown results in decreased protein synthesis in muscle cells.",
    "vicuna-13b_fact": [
      "PRKAR1A is a protein kinase that plays a role in regulating cellular metabolism and energy homeostasis.",
      "PRKAR1A knockdown increases glucose uptake and glycolysis in various cell types, including cancer cells and hepatocytes.",
      "PRKAR1A knockdown leads to increased fatty acid oxidation in liver cells.",
      "PRKAR1A knockdown boosts insulin sensitivity in muscle cells and adipocytes.",
      "PRKAR1A knockdown decreases cell proliferation and survival in various cell types, including cancer cells and fibroblasts.",
      "PRKAR1A knockdown results in decreased protein synthesis in muscle cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n6. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 72,
    "user_query": "Are transcribed ultraconserved regions involved in cancer?",
    "vicuna-13b_response": "Transcribed ultraconserved regions (T-UCRs) are a type of DNA sequence that are highly conserved across different species and are also actively transcribed, meaning they are converted from DNA into RNA. There is evidence to suggest that T-UCRs may be involved in cancer.\nOne study found that T-UCRs are often abnormally expressed in cancer cells, and that this can contribute to the development and progression of cancer. Additionally, T-UCRs have been found to be involved in the regulation of genes that are important for cell growth and division, which are processes that can become dysregulated in cancer cells.\nHowever, more research is needed to fully understand the role of T-UCRs in cancer. It is also important to note that T-UCRs are not the only type of DNA sequence that can be involved in cancer, and other factors such as genetic mutations and environmental exposures can also contribute to the development of cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Transcribed ultraconserved regions (T-UCRs) are highly conserved DNA sequences across different species.\n2. T-UCRs are actively transcribed, meaning they are converted from DNA into RNA. \n3. Some studies have found that T-UCRs are often abnormally expressed in cancer cells.\n4. T-UCRs are involved in the regulation of genes important for cell growth and division.\n5. Other factors such as genetic mutations and environmental exposures can also contribute to the development of cancer.",
    "vicuna-13b_fact": [
      "Transcribed ultraconserved regions (T-UCRs) are highly conserved DNA sequences across different species.",
      "T-UCRs are actively transcribed, meaning they are converted from DNA into RNA.",
      "Some studies have found that T-UCRs are often abnormally expressed in cancer cells.",
      "T-UCRs are involved in the regulation of genes important for cell growth and division.",
      "Other factors such as genetic mutations and environmental exposures can also contribute to the development of cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 75,
    "user_query": "List side effects of SGLT2 inhibitors?",
    "vicuna-13b_response": "SGLT2 inhibitors are a type of medication used to treat type 2 diabetes. They work by preventing the reabsorption of glucose in the kidneys, which in turn increases the amount of glucose excreted in the urine. Some of the common side effects of SGLT2 inhibitors include:\n1. Increased urination: SGLT2 inhibitors cause the kidneys to excrete more glucose in the urine, which can lead to increased urination. This can sometimes lead to dehydration, especially in older adults or people with kidney problems.\n2. Diarrhea: SGLT2 inhibitors can cause diarrhea, which can lead to dehydration and electrolyte imbalances.\n3. Nausea and vomiting: Some people taking SGLT2 inhibitors may experience nausea and vomiting, especially when taking the medication for the first time or when the dose is increased.\n4. Abdominal pain: SGLT2 inhibitors can cause abdominal pain, especially when taking the medication for the first time or when the dose is increased.\n5. Headache: Some people taking SGLT2 inhibitors may experience headaches.\n6. Fatigue: SGLT2 inhibitors can cause fatigue, which can be more pronounced in people with type 2 diabetes who have chronic fatigue.\n7. Yeast infections: SGLT2 inhibitors can cause yeast infections, especially in women.\n8. Genital yeast infections in women and men: SGLT2 inhibitors can cause genital yeast infections in women and men.\n9. Urinary tract infections: SGLT2 inhibitors can increase the risk of urinary tract infections, especially in women.\n10. Impaired renal function: SGLT2 inhibitors can cause impaired renal function, especially in people with pre-existing kidney problems.\nIt is important to note that not all people taking SGLT2 inhibitors will experience these side effects, and the severity of side effects can vary from person to person. If you experience any of these side",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SGLT2 inhibitors are a type of medication used to treat type 2 diabetes.\n2. SGLT2 inhibitors work by preventing the reabsorption of glucose in the kidneys.\n3. Increased urination can be a side effect of SGLT2 inhibitors.\n4. Diarrhea is another potential side effect of SGLT2 inhibitors.\n5. Some people taking SGLT2 inhibitors may experience nausea and vomiting.\n6. Abdominal pain and headache can sometimes be side effects of SGLT2 inhibitors.\n7. SGLT2 inhibitors can cause fatigue.\n8. Yeast infections, including genital yeast infections in both sexes, can be caused by SGLT2 inhibitors.\n9. SGLT2 inhibitors can increase the risk of urinary tract infections.\n10. Impaired renal function can be a side effect of SGLT2 inhibitors, especially in people with pre-existing kidney problems.",
    "vicuna-13b_fact": [
      "SGLT2 inhibitors are a type of medication used to treat type 2 diabetes.",
      "SGLT2 inhibitors work by preventing the reabsorption of glucose in the kidneys.",
      "Increased urination can be a side effect of SGLT2 inhibitors.",
      "Diarrhea is another potential side effect of SGLT2 inhibitors.",
      "Some people taking SGLT2 inhibitors may experience nausea and vomiting.",
      "Abdominal pain and headache can sometimes be side effects of SGLT2 inhibitors.",
      "SGLT2 inhibitors can cause fatigue.",
      "Yeast infections, including genital yeast infections in both sexes, can be caused by SGLT2 inhibitors.",
      "SGLT2 inhibitors can increase the risk of urinary tract infections.",
      ". Impaired renal function can be a side effect of SGLT2 inhibitors, especially in people with pre-existing kidney problems."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Diarrhea is not typically a mentioned side effect of SGLT2 inhibitors. Instead, a potential side effect can be genital or urinary tract infections.\n5. FALSE [correction]: Nausea and vomiting are not frequently reported side effects of SGLT2 inhibitors, instead common side effects may include urinary tract and yeast infections and increased urination.\n6. FALSE [correction]: Abdominal pain and headache are not commonly listed side effects of SGLT2 inhibitors. It's more common to experience urinary tract and yeast infections, increased urination, and possibly low blood sugar (hypoglycemia) when used with other diabetic medications.\n7. UNKNOWN\n8. TRUE\n9. TRUE\n10. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false",
      "false",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "vicuna-13b_response": "The JASPAR database is a repository of transcription factor (TF) binding profiles calculated using a variety of bioinformatics tools. Here is a list of the major releases of the JASPAR database:\n1. JASPAR 2014: This was the first official release of the JASPAR database, which included TF binding profiles for 1288 transcription factors and 6288 genomic regions.\n2. JASPAR 2016: This release expanded the database to include TF binding profiles for 1779 transcription factors and 10,507 genomic regions. It also introduced new features such as improved data quality control and visualization tools.\n3. JASPAR 2020: This release expanded the database to include TF binding profiles for 2129 transcription factors and 17,445 genomic regions. It also introduced new features such as improved data integration and analysis tools.\n4. JASPAR 2021: This is the latest release of the JASPAR database as of my knowledge cutoff (September 2021). It includes TF binding profiles for 2247 transcription factors and 20,891 genomic regions, and introduces new features such as improved data visualization and analysis tools.\nIt's worth noting that there may be additional, smaller releases of the JASPAR database between these major releases. However, these are the main releases that have been announced by the JASPAR team.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. JASPAR 2014 was the first official release of the JASPAR database, which included TF binding profiles for 1288 transcription factors and 6288 genomic regions.\n2. JASPAR 2016 expanded the database to include TF binding profiles for 1779 transcription factors and 10,507 genomic regions, and introduced new features such as improved data quality control and visualization tools.\n3. JASPAR 2020 further expanded the database to include TF binding profiles for 2129 transcription factors and 17,445 genomic regions, and introduced new features such as improved data integration and analysis tools.\n4. JASPAR 2021 includes TF binding profiles for 2247 transcription factors and 20,891 genomic regions, and introduced new features such as improved data visualization and analysis tools.\n5. There may be additional, smaller releases of the JASPAR database between these major releases.",
    "vicuna-13b_fact": [
      "JASPAR 2014 was the first official release of the JASPAR database, which included TF binding profiles for 1288 transcription factors and 6288 genomic regions.",
      "JASPAR 2016 expanded the database to include TF binding profiles for 1779 transcription factors and 10,507 genomic regions, and introduced new features such as improved data quality control and visualization tools.",
      "JASPAR 2020 further expanded the database to include TF binding profiles for 2129 transcription factors and 17,445 genomic regions, and introduced new features such as improved data integration and analysis tools.",
      "JASPAR 2021 includes TF binding profiles for 2247 transcription factors and 20,891 genomic regions, and introduced new features such as improved data visualization and analysis tools.",
      "There may be additional, smaller releases of the JASPAR database between these major releases."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 83,
    "user_query": "Which gene is required for the efficient function of clopidogrel?",
    "vicuna-13b_response": "Clopidogrel is an antiplatelet drug that is commonly used to prevent blood clots. The gene that is required for the efficient function of clopidogrel is CYP2C19. This gene codes for an enzyme that is involved in the metabolism of clopidogrel, which is necessary for its antiplatelet effects. CYP2C19 is a member of the cytochrome P450 family of enzymes, which are involved in the metabolism of a wide variety of drugs. Mutations in the CYP2C19 gene have been shown to affect the metabolism of clopidogrel, and can lead to reduced efficacy of the drug.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Clopidogrel is an antiplatelet drug used to prevent blood clots.\n2. The gene CYP2C19 is required for the efficient function of clopidogrel.\n3. CYP2C19 codes for an enzyme that is involved in the metabolism of clopidogrel.\n4. CYP2C19 is a member of the cytochrome P450 family of enzymes, which are involved in the metabolism of a variety of drugs.\n5. Mutations in the CYP2C19 gene can lead to reduced efficacy of clopidogrel.",
    "vicuna-13b_fact": [
      "Clopidogrel is an antiplatelet drug used to prevent blood clots.",
      "The gene CYP2C19 is required for the efficient function of clopidogrel.",
      "CYP2C19 codes for an enzyme that is involved in the metabolism of clopidogrel.",
      "CYP2C19 is a member of the cytochrome P450 family of enzymes, which are involved in the metabolism of a variety of drugs.",
      "Mutations in the CYP2C19 gene can lead to reduced efficacy of clopidogrel."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 86,
    "user_query": "Which antibiotics target peptidoglycan biosynthesis?",
    "vicuna-13b_response": "Peptidoglycan biosynthesis is the process by which bacteria synthesize and maintain their cell walls. Antibiotics that target peptidoglycan biosynthesis are called antibiotics that target the bacterial cell wall. These antibiotics work by inhibiting the synthesis or assembly of peptidoglycan, which is a key component of the bacterial cell wall. Some examples of antibiotics that target peptidoglycan biosynthesis include:\n1. Ampicillin: A broad-spectrum antibiotic that targets the transpeptidase enzyme involved in peptidoglycan synthesis.\n2. Carbenicillin: An antibiotic that targets the transpeptidase enzyme involved in peptidoglycan synthesis.\n3. Cephalosporins: A group of antibiotics that target the transpeptidase enzyme involved in peptidoglycan synthesis.\n4. Gentamicin: An antibiotic that targets the bacterial cell wall by binding to the peptidoglycan molecule.\n5. Vancomycin: An antibiotic that targets the bacterial cell wall by binding to the D-alanine residues in the peptidoglycan molecule.\nThese antibiotics are commonly used to treat infections caused by bacteria that are susceptible to them. However, the widespread use of these antibiotics has led to the emergence of antibiotic-resistant bacteria, which are difficult to treat with these antibiotics. Therefore, it is important to use these antibiotics judiciously and only when necessary to avoid the development of antibiotic resistance.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Peptidoglycan biosynthesis is the process by which bacteria synthesize and maintain their cell walls.\n2. Antibiotics that target the bacterial cell wall work by inhibiting the synthesis or assembly of peptidoglycan.\n3. Ampicillin, Carbenicillin and Cephalosporins are examples of antibiotics that target the transpeptidase enzyme involved in peptidoglycan synthesis.\n4. Gentamicin and Vancomycin are antibiotics that target the bacterial cell wall by binding to the peptidoglycan molecule.\n5. The widespread use of these antibiotics has led to the emergence of antibiotic-resistant bacteria.",
    "vicuna-13b_fact": [
      "Peptidoglycan biosynthesis is the process by which bacteria synthesize and maintain their cell walls.",
      "Antibiotics that target the bacterial cell wall work by inhibiting the synthesis or assembly of peptidoglycan.",
      "Ampicillin, Carbenicillin and Cephalosporins are examples of antibiotics that target the transpeptidase enzyme involved in peptidoglycan synthesis.",
      "Gentamicin and Vancomycin are antibiotics that target the bacterial cell wall by binding to the peptidoglycan molecule.",
      "The widespread use of these antibiotics has led to the emergence of antibiotic-resistant bacteria."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Gentamicin is an antibiotic that does not target the bacterial cell wall but works by inhibiting protein synthesis in bacteria. Vancomycin does target the bacterial cell wall by binding to the peptidoglycan molecule.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 92,
    "user_query": "What is the mode of action of everolimus?",
    "vicuna-13b_response": "Everolimus is a drug that is used to treat certain types of cancer, such as renal cell carcinoma and breast cancer. Its mode of action is related to its ability to inhibit the activity of a protein called mTOR.\nmTOR is a key regulator of cell growth and division, and is often activated in cancer cells. By inhibiting the activity of mTOR, everolimus can slow down the growth and division of cancer cells, leading to a reduction in tumor size.\nEverolimus works by binding to and inhibiting the activity of mTORC1, which is one of the two complexes that make up the mTOR pathway. By inhibiting mTORC1, everolimus prevents the activation of downstream signaling pathways that promote cell growth and division, leading to an antiproliferative effect on cancer cells.\nIn addition to its antiproliferative effects, everolimus has also been shown to have anti-angiogenic effects, which can further contribute to its anticancer activity by reducing the blood supply to the tumor.\nOverall, the mode of action of everolimus is to inhibit the activity of mTOR, which leads to a reduction in cell growth and division in cancer cells, ultimately leading to a reduction in tumor size.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Everolimus is used to treat certain types of cancer including renal cell carcinoma and breast cancer.\n2. The mode of action of everolimus is related to its ability to inhibit the activity of a protein called mTOR.\n3. mTOR is a key regulator of cell growth and division, often activated in cancer cells.\n4. Everolimus works by binding to and inhibiting the activity of mTORC1, which is one of the two complexes that make up the mTOR pathway.\n5. Beyond its antiproliferative effects, everolimus has also been shown to have anti-angiogenic effects, reducing the blood supply to the tumor.",
    "vicuna-13b_fact": [
      "Everolimus is used to treat certain types of cancer including renal cell carcinoma and breast cancer.",
      "The mode of action of everolimus is related to its ability to inhibit the activity of a protein called mTOR.",
      "mTOR is a key regulator of cell growth and division, often activated in cancer cells.",
      "Everolimus works by binding to and inhibiting the activity of mTORC1, which is one of the two complexes that make up the mTOR pathway.",
      "Beyond its antiproliferative effects, everolimus has also been shown to have anti-angiogenic effects, reducing the blood supply to the tumor."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 97,
    "user_query": "Which pathological condition of the heart is known as hypertrophic cardiomyopathy (HCM)?",
    "vicuna-13b_response": "Hypertrophic cardiomyopathy (HCM) is a pathological condition of the heart characterized by thickening of the heart muscle, particularly in the left ventricle. This thickening can lead to obstruction of blood flow out of the heart, which can cause symptoms such as chest pain, shortness of breath, and fatigue. HCM can also cause abnormal heart rhythms, which can be life-threatening. The condition is usually inherited and can affect people of all ages. Treatment options for HCM include medications to control symptoms and surgery to remove thickened heart muscle or to implant a device to help the heart pump blood more effectively.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hypertrophic cardiomyopathy (HCM) is a pathological condition of the heart characterized by thickening of the heart muscle.\n2. In HCM, thickening commonly occurs in the left ventricle.\n3. HCM can lead to obstruction of blood flow out of the heart.\n4. Symptoms of HCM can include chest pain, shortness of breath, fatigue and abnormal heart rhythms.\n5. Treatment options for HCM can include medication or surgery to remove thickened heart muscle or to implant a device to assist with blood pumping.",
    "vicuna-13b_fact": [
      "Hypertrophic cardiomyopathy (HCM) is a pathological condition of the heart characterized by thickening of the heart muscle.",
      "In HCM, thickening commonly occurs in the left ventricle.",
      "HCM can lead to obstruction of blood flow out of the heart.",
      "Symptoms of HCM can include chest pain, shortness of breath, fatigue and abnormal heart rhythms.",
      "Treatment options for HCM can include medication or surgery to remove thickened heart muscle or to implant a device to assist with blood pumping."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "vicuna-13b_response": "The KP4 protein is a viral protein that is produced by the KP strain of the bacteriophage ΦKP1. The KP4 protein is a structural protein that is involved in the assembly and stability of the virion, which is the infectious particle of the bacteriophage.\nThe KP4 protein is a major component of the virion and is thought to play a role in the recognition and binding of the virion to the host cell. The KP4 protein is also involved in the stability and resistance of the virion to host cell defenses and to environmental stresses.\nIn addition to its role in the virion, the KP4 protein has been shown to have antioxidant and anti-inflammatory properties, and it may play a role in protecting the host cell from oxidative stress and inflammation.\nOverall, the function of the KP4 protein is to support the assembly and stability of the virion, and to protect the virion from host cell defenses and environmental stresses. Additionally, the KP4 protein may have beneficial effects on the host cell by providing antioxidant and anti-inflammatory protection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The KP4 protein is produced by the KP strain of the bacteriophage ΦKP1.\n2. The KP4 protein is a structural protein that is involved in the assembly and stability of the virion.\n3. The KP4 protein plays a role in the recognition and binding of the virion to the host cell.\n4. The KP4 protein is involved in the stability and resistance of the virion to host cell defenses and environmental stresses.\n5. The KP4 protein has shown to have antioxidant and anti-inflammatory properties.",
    "vicuna-13b_fact": [
      "The KP4 protein is produced by the KP strain of the bacteriophage ΦKP1.",
      "The KP4 protein is a structural protein that is involved in the assembly and stability of the virion.",
      "The KP4 protein plays a role in the recognition and binding of the virion to the host cell.",
      "The KP4 protein is involved in the stability and resistance of the virion to host cell defenses and environmental stresses.",
      "The KP4 protein has shown to have antioxidant and anti-inflammatory properties."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 101,
    "user_query": "What is the principle of the PAR-CLIP methodology?",
    "vicuna-13b_response": "PAR-CLIP (Protein Abundance Ratio-Cross-Linking Immuno-Precipitation) is a methodology that combines the techniques of cross-linking, immunoprecipitation, and mass spectrometry to study protein-protein interactions in cells. The principle of the PAR-CLIP methodology is to first cross-link proteins that interact with a particular protein of interest, then use immunoprecipitation to enrich for the protein of interest and its interacting partners, and finally perform mass spectrometry to identify and quantify the interacting partners. This method allows for the identification of proteins that interact with a specific protein in a cellular context, and can provide insights into the function and regulation of protein interactions in cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PAR-CLIP stands for Protein Abundance Ratio-Cross-Linking Immuno-Precipitation.\n2. The PAR-CLIP methodology combines the techniques of cross-linking, immunoprecipitation, and mass spectrometry to study protein-protein interactions in cells.\n3. The procedure of the PAR-CLIP methodology is to first cross-link proteins that interact with a particular protein of interest.\n4. In the PAR-CLIP procedure, immunoprecipitation is used to enrich for the protein of interest and its interacting partners.\n5. Mass spectrometry is performed as a part of the procedure of the PAR-CLIP methodology to identify and quantify the interacting partners.",
    "vicuna-13b_fact": [
      "PAR-CLIP stands for Protein Abundance Ratio-Cross-Linking Immuno-Precipitation.",
      "The PAR-CLIP methodology combines the techniques of cross-linking, immunoprecipitation, and mass spectrometry to study protein-protein interactions in cells.",
      "The procedure of the PAR-CLIP methodology is to first cross-link proteins that interact with a particular protein of interest.",
      "In the PAR-CLIP procedure, immunoprecipitation is used to enrich for the protein of interest and its interacting partners.",
      "Mass spectrometry is performed as a part of the procedure of the PAR-CLIP methodology to identify and quantify the interacting partners."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: PAR-CLIP stands for Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation.\n2. FALSE [correction]: The PAR-CLIP methodology combines the techniques of photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation to study RNA-protein interactions in cells.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Sequencing is performed as a part of the procedure of the PAR-CLIP methodology to identify the RNA sequences that are bound by the protein.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 106,
    "user_query": "Which package is available for analysing genomic interactions in R/Bioconductor?",
    "vicuna-13b_response": "There are several packages available in R/Bioconductor for analyzing genomic interactions. Some of the popular ones include:\n1. String: It is a package for analyzing protein-protein interaction networks. It can be used to predict protein-protein interactions based on sequence similarity, extract and store protein-protein interaction data from literature, and visualize protein-protein interaction networks.\n2. Cluster: It is a package for clustering gene expression data. It can be used to identify groups of genes that are co-expressed, and can also be used for identifying differentially expressed genes.\n3. Molecular Complex Detection (MCODE): It is a package for identifying molecular complexes from genomic data. It can be used to detect protein-protein interactions, DNA-protein interactions, and other types of molecular interactions from genomic data.\n4. GenABEL: It is a package for analyzing genomic data. It can be used for analyzing gene expression data, identifying differentially expressed genes, and performing pathway analysis.\n5. BioNet: It is a package for analyzing biological networks. It can be used to visualize and analyze protein-protein interaction networks, metabolic pathways, and other types of biological networks.\nThese are some of the commonly used packages for analyzing genomic interactions in R/Bioconductor. Depending on the specific research question, different packages may be more appropriate.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. String is a package in R/Bioconductor used for analyzing protein-protein interaction networks.\n2. Cluster is a package in R/Bioconductor designed for clustering gene expression data.\n3. Molecular Complex Detection (MCODE) is a package in R/Bioconductor that can detect various types of molecular interactions from genomic data.\n4. GenABEL is a package in R/Bioconductor used for analyzing gene expression data and performing pathway analysis.\n5. BioNet is a package in R/Bioconductor that can be used to visualize and analyze different types of biological networks.",
    "vicuna-13b_fact": [
      "String is a package in R/Bioconductor used for analyzing protein-protein interaction networks.",
      "Cluster is a package in R/Bioconductor designed for clustering gene expression data.",
      "Molecular Complex Detection (MCODE) is a package in R/Bioconductor that can detect various types of molecular interactions from genomic data.",
      "GenABEL is a package in R/Bioconductor used for analyzing gene expression data and performing pathway analysis.",
      "BioNet is a package in R/Bioconductor that can be used to visualize and analyze different types of biological networks."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: GenABEL is a package in R/Bioconductor used for genome-wide association (GWA) analysis.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 107,
    "user_query": "How many clinical trials for off-label drugs in neonates are cited in the literature.",
    "vicuna-13b_response": "I'm sorry, I do not have the exact number of clinical trials for off-label drugs in neonates cited in the literature. The number of clinical trials can change over time and can vary depending on the search criteria and databases used. However, I can provide some general information on the topic.\nOff-label drug use refers to the use of drugs for an indication that is not included in the drug's labeling or approved by the regulatory authorities. In neonates, off-label drug use is common, particularly for drugs that are used to treat life-threatening conditions.\nClinical trials for off-label drugs in neonates are often difficult to conduct due to ethical and practical considerations. The number of clinical trials for off-label drugs in neonates is generally low, and the quality of evidence is often poor.\nIt is important to note that the use of off-label drugs in neonates should be based on sound clinical judgment and careful consideration of the available evidence. Healthcare providers should be aware of the potential risks and benefits of off-label drug use in neonates and should consult with a pediatric specialist when necessary.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Off-label drug use refers to the use of drugs for an indication that is not included in the drug's labeling or approved by the regulatory authorities.\n2. In neonates, off-label drug use is common, particularly for drugs that are used to treat life-threatening conditions.\n3. Clinical trials for off-label drugs in neonates are often difficult to conduct due to ethical and practical considerations.\n4. The number of clinical trials for off-label drugs in neonates is generally low, and the quality of evidence is often poor.\n5. The use of off-label drugs in neonates should be based on sound clinical judgment and careful consideration of the available evidence.",
    "vicuna-13b_fact": [
      "Off-label drug use refers to the use of drugs for an indication that is not included in the drug's labeling or approved by the regulatory authorities.",
      "In neonates, off-label drug use is common, particularly for drugs that are used to treat life-threatening conditions.",
      "Clinical trials for off-label drugs in neonates are often difficult to conduct due to ethical and practical considerations.",
      "The number of clinical trials for off-label drugs in neonates is generally low, and the quality of evidence is often poor.",
      "The use of off-label drugs in neonates should be based on sound clinical judgment and careful consideration of the available evidence."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 112,
    "user_query": "What kind of affinity purification would you use in order to isolate soluble lysosomal proteins?",
    "vicuna-13b_response": "There are several methods that can be used to isolate soluble lysosomal proteins, including affinity purification. One common method of affinity purification for lysosomal proteins is to use a column that has been coated with an antibody that specifically binds to the protein of interest. The lysosomal proteins are then passed through the column, and the non-specific proteins are washed away, leaving only the proteins that bind to the antibody. This method is known as immunoaffinity chromatography. Another method is to use a ligand affinity column, where the ligand is immobilized on the column and the lysosomal proteins are purified by binding to the ligand.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Soluble lysosomal proteins can be isolated using affinity purification.\n2. One method of affinity purification for lysosomal proteins involves using a column coated with an antibody that specifically binds to the protein of interest.\n3. In immunoaffinity chromatography, the lysosomal proteins are passed through a column and non-specific proteins are washed away.\n4. The proteins that bind to the antibody are retained in immunoaffinity chromatography.\n5. Another method to isolate lysosomal proteins is using a ligand affinity column, where the protein is purified by binding to an immobilized ligand.",
    "vicuna-13b_fact": [
      "Soluble lysosomal proteins can be isolated using affinity purification.",
      "One method of affinity purification for lysosomal proteins involves using a column coated with an antibody that specifically binds to the protein of interest.",
      "In immunoaffinity chromatography, the lysosomal proteins are passed through a column and non-specific proteins are washed away.",
      "The proteins that bind to the antibody are retained in immunoaffinity chromatography.",
      "Another method to isolate lysosomal proteins is using a ligand affinity column, where the protein is purified by binding to an immobilized ligand."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 113,
    "user_query": "Which are the genes thought to be regulated by EWS/FLI?",
    "vicuna-13b_response": "EWS/FLI is a chimeric oncogene that results from the fusion of the EWS gene with the FLI gene. This oncogene is involved in the development of a variety of human cancers, including Ewing sarcoma, and is thought to play a role in the regulation of a number of genes.\nSeveral studies have identified genes that are regulated by EWS/FLI in Ewing sarcoma cells. For example, a study published in the journal Cancer Research in 2008 identified a number of genes that were upregulated by EWS/FLI in Ewing sarcoma cells, including the genes for the transcription factors SRY-box transcription factor 2 (SOX2), and the ETS-domain transcription factor family member, ERG.\nAnother study published in the journal Cancer Research in 2011 identified a number of genes that were downregulated by EWS/FLI in Ewing sarcoma cells, including the genes for the tumor suppressor proteins, p53 and PTEN.\nAdditionally, a study published in the journal Molecular Cancer Research in 2013 identified a number of genes that were regulated by EWS/FLI in Ewing sarcoma cells, including genes involved in cell cycle progression, apoptosis, and angiogenesis.\nOverall, these studies suggest that EWS/FLI plays a role in the regulation of a number of genes in Ewing sarcoma cells, and that this oncogene may be involved in the development and progression of this cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. EWS/FLI is a chimeric oncogene that results from the fusion of the EWS gene with the FLI gene.\n2. This oncogene is involved in the development of various human cancers, including Ewing sarcoma.\n3. A study published in 2008 in the Cancer Research journal identified genes upregulated by EWS/FLI in Ewing sarcoma cells, including SOX2 and ERG.\n4. A study published in 2011 in the same journal found that EWS/FLI downregulated the genes for the tumor suppressor proteins, p53 and PTEN in Ewing sarcoma cells.\n5. Another study published in Molecular Cancer Research in 2013 identified genes regulated by EWS/FLI involved in cell cycle progression, apoptosis, and angiogenesis.",
    "vicuna-13b_fact": [
      "EWS/FLI is a chimeric oncogene that results from the fusion of the EWS gene with the FLI gene.",
      "This oncogene is involved in the development of various human cancers, including Ewing sarcoma.",
      "A study published in 2008 in the Cancer Research journal identified genes upregulated by EWS/FLI in Ewing sarcoma cells, including SOX2 and ERG.",
      "A study published in 2011 in the same journal found that EWS/FLI downregulated the genes for the tumor suppressor proteins, p53 and PTEN in Ewing sarcoma cells.",
      "Another study published in Molecular Cancer Research in 2013 identified genes regulated by EWS/FLI involved in cell cycle progression, apoptosis, and angiogenesis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 115,
    "user_query": "Which pathological conditions are caused by mutations in the CYLD gene?",
    "vicuna-13b_response": "The CYLD gene provides instructions for making an enzyme called CYLD, which is involved in a process called ubiquitination. Ubiquitination is a mechanism that helps regulate the activity and stability of proteins in cells.\nMutations in the CYLD gene have been associated with several different pathological conditions, including:\n1. Cancer: Studies have suggested that mutations in the CYLD gene may be involved in the development of certain types of cancer, such as colorectal cancer, gastric cancer, and lung cancer. Researchers believe that CYLD mutations may lead to the accumulation of abnormal proteins in cells, which can contribute to the development and progression of cancer.\n2. Neurodegenerative diseases: CYLD mutations have also been linked to several neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, and Huntington's disease. It is thought that CYLD mutations may disrupt the normal ubiquitination process, leading to the accumulation of abnormal proteins in the brain that contribute to the degeneration of nerve cells.\n3. Other diseases: In addition to cancer and neurodegenerative diseases, CYLD mutations have also been associated with other diseases, such as cardiovascular disease, diabetes, and autoimmune disorders.\nIt is important to note that CYLD mutations are rare, and most cases of these diseases are not caused by genetic mutations. However, understanding the role of CYLD in these diseases may help researchers develop new treatments and therapies in the future.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The CYLD gene provides instructions for making an enzyme called CYLD which is involved in a process called ubiquitination.\n2. Mutations in the CYLD gene have been associated with the development of certain types of cancer, like colorectal cancer, gastric cancer, and lung cancer.\n3. CYLD gene mutations have been linked to several neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, and Huntington's disease.\n4. CYLD gene mutations have also been associated with other diseases, such as cardiovascular disease, diabetes, and autoimmune disorders.\n5. CYLD mutations are rare, and most cases of these diseases are not caused by genetic mutations.",
    "vicuna-13b_fact": [
      "The CYLD gene provides instructions for making an enzyme called CYLD which is involved in a process called ubiquitination.",
      "Mutations in the CYLD gene have been associated with the development of certain types of cancer, like colorectal cancer, gastric cancer, and lung cancer.",
      "CYLD gene mutations have been linked to several neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, and Huntington's disease.",
      "CYLD gene mutations have also been associated with other diseases, such as cardiovascular disease, diabetes, and autoimmune disorders.",
      "CYLD mutations are rare, and most cases of these diseases are not caused by genetic mutations."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CYLD gene mutations have not been directly linked to neurodegenerative diseases like Parkinson's disease, Alzheimer's disease, and Huntington's disease.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 121,
    "user_query": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A).",
    "vicuna-13b_response": "CMT1A is a hereditary neuropathy that is caused by mutations in the MFN2 gene. The MFN2 gene provides instructions for making a protein called mitofusin 2, which is involved in the maintenance and function of mitochondria, the energy-producing structures in cells.\nMutations in the MFN2 gene have been identified as the cause of CMT1A. Some of the genes that have been found mutated in CMT1A include:\n* MFN2\n* PMP22\n* MPZ\n* GDAP1\n* GARS\n* Cx32\n* GJB1\n* GJB2\n* GJB6\n* GJB8\n* GJC1\n* GJC2\n* GJD1\n* GJD2\n* GJD3\n* GJD4\n* GJD5\n* GJD6\n* GJD7\n* GJD8\n* GJD9\n* GJDA\n* GJDB\n* GJDC\n* GJDD\n* GJDE\n* GJDF\n* GJDG\n* GJDH\n* GJDI\n* GJDJ\n* GJDK\n* GJDL\n* GJDM\n* GJDN\n* GJDO\n* GJDP\n* GJDQ\n* GJDS\n* GJDT\n* GJDU\n* GJDV\n* GJDW\n* GJDX\n* GJEY\n* GJEZ\n* GJF\n* GJFA\n* GJFB\n* GJFC\n* GJFD\n* GJFE\n* GJFF\n* GJFG\n* GJFH\n* GJFI\n* GJFJ\n* GJFK\n* GJFL\n* GJFM\n* GJFN\n* GJFO\n* GJFP\n* GJFQ\n* GJFR\n* GJFS\n* GJFT\n* GJFU\n* GJFV\n* GJFW\n* GJFX\n* GJFY\n* GJG\n*",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CMT1A is a hereditary neuropathy.\n2. CMT1A is caused by mutations in the MFN2 gene.\n3. MFN2 gene provides instructions for making a protein called mitofusin 2, which has a role in the maintenance and function of mitochondria.\n4. Some genes that have been found mutated in CMT1A include MFN2, PMP22, MPZ, GDAP1, GARS, Cx32, GJB1, GJB2, and GJB6.\n5. There are other genes aside from MFN2, PMP22, MPZ, GDAP1, GARS, Cx32, GJB1, GJB2, and GJB6 that have also been associated with CMT1A mutations.",
    "vicuna-13b_fact": [
      "CMT1A is a hereditary neuropathy.",
      "CMT1A is caused by mutations in the MFN2 gene.",
      "MFN2 gene provides instructions for making a protein called mitofusin 2, which has a role in the maintenance and function of mitochondria.",
      "Some genes that have been found mutated in CMT1A include MFN2, PMP22, MPZ, GDAP1, GARS, Cx32, GJB1, GJB2, and GJB6.",
      "There are other genes aside from MFN2, PMP22, MPZ, GDAP1, GARS, Cx32, GJB1, GJB2, and GJB6 that have also been associated with CMT1A mutations."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: CMT1A is caused by duplication of the PMP22 gene.\n3. TRUE\n4. FALSE [correction]: The gene that has been found mutated in CMT1A is PMP22.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 123,
    "user_query": "Which genes have been associated with Cerebral Cavernous Malformation?",
    "vicuna-13b_response": "Cerebral cavernous malformations (CCMs) are a type of vascular malformation that affects the brain and spinal cord. They are characterized by abnormal blood vessels that can cause seizures, headaches, and other neurological symptoms. Several genes have been associated with the development of CCMs, including:\n1. KRIT1: The KRIT1 gene provides instructions for making a protein that is involved in the development and function of blood vessels. Mutations in the KRIT1 gene have been linked to the formation of CCMs.\n2. PDCD10: The PDCD10 gene provides instructions for making a protein that is involved in the development and function of blood vessels. Mutations in the PDCD10 gene have been associated with the formation of CCMs.\n3. CCM2: The CCM2 gene provides instructions for making a protein that is involved in the development and function of blood vessels. Mutations in the CCM2 gene have been linked to the formation of CCMs.\n4. CCM1: The CCM1 gene provides instructions for making a protein that is involved in the development and function of blood vessels. Mutations in the CCM1 gene have been associated with the formation of CCMs.\n5. PHF21A: The PHF21A gene provides instructions for making a protein that is involved in the development and function of blood vessels. Mutations in the PHF21A gene have been linked to the formation of CCMs.\nIt's important to note that these genes are not the only genes associated with CCMs, and additional research is needed to fully understand the genetic basis of this condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cerebral cavernous malformations (CCMs) are a type of vascular malformation that affects the brain and spinal cord.\n2. The KRIT1 gene, when mutated, has been linked to the formation of CCMs.\n3. The PDCD10 gene, when mutated, has been associated with the formation of CCMs.\n4. The CCM2 gene, when mutated, has been linked to the formation of CCMs.\n5. The CCM1 gene, when mutated, has been associated with the formation of CCMs.\n6. The PHF21A gene, when mutated, has been linked to the formation of CCMs.",
    "vicuna-13b_fact": [
      "Cerebral cavernous malformations (CCMs) are a type of vascular malformation that affects the brain and spinal cord.",
      "The KRIT1 gene, when mutated, has been linked to the formation of CCMs.",
      "The PDCD10 gene, when mutated, has been associated with the formation of CCMs.",
      "The CCM2 gene, when mutated, has been linked to the formation of CCMs.",
      "The CCM1 gene, when mutated, has been associated with the formation of CCMs.",
      "The PHF21A gene, when mutated, has been linked to the formation of CCMs."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. FALSE [correction]: The PHF21A gene, when mutated, has not been specifically linked to the formation of CCMs.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "vicuna-13b_response": "Yes, DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog that has been used in experimental and clinical studies. It is a synthetic form of the thyroid hormone triiodothyronine (T3), which is one of the two major hormones produced by the thyroid gland. DITPA is similar in structure to T3, but it has some differences in its chemical properties and biological effects.\nDITPA has been used in research to study the effects of T3 on various physiological processes, such as metabolism and growth. It has also been used as a tracer in imaging studies to assess thyroid function and to identify abnormalities in thyroid hormone metabolism. In addition, DITPA has been investigated as a potential treatment for various conditions, such as hypothyroidism and obesity, although its use in clinical settings is limited.\nOverall, DITPA is an important tool in the study of thyroid physiology and pathology, and it has contributed to our understanding of the role of T3 in various biological processes. However, more research is needed to fully understand its potential therapeutic uses and to determine its safety and efficacy in clinical settings.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog. \n2. DITPA is a synthetic form of the thyroid hormone triiodothyronine (T3).\n3. T3 is one of the two major hormones produced by the thyroid gland.\n4. DITPA has been utilized in research to study the effects of T3 on metabolism and growth.\n5. DITPA has been used as a tracer in imaging studies to assess thyroid function and identify abnormalities in thyroid hormone metabolism.",
    "vicuna-13b_fact": [
      "DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog.",
      "DITPA is a synthetic form of the thyroid hormone triiodothyronine (T3).",
      "T3 is one of the two major hormones produced by the thyroid gland.",
      "DITPA has been utilized in research to study the effects of T3 on metabolism and growth.",
      "DITPA has been used as a tracer in imaging studies to assess thyroid function and identify abnormalities in thyroid hormone metabolism."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 130,
    "user_query": "What is needed for MMP proteins to be functional?",
    "vicuna-13b_response": "MMP (Matrix Metalloproteinase) proteins are a family of enzymes that play a crucial role in the degradation of extracellular matrix (ECM) components, such as collagen, fibronectin, and laminin. For MMP proteins to be functional, they require several key components:\n1. Zinc ions: MMPs are zinc-dependent enzymes, meaning that they require zinc ions for their activity. Zinc ions are essential for the proper folding of the MMP protein and for the activation of its catalytic site.\n2. Substrate: MMPs require a specific substrate, or target protein, to be degraded. MMPs recognize and bind to specific sequences in the ECM, such as the RGD sequence found in collagen.\n3. Activators and inhibitors: MMPs can be activated or inhibited by various molecules, including other proteases, growth factors, and inhibitors such as TIMPs (Tissue Inhibitors of Metalloproteinases).\n4. Oxygen: MMPs require oxygen for their activity, as they are oxygen-dependent enzymes.\n5. pH: MMPs have an optimal pH range for activity, typically between 5.5 and 6.5.\nIn summary, for MMP proteins to be functional, they require zinc ions, a specific substrate, activators and inhibitors, oxygen, and a specific pH range.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Matrix Metalloproteinase (MMP) proteins degrade extracellular matrix (ECM) components like collagen, fibronectin, and laminin.\n2. MMP proteins require zinc ions for their activity and proper folding.\n3. MMP proteins need a specific substrate or target protein to be degraded.\n4. Various molecules, including other proteases, growth factors, and inhibitors such as TIMPs, can activate or inhibit MMPs.\n5. MMP proteins require oxygen for their activity.\n6. MMPs have an optimal pH range for activity, typically between 5.5 and 6.5.",
    "vicuna-13b_fact": [
      "Matrix Metalloproteinase (MMP) proteins degrade extracellular matrix (ECM) components like collagen, fibronectin, and laminin.",
      "MMP proteins require zinc ions for their activity and proper folding.",
      "MMP proteins need a specific substrate or target protein to be degraded.",
      "Various molecules, including other proteases, growth factors, and inhibitors such as TIMPs, can activate or inhibit MMPs.",
      "MMP proteins require oxygen for their activity.",
      "MMPs have an optimal pH range for activity, typically between 5.5 and 6.5."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Matrix Metalloproteinase (MMP) proteins do not specifically require oxygen for their activity. \n6. FALSE [correction]: The optimal pH range for MMPs varies depending on the specific MMP, but it's typically neutral to slightly basic.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 133,
    "user_query": "Which is the most known bacterium responsible for botulism (sausage-poisoning)?",
    "vicuna-13b_response": "The most known bacterium responsible for botulism is Clostridium botulinum. It is a gram-positive, spore-forming, anaerobic bacterium that can produce a potent neurotoxin that causes botulism. Botulism is a serious foodborne illness that can cause symptoms such as muscle weakness, fatigue, and difficulty swallowing. It is often associated with the consumption of contaminated food, particularly home-canned or fermented foods. The toxin produced by C. botulinum can be destroyed by heat, which is why proper cooking and canning techniques are important in preventing botulism.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The bacterium responsible for botulism is Clostridium botulinum.\n2. Clostridium botulinum is a gram-positive, spore-forming, anaerobic bacterium.\n3. Clostridium botulinum can produce a potent neurotoxin that causes botulism.\n4. Botulism can cause symptoms such as muscle weakness, fatigue, and difficulty swallowing.\n5. The toxin produced by Clostridium botulinum can be destroyed by heat.",
    "vicuna-13b_fact": [
      "The bacterium responsible for botulism is Clostridium botulinum.",
      "Clostridium botulinum is a gram-positive, spore-forming, anaerobic bacterium.",
      "Clostridium botulinum can produce a potent neurotoxin that causes botulism.",
      "Botulism can cause symptoms such as muscle weakness, fatigue, and difficulty swallowing.",
      "The toxin produced by Clostridium botulinum can be destroyed by heat."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 138,
    "user_query": "Which are the plant DNA (cytosine-5) methyltransferase families?",
    "vicuna-13b_response": "Plant DNA (cytosine-5) methyltransferase (MT) families are enzymes that are responsible for adding a methyl group to the fifth carbon of cytosine, a process known as DNA methylation. DNA methylation is an important mechanism for regulating gene expression and plays a crucial role in various biological processes, such as development, growth, and stress responses in plants.\nThere are three main plant DNA MT families:\n1. Methyltransferase (MET) family: This family includes enzymes that add a methyl group to the fifth carbon of cytosine, resulting in 5-methylcytosine (5-mC) residues. The MET family is further divided into two subfamilies: MET1 and MET2.\n2. Methyltransferase-like (MTL) family: This family includes enzymes that add a methyl group to the fifth carbon of cytosine, resulting in 5-methylcytosine (5-mC) residues. The MTL family is further divided into two subfamilies: MTL1 and MTL2.\n3. Methyltransferase-like (MTL) and methyltransferase (MET) family: This family includes enzymes that add a methyl group to the fifth carbon of cytosine, resulting in 5-methylcytosine (5-mC) residues. The MTL and MET family is further divided into two subfamilies: MTL1/MET and MTL2/MET.\nOverall, these plant DNA MT families play important roles in regulating gene expression and other biological processes in plants.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Plant DNA (cytosine-5) methyltransferase (MT) families are responsible for adding a methyl group to the fifth carbon of cytosine, a process known as DNA methylation.\n2. DNA methylation is an important mechanism for regulating gene expression and plays a crucial role in various biological processes in plants.\n3. The MET family includes enzymes that add a methyl group to the fifth carbon of cytosine and is divided into MET1 and MET2 subfamilies.\n4. The MTL family includes enzymes that add a methyl group to the fifth carbon of cytosine and is divided into MTL1 and MTL2 subfamilies.\n5. The MTL/MET family includes enzymes that add a methyl group to the fifth carbon of cytosine and is divided into MTL1/MET and MTL2/MET subfamilies.",
    "vicuna-13b_fact": [
      "Plant DNA (cytosine-5) methyltransferase (MT) families are responsible for adding a methyl group to the fifth carbon of cytosine, a process known as DNA methylation.",
      "DNA methylation is an important mechanism for regulating gene expression and plays a crucial role in various biological processes in plants.",
      "The MET family includes enzymes that add a methyl group to the fifth carbon of cytosine and is divided into MET1 and MET2 subfamilies.",
      "The MTL family includes enzymes that add a methyl group to the fifth carbon of cytosine and is divided into MTL1 and MTL2 subfamilies.",
      "The MTL/MET family includes enzymes that add a methyl group to the fifth carbon of cytosine and is divided into MTL1/MET and MTL2/MET subfamilies."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The MET family includes enzymes that add a methyl group to cytosine but it is not specifically mentioned that it is to the fifth carbon.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 139,
    "user_query": "Where is the histone variant CENPA preferentially localized?",
    "vicuna-13b_response": "CENPA (Centromere Protein A) is a histone variant that plays a critical role in the formation and maintenance of functional centromeres, which are the regions of the chromosome where the sister chromatids are held together. CENPA is preferentially localized to the centromeric regions of the chromosomes, specifically to the pericentromeric heterochromatin, which is a region of highly condensed chromatin that surrounds the centromere.\nCENPA is recruited to the centromere through its interaction with the centromere-specific protein Sgo2, and it helps to maintain the structure and stability of the centromere. In addition, CENPA has been shown to play a role in the regulation of gene expression, cell cycle progression, and the response to DNA damage.\nOverall, the localization of CENPA to the centromeric regions of the chromosomes is critical for the proper functioning of the centromere and the maintenance of chromosomal stability.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CENPA (Centromere Protein A) is a histone variant that is involved in the formation and maintenance of functional centromeres.\n2. CENPA is preferentially localized to the centromeric regions of the chromosomes.\n3. CENPA is recruited to the centromere through its interaction with the centromere-specific protein Sgo2.\n4. CENPA plays a role in the regulation of gene expression, cell cycle progression, and the response to DNA damage.\n5. The localization of CENPA to the centromeric regions of the chromosomes is critical for the proper functioning of the centromere and the maintenance of chromosomal stability.",
    "vicuna-13b_fact": [
      "CENPA (Centromere Protein A) is a histone variant that is involved in the formation and maintenance of functional centromeres.",
      "CENPA is preferentially localized to the centromeric regions of the chromosomes.",
      "CENPA is recruited to the centromere through its interaction with the centromere-specific protein Sgo2.",
      "CENPA plays a role in the regulation of gene expression, cell cycle progression, and the response to DNA damage.",
      "The localization of CENPA to the centromeric regions of the chromosomes is critical for the proper functioning of the centromere and the maintenance of chromosomal stability."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CENPA is recruited to the centromere through interactions with various proteins, not specifically with Sgo2.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 140,
    "user_query": "In which proteins is the chromodomain present?",
    "vicuna-13b_response": "The chromodomain is a protein domain that is involved in the regulation of chromatin structure and gene expression. It is present in a number of proteins, including:\n1. Chromatin-modifying enzymes: Chromodomain-containing proteins are involved in the regulation of chromatin structure by modifying chromatin-associated proteins, such as histones and non-histone chromosomal proteins. Examples of chromatin-modifying enzymes that contain a chromodomain include the chromatin-modifying enzymes SWI/SNF, ISWI, and CHD.\n2. Chromatin-remodeling complexes: Chromodomain-containing proteins are also involved in the regulation of chromatin structure by remodeling chromatin structure. Examples of chromatin-remodeling complexes that contain a chromodomain include the ISWI complex and the SWI/SNF complex.\n3. Transcription factors: Some transcription factors contain a chromodomain, which allows them to interact with chromatin and regulate gene expression. Examples of transcription factors that contain a chromodomain include the p53 transcription factor and the glucocorticoid receptor.\nOverall, the chromodomain is a versatile protein domain that plays a critical role in the regulation of chromatin structure and gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The chromodomain is a protein domain involved in the regulation of chromatin structure and gene expression.\n2. The chromodomain is present in chromatin-modifying enzymes such as SWI/SNF, ISWI, and CHD.\n3. Chromodomain-containing proteins are found in chromatin-remodeling complexes like the ISWI complex and the SWI/SNF complex.\n4. Some transcription factors contain a chromodomain, such as the p53 transcription factor and the glucocorticoid receptor.\n5. The chromodomain interacts with chromatin and regulates gene expression.",
    "vicuna-13b_fact": [
      "The chromodomain is a protein domain involved in the regulation of chromatin structure and gene expression.",
      "The chromodomain is present in chromatin-modifying enzymes such as SWI/SNF, ISWI, and CHD.",
      "Chromodomain-containing proteins are found in chromatin-remodeling complexes like the ISWI complex and the SWI/SNF complex.",
      "Some transcription factors contain a chromodomain, such as the p53 transcription factor and the glucocorticoid receptor.",
      "The chromodomain interacts with chromatin and regulates gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Some transcription factors contain a chromodomain, such as the Polycomb and trithorax protein families, but not the p53 transcription factor and the glucocorticoid receptor.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 142,
    "user_query": "Is amiodarone a class I anti-arrhythmic drug?",
    "vicuna-13b_response": "Yes, amiodarone is a class I anti-arrhythmic drug. It is a type of medication used to treat irregular heartbeats (arrhythmias) by slowing down the heart rate and stabilizing the heart's electrical activity. Amiodarone is often used in patients with life-threatening arrhythmias that have not responded to other treatments. It is also used in patients with heart failure, as it has been shown to improve survival and reduce the risk of hospitalization for heart failure. Amiodarone is a potent anti-arrhythmic drug and can have serious side effects, including thyroid dysfunction, lung toxicity, and visual disturbances. Therefore, it should be used only under the close supervision of a physician.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. Amiodarone is a class I anti-arrhythmic drug.\n2. Amiodarone is used to treat irregular heartbeats (arrhythmias).\n3. Amiodarone works by slowing down the heart rate and stabilizing the heart's electrical activity.\n4. Amiodarone can improve survival and reduce the risk of hospitalization for patients with heart failure.\n5. Amiodarone can have serious side effects, including thyroid dysfunction, lung toxicity, and visual disturbances.",
    "vicuna-13b_fact": [
      "Amiodarone is a class I anti-arrhythmic drug.",
      "Amiodarone is used to treat irregular heartbeats (arrhythmias).",
      "Amiodarone works by slowing down the heart rate and stabilizing the heart's electrical activity.",
      "Amiodarone can improve survival and reduce the risk of hospitalization for patients with heart failure.",
      "Amiodarone can have serious side effects, including thyroid dysfunction, lung toxicity, and visual disturbances."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Amiodarone is a class III anti-arrhythmic drug.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "vicuna-13b_response": "COUGER is an open-source tool that is used for testing and evaluating the security of web applications. It is designed to identify vulnerabilities in web applications by exploiting known vulnerabilities and weaknesses. COUGER is a command-line tool that can be used to perform various tests, including SQL injection, cross-site scripting (XSS), and remote file inclusion (RFI) tests.\nCOUGER is a useful tool for security professionals, developers, and researchers who are interested in testing the security of web applications. It can be used to identify vulnerabilities and weaknesses in web applications, which can then be fixed to improve the overall security of the application. COUGER can also be used to test the effectiveness of security controls and to evaluate the security posture of a web application.\nOverall, COUGER is a powerful and useful tool for anyone who is interested in testing the security of web applications. It is easy to use and can provide valuable information about the security of a web application.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. COUGER is an open-source tool used for testing and evaluating the security of web applications.\n2. The tool is designed to identify vulnerabilities in web applications.\n3. COUGER can be used to perform various tests, including SQL injection, cross-site scripting (XSS), and remote file inclusion (RFI) tests.\n4. COUGER is used by security professionals, developers, and researchers.\n5. COUGER can be used to test the effectiveness of security controls and to evaluate the security posture of a web application.",
    "vicuna-13b_fact": [
      "COUGER is an open-source tool used for testing and evaluating the security of web applications.",
      "The tool is designed to identify vulnerabilities in web applications.",
      "COUGER can be used to perform various tests, including SQL injection, cross-site scripting (XSS), and remote file inclusion (RFI) tests.",
      "COUGER is used by security professionals, developers, and researchers.",
      "COUGER can be used to test the effectiveness of security controls and to evaluate the security posture of a web application."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "vicuna-13b_response": "Yes, there are drugs for Tick-borne Encephalitis (TBE). TBE is a viral infection that is spread through the bite of infected ticks, and can cause symptoms such as fever, headache, and muscle weakness.\nThe most common treatment for TBE is the use of antiviral medications, such as oseltamivir (Tamiflu) and zanamivir (Relenza). These drugs can help reduce the severity and duration of the illness, and may be prescribed by a doctor if the patient is experiencing severe symptoms.\nIt is important to note that antiviral medications work best when started early in the course of the illness, so it is important to seek medical attention if you suspect that you may have TBE. In addition to antiviral medications, supportive care such as rest, hydration, and pain management may also be provided to help manage symptoms.\nIt is also important to take measures to prevent tick bites, such as using tick repellents, wearing protective clothing, and tucking pants into socks. If you find a tick attached to your skin, remove it promptly using a tick removal tool or by using a pair of tweezers to grasp the tick as close to the skin as possible and pulling it out.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tick-borne Encephalitis (TBE) is a viral infection that is spread through the bite of infected ticks.\n2. Antiviral medications, like oseltamivir (Tamiflu) and zanamivir (Relenza), are commonly used treatments for TBE.\n3. These antiviral drugs can help reduce the severity and duration of TBE.\n4. Antiviral medications for TBE work best when started early in the course of the illness.\n5. Prevention of TBE includes measures such as using tick repellents, wearing protective clothing, and removing attached ticks promptly.",
    "vicuna-13b_fact": [
      "Tick-borne Encephalitis (TBE) is a viral infection that is spread through the bite of infected ticks.",
      "Antiviral medications, like oseltamivir (Tamiflu) and zanamivir (Relenza), are commonly used treatments for TBE.",
      "These antiviral drugs can help reduce the severity and duration of TBE.",
      "Antiviral medications for TBE work best when started early in the course of the illness.",
      "Prevention of TBE includes measures such as using tick repellents, wearing protective clothing, and removing attached ticks promptly."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: There are no specific antiviral treatments for TBE. Supportive care is usually provided for those infected.\n3. FALSE [correction]: There are no specific antiviral medications proven to reduce the severity and duration of TBE.\n4. FALSE [correction]: There is no specific antiviral treatment for TBE, but early management with supportive care can help alleviate symptoms.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 146,
    "user_query": "Is SLC22A3 expressed in the brain?",
    "vicuna-13b_response": "SLC22A3, also known as the organic cation transporter 1 (OCT1), is a protein that is expressed in various tissues in the body, including the brain. OCT1 is a member of the solute carrier family of transporters and plays a role in the transport of organic cations across the blood-brain barrier and other tissues.\nStudies have shown that OCT1 is expressed in various regions of the brain, including the cortex, hippocampus, striatum, and cerebellum. OCT1 is involved in the transport of a variety of organic cations, including dopamine, norepinephrine, and serotonin, which are important neurotransmitters involved in various brain functions.\nIn addition to its role in neurotransmitter transport, OCT1 has also been implicated in the transport of other substances, such as drugs and toxins, across the blood-brain barrier. Therefore, OCT1 is an important protein for the transport of substances into and out of the brain, and its expression in the brain plays a critical role in various brain functions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SLC22A3, also known as the organic cation transporter 1 (OCT1), is expressed in the human brain.\n2. OCT1 is a protein that plays a role in the transport of organic cations across the blood-brain barrier and other tissues.\n3. Studies have shown that OCT1 is expressed in various regions of the brain, including the cortex, hippocampus, striatum, and cerebellum.\n4. OCT1 is involved in the transport of several neurotransmitters, including dopamine, norepinephrine, and serotonin.\n5. OCT1 has also been implicated in the transport of substances, such as drugs and toxins, across the blood-brain barrier.",
    "vicuna-13b_fact": [
      "SLC22A3, also known as the organic cation transporter 1 (OCT1), is expressed in the human brain.",
      "OCT1 is a protein that plays a role in the transport of organic cations across the blood-brain barrier and other tissues.",
      "Studies have shown that OCT1 is expressed in various regions of the brain, including the cortex, hippocampus, striatum, and cerebellum.",
      "OCT1 is involved in the transport of several neurotransmitters, including dopamine, norepinephrine, and serotonin.",
      "OCT1 has also been implicated in the transport of substances, such as drugs and toxins, across the blood-brain barrier."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "vicuna-13b_response": "There are several genome browser databases available for DNA shape annotations, including:\n1. Ensembl: Ensembl is a comprehensive genome browser that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n2. UCSC Genome Browser: The UCSC Genome Browser is a widely used genome browser that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n3. Genome Data Viewer: The Genome Data Viewer is a genome browser developed by the Broad Institute that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n4. Integrative Genomics Viewer (IGV): IGV is a genome browser developed by the University of California, Santa Cruz that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n5. JBrowse: JBrowse is a genome browser developed by the European Bioinformatics Institute that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\nThese are just a few examples of the many genome browser databases available for DNA shape annotations.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ensembl is a genome browser that provides a variety of DNA shape annotations.\n2. The UCSC Genome Browser is a widely used genome browser that provides a variety of DNA shape annotations.\n3. The Genome Data Viewer is a genome browser developed by the Broad Institute.\n4. Integrative Genomics Viewer (IGV) is a genome browser developed by the University of California, Santa Cruz.\n5. JBrowse is a genome browser developed by the European Bioinformatics Institute.",
    "vicuna-13b_fact": [
      "Ensembl is a genome browser that provides a variety of DNA shape annotations.",
      "The UCSC Genome Browser is a widely used genome browser that provides a variety of DNA shape annotations.",
      "The Genome Data Viewer is a genome browser developed by the Broad Institute.",
      "Integrative Genomics Viewer (IGV) is a genome browser developed by the University of California, Santa Cruz.",
      "JBrowse is a genome browser developed by the European Bioinformatics Institute."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Genome Data Viewer is a genome browser developed by the National Center for Biotechnology Information (NCBI).\n4. FALSE [correction]: Integrative Genomics Viewer (IGV) is a genome browser developed by the Broad Institute.\n5. FALSE [correction]: JBrowse is a genome browser developed by the Genome Informatics group of the University of Cambridge.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 153,
    "user_query": "What is the relationship between TailorX and Oncotype?",
    "vicuna-13b_response": "TailorX and Oncotype are both liquid biopsy tests that use circulating tumor DNA (ctDNA) analysis to help diagnose and monitor cancer. Both tests are designed to detect and analyze ctDNA in the blood or other bodily fluids of cancer patients, and both tests provide information that can be used to help guide treatment decisions.\nHowever, there are some key differences between the two tests. Oncotype is a commercially available test that has been FDA-approved for use in breast, colon, and prostate cancer. It is designed to help predict the risk of recurrence in breast cancer patients and to help guide treatment decisions in colon and prostate cancer patients.\nTailorX, on the other hand, is a research test that is still in the development stage. It is being studied as a potential tool for diagnosing and monitoring a variety of different cancers, including breast, colon, lung, and ovarian cancer. TailorX is designed to be a more comprehensive test than Oncotype, and it analyzes a larger panel of genes and gene mutations in order to provide more detailed information about a patient's cancer.\nOverall, while both Oncotype and TailorX are liquid biopsy tests that use ctDNA analysis to help diagnose and monitor cancer, they have some key differences in terms of their approved uses, the cancers they are designed to diagnose and monitor, and the scope of the information they provide.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TailorX and Oncotype are both liquid biopsy tests that use circulating tumor DNA (ctDNA) analysis to diagnose and monitor cancer.\n2. Oncotype is a commercial test that is FDA-approved for use in breast, colon, and prostate cancer.\n3. Oncotype helps predict the risk of recurrence in breast cancer patients and guides treatment decisions in colon and prostate cancer patients.\n4. TailorX is a research test that is still in the development stage.\n5. TailorX is being studied to diagnose and monitor a variety of different cancers, including breast, colon, lung, and ovarian cancer.",
    "vicuna-13b_fact": [
      "TailorX and Oncotype are both liquid biopsy tests that use circulating tumor DNA (ctDNA) analysis to diagnose and monitor cancer.",
      "Oncotype is a commercial test that is FDA-approved for use in breast, colon, and prostate cancer.",
      "Oncotype helps predict the risk of recurrence in breast cancer patients and guides treatment decisions in colon and prostate cancer patients.",
      "TailorX is a research test that is still in the development stage.",
      "TailorX is being studied to diagnose and monitor a variety of different cancers, including breast, colon, lung, and ovarian cancer."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: TailorX was a clinical trial and Oncotype is a genomic test. Neither are liquid biopsy tests that use circulating tumor DNA (ctDNA) for diagnosis and monitoring of cancer.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: TailorX is not a test. It was a clinical trial designed to study whether breast cancer patients who are at an intermediate risk of recurrence can forgo chemotherapy.\n5. FALSE [correction]: TailorX is not a test. It was a clinical trial focused on breast cancer, not on diagnosing and monitoring various other cancers.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 154,
    "user_query": "Does strenuous physical activity affect thyroid hormone metabolism?",
    "vicuna-13b_response": "Yes, strenuous physical activity can affect thyroid hormone metabolism. Thyroid hormones, including triiodothyronine (T3) and thyroxine (T4), play important roles in regulating metabolism and energy production in the body. They are controlled by a complex network of hormones and signaling pathways, including the thyroid-stimulating hormone (TSH) produced by the pituitary gland.\nPhysical activity, particularly strenuous exercise, can increase the demand for energy in the body, leading to an increase in the release of T3 and T4 from the thyroid gland. This increase in thyroid hormone production can occur within minutes to hours of exercise and can last for several hours after exercise.\nHowever, prolonged or excessive physical activity can also lead to a decrease in thyroid hormone production due to the stress and inflammation that result from the exercise. This decrease in thyroid hormone production can lead to a condition known as hypothyroidism, which is characterized by symptoms such as fatigue, weight gain, and depression.\nIt is important to note that the effects of physical activity on thyroid hormone metabolism can vary depending on factors such as the intensity and duration of the exercise, the individual's fitness level, and their overall health. Therefore, it is recommended to consult with a healthcare professional before starting a new exercise program, especially if you have a history of thyroid disorders or other medical conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Strenuous physical activity can affect thyroid hormone metabolism.\n2. Thyroid hormones, including triiodothyronine (T3) and thyroxine (T4), play important roles in regulating metabolism and energy production in the body.\n3. The release of T3 and T4 from the thyroid gland can increase due to physical activity.\n4. Prolonged or excessive physical activity can lead to a decrease in thyroid hormone production, which can result in hypothyroidism.\n5. The effects of physical activity on thyroid hormone metabolism can vary depending on factors such as the intensity and duration of the exercise, the individual's fitness level, and their overall health.",
    "vicuna-13b_fact": [
      "Strenuous physical activity can affect thyroid hormone metabolism.",
      "Thyroid hormones, including triiodothyronine (T3) and thyroxine (T4), play important roles in regulating metabolism and energy production in the body.",
      "The release of T3 and T4 from the thyroid gland can increase due to physical activity.",
      "Prolonged or excessive physical activity can lead to a decrease in thyroid hormone production, which can result in hypothyroidism.",
      "The effects of physical activity on thyroid hormone metabolism can vary depending on factors such as the intensity and duration of the exercise, the individual's fitness level, and their overall health."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 155,
    "user_query": "Which is the main function of \"RNA sponges\"?",
    "vicuna-13b_response": "RNA sponges are a type of non-coding RNA that are named for their sponge-like properties, as they are able to absorb other RNAs and proteins. The main function of RNA sponges is to regulate gene expression by binding to RNAs and proteins, thereby blocking their activity or promoting their degradation.\nRNA sponges are found in all eukaryotic organisms, and they play important roles in a variety of cellular processes, including cell growth and differentiation, stress responses, and the regulation of gene expression. They are also involved in the development of certain diseases, such as cancer and neurodegenerative disorders.\nRNA sponges can act as RNA-binding proteins, binding to RNAs and proteins in a specific and selective manner. They can also act as RNA-degrading enzymes, cleaving RNAs and proteins in a controlled manner.\nOverall, the main function of RNA sponges is to regulate gene expression by controlling the levels and activities of RNAs and proteins, thereby contributing to the proper functioning of cells and organisms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. RNA sponges are a type of non-coding RNA.\n2. RNA sponges regulate gene expression by binding to RNAs and proteins, blocking their activity or promoting their degradation.\n3. RNA sponges are found in all eukaryotic organisms.\n4. RNA sponges can act as RNA-binding proteins and as RNA-degrading enzymes.\n5. RNA sponges play roles in cell growth and differentiation, stress responses, and regulation of gene expression.",
    "vicuna-13b_fact": [
      "RNA sponges are a type of non-coding RNA.",
      "RNA sponges regulate gene expression by binding to RNAs and proteins, blocking their activity or promoting their degradation.",
      "RNA sponges are found in all eukaryotic organisms.",
      "RNA sponges can act as RNA-binding proteins and as RNA-degrading enzymes.",
      "RNA sponges play roles in cell growth and differentiation, stress responses, and regulation of gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: RNA sponges do not act as RNA-binding proteins or RNA-degrading enzymes. They sequester microRNAs or other RNA-binding proteins.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 157,
    "user_query": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?",
    "vicuna-13b_response": "Cardiomyopathy is a heart condition characterized by the thickening and enlargement of the heart muscle, which can lead to heart failure. Mutations in the phospholamban gene have been found to be associated with the development of cardiomyopathy in some cases.\nPhospholamban is a protein that is involved in the regulation of calcium ion flow in the heart. Mutations in the phospholamban gene can lead to changes in the structure and function of the protein, which can disrupt the normal regulation of calcium ion flow and contribute to the development of cardiomyopathy.\nSeveral mutations in the phospholamban gene have been identified in patients with cardiomyopathy. Some of these mutations include:\n1. R142W: This mutation results in the substitution of a arginine amino acid for a tryptophan amino acid at position 142 in the protein. This mutation has been associated with an increased risk of cardiomyopathy.\n2. R164C: This mutation results in the substitution of a arginine amino acid for a cysteine amino acid at position 164 in the protein. This mutation has been associated with an increased risk of cardiomyopathy.\n3. R164H: This mutation results in the substitution of a arginine amino acid for a histidine amino acid at position 164 in the protein. This mutation has been associated with an increased risk of cardiomyopathy.\n4. R164L: This mutation results in the substitution of a arginine amino acid for a leucine amino acid at position 164 in the protein. This mutation has been associated with an increased risk of cardiomyopathy.\nIt is important to note that not all patients with cardiomyopathy will have mutations in the phospholamban gene, and the specific mutations found can vary between individuals. Additionally, other genetic and environmental factors may also contribute to the development of cardiomyopathy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cardiomyopathy is a heart condition characterized by the thickening and enlargement of the heart muscle.\n2. Mutations in the phospholamban gene have been found to be associated with the development of cardiomyopathy in some cases.\n3. The R142W mutation in the phospholamban gene results in the substitution of a arginine amino acid for a tryptophan amino acid at position 142 in the protein.\n4. The R164C mutation in the phospholamban gene results in the substitution of a arginine amino acid for a cysteine amino acid at position 164 in the protein.\n5. The R164H mutation in the phospholamban gene results in the substitution of a arginine amino acid for a histidine amino acid at position 164 in the protein.",
    "vicuna-13b_fact": [
      "Cardiomyopathy is a heart condition characterized by the thickening and enlargement of the heart muscle.",
      "Mutations in the phospholamban gene have been found to be associated with the development of cardiomyopathy in some cases.",
      "The R142W mutation in the phospholamban gene results in the substitution of a arginine amino acid for a tryptophan amino acid at position 142 in the protein.",
      "The R164C mutation in the phospholamban gene results in the substitution of a arginine amino acid for a cysteine amino acid at position 164 in the protein.",
      "The R164H mutation in the phospholamban gene results in the substitution of a arginine amino acid for a histidine amino acid at position 164 in the protein."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The R14W mutation in the phospholamban gene results in the substitution of a arginine amino acid for a tryptophan amino acid at position 14 in the protein.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 160,
    "user_query": "Is there any software for automated analysis of FISH images?",
    "vicuna-13b_response": "Yes, there are several software options available for automated analysis of FISH (fluorescence in situ hybridization) images. FISH is a technique used to detect and localize the presence of specific DNA sequences in cells or tissues, and it often involves the use of fluorescent probes to visualize the hybridized regions. Automated analysis of FISH images can help to speed up the process of interpreting the results and can also improve the accuracy and consistency of the analysis.\nSome examples of software for automated analysis of FISH images include:\n1. CellProfiler: This is an open-source software that is widely used for image analysis in biology. It can be used to analyze FISH images and extract information about the location and intensity of the hybridized probes.\n2. ImageJ: This is a popular open-source image analysis software that can be used for FISH image analysis. It provides a range of tools for image segmentation, feature extraction, and data analysis.\n3. CellVision: This is a commercial software that is specifically designed for image analysis in cell biology. It includes tools for FISH image analysis, as well as other techniques such as immunofluorescence and western blotting.\n4. MetaMorph: This is a commercial software that is used for a wide range of image analysis applications, including FISH imaging. It provides a range of tools for image segmentation, measurement, and data analysis.\nIt is important to note that while automated analysis can be helpful, it is not always 100% accurate and may require manual verification. It is also important to carefully validate any results obtained using automated analysis software to ensure that they are reliable.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. FISH (fluorescence in situ hybridization) is a technique used to detect and localize the presence of specific DNA sequences in cells or tissues.\n2. Automated analysis of FISH images can speed up the process of interpreting the results and improve the accuracy and consistency of the analysis.\n3. CellProfiler is an open-source software that is used for image analysis in biology, including FISH images.\n4. ImageJ is an open-source image analysis software that can be used for FISH image analysis.\n5. CellVision and MetaMorph are commercial softwares that provide tools for FISH image analysis.",
    "vicuna-13b_fact": [
      "FISH (fluorescence in situ hybridization) is a technique used to detect and localize the presence of specific DNA sequences in cells or tissues.",
      "Automated analysis of FISH images can speed up the process of interpreting the results and improve the accuracy and consistency of the analysis.",
      "CellProfiler is an open-source software that is used for image analysis in biology, including FISH images.",
      "ImageJ is an open-source image analysis software that can be used for FISH image analysis.",
      "CellVision and MetaMorph are commercial softwares that provide tools for FISH image analysis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 165,
    "user_query": "List markers for autophagy.",
    "vicuna-13b_response": "Autophagy is a process of self-digestion that occurs in cells, where damaged or unnecessary proteins and organelles are degraded and recycled. The process is essential for maintaining cellular homeostasis and preventing the accumulation of toxic substances. The following are some of the key markers for autophagy:\n1. Vacuoles: Vacuoles are formed when cytoplasm is engulfed by the autophagosome, which is a double-membrane structure that surrounds the material to be degraded. The formation of vacuoles is a key indicator of autophagy.\n2. Lysosomes: Lysosomes are responsible for breaking down the engulfed material, and their activity increases during autophagy. An increase in lysosomal activity can be used as a marker for autophagy.\n3. Autophagosomes: Autophagosomes are formed when the autophagic vesicle fuses with the lysosome. The presence of autophagosomes is a key marker for autophagy.\n4. P62: P62 is a protein that accumulates in cells during autophagy and is a key regulator of the process. The depletion of P62 can be used as a marker for autophagy.\n5. Beclin 1: Beclin 1 is an essential component of the autophagy machinery and is involved in the formation of autophagosomes. The depletion of Beclin 1 can inhibit autophagy, and its accumulation can be used as a marker for autophagy.\n6. ULK1: ULK1 is a protein that is involved in the formation of autophagosomes and is a key regulator of autophagy. The depletion of ULK1 can inhibit autophagy, and its accumulation can be used as a marker for autophagy.\nIn conclusion, the markers for autophagy include vacuoles, lysosomes, autophagosomes, P62, Beclin 1, and ULK1. The presence or accumulation of these markers can be used as indicators of autophagy in cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Autophagy is a process of self-digestion that occurs in cells.\n2. The formation of vacuoles is a key indicator of autophagy.\n3. An increase in lysosomal activity can be used as a marker for autophagy.\n4. The presence of autophagosomes is a key marker for autophagy.\n5. The accumulation of Beclin 1 and ULK1 can be used as a marker for autophagy.",
    "vicuna-13b_fact": [
      "Autophagy is a process of self-digestion that occurs in cells.",
      "The formation of vacuoles is a key indicator of autophagy.",
      "An increase in lysosomal activity can be used as a marker for autophagy.",
      "The presence of autophagosomes is a key marker for autophagy.",
      "The accumulation of Beclin 1 and ULK1 can be used as a marker for autophagy."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 169,
    "user_query": "Are there any specific antidotes for rivaroxaban?",
    "vicuna-13b_response": "Yes, there are specific antidotes for rivaroxaban, which is an oral anticoagulant medication used to prevent blood clots. If a patient takes an overdose of rivaroxaban or experiences bleeding complications, the following antidotes may be used:\n1. Vitamin K: Vitamin K can counteract the effects of rivaroxaban by promoting the production of clotting factors in the liver. Vitamin K can be given intravenously in the form of phytonadione or menadiol.\n2. Fresh frozen plasma (FFP): FFP is a blood product that contains clotting factors and can be used to reverse the anticoagulant effect of rivaroxaban. FFP can be given intravenously to patients experiencing bleeding complications.\n3. Protamine sulfate: Protamine sulfate is a medication that can neutralize the anticoagulant effect of rivaroxaban by binding to the drug and promoting the production of clotting factors. Protamine sulfate can be given intravenously to patients experiencing bleeding complications.\nIt is important to note that the use of antidotes for rivaroxaban should be done under the guidance of a healthcare professional, as the appropriate use of these medications can help to prevent or manage bleeding complications while minimizing the risk of further clotting.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Rivaroxaban is an oral anticoagulant medication used to prevent blood clots.\n2. Vitamin K can counteract the effects of rivaroxaban by promoting the production of clotting factors in the liver.\n3. Fresh frozen plasma (FFP) is a blood product that contains clotting factors and can be used to reverse the anticoagulant effect of rivaroxaban.\n4. Protamine sulfate is a medication that can neutralize the anticoagulant effect of rivaroxaban by binding to the drug and promoting the production of clotting factors.\n5. The use of antidotes for rivaroxaban should be done under the guidance of a healthcare professional.",
    "vicuna-13b_fact": [
      "Rivaroxaban is an oral anticoagulant medication used to prevent blood clots.",
      "Vitamin K can counteract the effects of rivaroxaban by promoting the production of clotting factors in the liver.",
      "Fresh frozen plasma (FFP) is a blood product that contains clotting factors and can be used to reverse the anticoagulant effect of rivaroxaban.",
      "Protamine sulfate is a medication that can neutralize the anticoagulant effect of rivaroxaban by binding to the drug and promoting the production of clotting factors.",
      "The use of antidotes for rivaroxaban should be done under the guidance of a healthcare professional."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Vitamin K can counteract the effects of warfarin, not rivaroxaban.\n3. FALSE [correction]: Fresh frozen plasma (FFP) is not generally recommended for reversal of rivaroxaban due to insufficient evidence of its efficacy.\n4. FALSE [correction]: Protamine sulfate does not have the capacity to neutralize the anticoagulant effect of rivaroxaban. \n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 171,
    "user_query": "What is the function of 6SRNA in bacteria?",
    "vicuna-13b_response": "6S RNA is a small RNA molecule found in bacteria that plays a critical role in the regulation of gene expression. It is a component of the bacterial small RNA pathway, which helps to regulate the activity of ribosomes, the molecular machines that synthesize proteins.\n6S RNA is produced by the action of the 6S RNA methyltransferase enzyme on the ribosomal RNA (rRNA) molecule. This modification of rRNA is thought to enhance the stability of the ribosome and improve its function. In addition, 6S RNA has been shown to play a role in the regulation of translation, the process by which the genetic code is converted into proteins.\nStudies have suggested that 6S RNA may also be involved in the regulation of stress responses and virulence in bacteria. For example, some strains of the bacterium Pseudomonas aeruginosa have been shown to produce high levels of 6S RNA in response to oxidative stress, which may help to protect the bacteria from damage.\nOverall, the function of 6S RNA in bacteria is complex and multifaceted, and further research is needed to fully understand its role in regulating gene expression and other cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. 6S RNA is a small RNA molecule found in bacteria.\n2. The function of 6S RNA in bacteria is the regulation of gene expression.\n3. 6S RNA is produced by the action of the 6S RNA methyltransferase enzyme on the ribosomal RNA (rRNA) molecule.\n4. 6S RNA plays a role in the regulation of translation.\n5. 6S RNA may also be involved in the regulation of stress responses and virulence in bacteria.",
    "vicuna-13b_fact": [
      "6S RNA is a small RNA molecule found in bacteria.",
      "The function of 6S RNA in bacteria is the regulation of gene expression.",
      "6S RNA is produced by the action of the 6S RNA methyltransferase enzyme on the ribosomal RNA (rRNA) molecule.",
      "6S RNA plays a role in the regulation of translation.",
      "6S RNA may also be involved in the regulation of stress responses and virulence in bacteria."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: 6S RNA is not produced by the action of any methyltransferase enzyme on the rRNA molecule. It's generally synthesized by RNA polymerases.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 172,
    "user_query": "Is cytisine superior to nicotine replacement therapy for smoking cessation?",
    "vicuna-13b_response": "Cytisine and nicotine replacement therapy (NRT) are both treatments used to help people quit smoking. Cytisine is a partial agonist of the nicotinic acetylcholine receptor, which means it activates the receptor but to a lesser extent than nicotine. NRT, on the other hand, works by providing the body with a source of nicotine without the harmful effects of smoking.\nThere is some evidence to suggest that cytisine may be more effective than NRT for smoking cessation. A review of clinical trials found that cytisine was associated with higher rates of abstinence at six months compared to placebo, while NRT was associated with lower rates of relapse compared to placebo. However, more research is needed to confirm these findings and to determine the long-term effectiveness of cytisine.\nIt is also important to note that both cytisine and NRT have potential side effects and risks, and should only be used under the guidance of a healthcare professional. Additionally, quitting smoking is a complex process and what works for one person may not work for another, so it's important to consider individual preferences and needs when choosing a treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cytisine and nicotine replacement therapy (NRT) are treatments used to help people quit smoking.\n2. Cytisine is a partial agonist of the nicotinic acetylcholine receptor.\n3. NRT works by providing the body with a source of nicotine without the harmful effects of smoking.\n4. A review of clinical trials found that cytisine was associated with higher rates of abstinence at six months compared to placebo, while NRT was associated with lower rates of relapse compared to placebo.\n5. Both cytisine and NRT have potential side effects and risks, and should only be used under the guidance of a healthcare professional.",
    "vicuna-13b_fact": [
      "Cytisine and nicotine replacement therapy (NRT) are treatments used to help people quit smoking.",
      "Cytisine is a partial agonist of the nicotinic acetylcholine receptor.",
      "NRT works by providing the body with a source of nicotine without the harmful effects of smoking.",
      "A review of clinical trials found that cytisine was associated with higher rates of abstinence at six months compared to placebo, while NRT was associated with lower rates of relapse compared to placebo.",
      "Both cytisine and NRT have potential side effects and risks, and should only be used under the guidance of a healthcare professional."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 173,
    "user_query": "Which amino acid residue appears mutated in most of the cases reported with  cadasil syndrome?",
    "vicuna-13b_response": "Cadasil syndrome is a rare genetic disorder caused by mutations in the CADASIL gene, which is responsible for the production of a protein known as cadherin-11. This protein is involved in the formation and maintenance of blood vessels, and mutations in the CADASIL gene can lead to the accumulation of abnormal deposits in the blood vessels, which can cause a range of symptoms including migraines, stroke, and dementia.\nIn terms of the specific amino acid residue that is most commonly mutated in cases of cadasil syndrome, it is not clear which one is most frequently affected. However, it is known that the majority of mutations in the CADASIL gene that cause cadasil syndrome are missense mutations, which means that the mutated amino acid is replaced by a different amino acid. The specific amino acid residue that is mutated can vary from one individual to another, and the nature of the mutation can also affect the severity of the symptoms and the progression of the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cadasil syndrome is a genetic disorder caused by mutations in the CADASIL gene.\n2. The CADASIL gene is responsible for the production of cadherin-11.\n3. Cadherin-11 is involved in the formation and maintenance of blood vessels.\n4. Mutations in the CADASIL gene can lead to the accumulation of abnormal deposits in the blood vessels.\n5. The majority of mutations in the CADASIL gene that cause cadasil syndrome are missense mutations.",
    "vicuna-13b_fact": [
      "Cadasil syndrome is a genetic disorder caused by mutations in the CADASIL gene.",
      "The CADASIL gene is responsible for the production of cadherin-11.",
      "Cadherin-11 is involved in the formation and maintenance of blood vessels.",
      "Mutations in the CADASIL gene can lead to the accumulation of abnormal deposits in the blood vessels.",
      "The majority of mutations in the CADASIL gene that cause cadasil syndrome are missense mutations."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Cadasil syndrome is a genetic disorder caused by mutations in the NOTCH3 gene, not the CADASIL gene.\n2. FALSE [correction]: The CADASIL gene does not exist. The NOTCH3 gene, not cadherin-11, is associated with Cadasil syndrome.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "vicuna-13b_response": "Mutations in the EZH2 gene have been associated with several syndromes, including:\n1. Beckwith-Wiedemann syndrome: a genetic disorder characterized by an overgrowth of certain parts of the body, such as an enlarged tongue (macroglossia), an overactive thyroid gland (hyperthyroidism), and an increased risk of developing certain tumors, such as Wilms tumor, hepatoblastoma, and rhabdomyosarcoma.\n2. Wiedemann-Beckwith syndrome: a condition that is similar to Beckwith-Wiedemann syndrome, but with less severe symptoms.\n3. Weaver syndrome: a rare genetic disorder characterized by an overgrowth of certain parts of the body, such as an enlarged tongue (macroglossia), an overactive thyroid gland (hyperthyroidism), and an increased risk of developing certain tumors, such as Wilms tumor and hepatoblastoma.\n4. Sotos syndrome: a genetic disorder characterized by an overgrowth of certain parts of the body, such as an enlarged tongue (macroglossia), an overactive thyroid gland (hyperthyroidism), and an increased risk of developing certain tumors, such as Wilms tumor and rhabdomyosarcoma.\nIt's important to note that these syndromes are rare and the association between EZH2 mutations and these syndromes is still being researched and understood.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mutations in the EZH2 gene have been associated with Beckwith-Wiedemann syndrome.\n2. Beckwith-Wiedemann syndrome is characterized by overgrowth in body parts and risk of developing specific tumors.\n3. Wiedemann-Beckwith syndrome, similar to Beckwith-Wiedemann syndrome but with less severe symptoms, is associated with EZH2 gene mutations.\n4. Mutations in the EZH2 gene have been associated with Weaver syndrome.\n5. Sotos syndrome, associated with EZH2 gene mutations, is characterized by overgrowth in body parts and risk of developing specific tumors.",
    "vicuna-13b_fact": [
      "Mutations in the EZH2 gene have been associated with Beckwith-Wiedemann syndrome.",
      "Beckwith-Wiedemann syndrome is characterized by overgrowth in body parts and risk of developing specific tumors.",
      "Wiedemann-Beckwith syndrome, similar to Beckwith-Wiedemann syndrome but with less severe symptoms, is associated with EZH2 gene mutations.",
      "Mutations in the EZH2 gene have been associated with Weaver syndrome.",
      "Sotos syndrome, associated with EZH2 gene mutations, is characterized by overgrowth in body parts and risk of developing specific tumors."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mutations in the CDKN1C gene, not the EZH2 gene, have been associated with Beckwith-Wiedemann syndrome.\n2. TRUE\n3. FALSE [correction]: Wiedemann-Beckwith syndrome is another name for Beckwith-Wiedemann syndrome, not a different condition with less severe symptoms. Both are associated with mutations in several genes, including the CDKN1C gene, not the EZH2 gene.\n4. TRUE\n5. FALSE [correction]: Sotos syndrome is associated with mutations in the NSD1 gene, not the EZH2 gene. It is characterized by overgrowth in body parts and risk of developing specific tumors.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 175,
    "user_query": "Which databases exist for experimentally determined topologies of α-helical transmembrane proteins ?",
    "vicuna-13b_response": "There are several databases that contain experimentally determined topologies of α-helical transmembrane proteins. Some of the most popular ones are:\n1. The Protein Data Bank (PDB): The PDB is a comprehensive database of experimentally determined protein structures. It contains a wide range of protein structures, including many α-helical transmembrane proteins. The structures in the PDB are annotated with information about the experimental methods used to determine their structures, which can be used to identify experimentally determined topologies of α-helical transmembrane proteins.\n2. The Transmembrane Protein Structure Database (TPSD): The TPSD is a specialized database that contains experimentally determined topologies of transmembrane proteins. It contains a large collection of α-helical transmembrane proteins, including many that have been determined using X-ray crystallography, nuclear magnetic resonance (NMR), and other experimental methods.\n3. The Experimental Transmembrane Protein Structure Database (ETPSD): The ETPSD is another specialized database that contains experimentally determined topologies of transmembrane proteins. It contains a large collection of α-helical transmembrane proteins, including many that have been determined using a variety of experimental methods.\n4. The Membrane Protein Structural Database (MPSD): The MPSD is a comprehensive database of experimentally determined membrane protein structures, including many α-helical transmembrane proteins. It contains a wide range of membrane protein structures, including those determined using X-ray crystallography, NMR, and other experimental methods.\nOverall, these databases provide a wealth of information on experimentally determined topologies of α-helical transmembrane proteins, and can be a valuable resource for researchers in the field.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Protein Data Bank (PDB) is a comprehensive database of experimentally determined protein structures, including α-helical transmembrane proteins.\n2. The Transmembrane Protein Structure Database (TPSD) specializes in experimentally determined topologies of transmembrane proteins, including α-helical transmembrane proteins determined using X-ray crystallography, nuclear magnetic resonance (NMR), and other methods.\n3. The Experimental Transmembrane Protein Structure Database (ETPSD) contains a large collection of α-helical transmembrane proteins determined using a variety of experimental methods.\n4. The Membrane Protein Structural Database (MPSD) is another comprehensive database of experimentally determined membrane protein structures, which includes α-helical transmembrane proteins.\n5. The structures in these databases are annotated with information about the experimental methods used to determine them.",
    "vicuna-13b_fact": [
      "The Protein Data Bank (PDB) is a comprehensive database of experimentally determined protein structures, including α-helical transmembrane proteins.",
      "The Transmembrane Protein Structure Database (TPSD) specializes in experimentally determined topologies of transmembrane proteins, including α-helical transmembrane proteins determined using X-ray crystallography, nuclear magnetic resonance (NMR), and other methods.",
      "The Experimental Transmembrane Protein Structure Database (ETPSD) contains a large collection of α-helical transmembrane proteins determined using a variety of experimental methods.",
      "The Membrane Protein Structural Database (MPSD) is another comprehensive database of experimentally determined membrane protein structures, which includes α-helical transmembrane proteins.",
      "The structures in these databases are annotated with information about the experimental methods used to determine them."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 178,
    "user_query": "How is oprozomib administered?",
    "vicuna-13b_response": "Oprozomib is administered as an intravenous (IV) infusion. The recommended dose of oprozomib is 125 mg given as an IV bolus injection, followed by a continuous IV infusion of 200 mg/hour. The infusion should be administered over 30 minutes to 1 hour. The infusion can be given using a standard infusion pump or a syringe pump. The infusion should be administered by a healthcare professional in a healthcare setting, such as a hospital or clinic. It is important to follow the instructions provided by your healthcare provider regarding the administration of oprozomib.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Oprozomib is administered as an intravenous (IV) infusion.\n2. The recommended dose of oprozomib is 125 mg given as an IV bolus injection, followed by a continuous IV infusion of 200 mg/hour.\n3. The oprozomib infusion should be administered over 30 minutes to 1 hour.\n4. The infusion can be given using a standard infusion pump or a syringe pump.\n5. The infusion should be administered by a healthcare professional in a healthcare setting, such as a hospital or clinic.",
    "vicuna-13b_fact": [
      "Oprozomib is administered as an intravenous (IV) infusion.",
      "The recommended dose of oprozomib is 125 mg given as an IV bolus injection, followed by a continuous IV infusion of 200 mg/hour.",
      "The oprozomib infusion should be administered over 30 minutes to 1 hour.",
      "The infusion can be given using a standard infusion pump or a syringe pump.",
      "The infusion should be administered by a healthcare professional in a healthcare setting, such as a hospital or clinic."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Oprozomib is administered orally.\n2. FALSE [correction]: The recommended dose of Oprozomib is not usually given as an infusion. It is an orally administered drug and the correct dose is determined by a healthcare professional.\n3. FALSE [correction]: Oprozomib is not administered as an infusion, it is an oral medication.\n4. FALSE [correction]: Oprozomib is not given via an infusion pump or syringe pump, it is taken orally.\n5. FALSE [correction]: Oprozomib should be administered orally, often at home, with specific instructions given by a healthcare provider.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 182,
    "user_query": "Does thyroid hormone regulate calcium transient in the myocardium?",
    "vicuna-13b_response": "Yes, thyroid hormone plays a role in regulating calcium transients in the myocardium. Thyroid hormone affects the contractility of the heart muscle cells (myocytes) by modulating the activity of ion channels, including the L-type calcium channel. This channel is important for the influx of calcium ions into the myocytes, which is necessary for muscle contraction.\nStudies have shown that thyroid hormone can increase the activity of the L-type calcium channel, leading to an increase in calcium influx and an increase in contractility of the heart muscle. Conversely, low levels of thyroid hormone can decrease the activity of the L-type calcium channel, leading to decreased calcium influx and decreased contractility of the heart muscle.\nIn addition, thyroid hormone also affects the activity of other ion channels, such as the sodium and potassium channels, which can also influence the electrical activity and contractility of the heart.\nOverall, the regulation of calcium transients in the myocardium is a complex process that is influenced by a variety of factors, including thyroid hormone.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Thyroid hormone plays a role in regulating calcium transients in the myocardium.\n2. Thyroid hormone affects the contractility of the heart muscle cells by modulating the activity of ion channels, including the L-type calcium channel.\n3. The L-type calcium channel is important for the influx of calcium ions into the myocytes, which is necessary for muscle contraction.\n4. Studies show that thyroid hormone can increase the activity of the L-type calcium channel, hence increasing calcium influx and the contractility of the heart muscle.\n5. Low levels of thyroid hormone can decrease the activity of the L-type calcium channel, leading to decreased calcium influx and decreased contractility of the heart muscle.",
    "vicuna-13b_fact": [
      "Thyroid hormone plays a role in regulating calcium transients in the myocardium.",
      "Thyroid hormone affects the contractility of the heart muscle cells by modulating the activity of ion channels, including the L-type calcium channel.",
      "The L-type calcium channel is important for the influx of calcium ions into the myocytes, which is necessary for muscle contraction.",
      "Studies show that thyroid hormone can increase the activity of the L-type calcium channel, hence increasing calcium influx and the contractility of the heart muscle.",
      "Low levels of thyroid hormone can decrease the activity of the L-type calcium channel, leading to decreased calcium influx and decreased contractility of the heart muscle."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 185,
    "user_query": "The protein NONO forms heterodimers. With which proteins?",
    "vicuna-13b_response": "NONO (also known as NOD2) is a protein that plays a role in the innate immune system. It forms heterodimers with other proteins called receptors of activated C-type lectin domain containing proteins (RLTPs). There are several different RLTPs that can form heterodimers with NONO, including:\n1. C-type lectin receptors (CLRs) - These are proteins that are involved in the recognition and binding of pathogens, such as bacteria and viruses.\n2. C-type lectin-like receptors (CLECs) - These are proteins that are involved in the recognition and binding of pathogens, similar to CLRs.\n3. C-type lectin domain containing proteins (CTLs) - These are proteins that contain a C-type lectin domain, which is a region of the protein that is involved in the recognition and binding of carbohydrates.\nOverall, the formation of NONO heterodimers with these different proteins allows NONO to play a role in the recognition and binding of pathogens, and to initiate an immune response.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. NONO, also known as NOD2, is a protein that plays a role in the innate immune system.\n2. NONO forms heterodimers with receptors of activated C-type lectin domain containing proteins (RLTPs).\n3. Different types of RLTPs include C-type lectin receptors (CLRs), C-type lectin-like receptors (CLECs), and C-type lectin domain containing proteins (CTLs).\n4. These RLTP proteins are involved in the recognition and binding of pathogens.\n5. These heterodimers between NONO and RLTPs help in the recognition and binding of pathogens, initiating an immune response.",
    "vicuna-13b_fact": [
      "NONO, also known as NOD2, is a protein that plays a role in the innate immune system.",
      "NONO forms heterodimers with receptors of activated C-type lectin domain containing proteins (RLTPs).",
      "Different types of RLTPs include C-type lectin receptors (CLRs), C-type lectin-like receptors (CLECs), and C-type lectin domain containing proteins (CTLs).",
      "These RLTP proteins are involved in the recognition and binding of pathogens.",
      "These heterodimers between NONO and RLTPs help in the recognition and binding of pathogens, initiating an immune response."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: NONO, also known as Non-POU domain-containing octamer-binding protein, is a protein involved in several nuclear processes including transcription, DNA repair and RNA splicing.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 188,
    "user_query": "Is there any link between CTF4 and CTF18 during sister chromatid cohesion?",
    "vicuna-13b_response": "CTF4 and CTF18 are two different proteins that play important roles in the process of sister chromatid cohesion during mitosis in eukaryotic cells.\nSister chromatid cohesion is the process by which the two sister chromatids, which are identical copies of a chromosome, are held together during the process of mitosis. This is necessary to ensure that each daughter cell receives a complete and accurate copy of the parental genome.\nCTF4 is a protein that is involved in the recruitment and activation of the cohesin complex, which is responsible for holding the sister chromatids together. CTF18 is a protein that is involved in the regulation of the cohesin complex, and is thought to play a role in the process of sister chromatid separation during anaphase.\nThere is some evidence to suggest that CTF4 and CTF18 may be involved in related processes during sister chromatid cohesion, but they are not directly linked to each other. CTF4 and CTF18 may function in different pathways or have different roles in the process of sister chromatid cohesion.\nOverall, while there may be some link between CTF4 and CTF18 during sister chromatid cohesion, more research is needed to fully understand their roles and how they interact with each other.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. CTF4 and CTF18 are two different proteins that play roles in the process of sister chromatid cohesion during mitosis in eukaryotic cells.\n2. Sister chromatid cohesion is the process by which the two sister chromatids, which are identical copies of a chromosome, are held together during the process of mitosis.\n3. CTF4 is involved in the recruitment and activation of the cohesin complex, which is responsible for holding the sister chromatids together. \n4. CTF18 is a protein that is involved in the regulation of the cohesin complex, and is thought to play a role in the process of sister chromatid separation during anaphase.\n5. CTF4 and CTF18 may be involved in related processes during sister chromatid cohesion, but they are not directly linked to each other.",
    "vicuna-13b_fact": [
      "CTF4 and CTF18 are two different proteins that play roles in the process of sister chromatid cohesion during mitosis in eukaryotic cells.",
      "Sister chromatid cohesion is the process by which the two sister chromatids, which are identical copies of a chromosome, are held together during the process of mitosis.",
      "CTF4 is involved in the recruitment and activation of the cohesin complex, which is responsible for holding the sister chromatids together.",
      "CTF18 is a protein that is involved in the regulation of the cohesin complex, and is thought to play a role in the process of sister chromatid separation during anaphase.",
      "CTF4 and CTF18 may be involved in related processes during sister chromatid cohesion, but they are not directly linked to each other."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: CTF4 and CTF18 work in concert in the process of sister chromatid cohesion and their actions are interrelated, hence they are directly linked to each other.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "vicuna-13b_response": "A dimer-to-tetramer transition refers to a change in the oligomerization state of a protein from a dimer (a protein consisting of two identical or similar subunits) to a tetramer (a protein consisting of four identical or similar subunits).\nThere are several human proteins that are subject to a dimer-to-tetramer transition, including:\n1. Hemoglobin: Hemoglobin is a protein found in red blood cells that is responsible for carrying oxygen from the lungs to the body's tissues and for carrying carbon dioxide from the tissues to the lungs. Hemoglobin is composed of two alpha and two beta chains, and it undergoes a dimer-to-tetramer transition as it binds to oxygen.\n2. Myoglobin: Myoglobin is a protein found in muscle cells that functions as an oxygen storage protein. Like hemoglobin, myoglobin is composed of two alpha and two beta chains, and it undergoes a dimer-to-tetramer transition as it binds to oxygen.\n3. Cytochrome c: Cytochrome c is a protein found in the mitochondria of cells that plays a role in cellular respiration. Cytochrome c is composed of three polypeptide chains, and it undergoes a dimer-to-tetramer transition as it participates in electron transport.\n4. Apolipoprotein A-1: Apolipoprotein A-1 is a protein found in lipoproteins that plays a role in the transport of cholesterol and other lipids in the blood. Apolipoprotein A-1 is composed of two identical subunits, and it undergoes a dimer-to-tetramer transition as it binds to lipids.\n5. Hemopexin: Hemopexin is a protein found in the blood that plays a role in the regulation of iron homeostasis. Hemopexin is composed of two identical subunits, and it undergoes a dimer-to-tetramer transition as it binds to iron.\nThese are just a few examples of human proteins that undergo a dimer-to-tetram",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hemoglobin is a human protein that undergoes a dimer-to-tetramer transition as it binds to oxygen.\n2. Myoglobin is found in muscle cells and it also undergoes a dimer-to-tetramer transition as it binds to oxygen.\n3. Cytochrome c, a protein found in the mitochondria of cells that participates in cellular respiration, undergoes a dimer-to-tetramer transition as it participates in electron transport.\n4. Apolipoprotein A-1, a protein found in lipoproteins, undergoes a dimer-to-tetramer transition as it binds to lipids.\n5. Hemopexin, a protein found in the blood, undergoes a dimer-to-tetramer transition as it binds to iron.",
    "vicuna-13b_fact": [
      "Hemoglobin is a human protein that undergoes a dimer-to-tetramer transition as it binds to oxygen.",
      "Myoglobin is found in muscle cells and it also undergoes a dimer-to-tetramer transition as it binds to oxygen.",
      "Cytochrome c, a protein found in the mitochondria of cells that participates in cellular respiration, undergoes a dimer-to-tetramer transition as it participates in electron transport.",
      "Apolipoprotein A-1, a protein found in lipoproteins, undergoes a dimer-to-tetramer transition as it binds to lipids.",
      "Hemopexin, a protein found in the blood, undergoes a dimer-to-tetramer transition as it binds to iron."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Hemoglobin is a protein in red blood cells that undergoes a transition from a relaxed state (R state) to a tense state (T state) upon binding to oxygen, but not from a dimer to a tetramer. Hemoglobin is already a tetrameric protein, consisting of two alpha and two beta subunits.\n2. FALSE [correction]: Myoglobin, found in muscle cells, is a monomeric protein that binds to oxygen. It does not undergo a dimer-to-tetramer transition when it binds to oxygen.\n3. FALSE [correction]: Cytochrome c does not undergo a dimer-to-tetramer transition. It is a monomeric protein involved in the electron transport chain during cellular respiration.\n4. UNKNOWN\n5. FALSE [correction]: Hemopexin, a plasma protein, binds free heme released during hemoglobin degradation. There is no known dimer-to-tetramer transition as it binds to iron or heme.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 197,
    "user_query": "Which gene strand is targeted by transcription-coupled repair (TCR)?",
    "vicuna-13b_response": "Transcription-coupled repair (TCR) is a DNA repair mechanism that is targeted to the template strand of active genes. The template strand is the strand of DNA that serves as a template for the synthesis of mRNA during transcription. TCR is activated when a DNA lesion is detected on the template strand, and it involves the recruitment of repair enzymes to the site of the lesion. These enzymes then remove the damaged base or strand and replace it with a correct base or strand, ensuring the integrity of the template strand and the accuracy of gene expression.\nTCR is an efficient and accurate repair mechanism that is specifically targeted to the template strand of active genes, which helps to minimize the risk of mutations and ensure the proper functioning of the gene.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Transcription-coupled repair (TCR) is a DNA repair mechanism that is targeted to the template strand of active genes.\n2. The template strand of DNA serves as a template for the synthesis of mRNA during transcription.\n3. TCR is activated when a DNA lesion is detected on the template strand.\n4. The TCR process involves the recruitment of repair enzymes to the site of the lesion to remove the damaged base or strand and replace it with a correct one.\n5. TCR helps to minimize the risk of mutations and ensure the proper functioning of the gene.",
    "vicuna-13b_fact": [
      "Transcription-coupled repair (TCR) is a DNA repair mechanism that is targeted to the template strand of active genes.",
      "The template strand of DNA serves as a template for the synthesis of mRNA during transcription.",
      "TCR is activated when a DNA lesion is detected on the template strand.",
      "The TCR process involves the recruitment of repair enzymes to the site of the lesion to remove the damaged base or strand and replace it with a correct one.",
      "TCR helps to minimize the risk of mutations and ensure the proper functioning of the gene."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 199,
    "user_query": "Which is the branch site consensus sequence in U12-dependent introns?",
    "vicuna-13b_response": "The branch site consensus sequence in U12-dependent introns is the sequence of nucleotides that is recognized and bound by the U12 protein, which is a component of the spliceosome. The U12 protein is involved in the recognition and binding of the branch site, which is the region of the intron that is located between the 5' donor site and the 3' acceptor site. The branch site consensus sequence is a specific sequence of nucleotides that is recognized and bound by the U12 protein, and it is thought to play a role in the recognition and binding of the intron to the spliceosome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The branch site consensus sequence in U12-dependent introns is recognized and bound by the U12 protein.\n2. The U12 protein is a component of the spliceosome.\n3. The U12 protein is involved in the recognition and binding of the branch site.\n4. The branch site is located between the 5' donor site and the 3' acceptor site.\n5. The branch site consensus sequence is thought to play a role in the recognition and binding of the intron to the spliceosome.",
    "vicuna-13b_fact": [
      "The branch site consensus sequence in U12-dependent introns is recognized and bound by the U12 protein.",
      "The U12 protein is a component of the spliceosome.",
      "The U12 protein is involved in the recognition and binding of the branch site.",
      "The branch site is located between the 5' donor site and the 3' acceptor site.",
      "The branch site consensus sequence is thought to play a role in the recognition and binding of the intron to the spliceosome."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 201,
    "user_query": "What is the suggested therapy for Mycobacterium avium infection?",
    "vicuna-13b_response": "The suggested therapy for Mycobacterium avium infection depends on the severity and location of the infection. M. avium is a slow-growing mycobacterium that can cause infections in various parts of the body, including the lungs, skin, and soft tissues.\nFor pulmonary (lung) infections with M. avium, the recommended treatment is a combination of antibiotics, typically including a first-line drug such as clarithromycin, rifampin, and ethambutol. The treatment duration is usually at least 12 months.\nFor skin and soft tissue infections, the treatment may involve surgical debridement (removal of infected tissue) in addition to antibiotics.\nIt is important to note that the choice of therapy and duration of treatment for M. avium infections may vary depending on the individual case and the healthcare provider's judgment. It is crucial to follow the guidance of a healthcare professional when treating a Mycobacterium avium infection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The suggested therapy for Mycobacterium avium infection depends on the severity and location of the infection.\n2. M. avium is a slow-growing mycobacterium that can cause infections in various parts of the body, including the lungs, skin, and soft tissues.\n3. For pulmonary (lung) infections with M. avium, the recommended treatment includes a combination of antibiotics, such as clarithromycin, rifampin, and ethambutol.\n4. The treatment for pulmonary infections with M. avium usually lasts at least 12 months.\n5. Skin and soft tissue infections treatment may involve surgical debridement in addition to antibiotics.",
    "vicuna-13b_fact": [
      "The suggested therapy for Mycobacterium avium infection depends on the severity and location of the infection.",
      "M. avium is a slow-growing mycobacterium that can cause infections in various parts of the body, including the lungs, skin, and soft tissues.",
      "For pulmonary (lung) infections with M. avium, the recommended treatment includes a combination of antibiotics, such as clarithromycin, rifampin, and ethambutol.",
      "The treatment for pulmonary infections with M. avium usually lasts at least 12 months.",
      "Skin and soft tissue infections treatment may involve surgical debridement in addition to antibiotics."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "vicuna-13b_response": "One protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is the protein known as \"Bcl-2\".\nBcl-2 is a member of the Bcl-2 protein family, which plays a critical role in regulating programmed cell death, or apoptosis. Bcl-2 is an anti-apoptotic protein, meaning that it helps to prevent cell death. Bcl-2 has been found to interact with phospholamban (PLN) through its N-terminal domain, which is involved in the regulation of its anti-apoptotic function.\nThe interaction between Bcl-2 and phospholamban (PLN) has been shown to be important in regulating the activity of the cardiac sarcoendoplasmic reticulum Ca2+-ATPase (SERCA), which is an enzyme that pumps calcium ions into the sarcoplasmic reticulum (SR) of heart muscle cells. The interaction between Bcl-2 and PLN has been shown to modulate the activity of SERCA, and this can have important implications for the regulation of heart function and the prevention of cell death in heart muscle cells.\nOverall, the interaction between Bcl-2 and phospholamban (PLN) is an important regulatory mechanism that helps to maintain the proper function of heart muscle cells and prevent cell death.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Bcl-2 is a protein that interacts with phospholamban (PLN) and is also an anti-apoptotic protein.\n2. Bcl-2 is a member of the Bcl-2 protein family, which plays a critical role in regulating programmed cell death or apoptosis.\n3. Bcl-2 interacts with phospholamban (PLN) through its N-terminal domain.\n4. The interaction between Bcl-2 and phospholamban (PLN) regulates the activity of the cardiac sarcoendoplasmic reticulum Ca2+-ATPase (SERCA).\n5. The interaction between Bcl-2 and phospholamban (PLN) is an important regulatory mechanism that helps to maintain the proper function of heart muscle cells and prevent cell death.",
    "vicuna-13b_fact": [
      "Bcl-2 is a protein that interacts with phospholamban (PLN) and is also an anti-apoptotic protein.",
      "Bcl-2 is a member of the Bcl-2 protein family, which plays a critical role in regulating programmed cell death or apoptosis.",
      "Bcl-2 interacts with phospholamban (PLN) through its N-terminal domain.",
      "The interaction between Bcl-2 and phospholamban (PLN) regulates the activity of the cardiac sarcoendoplasmic reticulum Ca2+-ATPase (SERCA).",
      "The interaction between Bcl-2 and phospholamban (PLN) is an important regulatory mechanism that helps to maintain the proper function of heart muscle cells and prevent cell death."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 213,
    "user_query": "Is protein M3/6 a dual specificity phosphatase?",
    "vicuna-13b_response": "Yes, protein M3/6 is a dual specificity phosphatase. It is also known as protein tyrosine phosphatase-like protein M3/6 (PTPRD) and is a member of the protein tyrosine phosphatase (PTP) family. PTPs are a group of enzymes that catalyze the removal of phosphate groups from tyrosine residues on proteins, which is known as dephosphorylation.\nDual specificity phosphatases (DSPs) are a subfamily of PTPs that can dephosphorylate both tyrosine and serine/threonine residues on proteins. DSPs are characterized by the presence of a conserved motif called the DSP domain, which is responsible for their dual specificity phosphatase activity.\nProtein M3/6 contains a DSP domain and has been shown to dephosphorylate both tyrosine and serine/threonine residues on a variety of target proteins. Therefore, it is considered a dual specificity phosphatase. The function of protein M3/6 and its role in regulating signaling pathways are areas of active research.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Protein M3/6 is a dual specificity phosphatase.\n2. Protein M3/6 is also known as protein tyrosine phosphatase-like protein M3/6 (PTPRD).\n3. Protein M3/6 is a member of the protein tyrosine phosphatase (PTP) family.\n4. Dual specificity phosphatases (DSPs) can dephosphorylate both tyrosine and serine/threonine residues on proteins.\n5. Protein M3/6 contains a DSP domain and can dephosphorylate both tyrosine and serine/threonine residues on target proteins.",
    "vicuna-13b_fact": [
      "Protein M3/6 is a dual specificity phosphatase.",
      "Protein M3/6 is also known as protein tyrosine phosphatase-like protein M3/6 (PTPRD).",
      "Protein M3/6 is a member of the protein tyrosine phosphatase (PTP) family.",
      "Dual specificity phosphatases (DSPs) can dephosphorylate both tyrosine and serine/threonine residues on proteins.",
      "Protein M3/6 contains a DSP domain and can dephosphorylate both tyrosine and serine/threonine residues on target proteins."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "vicuna-13b_response": "Yes, vitamin D has been shown to reduce the incidence of falls in older people in clinical trials. Several studies have found that vitamin D supplementation can improve balance and reduce the risk of falls in older adults.\nOne randomized controlled trial published in the Journal of the American Geriatrics Society found that older adults who took vitamin D supplements had a 20% lower risk of falling compared to those who did not take vitamin D supplements. Another study published in the Journal of Clinical Endocrinology & Metabolism found that vitamin D supplementation reduced the risk of falls in postmenopausal women by 30%.\nOther studies have also found that vitamin D supplementation can improve muscle strength, balance, and cognitive function, all of which can help reduce the risk of falls in older adults.\nIt's important to note that while vitamin D supplementation can be beneficial for reducing the risk of falls, it is not a guarantee and should not be the sole intervention for fall prevention. A comprehensive fall prevention program should include a combination of strategies such as exercise, home safety assessments, and medication management.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Vitamin D has been shown to reduce the incidence of falls in older people in clinical trials.\n2. A randomized controlled trial published in the Journal of the American Geriatrics Society found a 20% reduced risk of falling in older adults who took vitamin D supplements.\n3. Another study in the Journal of Clinical Endocrinology & Metabolism found that vitamin D reduced the risk of falls in postmenopausal women by 30%.\n4. Studies suggest that vitamin D supplementation can improve muscle strength, balance, and cognitive function.\n5. Vitamin D supplementation is not a guarantee for fall prevention and should be complemented with other strategies such as exercise, home safety assessments, and medication management.",
    "vicuna-13b_fact": [
      "Vitamin D has been shown to reduce the incidence of falls in older people in clinical trials.",
      "A randomized controlled trial published in the Journal of the American Geriatrics Society found a 20% reduced risk of falling in older adults who took vitamin D supplements.",
      "Another study in the Journal of Clinical Endocrinology & Metabolism found that vitamin D reduced the risk of falls in postmenopausal women by 30%.",
      "Studies suggest that vitamin D supplementation can improve muscle strength, balance, and cognitive function.",
      "Vitamin D supplementation is not a guarantee for fall prevention and should be complemented with other strategies such as exercise, home safety assessments, and medication management."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 221,
    "user_query": "What is the generic name of Gliolan?",
    "vicuna-13b_response": "Gliolan is the brand name for the generic drug oxaliplatin.",
    "vicuna-13b_fact_raw": "The factual statement is: \n1. The generic name for the drug Gliolan is oxaliplatin.",
    "vicuna-13b_fact": [
      "The generic name for the drug Gliolan is oxaliplatin."
    ],
    "vicuna-13b_judge_raw": "FALSE [correction]: The generic name for the drug Gliolan is 5-aminolevulinic acid.",
    "vicuna-13b_judge": [
      "false"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "vicuna-13b_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells.\nJarid2 is a transcriptional repressor that has been shown to play a role in regulating the differentiation and function of T helper 17 (Th17) cells, which are a subset of T cells that play a critical role in regulating the immune response.\nmiR-155 is a microRNA that has been shown to be involved in the regulation of Th17 cell differentiation and function. Specifically, miR-155 has been shown to target the Jarid2 gene, leading to the repression of Jarid2 expression and the promotion of Th17 cell differentiation.\nIn addition, miR-155 has been shown to be involved in the regulation of other aspects of Th17 cell biology, including their survival, proliferation, and cytokine production.\nOverall, the association between Jarid2 and miR-155 in Th17 cells is important for the regulation of Th17 cell differentiation and function, and dysregulation of this pathway has been implicated in the pathogenesis of a variety of autoimmune diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Jarid2 is a transcriptional repressor that plays a role in regulating the differentiation and function of T helper 17 (Th17) cells.\n2. Th17 cells are a subset of T cells that play a critical role in regulating the immune response.\n3. miR-155 is a microRNA that is involved in the regulation of Th17 cell differentiation and function.\n4. miR-155 has been shown to target the Jarid2 gene, leading to the repression of Jarid2 expression and the promotion of Th17 cell differentiation.\n5. Dysregulation of the pathway between Jarid2 and miR-155 in Th17 cells has been implicated in the pathogenesis of a variety of autoimmune diseases.",
    "vicuna-13b_fact": [
      "Jarid2 is a transcriptional repressor that plays a role in regulating the differentiation and function of T helper 17 (Th17) cells.",
      "Th17 cells are a subset of T cells that play a critical role in regulating the immune response.",
      "miR-155 is a microRNA that is involved in the regulation of Th17 cell differentiation and function.",
      "miR-155 has been shown to target the Jarid2 gene, leading to the repression of Jarid2 expression and the promotion of Th17 cell differentiation.",
      "Dysregulation of the pathway between Jarid2 and miR-155 in Th17 cells has been implicated in the pathogenesis of a variety of autoimmune diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "vicuna-13b_response": "The human hoxD cluster contains 39 genes. The hoxD cluster is a group of genes that are involved in the development of the body plan of an organism, and is located on chromosome 13. These genes play a crucial role in the process of embryonic development, and are responsible for the proper formation and differentiation of various body parts. The hoxD cluster is one of the largest clusters of genes in the human genome, and is thought to have evolved through a process of gene duplication and diversification.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The human hoxD cluster contains 39 genes.\n2. The hoxD cluster is involved in the development of the body plan of an organism.\n3. The hoxD cluster is located on chromosome 13.\n4. Genes in the hoxD cluster are responsible for the proper formation and differentiation of various body parts.\n5. The hoxD cluster is one of the largest clusters of genes in the human genome.",
    "vicuna-13b_fact": [
      "The human hoxD cluster contains 39 genes.",
      "The hoxD cluster is involved in the development of the body plan of an organism.",
      "The hoxD cluster is located on chromosome 13.",
      "Genes in the hoxD cluster are responsible for the proper formation and differentiation of various body parts.",
      "The hoxD cluster is one of the largest clusters of genes in the human genome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The human hoxD cluster contains 9 genes.\n2. TRUE\n3. FALSE [correction]: The hoxD cluster is located on chromosome 2.\n4. TRUE\n5. FALSE [correction]: The hoxD cluster is not one of the largest clusters of genes in the human genome.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 229,
    "user_query": "Which are the human glutamate transporters?",
    "vicuna-13b_response": "There are two main types of glutamate transporters in the human body:\n1. Excitatory Amino Acid Transporter 1 (EAAT1) also known as GLUT1: It is responsible for importing glutamate into cells, particularly in the central nervous system. It is expressed in high levels in astrocytes, which are a type of glial cell that play a critical role in supporting neuronal function.\n2. Excitatory Amino Acid Transporter 2 (EAAT2) also known as GLUT2: It is responsible for importing glutamate into cells, particularly in the peripheral tissues such as the kidney, pancreas and intestine. It is expressed in high levels in astrocytes and neurons in the central nervous system.\nBoth EAAT1 and EAAT2 are important for maintaining proper levels of glutamate in the brain and other tissues, and mutations in these genes have been linked to a variety of neurological disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. There are two main types of human glutamate transporters: Excitatory Amino Acid Transporter 1 (EAAT1) and Excitatory Amino Acid Transporter 2 (EAAT2).\n2. EAAT1, also known as GLUT1, is responsible for importing glutamate into cells, particularly in the central nervous system.\n3. EAAT1 is expressed in high levels in astrocytes, a type of glial cell that supports neuronal function.\n4. EAAT2, also known as GLUT2, is responsible for importing glutamate into cells, particularly in the peripheral tissues such as the kidney, pancreas and intestine.\n5. Mutations in genes EAAT1 and EAAT2 have been linked to a variety of neurological disorders.",
    "vicuna-13b_fact": [
      "There are two main types of human glutamate transporters: Excitatory Amino Acid Transporter 1 (EAAT1) and Excitatory Amino Acid Transporter 2 (EAAT2).",
      "EAAT1, also known as GLUT1, is responsible for importing glutamate into cells, particularly in the central nervous system.",
      "EAAT1 is expressed in high levels in astrocytes, a type of glial cell that supports neuronal function.",
      "EAAT2, also known as GLUT2, is responsible for importing glutamate into cells, particularly in the peripheral tissues such as the kidney, pancreas and intestine.",
      "Mutations in genes EAAT1 and EAAT2 have been linked to a variety of neurological disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: EAAT1, not known as GLUT1, is responsible for importing glutamate into cells, particularly in the central nervous system.\n3. TRUE\n4. FALSE [correction]: EAAT2, not known as GLUT2, is responsible for importing glutamate into cells, particularly in the central nervous system and not peripheral tissues.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 235,
    "user_query": "What is the causative agent of the \"Panama disease\" affecting bananas?",
    "vicuna-13b_response": "The causative agent of the \"Panama disease\" affecting bananas is a fungus called Fusarium oxysporum f. sp. cubense (Foc). It is also known as \"Panama TR4\" or \"Tropical Race 4.\" This fungus is a major threat to banana production worldwide and can cause significant yield losses in affected plants. The fungus infects the roots of the banana plant and can spread rapidly through the soil, making it difficult to control once it has taken hold. The use of resistant banana varieties, crop rotation, and proper soil management practices can help to reduce the impact of the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Panama disease in bananas is caused by a fungus called Fusarium oxysporum f. sp. cubense.\n2. The fungus Fusarium oxysporum f. sp. cubense is also known as \"Panama TR4\" or \"Tropical Race 4.\"\n3. This fungus is a major threat to banana production worldwide.\n4. The fungus Fusarium oxysporum f. sp. cubense infects the roots of the banana plant.\n5. Resistant banana varieties, crop rotation, and proper soil management practices can help to reduce the impact of the Panama disease.",
    "vicuna-13b_fact": [
      "Panama disease in bananas is caused by a fungus called Fusarium oxysporum f. sp. cubense.",
      "The fungus Fusarium oxysporum f. sp. cubense is also known as \"Panama TR4\" or \"Tropical Race 4.\"",
      "This fungus is a major threat to banana production worldwide.",
      "The fungus Fusarium oxysporum f. sp. cubense infects the roots of the banana plant.",
      "Resistant banana varieties, crop rotation, and proper soil management practices can help to reduce the impact of the Panama disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 237,
    "user_query": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?",
    "vicuna-13b_response": "The Mercedes Benz syndrome is a rare congenital disorder characterized by the fusion of certain cranial structures. Specifically, it is characterized by the fusion of the bilateral cribriform plates, which are bony structures that form the roof of the nasal cavity. This results in the formation of a single, wide nasal passage, which can lead to difficulty breathing through the nose and other associated symptoms. In addition to the fusion of the cribriform plates, the Mercedes Benz syndrome can also involve the fusion of other cranial structures, such as the sphenoid bone, the ethmoid bone, and the vomer bone. These additional fusions can lead to a range of symptoms, including difficulty swallowing, eye problems, and abnormalities of the middle ear and inner ear. It is important to note that the Mercedes Benz syndrome is a rare condition, and it is typically diagnosed in infancy or early childhood. Treatment may involve surgery, depending on the severity of the symptoms and the extent of the fusion.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mercedes Benz syndrome is a rare congenital disorder characterized by the fusion of certain cranial structures.\n2. The condition is characterized by the fusion of the bilateral cribriform plates.\n3. The fusion in the Mercedes Benz syndrome results in the formation of a single, wide nasal passage.\n4. The syndrome can also involve the fusion of other cranial structures, such as the sphenoid bone, the ethmoid bone, and the vomer bone.\n5. The Mercedes Benz syndrome is typically diagnosed in infancy or early childhood.",
    "vicuna-13b_fact": [
      "Mercedes Benz syndrome is a rare congenital disorder characterized by the fusion of certain cranial structures.",
      "The condition is characterized by the fusion of the bilateral cribriform plates.",
      "The fusion in the Mercedes Benz syndrome results in the formation of a single, wide nasal passage.",
      "The syndrome can also involve the fusion of other cranial structures, such as the sphenoid bone, the ethmoid bone, and the vomer bone.",
      "The Mercedes Benz syndrome is typically diagnosed in infancy or early childhood."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 242,
    "user_query": "What is a mitochondrial nucleoid?",
    "vicuna-13b_response": "The mitochondrial nucleoid is a region within the mitochondria of a cell that contains the genetic material, specifically the DNA. Mitochondria are organelles found in most eukaryotic cells that are responsible for generating energy for the cell through a process called cellular respiration. The mitochondrial nucleoid is a small, dense region within the mitochondria that contains the DNA that is specific to the mitochondria. This DNA is different from the nuclear DNA found in the cell nucleus, and it is thought to have evolved from bacterial plasmids. The mitochondrial nucleoid plays a role in the replication and expression of the mitochondrial genome, and it is also involved in the regulation of certain cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The mitochondrial nucleoid is a region within the mitochondria of a cell that contains the genetic material, specifically the DNA.\n2. Mitochondria are organelles found in most eukaryotic cells that are responsible for generating energy for the cell through cellular respiration.\n3. The mitochondrial nucleoid is a small, dense region within the mitochondria that contains the DNA that is specific to the mitochondria.\n4. Mitochondrial DNA is different from the nuclear DNA found in the cell nucleus, and it is thought to have evolved from bacterial plasmids.\n5. The mitochondrial nucleoid plays a role in the replication and expression of the mitochondrial genome, and it is also involved in the regulation of certain cellular processes.",
    "vicuna-13b_fact": [
      "The mitochondrial nucleoid is a region within the mitochondria of a cell that contains the genetic material, specifically the DNA.",
      "Mitochondria are organelles found in most eukaryotic cells that are responsible for generating energy for the cell through cellular respiration.",
      "The mitochondrial nucleoid is a small, dense region within the mitochondria that contains the DNA that is specific to the mitochondria.",
      "Mitochondrial DNA is different from the nuclear DNA found in the cell nucleus, and it is thought to have evolved from bacterial plasmids.",
      "The mitochondrial nucleoid plays a role in the replication and expression of the mitochondrial genome, and it is also involved in the regulation of certain cellular processes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 247,
    "user_query": "What is the effect of ivabradine in heart failure with preserved ejection fraction?",
    "vicuna-13b_response": "Ivabradine is a medication that is used to treat heart failure with preserved ejection fraction (HFpEF). It works by slowing down the heart rate and improving the heart's contractility, which can improve the symptoms of heart failure and reduce the risk of hospitalization.\nIn HFpEF, the heart muscle is still able to pump blood out effectively, but the heart rate is too fast, which can cause the heart to work harder and lead to symptoms such as fatigue, shortness of breath, and swelling in the legs and ankles. Ivabradine helps to lower the heart rate by selectively blocking the \"funny\" channels in the heart, which helps to slow down the conduction of electrical signals in the heart and reduce the heart rate.\nBy slowing down the heart rate, ivabradine can reduce the workload on the heart and improve the symptoms of heart failure. Additionally, ivabradine has been shown to improve the ejection fraction, which is a measure of the amount of blood pumped out of the heart with each beat, in patients with HFpEF.\nIvabradine is often used in combination with other heart failure medications, such as beta-blockers and diuretics, to improve the symptoms of heart failure and reduce the risk of hospitalization. However, it is important to note that ivabradine is not suitable for all patients with HFpEF and should only be used under the guidance of a healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ivabradine is a medication used to treat heart failure with preserved ejection fraction (HFpEF).\n2. Ivabradine works by slowing down the heart rate and improving the heart's contractility.\n3. In HFpEF, the heart still can pump blood out effectively, but the heart rate is too fast.\n4. The medication ivabradine slows down the heart rate by selectively blocking the \"funny\" channels in the heart to slow down the conduction of electrical signals.\n5. Ivabradine is often used in combination with other heart failure medications, such as beta-blockers and diuretics.",
    "vicuna-13b_fact": [
      "Ivabradine is a medication used to treat heart failure with preserved ejection fraction (HFpEF).",
      "Ivabradine works by slowing down the heart rate and improving the heart's contractility.",
      "In HFpEF, the heart still can pump blood out effectively, but the heart rate is too fast.",
      "The medication ivabradine slows down the heart rate by selectively blocking the \"funny\" channels in the heart to slow down the conduction of electrical signals.",
      "Ivabradine is often used in combination with other heart failure medications, such as beta-blockers and diuretics."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Ivabradine is primarily used to treat heart failure with reduced ejection fraction (HFrEF). The efficiency of Ivabradine for HFpEF patients has not been fully proven and is still under investigation.\n2. FALSE [correction]: Ivabradine works by slowing down the heart rate but it does not influence the heart's contractility.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 248,
    "user_query": "Is low T3 syndrome a prognostic marker in patients with renal insufficiency?",
    "vicuna-13b_response": "Low T3 syndrome is a condition characterized by low levels of triiodothyronine (T3), a thyroid hormone, in the blood. It can be caused by a variety of factors, including hypothyroidism, thyroid surgery, and medications that interfere with T3 production.\nIn patients with renal insufficiency, low T3 syndrome can be a prognostic marker for poor outcomes, such as increased risk of death and cardiovascular events. Studies have shown that patients with renal insufficiency and low T3 syndrome have higher rates of mortality and morbidity compared to those with normal T3 levels.\nHowever, it is important to note that the relationship between low T3 syndrome and renal insufficiency is complex and multifactorial. Other factors, such as the underlying cause of renal insufficiency, comorbidities, and treatment options, can also affect outcomes in these patients.\nTherefore, while low T3 syndrome may be a prognostic marker for poor outcomes in patients with renal insufficiency, it is important to consider other factors and to individualize treatment based on the specific needs and circumstances of each patient.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Low T3 syndrome is a condition characterized by low levels of triiodothyronine (T3) in the blood.\n2. Low T3 syndrome can be caused by hypothyroidism, thyroid surgery, and medications that interfere with T3 production.\n3. In patients with renal insufficiency, low T3 syndrome can be a prognostic marker for poor outcomes such as risk of death and cardiovascular events.\n4. Studies have shown that patients with renal insufficiency and low T3 syndrome have higher rates of mortality and morbidity compared to those with normal T3 levels.\n5. The relationship between low T3 syndrome and renal insufficiency is complex and multifactorial.",
    "vicuna-13b_fact": [
      "Low T3 syndrome is a condition characterized by low levels of triiodothyronine (T3) in the blood.",
      "Low T3 syndrome can be caused by hypothyroidism, thyroid surgery, and medications that interfere with T3 production.",
      "In patients with renal insufficiency, low T3 syndrome can be a prognostic marker for poor outcomes such as risk of death and cardiovascular events.",
      "Studies have shown that patients with renal insufficiency and low T3 syndrome have higher rates of mortality and morbidity compared to those with normal T3 levels.",
      "The relationship between low T3 syndrome and renal insufficiency is complex and multifactorial."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 254,
    "user_query": "Which is the relation between sweating and anaerobic threshold?",
    "vicuna-13b_response": "Sweating and anaerobic threshold are related in that sweating is one of the physiological responses that occurs during exercise at or above anaerobic threshold.\nAnaerobic threshold is the point during exercise at which the body's demand for oxygen exceeds its ability to supply it. This occurs when the body is working at a high intensity and is unable to generate energy through aerobic metabolism. Instead, the body relies on anaerobic metabolism, which generates energy without using oxygen.\nSweating is one of the ways that the body tries to cool down during exercise. When the body is working at a high intensity, it generates a lot of heat, and sweating helps to dissipate that heat. The amount of sweating that occurs during exercise is influenced by a number of factors, including the intensity of the exercise, the ambient temperature, and the humidity.\nResearch has shown that the onset of sweating during exercise is closely related to anaerobic threshold. As the body's demand for oxygen increases and it begins to rely more on anaerobic metabolism, the body's core temperature begins to rise. This triggers the onset of sweating as the body tries to cool down.\nIn summary, sweating and anaerobic threshold are related in that sweating is one of the physiological responses that occurs during exercise at or above anaerobic threshold. The onset of sweating during exercise is closely related to anaerobic threshold, as the body's demand for oxygen exceeds its ability to supply it and the body begins to rely more on anaerobic metabolism.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Sweating is a physiological response that occurs during exercise at or above the anaerobic threshold.\n2. The anaerobic threshold is the point during exercise at which the body's demand for oxygen exceeds its ability to supply it.\n3. When the body is unable to generate energy through aerobic metabolism, it relies on anaerobic metabolism.\n4. Sweating is a method that the body uses to cool down during exercise.\n5. The onset of sweating during exercise is closely related to the anaerobic threshold.",
    "vicuna-13b_fact": [
      "Sweating is a physiological response that occurs during exercise at or above the anaerobic threshold.",
      "The anaerobic threshold is the point during exercise at which the body's demand for oxygen exceeds its ability to supply it.",
      "When the body is unable to generate energy through aerobic metabolism, it relies on anaerobic metabolism.",
      "Sweating is a method that the body uses to cool down during exercise.",
      "The onset of sweating during exercise is closely related to the anaerobic threshold."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The onset of sweating during exercise is not directly related to the anaerobic threshold. It is rather a response to the increase in body temperature.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 256,
    "user_query": "What is the mode of action of bedaquiline?",
    "vicuna-13b_response": "Bedaquiline is an antibiotic that is used to treat tuberculosis (TB). It is a member of a class of drugs called diarylquinolines. The mode of action of bedaquiline is not fully understood, but it is thought to involve inhibition of the enzyme ATP synthase, which is responsible for generating energy in bacterial cells. This inhibition leads to the accumulation of toxic metabolites and ultimately to the death of the bacteria. Bedaquiline is bacteriostatic, meaning that it stops the growth of bacteria rather than killing them outright. It is often used in combination with other TB drugs to increase the effectiveness of treatment and reduce the risk of the bacteria becoming resistant to the antibiotics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Bedaquiline is an antibiotic used for treating tuberculosis (TB).\n2. Bedaquiline is a member of diarylquinolines, a class of drugs.\n3. It is thought that bedaquiline inhibits the enzyme ATP synthase, involved in generating energy in bacterial cells.\n4. Bedaquiline is bacteriostatic, meaning that it stops bacterial growth rather than killing the bacteria outright.\n5. Bedaquiline is often used with other TB drugs to enhance treatment effectiveness and reduce the risk of bacterial resistance to antibiotics.",
    "vicuna-13b_fact": [
      "Bedaquiline is an antibiotic used for treating tuberculosis (TB).",
      "Bedaquiline is a member of diarylquinolines, a class of drugs.",
      "It is thought that bedaquiline inhibits the enzyme ATP synthase, involved in generating energy in bacterial cells.",
      "Bedaquiline is bacteriostatic, meaning that it stops bacterial growth rather than killing the bacteria outright.",
      "Bedaquiline is often used with other TB drugs to enhance treatment effectiveness and reduce the risk of bacterial resistance to antibiotics."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Bedaquiline is bactericidal, meaning that it kills bacteria rather than just stopping its growth.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 259,
    "user_query": "Is oxidative stress affected by FOXO expression?",
    "vicuna-13b_response": "Yes, FOXO expression has been shown to affect oxidative stress. FOXO transcription factors are known to regulate the expression of genes involved in various cellular processes, including oxidative stress response.\nStudies have shown that FOXO transcription factors can regulate the expression of genes involved in antioxidant defense, such as catalase, superoxide dismutase, and glutathione peroxidase, thereby affecting the levels of reactive oxygen species (ROS) and oxidative stress in cells.\nFor example, FOXO1 has been shown to regulate the expression of the catalase gene in response to oxidative stress, thereby protecting cells from oxidative damage. Similarly, FOXO3a has been shown to regulate the expression of the glutathione peroxidase 1 gene, which is involved in the detoxification of ROS.\nIn addition, FOXO transcription factors have been shown to regulate the expression of genes involved in the cellular response to oxidative stress, such as the heat shock protein 70 (Hsp70) gene, which is involved in the protection of cells from oxidative damage.\nOverall, the regulation of FOXO expression and its downstream target genes involved in oxidative stress response can play a crucial role in protecting cells from oxidative damage and preserving cellular homeostasis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. FOXO expression affects oxidative stress.\n2. FOXO transcription factors regulate the expression of genes involved in various cellular processes, including the oxidative stress response.\n3. FOXO transcription factors regulate the expression of genes involved in antioxidant defense such as catalase, superoxide dismutase, and glutathione peroxidase.\n4. FOXO1 has been shown to regulate the expression of the catalase gene in response to oxidative stress.\n5. FOXO3a has been shown to regulate the expression of the glutathione peroxidase 1 gene, which is involved in the detoxification of ROS.",
    "vicuna-13b_fact": [
      "FOXO expression affects oxidative stress.",
      "FOXO transcription factors regulate the expression of genes involved in various cellular processes, including the oxidative stress response.",
      "FOXO transcription factors regulate the expression of genes involved in antioxidant defense such as catalase, superoxide dismutase, and glutathione peroxidase.",
      "FOXO1 has been shown to regulate the expression of the catalase gene in response to oxidative stress.",
      "FOXO3a has been shown to regulate the expression of the glutathione peroxidase 1 gene, which is involved in the detoxification of ROS."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 260,
    "user_query": "Describe the mechanism of action of the LINX system for treatment of gastroesophageal reflux disease.",
    "vicuna-13b_response": "The LINX system is a minimally invasive surgical device that is used to treat gastroesophageal reflux disease (GERD). GERD is a condition in which stomach acid and other contents flow back into the esophagus, causing symptoms such as heartburn, regurgitation, and difficulty swallowing.\nThe LINX system works by creating a barrier between the stomach and the esophagus. The device is made up of a series of interconnected, flexible beads that are placed around the lower esophageal sphincter (LES), which is the muscle that separates the stomach and the esophagus. The beads are attached to a thin, flexible wire that is connected to a small, implantable receiver.\nWhen the LINX system is activated, the receiver sends electrical signals to the beads, causing them to contract and relax in a coordinated pattern. This helps to keep the LES closed, preventing stomach acid and other contents from flowing back into the esophagus.\nThe LINX system is designed to be a reversible and adjustable treatment for GERD. It can be turned on or off as needed, and the strength of the electrical signals can be adjusted by a healthcare provider using an external device.\nOverall, the LINX system provides an alternative to traditional surgical treatments for GERD, such as fundoplication, and can be an effective option for patients who have not had success with medications or lifestyle changes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The LINX system is a minimally invasive surgical device used to treat gastroesophageal reflux disease (GERD).\n2. The LINX system works by creating a barrier between the stomach and the esophagus.\n3. The device is comprised of a series of interconnected, flexible beads that are placed around the lower esophageal sphincter (LES).\n4. When activated, the LINX system sends electrical signals to the beads, causing them to contract and relax in a coordinated pattern to prevent stomach acid and other contents from flowing back into the esophagus.\n5. The LINX system is designed to be a reversible and adjustable treatment for GERD.",
    "vicuna-13b_fact": [
      "The LINX system is a minimally invasive surgical device used to treat gastroesophageal reflux disease (GERD).",
      "The LINX system works by creating a barrier between the stomach and the esophagus.",
      "The device is comprised of a series of interconnected, flexible beads that are placed around the lower esophageal sphincter (LES).",
      "When activated, the LINX system sends electrical signals to the beads, causing them to contract and relax in a coordinated pattern to prevent stomach acid and other contents from flowing back into the esophagus.",
      "The LINX system is designed to be a reversible and adjustable treatment for GERD."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The LINX system does not need to be activated or send electrical signals. It uses magnetic attraction between the beads to augment the existing esophageal sphincter and thus prevent reflux from the stomach into the esophagus.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 262,
    "user_query": "What is the characteristic feature of the Dyke-Davidoff-Masson syndrome.",
    "vicuna-13b_response": "The Dyke-Davidoff-Masson (DDM) syndrome is a rare genetic disorder that is characterized by the triad of cranial nerve palsy (usually VII), facial diplegia (usually hemiplegia of the left side of the face), and urogenital abnormalities (such as hypospadias and micropenis). The syndrome is inherited in an autosomal recessive pattern and is caused by mutations in the TBX5 gene, which encodes a transcription factor involved in neural crest cell development. The characteristic feature of the DDM syndrome is the combination of these three key features: cranial nerve palsy, facial diplegia, and urogenital abnormalities.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dyke-Davidoff-Masson syndrome is a rare genetic disorder. \n2. The syndrome is characterized by cranial nerve palsy, facial diplegia, and urogenital abnormalities.\n3. The syndrome is inherited in an autosomal recessive pattern. \n4. It is caused by mutations in the TBX5 gene. \n5. The TBX5 gene encodes a transcription factor involved in neural crest cell development.",
    "vicuna-13b_fact": [
      "Dyke-Davidoff-Masson syndrome is a rare genetic disorder.",
      "The syndrome is characterized by cranial nerve palsy, facial diplegia, and urogenital abnormalities.",
      "The syndrome is inherited in an autosomal recessive pattern.",
      "It is caused by mutations in the TBX5 gene.",
      "The TBX5 gene encodes a transcription factor involved in neural crest cell development."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Dyke-Davidoff-Masson syndrome is not a genetic disorder; it is a condition that results from brain damage due to loss or poor blood supply to one part of the brain.\n2. FALSE [correction]: Dyke-Davidoff-Masson syndrome is characterized by cerebral hemiatrophy (shrinkage of one half of the brain), seizures, and facial asymmetry.\n3. FALSE [correction]: Dyke-Davidoff-Masson syndrome is not inherited; it is acquired due to a brain injury often occurring in fetal or early childhood stages.\n4. FALSE [correction]: Dyke-Davidoff-Masson syndrome is not caused by mutations in the TBX5 gene; it is usually caused by loss of blood supply to the brain.\n5. FALSE [correction]: TBX5 gene is not particularly associated with Dyke-Davidoff-Masson syndrome. It is associated with neural crest cell development, but it is more directly linked to specific conditions such as Holt-Oram syndrome, which affects heart and arm development.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 263,
    "user_query": "Which gene is involved in the development of Barth syndrome?",
    "vicuna-13b_response": "Barth syndrome is a rare genetic disorder that is caused by a deficiency of the enzyme 3-methyl-CoA synthase (3MCS). This enzyme is involved in the metabolism of long-chain fatty acids, and its deficiency leads to a buildup of certain metabolites in the body. The gene that is responsible for the production of 3MCS is called HADHA, which stands for 3-hydroxyacyl-CoA dehydrogenase, alpha subunit.\nHADHA is located on chromosome X, and it contains 19 exons. The gene produces a protein that is composed of three domains: an N-terminal domain that contains a zinc finger, a central domain that contains a catalytic site, and a C-terminal domain that interacts with electron transfer flavoproteins. The protein is expressed in many tissues, including the heart, liver, and kidneys, and it plays a critical role in the metabolism of long-chain fatty acids.\nMutations in the HADHA gene have been identified as the cause of Barth syndrome, which is characterized by cardiomyopathy, growth delay, and skeletal abnormalities. The severity of the symptoms can vary from person to person, and the condition is often progressive. There is currently no cure for Barth syndrome, but treatment is focused on managing the symptoms and preventing complications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Barth syndrome is a genetic disorder caused by a deficiency of the enzyme 3-methyl-CoA synthase (3MCS).\n2. The gene responsible for the production of 3MCS is HADHA.\n3. HADHA is located on chromosome X and contains 19 exons.\n4. Mutations in the HADHA gene cause Barth syndrome.\n5. Barth syndrome is characterized by cardiomyopathy, growth delay, and skeletal abnormalities.",
    "vicuna-13b_fact": [
      "Barth syndrome is a genetic disorder caused by a deficiency of the enzyme 3-methyl-CoA synthase (3MCS).",
      "The gene responsible for the production of 3MCS is HADHA.",
      "HADHA is located on chromosome X and contains 19 exons.",
      "Mutations in the HADHA gene cause Barth syndrome.",
      "Barth syndrome is characterized by cardiomyopathy, growth delay, and skeletal abnormalities."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Barth syndrome is a genetic disorder caused by a mutation in the TAZ gene, not a deficiency of the enzyme 3-methyl-CoA synthase (3MCS).\n2. FALSE [correction]: The gene responsible for the production of 3MCS is not HADHA, it's actually MCCC1 or MCCC2.\n3. UNKNOWN\n4. FALSE [correction]: Mutations in the TAZ gene, not the HADHA gene, cause Barth syndrome.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "vicuna-13b_response": "Casein Kinase 1 (CK1) is a family of serine/threonine protein kinases that play important roles in various cellular processes, such as cell cycle progression, differentiation, and apoptosis. The phosphorylation consensus motifs for CK1 are as follows:\n1. S/T-X-R/K-X-S/T\n2. S/T-P-S/T-P-S/T-P\n3. S/T-P-S/T-P-S/T-P-P\n4. S/T-P-S/T-P-S/T-P-P-P\n5. S/T-P-S/T-P-S/T-P-P-P-P\nThese consensus motifs are based on the sequence analysis of known CK1 substrates and are not exhaustive. Additionally, CK1 can also phosphorylate other amino acids such as tyrosine and histidine in some cases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Casein Kinase 1 (CK1) is a family of serine/threonine protein kinases.\n2. CK1 plays a role in cellular processes such as cell cycle progression, differentiation, and apoptosis.\n3. The phosphorylation consensus motifs for CK1 include S/T-X-R/K-X-S/T, S/T-P-S/T-P-S/T-P, S/T-P-S/T-P-S/T-P-P, S/T-P-S/T-P-S/T-P-P-P, and S/T-P-S/T-P-S/T-P-P-P-P.\n4. These consensus motifs are based on the sequence analysis of known CK1 substrates.\n5. CK1 can phosphorylate other amino acids such as tyrosine and histidine in some cases.",
    "vicuna-13b_fact": [
      "Casein Kinase 1 (CK1) is a family of serine/threonine protein kinases.",
      "CK1 plays a role in cellular processes such as cell cycle progression, differentiation, and apoptosis.",
      "The phosphorylation consensus motifs for CK1 include S/T-X-R/K-X-S/T, S/T-P-S/T-P-S/T-P, S/T-P-S/T-P-S/T-P-P, S/T-P-S/T-P-S/T-P-P-P, and S/T-P-S/T-P-S/T-P-P-P-P.",
      "These consensus motifs are based on the sequence analysis of known CK1 substrates.",
      "CK1 can phosphorylate other amino acids such as tyrosine and histidine in some cases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: CK1 cannot phosphorylate other amino acids such as tyrosine and histidine, it mainly phosphorylates serine and threonine residues.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 273,
    "user_query": "What is the Barr body?",
    "vicuna-13b_response": "The Barr body, also known as the Barr-Hackerman body or the Barr body-like inclusion, is a type of inclusion found in certain types of cells, particularly in the ovaries and testes. It is composed of small, dense, granular material and is surrounded by a membrane.\nThe Barr body is thought to be involved in the development of the ovaries and testes during fetal development. It is also found in some types of tumors, including certain types of ovarian and testicular cancers.\nThe presence of a Barr body is often used as a diagnostic indicator in the diagnosis of certain types of tumors, particularly in the ovaries and testes. It is also used in the diagnosis of certain genetic disorders, such as Turner syndrome, in which the presence of an extra X chromosome can lead to the development of Barr bodies in certain cells.\nOverall, the Barr body is an important structure in the development and diagnosis of certain types of cells and tumors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Barr body, also known as the Barr-Hackerman body or the Barr body-like inclusion, is a type of inclusion found in certain cell types.\n2. The Barr body is composed of small, dense, granular material and is surrounded by a membrane.\n3. The Barr body is thought to be involved in the development of the ovaries and testes during fetal development.\n4. The Barr body can be found in certain types of tumors, including certain types of ovarian and testicular cancers.\n5. The presence of a Barr body is used as a diagnostic indicator in the diagnosis of certain tumors and genetic disorders like Turner syndrome.",
    "vicuna-13b_fact": [
      "The Barr body, also known as the Barr-Hackerman body or the Barr body-like inclusion, is a type of inclusion found in certain cell types.",
      "The Barr body is composed of small, dense, granular material and is surrounded by a membrane.",
      "The Barr body is thought to be involved in the development of the ovaries and testes during fetal development.",
      "The Barr body can be found in certain types of tumors, including certain types of ovarian and testicular cancers.",
      "The presence of a Barr body is used as a diagnostic indicator in the diagnosis of certain tumors and genetic disorders like Turner syndrome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Barr body, also known as the sex chromatin, is an inactivated X chromosome present in most female mammals' cell nuclei.\n2. TRUE\n3. FALSE [correction]: The Barr body is not involved in the development of ovaries and testes during fetal development. It is the inactive X chromosome found in female cells.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 275,
    "user_query": "Is shotgun lipidomics the direct infusion of a lipid sample into a mass spectrometer?",
    "vicuna-13b_response": "Yes, shotgun lipidomics is a method that involves the direct infusion of a lipid sample into a mass spectrometer. This technique is used to analyze the lipid composition of a sample, such as a cell or tissue, by separating and identifying the various lipid molecules present. The sample is first extracted and purified, and then the lipids are separated by a technique such as HPLC (high-performance liquid chromatography) or SC-FA (supercritical fluid extraction). The separated lipids are then introduced into the mass spectrometer, where they are ionized and analyzed for their mass-to-charge ratio. The resulting data is used to identify and quantify the different lipid species present in the sample. Shotgun lipidomics is a powerful tool for studying lipid metabolism and the role of lipids in various biological processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Shotgun lipidomics involves the direct infusion of a lipid sample into a mass spectrometer.\n2. Shotgun lipidomics is used to analyze the lipid composition of a sample such as a cell or tissue.\n3. In shotgun lipidomics, the sample is first extracted and purified, then the lipids are separated by a technique such as HPLC (high-performance liquid chromatography) or SC-FA (supercritical fluid extraction).\n4. After separation, lipids are introduced into the mass spectrometer where they are ionized and analyzed for their mass-to-charge ratio.\n5. Shotgun lipidomics is used to identify and quantify different lipid species present in a sample.",
    "vicuna-13b_fact": [
      "Shotgun lipidomics involves the direct infusion of a lipid sample into a mass spectrometer.",
      "Shotgun lipidomics is used to analyze the lipid composition of a sample such as a cell or tissue.",
      "In shotgun lipidomics, the sample is first extracted and purified, then the lipids are separated by a technique such as HPLC (high-performance liquid chromatography) or SC-FA (supercritical fluid extraction).",
      "After separation, lipids are introduced into the mass spectrometer where they are ionized and analyzed for their mass-to-charge ratio.",
      "Shotgun lipidomics is used to identify and quantify different lipid species present in a sample."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: In shotgun lipidomics, lipids are directly introduced into a mass spectrometer without prior separation such as HPLC or SC-FA.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 283,
    "user_query": "List functions that are evaluated with the Full Outline of Unresponsiveness score?",
    "vicuna-13b_response": "The Full Outline of Unresponsiveness (FOUR) score is a measure of the level of consciousness and responsiveness in patients with acute brain injury. It is used to assess a patient's ability to respond to stimuli and to evaluate the effectiveness of treatment.\nThe FOUR score is based on a patient's response to a series of stimuli, including verbal commands, pain, eye opening, and motor response. Each of these categories is assigned a score, with a higher score indicating a better level of responsiveness.\nThe following functions may be evaluated with the FOUR score:\n1. Verbal response: The patient's ability to respond to verbal commands, such as \"open your eyes\" or \"squeeze my hand.\"\n2. Pain response: The patient's ability to respond to pain stimuli, such as pinching or slapping the cheek.\n3. Eye opening: The patient's ability to open their eyes in response to a stimulus, such as a bright light or a loud noise.\n4. Motor response: The patient's ability to respond to motor stimuli, such as moving their limbs or following commands to lift their arms or legs.\nOverall, the FOUR score is a useful tool for assessing a patient's level of consciousness and responsiveness after an acute brain injury, and can help healthcare providers to determine the most appropriate course of treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Full Outline of Unresponsiveness (FOUR) score is used to assess the level of consciousness and responsiveness in patients with acute brain injury.\n2. The FOUR score evaluates the patient's response to stimuli including verbal commands, pain, eye opening, and motor response. \n3. In the Four score system, each category is assigned a score, and a higher score indicates a better level of responsiveness. \n4. Verbal response in the FOUR score involves the patient's ability to respond to verbal commands.\n5. The FOUR score is used to determine the most appropriate course of treatment for a patient after an acute brain injury.",
    "vicuna-13b_fact": [
      "The Full Outline of Unresponsiveness (FOUR) score is used to assess the level of consciousness and responsiveness in patients with acute brain injury.",
      "The FOUR score evaluates the patient's response to stimuli including verbal commands, pain, eye opening, and motor response.",
      "In the Four score system, each category is assigned a score, and a higher score indicates a better level of responsiveness.",
      "Verbal response in the FOUR score involves the patient's ability to respond to verbal commands.",
      "The FOUR score is used to determine the most appropriate course of treatment for a patient after an acute brain injury."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 285,
    "user_query": "Is ospemifene effective for treatment of dyspareunia?",
    "vicuna-13b_response": "Ospemifene is a medication that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of dyspareunia, which is defined as pain during sexual intercourse. It is a selective estrogen receptor modulator (SERM) that acts on the genital tract to improve sexual function.\nClinical studies have shown that ospemifene is effective in improving dyspareunia symptoms in women. In a randomized, double-blind, placebo-controlled trial, women who received ospemifene experienced a statistically significant improvement in dyspareunia symptoms, including pain during sexual intercourse, compared to those who received a placebo.\nAdditionally, ospemifene has been shown to improve vaginal dryness, a common symptom associated with dyspareunia, by increasing the production of vaginal lubrication.\nIt is important to note that ospemifene is not recommended for women with a history of estrogen-dependent cancer, and should only be used under the guidance of a healthcare provider.\nIn conclusion, ospemifene is an effective treatment option for dyspareunia, and its use is supported by clinical studies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ospemifene is approved by the U.S. Food and Drug Administration (FDA) for the treatment of dyspareunia.\n2. Dyspareunia is defined as pain during sexual intercourse.\n3. Ospemifene is a selective estrogen receptor modulator that acts on the genital tract to improve sexual function.\n4. Clinical studies have shown that ospemifene improves dyspareunia symptoms in women.\n5. Ospemifene is not recommended for women with a history of estrogen-dependent cancer.",
    "vicuna-13b_fact": [
      "Ospemifene is approved by the U.S. Food and Drug Administration (FDA) for the treatment of dyspareunia.",
      "Dyspareunia is defined as pain during sexual intercourse.",
      "Ospemifene is a selective estrogen receptor modulator that acts on the genital tract to improve sexual function.",
      "Clinical studies have shown that ospemifene improves dyspareunia symptoms in women.",
      "Ospemifene is not recommended for women with a history of estrogen-dependent cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 287,
    "user_query": "What is the biological role of expansins in fungi?",
    "vicuna-13b_response": "Expansins are a group of proteins that are involved in the regulation of cell growth and differentiation in fungi. They are involved in the process of cell wall expansion, which is critical for the growth and development of fungal cells.\nIn fungi, the cell wall serves as a protective barrier and provides support for the cell. During growth and development, the cell wall must expand to accommodate the increasing size of the cell. Expansins play a key role in this process by helping to remodel the cell wall and create new space for the expanding cell.\nThere are several types of expansins, including alpha, beta, and gamma expansins. These proteins are synthesized as precursors that are processed into mature expansins. The mature expansins then bind to specific target sites on the cell wall and trigger the expansion of the wall.\nIn addition to their role in cell wall expansion, expansins are also involved in other aspects of fungal biology. For example, they are required for the proper formation of hyphae, the thread-like structures that allow fungi to spread and colonize new substrates. They are also involved in the response to environmental stimuli, such as changes in temperature or pH.\nOverall, expansins are essential for the growth and development of fungal cells, and their role in regulating cell wall expansion is critical for the survival and success of fungi in a variety of environments.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Expansins are a group of proteins involved in the regulation of cell growth and differentiation in fungi.\n2. Expansins are involved in the process of cell wall expansion in fungal cells.\n3. There are several types of expansins, including alpha, beta, and gamma expansins.\n4. Expansins are required for the proper formation of hyphae in fungi.\n5. Expansins are involved in the response to environmental stimuli, such as changes in temperature or pH, in fungi.",
    "vicuna-13b_fact": [
      "Expansins are a group of proteins involved in the regulation of cell growth and differentiation in fungi.",
      "Expansins are involved in the process of cell wall expansion in fungal cells.",
      "There are several types of expansins, including alpha, beta, and gamma expansins.",
      "Expansins are required for the proper formation of hyphae in fungi.",
      "Expansins are involved in the response to environmental stimuli, such as changes in temperature or pH, in fungi."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Expansins are a group of non-enzymatic proteins that play a pivotal role in cell wall loosening and extension during growth and development of plants, not fungi.\n2. FALSE [correction]: Expansins are involved in the process of cell wall expansion in plant cells, not fungal cells.\n3. TRUE\n4. FALSE [correction]: Expansins are required for the proper formation of plant tissues, not hyphae in fungi.\n5. FALSE [correction]: Expansins are involved in plant growth response to environmental stimuli, such as changes in temperature or pH, not in fungi.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 301,
    "user_query": "Which oncogenes are able to induce cellular senescence?",
    "vicuna-13b_response": "Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. Some oncogenes are able to induce cellular senescence, which is a state of irreversible cell growth arrest. Cellular senescence is a mechanism that helps prevent the development of cancer by preventing cells with damaged DNA from continuing to divide.\nOne example of an oncogene that can induce cellular senescence is the oncogene called RAS. RAS is a small GTPase that is involved in signal transduction and cell growth regulation. When RAS is mutated or overexpressed, it can cause cells to enter a state of senescence.\nAnother example of an oncogene that can induce cellular senescence is the oncogene called MYC. MYC is a transcription factor that is involved in the regulation of cell growth and differentiation. When MYC is overexpressed, it can cause cells to enter a state of senescence.\nIt is important to note that not all oncogenes are able to induce cellular senescence. The ability of an oncogene to induce senescence depends on the specific oncogene and the cellular context in which it is expressed.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels.\n2. Some oncogenes are able to induce cellular senescence, which prevents cells with damaged DNA from continuing to divide.\n3. The oncogene called RAS is an example that can induce cellular senescence.\n4. RAS is a small GTPase that is involved in signal transduction and cell growth regulation.\n5. Another oncogene that can induce cellular senescence is the oncogene called MYC.",
    "vicuna-13b_fact": [
      "Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels.",
      "Some oncogenes are able to induce cellular senescence, which prevents cells with damaged DNA from continuing to divide.",
      "The oncogene called RAS is an example that can induce cellular senescence.",
      "RAS is a small GTPase that is involved in signal transduction and cell growth regulation.",
      "Another oncogene that can induce cellular senescence is the oncogene called MYC."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The oncogene called RAS, when mutated, promotes uncontrolled cell proliferation rather than inducing cellular senescence.\n4. TRUE\n5. FALSE [correction]: The oncogene called MYC, when deregulated, promotes uncontrolled cell proliferation rather than inducing cellular senescence.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "vicuna-13b_response": "The ASPH gene in humans encodes for the aspartate beta-hydroxylase enzyme, which is involved in the metabolism of certain amino acids. There are several different proteins/isoforms that can be encoded by the ASPH gene, including:\n1. Aspartate beta-hydroxylase 1 (ABH1)\n2. Aspartate beta-hydroxylase 2 (ABH2)\n3. Aspartate beta-hydroxylase 3 (ABH3)\nEach of these isoforms of the enzyme has slightly different properties and functions, and they may be expressed in different tissues and under different conditions. For example, ABH1 is expressed in the liver and kidneys, while ABH2 is expressed in the brain and testis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The ASPH gene in humans encodes for the aspartate beta-hydroxylase enzyme.\n2. The aspartate beta-hydroxylase enzyme is involved in the metabolism of certain amino acids.\n3. The ASPH gene can encode different proteins/isoforms: Aspartate beta-hydroxylase 1 (ABH1), Aspartate beta-hydroxylase 2 (ABH2), and Aspartate beta-hydroxylase 3 (ABH3).\n4. Each isoform of the enzyme has different properties and functions, and they may be expressed in different tissues and under different conditions.\n5. ABH1 is expressed in the liver and kidneys, while ABH2 is expressed in the brain and testis.",
    "vicuna-13b_fact": [
      "The ASPH gene in humans encodes for the aspartate beta-hydroxylase enzyme.",
      "The aspartate beta-hydroxylase enzyme is involved in the metabolism of certain amino acids.",
      "The ASPH gene can encode different proteins/isoforms: Aspartate beta-hydroxylase 1 (ABH1), Aspartate beta-hydroxylase 2 (ABH2), and Aspartate beta-hydroxylase 3 (ABH3).",
      "Each isoform of the enzyme has different properties and functions, and they may be expressed in different tissues and under different conditions.",
      "ABH1 is expressed in the liver and kidneys, while ABH2 is expressed in the brain and testis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 310,
    "user_query": "Which is the most common measure of differences between dinucleotide relative abundance \"genomic signatures\"",
    "vicuna-13b_response": "The most common measure of differences between dinucleotide relative abundance \"genomic signatures\" is the correlation coefficient. The correlation coefficient is a statistical measure that ranges from -1 to 1 and indicates the strength and direction of the linear relationship between two variables. In the case of genomic signatures, the correlation coefficient is used to measure the association between the relative abundance of different dinucleotides in two or more samples. The correlation coefficient can be calculated using various statistical software packages or online tools, such as the Pearson correlation coefficient. Other measures of differences between genomic signatures include principal component analysis, hierarchical clustering, and machine learning algorithms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The most common measure of differences between dinucleotide relative abundance \"genomic signatures\" is the correlation coefficient.\n2. The correlation coefficient is a statistical measure that ranges from -1 to 1.\n3. The correlation coefficient indicates the strength and direction of the linear relationship between two variables.\n4. The correlation coefficient is used to measure the association between the relative abundance of different dinucleotides in two or more samples.\n5. Other measures of differences between genomic signatures include principal component analysis, hierarchical clustering, and machine learning algorithms.",
    "vicuna-13b_fact": [
      "The most common measure of differences between dinucleotide relative abundance \"genomic signatures\" is the correlation coefficient.",
      "The correlation coefficient is a statistical measure that ranges from -1 to 1.",
      "The correlation coefficient indicates the strength and direction of the linear relationship between two variables.",
      "The correlation coefficient is used to measure the association between the relative abundance of different dinucleotides in two or more samples.",
      "Other measures of differences between genomic signatures include principal component analysis, hierarchical clustering, and machine learning algorithms."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 312,
    "user_query": "Why do we use \"N-terminal proteomics\"?",
    "vicuna-13b_response": "N-terminal proteomics is a technique used to study the proteins in a biological sample. It involves the identification and quantification of proteins based on their N-terminal amino acids, which are the amino acids that are attached to the protein's nitrogen atom.\nThe main reason for using N-terminal proteomics is that it allows for the identification of proteins that are present in a sample, even if they are present in very low amounts. This is because the N-terminal amino acids are unique to each protein and can be used as a \"fingerprint\" to identify the protein.\nAnother advantage of N-terminal proteomics is that it can be used to study proteins that are not easily identified using other techniques, such as mass spectrometry-based methods. This is because the N-terminal amino acids are more resistant to degradation and modification than other parts of the protein, which can make it easier to identify proteins in complex samples.\nOverall, N-terminal proteomics is a valuable tool for studying proteins in biological samples, and it can provide important information about the proteins that are present and their relative abundance.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. N-terminal proteomics is a technique used to study proteins in a biological sample.\n2. N-terminal proteomics involves the identification and quantification of proteins based on their N-terminal amino acids.\n3. N-terminal amino acids are unique to each protein and can serve as a \"fingerprint\" to identify the protein.\n4. N-terminal proteomics can be used to study proteins that are not easily identified with other techniques, such as mass spectrometry-based methods.\n5. The N-terminal amino acids are more resistant to degradation and modification than other parts of the protein.",
    "vicuna-13b_fact": [
      "N-terminal proteomics is a technique used to study proteins in a biological sample.",
      "N-terminal proteomics involves the identification and quantification of proteins based on their N-terminal amino acids.",
      "N-terminal amino acids are unique to each protein and can serve as a \"fingerprint\" to identify the protein.",
      "N-terminal proteomics can be used to study proteins that are not easily identified with other techniques, such as mass spectrometry-based methods.",
      "The N-terminal amino acids are more resistant to degradation and modification than other parts of the protein."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: N-terminal proteomics can complement other techniques, including mass spectrometry-based methods, but is not specifically used for proteins that are not easily identified with other techniques.\n5. FALSE [correction]: There is no general rule that N-terminal amino acids are more resistant to degradation and modification than other parts of the protein. This may vary depending on the specific protein and the conditions under which it is studied.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 317,
    "user_query": "Have mutations in the Polycomb group been found in human diseases?",
    "vicuna-13b_response": "Yes, mutations in the Polycomb group (PcG) genes have been found to be associated with various human diseases. PcG genes are a family of genes that play a crucial role in regulating gene expression and maintaining proper cellular differentiation.\nMutations in PcG genes have been linked to several human diseases, including cancer. For example, mutations in the PcG gene BMI1 have been found to be associated with the development of various types of cancer, including leukemia, lymphoma, and solid tumors. Similarly, mutations in the PcG gene EZH2 have been linked to the development of various types of cancer, including glioblastoma, a type of brain cancer.\nIn addition to cancer, PcG mutations have also been associated with other human diseases, such as neurodevelopmental disorders, such as autism spectrum disorder, and inherited diseases, such as Beckwith-Wiedemann syndrome.\nOverall, the discovery of PcG mutations in human diseases has provided important insights into the role of these genes in disease pathogenesis and has led to the development of new therapeutic strategies for the treatment of these diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mutations in the Polycomb group (PcG) genes are associated with various human diseases.\n2. PcG genes play a crucial role in regulating gene expression and maintaining proper cellular differentiation.\n3. Mutations in the PcG gene BMI1 have been found to relate to various types of cancer, including leukemia, lymphoma and solid tumors.\n4. Mutations in the PcG gene EZH2 have been linked to the development of various types of cancer, including glioblastoma.\n5. PcG mutations have also been associated with neurodevelopmental disorders, such as autism spectrum disorder, and inherited diseases, such as Beckwith-Wiedemann syndrome.",
    "vicuna-13b_fact": [
      "Mutations in the Polycomb group (PcG) genes are associated with various human diseases.",
      "PcG genes play a crucial role in regulating gene expression and maintaining proper cellular differentiation.",
      "Mutations in the PcG gene BMI1 have been found to relate to various types of cancer, including leukemia, lymphoma and solid tumors.",
      "Mutations in the PcG gene EZH2 have been linked to the development of various types of cancer, including glioblastoma.",
      "PcG mutations have also been associated with neurodevelopmental disorders, such as autism spectrum disorder, and inherited diseases, such as Beckwith-Wiedemann syndrome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 318,
    "user_query": "Describe the mechanism of action of drisapersen",
    "vicuna-13b_response": "Drisapersen is an experimental drug that was being developed by GSK (GlaxoSmithKline) for the treatment of Duchenne muscular dystrophy (DMD). DMD is a rare genetic disorder that affects muscle strength and mobility, and is caused by a deficiency of dystrophin, a protein that helps keep muscle cells intact.\nThe mechanism of action of drisapersen is based on its ability to restore the expression of dystrophin in muscle cells. Drisapersen is a small molecule that binds to the promoter region of the dystrophin gene, which is located on the X chromosome. This binding causes the expression of the dystrophin gene to be increased, leading to the production of dystrophin protein in muscle cells.\nIt is thought that the increased expression of dystrophin protein in muscle cells helps to improve the structural integrity of muscle cells, which can slow the progression of DMD and improve muscle function.\nUnfortunately, the development of drisapersen was discontinued by GSK in 2019, due to lack of efficacy in clinical trials.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Drisapersen is an experimental drug that was being developed by GSK (GlaxoSmithKline) for the treatment of Duchenne muscular dystrophy (DMD).\n2. Duchenne muscular dystrophy (DMD) is caused by a deficiency of dystrophin, a protein that helps keep muscle cells intact.\n3. The mechanism of action of drisapersen is based on its ability to restore the expression of dystrophin in muscle cells.\n4. Drisapersen is a small molecule that binds to the promoter region of the dystrophin gene, leading to the production of dystrophin protein in muscle cells.\n5. The development of drisapersen was discontinued by GSK in 2019, due to lack of efficacy in clinical trials.",
    "vicuna-13b_fact": [
      "Drisapersen is an experimental drug that was being developed by GSK (GlaxoSmithKline) for the treatment of Duchenne muscular dystrophy (DMD).",
      "Duchenne muscular dystrophy (DMD) is caused by a deficiency of dystrophin, a protein that helps keep muscle cells intact.",
      "The mechanism of action of drisapersen is based on its ability to restore the expression of dystrophin in muscle cells.",
      "Drisapersen is a small molecule that binds to the promoter region of the dystrophin gene, leading to the production of dystrophin protein in muscle cells.",
      "The development of drisapersen was discontinued by GSK in 2019, due to lack of efficacy in clinical trials."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Drisapersen is an experimental drug that was being developed by BioMarin Pharmaceutical, not GSK (GlaxoSmithKline), for the treatment of Duchenne muscular dystrophy (DMD).\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Drisapersen is an antisense oligonucleotide that works by binding to the exon 51 of the dystrophin gene, leading to the skipping of this exon during mRNA processing, and thus allowing for the production of a partially functional dystrophin protein in muscle cells.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 325,
    "user_query": "How does ranolazine affect calcium handling in the heart",
    "vicuna-13b_response": "Ranolazine is a medication that is used to treat angina (chest pain) and certain types of irregular heartbeats. It works by blocking the late sodium channels in the heart, which helps to reduce the amount of calcium that enters the heart cells. This, in turn, helps to slow the rate of heart contractions and decrease the amount of oxygen needed by the heart. By affecting calcium handling in the heart, ranolazine can help to improve the overall function of the heart and reduce the risk of heart attacks. It is important to note that ranolazine should only be used as directed by a healthcare professional and that it may not be suitable for everyone.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ranolazine is a medication used to treat angina and certain types of irregular heartbeats.\n2. Ranolazine works by blocking the late sodium channels in the heart.\n3. This action reduces the amount of calcium that enters the heart cells.\n4. Ranolazine can help slow the rate of heart contractions and decrease the amount of oxygen needed by the heart.\n5. Ranolazine can improve the overall function of the heart and reduce the risk of heart attacks.",
    "vicuna-13b_fact": [
      "Ranolazine is a medication used to treat angina and certain types of irregular heartbeats.",
      "Ranolazine works by blocking the late sodium channels in the heart.",
      "This action reduces the amount of calcium that enters the heart cells.",
      "Ranolazine can help slow the rate of heart contractions and decrease the amount of oxygen needed by the heart.",
      "Ranolazine can improve the overall function of the heart and reduce the risk of heart attacks."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: This action reduces the amount of sodium that enters the heart cells, not calcium.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 326,
    "user_query": "Which is the primary distinction between the Reverse Warburg effect and the conventional Warburg effect?",
    "vicuna-13b_response": "The Reverse Warburg effect, also known as the cytoplasmic or extracellular acidification, is a metabolic process that occurs in cancer cells, where they acidify their environment to facilitate the production of ATP. In contrast, the conventional Warburg effect, also known as the mitochondrial or intracellular acidification, is a metabolic process that occurs in cancer cells, where they acidify their mitochondria to facilitate the production of ATP. The primary distinction between the two effects is the location of the acidification process. The Reverse Warburg effect occurs in the cytoplasm or extracellular space, while the conventional Warburg effect occurs in the mitochondria.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Reverse Warburg effect is also known as cytoplasmic or extracellular acidification.\n2. The Reverse Warburg effect is a metabolic process in cancer cells that acidifies their environment to facilitate the production of ATP.\n3. The conventional Warburg effect is also known as the mitochondrial or intracellular acidification.\n4. The conventional Warburg effect is a metabolic process in cancer cells that acidifies their mitochondria to facilitate the production of ATP.\n5. The primary distinction between the Reverse Warburg effect and the conventional Warburg effect is the location of the acidification process.",
    "vicuna-13b_fact": [
      "The Reverse Warburg effect is also known as cytoplasmic or extracellular acidification.",
      "The Reverse Warburg effect is a metabolic process in cancer cells that acidifies their environment to facilitate the production of ATP.",
      "The conventional Warburg effect is also known as the mitochondrial or intracellular acidification.",
      "The conventional Warburg effect is a metabolic process in cancer cells that acidifies their mitochondria to facilitate the production of ATP.",
      "The primary distinction between the Reverse Warburg effect and the conventional Warburg effect is the location of the acidification process."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The conventional Warburg effect is also known as aerobic glycolysis. \n4. FALSE [correction]: The conventional Warburg effect is a metabolic process in cancer cells that shifts their metabolism towards fermentation of glucose into lactate, irrespective of the presence of oxygen. \n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 327,
    "user_query": "What is the role of per genes in circadian rhythm control?",
    "vicuna-13b_response": "Per genes are a family of genes that play a crucial role in the regulation of circadian rhythm, also known as the circadian clock, in living organisms. The per genes are responsible for detecting environmental light-dark cycles and transmitting this information to the circadian clock, which is located in the hypothalamus of mammals.\nThe per genes are expressed in the retina of the eye, where they are activated by light and then transported to the hypothalamus, where they regulate the expression of other genes involved in the circadian clock. The per genes work by inhibiting the activity of the clock genes, keeping them in a dormant state during the day and allowing them to be activated at night when the environment is dark.\nThe per genes are crucial for maintaining proper circadian rhythm, as disruptions in their function can lead to disrupted sleep-wake cycles, which can have negative effects on overall health and well-being.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Per genes play a crucial role in the regulation of the circadian rhythm.\n2. The per genes are responsible for detecting environmental light-dark cycles and transmitting this information to the circadian clock.\n3. The circadian clock is located in the hypothalamus of mammals.\n4. The per genes are expressed in the retina of the eye, where they are activated by light and then transported to the hypothalamus.\n5. Disruptions in the function of per genes can lead to disrupted sleep-wake cycles, which can have negative effects on overall health and well-being.",
    "vicuna-13b_fact": [
      "Per genes play a crucial role in the regulation of the circadian rhythm.",
      "The per genes are responsible for detecting environmental light-dark cycles and transmitting this information to the circadian clock.",
      "The circadian clock is located in the hypothalamus of mammals.",
      "The per genes are expressed in the retina of the eye, where they are activated by light and then transported to the hypothalamus.",
      "Disruptions in the function of per genes can lead to disrupted sleep-wake cycles, which can have negative effects on overall health and well-being."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The per genes are not responsible for directly detecting environmental light-dark cycles but they are involved in the transduction of this information to entrain the circadian clock.\n3. TRUE\n4. FALSE [correction]: The per genes are not specifically expressed in the retina of the eye, but their protein products can be activated by light indirectly through other molecular pathways.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "vicuna-13b_response": "Empagliflozin is a medication used to treat type 2 diabetes. It was approved by the U.S. Food and Drug Administration (FDA) in 2014. The FDA approved empagliflozin under the brand name Jardiance, which is manufactured by Boehringer Ingelheim and Eli Lilly and Company. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which helps the body remove excess glucose through the urine. It is taken orally and is used in combination with diet and exercise to improve blood sugar control in people with type 2 diabetes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Empagliflozin is a medication used to treat type 2 diabetes.\n2. The FDA approved empagliflozin in 2014.\n3. Empagliflozin's brand name is Jardiance, manufactured by Boehringer Ingelheim and Eli Lilly and Company.\n4. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.\n5. Empagliflozin is taken orally and is used in combination with diet and exercise to improve blood sugar control in people with type 2 diabetes.",
    "vicuna-13b_fact": [
      "Empagliflozin is a medication used to treat type 2 diabetes.",
      "The FDA approved empagliflozin in 2014.",
      "Empagliflozin's brand name is Jardiance, manufactured by Boehringer Ingelheim and Eli Lilly and Company.",
      "Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.",
      "Empagliflozin is taken orally and is used in combination with diet and exercise to improve blood sugar control in people with type 2 diabetes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 331,
    "user_query": "Which R/bioconductor package is used for integrative genomics visualizations?",
    "vicuna-13b_response": "The R/Bioconductor package that is commonly used for integrative genomics visualizations is \"ggplot2\".\n\"ggplot2\" is a plotting library for R that provides a large number of customization options for creating various types of plots, including scatter plots, line plots, bar charts, and more. It is widely used in the bioinformatics community for visualizing genomic data, including DNA-seq, RNA-seq, and ChIP-seq data.\nSome of the key features of \"ggplot2\" that make it well-suited for genomics data visualization include:\n1. Easy to use: \"ggplot2\" has a user-friendly syntax that makes it easy to create custom plots with a wide range of customization options.\n2. Flexible: \"ggplot2\" allows users to create a wide range of plot types, including line plots, scatter plots, bar charts, and more.\n3. Customizable: \"ggplot2\" provides a large number of options for customizing the appearance of plots, including the ability to change the colors, fonts, and layout of the plot.\n4. Scalable: \"ggplot2\" is designed to handle large datasets, making it well-suited for analyzing large-scale genomic data.\nOverall, \"ggplot2\" is a powerful and flexible tool for creating integrative genomics visualizations in R, and is widely used in the bioinformatics community for this purpose.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The R/Bioconductor package \"ggplot2\" is commonly used for integrative genomics visualizations.\n2. \"ggplot2\" is a plotting library for R that provides a large number of customization options for creating various types of plots.\n3. \"ggplot2\" is widely used in the bioinformatics community for visualizing genomic data.\n4. Some of the features of \"ggplot2\" include being easy to use, flexible, customizable, and scalable.\n5. \"ggplot2\" is designed to handle large datasets, making it well-suited for analyzing large-scale genomic data.",
    "vicuna-13b_fact": [
      "The R/Bioconductor package \"ggplot2\" is commonly used for integrative genomics visualizations.",
      "\"ggplot2\" is a plotting library for R that provides a large number of customization options for creating various types of plots.",
      "\"ggplot2\" is widely used in the bioinformatics community for visualizing genomic data.",
      "Some of the features of \"ggplot2\" include being easy to use, flexible, customizable, and scalable.",
      "\"ggplot2\" is designed to handle large datasets, making it well-suited for analyzing large-scale genomic data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 333,
    "user_query": "How many genes are imprinted in the human genome?",
    "vicuna-13b_response": "Imprinting is a process where certain genes are expressed only from one parent, usually the mother, due to the presence of a methyl group on the DNA molecule. In the human genome, it is estimated that approximately 1-2% of all genes are imprinted. However, the exact number of imprinted genes is still being determined and may be higher.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Imprinting is a process where certain genes are expressed only from one parent due to the presence of a methyl group on the DNA molecule.\n2. Usually, the imprinted genes are expressed from the mother.\n3. In the human genome, it is estimated that approximately 1-2% of all genes are imprinted.\n4. The exact number of imprinted genes in the human genome is still being determined.",
    "vicuna-13b_fact": [
      "Imprinting is a process where certain genes are expressed only from one parent due to the presence of a methyl group on the DNA molecule.",
      "Usually, the imprinted genes are expressed from the mother.",
      "In the human genome, it is estimated that approximately 1-2% of all genes are imprinted.",
      "The exact number of imprinted genes in the human genome is still being determined."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 336,
    "user_query": "In which cells are A-type lamins expressed?",
    "vicuna-13b_response": "A-type lamins are a type of lamin protein that are expressed in the nucleus of most cells. They are composed of three subunits, A1, A2, and A3, and are involved in maintaining the structure and stability of the nucleus. A-type lamins are also involved in regulating gene expression and are thought to play a role in cellular aging and disease. They are expressed in most tissues and cells, including fibroblasts, muscle cells, and neurons.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A-type lamins are a type of lamin protein that are expressed in the nucleus of most cells. \n2. A-type lamins are composed of three subunits: A1, A2, and A3.\n3. A-type lamins play a role in maintaining the structure and stability of the nucleus.\n4. A-type lamins are involved in regulating gene expression.\n5. A-type lamins are expressed in most tissues and cells, including fibroblasts, muscle cells, and neurons.",
    "vicuna-13b_fact": [
      "A-type lamins are a type of lamin protein that are expressed in the nucleus of most cells.",
      "A-type lamins are composed of three subunits: A1, A2, and A3.",
      "A-type lamins play a role in maintaining the structure and stability of the nucleus.",
      "A-type lamins are involved in regulating gene expression.",
      "A-type lamins are expressed in most tissues and cells, including fibroblasts, muscle cells, and neurons."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 338,
    "user_query": "Gene silencing can be achieved by RNA interference (RNAi) in eukaryotic organisms. What is the name of the analogous process in prokaryotic organisms?",
    "vicuna-13b_response": "In prokaryotic organisms, gene silencing can be achieved by a process called RNA degradation. This process involves the degradation of messenger RNA (mRNA) molecules that carry genetic information from DNA to the ribosome for protein synthesis.\nRNA degradation can occur through several mechanisms, including:\n1. Transcriptional inhibition: This involves the inhibition of mRNA synthesis by blocking the activity of the enzyme RNA polymerase, which is responsible for synthesizing mRNA from DNA.\n2. RNA cleavage: This involves the cutting of mRNA molecules into smaller pieces by enzymes called RNases. This can occur either in the cytoplasm or in the nucleus, and can be targeted to specific mRNAs.\n3. RNA degradation: This involves the breakdown of mRNA molecules into smaller components, such as ribonucleotides, by enzymes called RNases.\nOverall, RNA degradation is an important mechanism for regulating gene expression in prokaryotic organisms, and plays a role in a variety of cellular processes, including stress responses, development, and cell cycle progression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. In prokaryotic organisms, gene silencing can be achieved by a process called RNA degradation.\n2. The RNA degradation process involves the degradation of messenger RNA (mRNA) molecules.\n3. Transcriptional inhibition can block the activity of the enzyme RNA polymerase, which is responsible for synthesizing mRNA from DNA.\n4. RNA cleavage involves the cutting of mRNA molecules into smaller pieces by enzymes called RNases and can be targeted to specific mRNAs. \n5. RNA degradation involves the breakdown of mRNA molecules into smaller components, such as ribonucleotides, by enzymes called RNases.",
    "vicuna-13b_fact": [
      "In prokaryotic organisms, gene silencing can be achieved by a process called RNA degradation.",
      "The RNA degradation process involves the degradation of messenger RNA (mRNA) molecules.",
      "Transcriptional inhibition can block the activity of the enzyme RNA polymerase, which is responsible for synthesizing mRNA from DNA.",
      "RNA cleavage involves the cutting of mRNA molecules into smaller pieces by enzymes called RNases and can be targeted to specific mRNAs.",
      "RNA degradation involves the breakdown of mRNA molecules into smaller components, such as ribonucleotides, by enzymes called RNases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 339,
    "user_query": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?",
    "vicuna-13b_response": "Mutational biases are introduced due to directional mutation pressure between adenine (A) and guanine (G) bases in DNA. Adenine and guanine are two of the four nitrogenous bases that make up DNA, and they are often referred to as \"purines\" because they contain a double ring structure.\nMutational biases occur when the normal function of a gene is disrupted, leading to changes in the DNA sequence. These biases can be introduced in several ways, including point mutations, insertions, deletions, and chromosomal rearrangements.\nPoint mutations are the most common type of mutation and involve a change in a single base pair in the DNA sequence. The most common type of point mutation is a transition, which occurs when a purine base (A or G) is replaced by another purine base (C or T). Transitions are more common than transversions, which occur when a purine base is replaced by a pyrimidine base (C or T).\nThe reason for the mutational bias towards purines is due to the structure of the DNA double helix. Purines are larger and more polar than pyrimidines, which makes them more susceptible to chemical and physical damage. Additionally, the double ring structure of purines makes them more prone to undergoing reactions that can lead to mutations.\nOverall, mutational biases are introduced due to directional mutation pressure between adenine and guanine bases in DNA, with purines being more susceptible to mutations than pyrimidines.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mutational biases are introduced due to directional mutation pressure between adenine (A) and guanine (G) bases in DNA.\n2. Adenine and guanine are two of the four nitrogenous bases that make up DNA.\n3. The most common type of mutation is a point mutation, which involves a change in a single base pair in the DNA sequence.\n4. In point mutations, a transition, which occurs when a purine base (A or G) is replaced by another purine base (C or T), is more common than a transversion.\n5. Purines, specifically adenine and guanine, are more susceptible to mutations than pyrimidines due to their double ring structure, size, and polarity.",
    "vicuna-13b_fact": [
      "Mutational biases are introduced due to directional mutation pressure between adenine (A) and guanine (G) bases in DNA.",
      "Adenine and guanine are two of the four nitrogenous bases that make up DNA.",
      "The most common type of mutation is a point mutation, which involves a change in a single base pair in the DNA sequence.",
      "In point mutations, a transition, which occurs when a purine base (A or G) is replaced by another purine base (C or T), is more common than a transversion.",
      "Purines, specifically adenine and guanine, are more susceptible to mutations than pyrimidines due to their double ring structure, size, and polarity."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE \n4. FALSE [correction]: In point mutations, a transition, which occurs when a purine base (A or G) is replaced by another purine base or when a pyrimidine base (C or T) is replaced by another pyrimidine base, is more common than a transversion.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 340,
    "user_query": "Is it feasible to determine the complete proteome of yeast?",
    "vicuna-13b_response": "The complete proteome of yeast, also known as Saccharomyces cerevisiae, has been determined through various experimental techniques. The proteome refers to the entire set of proteins that are expressed by an organism, including all isoforms and post-translational modifications.\nOne approach to determining the proteome of yeast is through the use of mass spectrometry-based methods, such as liquid chromatography-tandem mass spectrometry (LC-MS/MS). This technique involves separating the proteins by size and charge, and then fragmenting them into smaller peptides that can be identified and quantified by mass spectrometry. This approach has been used to identify and quantify thousands of proteins in yeast, but it is not yet possible to identify all proteins in a single organism.\nAnother approach to determining the proteome of yeast is through the use of genomic techniques, such as DNA sequencing. This approach involves determining the DNA sequence of the yeast genome and using computational methods to predict the protein-coding regions. This approach has been used to identify many of the proteins expressed in yeast, but it is also not yet possible to identify all proteins in a single organism.\nIn summary, while it is possible to determine the proteome of yeast through various experimental techniques, it is not yet possible to determine the complete proteome of yeast in a single experiment. Further research and advancements in technology are needed to improve our understanding of the proteome of this important model organism.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The proteome of yeast, or Saccharomyces cerevisiae, has been determined through various experimental techniques.\n2. The proteome refers to the entire set of proteins expressed by an organism, including all isoforms and post-translational modifications.\n3. Mass spectrometry-based methods like liquid chromatography-tandem mass spectrometry (LC-MS/MS) are used to determine the proteome of yeast.\n4. Genomic techniques, like DNA sequencing, are an additional method used to determine the proteome of yeast.\n5. A complete proteome of yeast can't be determined in a single experiment currently.",
    "vicuna-13b_fact": [
      "The proteome of yeast, or Saccharomyces cerevisiae, has been determined through various experimental techniques.",
      "The proteome refers to the entire set of proteins expressed by an organism, including all isoforms and post-translational modifications.",
      "Mass spectrometry-based methods like liquid chromatography-tandem mass spectrometry (LC-MS/MS) are used to determine the proteome of yeast.",
      "Genomic techniques, like DNA sequencing, are an additional method used to determine the proteome of yeast.",
      "A complete proteome of yeast can't be determined in a single experiment currently."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Genomic techniques, like DNA sequencing, are used to determine the genome of yeast, not the proteome.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 346,
    "user_query": "Which is the most common cause of sudden cardiac death in young athletes?",
    "vicuna-13b_response": "Sudden cardiac death (SCD) is a rare but tragic event in young athletes. The most common cause of SCD in young athletes is a heart condition called hypertrophic cardiomyopathy (HCM).\nHCM is a genetic disorder that affects the heart muscle and causes it to thicken, making it harder for the heart to pump blood. This thickening can cause the heart to become enlarged and can lead to abnormal electrical signals that can cause the heart to beat too fast or too slow, leading to SCD.\nOther causes of SCD in young athletes include underlying heart conditions such as arrhythmias, coronary artery abnormalities, and heart valve problems. These conditions may be undiagnosed or untreated, or may have been previously treated with medications or surgery.\nIt's important to note that SCD can occur in athletes of all ages and fitness levels, and not just in those who are highly competitive or have a history of heart problems. That's why it's important for all young athletes to undergo regular physical exams and screenings, including electrocardiograms (ECGs) and echocardiograms, to identify any underlying heart conditions and reduce the risk of SCD.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The most common cause of Sudden Cardiac Death (SCD) in young athletes is Hypertrophic Cardiomyopathy (HCM).\n2. Hypertrophic Cardiomyopathy is a genetic disorder that causes the heart muscle to thicken.\n3. The thickening of the heart muscle in HCM can cause abnormal electrical signals that can make the heart beat too fast or too slow.\n4. Other causes of SCD in young athletes include arrhythmias, coronary artery abnormalities, and heart valve problems.\n5. Regular physical exams and screenings, including electrocardiograms (ECGs) and echocardiograms, are advisable for young athletes to identify any underlying heart conditions and reduce the risk of SCD.",
    "vicuna-13b_fact": [
      "The most common cause of Sudden Cardiac Death (SCD) in young athletes is Hypertrophic Cardiomyopathy (HCM).",
      "Hypertrophic Cardiomyopathy is a genetic disorder that causes the heart muscle to thicken.",
      "The thickening of the heart muscle in HCM can cause abnormal electrical signals that can make the heart beat too fast or too slow.",
      "Other causes of SCD in young athletes include arrhythmias, coronary artery abnormalities, and heart valve problems.",
      "Regular physical exams and screenings, including electrocardiograms (ECGs) and echocardiograms, are advisable for young athletes to identify any underlying heart conditions and reduce the risk of SCD."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 347,
    "user_query": "Could the Menzerath-Altmann law be proved mathematically trivial in genomes?",
    "vicuna-13b_response": "The Menzerath-Altmann law states that the length of the shortest protein-coding sequence in a genome is proportional to the genome size. In other words, the shorter the protein, the larger the genome. This law has been observed in many different organisms, but it is not clear whether it is a fundamental property of genomes or simply a consequence of the way proteins are distributed in the genome.\nOne way to test the Menzerath-Altmann law mathematically is to compare the lengths of the shortest protein-coding sequences in different genomes and see if there is a relationship between the length of the shortest protein and the size of the genome. This can be done using statistical methods to determine if there is a correlation between the two variables.\nHowever, it is also possible that the Menzerath-Altmann law is simply a consequence of the way proteins are distributed in the genome. For example, if there are certain regions of the genome that are more likely to contain short proteins, then it is possible that the Menzerath-Altmann law simply reflects this distribution.\nOverall, while the Menzerath-Altmann law can be tested mathematically, it is not a trivial law and its underlying causes are still not well understood. Further research is needed to fully understand the relationship between protein length and genome size.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Menzerath-Altmann law states that the length of the shortest protein-coding sequence in a genome is proportional to the genome size.\n2. This law has been observed in many different organisms.\n3. It is possible to test the Menzerath-Altmann law by comparing the lengths of the shortest protein-coding sequences in different genomes and looking for a relationship to genome size.\n4. The Menzerath-Altmann law may also be a consequence of how proteins are distributed in the genome.\n5. The causes underlying the Menzerath-Altmann law are not yet fully understood, and further research is needed.",
    "vicuna-13b_fact": [
      "The Menzerath-Altmann law states that the length of the shortest protein-coding sequence in a genome is proportional to the genome size.",
      "This law has been observed in many different organisms.",
      "It is possible to test the Menzerath-Altmann law by comparing the lengths of the shortest protein-coding sequences in different genomes and looking for a relationship to genome size.",
      "The Menzerath-Altmann law may also be a consequence of how proteins are distributed in the genome.",
      "The causes underlying the Menzerath-Altmann law are not yet fully understood, and further research is needed."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Menzerath-Altmann law states that the larger the whole, the smaller the size of its constituents. It does not specifically refer to protein-coding sequences or genomes.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "vicuna-13b_response": "Loss of the protein Lon1 in the plant Arabidopsis has been shown to have a number of effects on plant growth and development. Some of the results of Lon1 loss in Arabidopsis include:\n1. Increased sensitivity to oxidative stress: Lon1 is involved in the degradation of proteins that are damaged by oxidative stress, and loss of Lon1 leads to an accumulation of these damaged proteins. This accumulation can make the plant more sensitive to oxidative stress, which can lead to decreased growth and development.\n2. Impaired chlorophyll synthesis: Lon1 is involved in the degradation of proteins that are involved in chlorophyll synthesis, and loss of Lon1 can lead to decreased chlorophyll content and a decrease in the ability of the plant to photosynthesize. This can lead to decreased growth and development.\n3. Altered plant growth and development: Loss of Lon1 can lead to altered growth and development in Arabidopsis, including decreased plant height, smaller leaves, and a delay in flowering.\n4. Increased susceptibility to disease: Loss of Lon1 can lead to increased susceptibility to disease in Arabidopsis, as the accumulation of damaged proteins can make the plant more vulnerable to pathogens.\nOverall, the loss of Lon1 in Arabidopsis can have a significant impact on plant growth and development, and further research is needed to fully understand the mechanisms underlying these effects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Loss of the protein Lon1 in the plant Arabidopsis increases sensitivity to oxidative stress.\n2. Lon1 in Arabidopsis is involved in the degradation of proteins damaged by oxidative stress.\n3. Loss of Lon1 in Arabidopsis can impair chlorophyll synthesis, leading to decreased chlorophyll content and less efficient photosynthesis.\n4. The absence of Lon1 can lead to altered growth and development in Arabidopsis, including decreased plant height, smaller leaves, and a delay in flowering.\n5. Loss of Lon1 can lead to increased susceptibility to disease in Arabidopsis due to accumulation of damaged proteins.",
    "vicuna-13b_fact": [
      "Loss of the protein Lon1 in the plant Arabidopsis increases sensitivity to oxidative stress.",
      "Lon1 in Arabidopsis is involved in the degradation of proteins damaged by oxidative stress.",
      "Loss of Lon1 in Arabidopsis can impair chlorophyll synthesis, leading to decreased chlorophyll content and less efficient photosynthesis.",
      "The absence of Lon1 can lead to altered growth and development in Arabidopsis, including decreased plant height, smaller leaves, and a delay in flowering.",
      "Loss of Lon1 can lead to increased susceptibility to disease in Arabidopsis due to accumulation of damaged proteins."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 352,
    "user_query": "Are there studies representing the involvement of Notch mutations in neurodegenerative diseases such as Down syndrome, Pick's and Prion's disease, and cadasil syndrome?",
    "vicuna-13b_response": "Yes, there have been studies that have investigated the involvement of Notch mutations in neurodegenerative diseases, including Down syndrome, Pick's disease, and prion disease, as well as cadasil syndrome.\nDown syndrome is a genetic disorder caused by an extra copy of chromosome 21, and it is the most common chromosomal disorder. Studies have shown that Notch signaling is altered in the brains of individuals with Down syndrome, and that Notch mutations may contribute to the development of this disorder.\nPick's disease is a rare, progressive neurodegenerative disorder that is characterized by the accumulation of abnormal protein aggregates in the brain. Some studies have suggested that Notch signaling may be involved in the development of Pick's disease, and that Notch mutations may contribute to the disease.\nPrion disease is a group of rare, progressive neurodegenerative disorders that are caused by the accumulation of abnormal prion protein in the brain. Some studies have suggested that Notch signaling may be involved in the development of prion disease, and that Notch mutations may contribute to the disease.\nCadasil syndrome is a rare genetic disorder that is characterized by the accumulation of abnormal protein deposits in the brain and other organs. Some studies have suggested that Notch signaling may be involved in the development of cadasil syndrome, and that Notch mutations may contribute to the disease.\nOverall, these studies suggest that Notch mutations may play a role in the development of various neurodegenerative diseases, and that targeting Notch signaling may be a potential therapeutic strategy for these disorders. However, more research is needed to fully understand the role of Notch mutations in these diseases and to develop effective treatments.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Studies suggest that Notch mutations are involved in neurodegenerative diseases, including Down syndrome, Pick's disease, prion disease, and cadasil syndrome.\n2. Down syndrome is a genetic disorder caused by an extra copy of chromosome 21.\n3. Studies have shown that Notch signaling is altered in the brains of individuals with Down syndrome.\n4. Pick's disease is characterized by the accumulation of abnormal protein aggregates in the brain.\n5. Cadasil syndrome is a rare genetic disorder characterized by the accumulation of abnormal protein deposits in the brain and other organs.",
    "vicuna-13b_fact": [
      "Studies suggest that Notch mutations are involved in neurodegenerative diseases, including Down syndrome, Pick's disease, prion disease, and cadasil syndrome.",
      "Down syndrome is a genetic disorder caused by an extra copy of chromosome 21.",
      "Studies have shown that Notch signaling is altered in the brains of individuals with Down syndrome.",
      "Pick's disease is characterized by the accumulation of abnormal protein aggregates in the brain.",
      "Cadasil syndrome is a rare genetic disorder characterized by the accumulation of abnormal protein deposits in the brain and other organs."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 353,
    "user_query": "Are there any functional differences between Mfd and its human Cocaine syndrome protein B (CSB) homolog?",
    "vicuna-13b_response": "Mfd (mitochondrial fission defect) is a protein that plays a role in regulating the dynamics of mitochondria, which are the energy-producing structures in cells. Cocaine syndrome protein B (CSB) is a protein that has been identified in humans and has been shown to have some similarities to Mfd.\nThere is currently limited information available about the functional differences between Mfd and its human CSB homolog. However, it is known that Mfd is involved in regulating the fission of mitochondria, which is the process by which mitochondria divide into smaller, more specialized structures. CSB has been shown to play a role in regulating the expression of certain genes, but its exact function is not yet fully understood.\nIt is possible that Mfd and CSB may have some similar functions, as they share some similarities in terms of their protein structure and the processes they are involved in. However, it is also possible that they have different functions and may regulate different aspects of mitochondrial dynamics. Further research is needed to fully understand the functional differences between Mfd and its human CSB homolog.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mfd is a protein that plays a role in regulating the dynamics of mitochondria.\n2. Cocaine syndrome protein B (CSB) is a protein identified in humans.\n3. Both Mfd and CSB share similarities in their protein structure.\n4. Mfd is involved in regulating the fission of mitochondria.\n5. CSB has been shown to play a role in regulating the expression of certain genes.",
    "vicuna-13b_fact": [
      "Mfd is a protein that plays a role in regulating the dynamics of mitochondria.",
      "Cocaine syndrome protein B (CSB) is a protein identified in humans.",
      "Both Mfd and CSB share similarities in their protein structure.",
      "Mfd is involved in regulating the fission of mitochondria.",
      "CSB has been shown to play a role in regulating the expression of certain genes."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 354,
    "user_query": "What is membrane scission?",
    "vicuna-13b_response": "Membrane scission is the process by which a cell divides its cytoplasm and organelles, and ultimately results in the formation of two daughter cells. This process is a crucial part of cell division and occurs during the final stages of mitosis.\nDuring interphase, the cell grows and replicates its DNA in preparation for cell division. As the cell enters mitosis, the nuclear membrane dissolves and the chromatin condenses into visible chromosomes. The chromosomes line up in the center of the cell, and the nuclear envelope reforms around them.\nNext, the cell divides into two daughter cells. This process involves the formation of a cleavage furrow, which starts at the center of the cell and gradually deepens until the cell divides. The cleavage furrow eventually pinches off the daughter cells, and they become separate entities.\nDuring membrane scission, the cell's plasma membrane, which surrounds the cytoplasm, also divides. This allows the cytoplasm and organelles to separate into the two daughter cells. The process of membrane scission is complex and requires the coordination of various cellular machinery, including the cytoskeleton and various enzymes.\nMembrane scission is a crucial step in the process of cell division, as it ensures that each daughter cell receives an equal share of the cytoplasm and organelles. This process is essential for the continuation of life and the reproduction of cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Membrane scission is the process by which a cell divides its cytoplasm and organelles, resulting in the formation of two daughter cells.\n2. Membrane scission occurs during the final stages of mitosis.\n3. During interphase, the cell grows and replicates its DNA in preparation for cell division.\n4. During membrane scission, the cell's plasma membrane also divides, allowing the cytoplasm and organelles to separate into the two daughter cells.\n5. Membrane scission ensures that each daughter cell receives an equal share of the cytoplasm and organelles.",
    "vicuna-13b_fact": [
      "Membrane scission is the process by which a cell divides its cytoplasm and organelles, resulting in the formation of two daughter cells.",
      "Membrane scission occurs during the final stages of mitosis.",
      "During interphase, the cell grows and replicates its DNA in preparation for cell division.",
      "During membrane scission, the cell's plasma membrane also divides, allowing the cytoplasm and organelles to separate into the two daughter cells.",
      "Membrane scission ensures that each daughter cell receives an equal share of the cytoplasm and organelles."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Membrane scission is the final process by which a vesicle pinches off from a membrane, not the process by which a cell divides its cytoplasm and organelles.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 356,
    "user_query": "Is the yeast Μac1 transcription factor induced upon copper deficiency?",
    "vicuna-13b_response": "Yes, the yeast Mac1 transcription factor is known to be induced upon copper deficiency. Mac1 is a zinc finger transcription factor that regulates the expression of genes involved in copper homeostasis and other cellular processes.\nIn response to copper deficiency, the yeast cell activates a signaling pathway that leads to the transcriptional induction of genes involved in copper uptake and storage, as well as the repression of genes involved in copper-dependent enzymes. Mac1 is a key transcription factor that regulates this response by binding to DNA elements in the promoters of copper-responsive genes.\nStudies have shown that Mac1 is rapidly induced upon copper deficiency in yeast, and that this induction requires the Cbf11 transcription factor, which is a key regulator of copper homeostasis in yeast. Additionally, Mac1 has been shown to play a role in the regulation of stress responses in yeast, including the response to copper deficiency.\nOverall, the induction of Mac1 transcription factor is an important aspect of the yeast cell's response to copper deficiency, and plays a crucial role in regulating the expression of genes involved in copper homeostasis and other cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. The yeast Mac1 transcription factor is induced upon copper deficiency.\n2. Mac1 is a zinc finger transcription factor that regulates the expression of genes involved in copper homeostasis and other cellular processes.\n3. In yeast, the induction of Mac1 upon copper deficiency requires the Cbf11 transcription factor.\n4. Mac1 binds to DNA elements in the promoters of copper-responsive genes.\n5. Mac1 also plays a role in the regulation of stress responses in yeast, including the response to copper deficiency.",
    "vicuna-13b_fact": [
      "The yeast Mac1 transcription factor is induced upon copper deficiency.",
      "Mac1 is a zinc finger transcription factor that regulates the expression of genes involved in copper homeostasis and other cellular processes.",
      "In yeast, the induction of Mac1 upon copper deficiency requires the Cbf11 transcription factor.",
      "Mac1 binds to DNA elements in the promoters of copper-responsive genes.",
      "Mac1 also plays a role in the regulation of stress responses in yeast, including the response to copper deficiency."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 357,
    "user_query": "What is the mechanism of DNA replication termination in vertebrates?",
    "vicuna-13b_response": "In vertebrates, DNA replication termination occurs through a process called the \"replication fork collapse mechanism.\" This process involves the coordinated action of several proteins and enzymes that work together to bring the replication process to a halt.\nThe replication fork collapse mechanism involves the following steps:\n1. The replication fork is stabilized by the action of the proteins and enzymes involved in the replication process.\n2. Once the replication fork has been stabilized, the enzyme helicase unwinds the double helix of DNA and separates the two strands.\n3. An enzyme called primase synthesizes short RNA primers, which are used as a starting point for the synthesis of new DNA strands.\n4. An enzyme called polymerase synthesizes new DNA strands by adding nucleotides to the RNA primers.\n5. Once the new DNA strands have been synthesized, an enzyme called ligase seals the gaps between the nucleotides, forming a continuous strand.\n6. The replication process is terminated when the replication fork collapses, resulting in the formation of a Y-shaped structure called a replication fork collapse.\n7. The replication fork collapse is resolved by the action of an enzyme called polymerase, which synthesizes a new DNA strand by adding nucleotides to the RNA primers.\nOverall, the replication fork collapse mechanism is a highly coordinated process that ensures the accurate and efficient replication of DNA in vertebrates.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. In vertebrates, DNA replication termination occurs through a process called the \"replication fork collapse mechanism.\"\n2. The replication fork is stabilized by the action of the proteins and enzymes involved in the replication process.\n3. The enzyme helicase unwinds the double helix of DNA and separates the two strands in the replication fork collapse mechanism.\n4. An enzyme called primase synthesizes short RNA primers, which are used as a starting point for the synthesis of new DNA strands in the replication fork collapse mechanism.\n5. The replication process is terminated when the replication fork collapses, resulting in the formation of a Y-shaped structure called a replication fork collapse.",
    "vicuna-13b_fact": [
      "In vertebrates, DNA replication termination occurs through a process called the \"replication fork collapse mechanism.\"",
      "The replication fork is stabilized by the action of the proteins and enzymes involved in the replication process.",
      "The enzyme helicase unwinds the double helix of DNA and separates the two strands in the replication fork collapse mechanism.",
      "An enzyme called primase synthesizes short RNA primers, which are used as a starting point for the synthesis of new DNA strands in the replication fork collapse mechanism.",
      "The replication process is terminated when the replication fork collapses, resulting in the formation of a Y-shaped structure called a replication fork collapse."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The replication process does not terminate with the formation of a Y-shaped structure but rather two new DNA molecules form from the original DNA molecule. The Y-shaped structure represents the replication fork during the replication process.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 360,
    "user_query": "Have thyronamines  effects on fat tissue?",
    "vicuna-13b_response": "Thyronamines are a group of hormones that are produced by the thyroid gland and play a role in regulating metabolism in the body. They include thyroxine (T4) and triiodothyronine (T3).\nThyronamines can have effects on fat tissue in the body. They can increase the metabolic rate, which can lead to an increase in the breakdown of fat cells and the release of fatty acids into the bloodstream. This can result in an increase in the burning of fat for energy and a decrease in body fat levels.\nAdditionally, thyronamines can also affect the growth and development of fat cells. They can stimulate the differentiation of preadipocytes (precursor cells that can develop into fat cells) into mature fat cells. This can result in an increase in the number of fat cells in the body.\nHowever, it is important to note that an imbalance in thyronamines levels can have negative effects on the body. For example, high levels of thyronamines can lead to hyperthyroidism, a condition characterized by an overactive thyroid gland and an increased metabolic rate, which can result in weight loss, anxiety, and other symptoms. Low levels of thyronamines can lead to hypothyroidism, a condition characterized by an underactive thyroid gland and a decreased metabolic rate, which can result in weight gain, fatigue, and other symptoms.\nIt is important to maintain a healthy balance of thyronamines levels in the body, and any changes in thyronamines levels should be monitored by a healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Thyronamines are hormones produced by the thyroid gland.\n2. Thyronamines include thyroxine (T4) and triiodothyronine (T3).\n3. Thyronamines can increase the metabolic rate, leading to the breakdown of fat cells and release of fatty acids into the bloodstream.\n4. Thyronamines can stimulate the differentiation of preadipocytes into mature fat cells.\n5. High levels of thyronamines can lead to hyperthyroidism, and low levels can lead to hypothyroidism.",
    "vicuna-13b_fact": [
      "Thyronamines are hormones produced by the thyroid gland.",
      "Thyronamines include thyroxine (T4) and triiodothyronine (T3).",
      "Thyronamines can increase the metabolic rate, leading to the breakdown of fat cells and release of fatty acids into the bloodstream.",
      "Thyronamines can stimulate the differentiation of preadipocytes into mature fat cells.",
      "High levels of thyronamines can lead to hyperthyroidism, and low levels can lead to hypothyroidism."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Thyronamines are derivatives of thyroid hormones, but they are not directly produced by the thyroid gland.\n2. TRUE\n3. FALSE [correction]: It is typically thyroid hormones (not thyronamines) such as thyroxine (T4) and triiodothyronine (T3) that tend to increase metabolic rate and the breakdown of fat cells.\n4. UNKNOWN\n5. FALSE [correction]: Elevated levels of thyroid hormones (not thyronamines) can lead to hyperthyroidism, and low levels can cause hypothyroidism. Thyronamines, in contrast, have generally been reported to have the opposite physiological effects of the classic thyroid hormones.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 361,
    "user_query": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?",
    "vicuna-13b_response": "The anti-CD52 monoclonal antibody that is used for the treatment of multiple sclerosis patients is called Alemtuzumab. It is also known by its brand name, Campath. Alemtuzumab is a monoclonal antibody that targets the CD52 protein, which is expressed on the surface of T cells and B cells. It is used to treat relapsing-remitting multiple sclerosis (RRMS) and has been shown to reduce the frequency of relapses and the accumulation of disability over time. However, it can also have significant side effects, including the risk of infections and the development of autoimmune conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Alemtuzumab is an anti-CD52 monoclonal antibody used for treating multiple sclerosis patients.\n2. Alemtuzumab is also known by its brand name, Campath.\n3. Alemtuzumab targets the CD52 protein, which is expressed on the surface of T cells and B cells.\n4. Alemtuzumab is used to treat relapsing-remitting multiple sclerosis (RRMS) and can reduce the frequency of relapses and the accumulation of disability over time.\n5. Alemtuzumab treatment can potentially cause significant side effects, including the risk of infections and the development of autoimmune conditions.",
    "vicuna-13b_fact": [
      "Alemtuzumab is an anti-CD52 monoclonal antibody used for treating multiple sclerosis patients.",
      "Alemtuzumab is also known by its brand name, Campath.",
      "Alemtuzumab targets the CD52 protein, which is expressed on the surface of T cells and B cells.",
      "Alemtuzumab is used to treat relapsing-remitting multiple sclerosis (RRMS) and can reduce the frequency of relapses and the accumulation of disability over time.",
      "Alemtuzumab treatment can potentially cause significant side effects, including the risk of infections and the development of autoimmune conditions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 369,
    "user_query": "At which kind of individuals is pharmacological treatment of subclinical hypothyroidism effective in reducing cardiovascular events?",
    "vicuna-13b_response": "Pharmacological treatment of subclinical hypothyroidism, a condition in which the thyroid gland produces insufficient amounts of hormones, is effective in reducing cardiovascular events in individuals with a history of cardiovascular disease or risk factors for cardiovascular disease.\nStudies have shown that treatment with levothyroxine, a synthetic form of the thyroid hormone thyroxine (T4), can reduce levels of low-density lipoprotein (LDL) cholesterol, a major risk factor for cardiovascular disease, in individuals with subclinical hypothyroidism. Levothyroxine also improves other cardiovascular risk factors such as blood pressure, insulin sensitivity, and lipid profiles.\nThe American Thyroid Association (ATA) recommends that individuals with subclinical hypothyroidism and a history of cardiovascular disease or risk factors for cardiovascular disease should be treated with levothyroxine. The ATA also recommends that treatment should be guided by the individual's clinical presentation, including their TSH level, and that treatment should be individualized based on the patient's specific medical history and circumstances.\nIt is important to note that the effectiveness of levothyroxine in reducing cardiovascular events in individuals with subclinical hypothyroidism may vary depending on the individual's specific medical history and circumstances. Therefore, it is important to discuss the potential benefits and risks of treatment with a healthcare provider.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pharmacological treatment of subclinical hypothyroidism can be effective in reducing cardiovascular events in individuals with a history of cardiovascular disease or risk factors for cardiovascular disease.\n2. Treatment with Levothyroxine can reduce levels of low-density lipoprotein (LDL) cholesterol, a major risk factor for cardiovascular disease, in individuals with subclinical hypothyroidism.\n3. Levothyroxine can also improve other cardiovascular risk factors such as blood pressure, insulin sensitivity, and lipid profiles.\n4. The American Thyroid Association (ATA) recommends that individuals with subclinical hypothyroidism and a history of cardiovascular disease or risk factors for cardiovascular disease should be treated with Levothyroxine.\n5. The effectiveness of Levothyroxine in reducing cardiovascular events in individuals with subclinical hypothyroidism may vary depending on the individual's specific medical history and circumstances.",
    "vicuna-13b_fact": [
      "Pharmacological treatment of subclinical hypothyroidism can be effective in reducing cardiovascular events in individuals with a history of cardiovascular disease or risk factors for cardiovascular disease.",
      "Treatment with Levothyroxine can reduce levels of low-density lipoprotein (LDL) cholesterol, a major risk factor for cardiovascular disease, in individuals with subclinical hypothyroidism.",
      "Levothyroxine can also improve other cardiovascular risk factors such as blood pressure, insulin sensitivity, and lipid profiles.",
      "The American Thyroid Association (ATA) recommends that individuals with subclinical hypothyroidism and a history of cardiovascular disease or risk factors for cardiovascular disease should be treated with Levothyroxine.",
      "The effectiveness of Levothyroxine in reducing cardiovascular events in individuals with subclinical hypothyroidism may vary depending on the individual's specific medical history and circumstances."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 372,
    "user_query": "What is known about the association between the use of selective serotonin reuptake inhibitors during pregnancy and risk for autism in offspring?",
    "vicuna-13b_response": "There is some evidence to suggest that the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy may be associated with an increased risk of autism in offspring. Studies have found that children exposed to SSRIs in utero have a higher risk of developing autism spectrum disorder (ASD) compared to children who were not exposed to these medications. However, it is important to note that the absolute risk of ASD associated with SSRI exposure is still low, and more research is needed to fully understand the potential link between SSRIs and autism.\nOne theory about the potential link between SSRIs and autism is that these medications may affect the development of certain brain regions, including the prefrontal cortex and the cerebellum, which are involved in the regulation of social behavior and communication. Some studies have also suggested that SSRIs may affect the levels of certain neurotransmitters, such as serotonin and dopamine, which play important roles in brain development and function.\nIt is important to note that the majority of studies on this topic have been observational in nature, and it is difficult to establish causality between SSRI use during pregnancy and the risk of autism in offspring. Therefore, it is important for pregnant women to carefully weigh the potential benefits and risks of SSRI use, and to discuss any concerns with their healthcare provider.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. Some studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy may be associated with an increased risk of autism in offspring.\n2. According to these studies, children exposed to SSRIs in utero have a higher risk of developing autism spectrum disorder (ASD) than those who were not exposed to these medications.\n3. It has been proposed that SSRIs may affect the development of certain brain regions, including the prefrontal cortex and the cerebellum.\n4. Some research suggests that SSRIs may affect the levels of certain neurotransmitters, such as serotonin and dopamine.\n5. The majority of studies on the potential link between SSRI use during pregnancy and risk of autism in offspring have been observational.",
    "vicuna-13b_fact": [
      "Some studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy may be associated with an increased risk of autism in offspring.",
      "According to these studies, children exposed to SSRIs in utero have a higher risk of developing autism spectrum disorder (ASD) than those who were not exposed to these medications.",
      "It has been proposed that SSRIs may affect the development of certain brain regions, including the prefrontal cortex and the cerebellum.",
      "Some research suggests that SSRIs may affect the levels of certain neurotransmitters, such as serotonin and dopamine.",
      "The majority of studies on the potential link between SSRI use during pregnancy and risk of autism in offspring have been observational."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 374,
    "user_query": "Is desmin an intermediate filament protein involved in Dilated Cardiomyopathy (DCM)?",
    "vicuna-13b_response": "Yes, desmin is an intermediate filament protein that has been implicated in the development of Dilated Cardiomyopathy (DCM). DCM is a type of heart disease characterized by the dilatation of the heart chambers and a decrease in contractility of the heart muscle.\nDesmin is a protein that is found in the sarcomeres of cardiac muscle cells and is important for the maintenance of the structure and function of these cells. Mutations in the desmin gene have been identified as a cause of DCM, and it is believed that these mutations may lead to abnormalities in the structure and function of the desmin protein, which can result in the degeneration of cardiac muscle cells and the development of DCM.\nAdditionally, desmin has been shown to play a role in the pathogenesis of other cardiovascular diseases such as hypertrophic cardiomyopathy, and it is also involved in the development of other diseases such as skeletal muscle disorders.\nIt is important to note that while desmin is implicated in the development of DCM, it is not the only gene or protein involved in this disease. Other genes and proteins have also been identified as playing a role in the development of DCM, and the specific cause of the disease can vary from person to person.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Desmin is an intermediate filament protein.\n2. Desmin is implicated in the development of Dilated Cardiomyopathy (DCM).\n3. DCM is characterized by the dilatation of the heart chambers and a decrease in contractility of the heart muscle.\n4. Mutations in the desmin gene have been identified as a cause of DCM.\n5. Desmin is believed to play a role in the pathogenesis of other cardiovascular diseases such as hypertrophic cardiomyopathy and also involved in the development of diseases such as skeletal muscle disorders.",
    "vicuna-13b_fact": [
      "Desmin is an intermediate filament protein.",
      "Desmin is implicated in the development of Dilated Cardiomyopathy (DCM).",
      "DCM is characterized by the dilatation of the heart chambers and a decrease in contractility of the heart muscle.",
      "Mutations in the desmin gene have been identified as a cause of DCM.",
      "Desmin is believed to play a role in the pathogenesis of other cardiovascular diseases such as hypertrophic cardiomyopathy and also involved in the development of diseases such as skeletal muscle disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 376,
    "user_query": "List human diseases involving genomic imprinting.",
    "vicuna-13b_response": "Genomic imprinting is a phenomenon in which a gene is expressed differently depending on whether it was inherited from the mother or the father. This can lead to diseases when the imprinting is disrupted. Here are some examples of human diseases involving genomic imprinting:\n1. Beckwith-Wiedemann syndrome: This is a genetic disorder caused by an overactive imprinting control region (ICR) on chromosome 11. It can lead to an overgrowth of certain tissues, such as the tongue and the placenta, and an increased risk of cancer.\n2. Prader-Willi syndrome: This is a genetic disorder caused by a deletion of genetic material on chromosome 15. It is characterized by low muscle tone, poor feeding, and slow development. It can also lead to an increased risk of obesity and diabetes.\n3. Angelman syndrome: This is a genetic disorder caused by a deletion of genetic material on chromosome 15. It is characterized by developmental delay, intellectual disability, and problems with movement and balance.\n4. Immunodeficiency, centromeric 4 (IC4) syndrome: This is a genetic disorder caused by a mutation in the MHC class II genes on chromosome 6. It leads to a defect in the immune system and an increased risk of infections.\n5. Klinefelter syndrome: This is a genetic disorder caused by an extra X chromosome in males. It is characterized by taller stature, breast enlargement, and infertility.\nThese are just a few examples of human diseases involving genomic imprinting. It is important to note that this is not an exhaustive list and there may be other diseases that involve genomic imprinting.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Genomic imprinting is a phenomenon in which a gene is expressed differently depending on whether it was inherited from the mother or the father.\n2. Beckwith-Wiedemann syndrome is a genetic disorder caused by an overactive imprinting control region (ICR) on chromosome 11.\n3. Prader-Willi syndrome is a genetic disorder caused by a deletion of genetic material on chromosome 15.\n4. Angelman syndrome is a genetic disorder caused by a deletion of genetic material on chromosome 15.\n5. Immunodeficiency, centromeric 4 (IC4) syndrome is a genetic disorder caused by a mutation in the MHC class II genes on chromosome 6.\n6. Klinefelter syndrome is a genetic disorder caused by an extra X chromosome in males.",
    "vicuna-13b_fact": [
      "Genomic imprinting is a phenomenon in which a gene is expressed differently depending on whether it was inherited from the mother or the father.",
      "Beckwith-Wiedemann syndrome is a genetic disorder caused by an overactive imprinting control region (ICR) on chromosome 11.",
      "Prader-Willi syndrome is a genetic disorder caused by a deletion of genetic material on chromosome 15.",
      "Angelman syndrome is a genetic disorder caused by a deletion of genetic material on chromosome 15.",
      "Immunodeficiency, centromeric 4 (IC4) syndrome is a genetic disorder caused by a mutation in the MHC class II genes on chromosome 6.",
      "Klinefelter syndrome is a genetic disorder caused by an extra X chromosome in males."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 378,
    "user_query": "Which deficiency is the cause of restless leg syndrome?",
    "vicuna-13b_response": "Restless leg syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations such as crawling, tingling, or burning. The exact cause of RLS is not well understood, but it is believed to be related to a deficiency or dysfunction in the brain's dopamine system.\nDopamine is a neurotransmitter that plays a crucial role in regulating movement, and it is believed to be involved in the control of muscle activity. In RLS, there may be a deficiency or dysfunction in the brain's dopamine system, which can lead to the uncomfortable sensations and urges associated with the disorder.\nAdditionally, genetics may play a role in the development of RLS, as the condition tends to run in families. Lifestyle factors such as smoking, alcohol consumption, and caffeine intake may also contribute to the development of RLS.\nOverall, while the exact cause of RLS is not yet fully understood, it is believed to be related to a deficiency or dysfunction in the brain's dopamine system, and may be influenced by genetic and lifestyle factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Restless leg syndrome (RLS) is a neurological disorder.\n2. RLS is characterized by an irresistible urge to move the legs along with uncomfortable sensations.\n3. A deficiency or dysfunction in the brain's dopamine system is believed to be related to RLS.\n4. Genetics may play a role in the development of RLS as it tends to run in families.\n5. Lifestyle factors such as smoking, alcohol consumption, and caffeine intake may contribute to the development of RLS.",
    "vicuna-13b_fact": [
      "Restless leg syndrome (RLS) is a neurological disorder.",
      "RLS is characterized by an irresistible urge to move the legs along with uncomfortable sensations.",
      "A deficiency or dysfunction in the brain's dopamine system is believed to be related to RLS.",
      "Genetics may play a role in the development of RLS as it tends to run in families.",
      "Lifestyle factors such as smoking, alcohol consumption, and caffeine intake may contribute to the development of RLS."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 379,
    "user_query": "What histone modification is recognized by the bromodomain?",
    "vicuna-13b_response": "The bromodomain is a protein domain that recognizes specific histone modifications, particularly the presence of acetylated lysine residues on histone proteins. The bromodomain is a type of reader domain that binds to acetylated lysine residues on histone proteins, which are involved in the regulation of gene expression and chromatin structure. The bromodomain is found in a variety of proteins, including transcription factors, chromatin-modifying enzymes, and histone deacetylases, and plays a role in regulating the activity of these proteins in response to changes in the acetylation status of histone proteins.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The bromodomain is a protein domain.\n2. The bromodomain recognizes specific histone modifications, particularly the presence of acetylated lysine residues on histone proteins.\n3. The bromodomain is a type of reader domain that binds to acetylated lysine residues on histone proteins.\n4. Histone proteins play a role in the regulation of gene expression and chromatin structure.\n5. The bromodomain is present in transcription factors, chromatin-modifying enzymes, and histone deacetylases.",
    "vicuna-13b_fact": [
      "The bromodomain is a protein domain.",
      "The bromodomain recognizes specific histone modifications, particularly the presence of acetylated lysine residues on histone proteins.",
      "The bromodomain is a type of reader domain that binds to acetylated lysine residues on histone proteins.",
      "Histone proteins play a role in the regulation of gene expression and chromatin structure.",
      "The bromodomain is present in transcription factors, chromatin-modifying enzymes, and histone deacetylases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 387,
    "user_query": "What is the methodological principle of ChIA-PET?",
    "vicuna-13b_response": "ChIA-PET (Chromatin Immunoprecipitation with Total Protein Extraction and Enhanced Chromatin Fragmentation) is a method used to study protein-DNA interactions in chromatin. The methodological principle of ChIA-PET is to first crosslink chromatin with formaldehyde, followed by sonication to shear the chromatin into small fragments. Then, antibodies against specific proteins of interest are used to immunoprecipitate the protein-DNA complexes from the chromatin fragments. The immunoprecipitated complexes are then purified and analyzed by mass spectrometry to identify the associated proteins.\nThe key features of ChIA-PET that distinguish it from other chromatin immunoprecipitation methods include:\n1. Total protein extraction: ChIA-PET uses total protein extraction, which means that all proteins in the sample are extracted and analyzed, rather than just the proteins associated with the chromatin.\n2. Enhanced chromatin fragmentation: ChIA-PET uses enhanced chromatin fragmentation to generate smaller chromatin fragments, which increases the sensitivity and specificity of the analysis.\n3. Mass spectrometry analysis: ChIA-PET uses mass spectrometry to identify the proteins associated with the chromatin, which provides high-resolution and quantitative information about the protein-DNA interactions.\nOverall, ChIA-PET is a powerful method for studying protein-DNA interactions in chromatin, and has been used to investigate a wide range of biological processes, including transcriptional regulation, DNA repair, and chromosome structure.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ChIA-PET is a method used to study protein-DNA interactions in chromatin.\n2. The ChIA-PET method involves crosslinking chromatin with formaldehyde followed by sonication to shear the chromatin into small fragments.\n3. In the ChIA-PET process, antibodies against specific proteins of interest are used to immunoprecipitate the protein-DNA complexes from the chromatin fragments.\n4. The immunoprecipitated complexes in the ChIA-PET method are purified and analyzed by mass spectrometry to identify the associated proteins.\n5. ChIA-PET uses total protein extraction which means that all proteins in the sample are extracted and analyzed, not just the proteins associated with the chromatin.",
    "vicuna-13b_fact": [
      "ChIA-PET is a method used to study protein-DNA interactions in chromatin.",
      "The ChIA-PET method involves crosslinking chromatin with formaldehyde followed by sonication to shear the chromatin into small fragments.",
      "In the ChIA-PET process, antibodies against specific proteins of interest are used to immunoprecipitate the protein-DNA complexes from the chromatin fragments.",
      "The immunoprecipitated complexes in the ChIA-PET method are purified and analyzed by mass spectrometry to identify the associated proteins.",
      "ChIA-PET uses total protein extraction which means that all proteins in the sample are extracted and analyzed, not just the proteins associated with the chromatin."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The immunoprecipitated complexes in the ChIA-PET method are subjected to proximity ligation, followed by high-throughput sequencing, not mass spectrometry to identify the associated DNA fragments.\n5. FALSE [correction]: ChIA-PET does not use total protein extraction, it focuses on the protein-DNA interactions involving the protein of interest.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 390,
    "user_query": "Does PU.1 (SPI1) affect NF-kB binding?",
    "vicuna-13b_response": "PU.1 (SPI1) is a transcription factor that plays a role in the regulation of immune cell function and development. It has been shown to be involved in the regulation of NF-kB signaling, which is a key pathway involved in the regulation of immune responses and inflammation.\nNF-kB is a transcription factor that is activated in response to various stimuli, such as viral infections or inflammation, and regulates the expression of genes involved in the immune response and inflammation. PU.1 has been shown to affect NF-kB binding to DNA by interacting with NF-kB proteins and modulating their activity.\nIn some studies, PU.1 has been shown to inhibit NF-kB activity by preventing its binding to DNA, while in other studies, it has been shown to enhance NF-kB activity by promoting its binding to DNA. The exact mechanism by which PU.1 affects NF-kB binding is not fully understood and is the subject of ongoing research.\nOverall, while PU.1 (SPI1) does affect NF-kB binding, the exact nature of this effect is complex and depends on various factors, including the context in which PU.1 is activated and the specific proteins with which it interacts.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PU.1 (SPI1) is a transcription factor that plays a role in the regulation of immune cell function and development.\n2. PU.1 (SPI1) has been shown to be involved in the regulation of NF-kB signaling.\n3. NF-kB is a transcription factor that is activated in response to various stimuli and regulates the expression of genes involved in the immune response and inflammation.\n4. PU.1 has been shown to affect NF-kB binding to DNA by interacting with NF-kB proteins and modulating their activity.\n5. The exact mechanism by which PU.1 affects NF-kB binding is currently the subject of ongoing research.",
    "vicuna-13b_fact": [
      "PU.1 (SPI1) is a transcription factor that plays a role in the regulation of immune cell function and development.",
      "PU.1 (SPI1) has been shown to be involved in the regulation of NF-kB signaling.",
      "NF-kB is a transcription factor that is activated in response to various stimuli and regulates the expression of genes involved in the immune response and inflammation.",
      "PU.1 has been shown to affect NF-kB binding to DNA by interacting with NF-kB proteins and modulating their activity.",
      "The exact mechanism by which PU.1 affects NF-kB binding is currently the subject of ongoing research."
    ],
    "vicuna-13b_judge_raw": "1. TRUE \n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 391,
    "user_query": "Does the majority of the mitochondrial genomes abide to the second parity rule (PR2)?",
    "vicuna-13b_response": "The second parity rule (PR2) states that the number of A and C nucleotides in the DNA sequence of a given genome should be roughly equal. The majority of mitochondrial genomes do abide by this rule, as it has been observed that the majority of mitochondrial DNA sequences have a roughly equal number of A and C nucleotides. This is due to the fact that the PR2 is a consequence of the mutational processes that occur in mitochondrial DNA, which tend to preserve the overall structure of the genome while introducing mutations that disrupt the function of the genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The second parity rule (PR2) states that the number of A and C nucleotides in the DNA sequence of a given genome should be roughly equal.\n2. The majority of mitochondrial genomes abide by the second parity rule (PR2).\n3. The majority of mitochondrial DNA sequences have a roughly equal number of A and C nucleotides.\n4. The PR2 rule is a consequence of the mutational processes that occur in mitochondrial DNA.\n5. Mutational processes in mitochondrial DNA tend to preserve the overall structure of the genome while introducing mutations that disrupt the function of the genes.",
    "vicuna-13b_fact": [
      "The second parity rule (PR2) states that the number of A and C nucleotides in the DNA sequence of a given genome should be roughly equal.",
      "The majority of mitochondrial genomes abide by the second parity rule (PR2).",
      "The majority of mitochondrial DNA sequences have a roughly equal number of A and C nucleotides.",
      "The PR2 rule is a consequence of the mutational processes that occur in mitochondrial DNA.",
      "Mutational processes in mitochondrial DNA tend to preserve the overall structure of the genome while introducing mutations that disrupt the function of the genes."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The second parity rule (PR2) states that the number of A and T nucleotides in the DNA sequence of a given genome should be roughly equal.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 396,
    "user_query": "Which hormone abnormalities are common in Williams syndrome ?",
    "vicuna-13b_response": "Williams syndrome is a rare genetic disorder that affects approximately 1 in 10,000 people worldwide. One of the key features of Williams syndrome is the presence of cardiovascular disease, which is often associated with hormone abnormalities.\nStudies have shown that individuals with Williams syndrome often have lower than normal levels of cortisol, a hormone produced by the adrenal gland that helps the body respond to stress. This can lead to a condition called \"cortisol deficiency,\" which can cause a range of symptoms, including fatigue, weakness, and poor blood sugar control.\nIndividuals with Williams syndrome may also have higher than normal levels of thyroid hormones, particularly triiodothyronine (T3), which can lead to a condition called \"hyperthyroidism.\" This can cause symptoms such as weight loss, anxiety, and an irregular heartbeat.\nAdditionally, individuals with Williams syndrome may have lower than normal levels of growth hormone, which can affect growth and development.\nIt is important to note that hormone abnormalities can vary from person to person with Williams syndrome, and not everyone with the disorder will experience these hormone imbalances. However, it is important for individuals with Williams syndrome to be monitored for hormone abnormalities and to receive appropriate medical treatment if necessary.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Williams syndrome affects approximately 1 in 10,000 people worldwide.\n2. Individuals with Williams syndrome often have lower than normal levels of cortisol.\n3. Low levels of cortisol in individuals with Williams syndrome can lead to a condition called \"cortisol deficiency.\"\n4. Individuals with Williams syndrome may have higher than normal levels of the thyroid hormone, triiodothyronine (T3).\n5. Those with Williams syndrome can have lower than normal levels of growth hormone.",
    "vicuna-13b_fact": [
      "Williams syndrome affects approximately 1 in 10,000 people worldwide.",
      "Individuals with Williams syndrome often have lower than normal levels of cortisol.",
      "Low levels of cortisol in individuals with Williams syndrome can lead to a condition called \"cortisol deficiency.\"",
      "Individuals with Williams syndrome may have higher than normal levels of the thyroid hormone, triiodothyronine (T3).",
      "Those with Williams syndrome can have lower than normal levels of growth hormone."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 398,
    "user_query": "Albumin depletion is a common first step for proteomic analysis of CSF fluid. What is the advantage and disadvantage of this procedure?",
    "vicuna-13b_response": "Albumin depletion is a common first step in proteomic analysis of cerebrospinal fluid (CSF) because albumin is a major protein in the blood and CSF and can interfere with the analysis of other proteins in the sample.\nThe advantages of albumin depletion include:\n1. Reduction of interference: Albumin is a large protein that can interfere with the analysis of smaller proteins in the sample. By removing albumin, the analysis of other proteins in the sample is improved.\n2. Increased sensitivity: By removing the interfering albumin, the sensitivity of the analysis is increased, allowing for the detection of lower levels of proteins in the sample.\n3. Improved resolution: Albumin depletion can improve the resolution of proteins in the sample, allowing for better separation and identification of proteins.\nThe disadvantages of albumin depletion include:\n1. Time-consuming: Albumin depletion can be a time-consuming process, requiring additional steps and time to perform the analysis.\n2. Potential loss of information: Albumin is a protein that can provide important information about the CSF and the patient's health. By removing albumin, some information may be lost.\n3. Technical challenges: Albumin depletion can be technically challenging, requiring specialized equipment and expertise to perform the analysis.\nIn conclusion, albumin depletion is a common first step in proteomic analysis of CSF fluid, and it has advantages such as reduction of interference, increased sensitivity, and improved resolution. However, it also has disadvantages such as being time-consuming, potentially leading to the loss of important information, and being technically challenging.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Albumin depletion is a common first step in proteomic analysis of cerebrospinal fluid.\n2. Albumin is a major protein in the blood and CSF and can interfere with the analysis of other proteins in the sample.\n3. Advantages of albumin depletion include reduction of interference, increased sensitivity, and improved resolution.\n4. Disadvantages of albumin depletion are it being time-consuming, potential loss of information, and technical challenges.\n5. Albumin depletion in proteomic analysis of CSF fluid can potentially lead to the loss of important information.",
    "vicuna-13b_fact": [
      "Albumin depletion is a common first step in proteomic analysis of cerebrospinal fluid.",
      "Albumin is a major protein in the blood and CSF and can interfere with the analysis of other proteins in the sample.",
      "Advantages of albumin depletion include reduction of interference, increased sensitivity, and improved resolution.",
      "Disadvantages of albumin depletion are it being time-consuming, potential loss of information, and technical challenges.",
      "Albumin depletion in proteomic analysis of CSF fluid can potentially lead to the loss of important information."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 401,
    "user_query": "Which residue of alpha-synuclein was found to be phosphorylated in Lewy bodies?",
    "vicuna-13b_response": "Several studies have reported the phosphorylation of different residues of alpha-synuclein in Lewy bodies, which are a hallmark of Parkinson's disease. One of the most commonly reported residues is serine 129, which is located in the NAC region of alpha-synuclein. Other studies have also reported the phosphorylation of tyrosine 39, serine 138, and threonine 113 in the Lewy bodies. However, it is important to note that the exact residue(s) that are phosphorylated in Lewy bodies may vary depending on the study and the methods used for detection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Lewy bodies are a hallmark of Parkinson's disease.\n2. Several studies have reported the phosphorylation of different residues of alpha-synuclein in Lewy bodies.\n3. For alpha-synuclein, one of the most commonly reported phosphorylated residues in Lewy bodies is serine 129.\n4. Other studies have reported phosphorylation of tyrosine 39, serine 138, and threonine 113 in Lewy bodies.\n5. The exact residue(s) that are phosphorylated in Lewy bodies may vary depending on the study and the methods used for detection.",
    "vicuna-13b_fact": [
      "Lewy bodies are a hallmark of Parkinson's disease.",
      "Several studies have reported the phosphorylation of different residues of alpha-synuclein in Lewy bodies.",
      "For alpha-synuclein, one of the most commonly reported phosphorylated residues in Lewy bodies is serine 129.",
      "Other studies have reported phosphorylation of tyrosine 39, serine 138, and threonine 113 in Lewy bodies.",
      "The exact residue(s) that are phosphorylated in Lewy bodies may vary depending on the study and the methods used for detection."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 403,
    "user_query": "What is known about thalidomide therapy and survival of glioblastoma patients?",
    "vicuna-13b_response": "Thalidomide is a medication that has been studied for its potential to treat various types of cancer, including glioblastoma, a type of brain cancer.\nOne study published in the journal Neuro-Oncology found that thalidomide may be effective in treating glioblastoma in certain patients. The study found that patients who received thalidomide in addition to standard chemotherapy and radiation therapy had a longer median survival time than those who did not receive thalidomide.\nAnother study published in the journal Cancer Research found that thalidomide may be effective in treating glioblastoma by targeting a specific protein called cereblon, which is involved in regulating the growth and survival of cancer cells.\nHowever, it is important to note that thalidomide therapy for glioblastoma is still in the experimental stages and more research is needed to fully understand its potential benefits and risks. Additionally, thalidomide can cause serious side effects, including birth defects, and its use in cancer treatment is limited by its potential to cause these side effects.\nIt is always recommended to consult with a healthcare professional before considering any alternative or complementary therapies for glioblastoma treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Thalidomide is a medication that has been studied for its potential to treat various types of cancer, including glioblastoma.\n2. A study published in the journal Neuro-Oncology found that thalidomide may be effective in treating glioblastoma in certain patients.\n3. The same study concluded that patients who received thalidomide in addition to standard chemotherapy and radiation therapy had a longer median survival time.\n4. Another research published in the journal Cancer Research found that thalidomide may work in treating glioblastoma by targeting a specific protein called cereblon.\n5. Thalidomide use can lead to serious side effects, including birth defects, and its use in cancer treatment is limited due to these potential side effects.",
    "vicuna-13b_fact": [
      "Thalidomide is a medication that has been studied for its potential to treat various types of cancer, including glioblastoma.",
      "A study published in the journal Neuro-Oncology found that thalidomide may be effective in treating glioblastoma in certain patients.",
      "The same study concluded that patients who received thalidomide in addition to standard chemotherapy and radiation therapy had a longer median survival time.",
      "Another research published in the journal Cancer Research found that thalidomide may work in treating glioblastoma by targeting a specific protein called cereblon.",
      "Thalidomide use can lead to serious side effects, including birth defects, and its use in cancer treatment is limited due to these potential side effects."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 404,
    "user_query": "Is endostatin a proangiogenic factor?",
    "vicuna-13b_response": "Endostatin is a protein that is produced by cells in the body and has been studied for its potential role in regulating angiogenesis, the process by which new blood vessels form.\nInitial studies suggested that endostatin might have pro-angiogenic effects, meaning that it could stimulate the growth of new blood vessels. However, more recent research has suggested that endostatin may actually have anti-angiogenic effects, meaning that it can inhibit the growth of new blood vessels.\nOne study found that endostatin can inhibit the formation of new blood vessels in mice by blocking the activity of angiogenic factors and preventing the migration and proliferation of endothelial cells, which are the cells that line the inside of blood vessels.\nOverall, the evidence suggests that endostatin may have both pro- and anti-angiogenic effects, and more research is needed to fully understand its role in regulating angiogenesis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Endostatin is a protein produced by cells in the body.\n2. Endostatin has been studied for its potential role in regulating angiogenesis.\n3. Initial studies suggested that endostatin might stimulate the growth of new blood vessels.\n4. Recent research has suggested that endostatin can inhibit the growth of new blood vessels.\n5. One study found that endostatin can inhibit the formation of new blood vessels in mice by blocking the activity of angiogenic factors and preventing the migration and proliferation of endothelial cells.",
    "vicuna-13b_fact": [
      "Endostatin is a protein produced by cells in the body.",
      "Endostatin has been studied for its potential role in regulating angiogenesis.",
      "Initial studies suggested that endostatin might stimulate the growth of new blood vessels.",
      "Recent research has suggested that endostatin can inhibit the growth of new blood vessels.",
      "One study found that endostatin can inhibit the formation of new blood vessels in mice by blocking the activity of angiogenic factors and preventing the migration and proliferation of endothelial cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Initial studies suggested that endostatin might inhibit the growth of new blood vessels.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 407,
    "user_query": "List the off-label use of SSRIs",
    "vicuna-13b_response": "SSRIs, or selective serotonin reuptake inhibitors, are a class of antidepressant medications that are commonly used to treat depression and anxiety disorders. While the FDA has only approved the use of SSRIs for the treatment of these conditions, there are several off-label uses for these medications. Here are some examples of off-label uses of SSRIs:\n1. Anxiety disorders: SSRIs are sometimes used to treat anxiety disorders, such as social anxiety disorder, panic disorder, and generalized anxiety disorder.\n2. Obsessive-compulsive disorder (OCD): SSRIs are often used to treat OCD, a condition characterized by repetitive thoughts or behaviors that are difficult to control.\n3. Post-traumatic stress disorder (PTSD): SSRIs may be used to treat PTSD, a condition that can develop after a person experiences a traumatic event.\n4. Premenstrual dysphoric disorder (PMDD): SSRIs may be used to treat PMDD, a condition that causes severe mood changes and physical symptoms in the days leading up to menstruation.\n5. Fibromyalgia: Some studies have suggested that SSRIs may be effective in treating fibromyalgia, a condition that causes widespread pain and fatigue.\n6. Chronic pain: SSRIs may be used to treat chronic pain conditions, such as back pain or headaches.\n7. Eating disorders: SSRIs may be used to treat eating disorders, such as anorexia nervosa or bulimia nervosa.\nIt's important to note that while off-label use of SSRIs may be effective in some cases, they have not been extensively studied or approved by the FDA for these uses. It's important to work with a healthcare provider to determine the appropriateness of using SSRIs for off-label purposes and to monitor for any potential side effects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SSRIs, or selective serotonin reuptake inhibitors, are a class of antidepressant medications.\n2. SSRIs are used to treat depression and anxiety disorders.\n3. Off-label uses of SSRIs can include the treatment of conditions like obsessive-compulsive disorder, post-traumatic stress disorder, and premenstrual dysphoric disorder.\n4. Some studies have suggested that SSRIs may be effective in treating fibromyalgia.\n5. SSRIs may be used to treat chronic pain conditions, such as back pain or headaches.",
    "vicuna-13b_fact": [
      "SSRIs, or selective serotonin reuptake inhibitors, are a class of antidepressant medications.",
      "SSRIs are used to treat depression and anxiety disorders.",
      "Off-label uses of SSRIs can include the treatment of conditions like obsessive-compulsive disorder, post-traumatic stress disorder, and premenstrual dysphoric disorder.",
      "Some studies have suggested that SSRIs may be effective in treating fibromyalgia.",
      "SSRIs may be used to treat chronic pain conditions, such as back pain or headaches."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While SSRIs may be used to treat a range of psychiatric and non-psychiatric conditions, there is not clear evidence demonstrating their effectiveness in treating chronic pain conditions like back pain or headaches.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 408,
    "user_query": "Which is the definition of pyknons in DNA?",
    "vicuna-13b_response": "Pyknons are short, non-coding sequences of DNA that are typically found near the ends of chromosomes. They are also known as \"pyrimidine-rich knots\" because they contain a high concentration of pyrimidine nucleotides (cytosine and thymine). Pyknons are thought to play a role in the regulation of gene expression and may be involved in the process of DNA replication and repair. They are also sometimes referred to as \"junk DNA\" because they do not code for any proteins and are thought to have no functional role in the cell. However, recent research has suggested that pyknons may have important functions in the regulation of gene expression and in the maintenance of genome stability.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pyknons are short, non-coding sequences of DNA typically found near the ends of chromosomes.\n2. Pyknons are known as \"pyrimidine-rich knots\" due to a high concentration of pyrimidine nucleotides.\n3. Pyknons are thought to play a role in the regulation of gene expression.\n4. Pyknons are sometimes referred to as \"junk DNA\".\n5. Recent research suggests that Pyknons could have functions in maintaining genome stability.",
    "vicuna-13b_fact": [
      "Pyknons are short, non-coding sequences of DNA typically found near the ends of chromosomes.",
      "Pyknons are known as \"pyrimidine-rich knots\" due to a high concentration of pyrimidine nucleotides.",
      "Pyknons are thought to play a role in the regulation of gene expression.",
      "Pyknons are sometimes referred to as \"junk DNA\".",
      "Recent research suggests that Pyknons could have functions in maintaining genome stability."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Pyknons are short, non-coding sequences of DNA that can be found throughout the genome, not just near the ends of chromosomes.\n2. FALSE [correction]: The term \"Pyknons\" does not refer to \"pyrimidine-rich knots\". It is a term derived from the Greek word 'pyknos,' which means 'dense' or 'compact'.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "vicuna-13b_response": "Yes, linker histones are present in the yeast genome. Linker histones are a type of non-coding RNA that play a role in regulating gene expression by binding to chromatin and modifying chromatin structure. In yeast, linker histones are essential for the proper organization of chromatin and the regulation of gene expression.\nThere are several types of linker histones in yeast, including H1, H2A, H2B, and H3. These linker histones are involved in the formation of a variety of chromatin structures, including chromosome condensation, chromatin compaction, and the regulation of access to the chromatin.\nIn addition to their role in chromatin regulation, linker histones also play a role in the regulation of transcription and the maintenance of chromosome stability. Overall, linker histones are essential for the proper functioning of the yeast genome and are an important component of the chromatin regulatory network.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Linker histones exist in the yeast genome.\n2. Linker histones are a type of non-coding RNA.\n3. In yeast, linker histones are essential for the proper organization of chromatin and the regulation of gene expression.\n4. Types of linker histones in yeast include H1, H2A, H2B, and H3.\n5. Linker histones play a role in the regulation of transcription and the maintenance of chromosome stability.",
    "vicuna-13b_fact": [
      "Linker histones exist in the yeast genome.",
      "Linker histones are a type of non-coding RNA.",
      "In yeast, linker histones are essential for the proper organization of chromatin and the regulation of gene expression.",
      "Types of linker histones in yeast include H1, H2A, H2B, and H3.",
      "Linker histones play a role in the regulation of transcription and the maintenance of chromosome stability."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Linker histones are a type of protein, not non-coding RNA.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 410,
    "user_query": "What is the role of deadenylases in the cell?",
    "vicuna-13b_response": "Deadenylases are enzymes that play a crucial role in regulating the stability of messenger RNA (mRNA) in cells. They are responsible for removing a type of modification called a \"cap\" from the ends of mRNA molecules, which helps to destabilize the mRNA and promote its degradation.\nThe removal of the cap by deadenylases is an important step in the process of mRNA turnover, which helps to ensure that only the necessary amount of a particular mRNA molecule is produced and translated into protein at any given time. This process is important for maintaining the proper levels of proteins in the cell, and for ensuring that the cell has the necessary resources to carry out its functions.\nIn addition to their role in mRNA turnover, deadenylases have also been implicated in a number of other cellular processes, including the regulation of gene expression, the response to stress, and the development of certain diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Deadenylases are enzymes that help regulate the stability of messenger RNA (mRNA) in cells.\n2. Deadenylases remove a \"cap\" from the ends of mRNA molecules, aiding in destabilizing the mRNA and promoting its degradation.\n3. The removal of the cap by deadenylases contributes to the process of mRNA turnover.\n4. The process of mRNA turnover helps maintain the proper levels of proteins in the cell.\n5. Deadenylases have been implicated in various cellular processes such as the regulation of gene expression, stress response, and the development of certain diseases.",
    "vicuna-13b_fact": [
      "Deadenylases are enzymes that help regulate the stability of messenger RNA (mRNA) in cells.",
      "Deadenylases remove a \"cap\" from the ends of mRNA molecules, aiding in destabilizing the mRNA and promoting its degradation.",
      "The removal of the cap by deadenylases contributes to the process of mRNA turnover.",
      "The process of mRNA turnover helps maintain the proper levels of proteins in the cell.",
      "Deadenylases have been implicated in various cellular processes such as the regulation of gene expression, stress response, and the development of certain diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Deadenylases remove a \"tail\" from the ends of mRNA molecules, aiding in destabilizing the mRNA and promoting its degradation.\n3. FALSE [correction]: The removal of the tail by deadenylases contributes to the process of mRNA turnover.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 412,
    "user_query": "How long, in kb (kilobases),  is a \"Long interspersed nuclear element\"?",
    "vicuna-13b_response": "A Long Interspersed Nuclear Element (LINE) is a type of transposable element, which are DNA sequences that can move around within a genome. LINEs are typically around 6-8 kilobases (kb) in length. However, it's important to note that the size of a LINE can vary and some may be larger or smaller than 6-8 kb. Additionally, the size of a LINE can also depend on the specific species and context in which it is found.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A Long Interspersed Nuclear Element (LINE) is a type of transposable element.\n2. Transposable elements are DNA sequences that can move around within a genome.\n3. LINEs are typically around 6-8 kilobases (kb) in length.\n4. The size of a LINE can vary and some may be larger or smaller than 6-8 kb.\n5. The size of a LINE can also depend on the specific species and context in which it is found.",
    "vicuna-13b_fact": [
      "A Long Interspersed Nuclear Element (LINE) is a type of transposable element.",
      "Transposable elements are DNA sequences that can move around within a genome.",
      "LINEs are typically around 6-8 kilobases (kb) in length.",
      "The size of a LINE can vary and some may be larger or smaller than 6-8 kb.",
      "The size of a LINE can also depend on the specific species and context in which it is found."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: LINEs are typically around 6-8 thousand bases (kb) in length. \n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 414,
    "user_query": "List receptors of the drug Cilengitide",
    "vicuna-13b_response": "Cilengitide is a drug that is primarily used in the treatment of cancer. It is a cyclic peptide that acts as a selective integrin antagonist, which means that it binds to specific proteins on the surface of cancer cells and prevents them from interacting with other proteins that are important for their growth and survival.\nThere are several types of integrin receptors on cancer cells that cilengitide can bind to, including:\n1. αvβ3 integrin: This integrin is expressed on the surface of many different types of cancer cells, including breast, ovarian, and lung cancer cells. Cilengitide binds to αvβ3 integrin and inhibits its activity, which can lead to a reduction in cancer cell proliferation and migration.\n2. α5β1 integrin: This integrin is expressed on the surface of many different types of cancer cells, including colon, pancreatic, and gastric cancer cells. Cilengitide binds to α5β1 integrin and inhibits its activity, which can lead to a reduction in cancer cell proliferation and migration.\n3. α4β1 integrin: This integrin is expressed on the surface of many different types of cancer cells, including melanoma and glioblastoma cells. Cilengitide binds to α4β1 integrin and inhibits its activity, which can lead to a reduction in cancer cell proliferation and migration.\nOverall, cilengitide is a promising drug for the treatment of cancer, and its ability to target specific integrin receptors on cancer cells makes it a potentially effective therapy for a variety of different cancer types.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cilengitide is primarily used in the treatment of cancer.\n2. Cilengitide is a cyclic peptide that acts as a selective integrin antagonist.\n3. Cilengitide can bind to αvβ3 integrin which is expressed on the surface of many different types of cancer cells.\n4. Cilengitide can also bind to α5β1 integrin which is also expressed on many different types of cancer cells.\n5. Additionally, Cilengitide can bind to α4β1 integrin, expressed on the surface of many different types of cancer cells.",
    "vicuna-13b_fact": [
      "Cilengitide is primarily used in the treatment of cancer.",
      "Cilengitide is a cyclic peptide that acts as a selective integrin antagonist.",
      "Cilengitide can bind to αvβ3 integrin which is expressed on the surface of many different types of cancer cells.",
      "Cilengitide can also bind to α5β1 integrin which is also expressed on many different types of cancer cells.",
      "Additionally, Cilengitide can bind to α4β1 integrin, expressed on the surface of many different types of cancer cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Cilengitide cannot bind to α5β1 integrin, it is not expressed on many different types of cancer cells.\n5. FALSE [correction]: Cilengitide cannot bind to α4β1 integrin, it is not expressed on many different types of cancer cells.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 415,
    "user_query": "Can protein coding exons originate from ALU sequences?",
    "vicuna-13b_response": "Protein-coding exons are segments of DNA that contain the instructions for building a protein. They are found within the coding regions of genes and are transcribed into messenger RNA (mRNA) which then gets translated into a protein.\nALU sequences, on the other hand, are non-coding sequences that are found in the introns of genes. They are thought to have originated from the accumulation of transposable elements, such as transposons and retrotransposons, in the genome.\nIt is generally believed that protein-coding exons are derived from functional regions of the genome, such as coding regions or regulatory regions, and not from non-coding regions like ALU sequences. However, it is possible that under certain circumstances, ALU sequences could be co-opted and used to generate new protein-coding exons. This process, known as exonization, would require the acquisition of new regulatory elements and the rearrangement of the ALU sequence to create a functional exon.\nIt's worth noting that this process is considered rare and not well understood, and it's not clear how many proteins have originated from ALU sequences. Additionally, the function of most ALU-derived exons is not yet known, and more research is needed to understand their role in the genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Protein-coding exons are segments of DNA that contain the instructions for building a protein.\n2. Protein-coding exons are found within the coding regions of genes and are transcribed into messenger RNA (mRNA) which then gets translated into a protein.\n3. ALU sequences are non-coding sequences that are found in the introns of genes.\n4. ALU sequences are thought to have originated from the accumulation of transposable elements in the genome.\n5. It is possible that ALU sequences could be used to generate new protein-coding exons through a process known as exonization.",
    "vicuna-13b_fact": [
      "Protein-coding exons are segments of DNA that contain the instructions for building a protein.",
      "Protein-coding exons are found within the coding regions of genes and are transcribed into messenger RNA (mRNA) which then gets translated into a protein.",
      "ALU sequences are non-coding sequences that are found in the introns of genes.",
      "ALU sequences are thought to have originated from the accumulation of transposable elements in the genome.",
      "It is possible that ALU sequences could be used to generate new protein-coding exons through a process known as exonization."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "vicuna-13b_response": "There is some evidence that drinking tomato juice may help to lower cholesterol levels. Tomatoes are a good source of a compound called lycopene, which has been shown to have cholesterol-lowering properties. Studies have found that consuming tomato products, such as tomato juice, can increase the levels of lycopene in the blood, which may help to lower cholesterol levels.\nOne study published in the Journal of the American College of Nutrition found that participants who drank 1.4 liters of tomato juice per week for 12 weeks had a significant decrease in total cholesterol and LDL (bad) cholesterol levels compared to a control group that did not drink tomato juice.\nAnother study published in the Journal of Nutrition found that consuming tomato products as part of a low-fat, low-cholesterol diet may help to further lower cholesterol levels.\nHowever, it's important to note that more research is needed to fully understand the effects of tomato juice on cholesterol levels, and it should not be relied upon as the sole means of managing cholesterol levels. It's always best to consult with a healthcare professional before making any changes to your diet or cholesterol-lowering regimen.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tomatoes are a source of a compound called lycopene, which has been shown to have cholesterol-lowering properties.\n2. Consuming tomato products can increase the levels of lycopene in the blood.\n3. A study published in the Journal of the American College of Nutrition found a decrease in total cholesterol and LDL (bad) cholesterol levels in participants who drank 1.4 liters of tomato juice per week for 12 weeks.\n4. Another study published in the Journal of Nutrition reported that consuming tomato products as part of a low-fat, low-cholesterol diet may help to further lower cholesterol levels.\n5. It's suggested to consult with a healthcare professional before making any changes to your diet or cholesterol-lowering regimen.",
    "vicuna-13b_fact": [
      "Tomatoes are a source of a compound called lycopene, which has been shown to have cholesterol-lowering properties.",
      "Consuming tomato products can increase the levels of lycopene in the blood.",
      "A study published in the Journal of the American College of Nutrition found a decrease in total cholesterol and LDL (bad) cholesterol levels in participants who drank 1.4 liters of tomato juice per week for 12 weeks.",
      "Another study published in the Journal of Nutrition reported that consuming tomato products as part of a low-fat, low-cholesterol diet may help to further lower cholesterol levels.",
      "It's suggested to consult with a healthcare professional before making any changes to your diet or cholesterol-lowering regimen."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 423,
    "user_query": "What is the mode of inheritance of nemaline myopathy?",
    "vicuna-13b_response": "Nemaline myopathy is a genetic disorder that is inherited in an autosomal recessive pattern. This means that an individual must inherit two copies of the gene mutation (one from each parent) in order to develop the condition. If an individual has only one copy of the mutation, they are a carrier of the disorder and may pass the gene on to their children, but they will not develop the condition themselves.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nemaline myopathy is a genetic disorder.\n2. Nemaline myopathy is inherited through an autosomal recessive pattern.\n3. An individual must inherit two copies of the gene mutation to develop the condition.\n4. One copy of the mutation makes an individual a carrier, but they will not develop the condition themselves.\n5. A carrier of the disorder can pass the gene onto their children.",
    "vicuna-13b_fact": [
      "Nemaline myopathy is a genetic disorder.",
      "Nemaline myopathy is inherited through an autosomal recessive pattern.",
      "An individual must inherit two copies of the gene mutation to develop the condition.",
      "One copy of the mutation makes an individual a carrier, but they will not develop the condition themselves.",
      "A carrier of the disorder can pass the gene onto their children."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 432,
    "user_query": "Is it possible to detect survivin protein expression in normal human adult tissues?",
    "vicuna-13b_response": "Survivin is a protein that is expressed in many different types of cells, including cancer cells, but it is also expressed in some normal adult tissues. Studies have shown that survivin is expressed in various normal adult tissues such as heart, lung, kidney, liver, and pancreas. However, the expression level of survivin in normal tissues is much lower compared to cancer cells.\nThere are several methods that can be used to detect survivin protein expression in normal human adult tissues, such as immunohistochemistry (IHC), which is a technique that uses antibodies to detect the presence of specific proteins in tissue samples. In IHC, a tissue sample is first fixed and then incubated with a primary antibody that binds to survivin protein, followed by a secondary antibody that is labeled with a detectable substance such as fluorescence or radioactivity. This method allows researchers to visualize the distribution and intensity of survivin protein expression in the tissue.\nAnother method is western blotting, which is a technique that uses electrophoresis to separate proteins by size and then transfer them onto a membrane, where they can be detected by an antibody that binds to survivin protein. This method is useful to measure the protein expression level of survivin in different tissues.\nIn summary, it is possible to detect survivin protein expression in normal human adult tissues using immunohistochemistry and western blotting. However, the expression level of survivin in normal tissues is much lower compared to cancer cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Survivin is a protein that is expressed in many different types of cells, including cancer cells.\n2. Survivin is expressed in various normal adult tissues such as heart, lung, kidney, liver, and pancreas.\n3. The expression level of survivin in normal tissues is much lower compared to cancer cells.\n4. Survivin protein expression in normal human adult tissues can be detected using techniques like immunohistochemistry and western blotting.\n5. Immunohistochemistry is a technique that uses antibodies to detect the presence of specific proteins in tissue samples while western blotting uses electrophoresis to separate proteins by size for detection.",
    "vicuna-13b_fact": [
      "Survivin is a protein that is expressed in many different types of cells, including cancer cells.",
      "Survivin is expressed in various normal adult tissues such as heart, lung, kidney, liver, and pancreas.",
      "The expression level of survivin in normal tissues is much lower compared to cancer cells.",
      "Survivin protein expression in normal human adult tissues can be detected using techniques like immunohistochemistry and western blotting.",
      "Immunohistochemistry is a technique that uses antibodies to detect the presence of specific proteins in tissue samples while western blotting uses electrophoresis to separate proteins by size for detection."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Survivin is rarely expressed in different normal adult tissues but is commonly expressed in many types of cancer cells.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 433,
    "user_query": "List symptoms of Meigs' Syndrome.",
    "vicuna-13b_response": "Meigs' Syndrome is a rare disorder that is characterized by the presence of abnormal blood vessels (hemangiomas) in the skin, gastrointestinal tract, and other organs. The symptoms of Meigs' Syndrome can vary depending on the location of the hemangiomas and the severity of the condition. Some common symptoms of Meigs' Syndrome include:\n1. Skin lesions: The most common symptom of Meigs' Syndrome is the presence of skin lesions, which are abnormal growths that can be either benign or cancerous. These lesions can appear as red, purple, or blue nodules on the skin, and they can be either superficial or deep.\n2. Gastrointestinal symptoms: Meigs' Syndrome can also affect the gastrointestinal tract, leading to symptoms such as abdominal pain, diarrhea, and bleeding.\n3. Other organ involvement: In addition to the skin and gastrointestinal tract, Meigs' Syndrome can affect other organs such as the liver, spleen, and lungs. This can lead to symptoms such as jaundice, anemia, and shortness of breath.\n4. Bleeding: Meigs' Syndrome can also cause bleeding, either internally or externally. This can be a serious complication, as it can lead to anemia and other health problems.\nIt is important to note that not all individuals with Meigs' Syndrome will experience all of these symptoms, and the severity of the condition can vary widely. If you are experiencing any of these symptoms, it is important to speak with a healthcare provider for proper diagnosis and treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Meigs' Syndrome is a disorder characterized by the presence of abnormal blood vessels in various parts of the body.\n2. Common symptoms of Meigs' Syndrome include skin lesions, which are abnormal growths that can be either benign or cancerous.\n3. Additional symptoms of Meigs' Syndrome include abdominal pain, diarrhea, and bleeding, indicating potential gastrointestinal involvement.\n4. Meigs' Syndrome can also affect other organs such as the liver, spleen, and lungs, potentially leading to jaundice, anemia, and shortness of breath.\n5. The members with Meigs' Syndrome may also experience bleeding, that can cause serious complications like anemia and other health issues.",
    "vicuna-13b_fact": [
      "Meigs' Syndrome is a disorder characterized by the presence of abnormal blood vessels in various parts of the body.",
      "Common symptoms of Meigs' Syndrome include skin lesions, which are abnormal growths that can be either benign or cancerous.",
      "Additional symptoms of Meigs' Syndrome include abdominal pain, diarrhea, and bleeding, indicating potential gastrointestinal involvement.",
      "Meigs' Syndrome can also affect other organs such as the liver, spleen, and lungs, potentially leading to jaundice, anemia, and shortness of breath.",
      "The members with Meigs' Syndrome may also experience bleeding, that can cause serious complications like anemia and other health issues."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Meigs' Syndrome is a disorder characterized by the presence of a benign ovarian tumor, ascites, and pleural effusion.\n2. FALSE [correction]: Common symptoms of Meigs' Syndrome do not include skin lesions. They mostly include abdominal bloating or discomfort, shortness of breath and rapid weight gain due to fluid accumulation.\n3. FALSE [correction]: Symptoms of Meigs' Syndrome do not include abdominal pain, diarrhea, and bleeding. The most common symptoms are related to fluid build-up such as bloating, shortness of breath and rapid weight gain.\n4. FALSE [correction]:  While Meigs' Syndrome can cause complications due to the fluid accumulation, there is no direct involvement of the liver, spleen or lungs that leads to issues such as jaundice or anemia.\n5. FALSE [correction]: Anemia is not a common symptom or complication of Meigs' Syndrome. Its main symptoms are due to fluid accumulation caused by a benign ovarian tumor.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 435,
    "user_query": "What is the molecular function of psoralen photobinding on DNA?",
    "vicuna-13b_response": "Psoralen photobinding is a process in which psoralen molecules bind to DNA upon exposure to ultraviolet (UV) light. Psoralens are a class of molecules that have been shown to have a range of biological activities, including the ability to bind to DNA. When psoralens are exposed to UV light, they undergo a photochemical reaction that results in the formation of covalent bonds between the psoralen molecule and the DNA molecule.\nThe molecular function of psoralen photobinding on DNA is to interfere with DNA replication and transcription. Psoralens can bind to DNA in a specific and selective manner, and this binding can prevent the DNA from being replicated or transcribed. Psoralens can also cause DNA damage, which can lead to mutations and other cellular effects.\nPsoralens have been used in a variety of applications, including as a tool for studying DNA structure and function, as a therapeutic agent for treating certain types of cancer, and as a means of preventing transplant rejection. However, psoralens can also have adverse effects, and their use in these applications must be carefully monitored and regulated.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Psoralen photobinding is a process where psoralen molecules bind to DNA on exposure to UV light.\n2. Psoralens undergo a photochemical reaction upon exposure to UV light which results in covalent bonds between the psoralen molecule and the DNA molecule.\n3. The molecular function of psoralen photobinding on DNA is to interfere with DNA replication and transcription.\n4. Psoralens can cause DNA damage, that can lead to mutations and other cellular effects.\n5. Psoralens have been used in various applications including studying DNA structure and function, treating certain types of cancer, and preventing transplant rejection.",
    "vicuna-13b_fact": [
      "Psoralen photobinding is a process where psoralen molecules bind to DNA on exposure to UV light.",
      "Psoralens undergo a photochemical reaction upon exposure to UV light which results in covalent bonds between the psoralen molecule and the DNA molecule.",
      "The molecular function of psoralen photobinding on DNA is to interfere with DNA replication and transcription.",
      "Psoralens can cause DNA damage, that can lead to mutations and other cellular effects.",
      "Psoralens have been used in various applications including studying DNA structure and function, treating certain types of cancer, and preventing transplant rejection."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Psoralens have been used in various applications including studying DNA structure and function, treating certain skin disorders such as psoriasis and eczema, and in combination with UVA radiation in a treatment known as PUVA for conditions like psoriasis, eczema and vitiligo. They have not been used for preventing transplant rejection.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 440,
    "user_query": "Which are the main causes of fetal echogenic bowel?",
    "vicuna-13b_response": "Fetal echogenic bowel is a condition where the bowel of a fetus appears brighter than normal on ultrasound imaging. The main causes of fetal echogenic bowel are:\n1. Increased peristalsis: Increased muscular contractions of the bowel can cause increased echogenicity.\n2. Increased bowel wall thickness: An increase in the thickness of the bowel wall can cause increased echogenicity.\n3. Increased bowel content: Increased amount of stool in the bowel can cause increased echogenicity.\n4. Inflammation: Inflammation of the bowel can cause increased echogenicity.\n5. Congenital bowel malformations: Congenital malformations of the bowel, such as Hirschsprung's disease, can cause increased echogenicity.\n6. Maternal diet: A diet high in fat and protein can cause increased echogenicity.\n7. Maternal medications: Certain medications, such as cimetidine, can cause increased echogenicity.\n8. Multiple pregnancies: Fetal echogenic bowel is more common in twin pregnancies.\nIt is important to note that fetal echogenic bowel is usually a benign condition and does not pose a threat to the fetus. However, it is important to monitor the fetus for any other associated anomalies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fetal echogenic bowel is a condition where the bowel of a fetus appears brighter than normal on ultrasound imaging.\n2. Increased peristalsis, bowel wall thickness, bowel content, and inflammation can cause increased echogenicity.\n3. Congenital malformations of the bowel, such as Hirschsprung's disease, can cause increased echogenicity.\n4. A diet high in fat and protein, certain medications like cimetidine, and multiple pregnancies (especially twins) can also cause increased echogenicity.\n5. Fetal echogenic bowel usually is a benign condition but should be monitored for any other associated anomalies.",
    "vicuna-13b_fact": [
      "Fetal echogenic bowel is a condition where the bowel of a fetus appears brighter than normal on ultrasound imaging.",
      "Increased peristalsis, bowel wall thickness, bowel content, and inflammation can cause increased echogenicity.",
      "Congenital malformations of the bowel, such as Hirschsprung's disease, can cause increased echogenicity.",
      "A diet high in fat and protein, certain medications like cimetidine, and multiple pregnancies (especially twins) can also cause increased echogenicity.",
      "Fetal echogenic bowel usually is a benign condition but should be monitored for any other associated anomalies."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The mother's diet and medication use, as well as multiple pregnancies, do not affect the echogenicity of the fetus's bowel. \n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 442,
    "user_query": "Which is the enzymatic activity of the myotubularin family of proteins?",
    "vicuna-13b_response": "Myotubularin family of proteins are involved in various enzymatic activities. They are involved in the regulation of cellular metabolism, signal transduction, and cell growth and differentiation. Myotubularin family of proteins are involved in the regulation of various enzymes such as protein kinase C, phospholipase D, and phosphatidylinositol 3-kinase. They also play a role in the regulation of ion channels and transporters, and are involved in the regulation of cellular responses to various stimuli. Additionally, myotubularin family of proteins are involved in the regulation of cellular metabolism, including glycolysis, glucose transport, and fatty acid metabolism.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Myotubularin family of proteins are involved in various enzymatic activities.\n2. They play a role in the regulation of cellular metabolism, signal transduction, and cell growth and differentiation. \n3. Myotubularin family of proteins are involved in the regulation of various enzymes such as protein kinase C, phospholipase D, and phosphatidylinositol 3-kinase.\n4. They play a role in the regulation of ion channels and transporters, and are involved in the regulation of cellular responses to various stimuli. \n5. Myotubularin family of proteins are involved in the regulation of cellular metabolism, including glycolysis, glucose transport, and fatty acid metabolism.",
    "vicuna-13b_fact": [
      "Myotubularin family of proteins are involved in various enzymatic activities.",
      "They play a role in the regulation of cellular metabolism, signal transduction, and cell growth and differentiation.",
      "Myotubularin family of proteins are involved in the regulation of various enzymes such as protein kinase C, phospholipase D, and phosphatidylinositol 3-kinase.",
      "They play a role in the regulation of ion channels and transporters, and are involved in the regulation of cellular responses to various stimuli.",
      "Myotubularin family of proteins are involved in the regulation of cellular metabolism, including glycolysis, glucose transport, and fatty acid metabolism."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE \n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 445,
    "user_query": "Is there any relationship between histone ubiquitylation and splicing?",
    "vicuna-13b_response": "Yes, there is a relationship between histone ubiquitylation and splicing. Histone ubiquitylation is a post-translational modification that involves the attachment of ubiquitin molecules to histone proteins. This modification can affect the structure of chromatin, the complex of DNA and proteins that makes up the chromosomes, and can influence the accessibility of the DNA to transcription factors and other proteins involved in gene expression.\nSplicing, on the other hand, is the process by which introns, non-coding sequences that interrupt the coding regions of a gene, are removed from the primary transcript of a gene, resulting in a mature, functional mRNA. The splicing process is regulated by a variety of factors, including transcription factors and RNA-binding proteins, and can be influenced by chromatin structure and histone modifications, including ubiquitylation.\nStudies have shown that histone ubiquitylation can affect splicing by regulating the accessibility of the DNA to splicing factors and by altering the structure of chromatin, which can influence the recruitment of splicing factors to specific regions of the genome. Additionally, some ubiquitin ligases have been shown to directly target splicing factors for degradation, leading to a reduction in splicing efficiency.\nIn summary, histone ubiquitylation and splicing are closely related, as histone ubiquitylation can affect the structure of chromatin and the accessibility of the DNA to splicing factors, and can also regulate splicing directly through the degradation of splicing factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Histone ubiquitylation is a post-translational modification that involves the attachment of ubiquitin molecules to histone proteins.\n2. Splicing is the process by which introns, non-coding sequences that interrupt the coding regions of a gene, are removed from the primary transcript of a gene, resulting in a mature, functional mRNA.\n3. Studies have shown that histone ubiquitylation can affect splicing by regulating the accessibility of the DNA to splicing factors and by altering the structure of chromatin.\n4. Some ubiquitin ligases have been shown to directly target splicing factors for degradation, leading to a reduction in splicing efficiency.\n5. Histone ubiquitylation can also regulate splicing directly through the degradation of splicing factors.",
    "vicuna-13b_fact": [
      "Histone ubiquitylation is a post-translational modification that involves the attachment of ubiquitin molecules to histone proteins.",
      "Splicing is the process by which introns, non-coding sequences that interrupt the coding regions of a gene, are removed from the primary transcript of a gene, resulting in a mature, functional mRNA.",
      "Studies have shown that histone ubiquitylation can affect splicing by regulating the accessibility of the DNA to splicing factors and by altering the structure of chromatin.",
      "Some ubiquitin ligases have been shown to directly target splicing factors for degradation, leading to a reduction in splicing efficiency.",
      "Histone ubiquitylation can also regulate splicing directly through the degradation of splicing factors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 448,
    "user_query": "What are the advantages of the top down mass spectrometric analysis of histones?",
    "vicuna-13b_response": "Top-down mass spectrometric analysis of histones is a method used to study the post-translational modifications (PTMs) of histones, which are proteins that are responsible for packaging DNA into chromatin. There are several advantages to using this method:\n1. High sensitivity: Top-down mass spectrometry is highly sensitive, which means that it can detect very small amounts of histone PTMs. This is particularly useful when studying rare or low-abundance PTMs.\n2. High specificity: Top-down mass spectrometry is highly specific, which means that it can accurately identify the type and location of histone PTMs. This is particularly useful when studying multiple PTMs or when studying PTMs in different cell types or tissues.\n3. High resolution: Top-down mass spectrometry is highly resolving, which means that it can accurately determine the mass-to-charge ratio of histone PTMs. This is particularly useful when studying PTMs that are very similar in mass or when studying PTMs in complex mixtures.\n4. High throughput: Top-down mass spectrometry can be performed in a high-throughput manner, which means that it can analyze large numbers of samples in a short period of time. This is particularly useful when studying large numbers of samples or when studying samples from different time points or conditions.\nOverall, the advantages of top-down mass spectrometric analysis of histones include high sensitivity, high specificity, high resolution, and high throughput. These advantages make it a powerful tool for studying histone PTMs and their role in regulating gene expression and other cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Top-down mass spectrometric analysis is a method used to study the post-translational modifications of histones.\n2. Histones are proteins that are responsible for packaging DNA into chromatin.\n3. Top-down mass spectrometry is highly sensitive and can detect very small amounts of histone PTMs.\n4. Top-down mass spectrometry is highly specific and can accurately identify the type and location of histone PTMs.\n5. Top-down mass spectrometry can be performed in a high-throughput manner and can analyze large numbers of samples in a short period of time.",
    "vicuna-13b_fact": [
      "Top-down mass spectrometric analysis is a method used to study the post-translational modifications of histones.",
      "Histones are proteins that are responsible for packaging DNA into chromatin.",
      "Top-down mass spectrometry is highly sensitive and can detect very small amounts of histone PTMs.",
      "Top-down mass spectrometry is highly specific and can accurately identify the type and location of histone PTMs.",
      "Top-down mass spectrometry can be performed in a high-throughput manner and can analyze large numbers of samples in a short period of time."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 451,
    "user_query": "What is the indication of Daonil (Glibenclamide)?",
    "vicuna-13b_response": "Daonil (Glibenclamide) is an oral antihyperglycemic drug used in the treatment of type 2 diabetes. Its primary indication is to lower blood glucose levels in patients with type 2 diabetes who are unable to achieve adequate control with diet and exercise alone. Daonil works by increasing the body's sensitivity to insulin, allowing the body to use insulin more effectively to lower blood glucose levels. It is usually prescribed in combination with lifestyle modifications, such as diet and exercise, to help manage type 2 diabetes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Daonil (Glibenclamide) is an oral antihyperglycemic drug.\n2. Daonil is used in the treatment of type 2 diabetes.\n3. The primary indication of Daonil is to lower blood glucose levels in patients with type 2 diabetes.\n4. Daonil works by increasing the body's sensitivity to insulin.\n5. Daonil is usually prescribed in combination with lifestyle modifications, such as diet and exercise, to help manage type 2 diabetes.",
    "vicuna-13b_fact": [
      "Daonil (Glibenclamide) is an oral antihyperglycemic drug.",
      "Daonil is used in the treatment of type 2 diabetes.",
      "The primary indication of Daonil is to lower blood glucose levels in patients with type 2 diabetes.",
      "Daonil works by increasing the body's sensitivity to insulin.",
      "Daonil is usually prescribed in combination with lifestyle modifications, such as diet and exercise, to help manage type 2 diabetes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Daonil works by stimulating the pancreas to produce more insulin.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 452,
    "user_query": "Which is the most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus?",
    "vicuna-13b_response": "The most typical peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus is the \"retention signal\" sequence. This sequence is typically located at the C-terminus of the protein and is responsible for targeting the protein to the ER. The retention signal sequence is recognized by the ER resident protein, called the retention protein, which then interacts with the protein to be retained in the ER. The interaction between the retention protein and the retention signal sequence causes the protein to be retained in the ER and prevents it from being transported further to other organelles.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus is known as the \"retention signal\" sequence.\n2. The \"retention signal\" sequence is usually located at the C-terminus of the protein.\n3. This sequence is responsible for targeting the protein to the ER.\n4. An ER resident protein, the retention protein, recognizes the retention signal sequence.\n5. Interaction between the retention protein and the retention signal sequence leads to the protein being retained in the ER.",
    "vicuna-13b_fact": [
      "The peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus is known as the \"retention signal\" sequence.",
      "The \"retention signal\" sequence is usually located at the C-terminus of the protein.",
      "This sequence is responsible for targeting the protein to the ER.",
      "An ER resident protein, the retention protein, recognizes the retention signal sequence.",
      "Interaction between the retention protein and the retention signal sequence leads to the protein being retained in the ER."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The peptide sequence responsible for retrieval of endoplasmic reticulum (ER) lumenal proteins from the Golgi apparatus is known as the \"retrieval signal\" sequence, not the \"retention signal\" sequence.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 454,
    "user_query": "List the main proteases used for sample digestion in proteomics.",
    "vicuna-13b_response": "Proteomics is the study of proteins, and one important step in proteomics research is the digestion of proteins to produce smaller peptides that can be analyzed by mass spectrometry. There are several proteases that are commonly used for protein digestion in proteomics, including:\n1. Trypsin: Trypsin is a protease that is commonly used for protein digestion in proteomics. It is a serine protease that cleaves peptide bonds at the carboxyl side of lysine and arginine residues. Trypsin is often used for digestion of intact proteins, but it can also be used for digestion of peptides.\n2. Chymotrypsin: Chymotrypsin is another protease that is commonly used for protein digestion in proteomics. It is a serine protease that cleaves peptide bonds at the carboxyl side of tyrosine and tryptophan residues. Chymotrypsin is often used for digestion of intact proteins, but it can also be used for digestion of peptides.\n3. Aspartic protease: Aspartic proteases, such as pepsin and renin, are also commonly used for protein digestion in proteomics. They cleave peptide bonds at the carboxyl side of aspartic acid residues. Aspartic proteases are often used for digestion of intact proteins, but they can also be used for digestion of peptides.\n4. Glu-C proteases: Glu-C proteases, such as glutamic acid proteases and caspases, are also used for protein digestion in proteomics. They cleave peptide bonds at the carboxyl side of glutamic acid residues. Glu-C proteases are often used for digestion of intact proteins, but they can also be used for digestion of peptides.\nOverall, the choice of protease for protein digestion in proteomics depends on the specific needs of the experiment and the properties of the proteins being studied.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Proteomics is the study of proteins.\n2. Trypsin is a type of protease used in proteomics that cleaves peptide bonds at the carboxyl side of lysine and arginine residues.\n3. Chymotrypsin is a type of protease used in proteomics that cleaves peptide bonds at the carboxyl side of tyrosine and tryptophan residues.\n4. Aspartic proteases, such as pepsin and renin, are used in proteomics and they cleave peptide bonds at the carboxyl side of aspartic acid residues.\n5. Glu-C proteases, including glutamic acid proteases and caspases, are used for protein digestion in proteomics and cleave peptide bonds at the carboxyl side of glutamic acid residues.",
    "vicuna-13b_fact": [
      "Proteomics is the study of proteins.",
      "Trypsin is a type of protease used in proteomics that cleaves peptide bonds at the carboxyl side of lysine and arginine residues.",
      "Chymotrypsin is a type of protease used in proteomics that cleaves peptide bonds at the carboxyl side of tyrosine and tryptophan residues.",
      "Aspartic proteases, such as pepsin and renin, are used in proteomics and they cleave peptide bonds at the carboxyl side of aspartic acid residues.",
      "Glu-C proteases, including glutamic acid proteases and caspases, are used for protein digestion in proteomics and cleave peptide bonds at the carboxyl side of glutamic acid residues."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Chymotrypsin is a type of protease used in proteomics that cleaves peptide bonds at the carboxyl side of phenylalanine, tryptophan, and tyrosine residues.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 456,
    "user_query": "What is the association between Generalized anxiety disorder and mortality risk?",
    "vicuna-13b_response": "Generalized anxiety disorder (GAD) is a mental health condition characterized by excessive and persistent worry and anxiety about a variety of events and activities. Studies have shown that individuals with GAD have an increased risk of mortality compared to the general population.\nSeveral studies have found that individuals with GAD have a higher risk of death from all causes, including cardiovascular disease, respiratory disease, and cancer. One study found that individuals with GAD had a 63% increased risk of death from all causes compared to those without GAD. Another study found that the risk of death was even higher for individuals with severe GAD, with a 2.5-fold increased risk of death from all causes.\nThe association between GAD and mortality risk may be due to several factors. Individuals with GAD often experience physical symptoms such as fatigue, headaches, and muscle tension, which can contribute to an increased risk of death. Additionally, individuals with GAD often have other health conditions, such as depression, substance abuse, and chronic pain, which can also increase the risk of death.\nFurthermore, individuals with GAD often engage in unhealthy behaviors such as smoking, excessive alcohol consumption, and a sedentary lifestyle, which can also contribute to an increased risk of death.\nIt is important to note that not all individuals with GAD will experience a higher risk of mortality, and that the risk of death can be reduced through appropriate treatment and management of GAD. Treatment for GAD typically includes a combination of medication and therapy, which can help individuals manage their symptoms and reduce their risk of death.\nIn conclusion, individuals with GAD have an increased risk of mortality compared to the general population. The association between GAD and mortality risk may be due to several factors, including physical symptoms, other health conditions, unhealthy behaviors, and reduced treatment seeking. However, appropriate treatment and management of GAD can help reduce the risk of death.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Generalized anxiety disorder (GAD) is a mental health condition characterized by excessive and persistent worry and anxiety about a variety of events and activities.\n2. Studies have shown that individuals with GAD have an increased risk of mortality compared to the general population.\n3. A study found that individuals with GAD had a 63% increased risk of death from all causes compared to those without GAD.\n4. Severe GAD can lead to even higher mortality risk, with a study showing a 2.5-fold increase in risk of death from all causes.\n5. Treatment for GAD often includes a combination of medication and therapy, which can help manage symptoms and reduce the risk of death.",
    "vicuna-13b_fact": [
      "Generalized anxiety disorder (GAD) is a mental health condition characterized by excessive and persistent worry and anxiety about a variety of events and activities.",
      "Studies have shown that individuals with GAD have an increased risk of mortality compared to the general population.",
      "A study found that individuals with GAD had a 63% increased risk of death from all causes compared to those without GAD.",
      "Severe GAD can lead to even higher mortality risk, with a study showing a 2.5-fold increase in risk of death from all causes.",
      "Treatment for GAD often includes a combination of medication and therapy, which can help manage symptoms and reduce the risk of death."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Current evidence suggests that while GAD can indeed impact quality of life, it does not necessarily increase the risk of mortality compared to the general population.\n3. FALSE [correction]: There are currently no definitive studies that quantify the increased risk of death from all causes for individuals with GAD.\n4. FALSE [correction]: While severe GAD can lead to significant functional and life impairment, there are no specific studies showing a 2.5-fold increase in risk of death from all causes.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 457,
    "user_query": "Which molecule is targeted by a monoclonal antibody Mepolizumab?",
    "vicuna-13b_response": "Mepolizumab is a monoclonal antibody that targets the interleukin-5 (IL-5) receptor alpha chain. It is used to treat a variety of autoimmune diseases, including asthma and chronic obstructive pulmonary disease (COPD). Mepolizumab works by binding to the IL-5 receptor and blocking the signal that triggers the production of inflammatory cells, including eosinophils, which are involved in the pathogenesis of these diseases. By reducing the number of eosinophils in the body, mepolizumab can help to reduce inflammation and improve symptoms in patients with asthma and COPD.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mepolizumab is a monoclonal antibody that targets the interleukin-5 (IL-5) receptor alpha chain.\n2. Mepolizumab is used to treat a variety of autoimmune diseases, including asthma and chronic obstructive pulmonary disease (COPD).\n3. Mepolizumab works by binding to the IL-5 receptor and blocking the signal that triggers the production of inflammatory cells.\n4. Eosinophils, which mepolizumab helps reduce, are involved in the pathogenesis of diseases like asthma and COPD.\n5. Mepolizumab can reduce inflammation and improve symptoms in patients with asthma and COPD by reducing the number of eosinophils in the body.",
    "vicuna-13b_fact": [
      "Mepolizumab is a monoclonal antibody that targets the interleukin-5 (IL-5) receptor alpha chain.",
      "Mepolizumab is used to treat a variety of autoimmune diseases, including asthma and chronic obstructive pulmonary disease (COPD).",
      "Mepolizumab works by binding to the IL-5 receptor and blocking the signal that triggers the production of inflammatory cells.",
      "Eosinophils, which mepolizumab helps reduce, are involved in the pathogenesis of diseases like asthma and COPD.",
      "Mepolizumab can reduce inflammation and improve symptoms in patients with asthma and COPD by reducing the number of eosinophils in the body."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mepolizumab is a monoclonal antibody that targets interleukin-5 (IL-5) itself, not the IL-5 receptor alpha chain.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 461,
    "user_query": "Which genes are affected in ROMANO-WARD syndrome?",
    "vicuna-13b_response": "ROMANO-WARD syndrome is a rare genetic disorder that is caused by mutations in the WARD1 gene. This gene is located on the X chromosome and is responsible for the production of a protein called WARD1, which is involved in regulating the transport of proteins within cells.\nMutations in the WARD1 gene can lead to a variety of symptoms, including intellectual disability, developmental delay, speech and language difficulties, and muscle weakness. Some individuals with ROMANO-WARD syndrome may also have a distinctive facial appearance, with a broad forehead, deep-set eyes, and a small jaw.\nThe specific genes that are affected in ROMANO-WARD syndrome depend on the specific mutation that is present. In general, however, the mutations in the WARD1 gene lead to a reduction in the amount of functional WARD1 protein that is produced, which can disrupt the normal functioning of cells and tissues in the body.\nIt is important to note that ROMANO-WARD syndrome is a rare disorder, and the exact prevalence is not known. It is also important to note that this disorder is typically diagnosed in childhood, and the symptoms can vary widely in severity. There is currently no cure for ROMANO-WARD syndrome, but treatment is focused on managing the symptoms and providing supportive care to affected individuals.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ROMANO-WARD syndrome is a genetic disorder caused by mutations in the WARD1 gene.\n2. The WARD1 gene is responsible for the production of a protein called WARD1.\n3. This protein is related with the transport of proteins within cells.\n4. Mutations in the WARD1 can cause intellectual disability, developmental delay, speech and language difficulties, and muscle weakness.\n5. ROMANO-WARD syndrome is typically diagnosed in childhood.",
    "vicuna-13b_fact": [
      "ROMANO-WARD syndrome is a genetic disorder caused by mutations in the WARD1 gene.",
      "The WARD1 gene is responsible for the production of a protein called WARD1.",
      "This protein is related with the transport of proteins within cells.",
      "Mutations in the WARD1 can cause intellectual disability, developmental delay, speech and language difficulties, and muscle weakness.",
      "ROMANO-WARD syndrome is typically diagnosed in childhood."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 462,
    "user_query": "Does melanoma  occur in people of African origin ?",
    "vicuna-13b_response": "Yes, melanoma can occur in people of African origin. Melanoma is a type of skin cancer that affects the pigment-producing cells in the skin, known as melanocytes. It can occur in people of all skin types, including those of African origin.\nIn fact, melanoma is the most common form of skin cancer in people of African descent, and it is often diagnosed at a later stage than in people of other races. This is due in part to the fact that people of African descent tend to have more melanin in their skin, which can make it harder to detect changes in the skin that might indicate the presence of melanoma.\nIt is important for people of all skin types, including those of African origin, to be aware of the signs and symptoms of melanoma, and to seek medical attention if they notice any unusual changes in their skin. Early detection and treatment can greatly improve the chances of a successful outcome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Melanoma can occur in people of all skin types, including those of African origin. \n2. Melanoma is a type of skin cancer that affects the pigment-producing cells in the skin, known as melanocytes. \n3. Melanoma is the most common form of skin cancer in people of African descent. \n4. Melanoma is often diagnosed at a later stage than in people of other races due to the higher melanin in the skin of people of African descent.\n5. Early detection and treatment can greatly improve the chances of a successful outcome in melanoma patients.",
    "vicuna-13b_fact": [
      "Melanoma can occur in people of all skin types, including those of African origin.",
      "Melanoma is a type of skin cancer that affects the pigment-producing cells in the skin, known as melanocytes.",
      "Melanoma is the most common form of skin cancer in people of African descent.",
      "Melanoma is often diagnosed at a later stage than in people of other races due to the higher melanin in the skin of people of African descent.",
      "Early detection and treatment can greatly improve the chances of a successful outcome in melanoma patients."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Melanoma is one of the least common but most deadly skin cancers in people of African descent.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 463,
    "user_query": "What is the effect of resveratrol on mTOR activity?",
    "vicuna-13b_response": "Resveratrol is a natural compound found in various plants, including grapes, berries, and peanuts. It has been shown to have a number of health benefits, including reducing inflammation, improving cardiovascular health, and increasing lifespan in some animal models. One of the key ways that resveratrol exerts these effects is by inhibiting the activity of the mammalian target of rapamycin (mTOR) signaling pathway.\nmTOR is a conserved serine/threonine kinase that plays a central role in regulating cell growth, proliferation, and metabolism. It is activated in response to various stimuli, such as nutrient availability, growth factors, and cellular stress, and promotes the production of proteins that are necessary for cell growth and survival. However, when mTOR activity is constantly high, it can lead to cellular damage and disease.\nResveratrol has been shown to inhibit mTOR activity by directly binding to the regulatory complex of mTOR, known as mTORC1, which is responsible for activating mTOR signaling. By inhibiting mTORC1, resveratrol reduces the production of proteins that promote cell growth and survival, leading to cell cycle arrest and apoptosis (programmed cell death) in some cell types.\nIn addition to its effects on mTORC1, resveratrol has also been shown to inhibit the activity of mTORC2, another regulatory complex of mTOR that is involved in the regulation of cell survival and metabolism. By inhibiting mTORC2, resveratrol has been shown to improve insulin sensitivity and reduce inflammation in some studies.\nOverall, the effect of resveratrol on mTOR activity is to inhibit its signaling, which can lead to a wide range of health benefits, including reducing inflammation, improving cardiovascular health, and increasing lifespan in some animal models. However, more research is needed to fully understand the mechanisms by which resveratrol exerts its effects and to determine the optimal dosage and delivery method for achieving these benefits in humans.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Resveratrol is a natural compound found in various plants, including grapes, berries, and peanuts.\n2. mTOR is a conserved serine/threonine kinase that regulates cell growth, proliferation, and metabolism.\n3. Resveratrol inhibits the activity of the mammalian target of rapamycin (mTOR) signaling pathway.\n4. Resveratrol directly binds to the regulatory complex of mTOR, known as mTORC1, to inhibit its activity.\n5. Resveratrol can also inhibit the activity of mTORC2, another regulatory complex of mTOR.",
    "vicuna-13b_fact": [
      "Resveratrol is a natural compound found in various plants, including grapes, berries, and peanuts.",
      "mTOR is a conserved serine/threonine kinase that regulates cell growth, proliferation, and metabolism.",
      "Resveratrol inhibits the activity of the mammalian target of rapamycin (mTOR) signaling pathway.",
      "Resveratrol directly binds to the regulatory complex of mTOR, known as mTORC1, to inhibit its activity.",
      "Resveratrol can also inhibit the activity of mTORC2, another regulatory complex of mTOR."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 464,
    "user_query": "Are people with blood group O protected against severe Malaria?",
    "vicuna-13b_response": "There is some evidence to suggest that people with blood group O may be protected against severe malaria. Studies have shown that individuals with blood group O have a lower risk of developing severe malaria compared to those with other blood types. This may be due to the presence of certain antigens on the surface of red blood cells that are associated with protection against the Plasmodium falciparum parasite, which causes severe malaria.\nHowever, it's important to note that the relationship between blood group and malaria susceptibility is not fully understood and more research is needed to confirm these findings. Additionally, having blood group O does not provide complete protection against malaria and it's still possible for individuals with this blood type to develop the disease.\nIt's also important to note that malaria is a serious disease that can cause severe complications and even death if left untreated. Therefore, it's important for people living in malaria-endemic areas to take preventive measures such as using insecticide-treated bed nets, wearing protective clothing, using repellents, and taking prophylactic medications as recommended by a healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Some evidence suggests that individuals with blood group O have a lower risk of developing severe malaria.\n2. The reduced risk of severe malaria in people with blood group O may be due to the presence of certain antigens on the surface of red blood cells.\n3. The Plasmodium falciparum parasite causes severe malaria.\n4. Having blood group O does not provide absolute protection against malaria.\n5. Malaria can cause severe complications and even death if left untreated.",
    "vicuna-13b_fact": [
      "Some evidence suggests that individuals with blood group O have a lower risk of developing severe malaria.",
      "The reduced risk of severe malaria in people with blood group O may be due to the presence of certain antigens on the surface of red blood cells.",
      "The Plasmodium falciparum parasite causes severe malaria.",
      "Having blood group O does not provide absolute protection against malaria.",
      "Malaria can cause severe complications and even death if left untreated."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 467,
    "user_query": "What is the mechanism of action of solanezumab?",
    "vicuna-13b_response": "Solanezumab is a monoclonal antibody that is used to treat Alzheimer's disease. It works by targeting beta-amyloid protein, which is a hallmark of the disease. Beta-amyloid protein forms plaques in the brain, which are thought to contribute to the degeneration of brain cells that lead to the symptoms of Alzheimer's disease.\nSolanezumab binds to beta-amyloid protein and helps to remove it from the brain. By reducing the amount of beta-amyloid protein in the brain, solanezumab may help to slow down or stop the progression of Alzheimer's disease.\nIt is important to note that solanezumab is not a cure for Alzheimer's disease, and it does not reverse the damage that has already been done to the brain. However, it may help to slow down the progression of the disease and improve the symptoms for some people.\nIt is given as an intravenous infusion and the dosage and frequency of administration are determined by the doctor. The most common side effects of solanezumab are headache, joint pain, and nausea.\nIt is important to note that solanezumab is not approved for use in all countries and it is not available in all hospitals. It is also very expensive and it is not covered by all insurance companies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Solanezumab is a monoclonal antibody used to treat Alzheimer's disease.\n2. Solanezumab works by targeting and reducing the amount of beta-amyloid protein in the brain thought to contribute to Alzheimer's disease.\n3. Solanezumab is not a cure for Alzheimer's disease and it does not reverse the damage that has already been done to the brain.\n4. Solanezumab is given as an intravenous infusion and its dosage and frequency of administration are determined by the doctor.\n5. The most commonly reported side effects of solanezumab are headache, joint pain, and nausea.",
    "vicuna-13b_fact": [
      "Solanezumab is a monoclonal antibody used to treat Alzheimer's disease.",
      "Solanezumab works by targeting and reducing the amount of beta-amyloid protein in the brain thought to contribute to Alzheimer's disease.",
      "Solanezumab is not a cure for Alzheimer's disease and it does not reverse the damage that has already been done to the brain.",
      "Solanezumab is given as an intravenous infusion and its dosage and frequency of administration are determined by the doctor.",
      "The most commonly reported side effects of solanezumab are headache, joint pain, and nausea."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Solanezumab is a monoclonal antibody that was studied for a potential role in treating Alzheimer's disease, but it has not been approved for this use.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 469,
    "user_query": "What is the treatment of neuropathic pain in children?",
    "vicuna-13b_response": "Neuropathic pain in children can be challenging to manage due to the complex nature of the nervous system and the various underlying conditions that can cause neuropathic pain. The treatment approach for neuropathic pain in children will depend on the underlying cause, the severity and duration of the pain, and the child's age and overall health.\nSome common treatments for neuropathic pain in children include:\n1. Pain medications: Over-the-counter pain relievers such as acetaminophen or ibuprofen may be recommended for mild to moderate pain. For more severe pain, prescription pain medications such as opioids or anticonvulsants may be used.\n2. Anticonvulsants: These medications are commonly used to treat epilepsy, but they can also be effective in treating neuropathic pain. They work by reducing the transmission of pain signals in the nervous system.\n3. Topical agents: Creams or ointments that contain numbing agents or anti-inflammatory drugs can be applied directly to the affected area to provide relief.\n4. Physical therapy: Physical therapy can help improve muscle strength and flexibility, reduce pain and improve function in children with neuropathic pain.\n5. Occupational therapy: Occupational therapy can help children with neuropathic pain learn ways to cope with the pain and improve their overall function and quality of life.\n6. Surgery: In some cases, surgery may be necessary to treat the underlying condition causing the neuropathic pain.\nIt is important to note that children with neuropathic pain should be closely monitored by a healthcare provider, as some treatments may not be safe or effective for children. Additionally, a multidisciplinary approach that involves collaboration between a pain specialist, neurologist, and other healthcare professionals may be necessary to effectively manage neuropathic pain in children.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Neuropathic pain in children can be caused by various underlying conditions.\n2. The treatment of neuropathic pain in children can include pain medications, anticonvulsants, topical agents, physical therapy, occupational therapy, and in some cases, surgery.\n3. Over-the-counter pain relievers such as acetaminophen or ibuprofen can be used for mild to moderate pain in children.\n4. Anticonvulsants used to treat epilepsy can also be effective in treating neuropathic pain.\n5. Children with neuropathic pain should be closely monitored by a healthcare provider.",
    "vicuna-13b_fact": [
      "Neuropathic pain in children can be caused by various underlying conditions.",
      "The treatment of neuropathic pain in children can include pain medications, anticonvulsants, topical agents, physical therapy, occupational therapy, and in some cases, surgery.",
      "Over-the-counter pain relievers such as acetaminophen or ibuprofen can be used for mild to moderate pain in children.",
      "Anticonvulsants used to treat epilepsy can also be effective in treating neuropathic pain.",
      "Children with neuropathic pain should be closely monitored by a healthcare provider."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 470,
    "user_query": "Which phenomenon is known as the \"calcium paradox\" in the isolated perfused heart?",
    "vicuna-13b_response": "The \"calcium paradox\" in the isolated perfused heart refers to the apparent paradoxical effect of calcium ions on the contractility of the heart muscle cells (myocytes) during perfusion with a high concentration of calcium ions.\nIn an isolated perfused heart, the myocytes are bathed in a solution that contains a high concentration of calcium ions, which should stimulate the contraction of the myocytes. However, instead of contracting, the myocytes often undergo a process called \"calcium overload\" in which an excessive amount of calcium ions enter the myocytes, leading to cellular damage and dysfunction.\nThe calcium paradox occurs because the high concentration of calcium ions in the perfusion solution causes an increase in the activity of the \"sarcoplasmic reticulum (SR)\" in the myocytes. The SR is a specialized type of endoplasmic reticulum that plays a crucial role in regulating the levels of calcium ions in the myocytes. When the SR becomes too active, it can cause an influx of calcium ions into the myocytes, leading to calcium overload and cellular damage.\nThe calcium paradox is a significant problem in the field of cardiac physiology and pharmacology, as it limits the ability to study the contractility of isolated heart muscle cells in a controlled manner. Researchers are actively working to develop new methods and treatments to prevent the calcium paradox and improve the reliability of experiments involving isolated perfused hearts.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The \"calcium paradox\" in the isolated perfused heart refers to the unexpected effect of high concentrations of calcium ions on the contractility of the heart muscle cells (myocytes).\n2. In the \"calcium paradox\", instead of contracting as expected, myocytes can undergo \"calcium overload\", leading to cellular damage and dysfunction.\n3. The condition occurs because the high concentration of calcium ions in the solution increases the activity of the \"sarcoplasmic reticulum (SR)\" in the myocytes.\n4. The sarcoplasmic reticulum is a specialized type of endoplacmic reticulum that plays a key role in regulating calcium ion levels in myocytes. \n5. The \"calcium paradox\" is a significant issue in cardiac physiology and pharmacology research.",
    "vicuna-13b_fact": [
      "The \"calcium paradox\" in the isolated perfused heart refers to the unexpected effect of high concentrations of calcium ions on the contractility of the heart muscle cells (myocytes).",
      "In the \"calcium paradox\", instead of contracting as expected, myocytes can undergo \"calcium overload\", leading to cellular damage and dysfunction.",
      "The condition occurs because the high concentration of calcium ions in the solution increases the activity of the \"sarcoplasmic reticulum (SR)\" in the myocytes.",
      "The sarcoplasmic reticulum is a specialized type of endoplacmic reticulum that plays a key role in regulating calcium ion levels in myocytes.",
      "The \"calcium paradox\" is a significant issue in cardiac physiology and pharmacology research."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The condition occurs due to a reperfusion injury when high concentrations of calcium ions reenter the cell, not due to an increased activity of the \"sarcoplasmic reticulum (SR)\".\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "vicuna-13b_response": "Hsp70 and Hsp110 are two different types of heat shock proteins (HSPs) that play important roles in the regulation of protein folding and mRNA stability.\nHsp70 proteins are molecular chaperones that help to fold and transport proteins to their correct locations within the cell. They also help to refold denatured proteins and prevent protein aggregation. Hsp70 proteins are involved in the regulation of mRNA stability by binding to and stabilizing mRNAs that are targeted for degradation. This binding prevents the degradation of these mRNAs and allows them to be translated into proteins.\nHsp110 proteins are also involved in the regulation of mRNA stability. They are capable of binding to and destabilizing mRNAs that are targeted for degradation, leading to their degradation and inhibition of protein translation. Hsp110 proteins also play a role in the regulation of protein folding and transport.\nIn conclusion, Hsp70 and Hsp110 play important roles in the regulation of mRNA stability by binding to and stabilizing or destabilizing mRNAs, respectively. These proteins help to ensure that the proper balance of protein synthesis and degradation is maintained in the cell, and they play a critical role in the response of cells to stress.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hsp70 and Hsp110 are types of heat shock proteins (HSPs) that play roles in the regulation of protein folding and mRNA stability.\n2. Hsp70 proteins are molecular chaperones that help to fold and transport proteins within the cell.\n3. Hsp70 proteins help regulate mRNA stability by binding to and stabilizing mRNAs that are targeted for degradation.\n4. Hsp110 proteins can bind to and destabilize mRNAs that are targeted for degradation.\n5. Hsp70 and Hsp110 play significant roles in maintaining the proper balance of protein synthesis and degradation in the cell.",
    "vicuna-13b_fact": [
      "Hsp70 and Hsp110 are types of heat shock proteins (HSPs) that play roles in the regulation of protein folding and mRNA stability.",
      "Hsp70 proteins are molecular chaperones that help to fold and transport proteins within the cell.",
      "Hsp70 proteins help regulate mRNA stability by binding to and stabilizing mRNAs that are targeted for degradation.",
      "Hsp110 proteins can bind to and destabilize mRNAs that are targeted for degradation.",
      "Hsp70 and Hsp110 play significant roles in maintaining the proper balance of protein synthesis and degradation in the cell."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 477,
    "user_query": "What is FINDbase?",
    "vicuna-13b_response": "FINDbase is a database management system that is designed to work with the FINDsystem. It is used to store and manage data related to the FINDsystem, such as user information, device information, and network information. FINDbase is a centralized database that allows for easy data retrieval and management, and it is an essential component of the FINDsystem.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. FINDbase is a database management system.\n2. It is designed to work with the FINDsystem.\n3. FINDbase is used to store and manage data related to the FINDsystem, such as user information, device information, and network information. \n4. FINDbase is a centralized database.\n5. FINDbase allows for easy data retrieval and management.",
    "vicuna-13b_fact": [
      "FINDbase is a database management system.",
      "It is designed to work with the FINDsystem.",
      "FINDbase is used to store and manage data related to the FINDsystem, such as user information, device information, and network information.",
      "FINDbase is a centralized database.",
      "FINDbase allows for easy data retrieval and management."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "vicuna-13b_response": "There are two main types of deiodinases present in skeletal muscle: deiodinase 1 (D1) and deiodinase 2 (D2).\nD1 is the main enzyme responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3) in skeletal muscle tissue. D1 is expressed at high levels in skeletal muscle, and its activity is regulated by a number of factors, including muscle contraction, exercise, and changes in the levels of other hormones such as glucocorticoids.\nD2, on the other hand, is responsible for converting T4 to T3, but it has a much lower activity than D1. D2 is also expressed in skeletal muscle, but at much lower levels than D1.\nBoth D1 and D2 are important for the proper functioning of thyroid hormone in skeletal muscle. D1 is critical for the conversion of T4 to T3, which is necessary for the regulation of muscle metabolism and protein synthesis. D2, on the other hand, plays a role in the regulation of T3 levels in the body, and may be involved in the feedback regulation of thyroid hormone synthesis and secretion by the thyroid gland.\nOverall, the balance between D1 and D2 activity is important for maintaining proper thyroid hormone levels in skeletal muscle, and dysregulation of these enzymes can have significant effects on muscle function and metabolism.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Deiodinase 1 (D1) and deiodinase 2 (D2) are present in skeletal muscle.\n2. D1 is responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3) in skeletal muscle tissue.\n3. The activity of D1 is regulated by a number of factors, including muscle contraction, exercise, and changes in the levels of other hormones such as glucocorticoids.\n4. D2 is also responsible for converting T4 to T3, but it has a much lower activity than D1.\n5. The balance between D1 and D2 activity is important for maintaining proper thyroid hormone levels in skeletal muscle.",
    "vicuna-13b_fact": [
      "Deiodinase 1 (D1) and deiodinase 2 (D2) are present in skeletal muscle.",
      "D1 is responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3) in skeletal muscle tissue.",
      "The activity of D1 is regulated by a number of factors, including muscle contraction, exercise, and changes in the levels of other hormones such as glucocorticoids.",
      "D2 is also responsible for converting T4 to T3, but it has a much lower activity than D1.",
      "The balance between D1 and D2 activity is important for maintaining proper thyroid hormone levels in skeletal muscle."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: D2, not D1, is primarily responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3) in skeletal muscle tissue.\n3. TRUE\n4. FALSE [correction]: D2 has a much higher activity than D1, not lower.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 483,
    "user_query": "Which is the molecular weight of the protein angiogenin?",
    "vicuna-13b_response": "Angiogenin is a small protein with a molecular weight of approximately 4.6 kDa. It is a potent angiogenic factor that plays a key role in the process of angiogenesis, which is the formation of new blood vessels from existing ones. Angiogenin is produced by a variety of cell types, including endothelial cells and immune cells, and it binds to specific receptors on the surface of endothelial cells to stimulate the formation of new blood vessels. Angiogenin has been studied as a potential therapeutic agent for a variety of diseases, including cancer and diabetic retinopathy, and it has also been used as a research tool to study the mechanisms of angiogenesis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The molecular weight of angiogenin is approximately 4.6 kDa.\n2. Angiogenin plays a key role in the process of angiogenesis.\n3. Angiogenesis is the formation of new blood vessels from existing ones.\n4. Angiogenin is produced by a variety of cell types, including endothelial cells and immune cells.\n5. Angiogenin binds to specific receptors on the surface of endothelial cells to stimulate the formation of new blood vessels.",
    "vicuna-13b_fact": [
      "The molecular weight of angiogenin is approximately 4.6 kDa.",
      "Angiogenin plays a key role in the process of angiogenesis.",
      "Angiogenesis is the formation of new blood vessels from existing ones.",
      "Angiogenin is produced by a variety of cell types, including endothelial cells and immune cells.",
      "Angiogenin binds to specific receptors on the surface of endothelial cells to stimulate the formation of new blood vessels."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The molecular weight of angiogenin is approximately 14.6 kDa.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 484,
    "user_query": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment.",
    "vicuna-13b_response": "Sodium glucose co-transporter-2 (SGLT2) inhibitors are a class of medications used to treat type 2 diabetes mellitus. Some examples of SGLT2 inhibitors that have been approved by the US Food and Drug Administration (FDA) for the treatment of type 2 diabetes include:\n1. Invokana (canagliflozin)\n2. Invokamet (canagliflozin and metformin)\n3. Farxiga (dapagliflozin)\n4. Xigduo (dapagliflozin and metformin)\n5. Jardiance (empagliflozin)\n6. Glyxambi (empagliflozin and linagliptin)\n7. Synjardy (empagliflozin and metformin)\nThese medications work by inhibiting the action of SGLT2, a protein found in the kidneys that helps to reabsorb glucose from the urine back into the bloodstream. By inhibiting SGLT2, these medications increase the amount of glucose that is excreted in the urine, leading to a decrease in blood glucose levels. SGLT2 inhibitors are often used in combination with other diabetes medications, such as metformin or sulfonylureas, to achieve better glycemic control.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Sodium glucose co-transporter-2 (SGLT2) inhibitors are a class of medications used to treat type 2 diabetes mellitus.\n2. Invokana (canagliflozin), Invokamet (canagliflozin and metformin), Farxiga (dapagliflozin), Xigduo (dapagliflozin and metformin), Jardiance (empagliflozin), Glyxambi (empagliflozin and linagliptin), and Synjardy (empagliflozin and metformin) are examples of SGLT2 inhibitors approved by the FDA for the treatment of type 2 diabetes.\n3. SGLT2 is a protein found in the kidneys that helps to reabsorb glucose from the urine back into the bloodstream.\n4. By inhibiting SGLT2, these medications increase the amount of glucose that is excreted in the urine.\n5. SGLT2 inhibitors are often used in combination with other diabetes medications, such as metformin or sulfonylureas, to achieve better glycemic control.",
    "vicuna-13b_fact": [
      "Sodium glucose co-transporter-2 (SGLT2) inhibitors are a class of medications used to treat type 2 diabetes mellitus.",
      "Invokana (canagliflozin), Invokamet (canagliflozin and metformin), Farxiga (dapagliflozin), Xigduo (dapagliflozin and metformin), Jardiance (empagliflozin), Glyxambi (empagliflozin and linagliptin), and Synjardy (empagliflozin and metformin) are examples of SGLT2 inhibitors approved by the FDA for the treatment of type 2 diabetes.",
      "SGLT2 is a protein found in the kidneys that helps to reabsorb glucose from the urine back into the bloodstream.",
      "By inhibiting SGLT2, these medications increase the amount of glucose that is excreted in the urine.",
      "SGLT2 inhibitors are often used in combination with other diabetes medications, such as metformin or sulfonylureas, to achieve better glycemic control."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 486,
    "user_query": "Why does the prodrug amifostine (ethyol) create hypoxia?",
    "vicuna-13b_response": "Amifostine (also known as ethyol) is a prodrug that is used to treat cancer. It is not known to create hypoxia directly. However, it is believed that amifostine may cause hypoxia indirectly by inhibiting the activity of the enzyme ornithine decarboxylase (ODC), which is involved in the production of polyamines, such as putrescine and spermidine. These polyamines are important for cell proliferation and survival, and their depletion may lead to cell death and tissue hypoxia. Additionally, amifostine has been shown to inhibit the activity of the enzyme thymidylate synthase, which is involved in the production of thymidine, a precursor for DNA synthesis. This may also lead to cell death and tissue hypoxia. However, it is important to note that the exact mechanism by which amifostine creates hypoxia is not well understood and further research is needed to fully understand its effects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Amifostine (also known as ethyol) is a prodrug that is used to treat cancer.\n2. Amifostine may cause hypoxia indirectly by inhibiting the activity of the enzyme ornithine decarboxylase (ODC).\n3. Ornithine decarboxylase (ODC) is involved in the production of polyamines, such as putrescine and spermidine.\n4. Amifostine has been shown to inhibit the activity of the enzyme thymidylate synthase.\n5. Thymidylate synthase is involved in the production of thymidine, a precursor for DNA synthesis.",
    "vicuna-13b_fact": [
      "Amifostine (also known as ethyol) is a prodrug that is used to treat cancer.",
      "Amifostine may cause hypoxia indirectly by inhibiting the activity of the enzyme ornithine decarboxylase (ODC).",
      "Ornithine decarboxylase (ODC) is involved in the production of polyamines, such as putrescine and spermidine.",
      "Amifostine has been shown to inhibit the activity of the enzyme thymidylate synthase.",
      "Thymidylate synthase is involved in the production of thymidine, a precursor for DNA synthesis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 493,
    "user_query": "Which disease is included as an additional feature in the Goldberg-Shprintzen syndrome?",
    "vicuna-13b_response": "Goldberg-Shprintzen syndrome is a rare genetic disorder that is characterized by a variety of physical and developmental features. One of the additional features that can be included in the Goldberg-Shprintzen syndrome is the presence of a cleft palate.\nA cleft palate is a congenital anomaly that occurs when there is an opening in the roof of the mouth, which can lead to difficulties with feeding, speech, and hearing. It can occur alone or in combination with other features of the Goldberg-Shprintzen syndrome, which can include intellectual disability, seizures, and distinctive facial features.\nThe exact cause of Goldberg-Shprintzen syndrome is not known, but it is thought to be due to mutations in the GTF2I gene, which is responsible for encoding a protein involved in regulating gene expression. There is no cure for the Goldberg-Shprintzen syndrome, but treatment is focused on managing the various symptoms associated with the condition. This may include surgery to repair a cleft palate, speech therapy, and medications to control seizures or other symptoms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Goldberg-Shprintzen syndrome is a rare genetic disorder.\n2. An additional feature that can be included in the Goldberg-Shprintzen syndrome is the presence of a cleft palate.\n3. A cleft palate is a congenital anomaly that occurs when there is an opening in the roof of the mouth.\n4. The believed cause of Goldberg-Shprintzen syndrome is due to mutations in the GTF2I gene, which is responsible for encoding a protein involved in regulating gene expression.\n5. Treatment of Goldberg-Shprintzen syndrome focusses on managing the various symptoms associated with the condition, which can include surgery to repair a cleft palate, speech therapy, and medications to control seizures or other symptoms.",
    "vicuna-13b_fact": [
      "Goldberg-Shprintzen syndrome is a rare genetic disorder.",
      "An additional feature that can be included in the Goldberg-Shprintzen syndrome is the presence of a cleft palate.",
      "A cleft palate is a congenital anomaly that occurs when there is an opening in the roof of the mouth.",
      "The believed cause of Goldberg-Shprintzen syndrome is due to mutations in the GTF2I gene, which is responsible for encoding a protein involved in regulating gene expression.",
      "Treatment of Goldberg-Shprintzen syndrome focusses on managing the various symptoms associated with the condition, which can include surgery to repair a cleft palate, speech therapy, and medications to control seizures or other symptoms."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The believed cause of Goldberg-Shprintzen syndrome is due to mutations in the KIAA1279 gene, which is responsible for encoding a protein involved in cell-cell adhesion.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 496,
    "user_query": "Which disease of the central nervous system is characterized by the presence of Lewy bodies?",
    "vicuna-13b_response": "The disease of the central nervous system characterized by the presence of Lewy bodies is called Parkinson's disease. Lewy bodies are abnormal clumps of protein that form inside nerve cells in the brain, and they are a hallmark of Parkinson's disease. These clumps disrupt the normal functioning of the cells and ultimately lead to the death of the cells, which can result in the symptoms of Parkinson's disease. Parkinson's disease is a progressive neurodegenerative disorder that affects movement, balance, and coordination, and it is often accompanied by other symptoms such as cognitive decline, mood changes, and sleep disturbances.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The disease of the central nervous system characterized by the presence of Lewy bodies is called Parkinson's disease.\n2. Lewy bodies are abnormal clumps of protein that form inside nerve cells in the brain.\n3. Lewy bodies disrupting the normal functioning of the cells can lead to the death of these cells.\n4. Parkinson's disease is a progressive neurodegenerative disorder that affects movement, balance, and coordination.\n5. Parkinson's disease can be accompanied by other symptoms such as cognitive decline, mood changes, and sleep disturbances.",
    "vicuna-13b_fact": [
      "The disease of the central nervous system characterized by the presence of Lewy bodies is called Parkinson's disease.",
      "Lewy bodies are abnormal clumps of protein that form inside nerve cells in the brain.",
      "Lewy bodies disrupting the normal functioning of the cells can lead to the death of these cells.",
      "Parkinson's disease is a progressive neurodegenerative disorder that affects movement, balance, and coordination.",
      "Parkinson's disease can be accompanied by other symptoms such as cognitive decline, mood changes, and sleep disturbances."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The disease of the central nervous system characterized by the presence of Lewy bodies is called Lewy body dementia. However, Parkinson's disease is also linked with the presence of Lewy bodies.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 512,
    "user_query": "Is vemurafenib effective for hairy-cell leukemia?",
    "vicuna-13b_response": "Vemurafenib is a BRAF inhibitor drug that is commonly used to treat melanoma, but it has not been approved by the FDA for the treatment of hairy cell leukemia. Hairy cell leukemia is a rare type of blood cancer that affects the bone marrow and results in an overproduction of abnormal white blood cells. It is typically treated with chemotherapy and/or bone marrow transplantation.\nWhile vemurafenib is not an approved treatment for hairy cell leukemia, there are ongoing clinical trials exploring the use of BRAF inhibitors in combination with other drugs for the treatment of various types of leukemia, including hairy cell leukemia. These trials are investigating the safety and efficacy of these combinations in treating the disease.\nIt is important to note that treatment options for hairy cell leukemia can vary depending on several factors, including the severity of the disease, the patient's overall health, and the presence of any specific genetic mutations. Therefore, it is crucial to consult with a hematologist or an oncologist who is experienced in treating hairy cell leukemia to determine the most appropriate treatment plan for each individual case.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Vemurafenib is a BRAF inhibitor drug that is commonly used to treat melanoma.\n2. Vemurafenib has not been approved by the FDA for the treatment of hairy cell leukemia.\n3. Hairy cell leukemia affects the bone marrow and results in an overproduction of abnormal white blood cells.\n4. There are ongoing clinical trials exploring the use of BRAF inhibitors, including vemurafenib, for the treatment of various types of leukemia, including hairy cell leukemia.\n5. Treatment options for hairy cell leukemia can vary depending on the severity of the disease, the patient's overall health, and the presence of any specific genetic mutations.",
    "vicuna-13b_fact": [
      "Vemurafenib is a BRAF inhibitor drug that is commonly used to treat melanoma.",
      "Vemurafenib has not been approved by the FDA for the treatment of hairy cell leukemia.",
      "Hairy cell leukemia affects the bone marrow and results in an overproduction of abnormal white blood cells.",
      "There are ongoing clinical trials exploring the use of BRAF inhibitors, including vemurafenib, for the treatment of various types of leukemia, including hairy cell leukemia.",
      "Treatment options for hairy cell leukemia can vary depending on the severity of the disease, the patient's overall health, and the presence of any specific genetic mutations."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Vemurafenib has been approved by the FDA for the treatment of hairy cell leukemia.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 513,
    "user_query": "Which are the inhibitors of histone methyltransferases?",
    "vicuna-13b_response": "Histone methyltransferases (HMTs) are enzymes that add methyl groups to histone proteins, leading to the regulation of gene expression and chromatin structure. Inhibitors of HMTs can be useful tools in understanding the role of histone methylation in various biological processes and in developing therapeutic strategies for diseases associated with abnormal histone methylation.\nThere are several types of inhibitors of HMTs, including:\n1. Small molecule inhibitors: These are small organic compounds that bind to the active site of the HMT, blocking its activity. Examples include the suicide inhibitor SAM (S-adenosylmethionine) and the phosphate analogue inhibitors.\n2. Peptide inhibitors: These are peptides that compete with the substrate for binding to the HMT, blocking its activity. Examples include the histone methyltransferase peptide inhibitors.\n3. RNA interference: This is a method of gene silencing in which small RNA molecules (siRNA or shRNA) are used to target specific HMTs for degradation.\n4. Chemical inhibitors: These are non-specific inhibitors that disrupt the activity of HMTs by interfering with various cellular processes. Examples include the proteasome inhibitors and the DNA damaging agents.\nIt is important to note that the specific inhibitors of HMTs may vary depending on the type of HMT being targeted and the cellular context in which it is operating. Additionally, the use of inhibitors of HMTs should be approached with caution, as they can have unintended consequences on cellular processes and may lead to off-target effects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Histone methyltransferases (HMTs) are enzymes that add methyl groups to histone proteins leading to the regulation of gene expression and chromatin structure.\n2. Small molecule inhibitors, peptide inhibitors, RNA interference, and chemical inhibitors are types of inhibitors of HMTs.\n3. Small molecule inhibitors bind to the active site of the HMT, blocking its activity.\n4. RNA interference is a method of gene silencing using small RNA molecules (siRNA or shRNA) to target specific HMTs for degradation.\n5. The specific inhibitors of HMTs may vary depending on the type of HMT being targeted and the cellular context in which it is operating.",
    "vicuna-13b_fact": [
      "Histone methyltransferases (HMTs) are enzymes that add methyl groups to histone proteins leading to the regulation of gene expression and chromatin structure.",
      "Small molecule inhibitors, peptide inhibitors, RNA interference, and chemical inhibitors are types of inhibitors of HMTs.",
      "Small molecule inhibitors bind to the active site of the HMT, blocking its activity.",
      "RNA interference is a method of gene silencing using small RNA molecules (siRNA or shRNA) to target specific HMTs for degradation.",
      "The specific inhibitors of HMTs may vary depending on the type of HMT being targeted and the cellular context in which it is operating."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 517,
    "user_query": "Which JAK (Janus kinase) inhibitor is approved for treatment of rheumatoid arthritis?",
    "vicuna-13b_response": "The JAK (Janus kinase) inhibitor that is approved for treatment of rheumatoid arthritis is called \"Baricitinib\" (brand name: Olumiant). It is a prescription medication that is taken orally as a tablet, and it works by inhibiting the activity of JAK1 and JAK2 enzymes, which are involved in the signaling pathways that contribute to the inflammation and joint damage associated with rheumatoid arthritis. Baricitinib is approved for use in adults who have had an inadequate response to traditional disease-modifying anti-rheumatic drugs (DMARDs) and is given in combination with methotrexate. It is important to note that the use of JAK inhibitors in rheumatoid arthritis is still relatively new and more research is needed to fully understand their long-term safety and efficacy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The JAK inhibitor approved for treatment of rheumatoid arthritis is Baricitinib, also known as Olumiant. \n2. Baricitinib is a prescription medication that is taken orally as a tablet. \n3. Baricitinib works by inhibiting the activity of JAK1 and JAK2 enzymes. \n4. The JAK1 and JAK2 enzymes are involved in the signaling pathways that contribute to the inflammation and joint damage associated with rheumatoid arthritis. \n5. Baricitinib is approved for use in adults who have had an inadequate response to traditional disease-modifying anti-rheumatic drugs (DMARDs) and the medication is given in combination with methotrexate.",
    "vicuna-13b_fact": [
      "The JAK inhibitor approved for treatment of rheumatoid arthritis is Baricitinib, also known as Olumiant.",
      "Baricitinib is a prescription medication that is taken orally as a tablet.",
      "Baricitinib works by inhibiting the activity of JAK1 and JAK2 enzymes.",
      "The JAK1 and JAK2 enzymes are involved in the signaling pathways that contribute to the inflammation and joint damage associated with rheumatoid arthritis.",
      "Baricitinib is approved for use in adults who have had an inadequate response to traditional disease-modifying anti-rheumatic drugs (DMARDs) and the medication is given in combination with methotrexate."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 519,
    "user_query": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?",
    "vicuna-13b_response": "Thalassemia is a genetic disorder that affects the production of hemoglobin in the body. Recently, researchers have identified several DNA nucleases that have shown promise in treating thalassemia.\nOne such nuclease is called CRISPR-Cas9. This system allows for precise editing of the genome by cutting out specific sequences of DNA. In thalassemia, this technology could be used to delete or replace the mutated gene that causes the disorder.\nAnother nuclease that has been studied is called TALENs (Transcription Activator-Like Effector Nucleases). These enzymes can also be used to cut specific sequences of DNA, and have been shown to be effective in correcting the genetic mutation that causes thalassemia.\nIn addition to these nucleases, researchers are also exploring the use of other enzymes such as zinc finger nucleases and meganucleases. These enzymes work by cutting DNA at specific sequences, and can also be used to correct the genetic mutation that causes thalassemia.\nIt is important to note that while these nucleases show promise in treating thalassemia, they are still in the early stages of development and more research is needed to determine their safety and efficacy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Thalassemia is a genetic disorder that affects the production of hemoglobin in the body.\n2. Researchers have identified a nuclease called CRISPR-Cas9 that could be used to treat thalassemia.\n3. CRISPR-Cas9 allows for precise editing of the genome by cutting out specific sequences of DNA.\n4. The nuclease TALENs has been studied for its ability to correct the genetic mutation that causes thalassemia.\n5. Other enzymes such as zinc finger nucleases and meganucleases are being explored for their potential use in treating thalassemia.",
    "vicuna-13b_fact": [
      "Thalassemia is a genetic disorder that affects the production of hemoglobin in the body.",
      "Researchers have identified a nuclease called CRISPR-Cas9 that could be used to treat thalassemia.",
      "CRISPR-Cas9 allows for precise editing of the genome by cutting out specific sequences of DNA.",
      "The nuclease TALENs has been studied for its ability to correct the genetic mutation that causes thalassemia.",
      "Other enzymes such as zinc finger nucleases and meganucleases are being explored for their potential use in treating thalassemia."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 524,
    "user_query": "Is the protein β1-integrin recycled?",
    "vicuna-13b_response": "Yes, the protein β1-integrin is recycled. β1-integrin is a type of integrin, a family of transmembrane proteins that play important roles in cell adhesion and signaling. Integrins are constantly being internalized and recycled to the cell surface, where they can interact with other proteins and play a role in cellular communication and behavior.\nThe recycling of integrins is a complex process that involves several steps. First, the integrin is internalized through clathrin-coated pits, which are small invaginations of the plasma membrane. The integrin is then transported to the endosome, where it is sorted and either degraded or returned to the cell surface. The recycling of integrins is regulated by several proteins, including the adaptor protein AP-2 and the GTPase dynamin.\nThe recycling of β1-integrin is important for maintaining cellular homeostasis and regulating cellular behavior. Mutations in the β1-integrin gene have been linked to several diseases, including cancer and immune disorders, highlighting the importance of proper regulation of integrin recycling.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The protein β1-integrin is recycled.\n2. β1-integrin is a type of integrin and they play important roles in cell adhesion and signaling.\n3. Integrins are internalized and recycled to the cell surface.\n4. The recycling process of integrins involves the integrin being internalized through clathrin-coated pits, transported to the endosome, and either degraded or returned to the cell surface.\n5. Mutations in the β1-integrin gene have been linked to several diseases, including cancer and immune disorders.",
    "vicuna-13b_fact": [
      "The protein β1-integrin is recycled.",
      "β1-integrin is a type of integrin and they play important roles in cell adhesion and signaling.",
      "Integrins are internalized and recycled to the cell surface.",
      "The recycling process of integrins involves the integrin being internalized through clathrin-coated pits, transported to the endosome, and either degraded or returned to the cell surface.",
      "Mutations in the β1-integrin gene have been linked to several diseases, including cancer and immune disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 526,
    "user_query": "Which signaling pathway is activating the dishevelled proteins?",
    "vicuna-13b_response": "The dishevelled proteins are activated through the signaling pathway known as the \"Wnt/β-catenin\" pathway. This pathway is activated in response to the binding of Wnt proteins to their receptors, which leads to the formation of a complex involving the dishevelled proteins, the adenomatous polyposis coli (APC) protein, and the GSK3β kinase. This complex then phosphorylates and activates the β-catenin protein, which then translocates to the nucleus and regulates the expression of target genes involved in cellular processes such as cell proliferation and differentiation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The dishevelled proteins are activated through the \"Wnt/β-catenin\" pathway.\n2. The \"Wnt/β-catenin\" pathway is activated in response to the binding of Wnt proteins to their receptors.\n3. The formation of a complex involving the dishevelled proteins, the adenomatous polyposis coli (APC) protein, and the GSK3β kinase is part of the \"Wnt/β-catenin\" pathway.\n4. This complex phosphorylates and activates the β-catenin protein.\n5. The activated β-catenin protein translocates to the nucleus and regulates the expression of target genes involved in cellular processes such as cell proliferation and differentiation.",
    "vicuna-13b_fact": [
      "The dishevelled proteins are activated through the \"Wnt/β-catenin\" pathway.",
      "The \"Wnt/β-catenin\" pathway is activated in response to the binding of Wnt proteins to their receptors.",
      "The formation of a complex involving the dishevelled proteins, the adenomatous polyposis coli (APC) protein, and the GSK3β kinase is part of the \"Wnt/β-catenin\" pathway.",
      "This complex phosphorylates and activates the β-catenin protein.",
      "The activated β-catenin protein translocates to the nucleus and regulates the expression of target genes involved in cellular processes such as cell proliferation and differentiation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: This complex prevents phosphorylation and stabilization of β-catenin protein.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 533,
    "user_query": "Can a peptide aptamer be used as protein inhibitor?",
    "vicuna-13b_response": "Yes, a peptide aptamer can be used as a protein inhibitor. Aptamers are short, single-stranded RNA or DNA molecules that bind to specific target molecules with high affinity and specificity. Peptide aptamers are aptamers that bind to peptides or proteins. These peptide aptamers can be used to inhibit the activity of the target protein by binding to it and blocking its function. Peptide aptamers have several advantages as inhibitors, including high specificity and affinity, ease of modification, and low immunogenicity. They can be used in a variety of applications, including basic research, diagnostics, and therapeutics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A peptide aptamer can be used as a protein inhibitor.\n2. Aptamers are short, single-stranded RNA or DNA molecules that bind to specific target molecules with high affinity and specificity.\n3. Peptide aptamers are aptamers that bind to peptides or proteins. \n4. Peptide aptamers can inhibit the activity of the target protein by binding to it and blocking its function.\n5. Peptide aptamers can be used in basic research, diagnostics, and therapeutics.",
    "vicuna-13b_fact": [
      "A peptide aptamer can be used as a protein inhibitor.",
      "Aptamers are short, single-stranded RNA or DNA molecules that bind to specific target molecules with high affinity and specificity.",
      "Peptide aptamers are aptamers that bind to peptides or proteins.",
      "Peptide aptamers can inhibit the activity of the target protein by binding to it and blocking its function.",
      "Peptide aptamers can be used in basic research, diagnostics, and therapeutics."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "vicuna-13b_response": "Caspases are a family of cysteine proteases that play a crucial role in cellular apoptosis (programmed cell death). There are several types of caspases, including inflammatory caspases. Inflammatory caspases are a subset of caspases that are involved in the inflammatory response. Here are some of the inflammatory caspases:\n1. Caspase-1: Caspase-1 is an inflammatory caspase that is activated by the inflammasome, a complex that plays a crucial role in the innate immune response. Caspase-1 cleaves and activates pro-inflammatory cytokines such as interleukin-1β (IL-1β) and interleukin-18 (IL-18), which play important roles in the immune response.\n2. Caspase-4: Caspase-4 is another inflammatory caspase that is activated by the inflammasome. It cleaves and activates pro-inflammatory cytokines such as IL-1β and IL-18.\n3. Caspase-5: Caspase-5 is an inflammatory caspase that is activated by the inflammasome. It cleaves and activates the pro-inflammatory cytokine gasdermin D, which plays a role in the immune response.\n4. Caspase-12: Caspase-12 is an inflammatory caspase that is activated by the inflammasome. It cleaves and activates the pro-inflammatory cytokine IL-18.\nOverall, inflammatory caspases play a crucial role in the inflammatory response and the immune system. Dysregulation of inflammatory caspases has been implicated in a variety of diseases, including autoimmune diseases and chronic inflammation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Caspases are a family of cysteine proteases that play a role in cellular apoptosis.\n2. There is a type of caspases called inflammatory caspases, which are involved in the inflammatory response.\n3. Caspase-1, caspase-4, caspase-5, and caspase-12 are examples of inflammatory caspases. \n4. Inflammatory caspases such as Caspase-1, Caspase-4, and Caspase-5 are activated by the inflammasome and they cleave and activate pro-inflammatory cytokines.\n5. Dysregulation of inflammatory caspases has been implicated in diseases like autoimmune diseases and chronic inflammation.",
    "vicuna-13b_fact": [
      "Caspases are a family of cysteine proteases that play a role in cellular apoptosis.",
      "There is a type of caspases called inflammatory caspases, which are involved in the inflammatory response.",
      "Caspase-1, caspase-4, caspase-5, and caspase-12 are examples of inflammatory caspases.",
      "Inflammatory caspases such as Caspase-1, Caspase-4, and Caspase-5 are activated by the inflammasome and they cleave and activate pro-inflammatory cytokines.",
      "Dysregulation of inflammatory caspases has been implicated in diseases like autoimmune diseases and chronic inflammation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 538,
    "user_query": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma",
    "vicuna-13b_response": "Subependymal Giant Cell Astrocytoma (SEGA) is a rare type of brain tumor that originates from astrocytes, a type of glial cell that supports the function of neurons. Chemotherapy is often used as a treatment option for SEGA, along with surgery and radiation therapy. Here are two chemotherapeutic agents that are commonly used for the treatment of SEGA:\n1. Temozolomide: Temozolomide is an oral chemotherapy drug that is commonly used for the treatment of SEGA. It works by interfering with the ability of cancer cells to divide and grow. Temozolomide is usually administered on a daily basis, either alone or in combination with other chemotherapy drugs.\n2. Carboplatin: Carboplatin is a chemotherapy drug that is commonly used for the treatment of SEGA. It works by damaging the DNA of cancer cells, which prevents them from dividing and growing. Carboplatin is usually administered intravenously, either alone or in combination with other chemotherapy drugs.\nIt's important to note that the treatment plan for SEGA will vary depending on the individual patient and the specific characteristics of their tumor. Chemotherapy may be used as the primary treatment for SEGA, or it may be used in combination with other treatments such as surgery or radiation therapy. It's important to discuss the best treatment options with a healthcare provider.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Subependymal Giant Cell Astrocytoma (SEGA) is a rare type of brain tumor that originates from astrocytes.\n2. Chemotherapy is used as a treatment option for SEGA.\n3. Temozolomide is an oral chemotherapy drug that is commonly used for the treatment of SEGA, including alone or in combination with other drugs.\n4. Carboplatin is a chemotherapy drug that is commonly used for the treatment of SEGA, including alone or in combination with other drugs.\n5. The treatment plan for SEGA can vary depending on the individual patient and the specific characteristics of their tumor.",
    "vicuna-13b_fact": [
      "Subependymal Giant Cell Astrocytoma (SEGA) is a rare type of brain tumor that originates from astrocytes.",
      "Chemotherapy is used as a treatment option for SEGA.",
      "Temozolomide is an oral chemotherapy drug that is commonly used for the treatment of SEGA, including alone or in combination with other drugs.",
      "Carboplatin is a chemotherapy drug that is commonly used for the treatment of SEGA, including alone or in combination with other drugs.",
      "The treatment plan for SEGA can vary depending on the individual patient and the specific characteristics of their tumor."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Temozolomide is an oral chemotherapy drug that is commonly used for the treatment of Glioblastoma Multiforme (GBM), not SEGA.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 541,
    "user_query": "List available databases containing information about conserved noncoding elements.",
    "vicuna-13b_response": "There are several databases available that contain information about conserved noncoding elements. Some of the most popular ones are:\n1. The Encyclopedia of DNA Elements (ENCODE) database: This database was created as a result of the ENCODE project, which was a large-scale effort to identify and characterize all functional elements in the human genome. The database contains information about conserved noncoding elements, including their genomic locations, functional annotations, and regulatory interactions.\n2. The Noncoding Disease Consortium (NDC) database: This database was created by the Noncoding Disease Consortium, which is a group of researchers who are working to identify the functional elements that contribute to the development of various diseases. The database contains information about conserved noncoding elements that have been associated with various diseases, including cancer, autoimmune disorders, and neurological diseases.\n3. The Consensus CDS (CCDS) database: This database was created by the Consensus CDS project, which is a collaborative effort to identify and annotate all functional elements in the genomes of several vertebrate species. The database contains information about conserved noncoding elements, including their functional annotations and evolutionary conservation.\n4. The Regulatory Genomics Database (RGD) database: This database was created by the Regulatory Genomics Consortium, which is a group of researchers who are working to identify and characterize the regulatory elements that control gene expression. The database contains information about conserved noncoding elements that have been associated with various regulatory functions, including transcriptional regulation, chromatin structure, and noncoding RNA biology.\n5. The Genome Browser database: This is a general-purpose genome browser that allows users to explore the genomic landscape of various organisms, including humans, mouse, and fruit fly. The browser provides access to a variety of data sets, including conserved noncoding elements, gene expression data, and genomic variation data.\nThese are just a few examples of the many databases that contain information about conserved noncoding elements. Each database has its own strengths and weaknesses, and researchers often use multiple databases to gain a more comprehensive understanding of the functional elements in the genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Encyclopedia of DNA Elements (ENCODE) database is a result of the ENCODE project, it contains information about conserved noncoding elements, including their genomic locations, functional annotations, and regulatory interactions.\n2. The Noncoding Disease Consortium (NDC) database was created by the Noncoding Disease Consortium, it contains information about conserved noncoding elements that have been associated with various diseases, including cancer, autoimmune disorders, and neurological diseases.\n3. The Consensus CDS (CCDS) database was created by the Consensus CDS project, and it contains information about conserved noncoding elements, including their functional annotations and evolutionary conservation.\n4. The Regulatory Genomics Database (RGD) was created by the Regulatory Genomics Consortium, it contains information about conserved noncoding elements that have been associated with various regulatory functions.\n5. The Genome Browser is a general-purpose genome browser that allows users to explore the genomic landscape of various organisms, including humans, mouse, and fruit fly, it provides access to a variety of data sets, including conserved noncoding elements, gene expression data, and genomic variation data.",
    "vicuna-13b_fact": [
      "The Encyclopedia of DNA Elements (ENCODE) database is a result of the ENCODE project, it contains information about conserved noncoding elements, including their genomic locations, functional annotations, and regulatory interactions.",
      "The Noncoding Disease Consortium (NDC) database was created by the Noncoding Disease Consortium, it contains information about conserved noncoding elements that have been associated with various diseases, including cancer, autoimmune disorders, and neurological diseases.",
      "The Consensus CDS (CCDS) database was created by the Consensus CDS project, and it contains information about conserved noncoding elements, including their functional annotations and evolutionary conservation.",
      "The Regulatory Genomics Database (RGD) was created by the Regulatory Genomics Consortium, it contains information about conserved noncoding elements that have been associated with various regulatory functions.",
      "The Genome Browser is a general-purpose genome browser that allows users to explore the genomic landscape of various organisms, including humans, mouse, and fruit fly, it provides access to a variety of data sets, including conserved noncoding elements, gene expression data, and genomic variation data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no such database as the Noncoding Disease Consortium (NDC) database created by the Noncoding Disease Consortium.\n3. FALSE [correction]: The Consensus CDS (CCDS) database is a collaborative effort to identify a core set of protein coding regions that are consistently annotated and high quality in the human and mouse genomes.\n4. FALSE [correction]: The Regulatory Genomics Database (RGD) does not exist. Moreover, RGD usually refers to Rat Genome Database.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 546,
    "user_query": "What disease in Loxapine prominently used for?",
    "vicuna-13b_response": "Loxapine is a medication that is primarily used to treat schizophrenia, a mental disorder characterized by symptoms such as delusions, hallucinations, and disorganized thinking. It is also sometimes used to treat bipolar disorder, another mental illness that involves episodes of mania or hypomania (less severe mania) and depression. Loxapine is a second-generation antipsychotic medication, which means it works by blocking the action of dopamine, a neurotransmitter in the brain that is involved in regulating mood, emotion, and movement. Loxapine is available under various brand names, including Loxitane and Admetocin. It is usually taken as a pill or a liquid, and is usually taken orally, but can also be given as an injection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Loxapine is a medication primarily used to treat schizophrenia.\n2. Loxapine is sometimes used to treat bipolar disorder.\n3. Loxapine is a second-generation antipsychotic medication.\n4. The drug works by blocking the action of dopamine in the brain.\n5. Loxapine is available under various brand names, including Loxitane and Admetocin.",
    "vicuna-13b_fact": [
      "Loxapine is a medication primarily used to treat schizophrenia.",
      "Loxapine is sometimes used to treat bipolar disorder.",
      "Loxapine is a second-generation antipsychotic medication.",
      "The drug works by blocking the action of dopamine in the brain.",
      "Loxapine is available under various brand names, including Loxitane and Admetocin."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Loxapine is a first-generation antipsychotic medication.\n4. TRUE\n5. FALSE [correction]: Loxapine is available under the brand name Loxitane, Adasuve is another known brand name for loxapine, not Admetocin.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 548,
    "user_query": "Which antibodies cause Riedel thyroiditis?",
    "vicuna-13b_response": "Riedel thyroiditis is an autoimmune disorder that occurs when the immune system mistakenly attacks the thyroid gland. The exact cause of Riedel thyroiditis is not fully understood, but it is thought to be related to a combination of genetic and environmental factors.\nIn Riedel thyroiditis, the immune system produces antibodies that attack the thyroid gland, leading to inflammation and damage to the gland. The antibodies that are most commonly associated with Riedel thyroiditis are thyroid-stimulating immunoglobulins (TSIs), also known as thyroid-stimulating antibodies (TSAbs).\nTSIs are a type of antibody that mimics the activity of thyroid-stimulating hormone (TSH), which is produced by the pituitary gland to stimulate the thyroid gland to produce thyroid hormones. When TSIs are present in the blood, they can bind to receptors on thyroid cells and stimulate the production of thyroid hormones, leading to hyperthyroidism.\nIn addition to TSIs, other types of antibodies that may be present in Riedel thyroiditis include anti-thyroglobulin antibodies (TgAb) and anti-peroxidase antibodies (TPOAb). These antibodies can also cause damage to the thyroid gland and lead to hyperthyroidism.\nIt is important to note that Riedel thyroiditis is a rare condition, and the presence of these antibodies does not necessarily mean that a person has Riedel thyroiditis. A diagnosis of Riedel thyroiditis is made based on a combination of clinical symptoms, laboratory tests, and imaging studies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Riedel thyroiditis is an autoimmune disorder in which the immune system mistakenly attacks the thyroid gland.\n2. In Riedel thyroiditis, the immune system produces antibodies that attack the thyroid gland, leading to inflammation and damage.\n3. The antibodies most commonly associated with Riedel thyroiditis are thyroid-stimulating immunoglobulins (TSIs) or thyroid-stimulating antibodies (TSAbs).\n4. Other types of antibodies that may be present in Riedel thyroiditis include anti-thyroglobulin antibodies (TgAb) and anti-peroxidase antibodies (TPOAb).\n5. The diagnosis of Riedel thyroiditis is made based on a mix of clinical symptoms, laboratory tests, and imaging studies.",
    "vicuna-13b_fact": [
      "Riedel thyroiditis is an autoimmune disorder in which the immune system mistakenly attacks the thyroid gland.",
      "In Riedel thyroiditis, the immune system produces antibodies that attack the thyroid gland, leading to inflammation and damage.",
      "The antibodies most commonly associated with Riedel thyroiditis are thyroid-stimulating immunoglobulins (TSIs) or thyroid-stimulating antibodies (TSAbs).",
      "Other types of antibodies that may be present in Riedel thyroiditis include anti-thyroglobulin antibodies (TgAb) and anti-peroxidase antibodies (TPOAb).",
      "The diagnosis of Riedel thyroiditis is made based on a mix of clinical symptoms, laboratory tests, and imaging studies."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Riedel thyroiditis is not an autoimmune disorder but a rare form of chronic inflammation that can lead to hardening of the thyroid gland.\n2. FALSE [correction]: In Riedel thyroiditis, there is no established autoimmune reaction proven by the presence of specific antibodies attacking the thyroid gland.\n3. FALSE [correction]: There is no specific type of antibodies, including thyroid-stimulating immunoglobulins (TSIs) or thyroid-stimulating antibodies (TSAbs), linked to Riedel thyroiditis.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 551,
    "user_query": "Which receptors are bound by Tasimelteon?",
    "vicuna-13b_response": "Tasimelteon is a drug that is used to treat sleep disorders such as insomnia. It binds to and activates melatonin receptors in the brain, which helps to regulate sleep and wakefulness. Specifically, tasimelteon binds to MT1 and MT2 melatonin receptors, which are G protein-coupled receptors that are expressed in various tissues including the brain, eyes, and gut. By activating these receptors, tasimelteon promotes the onset of sleep and improves the quality of sleep.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tasimelteon is a drug used to treat sleep disorders.\n2. Tasimelteon binds to and activates melatonin receptors in the brain.\n3. Specifically, tasimelteon binds to MT1 and MT2 melatonin receptors.\n4. MT1 and MT2 melatonin receptors are G protein-coupled receptors expressed in various tissues including the brain, eyes, and gut.\n5. Activating these receptors with tasimelteon promotes the onset of sleep and improves the quality of sleep.",
    "vicuna-13b_fact": [
      "Tasimelteon is a drug used to treat sleep disorders.",
      "Tasimelteon binds to and activates melatonin receptors in the brain.",
      "Specifically, tasimelteon binds to MT1 and MT2 melatonin receptors.",
      "MT1 and MT2 melatonin receptors are G protein-coupled receptors expressed in various tissues including the brain, eyes, and gut.",
      "Activating these receptors with tasimelteon promotes the onset of sleep and improves the quality of sleep."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 552,
    "user_query": "Is zyxin a focal adhesion protein?",
    "vicuna-13b_response": "Zyxin is a protein that is involved in cell adhesion and migration. It is a component of the adherens junction complex, which is a structure that forms between cells and helps to maintain tissue integrity. Zyxin is also involved in the formation of focal adhesions, which are structures that form when cells adhere to the extracellular matrix. Focal adhesions are important for cell survival and migration, and they play a role in the development of tissues and organs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Zyxin is a protein that is involved in cell adhesion and migration.\n2. Zyxin is a component of the adherens junction complex.\n3. The adherens junction complex is a structure that forms between cells and helps to maintain tissue integrity.\n4. Zyxin is involved in the formation of focal adhesions.\n5. Focal adhesions play a role in the development of tissues and organs.",
    "vicuna-13b_fact": [
      "Zyxin is a protein that is involved in cell adhesion and migration.",
      "Zyxin is a component of the adherens junction complex.",
      "The adherens junction complex is a structure that forms between cells and helps to maintain tissue integrity.",
      "Zyxin is involved in the formation of focal adhesions.",
      "Focal adhesions play a role in the development of tissues and organs."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Zyxin is a component of the focal adhesion complex.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 556,
    "user_query": "Which RNA polymerase is used for the replication of viroids?",
    "vicuna-13b_response": "Viroids are small, single-stranded RNA molecules that replicate through a rolling-circle mechanism. They do not have a protein coat like other viruses, and therefore do not require a specific RNA polymerase for replication. Instead, viroids use the host cell's own RNA polymerase to transcribe their RNA into DNA, which can then be replicated by the host cell's DNA polymerase.\nRNA polymerase is an enzyme that synthesizes RNA from DNA templates. There are three main types of RNA polymerase: RNA polymerase I, II, and III. RNA polymerase I is responsible for transcribing ribosomal RNA and transfer RNA genes, while RNA polymerase II transcribes protein-coding genes and some non-coding RNAs. RNA polymerase III transcribes small RNAs such as tRNAs and 5S rRNA.\nSince viroids do not have a protein coat and do not require a specific RNA polymerase for replication, they can infect a wide range of host cells and do not rely on a specific type of RNA polymerase for replication.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Viroids are small, single-stranded RNA molecules that replicate through a rolling-circle mechanism.\n2. Viroids do not have a protein coat and therefore do not require a specific RNA polymerase for replication.\n3. Viroids use the host cell's own RNA polymerase to transcribe RNA into DNA.\n4. RNA polymerase is an enzyme that synthesizes RNA from DNA templates.\n5. There are three main types of RNA polymerase: RNA polymerase I, II, and III.",
    "vicuna-13b_fact": [
      "Viroids are small, single-stranded RNA molecules that replicate through a rolling-circle mechanism.",
      "Viroids do not have a protein coat and therefore do not require a specific RNA polymerase for replication.",
      "Viroids use the host cell's own RNA polymerase to transcribe RNA into DNA.",
      "RNA polymerase is an enzyme that synthesizes RNA from DNA templates.",
      "There are three main types of RNA polymerase: RNA polymerase I, II, and III."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Viroids use the host cell's own RNA polymerase to transcribe their RNA into a DNA template.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 559,
    "user_query": "What is known about Vancomycin dosing in neonates?",
    "vicuna-13b_response": "Vancomycin is an antibiotic that is commonly used to treat serious infections caused by gram-positive bacteria. However, the use of vancomycin in neonates is limited due to the potential for serious adverse effects.\nThe dosing of vancomycin in neonates is generally based on body weight, with the recommended dose ranging from 10 to 15 milligrams per kilogram of body weight, administered every 12 hours. However, the actual dosage may vary depending on the specific infection being treated and the neonate's renal function.\nIt is important to closely monitor neonates receiving vancomycin therapy for potential adverse effects, such as ototoxicity, nephrotoxicity, and infusion-related reactions. Neonates with renal impairment may be at increased risk for toxicity, and should receive the drug at the lower end of the dosing range, if at all.\nIn addition, vancomycin should be used with caution in neonates with a history of allergy to the drug, as severe reactions may occur.\nOverall, vancomycin dosing in neonates should be individualized based on the specific infection being treated, the neonate's renal function, and other individual factors. Close monitoring of the neonate's clinical response and potential adverse effects is essential.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Vancomycin is an antibiotic commonly used to treat serious infections caused by gram-positive bacteria.\n2. The use of vancomycin in neonates is limited due to the potential for serious adverse effects.\n3. The recommended dose of vancomycin in neonates ranges from 10 to 15 milligrams per kilogram of body weight, administered every 12 hours.\n4. Adverse effects of vancomycin can include ototoxicity, nephrotoxicity, and infusion-related reactions.\n5. Neonates with renal impairment may be at an increased risk for toxicity from vancomycin.",
    "vicuna-13b_fact": [
      "Vancomycin is an antibiotic commonly used to treat serious infections caused by gram-positive bacteria.",
      "The use of vancomycin in neonates is limited due to the potential for serious adverse effects.",
      "The recommended dose of vancomycin in neonates ranges from 10 to 15 milligrams per kilogram of body weight, administered every 12 hours.",
      "Adverse effects of vancomycin can include ototoxicity, nephrotoxicity, and infusion-related reactions.",
      "Neonates with renal impairment may be at an increased risk for toxicity from vancomycin."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The recommended dose of vancomycin in neonates ranges from 15 to 20 milligrams per kilogram of body weight, administered every 8 to 12 hours.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 562,
    "user_query": "Which antiepileptic drug is most strongly associated with spina bifida?",
    "vicuna-13b_response": "There is no antiepileptic drug that is strongly associated with spina bifida. Spina bifida is a congenital disorder that occurs during fetal development and is caused by a failure of the neural tube to close properly. It can lead to a range of physical and cognitive disabilities, including difficulty with movement and sensation in the lower part of the body.\nAntiepileptic drugs (AEDs) are used to treat epilepsy, a condition characterized by seizures or convulsions. AEDs work by reducing the frequency and severity of seizures. Some AEDs may be used to treat other conditions, such as migraines or neuropathic pain, but they are not used to treat spina bifida.\nIt is important to note that while AEDs may be used to treat seizures in people with spina bifida, they are not a treatment for the underlying disorder itself. Treatment for spina bifida depends on the severity of the condition and may include physical therapy, occupational therapy, and surgery, among other interventions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Spina bifida is a congenital disorder that occurs during fetal development due to the failure of the neural tube to close properly.\n2. Spina bifida can lead to a range of physical and cognitive disabilities, including difficulty with movement and sensation in the lower part of the body.\n3. Antiepileptic drugs (AEDs) are used to treat epilepsy, a condition characterized by seizures or convulsions.\n4. Some AEDs may be used to treat other conditions, such as migraines or neuropathic pain.\n5. Treatment for spina bifida may include physical therapy, occupational therapy, and surgery, among other interventions.",
    "vicuna-13b_fact": [
      "Spina bifida is a congenital disorder that occurs during fetal development due to the failure of the neural tube to close properly.",
      "Spina bifida can lead to a range of physical and cognitive disabilities, including difficulty with movement and sensation in the lower part of the body.",
      "Antiepileptic drugs (AEDs) are used to treat epilepsy, a condition characterized by seizures or convulsions.",
      "Some AEDs may be used to treat other conditions, such as migraines or neuropathic pain.",
      "Treatment for spina bifida may include physical therapy, occupational therapy, and surgery, among other interventions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 564,
    "user_query": "The drug JTV519 is derivative of which group of chemical compounds?",
    "vicuna-13b_response": "JTV519 is a derivative of the group of chemical compounds known as antibiotics. Specifically, it is a member of the oxazolidinone class of antibiotics, which also includes drugs such as linezolid and oxazepam. Antibiotics are a type of antimicrobial drug that target and destroy bacteria, preventing their growth and reproduction. JTV519 is used to treat infections caused by Gram-positive bacteria, such as streptococci and staphylococci.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. JTV519 is a derivative of the group of chemical compounds known as antibiotics.\n2. JTV519 is specifically a member of the oxazolidinone class of antibiotics.\n3. Linezolid and oxazepam are also part of the oxazolidinone class of antibiotics.\n4. Antibiotics are a type of antimicrobial drug that target and destroy bacteria.\n5. JTV519 is used to treat infections caused by Gram-positive bacteria, such as streptococci and staphylococci.",
    "vicuna-13b_fact": [
      "JTV519 is a derivative of the group of chemical compounds known as antibiotics.",
      "JTV519 is specifically a member of the oxazolidinone class of antibiotics.",
      "Linezolid and oxazepam are also part of the oxazolidinone class of antibiotics.",
      "Antibiotics are a type of antimicrobial drug that target and destroy bacteria.",
      "JTV519 is used to treat infections caused by Gram-positive bacteria, such as streptococci and staphylococci."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: JTV519 is a synthetic benzothiazepine derivative, not a derivative of the group of chemical compounds known as antibiotics.\n2. FALSE [correction]: JTV519 acts as a stabilizer of the ryanodine receptor and is not a member of the oxazolidinone class of antibiotics.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: JTV519 is a therapeutic compound for heart failure treatment, it is not used to treat infections.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 566,
    "user_query": "Oxantel is used for periodontitis treatment. How does it work?",
    "vicuna-13b_response": "Oxantel is a medicated toothpaste that is used for the treatment of periodontitis. It contains the active ingredient sodium chlorite, which works by reducing the numbers of bacteria in the mouth that are associated with gum disease.\nWhen you use Oxantel, the sodium chlorite in the toothpaste breaks down into hypochlorous acid, which is a strong antimicrobial agent. This helps to kill the bacteria that are causing the infection in your gums.\nIn addition to its antimicrobial properties, Oxantel also helps to remove plaque and tartar from your teeth, which can contribute to gum disease.\nIt's important to note that Oxantel is not a substitute for professional dental care. If you have periodontitis, it's important to see a dentist regularly for treatment and to follow their recommendations for oral hygiene.\nOverall, Oxantel works by reducing the numbers of bacteria in the mouth that are associated with gum disease, and it helps to remove plaque and tartar from the teeth. It is an effective treatment for periodontitis when used as directed by a dentist.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Oxantel is a medicated toothpaste used for the treatment of periodontitis.\n2. The active ingredient in Oxantel is sodium chlorite.\n3. Sodium chlorite in Oxantel breaks down into hypochlorous acid, a strong antimicrobial agent.\n4. Oxantel helps to remove plaque and tartar from the teeth.\n5. Oxantel is not a substitute for professional dental care and must be used as directed by a dentist.",
    "vicuna-13b_fact": [
      "Oxantel is a medicated toothpaste used for the treatment of periodontitis.",
      "The active ingredient in Oxantel is sodium chlorite.",
      "Sodium chlorite in Oxantel breaks down into hypochlorous acid, a strong antimicrobial agent.",
      "Oxantel helps to remove plaque and tartar from the teeth.",
      "Oxantel is not a substitute for professional dental care and must be used as directed by a dentist."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Oxantel is an anthelmintic drug used for the treatment of intestinal parasitic infections, not periodontitis.\n2. FALSE [correction]: Oxantel does not contain sodium chlorite. It is an anthelmintic agent.\n3. FALSE [correction]: Sodium chlorite is not present in Oxantel, hence, it does not break down into hypochlorous acid. \n4. FALSE [correction]: Oxantel is used to treat parasitic infections, not to remove plaque or tartar from teeth.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 568,
    "user_query": "What is the function of the protein encoded by the gene PABPC4?",
    "vicuna-13b_response": "The protein encoded by the gene PABPC4 is a RNA-binding protein that plays a role in the regulation of gene expression. Specifically, it is involved in the process of alternative splicing, which allows for the creation of multiple different versions of a single gene's product (in this case, a protein). PABPC4 binds to the introns (non-coding regions) of RNA molecules and helps to regulate the splicing process, ensuring that the correct exons (coding regions) are included in the final RNA product. Mutations in the PABPC4 gene have been linked to several diseases, including cancer and neurological disorders, suggesting that this protein plays an important role in maintaining proper cellular function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The gene PABPC4 encodes for a RNA-binding protein.\n2. The protein encoded by PABPC4 plays a role in the regulation of gene expression.\n3. This protein is involved in the process of alternative splicing.\n4. PABPC4 binds to the introns of RNA molecules to regulate the splicing process.\n5. Mutations in the PABPC4 gene have been linked to diseases including cancer and neurological disorders.",
    "vicuna-13b_fact": [
      "The gene PABPC4 encodes for a RNA-binding protein.",
      "The protein encoded by PABPC4 plays a role in the regulation of gene expression.",
      "This protein is involved in the process of alternative splicing.",
      "PABPC4 binds to the introns of RNA molecules to regulate the splicing process.",
      "Mutations in the PABPC4 gene have been linked to diseases including cancer and neurological disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: PABPC4 binds to the poly(A) tail of RNA molecules, not the introns, to regulate processes like stability and translation efficiency.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 570,
    "user_query": "What is the mode of inheritance of Romano Ward long QT syndrome?",
    "vicuna-13b_response": "Romano-Ward syndrome, also known as Romano-Ward long QT syndrome, is a rare genetic disorder that affects the electrical activity of the heart. The mode of inheritance of this condition is autosomal dominant, which means that it is passed down from parent to child through one of the two copies of a gene located on an autosome (a non-sex chromosome).\nIn autosomal dominant inheritance, an individual has a 50% chance of inheriting the gene from a affected parent, and a 50% chance of inheriting it from an unaffected parent. If an individual inherits the gene, they will typically develop the condition, although the severity of the condition can vary from person to person.\nIt is important to note that genetics is a complex field and there can be variations and exceptions to the mode of inheritance of a condition. It is always best to consult with a healthcare professional for a proper diagnosis and genetic counseling.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Romano-Ward syndrome affects the electrical activity of the heart.\n2. The mode of inheritance for Romano-Ward syndrome is autosomal dominant.\n3. In autosomal dominant inheritance, an individual has a 50% chance of inheriting the gene from a parent.\n4. If an individual inherits the autosomal dominant gene for Romano-Ward syndrome, they will typically develop the condition.\n5. The severity of Romano-Ward syndrome can vary from person to person.",
    "vicuna-13b_fact": [
      "Romano-Ward syndrome affects the electrical activity of the heart.",
      "The mode of inheritance for Romano-Ward syndrome is autosomal dominant.",
      "In autosomal dominant inheritance, an individual has a 50% chance of inheriting the gene from a parent.",
      "If an individual inherits the autosomal dominant gene for Romano-Ward syndrome, they will typically develop the condition.",
      "The severity of Romano-Ward syndrome can vary from person to person."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 571,
    "user_query": "Which histone modifications have been associated to alternative splicing?",
    "vicuna-13b_response": "Several histone modifications have been associated with alternative splicing, which is a process by which a single gene can produce multiple transcripts with different exons included or excluded. Some of the histone modifications that have been linked to alternative splicing include:\n1. H3K36me3: This modification has been shown to be enriched at the boundaries of exons and introns, and it has been suggested to act as a marker for exon inclusion.\n2. H3K4me3: This modification has been shown to be enriched at the beginning of exons and it has been suggested to mark exon activation.\n3. H2BK5ac: This modification has been shown to be enriched at the boundaries of exons and introns, and it has been suggested to act as a marker for exon inclusion.\n4. H3K27me3: This modification has been shown to be enriched at the boundaries of exons and introns, and it has been suggested to act as a marker for exon inclusion.\n5. H3K36me3: This modification has been shown to be enriched at the boundaries of exons and introns, and it has been suggested to act as a marker for exon inclusion.\n6. H3K79me2: This modification has been shown to be enriched at the boundaries of exons and introns, and it has been suggested to act as a marker for exon inclusion.\nIt's important to note that these modifications are not mutually exclusive and they can be present in the same region, and also, the specific histone modification pattern in a region can change during different developmental stages or in response to different stimuli.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Several histone modifications have been associated with alternative splicing.\n2. H3K36me3, H3K4me3, H2BK5ac, H3K27me3, and H3K79me2 are histone modifications that have been shown to be enriched at the boundaries of exons and introns.\n3. H3K36me3, H3K4me3, H2BK5ac, H3K27me3, and H3K79me2 have been suggested to act as a marker for exon inclusion.\n4. These histone modifications can be present in the same region and are not mutually exclusive.\n5. The specific histone modification pattern in a region can change during different developmental stages or in response to different stimuli.",
    "vicuna-13b_fact": [
      "Several histone modifications have been associated with alternative splicing.",
      "H3K36me3, H3K4me3, H2BK5ac, H3K27me3, and H3K79me2 are histone modifications that have been shown to be enriched at the boundaries of exons and introns.",
      "H3K36me3, H3K4me3, H2BK5ac, H3K27me3, and H3K79me2 have been suggested to act as a marker for exon inclusion.",
      "These histone modifications can be present in the same region and are not mutually exclusive.",
      "The specific histone modification pattern in a region can change during different developmental stages or in response to different stimuli."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 575,
    "user_query": "What is the mechanism of action of decitabine?",
    "vicuna-13b_response": "Decitabine is a DNA hypomethylating agent, which means it works by altering the methylation status of DNA. Methylation is a process in which a methyl group is added to the DNA molecule, typically at the cytosine residue, resulting in the formation of 5-methylcytosine. This process is important for regulating gene expression and is involved in a variety of cellular processes, including cell growth and differentiation.\nDecitabine works by converting 5-methylcytosine back to cytosine, which can then be recognized by the cell's DNA repair machinery and replaced with the correct base, thymine. This process is called demethylation and it leads to a decrease in the overall methylation status of the DNA.\nDecitabine is used to treat a variety of hematological malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). It is thought to work by reversing the abnormal methylation patterns that are present in these diseases, leading to the re-expression of genes that are silenced by methylation and the correction of abnormal cell proliferation.\nIt is important to note that Decitabine is not a curative treatment and it is usually used in patients who are not candidates for intensive therapy or in patients who have relapsed after other treatments.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Decitabine is a DNA hypomethylating agent.\n2. Decitabine works by converting 5-methylcytosine back to cytosine, a process called demethylation.\n3. Demethylation leads to a decrease in the overall methylation status of the DNA.\n4. Decitabine is used to treat a variety of hematological malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).\n5. Decitabine is typically used in patients who are not candidates for intensive therapy or in patients who have relapsed after other treatments.",
    "vicuna-13b_fact": [
      "Decitabine is a DNA hypomethylating agent.",
      "Decitabine works by converting 5-methylcytosine back to cytosine, a process called demethylation.",
      "Demethylation leads to a decrease in the overall methylation status of the DNA.",
      "Decitabine is used to treat a variety of hematological malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).",
      "Decitabine is typically used in patients who are not candidates for intensive therapy or in patients who have relapsed after other treatments."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 576,
    "user_query": "Which gene is associated with the Mitchell-Riley syndrome?",
    "vicuna-13b_response": "Mitchell-Riley syndrome is a rare genetic disorder that is caused by mutations in the PAX9 gene. This gene provides instructions for making a protein that is essential for the development of the skeletal system, including the bones, cartilage, and connective tissue. Mutations in the PAX9 gene can disrupt the normal function of this protein, leading to the characteristic features of Mitchell-Riley syndrome, which include short stature, abnormalities of the ribs and spine, and other skeletal abnormalities.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mitchell-Riley syndrome is a rare genetic disorder.\n2. This syndrome is caused by mutations in the PAX9 gene.\n3. The PAX9 gene provides instructions for making a protein essential for the development of the skeletal system.\n4. Mutations in the PAX9 gene can disrupt the normal function of this protein.\n5. Some characteristic features of Mitchell-Riley syndrome include short stature, abnormalities of the ribs and spine, and other skeletal abnormalities.",
    "vicuna-13b_fact": [
      "Mitchell-Riley syndrome is a rare genetic disorder.",
      "This syndrome is caused by mutations in the PAX9 gene.",
      "The PAX9 gene provides instructions for making a protein essential for the development of the skeletal system.",
      "Mutations in the PAX9 gene can disrupt the normal function of this protein.",
      "Some characteristic features of Mitchell-Riley syndrome include short stature, abnormalities of the ribs and spine, and other skeletal abnormalities."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mitchell-Riley syndrome is caused by mutations in the RFX6 gene.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "vicuna-13b_response": "Yes, there is a link between the Aurora B kinase and the Polycomb protein Ring1B. Aurora B is a key regulator of mitosis, and it is involved in the formation of the mitotic spindle and the proper segregation of chromosomes during cell division. Ring1B is a member of the Polycomb group of proteins, which are involved in the regulation of gene expression and the maintenance of the cell's developmental state.\nStudies have shown that Ring1B interacts with and is phosphorylated by Aurora B. This interaction is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division. Ring1B also plays a role in the regulation of the Aurora B kinase, and it is thought to do so by modifying the activity of the protein or by controlling its localization.\nIn conclusion, there is a link between the Aurora B kinase and the Polycomb protein Ring1B, and their interaction is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Aurora B is a key regulator of mitosis and is involved in the formation of the mitotic spindle and the proper segregation of chromosomes during cell division.\n2. Ring1B is a member of the Polycomb group of proteins, which are involved in the regulation of gene expression and the maintenance of the cell's developmental state.\n3. Ring1B interacts with and is phosphorylated by Aurora B.\n4. The interaction between Ring1B and Aurora B is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division.\n5. Ring1B also plays a role in the regulation of the Aurora B kinase.",
    "vicuna-13b_fact": [
      "Aurora B is a key regulator of mitosis and is involved in the formation of the mitotic spindle and the proper segregation of chromosomes during cell division.",
      "Ring1B is a member of the Polycomb group of proteins, which are involved in the regulation of gene expression and the maintenance of the cell's developmental state.",
      "Ring1B interacts with and is phosphorylated by Aurora B.",
      "The interaction between Ring1B and Aurora B is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division.",
      "Ring1B also plays a role in the regulation of the Aurora B kinase."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 582,
    "user_query": "Name five programs for transcript quantification from RNASeq experiments",
    "vicuna-13b_response": "1. HISAT2\n2. STAR\n3. GSNAP\n4. Subread\n5. StringTie",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. HISAT2 is a program for transcript quantification from RNASeq experiments.\n2. STAR is a program for transcript quantification from RNASeq experiments.\n3. GSNAP is a program for transcript quantification from RNASeq experiments.\n4. Subread is a program for transcript quantification from RNASeq experiments.\n5. StringTie is a program for transcript quantification from RNASeq experiments.",
    "vicuna-13b_fact": [
      "HISAT2 is a program for transcript quantification from RNASeq experiments.",
      "STAR is a program for transcript quantification from RNASeq experiments.",
      "GSNAP is a program for transcript quantification from RNASeq experiments.",
      "Subread is a program for transcript quantification from RNASeq experiments.",
      "StringTie is a program for transcript quantification from RNASeq experiments."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: HISAT2 is a program for aligning sequencing reads during RNASeq experiments, not for transcript quantification.\n2. FALSE [correction]: STAR is a program for aligning sequencing reads from RNASeq experiments, not for transcript quantification.\n3. FALSE [correction]: GSNAP is a program for aligning sequencing reads from RNASeq experiments, not for transcript quantification.\n4. FALSE [correction]: Subread is a software package for read alignment and read counting in RNASeq experiments, not specifically for transcript quantification.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 587,
    "user_query": "List variants of the MC1R gene.",
    "vicuna-13b_response": "The MC1R gene, also known as the melanocortin 1 receptor gene, is a gene that plays a crucial role in determining the melanin pigmentation of an individual's skin, hair, and eyes. There are several known variants of the MC1R gene, including:\n1. rs1805087: This variant is associated with increased risk of skin cancer and decreased melanoma risk.\n2. rs2234753: This variant is associated with increased risk of skin cancer and decreased melanoma risk.\n3. rs12913832: This variant is associated with increased risk of skin cancer and decreased melanoma risk.\n4. rs762551: This variant is associated with increased risk of skin cancer and decreased melanoma risk.\n5. rs1799853: This variant is associated with increased risk of skin cancer and decreased melanoma risk.\n6. rs2070762: This variant is associated with increased risk of skin cancer and decreased melanoma risk.\n7. rs1805088: This variant is associated with increased risk of skin cancer and decreased melanoma risk.\n8. rs1799852: This variant is associated with increased risk of skin cancer and decreased melanoma risk.\n9. rs1805089: This variant is associated with increased risk of skin cancer and decreased melanoma risk.\n10. rs1799854: This variant is associated with increased risk of skin cancer and decreased melanoma risk.\nIt's important to note that these variants may have different effects on different populations and that the relationship between MC1R variants and pigmentation is complex and influenced by many other genetic and environmental factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The MC1R gene, also known as the melanocortin 1 receptor gene, plays a role in determining the melanin pigmentation of an individual's skin, hair, and eyes.\n2. There are several known variants of the MC1R gene.\n3. rs1805087 is a variant of the MC1R gene associated with increased risk of skin cancer and decreased melanoma risk.\n4. rs2234753 is a variant of the MC1R gene associated with increased risk of skin cancer and decreased melanoma risk.\n5. The relationship between MC1R variants and pigmentation is complex and influenced by many other genetic and environmental factors.",
    "vicuna-13b_fact": [
      "The MC1R gene, also known as the melanocortin 1 receptor gene, plays a role in determining the melanin pigmentation of an individual's skin, hair, and eyes.",
      "There are several known variants of the MC1R gene.",
      "rs1805087 is a variant of the MC1R gene associated with increased risk of skin cancer and decreased melanoma risk.",
      "rs2234753 is a variant of the MC1R gene associated with increased risk of skin cancer and decreased melanoma risk.",
      "The relationship between MC1R variants and pigmentation is complex and influenced by many other genetic and environmental factors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: rs1805087 is a variant of the MC1R gene associated with increased risk of skin cancer and increased melanoma risk.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 589,
    "user_query": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?",
    "vicuna-13b_response": "Heterozygous mutations of the BSCL2 gene have been associated with a variety of phenotypes, including:\n1. Neurodevelopmental disorders: Heterozygous mutations in BSCL2 have been identified in individuals with neurodevelopmental disorders such as intellectual disability, autism spectrum disorder, and attention deficit hyperactivity disorder.\n2. Speech and language impairment: Individuals with heterozygous mutations in BSCL2 may have difficulty with speech and language development, including expressive language, receptive language, and social communication.\n3. Epilepsy: Heterozygous mutations in BSCL2 have been linked to an increased risk of epilepsy, particularly in individuals with neurodevelopmental disorders.\n4. Motor impairment: Heterozygous mutations in BSCL2 have been associated with motor impairment, including hypotonia, hypertonia, and ataxia.\n5. Ocular abnormalities: Some heterozygous mutations in BSCL2 have been associated with ocular abnormalities, including strabismus, nystagmus, and optic nerve hypoplasia.\nIt is important to note that the specific phenotypes associated with heterozygous mutations in BSCL2 can vary widely depending on the specific mutation and the individual's overall genetic background. Additionally, the severity of the phenotypes can vary widely, with some individuals having mild symptoms while others may have more severe impairments.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Heterozygous mutations of the BSCL2 gene have been associated with neurodevelopmental disorders.\n2. These mutations have also been linked with speech and language impairment.\n3. An increased risk of epilepsy is associated with heterozygous mutations of the BSCL2 gene.\n4. Heterozygous mutations in BSCL2 can cause motor impairment.\n5. Some heterozygous mutations in BSCL2 have been associated with ocular abnormalities.",
    "vicuna-13b_fact": [
      "Heterozygous mutations of the BSCL2 gene have been associated with neurodevelopmental disorders.",
      "These mutations have also been linked with speech and language impairment.",
      "An increased risk of epilepsy is associated with heterozygous mutations of the BSCL2 gene.",
      "Heterozygous mutations in BSCL2 can cause motor impairment.",
      "Some heterozygous mutations in BSCL2 have been associated with ocular abnormalities."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 592,
    "user_query": "What is the genomic structure of the FAA (FANCA) gene?",
    "vicuna-13b_response": "The genomic structure of the FAA (FANCA) gene is a complex one, with multiple exons and introns. The gene is located on the long arm of chromosome X at position Xp11.22-23.\nThe FAA (FANCA) gene spans approximately 1.5 megabases and consists of 28 exons. The gene produces a protein of 724 amino acids in length. The protein encoded by the FAA (FANCA) gene is involved in DNA repair and is part of the Fanconi anemia pathway, which plays a critical role in maintaining genome stability.\nMutations in the FAA (FANCA) gene have been associated with Fanconi anemia, a rare genetic disorder characterized by bone marrow failure, developmental abnormalities, and an increased risk of cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The FAA (FANCA) gene is located on the long arm of chromosome X at position Xp11.22-23.\n2. The FAA (FANCA) gene spans approximately 1.5 megabases and consists of 28 exons.\n3. The FAA (FANCA) gene produces a protein of 724 amino acids in length.\n4. The protein encoded by the FAA (FANCA) gene is involved in DNA repair and is part of the Fanconi anemia pathway.\n5. Mutations in the FAA (FANCA) gene have been associated with Fanconi anemia.",
    "vicuna-13b_fact": [
      "The FAA (FANCA) gene is located on the long arm of chromosome X at position Xp11.22-23.",
      "The FAA (FANCA) gene spans approximately 1.5 megabases and consists of 28 exons.",
      "The FAA (FANCA) gene produces a protein of 724 amino acids in length.",
      "The protein encoded by the FAA (FANCA) gene is involved in DNA repair and is part of the Fanconi anemia pathway.",
      "Mutations in the FAA (FANCA) gene have been associated with Fanconi anemia."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The FAA (FANCA) gene is located on the long arm of chromosome 16 at position 16q24.3.\n2. FALSE [correction]: The FAA (FANCA) gene spans approximately 43 kilobases and consists of 43 exons.\n3. FALSE [correction]: The FAA (FANCA) gene produces a protein of 1455 amino acids in length.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 593,
    "user_query": "What is Snord116?",
    "vicuna-13b_response": "I'm sorry, but I am not familiar with the term \"Snord116.\" It is possible that it is a term that is specific to a certain field or context, or that it is a misspelling or variation of a word. Can you provide any additional context or information that might help me understand what you are asking about?",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 594,
    "user_query": "What is the functional role of the protein Drp1?",
    "vicuna-13b_response": "The protein Drp1, also known as the dynamin-related protein 1, is a key player in the regulation of mitochondrial dynamics. Mitochondria are organelles found in most eukaryotic cells that are responsible for generating energy for the cell through a process called cellular respiration.\nDrp1 is a GTPase, a type of enzyme that can bind and hydrolyze GTP, a molecule that plays a key role in many cellular processes. Drp1 is involved in the fission of mitochondria, which is the process by which mitochondria divide into smaller, more compact mitochondria. This process is important for maintaining the health and function of mitochondria, as well as for regulating their number and size.\nIn addition to its role in mitochondrial fission, Drp1 is also involved in the transport of proteins and RNA between mitochondria and the cytosol, the fluid inside the cell that surrounds the organelles. This transport process is important for maintaining the proper function and communication of mitochondria with the rest of the cell.\nOverall, the functional role of Drp1 is to regulate the dynamics of mitochondria, which is essential for maintaining the health and function of these organelles and the cells that they power.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The protein Drp1, also known as the dynamin-related protein 1, is involved in the regulation of mitochondrial dynamics.\n2. Mitochondria are organelles found in most eukaryotic cells that are responsible for generating energy for the cell through cellular respiration.\n3. Drp1 is a GTPase, a type of enzyme that can bind and hydrolyze GTP.\n4. Drp1 participates in the fission of mitochondria, which is the process by which mitochondria divide into smaller mitochondria.\n5. Drp1 is also involved in the transport of proteins and RNA between mitochondria and the cytosol.",
    "vicuna-13b_fact": [
      "The protein Drp1, also known as the dynamin-related protein 1, is involved in the regulation of mitochondrial dynamics.",
      "Mitochondria are organelles found in most eukaryotic cells that are responsible for generating energy for the cell through cellular respiration.",
      "Drp1 is a GTPase, a type of enzyme that can bind and hydrolyze GTP.",
      "Drp1 participates in the fission of mitochondria, which is the process by which mitochondria divide into smaller mitochondria.",
      "Drp1 is also involved in the transport of proteins and RNA between mitochondria and the cytosol."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 595,
    "user_query": "Which is the genetic cause for the development of Fanconi anemia complementation group D1?",
    "vicuna-13b_response": "Fanconi anemia (FA) is a rare genetic disorder characterized by bone marrow failure, developmental abnormalities, and an increased risk of cancer. There are eight complementation groups (A-H) of FA, and each is caused by a different genetic mutation.\nFanconi anemia complementation group D1 (FA-D1) is caused by a mutation in the FANCD1 gene. The FANCD1 gene provides instructions for making a protein that is essential for the proper function of the FA pathway, which helps repair damaged DNA.\nMutations in the FANCD1 gene lead to a deficiency in the FANCD1 protein, which disrupts the FA pathway and can cause the symptoms of FA-D1. These symptoms can include bone marrow failure, developmental delays, and an increased risk of cancer, particularly leukemia.\nOverall, the genetic cause of FA-D1 is a mutation in the FANCD1 gene, which leads to a deficiency in the FANCD1 protein and disrupts the FA pathway.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fanconi anemia (FA) is a rare genetic disorder characterized by bone marrow failure, developmental abnormalities, and an increased risk of cancer.\n2. There are eight complementation groups (A-H) of FA, each caused by a different genetic mutation.\n3. Fanconi anemia complementation group D1 (FA-D1) is caused by a mutation in the FANCD1 gene.\n4. The FANCD1 gene provides instructions for making a protein that is essential for the FA pathway, which helps repair damaged DNA.\n5. Mutations in the FANCD1 gene lead to a deficiency in the FANCD1 protein, which disrupts the FA pathway and can cause the symptoms of FA-D1.",
    "vicuna-13b_fact": [
      "Fanconi anemia (FA) is a rare genetic disorder characterized by bone marrow failure, developmental abnormalities, and an increased risk of cancer.",
      "There are eight complementation groups (A-H) of FA, each caused by a different genetic mutation.",
      "Fanconi anemia complementation group D1 (FA-D1) is caused by a mutation in the FANCD1 gene.",
      "The FANCD1 gene provides instructions for making a protein that is essential for the FA pathway, which helps repair damaged DNA.",
      "Mutations in the FANCD1 gene lead to a deficiency in the FANCD1 protein, which disrupts the FA pathway and can cause the symptoms of FA-D1."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: There are at least 22 recognized complementation groups of FA, not just eight (A-W, except for G, I, J, O, U, and V).\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 596,
    "user_query": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?",
    "vicuna-13b_response": "Calsequestrin 2 (CASQ2) is a gene that encodes for a protein that plays a role in the regulation of calcium release in muscle cells. Mutations in the CASQ2 gene have been linked to several diseases, including:\n1. Hypertrophic cardiomyopathy (HCM): HCM is a genetic heart condition that affects the thickness of the heart muscle. Mutations in the CASQ2 gene have been found to cause HCM in some cases.\n2. Familial atrial fibrillation: Atrial fibrillation is a type of irregular heartbeat that can increase the risk of stroke and heart failure. Mutations in the CASQ2 gene have been associated with an increased risk of atrial fibrillation in some families.\n3. Becker muscular dystrophy (BMD): BMD is a genetic disorder that affects muscle strength and function. Mutations in the CASQ2 gene have been found to cause BMD, which is a milder form of muscular dystrophy compared to Duchenne muscular dystrophy.\n4. Limb-girdle muscular dystrophy type 1B (LGMD1B): LGMD1B is a genetic disorder that affects muscle strength and function. Mutations in the CASQ2 gene have been found to cause LGMD1B, which is a subtype of limb-girdle muscular dystrophy.\nIt's important to note that these are not the only diseases caused by mutations in the CASQ2 gene, and additional research may identify additional conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Calsequestrin 2 (CASQ2) is a gene that regulates the release of calcium in muscle cells.\n2. Mutations in the CASQ2 gene have been linked to Hypertrophic cardiomyopathy.\n3. CASQ2 gene mutations can cause Familial atrial fibrillation.\n4. Becker muscular dystrophy can be caused by mutations in the CASQ2 gene.\n5. Limb-girdle muscular dystrophy type 1B (LGMD1B) can also be caused by mutations in the CASQ2 gene.",
    "vicuna-13b_fact": [
      "Calsequestrin 2 (CASQ2) is a gene that regulates the release of calcium in muscle cells.",
      "Mutations in the CASQ2 gene have been linked to Hypertrophic cardiomyopathy.",
      "CASQ2 gene mutations can cause Familial atrial fibrillation.",
      "Becker muscular dystrophy can be caused by mutations in the CASQ2 gene.",
      "Limb-girdle muscular dystrophy type 1B (LGMD1B) can also be caused by mutations in the CASQ2 gene."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mutations in the CASQ2 gene have been linked to Catecholaminergic Polymorphic Ventricular Tachycardia, not Hypertrophic cardiomyopathy.\n3. TRUE\n4. FALSE [correction]: Becker muscular dystrophy is caused by mutations in the DMD gene, not the CASQ2 gene.\n5. FALSE [correction]: Limb-girdle muscular dystrophy type 1B (LGMD1B) is caused by mutations in the LMNA gene, not the CASQ2 gene.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "vicuna-13b_response": "Non-canonical sequence motifs are sequence patterns that deviate from the typical splice site consensus sequence. In vertebrates, the most frequent non-canonical sequence motifs at the donor and acceptor splice sites are as follows:\nAt the donor splice site:\n1. The presence of a purine at the -3 position, immediately upstream of the splice site.\n2. The presence of a pyrimidine at the +1 position, immediately downstream of the splice site.\n3. The presence of a guanine at the +2 position, immediately downstream of the splice site.\nAt the acceptor splice site:\n1. The presence of a pyrimidine at the -3 position, immediately upstream of the splice site.\n2. The presence of a purine at the +1 position, immediately downstream of the splice site.\n3. The presence of a guanine at the +2 position, immediately downstream of the splice site.\nIt is important to note that these non-canonical sequence motifs are not exclusive to vertebrates, but are also observed in other organisms. Additionally, the presence of these motifs does not guarantee that a particular sequence will be included in the final mRNA transcript, as other factors such as the presence of regulatory elements and RNA-binding proteins can also influence the splicing process.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Non-canonical sequence motifs are sequence patterns that deviate from the typical splice site consensus sequence. \n2. The most frequent non-canonical sequence motifs at the donor splice site in vertebrates include the presence of a purine at the -3 position, a pyrimidine at the +1 position, and a guanine at the +2 position.\n3. The most frequent non-canonical sequence motifs at the acceptor splice site in vertebrates include the presence of a pyrimidine at the -3 position, a purine at the +1 position, and a guanine at the +2 position.\n4. The non-canonical sequence motifs are not exclusive to vertebrates.\n5. The presence of these motifs does not guarantee that a particular sequence will be included in the final mRNA transcript.",
    "vicuna-13b_fact": [
      "Non-canonical sequence motifs are sequence patterns that deviate from the typical splice site consensus sequence.",
      "The most frequent non-canonical sequence motifs at the donor splice site in vertebrates include the presence of a purine at the -3 position, a pyrimidine at the +1 position, and a guanine at the +2 position.",
      "The most frequent non-canonical sequence motifs at the acceptor splice site in vertebrates include the presence of a pyrimidine at the -3 position, a purine at the +1 position, and a guanine at the +2 position.",
      "The non-canonical sequence motifs are not exclusive to vertebrates.",
      "The presence of these motifs does not guarantee that a particular sequence will be included in the final mRNA transcript."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 602,
    "user_query": "Which are the Atg8 homologs in human?",
    "vicuna-13b_response": "In humans, the ATG8 gene family consists of three members: ATG8, ATG8-2, and ATG8-3. These genes encode proteins that are structurally and functionally similar to the yeast autophagy-related protein Atg8.\nATG8 is a ubiquitin-like protein that is involved in the formation of autophagosomes, which are the double-membrane vesicles that enclose the material to be degraded during autophagy. ATG8 is also involved in the regulation of the autophagy process, and it has been shown to interact with other autophagy-related proteins such as ATG5 and ATG12.\nATG8-2 and ATG8-3 are also ubiquitin-like proteins that are involved in autophagy. ATG8-2 is required for the formation of the phagophore, which is the initial stage of the autophagosome, while ATG8-3 is involved in the maturation of the autophagosome.\nOverall, the ATG8 gene family plays important roles in the regulation and execution of autophagy in humans, and mutations in these genes have been linked to various diseases, including neurodegenerative disorders and cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The ATG8 gene family in humans consists of three members: ATG8, ATG8-2, and ATG8-3.\n2. ATG8 is a ubiquitin-like protein involved in the formation of autophagosomes.\n3. ATG8 interacts with other autophagy-related proteins such as ATG5 and ATG12.\n4. ATG8-2 and ATG8-3 are also involved in autophagy, with ATG8-2 required for the formation of the phagophore and ATG8-3 involved in the maturation of the autophagosome.\n5. Mutations in the ATG8 gene family have been linked to various diseases, including neurodegenerative disorders and cancer.",
    "vicuna-13b_fact": [
      "The ATG8 gene family in humans consists of three members: ATG8, ATG8-2, and ATG8-3.",
      "ATG8 is a ubiquitin-like protein involved in the formation of autophagosomes.",
      "ATG8 interacts with other autophagy-related proteins such as ATG5 and ATG12.",
      "ATG8-2 and ATG8-3 are also involved in autophagy, with ATG8-2 required for the formation of the phagophore and ATG8-3 involved in the maturation of the autophagosome.",
      "Mutations in the ATG8 gene family have been linked to various diseases, including neurodegenerative disorders and cancer."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The ATG8 gene family in humans consists of several members such as MAP1LC3A, MAP1LC3B, MAP1LC3C, GABARAP, GABARAPL1, and GABARAPL2, not ATG8, ATG8-2, and ATG8-3.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 606,
    "user_query": "Which is the molecular mechanism underlying K-ras alterations in carcinomas?",
    "vicuna-13b_response": "K-ras is a gene that encodes a small GTPase protein that plays a role in cell signaling. Alterations in the K-ras gene have been found to be associated with the development and progression of certain types of cancer, including carcinomas.\nThe molecular mechanism underlying K-ras alterations in carcinomas is not fully understood, but it is thought to involve mutations or amplifications in the K-ras gene. These alterations can lead to increased activity of the K-ras protein, which can promote cell proliferation and inhibit programmed cell death (apoptosis), leading to the development and progression of cancer.\nIt is important to note that K-ras alterations are not specific to carcinomas and can be found in other types of cancer as well. Additionally, other genetic and epigenetic alterations are often present in carcinomas, and these alterations may work together to promote the development and progression of the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. K-ras is a gene that encodes a small GTPase protein that plays a role in cell signaling.\n2. Alterations in the K-ras gene have been found to be associated with the development and progression of certain types of cancer, including carcinomas.\n3. The molecular mechanism underlying K-ras alterations in carcinomas involves mutations or amplifications in the K-ras gene.\n4. K-ras alterations can lead to increased activity of the K-ras protein, promoting cell proliferation and inhibiting programmed cell death (apoptosis).\n5. K-ras alterations are not specific to carcinomas and can be found in other types of cancer as well.",
    "vicuna-13b_fact": [
      "K-ras is a gene that encodes a small GTPase protein that plays a role in cell signaling.",
      "Alterations in the K-ras gene have been found to be associated with the development and progression of certain types of cancer, including carcinomas.",
      "The molecular mechanism underlying K-ras alterations in carcinomas involves mutations or amplifications in the K-ras gene.",
      "K-ras alterations can lead to increased activity of the K-ras protein, promoting cell proliferation and inhibiting programmed cell death (apoptosis).",
      "K-ras alterations are not specific to carcinomas and can be found in other types of cancer as well."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 607,
    "user_query": "Is microRNA(miRNA) 30 involved in post-ischemic cardiac remodeling?",
    "vicuna-13b_response": "Yes, microRNA (miRNA) 30 has been shown to be involved in post-ischemic cardiac remodeling. miRNA 30 is a microRNA that has been shown to play a role in various cellular processes, including cell proliferation, differentiation, and apoptosis. In the context of post-ischemic cardiac remodeling, miRNA 30 has been shown to regulate the expression of genes involved in fibrosis, inflammation, and remodeling of the heart tissue following an ischemic event, such as a heart attack.\nSeveral studies have shown that miRNA 30 is upregulated following an ischemic event, and that this upregulation is associated with increased fibrosis and inflammation in the heart tissue. Additionally, miRNA 30 has been shown to regulate the expression of genes involved in the remodeling of the heart tissue, including genes involved in the development of fibrosis and inflammation.\nOverall, the evidence suggests that miRNA 30 plays a role in post-ischemic cardiac remodeling by regulating the expression of genes involved in fibrosis, inflammation, and remodeling of the heart tissue. Further research is needed to fully understand the role of miRNA 30 in this process and to develop potential therapeutic strategies targeting miRNA 30 for the treatment of post-ischemic cardiac remodeling.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MicroRNA (miRNA) 30 is involved in post-ischemic cardiac remodeling.\n2. miRNA 30 plays a role in various cellular processes, including cell proliferation, differentiation, and apoptosis.\n3. miRNA 30 regulates the expression of genes involved in fibrosis, inflammation, and remodeling of the heart tissue following an ischemic event, such as a heart attack.\n4. miRNA 30 is upregulated following an ischemic event, and this upregulation is associated with increased fibrosis and inflammation in the heart tissue.\n5. Further research is needed to fully understand the role of miRNA 30 in post-ischemic cardiac remodeling.",
    "vicuna-13b_fact": [
      "MicroRNA (miRNA) 30 is involved in post-ischemic cardiac remodeling.",
      "miRNA 30 plays a role in various cellular processes, including cell proliferation, differentiation, and apoptosis.",
      "miRNA 30 regulates the expression of genes involved in fibrosis, inflammation, and remodeling of the heart tissue following an ischemic event, such as a heart attack.",
      "miRNA 30 is upregulated following an ischemic event, and this upregulation is associated with increased fibrosis and inflammation in the heart tissue.",
      "Further research is needed to fully understand the role of miRNA 30 in post-ischemic cardiac remodeling."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 613,
    "user_query": "How is myotonic dystrophy inherited?",
    "vicuna-13b_response": "Myotonic dystrophy is inherited in an autosomal dominant pattern, which means that a person has a 50% chance of inheriting the gene from an affected parent. The gene that causes myotonic dystrophy is located on chromosome 19 and is called the DMPK gene.\nWhen a person with myotonic dystrophy has a child, they have a 50% chance of passing on the affected gene to their child. If the child inherits the affected gene, they will develop the condition. If the child does not inherit the affected gene, they will not develop the condition, but they can still pass it on to their own children in the future.\nIt's important to note that myotonic dystrophy can also be inherited in an autosomal recessive pattern, but this is much less common. In this case, a person must inherit two copies of the affected gene, one from each parent, in order to develop the condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Myotonic dystrophy is primarily inherited in an autosomal dominant pattern.\n2. A person with myotonic dystrophy has a 50% chance of passing the affected gene to their child.\n3. The gene that causes myotonic dystrophy, the DMPK gene, is located on chromosome 19.\n4. If a child does not inherit the affected gene, they will not develop the condition but they can pass it on to their own children.\n5. Myotonic dystrophy can also be inherited in an autosomal recessive pattern, though this is less common.",
    "vicuna-13b_fact": [
      "Myotonic dystrophy is primarily inherited in an autosomal dominant pattern.",
      "A person with myotonic dystrophy has a 50% chance of passing the affected gene to their child.",
      "The gene that causes myotonic dystrophy, the DMPK gene, is located on chromosome 19.",
      "If a child does not inherit the affected gene, they will not develop the condition but they can pass it on to their own children.",
      "Myotonic dystrophy can also be inherited in an autosomal recessive pattern, though this is less common."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: If a child does not inherit the affected gene, they will not develop the condition or pass it on to their own children.\n5. FALSE [correction]: Myotonic dystrophy is not inherited in an autosomal recessive manner. It's primarily inherited in an autosomal dominant pattern.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 615,
    "user_query": "Which are the mammalian orthologs of Drosophila Yki?",
    "vicuna-13b_response": "Drosophila Yki is a protein that plays a role in the regulation of the immune response in fruit flies. Mammalian orthologs of Drosophila Yki are proteins that have similar functions in mammals.\nOne mammalian ortholog of Drosophila Yki is the protein known as \"NF-kappaB essential modulator\" (NEMO), which is also known as \"IKK-gamma\" or \"IKK-epsilon\". NEMO is a component of the NF-kappaB signaling pathway, which is a key regulator of the immune response in mammals.\nAnother mammalian ortholog of Drosophila Yki is the protein known as \"TANK-binding kinase 1\" (TBK1), which is also involved in the regulation of the immune response.\nIt is important to note that while these proteins have similar functions to Drosophila Yki, they may not be identical and may have different roles in the regulation of the immune response in different species.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Drosophila Yki is a protein that plays a role in the regulation of the immune response in fruit flies.\n2. One mammalian ortholog of Drosophila Yki is the protein known as \"NF-kappaB essential modulator\" (NEMO).\n3. NEMO is a component of the NF-kappaB signaling pathway, which is a key regulator of the immune response in mammals.\n4. Another mammalian ortholog of Drosophila Yki is the protein known as \"TANK-binding kinase 1\" (TBK1).\n5. While these proteins have similar functions to Drosophila Yki, they may not be identical and may have different roles in the regulation of the immune response in different species.",
    "vicuna-13b_fact": [
      "Drosophila Yki is a protein that plays a role in the regulation of the immune response in fruit flies.",
      "One mammalian ortholog of Drosophila Yki is the protein known as \"NF-kappaB essential modulator\" (NEMO).",
      "NEMO is a component of the NF-kappaB signaling pathway, which is a key regulator of the immune response in mammals.",
      "Another mammalian ortholog of Drosophila Yki is the protein known as \"TANK-binding kinase 1\" (TBK1).",
      "While these proteins have similar functions to Drosophila Yki, they may not be identical and may have different roles in the regulation of the immune response in different species."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 618,
    "user_query": "Does molindone affect body weight?",
    "vicuna-13b_response": "Molindone is an atypical antipsychotic medication that is used to treat schizophrenia and bipolar disorder. While it is not known to cause significant weight gain, it can cause metabolic changes that may affect body weight.\nSome studies have suggested that molindone may cause a small increase in body weight, particularly in the early stages of treatment. However, other studies have found no significant association between molindone and changes in body weight.\nIt is important to note that weight gain can be a side effect of some antipsychotic medications, and it is possible that molindone may cause weight gain in some individuals. However, the extent to which molindone affects body weight is not well established, and the impact of the medication on individual patients can vary widely.\nIf you are taking molindone and are concerned about weight gain, it is important to speak with your doctor. Your doctor can monitor your weight and adjust your treatment plan as needed to help you manage any side effects that may occur.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Molindone is an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder.\n2. Studies have suggested that molindone may cause a small increase in body weight, especially during the early stages of treatment.\n3. Other studies have found no significant association between molindone and changes in body weight.\n4. Weight gain can be a side effect of some antipsychotic medications.\n5. The extent to which molindone affects body weight is not well established.",
    "vicuna-13b_fact": [
      "Molindone is an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder.",
      "Studies have suggested that molindone may cause a small increase in body weight, especially during the early stages of treatment.",
      "Other studies have found no significant association between molindone and changes in body weight.",
      "Weight gain can be a side effect of some antipsychotic medications.",
      "The extent to which molindone affects body weight is not well established."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Molindone is a typical antipsychotic medication used to treat schizophrenia.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 622,
    "user_query": "Neurostimulation of which nucleus is used for treatment of dystonia?",
    "vicuna-13b_response": "Dystonia is a movement disorder characterized by involuntary muscle contractions and abnormal postures. One type of neurostimulation that is used to treat dystonia is deep brain stimulation (DBS) of the globus pallidus interna (GPi) nucleus.\nThe GPi is a subcortical structure located in the brain's basal ganglia, and it plays a key role in regulating movement. DBS of the GPi has been shown to be effective in reducing the symptoms of dystonia, particularly in cases where the symptoms are caused by excessive activity in the basal ganglia.\nThe procedure involves implanting a small electrode into the GPi nucleus, and then using a device similar to a pacemaker to deliver electrical impulses to the electrode. The electrical impulses can help to normalize the activity in the GPi and reduce the symptoms of dystonia.\nIt's important to note that DBS of the GPi is not a cure for dystonia, and it may not work for everyone. However, for many people with dystonia, DBS can provide significant relief from their symptoms and improve their quality of life.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dystonia is a movement disorder characterized by involuntary muscle contractions and abnormal postures.\n2. Deep brain stimulation (DBS) of the globus pallidus interna (GPi) nucleus is used to treat dystonia.\n3. The GPi is a subcortical structure located in the brain's basal ganglia.\n4. The procedure of DBS involves implanting a small electrode into the GPi nucleus and using a device to deliver electrical impulses to the electrode.\n5. Deep brain stimulation of the GPi is not a cure for dystonia, but can provide significant relief from symptoms and improve quality of life for many people.",
    "vicuna-13b_fact": [
      "Dystonia is a movement disorder characterized by involuntary muscle contractions and abnormal postures.",
      "Deep brain stimulation (DBS) of the globus pallidus interna (GPi) nucleus is used to treat dystonia.",
      "The GPi is a subcortical structure located in the brain's basal ganglia.",
      "The procedure of DBS involves implanting a small electrode into the GPi nucleus and using a device to deliver electrical impulses to the electrode.",
      "Deep brain stimulation of the GPi is not a cure for dystonia, but can provide significant relief from symptoms and improve quality of life for many people."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 625,
    "user_query": "Where is the angiogenin binding element  located?",
    "vicuna-13b_response": "Angiogenin is a protein that plays a role in the process of angiogenesis, which is the formation of new blood vessels from existing ones. The angiogenin binding element (ABE) is a specific region on the surface of endothelial cells, which are the cells that line the inside of blood vessels. The ABE is a protein complex that is composed of several different proteins, including fibronectin and integrin.\nThe ABE is involved in the process of angiogenesis by serving as a binding site for angiogenin, which is a potent angiogenic factor that promotes the growth and formation of new blood vessels. When angiogenin binds to the ABE, it activates a signaling cascade that leads to the formation of new blood vessels. This process is important for the growth and development of embryos, as well as for the repair of tissues and organs in the adult body.\nIn summary, the angiogenin binding element is located on the surface of endothelial cells and plays a critical role in the process of angiogenesis by serving as a binding site for angiogenin.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Angiogenin is a protein that plays a role in the process of angiogenesis.\n2. The angiogenin binding element (ABE) is a specific region on the surface of endothelial cells.\n3. Endothelial cells are the cells that line the inside of blood vessels.\n4. The ABE is a protein complex that is composed of several different proteins, including fibronectin and integrin.\n5. When angiogenin binds to the ABE, it activates a signaling cascade that leads to the formation of new blood vessels.",
    "vicuna-13b_fact": [
      "Angiogenin is a protein that plays a role in the process of angiogenesis.",
      "The angiogenin binding element (ABE) is a specific region on the surface of endothelial cells.",
      "Endothelial cells are the cells that line the inside of blood vessels.",
      "The ABE is a protein complex that is composed of several different proteins, including fibronectin and integrin.",
      "When angiogenin binds to the ABE, it activates a signaling cascade that leads to the formation of new blood vessels."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 626,
    "user_query": "Which proteins cause cytoplasmic sequestration of NF-kB?",
    "vicuna-13b_response": "Cytoplasmic sequestration of NF-kB refers to the process by which certain proteins bind to NF-kB and prevent its translocation to the nucleus, where it plays a role in regulating gene expression. There are several proteins that can cause cytoplasmic sequestration of NF-kB, including:\n1. IkB proteins: IkB proteins are a family of proteins that can bind to NF-kB and prevent its translocation to the nucleus. There are several different IkB proteins, including IkBα, IkBβ, and IkBγ.\n2. p100: p100 is a protein that can bind to NF-kB and inhibit its transcriptional activity.\n3. p50: p50 is a subunit of NF-kB that can bind to DNA and regulate gene expression. However, p50 can also bind to other proteins, such as IkBα, and prevent NF-kB translocation to the nucleus.\n4. Rel proteins: Rel proteins are a family of transcription factors that can bind to DNA and regulate gene expression. Some Rel proteins, such as RelA, can also bind to NF-kB and prevent its translocation to the nucleus.\nOverall, the cytoplasmic sequestration of NF-kB is a complex process that is regulated by a variety of different proteins. Understanding the mechanisms that regulate NF-kB activity is important for understanding the role of NF-kB in cellular processes, such as inflammation and immune response.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cytoplasmic sequestration of NF-kB refers to the process by which certain proteins bind to NF-kB and prevent its translocation to the nucleus.\n2. IkB proteins, including IkBα, IkBβ, and IkBγ, can bind to NF-kB and prevent its translocation to the nucleus.\n3. p100 is a protein that can bind to NF-kB and inhibit its transcriptional activity.\n4. p50 can bind to other proteins, such as IkBα, and prevent NF-kB translocation to the nucleus.\n5. Some Rel proteins, such as RelA, can bind to NF-kB, preventing its translocation to the nucleus.",
    "vicuna-13b_fact": [
      "Cytoplasmic sequestration of NF-kB refers to the process by which certain proteins bind to NF-kB and prevent its translocation to the nucleus.",
      "IkB proteins, including IkBα, IkBβ, and IkBγ, can bind to NF-kB and prevent its translocation to the nucleus.",
      "p100 is a protein that can bind to NF-kB and inhibit its transcriptional activity.",
      "p50 can bind to other proteins, such as IkBα, and prevent NF-kB translocation to the nucleus.",
      "Some Rel proteins, such as RelA, can bind to NF-kB, preventing its translocation to the nucleus."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: p50 is a subunit of the NF-kB complex and does not bind to IkBα to prevent NF-kB translocation to the nucleus. It's IkBα that binds to NF-kB and prevent its translocation.\n5. FALSE [correction]: Rel proteins, such as RelA, are not binding to NF-kB to prevent its translocation, they are actually part of the NF-kB complex.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 627,
    "user_query": "What is the mode of inheritance of Marchesani syndrome?",
    "vicuna-13b_response": "Marchesani syndrome is a rare genetic disorder that is inherited in an autosomal recessive pattern. This means that an individual must inherit two copies of the gene responsible for the disorder, one from each parent, in order to develop the condition. If an individual has only one copy of the gene, they are a carrier of the disorder and may pass it on to their offspring, but they will not develop the condition themselves. The gene responsible for Marchesani syndrome has been identified as SLC22A3.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Marchesani syndrome is a rare genetic disorder.\n2. Marchesani syndrome is inherited in an autosomal recessive pattern.\n3. An individual must inherit two copies of the gene responsible for the disorder, one from each parent, in order to develop the condition. \n4. An individual with only one copy of the gene is a carrier of the disorder and may pass it on to their offspring.\n5. The gene responsible for Marchesani syndrome has been identified as SLC22A3.",
    "vicuna-13b_fact": [
      "Marchesani syndrome is a rare genetic disorder.",
      "Marchesani syndrome is inherited in an autosomal recessive pattern.",
      "An individual must inherit two copies of the gene responsible for the disorder, one from each parent, in order to develop the condition.",
      "An individual with only one copy of the gene is a carrier of the disorder and may pass it on to their offspring.",
      "The gene responsible for Marchesani syndrome has been identified as SLC22A3."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Marchesani syndrome is inherited in an autosomal dominant pattern.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The genes responsible for Marchesani syndrome are ADAMTS17 and ADAMTS10.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "vicuna-13b_response": "The event that results in the acetylation of S6K1 is the activation of the S6K1 kinase by the upstream kinase, such as mTOR. This leads to the phosphorylation of S6K1, which in turn results in its acetylation by acetyltransferase enzymes, such as CREB-binding protein (CBP) and p300. The acetylation of S6K1 modulates its activity and plays a role in regulating cellular metabolism and growth.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The activation of the S6K1 kinase by the upstream kinase, such as mTOR, results in the acetylation of S6K1.\n2. The process leads to the phosphorylation of S6K1.\n3. The acetylation of S6K1 is carried out by acetyltransferase enzymes, such as CREB-binding protein (CBP) and p300.\n4. Acetylation of S6K1 modulates its activity.\n5. The acetylation of S6K1 plays a role in regulating cellular metabolism and growth.",
    "vicuna-13b_fact": [
      "The activation of the S6K1 kinase by the upstream kinase, such as mTOR, results in the acetylation of S6K1.",
      "The process leads to the phosphorylation of S6K1.",
      "The acetylation of S6K1 is carried out by acetyltransferase enzymes, such as CREB-binding protein (CBP) and p300.",
      "Acetylation of S6K1 modulates its activity.",
      "The acetylation of S6K1 plays a role in regulating cellular metabolism and growth."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 630,
    "user_query": "List angiocrine factors",
    "vicuna-13b_response": "Angiocrine factors are a group of signaling molecules that are secreted by endothelial cells and regulate the functions of other cells in the vicinity. These factors play a crucial role in the development, maintenance, and repair of various organs and tissues in the body. Here are some of the key angiocrine factors:\n1. Vascular endothelial growth factor (VEGF): VEGF is a potent angiocrine factor that promotes the formation of new blood vessels. It also regulates the permeability of blood vessels and the survival of endothelial cells.\n2. Angiotensin-converting enzyme 2 (ACE2): ACE2 is an angiocrine factor that regulates the renin-angiotensin-aldosterone system, which plays a crucial role in blood pressure regulation and fluid balance.\n3. Platelet-derived growth factor (PDGF): PDGF is a family of angiocrine factors that stimulate the proliferation and differentiation of vascular smooth muscle cells, pericytes, and endothelial cells.\n4. Fibroblast growth factor 2 (FGF-2): FGF-2 is an angiocrine factor that promotes the survival and proliferation of endothelial cells, smooth muscle cells, and pericytes.\n5. Hepatocyte growth factor (HGF): HGF is an angiocrine factor that promotes the proliferation and differentiation of endothelial cells, smooth muscle cells, and pericytes. It also regulates the formation of new blood vessels.\n6. Thrombopoietin (TPO): TPO is an angiocrine factor that regulates the production of platelets by the bone marrow. It also promotes the survival and function of platelets.\nOverall, angiocrine factors play a crucial role in the regulation of various physiological processes, including blood vessel formation, blood pressure regulation, tissue repair, and platelet production.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Angiocrine factors are a group of signaling molecules secreted by endothelial cells.\n2. Vascular endothelial growth factor (VEGF) promotes the formation of new blood vessels.\n3. Angiotensin-converting enzyme 2 (ACE2) regulates the renin-angiotensin-aldosterone system, which plays a role in blood pressure regulation and fluid balance.\n4. Platelet-derived growth factor (PDGF) stimulates the proliferation and differentiation of vascular smooth muscle cells, pericytes, and endothelial cells.\n5. Hepatocyte growth factor (HGF) promotes the proliferation and differentiation of endothelial cells, smooth muscle cells, and pericytes.",
    "vicuna-13b_fact": [
      "Angiocrine factors are a group of signaling molecules secreted by endothelial cells.",
      "Vascular endothelial growth factor (VEGF) promotes the formation of new blood vessels.",
      "Angiotensin-converting enzyme 2 (ACE2) regulates the renin-angiotensin-aldosterone system, which plays a role in blood pressure regulation and fluid balance.",
      "Platelet-derived growth factor (PDGF) stimulates the proliferation and differentiation of vascular smooth muscle cells, pericytes, and endothelial cells.",
      "Hepatocyte growth factor (HGF) promotes the proliferation and differentiation of endothelial cells, smooth muscle cells, and pericytes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 631,
    "user_query": "What is protein carbamylation?",
    "vicuna-13b_response": "Protein carbamylation is a post-translational modification (PTM) that involves the addition of a carbamyl group (-CO-NH-) to a protein. This modification can occur on the side chains of amino acids such as lysine, arginine, and histidine, and is often seen in response to oxidative stress or inflammation. Protein carbamylation can affect protein function and stability, and has been implicated in a variety of diseases, including cancer and neurodegeneration. It can be detected by various techniques, such as mass spectrometry, and can be targeted therapeutically using small molecule inhibitors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Protein carbamylation is a post-translational modification that involves the addition of a carbamyl group to a protein.\n2. This modification can occur on the side chains of amino acids such as lysine, arginine, and histidine.\n3. Protein carbamylation is often seen in response to oxidative stress or inflammation.\n4. Protein carbamylation can affect protein function and stability.\n5. It is implicated in a variety of diseases, including cancer and neurodegeneration.",
    "vicuna-13b_fact": [
      "Protein carbamylation is a post-translational modification that involves the addition of a carbamyl group to a protein.",
      "This modification can occur on the side chains of amino acids such as lysine, arginine, and histidine.",
      "Protein carbamylation is often seen in response to oxidative stress or inflammation.",
      "Protein carbamylation can affect protein function and stability.",
      "It is implicated in a variety of diseases, including cancer and neurodegeneration."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "vicuna-13b_response": "Episodic ataxia type 6 (EA6) is a rare, inherited disorder that affects the nervous system and causes episodes of ataxia, which is a lack of coordination and balance. The cause of EA6 is a mutation in the CACNA1A gene, which provides instructions for making a protein called a voltage-gated calcium channel.\nThese channels play a critical role in the normal functioning of nerve cells, including the transmission of electrical signals that are important for movement and coordination. The mutation in the CACNA1A gene that causes EA6 leads to the production of an abnormal version of the protein, which disrupts the normal functioning of the voltage-gated calcium channels and can cause episodes of ataxia.\nEA6 is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Episodic ataxia type 6 (EA6) is a rare, inherited disorder.\n2. EA6 affects the nervous system and can cause a lack of coordination and balance.\n3. The cause of EA6 is a mutation in the CACNA1A gene.\n4. The CACNA1A gene provides instructions for making a protein called a voltage-gated calcium channel.\n5. EA6 is inherited in an autosomal recessive pattern, which means an individual must inherit two copies of the mutated gene to develop the condition.",
    "vicuna-13b_fact": [
      "Episodic ataxia type 6 (EA6) is a rare, inherited disorder.",
      "EA6 affects the nervous system and can cause a lack of coordination and balance.",
      "The cause of EA6 is a mutation in the CACNA1A gene.",
      "The CACNA1A gene provides instructions for making a protein called a voltage-gated calcium channel.",
      "EA6 is inherited in an autosomal recessive pattern, which means an individual must inherit two copies of the mutated gene to develop the condition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The cause of EA6 is currently unknown.\n4. TRUE\n5. FALSE [correction]: Episodic ataxia is typically inherited in an autosomal dominant pattern, which means an individual must inherit only one copy of the mutated gene to develop the condition.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 633,
    "user_query": "What is the main role of Ctf4 in dna replication?",
    "vicuna-13b_response": "Ctf4 is a protein that plays a crucial role in the DNA replication process in eukaryotic cells. The primary function of Ctf4 is to regulate the initiation of DNA replication by controlling the loading of the MCM helicase, which is responsible for unwinding the double helix and separating the two strands of DNA.\nCtf4 acts as a loader for the MCM helicase by recruiting and loading the helicase onto the DNA replication origin. It also helps to stabilize the MCM helicase on the DNA template, allowing it to continue unwinding the double helix and replicating the genome.\nIn addition to its role in DNA replication, Ctf4 has also been shown to play a role in the repair of damaged DNA, suggesting that it has a broader role in maintaining the integrity of the genome.\nOverall, Ctf4 is an essential protein that plays a critical role in the regulation of DNA replication and the maintenance of genome stability in eukaryotic cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ctf4 is a protein that plays a role in the DNA replication process in eukaryotic cells.\n2. The primary function of Ctf4 is to regulate the initiation of DNA replication.\n3. Ctf4 controls the loading of the MCM helicase, which is responsible for unwinding the double helix and separating the two strands of DNA.\n4. Ctf4 recruits and loads the MCM helicase onto the DNA replication origin.\n5. Ctf4 has also been shown to play a role in the repair of damaged DNA.",
    "vicuna-13b_fact": [
      "Ctf4 is a protein that plays a role in the DNA replication process in eukaryotic cells.",
      "The primary function of Ctf4 is to regulate the initiation of DNA replication.",
      "Ctf4 controls the loading of the MCM helicase, which is responsible for unwinding the double helix and separating the two strands of DNA.",
      "Ctf4 recruits and loads the MCM helicase onto the DNA replication origin.",
      "Ctf4 has also been shown to play a role in the repair of damaged DNA."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 634,
    "user_query": "Could Arimidex (anastrozole) cause hot flashes?",
    "vicuna-13b_response": "Arimidex (anastrozole) is a medication that is commonly used to treat breast cancer in postmenopausal women. It is a nonsteroidal aromatase inhibitor, which means that it works by reducing the production of estrogen in the body.\nWhile hot flashes are not a listed side effect of Arimidex, it is possible that the medication could cause this symptom in some women. Hot flashes are a common symptom of menopause, and they can also be caused by certain medications, including some breast cancer treatments.\nIf you are experiencing hot flashes while taking Arimidex, it is important to talk to your doctor. Your doctor may be able to adjust your medication or recommend other treatments to help manage your symptoms. In some cases, it may be possible to switch to a different medication that is less likely to cause hot flashes.\nIt is important to follow your doctor's instructions carefully and to report any side effects or concerns you may have while taking Arimidex. By working closely with your healthcare team, you can help ensure that you receive the best possible care and treatment for your condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Arimidex (anastrozole) is a medication used to treat breast cancer in postmenopausal women.\n2. Arimidex is a nonsteroidal aromatase inhibitor.\n3. Arimidex works by reducing the production of estrogen in the body.\n4. Hot flashes are a common symptom of menopause.\n5. Some medications, including some breast cancer treatments, can cause hot flashes.",
    "vicuna-13b_fact": [
      "Arimidex (anastrozole) is a medication used to treat breast cancer in postmenopausal women.",
      "Arimidex is a nonsteroidal aromatase inhibitor.",
      "Arimidex works by reducing the production of estrogen in the body.",
      "Hot flashes are a common symptom of menopause.",
      "Some medications, including some breast cancer treatments, can cause hot flashes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 635,
    "user_query": "What is the role of Inn1 in cytokinesis?",
    "vicuna-13b_response": "Inn1 is a protein that plays a critical role in the process of cytokinesis, which is the final stage of cell division. Cytokinesis is the process by which a cell divides into two daughter cells, and Inn1 is involved in the formation of the cleavage furrow, which is the physical separation between the two daughter cells.\nInn1 is a member of the INN1 family of proteins, which are involved in various cellular processes, including cell division, vesicle trafficking, and protein transport. Inn1 is localized to the endoplasmic reticulum (ER) and is involved in the formation of the contractile ring, which is a structure that forms around the equator of the cell and contracts to pull the cell apart during cytokinesis.\nSpecifically, Inn1 is involved in the assembly and function of the central spindle, which is a structure that forms during cytokinesis and is responsible for the separation of the chromosomes and the formation of the cleavage furrow. Inn1 interacts with other proteins involved in central spindle assembly, such as the kinase Cdc14, and is necessary for the proper positioning and function of the central spindle.\nMutations in Inn1 have been shown to disrupt cytokinesis and lead to cell division defects. Additionally, Inn1 has been shown to play a role in the proper localization and function of other proteins involved in cell division, such as the anaphase-promoting complex/cyclosome (APC/C), which is responsible for the initiation of anaphase and the proper progression of the cell cycle.\nOverall, Inn1 plays a critical role in the process of cytokinesis by participating in the formation of the contractile ring and the central spindle, and by interacting with other proteins involved in cell division.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Inn1 is a protein that plays a critical role in cytokinesis, the final stage of cell division.\n2. Inn1 is involved in the formation of the cleavage furrow, a process in cell division.\n3. The Inn1 protein is part of the INN1 family of proteins, which are involved in various cellular processes.\n4. Inn1 interacts with other proteins involved in central spindle assembly, such as the kinase Cdc14.\n5. Mutations in Inn1 have been shown to disrupt cytokinesis and lead to cell division defects.",
    "vicuna-13b_fact": [
      "Inn1 is a protein that plays a critical role in cytokinesis, the final stage of cell division.",
      "Inn1 is involved in the formation of the cleavage furrow, a process in cell division.",
      "The Inn1 protein is part of the INN1 family of proteins, which are involved in various cellular processes.",
      "Inn1 interacts with other proteins involved in central spindle assembly, such as the kinase Cdc14.",
      "Mutations in Inn1 have been shown to disrupt cytokinesis and lead to cell division defects."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 636,
    "user_query": "Which hormone deficiency is implicated in the Costello syndrome ?",
    "vicuna-13b_response": "The Costello syndrome is a rare genetic disorder that is caused by a deficiency of the hormone fibroblast growth factor 10 (FGF10). FGF10 is a protein that plays a crucial role in the development and maintenance of various tissues and organs in the body, including the heart, bones, and skin.\nIndividuals with Costello syndrome typically have a characteristic physical appearance, including short stature, a triangular face with a flat nose and low-set ears, and a thin, webbed neck. They may also have heart defects, skeletal abnormalities, and other medical problems.\nThe deficiency of FGF10 in Costello syndrome is caused by a mutation in the FGF10 gene, which is located on chromosome 10. This genetic mutation leads to reduced levels of FGF10 in the body, which in turn causes the characteristic features of the syndrome.\nThere is currently no cure for Costello syndrome, but treatment is focused on managing the symptoms and improving the quality of life for individuals with the condition. This may include surgery to correct heart defects, physical therapy to improve mobility and strength, and other medical interventions as needed.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Costello syndrome is a rare genetic disorder caused by a deficiency of the hormone fibroblast growth factor 10 (FGF10).\n2. FGF10 plays a crucial role in the development and maintenance of various tissues and organs in the body, including the heart, bones, and skin.\n3. Deficiency of FGF10 in Costello syndrome is caused by a mutation in the FGF10 gene, which is located on chromosome 10.\n4. Individuals with Costello syndrome typically have a characteristic physical appearance and may also have heart defects, skeletal abnormalities, and other medical problems.\n5. There is currently no cure for Costello syndrome, but treatment is focused on managing the symptoms and improving the quality of life for individuals with the condition.",
    "vicuna-13b_fact": [
      "Costello syndrome is a rare genetic disorder caused by a deficiency of the hormone fibroblast growth factor 10 (FGF10).",
      "FGF10 plays a crucial role in the development and maintenance of various tissues and organs in the body, including the heart, bones, and skin.",
      "Deficiency of FGF10 in Costello syndrome is caused by a mutation in the FGF10 gene, which is located on chromosome 10.",
      "Individuals with Costello syndrome typically have a characteristic physical appearance and may also have heart defects, skeletal abnormalities, and other medical problems.",
      "There is currently no cure for Costello syndrome, but treatment is focused on managing the symptoms and improving the quality of life for individuals with the condition."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Costello syndrome is a rare genetic disorder caused by a mutation in the HRAS gene, not a deficiency of the hormone fibroblast growth factor 10 (FGF10).\n2. TRUE (if assuming the role of FGF10 outside the context of Costello syndrome) \n3. FALSE [correction]: The mutation causing Costello syndrome is found in the HRAS gene, not the FGF10 gene.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 640,
    "user_query": "Which is the most common CFTR mutation in Caucasians?",
    "vicuna-13b_response": "The most common CFTR mutation in Caucasians is the ΔF508 mutation. This mutation is a deletion of a single nucleotide in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which results in the production of a non-functional CFTR protein. The ΔF508 mutation is responsible for approximately 70% of cases of cystic fibrosis in Caucasians.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The most common CFTR mutation in Caucasians is the ΔF508 mutation.\n2. The ΔF508 mutation is a deletion of a single nucleotide in the CFTR gene.\n3. The ΔF508 mutation results in the production of a non-functional CFTR protein.\n4. The ΔF508 mutation is responsible for approximately 70% of cases of cystic fibrosis in Caucasians.",
    "vicuna-13b_fact": [
      "The most common CFTR mutation in Caucasians is the ΔF508 mutation.",
      "The ΔF508 mutation is a deletion of a single nucleotide in the CFTR gene.",
      "The ΔF508 mutation results in the production of a non-functional CFTR protein.",
      "The ΔF508 mutation is responsible for approximately 70% of cases of cystic fibrosis in Caucasians."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The ΔF508 mutation is a deletion of three nucleotides in the CFTR gene.\n3. TRUE\n4. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 641,
    "user_query": "Which CDK targets control cytokinesis?",
    "vicuna-13b_response": "Cytokinesis is the final stage of cell division, where the cell physically splits into two daughter cells. The process of cytokinesis is regulated by a number of CDK (cyclin-dependent kinase) targets.\nOne of the key CDK targets that control cytokinesis is the CDK1 protein, also known as cyclin-dependent kinase 1. CDK1 is a complex of two proteins, a catalytic subunit (CDK1) and a regulatory subunit (CYR1). CDK1 is activated by the binding of cyclin B1, which leads to the formation of an active CDK1/CYR1 complex that can phosphorylate and activate other proteins involved in cell division.\nAnother CDK target that plays a role in cytokinesis is the CDK2 protein, which is a homolog of CDK1 and is also activated by the binding of cyclin A or B1. CDK2 has been shown to phosphorylate and activate the mitotic kinase (MKLP1), which is a protein that plays a key role in the formation of the cleavage furrow, the structure that forms during cytokinesis and eventually divides the cell in two.\nIn addition to CDK1 and CDK2, other CDK targets that have been implicated in the regulation of cytokinesis include CDK3, CDK4, and CDK5. These CDKs are involved in the regulation of various downstream targets, including the polo-like kinase 1 (PLK1) and the aurora kinase A (AURKA), which are both involved in the regulation of mitotic progression and cytokinesis.\nOverall, the regulation of cytokinesis by CDKs is a complex process that involves the coordination of multiple CDK targets and downstream effectors. Understanding the specific roles of these CDK targets in regulating cytokinesis is an active area of research, with implications for the development of new therapies for a variety of diseases, including cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cytokinesis is the final stage of cell division.\n2. CDK1, a cyclin-dependent kinase target, plays a key role in the control of cytokinesis.\n3. CDK2, also a CDK target, has been shown to be involved in cytokinesis by activating the mitotic kinase (MKLP1).\n4. Other cyclin-dependent kinase targets involved in the regulation of cytokinesis include CDK3, CDK4, and CDK5.\n5. The polo-like kinase 1 (PLK1) and the aurora kinase A (AURKA) are both regulated by CDKs and involved in cytokinesis.",
    "vicuna-13b_fact": [
      "Cytokinesis is the final stage of cell division.",
      "CDK1, a cyclin-dependent kinase target, plays a key role in the control of cytokinesis.",
      "CDK2, also a CDK target, has been shown to be involved in cytokinesis by activating the mitotic kinase (MKLP1).",
      "Other cyclin-dependent kinase targets involved in the regulation of cytokinesis include CDK3, CDK4, and CDK5.",
      "The polo-like kinase 1 (PLK1) and the aurora kinase A (AURKA) are both regulated by CDKs and involved in cytokinesis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CDK1, not CDK2, has been shown to be involved in cytokinesis by activating the mitotic kinase (MKLP1).\n4. FALSE [correction]: Not all cyclin-dependent kinase targets, like CDK3, CDK4, and CDK5, are known to be involved in the regulation of cytokinesis.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 643,
    "user_query": "In what type(s) of plant organelles we can detect prolamellar bodies?",
    "vicuna-13b_response": "Prolamellar bodies are a type of organelle found in the chloroplasts of plant cells. They are small, flattened, disk-shaped structures that are composed of thylakoids, which are the basic units of the chloroplast. Prolamellar bodies are involved in the process of photosynthesis, which is the process by which plants convert sunlight into energy. They contain the light-harvesting complexes, which are responsible for capturing light energy and converting it into chemical energy in the form of ATP and NADPH. These energy-rich molecules are then used by other organelles in the chloroplast, such as the Calvin cycle enzymes, to synthesize glucose and other organic compounds through the process of carbon fixation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Prolamellar bodies are found in the chloroplasts of plant cells.\n2. Prolamellar bodies are composed of thylakoids.\n3. Prolamellar bodies are involved in the process of photosynthesis.\n4. Prolamellar bodies contain the light-harvesting complexes.\n5. The energy-rich molecules formed in the prolamellar bodies are used to synthesize glucose and other organic compounds through the process of carbon fixation.",
    "vicuna-13b_fact": [
      "Prolamellar bodies are found in the chloroplasts of plant cells.",
      "Prolamellar bodies are composed of thylakoids.",
      "Prolamellar bodies are involved in the process of photosynthesis.",
      "Prolamellar bodies contain the light-harvesting complexes.",
      "The energy-rich molecules formed in the prolamellar bodies are used to synthesize glucose and other organic compounds through the process of carbon fixation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "vicuna-13b_response": "Chromomethylases are enzymes that add methyl groups to the DNA molecule, leading to the formation of 5-methylcytosine, a modified form of cytosine. These enzymes are present in certain bacteria and archaea, but their presence in animal genomes is less clear.\nSome studies have suggested that chromomethylases may be present in certain animal species, such as mice and rats. However, other studies have found no evidence of these enzymes in the genomes of other animal species, including humans.\nOverall, the presence of chromomethylases in animal genomes is still an area of active research and the exact extent of their presence in animal species is not yet fully understood.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Chromomethylases are enzymes that add methyl groups to the DNA molecule.\n2. They lead to the formation of 5-methylcytosine, a modified form of cytosine.\n3. These enzymes are present in certain bacteria and archaea.\n4. Some studies suggest that chromomethylases may be present in mice and rats.\n5. Some studies have found no evidence of these enzymes in the genomes of other animal species, including humans.",
    "vicuna-13b_fact": [
      "Chromomethylases are enzymes that add methyl groups to the DNA molecule.",
      "They lead to the formation of 5-methylcytosine, a modified form of cytosine.",
      "These enzymes are present in certain bacteria and archaea.",
      "Some studies suggest that chromomethylases may be present in mice and rats.",
      "Some studies have found no evidence of these enzymes in the genomes of other animal species, including humans."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 647,
    "user_query": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?",
    "vicuna-13b_response": "Autosomal dominant Charcot-Marie-Tooth (AD-CMT) is a neurodegenerative disorder that affects the peripheral nerves, and it is caused by mutations in various genes. The specific genes associated with AD-CMT can vary depending on the type of CMT that a person has.\nThere are several genes that have been identified as being associated with AD-CMT, including:\n1. CMT1A: This is the most common form of CMT, and it is caused by mutations in the MFN2 gene.\n2. CMT2A: This form of CMT is caused by mutations in the MPZ gene.\n3. CMT4A: This form of CMT is caused by mutations in the GDAP1 gene.\n4. CMTX1: This form of CMT is caused by mutations in the EGRR1 gene.\n5. CMTX2: This form of CMT is caused by mutations in the PMP22 gene.\n6. CMT4B: This form of CMT is caused by mutations in the GDAP1 gene.\n7. CMT4C: This form of CMT is caused by mutations in the GDAP1 gene.\n8. CMT4D: This form of CMT is caused by mutations in the GDAP1 gene.\n9. CMT4E: This form of CMT is caused by mutations in the GDAP1 gene.\n10. CMT4F: This form of CMT is caused by mutations in the GDAP1 gene.\nIt's important to note that this list is not exhaustive and other genes can also be associated with AD-CMT. It's also important to note that genetic testing is available to diagnose CMT and identify the specific gene that is causing the disorder in an individual.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Autosomal dominant Charcot-Marie-Tooth is a neurodegenerative disorder that is caused by mutations in various genes.\n2. CMT1A, a form of AD-CMT, is caused by mutations in the MFN2 gene.\n3. CMT2A is another form of AD-CMT and it is the result of mutations in the MPZ gene.\n4. CMT4A is caused by mutations in the GDAP1 gene.\n5. Genetic testing is available to diagnose CMT and identify the specific gene that is causing the disorder.",
    "vicuna-13b_fact": [
      "Autosomal dominant Charcot-Marie-Tooth is a neurodegenerative disorder that is caused by mutations in various genes.",
      "CMT1A, a form of AD-CMT, is caused by mutations in the MFN2 gene.",
      "CMT2A is another form of AD-CMT and it is the result of mutations in the MPZ gene.",
      "CMT4A is caused by mutations in the GDAP1 gene.",
      "Genetic testing is available to diagnose CMT and identify the specific gene that is causing the disorder."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: CMT1A, a form of AD-CMT, is caused by duplications in the PMP22 gene.\n3. FALSE [correction]: CMT2A is another form of AD-CMT and it is the result of mutations in the MFN2 gene.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 648,
    "user_query": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?",
    "vicuna-13b_response": "The interferon-beta (IFN-b) enhanceosome is a complex of transcription factors that regulates the expression of the IFN-b gene in response to viral infection. The following transcription factors have been identified as participating in the formation of the IFN-b enhanceosome:\n1. NF-κB: NF-κB is a ubiquitous transcription factor that plays a critical role in the regulation of genes involved in the immune response, inflammation, and stress responses. NF-κB is activated by various signaling pathways, including those triggered by viral infections, and it regulates the expression of genes involved in the antiviral response, including the IFN-b gene.\n2. AP-1: AP-1 is a transcription factor that is composed of a variety of proteins, including c-Jun, c-Fos, and Fra-1. AP-1 is activated by various signaling pathways, including those triggered by viral infections, and it regulates the expression of genes involved in the antiviral response, including the IFN-b gene.\n3. IRF-7: IRF-7 is a transcription factor that is specifically involved in the regulation of the IFN-b gene. IRF-7 is activated by viral infections and other stimuli, and it binds to the IFN-b promoter to enhance its expression.\n4. PU.1: PU.1 is a transcription factor that is involved in the regulation of hematopoietic cell differentiation and the immune response. PU.1 has been shown to play a role in the regulation of the IFN-b gene and to enhance its expression in response to viral infections.\nOverall, the formation of the IFN-b enhanceosome involves the coordinated action of multiple transcription factors, including NF-κB, AP-1, IRF-7, and PU.1, which work together to regulate the expression of the IFN-b gene in response to viral infection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The interferon-beta (IFN-b) enhanceosome is a complex of transcription factors that regulates the expression of the IFN-b gene in response to viral infection.\n2. NF-κB, AP-1, IRF-7, and PU.1 are identified as the transcription factors participating in the formation of the IFN-b enhanceosome.\n3. NF-κB is a ubiquitous transcription factor that regulates the expression of genes involved in the immune response, inflammation, and stress responses.\n4. AP-1 is a transcription factor that is composed of a variety of proteins, including c-Jun, c-Fos, and Fra-1, and it regulates the expression of genes involved in the antiviral response.\n5. IRF-7 is a transcription factor specifically involved in the regulation of the IFN-b gene, and PU.1 is a transcription factor involved in the regulation of hematopoietic cell differentiation and the immune response.",
    "vicuna-13b_fact": [
      "The interferon-beta (IFN-b) enhanceosome is a complex of transcription factors that regulates the expression of the IFN-b gene in response to viral infection.",
      "NF-κB, AP-1, IRF-7, and PU.1 are identified as the transcription factors participating in the formation of the IFN-b enhanceosome.",
      "NF-κB is a ubiquitous transcription factor that regulates the expression of genes involved in the immune response, inflammation, and stress responses.",
      "AP-1 is a transcription factor that is composed of a variety of proteins, including c-Jun, c-Fos, and Fra-1, and it regulates the expression of genes involved in the antiviral response.",
      "IRF-7 is a transcription factor specifically involved in the regulation of the IFN-b gene, and PU.1 is a transcription factor involved in the regulation of hematopoietic cell differentiation and the immune response."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: NF-κB, AP-1, IRF-3, and ATF-2/c-Jun are identified as the transcription factors participating in the formation of the IFN-b enhanceosome.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "vicuna-13b_response": "There are several packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis. Some of the most popular ones are:\n1. BioMart: BioMart is a comprehensive database of genomic data that provides access to a wide range of functional genomics data, including ChIP-seq and DNase-seq data for transcription factors. BioMart can be used to identify TFBS in the genome using ChIP-seq data.\n2. ChIPseeker: ChIPseeker is a tool for identifying transcription factor binding sites in ChIP-seq data. It uses a motif-based approach to identify TFBS and can be used with a variety of transcription factors.\n3. HOMER: HOMER is a package for modeling gene expression data, including ChIP-seq data, to identify TFBS in the genome. It uses a Bayesian approach to model gene expression and can identify TFBS using a variety of models.\n4. JASPAR: JASPAR is a database of transcription factor binding profiles that can be used to identify TFBS in the genome. It provides a collection of experimentally determined transcription factor binding profiles for a variety of transcription factors.\n5. TFBS: TFBS is a package for identifying transcription factor binding sites in ChIP-seq data. It uses a motif-based approach and can be used with a variety of transcription factors.\nThese are just a few examples of the packages available for TFBS analysis in R/Bioconductor. There are many other packages available, each with its own strengths and weaknesses, so it's important to choose the right tool for the job based on the specific needs of the experiment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BioMart, ChIPseeker, HOMER, JASPAR, and TFBS are packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis.\n2. BioMart is a database of genomic data that provides access to a wide range of functional genomics data.\n3. ChIPseeker and TFBS both use a motif-based approach to identify TFBS in ChIP-seq data.\n4. HOMER is a package that models gene expression data to identify TFBS in the genome, and uses a Bayesian approach.\n5. JASPAR is a database of transcription factor binding profiles and provides a collection of experimentally determined binding profiles for various transcription factors.",
    "vicuna-13b_fact": [
      "BioMart, ChIPseeker, HOMER, JASPAR, and TFBS are packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis.",
      "BioMart is a database of genomic data that provides access to a wide range of functional genomics data.",
      "ChIPseeker and TFBS both use a motif-based approach to identify TFBS in ChIP-seq data.",
      "HOMER is a package that models gene expression data to identify TFBS in the genome, and uses a Bayesian approach.",
      "JASPAR is a database of transcription factor binding profiles and provides a collection of experimentally determined binding profiles for various transcription factors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: HOMER is a suite of tools for Motif Discovery and ChIP-Seq analysis, not specifically for modeling gene expression data.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 651,
    "user_query": "Simpson grading is used to describe resection of which brain tumor?",
    "vicuna-13b_response": "Simpson grading is used to describe the resection of gliomas, which are a type of brain tumor that originates from glial cells. Gliomas can be classified into different grades based on the degree of malignancy, with Grade I being the least malignant and Grade IV being the most malignant. The Simpson grading system is one of the methods used to determine the grade of a glioma.\nThe Simpson grading system assigns a grade to a glioma based on the degree of tumor cell differentiation and the presence of necrosis (dead tissue). The grades are as follows:\n* Grade I: Well-differentiated tumors with a low degree of malignancy, consisting of small, well-formed cells that resemble normal glial cells. Necrosis is not present.\n* Grade II: Moderately differentiated tumors with a moderate degree of malignancy, consisting of cells that are larger and less regular in shape than Grade I tumors. Necrosis may be present.\n* Grade III: Poorly differentiated tumors with a high degree of malignancy, consisting of cells that are small and irregular in shape, with a high degree of nuclear atypia (abnormality). Necrosis is often present.\n* Grade IV: Anaplastic tumors, which are highly malignant and aggressive, consisting of cells that are small and irregular in shape, with a high degree of nuclear atypia and a high mitotic count (the number of cells in the process of dividing). Necrosis is often present.\nIt is important to note that the Simpson grading system is not the only method used to determine the grade of a glioma, and other systems, such as the World Health Organization (WHO) grading system, may also be used.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Simpson grading is used to describe the resection of gliomas.\n2. Gliomas are a type of brain tumor that originates from glial cells.\n3. The Simpson grading system assigns a grade to a glioma based on the degree of tumor cell differentiation and the presence of necrosis.\n4. Grade I, in the Simpson grading system, denotes well-differentiated tumors with a low degree of malignancy, consisting of small, well-formed cells that resemble normal glial cells and has no necrosis.\n5. Other systems such as the World Health Organization (WHO) grading system can be used to determine the grade of a glioma.",
    "vicuna-13b_fact": [
      "Simpson grading is used to describe the resection of gliomas.",
      "Gliomas are a type of brain tumor that originates from glial cells.",
      "The Simpson grading system assigns a grade to a glioma based on the degree of tumor cell differentiation and the presence of necrosis.",
      "Grade I, in the Simpson grading system, denotes well-differentiated tumors with a low degree of malignancy, consisting of small, well-formed cells that resemble normal glial cells and has no necrosis.",
      "Other systems such as the World Health Organization (WHO) grading system can be used to determine the grade of a glioma."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Simpson grading is used to describe the resection of meningiomas, not gliomas.\n2. TRUE\n3. FALSE [correction]: The World Health Organization (WHO) grading system assigns a grade to a glioma based on the degree of tumor cell differentiation and the presence of necrosis, not the Simpson grading system.\n4. FALSE [correction]: Grade I, in the World Health Organization (WHO) grading system, denotes well-differentiated tumors with a low degree of malignancy, consisting of small, well-formed cells that resemble normal glial cells and has no necrosis.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 653,
    "user_query": "Is delayed enhancement documented in patients with non-ischemic dilated cardiomyopathy?",
    "vicuna-13b_response": "Delayed enhancement (DE) is a cardiac magnetic resonance imaging (MRI) technique that can detect myocardial fibrosis, which is a hallmark of non-ischemic dilated cardiomyopathy (NIDC). NIDC is a type of dilated cardiomyopathy that occurs due to genetic or idiopathic causes and is not caused by coronary artery disease.\nStudies have shown that DE can be used to detect and quantify myocardial fibrosis in patients with NIDC. DE is particularly useful in identifying diffuse fibrosis, which is common in NIDC. In addition, DE can provide information about the timing and extent of myocardial injury, which can be helpful in understanding the underlying causes of NIDC.\nOverall, DE is a useful tool for the evaluation of NIDC and can provide important information about myocardial fibrosis and injury in these patients.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Delayed enhancement (DE) is a cardiac magnetic resonance imaging (MRI) technique that can detect myocardial fibrosis.\n2. Myocardial fibrosis is a hallmark of non-ischemic dilated cardiomyopathy (NIDC).\n3. NIDC is a type of dilated cardiomyopathy that occurs due to genetic or idiopathic causes and is not caused by coronary artery disease.\n4. Studies have shown that DE can be used to detect and quantify myocardial fibrosis in patients with NIDC.\n5. DE can provide information about the timing and extent of myocardial injury.",
    "vicuna-13b_fact": [
      "Delayed enhancement (DE) is a cardiac magnetic resonance imaging (MRI) technique that can detect myocardial fibrosis.",
      "Myocardial fibrosis is a hallmark of non-ischemic dilated cardiomyopathy (NIDC).",
      "NIDC is a type of dilated cardiomyopathy that occurs due to genetic or idiopathic causes and is not caused by coronary artery disease.",
      "Studies have shown that DE can be used to detect and quantify myocardial fibrosis in patients with NIDC.",
      "DE can provide information about the timing and extent of myocardial injury."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 654,
    "user_query": "Which enzyme is inhibited by Varespladib?",
    "vicuna-13b_response": "Varespladib is an oral direct-acting antiviral drug that is used to treat hepatitis C virus (HCV) infection. It is a protease inhibitor, which means it inhibits the activity of the HCV protease enzyme. The HCV protease enzyme is involved in the replication of the virus and is necessary for the formation of viral particles. By inhibiting the activity of this enzyme, varespladib can prevent the virus from replicating and can reduce the level of virus in the body.\nIt is important to note that varespladib is not currently approved for use in the United States and is only approved for use in certain other countries. Additionally, it should only be used under the guidance of a healthcare professional and as part of a complete treatment regimen for HCV infection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Varespladib is an oral direct-acting antiviral drug used to treat hepatitis C virus (HCV) infection.\n2. Varespladib is a protease inhibitor.\n3. The HCV protease enzyme is inhibited by Varespladib.\n4. The HCV protease enzyme is involved in the replication of the virus and the formation of viral particles.\n5. Varespladib is not currently approved for use in the United States.",
    "vicuna-13b_fact": [
      "Varespladib is an oral direct-acting antiviral drug used to treat hepatitis C virus (HCV) infection.",
      "Varespladib is a protease inhibitor.",
      "The HCV protease enzyme is inhibited by Varespladib.",
      "The HCV protease enzyme is involved in the replication of the virus and the formation of viral particles.",
      "Varespladib is not currently approved for use in the United States."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Varespladib is not an antiviral drug used to treat hepatitis C virus (HCV) infection; it was studied for use in reducing acute coronary syndromes.\n2. FALSE [correction]: Varespladib is not a protease inhibitor. It is a phospholipase A2 inhibitor.\n3. FALSE [correction]: The HCV protease enzyme is not inhibited by Varespladib; instead, Varespladib targets and inhibits secretory phospholipase A2.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 660,
    "user_query": "Which autophagy pathway is trigered by the KFERQ motif of cytosolic proteins?",
    "vicuna-13b_response": "The autophagy pathway that is triggered by the KFERQ motif of cytosolic proteins is the canonical autophagy pathway. This pathway is the most well-known and widely studied form of autophagy, and it is initiated by the formation of a phagophore, which is a double-membrane structure that surrounds the material to be degraded. The KFERQ motif is a conserved sequence of amino acids that is found in cytosolic proteins and is necessary for the initiation of autophagy. When a cytosolic protein containing the KFERQ motif is degraded, it triggers the formation of the phagophore and the initiation of autophagy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The KFERQ motif of cytosolic proteins triggers the canonical autophagy pathway.\n2. The canonical autophagy pathway is the most well-known and widely studied form of autophagy.\n3. The initiation of the canonical autophagy pathway is characterized by the formation of a phagophore.\n4. The KFERQ motif is a conserved sequence of amino acids found in cytosolic proteins.\n5. The degradation of a cytosolic protein with the KFERQ motif initiates the formation of the phagophore and the canonical autophagy pathway.",
    "vicuna-13b_fact": [
      "The KFERQ motif of cytosolic proteins triggers the canonical autophagy pathway.",
      "The canonical autophagy pathway is the most well-known and widely studied form of autophagy.",
      "The initiation of the canonical autophagy pathway is characterized by the formation of a phagophore.",
      "The KFERQ motif is a conserved sequence of amino acids found in cytosolic proteins.",
      "The degradation of a cytosolic protein with the KFERQ motif initiates the formation of the phagophore and the canonical autophagy pathway."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The recognition of the KFERQ motif in cytosolic proteins by HSC70 triggers the formation of the phagophore and the chaperone-mediated autophagy pathway, not the canonical autophagy pathway.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 665,
    "user_query": "Has overexpression of sirtuins been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae)?",
    "vicuna-13b_response": "Yes, overexpression of sirtuins has been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae). Sirtuins are a class of NAD+-dependent deacetylases that have been shown to play a role in regulating lifespan in various organisms, including yeast. In yeast, sirtuins have been shown to regulate the activity of the protein Sir2, which is a key regulator of lifespan.\nSeveral studies have reported that overexpression of sirtuins in yeast can increase lifespan. For example, one study found that overexpression of the sirtuin SIR2.1 in yeast increased lifespan and delayed the onset of age-related decline in cellular fitness. Another study found that overexpression of the sirtuin SIR2.2 also increased lifespan in yeast.\nOverexpression of sirtuins has also been shown to increase lifespan in other organisms, including mice and flies, suggesting that the effects of sirtuins on lifespan are conserved across different species.\nIt is important to note that the effects of sirtuin overexpression on lifespan may depend on the specific sirtuin isoform and the conditions under which it is overexpressed. Therefore, further research is needed to fully understand the role of sirtuins in regulating lifespan in yeast and other organisms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Overexpression of sirtuins has been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae).\n2. Sirtuins are a class of NAD+-dependent deacetylases that have been shown to play a role in regulating lifespan in various organisms.\n3. In yeast, sirtuins regulate the activity of the protein Sir2, a key regulator of lifespan.\n4. One study found that overexpression of the sirtuin SIR2.1 in yeast increased lifespan and delayed the onset of age-related decline in cellular fitness.\n5. Overexpression of sirtuins has also been shown to increase lifespan in other organisms, including mice and flies.",
    "vicuna-13b_fact": [
      "Overexpression of sirtuins has been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae).",
      "Sirtuins are a class of NAD+-dependent deacetylases that have been shown to play a role in regulating lifespan in various organisms.",
      "In yeast, sirtuins regulate the activity of the protein Sir2, a key regulator of lifespan.",
      "One study found that overexpression of the sirtuin SIR2.1 in yeast increased lifespan and delayed the onset of age-related decline in cellular fitness.",
      "Overexpression of sirtuins has also been shown to increase lifespan in other organisms, including mice and flies."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: In yeast, Sir2 is a sirtuin protein that plays a key role in regulating lifespan.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 669,
    "user_query": "How does phospholamban affect the biological activity of the calcium ATPase SERCA?",
    "vicuna-13b_response": "Phospholamban is a regulatory protein that binds to the calcium ATPase SERCA and inhibits its activity. SERCA is an important protein found in the endoplasmic reticulum (ER) of cells, which plays a crucial role in maintaining the proper levels of calcium ions (Ca2+) within the cell.\nWhen phospholamban binds to SERCA, it prevents the protein from binding to ATP, the energy molecule that is required for the calcium pumping activity of SERCA. This binding of phospholamban to SERCA results in the inhibition of the calcium pumping activity of SERCA, which in turn leads to an increase in the levels of Ca2+ within the cell.\nPhospholamban is a key regulator of SERCA activity, and its levels are tightly controlled in the cell. Increased levels of phospholamban can lead to a decrease in SERCA activity and an increase in Ca2+ levels within the cell, while decreased levels of phospholamban can lead to an increase in SERCA activity and a decrease in Ca2+ levels within the cell.\nOverall, phospholamban plays a crucial role in regulating the activity of SERCA and maintaining proper levels of Ca2+ within the cell. Dysregulation of phospholamban levels or activity can have significant effects on cellular function and can contribute to a variety of diseases, including cardiovascular disease and cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Phospholamban is a regulatory protein that binds to the calcium ATPase SERCA and inhibits its activity.\n2. SERCA is an important protein found in the endoplasmic reticulum (ER) of cells.\n3. SERCA plays a crucial role in maintaining the proper levels of calcium ions (Ca2+) within the cell.\n4. The binding of phospholamban to SERCA results in the inhibition of the calcium pumping activity of SERCA, leading to an increase in the levels of Ca2+ within the cell.\n5. Dysregulation of phospholamban levels or activity can have significant effects on cellular function and can contribute to a variety of diseases, including cardiovascular disease and cancer.",
    "vicuna-13b_fact": [
      "Phospholamban is a regulatory protein that binds to the calcium ATPase SERCA and inhibits its activity.",
      "SERCA is an important protein found in the endoplasmic reticulum (ER) of cells.",
      "SERCA plays a crucial role in maintaining the proper levels of calcium ions (Ca2+) within the cell.",
      "The binding of phospholamban to SERCA results in the inhibition of the calcium pumping activity of SERCA, leading to an increase in the levels of Ca2+ within the cell.",
      "Dysregulation of phospholamban levels or activity can have significant effects on cellular function and can contribute to a variety of diseases, including cardiovascular disease and cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 670,
    "user_query": "List the components of mTOR Complex 2 (mTORC2).",
    "vicuna-13b_response": "mTOR Complex 2 (mTORC2) is a complex of proteins that regulate cell growth and metabolism. The components of mTORC2 include:\n1. mTOR: mammalian target of rapamycin, a serine/threonine kinase that acts as a central regulator of cell growth and metabolism.\n2. mLST8: a GTPase-activating protein (GAP) that inhibits the activity of mTOR.\n3. mSIN1: a GTPase-activating protein (GAP) that inhibits the activity of mTOR.\n4. mATG1: a GTPase-activating protein (GAP) that inhibits the activity of mTOR.\n5. mTBR2: a GTPase-activating protein (GAP) that inhibits the activity of mTOR.\n6. mS6K1: a serine/threonine kinase that is a downstream target of mTORC2 and regulates cell growth and metabolism.\n7. mS6K2: a serine/threonine kinase that is a downstream target of mTORC2 and regulates cell growth and metabolism.\nThese components work together to regulate cell growth and metabolism in response to various signals, including nutrient availability and cellular energy levels.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. mTOR Complex 2 (mTORC2) is a complex of proteins that regulate cell growth and metabolism.\n2. The components of mTORC2 include mTOR, mLST8, mSIN1, mATG1, mTBR2, mS6K1, and mS6K2.\n3. mTOR in mTORC2 is a serine/threonine kinase that acts as a central regulator of cell growth and metabolism.\n4. mS6K1 and mS6K2 are serine/threonine kinases that are downstream targets of mTORC2 and regulate cell growth and metabolism.\n5. mTORC2 components work together to regulate cell growth and metabolism in response to various signals, including nutrient availability and cellular energy levels.",
    "vicuna-13b_fact": [
      "mTOR Complex 2 (mTORC2) is a complex of proteins that regulate cell growth and metabolism.",
      "The components of mTORC2 include mTOR, mLST8, mSIN1, mATG1, mTBR2, mS6K1, and mS6K2.",
      "mTOR in mTORC2 is a serine/threonine kinase that acts as a central regulator of cell growth and metabolism.",
      "mS6K1 and mS6K2 are serine/threonine kinases that are downstream targets of mTORC2 and regulate cell growth and metabolism.",
      "mTORC2 components work together to regulate cell growth and metabolism in response to various signals, including nutrient availability and cellular energy levels."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The components of mTORC2 include mTOR, mLST8, mSIN1, and RICTOR, not mATG1, mTBR2, mS6K1, and mS6K2.\n3. TRUE\n4. FALSE [correction]: mS6K1 and mS6K2 are serine/threonine kinases that are downstream targets of mTORC1, not mTORC2.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 675,
    "user_query": "Which multiple kinase inhibitors are used in cancer therapy?",
    "vicuna-13b_response": "Multiple kinase inhibitors are commonly used in cancer therapy to target specific enzymes that are involved in the growth and proliferation of cancer cells. Some examples of multiple kinase inhibitors used in cancer therapy include:\n1. Sorafenib: This drug targets several kinases involved in cell growth and angiogenesis, including the Raf kinase, VEGFR2, and PDGFRβ. It is approved for the treatment of several types of cancer, including kidney, liver, and thyroid cancer.\n2. Sunitinib: This drug targets several kinases involved in cell growth and angiogenesis, including the VEGFR1, VEGFR2, VEGFR3, PDGFRβ, and c-Kit. It is approved for the treatment of several types of cancer, including kidney, liver, and pancreatic cancer.\n3. Pazopanib: This drug targets several kinases involved in cell growth, angiogenesis, and metastasis, including the VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, and BRAF. It is approved for the treatment of several types of cancer, including kidney, liver, and lung cancer.\n4. Axitinib: This drug targets several kinases involved in cell growth and angiogenesis, including the VEGFR1, VEGFR2, and VEGFR3. It is approved for the treatment of advanced renal cell carcinoma.\n5. Erlotinib: This drug targets the epidermal growth factor receptor (EGFR), which is involved in cell growth and proliferation. It is approved for the treatment of non-small cell lung cancer.\nThese are just a few examples of multiple kinase inhibitors used in cancer therapy. The use of multiple kinase inhibitors in cancer treatment is a rapidly evolving field, and new drugs and targets are continually being developed and evaluated in clinical trials.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Sorafenib targets kinases involved in cell growth and angiogenesis, such as Raf kinase, VEGFR2, and PDGFRβ, and it is used for treating kidney, liver, and thyroid cancer.\n2. Sunitinib targets various kinases, including VEGFR1, VEGFR2, VEGFR3, PDGFRβ, and c-Kit, and is used in the treatment of kidney, liver, and pancreatic cancer.\n3. Pazopanib targets several kinases involved in cell growth, angiogenesis, and metastasis, including VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, and BRAF, and it's used to treat kidney, liver, and lung cancer.\n4. Axitinib targets kinases including VEGFR1, VEGFR2, and VEGFR3, and is approved for the treatment of advanced renal cell carcinoma.\n5. Erlotinib targets the epidermal growth factor receptor (EGFR), which is involved in cell growth and proliferation, and it is approved for the treatment of non-small cell lung cancer.",
    "vicuna-13b_fact": [
      "Sorafenib targets kinases involved in cell growth and angiogenesis, such as Raf kinase, VEGFR2, and PDGFRβ, and it is used for treating kidney, liver, and thyroid cancer.",
      "Sunitinib targets various kinases, including VEGFR1, VEGFR2, VEGFR3, PDGFRβ, and c-Kit, and is used in the treatment of kidney, liver, and pancreatic cancer.",
      "Pazopanib targets several kinases involved in cell growth, angiogenesis, and metastasis, including VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, and BRAF, and it's used to treat kidney, liver, and lung cancer.",
      "Axitinib targets kinases including VEGFR1, VEGFR2, and VEGFR3, and is approved for the treatment of advanced renal cell carcinoma.",
      "Erlotinib targets the epidermal growth factor receptor (EGFR), which is involved in cell growth and proliferation, and it is approved for the treatment of non-small cell lung cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Sunitinib targets various kinases, including VEGFR1, VEGFR2, VEGFR3, PDGFRβ, and c-Kit, and is used in the treatment of kidney, gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors.\n3. FALSE [correction]: Pazopanib targets several kinases involved in cell growth, angiogenesis, and metastasis, including VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, and BRAF, and it's used to treat kidney cancer and soft tissue sarcoma.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 678,
    "user_query": "List types of avoided words in bacterial genomes",
    "vicuna-13b_response": "Bacterial genomes can contain a variety of avoided words, which are words or phrases that are not included in the genome due to various mechanisms. Some examples of avoided words in bacterial genomes include:\n1. Stop codons: Stop codons are sequences of nucleotides that signal the end of protein synthesis. They are avoided in bacterial genomes because they would prematurely terminate the synthesis of proteins, which would be harmful to the bacterium.\n2. Intron sequences: Intron sequences are non-coding regions of DNA that are removed during the process of gene splicing. They are avoided in bacterial genomes because they do not code for any functional proteins or RNA molecules.\n3. Repeats: Repeats are sequences of nucleotides that are repeated multiple times in a row. They are avoided in bacterial genomes because they can cause genome instability and can lead to the formation of mobile genetic elements, such as transposons and plasmids.\n4. Pseudogenes: Pseudogenes are non-functional genes that have been rendered non-functional due to mutations or other genetic events. They are avoided in bacterial genomes because they do not code for any functional proteins or RNA molecules.\n5. Transposable elements: Transposable elements are mobile genetic elements that can move around the genome and disrupt gene function. They are avoided in bacterial genomes because they can cause genome instability and can lead to the loss or gain of functional genes.\nOverall, avoided words in bacterial genomes are those sequences that do not contribute to the functional integrity of the genome and can have deleterious effects on the bacterium.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Stop codons are sequences of nucleotides that signal the end of protein synthesis and are avoided in bacterial genomes.\n2. Intron sequences are non-coding regions of DNA that are removed during the process of gene splicing and are avoided in bacterial genomes.\n3. Repeats are sequences of nucleotides that are repeated multiple times in a row and are avoided in bacterial genomes due to genome instability and mobile genetic element formation.\n4. Pseudogenes are non-functional genes that have been rendered non-functional due to mutations or other genetic events and are avoided in bacterial genomes.\n5. Transposable elements are mobile genetic elements that can move around the genome and disrupt gene function and are avoided in bacterial genomes due to genome instability and loss or gain of functional genes.",
    "vicuna-13b_fact": [
      "Stop codons are sequences of nucleotides that signal the end of protein synthesis and are avoided in bacterial genomes.",
      "Intron sequences are non-coding regions of DNA that are removed during the process of gene splicing and are avoided in bacterial genomes.",
      "Repeats are sequences of nucleotides that are repeated multiple times in a row and are avoided in bacterial genomes due to genome instability and mobile genetic element formation.",
      "Pseudogenes are non-functional genes that have been rendered non-functional due to mutations or other genetic events and are avoided in bacterial genomes.",
      "Transposable elements are mobile genetic elements that can move around the genome and disrupt gene function and are avoided in bacterial genomes due to genome instability and loss or gain of functional genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Intron sequences are non-coding regions of DNA that are removed during the process of gene splicing but are not typically found in bacterial genomes.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 681,
    "user_query": "Which is the physiological target for LeuRS translational quality control?",
    "vicuna-13b_response": "LeuRS (leucine-rich repeat containing) is a protein that plays a role in translational quality control in cells. Translational quality control refers to the mechanisms that ensure that proteins are produced correctly and in the right place in the cell.\nThe physiological target for LeuRS translational quality control is the ribosome, which is the site where proteins are synthesized in the cell. LeuRS acts as a chaperone, helping to fold and assemble the growing polypeptide chain in the correct way, ensuring that the protein is produced correctly and in the right place in the cell.\nLeuRS also plays a role in regulating the translation of specific mRNAs, and can bind to the ribosome in a way that inhibits the translation of certain mRNAs, leading to their degradation. This helps to ensure that the cell only produces the proteins that it needs, and that the proteins are produced in the correct amounts and in the right place in the cell.\nOverall, LeuRS is an important component of the translational quality control machinery in cells, and plays a crucial role in ensuring that proteins are produced correctly and in the right place in the cell.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. LeuRS (leucine-rich repeat containing) is a protein that plays a role in translational quality control in cells.\n2. The physiological target for LeuRS translational quality control is the ribosome.\n3. LeuRS acts as a chaperone, helping to fold and assemble the growing polypeptide chain in the correct way.\n4. LeuRS plays a role in regulating the translation of specific mRNAs.\n5. LeuRS can bind to the ribosome in a way that inhibits the translation of certain mRNAs, leading to their degradation.",
    "vicuna-13b_fact": [
      "LeuRS (leucine-rich repeat containing) is a protein that plays a role in translational quality control in cells.",
      "The physiological target for LeuRS translational quality control is the ribosome.",
      "LeuRS acts as a chaperone, helping to fold and assemble the growing polypeptide chain in the correct way.",
      "LeuRS plays a role in regulating the translation of specific mRNAs.",
      "LeuRS can bind to the ribosome in a way that inhibits the translation of certain mRNAs, leading to their degradation."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: LeuRS (leucyl-tRNA synthetase) is an enzyme that plays a crucial role in protein synthesis in cells.\n2. TRUE\n3. FALSE [correction]: LeuRS does not act as a chaperone. Instead, it attaches leucine to its cognate tRNA molecules, a critical step in protein synthesis.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 693,
    "user_query": "Which gene test can be used for the X-linked myotubular myopathy?",
    "vicuna-13b_response": "X-linked myotubular myopathy is a rare genetic disorder that affects muscle strength and function. It is caused by mutations in the MTM1 gene, which is located on the X chromosome.\nThere are several gene tests that can be used to diagnose X-linked myotubular myopathy, including:\n1. Genetic testing: This involves analyzing a sample of the patient's DNA to identify any mutations in the MTM1 gene. This can be done through a variety of methods, including sequencing, PCR, and MLPA.\n2. Muscle biopsy: A muscle biopsy can be used to assess the structure and function of muscle cells. In patients with X-linked myotubular myopathy, the muscle cells will show characteristic changes, including centronuclear myopathy and ragged-red fibers.\n3. Electromyography (EMG): This is a test that measures the electrical activity of muscles. In patients with X-linked myotubular myopathy, the EMG may show characteristic patterns of muscle activity.\n4. Genetic counseling: Genetic counseling can be used to help families understand the risks of inheriting a genetic disorder, and to provide information about prenatal testing and management options.\nIt is important to note that genetic testing for X-linked myotubular myopathy should only be performed by a qualified healthcare professional, and the results should be interpreted by a clinical geneticist or molecular geneticist.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. X-linked myotubular myopathy is a rare genetic disorder that affects muscle strength and function.\n2. X-linked myotubular myopathy is caused by mutations in the MTM1 gene located on the X chromosome.\n3. Genetic testing, muscle biopsy, electromyography, and genetic counseling can be used to diagnose X-linked myotubular myopathy.\n4. Genetic test involves analyzing the patient's DNA to identify any mutations in the MTM1 gene.\n5. Genetic testing for X-linked myotubular myopathy should be performed by a qualified healthcare professional.",
    "vicuna-13b_fact": [
      "X-linked myotubular myopathy is a rare genetic disorder that affects muscle strength and function.",
      "X-linked myotubular myopathy is caused by mutations in the MTM1 gene located on the X chromosome.",
      "Genetic testing, muscle biopsy, electromyography, and genetic counseling can be used to diagnose X-linked myotubular myopathy.",
      "Genetic test involves analyzing the patient's DNA to identify any mutations in the MTM1 gene.",
      "Genetic testing for X-linked myotubular myopathy should be performed by a qualified healthcare professional."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 695,
    "user_query": "What is the association between adiponectin and migraine?",
    "vicuna-13b_response": "Adiponectin is a hormone that is produced by fat cells (adipocytes) and has been shown to play a role in various physiological processes, including metabolism, inflammation, and cardiovascular health. There is some evidence to suggest that adiponectin may also be involved in the pathophysiology of migraine.\nStudies have shown that levels of adiponectin are lower in individuals with migraine compared to those without migraine. Additionally, there is evidence to suggest that adiponectin may play a role in the regulation of inflammation, which is thought to play a role in the development of migraine. Some studies have shown that adiponectin can have anti-inflammatory effects, and that low levels of adiponectin may contribute to an increased risk of inflammation-related conditions, such as migraine.\nHowever, it is important to note that the relationship between adiponectin and migraine is still not well understood, and more research is needed to fully understand the role of adiponectin in the pathophysiology of migraine. Additionally, there are likely to be multiple factors that contribute to the development of migraine, and adiponectin is likely just one of many potential contributors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Adiponectin is a hormone that is produced by fat cells.\n2. Adiponectin plays a role in metabolism, inflammation, and cardiovascular health.\n3. Studies have shown that levels of adiponectin are lower in individuals with migraine compared to those without migraine.\n4. Adiponectin can have anti-inflammatory effects.\n5. Low levels of adiponectin may contribute to an increased risk of inflammation-related conditions, such as migraine.",
    "vicuna-13b_fact": [
      "Adiponectin is a hormone that is produced by fat cells.",
      "Adiponectin plays a role in metabolism, inflammation, and cardiovascular health.",
      "Studies have shown that levels of adiponectin are lower in individuals with migraine compared to those without migraine.",
      "Adiponectin can have anti-inflammatory effects.",
      "Low levels of adiponectin may contribute to an increased risk of inflammation-related conditions, such as migraine."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 703,
    "user_query": "Is there an association between FGFR3 mutation and plagiocephaly?",
    "vicuna-13b_response": "FGFR3 (fibroblast growth factor receptor 3) is a gene that plays a role in the development of the brain and other tissues. Mutations in the FGFR3 gene have been associated with various developmental disorders, including craniosynostosis, which is a condition in which the skull bones fuse together too early, leading to abnormal head shape and other problems.\nPlagiocephaly is a condition in which one side of the head is flatter than the other, often due to abnormal development of the skull bones. It is not directly caused by FGFR3 mutations, but it can be a symptom of craniosynostosis, which can be caused by FGFR3 mutations.\nTherefore, there is an association between FGFR3 mutations and plagiocephaly, as FGFR3 mutations can cause craniosynostosis, which can lead to abnormal head shape and plagiocephaly. However, it's important to note that not all cases of plagiocephaly are caused by FGFR3 mutations, and other factors can also contribute to the development of this condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. FGFR3 is a gene that plays a role in the development of the brain and other tissues.\n2. Mutations in the FGFR3 gene have been associated with developmental disorders, including craniosynostosis.\n3. Plagiocephaly is a condition in which one side of the head is flatter than the other.\n4. Craniosynostosis can lead to abnormal head shape and plagiocephaly.\n5. Not all cases of plagiocephaly are caused by FGFR3 mutations.",
    "vicuna-13b_fact": [
      "FGFR3 is a gene that plays a role in the development of the brain and other tissues.",
      "Mutations in the FGFR3 gene have been associated with developmental disorders, including craniosynostosis.",
      "Plagiocephaly is a condition in which one side of the head is flatter than the other.",
      "Craniosynostosis can lead to abnormal head shape and plagiocephaly.",
      "Not all cases of plagiocephaly are caused by FGFR3 mutations."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 708,
    "user_query": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?",
    "vicuna-13b_response": "7-methylguanosine (m7G) is a common modification found in the messenger RNA (mRNA) of eukaryotic cells. This modification is added to the base of the guanine nucleotide by a set of enzymes known as methyltransferases. The specific enzymes involved in the addition of m7G to mRNA can vary depending on the organism and the specific type of mRNA being modified. However, some of the key enzymes involved in m7G addition include:\n1. Methyltransferase 1 (MT1) - This enzyme is responsible for the addition of m7G to the guanine base of ribosomal RNA (rRNA) and other non-coding RNAs.\n2. Methyltransferase 2 (MT2) - This enzyme adds m7G to the guanine base of certain types of mRNA, including those involved in translation and splicing.\n3. Methyltransferase 3 (MT3) - This enzyme adds m7G to the guanine base of specific mRNAs involved in the regulation of gene expression.\n4. Methyltransferase 4 (MT4) - This enzyme adds m7G to the guanine base of mRNAs involved in the regulation of protein synthesis and cell growth.\nOverall, the addition of m7G to mRNA is a critical step in the regulation of gene expression and protein synthesis in eukaryotic cells. The specific enzymes involved in this process can vary depending on the organism and the specific type of mRNA being modified, but the overall mechanism of m7G addition involves the transfer of a methyl group from S-adenosylmethionine (SAM) to the guanine base of the target RNA by one of the methyltransferases mentioned above.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. 7-methylguanosine (m7G) is a common modification found in the messenger RNA (mRNA) of eukaryotic cells.\n2. The addition of m7G to the guanine base of the mRNA is done by a set of enzymes known as methyltransferases.\n3. Methyltransferase 1 (MT1) adds m7G to the guanine base of ribosomal RNA (rRNA) and other non-coding RNAs.\n4. Methyltransferase 2 (MT2) adds m7G to the guanine base of certain types of mRNA, including those involved in translation and splicing.\n5. The overall mechanism of m7G addition involves the transfer of a methyl group from S-adenosylmethionine (SAM) to the guanine base of the target RNA by one of the methyltransferases.",
    "vicuna-13b_fact": [
      "7-methylguanosine (m7G) is a common modification found in the messenger RNA (mRNA) of eukaryotic cells.",
      "The addition of m7G to the guanine base of the mRNA is done by a set of enzymes known as methyltransferases.",
      "Methyltransferase 1 (MT1) adds m7G to the guanine base of ribosomal RNA (rRNA) and other non-coding RNAs.",
      "Methyltransferase 2 (MT2) adds m7G to the guanine base of certain types of mRNA, including those involved in translation and splicing.",
      "The overall mechanism of m7G addition involves the transfer of a methyl group from S-adenosylmethionine (SAM) to the guanine base of the target RNA by one of the methyltransferases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 709,
    "user_query": "What is HOCOMOCO?",
    "vicuna-13b_response": "HOCOMOCO is a term that is used to describe a type of neural network architecture that is designed to perform well on a variety of tasks. It stands for \"High-dimensional Convolutional Mixture of Experts.\"\nIn a HOCOMOCO network, the input data is fed through a series of specialized \"expert\" modules, each of which is designed to perform a specific type of computation. These expert modules are then combined using a \"mixture of experts\" approach, which allows the network to dynamically select the most appropriate experts to use for a given task.\nThis approach allows HOCOMOCO networks to be highly flexible and adaptable, as they can be trained to perform a wide range of tasks by simply changing the expert modules used in the network. HOCOMOCO networks have been shown to perform well on tasks such as image classification, object detection, and natural language processing.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. HOCOMOCO is a term used to describe a type of neural network architecture.\n2. HOCOMOCO stands for \"High-dimensional Convolutional Mixture of Experts.\"\n3. In a HOCOMOCO network, input data is fed through a series of specialized \"expert\" modules.\n4. These expert modules in a HOCOMOCO network are combined using a \"mixture of experts\" approach.\n5. HOCOMOCO networks have been shown to perform well on tasks such as image classification, object detection, and natural language processing.",
    "vicuna-13b_fact": [
      "HOCOMOCO is a term used to describe a type of neural network architecture.",
      "HOCOMOCO stands for \"High-dimensional Convolutional Mixture of Experts.\"",
      "In a HOCOMOCO network, input data is fed through a series of specialized \"expert\" modules.",
      "These expert modules in a HOCOMOCO network are combined using a \"mixture of experts\" approach.",
      "HOCOMOCO networks have been shown to perform well on tasks such as image classification, object detection, and natural language processing."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: HOCOMOCO is not a term for a type of neural network architecture, it's a database of transcription factor binding models.\n2. FALSE [correction]: HOCOMOCO stands for \"HOMer COnsensus MOtif COnversion.\"\n3. FALSE [correction]: HOCOMOCO is not a neural network and doesn't employ expert modules.\n4. FALSE [correction]: HOCOMOCO does not use a \"mixture of experts\" approach as it's not a neural network architecture.\n5. FALSE [correction]: HOCOMOCO, being a database of transcription factor binding models, doesn't directly perform tasks such as image classification, object detection, or natural language processing.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 713,
    "user_query": "What is the typical alteration of the thyroid profile metabolism early after coronary artery bypass graft surgery?",
    "vicuna-13b_response": "Coronary artery bypass graft (CABG) surgery is a surgical procedure used to treat narrowed or blocked coronary arteries that can cause heart disease. One of the common alterations of the thyroid profile metabolism early after CABG surgery is an increase in thyroid hormone levels. This is due to the stress response of the body to the surgery, which can cause an increase in the release of adrenal hormones, including cortisol, that can stimulate the thyroid gland to produce more thyroid hormones.\nAdditionally, the use of beta-blockers, which are commonly given to patients after CABG surgery to help manage blood pressure and heart rate, can also affect thyroid hormone levels. Beta-blockers can block the effects of epinephrine, a hormone that can inhibit the production of thyroid hormones, resulting in an increase in thyroid hormone levels.\nIt is important to note that changes in thyroid hormone levels after CABG surgery can vary among individuals and may not be permanent. It is important for patients to discuss any changes in their thyroid function with their healthcare provider to ensure proper management and treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Coronary artery bypass graft (CABG) surgery is a surgical procedure used to treat narrowed or blocked coronary arteries that can cause heart disease.\n2. One of the common alterations of the thyroid profile metabolism early after CABG surgery is an increase in thyroid hormone levels.\n3. The increase in thyroid hormone levels is due to the stress response of the body to the surgery, which can cause an increase in the release of adrenal hormones, including cortisol.\n4. Beta-blockers, which are commonly given to patients after CABG surgery, can also affect thyroid hormone levels by blocking the effects of epinephrine.\n5. Changes in thyroid hormone levels after CABG surgery can vary among individuals and may not be permanent.",
    "vicuna-13b_fact": [
      "Coronary artery bypass graft (CABG) surgery is a surgical procedure used to treat narrowed or blocked coronary arteries that can cause heart disease.",
      "One of the common alterations of the thyroid profile metabolism early after CABG surgery is an increase in thyroid hormone levels.",
      "The increase in thyroid hormone levels is due to the stress response of the body to the surgery, which can cause an increase in the release of adrenal hormones, including cortisol.",
      "Beta-blockers, which are commonly given to patients after CABG surgery, can also affect thyroid hormone levels by blocking the effects of epinephrine.",
      "Changes in thyroid hormone levels after CABG surgery can vary among individuals and may not be permanent."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 715,
    "user_query": "What does the SAGA complex acronym stands for?",
    "vicuna-13b_response": "SAGA is an acronym that stands for \"Sustainable and Green Amenities for the Greater Good.\" It is a concept that emphasizes the importance of creating sustainable and environmentally friendly spaces and amenities that benefit the community and promote a healthy lifestyle. The goal of SAGA is to create a positive impact on the environment and society by promoting sustainable development and responsible use of resources.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SAGA is an acronym for \"Sustainable and Green Amenities for the Greater Good.\"\n2. The SAGA concept emphasizes sustainable and environmentally friendly spaces and amenities.\n3. SAGA aims to promote a healthy lifestyle.\n4. The goal of SAGA is to create a positive impact on the environment and society.\n5. SAGA promotes sustainable development and responsible use of resources.",
    "vicuna-13b_fact": [
      "SAGA is an acronym for \"Sustainable and Green Amenities for the Greater Good.\"",
      "The SAGA concept emphasizes sustainable and environmentally friendly spaces and amenities.",
      "SAGA aims to promote a healthy lifestyle.",
      "The goal of SAGA is to create a positive impact on the environment and society.",
      "SAGA promotes sustainable development and responsible use of resources."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 716,
    "user_query": "What is the result of the interaction between TSC1 and PLK1?",
    "vicuna-13b_response": "TSC1 (Tuberous Sclerosis Complex 1) and PLK1 (Polycomb-like kinase 1) are two different proteins that play important roles in regulating cell growth and division. The interaction between TSC1 and PLK1 has been shown to be important in the development and progression of certain types of cancer.\nTSC1 is a tumor suppressor protein that functions as an antagonist of the mTOR (mechanistic target of rapamycin) signaling pathway, which is a key regulator of cell growth and division. TSC1 promotes cell growth arrest and senescence by inhibiting the mTOR pathway.\nPLK1, on the other hand, is a protein kinase that plays a role in regulating the cell cycle by controlling the progression from G1 to S phase. PLK1 is also involved in the regulation of mitotic progression and cytokinesis.\nThe interaction between TSC1 and PLK1 has been shown to be important in the regulation of cell growth and division. In particular, TSC1 has been shown to inhibit the activity of PLK1, leading to the accumulation of cells in the G1 phase of the cell cycle. This can result in the suppression of cell proliferation and the induction of cell cycle arrest.\nIn conclusion, the interaction between TSC1 and PLK1 is important in the regulation of cell growth and division, and dysregulation of this interaction has been implicated in the development and progression of certain types of cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TSC1 (Tuberous Sclerosis Complex 1) and PLK1 (Polycomb-like kinase 1) are two different proteins that play important roles in regulating cell growth and division.\n2. The interaction between TSC1 and PLK1 has been shown to be important in the development and progression of certain types of cancer.\n3. TSC1 functions as an antagonist of the mTOR (mechanistic target of rapamycin) signaling pathway.\n4. PLK1 is a protein kinase that plays a role in regulating the cell cycle by controlling the progression from G1 to S phase.\n5. TSC1 has been shown to inhibit the activity of PLK1, leading to the accumulation of cells in the G1 phase of the cell cycle.",
    "vicuna-13b_fact": [
      "TSC1 (Tuberous Sclerosis Complex 1) and PLK1 (Polycomb-like kinase 1) are two different proteins that play important roles in regulating cell growth and division.",
      "The interaction between TSC1 and PLK1 has been shown to be important in the development and progression of certain types of cancer.",
      "TSC1 functions as an antagonist of the mTOR (mechanistic target of rapamycin) signaling pathway.",
      "PLK1 is a protein kinase that plays a role in regulating the cell cycle by controlling the progression from G1 to S phase.",
      "TSC1 has been shown to inhibit the activity of PLK1, leading to the accumulation of cells in the G1 phase of the cell cycle."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. FALSE [correction]: PLK1 is a protein kinase that plays a role in regulating the cell cycle by controlling the progression from G2 to M phase.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 717,
    "user_query": "What are the characteristics of the \"Universal Proteomics Standard 2\" (UPS2)?",
    "vicuna-13b_response": "Universal Proteomics Standard 2 (UPS2) is a set of guidelines and standards for the quantitative and qualitative analysis of proteins in biological samples. Some of the key characteristics of UPS2 include:\n1. Coverage: UPS2 is designed to be comprehensive, covering a wide range of proteins and protein modifications in different biological samples.\n2. Quantitative: UPS2 is a quantitative standard, meaning that it provides guidelines for the quantification of proteins in biological samples.\n3. Reproducibility: UPS2 is designed to be reproducible, meaning that results obtained using UPS2 should be consistent and comparable across different laboratories and experiments.\n4. Scalability: UPS2 is scalable, meaning that it can be applied to a wide range of sample types and experimental designs.\n5. Open access: UPS2 is an open-access standard, meaning that it is freely available to researchers and can be used without restriction.\n6. Modular: UPS2 is modular, meaning that it can be customized and adapted to specific research questions and experimental designs.\n7. Standardized: UPS2 is standardized, meaning that it provides a standardized set of protocols and methods for the analysis of proteins in biological samples.\nOverall, UPS2 is a comprehensive and standardized set of guidelines and standards for the quantitative and qualitative analysis of proteins in biological samples, designed to be reproducible, scalable, and open-access.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Universal Proteomics Standard 2 (UPS2) is a set of guidelines and standards for the quantitative and qualitative analysis of proteins in biological samples.\n2. UPS2 is designed to cover a wide range of proteins and protein modifications in different biological samples.\n3. UPS2 provides guidelines for the quantification of proteins in biological samples.\n4. UPS2 is designed to be reproducible, ensuring consistent results across different laboratories and experiments.\n5. UPS2 is an open-access standard, freely available to researchers and can be used without restrictions.",
    "vicuna-13b_fact": [
      "Universal Proteomics Standard 2 (UPS2) is a set of guidelines and standards for the quantitative and qualitative analysis of proteins in biological samples.",
      "UPS2 is designed to cover a wide range of proteins and protein modifications in different biological samples.",
      "UPS2 provides guidelines for the quantification of proteins in biological samples.",
      "UPS2 is designed to be reproducible, ensuring consistent results across different laboratories and experiments.",
      "UPS2 is an open-access standard, freely available to researchers and can be used without restrictions."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Universal Proteomics Standard 2 (UPS2) is a mixture of proteins used for the standardization of proteomics research, not a set of guidelines.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 719,
    "user_query": "Which are the smallest known subviral pathogens of plants?",
    "vicuna-13b_response": "Subviral pathogens are small infectious agents that are smaller than viruses, but larger than bacteria and archaea. They are a diverse group of pathogens that can infect a wide range of hosts, including plants, animals, and fungi.\nIn terms of the smallest known subviral pathogens of plants, there are several candidates. One of the smallest is a group of agents called viroids. Viroids are small, single-stranded RNA molecules that replicate through a rolling-circle mechanism. They are typically around 240-300 nucleotides in length and are not enclosed by a lipid membrane.\nAnother group of subviral pathogens that can infect plants are the satellites. Satellites are small, single-stranded RNA or DNA molecules that require a helper virus to replicate. They are typically around 2-3 kilobases in length and can be found in a variety of plant hosts.\nIn addition to viroids and satellites, there are also other subviral pathogens that can infect plants, such as the circoviruses and the geminiviruses. Circoviruses are small, single-stranded DNA viruses that infect a wide range of plant hosts. Geminiviruses, on the other hand, are small, single-stranded DNA viruses that are specialized to infect plants in the family Geminiviridae.\nOverall, the smallest known subviral pathogens of plants are a diverse group of infectious agents that can cause a range of plant diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Viroids are among the smallest known subviral pathogens of plants.\n2. Viroids are small, single-stranded RNA molecules that replicate through a rolling-circle mechanism.\n3. Satellites are subviral pathogens that require a helper virus to replicate.\n4. Circoviruses and geminiviruses are other subviral pathogens that can infect plants.\n5. Geminiviruses are small, single-stranded DNA viruses that infect plants in the family Geminiviridae.",
    "vicuna-13b_fact": [
      "Viroids are among the smallest known subviral pathogens of plants.",
      "Viroids are small, single-stranded RNA molecules that replicate through a rolling-circle mechanism.",
      "Satellites are subviral pathogens that require a helper virus to replicate.",
      "Circoviruses and geminiviruses are other subviral pathogens that can infect plants.",
      "Geminiviruses are small, single-stranded DNA viruses that infect plants in the family Geminiviridae."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Geminiviruses are small, double-stranded DNA viruses that infect plants in the family Geminiviridae.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 720,
    "user_query": "What causes Katayama Fever?",
    "vicuna-13b_response": "Katayama fever is a rare and potentially life-threatening condition caused by the bacterium Francisella tularensis subspecies tularensis. It is a type of fever that is characterized by a sudden onset of high fever, chills, headache, and muscle aches. The bacteria that cause Katayama fever are usually found in animals, particularly in rodents and rabbits, and they can be transmitted to humans through contact with infected animal tissue, blood, or other fluids.\nThe bacteria can enter the body through cuts, wounds, or mucous membranes, such as the eyes, nose, or mouth. Once inside the body, the bacteria can multiply and cause an immune response that leads to inflammation and tissue damage. This can result in a range of symptoms, including fever, chills, headache, muscle aches, and fatigue.\nKatayama fever is a serious condition that requires prompt medical attention. If you suspect that you may have been exposed to the bacteria that cause Katayama fever, it is important to seek medical care immediately. Antibiotics are effective at treating the condition, but they must be started early in the course of the illness to be effective. In severe cases, hospitalization may be necessary to provide supportive care and monitor the patient's condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Katayama fever is caused by the bacterium Francisella tularensis subspecies tularensis.\n2. The bacteria that cause Katayama fever are usually found in animals, particularly in rodents and rabbits.\n3. The bacteria for Katayama fever can be transmitted to humans through contact with infected animal tissue, blood, or other fluids.\n4. Antibiotics are effective at treating Katayama fever, but they must be started early in the course of the illness to be effective.\n5. In severe cases of Katayama fever, hospitalization may be necessary to provide supportive care and monitor the patient's condition.",
    "vicuna-13b_fact": [
      "Katayama fever is caused by the bacterium Francisella tularensis subspecies tularensis.",
      "The bacteria that cause Katayama fever are usually found in animals, particularly in rodents and rabbits.",
      "The bacteria for Katayama fever can be transmitted to humans through contact with infected animal tissue, blood, or other fluids.",
      "Antibiotics are effective at treating Katayama fever, but they must be started early in the course of the illness to be effective.",
      "In severe cases of Katayama fever, hospitalization may be necessary to provide supportive care and monitor the patient's condition."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Katayama fever is caused by the parasite Schistosoma mansoni.\n2. FALSE [correction]: The parasite that cause Katayama fever are usually found in freshwater snails, not in rodents or rabbits.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "vicuna-13b_response": "Sarcopenia is the loss of muscle mass and strength that can occur with aging. Clinical trials are research studies that involve people, and they are designed to determine whether a treatment is safe and effective. Here are some examples of clinical trials that are focused on the prevention of sarcopenia:\n1. The Sarcopenia and Obesity: Rehabilitation, Exercise, and Nutrition (SOREAN) Study: This is a randomized controlled trial that is investigating the effectiveness of a comprehensive rehabilitation program, including exercise and nutrition counseling, in preventing or reversing sarcopenia in older adults.\n2. The Sarcopenia Prevention and Treatment Trial (SPOTT): This is a randomized controlled trial that is investigating the effectiveness of resistance training and nutritional supplementation in preventing or treating sarcopenia in older adults.\n3. The Sarcopenia in Older Adults: Prevention and Treatment (SOPHIA) Study: This is a randomized controlled trial that is investigating the effectiveness of a combination of exercise and nutritional supplementation in preventing or treating sarcopenia in older adults.\n4. The Effect of Exercise and Nutrition on Sarcopenia in Older Adults (ENSCO) Study: This is a randomized controlled trial that is investigating the effectiveness of a comprehensive exercise and nutrition program in preventing or treating sarcopenia in older adults.\nThese are just a few examples of clinical trials that are focused on the prevention of sarcopenia. It is important to note that these trials are still in progress, and it will be some time before the results are available. If you are interested in participating in a clinical trial, it is important to speak with your doctor or a research coordinator to determine whether you are eligible and to get more information about the trial.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Sarcopenia is the loss of muscle mass and strength that can occur with aging. \n2. The SOREAN Study is a randomized controlled trial focused on preventing or reversing sarcopenia in older adults using a comprehensive rehabilitation program, including exercise and nutrition counseling.\n3. The SPOTT is another randomized controlled trial studying the effectiveness of resistance training and nutritional supplementation in preventing or treating sarcopenia in older adults.\n4. The SOPHIA Study is a randomized controlled trial investigating the combination of exercise and nutritional supplementation in preventing or treating sarcopenia in older adults.\n5. The ENSCO Study is examining the effectiveness of a comprehensive exercise and nutrition program in preventing or treating sarcopenia in older adults through a randomized controlled trial.",
    "vicuna-13b_fact": [
      "Sarcopenia is the loss of muscle mass and strength that can occur with aging.",
      "The SOREAN Study is a randomized controlled trial focused on preventing or reversing sarcopenia in older adults using a comprehensive rehabilitation program, including exercise and nutrition counseling.",
      "The SPOTT is another randomized controlled trial studying the effectiveness of resistance training and nutritional supplementation in preventing or treating sarcopenia in older adults.",
      "The SOPHIA Study is a randomized controlled trial investigating the combination of exercise and nutritional supplementation in preventing or treating sarcopenia in older adults.",
      "The ENSCO Study is examining the effectiveness of a comprehensive exercise and nutrition program in preventing or treating sarcopenia in older adults through a randomized controlled trial."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "vicuna-13b_response": "There are several databases that contain information on molecular recognition features in membrane proteins. Some of the most well-known databases include:\n1. The Membrane Protein Data Bank (MPDB): This database contains a large collection of three-dimensional structures of membrane proteins, along with information on the molecular recognition features that are important for their function.\n2. The Protein Data Bank (PDB): This database contains a wide range of protein structures, including membrane proteins, and can be searched using various criteria, including molecular recognition features.\n3. The Comparative Membrane Protein Structure Database (COMPASS): This database provides a comprehensive collection of membrane protein structures and associated information, including details on molecular recognition features.\n4. The Molecular Recognition Database (MoRD): This database contains a large collection of molecular recognition data, including information on the interactions between proteins and small molecules, which can be used to study membrane protein function.\n5. The Membrane Protein Interaction Database (MPIDB): This database contains information on the interactions between membrane proteins and other proteins, lipids, and small molecules, including details on the molecular recognition features involved in these interactions.\nThese databases can be useful resources for researchers studying membrane protein function and molecular recognition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Membrane Protein Data Bank (MPDB) contains a large collection of three-dimensional structures of membrane proteins.\n2. The Protein Data Bank (PDB) includes a wide range of protein structures, which can be searched using various criteria.\n3. The Comparative Membrane Protein Structure Database (COMPASS) provides a comprehensive collection of membrane protein structures.\n4. The Molecular Recognition Database (MoRD) contains a large collection of molecular recognition data.\n5. The Membrane Protein Interaction Database (MPIDB) includes information on the interactions between membrane proteins and other proteins, lipids, and small molecules.",
    "vicuna-13b_fact": [
      "The Membrane Protein Data Bank (MPDB) contains a large collection of three-dimensional structures of membrane proteins.",
      "The Protein Data Bank (PDB) includes a wide range of protein structures, which can be searched using various criteria.",
      "The Comparative Membrane Protein Structure Database (COMPASS) provides a comprehensive collection of membrane protein structures.",
      "The Molecular Recognition Database (MoRD) contains a large collection of molecular recognition data.",
      "The Membrane Protein Interaction Database (MPIDB) includes information on the interactions between membrane proteins and other proteins, lipids, and small molecules."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 731,
    "user_query": "What kind of bonds are connecting keratin molecules?",
    "vicuna-13b_response": "Keratin is a type of protein that is found in the hair, skin, and nails. The bonds that connect keratin molecules are covalent bonds. These bonds are formed between the amino acid residues in the keratin molecule and give the protein its unique structure and properties. The specific type of covalent bond that connects keratin molecules is an ionic bond, which is formed between a positively charged amino acid residue and a negatively charged one. This type of bond is important for the stability and strength of the keratin protein, which is essential for the function of hair, skin, and nails.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Keratin is a type of protein found in hair, skin, and nails.\n2. The bonds that connect keratin molecules are covalent bonds.\n3. These covalent bonds are formed between the amino acid residues in the keratin molecule.\n4. The specific type of covalent bond that connects keratin molecules is an ionic bond.\n5. This type of bond contributes to the stability and strength of the keratin protein.",
    "vicuna-13b_fact": [
      "Keratin is a type of protein found in hair, skin, and nails.",
      "The bonds that connect keratin molecules are covalent bonds.",
      "These covalent bonds are formed between the amino acid residues in the keratin molecule.",
      "The specific type of covalent bond that connects keratin molecules is an ionic bond.",
      "This type of bond contributes to the stability and strength of the keratin protein."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The specific type of covalent bond that connects keratin molecules is a disulfide bond, not an ionic bond.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 734,
    "user_query": "What is the risk of developing acute myelogenous leukemia in Fanconi anemia?",
    "vicuna-13b_response": "Fanconi anemia is a rare genetic disorder that affects the body's ability to repair DNA damage. It is associated with an increased risk of developing certain types of cancer, including acute myelogenous leukemia (AML).\nAML is a type of cancer that affects the bone marrow and blood cells. It is characterized by the production of abnormal white blood cells, called leukemia cells, which do not function properly. These leukemia cells can accumulate in the bone marrow and interfere with the production of normal blood cells, leading to anemia, infections, and other complications.\nThe risk of developing AML in individuals with Fanconi anemia is higher than in the general population. According to the National Cancer Institute, the risk of developing AML in people with Fanconi anemia is estimated to be around 10-20%. This is much higher than the estimated 1-2% risk of developing AML in the general population.\nIt is important to note that not everyone with Fanconi anemia will develop AML, and some people with the disorder may never develop cancer. However, individuals with Fanconi anemia should be closely monitored for the development of cancer, and may require regular blood tests and other medical procedures to detect and treat any cancerous cells as early as possible.\nOverall, the risk of developing AML in individuals with Fanconi anemia is higher than in the general population, and close monitoring is necessary to detect and treat any cancerous cells as early as possible.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fanconi anemia is a rare genetic disorder that affects the body's ability to repair DNA damage.\n2. This disorder is associated with an increased risk of developing certain types of cancer, including acute myelogenous leukemia (AML).\n3. Acute myelogenous leukemia is a type of cancer that affects the bone marrow and blood cells, with the production of abnormal white blood cells called leukemia cells.\n4. The risk of developing acute myelogenous leukemia in individuals with Fanconi anemia is estimated to be around 10-20%, whereas in the general population it is estimated to be around 1-2%.\n5. Not all Fanconi anemia patients will develop acute myelogenous leukemia, but they should be closely monitored for the development of cancer.",
    "vicuna-13b_fact": [
      "Fanconi anemia is a rare genetic disorder that affects the body's ability to repair DNA damage.",
      "This disorder is associated with an increased risk of developing certain types of cancer, including acute myelogenous leukemia (AML).",
      "Acute myelogenous leukemia is a type of cancer that affects the bone marrow and blood cells, with the production of abnormal white blood cells called leukemia cells.",
      "The risk of developing acute myelogenous leukemia in individuals with Fanconi anemia is estimated to be around 10-20%, whereas in the general population it is estimated to be around 1-2%.",
      "Not all Fanconi anemia patients will develop acute myelogenous leukemia, but they should be closely monitored for the development of cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 735,
    "user_query": "How many different mutations have been associated with Muenke syndrome?",
    "vicuna-13b_response": "Muenke syndrome is a rare genetic disorder that is characterized by a specific pattern of physical features, including a flat face with a broad nose and puffy cheeks, a small jaw and chin, and a thin, long upper lip. The syndrome is caused by mutations in the FGFR3 gene, which plays a role in regulating the development of bones and other tissues.\nThere have been many different mutations that have been associated with Muenke syndrome. Over 100 different mutations have been identified in the FGFR3 gene, and it is thought that many more mutations may exist that have not yet been identified. These mutations can be either inherited from the person's parents or can occur spontaneously.\nIt is important to note that not all people with Muenke syndrome will have the exact same set of physical features. The severity and specific features of the syndrome can vary widely depending on the specific mutation that is present. Additionally, some people with Muenke syndrome may have other medical conditions or developmental delays in addition to the physical features of the syndrome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Muenke syndrome is a rare genetic disorder characterized by specific physical features.\n2. Muenke syndrome is caused by mutations in the FGFR3 gene.\n3. Over 100 different mutations have been identified in the FGFR3 gene related to Muenke syndrome.\n4. The mutations associated with Muenke syndrome can either be inherited or occur spontaneously.\n5. The severity and specific features of Muenke syndrome can vary widely depending on the specific mutation present.",
    "vicuna-13b_fact": [
      "Muenke syndrome is a rare genetic disorder characterized by specific physical features.",
      "Muenke syndrome is caused by mutations in the FGFR3 gene.",
      "Over 100 different mutations have been identified in the FGFR3 gene related to Muenke syndrome.",
      "The mutations associated with Muenke syndrome can either be inherited or occur spontaneously.",
      "The severity and specific features of Muenke syndrome can vary widely depending on the specific mutation present."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There is one specific mutation in the FGFR3 gene that is associated with Muenke syndrome.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 737,
    "user_query": "Which genes have been proposed as potential candidates for gene therapy of heart failure?",
    "vicuna-13b_response": "There are several genes that have been proposed as potential candidates for gene therapy of heart failure. Some of these genes include:\n1. Angiotensin-converting enzyme (ACE): ACE is an enzyme that plays a role in regulating blood pressure and fluid balance. Mutations in the ACE gene have been linked to an increased risk of heart failure.\n2. Beta-adrenergic receptor kinase (betaARK): BetaARK is a protein that plays a role in regulating the response of heart cells to beta-adrenergic stimulation. Mutations in the betaARK gene have been linked to an increased risk of heart failure.\n3. Calsequestrin 2 (CSQ2): CSQ2 is a protein that plays a role in regulating the contractility of heart muscle cells. Mutations in the CSQ2 gene have been linked to an increased risk of heart failure.\n4. Desmoplakin (DSP): DSP is a protein that plays a role in maintaining the structure of heart muscle cells. Mutations in the DSP gene have been linked to an increased risk of heart failure.\n5. Myosin binding protein C (MYBPC): MYBPC is a protein that plays a role in regulating the contraction of heart muscle cells. Mutations in the MYBPC gene have been linked to an increased risk of heart failure.\nIt is important to note that gene therapy is a complex and rapidly evolving field, and the effectiveness of these genes as potential candidates for gene therapy of heart failure is still being studied.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Angiotensin-converting enzyme (ACE) is an enzyme that can regulate blood pressure and fluid balance. \n2. Mutations in the ACE gene have been associated with an increased risk of heart failure.\n3. Beta-adrenergic receptor kinase is proposed to regulate the response of heart cells to beta-adrenergic stimulation.\n4. Mutations in the beta-adrenergic receptor kinase gene have been associated with an increased risk of heart failure.\n5. Myosin binding protein C (MYBPC) is a protein that is suggested to play a role in regulating the contraction of heart muscle cells.",
    "vicuna-13b_fact": [
      "Angiotensin-converting enzyme (ACE) is an enzyme that can regulate blood pressure and fluid balance.",
      "Mutations in the ACE gene have been associated with an increased risk of heart failure.",
      "Beta-adrenergic receptor kinase is proposed to regulate the response of heart cells to beta-adrenergic stimulation.",
      "Mutations in the beta-adrenergic receptor kinase gene have been associated with an increased risk of heart failure.",
      "Myosin binding protein C (MYBPC) is a protein that is suggested to play a role in regulating the contraction of heart muscle cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Mutations in the beta-adrenergic receptor kinase gene have not been directly associated with an increased risk of heart failure. Mutations in certain beta-adrenergic receptor genes, on the other hand, have been associated with heart diseases.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 738,
    "user_query": "DX-88 is investigational name of which drug?",
    "vicuna-13b_response": "I'm sorry, but I don't have information about a drug called DX-88. Could you provide more context or specify what type of drug DX-88 is?",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 740,
    "user_query": "Which genes have been found to be associated with restless leg syndrome",
    "vicuna-13b_response": "Restless leg syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations such as crawling, tingling, or burning. Several genes have been found to be associated with RLS, including:\n1. SLC12A1: This gene encodes a zinc transporter that is involved in the regulation of dopamine neurotransmission. Mutations in this gene have been found to be associated with RLS.\n2. BTBD9: This gene encodes a protein that functions as a transcriptional regulator. Mutations in this gene have been found to be associated with RLS.\n3. GBA: This gene encodes an enzyme involved in the catabolism of gangliosides. Mutations in this gene have been found to be associated with RLS.\n4. PRNP: This gene encodes a protein involved in the production of prions, which are abnormal forms of the protein. Mutations in this gene have been found to be associated with RLS.\n5. TREM2: This gene encodes a protein involved in the regulation of inflammation and the immune response. Mutations in this gene have been found to be associated with RLS.\nIt's important to note that these genes are not the only genes associated with RLS, and the exact genetic basis of RLS is still not fully understood. Additionally, genetics are thought to be one of the many contributing factors to the development of RLS, and environmental and lifestyle factors are also believed to play a role.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Restless leg syndrome is a neurological disorder characterized by an irresistible urge to move the legs.\n2. The gene SLC12A1 has been found to be associated with Restless Leg Syndrome.\n3. The gene BTBD9 has been found to be associated with Restless Leg Syndrome.\n4. The gene GBA has been found to be associated with Restless Leg Syndrome.\n5. The gene PRNP has been found to be associated with Restless Leg Syndrome.\n6. The gene TREM2 has been found to be associated with Restless Leg Syndrome.",
    "vicuna-13b_fact": [
      "Restless leg syndrome is a neurological disorder characterized by an irresistible urge to move the legs.",
      "The gene SLC12A1 has been found to be associated with Restless Leg Syndrome.",
      "The gene BTBD9 has been found to be associated with Restless Leg Syndrome.",
      "The gene GBA has been found to be associated with Restless Leg Syndrome.",
      "The gene PRNP has been found to be associated with Restless Leg Syndrome.",
      "The gene TREM2 has been found to be associated with Restless Leg Syndrome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The gene SLC12A1 has not been found to be associated with Restless Leg Syndrome.\n3. TRUE\n4. FALSE [correction]: The gene GBA has not been found to be associated with Restless Leg Syndrome.\n5. TRUE\n6. FALSE [correction]: The gene TREM2 has not been found to be associated with Restless Leg Syndrome.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 743,
    "user_query": "Do the Sleeping Beauty or the piggyBac transposons have higher transposition efficiency?",
    "vicuna-13b_response": "The Sleeping Beauty (SB) and piggyBac transposons are two different types of transposable elements that can move around in the genome. The transposition efficiency of a transposon refers to how efficiently it can move from one location in the genome to another.\nBoth the SB and piggyBac transposons have been shown to have high transposition efficiency in different contexts. The SB transposon has been reported to have a transposition frequency of up to 1 in 1000 base pairs, while the piggyBac transposon has been reported to have a transposition frequency of up to 1 in 100 base pairs.\nHowever, it is important to note that the transposition efficiency of a transposon can vary depending on the specific conditions and the host organism in which it is present. Additionally, different studies may use different methods to measure transposition efficiency, which can lead to variations in the reported frequencies.\nOverall, both the SB and piggyBac transposons are known to have high transposition efficiency, but the exact level of efficiency can depend on the specific context in which they are studied.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Sleeping Beauty (SB) and piggyBac transposons are two different types of transposable elements that can move around in the genome.\n2. The transposition efficiency of a transposon refers to how efficiently it can move from one location in the genome to another.\n3. The SB transposon has been reported to have a transposition frequency of up to 1 in 1000 base pairs.\n4. The piggyBac transposon has been reported to have a transposition frequency of up to 1 in 100 base pairs. \n5. The transposition efficiency of a transposon can vary depending on the specific conditions and the host organism in which it is present.",
    "vicuna-13b_fact": [
      "The Sleeping Beauty (SB) and piggyBac transposons are two different types of transposable elements that can move around in the genome.",
      "The transposition efficiency of a transposon refers to how efficiently it can move from one location in the genome to another.",
      "The SB transposon has been reported to have a transposition frequency of up to 1 in 1000 base pairs.",
      "The piggyBac transposon has been reported to have a transposition frequency of up to 1 in 100 base pairs.",
      "The transposition efficiency of a transposon can vary depending on the specific conditions and the host organism in which it is present."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 744,
    "user_query": "Where does TORC1 sequester during heat stress?",
    "vicuna-13b_response": "TORC1 is a complex of proteins that regulate cell growth and metabolism in response to nutrient availability and other signals. During heat stress, TORC1 activity is inhibited in order to protect cells from damage.\nOne way that TORC1 activity is inhibited during heat stress is through the action of the heat shock factor 1 (HSF1) protein. HSF1 is activated by heat stress and promotes the transcription of genes that encode proteins involved in the heat shock response, including the inhibition of TORC1.\nIn addition to the inhibition of TORC1 by HSF1, other mechanisms may also be involved in regulating TORC1 activity during heat stress. For example, some studies have suggested that TORC1 activity may be regulated by changes in the levels of certain amino acids, such as glutamine, during heat stress.\nOverall, the regulation of TORC1 during heat stress is a complex process that involves multiple mechanisms and pathways. Further research is needed to fully understand the specific ways in which TORC1 activity is regulated during heat stress and how this regulation contributes to the overall response of cells to high temperatures.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TORC1 is a complex of proteins that regulate cell growth and metabolism in response to nutrient availability and other signals.\n2. TORC1 activity is inhibited during heat stress.\n3. Heat shock factor 1 (HSF1) protein is activated by heat stress and inhibits TORC1.\n4. HSF1 promotes the transcription of genes that encode proteins involved in the heat shock response.\n5. Some studies suggest that TORC1 activity may be regulated by changes in the levels of certain amino acids, such as glutamine, during heat stress.",
    "vicuna-13b_fact": [
      "TORC1 is a complex of proteins that regulate cell growth and metabolism in response to nutrient availability and other signals.",
      "TORC1 activity is inhibited during heat stress.",
      "Heat shock factor 1 (HSF1) protein is activated by heat stress and inhibits TORC1.",
      "HSF1 promotes the transcription of genes that encode proteins involved in the heat shock response.",
      "Some studies suggest that TORC1 activity may be regulated by changes in the levels of certain amino acids, such as glutamine, during heat stress."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Heat shock factor 1 (HSF1) protein is activated by heat stress but doesn't inhibit TORC1.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "vicuna-13b_response": "Yes, rivaroxaban is metabolized in the kidneys. Rivaroxaban is an oral anticoagulant medication that is used to prevent blood clots from forming in the body. It is a direct factor Xa inhibitor and works by inhibiting the activity of factor Xa, which is an enzyme that plays a role in the coagulation cascade.\nRivaroxaban is metabolized in the liver and kidneys by enzymes such as CYP3A4 and CYP2J2. The metabolism of rivaroxaban results in the formation of several active and inactive metabolites. The active metabolites of rivaroxaban have similar anticoagulant activity as the parent compound, while the inactive metabolites are eliminated from the body in the urine.\nIt is important to note that the metabolism of rivaroxaban can be affected by other medications that a patient is taking, as well as by certain genetic factors. Therefore, the dosage and monitoring of rivaroxaban therapy should be individualized based on the patient's specific medical condition and other factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Rivaroxaban is metabolized in the kidneys.\n2. Rivaroxaban is an oral anticoagulant medication that is used to prevent blood clots.\n3. It works by inhibiting the activity of factor Xa, an enzyme involved in the coagulation cascade.\n4. Rivaroxaban is metabolized by enzymes such as CYP3A4 and CYP2J2 in the liver and kidneys.\n5. The inactive metabolites of rivaroxaban are eliminated from the body in the urine.",
    "vicuna-13b_fact": [
      "Rivaroxaban is metabolized in the kidneys.",
      "Rivaroxaban is an oral anticoagulant medication that is used to prevent blood clots.",
      "It works by inhibiting the activity of factor Xa, an enzyme involved in the coagulation cascade.",
      "Rivaroxaban is metabolized by enzymes such as CYP3A4 and CYP2J2 in the liver and kidneys.",
      "The inactive metabolites of rivaroxaban are eliminated from the body in the urine."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Rivaroxaban is metabolized in the liver.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 746,
    "user_query": "What are the side effects of Nalmefene?",
    "vicuna-13b_response": "Nalmefene is a medication that is primarily used to treat alcohol and opioid dependence. It works by reducing cravings for alcohol or opioids and decreasing the pleasurable effects of these substances.\nThe most common side effects of nalmefene include:\n1. Nausea\n2. Vomiting\n3. Headache\n4. Fatigue\n5. Insomnia\n6. Dizziness\n7. Constipation\n8. Rash\n9. Itching\n10. Tremors\nIt is important to note that nalmefene can cause serious side effects, including:\n1. Liver problems\n2. Increased risk of suicidal thoughts and behaviors in people with a history of suicide attempt or ideation\n3. Interaction with other medications, including opioid pain relievers, benzodiazepines, and some antibiotics\nIt is important to follow your doctor's instructions carefully when taking nalmefene and to report any side effects or concerns promptly.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nalmefene is used to treat alcohol and opioid dependence.\n2. Nalmefene works by reducing cravings for alcohol or opioids and decreasing the pleasurable effects of these substances.\n3. Common side effects of nalmefene include nausea, vomiting, headache, fatigue, insomnia, dizziness, constipation, rash, itching, and tremors. \n4. Nalmefene can cause serious side effects, including liver problems, increased risk of suicidal thoughts and behaviors in people with a history of suicide attempt or ideation, and interaction with other medications. \n5. It is important to follow your doctor's instructions carefully when taking nalmefene and to report any side effects or concerns promptly.",
    "vicuna-13b_fact": [
      "Nalmefene is used to treat alcohol and opioid dependence.",
      "Nalmefene works by reducing cravings for alcohol or opioids and decreasing the pleasurable effects of these substances.",
      "Common side effects of nalmefene include nausea, vomiting, headache, fatigue, insomnia, dizziness, constipation, rash, itching, and tremors.",
      "Nalmefene can cause serious side effects, including liver problems, increased risk of suicidal thoughts and behaviors in people with a history of suicide attempt or ideation, and interaction with other medications.",
      "It is important to follow your doctor's instructions carefully when taking nalmefene and to report any side effects or concerns promptly."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 756,
    "user_query": "Which is the E3 ubiquitin ligase of Hsp90?",
    "vicuna-13b_response": "The E3 ubiquitin ligase that targets Hsp90 for degradation is called Hsp90 binding protein (HSPBP). HSPBP is a protein that interacts with Hsp90 and ubiquitin-conjugating enzymes (E2s) to form a complex that promotes the degradation of Hsp90 through the ubiquitin-proteasome pathway. HSPBP recognizes and binds to Hsp90, and then recruits E2s to the complex, which then ubiquitinates Hsp90, leading to its degradation by the proteasome. HSPBP plays a critical role in regulating the levels of Hsp90 in cells, and mutations in HSPBP have been linked to various neurodegenerative diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The E3 ubiquitin ligase that targets Hsp90 for degradation is called Hsp90 binding protein (HSPBP).\n2. HSPBP interacts with Hsp90 and ubiquitin-conjugating enzymes to form a complex.\n3. This complex promotes the degradation of Hsp90 through the ubiquitin-proteasome pathway.\n4. HSPBP plays a vital role in regulating the levels of Hsp90 in cells.\n5. Mutations in HSPBP have been linked to various neurodegenerative diseases.",
    "vicuna-13b_fact": [
      "The E3 ubiquitin ligase that targets Hsp90 for degradation is called Hsp90 binding protein (HSPBP).",
      "HSPBP interacts with Hsp90 and ubiquitin-conjugating enzymes to form a complex.",
      "This complex promotes the degradation of Hsp90 through the ubiquitin-proteasome pathway.",
      "HSPBP plays a vital role in regulating the levels of Hsp90 in cells.",
      "Mutations in HSPBP have been linked to various neurodegenerative diseases."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 757,
    "user_query": "Which are the major phycobiliproteins present in cyanobacteria?",
    "vicuna-13b_response": "Cyanobacteria are a type of bacteria that can perform photosynthesis and are capable of producing energy from sunlight. They are also known as blue-green algae. Phycobiliproteins are pigments that are present in cyanobacteria and other types of photosynthetic bacteria. These pigments play a crucial role in the process of photosynthesis by capturing light energy and converting it into chemical energy.\nThere are three major types of phycobiliproteins that are present in cyanobacteria: phycocyanin, phycoerythrin, and allophycocyanin.\n1. Phycocyanin: Phycocyanin is a blue or green pigment that is present in many species of cyanobacteria. It is made up of large molecules that contain a central magnesium ion and are surrounded by multiple pigment molecules. Phycocyanin is involved in the process of light absorption during photosynthesis.\n2. Phycoerythrin: Phycoerythrin is a red or yellow pigment that is present in many species of cyanobacteria. It is made up of smaller molecules than phycocyanin and contains a central iron ion. Phycoerythrin is involved in the process of light absorption during photosynthesis.\n3. Allophycocyanin: Allophycocyanin is a blue or green pigment that is present in some species of cyanobacteria. It is made up of smaller molecules than phycocyanin and contains a central zinc ion. Allophycocyanin is involved in the process of light absorption during photosynthesis.\nIn summary, phycobiliproteins are pigments that are present in cyanobacteria and play a crucial role in the process of photosynthesis. The three major types of phycobiliproteins present in cyanobacteria are phycocyanin, phycoerythrin, and allophycocyanin, which are involved in the process of light absorption during photosynthesis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cyanobacteria are capable of performing photosynthesis and producing energy from sunlight.\n2. Phycobiliproteins are pigments present in cyanobacteria that play a crucial role in photosynthesis by converting light energy into chemical energy.\n3. Three major types of phycobiliproteins in cyanobacteria are phycocyanin, phycoerythrin, and allophycocyanin.\n4. Phycocyanin is a blue or green pigment present in many species of cyanobacteria and has a central magnesium ion.\n5. Phycoerythrin is a red or yellow pigment in many species of cyanobacteria and contains a central iron ion.",
    "vicuna-13b_fact": [
      "Cyanobacteria are capable of performing photosynthesis and producing energy from sunlight.",
      "Phycobiliproteins are pigments present in cyanobacteria that play a crucial role in photosynthesis by converting light energy into chemical energy.",
      "Three major types of phycobiliproteins in cyanobacteria are phycocyanin, phycoerythrin, and allophycocyanin.",
      "Phycocyanin is a blue or green pigment present in many species of cyanobacteria and has a central magnesium ion.",
      "Phycoerythrin is a red or yellow pigment in many species of cyanobacteria and contains a central iron ion."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Phycocyanin is a blue pigment present in many species of cyanobacteria and does not have a central magnesium ion; it has a phycocyanobilin chromophore attached.\n5. FALSE [correction]: Phycoerythrin is a red pigment in many species of cyanobacteria and does not contain a central iron ion; it has phycoerythrobilin chromophores attached.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 759,
    "user_query": "In which kingdom do microsporidia belong, according to their current classification scheme?",
    "vicuna-13b_response": "Microsporidia belong to the kingdom Microspora, according to the current classification scheme. Microspora is a small kingdom of fungi that includes only a few species, and it is characterized by the presence of spores that are typically smaller than those of other fungi. Microsporidia are parasites that can infect a wide range of hosts, including animals and plants, and they are known for their complex life cycles and unique biology.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. According to the current classification scheme, Microsporidia belong to the kingdom Microspora.\n2. Microspora is a small kingdom of fungi.\n3. Spores in the kingdom Microspora are typically smaller than those of other fungi.\n4. Microsporidia can infect a wide range of hosts, including animals and plants.\n5. Microsporidia are known for their complex life cycles and unique biology.",
    "vicuna-13b_fact": [
      "According to the current classification scheme, Microsporidia belong to the kingdom Microspora.",
      "Microspora is a small kingdom of fungi.",
      "Spores in the kingdom Microspora are typically smaller than those of other fungi.",
      "Microsporidia can infect a wide range of hosts, including animals and plants.",
      "Microsporidia are known for their complex life cycles and unique biology."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: According to the current classification scheme, Microsporidia belong to the kingdom Fungi.\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "vicuna-13b_response": "TRα2 (also known as TR2) is a transcription factor that plays a role in the regulation of several genes involved in cardiac development and function. Some of the genes that have been shown to be regulated by TRα2 in the heart include:\n1. Ankyrin-2: TRα2 has been shown to regulate the expression of Ankyrin-2, a protein that is important for the formation of cardiac sarcomeres and the maintenance of cardiac muscle integrity.\n2. Beta-myosin heavy chain: TRα2 has been shown to regulate the expression of Beta-myosin heavy chain, a protein that is important for the contraction of cardiac muscle.\n3. Cardiac troponin I: TRα2 has been shown to regulate the expression of Cardiac troponin I, a protein that is important for the regulation of muscle contraction in the heart.\n4. Nkx2-5: TRα2 has been shown to regulate the expression of Nkx2-5, a transcription factor that is important for the development and differentiation of cardiac muscle cells.\n5. GATA4: TRα2 has been shown to regulate the expression of GATA4, a transcription factor that is important for the development and function of the heart.\nThese are just a few examples of the genes that have been shown to be regulated by TRα2 in the heart. It is important to note that the specific genes regulated by TRα2 can vary depending on the context and the stage of development or disease being studied.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TRα2 is a transcription factor that regulates several genes involved in cardiac development and function.\n2. TRα2 regulates the expression of Ankyrin-2, a protein important for the formation of cardiac sarcomeres and the maintenance of cardiac muscle integrity.\n3. TRα2 regulates the expression of Beta-myosin heavy chain, which is important for the contraction of cardiac muscle.\n4. TRα2 regulates the expression of Cardiac troponin I, a protein that is vital for the regulation of muscle contraction in the heart.\n5. TRα2 also regulates the expression of Nkx2-5, a transcription factor essential for the development and differentiation of cardiac muscle cells.\n6. Finally, TRα2 has been found to regulate the expression of GATA4, another transcription factor crucial for the development and function of the heart.",
    "vicuna-13b_fact": [
      "TRα2 is a transcription factor that regulates several genes involved in cardiac development and function.",
      "TRα2 regulates the expression of Ankyrin-2, a protein important for the formation of cardiac sarcomeres and the maintenance of cardiac muscle integrity.",
      "TRα2 regulates the expression of Beta-myosin heavy chain, which is important for the contraction of cardiac muscle.",
      "TRα2 regulates the expression of Cardiac troponin I, a protein that is vital for the regulation of muscle contraction in the heart.",
      "TRα2 also regulates the expression of Nkx2-5, a transcription factor essential for the development and differentiation of cardiac muscle cells.",
      "Finally, TRα2 has been found to regulate the expression of GATA4, another transcription factor crucial for the development and function of the heart."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n6. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 767,
    "user_query": "Is tubulin acetylation involved in cell motility?",
    "vicuna-13b_response": "Yes, tubulin acetylation is involved in cell motility. Tubulin is a key component of microtubules, which are dynamic structures that play a crucial role in cellular transport, cell division, and cell motility. Acetylation of tubulin has been shown to regulate microtubule dynamics and stability, and this in turn can influence cell motility.\nStudies have shown that alterations in tubulin acetylation levels can affect the ability of cells to move and migrate. For example, increased tubulin acetylation has been linked to impaired cell migration and reduced cell motility, while decreased tubulin acetylation has been associated with enhanced cell migration and increased cell motility.\nThe exact mechanisms by which tubulin acetylation regulates cell motility are not fully understood, but it is thought to involve changes in microtubule dynamics and stability, as well as effects on the interactions between microtubules and other cellular structures.\nOverall, the role of tubulin acetylation in cell motility is an active area of research, and further studies are needed to fully understand the underlying mechanisms and to determine the potential therapeutic applications of targeting tubulin acetylation in cell motility.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tubulin acetylation is involved in cell motility.\n2. Tubulin is a key component of microtubules, which are involved in cellular transport, cell division, and cell motility.\n3. Acetylation of tubulin regulates microtubule dynamics and stability.\n4. Increased tubulin acetylation has been linked to impaired cell migration and reduced cell motility.\n5. Decreased tubulin acetylation has been associated with enhanced cell migration and increased cell motility.",
    "vicuna-13b_fact": [
      "Tubulin acetylation is involved in cell motility.",
      "Tubulin is a key component of microtubules, which are involved in cellular transport, cell division, and cell motility.",
      "Acetylation of tubulin regulates microtubule dynamics and stability.",
      "Increased tubulin acetylation has been linked to impaired cell migration and reduced cell motility.",
      "Decreased tubulin acetylation has been associated with enhanced cell migration and increased cell motility."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 768,
    "user_query": "List available genetic multicolor cell labeling techiniques in Drosophila",
    "vicuna-13b_response": "There are several genetic multicolor cell labeling techniques available for use in Drosophila (fruit fly) research. Some of the most commonly used techniques include:\n1. GAL4/UAS: This technique uses the GAL4 transcription factor and UAS (upstream activating sequence) promoter to drive the expression of fluorescent proteins in specific cell types or developmental stages.\n2. Flp/FRT: This technique uses the Flp and FRT (flp-out recombination target) systems to excise a specific gene of interest and replace it with a fluorescent reporter gene.\n3. Transgenic flies: This technique involves the introduction of a transgene into the genome of Drosophila, which can be used to express fluorescent proteins in specific cell types or developmental stages.\n4. CRISPR/Cas9: This technique uses the CRISPR/Cas9 system to edit the genome of Drosophila, allowing for the insertion or deletion of fluorescent reporter genes in specific locations.\n5. Phosphorescent in situ hybridization (P-FISH): This technique uses phosphorescent probes to label specific RNA molecules in Drosophila, allowing for the visualization of gene expression in specific cell types or developmental stages.\nThese techniques can be used in combination to provide a multi-dimensional view of gene expression and cellular processes in Drosophila, and are widely used in research to study various aspects of development, cell biology, and disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GAL4/UAS is a genetic multicolor cell labeling technique used in Drosophila research.\n2. Flp/FRT is another technique used, which involves excising a specific gene of interest and replacing it with a fluorescent reporter gene.\n3. Creating transgenic flies, involving the introduction of a transgene into the genome of Drosophila, is also a technique used.\n4. CRISPR/Cas9 can be used in Drosophila research to edit the genome, allowing for the insertion or deletion of fluorescent reporter genes in specific locations.\n5. Phosphorescent in situ hybridization (P-FISH) uses phosphorescent probes to label specific RNA molecules in Drosophila.",
    "vicuna-13b_fact": [
      "GAL4/UAS is a genetic multicolor cell labeling technique used in Drosophila research.",
      "Flp/FRT is another technique used, which involves excising a specific gene of interest and replacing it with a fluorescent reporter gene.",
      "Creating transgenic flies, involving the introduction of a transgene into the genome of Drosophila, is also a technique used.",
      "CRISPR/Cas9 can be used in Drosophila research to edit the genome, allowing for the insertion or deletion of fluorescent reporter genes in specific locations.",
      "Phosphorescent in situ hybridization (P-FISH) uses phosphorescent probes to label specific RNA molecules in Drosophila."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Fluorescent in situ hybridization (FISH) uses fluorescent probes to label specific RNA molecules in Drosophila.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 769,
    "user_query": "Which growth factors are known to be involved in the induction of EMT?",
    "vicuna-13b_response": "Several growth factors are known to be involved in the induction of EMT (Epithelial-Mesenchymal Transition), a process by which epithelial cells lose their epithelial characteristics and acquire a mesenchymal phenotype. Some of the key growth factors involved in EMT include:\n1. TGF-β: Transforming growth factor beta (TGF-β) is a potent inducer of EMT. TGF-β is a cytokine that is secreted by a variety of cell types, including fibroblasts, macrophages, and T cells. TGF-β signaling is activated in response to injury or inflammation, and it promotes the transition of epithelial cells to a mesenchymal phenotype.\n2. PDGF: Platelet-derived growth factor (PDGF) is a potent mitogen that can stimulate the proliferation and differentiation of a variety of cell types, including fibroblasts and smooth muscle cells. PDGF signaling has been shown to play a role in the induction of EMT in several cell types.\n3. FGF: Fibroblast growth factors (FGF) are a family of proteins that are involved in a variety of biological processes, including cell growth, differentiation, and migration. Several members of the FGF family have been shown to play a role in the induction of EMT.\n4. Wnt: The Wnt signaling pathway is a highly conserved signaling pathway that is involved in the regulation of cell proliferation, differentiation, and migration. Wnt signaling has been shown to play a role in the induction of EMT in several cell types.\n5. HGF: Hepatocyte growth factor (HGF) is a potent mitogen that promotes the proliferation and differentiation of a variety of cell types, including fibroblasts and smooth muscle cells. HGF signaling has been shown to play a role in the induction of EMT in several cell types.\nOverall, these growth factors are known to play a role in the induction of EMT, a process that is involved in a variety of biological processes, including tissue repair, regeneration, and",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Several growth factors are known to be involved in the induction of EMT, a process by which epithelial cells lose their characteristics and acquire a mesenchymal phenotype.\n2. Transforming growth factor beta (TGF-β) is a potent inducer of EMT and it promotes the transition of epithelial cells to a mesenchymal phenotype.\n3. Platelet-derived growth factor (PDGF) stimulates the proliferation and differentiation of a variety of cell types and plays a role in the induction of EMT.\n4. Fibroblast growth factors (FGF) are involved in cell growth, differentiation, and migration, and several members of the FGF family play a role in the induction of EMT.\n5. The Wnt signaling pathway is involved in the regulation of cell proliferation, differentiation, and migration and it plays a role in the induction of EMT.\n6. Hepatocyte growth factor (HGF) promotes the proliferation and differentiation of a variety of cell types and has been shown to play a role in the induction of EMT.",
    "vicuna-13b_fact": [
      "Several growth factors are known to be involved in the induction of EMT, a process by which epithelial cells lose their characteristics and acquire a mesenchymal phenotype.",
      "Transforming growth factor beta (TGF-β) is a potent inducer of EMT and it promotes the transition of epithelial cells to a mesenchymal phenotype.",
      "Platelet-derived growth factor (PDGF) stimulates the proliferation and differentiation of a variety of cell types and plays a role in the induction of EMT.",
      "Fibroblast growth factors (FGF) are involved in cell growth, differentiation, and migration, and several members of the FGF family play a role in the induction of EMT.",
      "The Wnt signaling pathway is involved in the regulation of cell proliferation, differentiation, and migration and it plays a role in the induction of EMT.",
      "Hepatocyte growth factor (HGF) promotes the proliferation and differentiation of a variety of cell types and has been shown to play a role in the induction of EMT."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 774,
    "user_query": "Which histone modification discriminates between active and poised enhancers?",
    "vicuna-13b_response": "One histone modification that is commonly used to discriminate between active and poised enhancers is the presence or absence of the histone modification called H3K4me1.\nH3K4me1 is a mark that is typically associated with active enhancers, while poised enhancers tend to have lower levels or no detectable levels of this modification. This difference in H3K4me1 levels can be used to distinguish between active and poised enhancers, as well as to identify potential regulatory elements in the genome.\nIt's worth noting that other histone modifications can also be used to distinguish between active and poised enhancers, and the specific modifications used can depend on the context and the research question being addressed.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The histone modification H3K4me1 is used to distinguish between active and poised enhancers.\n2. H3K4me1 is usually associated with active enhancers.\n3. Poised enhancers tend to have lower or no detectable levels of H3K4me1.\n4. The difference in H3K4me1 levels can be used to identify potential regulatory elements in the genome.\n5. Other histone modifications can also be used to distinguish between active and poised enhancers.",
    "vicuna-13b_fact": [
      "The histone modification H3K4me1 is used to distinguish between active and poised enhancers.",
      "H3K4me1 is usually associated with active enhancers.",
      "Poised enhancers tend to have lower or no detectable levels of H3K4me1.",
      "The difference in H3K4me1 levels can be used to identify potential regulatory elements in the genome.",
      "Other histone modifications can also be used to distinguish between active and poised enhancers."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Poised enhancers also tend to have H3K4me1, but lack the specific activation-related marks like H3K27ac that active enhancers have.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 776,
    "user_query": "What is the inheritance pattern of Li–Fraumeni syndrome?",
    "vicuna-13b_response": "Li–Fraumeni syndrome (LFS) is a rare genetic disorder that is inherited in an autosomal dominant pattern. This means that a person has a 50% chance of inheriting the gene mutation from an affected parent, and a 50% chance of inheriting it from an unaffected parent.\nWhen a person with LFS has a child, there is a 50% chance that the child will inherit the gene mutation and a 50% chance that the child will not inherit the mutation. If the child does not inherit the mutation, they cannot pass the condition on to their children.\nIt's important to note that not everyone with LFS will have children, and some people may choose not to have children for various reasons. Additionally, there are other ways to have children, such as adoption or using a sperm or egg donor, that can be considered for people who are affected by LFS.\nIt's also important to note that genetic counseling is recommended for people who are affected by LFS or who are at risk of inheriting the condition, as it can provide information and support to help people make informed decisions about their reproductive options.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Li-Fraumeni syndrome is a rare genetic disorder.\n2. Li-Fraumeni syndrome is inherited in an autosomal dominant pattern.\n3. A person has a 50% chance of inheriting the gene mutation from an affected parent.\n4. If the child does not inherit the mutation, they cannot pass the condition on to their children.\n5. Genetic counseling is recommended for people who are affected by LFS or who are at risk of inheriting the condition.",
    "vicuna-13b_fact": [
      "Li-Fraumeni syndrome is a rare genetic disorder.",
      "Li-Fraumeni syndrome is inherited in an autosomal dominant pattern.",
      "A person has a 50% chance of inheriting the gene mutation from an affected parent.",
      "If the child does not inherit the mutation, they cannot pass the condition on to their children.",
      "Genetic counseling is recommended for people who are affected by LFS or who are at risk of inheriting the condition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 781,
    "user_query": "Which are the synonyms of prostate-specific antigen?",
    "vicuna-13b_response": "Prostate-specific antigen (PSA) is a protein produced by the prostate gland. It is often used as a biomarker for prostate cancer, but it can also be elevated in other conditions such as prostatitis and benign prostatic hyperplasia (BPH). Here are some synonyms for PSA:\n1. Prostate-specific acid phosphatase (PSAP)\n2. Prostate-specific protein (PSP)\n3. Prostate-specific antigen-1 (PSA-1)\n4. Prostate-specific antigen-2 (PSA-2)\n5. Prostate-specific antigen-3 (PSA-3)\n6. Prostate-specific antigen-4 (PSA-4)\n7. Prostate-specific antigen-5 (PSA-5)\n8. Prostate-specific antigen-6 (PSA-6)\n9. Prostate-specific antigen-7 (PSA-7)\n10. Prostate-specific antigen-8 (PSA-8)\nIt's important to note that not all of these synonyms may be used interchangeably, and some may refer to specific isoforms of PSA.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Prostate-specific antigen (PSA) is a protein produced by the prostate gland. \n2. PSA is often used as a biomarker for prostate cancer.\n3. PSA can be elevated in other conditions such as prostatitis and benign prostatic hyperplasia. \n4. Prostate-specific acid phosphatase (PSAP) is a synonym for PSA.\n5. Some synonyms for PSA may refer to specific isoforms of PSA.",
    "vicuna-13b_fact": [
      "Prostate-specific antigen (PSA) is a protein produced by the prostate gland.",
      "PSA is often used as a biomarker for prostate cancer.",
      "PSA can be elevated in other conditions such as prostatitis and benign prostatic hyperplasia.",
      "Prostate-specific acid phosphatase (PSAP) is a synonym for PSA.",
      "Some synonyms for PSA may refer to specific isoforms of PSA."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Prostate-specific acid phosphatase (PSAP) is not a synonym for PSA, but instead, it is a different enzyme that is also produced by the prostate gland.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 783,
    "user_query": "What is the function of circular RNA?",
    "vicuna-13b_response": "Circular RNA (circRNA) is a type of non-coding RNA that is processed from larger RNA precursors and is characterized by a covalently closed loop structure. CircRNA has been found to play important roles in various cellular processes, including gene regulation, protein synthesis, and cellular metabolism.\nOne of the key functions of circRNA is as a regulator of gene expression. CircRNA can bind to messenger RNA (mRNA) molecules and prevent them from being translated into proteins, thereby regulating the expression of specific genes. This process is known as RNA interference (RNAi), and it is a mechanism for controlling gene expression that is conserved across many different organisms.\nIn addition to its role in gene regulation, circRNA has also been implicated in the regulation of protein synthesis and cellular metabolism. For example, circRNA can act as a scaffold for the assembly of protein complexes, or it can bind to enzymes and modulate their activity.\nOverall, the function of circRNA is complex and multifaceted, and further research is needed to fully understand its role in cellular processes and its potential as a therapeutic target.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Circular RNA (circRNA) is a type of non-coding RNA.\n2. CircRNA is processed from larger RNA precursors and is characterized by a covalently closed loop structure.\n3. One of the key functions of circRNA is as a regulator of gene expression.\n4. CircRNA can bind to messenger RNA molecules and prevent them from being translated into proteins.\n5. In addition to gene regulation, circRNA has also been implicated in the regulation of protein synthesis and cellular metabolism.",
    "vicuna-13b_fact": [
      "Circular RNA (circRNA) is a type of non-coding RNA.",
      "CircRNA is processed from larger RNA precursors and is characterized by a covalently closed loop structure.",
      "One of the key functions of circRNA is as a regulator of gene expression.",
      "CircRNA can bind to messenger RNA molecules and prevent them from being translated into proteins.",
      "In addition to gene regulation, circRNA has also been implicated in the regulation of protein synthesis and cellular metabolism."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: CircRNA can bind to microRNA molecules and prevent them from regulating (usually inhibiting) gene expression.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "vicuna-13b_response": "There are several biomedical question answering systems available, including:\n1. BM25: A statistical model that uses a combination of term frequency and inverse document frequency to rank the relevance of documents to a given query.\n2. MedSpacy: A biomedical text mining library built on top of the Spacy library that provides tools for text preprocessing, entity recognition, and relation extraction.\n3. BERT: A pre-trained language model that can be fine-tuned for biomedical question answering tasks using a variety of neural network architectures.\n4. Unified Medical Language System (UMLS): A set of integrated biomedical terminologies and ontologies that can be used for question answering, information retrieval, and other biomedical text processing tasks.\n5. Neural Information Processing System (NIPS): A collection of biomedical datasets and tools for training and evaluating machine learning models for question answering tasks.\n6. PubMed Query Language (PubMedQL): A natural language processing tool that can be used to search the PubMed database of biomedical literature using a variety of query types.\n7. BioASQ: A biomedical question answering challenge that provides a large dataset of biomedical questions and answers for researchers to develop and evaluate their question answering systems.\nThese are just a few examples of the many biomedical question answering systems that are available.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BM25 is a statistical model that uses a combination of term frequency and inverse document frequency to rank the relevance of documents to a query.\n2. MedSpacy is a biomedical text mining library built on top of the Spacy library.\n3. BERT is a pre-trained language model that can be fine-tuned for biomedical question answering tasks using various neural network architectures.\n4. The Unified Medical Language System (UMLS) is a set of integrated biomedical terminologies and ontologies used for question answering, information retrieval, and other biomedical text processing tasks.\n5. The Neural Information Processing System (NIPS) is a collection of biomedical datasets and tools for training and evaluating machine learning models for question answering tasks.",
    "vicuna-13b_fact": [
      "BM25 is a statistical model that uses a combination of term frequency and inverse document frequency to rank the relevance of documents to a query.",
      "MedSpacy is a biomedical text mining library built on top of the Spacy library.",
      "BERT is a pre-trained language model that can be fine-tuned for biomedical question answering tasks using various neural network architectures.",
      "The Unified Medical Language System (UMLS) is a set of integrated biomedical terminologies and ontologies used for question answering, information retrieval, and other biomedical text processing tasks.",
      "The Neural Information Processing System (NIPS) is a collection of biomedical datasets and tools for training and evaluating machine learning models for question answering tasks."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The Neural Information Processing System (NIPS) is a conference on machine learning and computational neuroscience, not a collection of biomedical datasets and tools for training and evaluating machine learning models for question answering tasks.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "vicuna-13b_response": "The transcription factor that activates the betalain pathway is called \"Betalain-responsive transcription factor 1\" (BTF1). BTF1 is a transcription factor that regulates the expression of genes involved in the betalain pathway, which is responsible for the production of the pigments that give red and yellow color to some fruits and vegetables, such as beets and carrots. BTF1 is a key regulator of the betalain pathway, and it is activated in response to environmental stress, such as high temperatures, drought, and disease. The activation of BTF1 leads to the upregulation of genes involved in the betalain pathway, which results in the production of the pigments that give red and yellow color to some fruits and vegetables.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The transcription factor that activates the betalain pathway is Betalain-responsive transcription factor 1 (BTF1).\n2. BTF1 regulates the expression of genes involved in the betalain pathway.\n3. The betalain pathway is responsible for the production of pigments that give red and yellow color to some fruits and vegetables.\n4. BTF1 is activated in response to environmental stress such as high temperatures, drought, and disease.\n5. The activation of BTF1 leads to the upregulation of genes involved in the betalain pathway.",
    "vicuna-13b_fact": [
      "The transcription factor that activates the betalain pathway is Betalain-responsive transcription factor 1 (BTF1).",
      "BTF1 regulates the expression of genes involved in the betalain pathway.",
      "The betalain pathway is responsible for the production of pigments that give red and yellow color to some fruits and vegetables.",
      "BTF1 is activated in response to environmental stress such as high temperatures, drought, and disease.",
      "The activation of BTF1 leads to the upregulation of genes involved in the betalain pathway."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 796,
    "user_query": "Which is the most well-accepted method for Down syndrome non-invasive prenatal diagnosis?",
    "vicuna-13b_response": "The most well-accepted method for non-invasive prenatal diagnosis of Down syndrome is the analysis of cell-free fetal DNA in the mother's blood. This method, known as non-invasive prenatal testing (NIPT), can detect the presence of Down syndrome in the fetus with high accuracy, and is considered to be a safe and effective way to screen for the condition.\nNIPT works by analyzing the DNA that is present in the mother's bloodstream, which comes from the fetus. This DNA is typically found in small amounts, but it can be detected using advanced molecular techniques, such as next-generation sequencing. By analyzing the fetal DNA in the mother's blood, it is possible to determine whether the fetus has an extra copy of chromosome 21, which is the hallmark of Down syndrome.\nNIPT is typically offered to women who are at high risk of having a child with Down syndrome, such as those who are older than 35, or who have a family history of the condition. The test is typically performed between 10 and 12 weeks of pregnancy, and can be done in a doctor's office or a laboratory.\nIt is important to note that NIPT is not a diagnostic test, and it is not 100% accurate. False positives can occur, which means that a woman may be told that her fetus has Down syndrome when it does not. False negatives can also occur, which means that a woman may be told that her fetus does not have Down syndrome when it does. Therefore, it is important for women to understand the limitations of the test and to discuss the results with their healthcare provider.\nIn summary, the most well-accepted method for non-invasive prenatal diagnosis of Down syndrome is the analysis of cell-free fetal DNA in the mother's blood. This method is considered to be safe and effective, and is typically offered to women who are at high risk of having a child with Down syndrome. However, it is important to understand the limitations of the test and to discuss the results with a healthcare provider.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The most well-accepted method for non-invasive prenatal diagnosis of Down syndrome is the analysis of cell-free fetal DNA in the mother's blood, known as non-invasive prenatal testing (NIPT).\n2. NIPT works by analyzing fetal DNA present in the mother's bloodstream to detect an extra copy of chromosome 21, the hallmark of Down syndrome.\n3. NIPT is typically offered to women who are at high risk of having a child with Down syndrome, such as those who are older than 35, or have a family history of the condition.\n4. The test is typically performed between 10 and 12 weeks of pregnancy in a doctor's office or a laboratory.\n5. NIPT is not 100% accurate and can have false positive and false negative results.",
    "vicuna-13b_fact": [
      "The most well-accepted method for non-invasive prenatal diagnosis of Down syndrome is the analysis of cell-free fetal DNA in the mother's blood, known as non-invasive prenatal testing (NIPT).",
      "NIPT works by analyzing fetal DNA present in the mother's bloodstream to detect an extra copy of chromosome 21, the hallmark of Down syndrome.",
      "NIPT is typically offered to women who are at high risk of having a child with Down syndrome, such as those who are older than 35, or have a family history of the condition.",
      "The test is typically performed between 10 and 12 weeks of pregnancy in a doctor's office or a laboratory.",
      "NIPT is not 100% accurate and can have false positive and false negative results."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The test is typically performed after 10 weeks of pregnancy.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 799,
    "user_query": "What is the average diameter of intermediate filaments?",
    "vicuna-13b_response": "Intermediate filaments (IFs) are a type of cytoskeletal element found in most cells, and their diameter can vary depending on the type of cell and the physiological state of the cell. On average, the diameter of intermediate filaments is around 10-20 nanometers (nm).\nThere are several types of intermediate filaments, including vimentin, desmin, and neurofilaments, each with a slightly different diameter. Vimentin is the most common type of intermediate filament and has a diameter of around 12-14 nm, while desmin has a diameter of around 10-12 nm and neurofilaments have a diameter of around 20-25 nm.\nIt is important to note that the diameter of intermediate filaments can change depending on the physiological state of the cell. For example, during cell division, the intermediate filaments can disassemble and reassemble in a different pattern. Additionally, changes in the tension of the intermediate filaments can cause them to change in diameter.\nOverall, the average diameter of intermediate filaments is around 10-20 nm, with variations depending on the type of intermediate filament and the physiological state of the cell.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Intermediate filaments (IFs) are a type of cytoskeletal element found in most cells.\n2. The average diameter of intermediate filaments is around 10-20 nanometers (nm).\n3. There are several types of intermediate filaments, including vimentin, desmin, and neurofilaments.\n4. Vimentin has a diameter of around 12-14 nm, while desmin has a diameter of around 10-12 nm and neurofilaments have a diameter of around 20-25 nm.\n5. The diameter of intermediate filaments can change depending on the physiological state of the cell.",
    "vicuna-13b_fact": [
      "Intermediate filaments (IFs) are a type of cytoskeletal element found in most cells.",
      "The average diameter of intermediate filaments is around 10-20 nanometers (nm).",
      "There are several types of intermediate filaments, including vimentin, desmin, and neurofilaments.",
      "Vimentin has a diameter of around 12-14 nm, while desmin has a diameter of around 10-12 nm and neurofilaments have a diameter of around 20-25 nm.",
      "The diameter of intermediate filaments can change depending on the physiological state of the cell."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 805,
    "user_query": "Which intermediate filament (IF) protein can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone?",
    "vicuna-13b_response": "The intermediate filament (IF) protein nestin can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone. The subventricular zone is a region of the brain that contains neural stem cells that give rise to a variety of neuronal cell types. Nestin is a type of IF protein that is expressed in a variety of neural cell types, including neural stem cells and their progeny. Therefore, the expression of nestin can be used as a marker to identify neuronal precursor cells in the subventricular zone. Other IF proteins, such as GFAP and vimentin, are also expressed in neural cells, but they are not specific to neuronal precursor cells in the subventricular zone.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The intermediate filament (IF) protein nestin can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone.\n2. The subventricular zone is a region of the brain that contains neural stem cells.\n3. Neural stem cells in the subventricular zone can give rise to a variety of neuronal cell types.\n4. Nestin is a type of IF protein that is expressed in a variety of neural cell types, including neural stem cells and their progeny.\n5. IF proteins such as GFAP and vimentin are also expressed in neural cells, but they are not specific to neuronal precursor cells in the subventricular zone.",
    "vicuna-13b_fact": [
      "The intermediate filament (IF) protein nestin can be used as a non-specific marker of the neuronal precursor cells of the subventricular zone.",
      "The subventricular zone is a region of the brain that contains neural stem cells.",
      "Neural stem cells in the subventricular zone can give rise to a variety of neuronal cell types.",
      "Nestin is a type of IF protein that is expressed in a variety of neural cell types, including neural stem cells and their progeny.",
      "IF proteins such as GFAP and vimentin are also expressed in neural cells, but they are not specific to neuronal precursor cells in the subventricular zone."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 806,
    "user_query": "Which enzyme is involved in the maintenance of DNA (cytosine-5-)-methylation?",
    "vicuna-13b_response": "The enzyme responsible for the maintenance of DNA (cytosine-5-)-methylation is called DNMT1 (DNA methyltransferase 1). DNMT1 is a key enzyme in the process of DNA methylation, which is a mechanism used by cells to regulate gene expression. DNA methylation involves the addition of a methyl group to the fifth carbon of cytosine residues in the DNA molecule, resulting in the formation of 5-methylcytosine. This process is important for the proper functioning of cells and is involved in a variety of biological processes, including embryonic development, cell differentiation, and the regulation of gene expression. DNMT1 is responsible for maintaining the methylation patterns in the DNA, by transferring a methyl group to the cytosine residues.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. DNMT1 (DNA methyltransferase 1) is the enzyme responsible for the maintenance of DNA (cytosine-5-)-methylation.\n2. DNA methylation is a mechanism used by cells to regulate gene expression.\n3. DNA methylation involves the addition of a methyl group to the fifth carbon of cytosine residues in the DNA molecule.\n4. DNMT1 is responsible for maintaining the methylation patterns in the DNA by transferring a methyl group to the cytosine residues.\n5. DNA methylation is important for several biological processes, including embryonic development, cell differentiation, and the regulation of gene expression.",
    "vicuna-13b_fact": [
      "DNMT1 (DNA methyltransferase 1) is the enzyme responsible for the maintenance of DNA (cytosine-5-)-methylation.",
      "DNA methylation is a mechanism used by cells to regulate gene expression.",
      "DNA methylation involves the addition of a methyl group to the fifth carbon of cytosine residues in the DNA molecule.",
      "DNMT1 is responsible for maintaining the methylation patterns in the DNA by transferring a methyl group to the cytosine residues.",
      "DNA methylation is important for several biological processes, including embryonic development, cell differentiation, and the regulation of gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 807,
    "user_query": "Is transcapillary  albumin escape altered in diabetic patients?",
    "vicuna-13b_response": "Transcapillary albumin escape (TCAE) is the process by which albumin leaks from the blood vessels into the interstitial space. TCAE is increased in diabetic patients, and it is believed to be due to a combination of factors related to diabetes, such as hyperglycemia, oxidative stress, and inflammation.\nStudies have shown that TCAE is elevated in patients with both type 1 and type 2 diabetes, and that it is associated with increased levels of glycated hemoglobin (HbA1c), a measure of long-term blood glucose levels. Additionally, TCAE is also associated with other diabetes-related complications such as diabetic nephropathy and retinopathy.\nThe exact mechanisms by which diabetes leads to increased TCAE are not fully understood, but it is believed to be related to the increased oxidative stress and inflammation that occurs in diabetes. High glucose levels lead to the formation of advanced glycation end products (AGEs), which can cause damage to the endothelial cells that line the blood vessels. This damage can lead to increased permeability, allowing albumin to leak into the interstitial space.\nIn summary, TCAE is increased in diabetic patients and it is associated with increased levels of glycated hemoglobin (HbA1c) and other diabetes-related complications. The exact mechanisms by which diabetes leads to increased TCAE are not fully understood, but it is believed to be related to the increased oxidative stress and inflammation that occurs in diabetes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Transcapillary albumin escape (TCAE) is the process by which albumin leaks from the blood vessels into the interstitial space. \n2. TCAE is increased in diabetic patients.\n3. TCAE is elevated in patients with both type 1 and type 2 diabetes, and it is associated with increased levels of glycated hemoglobin (HbA1c).\n4. TCAE is also associated with diabetes-related complications such as diabetic nephropathy and retinopathy.\n5. High glucose levels lead to the formation of advanced glycation end products (AGEs), which can cause damage to the endothelial cells that line the blood vessels.",
    "vicuna-13b_fact": [
      "Transcapillary albumin escape (TCAE) is the process by which albumin leaks from the blood vessels into the interstitial space.",
      "TCAE is increased in diabetic patients.",
      "TCAE is elevated in patients with both type 1 and type 2 diabetes, and it is associated with increased levels of glycated hemoglobin (HbA1c).",
      "TCAE is also associated with diabetes-related complications such as diabetic nephropathy and retinopathy.",
      "High glucose levels lead to the formation of advanced glycation end products (AGEs), which can cause damage to the endothelial cells that line the blood vessels."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 812,
    "user_query": "Which cell type has the protein Chromogranin A as marker?",
    "vicuna-13b_response": "Chromogranin A is a protein that is primarily found in secretory granules of neuroendocrine cells, including cells of the pancreas, gastrointestinal tract, and lung. Therefore, the cell type that has Chromogranin A as a marker is a neuroendocrine cell.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Chromogranin A is a protein.\n2. Chromogranin A is primarily found in secretory granules of neuroendocrine cells.\n3. Neuroendocrine cells can be found in the pancreas, gastrointestinal tract, and lung.\n4. The cell type that has Chromogranin A as a marker is a neuroendocrine cell.",
    "vicuna-13b_fact": [
      "Chromogranin A is a protein.",
      "Chromogranin A is primarily found in secretory granules of neuroendocrine cells.",
      "Neuroendocrine cells can be found in the pancreas, gastrointestinal tract, and lung.",
      "The cell type that has Chromogranin A as a marker is a neuroendocrine cell."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 813,
    "user_query": "Does a selective sweep increase genetic variation?",
    "vicuna-13b_response": "A selective sweep is a genetic process that occurs when a beneficial mutation arises in a population and is then rapidly spread through the population due to natural selection. While a selective sweep can lead to an increase in the frequency of the beneficial mutation in the population, it does not necessarily increase overall genetic variation.\nGenetic variation refers to the differences in genetic makeup among individuals within a population. Genetic variation is important because it provides the raw material for natural selection to act upon and it allows populations to adapt to changing environments.\nDuring a selective sweep, the beneficial mutation is favored by natural selection and its frequency increases in the population. However, this can come at the cost of reducing genetic variation in the population. This is because the selective sweep reduces the frequency of other alleles (different forms of a gene) in the population, which can lead to a reduction in genetic variation.\nAdditionally, selective sweeps can also lead to the fixation of the beneficial mutation in the population, which means that the mutation becomes the dominant allele and is present in all individuals in the population. This can further reduce genetic variation by eliminating all other alleles of the gene.\nIn conclusion, while a selective sweep can increase the frequency of a beneficial mutation in a population, it does not necessarily increase overall genetic variation. In fact, it can lead to a reduction in genetic variation by reducing the frequency of other alleles in the population.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A selective sweep is a genetic process that occurs when a beneficial mutation arises in a population and is then rapidly spread due to natural selection.\n2. Genetic variation refers to the differences in genetic makeup among individuals within a population.\n3. During a selective sweep, the frequency of the beneficial mutation in the population increases.\n4. Selective sweeps can reduce the frequency of other alleles in the population, leading to a reduction in genetic variation.\n5. Selective sweeps can lead to the fixation of the beneficial mutation in the population, eliminating all other alleles of the gene.",
    "vicuna-13b_fact": [
      "A selective sweep is a genetic process that occurs when a beneficial mutation arises in a population and is then rapidly spread due to natural selection.",
      "Genetic variation refers to the differences in genetic makeup among individuals within a population.",
      "During a selective sweep, the frequency of the beneficial mutation in the population increases.",
      "Selective sweeps can reduce the frequency of other alleles in the population, leading to a reduction in genetic variation.",
      "Selective sweeps can lead to the fixation of the beneficial mutation in the population, eliminating all other alleles of the gene."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 814,
    "user_query": "Which disease phenotypes are associated to PRPS1 mutations?",
    "vicuna-13b_response": "PRPS1 is a gene that encodes for protein phosphatase 2, regulatory subunit B, alpha 1. Mutations in this gene have been associated with several disease phenotypes, including:\n1. Parkinson's disease: Studies have shown that mutations in PRPS1 can increase the risk of developing Parkinson's disease, a progressive neurodegenerative disorder characterized by motor symptoms such as tremors, stiffness, and difficulty with movement.\n2. Cancer: Some studies have suggested that PRPS1 mutations may be associated with an increased risk of certain types of cancer, such as breast cancer, ovarian cancer, and prostate cancer. However, more research is needed to confirm these findings and to understand the underlying mechanisms.\n3. Intellectual disability: PRPS1 mutations have been identified in individuals with intellectual disability, although the frequency and clinical spectrum of this condition is not well understood.\n4. Other neurological disorders: Some studies have also suggested that PRPS1 mutations may be associated with other neurological disorders, such as dystonia and Huntington's disease.\nIt's important to note that the association between PRPS1 mutations and these disease phenotypes is still being actively researched and the exact mechanisms by which PRPS1 mutations contribute to these conditions are not fully understood.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PRPS1 is a gene that encodes for protein phosphatase 2, regulatory subunit B, alpha 1.\n2. Mutations in the PRPS1 gene have been associated with Parkinson's disease, a progressive neurodegenerative disorder.\n3. Some studies suggest that PRPS1 mutations may be associated with an increased risk of certain types of cancer, such as breast cancer, ovarian cancer, and prostate cancer.\n4. PRPS1 mutations have been identified in individuals with intellectual disability.\n5. Some studies have suggested that PRPS1 mutations may be associated with other neurological disorders, such as dystonia and Huntington's disease.",
    "vicuna-13b_fact": [
      "PRPS1 is a gene that encodes for protein phosphatase 2, regulatory subunit B, alpha 1.",
      "Mutations in the PRPS1 gene have been associated with Parkinson's disease, a progressive neurodegenerative disorder.",
      "Some studies suggest that PRPS1 mutations may be associated with an increased risk of certain types of cancer, such as breast cancer, ovarian cancer, and prostate cancer.",
      "PRPS1 mutations have been identified in individuals with intellectual disability.",
      "Some studies have suggested that PRPS1 mutations may be associated with other neurological disorders, such as dystonia and Huntington's disease."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: PRPS1 is a gene that encodes for phosphoribosyl pyrophosphate synthetase 1.\n2. FALSE [correction]: Mutations in the PRPS1 gene have been associated with several genetic disorders such as PRPS-related gout, Charcot-Marie-Tooth disease type 5 and Arts syndrome, not Parkinson's disease.\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: PRPS1 mutations are associated with several genetic disorders but not specifically linked with dystonia and Huntington's disease.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 815,
    "user_query": "Is indicated the use of antioxidant supplements in patients at risk for coronary artery disease?",
    "vicuna-13b_response": "The use of antioxidant supplements in patients at risk for coronary artery disease (CAD) is a topic of ongoing debate and research. While some studies have suggested that antioxidants may have a protective effect against CAD, others have found no benefit or even potential harm.\nOne of the main antioxidants used in CAD prevention is Vitamin E. Studies have shown that Vitamin E supplementation may reduce the risk of CAD in certain populations, such as smokers and people with high blood pressure. However, other studies have found no benefit or even an increased risk of death in people taking high doses of Vitamin E.\nAnother antioxidant that has been studied for CAD prevention is Vitamin C. Some studies have found that high levels of Vitamin C may be associated with a lower risk of CAD, while others have found no benefit.\nOther antioxidants that have been studied for CAD prevention include beta-carotene, lycopene, and selenium. However, the evidence for their effectiveness is limited and inconclusive.\nIt is important to note that while antioxidant supplements may have some potential benefits, they should not be used as a substitute for proven methods of CAD prevention, such as lifestyle changes and medications. Additionally, people at risk for CAD should always consult with their healthcare provider before taking any supplements, as some may interact with medications or have other potential side effects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The use of antioxidant supplements in patients at risk for coronary artery disease (CAD) is a topic of ongoing research and debate.\n2. Some studies show that Vitamin E supplementation may reduce the risk of CAD in certain populations.\n3. Other studies indicate that high levels of Vitamin C may be associated with a lower risk of CAD.\n4. Antioxidants like beta-carotene, lycopene, and selenium have been studied for CAD prevention.\n5. Patients at risk for CAD should consult their healthcare provider before taking any supplements due to potential interactions with medications or possible side effects.",
    "vicuna-13b_fact": [
      "The use of antioxidant supplements in patients at risk for coronary artery disease (CAD) is a topic of ongoing research and debate.",
      "Some studies show that Vitamin E supplementation may reduce the risk of CAD in certain populations.",
      "Other studies indicate that high levels of Vitamin C may be associated with a lower risk of CAD.",
      "Antioxidants like beta-carotene, lycopene, and selenium have been studied for CAD prevention.",
      "Patients at risk for CAD should consult their healthcare provider before taking any supplements due to potential interactions with medications or possible side effects."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 821,
    "user_query": "Is K-63 linked protein ubiquitination related to proteasomal degradation?",
    "vicuna-13b_response": "Yes, K-63 linked protein ubiquitination is related to proteasomal degradation. Ubiquitination is a post-translational modification that involves the attachment of a ubiquitin molecule to a target protein. This modification can have various effects on the target protein, including regulation of its stability. When a protein is ubiquitinated, it can be targeted for degradation by the proteasome, a large proteolytic complex that breaks down proteins.\nK-63 linked protein ubiquitination is a specific type of ubiquitination in which the ubiquitin molecule is attached to a lysine residue in the target protein, via a linkage to the ε-amino group of the lysine. This type of ubiquitination is often involved in the regulation of protein stability, and can lead to degradation of the target protein via the proteasome.\nIn summary, K-63 linked protein ubiquitination is a mechanism for regulating protein stability, and it can lead to degradation of the target protein via the proteasome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. K-63 linked protein ubiquitination is related to proteasomal degradation.\n2. Ubiquitination is a post-translational modification that involves the attachment of a ubiquitin molecule to a target protein.\n3. When a protein is ubiquitinated, it can be targeted for degradation by the proteasome.\n4. K-63 linked protein ubiquitination involves the attachment of the ubiquitin molecule to a lysine residue in the target protein.\n5. K-63 linked protein ubiquitination can lead to degradation of the target protein via the proteasome.",
    "vicuna-13b_fact": [
      "K-63 linked protein ubiquitination is related to proteasomal degradation.",
      "Ubiquitination is a post-translational modification that involves the attachment of a ubiquitin molecule to a target protein.",
      "When a protein is ubiquitinated, it can be targeted for degradation by the proteasome.",
      "K-63 linked protein ubiquitination involves the attachment of the ubiquitin molecule to a lysine residue in the target protein.",
      "K-63 linked protein ubiquitination can lead to degradation of the target protein via the proteasome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: K-63 linked protein ubiquitination is generally associated with non-proteolytic functions (such as cellular trafficking, DNA repair, etc.) rather than proteasomal degradation. \n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: K63-linked ubiquitination does not typically lead to proteasomal degradation of the target protein, it's often associated with other cellular processes.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 822,
    "user_query": "Could transcription factors act as cell-cell signalling molecules?",
    "vicuna-13b_response": "Yes, transcription factors can act as cell-cell signaling molecules. Transcription factors are proteins that bind to specific DNA sequences and regulate gene expression by controlling the transcription of genes into mRNA. These proteins can also interact with other proteins, including those involved in cell-cell signaling, to modulate cellular behavior.\nFor example, some transcription factors can act as signaling molecules by binding to specific DNA sequences in response to cellular signals, such as growth factors or cytokines. This can lead to changes in gene expression that can affect cellular behavior, such as proliferation, differentiation, or apoptosis.\nAdditionally, some transcription factors can interact with other signaling molecules, such as growth factors or cytokines, to modulate their activity. For example, a transcription factor may bind to a specific DNA sequence in response to a signaling molecule, which can then recruit other proteins to the DNA to modulate gene expression.\nOverall, transcription factors play a critical role in cellular signaling and can act as key regulators of cellular behavior by modulating gene expression in response to cellular signals.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Transcription factors are proteins that bind to specific DNA sequences.\n2. Transcription factors regulate gene expression by controlling the transcription of genes into mRNA.\n3. Some transcription factors can act as signaling molecules by binding to specific DNA sequences in response to cellular signals.\n4. Changes in gene expression due to transcription factors can affect cellular behavior, such as proliferation, differentiation, or apoptosis.\n5. Transcription factors can interact with other signaling molecules, such as growth factors or cytokines, to modulate their activity.",
    "vicuna-13b_fact": [
      "Transcription factors are proteins that bind to specific DNA sequences.",
      "Transcription factors regulate gene expression by controlling the transcription of genes into mRNA.",
      "Some transcription factors can act as signaling molecules by binding to specific DNA sequences in response to cellular signals.",
      "Changes in gene expression due to transcription factors can affect cellular behavior, such as proliferation, differentiation, or apoptosis.",
      "Transcription factors can interact with other signaling molecules, such as growth factors or cytokines, to modulate their activity."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 828,
    "user_query": "Is muscle lim protein (MLP) involved in cardiomyopathies?",
    "vicuna-13b_response": "Yes, muscle lim protein (MLP) is involved in cardiomyopathies. Cardiomyopathies are a group of heart conditions that affect the muscle of the heart. MLP is a protein that is found in the muscle cells of the heart and is involved in the regulation of muscle contraction.\nStudies have shown that mutations in the MLP gene can cause cardiomyopathies, a group of heart conditions characterized by the thickening and enlargement of the heart muscle. These mutations can lead to abnormalities in the structure and function of the heart muscle, which can result in heart failure and other complications.\nAdditionally, MLP has been shown to play a role in the regulation of ion channels, which are important for the electrical activity of the heart. Dysfunction of MLP has been linked to abnormal ion channel function, which can contribute to the development of cardiomyopathies.\nOverall, while MLP is not the only gene associated with cardiomyopathies, it is one of the genes that has been implicated in the development of this group of heart conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Muscle lim protein (MLP) is involved in cardiomyopathies.\n2. MLP is found in the muscle cells of the heart and is involved in the regulation of muscle contraction.\n3. Studies have found that mutations in the MLP gene can cause cardiomyopathies.\n4. Abnormalities caused by MLP mutations can lead to heart failure and other complications.\n5. MLP plays a role in the regulation of ion channels, which are important for the electrical activity of the heart.",
    "vicuna-13b_fact": [
      "Muscle lim protein (MLP) is involved in cardiomyopathies.",
      "MLP is found in the muscle cells of the heart and is involved in the regulation of muscle contraction.",
      "Studies have found that mutations in the MLP gene can cause cardiomyopathies.",
      "Abnormalities caused by MLP mutations can lead to heart failure and other complications.",
      "MLP plays a role in the regulation of ion channels, which are important for the electrical activity of the heart."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 834,
    "user_query": "What is Tn-seq?",
    "vicuna-13b_response": "Tn-seq (Transposon sequencing) is a method used to identify and quantify the transposable elements (TEs) in a genome. TEs are DNA sequences that can move around within a genome, and they make up a significant portion of the genome in many organisms. Tn-seq is a high-throughput sequencing-based approach that uses transposase enzymes to insert short DNA sequences (often called \"tags\") into the genome at specific locations. These tags are then used to identify and quantify the presence of TEs in the genome. Tn-seq is a powerful tool for studying the dynamics of TEs in a genome, and has been used in a variety of organisms and applications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tn-seq (Transposon sequencing) is a method used to identify and quantify the transposable elements (TEs) in a genome.\n2. Transposable elements are DNA sequences that can move within a genome.\n3. Tn-seq uses transposase enzymes to insert short DNA sequences, referred to as \"tags\", into the genome at specific locations.\n4. These inserted \"tags\" in Tn-seq are used to identify and quantify the presence of TEs in the genome.\n5. Tn-seq has been used in a variety of organisms and applications.",
    "vicuna-13b_fact": [
      "Tn-seq (Transposon sequencing) is a method used to identify and quantify the transposable elements (TEs) in a genome.",
      "Transposable elements are DNA sequences that can move within a genome.",
      "Tn-seq uses transposase enzymes to insert short DNA sequences, referred to as \"tags\", into the genome at specific locations.",
      "These inserted \"tags\" in Tn-seq are used to identify and quantify the presence of TEs in the genome.",
      "Tn-seq has been used in a variety of organisms and applications."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Tn-seq (Transposon sequencing) is a method used to determine the contribution of genes to the fitness of an organism, not to identify and quantify the transposable elements (TEs) in a genome.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The inserted \"tags\" in Tn-seq are used to identify fitness contributions of individual genes in the genome, not to identify and quantify the presence of TEs.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 836,
    "user_query": "Is there any functional association during viral replication between flaviviridae viral RNA depended RNA polymerase and viral helicase?",
    "vicuna-13b_response": "Yes, there is a functional association between flaviviridae viral RNA-dependent RNA polymerase and viral helicase during viral replication.\nThe viral helicase is an enzyme that unwinds double-stranded RNA and separates the strands, allowing the viral RNA-dependent RNA polymerase to access and transcribe the viral RNA genome. The viral helicase also plays a role in viral replication by unwinding the positive-sense RNA template and facilitating the synthesis of negative-sense RNA.\nThe viral RNA-dependent RNA polymerase, on the other hand, is responsible for transcribing the viral RNA genome into messenger RNA (mRNA), which can then be translated into protein. The viral RNA-dependent RNA polymerase requires the unwound RNA template provided by the viral helicase to initiate transcription.\nTherefore, the functional association between the viral helicase and the viral RNA-dependent RNA polymerase is crucial for the viral replication process, as both enzymes work together to unwind the RNA template and facilitate the synthesis of viral RNA and protein.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. There is a functional association between flaviviridae viral RNA-dependent RNA polymerase and viral helicase during viral replication.\n2. The viral helicase is an enzyme that unwinds double-stranded RNA.\n3. Viral helicase allows the viral RNA-dependent RNA polymerase to access and transcribe the viral RNA genome.\n4. The viral RNA-dependent RNA polymerase transcribes the viral RNA genome into messenger RNA (mRNA).\n5. The functional association between the viral helicase and the viral RNA-dependent RNA polymerase is crucial for the viral replication process.",
    "vicuna-13b_fact": [
      "There is a functional association between flaviviridae viral RNA-dependent RNA polymerase and viral helicase during viral replication.",
      "The viral helicase is an enzyme that unwinds double-stranded RNA.",
      "Viral helicase allows the viral RNA-dependent RNA polymerase to access and transcribe the viral RNA genome.",
      "The viral RNA-dependent RNA polymerase transcribes the viral RNA genome into messenger RNA (mRNA).",
      "The functional association between the viral helicase and the viral RNA-dependent RNA polymerase is crucial for the viral replication process."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 838,
    "user_query": "Which is the prevalence of cystic fibrosis in the human population?",
    "vicuna-13b_response": "Cystic fibrosis is a genetic disorder that affects the respiratory, digestive, and reproductive systems of the body. The prevalence of cystic fibrosis varies depending on the population and the specific geographic location.\nIn the United States, it is estimated that approximately 1 in 25 people are carriers of the cystic fibrosis gene, while 1 in 3000 people are affected by the disease. In Europe, the prevalence is similar, with 1 in 26 people being carriers and 1 in 3000 people being affected.\nWorldwide, it is estimated that approximately 70,000 people have cystic fibrosis, with the highest prevalence in North America and Europe, and the lowest prevalence in Asia and Africa.\nIt's important to note that these numbers are estimates and can vary depending on the source and the specific population being studied. Also, these numbers are based on the prevalence of the disease and not on the incidence, which is the number of new cases that occur each year.\nIt's important to note that cystic fibrosis is an inherited disorder, which means that it is passed down from parent to child through genes. If both parents are carriers of the gene, there is a 25% chance that their child will be born with the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cystic fibrosis is a genetic disorder that affects the respiratory, digestive, and reproductive systems of the body.\n2. In the United States, approximately 1 in 25 people are carriers of the cystic fibrosis gene and 1 in 3000 people are affected by the disease.\n3. In Europe, it is estimated that 1 in 26 people are carriers of the cystic fibrosis gene and 1 in 3000 people are affected by the disease.\n4. Worldwide, it is estimated that approximately 70,000 people have cystic fibrosis.\n5. If both parents are carriers of the cystic fibrosis gene, there is a 25% chance that their child will be born with the disease.",
    "vicuna-13b_fact": [
      "Cystic fibrosis is a genetic disorder that affects the respiratory, digestive, and reproductive systems of the body.",
      "In the United States, approximately 1 in 25 people are carriers of the cystic fibrosis gene and 1 in 3000 people are affected by the disease.",
      "In Europe, it is estimated that 1 in 26 people are carriers of the cystic fibrosis gene and 1 in 3000 people are affected by the disease.",
      "Worldwide, it is estimated that approximately 70,000 people have cystic fibrosis.",
      "If both parents are carriers of the cystic fibrosis gene, there is a 25% chance that their child will be born with the disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 844,
    "user_query": "Is there a genome-wide technique for the detection of R-loop formation?",
    "vicuna-13b_response": "Yes, there are genome-wide techniques for the detection of R-loop formation. R-loops are a type of DNA structure that form when a protein complex, such as RNA polymerase, binds to the DNA and causes the formation of a loop. These loops can affect gene expression and other cellular processes, so understanding the formation and dynamics of R-loops is important.\nOne technique for genome-wide detection of R-loop formation is DNA fluorescence in situ hybridization (FISH). This method uses labeled probes to bind to specific regions of the genome, and then visualizes the location of the R-loops by fluorescence microscopy. This technique can be used to map the distribution of R-loops across the genome and to identify regions where R-loops are more or less prevalent.\nAnother technique is Chromosome Conformation Capture Carbon Copy (5C). This method uses a combination of restriction enzyme digestion, ligation, and sequencing to map the spatial organization of chromatin and identify regions where R-loops are formed.\nIn addition, there are also other techniques such as RNA-seq, ChIP-seq, and ATAC-seq that can be used to study the formation and dynamics of R-loops, by measuring the presence of specific proteins or RNA molecules at specific regions of the genome.\nIt's worth noting that these techniques are not specific to R-loop detection, but can be used to study other types of DNA-protein interactions and chromatin structure.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. R-loops are a type of DNA structure that form when a protein complex binds to the DNA and causes the formation of a loop.\n2. DNA fluorescence in situ hybridization (FISH) is a technique for genome-wide detection of R-loop formation.\n3. Chromosome Conformation Capture Carbon Copy (5C) is another technique used to identify regions where R-loops are formed.\n4. RNA-seq, ChIP-seq, and ATAC-seq are techniques used to study the formation and dynamics of R-loops.\n5. The mentioned techniques are not specific to R-loop detection, but can be used to study other types of DNA-protein interactions and chromatin structure.",
    "vicuna-13b_fact": [
      "R-loops are a type of DNA structure that form when a protein complex binds to the DNA and causes the formation of a loop.",
      "DNA fluorescence in situ hybridization (FISH) is a technique for genome-wide detection of R-loop formation.",
      "Chromosome Conformation Capture Carbon Copy (5C) is another technique used to identify regions where R-loops are formed.",
      "RNA-seq, ChIP-seq, and ATAC-seq are techniques used to study the formation and dynamics of R-loops.",
      "The mentioned techniques are not specific to R-loop detection, but can be used to study other types of DNA-protein interactions and chromatin structure."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: R-loops are a type of DNA structure that form during transcription when the RNA molecule hybridizes with the DNA template, forming a RNA-DNA loop, not due to protein complex binding.\n2. TRUE\n3. FALSE [correction]: Chromosome Conformation Capture Carbon Copy (5C) technique is used for the detection of physical interactions between chromosomal regions rather than specific identification of R-loop regions.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 847,
    "user_query": "Is transcription-associated mutagenesis (TAM) related to gene expression levels?",
    "vicuna-13b_response": "Transcription-associated mutagenesis (TAM) is a process that occurs during DNA replication and involves the insertion or deletion of nucleotides during the transcription of DNA into RNA. This process can lead to mutations in the DNA sequence, which can affect gene expression levels.\nTAM can occur in two ways:\n1. Transcription-coupled repair (TCR): This process occurs during the transcription of DNA into RNA and involves the insertion of nucleotides into the DNA sequence to repair damaged regions. This can lead to mutations in the DNA sequence, which can affect gene expression levels.\n2. Transcription-associated mutagenesis (TAM): This process also occurs during the transcription of DNA into RNA, but it involves the deletion of nucleotides from the DNA sequence. This can also lead to mutations in the DNA sequence, which can affect gene expression levels.\nIn summary, TAM is related to gene expression levels because it can lead to mutations in the DNA sequence that can affect the expression of genes. These mutations can either increase or decrease gene expression levels, depending on the specifics of the mutation and the gene in question.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Transcription-associated mutagenesis (TAM) is a process that occurs during DNA replication.\n2. TAM involves the insertion or deletion of nucleotides during the transcription of DNA into RNA.\n3. Transcription-associated mutagenesis can lead to mutations in the DNA sequence.\n4. Mutations in the DNA sequence can affect gene expression levels.\n5. There are two ways TAM can occur: through Transcription-coupled repair (TCR) and through Transcription-associated mutagenesis (TAM).",
    "vicuna-13b_fact": [
      "Transcription-associated mutagenesis (TAM) is a process that occurs during DNA replication.",
      "TAM involves the insertion or deletion of nucleotides during the transcription of DNA into RNA.",
      "Transcription-associated mutagenesis can lead to mutations in the DNA sequence.",
      "Mutations in the DNA sequence can affect gene expression levels.",
      "There are two ways TAM can occur: through Transcription-coupled repair (TCR) and through Transcription-associated mutagenesis (TAM)."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Transcription-associated mutagenesis (TAM) is a process that occurs during DNA transcription, not replication.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: There are two ways transcription can result in mutations: through Transcription-coupled repair (TCR) and Transcription-associated mutagenesis (TAM) is itself a way, not a separate method.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 848,
    "user_query": "Is there a pharmacogenetic test for trastuzumab?",
    "vicuna-13b_response": "Yes, there is a pharmacogenetic test for trastuzumab, which is a monoclonal antibody used to treat breast cancer. The test is called the HER2 gene mutation test, and it is used to determine whether a patient's breast cancer is HER2-positive, which means that the cancer cells have an excessive number of HER2 receptors on their surface.\nTrastuzumab is designed to target these receptors and inhibit the growth and survival of HER2-positive cancer cells. The HER2 gene mutation test is used to identify patients who are likely to benefit from treatment with trastuzumab, as well as to identify potential side effects and toxicity associated with the drug.\nThe test is typically performed on a sample of cancer tissue, and it can be done either before or after treatment with trastuzumab. The results of the test can help guide treatment decisions and ensure that patients receive the most appropriate therapy for their specific cancer.\nIt's important to note that not all breast cancers are HER2-positive, and not all patients who test positive for the mutation will benefit from treatment with trastuzumab. Therefore, the test should be used in conjunction with other diagnostic tests and clinical evaluation to determine the most appropriate treatment for each individual patient.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. There is a pharmacogenetic test for trastuzumab.\n2. The test for trastuzumab is called HER2 gene mutation test.\n3. HER2 gene mutation test is used to determine whether a patient's breast cancer is HER2-positive.\n4. Trastuzumab is a drug designed to target HER2 receptors and inhibit the growth of HER2-positive cancer cells.\n5. Not all breast cancers are HER2-positive, and not all patients who test positive for the mutation will benefit from treatment with trastuzumab.",
    "vicuna-13b_fact": [
      "There is a pharmacogenetic test for trastuzumab.",
      "The test for trastuzumab is called HER2 gene mutation test.",
      "HER2 gene mutation test is used to determine whether a patient's breast cancer is HER2-positive.",
      "Trastuzumab is a drug designed to target HER2 receptors and inhibit the growth of HER2-positive cancer cells.",
      "Not all breast cancers are HER2-positive, and not all patients who test positive for the mutation will benefit from treatment with trastuzumab."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 849,
    "user_query": "Which calcium channels does ethosuximide target?",
    "vicuna-13b_response": "Ethosuximide is a medication that is used to treat seizures in people with epilepsy. It works by altering the activity of certain types of calcium channels in the brain. Specifically, ethosuximide is a antiepileptic drug that belongs to the class of drugs called benzodiazepines. It acts by increasing the activity of a type of calcium channel called the T-type calcium channel, which is involved in the regulation of neuronal excitability and synaptic transmission. By increasing the activity of these channels, ethosuximide helps to reduce the likelihood of seizures occurring.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ethosuximide is used to treat seizures in people with epilepsy.\n2. Ethosuximide works by altering the activity of certain types of calcium channels in the brain.\n3. Ethosuximide belongs to the class of drugs called benzodiazepines.\n4. Ethosuximide increases the activity of the T-type calcium channel.\n5. The T-type calcium channel is involved in the regulation of neuronal excitability and synaptic transmission.",
    "vicuna-13b_fact": [
      "Ethosuximide is used to treat seizures in people with epilepsy.",
      "Ethosuximide works by altering the activity of certain types of calcium channels in the brain.",
      "Ethosuximide belongs to the class of drugs called benzodiazepines.",
      "Ethosuximide increases the activity of the T-type calcium channel.",
      "The T-type calcium channel is involved in the regulation of neuronal excitability and synaptic transmission."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ethosuximide belongs to the class of drugs called succinimides, not benzodiazepines.\n4. FALSE [correction]: Ethosuximide decreases the activity of the T-type calcium channel, not increases.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 850,
    "user_query": "What is the sedimentation coefficient of the mammalian mitoribosome?",
    "vicuna-13b_response": "The sedimentation coefficient (Sed Coefficient) is a measure of the rate at which a particle settles in a liquid. In the case of the mammalian mitoribosome, it is a complex of ribosomal proteins and RNA that plays a role in the process of protein synthesis. The Sed Coefficient of the mammalian mitoribosome has not been well characterized, as it is a relatively new area of research. However, studies have shown that the mitoribosome has a lower Sed Coefficient compared to the ribosome, which suggests that it may have a different sedimentation behavior. Further research is needed to fully understand the Sed Coefficient of the mammalian mitoribosome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The sedimentation coefficient is a measure of the rate at which a particle settles in a liquid.\n2. The mammalian mitoribosome is a complex of ribosomal proteins and RNA that plays a role in protein synthesis.\n3. The sedimentation coefficient of the mammalian mitoribosome has not yet been well characterized.\n4. The mitoribosome reportedly has a lower sedimentation coefficient compared to the ribosome.\n5. It's suggested that the mammalian mitoribosome may have a different sedimentation behavior than the ribosome.",
    "vicuna-13b_fact": [
      "The sedimentation coefficient is a measure of the rate at which a particle settles in a liquid.",
      "The mammalian mitoribosome is a complex of ribosomal proteins and RNA that plays a role in protein synthesis.",
      "The sedimentation coefficient of the mammalian mitoribosome has not yet been well characterized.",
      "The mitoribosome reportedly has a lower sedimentation coefficient compared to the ribosome.",
      "It's suggested that the mammalian mitoribosome may have a different sedimentation behavior than the ribosome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 852,
    "user_query": "Which proteins act as histone-like molecules in prokaryotes?",
    "vicuna-13b_response": "In prokaryotes, histone-like proteins are called histones. Histones are proteins that are involved in the compaction of DNA into chromatin, which helps to regulate gene expression. The main histone proteins found in prokaryotes are:\n1. Histone H2A: This protein is involved in the formation of nucleosome, the basic unit of chromatin.\n2. Histone H2B: This protein is also involved in the formation of nucleosome and helps to stabilize the structure of the nucleosome.\n3. Histone H3: This protein is involved in the compaction of chromatin and is also involved in the regulation of gene expression.\n4. Histone H4: This protein is involved in the compaction of chromatin and is also involved in the regulation of gene expression.\nThese histone proteins play a crucial role in the regulation of gene expression in prokaryotes, similar to the way they do in eukaryotes. They help to compact the DNA into a smaller space, making it more difficult for proteins involved in gene expression to access the DNA and read the genes. By regulating the access to the DNA, histones help to control the expression of genes and maintain the stability of the genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. In prokaryotes, histone-like proteins are involved in the compaction of DNA into chromatin.\n2. Histone H2A is involved in the formation of the nucleosome, the basic unit of chromatin.\n3. Histone H2B helps to stabilize the structure of the nucleosome.\n4. Histone H3 is involved in the compaction of chromatin and the regulation of gene expression.\n5. Histone H4 helps in chromatin compaction and aids in the regulation of gene expression.",
    "vicuna-13b_fact": [
      "In prokaryotes, histone-like proteins are involved in the compaction of DNA into chromatin.",
      "Histone H2A is involved in the formation of the nucleosome, the basic unit of chromatin.",
      "Histone H2B helps to stabilize the structure of the nucleosome.",
      "Histone H3 is involved in the compaction of chromatin and the regulation of gene expression.",
      "Histone H4 helps in chromatin compaction and aids in the regulation of gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 860,
    "user_query": "Is hypersensitivity to DNA crosslinking agents a hallmark of Fanconi anemia?",
    "vicuna-13b_response": "Yes, hypersensitivity to DNA crosslinking agents is a hallmark of Fanconi anemia. Fanconi anemia is a rare genetic disorder that is characterized by a defect in the repair of DNA damage. One of the key features of Fanconi anemia is sensitivity to DNA crosslinking agents, which are chemicals that bind to DNA and crosslink it, causing damage.\nDNA crosslinking agents are commonly used in chemotherapy and other treatments for cancer, and people with Fanconi anemia are at increased risk of developing side effects from these treatments due to their hypersensitivity to these agents. In addition, people with Fanconi anemia are also at increased risk of developing cancer, likely due to their impaired ability to repair DNA damage.\nOverall, the hypersensitivity to DNA crosslinking agents is a key diagnostic feature of Fanconi anemia, and it is important for people with this condition to be carefully monitored and managed to minimize the risk of complications from DNA damage and treatment with DNA crosslinking agents.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hypersensitivity to DNA crosslinking agents is a hallmark of Fanconi anemia.\n2. Fanconi anemia is a rare genetic disorder characterized by a defect in the repair of DNA damage.\n3. DNA crosslinking agents are commonly used in chemotherapy and other treatments for cancer.\n4. People with Fanconi anemia are at increased risk of developing side effects from treatments using DNA crosslinking agents.\n5. People with Fanconi anemia are also at increased risk of developing cancer.",
    "vicuna-13b_fact": [
      "Hypersensitivity to DNA crosslinking agents is a hallmark of Fanconi anemia.",
      "Fanconi anemia is a rare genetic disorder characterized by a defect in the repair of DNA damage.",
      "DNA crosslinking agents are commonly used in chemotherapy and other treatments for cancer.",
      "People with Fanconi anemia are at increased risk of developing side effects from treatments using DNA crosslinking agents.",
      "People with Fanconi anemia are also at increased risk of developing cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 869,
    "user_query": "What is the pyroptotic pathway?",
    "vicuna-13b_response": "Pyroptosis is a type of programmed cell death that is characterized by the release of pro-inflammatory cytokines, such as interferon-γ (IFN-γ), from the dying cells. This process is triggered by the activation of the inflammasome, which is a multi-protein complex that acts as a sensor of cellular stress.\nThe inflammasome is activated in response to various types of cellular stress, including infection with certain types of bacteria and viruses, as well as exposure to toxins and other harmful substances. Once activated, the inflammasome triggers the formation of a large pore in the cell membrane, which allows the release of pro-inflammatory cytokines and other molecules that help to recruit immune cells to the site of infection or injury.\nPyroptosis is a rapid and inflammatory form of cell death that plays an important role in the immune response. It helps to clear infected or damaged cells and to recruit immune cells to the site of infection or injury, where they can help to eliminate the pathogen or repair the damaged tissue.\nOverall, the pyroptotic pathway is a critical component of the immune response, and dysregulation of this process has been implicated in a variety of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pyroptosis is a type of programmed cell death characterized by the release of pro-inflammatory cytokines from dying cells.\n2. The inflammasome, a multi-protein complex that acts as a sensor of cellular stress, triggers pyroptosis.\n3. The inflammasome activates and forms a pore in the cell membrane that allows the release of cytokines and other molecules.\n4. Pyroptosis plays an important role in the immune response.\n5. Dysregulation of the pyroptotic process has been implicated in a variety of diseases including cancer, autoimmune disorders, and neurodegenerative diseases.",
    "vicuna-13b_fact": [
      "Pyroptosis is a type of programmed cell death characterized by the release of pro-inflammatory cytokines from dying cells.",
      "The inflammasome, a multi-protein complex that acts as a sensor of cellular stress, triggers pyroptosis.",
      "The inflammasome activates and forms a pore in the cell membrane that allows the release of cytokines and other molecules.",
      "Pyroptosis plays an important role in the immune response.",
      "Dysregulation of the pyroptotic process has been implicated in a variety of diseases including cancer, autoimmune disorders, and neurodegenerative diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 871,
    "user_query": "What are the known families of deadenylases?",
    "vicuna-13b_response": "Deadenylases are enzymes that remove the nitrogen group (N-group) from the guanine base of an adenine nucleotide, resulting in the formation of an inactive adenine base. There are several known families of deadenylases, including:\n1. CCR4-NOT deadenylase: This enzyme is involved in the regulation of gene expression in eukaryotic cells. It recognizes and removes the N-group from the adenine nucleotide in the CCR4-NOT complex, which is involved in the degradation of mRNA.\n2. DEN1 deadenylase: This enzyme is involved in the regulation of gene expression in yeast cells. It recognizes and removes the N-group from the adenine nucleotide in the DEN1 complex, which is involved in the degradation of mRNA.\n3. Nrd1 deadenylase: This enzyme is involved in the regulation of gene expression in yeast cells. It recognizes and removes the N-group from the adenine nucleotide in the Nrd1 complex, which is involved in the degradation of mRNA.\n4. Swe1 deadenylase: This enzyme is involved in the regulation of gene expression in yeast cells. It recognizes and removes the N-group from the adenine nucleotide in the Swe1 complex, which is involved in the degradation of mRNA.\nOverall, deadenylases play important roles in the regulation of gene expression by removing the N-group from adenine nucleotides in various complexes, leading to the degradation of mRNA.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Deadenylases are enzymes that remove the nitrogen group from the guanine base of an adenine nucleotide, resulting in an inactive adenine base.\n2. The CCR4-NOT deadenylase is involved in the regulation of gene expression in eukaryotic cells.\n3. DEN1 deadenylase is involved in the regulation of gene expression in yeast cells.\n4. Nrd1 deadenylase is also involved in the regulation of gene expression in yeast cells.\n5. Swe1 deadenylase is involved in the regulation of gene expression in yeast cells.",
    "vicuna-13b_fact": [
      "Deadenylases are enzymes that remove the nitrogen group from the guanine base of an adenine nucleotide, resulting in an inactive adenine base.",
      "The CCR4-NOT deadenylase is involved in the regulation of gene expression in eukaryotic cells.",
      "DEN1 deadenylase is involved in the regulation of gene expression in yeast cells.",
      "Nrd1 deadenylase is also involved in the regulation of gene expression in yeast cells.",
      "Swe1 deadenylase is involved in the regulation of gene expression in yeast cells."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Deadenylases are enzymes that remove the poly(A) tail from the mRNAs, not the nitrogen group from the guanine base of an adenine nucleotide.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Nrd1 is not a deadenylase, but it is involved in the regulation of gene expression in yeast cells as a termination factor.\n5. FALSE [correction]: Swe1 is a protein kinase in yeast involved in mitotic control, not a deadenylase.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 872,
    "user_query": "Which translocation is harbored in the Askin tumor cells?",
    "vicuna-13b_response": "The Askin tumor is a rare type of cancer that primarily affects the salivary glands. One of the key genetic abnormalities associated with the Askin tumor is the translocation t(X;18)(p11.2;q11.2), which involves the exchange of genetic material between the X chromosome and chromosome 18. This translocation results in the formation of a fusion gene called TFE3-TFE7, which is composed of parts of the transcription factor genes TFE3 and TFE7. The TFE3-TFE7 fusion gene is thought to be involved in the development and progression of Askin tumors, and it is often detected by fluorescence in situ hybridization (FISH) or other molecular genetic techniques.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Askin tumor is a type of cancer that primarily affects the salivary glands.\n2. One key genetic abnormality associated with the Askin tumor is the translocation t(X;18)(p11.2;q11.2).\n3. The t(X;18)(p11.2;q11.2) translocation involves the exchange of genetic material between the X chromosome and chromosome 18.\n4. This translocation results in the creation of the TFE3-TFE7 fusion gene.\n5. The TFE3-TFE7 fusion gene is often detected by fluorescence in situ hybridization (FISH) or other molecular genetic techniques.",
    "vicuna-13b_fact": [
      "The Askin tumor is a type of cancer that primarily affects the salivary glands.",
      "One key genetic abnormality associated with the Askin tumor is the translocation t(X;18)(p11.2;q11.2).",
      "The t(X;18)(p11.2;q11.2) translocation involves the exchange of genetic material between the X chromosome and chromosome 18.",
      "This translocation results in the creation of the TFE3-TFE7 fusion gene.",
      "The TFE3-TFE7 fusion gene is often detected by fluorescence in situ hybridization (FISH) or other molecular genetic techniques."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Askin tumor, also known as Askin's tumor, is a type of cancer that primarily affects the chest wall, not the salivary glands.\n2. FALSE [correction]: The key genetic abnormality associated with the Askin tumor is the translocation t(11;22)(q24;q12), not t(X;18)(p11.2;q11.2).\n3. FALSE [correction]: The t(11;22)(q24;q12) translocation, typically associated with Askin tumor, involves the exchange of genetic material between chromosome 11 and chromosome 22, not the X chromosome and chromosome 18.\n4. FALSE [correction]: The translocation related to Askin tumor typically results in the creation of the EWSR1-FLI1 fusion gene, not the TFE3-TFE7 fusion gene.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 875,
    "user_query": "Which R/bioconductor package utilizes the Hilbert curve in order to visualize genomic data?",
    "vicuna-13b_response": "The R/Bioconductor package that utilizes the Hilbert curve for visualizing genomic data is the \"edgeR\" package. The Hilbert curve is used in edgeR to visualize the distribution of counts of reads that map to a specific genomic location, and to identify potential regions of enrichment or depletion of certain features in the genome. The edgeR package is widely used for the analysis of count data generated from high-throughput sequencing experiments, such as RNA-seq or ChIP-seq.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The R/Bioconductor package called \"edgeR\" utilizes the Hilbert curve to visualize genomic data.\n2. The Hilbert curve is used in edgeR to visualize the distribution of counts of reads that map to a specific genomic location.\n3. EdgeR also uses the Hilbert curve to identify potential regions of enrichment or depletion of certain features in the genome.\n4. The edgeR package is used for the analysis of count data generated from high-throughput sequencing experiments.\n5. EdgeR package is used in RNA-seq or ChIP-seq experiments.",
    "vicuna-13b_fact": [
      "The R/Bioconductor package called \"edgeR\" utilizes the Hilbert curve to visualize genomic data.",
      "The Hilbert curve is used in edgeR to visualize the distribution of counts of reads that map to a specific genomic location.",
      "EdgeR also uses the Hilbert curve to identify potential regions of enrichment or depletion of certain features in the genome.",
      "The edgeR package is used for the analysis of count data generated from high-throughput sequencing experiments.",
      "EdgeR package is used in RNA-seq or ChIP-seq experiments."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The R/Bioconductor package called \"edgeR\" does not utilize the Hilbert curve to visualize genomic data. \n2. FALSE [correction]: The Hilbert curve is not used in edgeR to visualize the distribution of counts of reads that map to a specific genomic location.\n3. FALSE [correction]: EdgeR doesn't use the Hilbert curve to identify potential regions of enrichment or depletion of certain features in the genome.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 876,
    "user_query": "Can fetal aneuploidy be detected with non-invasive prenatal testing?",
    "vicuna-13b_response": "Yes, fetal aneuploidy can be detected with non-invasive prenatal testing (NIPT). NIPT is a type of prenatal testing that can detect certain chromosomal abnormalities in a fetus, such as Down syndrome, by analyzing fetal DNA in the mother's blood.\nNIPT is typically performed after the 10th week of pregnancy and is considered a non-invasive option because it does not involve any procedures that would harm the fetus. The test is done by drawing a sample of the mother's blood and analyzing the fetal DNA that is present in the sample.\nWhile NIPT is not a diagnostic test and cannot detect all chromosomal abnormalities, it is highly accurate for detecting common aneuploidies such as Down syndrome, and can provide valuable information to expectant parents. It is important to note that NIPT is not a replacement for diagnostic testing, and further diagnostic testing may be necessary to confirm the results of the NIPT.\nIt is important to discuss the risks and benefits of NIPT with a healthcare provider to determine if it is appropriate for a particular pregnancy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fetal aneuploidy can be detected with non-invasive prenatal testing (NIPT).\n2. NIPT is a type of prenatal testing that can detect certain chromosomal abnormalities in a fetus, such as Down syndrome, by analyzing fetal DNA in the mother's blood.\n3. NIPT is typically performed after the 10th week of pregnancy.\n4. The NIPT procedure involves drawing a sample of the mother's blood and analyzing the fetal DNA that is present in the sample.\n5. NIPT is not a diagnostic test and cannot detect all chromosomal abnormalities but it is highly accurate for detecting common aneuploidies such as Down syndrome.",
    "vicuna-13b_fact": [
      "Fetal aneuploidy can be detected with non-invasive prenatal testing (NIPT).",
      "NIPT is a type of prenatal testing that can detect certain chromosomal abnormalities in a fetus, such as Down syndrome, by analyzing fetal DNA in the mother's blood.",
      "NIPT is typically performed after the 10th week of pregnancy.",
      "The NIPT procedure involves drawing a sample of the mother's blood and analyzing the fetal DNA that is present in the sample.",
      "NIPT is not a diagnostic test and cannot detect all chromosomal abnormalities but it is highly accurate for detecting common aneuploidies such as Down syndrome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 877,
    "user_query": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?",
    "vicuna-13b_response": "In R/bioconductor, there are several packages that can be used for performing overlap analysis of genomic regions, including:\n1. sva: This package provides a set of tools for analyzing genomic variation, including tools for identifying overlapping regions between variants.\n2. bcftools: This package provides a set of tools for working with variation call format (VCF) files, including tools for identifying overlapping regions between variants.\n3. samtools: This package provides a set of tools for working with SAM/BAM files, including tools for identifying overlapping regions between reads.\n4. picard: This package provides a set of tools for working with SAM/BAM files, including tools for identifying overlapping regions between reads.\n5. bedtools: This package provides a set of tools for working with BED files, including tools for identifying overlapping regions between genomic regions.\n6. intersectBed: This package provides a simple command-line tool for identifying overlapping regions between two sets of genomic regions.\n7. GenABEL: This package provides a set of tools for working with genomic data, including tools for identifying overlapping regions between genomic regions.\n8. Biostrings: This package provides a set of tools for working with biological sequences, including tools for identifying overlapping regions between sequences.\nIt's worth noting that some of these packages are more geared towards specific types of data or specific types of analyses, so it's important to choose the right tool for the job.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The sva package in R/bioconductor can be used for analyzing genomic variation, including identifying overlapping regions between variants.\n2. The bcftools package provides tools for working with variation call format (VCF) files, including identifying overlapping regions between variants.\n3. The samtools package in R/bioconductor provides tools for working with SAM/BAM files, including identifying overlapping regions between reads.\n4. The picard package in R/bioconductor provides tools for working with SAM/BAM files, including identifying overlapping regions between reads.\n5. The bedtools package in R/bioconductor can be used for working with BED files, including identifying overlapping regions between genomic regions.",
    "vicuna-13b_fact": [
      "The sva package in R/bioconductor can be used for analyzing genomic variation, including identifying overlapping regions between variants.",
      "The bcftools package provides tools for working with variation call format (VCF) files, including identifying overlapping regions between variants.",
      "The samtools package in R/bioconductor provides tools for working with SAM/BAM files, including identifying overlapping regions between reads.",
      "The picard package in R/bioconductor provides tools for working with SAM/BAM files, including identifying overlapping regions between reads.",
      "The bedtools package in R/bioconductor can be used for working with BED files, including identifying overlapping regions between genomic regions."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The picard package in does not belong to R/bioconductor. It is a set of command line tools for manipulating high-throughput sequencing (HTS) data and formats such as SAM/BAM/CRAM and VCF.\n5. FALSE [correction]: The bedtools package doesn't belong to R/bioconductor. It is a powerful toolset for genome arithmetic. It allows one to intersect, merge, count, complement and shuffle genomic intervals from multiple files.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 878,
    "user_query": "Is dichlorphenamide effective for periodic paralysis?",
    "vicuna-13b_response": "Dichlorphenamide is a medication that is sometimes used to treat periodic paralysis, a condition characterized by episodes of muscle weakness and stiffness that can be triggered by changes in temperature, stress, or physical activity.\nDichlorphenamide works by blocking the action of a protein called the sodium channel, which is involved in the transmission of nerve signals in the body. By blocking the sodium channel, dichlorphenamide can help to reduce muscle spasms and improve muscle strength in people with periodic paralysis.\nHowever, it's important to note that dichlorphenamide is not a cure for periodic paralysis, and it may not work for everyone with the condition. Additionally, dichlorphenamide can have side effects, and it may interact with other medications that a person is taking.\nIf you have been diagnosed with periodic paralysis and your doctor has recommended dichlorphenamide as a treatment, it's important to follow their instructions carefully and to report any side effects or concerns that you may have. Your doctor may also recommend other lifestyle changes, such as regular exercise, a balanced diet, and stress reduction techniques, to help manage your condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dichlorphenamide is sometimes used to treat periodic paralysis.\n2. Periodic paralysis is characterized by episodes of muscle weakness and stiffness.\n3. Dichlorphenamide works by blocking the action of a protein called the sodium channel.\n4. Dichlorphenamide is not a cure for periodic paralysis and may not work for everyone with the condition.\n5. Dichlorphenamide can have side effects and may interact with other medications.",
    "vicuna-13b_fact": [
      "Dichlorphenamide is sometimes used to treat periodic paralysis.",
      "Periodic paralysis is characterized by episodes of muscle weakness and stiffness.",
      "Dichlorphenamide works by blocking the action of a protein called the sodium channel.",
      "Dichlorphenamide is not a cure for periodic paralysis and may not work for everyone with the condition.",
      "Dichlorphenamide can have side effects and may interact with other medications."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Dichlorphenamide works by influencing how kidneys handle bicarbonate, a substance the body uses to manage pH, thereby indirectly affecting muscle cell stability.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 881,
    "user_query": "Which pathway is activated by ficolin-3?",
    "vicuna-13b_response": "Ficolin-3 is a protein that plays a role in the innate immune system, which is the body's first line of defense against infection. Ficolin-3 is involved in the recognition and elimination of pathogens, such as bacteria and viruses.\nFicolin-3 is part of the lectin pathway, also known as the mannan-binding lectin (MBL) pathway, which is one of the pathways that the innate immune system uses to detect and eliminate pathogens. The lectin pathway is activated when ficolin-3 binds to a specific carbohydrate structure (called a lectin) that is found on the surface of some pathogens. This binding activates a cascade of events that leads to the elimination of the pathogen.\nIn summary, ficolin-3 is a protein that is involved in the innate immune system and is part of the lectin pathway, which is activated when ficolin-3 binds to a specific carbohydrate structure on the surface of some pathogens. This binding leads to the elimination of the pathogen.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ficolin-3 is a protein that plays a role in the innate immune system.\n2. The innate immune system is the body's first line of defense against infection.\n3. Ficolin-3 is part of the lectin pathway, also known as the mannan-binding lectin (MBL) pathway.\n4. The lectin pathway is activated when ficolin-3 binds to a specific carbohydrate structure that is found on the surface of some pathogens.\n5. This binding activates a cascade of events that leads to the elimination of the pathogen.",
    "vicuna-13b_fact": [
      "Ficolin-3 is a protein that plays a role in the innate immune system.",
      "The innate immune system is the body's first line of defense against infection.",
      "Ficolin-3 is part of the lectin pathway, also known as the mannan-binding lectin (MBL) pathway.",
      "The lectin pathway is activated when ficolin-3 binds to a specific carbohydrate structure that is found on the surface of some pathogens.",
      "This binding activates a cascade of events that leads to the elimination of the pathogen."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "vicuna-13b_response": "There are several technologies that can be used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses. The choice of technology depends on various factors, such as the sample type, the number of phosphorylation sites, the dynamic range of phosphorylation levels, and the sensitivity required. Here are some of the preferred technologies for the enrichment of phosphorylated peptides:\n1. Ion Mobility Mass Spectrometry (IM-MS): IM-MS is a powerful tool for the enrichment and identification of phosphorylated peptides. IM-MS separates ions based on their mobility in a strong electric field, which allows for the separation of ions based on their mass-to-charge ratio and shape. IM-MS can be used for the enrichment of phosphorylated peptides by trapping ions based on their mobility and charge state.\n2. Phospho-specific antibodies: Phospho-specific antibodies can be used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes. This method is widely used in proteomics and has been used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses.\n3. Phosphate affinity chromatography: Phosphate affinity chromatography is a method that uses a phosphate-based ligand to bind to phosphorylated peptides. This method can be used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes.\n4. TiO2: TiO2 is a material that can be used for the enrichment of phosphorylated peptides by immobilizing phosphorylated peptides on its surface. This method is based on the interaction between phosphate groups and TiO2, which can be used to enrich for phosphorylated peptides.\n5. HPLC: High-performance liquid chromatography (HPLC) can be used for the enrichment of phosphorylated peptides by separating peptides based on their hydrophobicity, size",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ion Mobility Mass Spectrometry (IM-MS) separates ions based on their mobility in a strong electric field.\n2. IM-MS can be used for the enrichment of phosphorylated peptides by trapping ions based on their mobility and charge state.\n3. Phospho-specific antibodies can be used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes.\n4. Phosphate affinity chromatography is a method that uses a phosphate-based ligand to bind to phosphorylated peptides.\n5. TiO2 can be used for the enrichment of phosphorylated peptides by immobilizing phosphorylated peptides on its surface.",
    "vicuna-13b_fact": [
      "Ion Mobility Mass Spectrometry (IM-MS) separates ions based on their mobility in a strong electric field.",
      "IM-MS can be used for the enrichment of phosphorylated peptides by trapping ions based on their mobility and charge state.",
      "Phospho-specific antibodies can be used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes.",
      "Phosphate affinity chromatography is a method that uses a phosphate-based ligand to bind to phosphorylated peptides.",
      "TiO2 can be used for the enrichment of phosphorylated peptides by immobilizing phosphorylated peptides on its surface."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 884,
    "user_query": "Which histone modifications are correlated with transcription elongation?",
    "vicuna-13b_response": "Several histone modifications have been correlated with transcription elongation, which is the process by which RNA polymerase moves along the DNA template and synthesizes mRNA. These modifications include:\n1. Ser5P: This modification is associated with the recruitment of RNA polymerase to the promoter region of a gene and the initiation of transcription elongation.\n2. Ser2P: This modification is involved in the regulation of transcription elongation and is often found at the coding regions of active genes.\n3. Ser1P: This modification is involved in the regulation of transcription elongation and is often found at the coding regions of active genes.\n4. Acetylation: This modification is associated with the activation of transcription and the recruitment of RNA polymerase to the promoter region of a gene.\n5. Methylation: This modification is associated with the repression of transcription and is often found at the promoter and coding regions of inactive genes.\n6. H3K36me3: This modification is associated with the repression of transcription and is often found at the coding regions of inactive genes.\n7. H3K79me2: This modification is associated with the repression of transcription and is often found at the coding regions of inactive genes.\n8. H3K27me3: This modification is associated with the repression of transcription and is often found at the promoter and coding regions of inactive genes.\nIt's important to note that these modifications are not mutually exclusive and can work together to regulate transcription elongation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ser5P is a histone modification associated with the recruitment of RNA polymerase to the promoter region of a gene and the initiation of transcription elongation.\n2. Ser2P is a histone modification involved in the regulation of transcription elongation and is often found at the coding regions of active genes.\n3. Ser1P is a histone modification involved in the regulation of transcription elongation and is often found at the coding regions of active genes.\n4. Acetylation is a histone modification associated with the activation of transcription and the recruitment of RNA polymerase to the promoter region of a gene.\n5. Methylation is a histone modification associated with the repression of transcription and is often found at the promoter and coding regions of inactive genes.",
    "vicuna-13b_fact": [
      "Ser5P is a histone modification associated with the recruitment of RNA polymerase to the promoter region of a gene and the initiation of transcription elongation.",
      "Ser2P is a histone modification involved in the regulation of transcription elongation and is often found at the coding regions of active genes.",
      "Ser1P is a histone modification involved in the regulation of transcription elongation and is often found at the coding regions of active genes.",
      "Acetylation is a histone modification associated with the activation of transcription and the recruitment of RNA polymerase to the promoter region of a gene.",
      "Methylation is a histone modification associated with the repression of transcription and is often found at the promoter and coding regions of inactive genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ser1P is a histone modification involved in the regulation of gene expression but is not typically associated with transcription elongation or the coding regions of active genes.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 885,
    "user_query": "Does  thyroid hormone receptor beta1 affect insulin secretion?",
    "vicuna-13b_response": "Yes, thyroid hormone receptor beta1 (TRβ1) can affect insulin secretion. TRβ1 is a type of nuclear receptor that plays a critical role in regulating the expression of genes involved in glucose metabolism and insulin secretion.\nStudies have shown that TRβ1 is expressed in pancreatic beta cells, which are responsible for producing insulin. TRβ1 can bind to DNA and regulate the expression of genes involved in insulin secretion, such as the insulin gene itself. In addition, TRβ1 can also modulate the activity of other transcription factors that regulate insulin secretion, such as the glucose-responsive insulin gene (GRIP1) and the pancreatic duodenal homeobox 1 (PDX1) transcription factor.\nActivation of TRβ1 by thyroid hormone can enhance insulin secretion from pancreatic beta cells, while inhibition of TRβ1 by antithyroid drugs can reduce insulin secretion. In addition, mutations in TRβ1 have been associated with disorders of glucose metabolism and insulin secretion, such as type 2 diabetes.\nOverall, TRβ1 plays an important role in regulating insulin secretion from pancreatic beta cells, and dysregulation of TRβ1 activity can contribute to disorders of glucose metabolism and insulin secretion.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Thyroid hormone receptor beta1 (TRβ1) can affect insulin secretion.\n2. TRβ1 is a type of nuclear receptor that regulates the expression of genes involved in glucose metabolism and insulin secretion.\n3. TRβ1 is expressed in pancreatic beta cells, which are responsible for producing insulin.\n4. Activation of TRβ1 by thyroid hormone can enhance insulin secretion from pancreatic beta cells.\n5. Mutations in TRβ1 have been associated with disorders of glucose metabolism and insulin secretion, such as type 2 diabetes.",
    "vicuna-13b_fact": [
      "Thyroid hormone receptor beta1 (TRβ1) can affect insulin secretion.",
      "TRβ1 is a type of nuclear receptor that regulates the expression of genes involved in glucose metabolism and insulin secretion.",
      "TRβ1 is expressed in pancreatic beta cells, which are responsible for producing insulin.",
      "Activation of TRβ1 by thyroid hormone can enhance insulin secretion from pancreatic beta cells.",
      "Mutations in TRβ1 have been associated with disorders of glucose metabolism and insulin secretion, such as type 2 diabetes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 893,
    "user_query": "What is commotio cordis?",
    "vicuna-13b_response": "Commotio cordis is a Latin term that means \"agitation of the heart.\" It refers to a rare but potentially life-threatening condition that occurs when the heart is struck or otherwise affected by a sudden, forceful blow or impact. This can cause the heart to stop beating or to beat in an abnormal rhythm, leading to cardiac arrest or other serious complications. Commotio cordis is most commonly seen in young athletes, particularly those participating in contact sports such as football or basketball. Treatment for commotio cordis typically involves cardiopulmonary resuscitation (CPR) and other emergency measures to stabilize the heart and restore normal heart function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Commotio cordis is a Latin term that means \"agitation of the heart.\"\n2. Commotio cordis is a condition that can occur when the heart is affected by a sudden, forceful blow or impact.\n3. One of the main symptoms of commotio cordis is an abnormal heart rhythm or cardiac arrest.\n4. Commotio cordis most commonly affects young athletes who participate in contact sports such as football or basketball.\n5. The treatment for commotio cordis usually involves cardiopulmonary resuscitation (CPR) and other emergency measures to restore normal heart function.",
    "vicuna-13b_fact": [
      "Commotio cordis is a Latin term that means \"agitation of the heart.\"",
      "Commotio cordis is a condition that can occur when the heart is affected by a sudden, forceful blow or impact.",
      "One of the main symptoms of commotio cordis is an abnormal heart rhythm or cardiac arrest.",
      "Commotio cordis most commonly affects young athletes who participate in contact sports such as football or basketball.",
      "The treatment for commotio cordis usually involves cardiopulmonary resuscitation (CPR) and other emergency measures to restore normal heart function."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 894,
    "user_query": "What is the cause of Phthiriasis Palpebrarum?",
    "vicuna-13b_response": "Phthiriasis palpebrarum is a medical condition caused by a parasitic infestation of the eyelashes by a mite called Demodex folliculorum. This mite is a common inhabitant of human hair follicles and is usually harmless. However, in some cases, the infestation can become excessive, leading to the formation of red, itchy bumps on the eyelashes, which is known as phthiriasis palpebrarum.\nThe exact cause of excessive infestation is not well understood, but it is thought to be related to a weakened immune system, hormonal changes, or poor hygiene. The condition is more commonly seen in people with a family history of atopic diseases, such as eczema or asthma, and in those who use eye makeup or wear contact lenses.\nPhthiriasis palpebrarum can be diagnosed by a dermatologist or an ophthalmologist through a physical examination of the eyelashes. Treatment typically involves applying a topical anti-inflammatory medication, such as corticosteroids, to the affected area. In some cases, oral medication may be prescribed to address the underlying infestation. It is important to follow proper hygiene practices, such as regular cleaning of the eyelashes and eyelids, to prevent recurrence of the condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Phthiriasis palpebrarum is a condition caused by an infestation of the eyelashes by a mite called Demodex folliculorum.\n2. Demodex folliculorum is a common inhabitant of human hair follicles and is usually harmless.\n3. Excessive infestation causing phthiriasis palpebrarum may be related to a weakened immune system, hormonal changes, or poor hygiene.\n4. Phthiriasis palpebrarum is more commonly seen in people with a family history of atopic diseases, such as eczema or asthma, and in those who use eye makeup or wear contact lenses.\n5. The treatment of Phthiriasis palpebrarum typically involves applying a topical anti-inflammatory medication, such as corticosteroids, to the affected area.",
    "vicuna-13b_fact": [
      "Phthiriasis palpebrarum is a condition caused by an infestation of the eyelashes by a mite called Demodex folliculorum.",
      "Demodex folliculorum is a common inhabitant of human hair follicles and is usually harmless.",
      "Excessive infestation causing phthiriasis palpebrarum may be related to a weakened immune system, hormonal changes, or poor hygiene.",
      "Phthiriasis palpebrarum is more commonly seen in people with a family history of atopic diseases, such as eczema or asthma, and in those who use eye makeup or wear contact lenses.",
      "The treatment of Phthiriasis palpebrarum typically involves applying a topical anti-inflammatory medication, such as corticosteroids, to the affected area."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Phthiriasis palpebrarum is a condition caused by an infestation of the eyelashes by a louse, Phthirus pubis, not a mite called Demodex folliculorum.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: The treatment of Phthiriasis palpebrarum typically involves manual removal of the lice and eggs, and applying a topical pediculicide such as Mercuric oxide ointment to the affected area. Anti-inflammatory medication, such as corticosteroids, is not typically used in the treatment.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 896,
    "user_query": "How are CpG island shores defined?",
    "vicuna-13b_response": "CpG islands are defined as regions of DNA that contain a high density of CpG dinucleotides and are typically located near the shores of larger CpG islands. They are also characterized by a lack of gene promoters and tend to be methylated, which is thought to protect them from being recognized as CpG islands. CpG islands are important in the regulation of gene expression and are often associated with the silencing of nearby genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CpG islands are regions of DNA that contain a high density of CpG dinucleotides.\n2. CpG islands are typically located near the shores of larger CpG islands.\n3. CpG island shores lack gene promoters.\n4. CpG island shores tend to be methylated, which is thought to protect them from being recognized as CpG islands.\n5. CpG islands are often associated with the silencing of nearby genes.",
    "vicuna-13b_fact": [
      "CpG islands are regions of DNA that contain a high density of CpG dinucleotides.",
      "CpG islands are typically located near the shores of larger CpG islands.",
      "CpG island shores lack gene promoters.",
      "CpG island shores tend to be methylated, which is thought to protect them from being recognized as CpG islands.",
      "CpG islands are often associated with the silencing of nearby genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: CpG islands are typically located near the transcription start sites of genes, not near the shores of larger CpG islands.\n3. FALSE [correction]: CpG island shores can contain gene promoters.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 898,
    "user_query": "Which gene is mutated in a subtype of arrhythmogenic right ventricular cardiomyopathy known as Naxos disease?",
    "vicuna-13b_response": "Naxos disease is a subtype of arrhythmogenic right ventricular cardiomyopathy (ARVC) that is caused by mutations in the desmoplakin-2 (DSP2) gene. The DSP2 gene provides instructions for making a protein called desmoplakin-2, which is involved in the formation and maintenance of the specialized cell junctions called desmosomes. These junctions play a critical role in maintaining the structure and function of heart muscle cells (cardiomyocytes). Mutations in the DSP2 gene can disrupt the normal function of desmosomes, leading to the progressive weakening and scarring of heart muscle cells that characterizes ARVC. The presence of DSP2 mutations is typically confirmed by genetic testing, which can identify the specific mutation that is present in an individual with Naxos disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Naxos disease is a subtype of arrhythmogenic right ventricular cardiomyopathy (ARVC).\n2. Naxos disease is caused by mutations in the desmoplakin-2 (DSP2) gene.\n3. The DSP2 gene provides instructions for making a protein called desmoplakin-2.\n4. Desmoplakin-2 is involved in the formation and maintenance of desmosomes in heart muscle cells.\n5. The presence of DSP2 mutations is typically confirmed by genetic testing.",
    "vicuna-13b_fact": [
      "Naxos disease is a subtype of arrhythmogenic right ventricular cardiomyopathy (ARVC).",
      "Naxos disease is caused by mutations in the desmoplakin-2 (DSP2) gene.",
      "The DSP2 gene provides instructions for making a protein called desmoplakin-2.",
      "Desmoplakin-2 is involved in the formation and maintenance of desmosomes in heart muscle cells.",
      "The presence of DSP2 mutations is typically confirmed by genetic testing."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Naxos disease is caused by mutations in the plakoglobin (JUP) gene.\n3. FALSE [correction]: The DSP2 gene does not exist. The DSP gene provides instructions for making a protein called desmoplakin.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 899,
    "user_query": "What is the role of edaravone in traumatic brain injury?",
    "vicuna-13b_response": "Edaravone is a drug that has been studied for its potential to treat traumatic brain injury (TBI). TBI is a type of injury that occurs when the brain is subjected to external forces, such as from a car accident or a sports injury. Edaravone is a free radical scavenger that has been shown to have neuroprotective effects in animal models of TBI.\nIn clinical trials, edaravone has been shown to reduce the number of brain lesions and improve outcomes in patients with TBI. The exact mechanism of action of edaravone in TBI is not fully understood, but it is thought to involve reducing oxidative stress and inflammation in the brain.\nEdaravone is currently not approved for use in the treatment of TBI in the United States, but it is approved in Japan for the treatment of TBI and other neurological conditions. Further research is needed to fully understand the potential benefits and risks of edaravone in the treatment of TBI.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Edaravone is a drug that has been studied for its potential to treat traumatic brain injury (TBI).\n2. TBI is an injury that occurs when the brain is subjected to external forces, such as from a car accident or a sports injury.\n3. Edaravone is a free radical scavenger that has been shown to have neuroprotective effects in animal models of TBI.\n4. In clinical trials, edaravone has been shown to reduce the number of brain lesions and improve outcomes in patients with TBI.\n5. Edaravone is currently not approved for use in the treatment of TBI in the United States, but it is approved in Japan for the treatment of TBI and other neurological conditions.",
    "vicuna-13b_fact": [
      "Edaravone is a drug that has been studied for its potential to treat traumatic brain injury (TBI).",
      "TBI is an injury that occurs when the brain is subjected to external forces, such as from a car accident or a sports injury.",
      "Edaravone is a free radical scavenger that has been shown to have neuroprotective effects in animal models of TBI.",
      "In clinical trials, edaravone has been shown to reduce the number of brain lesions and improve outcomes in patients with TBI.",
      "Edaravone is currently not approved for use in the treatment of TBI in the United States, but it is approved in Japan for the treatment of TBI and other neurological conditions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: Edaravone is approved for use in the treatment of Amyotrophic Lateral Sclerosis in the United States and in Japan for the treatment of acute ischemic stroke, not TBI.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 900,
    "user_query": "Are there plasma membrane receptors for thyroid hormones?",
    "vicuna-13b_response": "Yes, there are plasma membrane receptors for thyroid hormones. These receptors are called thyroid hormone receptors (TRs), and they are members of the nuclear receptor superfamily. There are two main types of TRs: TRα (also known as TRβ) and TRβ.\nTRα is the main receptor for thyroid hormones, and it is responsible for regulating the expression of genes involved in metabolism, growth, and development. TRα is found in many tissues, including the heart, skeletal muscle, and brown adipose tissue.\nTRβ is a relatively weak thyroid hormone receptor and is thought to play a minor role in the regulation of gene expression. TRβ is found in the brain and other tissues, and it may play a role in the regulation of brain development and function.\nThyroid hormones bind to TRs in the plasma membrane, which then translocate to the nucleus and regulate the expression of target genes. The binding of thyroid hormones to TRs can affect a wide range of physiological processes, including metabolism, growth and development, and reproduction.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. There are plasma membrane receptors for thyroid hormones called thyroid hormone receptors (TRs).\n2. TRs are part of the nuclear receptor superfamily.\n3. TRα is the main receptor for thyroid hormones and helps regulate the expression of genes involved in metabolism, growth, and development.\n4. TRβ is a relatively weak thyroid hormone receptor that is thought to play a minor role in the regulation of gene expression.\n5. Thyroid hormones bind to TRs in the plasma membrane, which then translocate to the nucleus and regulate the expression of target genes.",
    "vicuna-13b_fact": [
      "There are plasma membrane receptors for thyroid hormones called thyroid hormone receptors (TRs).",
      "TRs are part of the nuclear receptor superfamily.",
      "TRα is the main receptor for thyroid hormones and helps regulate the expression of genes involved in metabolism, growth, and development.",
      "TRβ is a relatively weak thyroid hormone receptor that is thought to play a minor role in the regulation of gene expression.",
      "Thyroid hormones bind to TRs in the plasma membrane, which then translocate to the nucleus and regulate the expression of target genes."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Thyroid hormone receptors (TRs) are not located in the plasma membrane, but they are found within cells, typically in the nucleus.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: TRβ is not a weak thyroid hormone receptor and it does play an important role in the regulation of gene expression.\n5. FALSE [correction]: Thyroid hormones do bind to TRs, but these receptors are located within the cell, not in the plasma membrane. Upon binding, they help regulate gene expression within the nucleus.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 904,
    "user_query": "Are there any desmins present in plants?",
    "vicuna-13b_response": "Yes, there are several types of demins present in plants. These include:\n1. Chloroplasts: These are the site of photosynthesis in plants and contain the pigment chlorophyll.\n2. Mitochondria: These are the powerhouses of the cell and generate energy for the plant through a process called cellular respiration.\n3. Endoplasmic reticulum: This is a network of flattened sacs that are involved in the production and transport of various molecules within the plant cell.\n4. Golgi apparatus: This is a structure that packages and ships various molecules, including proteins and lipids, to different parts of the plant.\n5. Vacuoles: These are fluid-filled organelles that play a role in maintaining the overall shape and stability of the plant cell, as well as in the storage of nutrients and waste.\nIt's important to note that the specific types and functions of demins in plants can vary depending on the type of plant and its specific needs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Chloroplasts are the site of photosynthesis in plants and contain the pigment chlorophyll.\n2. Mitochondria in plants generate energy for the plant through a process called cellular respiration.\n3. The endoplasmic reticulum in plants is a network of flattened sacs that are involved in the production and transport of various molecules within the plant cell.\n4. The Golgi apparatus in plants packages and ships various molecules, including proteins and lipids, to different parts of the plant.\n5. Vacuoles in plants are fluid-filled organelles that play a role in maintaining the overall shape and stability of the plant cell, as well as in the storage of nutrients and waste.",
    "vicuna-13b_fact": [
      "Chloroplasts are the site of photosynthesis in plants and contain the pigment chlorophyll.",
      "Mitochondria in plants generate energy for the plant through a process called cellular respiration.",
      "The endoplasmic reticulum in plants is a network of flattened sacs that are involved in the production and transport of various molecules within the plant cell.",
      "The Golgi apparatus in plants packages and ships various molecules, including proteins and lipids, to different parts of the plant.",
      "Vacuoles in plants are fluid-filled organelles that play a role in maintaining the overall shape and stability of the plant cell, as well as in the storage of nutrients and waste."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "vicuna-13b_response": "Human subacute thyroiditis is a type of inflammatory thyroid disease that is characterized by inflammation and swelling of the thyroid gland. The exact cause of subacute thyroiditis is not fully understood, but it is thought to be triggered by a viral infection in some cases.\nThere is evidence to suggest that certain viruses, such as the Epstein-Barr virus (EBV) and the cytomegalovirus (CMV), may play a role in the development of subacute thyroiditis. These viruses are known to cause inflammation and swelling of the thyroid gland, leading to the symptoms of subacute thyroiditis.\nHowever, it is important to note that not all cases of subacute thyroiditis are caused by viral infections. In some cases, the condition may be caused by other factors, such as a reaction to certain medications or an autoimmune disorder.\nIf you are experiencing symptoms of subacute thyroiditis, it is important to speak with a healthcare provider for proper diagnosis and treatment. They will be able to determine the underlying cause of your condition and recommend the appropriate course of treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Human subacute thyroiditis is a type of inflammatory thyroid disease characterized by inflammation and swelling of the thyroid gland.\n2. Subacute thyroiditis is thought to be triggered by a viral infection in some cases.\n3. Evidence suggests that the Epstein-Barr virus (EBV) and the cytomegalovirus (CMV) might play a role in the development of subacute thyroiditis.\n4. Not all cases of subacute thyroiditis are caused by viral infections; it can also be caused by a reaction to certain medications or an autoimmune disorder.\n5. Symptoms of subacute thyroiditis require consultation with a healthcare provider for proper diagnosis and treatment.",
    "vicuna-13b_fact": [
      "Human subacute thyroiditis is a type of inflammatory thyroid disease characterized by inflammation and swelling of the thyroid gland.",
      "Subacute thyroiditis is thought to be triggered by a viral infection in some cases.",
      "Evidence suggests that the Epstein-Barr virus (EBV) and the cytomegalovirus (CMV) might play a role in the development of subacute thyroiditis.",
      "Not all cases of subacute thyroiditis are caused by viral infections; it can also be caused by a reaction to certain medications or an autoimmune disorder.",
      "Symptoms of subacute thyroiditis require consultation with a healthcare provider for proper diagnosis and treatment."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 910,
    "user_query": "Which is the receptor for substrates of Chaperone Mediated Autophagy?",
    "vicuna-13b_response": "The receptor for substrates of Chaperone Mediated Autophagy (CMA) is the heat shock protein (Hsp70) also known as the major facilitator superfamily (MFS) transporter. Hsp70 is a type of chaperone protein that helps to transport and deliver substrates to the autophagosome for degradation. Hsp70 recognizes and binds to the substrates, which are then transported through the cell membrane and into the lysosome where they are degraded. CMA is a type of autophagy that is triggered by the accumulation of misfolded or aggregated proteins, which are recognized by Hsp70 and transported to the autophagosome for degradation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The receptor for substrates of Chaperone Mediated Autophagy (CMA) is the heat shock protein (Hsp70).\n2. Hsp70 is also known as the major facilitator superfamily (MFS) transporter.\n3. Hsp70 is a type of chaperone protein that helps to transport and deliver substrates to the autophagosome for degradation.\n4. Chaperone Mediated Autophagy is triggered by the accumulation of misfolded or aggregated proteins.\n5. Hsp70 recognizes and binds substrates, which are then transported through the cell membrane into the lysosome for degradation.",
    "vicuna-13b_fact": [
      "The receptor for substrates of Chaperone Mediated Autophagy (CMA) is the heat shock protein (Hsp70).",
      "Hsp70 is also known as the major facilitator superfamily (MFS) transporter.",
      "Hsp70 is a type of chaperone protein that helps to transport and deliver substrates to the autophagosome for degradation.",
      "Chaperone Mediated Autophagy is triggered by the accumulation of misfolded or aggregated proteins.",
      "Hsp70 recognizes and binds substrates, which are then transported through the cell membrane into the lysosome for degradation."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The receptor for substrates of Chaperone Mediated Autophagy (CMA) is LAMP-2A, not the heat shock protein (Hsp70).\n2. FALSE [correction]: Hsp70 is not known as the major facilitator superfamily (MFS) transporter. They are distinct from each other.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Hsp70 recognizes and binds substrates but they are transported into the lysosome for degradation, not through the cell membrane.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 913,
    "user_query": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?",
    "vicuna-13b_response": "There have been several clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms. Here are some of the major trials:\n1. International Subarachnoid Aneurysm Trial (ISAT): This was a multicenter, randomized controlled trial that compared the safety and efficacy of endovascular coiling versus microsurgical clipping for the treatment of ruptured brain aneurysms. The trial included 2,605 patients from 30 centers in 12 countries. The results showed that endovascular coiling was associated with a lower rate of death or disability at 6 months compared to microsurgical clipping (31% vs. 42%, p<0.001). However, there was no significant difference in the rate of aneurysm occlusion between the two groups.\n2. European Cooperative Study on the Management of Aneurysmal Subarachnoid Haemorrhage (ECASS): This was a multicenter, observational study that compared the outcomes of patients treated with endovascular coiling versus microsurgical clipping for ruptured brain aneurysms. The study included 1,004 patients from 37 centers in Europe. The results showed that endovascular coiling was associated with a lower rate of death or disability at 6 months compared to microsurgical clipping (30% vs. 43%, p<0.001).\n3. Clinical Trial of Unruptured Aneurysms (CTUA): This was a multicenter, randomized controlled trial that compared the safety and efficacy of endovascular coiling versus microsurgical clipping for the treatment of unruptured brain aneurysms. The trial included 285 patients from 21 centers in the United States. The results showed that endovascular coiling was associated with a lower rate of aneurysm rupture and a higher rate of retreatment compared to microsurgical clipping (10% vs. 22%, p=0.04).\nOverall, these trials suggest that endovascular coiling may be associated with better out",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The International Subarachnoid Aneurysm Trial (ISAT) was a multicenter, randomized controlled trial comparing the safety and efficacy of endovascular coiling versus microsurgical clipping for the treatment of ruptured brain aneurysms.\n2. ISAT included 2,605 patients from 30 centers in 12 countries.\n3. The European Cooperative Study on the Management of Aneurysmal Subarachnoid Haemorrhage (ECASS) was a multicenter, observational study that compared the outcomes of patients treated with endovascular coiling versus microsurgical clipping for ruptured brain aneurysms.\n4. ECASS included 1,004 patients from 37 centers in Europe.\n5. The Clinical Trial of Unruptured Aneurysms (CTUA) was a multicenter, randomized controlled trial that compared the safety and efficacy of endovascular coiling versus microsurgical clipping for the treatment of unruptured brain aneurysms. The trial included 285 patients from 21 centers in the United States.",
    "vicuna-13b_fact": [
      "The International Subarachnoid Aneurysm Trial (ISAT) was a multicenter, randomized controlled trial comparing the safety and efficacy of endovascular coiling versus microsurgical clipping for the treatment of ruptured brain aneurysms.",
      "ISAT included 2,605 patients from 30 centers in 12 countries.",
      "The European Cooperative Study on the Management of Aneurysmal Subarachnoid Haemorrhage (ECASS) was a multicenter, observational study that compared the outcomes of patients treated with endovascular coiling versus microsurgical clipping for ruptured brain aneurysms.",
      "ECASS included 1,004 patients from 37 centers in Europe.",
      "The Clinical Trial of Unruptured Aneurysms (CTUA) was a multicenter, randomized controlled trial that compared the safety and efficacy of endovascular coiling versus microsurgical clipping for the treatment of unruptured brain aneurysms. The trial included 285 patients from 21 centers in the United States."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The European Cooperative Acute Stroke Study (ECASS) was a multicenter, randomized controlled trial that assessed the benefits of intravenous thrombolysis treatment within 6 hours of onset of acute ischemic stroke.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 919,
    "user_query": "Which are the mutational hotspots of the human KRAS oncogene?",
    "vicuna-13b_response": "The human KRAS oncogene is a well-known cancer-causing gene that is frequently mutated in many different types of cancer. There are several known mutational hotspots within the KRAS oncogene, which are regions of the gene that are more prone to mutations than other parts of the gene. Some of the most common mutational hotspots in the KRAS oncogene include:\n1. G12D: This mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with aspartic acid. This mutation has been identified in a variety of cancer types, including lung, colon, and pancreatic cancer.\n2. G12V: This mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with valine. This mutation has been identified in a variety of cancer types, including lung, colon, and pancreatic cancer.\n3. G12A: This mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with alanine. This mutation has been identified in a variety of cancer types, including lung, colon, and pancreatic cancer.\n4. G12C: This mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with cysteine. This mutation has been identified in a variety of cancer types, including lung, colon, and pancreatic cancer.\nOverall, these mutations can lead to the activation of the KRAS oncogene, which can promote the growth and survival of cancer cells. Targeting these mutations with specific therapies is an area of active research in the field of cancer treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The human KRAS oncogene is a cancer-causing gene that is frequently mutated in many types of cancer.\n2. Know mutational hotspots in the KRAS oncogene include mutations G12D, G12V, G12A, and G12C.\n3. The G12D mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with aspartic acid.\n4. The G12V mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with valine.\n5. The G12A mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with alanine.\n6. The G12C mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with cysteine.\n7. The above-mentioned mutations are known to promote the growth and survival of cancer cells by activating the KRAS oncogene.",
    "vicuna-13b_fact": [
      "The human KRAS oncogene is a cancer-causing gene that is frequently mutated in many types of cancer.",
      "Know mutational hotspots in the KRAS oncogene include mutations G12D, G12V, G12A, and G12C.",
      "The G12D mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with aspartic acid.",
      "The G12V mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with valine.",
      "The G12A mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with alanine.",
      "The G12C mutation involves the substitution of the glycine amino acid at position 12 in the KRAS protein with cysteine.",
      "The above-mentioned mutations are known to promote the growth and survival of cancer cells by activating the KRAS oncogene."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Known mutational hotspots in the KRAS oncogene include mutations G12D, G12V, G12A, and G12C.\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE\n7. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 921,
    "user_query": "What is the mechanism of action of ocrelizumab for treatment of multiple sclerosis?",
    "vicuna-13b_response": "Ocrelizumab is a monoclonal antibody that works by targeting and depleting a type of immune cell called CD20-positive B cells. In multiple sclerosis, the immune system mistakenly attacks the myelin sheath surrounding nerve cells, leading to damage and inflammation.\nOcrelizumab binds to CD20 on the surface of B cells and triggers an immune response that leads to their destruction. By depleting B cells, ocrelizumab reduces the autoimmune response that causes damage to the central nervous system, which is the underlying mechanism of multiple sclerosis.\nOcrelizumab is given by intravenous infusion and is approved for the treatment of relapsing-remitting multiple sclerosis and primary progressive multiple sclerosis. It is also being studied for potential use in other autoimmune conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ocrelizumab is a monoclonal antibody that works by targeting and depleting a type of immune cell called CD20-positive B cells.\n2. In multiple sclerosis, the immune system attacks the myelin sheath surrounding nerve cells.\n3. Ocrelizumab binds to CD20 on the surface of B cells and triggers their destruction.\n4. The drug is given by intravenous infusion.\n5. Ocrelizumab is approved for the treatment of relapsing-remitting multiple sclerosis and primary progressive multiple sclerosis.",
    "vicuna-13b_fact": [
      "Ocrelizumab is a monoclonal antibody that works by targeting and depleting a type of immune cell called CD20-positive B cells.",
      "In multiple sclerosis, the immune system attacks the myelin sheath surrounding nerve cells.",
      "Ocrelizumab binds to CD20 on the surface of B cells and triggers their destruction.",
      "The drug is given by intravenous infusion.",
      "Ocrelizumab is approved for the treatment of relapsing-remitting multiple sclerosis and primary progressive multiple sclerosis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 933,
    "user_query": "Are patients with marfan syndrome at increased risk of arrhythmias?",
    "vicuna-13b_response": "Marfan syndrome is a genetic disorder that affects the connective tissue. It is characterized by tall stature, thin fingers, and aortic dilatation. Patients with Marfan syndrome are at increased risk of developing arrhythmias, which are abnormal heart rhythms.\nArrhythmias can be caused by a variety of factors, including electrical abnormalities in the heart, such as conduction disorders or abnormal ion channels, and structural abnormalities, such as dilated cardiomyopathy or left ventricular hypertrophy. Marfan syndrome can cause both of these types of abnormalities, which increases the risk of arrhythmias.\nStudies have shown that up to 80% of patients with Marfan syndrome have some form of arrhythmia, with the most common being supraventricular tachycardia (SVT) and atrial fibrillation. These arrhythmias can be asymptomatic or can cause symptoms such as palpitations, shortness of breath, and fatigue.\nIt is important for patients with Marfan syndrome to be monitored for arrhythmias, as they can lead to serious complications such as stroke, heart failure, and even sudden death. Treatment options for arrhythmias in Marfan syndrome include medications, cardioversion or defibrillation, and implantable cardioverter-defibrillators (ICDs).\nIn summary, patients with Marfan syndrome are at increased risk of developing arrhythmias, which can cause serious complications. It is important for these patients to be monitored for arrhythmias and to receive appropriate treatment if necessary.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Marfan syndrome is a genetic disorder that affects the connective tissue.\n2. Patients with Marfan syndrome are at increased risk of developing arrhythmias.\n3. Studies have shown that up to 80% of patients with Marfan syndrome have some form of arrhythmia.\n4. Arrhythmias in Marfan syndrome can cause serious complications such as stroke, heart failure, and even sudden death.\n5. Treatment options for arrhythmias in Marfan syndrome include medications, cardioversion or defibrillation, and implantable cardioverter-defibrillators (ICDs).",
    "vicuna-13b_fact": [
      "Marfan syndrome is a genetic disorder that affects the connective tissue.",
      "Patients with Marfan syndrome are at increased risk of developing arrhythmias.",
      "Studies have shown that up to 80% of patients with Marfan syndrome have some form of arrhythmia.",
      "Arrhythmias in Marfan syndrome can cause serious complications such as stroke, heart failure, and even sudden death.",
      "Treatment options for arrhythmias in Marfan syndrome include medications, cardioversion or defibrillation, and implantable cardioverter-defibrillators (ICDs)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 935,
    "user_query": "List Kartagener Syndrome Triad.",
    "vicuna-13b_response": "Kartagener Syndrome is a rare genetic disorder that affects the respiratory, digestive, and immune systems. The triad of symptoms that characterize this disorder includes:\n1. Respiratory symptoms: People with Kartagener Syndrome often have recurrent respiratory infections, such as pneumonia and bronchitis, due to a lack of mucus in the lungs. They may also have a persistent cough, wheezing, and shortness of breath.\n2. Digestive symptoms: People with Kartagener Syndrome often have difficulty swallowing, and may experience heartburn, regurgitation, and constipation. They may also have a lack of tears, which can lead to dryness of the eyes and mouth.\n3. Immunological symptoms: People with Kartagener Syndrome have a decreased ability to fight infections, and may have a low white blood cell count. They are also more susceptible to certain types of infections, such as tuberculosis.\nIt is important to note that not all people with Kartagener Syndrome will have all three symptoms, and the severity of symptoms can vary from person to person. A diagnosis of Kartagener Syndrome is made through a combination of physical examination, medical history, and genetic testing.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Kartagener Syndrome is a rare genetic disorder that affects the respiratory, digestive, and immune systems.\n2. The triad of symptoms characterizing Kartagener Syndrome includes respiratory symptoms, digestive symptoms, and immunological symptoms.\n3. Respiratory symptoms can involve recurrent respiratory infections, persistent cough, wheezing, and shortness of breath.\n4. Digestive symptoms can involve difficulty swallowing, heartburn, regurgitation, constipation, and dryness of the eyes and mouth due to a lack of tears.\n5. People with Kartagener Syndrome may have a decreased ability to fight infections and may be more susceptible to certain types of infections such as tuberculosis.",
    "vicuna-13b_fact": [
      "Kartagener Syndrome is a rare genetic disorder that affects the respiratory, digestive, and immune systems.",
      "The triad of symptoms characterizing Kartagener Syndrome includes respiratory symptoms, digestive symptoms, and immunological symptoms.",
      "Respiratory symptoms can involve recurrent respiratory infections, persistent cough, wheezing, and shortness of breath.",
      "Digestive symptoms can involve difficulty swallowing, heartburn, regurgitation, constipation, and dryness of the eyes and mouth due to a lack of tears.",
      "People with Kartagener Syndrome may have a decreased ability to fight infections and may be more susceptible to certain types of infections such as tuberculosis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The triad of symptoms characterizing Kartagener Syndrome includes situs inversus, bronchiectasis, and sinusitis.\n3. TRUE\n4. FALSE [correction]: Digestive symptoms, such as difficulty swallowing, heartburn, and constipation, are not typically associated with Kartagener Syndrome.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 936,
    "user_query": "Which disease is associated with the ectopic expression of the protein encoded by the gene DUX4?",
    "vicuna-13b_response": "Ectopic expression of the protein encoded by the gene DUX4 is associated with a group of diseases known as facioscapulohumeral dystrophy (FSHD). FSHD is a genetic disorder that affects muscle strength and size, and is characterized by progressive muscle weakness and atrophy in the face, shoulder blades, and upper arms. The ectopic expression of DUX4 protein is thought to play a role in the development of FSHD by interfering with the normal regulation of muscle growth and development.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The ectopic expression of the protein encoded by the gene DUX4 is associated with facioscapulohumeral dystrophy (FSHD).\n2. FSHD is a genetic disorder that affects muscle strength and size.\n3. FSHD is characterized by progressive muscle weakness and atrophy in the face, shoulder blades, and upper arms.\n4. The ectopic expression of DUX4 protein is believed to interfere with the normal regulation of muscle growth and development.\n5. DUX4 protein is assumed to play a role in the development of FSHD.",
    "vicuna-13b_fact": [
      "The ectopic expression of the protein encoded by the gene DUX4 is associated with facioscapulohumeral dystrophy (FSHD).",
      "FSHD is a genetic disorder that affects muscle strength and size.",
      "FSHD is characterized by progressive muscle weakness and atrophy in the face, shoulder blades, and upper arms.",
      "The ectopic expression of DUX4 protein is believed to interfere with the normal regulation of muscle growth and development.",
      "DUX4 protein is assumed to play a role in the development of FSHD."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 938,
    "user_query": "Which are the main functions of the APOBEC3 family of proteins?",
    "vicuna-13b_response": "The APOBEC3 (A3) family of proteins is a group of enzymes that play a critical role in the innate immune system by acting as cytidine deaminases, which modify the DNA of invading viruses. The main functions of the APOBEC3 family of proteins are:\n1. Viral restriction: The APOBEC3 proteins are known to restrict the replication of a wide range of viruses by deaminating their DNA, leading to mutations that can inhibit viral replication.\n2. DNA damage response: The APOBEC3 proteins also play a role in the DNA damage response by inducing DNA breaks and promoting DNA repair mechanisms.\n3. Antiviral defense: The APOBEC3 proteins act as antiviral defense proteins by inhibiting the replication of viruses and promoting the clearance of viral infections.\n4. Immune tolerance: The APOBEC3 proteins are also involved in the regulation of immune tolerance, by preventing the activation of self-reactive T cells and B cells.\nOverall, the APOBEC3 family of proteins plays a crucial role in the innate immune system by restricting viral replication, promoting DNA repair, and regulating immune tolerance.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The APOBEC3 (A3) family of proteins plays a critical role in the innate immune system as cytidine deaminases, modifying the DNA of invading viruses.\n2. The APOBEC3 family of proteins restricts the replication of a wide range of viruses by inducing mutations in their DNA.\n3. The APOBEC3 proteins are involved in the DNA damage response by inducing DNA breaks and promoting repair mechanisms.\n4. APOBEC3 proteins act as antiviral defense by inhibiting the replication of viruses and promoting the clearance of viral infections.\n5. The APOBEC3 proteins are involved in the regulation of immune tolerance by preventing the activation of self-reactive T cells and B cells.",
    "vicuna-13b_fact": [
      "The APOBEC3 (A3) family of proteins plays a critical role in the innate immune system as cytidine deaminases, modifying the DNA of invading viruses.",
      "The APOBEC3 family of proteins restricts the replication of a wide range of viruses by inducing mutations in their DNA.",
      "The APOBEC3 proteins are involved in the DNA damage response by inducing DNA breaks and promoting repair mechanisms.",
      "APOBEC3 proteins act as antiviral defense by inhibiting the replication of viruses and promoting the clearance of viral infections.",
      "The APOBEC3 proteins are involved in the regulation of immune tolerance by preventing the activation of self-reactive T cells and B cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The APOBEC3 proteins are not known to be directly involved in the regulation of immune tolerance by preventing the activation of self-reactive T cells and B cells. Their primary function is to restrict viral replication through mutation induction.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 939,
    "user_query": "Which histone modifications are associated with constitutive heterochromatin?",
    "vicuna-13b_response": "Constitutive heterochromatin is a region of the genome that is compacted and repressed, and it is characterized by a specific set of histone modifications. The most common histone modifications associated with constitutive heterochromatin are:\n1. H3K9me3 (trimethylation of lysine 9 on histone H3)\n2. H3K27me3 (trimethylation of lysine 27 on histone H3)\n3. H3K36me3 (trimethylation of lysine 36 on histone H3)\n4. H3K79me1 (methylation of lysine 79 on histone H3)\n5. H3K21me1 (methylation of lysine 21 on histone H3)\n6. H3K9me2 (dimethylation of lysine 9 on histone H3)\n7. H3K27me1 (methylation of lysine 27 on histone H3)\n8. H3K36me1 (methylation of lysine 36 on histone H3)\nThese modifications are usually found together in constitutive heterochromatin and are thought to be responsible for the repression of gene expression in these regions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Constitutive heterochromatin is a region of the genome that is compacted and repressed.\n2. Constitutive heterochromatin is characterized by specific histone modifications.\n3. H3K9me3 is a common histone modification associated with constitutive heterochromatin.\n4. H3K27me3 is another histone modification associated with constitutive heterochromatin.\n5. These histone modifications are thought to be responsible for the repression of gene expression in constitutive heterochromatin regions.",
    "vicuna-13b_fact": [
      "Constitutive heterochromatin is a region of the genome that is compacted and repressed.",
      "Constitutive heterochromatin is characterized by specific histone modifications.",
      "H3K9me3 is a common histone modification associated with constitutive heterochromatin.",
      "H3K27me3 is another histone modification associated with constitutive heterochromatin.",
      "These histone modifications are thought to be responsible for the repression of gene expression in constitutive heterochromatin regions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: H3K27me3 is a histone modification associated with facultative heterochromatin, not constitutive heterochromatin.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 940,
    "user_query": "What is the main application of SWATH-MS in proteomics?",
    "vicuna-13b_response": "SWATH-MS (Selective Winged Amplification of Transcripts using High-throughput Mass Spectrometry) is a technique used in proteomics, which is the large-scale study of proteins and their functions. The main application of SWATH-MS in proteomics is to identify and quantify proteins in a sample, such as a biological tissue or a cell culture.\nSWATH-MS is a highly sensitive and specific method for measuring protein expression levels in complex biological samples. It combines the selectivity of transcriptomic techniques, such as RNA sequencing, with the sensitivity and accuracy of mass spectrometry-based methods.\nThe SWATH-MS method involves the selective amplification of specific transcripts using a combination of enzymatic and chemical reactions. This amplification step allows for the detection of low-abundance proteins, which are often difficult to detect using traditional mass spectrometry-based methods.\nAfter the selective amplification step, the resulting transcripts are fragmented and analyzed using high-resolution mass spectrometry. This allows for the identification and quantification of proteins in the sample, as well as the detection of post-translational modifications and other protein attributes.\nOverall, SWATH-MS is a powerful tool for proteomics research, as it allows for the simultaneous measurement of protein abundance and post-translational modifications in complex biological samples. It has applications in a wide range of fields, including cancer research, neuroscience, and environmental science.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SWATH-MS stands for Selective Winged Amplification of Transcripts using High-throughput Mass Spectrometry.\n2. The main application of SWATH-MS in proteomics is to identify and quantify proteins in a sample.\n3. The method involves the selective amplification of specific transcripts using a combination of enzymatic and chemical reactions.\n4. After the amplification step, the transcripts are fragmented and analyzed using high-resolution mass spectrometry.\n5. SWATH-MS technique can be used in a wide range of fields including, cancer research, neuroscience, and environmental science.",
    "vicuna-13b_fact": [
      "SWATH-MS stands for Selective Winged Amplification of Transcripts using High-throughput Mass Spectrometry.",
      "The main application of SWATH-MS in proteomics is to identify and quantify proteins in a sample.",
      "The method involves the selective amplification of specific transcripts using a combination of enzymatic and chemical reactions.",
      "After the amplification step, the transcripts are fragmented and analyzed using high-resolution mass spectrometry.",
      "SWATH-MS technique can be used in a wide range of fields including, cancer research, neuroscience, and environmental science."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: SWATH-MS stands for Sequential Windowed Acquisition of All Theoretical Mass Spectra.\n2. TRUE\n3. FALSE [correction]: The method involves creating a complete fragment ion map of all peptides in a complex sample.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 949,
    "user_query": "Do R-loops tend to form at sites of DNA replication?",
    "vicuna-13b_response": "R-loops are a type of DNA structure that can form when a protein called RNA polymerase II (RNAP II) is transcribing a gene into mRNA. RNAP II moves along the DNA template in the 5' to 3' direction, unwinding the DNA as it goes. If the RNAP II complex gets stuck to the DNA and cannot move, it can create a loop structure called an R-loop.\nR-loops can form at any site where RNAP II is transcribing DNA, but they are more likely to form at sites of DNA replication. This is because during replication, the DNA template is being unwound and replicated in the 5' to 3' direction, which can create a favorable environment for R-loop formation. Additionally, the presence of replication proteins and enzymes at replication sites may also contribute to the formation of R-loops.\nIt is important to note that R-loops can also form spontaneously, even in the absence of RNAP II or replication proteins. Additionally, R-loops can also form as a result of DNA damage or replication stress, and they can have a variety of effects on cellular processes, including transcription, replication, and repair.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. R-loops are a type of DNA structure that can form when a protein called RNA polymerase II (RNAP II) is transcribing a gene into mRNA.\n2. RNAP II moves along the DNA template in the 5' to 3' direction, unwinding the DNA as it goes.\n3. R-loops can form at sites where RNAP II is transcribing DNA. \n4. R-loops are more likely to form at sites of DNA replication. \n5. R-loops can also form as a result of DNA damage or replication stress.",
    "vicuna-13b_fact": [
      "R-loops are a type of DNA structure that can form when a protein called RNA polymerase II (RNAP II) is transcribing a gene into mRNA.",
      "RNAP II moves along the DNA template in the 5' to 3' direction, unwinding the DNA as it goes.",
      "R-loops can form at sites where RNAP II is transcribing DNA.",
      "R-loops are more likely to form at sites of DNA replication.",
      "R-loops can also form as a result of DNA damage or replication stress."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 951,
    "user_query": "What are the structures formed when keratin molecules come together?",
    "vicuna-13b_response": "Keratin is a type of protein that is found in the hair, skin, and nails of humans and other animals. When keratin molecules come together, they form structures such as hair, nails, and skin. These structures are made up of long chains of keratin molecules that are packed together tightly. The structure of these proteins gives hair its strength and durability, and helps to protect the body from external damage. Additionally, keratin helps to keep the skin and nails moisturized and healthy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Keratin is a type of protein found in the hair, skin, and nails of humans and other animals.\n2. Hair, nails, and skin are structures formed when keratin molecules come together.\n3. These structures are made up of long chains of keratin molecules that are tightly packed together.\n4. The structure of these proteins gives hair its strength and durability, and helps protect the body from external damage.\n5. Keratin helps to keep the skin and nails moisturized and healthy.",
    "vicuna-13b_fact": [
      "Keratin is a type of protein found in the hair, skin, and nails of humans and other animals.",
      "Hair, nails, and skin are structures formed when keratin molecules come together.",
      "These structures are made up of long chains of keratin molecules that are tightly packed together.",
      "The structure of these proteins gives hair its strength and durability, and helps protect the body from external damage.",
      "Keratin helps to keep the skin and nails moisturized and healthy."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Keratin helps to make the skin, hair, and nails strong and resilient, but it doesn't directly keep them moisturized and healthy. Other factors, such as oil glands, hydration, nutrition and general health play a role in moisture and health of skin and nails.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 953,
    "user_query": "Which are the main features of CREST and other ALS-linked proteins?",
    "vicuna-13b_response": "CREST (CRISP-1, CREB-binding protein, and SMAD-binding protein) and other ALS-linked proteins are involved in various cellular processes, including gene expression, cell growth and differentiation, and response to stress. Some of the main features of these proteins include:\n1. CREST:\n* CREST is a transcriptional coactivator that plays a role in regulating the expression of genes involved in cell growth and differentiation.\n* CREST interacts with the CRISP-1 protein to regulate the activity of the androgen receptor, a hormone receptor that plays a role in male sexual development and other processes.\n* CREST also interacts with the CREB protein, a transcription factor that regulates the expression of genes involved in cellular responses to stress.\n2. Other ALS-linked proteins:\n* TAR DNA-binding protein 43 (TDP-43) is a protein that is found in the cytoplasm and nucleus of cells and is involved in various cellular processes, including transcriptional regulation and RNA processing. TDP-43 is a major component of inclusions found in the cytoplasm of cells from individuals with ALS.\n* Fused in sarcoma (FUS) is a protein that is involved in RNA processing and transport. FUS is also found in the cytoplasm of cells from individuals with ALS and is a major component of inclusions in these cells.\n* RNA-binding motif protein 4 (RBM4) is a protein that is involved in various cellular processes, including RNA processing and transport. RBM4 is also found in the cytoplasm of cells from individuals with ALS and is a major component of inclusions in these cells.\nOverall, CREST and other ALS-linked proteins play important roles in regulating various cellular processes, and their dysfunction has been implicated in the development of ALS.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CREST is a transcriptional coactivator that regulates the expression of genes involved in cell growth and differentiation.\n2. CREST interacts with the CRISP-1 protein to regulate the activity of the androgen receptor.\n3. CREST also interacts with the CREB protein, a transcription factor that regulates the expression of genes involved in cellular responses to stress.\n4. TAR DNA-binding protein 43 (TDP-43) is a protein involved in transcriptional regulation and RNA processing. It's a major component of inclusions found in the cytoplasm of cells from individuals with ALS.\n5. Fused in sarcoma (FUS) is a protein involved in RNA processing and transport, and is a major component of inclusions in the cytoplasm of cells from individuals with ALS.",
    "vicuna-13b_fact": [
      "CREST is a transcriptional coactivator that regulates the expression of genes involved in cell growth and differentiation.",
      "CREST interacts with the CRISP-1 protein to regulate the activity of the androgen receptor.",
      "CREST also interacts with the CREB protein, a transcription factor that regulates the expression of genes involved in cellular responses to stress.",
      "TAR DNA-binding protein 43 (TDP-43) is a protein involved in transcriptional regulation and RNA processing. It's a major component of inclusions found in the cytoplasm of cells from individuals with ALS.",
      "Fused in sarcoma (FUS) is a protein involved in RNA processing and transport, and is a major component of inclusions in the cytoplasm of cells from individuals with ALS."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 955,
    "user_query": "What is the relationship between nucleosomes and exons?",
    "vicuna-13b_response": "Nucleosomes and exons are both important components of the structure of eukaryotic DNA, but they have different functions and are located in different regions of the genome.\nNucleosomes are the basic units of chromatin, the complex of DNA and proteins that makes up the chromosomes. A nucleosome consists of a DNA molecule wrapped around a core of histone proteins. Nucleosomes play a role in compacting the DNA molecule and regulating access to the genetic information encoded in the DNA. They also serve as binding sites for various proteins and enzymes that modify chromatin structure or regulate gene expression.\nExons, on the other hand, are the regions of a gene that encode for protein sequences. They are the functional units of a gene, and the exons from different genes are spliced together to form a single, continuous RNA molecule during the process of transcription. Exons are defined by the presence of specific sequences, called intron-exon boundaries, which separate them from other regions of the genome.\nIn summary, while nucleosomes and exons are both important components of the DNA molecule, they have different functions and are located in different regions of the genome. Nucleosomes are responsible for compacting the DNA and regulating access to the genetic information, while exons are the functional units of a gene that encode for protein sequences.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nucleosomes and exons are components of the structure of eukaryotic DNA.\n2. Nucleosomes are the basic units of chromatin, which is a complex of DNA and proteins that makes up the chromosomes.\n3. Nucleosomes play a role in compacting the DNA molecule and regulating access to the genetic information encoded in the DNA.\n4. Exons are the regions of a gene that encode for protein sequences.\n5. The exons from different genes are spliced together to form a single, continuous RNA molecule during the process of transcription.",
    "vicuna-13b_fact": [
      "Nucleosomes and exons are components of the structure of eukaryotic DNA.",
      "Nucleosomes are the basic units of chromatin, which is a complex of DNA and proteins that makes up the chromosomes.",
      "Nucleosomes play a role in compacting the DNA molecule and regulating access to the genetic information encoded in the DNA.",
      "Exons are the regions of a gene that encode for protein sequences.",
      "The exons from different genes are spliced together to form a single, continuous RNA molecule during the process of transcription."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The exons from a single gene are spliced together to form a single, continuous RNA molecule during the process of RNA splicing, not transcription.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 956,
    "user_query": "List programs suitable for pharmacophore modelling",
    "vicuna-13b_response": "Pharmacophore modeling is a computational method used to identify the common features or patterns in the molecular structures of drugs that are responsible for their biological activity. The following are some of the programs that are suitable for pharmacophore modeling:\n1. MOE: MOE (Molecular Operating Environment) is a software package developed by the Institute of Molecular Biotechnology at the University of Washington. It provides a range of tools for drug discovery, including pharmacophore modeling.\n2. PHASE: PHASE (Pharmacophore Assisted Selection of HitS) is a software tool developed by GlaxoSmithKline. It uses pharmacophore models to identify potential lead compounds from large compound libraries.\n3. Catalyst: Catalyst is a software package developed by Accelrys (now part of Biovia). It provides a range of tools for drug discovery, including pharmacophore modeling, molecular docking, and molecular dynamics simulations.\n4. Dragon: Dragon is a software package developed by Schrödinger. It provides a range of tools for drug discovery, including pharmacophore modeling, molecular docking, and molecular dynamics simulations.\n5. PyMOL: PyMOL is a molecular visualization tool that can be used for pharmacophore modeling. It provides a range of tools for creating and analyzing molecular structures and can be used in conjunction with other software packages for pharmacophore modeling.\nThese are just a few examples of programs that are suitable for pharmacophore modeling. There are many other software packages available for this purpose, and the choice of software will depend on the specific needs and requirements of the user.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pharmacophore modeling is a method used to identify the common features in the molecular structures of drugs that cause their biological activity.\n2. Molecular Operating Environment (MOE) is a software package used for drug discovery including pharmacophore modeling.\n3. PHASE (Pharmacophore Assisted Selection of HitS) is a software tool developed by GlaxoSmithKline.\n4. Catalyst is a software package developed by Accelrys that includes tools for pharmacophore modeling, molecular docking, and molecular dynamics simulations.\n5. Dragon is a software package developed by Schrödinger that provides tools for drug discovery.\n6. PyMOL is a molecular visualization tool that can be used for pharmacophore modeling.",
    "vicuna-13b_fact": [
      "Pharmacophore modeling is a method used to identify the common features in the molecular structures of drugs that cause their biological activity.",
      "Molecular Operating Environment (MOE) is a software package used for drug discovery including pharmacophore modeling.",
      "PHASE (Pharmacophore Assisted Selection of HitS) is a software tool developed by GlaxoSmithKline.",
      "Catalyst is a software package developed by Accelrys that includes tools for pharmacophore modeling, molecular docking, and molecular dynamics simulations.",
      "Dragon is a software package developed by Schrödinger that provides tools for drug discovery.",
      "PyMOL is a molecular visualization tool that can be used for pharmacophore modeling."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: PHASE (Pharmacophore Assisted Selection of HitS) is a software tool developed by Schrödinger.\n4. FALSE [correction]: Catalyst is a software package developed by SciTegic (later acquired by Accelrys, now Biovia) that includes tools for molecular modeling but not specifically for pharmacophore modeling, molecular docking, and molecular dynamics simulations.\n5. FALSE [correction]: Dragon is a software package developed by Talete srl that provides tools for molecular descriptor calculation, not specifically for drug discovery.\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 959,
    "user_query": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?",
    "vicuna-13b_response": "There are several methods for detecting circulating tumor DNA (ctDNA) in the blood of cancer patients. The most common methods include:\n1. Targeted sequencing: This method uses a panel of cancer-specific genes to detect ctDNA in the blood. It is a highly sensitive and specific method, but it is also more expensive and time-consuming than other methods.\n2. Non-targeted sequencing: This method uses whole-genome sequencing to detect ctDNA in the blood. It is less expensive and time-consuming than targeted sequencing, but it is also less specific and may detect non-cancerous DNA.\n3. PCR-based methods: This method uses PCR amplification to detect ctDNA in the blood. It is less expensive and time-consuming than sequencing-based methods, but it is also less sensitive and specific.\n4. Hybridization-based methods: This method uses hybridization of ctDNA to a capture probe to detect ctDNA in the blood. It is less expensive and time-consuming than sequencing-based methods, but it is also less sensitive and specific.\nOverall, the choice of method depends on the specific needs of the clinical setting and the patient population being tested.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Targeted sequencing is a method used to detect circulating tumor DNA (ctDNA) and uses a panel of cancer-specific genes.\n2. Non-targeted sequencing method uses whole-genome sequencing to detect ctDNA.\n3. PCR-based methods employ PCR amplification for the detection of ctDNA.\n4. Hybridization-based methods detect ctDNA by using hybridization of ctDNA to a capture probe.\n5. The choice of ctDNA detection method depends on the specific needs of the clinical setting and patient population.",
    "vicuna-13b_fact": [
      "Targeted sequencing is a method used to detect circulating tumor DNA (ctDNA) and uses a panel of cancer-specific genes.",
      "Non-targeted sequencing method uses whole-genome sequencing to detect ctDNA.",
      "PCR-based methods employ PCR amplification for the detection of ctDNA.",
      "Hybridization-based methods detect ctDNA by using hybridization of ctDNA to a capture probe.",
      "The choice of ctDNA detection method depends on the specific needs of the clinical setting and patient population."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 960,
    "user_query": "Which gene is associated with Muenke syndrome?",
    "vicuna-13b_response": "Muenke syndrome is a rare genetic disorder that is inherited in an autosomal recessive pattern. It is caused by mutations in the IRF6 gene, which is located on chromosome 20p13. The IRF6 gene provides instructions for making a protein called interferon regulatory factor 6, which plays a role in regulating the immune system and the development of certain tissues and organs.\nMutations in the IRF6 gene can lead to a variety of features that are characteristic of Muenke syndrome, including growth delays, developmental delay, and distinctive facial features. Other features of Muenke syndrome can include hearing loss, eye abnormalities, and a higher risk of infections.\nIt is important to note that Muenke syndrome is a rare disorder, and the diagnosis can be challenging. A diagnosis of Muenke syndrome is typically made based on a combination of clinical features, genetic testing, and other diagnostic tests. If you have concerns about Muenke syndrome or think you may be affected, it is important to speak with a healthcare provider for proper diagnosis and management.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Muenke syndrome is a rare genetic disorder that is inherited in an autosomal recessive pattern.\n2. Muenke syndrome is caused by mutations in the IRF6 gene.\n3. The IRF6 gene is located on chromosome 20p13.\n4. The IRF6 gene provides instructions for making a protein called interferon regulatory factor 6, which plays a role in regulating the immune system and the development of certain tissues and organs.\n5. Diagnosis of Muenke syndrome is typically made based on a combination of clinical features, genetic testing, and other diagnostic tests.",
    "vicuna-13b_fact": [
      "Muenke syndrome is a rare genetic disorder that is inherited in an autosomal recessive pattern.",
      "Muenke syndrome is caused by mutations in the IRF6 gene.",
      "The IRF6 gene is located on chromosome 20p13.",
      "The IRF6 gene provides instructions for making a protein called interferon regulatory factor 6, which plays a role in regulating the immune system and the development of certain tissues and organs.",
      "Diagnosis of Muenke syndrome is typically made based on a combination of clinical features, genetic testing, and other diagnostic tests."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Muenke syndrome is a rare genetic disorder that is inherited in an autosomal dominant pattern.\n2. FALSE [correction]: Muenke syndrome is caused by mutations in the FGFR3 gene.\n3. FALSE [correction]: The FGFR3 gene, not the IRF6 gene, is located on chromosome 4p16.3.\n4. FALSE [correction]: The IRF6 gene encodes for a protein involved in oral and facial development. The FGFR3 gene associated with Muenke Syndrome encodes fibroblast growth factor receptor 3, which plays a role in bone development.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "vicuna-13b_response": "Yes, STAT3 is involved in EIF2AK2-dependent suppression of autophagy. EIF2AK2, also known as PKR-like endoplasmic reticulum (ER) kinase (PERK), is a protein kinase that plays a critical role in the regulation of protein synthesis and the unfolded protein response (UPR) in the ER. STAT3, on the other hand, is a transcription factor that is involved in a variety of cellular processes, including cell proliferation, differentiation, and survival.\nSeveral studies have shown that EIF2AK2 can phosphorylate and activate STAT3, leading to the suppression of autophagy. When EIF2AK2 is activated by ER stress, it phosphorylates and activates PERK, which then phosphorylates and activates STAT3. This activation of STAT3 then leads to the suppression of autophagy by inhibiting the expression of autophagy-related genes.\nIn conclusion, EIF2AK2-dependent suppression of autophagy is mediated, in part, by the activation of STAT3. The activation of STAT3 by EIF2AK2 in response to ER stress inhibits autophagy, which helps to maintain protein synthesis and prevent cell death.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. STAT3 is involved in EIF2AK2-dependent suppression of autophagy.\n2. EIF2AK2, also known as PKR-like endoplasmic reticulum (ER) kinase (PERK), is a protein kinase.\n3. EIF2AK2 plays a critical role in the regulation of protein synthesis and the unfolded protein response (UPR) in the ER.\n4. STAT3 is a transcription factor involved in cellular processes, including cell proliferation, differentiation, and survival.\n5. When EIF2AK2 is activated by ER stress, it phosphorylates and activates STAT3, leading to the suppression of autophagy.",
    "vicuna-13b_fact": [
      "STAT3 is involved in EIF2AK2-dependent suppression of autophagy.",
      "EIF2AK2, also known as PKR-like endoplasmic reticulum (ER) kinase (PERK), is a protein kinase.",
      "EIF2AK2 plays a critical role in the regulation of protein synthesis and the unfolded protein response (UPR) in the ER.",
      "STAT3 is a transcription factor involved in cellular processes, including cell proliferation, differentiation, and survival.",
      "When EIF2AK2 is activated by ER stress, it phosphorylates and activates STAT3, leading to the suppression of autophagy."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: EIF2AK2, also known as Protein kinase R (PKR), is a protein kinase. PERK is another kinase called EIF2AK3.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 965,
    "user_query": "What are the Topological Domains (TADs)?",
    "vicuna-13b_response": "Topological Domains (TADs) are a computational tool used in protein structure prediction and analysis. They are a way of dividing a protein's sequence and structure into smaller, more manageable regions, called domains, that can be analyzed separately.\nTADs are defined based on the three-dimensional structure of a protein, and they are typically identified by looking for regions of the protein where the local density of protein atoms is higher than average. These regions are then grouped together to form a TAD.\nTADs are useful for a number of purposes in protein structure prediction and analysis. For example, they can be used to identify regions of the protein that are important for function, such as binding sites or active sites. They can also be used to predict the overall structure of a protein, by analyzing the structures of individual TADs and how they fit together.\nIn addition, TADs can be used to study protein evolution and how proteins have evolved over time. By comparing the structures of TADs in different proteins, researchers can identify conserved regions, which are likely to be important for function, and non-conserved regions, which may be more flexible and subject to evolutionary change.\nOverall, TADs are a powerful tool for understanding the structure and function of proteins, and they have been widely used in a variety of applications in computational biology and bioinformatics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Topological Domains (TADs) are a computational tool used in protein structure prediction and analysis.\n2. TADs divide a protein's sequence and structure into smaller, more manageable regions, called domains.\n3. TADs are defined based on the three-dimensional structure of a protein.\n4. They can be used to identify regions of the protein that are important for function, such as binding sites or active sites.\n5. TADs are used to study protein evolution and how proteins have evolved over time.",
    "vicuna-13b_fact": [
      "Topological Domains (TADs) are a computational tool used in protein structure prediction and analysis.",
      "TADs divide a protein's sequence and structure into smaller, more manageable regions, called domains.",
      "TADs are defined based on the three-dimensional structure of a protein.",
      "They can be used to identify regions of the protein that are important for function, such as binding sites or active sites.",
      "TADs are used to study protein evolution and how proteins have evolved over time."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Topological Domains (TADs) are not just a computational tool. In genomics, they refer to self-interacting genomic regions, where DNA sequences within a TAD physically interact with each other more frequently than with sequences outside the TAD. But in computational protein analysis, a similar concept called Protein Domains is used, not TADs.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While protein domains can be used to track the evolutionary history of proteins, TADs in the context of genomics primarily help to understand the spatial organization of chromosomes and gene regulation.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 966,
    "user_query": "What is the vibrational theory of olfaction?",
    "vicuna-13b_response": "The vibrational theory of olfaction, also known as the molecular theory of olfaction, is a scientific theory that explains how the sense of smell works. According to this theory, olfaction (the sense of smell) is mediated by molecules called odorants, which bind to specific receptors in the nasal cavity.\nThe vibrational theory of olfaction suggests that odorants bind to receptors in the nasal cavity by means of vibrational molecular interactions. This means that the molecules of an odorant must be able to vibrate in a specific way that allows them to interact with the receptors in the nasal cavity.\nThe vibrational theory of olfaction also suggests that the sense of smell is highly specific, meaning that different odorants can bind to different receptors in the nasal cavity, allowing the brain to distinguish between different odors.\nThe vibrational theory of olfaction is supported by a large body of scientific evidence, including studies of the structure and function of olfactory receptors, as well as studies of the behavior of odorants in the nasal cavity.\nIn summary, the vibrational theory of olfaction is a scientific theory that explains how the sense of smell works by means of molecular interactions in the nasal cavity. This theory suggests that olfaction is mediated by odorants that bind to specific receptors in the nasal cavity by means of vibrational molecular interactions, and that the sense of smell is highly specific, allowing the brain to distinguish between different odors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The vibrational theory of olfaction, also known as the molecular theory of olfaction, is a scientific theory that explains how the sense of smell works.\n2. According to the vibrational theory of olfaction, the sense of smell is mediated by molecules called odorants, which bind to specific receptors in the nasal cavity.\n3. This theory suggests that odorants bind to receptors in the nasal cavity by means of vibrational molecular interactions.\n4. The vibrational theory of olfaction suggests that the sense of smell is highly specific and different odorants can bind to different receptors in the nasal cavity.\n5. This theory is supported by scientific evidence, including studies of the structure and function of olfactory receptors and the behavior of odorants in the nasal cavity.",
    "vicuna-13b_fact": [
      "The vibrational theory of olfaction, also known as the molecular theory of olfaction, is a scientific theory that explains how the sense of smell works.",
      "According to the vibrational theory of olfaction, the sense of smell is mediated by molecules called odorants, which bind to specific receptors in the nasal cavity.",
      "This theory suggests that odorants bind to receptors in the nasal cavity by means of vibrational molecular interactions.",
      "The vibrational theory of olfaction suggests that the sense of smell is highly specific and different odorants can bind to different receptors in the nasal cavity.",
      "This theory is supported by scientific evidence, including studies of the structure and function of olfactory receptors and the behavior of odorants in the nasal cavity."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The vibrational theory of olfaction, also known as the molecular vibrational theory, is a scientific theory that explains how the sense of smell works.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While the vibrational theory of olfaction does have some experimental support, it is not universally accepted and other theories, such as the shape theory of olfaction, also have significant experimental support.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 971,
    "user_query": "Which deiodinases are best known to be present in brain?",
    "vicuna-13b_response": "Deiodinases are enzymes that can activate or inactivate thyroid hormones by removing or adding iodine atoms to the hormone molecule. There are five known types of deiodinases: D1, D2, D3, D4, and D5.\nD1, D2, and D3 are the most well-known deiodinases to be present in the brain. D1 is expressed in various brain regions, including the hypothalamus, and is involved in the regulation of thyroid hormone levels. D2 is also expressed in the brain, particularly in the cerebellum, and is involved in the regulation of local thyroid hormone levels. D3 is expressed in various brain regions, including the hippocampus, and is involved in the regulation of thyroid hormone-mediated gene expression.\nOverall, deiodinases play an important role in the regulation of thyroid hormone levels in the brain, and their dysregulation has been implicated in various neurological disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Deiodinases are enzymes that can activate or inactivate thyroid hormones by removing or adding iodine atoms to the hormone molecule.\n2. There are five known types of deiodinases: D1, D2, D3, D4, and D5.\n3. D1, D2, and D3 are the most well-known deiodinases to be present in the brain.\n4. D1 is expressed in various brain regions, including the hypothalamus, and is involved in the regulation of thyroid hormone levels.\n5. Deiodinases play an important role in the regulation of thyroid hormone levels in the brain.",
    "vicuna-13b_fact": [
      "Deiodinases are enzymes that can activate or inactivate thyroid hormones by removing or adding iodine atoms to the hormone molecule.",
      "There are five known types of deiodinases: D1, D2, D3, D4, and D5.",
      "D1, D2, and D3 are the most well-known deiodinases to be present in the brain.",
      "D1 is expressed in various brain regions, including the hypothalamus, and is involved in the regulation of thyroid hormone levels.",
      "Deiodinases play an important role in the regulation of thyroid hormone levels in the brain."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: There are three known types of deiodinases: D1, D2, and D3.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "vicuna-13b_response": "Theatre is a software tool that is used for genomic analysis. It is designed to help researchers and scientists analyze large amounts of genomic data, such as DNA sequencing data, in a more efficient and effective way.\nTheatre allows users to easily visualize and explore their genomic data, using a variety of different visualization and analysis tools. This can help researchers to identify patterns and trends in their data, and to gain insights into the underlying biology of their samples.\nSome of the key features of Theatre include:\n* Support for a wide range of different file formats, including FASTQ, BAM, and VCF\n* A powerful query and filtering system, which allows users to quickly narrow down their data to specific subsets\n* A range of different visualization tools, including track viewers, heatmaps, and gene expression plots\n* Integration with other popular genomic analysis tools, such as GATK and bcftools\nOverall, Theatre is a valuable tool for anyone who needs to analyze large amounts of genomic data, and it is widely used in a variety of different research and clinical settings.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Theatre is a software tool used for genomic analysis.\n2. Theatre is designed to help analyze large amounts of genomic data such as DNA sequencing data. \n3. Theatre supports a wide range of different file formats, including FASTQ, BAM, and VCF.\n4. Theatre has a powerful query and filtering system that allows users to narrow down their data to specific subsets.\n5. Theatre integrates with other popular genomic analysis tools, such as GATK and bcftools.",
    "vicuna-13b_fact": [
      "Theatre is a software tool used for genomic analysis.",
      "Theatre is designed to help analyze large amounts of genomic data such as DNA sequencing data.",
      "Theatre supports a wide range of different file formats, including FASTQ, BAM, and VCF.",
      "Theatre has a powerful query and filtering system that allows users to narrow down their data to specific subsets.",
      "Theatre integrates with other popular genomic analysis tools, such as GATK and bcftools."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 974,
    "user_query": "How are CRM (cis-regulatory modules) defined?",
    "vicuna-13b_response": "CRM (cis-regulatory modules) are defined as specific regions of DNA that are involved in the regulation of gene expression. These regions are located near the genes they regulate, and are typically between 10 and 1000 base pairs in length. CRMs can be either enhancers or silencers, and they work by binding to transcription factors, which are proteins that control the expression of genes. The binding of transcription factors to CRMs can either increase or decrease the expression of the genes they regulate, depending on the specific sequence of the CRM and the identity of the transcription factor. CRMs play a crucial role in the development and differentiation of cells, and mutations in CRMs can lead to a variety of diseases, including cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CRM (cis-regulatory modules) are regions of DNA involved in the regulation of gene expression. \n2. CRMs are typically located near the genes they regulate and are between 10 and 1000 base pairs in length.\n3. CRMs can be either enhancers or silencers and work by binding to transcription factors. \n4. The binding of transcription factors to CRMs can either increase or decrease the expression of the genes they regulate.\n5. Mutations in CRMs can lead to a variety of diseases, including cancer.",
    "vicuna-13b_fact": [
      "CRM (cis-regulatory modules) are regions of DNA involved in the regulation of gene expression.",
      "CRMs are typically located near the genes they regulate and are between 10 and 1000 base pairs in length.",
      "CRMs can be either enhancers or silencers and work by binding to transcription factors.",
      "The binding of transcription factors to CRMs can either increase or decrease the expression of the genes they regulate.",
      "Mutations in CRMs can lead to a variety of diseases, including cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: CRMs are not strictly defined by size, and they can vary greatly depending on the complexity of the gene regulation involved. Also, they can be located near, far, or even inside the genes they regulate.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 978,
    "user_query": "Which factor interacts with Treslin/TICRR throughout the cell cycle of human cells?",
    "vicuna-13b_response": "Treslin/TICRR is a protein that plays a role in regulating the cell cycle in human cells. The cell cycle is a process by which cells grow, divide, and replicate their genetic material. Treslin/TICRR is involved in regulating the progression of cells through the G1 phase of the cell cycle, which is the phase during which cells prepare to divide.\nSeveral factors interact with Treslin/TICRR throughout the cell cycle of human cells. These factors include:\n1. Cyclin-dependent kinase inhibitors (CKIs): CKIs are proteins that inhibit the activity of cyclin-dependent kinases (CDKs), which are enzymes that regulate the progression of cells through the cell cycle. Treslin/TICRR interacts with CKIs, such as p21Cip1 and p27Kip1, to inhibit the activity of CDKs and prevent the progression of cells through the G1 phase of the cell cycle.\n2. CDK inhibitors: CDK inhibitors are proteins that inhibit the activity of CDKs, which are enzymes that regulate the progression of cells through the cell cycle. Treslin/TICRR interacts with CDK inhibitors, such as p21Cip1 and p27Kip1, to inhibit the activity of CDKs and prevent the progression of cells through the G1 phase of the cell cycle.\n3. Transcription factors: Transcription factors are proteins that bind to specific sequences of DNA and regulate the expression of genes. Treslin/TICRR interacts with transcription factors, such as E2F1 and E2F4, to regulate the expression of genes that are involved in the progression of cells through the G1 phase of the cell cycle.\nOverall, Treslin/TICRR is involved in regulating the progression of cells through the G1 phase of the cell cycle in human cells. It interacts with several factors, including cyclin-dependent kinase inhibitors, CDK inhibitors, and transcription factors, to inhibit the activity of cyclin-dependent kinases and prevent the progression of cells through the G1 phase of the",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Treslin/TICRR is a protein that regulates the cell cycle in human cells.\n2. Treslin/TICRR is involved in regulating the progression of cells through the G1 phase of the cell cycle.\n3. Treslin/TICRR interacts with Cyclin-dependent kinase inhibitors (CKIs), such as p21Cip1 and p27Kip1.\n4. Treslin/TICRR also interacts with CDK inhibitors such as p21Cip1 and p27Kip1.\n5. Treslin/TICRR interacts with transcription factors like E2F1 and E2F4 to regulate the expression of genes.",
    "vicuna-13b_fact": [
      "Treslin/TICRR is a protein that regulates the cell cycle in human cells.",
      "Treslin/TICRR is involved in regulating the progression of cells through the G1 phase of the cell cycle.",
      "Treslin/TICRR interacts with Cyclin-dependent kinase inhibitors (CKIs), such as p21Cip1 and p27Kip1.",
      "Treslin/TICRR also interacts with CDK inhibitors such as p21Cip1 and p27Kip1.",
      "Treslin/TICRR interacts with transcription factors like E2F1 and E2F4 to regulate the expression of genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Treslin/TICRR regulates the initiation of DNA replication during the S phase of the cell cycle, not the G1 phase.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 981,
    "user_query": "Which medication should be administered when managing patients with suspected acute opioid overdose?",
    "vicuna-13b_response": "When managing patients with suspected acute opioid overdose, the medication of choice is naloxone. Naloxone is a potent antagonist of opioid receptors and can reverse the effects of opioid overdose by binding to opioid receptors and blocking the effects of opioids. It is administered intravenously or intramuscularly, depending on the severity of the overdose and the patient's response to the medication.\nNaloxone is typically given in doses ranging from 0.4 to 2 mg, depending on the patient's weight and the severity of the overdose. Multiple doses may be given if the patient's condition does not improve or if the opioid overdose is caused by a long-acting opioid.\nOther medications that may be used in the management of opioid overdose include benzodiazepines, which can help to reverse the respiratory depression caused by opioids, and activated charcoal, which can help to absorb any remaining opioids in the stomach and prevent further absorption.\nIt is important to note that naloxone is not a substitute for effective opioid addiction treatment and that patients who have experienced an opioid overdose should be evaluated for underlying substance use disorder and provided with appropriate treatment and support.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Naloxone is the medication of choice for managing patients with suspected acute opioid overdose.\n2. Naloxone is a potent antagonist of opioid receptors.\n3. Naloxone can reverse the effects of opioid overdose by binding to opioid receptors and blocking the effects of opioids.\n4. Naloxone can be administered either intravenously or intramuscularly.\n5. Other medications that may be used in the management of opioid overdose include benzodiazepines and activated charcoal.",
    "vicuna-13b_fact": [
      "Naloxone is the medication of choice for managing patients with suspected acute opioid overdose.",
      "Naloxone is a potent antagonist of opioid receptors.",
      "Naloxone can reverse the effects of opioid overdose by binding to opioid receptors and blocking the effects of opioids.",
      "Naloxone can be administered either intravenously or intramuscularly.",
      "Other medications that may be used in the management of opioid overdose include benzodiazepines and activated charcoal."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Other medications that may be used in the management of opioid overdose include oxygen, intravenous fluids, and other supportive measures. Benzodiazepines may be used to manage seizures or severe agitation. Activated charcoal is not routinely recommended.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 982,
    "user_query": "In which nuclear compartments is heterochromatin located?",
    "vicuna-13b_response": "Heterochromatin is a type of chromatin that is found in specific nuclear compartments in eukaryotic cells. Heterochromatin is typically located in the perinuclear region, which is the area around the nucleus, and in the chromatin bodies, which are small, dense structures found within the nucleus.\nHeterochromatin is composed of tightly packed chromatin fibers and is typically associated with the nuclear lamina, which is a protein structure that surrounds the nucleus. Heterochromatin is also often found near the nuclear pore complexes, which are the channels that allow for the exchange of molecules between the nucleus and the cytoplasm.\nHeterochromatin is typically more compact and less accessible to the cell's machinery for reading and modifying the DNA code than euchromatin, which is the type of chromatin found in active genic regions. This compactness is thought to play a role in the regulation of gene expression and the maintenance of chromosome structure.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Heterochromatin is a type of chromatin found in specific nuclear compartments in eukaryotic cells.\n2. Heterochromatin is typically located in the perinuclear region and in the chromatin bodies.\n3. Heterochromatin is composed of tightly packed chromatin fibers.\n4. Heterochromatin is typically associated with the nuclear lamina and is often found near the nuclear pore complexes.\n5. Heterochromatin is typically more compact and less accessible to the cell's machinery for reading and modifying the DNA code than euchromatin.",
    "vicuna-13b_fact": [
      "Heterochromatin is a type of chromatin found in specific nuclear compartments in eukaryotic cells.",
      "Heterochromatin is typically located in the perinuclear region and in the chromatin bodies.",
      "Heterochromatin is composed of tightly packed chromatin fibers.",
      "Heterochromatin is typically associated with the nuclear lamina and is often found near the nuclear pore complexes.",
      "Heterochromatin is typically more compact and less accessible to the cell's machinery for reading and modifying the DNA code than euchromatin."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 984,
    "user_query": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?",
    "vicuna-13b_response": "Global genome nucleotide excision repair (GG-NER) is a mechanism used by bacteria to repair DNA damage caused by UV radiation, chemical mutagens, and other genotoxic agents. GG-NER involves the removal of a damaged DNA base or sugar, followed by the excision of the damaged nucleotide and the insertion of a new one. The enzymes involved in GG-NER in bacteria include:\n1. RecA protein: RecA is a single-stranded DNA binding protein that plays a crucial role in the initiation of GG-NER. RecA recognizes the damaged region of the DNA and initiates the formation of a filamentous structure called the RecA filament.\n2. UvrA and UvrB proteins: UvrA and UvrB are helicases that unwind the DNA around the damaged region, allowing access to the repair enzymes.\n3. Endonuclease V: Endonuclease V is an endonuclease that cleaves the DNA at the site of the damaged nucleotide, creating a double-stranded break.\n4. Ligase: Ligase is an enzyme that seals the gap created by the double-stranded break, ensuring that the repair process is completed.\n5. Polymerase: Polymerase is an enzyme that synthesizes new DNA nucleotides, which are then inserted into the gap created by the excision of the damaged nucleotide.\nOverall, GG-NER is a complex process that involves multiple enzymes and proteins working together to repair damaged DNA in bacteria.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Global genome nucleotide excision repair (GG-NER) is a mechanism used by bacteria to repair DNA damage caused by agents like UV radiation and chemical mutagens.\n2. In the GG-NER process, a damaged DNA base or sugar is removed, the damaged nucleotide is excised, and a new nucleotide is inserted.\n3. RecA is a protein that plays a crucial role in initiating GG-NER in bacteria and it recognizes the damaged region of the DNA.\n4. UvrA and UvrB are helicases involved in GG-NER, they unwind the DNA around the damaged region.\n5. Endonuclease V cleaves the DNA at the site of the damaged nucleotide during GG-NER.\n6. Ligase is an enzyme involved in GG-NER that seals the gap created by the double-stranded break.\n7. DNA Polymerase is another enzyme involved in GG-NER that synthesizes new DNA nucleotides for the gap created by the excision of the damaged nucleotide.",
    "vicuna-13b_fact": [
      "Global genome nucleotide excision repair (GG-NER) is a mechanism used by bacteria to repair DNA damage caused by agents like UV radiation and chemical mutagens.",
      "In the GG-NER process, a damaged DNA base or sugar is removed, the damaged nucleotide is excised, and a new nucleotide is inserted.",
      "RecA is a protein that plays a crucial role in initiating GG-NER in bacteria and it recognizes the damaged region of the DNA.",
      "UvrA and UvrB are helicases involved in GG-NER, they unwind the DNA around the damaged region.",
      "Endonuclease V cleaves the DNA at the site of the damaged nucleotide during GG-NER.",
      "Ligase is an enzyme involved in GG-NER that seals the gap created by the double-stranded break.",
      "DNA Polymerase is another enzyme involved in GG-NER that synthesizes new DNA nucleotides for the gap created by the excision of the damaged nucleotide."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The UvrA protein and then UvrB recognize the damage in the DNA during GG-NER in bacteria. RecA is crucial in another type of DNA repair process called homologous recombination.\n4. TRUE\n5. FALSE [correction]: UvrC, not Endonuclease V, cleaves the DNA at the site of the damaged nucleotide during GG-NER.\n6. TRUE\n7. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 988,
    "user_query": "In which genomic regions are Alu enriched?",
    "vicuna-13b_response": "Alu elements are a type of SINE (short interspersed nuclear element) that are found in the genomes of many species, including humans. They are thought to have originated from the insertion of retrotransposons into the genome, and are characterized by their ability to move around the genome and insert into new locations.\nAlu elements are enriched in certain genomic regions, including:\n1. Promoter regions: Alu elements are often found in the promoter regions of genes, which are the regions that control the expression of the gene. This suggests that Alu elements may play a role in regulating gene expression.\n2. Introns: Alu elements are often found in the introns (non-coding regions) of genes, and can disrupt the normal splicing of the gene, leading to the production of abnormal mRNA transcripts.\n3. Chromosome X: Alu elements are particularly abundant on the X chromosome, and it is thought that this may be due to the fact that the X chromosome has a higher rate of gene conversion than the other chromosomes.\n4. Telomeres: Alu elements are also found at the ends of chromosomes, called telomeres, where they can help to maintain the stability of the chromosome.\nOverall, Alu elements are enriched in regions that are important for gene regulation and chromosome stability, and their presence in these regions can have a significant impact on the function of the genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Alu elements are a type of SINE (short interspersed nuclear element) found in the genomes of many species.\n2. Alu elements are often found in the promoter regions of genes.\n3. Introns in genes often contain Alu elements.\n4. Alu elements are abundant on the X chromosome.\n5. Alu elements are found at the ends of chromosomes, known as telomeres.",
    "vicuna-13b_fact": [
      "Alu elements are a type of SINE (short interspersed nuclear element) found in the genomes of many species.",
      "Alu elements are often found in the promoter regions of genes.",
      "Introns in genes often contain Alu elements.",
      "Alu elements are abundant on the X chromosome.",
      "Alu elements are found at the ends of chromosomes, known as telomeres."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Alu elements are not typically found at the ends of chromosomes, known as telomeres.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 993,
    "user_query": "Are there clinical trials using stem cells for the treatment of cardiac disease?",
    "vicuna-13b_response": "Yes, there are clinical trials using stem cells for the treatment of cardiac disease. Stem cells have the potential to differentiate into various cell types, including cardiac cells, making them a promising tool for the treatment of cardiac disease.\nThere have been several clinical trials using stem cells for the treatment of cardiac disease, including trials using embryonic stem cells, induced pluripotent stem cells (iPSCs), and adult stem cells. These trials have focused on treating conditions such as heart attack, heart failure, and dilated cardiomyopathy.\nFor example, a phase I/IIa clinical trial is currently underway in the United States using a patient's own bone marrow-derived stem cells to treat heart attack damage. Another clinical trial is using iPSCs to generate cardiac cells that are implanted into the heart to replace damaged tissue in patients with heart failure.\nWhile the results of these trials are still being evaluated, the use of stem cells for the treatment of cardiac disease holds promise for the development of new therapies that could potentially improve patient outcomes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. There are clinical trials using stem cells for the treatment of cardiac disease.\n2. Stem cells can differentiate into various cell types, including cardiac cells.\n3. Trials have been using embryonic stem cells, induced pluripotent stem cells (iPSCs), and adult stem cells for the treatment of cardiac disease.\n4. A phase I/IIa clinical trial is currently underway in the United States using a patient's own bone marrow-derived stem cells to treat heart attack damage.\n5. Another clinical trial is using induced pluripotent stem cells to generate cardiac cells that are implanted into the heart to replace damaged tissue in patients with heart failure.",
    "vicuna-13b_fact": [
      "There are clinical trials using stem cells for the treatment of cardiac disease.",
      "Stem cells can differentiate into various cell types, including cardiac cells.",
      "Trials have been using embryonic stem cells, induced pluripotent stem cells (iPSCs), and adult stem cells for the treatment of cardiac disease.",
      "A phase I/IIa clinical trial is currently underway in the United States using a patient's own bone marrow-derived stem cells to treat heart attack damage.",
      "Another clinical trial is using induced pluripotent stem cells to generate cardiac cells that are implanted into the heart to replace damaged tissue in patients with heart failure."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 996,
    "user_query": "Has Revlimid been approved by the US Food and Drug Administration?",
    "vicuna-13b_response": "Yes, Revlimid (lenalidomide) has been approved by the US Food and Drug Administration (FDA) for the treatment of multiple myeloma and for use in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma. It is marketed by Celgene Corporation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Revlimid, known scientifically as lenalidomide, has been approved by the US Food and Drug Administration.\n2. The FDA has approved Revlimid for the treatment of multiple myeloma.\n3. Revlimid is approved for use in combination with dexamethasone for treating relapsed or refractory multiple myeloma.\n4.  Revlimid is marketed by the Celgene Corporation.",
    "vicuna-13b_fact": [
      "Revlimid, known scientifically as lenalidomide, has been approved by the US Food and Drug Administration.",
      "The FDA has approved Revlimid for the treatment of multiple myeloma.",
      "Revlimid is approved for use in combination with dexamethasone for treating relapsed or refractory multiple myeloma.",
      "Revlimid is marketed by the Celgene Corporation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "vicuna-13b_response": "The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences depends on several factors, including:\n1. Length of the sequences: The longer the sequences, the more computational time is required for the alignment.\n2. Number of gaps in the sequences: The more gaps in the sequences, the more computational time is required for the alignment.\n3. Number of mismatches allowed: The more mismatches allowed in the alignment, the more computational time is required for the alignment.\n4. The scoring matrix used: The scoring matrix used in the Smith-Waterman algorithm can affect the computational time. For example, using a diagonal matrix as the scoring matrix can reduce the computational time, but it may not provide the best alignment.\nIn general, the Smith-Waterman algorithm has a time complexity of O(n \\* m \\* log(n \\* m)), where n and m are the lengths of the sequences. This makes it an efficient algorithm for aligning large sequences. However, the actual execution time can be much longer than this, depending on the factors mentioned above.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The execution time or complexity of the Smith-Waterman algorithm depends on the length of the sequences.\n2. The execution time or complexity of the Smith-Waterman algorithm depends on the number of gaps in the sequences.\n3. The execution time or complexity of the Smith-Waterman algorithm depends on the number of mismatches allowed in the alignment.\n4. The scoring matrix used in the Smith-Waterman algorithm can affect the computational time.\n5. The Smith-Waterman algorithm has a time complexity of O(n*m*log(n*m)), where n and m are the lengths of the sequences.",
    "vicuna-13b_fact": [
      "The execution time or complexity of the Smith-Waterman algorithm depends on the length of the sequences.",
      "The execution time or complexity of the Smith-Waterman algorithm depends on the number of gaps in the sequences.",
      "The execution time or complexity of the Smith-Waterman algorithm depends on the number of mismatches allowed in the alignment.",
      "The scoring matrix used in the Smith-Waterman algorithm can affect the computational time.",
      "The Smith-Waterman algorithm has a time complexity of O(n*m*log(n*m)), where n and m are the lengths of the sequences."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The execution time or complexity of the Smith-Waterman algorithm does not directly depend on the number of gaps in the sequences, but on the lengths of the sequences.\n3. FALSE [correction]: The execution time or complexity of the Smith-Waterman algorithm does not directly depend on the number of mismatches allowed in the alignment, but on the lengths of the sequences.\n4. TRUE\n5. FALSE [correction]: The Smith-Waterman algorithm has a time complexity of O(n*m), where n and m are the lengths of the sequences.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1003,
    "user_query": "What is Piebaldism?",
    "vicuna-13b_response": "Piebaldism, also known as congenital leukoderma, is a rare skin condition characterized by a lack of pigment in certain areas of the skin, resulting in patches of white skin surrounded by normal skin. It is a genetic disorder that affects the development of melanin, the pigment that gives skin its color.\nPiebaldism typically appears at birth or within the first year of life, and the patches of white skin can vary in size and location. The condition is usually not painful or harmful, but it can lead to social and psychological problems for those affected.\nThere is no cure for piebaldism, but treatment options include skin grafting, cosmetic procedures such as tattooing or skin dyes, and psychological support for those affected. It is important to note that piebaldism is a genetic condition and it can be inherited from parents.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Piebaldism is a rare skin condition characterized by a lack of pigment in certain areas of the skin.\n2. The condition is a genetic disorder that affects the development of melanin.\n3. Piebaldism typically appears at birth or within the first year of life.\n4. There is no cure for piebaldism.\n5. Piebaldism can be inherited from parents.",
    "vicuna-13b_fact": [
      "Piebaldism is a rare skin condition characterized by a lack of pigment in certain areas of the skin.",
      "The condition is a genetic disorder that affects the development of melanin.",
      "Piebaldism typically appears at birth or within the first year of life.",
      "There is no cure for piebaldism.",
      "Piebaldism can be inherited from parents."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "vicuna-13b_response": "FLVCR1 (Follicular Dendritic Cell Sarcoma Recurrence 1) is a member of the SLC (Solute Carrier) family of proteins. SLC proteins are a diverse family of transmembrane proteins that play important roles in the transport of solutes across cell membranes. FLVCR1 is a type I transmembrane protein that functions as a folate transporter and is involved in the uptake of folate, a B vitamin essential for cellular metabolism, into cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. FLVCR1 is a member of the SLC family of proteins.\n2. SLC proteins are a family of transmembrane proteins.\n3. SLC proteins play important roles in the transport of solutes across cell membranes.\n4. FLVCR1 is a type I transmembrane protein.\n5. FLVCR1 functions as a folate transporter and is involved in the uptake of folate into cells.",
    "vicuna-13b_fact": [
      "FLVCR1 is a member of the SLC family of proteins.",
      "SLC proteins are a family of transmembrane proteins.",
      "SLC proteins play important roles in the transport of solutes across cell membranes.",
      "FLVCR1 is a type I transmembrane protein.",
      "FLVCR1 functions as a folate transporter and is involved in the uptake of folate into cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: FLVCR1 functions as a heme transporter and is involved in the efflux of heme from cells.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1008,
    "user_query": "Which inherited disorder is known to be caused by mutations in the NEMO gene?",
    "vicuna-13b_response": "The inherited disorder known to be caused by mutations in the NEMO gene is called \"Nemaline myopathy.\" It is a rare, inherited muscle disorder characterized by muscle weakness and degeneration, as well as abnormalities in muscle structure. The NEMO gene provides instructions for making a protein called \"Nemaline,\" which is essential for the proper function of muscle cells. Mutations in the NEMO gene can disrupt the production of Nemaline, leading to the characteristic features of nemaline myopathy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nemaline myopathy is an inherited disorder.\n2. The NEMO gene mutations are known to cause Nemaline myopathy.\n3. The NEMO gene provides instructions for making a protein called \"Nemaline.\"\n4. The protein 'Nemaline' is essential for the proper function of muscle cells.\n5. Mutations in the NEMO gene can disrupt the production of Nemaline.",
    "vicuna-13b_fact": [
      "Nemaline myopathy is an inherited disorder.",
      "The NEMO gene mutations are known to cause Nemaline myopathy.",
      "The NEMO gene provides instructions for making a protein called \"Nemaline.\"",
      "The protein 'Nemaline' is essential for the proper function of muscle cells.",
      "Mutations in the NEMO gene can disrupt the production of Nemaline."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mutations in several genes namely ACTA1, NEB, TPM2, TPM3, TNNT1, CFL2 and KBTBD13 are known to cause Nemaline myopathy.\n3. FALSE [correction]: The NEMO gene provides instructions for making a protein which is important for immune system function. It does not produce a protein called \"Nemaline.\"\n4. UNKNOWN\n5. FALSE [correction]: Mutations in the NEMO gene can disrupt the immune response, but they're not known to produce or disrupt the production of a protein called Nemaline.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1009,
    "user_query": "What is ISMARA?",
    "vicuna-13b_response": "ISMARA is not a commonly recognized term or acronym in any specific field or industry. It is possible that it may have a specific meaning or usage in a particular context or organization, but without further information, it is difficult to provide a specific answer.\nIf you could provide more context or information about the context or industry in which you encountered the term \"ISMARA,\" I may be able to provide a more specific answer.",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 1014,
    "user_query": "What histone variants play a role in the DNA damage reponse?",
    "vicuna-13b_response": "Histone variants are modified forms of the core histone proteins that are involved in the structure of chromatin, the complex of DNA, RNA, and proteins that makes up the chromosomes in the nucleus of eukaryotic cells. Histone variants can play a role in the DNA damage response, which is the cellular response to DNA damage that occurs as a result of environmental stress, errors during DNA replication, or other factors.\nOne histone variant that is known to play a role in the DNA damage response is H2A.X. H2A.X is a histone variant that is rapidly and transiently modified in response to DNA damage, and this modification is thought to recruit repair factors to the damaged region of the genome. Other histone variants that have been implicated in the DNA damage response include H3.3, which is involved in the repair of double-strand breaks, and H1.0, which is involved in the regulation of chromatin structure in response to DNA damage.\nOverall, histone variants play an important role in the regulation of chromatin structure and the DNA damage response, and their modifications can provide important clues about the state of the genome and the cell's response to environmental stress.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Histone variants are modified forms of core histone proteins involved in the structure of chromatin.\n2. Some histone variants play a role in the DNA damage response, the cellular response to DNA damage.\n3. H2A.X is a histone variant that plays a role in the DNA damage response.\n4. H2A.X is rapidly and transiently modified in response to DNA damage.\n5. Other histone variants implicated in the DNA damage response include H3.3, involved in the repair of double-strand breaks, and H1.0, which regulates chromatin structure in response to DNA damage.",
    "vicuna-13b_fact": [
      "Histone variants are modified forms of core histone proteins involved in the structure of chromatin.",
      "Some histone variants play a role in the DNA damage response, the cellular response to DNA damage.",
      "H2A.X is a histone variant that plays a role in the DNA damage response.",
      "H2A.X is rapidly and transiently modified in response to DNA damage.",
      "Other histone variants implicated in the DNA damage response include H3.3, involved in the repair of double-strand breaks, and H1.0, which regulates chromatin structure in response to DNA damage."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1019,
    "user_query": "Which disease has been associated to a disruptive ALX1 protein?",
    "vicuna-13b_response": "ALX1 is a protein that plays a role in regulating cell growth and division. Mutations in the ALX1 gene have been associated with the development of certain types of cancer, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). In these diseases, the ALX1 protein is thought to be disrupted or dysregulated, leading to the uncontrolled growth and division of blood cells. Additionally, ALX1 mutations have also been linked to the development of other types of cancer, such as ovarian and breast cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ALX1 is a protein that plays a role in regulating cell growth and division.\n2. Mutations in the ALX1 gene have been associated with the development of certain types of cancer.\n3. The ALX1 protein is disrupted or dysregulated in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).\n4. When the ALX1 protein is disrupted or dysregulated, it leads to the uncontrolled growth and division of blood cells.\n5. ALX1 mutations have also been linked to the development of ovarian and breast cancer.",
    "vicuna-13b_fact": [
      "ALX1 is a protein that plays a role in regulating cell growth and division.",
      "Mutations in the ALX1 gene have been associated with the development of certain types of cancer.",
      "The ALX1 protein is disrupted or dysregulated in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).",
      "When the ALX1 protein is disrupted or dysregulated, it leads to the uncontrolled growth and division of blood cells.",
      "ALX1 mutations have also been linked to the development of ovarian and breast cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1022,
    "user_query": "In which yeast chromosome does the rDNA cluster reside?",
    "vicuna-13b_response": "The rDNA (ribosomal DNA) cluster resides on yeast chromosome XV. This is a well-known fact in the field of genetics and yeast research. The rDNA cluster is responsible for the synthesis of ribosomes, which are essential for protein synthesis in all living organisms. The rDNA cluster on chromosome XV contains more than 100 genes that encode for different ribosomal proteins. The organization of the rDNA cluster on chromosome XV is highly conserved among different species of yeast, and it is also found in other eukaryotes such as plants and animals.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The rDNA (ribosomal DNA) cluster resides on yeast chromosome XV.\n2. The rDNA cluster is responsible for the synthesis of ribosomes.\n3. Ribosomes are essential for protein synthesis in all living organisms.\n4. The rDNA cluster on chromosome XV contains more than 100 genes that encode for different ribosomal proteins.\n5. The organization of the rDNA cluster on chromosome XV is highly conserved among different species of yeast, and in other eukaryotes such as plants and animals.",
    "vicuna-13b_fact": [
      "The rDNA (ribosomal DNA) cluster resides on yeast chromosome XV.",
      "The rDNA cluster is responsible for the synthesis of ribosomes.",
      "Ribosomes are essential for protein synthesis in all living organisms.",
      "The rDNA cluster on chromosome XV contains more than 100 genes that encode for different ribosomal proteins.",
      "The organization of the rDNA cluster on chromosome XV is highly conserved among different species of yeast, and in other eukaryotes such as plants and animals."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The rDNA cluster on chromosome XV contains approximately 150-200 repeats of a 9.1-kilobase sequence encoding the 18S, 5.8S, and 25S rRNA, but it does not encode for ribosomal proteins.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1023,
    "user_query": "Which is the underlying mechanism for exon skipping used to treat Duchenne muscular dystrophy?",
    "vicuna-13b_response": "Exon skipping is a mechanism used to treat Duchenne muscular dystrophy (DMD) by skipping over exons, or sections of DNA, that contain mutations that cause the disease. DMD is caused by mutations in the dystrophin gene, which leads to the production of a faulty protein that weakens muscles and leads to progressive muscle degeneration.\nExon skipping works by using a molecule called an antisense oligonucleotide (ASO) to bind to the messenger RNA (mRNA) carrying the faulty exon. The ASO then directs the mRNA to skip over the faulty exon, allowing the cell to produce a functional dystrophin protein.\nThere are two main types of exon skipping:\n1. Exon 51 skipping: This method is used to treat DMD patients who have a mutation in exon 51. The ASO molecule is designed to bind to the mRNA carrying exon 51, causing it to be skipped over, resulting in the production of a functional dystrophin protein.\n2. Exon 53 skipping: This method is used to treat DMD patients who have a mutation in exon 53. The ASO molecule is designed to bind to the mRNA carrying exon 53, causing it to be skipped over, resulting in the production of a functional dystrophin protein.\nExon skipping is a promising approach for treating DMD, as it allows for the production of functional dystrophin protein in patients with mutations in specific exons, and it has been shown to be effective in clinical trials. However, it is important to note that exon skipping is not a cure for DMD and it does not work for all patients.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Exon skipping is a mechanism used to treat Duchenne muscular dystrophy by skipping mutations that cause the disease.\n2. Duchenne muscular dystrophy is caused by mutations in the dystrophin gene which leads to the production of a faulty protein that weakens muscles.\n3. Exon skipping uses a molecule called an antisense oligonucleotide (ASO) to bind to the messenger RNA (mRNA) carrying the faulty exon.\n4. Exon 51 skipping is a method used to treat patients who have a mutation in exon 51.\n5. Exon 53 skipping is a method used to treat patients who have a mutation in exon 53.",
    "vicuna-13b_fact": [
      "Exon skipping is a mechanism used to treat Duchenne muscular dystrophy by skipping mutations that cause the disease.",
      "Duchenne muscular dystrophy is caused by mutations in the dystrophin gene which leads to the production of a faulty protein that weakens muscles.",
      "Exon skipping uses a molecule called an antisense oligonucleotide (ASO) to bind to the messenger RNA (mRNA) carrying the faulty exon.",
      "Exon 51 skipping is a method used to treat patients who have a mutation in exon 51.",
      "Exon 53 skipping is a method used to treat patients who have a mutation in exon 53."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1028,
    "user_query": "What is the link between Dax1 and Esrrb?",
    "vicuna-13b_response": "Dax1 and ESRRB are two different genes that have been studied in the context of prostate cancer. Dax1 is a transcription factor that has been shown to play a role in the development and progression of prostate cancer. It is involved in the regulation of genes that are important for cell growth and survival, and its overexpression has been associated with poor prognosis in prostate cancer patients.\nESRRB, on the other hand, is a receptor tyrosine kinase that has also been studied in the context of prostate cancer. It is involved in the signaling pathways that regulate cell growth and survival, and its overexpression has been associated with the development and progression of prostate cancer.\nThere is some evidence to suggest that Dax1 and ESRRB may be involved in similar signaling pathways and may interact with each other in prostate cancer cells. However, more research is needed to fully understand the link between these two genes and their roles in prostate cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dax1 and ESRRB are two different genes that have been studied in the context of prostate cancer.\n2. Dax1 is a transcription factor that plays a role in the development and progression of prostate cancer.\n3. Overexpression of Dax1 has been associated with poor prognosis in prostate cancer patients.\n4. ESRRB is a receptor tyrosine kinase that is involved in the signaling pathways that regulate cell growth and survival.\n5. Overexpression of ESRRB has been associated with the development and progression of prostate cancer.",
    "vicuna-13b_fact": [
      "Dax1 and ESRRB are two different genes that have been studied in the context of prostate cancer.",
      "Dax1 is a transcription factor that plays a role in the development and progression of prostate cancer.",
      "Overexpression of Dax1 has been associated with poor prognosis in prostate cancer patients.",
      "ESRRB is a receptor tyrosine kinase that is involved in the signaling pathways that regulate cell growth and survival.",
      "Overexpression of ESRRB has been associated with the development and progression of prostate cancer."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: ESRRB (Estrogen related receptor beta) is a nuclear hormone receptor and not a receptor tyrosine kinase.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1030,
    "user_query": "Are DNA helicases involved in progeroid syndromes?",
    "vicuna-13b_response": "Progeroid syndromes are a group of rare genetic disorders that cause premature aging. DNA helicases are enzymes that play a crucial role in maintaining the integrity of DNA by unwinding and rewinding DNA strands during various cellular processes, such as replication, repair, and transcription.\nThere is some evidence to suggest that DNA helicases may be involved in progeroid syndromes. For example, some progeroid syndromes are caused by mutations in genes that encode DNA helicases, such as the Xeroderma Pigmentosum Group A (XPA) and Group B (XPG) helicases. These mutations can lead to defects in DNA repair and increased sensitivity to sunlight, which are both features of progeroid syndromes.\nAdditionally, some studies have suggested that DNA helicases may play a role in regulating the activity of telomerase, an enzyme that maintains the length of telomeres, which are the protective caps on the ends of chromosomes. Telomere shortening is a hallmark of progeroid syndromes, and it is thought to contribute to the premature aging observed in these disorders.\nOverall, while more research is needed to fully understand the role of DNA helicases in progeroid syndromes, there is some evidence to suggest that they may play a role in the development of these disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Progeroid syndromes are a group of rare genetic disorders causing premature aging.\n2. DNA helicases are enzymes that play a role in maintaining the integrity of DNA by unwinding and rewinding DNA strands during cellular processes like replication, repair, and transcription.\n3. Some progeroid syndromes are caused by mutations in genes encoding DNA helicases including the Xeroderma Pigmentosum Group A (XPA) and Group B (XPG) helicases.\n4. The mutations in genes encoding DNA helicases can lead to defects in DNA repair and increased sensitivity to sunlight.\n5. Some studies suggest that DNA helicases may play a role in regulating the activity of telomerase, an enzyme that maintains the length of telomeres, the protective caps at the ends of chromosomes.",
    "vicuna-13b_fact": [
      "Progeroid syndromes are a group of rare genetic disorders causing premature aging.",
      "DNA helicases are enzymes that play a role in maintaining the integrity of DNA by unwinding and rewinding DNA strands during cellular processes like replication, repair, and transcription.",
      "Some progeroid syndromes are caused by mutations in genes encoding DNA helicases including the Xeroderma Pigmentosum Group A (XPA) and Group B (XPG) helicases.",
      "The mutations in genes encoding DNA helicases can lead to defects in DNA repair and increased sensitivity to sunlight.",
      "Some studies suggest that DNA helicases may play a role in regulating the activity of telomerase, an enzyme that maintains the length of telomeres, the protective caps at the ends of chromosomes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Some progeroid syndromes are caused by mutations in genes encoding DNA helicases, but not specifically Xeroderma Pigmentosum Group A (XPA) and Group B (XPG) helicases. An example would be Werner syndrome, caused by mutations in the WRN gene, which encodes a DNA helicase.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1034,
    "user_query": "Which heat shock protein is found to be upregulated during Hsp90 inhibition?",
    "vicuna-13b_response": "Heat shock protein (Hsp) 70 is found to be upregulated during Hsp90 inhibition. Hsp90 is a molecular chaperone that plays a critical role in the folding and stability of other proteins, including Hsp70. Hsp90 inhibition disrupts the interaction between Hsp90 and its client proteins, leading to the degradation of these proteins. In response to Hsp90 inhibition, cells upregulate the expression of Hsp70 to compensate for the loss of stability provided by Hsp90. This upregulation of Hsp70 helps to ensure that proteins that are no longer chaperoned by Hsp90 are still properly folded and functional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Heat shock protein (Hsp) 70 is found to be upregulated during Hsp90 inhibition.\n2. Hsp90 is a molecular chaperone that plays a role in the folding and stability of other proteins, including Hsp70.\n3. Hsp90 inhibition disrupts the interaction between Hsp90 and its client proteins.\n4. The degradation of these proteins occur in response to Hsp90 inhibition.\n5. In response to Hsp90 inhibition, cells upregulate the expression of Hsp70 to compensate for the loss of stability.",
    "vicuna-13b_fact": [
      "Heat shock protein (Hsp) 70 is found to be upregulated during Hsp90 inhibition.",
      "Hsp90 is a molecular chaperone that plays a role in the folding and stability of other proteins, including Hsp70.",
      "Hsp90 inhibition disrupts the interaction between Hsp90 and its client proteins.",
      "The degradation of these proteins occur in response to Hsp90 inhibition.",
      "In response to Hsp90 inhibition, cells upregulate the expression of Hsp70 to compensate for the loss of stability."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1036,
    "user_query": "What is the name for anorexia in gymnasts?",
    "vicuna-13b_response": "The name for anorexia in gymnasts is \"Gymnastics Anorexia\" or \"Gymnastics Anorexic Syndrome.\" This condition is characterized by a severe restriction of caloric intake and an excessive focus on weight loss, often to the point of endangering one's health. Gymnasts, particularly those in the elite level, are at a higher risk of developing this condition due to the pressure to maintain a low body weight and a lean physique for competition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Anorexia in gymnasts is referred to as \"Gymnastics Anorexia\" or \"Gymnastics Anorexic Syndrome.\"\n2. This condition is characterized by a severe restriction of caloric intake and an excessive focus on weight loss.\n3. The symptoms of Gymnastics Anorexia can threaten one's health.\n4. Elite-level gymnasts are reported to be at a higher risk of developing Gymnastics Anorexia.\n5. The condition's high prevalence in gymnasts is often attributed to the pressure to maintain a low body weight and a lean physique for competition.",
    "vicuna-13b_fact": [
      "Anorexia in gymnasts is referred to as \"Gymnastics Anorexia\" or \"Gymnastics Anorexic Syndrome.\"",
      "This condition is characterized by a severe restriction of caloric intake and an excessive focus on weight loss.",
      "The symptoms of Gymnastics Anorexia can threaten one's health.",
      "Elite-level gymnasts are reported to be at a higher risk of developing Gymnastics Anorexia.",
      "The condition's high prevalence in gymnasts is often attributed to the pressure to maintain a low body weight and a lean physique for competition."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The term \"Athlete Triad\" or \"Female Athlete Triad\" is often used to refer to disordered eating, menstrual dysfunction and bone loss in athletes, not \"Gymnastics Anorexia\" or \"Gymnastics Anorexic Syndrome.\"\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1038,
    "user_query": "What are the indications for alteplase?",
    "vicuna-13b_response": "Alteplase is a medication used to dissolve blood clots and improve blood flow. It is primarily used in the treatment of acute ischemic stroke, which is a type of stroke caused by a blockage of blood flow to the brain. Alteplase is given intravenously and works by breaking down the clot that is causing the blockage.\nIn addition to its use in stroke, alteplase may also be used in certain other conditions where blood clots are present, such as deep vein thrombosis (DVT) or pulmonary embolism (PE). However, the use of alteplase in these conditions is less common and typically only considered in certain circumstances.\nIt is important to note that alteplase is given under the supervision of a healthcare professional in a medical setting, and its use is generally reserved for cases where the potential benefits outweigh the potential risks.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Alteplase is a medication used to dissolve blood clots and improve blood flow.\n2. Alteplase is primarily used in the treatment of acute ischemic stroke.\n3. The medication is given intravenously and works by breaking down the clot that is causing the blockage.\n4. Alteplase may be used in conditions where blood clots are present, such as deep vein thrombosis (DVT) or pulmonary embolism (PE).\n5. Alteplase is given under the supervision of a healthcare professional in a medical setting.",
    "vicuna-13b_fact": [
      "Alteplase is a medication used to dissolve blood clots and improve blood flow.",
      "Alteplase is primarily used in the treatment of acute ischemic stroke.",
      "The medication is given intravenously and works by breaking down the clot that is causing the blockage.",
      "Alteplase may be used in conditions where blood clots are present, such as deep vein thrombosis (DVT) or pulmonary embolism (PE).",
      "Alteplase is given under the supervision of a healthcare professional in a medical setting."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1039,
    "user_query": "List scaffold proteins of the ERK signaling pathway.",
    "vicuna-13b_response": "Scaffold proteins are important components of signaling pathways, including the ERK (Extracellular Signal-Regulated Kinase) signaling pathway, which plays a critical role in regulating cell growth and differentiation. Here are some of the scaffold proteins involved in the ERK signaling pathway:\n1. Raf: A small GTPase that activates the MEK/ERK pathway by binding to and activating MEK.\n2. MEK: A serine/threonine kinase that acts as a mediator of the ERK pathway, activating ERK by phosphorylating it.\n3. ERK: A protein kinase that is activated by MEK and phosphorylates a variety of downstream targets, including transcription factors that regulate gene expression.\n4. Elk: A protein kinase that is closely related to ERK and also phosphorylates downstream targets.\n5. Sos: A guanine nucleotide exchange factor that activates Ras by exchanging GDP for GTP.\n6. Ras: A small GTPase that activates the PI3K/Akt pathway and the ERK pathway by binding to and activating Raf.\nThese scaffold proteins help to coordinate the activities of the various components of the ERK signaling pathway, allowing for efficient and coordinated signaling.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Scaffold proteins play a critical role in regulating cell growth and differentiation in the ERK signaling pathway.\n2. Raf is a small GTPase that activates the MEK/ERK pathway by binding to and activating MEK.\n3. MEK is a serine/threonine kinase that activates ERK by phosphorylating it.\n4. ERK is a protein kinase that phosphorylates a variety of downstream targets, including transcription factors that regulate gene expression.\n5. Sos is a guanine nucleotide exchange factor that activates Ras by exchanging GDP for GTP.\n6. Ras activates the PI3K/Akt pathway and the ERK pathway by binding to and activating Raf.",
    "vicuna-13b_fact": [
      "Scaffold proteins play a critical role in regulating cell growth and differentiation in the ERK signaling pathway.",
      "Raf is a small GTPase that activates the MEK/ERK pathway by binding to and activating MEK.",
      "MEK is a serine/threonine kinase that activates ERK by phosphorylating it.",
      "ERK is a protein kinase that phosphorylates a variety of downstream targets, including transcription factors that regulate gene expression.",
      "Sos is a guanine nucleotide exchange factor that activates Ras by exchanging GDP for GTP.",
      "Ras activates the PI3K/Akt pathway and the ERK pathway by binding to and activating Raf."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Raf is a serine/threonine-specific protein kinase that activates the MEK/ERK pathway by phosphorylating and activating MEK.\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1041,
    "user_query": "Which classes of endogenous retroelements are known to date?",
    "vicuna-13b_response": "Endogenous retroelements are a class of mobile genetic elements that can move within the genome and can be classified into several classes based on their structural and functional characteristics. The following classes of endogenous retroelements are known to date:\n1. L1 elements: L1 elements are the most abundant class of endogenous retroelements in the human genome. They are DNA elements that can move within the genome and can be found in introns, exons, and intergenic regions. L1 elements can be classified into several subclasses based on their structure and function, including L1c, L1d, and L1h.\n2. L2 elements: L2 elements are another class of endogenous retroelements that are found in the human genome. They are smaller than L1 elements and are typically found in intronic regions. L2 elements can be further classified into several subclasses, including L2a, L2b, and L2c.\n3. SINE elements: SINE elements (short interspersed nuclear elements) are a class of endogenous retroelements that are found in the intronic regions of genes. They are typically shorter than L1 and L2 elements and can be further classified into several subclasses, including SINE-1, SINE-2, and SINE-3.\n4. LTR elements: LTR elements (long terminal repeat elements) are a class of endogenous retroelements that are found in the intronic regions of genes. They are typically longer than SINE elements and can be further classified into several subclasses, including LTR-1 and LTR-2.\nOverall, endogenous retroelements play important roles in genome evolution and can have a significant impact on gene expression and regulation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Endogenous retroelements can move within the genome.\n2. The L1 elements are the most abundant class of endogenous retroelements in the human genome.\n3. L2 elements are another class of endogenous retroelements that are found in the human genome.\n4. SINE elements (short interspersed nuclear elements) are a class of endogenous retroelements that are found in the intronic regions of genes.\n5. LTR elements (long terminal repeat elements) are a class of endogenous retroelements found in the intronic regions of genes.",
    "vicuna-13b_fact": [
      "Endogenous retroelements can move within the genome.",
      "The L1 elements are the most abundant class of endogenous retroelements in the human genome.",
      "L2 elements are another class of endogenous retroelements that are found in the human genome.",
      "SINE elements (short interspersed nuclear elements) are a class of endogenous retroelements that are found in the intronic regions of genes.",
      "LTR elements (long terminal repeat elements) are a class of endogenous retroelements found in the intronic regions of genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "vicuna-13b_response": "GATA-1 is a transcription factor that plays a crucial role in the development and differentiation of hematopoietic cells. Several studies have identified GATA-1 interacting partners using the biotinylation tagging approach. Here are some of the known GATA-1 interacting partners:\n1. TFIIB: GATA-1 was shown to interact with TFIIB, a transcription factor that plays a role in the initiation of transcription.\n2. TBP: GATA-1 was found to interact with TBP, a component of the transcriptional preinitiation complex.\n3. RFX: GATA-1 was shown to interact with RFX, a transcription factor involved in the regulation of immune cell development.\n4. NF-E2: GATA-1 was found to interact with NF-E2, a transcription factor that regulates the expression of genes involved in erythropoiesis.\n5. GATA-2: GATA-1 was shown to interact with GATA-2, another GATA transcription factor that is involved in the development of hematopoietic cells.\n6. PU.1: GATA-1 was found to interact with PU.1, a transcription factor that plays a role in the differentiation of myeloid cells.\nThese are just a few examples of GATA-1 interacting partners that have been identified using the biotinylation tagging approach. Further studies are needed to fully understand the role of these interactions in the regulation of hematopoietic cell development and function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GATA-1 is a transcription factor that plays a role in the development and differentiation of hematopoietic cells.\n2. GATA-1 was shown to interact with TFIIB, a transcription factor involved in the initiation of transcription.\n3. GATA-1 was found to interact with TBP, a component of the transcriptional preinitiation complex.\n4. GATA-1 was shown to interact with RFX, a transcription factor involved in the regulation of immune cell development.\n5. GATA-1 was found to interact with NF-E2, a transcription factor that regulates the expression of genes involved in erythropoiesis.\n5. GATA-1 was shown to interact with GATA-2, another GATA transcription factor involved in the development of hematopoietic cells.\n6. GATA-1 was found to interact with PU.1, a transcription factor that plays a role in the differentiation of myeloid cells.",
    "vicuna-13b_fact": [
      "GATA-1 is a transcription factor that plays a role in the development and differentiation of hematopoietic cells.",
      "GATA-1 was shown to interact with TFIIB, a transcription factor involved in the initiation of transcription.",
      "GATA-1 was found to interact with TBP, a component of the transcriptional preinitiation complex.",
      "GATA-1 was shown to interact with RFX, a transcription factor involved in the regulation of immune cell development.",
      "GATA-1 was found to interact with NF-E2, a transcription factor that regulates the expression of genes involved in erythropoiesis.",
      "GATA-1 was shown to interact with GATA-2, another GATA transcription factor involved in the development of hematopoietic cells.",
      "GATA-1 was found to interact with PU.1, a transcription factor that plays a role in the differentiation of myeloid cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE\n6. TRUE\n7. FALSE [correction]: GATA-1 was found to repress, not interact with PU.1, a transcription factor that plays a role in the differentiation of myeloid cells.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1053,
    "user_query": "Which proteins are the different members of the NF-kappaB family of transcription factors?",
    "vicuna-13b_response": "The NF-kappaB family of transcription factors is a group of proteins that play a crucial role in regulating the expression of genes involved in immune response, inflammation, and cell survival. The different members of the NF-kappaB family are:\n1. NF-kappaB1 (p50): This protein is a heterodimer composed of two subunits, p50 and p50, and is involved in the regulation of genes involved in immune response and inflammation.\n2. NF-kappaB2 (p52): This protein is a heterodimer composed of two subunits, p52 and p52, and is involved in the regulation of genes involved in immune response and inflammation.\n3. NF-kappaB2 (p49): This protein is a heterodimer composed of two subunits, p49 and p49, and is involved in the regulation of genes involved in immune response and inflammation.\n4. RelA (p65): This protein is a homodimer and is involved in the regulation of genes involved in immune response and inflammation.\n5. c-Rel: This protein is a homodimer and is involved in the regulation of genes involved in immune response and inflammation.\n6. NF-kappaB2 (p100): This protein is a homodimer and is involved in the regulation of genes involved in immune response and inflammation.\nThese proteins play a crucial role in regulating the expression of genes involved in immune response, inflammation, and cell survival. They are activated in response to various stimuli, such as viral infections, bacterial infections, and toxic substances, and they regulate the expression of genes involved in the immune response and inflammation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The NF-kappaB family of transcription factors consist of proteins that regulate the expression of genes involved in immune response, inflammation, and cell survival.\n2. NF-kappaB1 (p50) is a protein made up of two subunits and plays a role in the regulation of genes involved in immune responses and inflammation.\n3. NF-kappaB2 (p52) is a protein made up of two subunits and regulates the expression of genes involved in immune responses and inflammation.\n4. RelA (p65) is a protein involved in the regulation of genes involved in immune response and inflammation.\n5. c-Rel is a protein involved in the regulation of genes involved in immune response and inflammation.\n6. NF-kappaB2 (p100) is a protein that plays a role in the regulation of genes involved in immune responses and inflammation.",
    "vicuna-13b_fact": [
      "The NF-kappaB family of transcription factors consist of proteins that regulate the expression of genes involved in immune response, inflammation, and cell survival.",
      "NF-kappaB1 (p50) is a protein made up of two subunits and plays a role in the regulation of genes involved in immune responses and inflammation.",
      "NF-kappaB2 (p52) is a protein made up of two subunits and regulates the expression of genes involved in immune responses and inflammation.",
      "RelA (p65) is a protein involved in the regulation of genes involved in immune response and inflammation.",
      "c-Rel is a protein involved in the regulation of genes involved in immune response and inflammation.",
      "NF-kappaB2 (p100) is a protein that plays a role in the regulation of genes involved in immune responses and inflammation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1061,
    "user_query": "Which proteins have been identified as RET ligands?",
    "vicuna-13b_response": "RET (rearranged during transfection) is a tyrosine kinase receptor that plays a role in cell growth and differentiation. Several proteins have been identified as ligands for RET, including:\n1. GDNF (glial cell-derived neurotrophic factor)\n2. NRTN (neurturin)\n3. CNTF (ciliary neurotrophic factor)\n4. TDGF1 (trk-like protein 2)\n5. AON (axon guidance protein)\nThese proteins bind to RET and activate its tyrosine kinase activity, leading to cellular signaling and downstream effects on cell growth and differentiation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. RET is a tyrosine kinase receptor that contributes to cell growth and differentiation.\n2. There are several proteins identified as ligands for RET.\n3. Glial cell-derived neurotrophic factor (GDNF) is identified as a ligand for RET.\n4. Neurturin (NRTN) is identified as a ligand for RET.\n5. Ciliary neurotrophic factor (CNTF) is associated with RET.",
    "vicuna-13b_fact": [
      "RET is a tyrosine kinase receptor that contributes to cell growth and differentiation.",
      "There are several proteins identified as ligands for RET.",
      "Glial cell-derived neurotrophic factor (GDNF) is identified as a ligand for RET.",
      "Neurturin (NRTN) is identified as a ligand for RET.",
      "Ciliary neurotrophic factor (CNTF) is associated with RET."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1066,
    "user_query": "List all articles on network meta-analysis for smoking cessation",
    "vicuna-13b_response": "Here are some articles on network meta-analysis for smoking cessation:\n1. \"Network meta-analysis of pharmacological interventions for smoking cessation\" (PubMed, PMID: 29292717)\n2. \"A network meta-analysis of behavioral interventions for smoking cessation in adults\" (PubMed, PMID: 29292716)\n3. \"A systematic review and network meta-analysis of nicotine replacement therapy for smoking cessation\" (PubMed, PMID: 29292715)\n4. \"A network meta-analysis of bupropion and varenicline for smoking cessation\" (PubMed, PMID: 29292714)\n5. \"A systematic review and network meta-analysis of non-nicotine medications for smoking cessation\" (PubMed, PMID: 29292713)\n6. \"A network meta-analysis of counseling and behavioral interventions for smoking cessation in adults\" (PubMed, PMID: 29292712)\n7. \"A systematic review and network meta-analysis of the effectiveness of smoking cessation programs in the workplace\" (PubMed, PMID: 29292711)\n8. \"A network meta-analysis of the effectiveness of smoking cessation programs for young people\" (PubMed, PMID: 29292710)\n9. \"A systematic review and network meta-analysis of the effectiveness of smoking cessation programs for pregnant women\" (PubMed, PMID: 29292709)\n10. \"A network meta-analysis of the effectiveness of smoking cessation programs for individuals with mental illness\" (PubMed, PMID: 29292708)\nNote: These articles may be available through your library or other online resources.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. \"Network meta-analysis of pharmacological interventions for smoking cessation\" is an article listed on PubMed with PMID: 29292717.\n2. \"A network meta-analysis of behavioral interventions for smoking cessation in adults\" is an article listed on PubMed with PMID: 29292716.\n3. \"A systematic review and network meta-analysis of nicotine replacement therapy for smoking cessation\" is an article listed on PubMed with PMID: 29292715.\n4. \"A network meta-analysis of bupropion and varenicline for smoking cessation\" is an article listed on PubMed with PMID: 29292714.\n5. \"A systematic review and network meta-analysis of non-nicotine medications for smoking cessation\" is an article listed on PubMed with PMID: 29292713.",
    "vicuna-13b_fact": [
      "\"Network meta-analysis of pharmacological interventions for smoking cessation\" is an article listed on PubMed with PMID: 29292717.",
      "\"A network meta-analysis of behavioral interventions for smoking cessation in adults\" is an article listed on PubMed with PMID: 29292716.",
      "\"A systematic review and network meta-analysis of nicotine replacement therapy for smoking cessation\" is an article listed on PubMed with PMID: 29292715.",
      "\"A network meta-analysis of bupropion and varenicline for smoking cessation\" is an article listed on PubMed with PMID: 29292714.",
      "\"A systematic review and network meta-analysis of non-nicotine medications for smoking cessation\" is an article listed on PubMed with PMID: 29292713."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1068,
    "user_query": "Which clotting factor is inhibited by betrixaban?",
    "vicuna-13b_response": "Betrixaban is an anticoagulant medication that works by inhibiting the activity of the clotting factor Factor X. Factor X is a vitamin K-dependent clotting factor that plays a critical role in the coagulation cascade, which is the series of chemical reactions that lead to the formation of a blood clot. By inhibiting the activity of Factor X, betrixaban helps to prevent the formation of blood clots, which can reduce the risk of heart attack, stroke, and other serious cardiovascular events. Betrixaban is commonly used to prevent blood clots in people who have atrial fibrillation, which is a common type of irregular heartbeat that can increase the risk of blood clots. It is also used to prevent blood clots in people who have undergone hip or knee replacement surgery.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Betrixaban inhibits the activity of the clotting factor Factor X.\n2. Factor X is a vitamin K-dependent clotting factor that plays a role in the coagulation cascade.\n3. Betrixaban is used to prevent the formation of blood clots, reducing the risk of heart attack, stroke, and other serious cardiovascular events.\n4. Betrixaban is commonly used in individuals with atrial fibrillation, a type of irregular heartbeat.\n5. Betrixaban is also used to prevent blood clots in people who have undergone hip or knee replacement surgery.",
    "vicuna-13b_fact": [
      "Betrixaban inhibits the activity of the clotting factor Factor X.",
      "Factor X is a vitamin K-dependent clotting factor that plays a role in the coagulation cascade.",
      "Betrixaban is used to prevent the formation of blood clots, reducing the risk of heart attack, stroke, and other serious cardiovascular events.",
      "Betrixaban is commonly used in individuals with atrial fibrillation, a type of irregular heartbeat.",
      "Betrixaban is also used to prevent blood clots in people who have undergone hip or knee replacement surgery."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1071,
    "user_query": "Are there any specific antidotes for dabigatran?",
    "vicuna-13b_response": "Yes, there are specific antidotes for dabigatran, a type of anticoagulant medication used to prevent blood clots.\nIf a patient has an accidental overdose or bleeding episode while taking dabigatran, the following antidotes may be used:\n1. Activated charcoal: Activated charcoal can be given orally or via nasogastric tube to adsorb dabigatran and reduce its absorption.\n2. Sodium bicarbonate: Sodium bicarbonate can be administered intravenously to alkalinize the urine and increase the renal excretion of dabigatran.\n3. Vitamin K: Vitamin K can be given intravenously to reverse the anticoagulant effect of dabigatran by promoting the formation of clotting factors.\n4. Fresh frozen plasma or platelets: In severe bleeding episodes, fresh frozen plasma or platelets may be given to replace clotting factors and promote hemostasis.\nIt is important to note that the use of these antidotes should be based on the severity of the bleeding episode and the patient's clinical condition. The patient should be closely monitored for any adverse reactions or recurrence of bleeding.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dabigatran is a type of anticoagulant medication used to prevent blood clots.\n2. Activated charcoal can be used as an antidote for dabigatran to reduce its absorption.\n3. Sodium bicarbonate can be administered intravenously to increase the renal excretion of dabigatran.\n4. Vitamin K can be given intravenously to reverse the anticoagulant effect of dabigatran by promoting the formation of clotting factors.\n5. In severe bleeding episodes, fresh frozen plasma or platelets may be given to replace clotting factors and promote hemostasis.",
    "vicuna-13b_fact": [
      "Dabigatran is a type of anticoagulant medication used to prevent blood clots.",
      "Activated charcoal can be used as an antidote for dabigatran to reduce its absorption.",
      "Sodium bicarbonate can be administered intravenously to increase the renal excretion of dabigatran.",
      "Vitamin K can be given intravenously to reverse the anticoagulant effect of dabigatran by promoting the formation of clotting factors.",
      "In severe bleeding episodes, fresh frozen plasma or platelets may be given to replace clotting factors and promote hemostasis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: Vitamin K is not effective in reversing the anticoagulant effect of dabigatran. It is used to reverse the effects of vitamin K antagonist anticoagulants such as warfarin.\n5. FALSE [correction]: In severe bleeding episodes related to dabigatran, idarucizumab, a specific reversal agent for dabigatran, can be given. Fresh frozen plasma or platelets are not typically used because they may not effectively reverse the anticoagulant effect of dabigatran.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "vicuna-13b_response": "TAF10 is a transcription factor that plays a role in the regulation of gene expression in many organisms, including humans. GATA1 is another transcription factor that is involved in the regulation of gene expression, particularly in the development and function of hematopoietic cells.\nThe outcome of TAF10 interacting with the GATA1 transcription factor can vary depending on the specific context and the target genes being regulated. However, in general, the interaction of TAF10 with GATA1 can enhance the transcriptional activity of GATA1, leading to the upregulation of target genes involved in hematopoiesis and other processes.\nFor example, TAF10 has been shown to interact with GATA1 and enhance its transcriptional activity in the regulation of the erythroid differentiation pathway in hematopoietic cells. In addition, TAF10 has been shown to interact with GATA1 and regulate the expression of genes involved in the immune response and inflammation.\nOverall, the interaction of TAF10 with GATA1 can play an important role in the regulation of gene expression and cellular processes, and further research is needed to fully understand the mechanisms and outcomes of this interaction.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TAF10 is a transcription factor that plays a role in the regulation of gene expression in many organisms.\n2. GATA1 is a transcription factor implicated in the regulation of gene expression, particularly in hematopoietic cells.\n3. The interaction of TAF10 with GATA1 can enhance the transcriptional activity of GATA1, leading to the upregulation of target genes.\n4. TAF10 has been shown to interact with GATA1 and enhance its transcriptional activity in the regulation of the erythroid differentiation pathway in hematopoietic cells.\n5. TAF10 has been shown to interact with GATA1 and regulate the expression of genes involved in the immune response and inflammation.",
    "vicuna-13b_fact": [
      "TAF10 is a transcription factor that plays a role in the regulation of gene expression in many organisms.",
      "GATA1 is a transcription factor implicated in the regulation of gene expression, particularly in hematopoietic cells.",
      "The interaction of TAF10 with GATA1 can enhance the transcriptional activity of GATA1, leading to the upregulation of target genes.",
      "TAF10 has been shown to interact with GATA1 and enhance its transcriptional activity in the regulation of the erythroid differentiation pathway in hematopoietic cells.",
      "TAF10 has been shown to interact with GATA1 and regulate the expression of genes involved in the immune response and inflammation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1073,
    "user_query": "How does TNF affect thyroid hormone receptors?",
    "vicuna-13b_response": "Tumor Necrosis Factor (TNF) is a cytokine that plays a crucial role in regulating the immune response and inflammation. TNF has been shown to affect the function of thyroid hormone receptors (TRs), which are responsible for regulating the expression of genes involved in metabolism, growth, and development.\nTNF can bind to TRs and block their ability to activate gene expression, leading to a decrease in thyroid hormone-mediated processes. This can result in a decrease in metabolism and an increase in inflammation, which can be detrimental to the body.\nIn addition, TNF can also induce the expression of TR-interacting proteins, such as inhibitory proteins, which can further inhibit TR activity and decrease thyroid hormone-mediated processes.\nOverall, TNF can have a significant impact on thyroid hormone receptors and their ability to regulate gene expression, which can have a wide range of effects on the body. It is important to maintain a healthy balance of TNF and thyroid hormone activity to maintain proper physiological function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tumor Necrosis Factor (TNF) is a cytokine that plays a role in regulating the immune response and inflammation.\n2. TNF can affect the function of thyroid hormone receptors (TRs).\n3. TNF has the ability to bind to TRs and block their ability to activate gene expression, leading to a decrease in thyroid hormone-mediated processes.\n4. TNF can induce the expression of TR-interacting proteins, such as inhibitory proteins, which can further inhibit TR activity.\n5. TNF can have a significant impact on thyroid hormone receptors and their ability to regulate gene expression.",
    "vicuna-13b_fact": [
      "Tumor Necrosis Factor (TNF) is a cytokine that plays a role in regulating the immune response and inflammation.",
      "TNF can affect the function of thyroid hormone receptors (TRs).",
      "TNF has the ability to bind to TRs and block their ability to activate gene expression, leading to a decrease in thyroid hormone-mediated processes.",
      "TNF can induce the expression of TR-interacting proteins, such as inhibitory proteins, which can further inhibit TR activity.",
      "TNF can have a significant impact on thyroid hormone receptors and their ability to regulate gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1078,
    "user_query": "What is the action of molindone?",
    "vicuna-13b_response": "Molindone is a medication that is primarily used to treat schizophrenia. It is a typical antipsychotic medication, which means it works by blocking the action of dopamine in the brain. Dopamine is a neurotransmitter that is involved in many different brain functions, including movement, emotion, and mood regulation.\nIn schizophrenia, there is an imbalance in the levels of dopamine in the brain, which can lead to symptoms such as hallucinations, delusions, and disorganized thinking. Molindone works by blocking the action of dopamine receptors in the brain, which helps to reduce the symptoms of schizophrenia.\nMolindone is usually taken orally, either as a tablet or a liquid. It is usually taken two or three times a day, with or without food. The dosage and duration of treatment will depend on the individual patient and their response to the medication.\nIt is important to note that molindone should only be taken as prescribed by a doctor, and any changes to the dosage or frequency of use should be discussed with a healthcare provider. Additionally, molindone may have side effects, so it is important to report any unusual symptoms to a doctor.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Molindone is primarily used to treat schizophrenia.\n2. The medication works by blocking the action of dopamine in the brain.\n3. Dopamine is a neurotransmitter involved in functions such as movement, emotion, and mood regulation.\n4. Schizophrenia may be linked to an imbalance in the levels of dopamine in the brain.\n5. Molindone can be taken orally, as a tablet or a liquid.",
    "vicuna-13b_fact": [
      "Molindone is primarily used to treat schizophrenia.",
      "The medication works by blocking the action of dopamine in the brain.",
      "Dopamine is a neurotransmitter involved in functions such as movement, emotion, and mood regulation.",
      "Schizophrenia may be linked to an imbalance in the levels of dopamine in the brain.",
      "Molindone can be taken orally, as a tablet or a liquid."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "vicuna-13b_response": "Yes, there are decision support systems for chronic pain management. These systems are designed to help healthcare professionals, such as doctors and nurses, make informed decisions about the treatment of chronic pain. They typically use algorithms and other tools to analyze patient data, such as medical history, symptoms, and test results, and provide recommendations for treatment options. Some decision support systems for chronic pain management may also take into account patient preferences and values, as well as the latest research and guidelines. These systems can be useful in helping healthcare professionals to select the most appropriate treatment for each individual patient, and to optimize pain management strategies over time.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. There are decision support systems available for chronic pain management.\n2. Decision support systems for chronic pain management are designed to assist healthcare professionals in making treatment decisions.\n3. These systems use algorithms and other tools to analyze patient data including medical history, symptoms, and test results.\n4. Some chronic pain management decision support systems may consider patient preferences, values, and the latest research and guidelines.\n5. These systems can aid healthcare professionals in selecting an appropriate treatment for an individual patient and optimizing pain management strategies over time.",
    "vicuna-13b_fact": [
      "There are decision support systems available for chronic pain management.",
      "Decision support systems for chronic pain management are designed to assist healthcare professionals in making treatment decisions.",
      "These systems use algorithms and other tools to analyze patient data including medical history, symptoms, and test results.",
      "Some chronic pain management decision support systems may consider patient preferences, values, and the latest research and guidelines.",
      "These systems can aid healthcare professionals in selecting an appropriate treatment for an individual patient and optimizing pain management strategies over time."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1084,
    "user_query": "Which is the methyl donor of histone methyltransferases?",
    "vicuna-13b_response": "Histone methyltransferases (HMTs) are enzymes that add methyl groups to histone proteins, which are involved in the regulation of gene expression and chromatin structure. The methyl donor of HMTs is S-adenosylmethionine (SAM), which is a universal methyl donor in mammalian cells.\nSAM is derived from the amino acid methionine, which is obtained from dietary sources or produced in the body from homocysteine. It is converted to SAM by the enzyme methionine adenosyltransferase (MAT). SAM is then converted to various methyl donors, including methyl groups, by the enzyme methyltransferases.\nIn the case of HMTs, SAM is converted to a methyl group, which is then added to the histone protein by the HMT enzyme. This methylation of histones can lead to the repression or activation of gene expression, depending on the location and nature of the methylation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Histone methyltransferases (HMTs) are enzymes that add methyl groups to histone proteins.\n2. The regulation of gene expression and chromatin structure involve histone proteins.\n3. The methyl donor of HMTs is S-adenosylmethionine (SAM).\n4. S-adenosylmethionine (SAM) is derived from the amino acid methionine.\n5. The methylation of histones by HMTs can lead to the repression or activation of gene expression.",
    "vicuna-13b_fact": [
      "Histone methyltransferases (HMTs) are enzymes that add methyl groups to histone proteins.",
      "The regulation of gene expression and chromatin structure involve histone proteins.",
      "The methyl donor of HMTs is S-adenosylmethionine (SAM).",
      "S-adenosylmethionine (SAM) is derived from the amino acid methionine.",
      "The methylation of histones by HMTs can lead to the repression or activation of gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1085,
    "user_query": "How are human accelerated regions (HAR) defined?",
    "vicuna-13b_response": "Human accelerated regions (HAR) are defined as regions of the genome that have undergone rapid and recent evolutionary changes in comparison to other regions of the genome. These regions are typically associated with positive selection, which is a type of natural selection that favors the survival and reproduction of individuals with certain genetic traits.\nThe definition of HARs is based on the analysis of genetic variation within the human population. Researchers use a variety of methods to identify regions of the genome that have undergone rapid evolutionary change, such as comparing the genomes of different human populations, or comparing the genomes of humans to those of other species.\nOne common method used to identify HARs is to compare the genomes of different human populations and look for regions that have undergone a greater than expected number of mutations. These regions are then considered to be under positive selection, as the high rate of mutations is unlikely to occur by chance.\nAnother method used to identify HARs is to compare the genomes of humans to those of other species, such as chimpanzees. Regions of the genome that are unique to humans and have undergone rapid evolutionary change are considered to be HARs.\nHARs have been identified in many different regions of the genome, and they are associated with a wide range of biological processes, such as immune function, brain development, and reproduction. Some HARs have been linked to specific diseases, such as autoimmune disorders and certain types of cancer.\nOverall, HARs are an important tool for understanding the evolutionary history of the human genome and the biological processes that have shaped it. They also have important implications for human health and disease, as they may provide clues about the genetic basis of certain diseases and the mechanisms by which they evolved.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Human accelerated regions (HAR) are areas of the genome that have experienced recent and rapid evolutionary changes.\n2. HARs are often associated with positive selection, a type of natural selection favoring traits that boost survival and reproduction.\n3. The identification of HARs involves the analysis of genetic variation within the human population.\n4. One common method used to identify HARs is comparing genomes of different human populations and looking for regions with an unexpectedly high number of mutations.\n5. Another method is comparing human genomes to those of other species, like chimpanzees, targeting regions unique to humans that have undergone rapid evolutionary change.",
    "vicuna-13b_fact": [
      "Human accelerated regions (HAR) are areas of the genome that have experienced recent and rapid evolutionary changes.",
      "HARs are often associated with positive selection, a type of natural selection favoring traits that boost survival and reproduction.",
      "The identification of HARs involves the analysis of genetic variation within the human population.",
      "One common method used to identify HARs is comparing genomes of different human populations and looking for regions with an unexpectedly high number of mutations.",
      "Another method is comparing human genomes to those of other species, like chimpanzees, targeting regions unique to humans that have undergone rapid evolutionary change."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1091,
    "user_query": "In which genomic positions is the histone variant macroH2A enriched?",
    "vicuna-13b_response": "MacroH2A is a histone variant that is enriched at regulatory regions, such as promoters, enhancers, and silencers, in various cell types. It is also enriched at transcriptional start sites and in the vicinity of nucleosome-free regions. MacroH2A is involved in the regulation of gene expression, DNA repair, and chromatin structure. It is also involved in the formation of higher-order chromatin structures, such as chromatin loops and insulators. MacroH2A is essential for the proper regulation of gene expression and cellular differentiation, and its dysregulation has been linked to various diseases, including cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MacroH2A is a histone variant that is enriched at regulatory regions, such as promoters, enhancers, and silencers, in various cell types.\n2. MacroH2A is enriched at transcriptional start sites and in the vicinity of nucleosome-free regions.\n3. MacroH2A is involved in the regulation of gene expression, DNA repair, and chromatin structure. \n4. MacroH2A contributes to the formation of higher-order chromatin structures, such as chromatin loops and insulators.\n5. The dysregulation of macroH2A has been linked to various diseases, including cancer.",
    "vicuna-13b_fact": [
      "MacroH2A is a histone variant that is enriched at regulatory regions, such as promoters, enhancers, and silencers, in various cell types.",
      "MacroH2A is enriched at transcriptional start sites and in the vicinity of nucleosome-free regions.",
      "MacroH2A is involved in the regulation of gene expression, DNA repair, and chromatin structure.",
      "MacroH2A contributes to the formation of higher-order chromatin structures, such as chromatin loops and insulators.",
      "The dysregulation of macroH2A has been linked to various diseases, including cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1093,
    "user_query": "From which sequence does the Alu repeat originate from?",
    "vicuna-13b_response": "The Alu sequence is a family of SINE (short interspersed nuclear elements) that are found in the genomes of many species, including humans. These sequences are thought to have originated from the genomes of ancient retroviruses, which are viruses that use RNA as their genetic material.\nThe Alu sequence is named after the Alu family of SINEs, which were the first SINEs to be identified in the human genome. Alu sequences are typically around 300 base pairs in length and are found in introns (non-coding regions) of genes. They are thought to have arisen through the process of retrotransposition, which is the reverse of the process of transcription.\nRetrotransposition occurs when a retrovirus infects a cell and integrates its genetic material into the host genome. Over time, the retroviral genetic material can become dislodged from its original location and move to a new location in the genome. If the retroviral genetic material integrates into an intron of a gene, it can create a new Alu sequence.\nAlu sequences are thought to have played an important role in the evolution of the human genome. They have been involved in a number of genetic processes, including the creation of new genes, the disruption of existing genes, and the generation of genetic diversity. Alu sequences are also used as molecular markers, which can be used to track the evolutionary history of a species.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Alu sequence is a family of SINE (short interspersed nuclear elements) found in the genomes of many species, including humans. \n2. Alu sequences are thought to have originated from the genomes of ancient retroviruses. \n3. Alu sequences are typically around 300 base pairs in length and are found in introns (non-coding regions) of genes.\n4. Retrotransposition, a process by which a retrovirus integrates its genetic material into the host genome, is thought to create new Alu sequences. \n5. Alu sequences are used as molecular markers to track the evolutionary history of a species.",
    "vicuna-13b_fact": [
      "The Alu sequence is a family of SINE (short interspersed nuclear elements) found in the genomes of many species, including humans.",
      "Alu sequences are thought to have originated from the genomes of ancient retroviruses.",
      "Alu sequences are typically around 300 base pairs in length and are found in introns (non-coding regions) of genes.",
      "Retrotransposition, a process by which a retrovirus integrates its genetic material into the host genome, is thought to create new Alu sequences.",
      "Alu sequences are used as molecular markers to track the evolutionary history of a species."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Alu sequences are believed to have originated from a gene, not from the genomes of ancient retroviruses.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1099,
    "user_query": "Are there any HCV replication inhibitors available?",
    "vicuna-13b_response": "Yes, there are several HCV replication inhibitors available. These are drugs that target different stages of the HCV replication cycle and can be used in combination therapy to increase the effectiveness of treatment. Some examples of HCV replication inhibitors include:\n1. Direct-acting antivirals (DAAs): These drugs target specific viral enzymes involved in HCV replication, such as the NS3/4A protease, NS5B polymerase, and NS5A. Examples of DAAs include sofosbuvir, daclatasvir, and velpatasvir.\n2. Nucleotide analog inhibitors: These drugs target the viral RNA-dependent RNA polymerase and inhibit viral replication by blocking viral RNA synthesis. Examples of nucleotide analog inhibitors include ribavirin and telaprevir.\n3. NS5B polymerase inhibitors: These drugs target the viral RNA-dependent RNA polymerase and inhibit viral replication by blocking viral RNA synthesis. Examples of NS5B polymerase inhibitors include sofosbuvir and ledipasvir.\n4. Cysteine protease inhibitors: These drugs target the viral protease enzyme and inhibit viral replication by blocking viral protein synthesis. Examples of cysteine protease inhibitors include boceprevir and telaprevir.\nIt's important to note that the availability of HCV replication inhibitors may vary depending on the country and the specific treatment guidelines. Additionally, the use of these drugs in combination with other antiviral drugs and treatments may be necessary for effective treatment of HCV infection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. There are several HCV replication inhibitors available.\n2. Direct-acting antivirals, nucleotide analog inhibitors, NS5B polymerase inhibitors, and Cysteine protease inhibitors are examples of HCV replication inhibitors.\n3. Direct-acting antivirals target specific viral enzymes involved in HCV replication.\n4. Examples of direct-acting antivirals include sofosbuvir, daclatasvir, and velpatasvir.\n5. The availability of HCV replication inhibitors may vary depending on the country and the specific treatment guidelines.",
    "vicuna-13b_fact": [
      "There are several HCV replication inhibitors available.",
      "Direct-acting antivirals, nucleotide analog inhibitors, NS5B polymerase inhibitors, and Cysteine protease inhibitors are examples of HCV replication inhibitors.",
      "Direct-acting antivirals target specific viral enzymes involved in HCV replication.",
      "Examples of direct-acting antivirals include sofosbuvir, daclatasvir, and velpatasvir.",
      "The availability of HCV replication inhibitors may vary depending on the country and the specific treatment guidelines."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1108,
    "user_query": "Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?",
    "vicuna-13b_response": "PLK2 (polo-like kinase 2) is a serine/threonine kinase that has been implicated in various cellular processes, including cell division and survival. There is some evidence to suggest that PLK2 may be involved in the phosphorylation of alpha-synuclein in Parkinson's disease (PD).\nAlpha-synuclein is a protein that is abundant in the brain and is involved in the formation of Lewy bodies, which are a hallmark of PD. Phosphorylation of alpha-synuclein has been implicated in the development of PD, and there is evidence to suggest that PLK2 may play a role in this process.\nOne study published in the journal \"Nature\" in 2018 found that PLK2 was associated with the phosphorylation of alpha-synuclein in PD brain tissue. The study also found that inhibiting PLK2 reduced the levels of phosphorylated alpha-synuclein in PD brain tissue and reduced the formation of Lewy bodies.\nAnother study published in the journal \"Journal of Neurochemistry\" in 2020 found that PLK2 was involved in the phosphorylation of alpha-synuclein in PD. The study found that inhibiting PLK2 reduced the levels of phosphorylated alpha-synuclein and reduced the formation of Lewy bodies in PD models.\nOverall, while more research is needed to fully understand the role of PLK2 in alpha-synuclein phosphorylation in PD, the available evidence suggests that PLK2 may be involved in this process and may be a potential target for treating PD.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PLK2 (polo-like kinase 2) is a serine/threonine kinase that has been implicated in various cellular processes, including cell division and survival.\n2. Alpha-synuclein is a protein that is abundant in the brain and is involved in the formation of Lewy bodies.\n3. A study published in the journal \"Nature\" in 2018 found that PLK2 was associated with the phosphorylation of alpha-synuclein in Parkinson's disease brain tissue.\n4. A study published in the \"Journal of Neurochemistry\" in 2020 found that PLK2 was involved in the phosphorylation of alpha-synuclein in Parkinson's disease.\n5. Research exists indicating that inhibiting PLK2 reduced the levels of phosphorylated alpha-synuclein and reduced the formation of Lewy bodies in Parkinson's disease models.",
    "vicuna-13b_fact": [
      "PLK2 (polo-like kinase 2) is a serine/threonine kinase that has been implicated in various cellular processes, including cell division and survival.",
      "Alpha-synuclein is a protein that is abundant in the brain and is involved in the formation of Lewy bodies.",
      "A study published in the journal \"Nature\" in 2018 found that PLK2 was associated with the phosphorylation of alpha-synuclein in Parkinson's disease brain tissue.",
      "A study published in the \"Journal of Neurochemistry\" in 2020 found that PLK2 was involved in the phosphorylation of alpha-synuclein in Parkinson's disease.",
      "Research exists indicating that inhibiting PLK2 reduced the levels of phosphorylated alpha-synuclein and reduced the formation of Lewy bodies in Parkinson's disease models."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1111,
    "user_query": "Name five popular  computer  programs used to identify genes in genomic sequences",
    "vicuna-13b_response": "1. BLAST (Basic Local Alignment Search Tool)\n2. HMMER (Hidden Markov Model for Evolutionary Genomics)\n3. GENEVESTIGATOR\n4. NCBI GenBank\n5. Ensembl",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BLAST (Basic Local Alignment Search Tool) is a computer program used to identify genes in genomic sequences.\n2. HMMER (Hidden Markov Model for Evolutionary Genomics) is a computer program used to identify genes in genomic sequences.\n3. GENEVESTIGATOR is a computer program used to identify genes in genomic sequences.\n4. NCBI GenBank is a computer program used to identify genes in genomic sequences.\n5. Ensembl is a computer program used to identify genes in genomic sequences.",
    "vicuna-13b_fact": [
      "BLAST (Basic Local Alignment Search Tool) is a computer program used to identify genes in genomic sequences.",
      "HMMER (Hidden Markov Model for Evolutionary Genomics) is a computer program used to identify genes in genomic sequences.",
      "GENEVESTIGATOR is a computer program used to identify genes in genomic sequences.",
      "NCBI GenBank is a computer program used to identify genes in genomic sequences.",
      "Ensembl is a computer program used to identify genes in genomic sequences."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: HMMER (Hidden Markov Model for Evolutionary Genomics) is a computer program used to detect homologous protein or nucleotide sequences.\n3. FALSE [correction]: GENEVESTIGATOR is a high-performance search engine for functional genomics. It helps researchers to find expression patterns of genes under thousands of experimental conditions.\n4. FALSE [correction]: NCBI GenBank is not a computer program. It is a public database of all known genetic sequences, collected from researchers worldwide.\n5. FALSE [correction]: Ensembl is not a computer program, but a project that maintains and provides a database of a large number of genomes, annotations, and related information.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1112,
    "user_query": "Which are the major transcription factors regulating glycolysis in mammals?",
    "vicuna-13b_response": "Glycolysis is the initial metabolic pathway for the breakdown of glucose, which is the primary source of energy for most living organisms. In mammals, several transcription factors play important roles in regulating glycolysis. Here are some of the major transcription factors that regulate glycolysis in mammals:\n1. PPAR-alpha (peroxisome proliferator-activated receptor-alpha): PPAR-alpha is a nuclear receptor that regulates genes involved in fatty acid metabolism, glucose metabolism, and inflammation. PPAR-alpha has been shown to regulate the expression of genes involved in glycolysis, such as the glucose transporter GLUT1 and the glycolytic enzyme hexokinase.\n2. HIF-1 (hypoxia-inducible factor 1): HIF-1 is a transcription factor that is activated in response to low oxygen levels, which is a condition that can lead to increased glycolysis. HIF-1 regulates the expression of genes involved in glycolysis, such as the glucose transporter GLUT1 and the glycolytic enzyme pyruvate kinase.\n3. c-Myc: c-Myc is a transcription factor that is involved in regulating cell growth and proliferation. c-Myc has been shown to regulate the expression of genes involved in glycolysis, such as the glucose transporter GLUT1 and the glycolytic enzyme phosphoglycerate mutase.\n4. AMPK (AMP-activated protein kinase): AMPK is a protein kinase that is activated in response to low ATP levels, which can occur during exercise or other conditions of high energy demand. AMPK has been shown to regulate the expression of genes involved in glycolysis, such as the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase.\n5. SREBPs (sterol regulatory element-binding proteins): SREBPs are transcription factors that regulate the expression of genes involved in cholesterol synthesis and fatty acid",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Glycolysis is the initial metabolic pathway for the breakdown of glucose.\n2. The transcription factor PPAR-alpha regulates genes involved in fatty acid metabolism, glucose metabolism, and inflammation.\n3. The transcription factor HIF-1 is activated in response to low oxygen levels, which can lead to increased glycolysis.\n4. c-Myc is a transcription factor involved in regulating cell growth and proliferation and it regulates the expression of genes involved in glycolysis.\n5. AMPK is a protein kinase that is activated in response to low ATP levels. This protein is involved in the regulation of genes associated with glycolysis.\n6. SREBPs are transcription factors that regulate the expression of genes involved in cholesterol synthesis and fatty acid.",
    "vicuna-13b_fact": [
      "Glycolysis is the initial metabolic pathway for the breakdown of glucose.",
      "The transcription factor PPAR-alpha regulates genes involved in fatty acid metabolism, glucose metabolism, and inflammation.",
      "The transcription factor HIF-1 is activated in response to low oxygen levels, which can lead to increased glycolysis.",
      "c-Myc is a transcription factor involved in regulating cell growth and proliferation and it regulates the expression of genes involved in glycolysis.",
      "AMPK is a protein kinase that is activated in response to low ATP levels. This protein is involved in the regulation of genes associated with glycolysis.",
      "SREBPs are transcription factors that regulate the expression of genes involved in cholesterol synthesis and fatty acid."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1113,
    "user_query": "Mutations in which gene determine response to both erlotinib and gefitinib?",
    "vicuna-13b_response": "Mutations in the epidermal growth factor receptor (EGFR) gene determine response to both erlotinib and gefitinib. EGFR is a receptor tyrosine kinase that plays a role in cell growth and survival. Mutations in the EGFR gene can lead to the formation of a constitutively active receptor, which can drive cancer cell growth and survival. Erlotinib and gefitinib are small molecule inhibitors of EGFR tyrosine kinase activity, and they have been approved for the treatment of non-small cell lung cancer (NSCLC) in patients with EGFR-mutated tumors.\nErlotinib and gefitinib have different binding sites on EGFR, and they have different effects on downstream signaling pathways. Erlotinib binds to the ATP-binding site of EGFR and inhibits ATP binding, while gefitinib binds to the transition state of ATP binding and inhibits the transfer of the phosphate group from ATP to EGFR. Both drugs have been shown to be effective in treating patients with EGFR-mutated NSCLC, and they have similar response rates in this patient population.\nIt is important to note that not all patients with EGFR-mutated NSCLC will respond to erlotinib or gefitinib, and other factors such as the presence of other genetic mutations, the patient's overall health, and the specific type of EGFR mutation can affect response to these drugs. Therefore, genetic testing for EGFR mutations should be performed on tumor tissue to determine whether a patient is a candidate for treatment with erlotinib or gefitinib.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mutations in the epidermal growth factor receptor (EGFR) gene determine response to both erlotinib and gefitinib.\n2. EGFR is a receptor tyrosine kinase that plays a role in cell growth and survival.\n3. Erlotinib and gefitinib are small molecule inhibitors of EGFR tyrosine kinase activity that are used in the treatment of non-small cell lung cancer (NSCLC) in patients with EGFR-mutated tumors.\n4. Erlotinib and gefitinib have different binding sites on EGFR, and different effects on downstream signaling pathways.\n5. Not all patients with EGFR-mutated NSCLC will respond to erlotinib or gefitinib.",
    "vicuna-13b_fact": [
      "Mutations in the epidermal growth factor receptor (EGFR) gene determine response to both erlotinib and gefitinib.",
      "EGFR is a receptor tyrosine kinase that plays a role in cell growth and survival.",
      "Erlotinib and gefitinib are small molecule inhibitors of EGFR tyrosine kinase activity that are used in the treatment of non-small cell lung cancer (NSCLC) in patients with EGFR-mutated tumors.",
      "Erlotinib and gefitinib have different binding sites on EGFR, and different effects on downstream signaling pathways.",
      "Not all patients with EGFR-mutated NSCLC will respond to erlotinib or gefitinib."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Erlotinib and gefitinib bind to the same site on EGFR, the ATP-binding pocket of the tyrosine kinase domain, but may have different effects on downstream signaling pathways.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1114,
    "user_query": "Which protein complexes contain mitofilin?",
    "vicuna-13b_response": "MitoFilin is a protein complex that is found in the mitochondria of cells. It is composed of three main subunits: Mitofilin, Mitofilin-2, and Cox10. Mitofilin is a dynamic protein that plays a role in the maintenance of mitochondrial structure and function. It is involved in the regulation of mitochondrial protein synthesis, and is necessary for the proper assembly of the mitochondrial respiratory chain. Mitofilin-2 is a smaller protein that interacts with Mitofilin, and is thought to play a role in the regulation of Mitofilin activity. Cox10 is an enzyme that is involved in the biosynthesis of coenzyme Q, a molecule that is essential for the function of the mitochondrial respiratory chain.\nIn addition to these subunits, there are several other proteins that have been shown to interact with Mitofilin, including Drp1, a protein involved in mitochondrial fission, and Mitofusin, a protein that plays a role in the regulation of mitochondrial dynamics.\nOverall, Mitofilin is an important protein complex that is involved in the regulation of mitochondrial structure and function, and is necessary for the proper functioning of the mitochondrial respiratory chain.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MitoFilin is a protein complex that is found in the mitochondria of cells.\n2. MitoFilin is composed of three main subunits: Mitofilin, Mitofilin-2, and Cox10.\n3. Mitofilin is involved in the maintenance of mitochondrial structure and function and the regulation of mitochondrial protein synthesis.\n4. Mitofilin-2 is thought to play a role in the regulation of Mitofilin activity.\n5. Cox10, a subunit of Mitofilin, is an enzyme involved in the biosynthesis of coenzyme Q, essential for the function of the mitochondrial respiratory chain.",
    "vicuna-13b_fact": [
      "MitoFilin is a protein complex that is found in the mitochondria of cells.",
      "MitoFilin is composed of three main subunits: Mitofilin, Mitofilin-2, and Cox10.",
      "Mitofilin is involved in the maintenance of mitochondrial structure and function and the regulation of mitochondrial protein synthesis.",
      "Mitofilin-2 is thought to play a role in the regulation of Mitofilin activity.",
      "Cox10, a subunit of Mitofilin, is an enzyme involved in the biosynthesis of coenzyme Q, essential for the function of the mitochondrial respiratory chain."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1120,
    "user_query": "Which computational frameworks are available for predicting enhancers?",
    "vicuna-13b_response": "There are several computational frameworks available for predicting enhancers, including:\n1. Genome-wide association studies (GWAS): This approach uses genetic variation data to identify regions of the genome that are associated with a particular trait or disease. Enhancers in these regions may be potential targets for therapeutic intervention.\n2. Chromatin immunoprecipitation (ChIP) sequencing: This approach uses antibodies to specifically bind to proteins of interest, such as transcription factors, and then uses sequencing technologies to identify the associated DNA fragments. Enhancers in the bound regions may be potential targets for therapeutic intervention.\n3. Machine learning approaches: This approach uses machine learning algorithms to identify enhancers based on patterns in large-scale genomic data, such as gene expression data or DNA sequence data.\n4. Genome-wide transcriptional profiling: This approach uses technologies such as RNA sequencing to identify which genes are actively transcribed in a particular cell type or tissue. Enhancers that are associated with the active transcription of a particular gene may be potential targets for therapeutic intervention.\n5. Genome-wide histone modification maps: This approach uses technologies such as chromatin immunoprecipitation sequencing (ChIP-seq) to identify the locations of specific histone modifications, which can be used to infer the activity of nearby enhancers.\nThese are some of the most commonly used computational frameworks for predicting enhancers, and the choice of framework will depend on the specific question being asked and the available data.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Genome-wide association studies (GWAS) is a computational framework for predicting enhancers.\n2. Chromatin immunoprecipitation (ChIP) sequencing is another method used for enhancer prediction.\n3. Machine learning approaches can be used to identify enhancers.\n4. Genome-wide transcriptional profiling is a method employed for predicting enhancers.\n5. Genome-wide histone modification maps are used to predict enhancers.",
    "vicuna-13b_fact": [
      "Genome-wide association studies (GWAS) is a computational framework for predicting enhancers.",
      "Chromatin immunoprecipitation (ChIP) sequencing is another method used for enhancer prediction.",
      "Machine learning approaches can be used to identify enhancers.",
      "Genome-wide transcriptional profiling is a method employed for predicting enhancers.",
      "Genome-wide histone modification maps are used to predict enhancers."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Genome-wide association studies (GWAS) are observational studies of a genome-wide set of genetic variants in different individuals to see if any variant is associated with a trait, not specifically used for predicting enhancers.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Genome-wide transcriptional profiling is a method employed for studying gene expression, not predicting enhancers.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1123,
    "user_query": "What is GRO-seq?",
    "vicuna-13b_response": "GRO-seq (Gene Regulatory Oscillation-seq) is a high-throughput sequencing-based technique used to study the dynamics of gene expression in living cells. It is a single-cell, single-molecule approach that allows for the analysis of gene expression at the transcriptional and post-transcriptional levels, providing insight into the regulatory mechanisms that control gene expression in cells.\nThe GRO-seq protocol involves the isolation of individual cells, the lysis of the cells, and the sequencing of the resulting mRNA and long non-coding RNA (lncRNA) molecules. The sequencing data is then analyzed to identify the temporal dynamics of gene expression, including the detection of gene expression oscillations, which can provide insight into the underlying regulatory mechanisms controlling gene expression in cells.\nGRO-seq has been used in a variety of applications, including the study of cell cycle regulation, the analysis of gene expression in different cell types, and the investigation of the regulatory mechanisms controlling gene expression in response to environmental stimuli.\nIn summary, GRO-seq is a powerful technique that allows for the analysis of gene expression dynamics in individual cells, providing valuable insights into the regulatory mechanisms controlling gene expression in cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GRO-seq is a high-throughput sequencing-based technique used to study the dynamics of gene expression in living cells.\n2. GRO-seq is a single-cell, single-molecule approach that allows for the analysis of gene expression at the transcriptional and post-transcriptional levels.\n3. The GRO-seq protocol involves the isolation of individual cells, cell lysis, and the sequencing of mRNA and long non-coding RNA.\n4. GRO-seq has been used to study cell cycle regulation, gene expression in different cell types, and the regulatory mechanisms controlling gene expression in response to environmental stimuli.\n5. With GRO-seq, the temporal dynamics of gene expression, including gene expression oscillations can be identified.",
    "vicuna-13b_fact": [
      "GRO-seq is a high-throughput sequencing-based technique used to study the dynamics of gene expression in living cells.",
      "GRO-seq is a single-cell, single-molecule approach that allows for the analysis of gene expression at the transcriptional and post-transcriptional levels.",
      "The GRO-seq protocol involves the isolation of individual cells, cell lysis, and the sequencing of mRNA and long non-coding RNA.",
      "GRO-seq has been used to study cell cycle regulation, gene expression in different cell types, and the regulatory mechanisms controlling gene expression in response to environmental stimuli.",
      "With GRO-seq, the temporal dynamics of gene expression, including gene expression oscillations can be identified."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: GRO-seq is not a single-cell, single-molecule approach. It does allow the analysis of gene expression at the transcriptional level, but it is typically performed on a population of cells.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1134,
    "user_query": "Are Drosophila ultraconserved elements candidate ncRNAs?",
    "vicuna-13b_response": "Drosophila ultraconserved elements (UCEs) are genomic regions that are highly conserved across different species of Drosophila, and are thought to play important roles in the regulation of gene expression. Some UCEs have been shown to act as candidate non-coding RNAs (ncRNAs), which are RNA molecules that do not code for proteins but still play important roles in regulating gene expression.\nOne example of a UCE that acts as an ncRNA is the UCE-214, which has been shown to act as a microRNA (miRNA) in Drosophila. miRNAs are a class of ncRNAs that bind to messenger RNAs (mRNAs) and inhibit their translation into proteins. UCE-214 has been shown to regulate the expression of the gene encoding the protein twist, which is involved in the development of the fly's wing.\nAnother example of a UCE that acts as an ncRNA is the UCE-101, which has been shown to act as a long non-coding RNA (lncRNA). LncRNAs are RNA molecules that are longer than 200 nucleotides and do not code for proteins, but still play important roles in regulating gene expression. UCE-101 has been shown to regulate the expression of the gene encoding the protein hunchback, which is involved in the development of the fly's embryo.\nOverall, while not all UCEs are ncRNAs, some UCEs have been shown to act as ncRNAs, and are therefore considered to be candidate ncRNAs. Further research is needed to fully understand the functions of UCEs and their roles in regulating gene expression in Drosophila.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Drosophila ultraconserved elements (UCEs) are genomic regions that are conserved across different species of Drosophila.\n2. Some UCEs act as non-coding RNAs (ncRNAs).\n3. UCE-214, one of the UCEs, acts as a microRNA (miRNA) in Drosophila and regulates the expression of the gene encoding the protein twist.\n4. Another UCE, UCE-101, acts as a long non-coding RNA (lncRNA) and regulates the expression of the gene encoding the protein hunchback.\n5. Further research is needed to fully understand the functions of UCEs and their roles in regulating gene expression in Drosophila.",
    "vicuna-13b_fact": [
      "Drosophila ultraconserved elements (UCEs) are genomic regions that are conserved across different species of Drosophila.",
      "Some UCEs act as non-coding RNAs (ncRNAs).",
      "UCE-214, one of the UCEs, acts as a microRNA (miRNA) in Drosophila and regulates the expression of the gene encoding the protein twist.",
      "Another UCE, UCE-101, acts as a long non-coding RNA (lncRNA) and regulates the expression of the gene encoding the protein hunchback.",
      "Further research is needed to fully understand the functions of UCEs and their roles in regulating gene expression in Drosophila."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1142,
    "user_query": "How are thyroid hormones involved in the development of diabetic cardiomyopathy?",
    "vicuna-13b_response": "Thyroid hormones play a crucial role in the development of diabetic cardiomyopathy, a type of heart disease that occurs in individuals with diabetes. Diabetic cardiomyopathy is characterized by impaired contractility of the heart muscle, which can lead to heart failure and other complications.\nThyroid hormones are involved in the development of diabetic cardiomyopathy in several ways. Firstly, thyroid hormones play a crucial role in the regulation of metabolism, which is closely linked to the development of diabetic cardiomyopathy. Individuals with diabetes have altered metabolic function, which can lead to an imbalance in thyroid hormone levels. This imbalance can contribute to the development of diabetic cardiomyopathy.\nSecondly, thyroid hormones play a crucial role in the regulation of the contractility of heart muscle. Thyroid hormones help to regulate the expression of genes that are involved in the contraction of heart muscle. In individuals with diabetes, an imbalance in thyroid hormone levels can lead to impaired contractility of the heart muscle, which can contribute to the development of diabetic cardiomyopathy.\nThirdly, thyroid hormones play a crucial role in the regulation of inflammation, which is closely linked to the development of diabetic cardiomyopathy. Individuals with diabetes have increased levels of inflammation, which can lead to damage to the heart muscle and contribute to the development of diabetic cardiomyopathy. Thyroid hormones have anti-inflammatory effects, which can help to protect the heart muscle from damage and contribute to the prevention of diabetic cardiomyopathy.\nIn conclusion, thyroid hormones play a crucial role in the development of diabetic cardiomyopathy. They are involved in the regulation of metabolism, the contraction of heart muscle, and the regulation of inflammation. An imbalance in thyroid hormone levels can contribute to the development of diabetic cardiomyopathy, and maintaining optimal",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Thyroid hormones play a crucial role in the development of diabetic cardiomyopathy.\n2. Diabetic cardiomyopathy is characterized by impaired contractility of the heart muscle.\n3. Altered metabolic function in individuals with diabetes can lead to an imbalance in thyroid hormone levels.\n4. Thyroid hormones regulate the expression of genes involved in heart muscle contraction.\n5. Thyroid hormones have anti-inflammatory effects, which can protect the heart muscle from damage and contribute to the prevention of diabetic cardiomyopathy.",
    "vicuna-13b_fact": [
      "Thyroid hormones play a crucial role in the development of diabetic cardiomyopathy.",
      "Diabetic cardiomyopathy is characterized by impaired contractility of the heart muscle.",
      "Altered metabolic function in individuals with diabetes can lead to an imbalance in thyroid hormone levels.",
      "Thyroid hormones regulate the expression of genes involved in heart muscle contraction.",
      "Thyroid hormones have anti-inflammatory effects, which can protect the heart muscle from damage and contribute to the prevention of diabetic cardiomyopathy."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "vicuna-13b_response": "Angiogenin is a protein that plays a role in the process of angiogenesis, which is the formation of new blood vessels. The subcellular localization of angiogenin is not well understood, but it is thought to be involved in the regulation of various cellular processes, including cell division and differentiation. Some studies have suggested that angiogenin may be localized in the cytoplasm and the nucleus of cells, and that it may be involved in the regulation of gene expression. However, further research is needed to fully understand the subcellular localization of angiogenin and its role in cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Angiogenin is a protein.\n2. This protein plays a role in the process of angiogenesis.\n3. Angiogenesis is the formation of new blood vessels.\n4. Some studies suggest that angiogenin may be localized in the cytoplasm and the nucleus of cells.\n5. It is thought that angiogenin may be involved in the regulation of gene expression.",
    "vicuna-13b_fact": [
      "Angiogenin is a protein.",
      "This protein plays a role in the process of angiogenesis.",
      "Angiogenesis is the formation of new blood vessels.",
      "Some studies suggest that angiogenin may be localized in the cytoplasm and the nucleus of cells.",
      "It is thought that angiogenin may be involved in the regulation of gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1151,
    "user_query": "Which bone protein is used in archaelogy for dating and species identification?",
    "vicuna-13b_response": "In archaeology, a common protein used for dating and species identification is collagen. Collagen is a protein found in the bones, skin, and connective tissue of animals. It is a very stable protein and can survive for thousands of years in fossilized bones. By analyzing the collagen in bones, scientists can determine the age of the bone and the species of animal it came from. This information can be used to help piece together the evolutionary history of a particular species, as well as to understand the environmental conditions and diet of ancient humans and animals.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The protein collagen is used in archaeology for dating and species identification.\n2. Collagen is a protein found in the bones, skin, and connective tissue of animals.\n3. Collagen is a stable protein and can survive for thousands of years in fossilized bones.\n4. By analyzing the collagen in bones, scientists can determine the age of the bone and the species of animal it came from.\n5. The information obtained from collagen analysis can be used to piece together the evolutionary history of a particular species, and to understand the environmental conditions and diet of ancient humans and animals.",
    "vicuna-13b_fact": [
      "The protein collagen is used in archaeology for dating and species identification.",
      "Collagen is a protein found in the bones, skin, and connective tissue of animals.",
      "Collagen is a stable protein and can survive for thousands of years in fossilized bones.",
      "By analyzing the collagen in bones, scientists can determine the age of the bone and the species of animal it came from.",
      "The information obtained from collagen analysis can be used to piece together the evolutionary history of a particular species, and to understand the environmental conditions and diet of ancient humans and animals."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1156,
    "user_query": "Is armodafinil used for treatment of insomnia?",
    "vicuna-13b_response": "Armodafinil is a medication that is primarily used to treat conditions such as narcolepsy, sleep apnea, and shift work sleep disorder. While it is not specifically approved by the FDA for the treatment of insomnia, it has been shown to improve sleepiness in people with these conditions, which can in turn help improve sleep quality. However, it is important to note that armodafinil is not a first-line treatment for insomnia and should only be used under the guidance of a healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Armodafinil is a medication used primarily to treat conditions such as narcolepsy, sleep apnea, and shift work sleep disorder.\n2. Armodafinil is not specifically approved by the FDA for the treatment of insomnia.\n3. Armodafinil has been shown to improve sleepiness in people with conditions such as narcolepsy, sleep apnea, and shift work sleep disorder.\n4. Armodafinil is not a first-line treatment for insomnia.\n5. Armodafinil should only be used under the guidance of a healthcare professional.",
    "vicuna-13b_fact": [
      "Armodafinil is a medication used primarily to treat conditions such as narcolepsy, sleep apnea, and shift work sleep disorder.",
      "Armodafinil is not specifically approved by the FDA for the treatment of insomnia.",
      "Armodafinil has been shown to improve sleepiness in people with conditions such as narcolepsy, sleep apnea, and shift work sleep disorder.",
      "Armodafinil is not a first-line treatment for insomnia.",
      "Armodafinil should only be used under the guidance of a healthcare professional."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1159,
    "user_query": "What is Trypan blue used for?",
    "vicuna-13b_response": "Trypan blue is a dye that is commonly used in medical research and in certain medical procedures. It is a blue or green dye that is used to stain cells and tissues in order to make them more visible under a microscope.\nIn medical research, trypan blue is often used to stain and visualize cells in culture dishes or in animal models. It can be used to label specific types of cells, such as cancer cells or immune cells, and can help researchers to better understand how these cells function and behave.\nIn certain medical procedures, trypan blue is used as a dye to help visualize certain tissues or structures in the body. For example, during surgery on the brain or spinal cord, trypan blue may be used to help visualize the nerves and blood vessels in the area being operated on.\nTrypan blue is also sometimes used as a treatment for certain conditions, such as hemorrhagic shock, which is a condition characterized by excessive bleeding and low blood pressure. In this case, trypan blue is used to help slow down the bleeding and improve blood pressure.\nOverall, trypan blue is a versatile and useful tool in medical research and in certain medical procedures. It is important to note that trypan blue should only be used by trained professionals in controlled settings, as it can have adverse effects if used improperly.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Trypan blue is a dye commonly used in medical research and certain medical procedures.\n2. The dye is used to stain cells and tissues to make them more visible under a microscope.\n3. Trypan blue can be used to label specific types of cells, such as cancer cells or immune cells.\n4. In some medical procedures, trypan blue is used to help visualize tissues or structures in the body.\n5. Trypan blue can be used as a treatment for certain conditions, such as hemorrhagic shock.",
    "vicuna-13b_fact": [
      "Trypan blue is a dye commonly used in medical research and certain medical procedures.",
      "The dye is used to stain cells and tissues to make them more visible under a microscope.",
      "Trypan blue can be used to label specific types of cells, such as cancer cells or immune cells.",
      "In some medical procedures, trypan blue is used to help visualize tissues or structures in the body.",
      "Trypan blue can be used as a treatment for certain conditions, such as hemorrhagic shock."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Trypan blue is not used to label specific types of cells like cancer cells or immune cells; it is used to distinguish dead cells from living cells as it does not permeate through the membranes of viable cells.\n4. TRUE\n5. FALSE [correction]: Trypan blue is not used as a treatment for conditions like hemorrhagic shock. It is primarily used as a staining agent in biomedical research.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "vicuna-13b_response": "Ranolazine is a medication that is used to treat angina (chest pain) and heart rhythm disorders. It works by blocking the late sodium channels in the heart, which helps to reduce the amount of oxygen needed by the heart muscle during exercise.\nRanolazine has also been shown to affect kinase signaling activation in the heart. Kinases are enzymes that play a role in cell signaling and are involved in a variety of cellular processes, including the regulation of cell growth and division.\nRanolazine has been shown to inhibit the activation of certain kinases in the heart, including the Akt and extracellular signal-regulated kinase (ERK) pathways. These kinases are involved in the regulation of cell survival and proliferation, and their inhibition has been shown to have a negative impact on cardiac function.\nIn addition, ranolazine has been shown to inhibit the activation of the protein kinase C (PKC) pathway in the heart. The PKC pathway is involved in the regulation of cardiac contractility and is thought to play a role in the development of heart failure.\nOverall, the effects of ranolazine on kinase signaling activation in the heart are complex and depend on the specific kinase pathway being considered. While ranolazine has been shown to have a negative impact on cardiac function in some cases, it is still an important treatment option for certain heart conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ranolazine is a medication used to treat angina and heart rhythm disorders.\n2. Ranolazine works by blocking the late sodium channels in the heart.\n3. Ranolazine has been shown to inhibit the activation of certain kinases in the heart, including the Akt and extracellular signal-regulated kinase (ERK) pathways. \n4. Ranolazine has been shown to inhibit the activation of the protein kinase C (PKC) pathway in the heart. \n5. The effects of ranolazine on kinase signaling activation in the heart are complex and depend on the specific kinase pathway being considered.",
    "vicuna-13b_fact": [
      "Ranolazine is a medication used to treat angina and heart rhythm disorders.",
      "Ranolazine works by blocking the late sodium channels in the heart.",
      "Ranolazine has been shown to inhibit the activation of certain kinases in the heart, including the Akt and extracellular signal-regulated kinase (ERK) pathways.",
      "Ranolazine has been shown to inhibit the activation of the protein kinase C (PKC) pathway in the heart.",
      "The effects of ranolazine on kinase signaling activation in the heart are complex and depend on the specific kinase pathway being considered."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1164,
    "user_query": "Pridopidine has been tested for treatment of which disorder?",
    "vicuna-13b_response": "Pridopidine is a medication that has been studied for the treatment of various neurological disorders, including Huntington's disease, a genetic disorder that affects movement, cognition, and behavior. It has also been studied for the treatment of Parkinson's disease, a progressive neurological disorder that affects movement. Pridopidine has been shown to have potential in reducing the symptoms of these disorders, but it is not currently approved for use in the treatment of these conditions. Further research and clinical trials are needed to determine the safety and efficacy of pridopidine for the treatment of these disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pridopidine is a medication that has been studied for the treatment of various neurological disorders.\n2. Huntington's disease is a genetic disorder that affects movement, cognition, and behavior.\n3. Parkinson's disease is a progressive neurological disorder that affects movement.\n4. Pridopidine isn't currently approved for use in the treatment of Huntington's or Parkinson's disease.\n5. Further research and clinical trials are needed to determine the safety and efficacy of pridopidine for the treatment of these disorders.",
    "vicuna-13b_fact": [
      "Pridopidine is a medication that has been studied for the treatment of various neurological disorders.",
      "Huntington's disease is a genetic disorder that affects movement, cognition, and behavior.",
      "Parkinson's disease is a progressive neurological disorder that affects movement.",
      "Pridopidine isn't currently approved for use in the treatment of Huntington's or Parkinson's disease.",
      "Further research and clinical trials are needed to determine the safety and efficacy of pridopidine for the treatment of these disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1166,
    "user_query": "Are CpG islands located close to housekeeping genes?",
    "vicuna-13b_response": "CpG islands are regions of DNA that contain a high density of cytosine-guanine (CpG) pairs, and are often located near the promoter regions of genes. While it is true that CpG islands are often found near the promoter regions of genes, it is not necessarily the case that they are located close to housekeeping genes.\nHousekeeping genes are a class of genes that are essential for the basic functions of a cell, and are therefore always active. These genes are typically located in regions of the genome that are relatively free of CpG islands, and are often found in the introns of active genes.\nCpG islands, on the other hand, are often found in the promoter regions of genes that are involved in specific cellular processes or tissue-specific functions. These genes may be expressed only in certain cell types or under certain conditions, and their expression is regulated by the presence or absence of CpG islands in their promoter regions.\nTherefore, while it is possible for CpG islands to be located near housekeeping genes, it is not a requirement, and the two types of genes are typically found in different regions of the genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CpG islands are regions of DNA that contain a high density of cytosine-guanine pairs.\n2. CpG islands are often located near the promoter regions of genes.\n3. Housekeeping genes are a class of genes that are essential for the basic functions of a cell, and are therefore always active.\n4. Housekeeping genes are typically located in regions of the genome that are relatively free of CpG islands. \n5. CpG islands are often found in the promoter regions of genes that are involved in specific cellular processes or tissue-specific functions.",
    "vicuna-13b_fact": [
      "CpG islands are regions of DNA that contain a high density of cytosine-guanine pairs.",
      "CpG islands are often located near the promoter regions of genes.",
      "Housekeeping genes are a class of genes that are essential for the basic functions of a cell, and are therefore always active.",
      "Housekeeping genes are typically located in regions of the genome that are relatively free of CpG islands.",
      "CpG islands are often found in the promoter regions of genes that are involved in specific cellular processes or tissue-specific functions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Housekeeping genes are often associated with CpG islands.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1168,
    "user_query": "Which is the target of bortezomib used in cancer therapy?",
    "vicuna-13b_response": "Bortezomib is a proteasome inhibitor used in cancer therapy. The proteasome is a large protein complex that is responsible for breaking down and recycling proteins in cells. In cancer cells, the proteasome helps to degrade proteins that are important for cell survival, such as tumor suppressor proteins. By inhibiting the proteasome, bortezomib can cause the accumulation of these proteins, leading to cell death and inhibition of cancer cell growth. Bortezomib is approved for the treatment of multiple myeloma and mantle cell lymphoma.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Bortezomib is a proteasome inhibitor used in cancer therapy.\n2. The proteasome is a large protein complex that degrades and recycles proteins in cells.\n3. In cancer cells, the proteasome helps to degrade proteins important for cell survival, such as tumor suppressor proteins.\n4. Inhibiting the proteasome can lead to cell death and inhibition of cancer cell growth.\n5. Bortezomib is approved for the treatment of multiple myeloma and mantle cell lymphoma.",
    "vicuna-13b_fact": [
      "Bortezomib is a proteasome inhibitor used in cancer therapy.",
      "The proteasome is a large protein complex that degrades and recycles proteins in cells.",
      "In cancer cells, the proteasome helps to degrade proteins important for cell survival, such as tumor suppressor proteins.",
      "Inhibiting the proteasome can lead to cell death and inhibition of cancer cell growth.",
      "Bortezomib is approved for the treatment of multiple myeloma and mantle cell lymphoma."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: In cancer cells, the proteasome degrades proteins that regulate cell cycle and apoptosis, which when inhibited could lead to a build-up of these regulatory proteins and potentially trigger cell death.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1178,
    "user_query": "Idarucizumab is an antidote of which drug?",
    "vicuna-13b_response": "Idarucizumab is an antidote for dabigatran, a direct oral anticoagulant (DOAC) used to prevent blood clots. It is specifically indicated for the reversal of the anticoagulant effect of dabigatran in patients with bleeding or at risk of bleeding. Idarucizumab works by binding to dabigatran and neutralizing its anticoagulant effect, allowing the body to naturally restore clotting function. It is given as an intravenous (IV) infusion and the dosage and administration should be closely monitored by a healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Idarucizumab is an antidote for dabigatran.\n2. Dabigatran is a direct oral anticoagulant used to prevent blood clots.\n3. Idarucizumab is indicated for the reversal of dabigatran's anticoagulant effects in patients with bleeding or at risk of bleeding.\n4. Idarucizumab neutralizes the anticoagulant effect of dabigatran by binding to it.\n5. Idarucizumab is administered as an intravenous infusion.",
    "vicuna-13b_fact": [
      "Idarucizumab is an antidote for dabigatran.",
      "Dabigatran is a direct oral anticoagulant used to prevent blood clots.",
      "Idarucizumab is indicated for the reversal of dabigatran's anticoagulant effects in patients with bleeding or at risk of bleeding.",
      "Idarucizumab neutralizes the anticoagulant effect of dabigatran by binding to it.",
      "Idarucizumab is administered as an intravenous infusion."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1179,
    "user_query": "What are the main clinical characteristics of Pendred syndrome?",
    "vicuna-13b_response": "Pendred syndrome is a rare genetic disorder that affects the development of the thyroid gland and the inner ear. It is characterized by the following main clinical characteristics:\n1. Congenital hypothyroidism: Pendred syndrome is characterized by congenital hypothyroidism, which is a condition in which the thyroid gland does not produce enough thyroid hormones. This can lead to a range of symptoms, including poor growth, developmental delays, and an enlarged tongue.\n2. Sensorineural hearing loss: Pendred syndrome is also associated with sensorineural hearing loss, which is a type of hearing loss that occurs when there is damage to the inner ear or the nerve pathways that transmit sound to the brain. This can lead to difficulty hearing, especially in noisy environments.\n3. Goiter: Pendred syndrome can also cause a goiter, which is an enlarged thyroid gland. The goiter may be noticeable as a swelling in the neck.\n4. Other features: Some people with Pendred syndrome may also have other features, such as a cleft palate, a low-pitched voice, or a history of thyroid cancer.\nIt is important to note that not all people with Pendred syndrome will have all of these symptoms, and the severity of the symptoms can vary from person to person. If you have any concerns about Pendred syndrome or think you may be experiencing symptoms, it is important to speak with a healthcare provider for a proper diagnosis and treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pendred syndrome is a rare genetic disorder that affects the development of the thyroid gland and the inner ear.\n2. Pendred syndrome is characterized by congenital hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormones.\n3. Pendred syndrome is associated with sensorineural hearing loss, a type of hearing loss that occurs when there is damage to the inner ear or the nerve pathways.\n4. Pendred syndrome can cause a goiter, which is an enlarged thyroid gland.\n5. Some people with Pendred syndrome may have other features such as a cleft palate, a low-pitched voice, or a history of thyroid cancer.",
    "vicuna-13b_fact": [
      "Pendred syndrome is a rare genetic disorder that affects the development of the thyroid gland and the inner ear.",
      "Pendred syndrome is characterized by congenital hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormones.",
      "Pendred syndrome is associated with sensorineural hearing loss, a type of hearing loss that occurs when there is damage to the inner ear or the nerve pathways.",
      "Pendred syndrome can cause a goiter, which is an enlarged thyroid gland.",
      "Some people with Pendred syndrome may have other features such as a cleft palate, a low-pitched voice, or a history of thyroid cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Pendred syndrome is characterized by deafness and goiter due to thyroid dysfunction, not necessarily congenital hypothyroidism. \n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1181,
    "user_query": "What is a popular mesaure of gene expression in RNA-seq experiments?",
    "vicuna-13b_response": "One popular measure of gene expression in RNA-seq experiments is the count of reads that map to a gene's reference sequence. This is often referred to as the \"read count\" or \"mapping quality score\" and is a way to quantify the amount of RNA from a particular gene that was sequenced in the experiment. Other measures of gene expression, such as the ratio of exon-exon junction reads (exon-exon junctions are the regions where exons are joined together to form a mature mRNA) or the number of splice isoforms (different forms of a gene's mRNA that result from alternative splicing) can also be used to gain insights into gene expression in RNA-seq experiments.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A popular measure of gene expression in RNA-seq experiments is the count of reads that map to a gene's reference sequence.\n2. This measure is often referred to as the \"read count\" or \"mapping quality score\".\n3. The read count quantifies the amount of RNA from a specific gene that was sequenced in the experiment.\n4. Other measures of gene expression include the ratio of exon-exon junction reads.\n5. Another measure of gene expression is the number of splice isoforms, which result from alternative splicing.",
    "vicuna-13b_fact": [
      "A popular measure of gene expression in RNA-seq experiments is the count of reads that map to a gene's reference sequence.",
      "This measure is often referred to as the \"read count\" or \"mapping quality score\".",
      "The read count quantifies the amount of RNA from a specific gene that was sequenced in the experiment.",
      "Other measures of gene expression include the ratio of exon-exon junction reads.",
      "Another measure of gene expression is the number of splice isoforms, which result from alternative splicing."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: This measure is often referred to as the \"read count\", but not \"mapping quality score\". The \"mapping quality score\" is a value which represents the statistical likelihood that a read is mapped correctly.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1182,
    "user_query": "Is macroautophagy a selective degradation process?",
    "vicuna-13b_response": "Yes, macroautophagy is a selective degradation process. It is a mechanism by which cells break down and recycle their own damaged or unnecessary organelles and proteins. Macroautophagy is also known as autophagy, which comes from the Greek words \"auto\" meaning \"self\" and \"phagy\" meaning \"eating\".\nDuring autophagy, the cell's lysosomes, which are responsible for breaking down and recycling cellular debris, engulf and digest the damaged or unnecessary organelles and proteins. The engulfed material is then broken down into smaller pieces, which can then be recycled and used to build new cellular components.\nThe process of autophagy is regulated by several factors, including the level of nutrients in the cell, the cell's energy levels, and the presence of stress signals. When the cell is under stress, such as when it is starving or experiencing oxidative stress, the process of autophagy is activated in order to recycle and reuse the damaged or unnecessary cellular components.\nAutophagy is a selective process, as it targets specific organelles or proteins for degradation. This is achieved through the use of specialized receptors on the lysosomes that recognize and bind to the targeted material. Once bound, the lysosomes fuse with the targeted organelle or protein, and the degradation process begins.\nIn conclusion, macroautophagy is a selective degradation process that plays a crucial role in maintaining cellular homeostasis by recycling and reusing damaged or unnecessary cellular components.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Macroautophagy is a selective degradation process.\n2. Macroatuophagy is a mechanism by which cells break down and recycle their own damaged or unnecessary organelles and proteins.\n3. The process of autophagy is regulated by several factors, including the level of nutrients in the cell, the cell's energy levels, and the presence of stress signals.\n4. Autophagy targets specific organelles or proteins for degradation through the use of specialized receptors on the lysosomes.\n5. Macroatuophagy is a crucial process in maintaining cellular homeostasis by recycling and reusing damaged or unnecessary cellular components.",
    "vicuna-13b_fact": [
      "Macroautophagy is a selective degradation process.",
      "Macroatuophagy is a mechanism by which cells break down and recycle their own damaged or unnecessary organelles and proteins.",
      "The process of autophagy is regulated by several factors, including the level of nutrients in the cell, the cell's energy levels, and the presence of stress signals.",
      "Autophagy targets specific organelles or proteins for degradation through the use of specialized receptors on the lysosomes.",
      "Macroatuophagy is a crucial process in maintaining cellular homeostasis by recycling and reusing damaged or unnecessary cellular components."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Macroautophagy is a non-selective degradation process.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Autophagy targets specific organelles or proteins for degradation through the use of specialized receptors on the autophagosomes, not the lysosomes.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1188,
    "user_query": "Which protein is affected by dusp8 activation?",
    "vicuna-13b_response": "DUSP8 (also known as CAMKK2) is a protein that is activated by the immune system in response to infections. When activated, DUSP8 dephosphorylates and inactivates the transcription factor NF-κB, which is a key regulator of the immune response.\nNF-κB is activated in response to various stimuli, such as the presence of pathogens or the activation of immune cells. Once activated, NF-κB translocates to the nucleus and activates the transcription of genes involved in the immune response, such as cytokines and chemokines.\nDUSP8 is a negative regulator of the NF-κB signaling pathway, and its activation by the immune system helps to limit the duration and intensity of the immune response. DUSP8 has been shown to play a role in the regulation of several diseases, including cancer, inflammation, and autoimmune disorders.\nIn summary, DUSP8 activation affects the NF-κB signaling pathway, which is a key regulator of the immune response. DUSP8 is activated in response to infections and helps to limit the duration and intensity of the immune response.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. DUSP8, also known as CAMKK2, is a protein that is activated by the immune system in response to infections.\n2. When activated, DUSP8 dephosphorylates and inactivates the transcription factor NF-κB.\n3. NF-κB is activated in response to stimuli like the presence of pathogens or the activation of immune cells.\n4. DUSP8 is a negative regulator of the NF-κB signaling pathway.\n5. DUSP8 plays a role in the regulation of several diseases, including cancer, inflammation, and autoimmune disorders.",
    "vicuna-13b_fact": [
      "DUSP8, also known as CAMKK2, is a protein that is activated by the immune system in response to infections.",
      "When activated, DUSP8 dephosphorylates and inactivates the transcription factor NF-κB.",
      "NF-κB is activated in response to stimuli like the presence of pathogens or the activation of immune cells.",
      "DUSP8 is a negative regulator of the NF-κB signaling pathway.",
      "DUSP8 plays a role in the regulation of several diseases, including cancer, inflammation, and autoimmune disorders."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: DUSP8, also known as Dual Specificity Phosphatase 8, is not known as CAMKK2. They are different proteins.\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1191,
    "user_query": "Which drugs are utilized to treat eosinophilic esophagitis?",
    "vicuna-13b_response": "Eosinophilic esophagitis (EoE) is a chronic immune system disease that affects the esophagus, the tube that connects the mouth to the stomach. It is characterized by the buildup of eosinophils, a type of white blood cell, in the esophagus, which can lead to symptoms such as difficulty swallowing, chest pain, and heartburn.\nThe treatment of EoE typically involves the use of medications that aim to reduce the number of eosinophils in the esophagus, as well as to relieve symptoms. The following are some of the drugs that are commonly used to treat EoE:\n1. Elotuzumab: This is a monoclonal antibody that targets the IL-5 receptor alpha chain, which is involved in the activation and survival of eosinophils. Elotuzumab is given as an intravenous infusion and has been shown to reduce the number of eosinophils in the esophagus and improve symptoms in patients with EoE.\n2. Montelukast: This is a leukotriene receptor antagonist that works by blocking the action of leukotrienes, which are chemicals that contribute to inflammation and eosinophil activation. Montelukast is taken orally and has been shown to reduce symptoms and improve esophageal eosinophilia in patients with EoE.\n3. Prednisone: This is a corticosteroid that is commonly used to reduce inflammation and suppress the immune system. Prednisone is given orally and has been shown to improve symptoms and reduce esophageal eosinophilia in patients with EoE.\n4. Omeprazole: This is a proton pump inhibitor that is commonly used to reduce acid production in the stomach. Omeprazole is given orally and has been shown to reduce symptoms such as heartburn and regurgitation in patients with EoE.\nIt is important to note that the choice of medication and the treatment plan for EoE will depend on the severity of the disease and the specific symptoms experienced by the patient. It is important to work with",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Eosinophilic esophagitis (EoE) is a chronic immune system disease that affects the esophagus.\n2. EoE is characterized by the buildup of eosinophils, a type of white blood cell, in the esophagus.\n3. Elotuzumab is a monoclonal antibody used to treat EoE, which works by targeting the IL-5 receptor alpha chain.\n4. Montelukast, a leukotriene receptor antagonist, is used to treat EoE by blocking the action of leukotrienes.\n5. Prednisone, a corticosteroid, and Omeprazole, a proton pump inhibitor, are commonly used drugs in the treatment of EoE.",
    "vicuna-13b_fact": [
      "Eosinophilic esophagitis (EoE) is a chronic immune system disease that affects the esophagus.",
      "EoE is characterized by the buildup of eosinophils, a type of white blood cell, in the esophagus.",
      "Elotuzumab is a monoclonal antibody used to treat EoE, which works by targeting the IL-5 receptor alpha chain.",
      "Montelukast, a leukotriene receptor antagonist, is used to treat EoE by blocking the action of leukotrienes.",
      "Prednisone, a corticosteroid, and Omeprazole, a proton pump inhibitor, are commonly used drugs in the treatment of EoE."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Elotuzumab is a monoclonal antibody used to treat multiple myeloma by targeting the SLAMF7 protein, not EoE.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1194,
    "user_query": "What is the Her2 status in Li-Fraumeni syndrome?",
    "vicuna-13b_response": "Li-Fraumeni syndrome (LFS) is a rare inherited cancer predisposition syndrome that is characterized by an increased risk of developing a variety of different cancers, including breast cancer, ovarian cancer, and sarcomas. The condition is caused by mutations in the TP53 gene, which is responsible for regulating the repair of DNA damage and maintaining genomic stability.\nThe Her2 status in Li-Fraumeni syndrome refers to the expression of the HER2/neu gene, which is a gene that codes for a receptor tyrosine kinase that is involved in cell growth and differentiation. HER2/neu is often amplified or overexpressed in certain types of cancer, including breast cancer, and is associated with a poor prognosis and increased risk of recurrence.\nIn Li-Fraumeni syndrome, the risk of developing breast cancer is increased, and it is known that Her2/neu amplification is more frequent in LFS-associated breast cancer than in sporadic breast cancer. Approximately 20-30% of LFS-associated breast cancers have Her2/neu amplification, which is higher than the 10-20% frequency in sporadic breast cancer.\nIt's important to note that the management of LFS-associated breast cancer is similar to that of other breast cancers, and it is based on the patient's individual characteristics, such as the stage and grade of the cancer, as well as the patient's overall health and preferences.\nIn summary, the Her2 status in Li-Fraumeni syndrome is associated with an increased risk of developing breast cancer, and it is known that Her2/neu amplification is more frequent in LFS-associated breast cancer than in sporadic breast cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Li-Fraumeni syndrome (LFS) is a rare inherited cancer predisposition syndrome.\n2. LFS is associated with an increased risk of developing various types of cancers, including breast cancer, ovarian cancer, and sarcomas.\n3. The condition LFS is caused by mutations in the TP53 gene.\n4. Approximately 20-30% of LFS-associated breast cancers have Her2/neu amplification, which is higher than the 10-20% frequency in sporadic breast cancer.\n5. The management of LFS-associated breast cancer is similar to that of other breast cancers, and it is based on the patient's individual characteristics, such as the stage and grade of the cancer, as well as the patient's overall health and preferences.",
    "vicuna-13b_fact": [
      "Li-Fraumeni syndrome (LFS) is a rare inherited cancer predisposition syndrome.",
      "LFS is associated with an increased risk of developing various types of cancers, including breast cancer, ovarian cancer, and sarcomas.",
      "The condition LFS is caused by mutations in the TP53 gene.",
      "Approximately 20-30% of LFS-associated breast cancers have Her2/neu amplification, which is higher than the 10-20% frequency in sporadic breast cancer.",
      "The management of LFS-associated breast cancer is similar to that of other breast cancers, and it is based on the patient's individual characteristics, such as the stage and grade of the cancer, as well as the patient's overall health and preferences."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1197,
    "user_query": "Why can't humans synthesize Neu5Gc (N-Glycolylneuraminic acid)?",
    "vicuna-13b_response": "Humans are unable to synthesize Neu5Gc (N-Glycolylneuraminic acid) because the gene responsible for its production was mutated in our evolutionary history. The gene that codes for the enzyme that synthesizes Neu5Gc was inactivated in the lineage leading to humans and other great apes, such as chimpanzees and gorillas. This mutation occurred around 25-30 million years ago, during the evolution of the lineage that led to the great apes.\nAs a result, humans and other great apes are unable to synthesize Neu5Gc, and must obtain it from their diet. Neu5Gc is found in small amounts in some mammalian tissues, including the brain, but it is not known to have any essential function in humans. However, some research suggests that it may play a role in the development of certain diseases, such as cancer and Alzheimer's disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Humans are unable to synthesize Neu5Gc (N-Glycolylneuraminic acid) because the gene responsible for its production was mutated in our evolutionary history.\n2. The gene that codes for the enzyme that synthesizes Neu5Gc was inactivated in the lineage leading to humans and other great apes.\n3. This mutation occurred around 25-30 million years ago.\n4. Neu5Gc is found in small amounts in some mammalian tissues, including the brain.\n5. Research suggests that Neu5Gc may play a role in the development of certain diseases, such as cancer and Alzheimer's disease.",
    "vicuna-13b_fact": [
      "Humans are unable to synthesize Neu5Gc (N-Glycolylneuraminic acid) because the gene responsible for its production was mutated in our evolutionary history.",
      "The gene that codes for the enzyme that synthesizes Neu5Gc was inactivated in the lineage leading to humans and other great apes.",
      "This mutation occurred around 25-30 million years ago.",
      "Neu5Gc is found in small amounts in some mammalian tissues, including the brain.",
      "Research suggests that Neu5Gc may play a role in the development of certain diseases, such as cancer and Alzheimer's disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The gene that codes for the enzyme that synthesizes Neu5Gc was inactivated in the lineage leading to humans, not in other great apes.\n3. FALSE [correction]: This mutation is believed to have occurred around 2-3 million years ago.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1198,
    "user_query": "Which enzyme is inhibited by Orteronel?",
    "vicuna-13b_response": "Orteronel is an inhibitor of the enzyme HSP90, which is a molecular chaperone that plays a critical role in the folding and stability of other proteins. HSP90 is involved in many cellular processes, including protein folding, degradation, and transport, and it has been implicated in a variety of diseases, including cancer and neurodegeneration. Inhibition of HSP90 by orteronel has been shown to have anti-cancer effects in cell culture and animal models, and it is currently being studied as a potential therapeutic agent for a variety of diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Orteronel is an inhibitor of the enzyme HSP90.\n2. HSP90 is a molecular chaperone that plays a critical role in the folding and stability of other proteins.\n3. HSP90 is involved in many cellular processes, including protein folding, degradation, and transport.\n4. HSP90 is implicated in a variety of diseases, including cancer and neurodegeneration.\n5. Inhibition of HSP90 by orteronel has been shown to have anti-cancer effects in cell culture and animal models.",
    "vicuna-13b_fact": [
      "Orteronel is an inhibitor of the enzyme HSP90.",
      "HSP90 is a molecular chaperone that plays a critical role in the folding and stability of other proteins.",
      "HSP90 is involved in many cellular processes, including protein folding, degradation, and transport.",
      "HSP90 is implicated in a variety of diseases, including cancer and neurodegeneration.",
      "Inhibition of HSP90 by orteronel has been shown to have anti-cancer effects in cell culture and animal models."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Orteronel is an inhibitor of the enzyme CYP17A1, not HSP90.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1202,
    "user_query": "Elaborate on the TREAT-NMD initiative for DMD patients",
    "vicuna-13b_response": "TREAT-NMD (Translational Research in Experimental Androgenetic Muscular Dystrophy) is an international initiative that aims to advance the development of treatments for Duchenne muscular dystrophy (DMD). DMD is a severe and progressive muscle-wasting disorder that affects approximately 1 in every 3,500 male births worldwide.\nThe TREAT-NMD initiative was launched in 2007 by the European Union's Sixth Framework Programme for Research and Technological Development, with the goal of creating a platform for collaboration and coordination among researchers, clinicians, and patient organizations working on DMD. The initiative is supported by a network of clinical and research centers of excellence in DMD from around the world.\nThe TREAT-NMD initiative has several key components:\n1. Clinical Trials: TREAT-NMD supports the development of clinical trials for potential treatments for DMD. These trials involve testing the safety and efficacy of various therapies, including gene therapy, enzyme replacement therapy, and small molecule drugs.\n2. Natural History Studies: TREAT-NMD conducts natural history studies to better understand the progression of DMD and the impact of different treatments on disease progression. This information is critical for the design of clinical trials and the evaluation of treatment efficacy.\n3. Biomarkers: TREAT-NMD is developing biomarkers to measure the effectiveness of different treatments and to track disease progression over time. Biomarkers are important for monitoring disease activity and response to treatment, and for identifying potential side effects.\n4. Data Management: TREAT-NMD maintains a centralized database of DMD patient information, including clinical data, genetic data, and biomarker data. This database is a valuable resource for researchers and clinicians working on DMD, and helps to facilitate collaboration and data sharing among different research groups.\n5. Patient Advocacy: TREAT-NMD engages with patient organizations and advocates for increased research funding and awareness of DMD. The initiative also provides information and support to patients and families affected by DMD.\nOverall,",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TREAT-NMD is an international initiative focused on advancing development of Duchenne muscular dystrophy (DMD) treatments.\n2. Duchenne muscular dystrophy (DMD) affects approximately 1 in every 3,500 male births worldwide.\n3. The TREAT-NMD initiative was launched in 2007 by the European Union's Sixth Framework Programme for Research and Technological Development.\n4. TREAT-NMD initiative supports the development of clinical trials for potential treatments for DMD. \n5. TREAT-NMD maintains a centralized database of DMD patient information which includes clinical data, genetic data, and biomarker data.",
    "vicuna-13b_fact": [
      "TREAT-NMD is an international initiative focused on advancing development of Duchenne muscular dystrophy (DMD) treatments.",
      "Duchenne muscular dystrophy (DMD) affects approximately 1 in every 3,500 male births worldwide.",
      "The TREAT-NMD initiative was launched in 2007 by the European Union's Sixth Framework Programme for Research and Technological Development.",
      "TREAT-NMD initiative supports the development of clinical trials for potential treatments for DMD.",
      "TREAT-NMD maintains a centralized database of DMD patient information which includes clinical data, genetic data, and biomarker data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1207,
    "user_query": "What is the physiological role of LKB1 involved in Peutz-Jeghers syndrome?",
    "vicuna-13b_response": "LKB1 (liver kinase B1) is a serine/threonine kinase that plays a role in various cellular processes, including cell growth, metabolism, and apoptosis (programmed cell death). In Peutz-Jeghers syndrome, a genetic disorder characterized by the development of benign tumors in the gastrointestinal tract and the skin, LKB1 is thought to play a role in the regulation of cell growth and proliferation.\nStudies have shown that mutations in the LKB1 gene can lead to increased activity of the AMP-activated protein kinase (AMPK) pathway, which is a signaling pathway that regulates cellular energy metabolism. This increased activity of the AMPK pathway is thought to contribute to the development of the benign tumors (called hamartomas) that are characteristic of Peutz-Jeghers syndrome.\nIn addition to its role in regulating cell growth and proliferation, LKB1 is also involved in the regulation of apoptosis. Studies have suggested that LKB1 may play a role in the survival of cells in the gastrointestinal tract, and that decreased LKB1 activity may contribute to the development of hamartomas in Peutz-Jeghers syndrome.\nOverall, while the exact mechanisms by which LKB1 contributes to the development of Peutz-Jeghers syndrome are not fully understood, studies have suggested that LKB1 plays a role in regulating cell growth, proliferation, and apoptosis, and that mutations in the LKB1 gene can lead to the development of benign tumors in the gastrointestinal tract and the skin.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. LKB1 is a serine/threonine kinase involved in cellular processes such as cell growth, metabolism, and apoptosis.\n2. Peutz-Jeghers syndrome is a genetic disorder characterized by the development of benign tumors in the gastrointestinal tract and skin.\n3. Mutations in the LKB1 gene can lead to increased activity of the AMP-activated protein kinase (AMPK) pathway.\n4. Increased activity of the AMPK pathway can contribute to the development of the benign tumors, or hamartomas, found in Peutz-Jeghers syndrome.\n5. LKB1 is involved in the regulation of apoptosis and decreased LKB1 activity might contribute to the development of hamartomas in Peutz-Jeghers syndrome.",
    "vicuna-13b_fact": [
      "LKB1 is a serine/threonine kinase involved in cellular processes such as cell growth, metabolism, and apoptosis.",
      "Peutz-Jeghers syndrome is a genetic disorder characterized by the development of benign tumors in the gastrointestinal tract and skin.",
      "Mutations in the LKB1 gene can lead to increased activity of the AMP-activated protein kinase (AMPK) pathway.",
      "Increased activity of the AMPK pathway can contribute to the development of the benign tumors, or hamartomas, found in Peutz-Jeghers syndrome.",
      "LKB1 is involved in the regulation of apoptosis and decreased LKB1 activity might contribute to the development of hamartomas in Peutz-Jeghers syndrome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Mutations in the LKB1 gene can lead to decreased activity of the AMP-activated protein kinase (AMPK) pathway.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1213,
    "user_query": "Which is the major function of sororin?",
    "vicuna-13b_response": "Sororin is a protein that is primarily expressed in the heart and is involved in various cardiac functions. Its major function is to regulate the activity of ion channels, particularly those involved in the control of cardiac muscle contraction and relaxation.\nSororin is a member of the small conductance calcium-activated potassium (SK) channel family, which plays a critical role in regulating the flow of potassium ions across the cell membrane. In the heart, sororin helps to regulate the activity of SK channels, which are important for the proper functioning of the cardiac action potential and the control of heart rate.\nIn addition to its role in regulating ion channel activity, sororin has also been shown to have anti-arrhythmic effects, meaning that it can help to prevent abnormal heart rhythms. It does this by inhibiting the activity of certain types of ion channels that can contribute to arrhythmias, such as the delayed-rectifier potassium channels.\nOverall, sororin plays a crucial role in the regulation of cardiac function and has potential therapeutic applications for the treatment of cardiac arrhythmias and other cardiac disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Sororin is a protein primarily expressed in the heart.\n2. The major function of sororin is to regulate the activity of ion channels, particularly those involved in the control of cardiac muscle contraction and relaxation.\n3. Sororin is part of the small conductance calcium-activated potassium (SK) channel family.\n4. In the heart, sororin helps to regulate the activity of SK channels, which are important for the functioning of the cardiac action potential and the control of heart rate.\n5. Sororin can have anti-arrhythmic effects, as it can inhibit the activity of certain ion channels, such as the delayed-rectifier potassium channels, that can contribute to arrhythmias.",
    "vicuna-13b_fact": [
      "Sororin is a protein primarily expressed in the heart.",
      "The major function of sororin is to regulate the activity of ion channels, particularly those involved in the control of cardiac muscle contraction and relaxation.",
      "Sororin is part of the small conductance calcium-activated potassium (SK) channel family.",
      "In the heart, sororin helps to regulate the activity of SK channels, which are important for the functioning of the cardiac action potential and the control of heart rate.",
      "Sororin can have anti-arrhythmic effects, as it can inhibit the activity of certain ion channels, such as the delayed-rectifier potassium channels, that can contribute to arrhythmias."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Sororin is a protein that is primarily associated with the process of cohesion in cell division, not primarily expressed in the heart.\n2. FALSE [correction]: Sororin works within the cohesion complex which assists in the separation of sister chromatids during cell division, not in the regulation of ion channels.\n3. FALSE [correction]: Sororin is not part of the small conductance calcium-activated potassium (SK) channel family. It is rather involved in the process of mitosis.\n4. FALSE [correction]: Sororin is not involved in the regulation of SK channels in the heart, as its primary role pertains to cell division.\n5. FALSE [correction]: Sororin does not have direct involvement in cardiac processes and, therefore, does not have anti-arrhythmic effects. Its role is central to the cell division process.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1216,
    "user_query": "Can desvenlafaxine be used at a dose of 50mg/day?",
    "vicuna-13b_response": "Desvenlafaxine is a medication that is primarily used to treat depression, and it is typically taken at doses of 50-100 mg per day. However, the appropriate dosage for an individual patient depends on a number of factors, including their age, weight, medical history, and response to the medication.\nBefore starting treatment with desvenlafaxine, it is important to consult with a healthcare professional to determine the appropriate dosage for your individual needs. They will consider these factors and any other medications you are taking to ensure that the dosage is safe and effective for you.\nIt is important to follow the dosage instructions provided by your healthcare professional and to take the medication as directed. If you have any questions or concerns about your dosage, you should contact your healthcare professional for further guidance.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Desvenlafaxine is a medication primarily used to treat depression.\n2. Desvenlafaxine is typically taken at doses of 50-100 mg per day.\n3. The appropriate dosage for an individual patient depends on a number of factors, including their age, weight, medical history, and response to the medication.\n4. It is important to consult with a healthcare professional before starting treatment with desvenlafaxine.\n5. If you have any questions or concerns about your dosage, you should contact your healthcare professional.",
    "vicuna-13b_fact": [
      "Desvenlafaxine is a medication primarily used to treat depression.",
      "Desvenlafaxine is typically taken at doses of 50-100 mg per day.",
      "The appropriate dosage for an individual patient depends on a number of factors, including their age, weight, medical history, and response to the medication.",
      "It is important to consult with a healthcare professional before starting treatment with desvenlafaxine.",
      "If you have any questions or concerns about your dosage, you should contact your healthcare professional."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1219,
    "user_query": "Can ferric carboxymaltose be used to treat anemia in inflammatory bowel disease patients?",
    "vicuna-13b_response": "Ferric carboxymaltose (FCM) is a medication that is used to treat anemia in patients with inflammatory bowel disease (IBD). FCM is a form of iron replacement therapy that works by increasing the amount of iron in the body, which is essential for the production of hemoglobin in red blood cells.\nFCM is typically used in patients with IBD who have anemia that is not responding to other treatments, such as oral iron supplements or intravenous (IV) iron therapy. It is administered as an infusion, usually over the course of several hours, and is given in a healthcare setting such as a hospital or clinic.\nWhile FCM can be effective in treating anemia in some patients with IBD, it is not without risks. FCM can cause side effects such as nausea, vomiting, diarrhea, and constipation, and in rare cases, it can lead to more serious complications such as allergic reactions or anaphylaxis.\nIt is important for patients with IBD who are being treated with FCM to follow their treatment plan closely and report any side effects or concerns to their healthcare provider. In addition, FCM should only be used under the guidance of a healthcare professional who is experienced in treating patients with IBD and anemia.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ferric carboxymaltose (FCM) is a medication used to treat anemia in patients with inflammatory bowel disease (IBD).\n2. Ferric carboxymaltose works by increasing the amount of iron in the body, essential for the production of hemoglobin in red blood cells.\n3. FCM is typically used in patients with IBD who have anemia that is not responding to other treatments, such as oral iron supplements or intravenous (IV) iron therapy.\n4. The administration of FCM typically happens as an infusion, over the course of several hours, in a healthcare setting such as a hospital or clinic.\n5. Ferric carboxymaltose can cause certain side effects such as nausea, vomiting, diarrhea, constipation, and in rare cases, serious complications like allergic reactions or anaphylaxis.",
    "vicuna-13b_fact": [
      "Ferric carboxymaltose (FCM) is a medication used to treat anemia in patients with inflammatory bowel disease (IBD).",
      "Ferric carboxymaltose works by increasing the amount of iron in the body, essential for the production of hemoglobin in red blood cells.",
      "FCM is typically used in patients with IBD who have anemia that is not responding to other treatments, such as oral iron supplements or intravenous (IV) iron therapy.",
      "The administration of FCM typically happens as an infusion, over the course of several hours, in a healthcare setting such as a hospital or clinic.",
      "Ferric carboxymaltose can cause certain side effects such as nausea, vomiting, diarrhea, constipation, and in rare cases, serious complications like allergic reactions or anaphylaxis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The administration of FCM typically happens as an infusion, over a short duration of time, not several hours, in a healthcare setting such as a hospital or clinic.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1220,
    "user_query": "Which disease is treated with Eliglustat?",
    "vicuna-13b_response": "Eliglustat is a medication that is used to treat a rare genetic disorder called Gaucher disease. Gaucher disease is a lysosomal storage disorder caused by a deficiency of the enzyme glucocerebrosidase, which is responsible for breaking down a certain type of fat molecule. This results in the accumulation of these fat molecules in the spleen, liver, and bone marrow, leading to anemia, fatigue, and other symptoms. Eliglustat works by increasing the production of glucocerebrosidase in the body, which helps to break down the accumulated fat molecules and reduce the symptoms of the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Eliglustat is used to treat Gaucher disease.\n2. Gaucher disease is a rare genetic disorder.\n3. Gaucher disease is caused by a deficiency of the enzyme glucocerebrosidase.\n4. Lack of glucocerebrosidase enzyme leads to accumulation of certain fat molecules in the spleen, liver, and bone marrow.\n5. Eliglustat increases the production of glucocerebrosidase in the body.",
    "vicuna-13b_fact": [
      "Eliglustat is used to treat Gaucher disease.",
      "Gaucher disease is a rare genetic disorder.",
      "Gaucher disease is caused by a deficiency of the enzyme glucocerebrosidase.",
      "Lack of glucocerebrosidase enzyme leads to accumulation of certain fat molecules in the spleen, liver, and bone marrow.",
      "Eliglustat increases the production of glucocerebrosidase in the body."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Eliglustat does not increase the production of glucocerebrosidase in the body. It works by reducing the production of the fat molecules that would accumulate due to the lack of the enzyme.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "vicuna-13b_response": "The regulation of Vsr endonuclease is not necessarily independent of the growth phase of bacteria. Vsr endonuclease is an enzyme that is involved in the regulation of gene expression in bacteria, and its activity can be affected by various factors, including the growth phase of the bacteria.\nStudies have shown that the expression of the Vsr endonuclease gene is regulated by the transcription factor VcrA, which is involved in the regulation of virulence genes in bacteria. The expression of VcrA is itself regulated by the global transcriptional regulator Lrp, which is involved in the regulation of bacterial metabolism and stress responses.\nIn addition, the activity of Vsr endonuclease can be affected by the growth phase of the bacteria. For example, Vsr endonuclease activity has been shown to be highest in the exponential growth phase and lowest in the stationary phase of bacteria. This suggests that the regulation of Vsr endonuclease may be influenced by the growth phase of the bacteria.\nOverall, while the regulation of Vsr endonuclease is not necessarily independent of the growth phase of bacteria, it is a complex process that is influenced by a variety of factors, including the transcription factor VcrA, the global transcriptional regulator Lrp, and the growth phase of the bacteria.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Vsr endonuclease is an enzyme that is involved in the regulation of gene expression in bacteria.\n2. The expression of the Vsr endonuclease gene is regulated by the transcription factor VcrA, which is involved in the regulation of virulence genes in bacteria.\n3. The expression of VcrA is regulated by the global transcriptional regulator Lrp, which is involved in the regulation of bacterial metabolism and stress responses.\n4. Vsr endonuclease activity has been shown to be highest in the exponential growth phase and lowest in the stationary phase of bacteria.\n5. The regulation of Vsr endonuclease is influenced by factors, including the transcription factor VcrA, the global transcriptional regulator Lrp, and the growth phase of the bacteria.",
    "vicuna-13b_fact": [
      "Vsr endonuclease is an enzyme that is involved in the regulation of gene expression in bacteria.",
      "The expression of the Vsr endonuclease gene is regulated by the transcription factor VcrA, which is involved in the regulation of virulence genes in bacteria.",
      "The expression of VcrA is regulated by the global transcriptional regulator Lrp, which is involved in the regulation of bacterial metabolism and stress responses.",
      "Vsr endonuclease activity has been shown to be highest in the exponential growth phase and lowest in the stationary phase of bacteria.",
      "The regulation of Vsr endonuclease is influenced by factors, including the transcription factor VcrA, the global transcriptional regulator Lrp, and the growth phase of the bacteria."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1230,
    "user_query": "What is the life expectancy of professional athletes in respect to the general population?",
    "vicuna-13b_response": "The life expectancy of professional athletes is generally higher than that of the general population. According to a study published in the Journal of the American Medical Association, the life expectancy of male professional athletes in the United States is about 92 years, which is about 10 years higher than the average life expectancy for men in the United States.\nAnother study published in the Journal of Sports Sciences found that retired professional athletes had a higher life expectancy than the general population, with the highest life expectancy found in retired professional football players. The study found that retired professional football players had a life expectancy of 90.8 years, which is higher than the average life expectancy for men in the United States, which is about 76 years.\nIt is important to note that while professional athletes may have a higher life expectancy than the general population, this does not mean that they are immune to the health problems that can affect anyone. Professional athletes are still at risk of developing health conditions such as heart disease, diabetes, and joint problems, among others.\nIt is also worth noting that the life expectancy of professional athletes can vary depending on the sport and the specific demands of the sport. For example, professional athletes in contact sports such as football or boxing may be at a higher risk of developing health problems due to the physical nature of the sport.\nIn summary, the life expectancy of professional athletes is generally higher than that of the general population, but this does not mean that they are immune to the health problems that can affect anyone. It is important for professional athletes to take care of their health and seek medical attention when necessary to maintain their health and well-being.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The life expectancy of professional athletes is generally higher than that of the general population.\n2. A study published in the Journal of the American Medical Association reports the life expectancy of male professional athletes in the United States to be about 92 years.\n3. Another study published in the Journal of Sports Sciences found that retired professional athletes had a higher life expectancy than the general population.\n4. The same study in the Journal of Sports Sciences found that retired professional football players had a life expectancy of 90.8 years.\n5. The average life expectancy for men in the United States is about 76 years.",
    "vicuna-13b_fact": [
      "The life expectancy of professional athletes is generally higher than that of the general population.",
      "A study published in the Journal of the American Medical Association reports the life expectancy of male professional athletes in the United States to be about 92 years.",
      "Another study published in the Journal of Sports Sciences found that retired professional athletes had a higher life expectancy than the general population.",
      "The same study in the Journal of Sports Sciences found that retired professional football players had a life expectancy of 90.8 years.",
      "The average life expectancy for men in the United States is about 76 years."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1232,
    "user_query": "How does adrenergic signaling affect thyroid hormone receptors?",
    "vicuna-13b_response": "Adrenergic signaling can affect thyroid hormone receptors in several ways. One of the main effects is that it can increase the activity of the receptors, leading to increased sensitivity to thyroid hormones. This can occur through a number of mechanisms, including increased gene expression of the receptors, increased stability of the receptors, and increased activity of the receptors once they are bound to thyroid hormones.\nOne of the key ways that adrenergic signaling affects thyroid hormone receptors is through the activation of protein kinase A (PKA). PKA is a cAMP-dependent protein kinase that can phosphorylate and activate thyroid hormone receptors, leading to increased sensitivity to thyroid hormones. This can occur through the activation of adrenergic receptors, such as alpha-adrenergic receptors, which can increase the levels of cAMP in cells, leading to activation of PKA and phosphorylation of the receptors.\nIn addition to increasing the activity of the receptors, adrenergic signaling can also affect the localization of the receptors. For example, adrenergic signaling can increase the expression of the receptors in the nucleus, where they can regulate gene expression, or in the cytoplasm, where they can regulate metabolic processes.\nOverall, adrenergic signaling can have a significant impact on the activity of thyroid hormone receptors, and can play a role in the regulation of a wide range of physiological processes, including metabolism, growth, and development.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Adrenergic signaling can increase the activity of thyroid hormone receptors.\n2. Adrenergic signaling can increase gene expression of the receptors, receptor stability, and activity once they are bound to thyroid hormones.\n3. A key way adrenergic signaling affects thyroid hormone receptors is through the activation of protein kinase A (PKA), which can phosphorylate and activate the receptors.\n4. Alpha-adrenergic receptors, when activated, can increase the levels of cAMP in cells, leading to activation of PKA and phosphorylation of thyroid hormone receptors.\n5. Apart from its impact on activity, adrenergic signaling can also affect the localization of thyroid hormone receptors.",
    "vicuna-13b_fact": [
      "Adrenergic signaling can increase the activity of thyroid hormone receptors.",
      "Adrenergic signaling can increase gene expression of the receptors, receptor stability, and activity once they are bound to thyroid hormones.",
      "A key way adrenergic signaling affects thyroid hormone receptors is through the activation of protein kinase A (PKA), which can phosphorylate and activate the receptors.",
      "Alpha-adrenergic receptors, when activated, can increase the levels of cAMP in cells, leading to activation of PKA and phosphorylation of thyroid hormone receptors.",
      "Apart from its impact on activity, adrenergic signaling can also affect the localization of thyroid hormone receptors."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: Beta-adrenergic receptors, when activated, can increase the levels of cAMP in cells, leading to activation of PKA and phosphorylation of thyroid hormone receptors.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "vicuna-13b_response": "Beta-barrel transmembrane proteins are a type of protein that are characterized by having a beta-sheet structure that forms a barrel-shaped structure across the membrane. These proteins play important roles in various cellular processes, such as transport of molecules across the cell membrane, and are often targets for drug development. There are several computational tools that can be used for the prediction of beta-barrel transmembrane proteins, including:\n1. TMHMM: TMHMM (Transmembrane Helix Membrane Modeling) is a widely used tool for predicting transmembrane proteins, including beta-barrel proteins. It uses a combination of machine learning and statistical methods to predict transmembrane helices and the location of the membrane-spanning segments.\n2. Phobos: Phobos is a web-based tool that uses a combination of sequence and structural features to predict transmembrane proteins, including beta-barrel proteins. It can also predict the topology of the protein and the location of the transmembrane segments.\n3. BetaBarrel: BetaBarrel is a standalone tool that can be used for the prediction of beta-barrel transmembrane proteins. It uses a combination of sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.\n4. TOPCONS: TOPCONS (Transmembrane Protein Structure Prediction using Consensus Sites) is a tool that uses a combination of machine learning and consensus sites to predict the topology and structure of transmembrane proteins, including beta-barrel proteins.\n5. BetaRod: BetaRod is a web-based tool that can be used for the prediction of beta-barrel transmembrane proteins. It uses a combination of sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.\nThese are some of the computational tools that can be used for the prediction of beta-barrel transmembrane proteins. It is important to note that these tools are not perfect and may have some limitations in their predictions. Therefore, it is important to validate the predictions using experimental data.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Beta-barrel transmembrane proteins are characterized by a beta-sheet structure that forms a barrel-shaped structure across the membrane.\n2. TMHMM is used for predicting transmembrane proteins, using a combination of machine learning and statistical methods.\n3. Phobos is a tool that uses sequence and structural features to predict transmembrane proteins including their topology and the location of the transmembrane segments.\n4. BetaBarrel uses sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.\n5. TOPCONS uses machine learning and consensus sites to predict the topology and structure of transmembrane proteins.\n6. BetaRod uses sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.",
    "vicuna-13b_fact": [
      "Beta-barrel transmembrane proteins are characterized by a beta-sheet structure that forms a barrel-shaped structure across the membrane.",
      "TMHMM is used for predicting transmembrane proteins, using a combination of machine learning and statistical methods.",
      "Phobos is a tool that uses sequence and structural features to predict transmembrane proteins including their topology and the location of the transmembrane segments.",
      "BetaBarrel uses sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.",
      "TOPCONS uses machine learning and consensus sites to predict the topology and structure of transmembrane proteins.",
      "BetaRod uses sequence and structural features to predict the presence of beta-barrel domains in a protein sequence."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Phobius is a tool that uses sequence and structural features to predict transmembrane proteins including their topology and the location of the transmembrane segments.\n4. UNKNOWN\n5. TRUE\n6. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1236,
    "user_query": "Is there any cross-talk between the Wnt and the Akt pathways?",
    "vicuna-13b_response": "Yes, there is cross-talk between the Wnt and the Akt pathways. The Wnt pathway is a signaling pathway that plays a role in cell proliferation, differentiation, and migration, while the Akt pathway is a signaling pathway that regulates cell survival and metabolism.\nOne of the ways in which the Wnt and Akt pathways interact is through the regulation of the transcription factor β-catenin. In the Wnt pathway, β-catenin is a key component that helps to activate the transcription of target genes. In the Akt pathway, β-catenin can also be activated by Akt, which leads to the transcription of genes involved in cell survival and metabolism.\nAdditionally, the Wnt pathway can also activate the Akt pathway through the activation of the receptor tyrosine kinase (RTK) pathway. The RTK pathway is a signaling pathway that regulates cell growth and survival, and it can be activated by Wnt signaling. Activation of the RTK pathway can lead to the activation of Akt, which in turn can regulate cell survival and metabolism.\nOverall, the cross-talk between the Wnt and Akt pathways is complex and can involve multiple signaling mechanisms. Understanding the interactions between these pathways is important for understanding the regulation of cell behavior and for the development of therapeutic strategies for diseases such as cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Wnt pathway is a signaling pathway that plays a role in cell proliferation, differentiation, and migration.\n2. The Akt pathway is a signaling pathway that regulates cell survival and metabolism.\n3. The transcription factor β-catenin is a key component in the Wnt pathway that helps to activate the transcription of target genes.\n4. In the Akt pathway, β-catenin can also be activated by Akt, which leads to the transcription of genes involved in cell survival and metabolism.\n5. The Wnt pathway can activate the Akt pathway through the activation of the receptor tyrosine kinase (RTK) pathway.",
    "vicuna-13b_fact": [
      "The Wnt pathway is a signaling pathway that plays a role in cell proliferation, differentiation, and migration.",
      "The Akt pathway is a signaling pathway that regulates cell survival and metabolism.",
      "The transcription factor β-catenin is a key component in the Wnt pathway that helps to activate the transcription of target genes.",
      "In the Akt pathway, β-catenin can also be activated by Akt, which leads to the transcription of genes involved in cell survival and metabolism.",
      "The Wnt pathway can activate the Akt pathway through the activation of the receptor tyrosine kinase (RTK) pathway."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The Wnt pathway and Akt pathway can interact with each other, but it's not exactly accurate to say that one pathway can activate the other through the activation of the receptor tyrosine kinase (RTK) pathway. Interaction between these pathways often involves multiple complex steps and mechanisms beyond the activation of a single pathway.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1238,
    "user_query": "Is the Snord116 cluster associated with the Prader-Willi syndrome?",
    "vicuna-13b_response": "The Snord116 cluster is a region on chromosome 15 that has been identified as a potential candidate gene for Prader-Willi syndrome (PWS). PWS is a genetic disorder that is characterized by a range of symptoms, including hypotonia (floppiness), feeding difficulties, and developmental delay.\nThe Snord116 cluster is a region that contains several genes, including the SNORD116 gene itself. The SNORD116 gene is thought to play a role in the development of the brain and other organs, and it has been suggested that mutations in this gene may contribute to the symptoms of PWS.\nHowever, it is important to note that the relationship between the Snord116 cluster and PWS is still an area of active research, and more studies are needed to fully understand the role of this region in the development of PWS. Additionally, it is important to note that PWS is a complex disorder that is caused by a combination of genetic and environmental factors, and the exact cause of PWS varies from person to person.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Snord116 cluster is a region on chromosome 15.\n2. The Snord116 cluster has been identified as a potential candidate gene for Prader-Willi syndrome.\n3. Prader-Willi syndrome is a genetic disorder characterized by hypotonia, feeding difficulties, and developmental delay.\n4. The SNORD116 gene is thought to play a role in the development of the brain and other organs.\n5. The exact cause of Prader-Willi syndrome varies from person to person.",
    "vicuna-13b_fact": [
      "The Snord116 cluster is a region on chromosome 15.",
      "The Snord116 cluster has been identified as a potential candidate gene for Prader-Willi syndrome.",
      "Prader-Willi syndrome is a genetic disorder characterized by hypotonia, feeding difficulties, and developmental delay.",
      "The SNORD116 gene is thought to play a role in the development of the brain and other organs.",
      "The exact cause of Prader-Willi syndrome varies from person to person."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The Snord116 cluster, not a single gene, is thought to play a role in the development of the brain and other organs.\n5. FALSE [correction]: The cause of Prader-Willi syndrome is specific. It is a complex genetic condition that results from the loss of gene function in a particular region of chromosome 15.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1242,
    "user_query": "Is nimodipine recommended for prevention of vasospasm in aneurysmal subarachnoid hemorrhage patients?",
    "vicuna-13b_response": "Nimodipine is a calcium channel blocker that is sometimes used to treat cerebral vasospasm, which is a common complication of aneurysmal subarachnoid hemorrhage (aSAH). It is not specifically recommended for the prevention of vasospasm in aSAH patients, but it may be used as a treatment in certain cases.\nThe use of nimodipine for the prevention of vasospasm in aSAH patients is somewhat controversial, as there is limited evidence to support its effectiveness in this regard. Some studies have suggested that nimodipine may be effective in preventing vasospasm, while others have found no benefit.\nIn general, the use of nimodipine for the prevention of vasospasm in aSAH patients is considered to be a secondary option, to be used in cases where other treatments have been ineffective or contraindicated. The decision to use nimodipine for this purpose should be made on a case-by-case basis, based on the specific needs and medical history of the patient.\nIt is important to note that the use of nimodipine for the prevention of vasospasm in aSAH patients should only be done under the close supervision of a qualified healthcare professional, as it may have potential side effects and interactions with other medications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nimodipine is a calcium channel blocker.\n2. Nimodipine is sometimes used to treat cerebral vasospasm, which is a common complication of aneurysmal subarachnoid hemorrhage (aSAH).\n3. The use of nimodipine for the prevention of vasospasm in aSAH patients is somewhat controversial with varying evidence on its effectiveness.\n4. The use of nimodipine for the prevention of vasospasm in aSAH patients is considered to be a secondary option.\n5. The use of nimodipine for the prevention of vasospasm in aSAH patients should only be done under the close supervision of a qualified healthcare professional.",
    "vicuna-13b_fact": [
      "Nimodipine is a calcium channel blocker.",
      "Nimodipine is sometimes used to treat cerebral vasospasm, which is a common complication of aneurysmal subarachnoid hemorrhage (aSAH).",
      "The use of nimodipine for the prevention of vasospasm in aSAH patients is somewhat controversial with varying evidence on its effectiveness.",
      "The use of nimodipine for the prevention of vasospasm in aSAH patients is considered to be a secondary option.",
      "The use of nimodipine for the prevention of vasospasm in aSAH patients should only be done under the close supervision of a qualified healthcare professional."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The use of nimodipine for the prevention of vasospasm in aSAH patients is considered to be a primary, not secondary, treatment option.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1245,
    "user_query": "Where can we find the protein lacritin?",
    "vicuna-13b_response": "Lactritin is a protein found in milk and other dairy products. It is a member of the lipocalin family of proteins, which are characterized by their ability to bind to and transport lipids. Lactritin is responsible for the ability of milk to clot, and it is also involved in the immune response of the mammary gland. It can be found in the whey protein fraction of milk, and it is also present in the milk fat globule membrane. Lactritin has been used as a research tool in the study of lipid transport and metabolism, and it has also been studied for its potential use as a therapeutic agent in the treatment of various diseases, such as atherosclerosis and cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Lacritin is a protein found in milk and other dairy products.\n2. Lacritin is a member of the lipocalin family of proteins.\n3. Lacritin is responsible for the ability of milk to clot and is involved in the immune response of the mammary gland.\n4. Lacritin can be found in the whey protein fraction of milk and in the milk fat globule membrane.\n5. Lacritin has been used in research on lipid transport and metabolism and in studies on potential therapies for diseases like atherosclerosis and cancer.",
    "vicuna-13b_fact": [
      "Lacritin is a protein found in milk and other dairy products.",
      "Lacritin is a member of the lipocalin family of proteins.",
      "Lacritin is responsible for the ability of milk to clot and is involved in the immune response of the mammary gland.",
      "Lacritin can be found in the whey protein fraction of milk and in the milk fat globule membrane.",
      "Lacritin has been used in research on lipid transport and metabolism and in studies on potential therapies for diseases like atherosclerosis and cancer."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Lacritin is a protein found in tears, not in milk or dairy products. \n2. FALSE [correction]: Lacritin is not a member of the lipocalin family of proteins.\n3. FALSE [correction]: Lacritin is not responsible for the ability of milk to clot and it's not involved in the immune response of the mammary gland.\n4. FALSE [correction]: Lacritin can be found in tears, saliva, and other body fluids, not in the whey protein fraction of milk or in the milk fat globule membrane. \n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1247,
    "user_query": "What is the triple screening test performed during pregnancy measuring?",
    "vicuna-13b_response": "The triple screening test is a blood test that is performed during pregnancy to measure the levels of three different substances: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated estriol (uE3). These substances are produced by the developing fetus and can be detected in the mother's blood.\nThe triple screening test is typically performed between 15 and 20 weeks of pregnancy, and it is used to detect the risk of certain birth defects, such as Down syndrome, and to detect potential issues with the pregnancy, such as a possible miscarriage or ectopic pregnancy.\nThe levels of these substances can be used to calculate a \"risk score\" which indicates the likelihood of the fetus having certain birth defects or chromosomal abnormalities. However, it's important to note that the triple screening test is not diagnostic and it can't predict with 100% accuracy whether a baby will have a birth defect or chromosomal abnormality. It's also important to note that the test is not a substitute for prenatal care and regular ultrasound, which are important for monitoring the health of the fetus and the pregnancy.\nIt's important to discuss the results of the triple screening test with a healthcare provider, who can provide more information about the test and its implications, as well as discuss any further testing or management that may be necessary based on the results.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The triple screening test is a blood test performed during pregnancy that measures levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated estriol (uE3).\n2. These substances measured in the triple screening test are produced by the developing fetus and can be detected in the mother's blood.\n3. The triple screening test is typically performed between 15 and 20 weeks of pregnancy.\n4. The primary purpose of the triple screening test is to detect the risk of certain birth defects and potential issues with the pregnancy.\n5. The triple screening test is not diagnostic and can't predict with 100% accuracy whether a baby will have a birth defect or chromosomal abnormality.",
    "vicuna-13b_fact": [
      "The triple screening test is a blood test performed during pregnancy that measures levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated estriol (uE3).",
      "These substances measured in the triple screening test are produced by the developing fetus and can be detected in the mother's blood.",
      "The triple screening test is typically performed between 15 and 20 weeks of pregnancy.",
      "The primary purpose of the triple screening test is to detect the risk of certain birth defects and potential issues with the pregnancy.",
      "The triple screening test is not diagnostic and can't predict with 100% accuracy whether a baby will have a birth defect or chromosomal abnormality."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1249,
    "user_query": "Which protein interacts with the Ragulator-RAG GTPases to control mTOR activity?",
    "vicuna-13b_response": "The protein that interacts with the Ragulator-RAG GTPases to control mTOR activity is mammalian lethal with SEC13 protein 8 (mLST8). mLST8 is a protein that regulates the activity of the mTOR complex 1 (mTORC1) by interacting with the Ragulator-RAG GTPases, which are involved in the regulation of mTORC1 activity. mLST8 promotes the interaction between the Ragulator-RAG GTPases and mTORC1, leading to the activation of mTORC1 and the subsequent activation of protein synthesis and cell growth.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The protein mammalian lethal with SEC13 protein 8 (mLST8) interacts with the Ragulator-RAG GTPases to control mTOR activity.\n2. mLST8 is a protein that regulates the activity of mTOR complex 1 (mTORC1).\n3. Ragulator-RAG GTPases influence the regulation of mTORC1 activity.\n4. mLST8 promotes the interaction between the Ragulator-RAG GTPases and mTORC1.\n5. Activation of mTORC1 leads to the subsequent activation of protein synthesis and cell growth.",
    "vicuna-13b_fact": [
      "The protein mammalian lethal with SEC13 protein 8 (mLST8) interacts with the Ragulator-RAG GTPases to control mTOR activity.",
      "mLST8 is a protein that regulates the activity of mTOR complex 1 (mTORC1).",
      "Ragulator-RAG GTPases influence the regulation of mTORC1 activity.",
      "mLST8 promotes the interaction between the Ragulator-RAG GTPases and mTORC1.",
      "Activation of mTORC1 leads to the subsequent activation of protein synthesis and cell growth."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "vicuna-13b_response": "Galassi classification is used for the classification of mental and behavioral disorders. It is a system of classification that was developed by the Italian psychiatrist, Enrico Galassi, in the early 20th century. The Galassi classification system is based on the principle of grouping disorders based on their underlying psychological mechanisms, rather than on their symptoms or external features.\nThe Galassi classification system is divided into three main categories:\n1. Psychoneurotic disorders: These are disorders that are characterized by anxiety, depression, and other emotional disturbances.\n2. Personality disorders: These are disorders that are characterized by long-term patterns of behavior and thinking that deviate from the norm of the individual's culture.\n3. Organic mental disorders: These are disorders that are caused by physical illness or injury, or by the use of certain medications.\nThe Galassi classification system is not widely used in modern psychiatry, as it has been replaced by other classification systems, such as the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD). However, the principles of the Galassi classification system continue to influence the way that mental and behavioral disorders are understood and treated.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Galassi classification is used for the classification of mental and behavioral disorders.\n2. The Galassi classification system was developed by Italian psychiatrist, Enrico Galassi.\n3. The Galassi classification divides disorders into three categories: Psychoneurotic disorders, Personality disorders, and Organic mental disorders.\n4. The Galassi classification system is not widely used in modern psychiatry.\n5. The Galassi classification system has been replaced by the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD).",
    "vicuna-13b_fact": [
      "Galassi classification is used for the classification of mental and behavioral disorders.",
      "The Galassi classification system was developed by Italian psychiatrist, Enrico Galassi.",
      "The Galassi classification divides disorders into three categories: Psychoneurotic disorders, Personality disorders, and Organic mental disorders.",
      "The Galassi classification system is not widely used in modern psychiatry.",
      "The Galassi classification system has been replaced by the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD)."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Galassi classification is not used for the classification of mental and behavioral disorders. It is a classification system for types of femoral neck fractures.\n2. FALSE [correction]: The Galassi classification system was not developed by Italian psychiatrist, Enrico Galassi. It is a classification system for types of femoral neck fractures developed by orthopedic surgeon, Arthur G. Galassi.\n3. FALSE [correction]: The Galassi classification does not divide disorders into three categories: Psychoneurotic disorders, Personality disorders, and Organic mental disorders. It classifies femoral neck fractures into three types based on the complexity and location of the fracture.\n4. UNKNOWN \n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1258,
    "user_query": "List fluorescent reporter proteins.",
    "vicuna-13b_response": "Fluorescent reporter proteins are proteins that can be used to monitor the activity of a specific gene or protein in a living cell or organism. These proteins typically consist of a DNA-binding domain, which allows them to localize to specific regions of the genome, and a fluorescent reporter molecule, which can be used to visualize the localization of the protein in real-time. Some examples of fluorescent reporter proteins include:\n1. Green Fluorescent Protein (GFP): This is a widely used fluorescent reporter protein that is derived from the jellyfish Aequorea victoria. GFP is a monomeric protein that is capable of emitting bright green fluorescence when excited with blue or ultraviolet light. GFP is commonly used to label and track cells, proteins, and other biomolecules in living cells and organisms.\n2. Red Fluorescent Protein (RFP): This is a fluorescent reporter protein that is derived from the coral species Discosoma sp. RFP is a monomeric protein that is capable of emitting bright red fluorescence when excited with blue or ultraviolet light. RFP is commonly used to label and track cells, proteins, and other biomolecules in living cells and organisms.\n3. Yellow Fluorescent Protein (YFP): This is a fluorescent reporter protein that is derived from the jellyfish Phialella zappai. YFP is a monomeric protein that is capable of emitting yellow fluorescence when excited with blue or ultraviolet light. YFP is commonly used to label and track cells, proteins, and other biomolecules in living cells and organisms.\n4. Cyan Fluorescent Protein (CFP): This is a fluorescent reporter protein that is derived from the marine alga Volvox carteri. CFP is a monomeric protein that is capable of emitting blue fluorescence when excited with ultraviolet light. CFP is commonly used to label and track cells, proteins, and other biomolecules in living cells and organisms.\n5. Far-Red Fluorescent Protein (FRFP): This is a fluorescent reporter protein that is derived from",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fluorescent reporter proteins are used to monitor the activity of a specific gene or protein in a living cell or organism.\n2. Green Fluorescent Protein (GFP) is derived from the jellyfish Aequorea victoria.\n3. Red Fluorescent Protein (RFP) is derived from the coral species Discosoma sp.\n4. Yellow Fluorescent Protein (YFP) is derived from the jellyfish Phialella zappai.\n5. Cyan Fluorescent Protein (CFP) is derived from the marine alga Volvox carteri.",
    "vicuna-13b_fact": [
      "Fluorescent reporter proteins are used to monitor the activity of a specific gene or protein in a living cell or organism.",
      "Green Fluorescent Protein (GFP) is derived from the jellyfish Aequorea victoria.",
      "Red Fluorescent Protein (RFP) is derived from the coral species Discosoma sp.",
      "Yellow Fluorescent Protein (YFP) is derived from the jellyfish Phialella zappai.",
      "Cyan Fluorescent Protein (CFP) is derived from the marine alga Volvox carteri."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Yellow Fluorescent Protein (YFP) is a genetic mutant of Green Fluorescent Protein (GFP).\n5. FALSE [correction]: Cyan Fluorescent Protein (CFP) is also a genetic mutant of Green Fluorescent Protein (GFP), not derived from Volvox carteri.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1259,
    "user_query": "By which mechanism MutT proteins act against DNA lesions in bacteria?",
    "vicuna-13b_response": "MutT proteins are a family of DNA repair enzymes that play a crucial role in protecting bacterial cells against DNA damage caused by various types of mutagens, including alkylating agents, oxidative stress, and UV radiation. MutT proteins are responsible for recognizing and removing a variety of DNA lesions, including base modifications, such as methylated or hydroxylated bases, and DNA adducts, such as cross-links and interstrand cross-links.\nThe mechanism by which MutT proteins act against DNA lesions involves several steps:\n1. Recognition: MutT proteins recognize specific DNA lesions through their binding domains, which are highly specific for particular types of DNA damage.\n2. Unwinding: Once a lesion is recognized, MutT proteins unwind the DNA helix and create a Y-shaped structure called a replication fork, which allows for the efficient repair of the damaged region.\n3. Repair: MutT proteins then recruit other repair enzymes, such as DNA polymerase and ligase, to the site of the lesion. These enzymes work together to repair the damaged DNA by either removing the lesion or replacing the damaged base with a correct base.\n4. Rejoining: Once the repair is complete, the MutT protein helps to rejoin the two strands of the DNA helix, ensuring that the genome is restored to its original state.\nOverall, MutT proteins play a crucial role in maintaining the integrity of the bacterial genome by removing DNA lesions and ensuring the accurate replication of the genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MutT proteins are a family of DNA repair enzymes.\n2. They play a crucial role in protecting bacterial cells against DNA damage caused by various types of mutagens, including alkylating agents, oxidative stress, and UV radiation.\n3. MutT proteins recognize and remove DNA lesions, including base modifications and DNA adducts.\n4. The mechanism by which MutT proteins act against DNA lesions involves several steps, including recognition, unwinding, repair, and rejoining.\n5. MutT proteins play a crucial role in maintaining the integrity of the bacterial genome by removing DNA lesions and ensuring the accurate replication of the genome.",
    "vicuna-13b_fact": [
      "MutT proteins are a family of DNA repair enzymes.",
      "They play a crucial role in protecting bacterial cells against DNA damage caused by various types of mutagens, including alkylating agents, oxidative stress, and UV radiation.",
      "MutT proteins recognize and remove DNA lesions, including base modifications and DNA adducts.",
      "The mechanism by which MutT proteins act against DNA lesions involves several steps, including recognition, unwinding, repair, and rejoining.",
      "MutT proteins play a crucial role in maintaining the integrity of the bacterial genome by removing DNA lesions and ensuring the accurate replication of the genome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE \n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1269,
    "user_query": "Which is the molecular function of the protein CCDC40?",
    "vicuna-13b_response": "CCDC40 is a protein that is involved in several cellular processes, including cell cycle progression, apoptosis, and protein folding. Its molecular function is not well understood, but it is thought to play a role in the regulation of cellular events.\nOne study suggests that CCDC40 may act as a chaperone, helping to fold and assemble other proteins. It has also been shown to interact with other proteins, such as p53 and CDK1, which are involved in cell cycle regulation and apoptosis.\nOverall, the exact molecular function of CCDC40 is still being studied and is an active area of research.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CCDC40 is a protein involved in various cellular processes including cell cycle progression, apoptosis, and protein folding.\n2. The molecular function of CCDC40 is not well understood.\n3. Some studies suggest CCDC40 may act as a chaperone to help fold and assemble other proteins.\n4. CCDC40 has been shown to interact with other proteins, such as p53 and CDK1.\n5. The molecular function of CCDC40 is an active area of research.",
    "vicuna-13b_fact": [
      "CCDC40 is a protein involved in various cellular processes including cell cycle progression, apoptosis, and protein folding.",
      "The molecular function of CCDC40 is not well understood.",
      "Some studies suggest CCDC40 may act as a chaperone to help fold and assemble other proteins.",
      "CCDC40 has been shown to interact with other proteins, such as p53 and CDK1.",
      "The molecular function of CCDC40 is an active area of research."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1273,
    "user_query": "What is Cerebral Cavernous Malformation?",
    "vicuna-13b_response": "Cerebral cavernous malformations (CCMs) are a type of vascular malformation that affects the brain. They are also known as cavernous angiomas or cavernomas. CCMs are composed of a network of abnormal blood vessels that are filled with blood and have a thick, muscular wall. These blood vessels are usually located in the brain, but they can also occur in other parts of the body, including the spinal cord, kidneys, and lungs.\nCCMs are congenital, meaning that they are present at birth, and they can be found in up to 1 in 200 people. They are more common in women than in men, and they can occur in people of all ages. CCMs can be small, medium, or large in size, and they can cause a range of symptoms depending on their size and location.\nThe most common symptoms of CCMs are seizures, headaches, and stroke-like symptoms such as weakness or numbness on one side of the body. CCMs can also cause other symptoms, such as vision problems, difficulty speaking or swallowing, and changes in mood or behavior.\nThe diagnosis of CCMs is typically made through a combination of imaging studies, such as MRI or CT scans, and clinical evaluation. Treatment options for CCMs include surgery, radiation therapy, and medications to control seizures or other symptoms. The goal of treatment is to manage symptoms and prevent complications, such as stroke or seizures.\nIt is important to note that CCMs are usually benign and do not require treatment unless they cause symptoms or pose a risk of complications. However, people with CCMs should be closely monitored by a healthcare provider to ensure that any changes in symptoms or size of the malformation are detected and treated appropriately.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cerebral cavernous malformations (CCMs) are vascular malformations that affect the brain and other parts of the body such as the spinal cord, kidneys, and lungs.\n2. CCMs are congenital, meaning that they are present at birth.\n3. CCMs can be found in up to 1 in 200 people and are more common in women than in men.\n4. Common symptoms of CCMs include seizures, headaches, and stroke-like symptoms such as weakness or numbness on one side of the body.\n5. The diagnosis of CCMs is typically made through MRI or CT scans and clinical evaluation.",
    "vicuna-13b_fact": [
      "Cerebral cavernous malformations (CCMs) are vascular malformations that affect the brain and other parts of the body such as the spinal cord, kidneys, and lungs.",
      "CCMs are congenital, meaning that they are present at birth.",
      "CCMs can be found in up to 1 in 200 people and are more common in women than in men.",
      "Common symptoms of CCMs include seizures, headaches, and stroke-like symptoms such as weakness or numbness on one side of the body.",
      "The diagnosis of CCMs is typically made through MRI or CT scans and clinical evaluation."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Cerebral cavernous malformations (CCMs) are vascular malformations that affect the brain and spinal cord, not the kidneys or lungs.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1275,
    "user_query": "Which protein pathway is regulating SGK1-mediated phosphorylation of FOXO3a to control cell proliferation?",
    "vicuna-13b_response": "SGK1 (Serum/glucocorticoid-regulated kinase 1) is a protein kinase that is known to regulate cell proliferation through the phosphorylation of FOXO3a (Forkhead box O3a), a transcription factor that plays a role in cell cycle regulation. The specific protein pathway that regulates this process is the PI3K/Akt pathway.\nWhen activated by insulin or other growth factors, the PI3K/Akt pathway leads to the phosphorylation of Akt at Ser473, which in turn activates Akt to promote cell survival and proliferation. One of the downstream targets of Akt is SGK1, which is phosphorylated and activated by Akt. Once activated, SGK1 can phosphorylate and inactivate FOXO3a, leading to the promotion of cell proliferation.\nIn conclusion, the protein pathway that regulates SGK1-mediated phosphorylation of FOXO3a to control cell proliferation is the PI3K/Akt pathway.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Serum/glucocorticoid-regulated kinase 1 (SGK1) is a protein kinase that regulates cell proliferation. \n2. Forkhead box O3a (FOXO3a) is a transcription factor that plays a role in cell cycle regulation.\n3. The PI3K/Akt pathway regulates the SGK1-mediated phosphorylation of FOXO3a.\n4. The PI3K/Akt pathway leads to the phosphorylation of Akt at Ser473 when activated by insulin or other growth factors.\n5. Once activated, SGK1 can phosphorylate and inactivate FOXO3a, promoting cell proliferation.",
    "vicuna-13b_fact": [
      "Serum/glucocorticoid-regulated kinase 1 (SGK1) is a protein kinase that regulates cell proliferation.",
      "Forkhead box O3a (FOXO3a) is a transcription factor that plays a role in cell cycle regulation.",
      "The PI3K/Akt pathway regulates the SGK1-mediated phosphorylation of FOXO3a.",
      "The PI3K/Akt pathway leads to the phosphorylation of Akt at Ser473 when activated by insulin or other growth factors.",
      "Once activated, SGK1 can phosphorylate and inactivate FOXO3a, promoting cell proliferation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1281,
    "user_query": "Is TNNI3K a cardiac-specific protein?",
    "vicuna-13b_response": "TNNI3K (also known as CASQ1) is a protein that is expressed in the heart, but it is also expressed in other tissues, such as the brain, pancreas, and kidney. It is not exclusively a cardiac-specific protein. However, it plays an important role in cardiac physiology, particularly in the regulation of cardiac contractility and calcium handling.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TNNI3K is also known as CASQ1.\n2. TNNI3K is a protein that is expressed in the heart.\n3. TNNI3K is also expressed in other tissues, such as the brain, pancreas, and kidney.\n4. TNNI3K is not exclusively a cardiac-specific protein.\n5. TNNI3K plays an important role in cardiac physiology.",
    "vicuna-13b_fact": [
      "TNNI3K is also known as CASQ1.",
      "TNNI3K is a protein that is expressed in the heart.",
      "TNNI3K is also expressed in other tissues, such as the brain, pancreas, and kidney.",
      "TNNI3K is not exclusively a cardiac-specific protein.",
      "TNNI3K plays an important role in cardiac physiology."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: TNNI3K is also known as TNNI3 Interacting Kinase, not CASQ1.\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1287,
    "user_query": "Can the apoptosis regulator BAX trigger the release of cytochrome c?",
    "vicuna-13b_response": "Yes, the apoptosis regulator BAX can trigger the release of cytochrome c from the mitochondria. BAX is a member of the Bcl-2 protein family, which plays a critical role in regulating apoptosis, or programmed cell death. BAX is a pro-apoptotic protein that can induce mitochondrial outer membrane permeabilization (MOMP), leading to the release of cytochrome c and other pro-apoptotic factors from the mitochondria.\nWhen BAX binds to the mitochondrial outer membrane, it forms pores that disrupt the membrane integrity, leading to the release of cytochrome c and other pro-apoptotic factors into the cytosol. These factors then trigger a cascade of events that ultimately lead to cell death.\nIn conclusion, BAX plays a crucial role in triggering the release of cytochrome c from the mitochondria, which is a key event in the process of apoptosis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The apoptosis regulator BAX can trigger the release of cytochrome c from the mitochondria.\n2. BAX is a member of the Bcl-2 protein family.\n3. Bcl-2 protein family has a critical role in regulating apoptosis, or programmed cell death.\n4. BAX binds to the mitochondrial outer membrane and forms pores that disrupt the membrane integrity.\n5. The release of cytochrome c and other pro-apoptotic factors from the mitochondria triggers a series of events that lead to cell death.",
    "vicuna-13b_fact": [
      "The apoptosis regulator BAX can trigger the release of cytochrome c from the mitochondria.",
      "BAX is a member of the Bcl-2 protein family.",
      "Bcl-2 protein family has a critical role in regulating apoptosis, or programmed cell death.",
      "BAX binds to the mitochondrial outer membrane and forms pores that disrupt the membrane integrity.",
      "The release of cytochrome c and other pro-apoptotic factors from the mitochondria triggers a series of events that lead to cell death."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1289,
    "user_query": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients",
    "vicuna-13b_response": "BRAF inhibitors are a type of targeted therapy used to treat melanoma patients. Here are some BRAF inhibitors that have been tested in clinical trials:\n1. Vemurafenib (Zelboraf)\n2. Dabrafenib (Tafinlar)\n3. Trametinib (Mekinist)\n4. Encorafenib (Braftovi)\n5. Binimetinib (Mekinist)\nThese BRAF inhibitors have been shown to be effective in treating certain types of melanoma, particularly those with BRAF mutations. However, it's important to note that not all patients respond to these therapies, and some may experience side effects. It's important for patients to discuss the potential benefits and risks of BRAF inhibitors with their healthcare provider before starting treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BRAF inhibitors are a type of targeted therapy used to treat melanoma patients.\n2. Vemurafenib (Zelboraf) is a BRAF inhibitor that has been tested in clinical trials.\n3. Dabrafenib (Tafinlar) is a BRAF inhibitor that has been tested in clinical trials.\n4. Trametinib (Mekinist) is a BRAF inhibitor that has been tested in clinical trials.\n5. Encorafenib (Braftovi) and Binimetinib (Mekinist) are BRAF inhibitors that have been tested in clinical trials.",
    "vicuna-13b_fact": [
      "BRAF inhibitors are a type of targeted therapy used to treat melanoma patients.",
      "Vemurafenib (Zelboraf) is a BRAF inhibitor that has been tested in clinical trials.",
      "Dabrafenib (Tafinlar) is a BRAF inhibitor that has been tested in clinical trials.",
      "Trametinib (Mekinist) is a BRAF inhibitor that has been tested in clinical trials.",
      "Encorafenib (Braftovi) and Binimetinib (Mekinist) are BRAF inhibitors that have been tested in clinical trials."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Trametinib (Mekinist) is a MEK inhibitor that has been tested in clinical trials.\n5. FALSE [correction]: Encorafenib (Braftovi) is a BRAF inhibitor and Binimetinib (Mektovi) is a MEK inhibitor. Both have been tested in clinical trials.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1292,
    "user_query": "Which are the coactivators of the Yes-associated protein (yap)?",
    "vicuna-13b_response": "The coactivators of the Yes-associated protein (YAP) are proteins that interact with YAP and enhance its transcriptional activity. Some of the known coactivators of YAP include:\n1. PGC-1α: This protein is a transcriptional coactivator that regulates the expression of genes involved in mitochondrial biogenesis, oxidative phosphorylation, and other metabolic pathways. PGC-1α has been shown to interact with YAP and enhance its transcriptional activity in various cell types.\n2. PPARγ: This protein is a nuclear receptor that regulates the expression of genes involved in lipid metabolism, glucose homeostasis, and other processes. PPARγ has been shown to interact with YAP and enhance its transcriptional activity in adipocytes and other cell types.\n3. PAX7: This protein is a transcriptional factor that regulates the expression of genes involved in muscle development and differentiation. PAX7 has been shown to interact with YAP and enhance its transcriptional activity in muscle cells.\n4. PAX3: This protein is a transcriptional factor that regulates the expression of genes involved in development, differentiation, and oncogenesis. PAX3 has been shown to interact with YAP and enhance its transcriptional activity in various cell types.\n5. PPARα: This protein is a nuclear receptor that regulates the expression of genes involved in lipid metabolism, glucose homeostasis, and other processes. PPARα has been shown to interact with YAP and enhance its transcriptional activity in various cell types.\nThese are some of the known coactivators of YAP, and it is likely that additional coactivators will be identified in the future.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Coactivators of the Yes-associated protein (YAP) interact with YAP and enhance its transcriptional activity.\n2. PGC-1α is a known coactivator of YAP that interacts with it in various cell types.\n3. PPARγ interacts with YAP and enhances its transcriptional activity in adipocytes and other cell types.\n4. PAX7 is a coactivator of YAP that enhances its transcriptional activity in muscle cells.\n5. PAX3 and PPARα interact with YAP and enhance its transcriptional activity in various cell types.",
    "vicuna-13b_fact": [
      "Coactivators of the Yes-associated protein (YAP) interact with YAP and enhance its transcriptional activity.",
      "PGC-1α is a known coactivator of YAP that interacts with it in various cell types.",
      "PPARγ interacts with YAP and enhances its transcriptional activity in adipocytes and other cell types.",
      "PAX7 is a coactivator of YAP that enhances its transcriptional activity in muscle cells.",
      "PAX3 and PPARα interact with YAP and enhance its transcriptional activity in various cell types."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1296,
    "user_query": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?",
    "vicuna-13b_response": "During the process of epithelial-mesenchymal transition (EMT), cells lose their cell-cell adhesion properties and acquire a more mobile and mesenchymal phenotype. This process is essential for tissue development and regeneration, but it can also be involved in the progression of certain diseases, such as cancer.\nSeveral proteins have been identified as being involved in the loss of cell-cell adhesion during EMT. One of the most well-known is the transcription factor Snail, which represses the expression of genes involved in cell-cell adhesion and promotes the expression of genes involved in mesenchymal characteristics. Other proteins that have been implicated in this process include Zeb1, Zeb2, and Twist, which also play important roles in regulating EMT.\nIn addition to these transcription factors, there are also several signaling pathways that are involved in the regulation of EMT and the loss of cell-cell adhesion. These include the TGF-β pathway, the PI3K/Akt pathway, and the Wnt/β-catenin pathway, among others.\nOverall, the loss of cell-cell adhesion during EMT is a complex process that is regulated by a variety of proteins and signaling pathways. Understanding the mechanisms involved in this process is important for developing new therapeutic strategies to treat diseases that are associated with abnormal EMT, such as cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. During epithelial-mesenchymal transition (EMT), cells lose their cell-cell adhesion properties and acquire a more mobile and mesenchymal phenotype.\n2. This process is involved in the progression of diseases like cancer.\n3. The transcription factor Snail is associated with the loss of cell-cell adhesion during EMT.\n4. Other proteins implicated in loss of cell-cell adhesion during EMT include Zeb1, Zeb2, and Twist.\n5. The TGF-β pathway, the PI3K/Akt pathway, and the Wnt/β-catenin pathway are among the signaling pathways involved in the regulation of EMT and the loss of cell-cell adhesion.",
    "vicuna-13b_fact": [
      "During epithelial-mesenchymal transition (EMT), cells lose their cell-cell adhesion properties and acquire a more mobile and mesenchymal phenotype.",
      "This process is involved in the progression of diseases like cancer.",
      "The transcription factor Snail is associated with the loss of cell-cell adhesion during EMT.",
      "Other proteins implicated in loss of cell-cell adhesion during EMT include Zeb1, Zeb2, and Twist.",
      "The TGF-β pathway, the PI3K/Akt pathway, and the Wnt/β-catenin pathway are among the signaling pathways involved in the regulation of EMT and the loss of cell-cell adhesion."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1300,
    "user_query": "What is known about diseases associated with mutations in the CHCHD10 gene?",
    "vicuna-13b_response": "CHCHD10 is a gene that provides instructions for making a protein called CHCHD10. This protein is involved in many cellular processes, including the regulation of chromatin structure, which is the way that DNA is packaged within a cell.\nMutations in the CHCHD10 gene have been associated with several diseases, including:\n1. Cornelia de Lange syndrome: This is a rare genetic disorder that affects growth and development. People with this condition typically have developmental delays, intellectual disability, and physical abnormalities, such as limb differences and facial features that are distinctive but variable. Mutations in the CHCHD10 gene have been identified as a cause of Cornelia de Lange syndrome.\n2. Joubert syndrome: This is a rare genetic disorder that affects the brain and other parts of the body. People with Joubert syndrome typically have developmental delays, intellectual disability, and a characteristic facial appearance. Mutations in the CHCHD10 gene have been identified as a cause of Joubert syndrome.\n3. Mowat-Wilson syndrome: This is a rare genetic disorder that affects growth and development. People with this condition typically have developmental delays, intellectual disability, and a characteristic facial appearance. Mutations in the CHCHD10 gene have been identified as a cause of Mowat-Wilson syndrome.\nIt is important to note that these are the only diseases that have been associated with mutations in the CHCHD10 gene, and more research is needed to understand the full clinical spectrum of diseases associated with CHCHD10 mutations.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CHCHD10 is a gene that provides instructions for making a protein called CHCHD10.\n2. The protein CHCHD10 is involved in many cellular processes, including the regulation of chromatin structure.\n3. Mutations in the CHCHD10 gene have been associated with Cornelia de Lange syndrome.\n4. Mutations in the CHCHD10 gene have been associated with Joubert syndrome.\n5. Mutations in the CHCHD10 gene have been associated with Mowat-Wilson syndrome.",
    "vicuna-13b_fact": [
      "CHCHD10 is a gene that provides instructions for making a protein called CHCHD10.",
      "The protein CHCHD10 is involved in many cellular processes, including the regulation of chromatin structure.",
      "Mutations in the CHCHD10 gene have been associated with Cornelia de Lange syndrome.",
      "Mutations in the CHCHD10 gene have been associated with Joubert syndrome.",
      "Mutations in the CHCHD10 gene have been associated with Mowat-Wilson syndrome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The protein CHCHD10 is involved in many cellular processes, including the regulation of cellular energy production and the response to cellular stress.\n3. FALSE [correction]: Mutations in the CHCHD10 gene have not been associated with Cornelia de Lange syndrome.\n4. FALSE [correction]: Mutations in the CHCHD10 gene have not been associated with Joubert syndrome.\n5. FALSE [correction]: Mutations in the CHCHD10 gene have not been associated with Mowat-Wilson syndrome. Instead, they have been linked with certain forms of motor neuron disease and dementia.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "vicuna-13b_response": "Shapiro syndrome, also known as Shapiro-Thompson syndrome, is a rare genetic disorder that affects the development of the eyes, ears, and other parts of the body. Some common features of this condition include:\n1. Developmental delays: Children with Shapiro syndrome may experience developmental delays in reaching certain milestones, such as crawling, walking, and talking.\n2. Intellectual disability: Many individuals with Shapiro syndrome have some degree of intellectual disability, which can range from mild to severe.\n3. Eye abnormalities: People with Shapiro syndrome often have abnormalities of the eyes, such as cataracts, glaucoma, and strabismus (a condition in which the eyes do not align properly).\n4. Hearing loss: Many individuals with Shapiro syndrome have hearing loss, which can range from mild to severe.\n5. Facial abnormalities: Some people with Shapiro syndrome have distinctive facial features, such as a flat face, a small jaw, and a broad nasal bridge.\n6. Skeletal abnormalities: People with Shapiro syndrome may have abnormalities of the skeletal system, such as short stature, joint laxity, and loose ligaments.\n7. Cardiovascular problems: Some individuals with Shapiro syndrome may have heart defects or other cardiovascular problems.\n8. Kidney problems: Some people with Shapiro syndrome may have kidney problems, such as nephrotic syndrome (a condition in which the kidneys do not properly filter waste and fluids from the blood).\nIt's important to note that not everyone with Shapiro syndrome will have all of these features, and the severity of the condition can vary from person to person.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Shapiro syndrome is a rare genetic disorder that affects the development of the eyes, ears, and other parts of the body.\n2. People with Shapiro syndrome may experience developmental delays.\n3. Intellectual disability can often be seen in individuals with Shapiro syndrome.\n4. Abnormalities of the eyes, such as cataracts, glaucoma, and strabismus are often present in people with Shapiro syndrome.\n5. Many individuals with Shapiro syndrome have hearing loss.\n6. Distinctive facial features may exist in some people with Shapiro syndrome, such as a flat face, a small jaw, and a broad nasal bridge.\n7. Shapiro Syndrome can result in skeletal abnormalities, such as short stature, joint laxity, and loose ligaments.\n8. Some individuals with Shapiro syndrome may have heart defects or other cardiovascular problems.\n9. Some people with Shapiro syndrome may have kidney problems, such as nephrotic syndrome.",
    "vicuna-13b_fact": [
      "Shapiro syndrome is a rare genetic disorder that affects the development of the eyes, ears, and other parts of the body.",
      "People with Shapiro syndrome may experience developmental delays.",
      "Intellectual disability can often be seen in individuals with Shapiro syndrome.",
      "Abnormalities of the eyes, such as cataracts, glaucoma, and strabismus are often present in people with Shapiro syndrome.",
      "Many individuals with Shapiro syndrome have hearing loss.",
      "Distinctive facial features may exist in some people with Shapiro syndrome, such as a flat face, a small jaw, and a broad nasal bridge.",
      "Shapiro Syndrome can result in skeletal abnormalities, such as short stature, joint laxity, and loose ligaments.",
      "Some individuals with Shapiro syndrome may have heart defects or other cardiovascular problems.",
      "Some people with Shapiro syndrome may have kidney problems, such as nephrotic syndrome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Shapiro syndrome is a rare genetic disorder characterized by recurrent episodes of excessive sweating and heat intolerance, along with a loss of deep tendon reflexes and a decrease in muscle tone.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While Shapiro syndrome can involve ocular abnormalities, they do not typically include cataracts, glaucoma, and strabismus.\n5. UNKNOWN\n6. UNKNOWN\n7. FALSE [correction]: Shapiro Syndrome does not directly result in skeletal abnormalities such as short stature, joint laxity, and loose ligaments.\n8. UNKNOWN\n9. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1309,
    "user_query": "What is the role of the histidine rich calcium binding protein (HRC) in cardiomyopathy?",
    "vicuna-13b_response": "The histidine rich calcium binding protein (HRC) is a protein that is found in the heart and is involved in regulating the contraction and relaxation of heart muscle cells. In cardiomyopathy, a group of diseases that affect the heart muscle, the function of HRC is disrupted, leading to abnormal contractions and potentially leading to heart failure. HRC plays a role in the regulation of calcium ions, which are important in the contraction of heart muscle cells. In cardiomyopathy, the dysfunction of HRC can lead to an imbalance in the levels of calcium ions, which can lead to abnormal contractions and heart failure. Additionally, HRC also plays a role in the regulation of the amount of calcium that enters the heart muscle cells, and in cardiomyopathy, the dysfunction of HRC can lead to an increase in the amount of calcium that enters the heart muscle cells, which can also contribute to heart failure.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The histidine rich calcium binding protein (HRC) is a protein found in the heart.\n2. HRC is involved in regulating the contraction and relaxation of heart muscle cells.\n3. In cardiomyopathy, the function of HRC can be disrupted leading to abnormal contractions and potentially heart failure.\n4. HRC plays a role in the regulation of calcium ions, which are important in the contraction of heart muscle cells.\n5. In cardiomyopathy, the dysfunction of HRC can lead to an increase in the amount of calcium that enters the heart muscle cells, contributing to heart failure.",
    "vicuna-13b_fact": [
      "The histidine rich calcium binding protein (HRC) is a protein found in the heart.",
      "HRC is involved in regulating the contraction and relaxation of heart muscle cells.",
      "In cardiomyopathy, the function of HRC can be disrupted leading to abnormal contractions and potentially heart failure.",
      "HRC plays a role in the regulation of calcium ions, which are important in the contraction of heart muscle cells.",
      "In cardiomyopathy, the dysfunction of HRC can lead to an increase in the amount of calcium that enters the heart muscle cells, contributing to heart failure."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1312,
    "user_query": "Which post-translational histone modifications are characteristic of facultative heterochromatin?",
    "vicuna-13b_response": "Facultative heterochromatin is a type of chromatin that can be either active or inactive, depending on the cellular context. The post-translational histone modifications that are characteristic of facultative heterochromatin include:\n1. Histone H3 lysine 4 trimethylation (H3K4me3): This modification is typically associated with active chromatin and is thought to promote transcriptional activation. However, in facultative heterochromatin, H3K4me3 may also be present in regions that are repressed or poised for repression.\n2. Histone H3 lysine 27 trimethylation (H3K27me3): This modification is typically associated with repressed chromatin and is thought to promote transcriptional silencing. However, in facultative heterochromatin, H3K27me3 may also be present in regions that are poised for activation.\n3. Histone H3 lysine 9 dimethylation (H3K9me2): This modification is thought to promote chromatin compaction and may be present in both active and repressed chromatin regions.\n4. Histone H3 lysine 18 acetylation (H3K18ac): This modification is thought to promote transcriptional activation and may be present in active chromatin regions.\nOverall, the presence of these modifications in a particular region of the genome can provide insight into its potential activity or repression status. However, it is important to note that the presence of these modifications does not necessarily indicate a definitive chromatin state, as multiple modifications can coexist in a single region, and the relative levels of these modifications can also change dynamically in response to different cellular signals.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Facultative heterochromatin is a type of chromatin that can be either active or inactive, depending on the cellular context.\n2. Histone H3 lysine 4 trimethylation is typically associated with active chromatin but can also be present in repressed or poised regions of facultative heterochromatin.\n3. Histone H3 lysine 27 trimethylation is typically associated with repressed chromatin but can also be present in regions poised for activation in facultative heterochromatin.\n4. Histone H3 lysine 9 dimethylation is thought to promote chromatin compaction and may be present in both active and repressed chromatin regions.\n5. Histone H3 lysine 18 acetylation is thought to promote transcriptional activation and may be present in active chromatin regions.",
    "vicuna-13b_fact": [
      "Facultative heterochromatin is a type of chromatin that can be either active or inactive, depending on the cellular context.",
      "Histone H3 lysine 4 trimethylation is typically associated with active chromatin but can also be present in repressed or poised regions of facultative heterochromatin.",
      "Histone H3 lysine 27 trimethylation is typically associated with repressed chromatin but can also be present in regions poised for activation in facultative heterochromatin.",
      "Histone H3 lysine 9 dimethylation is thought to promote chromatin compaction and may be present in both active and repressed chromatin regions.",
      "Histone H3 lysine 18 acetylation is thought to promote transcriptional activation and may be present in active chromatin regions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1313,
    "user_query": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?",
    "vicuna-13b_response": "Aicardi-Goutieres syndrome is a rare genetic disorder that is characterized by severe inflammation and damage to the brain and spinal cord, as well as other symptoms such as fever, rash, and joint pain. It is caused by mutations in the TREX1 gene, which is responsible for regulating the body's immune response.\nThe TREX1 gene provides instructions for making an enzyme called TREX1 protein, which is involved in the process by which the body recognizes and eliminates damaged or infected cells. When the TREX1 gene is mutated, it can lead to an overactive immune response, which can cause the damage to the brain and spinal cord that is characteristic of Aicardi-Goutieres syndrome.\nThere are several different types of mutations that can occur in the TREX1 gene, and each type of mutation can have a different effect on the function of the TREX1 protein. Some mutations may lead to a complete loss of TREX1 protein function, while others may result in a reduced level of TREX1 protein or a protein that is not properly processed.\nIt is important to note that Aicardi-Goutieres syndrome is a rare disorder, and it is estimated to occur in approximately 1 in 100,000 newborns. It is more common in girls than in boys, and it typically presents in the first few months of life. The diagnosis of Aicardi-Goutieres syndrome is based on a combination of clinical symptoms and genetic testing, which can confirm the presence of a mutation in the TREX1 gene.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Aicardi-Goutieres syndrome is a rare genetic disorder characterized by severe inflammation and damage to the brain and spinal cord.\n2. Mutations in the TREX1 gene cause Aicardi-Goutieres syndrome.\n3. The TREX1 gene provides instructions for making an enzyme called TREX1 protein, which is involved in the process by which the body recognizes and eliminates damaged or infected cells.\n4. Multiple types of mutations can occur in the TREX1 gene, affecting the function of the TREX1 protein in different ways.\n5. Aicardi-Goutieres syndrome is estimated to occur in approximately 1 in 100,000 newborns, and is more common in girls than boys.",
    "vicuna-13b_fact": [
      "Aicardi-Goutieres syndrome is a rare genetic disorder characterized by severe inflammation and damage to the brain and spinal cord.",
      "Mutations in the TREX1 gene cause Aicardi-Goutieres syndrome.",
      "The TREX1 gene provides instructions for making an enzyme called TREX1 protein, which is involved in the process by which the body recognizes and eliminates damaged or infected cells.",
      "Multiple types of mutations can occur in the TREX1 gene, affecting the function of the TREX1 protein in different ways.",
      "Aicardi-Goutieres syndrome is estimated to occur in approximately 1 in 100,000 newborns, and is more common in girls than boys."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1317,
    "user_query": "What is the mechanism of action of abiraterone?",
    "vicuna-13b_response": "Abiraterone is a medication used to treat prostate cancer. It works by inhibiting the activity of an enzyme called CYP17A1, which is involved in the production of hormones that promote the growth of prostate cancer cells. By inhibiting CYP17A1, abiraterone reduces the amount of hormones that are available to fuel the growth of the cancer, leading to a decrease in prostate-specific antigen (PSA) levels and a decrease in the size of the prostate gland. Abiraterone is typically used in combination with other medications, such as prednisone, to enhance its effectiveness.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Abiraterone is a medication used to treat prostate cancer.\n2. Abiraterone works by inhibiting the activity of an enzyme called CYP17A1.\n3. The enzyme CYP17A1 is involved in the production of hormones that promote the growth of prostate cancer cells.\n4. Abiraterone can decrease in prostate-specific antigen (PSA) levels and the size of the prostate gland.\n5. Abiraterone is typically used in combination with other medications, such as prednisone, to enhance its effectiveness.",
    "vicuna-13b_fact": [
      "Abiraterone is a medication used to treat prostate cancer.",
      "Abiraterone works by inhibiting the activity of an enzyme called CYP17A1.",
      "The enzyme CYP17A1 is involved in the production of hormones that promote the growth of prostate cancer cells.",
      "Abiraterone can decrease in prostate-specific antigen (PSA) levels and the size of the prostate gland.",
      "Abiraterone is typically used in combination with other medications, such as prednisone, to enhance its effectiveness."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1318,
    "user_query": "The protein neprilysin  has an positive effect on Alzheimer disease, how can it be delivered to the brain?",
    "vicuna-13b_response": "Neprilysin, also known as neprilysin 1 (NEP1), is a protein that has been shown to have a positive effect on Alzheimer's disease. It is a member of the metalloproteinase family of enzymes, which play a role in the degradation of proteins.\nThere are several ways to deliver neprilysin to the brain, including:\n1. Intracerebroventricular (ICV) injection: This involves injecting neprilysin directly into the brain through a catheter placed in the intraventricular space of the brain. This method of delivery allows for high levels of neprilysin to be delivered directly to the brain, and has been shown to be effective in reducing the symptoms of Alzheimer's disease in animal models.\n2. Convection-enhanced delivery (CED): This method involves infusing neprilysin through a catheter placed in a vein in the neck, and using a pump to drive the infusion at a high flow rate. This causes the neprilysin to be delivered to the brain through the brain's vasculature, and has been shown to be effective in reducing the symptoms of Alzheimer's disease in animal models.\n3. Adeno-associated virus (AAV) gene therapy: This method involves using a virus to deliver the gene for neprilysin to cells in the brain. The virus is modified so that it cannot cause disease, and is used to deliver the gene for neprilysin to cells in the brain. This method has the advantage of being able to deliver neprilysin to specific cells in the brain, and has been shown to be effective in reducing the symptoms of Alzheimer's disease in animal models.\nOverall, these methods of delivering neprilysin to the brain have shown promise in reducing the symptoms of Alzheimer's disease in animal models, and are being studied as potential treatments for the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Neprilysin, also known as NEP1, is a protein that has been linked with having a positive effect on Alzheimer's disease.\n2. Neprilysin is a member of the metalloproteinase family of enzymes, which are involved in protein degradation.\n3. Intracerebroventricular injection is a method for delivering neprilysin to the brain and involves injecting the protein directly into the brain via a catheter.\n4. Convection-enhanced delivery involves infusing neprilysin through a catheter in a neck vein and using a pump to drive the infusion.\n5. Adeno-associated virus gene therapy uses a modified virus that does not cause disease to deliver the gene for neprilysin to brain cells.",
    "vicuna-13b_fact": [
      "Neprilysin, also known as NEP1, is a protein that has been linked with having a positive effect on Alzheimer's disease.",
      "Neprilysin is a member of the metalloproteinase family of enzymes, which are involved in protein degradation.",
      "Intracerebroventricular injection is a method for delivering neprilysin to the brain and involves injecting the protein directly into the brain via a catheter.",
      "Convection-enhanced delivery involves infusing neprilysin through a catheter in a neck vein and using a pump to drive the infusion.",
      "Adeno-associated virus gene therapy uses a modified virus that does not cause disease to deliver the gene for neprilysin to brain cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Convection-enhanced delivery involves infusing therapeutics directly into the brain through a catheter, not through a neck vein.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "vicuna-13b_response": "BRAG1 is a gene that plays a role in regulating cell growth and division. Mutations in the BRAG1 gene have been linked to the development of certain types of cancer, including ovarian cancer, glioblastoma, and acute myeloid leukemia. BRAG1 mutations have also been associated with the development of other diseases, such as inherited bone marrow disorders and neurodegenerative diseases. However, it is important to note that not all diseases are directly linked to mutations within BRAG1, and the specific disease associated with BRAG1 mutations can vary depending on the specific mutation and other factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BRAG1 is a gene that regulates cell growth and division.\n2. Mutations in the BRAG1 gene have been linked to the development of certain types of cancer.\n3. The types of cancer associated with BRAG1 mutations include ovarian cancer, glioblastoma, and acute myeloid leukemia.\n4. BRAG1 mutations have also been associated with the development of inherited bone marrow disorders and neurodegenerative diseases.\n5. The specific disease associated with BRAG1 mutations can vary depending on the specific mutation and other factors.",
    "vicuna-13b_fact": [
      "BRAG1 is a gene that regulates cell growth and division.",
      "Mutations in the BRAG1 gene have been linked to the development of certain types of cancer.",
      "The types of cancer associated with BRAG1 mutations include ovarian cancer, glioblastoma, and acute myeloid leukemia.",
      "BRAG1 mutations have also been associated with the development of inherited bone marrow disorders and neurodegenerative diseases.",
      "The specific disease associated with BRAG1 mutations can vary depending on the specific mutation and other factors."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1328,
    "user_query": "What is the effect induced by sympathetic nervous system on pupil size?",
    "vicuna-13b_response": "The sympathetic nervous system is responsible for the \"fight or flight\" response, which is a natural instinct that prepares the body for action. One of the effects of the sympathetic nervous system is to dilate the pupils, which allows more light to enter the eye and improves visual acuity. This dilation of the pupils is known as mydriasis.\nThe sympathetic nervous system works by releasing a neurotransmitter called acetylcholine, which binds to receptors in the iris of the eye and causes the muscarinic receptors to contract, resulting in the dilation of the pupil. This process is known as cholinergic dilation.\nIn contrast, the parasympathetic nervous system is responsible for the \"rest and digest\" response, which helps the body to relax and conserve energy. One of the effects of the parasympathetic nervous system is to constrict the pupils, which reduces the amount of light entering the eye and helps to prevent eye strain. This constriction of the pupils is known as miosis.\nOverall, the sympathetic nervous system and the parasympathetic nervous system work together to regulate the size of the pupils and maintain proper visual function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The sympathetic nervous system dilates the pupils, allowing more light to enter the eye and improving visual acuity.\n2. This dilation of the pupils by the sympathetic nervous system is known as mydriasis.\n3. The sympathetic nervous system releases a neurotransmitter called acetylcholine, which binds to the iris' receptors, causing muscle contraction that results in pupil dilation.\n4. The parasympathetic nervous system constricts the pupils, reducing the amount of light entering the eye and helping prevent eye strain.\n5. Constriction of the pupils by the parasympathetic nervous system is known as miosis.",
    "vicuna-13b_fact": [
      "The sympathetic nervous system dilates the pupils, allowing more light to enter the eye and improving visual acuity.",
      "This dilation of the pupils by the sympathetic nervous system is known as mydriasis.",
      "The sympathetic nervous system releases a neurotransmitter called acetylcholine, which binds to the iris' receptors, causing muscle contraction that results in pupil dilation.",
      "The parasympathetic nervous system constricts the pupils, reducing the amount of light entering the eye and helping prevent eye strain.",
      "Constriction of the pupils by the parasympathetic nervous system is known as miosis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The sympathetic nervous system releases a neurotransmitter called norepinephrine, not acetylcholine, which binds to the iris' receptors, causing muscle contraction that results in pupil dilation.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1329,
    "user_query": "Is p100 the precursor protein molecule of the NF-kappaB transcription factor subunit p50?",
    "vicuna-13b_response": "Yes, p100 is the precursor protein molecule of the NF-kappaB transcription factor subunit p50.\nNF-kappaB is a family of transcription factors that play a crucial role in regulating the expression of genes involved in immune response, inflammation, and cell survival. NF-kappaB consists of several subunits, including p50, p65, and p52, which are derived from the processing of larger precursor proteins.\nThe precursor protein for p50 is called p100, which is synthesized as a large precursor protein called p105. The processing of p105 to p50 is regulated by proteolytic enzymes, which cleave the amino-terminal domain of p105 to generate p50. The resulting p50 protein is a transcription factor that can bind to DNA and regulate the expression of target genes involved in immune response and inflammation.\nIn conclusion, p100 is the precursor protein molecule of the NF-kappaB transcription factor subunit p50, and the processing of p105 to p50 is crucial for the regulation of immune response and inflammation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. p100 is the precursor protein molecule of the NF-kappaB transcription factor subunit p50.\n2. NF-kappaB is a family of transcription factors that regulate the expression of genes involved in immune response, inflammation, and cell survival.\n3. NF-kappaB consists of several subunits, including p50, p65, and p52.\n4. The processing of p105 to p50 is regulated by proteolytic enzymes, which cleave the amino-terminal domain of p105 to generate p50.\n5. The resulting p50 protein can bind to DNA and regulate the expression of target genes involved in immune response and inflammation.",
    "vicuna-13b_fact": [
      "p100 is the precursor protein molecule of the NF-kappaB transcription factor subunit p50.",
      "NF-kappaB is a family of transcription factors that regulate the expression of genes involved in immune response, inflammation, and cell survival.",
      "NF-kappaB consists of several subunits, including p50, p65, and p52.",
      "The processing of p105 to p50 is regulated by proteolytic enzymes, which cleave the amino-terminal domain of p105 to generate p50.",
      "The resulting p50 protein can bind to DNA and regulate the expression of target genes involved in immune response and inflammation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The processing of p100 to p52 is regulated by proteolytic enzymes, which cleave the amino-terminal domain of p100 to generate p52.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1331,
    "user_query": "Is there a difference in the rate between gene fusion and gene fission?",
    "vicuna-13b_response": "Yes, there is a difference in the rate between gene fusion and gene fission.\nGene fusion is the process of combining two or more genes into a single gene, while gene fission is the process of dividing a single gene into two or more genes.\nThe rate of gene fusion is generally thought to be lower than the rate of gene fission. This is because gene fusion requires the precise alignment and integration of two or more genes into a single gene, which is a more complex process that is subject to more constraints than gene fission.\nGene fission, on the other hand, is a more common event that can occur through various mechanisms, such as unequal crossing over, gene conversion, or replication-associated mechanisms.\nOverall, while both gene fusion and gene fission can lead to changes in gene structure and function, the rate at which they occur can vary, with gene fission being more common than gene fusion.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Gene fusion is the process of combining two or more genes into a single gene.\n2. Gene fission is the process of dividing a single gene into two or more genes.\n3. Gene fusion requires the precise alignment and integration of two or more genes, making it a complex process subject to constraints.\n4. Gene fission can occur through various mechanisms, such as unequal crossing over, gene conversion, or replication-associated mechanisms.\n5. The rate of gene fusion is generally thought to be lower than the rate of gene fission.",
    "vicuna-13b_fact": [
      "Gene fusion is the process of combining two or more genes into a single gene.",
      "Gene fission is the process of dividing a single gene into two or more genes.",
      "Gene fusion requires the precise alignment and integration of two or more genes, making it a complex process subject to constraints.",
      "Gene fission can occur through various mechanisms, such as unequal crossing over, gene conversion, or replication-associated mechanisms.",
      "The rate of gene fusion is generally thought to be lower than the rate of gene fission."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1344,
    "user_query": "Which genes were found to be methylated in bladder cancer cells?",
    "vicuna-13b_response": "Several genes have been found to be methylated in bladder cancer cells. One of the most commonly methylated genes is the p16INK4a gene, which is often inactivated through promoter methylation in bladder cancer. Other genes that have been found to be methylated in bladder cancer include CDKN2A, RASSF1A, and GSTP1. These genes are involved in various biological processes such as cell cycle regulation, tumor suppressor signaling, and detoxification. Methylation of these genes has been shown to play a role in the development and progression of bladder cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The p16INK4a gene is one of the most commonly methylated genes in bladder cancer cells.\n2. The p16INK4a gene is often inactivated through promoter methylation in bladder cancer.\n3. Other genes found to be methylated in bladder cancer include CDKN2A, RASSF1A, and GSTP1.\n4. These methylated genes are involved in biological processes such as cell cycle regulation, tumor suppressor signaling, and detoxification.\n5. Methylation of these genes plays a role in the development and progression of bladder cancer.",
    "vicuna-13b_fact": [
      "The p16INK4a gene is one of the most commonly methylated genes in bladder cancer cells.",
      "The p16INK4a gene is often inactivated through promoter methylation in bladder cancer.",
      "Other genes found to be methylated in bladder cancer include CDKN2A, RASSF1A, and GSTP1.",
      "These methylated genes are involved in biological processes such as cell cycle regulation, tumor suppressor signaling, and detoxification.",
      "Methylation of these genes plays a role in the development and progression of bladder cancer."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1348,
    "user_query": "What is the characteristic domain of histone methyltransferases?",
    "vicuna-13b_response": "Histone methyltransferases (HMTs) are enzymes that add methyl groups to histone proteins, which are involved in the compaction of DNA into chromatin. The characteristic domain of HMTs is a catalytic SET domain, which is responsible for the transfer of the methyl group from the methyl donor S-adenosylmethionine (SAM) to the histone substrate.\nThe SET domain of HMTs contains a conserved cysteine residue that is involved in the formation of a sulfuric acid derivative, which is necessary for the transfer of the methyl group to the histone substrate. The SET domain also contains a zinc ion, which is thought to stabilize the active site of the enzyme and coordinate the transfer of the methyl group.\nIn addition to the SET domain, HMTs may also contain other domains, such as a histone-binding domain, which is responsible for recognizing and binding to specific histone proteins. Some HMTs may also contain domains that allow them to interact with other proteins, such as transcription factors or chromatin-modifying enzymes, which may regulate their activity or localization.\nOverall, the characteristic domain of HMTs is the SET domain, which is responsible for the transfer of the methyl group to histone proteins. The presence of other domains in HMTs may allow for additional functions, such as regulation of activity or localization, and may also contribute to the specificity of the enzyme for different histone proteins.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Histone methyltransferases (HMTs) are enzymes that add methyl groups to histone proteins.\n2. The characteristic domain of histone methyltransferases is a catalytic SET domain.\n3. The SET domain of HMTs is responsible for the transfer of the methyl group from S-adenosylmethionine to the histone substrate.\n4. The SET domain of HMTs contains both a conserved cysteine residue and a zinc ion.\n5. Some histone methyltransferases may also contain additional domains, such as a histone-binding domain, that allow them to perform other functions.",
    "vicuna-13b_fact": [
      "Histone methyltransferases (HMTs) are enzymes that add methyl groups to histone proteins.",
      "The characteristic domain of histone methyltransferases is a catalytic SET domain.",
      "The SET domain of HMTs is responsible for the transfer of the methyl group from S-adenosylmethionine to the histone substrate.",
      "The SET domain of HMTs contains both a conserved cysteine residue and a zinc ion.",
      "Some histone methyltransferases may also contain additional domains, such as a histone-binding domain, that allow them to perform other functions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1350,
    "user_query": "Which are the bioinformatics tools for gene structure prediction?",
    "vicuna-13b_response": "There are several bioinformatics tools that can be used for gene structure prediction, including:\n1. GENEHUNTER: A software tool that uses a combination of hidden Markov models and statistical methods to predict gene structures from DNA sequences.\n2. GENSCAN: A software tool that uses a combination of probabilistic models and statistical methods to predict gene structures from DNA sequences.\n3. GENEFIND: A software tool that uses a combination of statistical methods and evolutionary conservation to predict gene structures from DNA sequences.\n4. GENEW: A software tool that uses a combination of probabilistic models and statistical methods to predict gene structures from DNA sequences.\n5. GENEMAPPER: A software tool that uses a combination of probabilistic models and statistical methods to predict gene structures from DNA sequences.\n6. GENEPRO: A software tool that uses a combination of probabilistic models and statistical methods to predict gene structures from DNA sequences.\n7. GENEPILOT: A software tool that uses a combination of probabilistic models and statistical methods to predict gene structures from DNA sequences.\n8. GENEANALYZER: A software tool that uses a combination of probabilistic models and statistical methods to predict gene structures from DNA sequences.\n9. GENESTRUCT: A software tool that uses a combination of probabilistic models and statistical methods to predict gene structures from DNA sequences.\n10. GENEJUMP: A software tool that uses a combination of probabilistic models and statistical methods to predict gene structures from DNA sequences.\nThese are some of the most commonly used tools for gene structure prediction, but there are many other tools available as well, and the choice of tool will depend on the specific needs of the user.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GENEHUNTER is a bioinformatics tool for gene structure prediction.\n2. GENSCAN is a software tool utilized for predicting gene structures from DNA sequences.\n3. GENEFIND employs both statistical methods and evolutionary conservation for gene structure prediction.\n4. GENEW relies on a combination of probabilistic models and statistical methods for gene structure prediction.\n5. GENEMAPPER uses a mix of probabilistic models and statistical methods for predicting gene structures from DNA sequences.",
    "vicuna-13b_fact": [
      "GENEHUNTER is a bioinformatics tool for gene structure prediction.",
      "GENSCAN is a software tool utilized for predicting gene structures from DNA sequences.",
      "GENEFIND employs both statistical methods and evolutionary conservation for gene structure prediction.",
      "GENEW relies on a combination of probabilistic models and statistical methods for gene structure prediction.",
      "GENEMAPPER uses a mix of probabilistic models and statistical methods for predicting gene structures from DNA sequences."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: GENEHUNTER is a bioinformatics tool for linkage analysis.\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: GENEMAPPER is a bioinformatics software used for analyzing and visualizing genetic marker data, not for predicting gene structures from DNA sequences.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1352,
    "user_query": "What is the correlation between SPARC expression and growth inhibition in human cancer?",
    "vicuna-13b_response": "SPARC (secreted protein acidic and rich in cysteine) is a protein that is expressed in many types of cancer, including breast, lung, and ovarian cancer. Studies have shown that high levels of SPARC expression are associated with poor prognosis and reduced survival in patients with cancer.\nOne study found that high levels of SPARC expression were associated with decreased response to chemotherapy in patients with ovarian cancer. Another study found that high levels of SPARC expression were associated with decreased response to chemotherapy in patients with non-small cell lung cancer.\nIn addition, SPARC has been shown to play a role in the growth and survival of cancer cells. For example, SPARC has been shown to promote the growth and survival of breast cancer cells by inhibiting programmed cell death (apoptosis).\nIn conclusion, there is a correlation between SPARC expression and growth inhibition in human cancer. High levels of SPARC expression are associated with poor prognosis, decreased response to chemotherapy, and increased cancer cell growth and survival.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SPARC (secreted protein acidic and rich in cysteine) is expressed in many types of cancer, including breast, lung, and ovarian cancer.\n2. High levels of SPARC expression are associated with poor prognosis and reduced survival in patients with cancer.\n3. One study found that high levels of SPARC expression were associated with decreased response to chemotherapy in patients with ovarian cancer.\n4. Another study found that high levels of SPARC expression were associated with decreased response to chemotherapy in patients with non-small cell lung cancer.\n5. SPARC has been shown to promote the growth and survival of breast cancer cells by inhibiting programmed cell death (apoptosis).",
    "vicuna-13b_fact": [
      "SPARC (secreted protein acidic and rich in cysteine) is expressed in many types of cancer, including breast, lung, and ovarian cancer.",
      "High levels of SPARC expression are associated with poor prognosis and reduced survival in patients with cancer.",
      "One study found that high levels of SPARC expression were associated with decreased response to chemotherapy in patients with ovarian cancer.",
      "Another study found that high levels of SPARC expression were associated with decreased response to chemotherapy in patients with non-small cell lung cancer.",
      "SPARC has been shown to promote the growth and survival of breast cancer cells by inhibiting programmed cell death (apoptosis)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1353,
    "user_query": "Which syndrome is associated with mutations in the LYST gene?",
    "vicuna-13b_response": "The LYST gene is associated with the development of the Wiskott-Aldrich syndrome, a rare X-linked recessive disorder characterized by thrombocytopenia, eczema, and recurrent infections. The LYST gene provides instructions for making a protein called LYST, which is involved in the regulation of the immune system and the development of blood cells. Mutations in the LYST gene can lead to reduced levels of LYST protein, which can result in the characteristic features of the Wiskott-Aldrich syndrome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The LYST gene is associated with the development of the Wiskott-Aldrich syndrome.\n2. Wiskott-Aldrich syndrome is a rare X-linked recessive disorder characterized by thrombocytopenia, eczema, and recurrent infections.\n3. The LYST gene provides instructions for making a protein called LYST.\n4. The LYST protein is involved in the regulation of the immune system and the development of blood cells.\n5. Mutations in the LYST gene can lead to reduced levels of LYST protein, which can result in the characteristic features of the Wiskott-Aldrich syndrome.",
    "vicuna-13b_fact": [
      "The LYST gene is associated with the development of the Wiskott-Aldrich syndrome.",
      "Wiskott-Aldrich syndrome is a rare X-linked recessive disorder characterized by thrombocytopenia, eczema, and recurrent infections.",
      "The LYST gene provides instructions for making a protein called LYST.",
      "The LYST protein is involved in the regulation of the immune system and the development of blood cells.",
      "Mutations in the LYST gene can lead to reduced levels of LYST protein, which can result in the characteristic features of the Wiskott-Aldrich syndrome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The WAS gene, not the LYST gene, is associated with the development of the Wiskott-Aldrich syndrome.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Mutations in the WAS gene, not the LYST gene, can lead to the characteristic features of the Wiskott-Aldrich syndrome.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1354,
    "user_query": "Has the presence of delayed enhancement been documented in athletes performing strenuous exercise?",
    "vicuna-13b_response": "Yes, the presence of delayed enhancement (DE) has been documented in athletes performing strenuous exercise. DE is a type of magnetic resonance imaging (MRI) finding that is often seen in the setting of acute cerebral injury, such as a concussion or traumatic brain injury. It is characterized by a delay in the appearance of contrast agent in the brain, which is thought to reflect changes in the integrity of the blood-brain barrier and increased permeability of the brain.\nSeveral studies have shown that DE can be detected in athletes following strenuous exercise, such as marathon running or American football. For example, one study found that DE was present in 25% of marathon runners following the race, and another study found that DE was present in 20% of American football players following a game.\nThe exact significance of DE in athletes is not yet fully understood, but it has been suggested that it may be a marker of brain injury or stress. Some studies have suggested that DE may be a risk factor for future neurological problems, such as chronic traumatic encephalopathy (CTE). However, more research is needed to fully understand the clinical significance of DE in athletes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Delayed enhancement (DE) is a type of magnetic resonance imaging (MRI) finding often seen in acute cerebral injury.\n2. DE is characterized by a delay in the appearance of contrast agent in the brain, which is thought to reflect changes in the integrity of the blood-brain barrier and increased permeability of the brain.\n3. Studies have shown that DE can be detected in athletes following strenuous exercise, such as marathon running or American football.\n4. One study found that DE was present in 25% of marathon runners following the race.\n5. Another study found that DE was present in 20% of American football players following a game.",
    "vicuna-13b_fact": [
      "Delayed enhancement (DE) is a type of magnetic resonance imaging (MRI) finding often seen in acute cerebral injury.",
      "DE is characterized by a delay in the appearance of contrast agent in the brain, which is thought to reflect changes in the integrity of the blood-brain barrier and increased permeability of the brain.",
      "Studies have shown that DE can be detected in athletes following strenuous exercise, such as marathon running or American football.",
      "One study found that DE was present in 25% of marathon runners following the race.",
      "Another study found that DE was present in 20% of American football players following a game."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1356,
    "user_query": "Name the factors required for selenoprotein synthesis in eukaryotes",
    "vicuna-13b_response": "Selenoprotein synthesis in eukaryotes involves a complex process that requires several factors. Here are some of the key factors involved in selenoprotein synthesis:\n1. Selenocysteine tRNA: Selenocysteine is the amino acid that contains selenium, and it is inserted into proteins by a specialized transfer RNA molecule called selenocysteine tRNA. This tRNA is synthesized in the cytoplasm of the cell and imported into the mitochondria, where it is processed and inserted into the growing polypeptide chain.\n2. Selenophylic acid: Selenophylic acid is a precursor of selenocysteine, and it is synthesized in the cytosol of the cell. This compound is then transported to the mitochondria, where it is converted into selenocysteine by the enzyme selenophylic acid synthase.\n3. Selenoprotein P: Selenoprotein P is a mitochondrial protein that plays a critical role in selenoprotein synthesis. It recognizes the selenocysteine tRNA and delivers it to the ribosome, where it is inserted into the growing polypeptide chain.\n4. Selenoprotein W: Selenoprotein W is another mitochondrial protein that is involved in selenoprotein synthesis. It recognizes the selenocysteine tRNA and helps to protect it from degradation.\n5. Selenoprotein synthesis enzymes: Several enzymes are involved in the synthesis of selenoproteins, including selenocysteine tRNA synthase, selenophylic acid synthase, and the selenoprotein P and W proteins.\nOverall, the synthesis of selenoproteins in eukaryotes is a complex process that requires the coordinated action of several factors, including the synthesis of selenocysteine tRNA, the conversion of selenophylic acid into selenocysteine, the recognition and delivery of selenocysteine tRNA to the ribosome, and the protection of selenocysteine t",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Selenoprotein synthesis in eukaryotes involves selenocysteine tRNA.\n2. Selenocysteine is an amino acid that contains selenium and it is inserted into proteins through selenocysteine tRNA.\n3. Selenophylic acid is a precursor of selenocysteine and it is synthesized in the cytosol of the cell.\n4. Selenoprotein P is a mitochondrial protein that recognizes the selenocysteine tRNA and delivers it to the ribosome.\n5. Selenoprotein W is a mitochondrial protein that helps to protect selenocysteine tRNA from degradation.",
    "vicuna-13b_fact": [
      "Selenoprotein synthesis in eukaryotes involves selenocysteine tRNA.",
      "Selenocysteine is an amino acid that contains selenium and it is inserted into proteins through selenocysteine tRNA.",
      "Selenophylic acid is a precursor of selenocysteine and it is synthesized in the cytosol of the cell.",
      "Selenoprotein P is a mitochondrial protein that recognizes the selenocysteine tRNA and delivers it to the ribosome.",
      "Selenoprotein W is a mitochondrial protein that helps to protect selenocysteine tRNA from degradation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: No existing scientific literature confirms the existence or role of \"Selenophylic acid\" as a precursor of selenocysteine. Selenocysteine is synthesized from a serine residue linked to a specialized tRNA known as tRNA[Ser]Sec.\n4. FALSE [correction]: Selenoprotein P is not a mitochondrial protein that recognizes selenocysteine tRNA. It is a protein that contains multiple selenocysteine residues and is important for selenium transport within the body.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1359,
    "user_query": "What is the role of TRH in hypertension?",
    "vicuna-13b_response": "TRH (Thyrotropin-Releasing Hormone) is a hormone that plays a role in regulating the thyroid gland and the body's metabolic rate. It is produced by the hypothalamus in the brain and stimulates the release of thyroid-stimulating hormone (TSH) from the pituitary gland. TSH, in turn, stimulates the production and release of the hormones triiodothyronine (T3) and thyroxine (T4) from the thyroid gland. These hormones are important for regulating metabolism, growth, and development in the body.\nIn terms of hypertension, there is some evidence to suggest that TRH may play a role in the development of high blood pressure. Studies have shown that TRH can cause vasoconstriction, or the narrowing of blood vessels, which can lead to an increase in blood pressure. Additionally, TRH has been shown to increase levels of stress hormones, such as cortisol and adrenaline, which can also contribute to the development of hypertension. However, more research is needed to fully understand the relationship between TRH and hypertension.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Thyrotropin-Releasing Hormone (TRH) regulates the thyroid gland and the body's metabolic rate.\n2. TRH is produced by the hypothalamus in the brain.\n3. TRH stimulates the release of thyroid-stimulating hormone (TSH) from the pituitary gland.\n4. TSH stimulates the production and release of the hormones triiodothyronine (T3) and thyroxine (T4) from the thyroid gland.\n5. Studies have shown that TRH can cause vasoconstriction, leading to an increase in blood pressure.",
    "vicuna-13b_fact": [
      "Thyrotropin-Releasing Hormone (TRH) regulates the thyroid gland and the body's metabolic rate.",
      "TRH is produced by the hypothalamus in the brain.",
      "TRH stimulates the release of thyroid-stimulating hormone (TSH) from the pituitary gland.",
      "TSH stimulates the production and release of the hormones triiodothyronine (T3) and thyroxine (T4) from the thyroid gland.",
      "Studies have shown that TRH can cause vasoconstriction, leading to an increase in blood pressure."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1360,
    "user_query": "Is triadin involved in cardiac function?",
    "vicuna-13b_response": "Triadin is a protein that is expressed in the heart and other tissues, and it has been shown to play a role in cardiac function. Triadin is a member of the triadin family of proteins, which are involved in various cellular processes, including cell adhesion, migration, and differentiation.\nIn the heart, triadin is expressed in the cardiac muscle cells, and it has been shown to play a role in the regulation of cardiac contractility and the maintenance of cardiac muscle integrity. Triadin has been shown to interact with other proteins that are important for cardiac function, such as the sarcomeric proteins that form the contractile apparatus in cardiac muscle cells.\nIn addition, triadin has been shown to play a role in the response to injury in the heart, as it has been shown to be upregulated in response to myocardial infarction (heart attack) and other forms of cardiac injury.\nOverall, while more research is needed to fully understand the role of triadin in cardiac function, it is clear that this protein plays an important role in the regulation of cardiac muscle contraction and the maintenance of cardiac muscle integrity, and may also play a role in the response to injury in the heart.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Triadin is a protein that is expressed in the heart and other tissues.\n2. Triadin plays a role in cardiac function, regulation of cardiac contractility, and the maintenance of cardiac muscle integrity.\n3. Triadin is a member of the triadin family of proteins, which are involved in various cellular processes, including cell adhesion, migration, and differentiation.\n4. In the heart, triadin is expressed in the cardiac muscle cells.\n5. Triadin has been shown to be upregulated in response to myocardial infarction and other forms of cardiac injury.",
    "vicuna-13b_fact": [
      "Triadin is a protein that is expressed in the heart and other tissues.",
      "Triadin plays a role in cardiac function, regulation of cardiac contractility, and the maintenance of cardiac muscle integrity.",
      "Triadin is a member of the triadin family of proteins, which are involved in various cellular processes, including cell adhesion, migration, and differentiation.",
      "In the heart, triadin is expressed in the cardiac muscle cells.",
      "Triadin has been shown to be upregulated in response to myocardial infarction and other forms of cardiac injury."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Triadin is not a member of a \"triadin family\" because no such family exists. Triadin is an integral membrane protein.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "vicuna-13b_response": "Protein phosphatase 1 (PP1) is a ubiquitous serine/threonine phosphatase that plays a critical role in regulating a wide range of cellular processes, including cell growth, differentiation, and survival. PP1 is regulated by a number of different proteins, including inhibitors that modulate its activity.\nOne of the main inhibitors of PP1 is a protein called PP1-binding protein (PP1B). PP1B is a large, structurally complex protein that binds to the regulatory subunit of PP1 and inhibits its activity. PP1B is expressed in a variety of tissues and cells, and its expression is regulated by a number of different signaling pathways.\nAnother inhibitor of PP1 is a protein called PP1-interacting protein (PP1IP). PP1IP is a small protein that binds to the catalytic subunit of PP1 and inhibits its activity. PP1IP is expressed in a variety of tissues and cells, and its expression is regulated by a number of different signaling pathways.\nIn summary, PP1 is inhibited by PP1-binding protein (PP1B) and PP1-interacting protein (PP1IP). These inhibitors play important roles in regulating the activity of PP1 and modulating its effects on cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Protein phosphatase 1 (PP1) is a serine/threonine phosphatase that regulates a wide range of cellular processes.\n2. PP1 is regulated by different proteins including inhibitors.\n3. One main inhibitor of PP1 is a protein called PP1-binding protein (PP1B), which binds to the regulatory subunit of PP1 and inhibits its activity.\n4. Another inhibitor of PP1 is a protein called PP1-interacting protein (PP1IP), which binds to the catalytic subunit of PP1 and inhibits its activity.\n5. The expression of both PP1-binding protein (PP1B) and PP1-interacting protein (PP1IP) is regulated by different signaling pathways.",
    "vicuna-13b_fact": [
      "Protein phosphatase 1 (PP1) is a serine/threonine phosphatase that regulates a wide range of cellular processes.",
      "PP1 is regulated by different proteins including inhibitors.",
      "One main inhibitor of PP1 is a protein called PP1-binding protein (PP1B), which binds to the regulatory subunit of PP1 and inhibits its activity.",
      "Another inhibitor of PP1 is a protein called PP1-interacting protein (PP1IP), which binds to the catalytic subunit of PP1 and inhibits its activity.",
      "The expression of both PP1-binding protein (PP1B) and PP1-interacting protein (PP1IP) is regulated by different signaling pathways."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1364,
    "user_query": "Which protein is required for Argonaute 2 recruitment to stress granules and P-bodies?",
    "vicuna-13b_response": "Argonaute 2 (Ago2) is a key component of the RNA interference (RNAi) machinery in eukaryotic cells, which plays a crucial role in the regulation of gene expression by degrading target mRNAs. Ago2 is recruited to stress granules and P-bodies, which are cytoplasmic RNA-rich structures that form in response to various cellular stresses, such as heat shock, nutrient deprivation, or viral infection.\nThe protein required for Ago2 recruitment to stress granules and P-bodies is TTP (transfer RNA-binding protein). TTP is a RNA-binding protein that interacts with Ago2 and other RNA-binding proteins, such as GW182, to form the RNAi machinery. TTP recognizes and binds to specific RNA elements, such as the 5' untranslated region (5' UTR) of target mRNAs, and recruits the RNAi machinery to these RNAs, leading to their degradation.\nIn addition to TTP, other proteins, such as GW182, DDX6, and DDX17, have also been shown to be involved in Ago2 recruitment to stress granules and P-bodies. However, TTP is considered to be the primary protein required for Ago2 recruitment to these structures.\nIn conclusion, TTP is the protein required for Ago2 recruitment to stress granules and P-bodies. TTP recognizes and binds to specific RNA elements, such as the 5' UTR of target mRNAs, and recruits the RNAi machinery to these RNAs, leading to their degradation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Argonaute 2 (Ago2) is a component of the RNA interference (RNAi) machinery in eukaryotic cells.\n2. Ago2 is recruited to stress granules and P-bodies.\n3. The protein required for Ago2 recruitment to stress granules and P-bodies is TTP (transfer RNA-binding protein).\n4. TTP is a RNA-binding protein that interacts with Ago2 and other RNA-binding proteins, such as GW182, to form the RNAi machinery.\n5. Proteins such as GW182, DDX6, and DDX17 are involved in Ago2 recruitment to stress granules and P-bodies.",
    "vicuna-13b_fact": [
      "Argonaute 2 (Ago2) is a component of the RNA interference (RNAi) machinery in eukaryotic cells.",
      "Ago2 is recruited to stress granules and P-bodies.",
      "The protein required for Ago2 recruitment to stress granules and P-bodies is TTP (transfer RNA-binding protein).",
      "TTP is a RNA-binding protein that interacts with Ago2 and other RNA-binding proteins, such as GW182, to form the RNAi machinery.",
      "Proteins such as GW182, DDX6, and DDX17 are involved in Ago2 recruitment to stress granules and P-bodies."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The protein required for Ago2 recruitment to stress granules and P-bodies is TRBP (TAR RNA-binding protein), not TTP.\n4. FALSE [correction]: TTP is a RNA-binding protein but it does not interact with Ago2 or other RNA-binding proteins such as GW182 to form the RNAi machinery. TRBP is the RNA-binding protein that interacts with Ago2 and other RNA-binding proteins, such as GW182, to form the RNAi machinery.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1368,
    "user_query": "Which pharmacogenetic test is available for abacavir?",
    "vicuna-13b_response": "Abacavir is a medication used to treat HIV infection. There are several pharmacogenetic tests available to help predict how a patient will respond to abacavir treatment. One of the most commonly used tests is the HLA-B*5701 test, which is a genetic test that looks for a specific gene variation that is associated with a increased risk of a severe reaction to abacavir. This test is recommended for all patients before starting treatment with abacavir, as those who are positive for this gene variation are at increased risk of developing a severe, life-threatening rash if they take the medication. Other pharmacogenetic tests may also be used to predict how a patient will respond to abacavir treatment, and these tests may be used in certain circumstances, such as when a patient has a history of hypersensitivity reactions to the medication. It is important to note that pharmacogenetic testing is not always necessary, and the decision to perform these tests should be made on a case-by-case basis, taking into account the patient's medical history and other factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Abacavir is a medication used to treat HIV infection.\n2. The HLA-B*5701 test is a commonly used pharmacogenetic test for predicting responses to abacavir treatment.\n3. The HLA-B*5701 test looks for a specific gene variation linked to an increased risk of severe reactions to abacavir.\n4. It's recommended that all patients get tested for the HLA-B*5701 gene variation before starting treatment with abacavir.\n5. The decision to perform pharmacogenetic testing should be made on a case-by-case basis, taking into account the patient's medical history and other factors.",
    "vicuna-13b_fact": [
      "Abacavir is a medication used to treat HIV infection.",
      "The HLA-B*5701 test is a commonly used pharmacogenetic test for predicting responses to abacavir treatment.",
      "The HLA-B*5701 test looks for a specific gene variation linked to an increased risk of severe reactions to abacavir.",
      "It's recommended that all patients get tested for the HLA-B*5701 gene variation before starting treatment with abacavir.",
      "The decision to perform pharmacogenetic testing should be made on a case-by-case basis, taking into account the patient's medical history and other factors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The decision to perform HLA-B*5701 testing is not a case-by-case decision; it is recommended for all patients before starting treatment with abacavir to prevent hypersensitivity reactions.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1370,
    "user_query": "Are nucleosomes positioned at DNA replication origins?",
    "vicuna-13b_response": "Nucleosomes are positioned at DNA replication origins in eukaryotic cells. DNA replication origins are regions of the genome where replication is initiated. Nucleosomes are structures composed of four proteins (H2A, H2B, H3, and H4) and DNA that wrap around the DNA helix and help to compact it into a more manageable structure.\nNucleosomes play a role in the regulation of DNA replication by controlling access to the DNA template. At replication origins, the presence of nucleosomes can help to recruit and activate the replication machinery, leading to the initiation of replication. Additionally, the positioning of nucleosomes at replication origins can help to ensure that replication is initiated at the correct time and in the correct place, thereby maintaining the integrity of the genome.\nOverall, the positioning of nucleosomes at DNA replication origins is an important aspect of the regulation of DNA replication in eukaryotic cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nucleosomes are positioned at DNA replication origins in eukaryotic cells.\n2. DNA replication origins are regions of the genome where replication is initiated.\n3. Nucleosomes are structures composed of four proteins (H2A, H2B, H3, and H4) and DNA.\n4. Nucleosomes play a role in the regulation of DNA replication by controlling access to the DNA template.\n5. The positioning of nucleosomes at DNA replication origins can help to ensure that replication is initiated at the correct time and in the correct place.",
    "vicuna-13b_fact": [
      "Nucleosomes are positioned at DNA replication origins in eukaryotic cells.",
      "DNA replication origins are regions of the genome where replication is initiated.",
      "Nucleosomes are structures composed of four proteins (H2A, H2B, H3, and H4) and DNA.",
      "Nucleosomes play a role in the regulation of DNA replication by controlling access to the DNA template.",
      "The positioning of nucleosomes at DNA replication origins can help to ensure that replication is initiated at the correct time and in the correct place."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Nucleosomes are not positioned at DNA replication origins, rather they are periodically spaced along the DNA allowing for the DNA to be packed into a more condensed structure called chromatin.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1371,
    "user_query": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?",
    "vicuna-13b_response": "Oligonucleotides are short sequences of nucleotides that play important roles in various cellular processes, such as gene expression and DNA repair. In higher eukaryotes, oligonucleotides are synthesized by enzymes called polymerases, which add nucleotides to the 3' end of an existing strand of DNA or RNA.\nThere are many different types of oligonucleotides, and the specific types that are under-represented in higher eukaryote genomes can vary depending on the species and the specific context. However, some examples of oligonucleotides that are commonly under-represented in higher eukaryote genomes include:\n1. T-oligonucleotides: These are oligonucleotides that have a terminal T nucleotide. T-oligonucleotides are important for the initiation of DNA replication and are also involved in DNA repair and gene expression.\n2. A-oligonucleotides: These are oligonucleotides that have a terminal A nucleotide. A-oligonucleotides are important for the elongation phase of DNA replication and are also involved in DNA repair and gene expression.\n3. U-oligonucleotides: These are oligonucleotides that have a terminal U nucleotide. U-oligonucleotides are important for the elongation phase of DNA replication and are also involved in DNA repair and gene expression.\n4. R-oligonucleotides: These are oligonucleotides that have a terminal R nucleotide. R-oligonucleotides are important for the elongation phase of DNA replication and are also involved in DNA repair and gene expression.\nOverall, the specific oligonucleotides that are under-represented in higher eukaryote genomes can vary depending on the species and the specific context. However, T-oligonucleotides, A-oligonucleotides, U-oligonucleotides, and R-oligonucleotides are all examples of oligonucleotides that are commonly under-represented in higher e",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Oligonucleotides are short sequences of nucleotides that play important roles in various cellular processes, such as gene expression and DNA repair.\n2. In higher eukaryotes, oligonucleotides are synthesized by enzymes called polymerases.\n3. T-oligonucleotides, which have a terminal T nucleotide, are important for the initiation of DNA replication, DNA repair, and gene expression.\n4. A-oligonucleotides, having a terminal A nucleotide, have roles in the elongation phase of DNA replication, as well as in DNA repair and gene expression.\n5. U-oligonucleotides and R-oligonucleotides, which have terminal U and R nucleotides respectively, are important for the elongation phase of DNA replication, DNA repair, and gene expression.",
    "vicuna-13b_fact": [
      "Oligonucleotides are short sequences of nucleotides that play important roles in various cellular processes, such as gene expression and DNA repair.",
      "In higher eukaryotes, oligonucleotides are synthesized by enzymes called polymerases.",
      "T-oligonucleotides, which have a terminal T nucleotide, are important for the initiation of DNA replication, DNA repair, and gene expression.",
      "A-oligonucleotides, having a terminal A nucleotide, have roles in the elongation phase of DNA replication, as well as in DNA repair and gene expression.",
      "U-oligonucleotides and R-oligonucleotides, which have terminal U and R nucleotides respectively, are important for the elongation phase of DNA replication, DNA repair, and gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "vicuna-13b_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, is a phenomenon observed in Bacillus subtilis where the rate of spontaneous mutations increases during the stationary phase of growth. This occurs when the bacteria have reached a state of exponential growth and are no longer able to increase their population size.\nSeveral mechanisms have been proposed to underlie adaptive mutagenesis in Bacillus subtilis. One of the main mechanisms is the activation of stress response pathways, such as the DNA damage response and the SOS response, during the stationary phase of growth. These pathways induce the expression of genes that promote mutagenesis, such as those involved in DNA repair and replication, as well as those that inhibit translesion DNA synthesis.\nAnother mechanism that has been proposed to contribute to adaptive mutagenesis is the accumulation of mutations in key genes involved in DNA repair and replication during the stationary phase of growth. These mutations can lead to changes in the activity of these genes, which can further increase the rate of mutations.\nAdditionally, it has been suggested that the decrease in the rate of bacterial division during the stationary phase of growth may lead to an increase in the rate of mutations, as the cells are more likely to undergo DNA replication errors.\nOverall, the mechanisms underlying adaptive mutagenesis in Bacillus subtilis are complex and multifactorial, and likely involve a combination of the mechanisms mentioned above.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Adaptive mutagenesis is a phenomenon observed in Bacillus subtilis where the rate of spontaneous mutations increases during the stationary phase of growth.\n2. One proposed mechanism for adaptive mutagenesis is the activation of stress response pathways, such as the DNA damage response and the SOS response, during the stationary phase of growth.\n3. The activation of these pathways can induce the expression of genes that promote mutagenesis.\n4. Another suggested mechanism is the accumulation of mutations in key genes involved in DNA repair and replication in the stationary phase of growth.\n5. A decrease in bacterial division during the stationary phase of growth may lead to an increase in the rate of mutations due to more likely DNA replication errors.",
    "vicuna-13b_fact": [
      "Adaptive mutagenesis is a phenomenon observed in Bacillus subtilis where the rate of spontaneous mutations increases during the stationary phase of growth.",
      "One proposed mechanism for adaptive mutagenesis is the activation of stress response pathways, such as the DNA damage response and the SOS response, during the stationary phase of growth.",
      "The activation of these pathways can induce the expression of genes that promote mutagenesis.",
      "Another suggested mechanism is the accumulation of mutations in key genes involved in DNA repair and replication in the stationary phase of growth.",
      "A decrease in bacterial division during the stationary phase of growth may lead to an increase in the rate of mutations due to more likely DNA replication errors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: A decrease in bacterial division during the stationary phase of growth may lead to a decrease in the rate of mutations due to less frequent DNA replication.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1375,
    "user_query": "What personality traits can be evaluated with the Ten Item Personality Inventory.",
    "vicuna-13b_response": "The Ten Item Personality Inventory (TIPI) is a self-report questionnaire designed to assess a broad range of personality traits. The TIPI consists of 10 items that are rated on a 5-point scale, ranging from \"strongly disagree\" to \"strongly agree.\" The items are designed to assess the following personality traits:\n1. Warmth: This trait assesses how friendly, kind, and caring a person is.\n2. Abstractedness: This trait assesses how imaginative and creative a person is.\n3. Openness to change: This trait assesses how open a person is to new experiences and ideas.\n4. Assertiveness: This trait assesses how confident and self-assured a person is.\n5. Self-directedness: This trait assesses how independent and self-motivated a person is.\n6. Emotional stability: This trait assesses how stable and even-tempered a person is.\n7. Locus of control: This trait assesses how much a person believes they can control their own destiny.\n8. Social boldness: This trait assesses how outgoing and sociable a person is.\n9. Interpersonal sensitivity: This trait assesses how attuned a person is to other people's feelings and emotions.\n10. Vigilance: This trait assesses how alert and aware a person is of their surroundings.\nOverall, the TIPI is a useful tool for assessing a wide range of personality traits, and can be used in research, clinical, and counseling settings.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Ten Item Personality Inventory (TIPI) is a self-report questionnaire designed to assess a broad range of personality traits.\n2. The TIPI consists of 10 items that are rated on a 5-point scale, from \"strongly disagree\" to \"strongly agree.\"\n3. The assessed personality traits include warmth, abstractedness, openness to change, assertiveness, self-directedness, emotional stability, locus of control, social boldness, interpersonal sensitivity, and vigilance.\n4. The trait of \"warmth\" in the TIPI assesses friendliness, kindness, and caring.\n5. The TIPI can be used in research, clinical, and counseling settings.",
    "vicuna-13b_fact": [
      "The Ten Item Personality Inventory (TIPI) is a self-report questionnaire designed to assess a broad range of personality traits.",
      "The TIPI consists of 10 items that are rated on a 5-point scale, from \"strongly disagree\" to \"strongly agree.\"",
      "The assessed personality traits include warmth, abstractedness, openness to change, assertiveness, self-directedness, emotional stability, locus of control, social boldness, interpersonal sensitivity, and vigilance.",
      "The trait of \"warmth\" in the TIPI assesses friendliness, kindness, and caring.",
      "The TIPI can be used in research, clinical, and counseling settings."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The assessed personality traits include Extraversion, Agreeableness, Conscientiousness, Emotional Stability, and Openness to Experience.  \n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1376,
    "user_query": "Which are the enzymes involved in the control of tubulin acetylation?",
    "vicuna-13b_response": "Tubulin acetylation is a post-translational modification that plays a critical role in regulating microtubule dynamics and stability. Several enzymes are involved in the control of tubulin acetylation, including:\n1. Tubulin acetyltransferases (TATs): TATs are enzymes that add acetyl groups to tubulin. There are several types of TATs, including histone acetyltransferases (HATs) and tubulin-specific acetyltransferases (TATs). TATs are responsible for regulating microtubule dynamics by controlling the level of acetylation on tubulin.\n2. Tubulin deacetylases (TDACs): TDACs are enzymes that remove acetyl groups from tubulin. TDACs are responsible for regulating microtubule stability by controlling the level of acetylation on tubulin.\n3. Deacetylase-binding proteins (DAPs): DAPs are proteins that bind to TDACs and inhibit their activity, thereby increasing the level of acetylation on tubulin. DAPs play a critical role in regulating microtubule dynamics by controlling the level of acetylation on tubulin.\n4. Acetyl-tubulin synthase (ATS): ATS is an enzyme that synthesizes acetyl-tubulin from tubulin and acetyl-CoA. ATS plays a critical role in regulating microtubule dynamics by controlling the level of acetylation on tubulin.\nOverall, the regulation of tubulin acetylation is a complex process that involves multiple enzymes and proteins. Dysregulation of tubulin acetylation has been implicated in a variety of diseases, including cancer and neurodegenerative disorders, highlighting the importance of understanding the mechanisms that control tubulin acetylation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tubulin acetylation is a post-translational modification that plays a critical role in regulating microtubule dynamics and stability.\n2. Tubulin acetyltransferases (TATs) are enzymes that add acetyl groups to tubulin.\n3. Tubulin deacetylases (TDACs) are enzymes that remove acetyl groups from tubulin.\n4. Deacetylase-binding proteins (DAPs) are proteins that bind to TDACs and inhibit their activity.\n5. Acetyl-tubulin synthase (ATS) is an enzyme that synthesizes acetyl-tubulin from tubulin and acetyl-CoA.",
    "vicuna-13b_fact": [
      "Tubulin acetylation is a post-translational modification that plays a critical role in regulating microtubule dynamics and stability.",
      "Tubulin acetyltransferases (TATs) are enzymes that add acetyl groups to tubulin.",
      "Tubulin deacetylases (TDACs) are enzymes that remove acetyl groups from tubulin.",
      "Deacetylase-binding proteins (DAPs) are proteins that bind to TDACs and inhibit their activity.",
      "Acetyl-tubulin synthase (ATS) is an enzyme that synthesizes acetyl-tubulin from tubulin and acetyl-CoA."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1378,
    "user_query": "List all approved indications for Glivec",
    "vicuna-13b_response": "Glivec (imatinib) is a medication used to treat various types of cancer, including:\n1. Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in adults and children.\n2. Gastrointestinal stromal tumors (GIST) in adults.\n3. Acute lymphoblastic leukemia (ALL) in adults and children with Philadelphia chromosome-positive (Ph+) ALL.\n4. Hypereosinophilic syndrome (HES) and systemic mastocytosis (SM) in adults.\nIt is important to note that the use of Glivec in any other cancer types or in other patient populations is not approved by regulatory authorities.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Glivec, also known as imatinib, is a medication used to treat various types of cancer.\n2. Glivec is used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in adults and children.\n3. Glivec is used to treat gastrointestinal stromal tumors (GIST) in adults.\n4. Glivec is used to treat acute lymphoblastic leukemia (ALL) in adults and children with Philadelphia chromosome-positive (Ph+) ALL.\n5. Glivec is used to treat hypereosinophilic syndrome (HES) and systemic mastocytosis (SM) in adults.",
    "vicuna-13b_fact": [
      "Glivec, also known as imatinib, is a medication used to treat various types of cancer.",
      "Glivec is used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in adults and children.",
      "Glivec is used to treat gastrointestinal stromal tumors (GIST) in adults.",
      "Glivec is used to treat acute lymphoblastic leukemia (ALL) in adults and children with Philadelphia chromosome-positive (Ph+) ALL.",
      "Glivec is used to treat hypereosinophilic syndrome (HES) and systemic mastocytosis (SM) in adults."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1379,
    "user_query": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?",
    "vicuna-13b_response": "Several proteins have been identified that can inhibit the retrotransposition of LINE-1 and Alu elements. Some of these proteins include:\n1. PIWIL2: This protein has been shown to bind to and inhibit the activity of both LINE-1 and Alu elements. PIWIL2 is a chromatin-associated protein that can recruit histone-modifying enzymes to repress transcription of these elements.\n2. REST: This protein is a transcriptional repressor that can bind to and inhibit the activity of LINE-1 and Alu elements. REST has been shown to be important for the repression of these elements in neural stem cells.\n3. SCNN1D: This protein is a sodium-dependent nucleoside transporter that has been shown to inhibit the retrotransposition of LINE-1 elements. SCNN1D can transport the antiviral drug acyclovir, which can then inhibit the activity of LINE-1 elements.\n4. APOBEC3B: This protein is a member of the APOBEC3 family of proteins, which are known to be important for the innate immune response. APOBEC3B has been shown to inhibit the retrotransposition of LINE-1 elements by binding to and degrading the reverse transcriptase of the LINE-1 element.\nOverall, these proteins play important roles in regulating the activity of LINE-1 and Alu elements, and their dysregulation has been implicated in various diseases, including cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PIWIL2 is a protein that can inhibit the activity of both LINE-1 and Alu elements.\n2. REST is a transcriptional repressor that can inhibit the activity of LINE-1 and Alu elements. \n3. SCNN1D is a protein that inhibits the retrotransposition of LINE-1 elements. \n4. APOBEC3B is a protein that inhibits the retrotransposition of LINE-1 elements by binding to and degrading the reverse transcriptase of the LINE-1 element.\n5. The dysregulation of these proteins regulating the activity of LINE-1 and Alu elements has been implicated in various diseases, including cancer.",
    "vicuna-13b_fact": [
      "PIWIL2 is a protein that can inhibit the activity of both LINE-1 and Alu elements.",
      "REST is a transcriptional repressor that can inhibit the activity of LINE-1 and Alu elements.",
      "SCNN1D is a protein that inhibits the retrotransposition of LINE-1 elements.",
      "APOBEC3B is a protein that inhibits the retrotransposition of LINE-1 elements by binding to and degrading the reverse transcriptase of the LINE-1 element.",
      "The dysregulation of these proteins regulating the activity of LINE-1 and Alu elements has been implicated in various diseases, including cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1382,
    "user_query": "Describe the usefulness of Macrostomum lignano in ion channel and stem cell research",
    "vicuna-13b_response": "Macrostomum lignano is a model organism that is commonly used in scientific research, particularly in the fields of ion channel and stem cell research.\nIn ion channel research, Macrostomum lignano is useful because it has a simple and accessible nervous system that is composed of a single nerve cord running along the entire length of the worm. This makes it an ideal model organism for studying the function and regulation of ion channels, which are important for the transmission of electrical signals in the nervous system.\nIn particular, researchers have used Macrostomum lignano to study the function of ion channels that are involved in pain perception, muscle contraction, and other important physiological processes. By studying these ion channels in Macrostomum lignano, researchers can gain insights into how they function in more complex organisms, including humans.\nIn stem cell research, Macrostomum lignano is useful because it has a relatively simple and accessible system for studying stem cell biology. Researchers have used Macrostomum lignano to study the behavior and differentiation of stem cells in the context of tissue repair and regeneration.\nIn particular, researchers have used Macrostomum lignano to study the role of stem cells in the regeneration of damaged tissues, such as the nervous system. By studying the behavior of stem cells in Macrostomum lignano, researchers can gain insights into the mechanisms that regulate stem cell behavior and differentiation, which may have implications for the development of therapies for a variety of diseases.\nOverall, Macrostomum lignano is a valuable model organism for both ion channel and stem cell research, providing valuable insights into important physiological processes and the behavior of stem cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Macrostomum lignano is commonly used as a model organism in scientific research, particularly in the fields of ion channel and stem cell research.\n2. The nervous system of Macrostomum lignano is composed of a single nerve cord running the full length of the worm.\n3. Macrostomum lignano is used to study ion channels that are involved in various physiological processes such as pain perception and muscle contraction.\n4. Macrostomum lignano is used in stem cell research to study the behavior and differentiation of stem cells regarding tissue repair and regeneration.\n5. Research into the role of stem cells in the regeneration of damaged tissues, such as the nervous system, has been conducted using Macrostomum lignano.",
    "vicuna-13b_fact": [
      "Macrostomum lignano is commonly used as a model organism in scientific research, particularly in the fields of ion channel and stem cell research.",
      "The nervous system of Macrostomum lignano is composed of a single nerve cord running the full length of the worm.",
      "Macrostomum lignano is used to study ion channels that are involved in various physiological processes such as pain perception and muscle contraction.",
      "Macrostomum lignano is used in stem cell research to study the behavior and differentiation of stem cells regarding tissue repair and regeneration.",
      "Research into the role of stem cells in the regeneration of damaged tissues, such as the nervous system, has been conducted using Macrostomum lignano."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The nervous system of Macrostomum lignano is composed of two nerve cords running the full length of the worm.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1384,
    "user_query": "Which drug is benserazide usually co-administered with?",
    "vicuna-13b_response": "Benserazide is a benzodiazepine receptor antagonist that is commonly used to treat hypertension, and it is often co-administered with other drugs to enhance its effectiveness or to reduce its side effects. Some of the drugs that are commonly co-administered with benserazide include:\n1. Diuretics: Diuretics are drugs that help the body to eliminate excess fluid by increasing urine production. They are often co-administered with benserazide to help reduce blood pressure and prevent the accumulation of fluid in the body. Examples of diuretics that may be co-administered with benserazide include furosemide, bumetanide, and hydrochlorothiazide.\n2. Calcium channel blockers: Calcium channel blockers are drugs that help to relax the smooth muscle in blood vessels, which can help to lower blood pressure. They are often co-administered with benserazide to enhance their effectiveness in treating hypertension. Examples of calcium channel blockers that may be co-administered with benserazide include amlodipine, diltiazem, and verapamil.\n3. ACE inhibitors: Angiotensin-converting enzyme (ACE) inhibitors are drugs that help to block the action of a hormone called angiotensin II, which can cause blood vessels to constrict and blood pressure to rise. They are often co-administered with benserazide to further lower blood pressure and prevent damage to the blood vessels. Examples of ACE inhibitors that may be co-administered with benserazide include lisinopril, ramipril, and enalapril.\nIt is important to note that the use of multiple drugs to treat a single condition is known as polypharmacy, and it can increase the risk of side effects and drug interactions. Therefore, it is important to follow the advice of a healthcare professional when taking any medication, including benserazide.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Benserazide is a benzodiazepine receptor antagonist used to treat hypertension.\n2. Benserazide is often co-administered with other drugs to enhance its effectiveness or to reduce its side effects.\n3. Diuretics, calcium channel blockers, and ACE inhibitors are examples of drugs that can be co-administered with benserazide.\n4. Diuretics help the body eliminate excess fluid by increasing urine production.\n5. The use of multiple drugs to treat a single condition is known as polypharmacy.",
    "vicuna-13b_fact": [
      "Benserazide is a benzodiazepine receptor antagonist used to treat hypertension.",
      "Benserazide is often co-administered with other drugs to enhance its effectiveness or to reduce its side effects.",
      "Diuretics, calcium channel blockers, and ACE inhibitors are examples of drugs that can be co-administered with benserazide.",
      "Diuretics help the body eliminate excess fluid by increasing urine production.",
      "The use of multiple drugs to treat a single condition is known as polypharmacy."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Benserazide is not a benzodiazepine receptor antagonist used to treat hypertension. It is a decarboxylase inhibitor that is often used in combination with levodopa for the treatment of Parkinson's disease.\n2. TRUE\n3. FALSE [correction]: Diuretics, calcium channel blockers, and ACE inhibitors are not typically co-administered with benserazide, as they are used for other medical conditions like high blood pressure or heart failure.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1387,
    "user_query": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?",
    "vicuna-13b_response": "There are several biomedical text mining tools available for the detection of protein-protein interactions. Some of the most popular ones are:\n1. BM25: BM25 is a rule-based text mining tool that uses a combination of statistical and linguistic features to identify protein-protein interactions. It is a widely used tool for information retrieval in the biomedical domain.\n2. TM2: TM2 is a text mining tool that uses a combination of rule-based and statistical methods to identify protein-protein interactions. It is a more advanced version of BM25 and has been shown to achieve higher precision and recall scores.\n3. PRotein-Protein Interaction Extraction (PRIDE): PRIDE is a web-based tool that uses a combination of rule-based and machine learning methods to extract protein-protein interactions from biomedical text. It is a widely used tool for protein-protein interaction extraction and has been used in many research studies.\n4. Textpresso: Textpresso is a text mining tool that uses a combination of rule-based and machine learning methods to extract protein-protein interactions from biomedical text. It is a user-friendly tool that can be easily used by non-experts.\n5. PINT: PINT is a protein-protein interaction extraction tool that uses a combination of rule-based and machine learning methods to extract protein-protein interactions from biomedical text. It is a widely used tool for protein-protein interaction extraction and has been used in many research studies.\nThese are some of the most popular biomedical text mining tools for the detection of protein-protein interactions. It is important to note that the choice of tool will depend on the specific requirements of the user and the type of data being analyzed.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BM25 is a biomedical text mining tool that identifies protein-protein interactions and is used for information retrieval in the biomedical domain.\n2. TM2 is a text mining tool that uses a combination of rule-based and statistical methods to identify protein-protein interactions. \n3. PRotein-Protein Interaction Extraction (PRIDE) is a web-based tool that extracts protein-protein interactions from biomedical text.\n4. Textpresso is a user-friendly text mining tool that extracts protein-protein interactions from biomedical text.\n5. PINT is a protein-protein interaction extraction tool widely used in many research studies.",
    "vicuna-13b_fact": [
      "BM25 is a biomedical text mining tool that identifies protein-protein interactions and is used for information retrieval in the biomedical domain.",
      "TM2 is a text mining tool that uses a combination of rule-based and statistical methods to identify protein-protein interactions.",
      "PRotein-Protein Interaction Extraction (PRIDE) is a web-based tool that extracts protein-protein interactions from biomedical text.",
      "Textpresso is a user-friendly text mining tool that extracts protein-protein interactions from biomedical text.",
      "PINT is a protein-protein interaction extraction tool widely used in many research studies."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: BM25 is an algorithm used for ranking information retrieval system, not specifically for identifying protein-protein interactions in the biomedical domain.\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1391,
    "user_query": "Can RNASeq be used for the analysis of nascent transcripts?",
    "vicuna-13b_response": "Yes, RNA-seq (RNA sequencing) can be used for the analysis of nascent transcripts, which are RNA molecules that are in the process of being synthesized from DNA. RNA-seq is a powerful technique that allows researchers to study the expression levels of all RNA molecules in a sample, including both mature and nascent transcripts.\nTo analyze nascent transcripts using RNA-seq, researchers can use a variety of approaches. One common approach is to use RNA-seq to analyze the transcriptome of a cell or tissue at different time points after the initiation of gene expression. This can reveal the temporal dynamics of gene expression and provide insights into the process of transcriptional initiation and elongation.\nAnother approach is to use RNA-seq to analyze the transcriptome of a cell or tissue under different experimental conditions, such as in the presence of drugs or other compounds that affect transcription. This can reveal the effects of these compounds on gene expression and provide insights into the mechanisms of action of these compounds.\nIn addition, RNA-seq can be used to analyze the transcriptome of specific cell types or tissues, such as neurons or heart tissue, to identify the specific genes that are expressed in these cells and to study the functions of these genes.\nOverall, RNA-seq is a powerful tool that can be used to analyze nascent transcripts and gain insights into the process of transcription and the regulation of gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. RNA-seq (RNA sequencing) can be used for the analysis of nascent transcripts.\n2. Nascent transcripts are RNA molecules that are in the process of being synthesized from DNA.\n3. RNA-seq allows for the study of expression levels of all RNA molecules in a sample, including both mature and nascent transcripts.\n4. RNA-seq can be used to analyze the transcriptome of a cell or tissue at different time points after the initiation of gene expression.\n5. RNA-seq can be utilized to determine the effects of experimental conditions, such as the presence of drugs or other compounds, on gene expression.",
    "vicuna-13b_fact": [
      "RNA-seq (RNA sequencing) can be used for the analysis of nascent transcripts.",
      "Nascent transcripts are RNA molecules that are in the process of being synthesized from DNA.",
      "RNA-seq allows for the study of expression levels of all RNA molecules in a sample, including both mature and nascent transcripts.",
      "RNA-seq can be used to analyze the transcriptome of a cell or tissue at different time points after the initiation of gene expression.",
      "RNA-seq can be utilized to determine the effects of experimental conditions, such as the presence of drugs or other compounds, on gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1392,
    "user_query": "Do RNA:DNA hybrids preferentially form in high or low GC regions?",
    "vicuna-13b_response": "RNA:DNA hybrids, also known as R-loops, form when an RNA molecule binds to a DNA template strand, creating a hybrid structure that can affect gene expression and DNA replication. The formation of RNA:DNA hybrids is influenced by several factors, including the local DNA structure and the presence of proteins that regulate RNA:DNA interactions.\nThere is evidence that RNA:DNA hybrids tend to form more frequently in regions of high GC content, such as in the introns of genes or in non-coding regions, compared to low GC regions. This is because high GC regions have a higher propensity for RNA:DNA hybridization due to the increased stability of RNA:DNA duplexes in these regions.\nAdditionally, the presence of transcription factors and other proteins that regulate RNA:DNA interactions can also affect the formation of RNA:DNA hybrids. For example, some transcription factors have been shown to promote the formation of RNA:DNA hybrids in high GC regions, while other proteins can protect against RNA:DNA hybridization in these regions.\nOverall, while there is a tendency for RNA:DNA hybrids to form more frequently in high GC regions, the formation of these structures is a complex process that is influenced by a variety of factors, including local DNA structure, protein binding, and RNA:DNA interactions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. RNA:DNA hybrids, also known as R-loops, form when an RNA molecule binds to a DNA template strand.\n2. These hybrids can affect gene expression and DNA replication.\n3. RNA:DNA hybrids tend to form more frequently in regions of high GC content.\n4. The formation of RNA:DNA hybrids is influenced by factors such as the local DNA structure and the presence of proteins that regulate RNA:DNA interactions.\n5. Some transcription factors have been shown to promote the formation of RNA:DNA hybrids in high GC regions.",
    "vicuna-13b_fact": [
      "RNA:DNA hybrids, also known as R-loops, form when an RNA molecule binds to a DNA template strand.",
      "These hybrids can affect gene expression and DNA replication.",
      "RNA:DNA hybrids tend to form more frequently in regions of high GC content.",
      "The formation of RNA:DNA hybrids is influenced by factors such as the local DNA structure and the presence of proteins that regulate RNA:DNA interactions.",
      "Some transcription factors have been shown to promote the formation of RNA:DNA hybrids in high GC regions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1397,
    "user_query": "Which drugs are included in TAS-102?",
    "vicuna-13b_response": "TAS-102 is a drug that is used to treat cancer. It is a combination of two drugs: temozolomide and capecitabine. Temozolomide is a chemotherapy drug that works by interfering with the ability of cancer cells to divide and grow. Capecitabine is a chemotherapy drug that is converted to 5-fluorouracil (5-FU) in the body, which also interferes with the ability of cancer cells to divide and grow. TAS-102 is used to treat various types of cancer, including brain tumors, metastatic breast cancer, and metastatic colorectal cancer. It is usually given as a pill or a liquid that is taken orally.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TAS-102 is a drug used to treat cancer.\n2. TAS-102 is a combination of two drugs: temozolomide and capecitabine.\n3. Temozolomide is a chemotherapy drug that works by interfering with the ability of cancer cells to divide and grow.\n4. Capecitabine is a chemotherapy drug that is converted to 5-fluorouracil (5-FU) in the body.\n5. TAS-102 is used to treat various types of cancer, including brain tumors, metastatic breast cancer, and metastatic colorectal cancer.",
    "vicuna-13b_fact": [
      "TAS-102 is a drug used to treat cancer.",
      "TAS-102 is a combination of two drugs: temozolomide and capecitabine.",
      "Temozolomide is a chemotherapy drug that works by interfering with the ability of cancer cells to divide and grow.",
      "Capecitabine is a chemotherapy drug that is converted to 5-fluorouracil (5-FU) in the body.",
      "TAS-102 is used to treat various types of cancer, including brain tumors, metastatic breast cancer, and metastatic colorectal cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: TAS-102 is a combination of two drugs: trifluridine and tipiracil.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: TAS-102 is used to treat colorectal cancer and gastric cancer. It is not used for treating brain tumors or breast cancer.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "vicuna-13b_response": "Erucism is a term that refers to the phenomenon of feeling an itching or tickling sensation on the skin, often in response to an external stimulus such as the presence of an insect or a piece of lint on the skin. There are several possible causes of erucism:\n1. Insect bites or stings: Insects such as mosquitoes, ticks, and bed bugs can cause an itchy sensation on the skin when they bite or sting the person.\n2. Contact dermatitis: This is a type of skin irritation that occurs when the skin comes into contact with an irritant, such as a chemical or an allergen. The itching sensation that occurs with contact dermatitis is often accompanied by redness, swelling, and blisters.\n3. Dry skin: When the skin becomes dry, it can become itchy and flaky. This can be caused by a lack of moisture in the air, or by using harsh soaps or detergents on the skin.\n4. Allergies: Some people are allergic to certain substances, such as pollen or animal dander, which can cause an itchy rash on the skin.\n5. Psychological factors: In some cases, the itching sensation on the skin can be caused by psychological factors such as stress, anxiety, or obsessive-compulsive disorder (OCD).\nOverall, erucism can be caused by a variety of factors, and the specific cause will depend on the individual case. If you are experiencing persistent or severe itching, it is important to speak with a healthcare provider to determine the underlying cause and to receive appropriate treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Erucism refers to the phenomenon of feeling an itching or tickling sensation on the skin.\n2. Insect bites or stings can cause an itchy sensation on the skin.\n3. Contact dermatitis, a skin irritation caused by contact with an irritant, can cause erucism.\n4. Dry skin, often due to a lack of moisture in the air or using harsh soaps or detergents, can result in itching and flakiness.\n5. Allergies to substances like pollen or animal dander might cause an itchy rash on the skin.\n6. In some cases, psychological factors like stress, anxiety, or obsessive-compulsive disorder can cause the itching sensation associated with erucism.",
    "vicuna-13b_fact": [
      "Erucism refers to the phenomenon of feeling an itching or tickling sensation on the skin.",
      "Insect bites or stings can cause an itchy sensation on the skin.",
      "Contact dermatitis, a skin irritation caused by contact with an irritant, can cause erucism.",
      "Dry skin, often due to a lack of moisture in the air or using harsh soaps or detergents, can result in itching and flakiness.",
      "Allergies to substances like pollen or animal dander might cause an itchy rash on the skin.",
      "In some cases, psychological factors like stress, anxiety, or obsessive-compulsive disorder can cause the itching sensation associated with erucism."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Erucism refers to a type of contact dermatitis caused by the stinging hairs or bristles of caterpillars or moth larvae.\n2. TRUE\n3. FALSE [correction]: Contact dermatitis, a skin irritation caused by contact with an irritant, can cause itchiness but it is not called erucism.\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1400,
    "user_query": "How does Hst5 (histatin 5) affect infections by Candida glabrata?",
    "vicuna-13b_response": "Hst5 (histatin 5) is a protein that is naturally produced by the human body and has been shown to have antifungal properties. Candida glabrata is a type of yeast that can cause infections, particularly in individuals with weakened immune systems.\nStudies have shown that Hst5 can inhibit the growth of Candida glabrata in vitro, meaning that it can prevent the yeast from growing in a laboratory setting. Hst5 has been shown to be effective against a range of Candida species, including Candida glabrata, by binding to the cell wall of the yeast and disrupting its normal function.\nHowever, it is important to note that the effectiveness of Hst5 in vivo (in a living organism) is not yet fully understood and more research is needed to determine its potential as a treatment for Candida infections. Additionally, Hst5 may have potential side effects and toxicity, so further studies are needed to evaluate its safety and efficacy.\nIn conclusion, Hst5 (histatin 5) has been shown to have antifungal properties and can inhibit the growth of Candida glabrata in vitro. However, more research is needed to fully understand its effectiveness and safety in treating Candida infections in vivo.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hst5 (histatin 5) is a protein naturally produced by the human body with antifungal properties.\n2. Candida glabrata is a type of yeast that can cause infections, particularly in individuals with weakened immune systems.\n3. Hst5 (histatin 5) can inhibit the growth of Candida glabrata in vitro.\n4. Hst5 functions by binding to the cell wall of the yeast and disrupting its normal function.\n5. The effectiveness and safety of Hst5 in treating Candida infections in vivo are not yet fully understood so more research is needed.",
    "vicuna-13b_fact": [
      "Hst5 (histatin 5) is a protein naturally produced by the human body with antifungal properties.",
      "Candida glabrata is a type of yeast that can cause infections, particularly in individuals with weakened immune systems.",
      "Hst5 (histatin 5) can inhibit the growth of Candida glabrata in vitro.",
      "Hst5 functions by binding to the cell wall of the yeast and disrupting its normal function.",
      "The effectiveness and safety of Hst5 in treating Candida infections in vivo are not yet fully understood so more research is needed."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1402,
    "user_query": "Are there Conserved Noncoding Elements (CNEs) in plant genomes?",
    "vicuna-13b_response": "Yes, there are Conserved Noncoding Elements (CNEs) in plant genomes. CNEs are sequences of DNA that are conserved across different plant species, but do not encode proteins. They are also known as \"junk DNA\" or \"dark matter\" because their function was not well understood for a long time. However, recent studies have shown that CNEs play important roles in regulating gene expression, controlling chromosome structure, and mediating interactions between different species. Some examples of CNEs in plants include transposable elements, repetitive sequences, and non-coding RNA genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Conserved Noncoding Elements (CNEs) exist in plant genomes.\n2. CNEs are sequences of DNA that are conserved across different plant species, but do not encode proteins.\n3. CNEs are also referred to as \"junk DNA\" or \"dark matter\".\n4. Recent studies have shown that CNEs have roles in regulating gene expression, controlling chromosome structure, and mediating interactions between different species.\n5. Some examples of CNEs in plants include transposable elements, repetitive sequences, and non-coding RNA genes.",
    "vicuna-13b_fact": [
      "Conserved Noncoding Elements (CNEs) exist in plant genomes.",
      "CNEs are sequences of DNA that are conserved across different plant species, but do not encode proteins.",
      "CNEs are also referred to as \"junk DNA\" or \"dark matter\".",
      "Recent studies have shown that CNEs have roles in regulating gene expression, controlling chromosome structure, and mediating interactions between different species.",
      "Some examples of CNEs in plants include transposable elements, repetitive sequences, and non-coding RNA genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CNEs should not be confused with \"junk DNA\" or \"dark matter\". While they don't code for proteins, they are highly functional and perform important roles in the genome.\n4. TRUE\n5. FALSE [correction]: Transposable elements, repetitive sequences, and non-coding RNA genes may contribute to noncoding regions of the genome, but these are not examples of CNEs. CNEs refer to highly conserved sequences found in noncoding regions across multiple species.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1403,
    "user_query": "Which is the localization of the RIFIN family of proteins?",
    "vicuna-13b_response": "The RIFIN family of proteins is localized in the endoplasmic reticulum (ER) and the Golgi apparatus. RIFIN proteins are involved in various cellular processes, including protein folding, transport, and degradation. They are also involved in the regulation of cellular calcium levels and have been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The RIFIN family of proteins is localized in the endoplasmic reticulum (ER) and the Golgi apparatus.\n2. RIFIN proteins are involved in various cellular processes.\n3. RIFIN proteins are involved in protein folding, transport, and degradation.\n4. RIFIN proteins are involved in the regulation of cellular calcium levels.\n5. The RIFIN family of proteins have been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact": [
      "The RIFIN family of proteins is localized in the endoplasmic reticulum (ER) and the Golgi apparatus.",
      "RIFIN proteins are involved in various cellular processes.",
      "RIFIN proteins are involved in protein folding, transport, and degradation.",
      "RIFIN proteins are involved in the regulation of cellular calcium levels.",
      "The RIFIN family of proteins have been implicated in various diseases, including cancer and neurodegenerative disorders."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1406,
    "user_query": "Is there any genetic determinant of hair pigmentation that could be useful in forensic analyses?",
    "vicuna-13b_response": "Yes, there is a genetic determinant of hair pigmentation that could be useful in forensic analyses. The genetic determinant of hair pigmentation is located on the X chromosome and is known as the melanocortin 1 receptor (MC1R) gene.\nThe MC1R gene provides instructions for making a protein called the melanocortin 1 receptor, which is involved in the production of melanin, the pigment that gives color to skin, hair, and eyes. The MC1R gene has been shown to play a role in determining the color of hair in humans, with certain variations in the gene leading to different hair colors.\nForensic analysts can use genetic testing to determine the presence of specific variations in the MC1R gene that are associated with different hair colors. This information can be used to help identify individuals and provide additional information about a crime scene or victim.\nHowever, it's important to note that hair pigmentation is also influenced by environmental factors, such as sun exposure and aging, which can affect the appearance of hair color over time. Therefore, forensic analysts must consider these factors when interpreting the results of genetic testing for hair pigmentation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The genetic determinant of hair pigmentation is located on the X chromosome and is known as the melanocortin 1 receptor (MC1R) gene.\n2. The MC1R gene provides instructions for making a protein called the melanocortin 1 receptor, which is involved in the production of melanin.\n3. Melanin is the pigment that gives color to skin, hair, and eyes.\n4. Specific variations in the MC1R gene contribute to different hair colors.\n5. Environmental factors, such as sun exposure and aging, can impact hair color as well.",
    "vicuna-13b_fact": [
      "The genetic determinant of hair pigmentation is located on the X chromosome and is known as the melanocortin 1 receptor (MC1R) gene.",
      "The MC1R gene provides instructions for making a protein called the melanocortin 1 receptor, which is involved in the production of melanin.",
      "Melanin is the pigment that gives color to skin, hair, and eyes.",
      "Specific variations in the MC1R gene contribute to different hair colors.",
      "Environmental factors, such as sun exposure and aging, can impact hair color as well."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The genetic determinant of hair pigmentation is not specifically located on the X chromosome. It involves multiple genes, one of which is the melanocortin 1 receptor (MC1R) gene.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1408,
    "user_query": "Could Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) cause sudden cardiac death?",
    "vicuna-13b_response": "Yes, CPVT can cause sudden cardiac death. CPVT is a type of heart condition that affects the electrical activity of the heart. It can cause abnormal heart rhythms, including ventricular tachycardia (VT), which can be life-threatening. VT is a rapid and potentially deadly heart rhythm that can cause the heart to pump blood ineffectively. If left untreated, VT can lead to sudden cardiac death.\nCPVT is a genetic condition that is inherited from a person's parents. It is caused by changes in certain genes that affect the way the heart functions. People with CPVT have an increased risk of developing VT and other abnormal heart rhythms.\nIt is important for people with CPVT to receive proper medical care and follow-up with their healthcare provider. Treatment options for CPVT include medications, lifestyle changes, and sometimes an implantable cardioverter-defibrillator (ICD). An ICD is a device that is implanted in the chest and can deliver an electric shock to the heart to restore a normal heart rhythm in the event of a life-threatening arrhythmia.\nIf you have CPVT or suspect you may have the condition, it is important to seek medical attention right away. Early diagnosis and treatment can help reduce the risk of sudden cardiac death and other complications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) can cause sudden cardiac death.\n2. CPVT is a type of heart condition that affects the electrical activity of the heart.\n3. CPVT is a genetic condition that is inherited from a person's parents.\n4. Treatment options for CPVT include medications, lifestyle changes, and sometimes an implantable cardioverter-defibrillator (ICD).\n5. An ICD is a device that is implanted in the chest and can deliver an electric shock to the heart to restore a normal heart rhythm in the event of a life-threatening arrhythmia.",
    "vicuna-13b_fact": [
      "Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) can cause sudden cardiac death.",
      "CPVT is a type of heart condition that affects the electrical activity of the heart.",
      "CPVT is a genetic condition that is inherited from a person's parents.",
      "Treatment options for CPVT include medications, lifestyle changes, and sometimes an implantable cardioverter-defibrillator (ICD).",
      "An ICD is a device that is implanted in the chest and can deliver an electric shock to the heart to restore a normal heart rhythm in the event of a life-threatening arrhythmia."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1411,
    "user_query": "Is the ACE inhibitor indicated for lung cancer treatment?",
    "vicuna-13b_response": "No, ACE inhibitors are not indicated for the treatment of lung cancer. ACE inhibitors are a type of medication that is primarily used to treat conditions related to the heart and blood vessels, such as hypertension, heart failure, and kidney disease. While some studies have suggested that ACE inhibitors may have some potential benefits in the treatment of certain types of cancer, such as lung cancer, they are not currently used as a first-line treatment for lung cancer. Instead, lung cancer is typically treated with a combination of surgery, radiation therapy, and chemotherapy, depending on the stage and severity of the cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ACE inhibitors are not indicated for the treatment of lung cancer.\n2. ACE inhibitors are primarily used to treat conditions related to the heart and blood vessels.\n3. ACE inhibitors can be used for the treatment of hypertension, heart failure, and kidney disease.\n4. Lung cancer is typically treated with a combination of surgery, radiation therapy, and chemotherapy.\n5. ACE inhibitors are not currently used as a first-line treatment for lung cancer.",
    "vicuna-13b_fact": [
      "ACE inhibitors are not indicated for the treatment of lung cancer.",
      "ACE inhibitors are primarily used to treat conditions related to the heart and blood vessels.",
      "ACE inhibitors can be used for the treatment of hypertension, heart failure, and kidney disease.",
      "Lung cancer is typically treated with a combination of surgery, radiation therapy, and chemotherapy.",
      "ACE inhibitors are not currently used as a first-line treatment for lung cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "vicuna-13b_response": "Hydrochlorothiazide is a diuretic medication that is primarily used to treat hypertension (high blood pressure) and edema (swelling). It is also sometimes used in combination with other medications to treat diabetes insipidus, a condition in which the body produces too much urine and has an excessive thirst. Hydrochlorothiazide works by increasing the excretion of sodium and chloride ions in the urine, which in turn helps to lower blood pressure and reduce edema. It is usually taken orally, and the dosage and duration of treatment will depend on the individual patient's condition and response to the medication.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hydrochlorothiazide is a diuretic medication.\n2. Hydrochlorothiazide is primarily used to treat hypertension and edema.\n3. This medication can sometimes be used to treat diabetes insipidus.\n4. Hydrochlorothiazide works by increasing the excretion of sodium and chloride ions in the urine.\n5. Hydrochlorothiazide is usually taken orally.",
    "vicuna-13b_fact": [
      "Hydrochlorothiazide is a diuretic medication.",
      "Hydrochlorothiazide is primarily used to treat hypertension and edema.",
      "This medication can sometimes be used to treat diabetes insipidus.",
      "Hydrochlorothiazide works by increasing the excretion of sodium and chloride ions in the urine.",
      "Hydrochlorothiazide is usually taken orally."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1418,
    "user_query": "Which genes are thought to be involved in medulloblastoma development?",
    "vicuna-13b_response": "Medulloblastoma is a type of brain cancer that develops from cells in the cerebellum, which is the part of the brain responsible for coordination and balance. Several genes have been identified as being involved in the development of medulloblastoma.\nOne of the most well-known genes associated with medulloblastoma is the Sonic Hedgehog (SHH) gene. Mutations in the SHH gene have been found to be present in a significant percentage of medulloblastoma cases. The SHH signaling pathway is critical for the development and maintenance of the cerebellum, and abnormal activation of this pathway has been implicated in the development of medulloblastoma.\nAnother gene that has been implicated in medulloblastoma development is the BRAF gene. Mutations in the BRAF gene have been found to be present in a subset of medulloblastoma cases, and it is thought that these mutations may lead to the activation of the mitogen-activated protein kinase (MAPK) signaling pathway, which is involved in cell growth and proliferation.\nAdditionally, several other genes have been identified as being potentially involved in medulloblastoma development, including PTCH1, SUFU, and CBFA2T3. Further research is needed to better understand the role of these genes in medulloblastoma development and to identify potential targets for therapeutic intervention.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Medulloblastoma is a type of brain cancer that develops from cells in the cerebellum.\n2. The Sonic Hedgehog (SHH) gene has been associated with medulloblastoma and mutations in this gene have been found in a significant percentage of medulloblastoma cases.\n3. Abnormal activation of the SHH signaling pathway is implicated in the development of medulloblastoma. \n4. The BRAF gene has also been implicated in medulloblastoma development, with mutations leading to the activation of the MAPK signaling pathway.\n5. Additional genes such as PTCH1, SUFU, and CBFA2T3 have been identified as potentially involved in medulloblastoma development.",
    "vicuna-13b_fact": [
      "Medulloblastoma is a type of brain cancer that develops from cells in the cerebellum.",
      "The Sonic Hedgehog (SHH) gene has been associated with medulloblastoma and mutations in this gene have been found in a significant percentage of medulloblastoma cases.",
      "Abnormal activation of the SHH signaling pathway is implicated in the development of medulloblastoma.",
      "The BRAF gene has also been implicated in medulloblastoma development, with mutations leading to the activation of the MAPK signaling pathway.",
      "Additional genes such as PTCH1, SUFU, and CBFA2T3 have been identified as potentially involved in medulloblastoma development."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1425,
    "user_query": "Which diseases can be treated with Afamelanotide?",
    "vicuna-13b_response": "Afamelanotide is a medication that is used to treat a condition called erythropoietic protoporphyria (EPP). EPP is a rare inherited disorder that affects the production of hemoglobin in the body. Hemoglobin is a protein in red blood cells that carries oxygen to different parts of the body. In people with EPP, the abnormal production of hemoglobin leads to the accumulation of a toxic substance called protoporphyrin in the body. This can cause a range of symptoms, including skin sensitivity to light, abdominal pain, and anemia.\nAfamelanotide works by stimulating the production of normal hemoglobin in the body, which helps to reduce the levels of protoporphyrin and alleviate the symptoms of EPP. It is not used to treat any other diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Afamelanotide is used to treat a condition called erythropoietic protoporphyria (EPP).\n2. Erythropoietic protoporphyria is a rare inherited disorder that affects the production of hemoglobin in the body.\n3. Hemoglobin is a protein in red blood cells that carries oxygen to different parts of the body.\n4. An abnormal production of hemoglobin leads to the accumulation of a toxic substance called protoporphyrin in the body in people with EPP.\n5. Afamelanotide works by stimulating the production of normal hemoglobin in the body.",
    "vicuna-13b_fact": [
      "Afamelanotide is used to treat a condition called erythropoietic protoporphyria (EPP).",
      "Erythropoietic protoporphyria is a rare inherited disorder that affects the production of hemoglobin in the body.",
      "Hemoglobin is a protein in red blood cells that carries oxygen to different parts of the body.",
      "An abnormal production of hemoglobin leads to the accumulation of a toxic substance called protoporphyrin in the body in people with EPP.",
      "Afamelanotide works by stimulating the production of normal hemoglobin in the body."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Afamelanotide works by increasing the production of melanin in the skin, not hemoglobin in the body.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1429,
    "user_query": "Which is the main calcium binding protein of the sarcoplasmic reticulum?",
    "vicuna-13b_response": "The main calcium binding protein of the sarcoplasmic reticulum is called calsequestrin. It is a protein that is found in the sarcoplasmic reticulum (SR) of muscle cells and plays a crucial role in the regulation of calcium levels in the SR. Calsequestrin binds to calcium ions (Ca2+) with high affinity and helps to maintain the proper levels of calcium in the SR, which is necessary for muscle contraction.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The main calcium binding protein of the sarcoplasmic reticulum is called calsequestrin.\n2. Calsequestrin is found in the sarcoplasmic reticulum of muscle cells.\n3. This protein plays a crucial role in the regulation of calcium levels in the sarcoplasmic reticulum.\n4. Calsequestrin binds to calcium ions (Ca2+) with high affinity.\n5. Maintaining the proper levels of calcium in the sarcoplasmic reticulum is necessary for muscle contraction.",
    "vicuna-13b_fact": [
      "The main calcium binding protein of the sarcoplasmic reticulum is called calsequestrin.",
      "Calsequestrin is found in the sarcoplasmic reticulum of muscle cells.",
      "This protein plays a crucial role in the regulation of calcium levels in the sarcoplasmic reticulum.",
      "Calsequestrin binds to calcium ions (Ca2+) with high affinity.",
      "Maintaining the proper levels of calcium in the sarcoplasmic reticulum is necessary for muscle contraction."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1430,
    "user_query": "Is the UGT1A1*28 polymorphism associated with irinotecan response in Caucasians?",
    "vicuna-13b_response": "The UGT1A1*28 polymorphism is a genetic variation that has been studied in relation to the efficacy and toxicity of irinotecan, a chemotherapy drug used to treat various types of cancer. The UGT1A1 gene encodes an enzyme involved in the metabolism of irinotecan, and the *28 variant has been associated with reduced enzyme activity.\nSeveral studies have investigated the association between UGT1A1*28 and irinotecan response in Caucasian patients. A meta-analysis of 12 studies found that the *28 variant was associated with decreased overall survival in patients receiving irinotecan-based chemotherapy (Liu et al., 2018). Another study in Caucasian patients with colorectal cancer found that the *28 variant was associated with decreased response rate and increased toxicity with irinotecan-based therapy (Sargent et al., 2005).\nHowever, other studies have reported conflicting results or have failed to find an association between UGT1A1*28 and irinotecan response in Caucasian patients. Therefore, the relationship between UGT1A1*28 and irinotecan response in Caucasians is still not fully understood and may depend on other factors such as patient characteristics and treatment regimens.\nIn conclusion, while some studies have suggested that the UGT1A1*28 polymorphism may be associated with decreased response to irinotecan in Caucasian patients, the evidence is not consistent and further research is needed to fully understand the relationship between these two factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The UGT1A1*28 polymorphism is a genetic variation that has been studied in relation to the efficacy and toxicity of irinotecan.\n2. The UGT1A1 gene encodes an enzyme involved in the metabolism of irinotecan.\n3. A meta-analysis of 12 studies found that the *28 variant was associated with decreased overall survival in patients receiving irinotecan-based chemotherapy (Liu et al., 2018).\n4. A study on Caucasian patients with colorectal cancer found that the *28 variant was associated with decreased response rate and increased toxicity with irinotecan-based therapy (Sargent et al., 2005).\n5. Some studies have reported conflicting results or have failed to find an association between UGT1A1*28 and irinotecan response in Caucasian patients.",
    "vicuna-13b_fact": [
      "The UGT1A1*28 polymorphism is a genetic variation that has been studied in relation to the efficacy and toxicity of irinotecan.",
      "The UGT1A1 gene encodes an enzyme involved in the metabolism of irinotecan.",
      "A meta-analysis of 12 studies found that the *28 variant was associated with decreased overall survival in patients receiving irinotecan-based chemotherapy (Liu et al., 2018).",
      "A study on Caucasian patients with colorectal cancer found that the *28 variant was associated with decreased response rate and increased toxicity with irinotecan-based therapy (Sargent et al., 2005).",
      "Some studies have reported conflicting results or have failed to find an association between UGT1A1*28 and irinotecan response in Caucasian patients."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1433,
    "user_query": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease.",
    "vicuna-13b_response": "Anti-amyloid-beta monoclonal antibodies are a type of therapeutic agent that have been investigated in clinical trials for the treatment of Alzheimer's disease (AD). These antibodies target the beta-amyloid protein, which is a key component of the amyloid plaques that are a hallmark of AD. Here are some examples of anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for AD treatment:\n1. Bapineuzumab (Axsome Therapeutics)\n2. Gantenerumab (Roche)\n3. Crenezumab (Genentech/Roche)\n4. Solanezumab (Eli Lilly and Company)\n5. Itacitinib (AstraZeneca)\n6. GSK-2601738 (GlaxoSmithKline)\n7. MK-8931 (Merck & Co., Inc.)\n8. BHV-3500 (Biogen)\n9. LY2159268 (Lilly)\n10. Aducanumab (Biogen)\nIt is important to note that while these antibodies have shown promise in clinical trials, none have yet been approved by regulatory authorities for the treatment of AD.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Anti-amyloid-beta monoclonal antibodies are therapeutic agents that have been investigated in clinical trials for the treatment of Alzheimer's disease.\n2. Beta-amyloid protein, the target of these antibodies, is a key component of the amyloid plaques that are a hallmark of Alzheimer's disease.\n3. Bapineuzumab, an anti-amyloid-beta monoclonal antibody, was developed by Axsome Therapeutics for Alzheimer's disease trial.\n4. Gantenerumab is an anti-amyloid-beta monoclonal antibody developed by Roche.\n5. Solanezumab is an anti-amyloid-beta monoclonal antibody developed by Eli Lilly and Company for Alzheimer's disease trial.\nNote: Although there are more factual statements in the context, you asked for up to five.",
    "vicuna-13b_fact": [
      "Anti-amyloid-beta monoclonal antibodies are therapeutic agents that have been investigated in clinical trials for the treatment of Alzheimer's disease.",
      "Beta-amyloid protein, the target of these antibodies, is a key component of the amyloid plaques that are a hallmark of Alzheimer's disease.",
      "Bapineuzumab, an anti-amyloid-beta monoclonal antibody, was developed by Axsome Therapeutics for Alzheimer's disease trial.",
      "Gantenerumab is an anti-amyloid-beta monoclonal antibody developed by Roche.",
      "Solanezumab is an anti-amyloid-beta monoclonal antibody developed by Eli Lilly and Company for Alzheimer's disease trial.",
      "te: Although there are more factual statements in the context, you asked for up to five."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Bapineuzumab, an anti-amyloid-beta monoclonal antibody, was developed by Pfizer and Johnson & Johnson for Alzheimer's disease trial.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1434,
    "user_query": "Does MVIIA and MVIIC bind to the same calcium channel?",
    "vicuna-13b_response": "MVIIA and MVIIC are two different splice variants of the voltage-gated calcium channel subunit alpha-1G. These splice variants differ in the presence of an additional 34 amino acids in the N-terminus of MVIIC compared to MVIIA.\nBoth MVIIA and MVIIC bind to the same calcium channel, but they may have different effects on channel function and behavior. The presence of the additional 34 amino acids in MVIIC may alter the gating properties of the channel and affect its response to changes in voltage.\nOverall, while MVIIA and MVIIC are both components of the same calcium channel, they may have distinct functions and effects on channel behavior.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MVIIA and MVIIC are two different splice variants of the voltage-gated calcium channel subunit alpha-1G.\n2. The splice variants differ due to an additional 34 amino acids in the N-terminus of MVIIC compared to MVIIA.\n3. Both MVIIA and MVIIC bind to the same calcium channel.\n4. The presence of the additional 34 amino acids in MVIIC may alter the gating properties of the calcium channel and affect its response to changes in voltage.\n5. Although MVIIA and MVIIC are both components of the same calcium channel, they may have distinct functions and effects on channel behavior.",
    "vicuna-13b_fact": [
      "MVIIA and MVIIC are two different splice variants of the voltage-gated calcium channel subunit alpha-1G.",
      "The splice variants differ due to an additional 34 amino acids in the N-terminus of MVIIC compared to MVIIA.",
      "Both MVIIA and MVIIC bind to the same calcium channel.",
      "The presence of the additional 34 amino acids in MVIIC may alter the gating properties of the calcium channel and affect its response to changes in voltage.",
      "Although MVIIA and MVIIC are both components of the same calcium channel, they may have distinct functions and effects on channel behavior."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1437,
    "user_query": "What is SHAPE-Seq?",
    "vicuna-13b_response": "SHAPE-Seq (Selective High-Throughput Amplicon-based Paired-end Sequencing) is a next-generation sequencing (NGS) method that is used to analyze the structure and organization of genomic regions. It is a targeted sequencing approach that allows for the simultaneous analysis of multiple regions of interest in a single sequencing run.\nThe SHAPE-Seq method involves the use of amplicons, which are short, specific sequences that are amplified from a targeted region of interest. These amplicons are then paired-end sequenced, which means that the sequences are read in pairs, with one read starting from a specific location on one strand of the amplicon and the other read starting from the same location on the complementary strand.\nThe paired-end sequencing data is then analyzed to determine the structure and organization of the targeted region. This can include identifying the presence of specific chromatin modifications, such as DNA methylation or histone modifications, as well as identifying the spatial organization of the region, such as the location of transcription start sites or the presence of specific regulatory elements.\nSHAPE-Seq is a powerful tool for studying the epigenetics and transcriptional regulation of specific regions of the genome, and has been used in a wide range of applications, including the study of gene regulation, cancer, and infectious diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SHAPE-Seq is a next-generation sequencing method used to analyze the structure and organization of genomic regions.\n2. SHAPE-Seq allows for simultaneous analysis of multiple regions of interest in a single sequencing run.\n3. The SHAPE-Seq method involves the use of amplicons, which are short sequences that are amplified from a targeted region.\n4. The sequences in SHAPE-Seq are read in pairs, one from a specific location on one strand of the amplicon and the other from the same location on the complementary strand.\n5. SHAPE-Seq has been used in various applications, including studying gene regulation, cancer, and infectious diseases.",
    "vicuna-13b_fact": [
      "SHAPE-Seq is a next-generation sequencing method used to analyze the structure and organization of genomic regions.",
      "SHAPE-Seq allows for simultaneous analysis of multiple regions of interest in a single sequencing run.",
      "The SHAPE-Seq method involves the use of amplicons, which are short sequences that are amplified from a targeted region.",
      "The sequences in SHAPE-Seq are read in pairs, one from a specific location on one strand of the amplicon and the other from the same location on the complementary strand.",
      "SHAPE-Seq has been used in various applications, including studying gene regulation, cancer, and infectious diseases."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: SHAPE-Seq, standing for Selective 2'-Hydroxyl Acylation analyzed by Primer Extension and deep Sequencing, is a high-throughput method used for analyzing RNA structure and interactions, not the structure and organization of genomic regions.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1446,
    "user_query": "Describe Heyde syndrome.",
    "vicuna-13b_response": "Heyde syndrome, also known as juvenile amyotrophic lateral sclerosis (JALS), is a rare inherited disorder that affects the nervous system. It is characterized by progressive muscle weakness and wasting (amyotrophy), particularly in the legs, and progressive loss of the nerve cells that control movement (motor neurons).\nThe symptoms of Heyde syndrome typically begin in early childhood and progress rapidly, leading to significant disability by the early teenage years. The muscle weakness and wasting can affect the face, arms, and other parts of the body in addition to the legs.\nHeyde syndrome is caused by a mutation in the SOD1 gene, which provides instructions for making a protein called superoxide dismutase 1. This protein plays a critical role in protecting cells from damage caused by harmful molecules called free radicals. In people with Heyde syndrome, the mutation in the SOD1 gene leads to a deficiency of this protein, which can cause damage to motor neurons and other nerve cells.\nThere is no cure for Heyde syndrome, and treatment is focused on managing symptoms and improving quality of life. This may include physical therapy, occupational therapy, and medications to help manage pain and muscle stiffness. In some cases, surgery may be recommended to help improve mobility and function.\nOverall, Heyde syndrome is a serious and progressive disorder that can have a significant impact on a person's life. It is important for people with this condition to receive appropriate medical care and support to help manage their symptoms and maintain their quality of life.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Heyde syndrome is also known as juvenile amyotrophic lateral sclerosis (JALS).\n2. Heyde syndrome is a rare inherited disorder that affects the nervous system.\n3. Symptoms of Heyde syndrome typically begin in early childhood and progress rapidly, leading to significant disability by the early teenage years.\n4. Heyde syndrome is caused by a mutation in the SOD1 gene.\n5. There is no cure for Heyde syndrome, and treatment focuses on symptom management and improving quality of life.",
    "vicuna-13b_fact": [
      "Heyde syndrome is also known as juvenile amyotrophic lateral sclerosis (JALS).",
      "Heyde syndrome is a rare inherited disorder that affects the nervous system.",
      "Symptoms of Heyde syndrome typically begin in early childhood and progress rapidly, leading to significant disability by the early teenage years.",
      "Heyde syndrome is caused by a mutation in the SOD1 gene.",
      "There is no cure for Heyde syndrome, and treatment focuses on symptom management and improving quality of life."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Heyde syndrome is not known as juvenile amyotrophic lateral sclerosis (JALS). It is a condition characterized by the combination of gastrointestinal bleeding from angiodysplasia and aortic stenosis.\n2. FALSE [correction]: Heyde syndrome is not an inherited disorder that affects the nervous system, but a disorder associated with gastrointestinal bleeding from angiodysplasia and aortic stenosis.\n3. FALSE [correction]: Symptoms of Heyde syndrome do not typically begin in early childhood and do not involve rapid progression to disability. Instead, they often include gastrointestinal bleeding and symptoms related to aortic stenosis, like chest pain, fainting, and heart failure.\n4. FALSE [correction]: Heyde syndrome is not caused by a mutation in the SOD1 gene. The exact cause is unknown but it is associated with aortic stenosis and gastrointestinal bleeding.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "vicuna-13b_response": "Yes, silicone has been used in the treatment of incontinence. Incontinence is the loss of bladder or bowel control, which can be caused by a variety of factors such as aging, childbirth, surgery, or neurological conditions.\nSilicone is a material that is commonly used in medical devices, including those used for incontinence treatment. One type of device that uses silicone is the silicone urethral sling, which is a surgical procedure used to treat stress urinary incontinence in women. In this procedure, a strip of silicone is placed under the urethra to help support it and prevent leakage of urine.\nSilicone is also used in other types of incontinence devices, such as pads and liners, which are designed to absorb urine or feces and prevent skin irritation or rashes. These devices can be worn internally or externally, depending on the type of incontinence and the individual's needs.\nIt's important to note that not all incontinence treatments involve the use of silicone, and the effectiveness of silicone-based treatments may vary depending on the individual's specific condition and needs. If you are experiencing incontinence, it's important to speak with a healthcare provider to determine the best treatment options for you.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Silicone has been used in the treatment of incontinence.\n2. Incontinence is the loss of bladder or bowel control.\n3. A silicone urethral sling is a surgical procedure used to treat stress urinary incontinence in women.\n4. Silicone is used in incontinence devices, such as pads and liners, designed to absorb urine or feces and prevent skin irritation or rashes.\n5. Not all incontinence treatments involve the use of silicone, and the effectiveness of silicone-based treatments may vary depending on the individual's specific condition and needs.",
    "vicuna-13b_fact": [
      "Silicone has been used in the treatment of incontinence.",
      "Incontinence is the loss of bladder or bowel control.",
      "A silicone urethral sling is a surgical procedure used to treat stress urinary incontinence in women.",
      "Silicone is used in incontinence devices, such as pads and liners, designed to absorb urine or feces and prevent skin irritation or rashes.",
      "Not all incontinence treatments involve the use of silicone, and the effectiveness of silicone-based treatments may vary depending on the individual's specific condition and needs."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Some incontinence devices, such as pads and liners, are often made of absorbent materials such as cotton or synthetic fibers, not silicone, to absorb urine or feces and prevent skin irritation or rashes.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1448,
    "user_query": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?",
    "vicuna-13b_response": "The error prevention GO (8-oxo-G) system in Pseudomonas putida is composed of three proteins: AlkB, AlkD, and AlkE. AlkB is a DNA-binding protein that recognizes and repairs 8-oxo-G DNA lesions. AlkD is an enzyme that converts 8-oxo-G to a less reactive intermediate, which is then repaired by AlkB. AlkE is an enzyme that cleaves the intermediate to prevent further damage. Together, these proteins work to prevent the accumulation of mutations caused by 8-oxo-G DNA lesions, which can lead to cell death or other negative outcomes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The error prevention GO (8-oxo-G) system in Pseudomonas putida is composed of three proteins: AlkB, AlkD, and AlkE.\n2. AlkB is a DNA-binding protein that recognizes and repairs 8-oxo-G DNA lesions.\n3. AlkD is an enzyme that converts 8-oxo-G to a less reactive intermediate.\n4. This intermediate is then repaired by AlkB.\n5. AlkE is an enzyme that cleaves the intermediate to prevent further damage.",
    "vicuna-13b_fact": [
      "The error prevention GO (8-oxo-G) system in Pseudomonas putida is composed of three proteins: AlkB, AlkD, and AlkE.",
      "AlkB is a DNA-binding protein that recognizes and repairs 8-oxo-G DNA lesions.",
      "AlkD is an enzyme that converts 8-oxo-G to a less reactive intermediate.",
      "This intermediate is then repaired by AlkB.",
      "AlkE is an enzyme that cleaves the intermediate to prevent further damage."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1449,
    "user_query": "List five applications of machine learning algorithms in medical diagnosis.",
    "vicuna-13b_response": "1. Image-based diagnosis: Machine learning algorithms can be used to analyze medical images such as X-rays, CT scans, and MRIs to diagnose diseases like cancer, diabetic retinopathy, and cardiovascular disease.\n2. Disease prediction: Machine learning algorithms can be trained on large amounts of patient data to predict the likelihood of a patient developing a certain disease in the future.\n3. Drug discovery: Machine learning algorithms can be used to analyze large amounts of data on potential drugs and their effects, helping researchers identify new drugs and repurpose existing drugs for new treatments.\n4. Personalized medicine: Machine learning algorithms can be used to analyze patient data and tailor treatment plans to individual patients based on their specific needs and medical histories.\n5. Clinical decision support: Machine learning algorithms can be integrated into electronic health records to provide real-time support to medical professionals, helping them make more informed decisions and improve patient outcomes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Machine learning algorithms are used in the analysis of medical images like X-rays, CT scans, and MRIs for disease diagnosis.\n2. Machine learning algorithms can be trained on patient data to predict the likelihood of them developing a certain disease in the future.\n3. Machine learning can analyze data on potential drugs and their effects, aiding in the discovery of new drugs and the repurposing of existing ones.\n4. Machine learning algorithms can be used for personalized medicine, tailoring treatment plans to individual patients based on their specific needs and medical histories.\n5. Machine learning algorithms can be incorporated into electronic health records to offer real-time support to medical professionals, aiding in improved decision making and patient outcomes.",
    "vicuna-13b_fact": [
      "Machine learning algorithms are used in the analysis of medical images like X-rays, CT scans, and MRIs for disease diagnosis.",
      "Machine learning algorithms can be trained on patient data to predict the likelihood of them developing a certain disease in the future.",
      "Machine learning can analyze data on potential drugs and their effects, aiding in the discovery of new drugs and the repurposing of existing ones.",
      "Machine learning algorithms can be used for personalized medicine, tailoring treatment plans to individual patients based on their specific needs and medical histories.",
      "Machine learning algorithms can be incorporated into electronic health records to offer real-time support to medical professionals, aiding in improved decision making and patient outcomes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1450,
    "user_query": "Does the 3D structure of  the genome remain stable during cell differentiation?",
    "vicuna-13b_response": "The 3D structure of the genome is a complex and dynamic process that can be influenced by various factors, including cell differentiation. Cell differentiation is a process by which a cell changes its characteristics and function, and it is a crucial aspect of embryonic development, tissue repair, and cancer progression.\nDuring cell differentiation, the 3D structure of the genome can undergo significant changes. For example, in stem cells, the genome is highly compacted and organized into chromatin fibers, which are responsible for regulating gene expression. However, during differentiation, the 3D structure of the genome can become less compact and more accessible to the regulatory elements that control gene expression.\nAdditionally, the 3D structure of the genome can be influenced by the interactions between different cells and the extracellular matrix, which can lead to changes in the organization of the genome. For example, in tissue development, the 3D structure of the genome can become more complex and organized as cells differentiate and specialize.\nOverall, while the 3D structure of the genome can remain stable during cell differentiation, it is also subject to dynamic changes that can be influenced by various cellular and environmental factors. Further research is needed to fully understand the role of the 3D structure of the genome in cell differentiation and its implications for disease and therapy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The 3D structure of the genome can be influenced by various factors, including cell differentiation.\n2. Cell differentiation is a process by which a cell changes its characteristics and function.\n3. During cell differentiation, the 3D structure of the genome can undergo significant changes.\n4. In stem cells, the genome is highly compacted and organized into chromatin fibers, which are responsible for regulating gene expression.\n5. The 3D structure of the genome can be influenced by the interactions between different cells and the extracellular matrix.",
    "vicuna-13b_fact": [
      "The 3D structure of the genome can be influenced by various factors, including cell differentiation.",
      "Cell differentiation is a process by which a cell changes its characteristics and function.",
      "During cell differentiation, the 3D structure of the genome can undergo significant changes.",
      "In stem cells, the genome is highly compacted and organized into chromatin fibers, which are responsible for regulating gene expression.",
      "The 3D structure of the genome can be influenced by the interactions between different cells and the extracellular matrix."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1453,
    "user_query": "What is 2d 4d ratio in athletes.",
    "vicuna-13b_response": "The 2D:4D ratio refers to the ratio of the length of the second digit (index finger) to the length of the fourth digit (ring finger). This ratio is often used as an indicator of exposure to certain hormones in the womb, specifically androgens (male hormones) and estrogens (female hormones).\nIn athletes, a lower 2D:4D ratio is often associated with higher levels of androgen exposure, which can lead to a variety of physical characteristics that are beneficial for athletic performance, such as increased muscle mass and bone density. However, it's important to note that the relationship between 2D:4D ratio and athletic performance is not well established and more research is needed to understand the connection.\nAdditionally, it's important to note that the 2D:4D ratio is only one factor that contributes to athletic performance and other factors such as genetics, training, and nutrition also play a significant role.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The 2D:4D ratio refers to the ratio of the length of the second digit (index finger) to the length of the fourth digit (ring finger).\n2. This ratio is used as an indicator of exposure to androgens and estrogens in the womb.\n3. In athletes, a lower 2D:4D ratio is often associated with higher levels of androgen exposure.\n4. Effects of higher androgen exposure can include increased muscle mass and bone density.\n5. Other factors like genetics, training, and nutrition also contribute to athletic performance.",
    "vicuna-13b_fact": [
      "The 2D:4D ratio refers to the ratio of the length of the second digit (index finger) to the length of the fourth digit (ring finger).",
      "This ratio is used as an indicator of exposure to androgens and estrogens in the womb.",
      "In athletes, a lower 2D:4D ratio is often associated with higher levels of androgen exposure.",
      "Effects of higher androgen exposure can include increased muscle mass and bone density.",
      "Other factors like genetics, training, and nutrition also contribute to athletic performance."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "vicuna-13b_response": "There is some evidence to suggest that there may be an association between the moon cycle and the rupture risk of intracranial aneurysms. Intracranial aneurysms are abnormal, weakened areas in the blood vessels that supply blood to the brain. They can rupture and cause bleeding into the brain, which can be life-threatening.\nSeveral studies have suggested that there may be a correlation between the moon cycle and the risk of intracranial aneurysm rupture. One study published in the journal Neurosurgery found that there was a significant increase in the number of ruptured aneurysms admitted to the hospital on days corresponding to full moon and new moon phases, compared to other days of the month. Another study published in the journal Stroke found that the risk of ruptured aneurysm was higher on full moon days compared to other days.\nThe exact mechanism by which the moon cycle may affect the rupture risk of intracranial aneurysms is not well understood. Some researchers have suggested that the increased gravitational force of the full moon may contribute to the increased risk of rupture. However, more research is needed to confirm these findings and to determine the underlying mechanisms involved.\nIt is important to note that the association between the moon cycle and intracranial aneurysm rupture risk is still a topic of debate and further research is needed to fully understand this potential relationship.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Intracranial aneurysms are abnormal, weakened areas in the blood vessels that supply blood to the brain.\n2. A ruptured intracranial aneurysm can lead to bleeding into the brain, which can be life-threatening.\n3. A study published in the journal Neurosurgery found a significant increase in the number of ruptured aneurysms admitted to the hospital on full moon and new moon days compared to other days of the month.\n4. Another study in the journal Stroke found the risk of ruptured aneurysm was higher on full moon days.\n5. The relationship between the moon cycle and intracranial aneurysm rupture risk is a topic of debate and further research is needed for clarification.",
    "vicuna-13b_fact": [
      "Intracranial aneurysms are abnormal, weakened areas in the blood vessels that supply blood to the brain.",
      "A ruptured intracranial aneurysm can lead to bleeding into the brain, which can be life-threatening.",
      "A study published in the journal Neurosurgery found a significant increase in the number of ruptured aneurysms admitted to the hospital on full moon and new moon days compared to other days of the month.",
      "Another study in the journal Stroke found the risk of ruptured aneurysm was higher on full moon days.",
      "The relationship between the moon cycle and intracranial aneurysm rupture risk is a topic of debate and further research is needed for clarification."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1461,
    "user_query": "List functional roles of the FtsZ protein.",
    "vicuna-13b_response": "FtsZ is an essential bacterial protein that plays a crucial role in the division process of bacteria. The functional roles of FtsZ protein are as follows:\n1. Cell division: FtsZ is a key component of the Z ring, which forms at the midpoint of the cell and plays a crucial role in the division process. The Z ring is a ring-shaped structure that forms around the cell's midpoint and helps to constrict the cell in half during division.\n2. Peptidoglycan synthesis: FtsZ is involved in the synthesis of peptidoglycan, which is a key component of the bacterial cell wall. FtsZ helps to recruit the enzymes that are responsible for peptidoglycan synthesis to the division site.\n3. Cell elongation: FtsZ is also involved in cell elongation, as it helps to coordinate the growth of the cell with the synthesis of peptidoglycan.\n4. Chromosome segregation: FtsZ is involved in the segregation of the bacterial chromosome during cell division. It helps to recruit the enzymes that are responsible for chromosome segregation to the division site.\n5. Stress response: FtsZ is also involved in the bacterial stress response, as it helps to protect the bacteria from environmental stressors that can disrupt the division process.\nOverall, FtsZ is a crucial protein that plays a vital role in the division process of bacteria, and its dysfunction can lead to bacterial lysis, a condition in which the bacterial cell breaks apart and dies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. FtsZ is an essential bacterial protein that plays a role in the division process of bacteria.\n2. FtsZ forms part of the Z ring, a central structure in bacterial cell division.\n3. FtsZ is involved in the synthesis of peptidoglycan, a key component of the bacterial cell wall.\n4. The protein FtsZ plays a role in bacterial cell elongation.\n5. FtsZ helps with the segregation of the bacterial chromosome during cell division.\n6. FtsZ is involved in the bacterial response to environmental stress.\n7. The dysfunction of FtsZ can lead to bacterial lysis, which is typified by the cell breaking apart and dying.",
    "vicuna-13b_fact": [
      "FtsZ is an essential bacterial protein that plays a role in the division process of bacteria.",
      "FtsZ forms part of the Z ring, a central structure in bacterial cell division.",
      "FtsZ is involved in the synthesis of peptidoglycan, a key component of the bacterial cell wall.",
      "The protein FtsZ plays a role in bacterial cell elongation.",
      "FtsZ helps with the segregation of the bacterial chromosome during cell division.",
      "FtsZ is involved in the bacterial response to environmental stress.",
      "The dysfunction of FtsZ can lead to bacterial lysis, which is typified by the cell breaking apart and dying."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: FtsZ is not directly involved in the synthesis of peptidoglycan. It plays a role in bacterial cytokinesis by assembling into a ring that separates the daughter cells. \n4. TRUE\n5. TRUE\n6. UNKNOWN\n7. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1463,
    "user_query": "Is there any evidence of dysregulated long non coding RNAs and Alzheimer's disease?",
    "vicuna-13b_response": "Yes, there is evidence of dysregulated long non-coding RNAs (lncRNAs) in Alzheimer's disease (AD). LncRNAs are a class of non-protein-coding RNAs that are longer than 200 nucleotides and play important roles in various cellular processes.\nSeveral studies have reported altered expression levels of lncRNAs in AD brain tissue and cell models. For example, one study found that the expression of the lncRNA named NEAT1 was decreased in the brains of AD patients compared to age-matched controls. Another study found that the lncRNA named H19 was increased in AD brain tissue and that its overexpression in mouse models of AD led to increased levels of beta-amyloid and phosphorylated tau, two hallmark proteins of AD.\nAdditionally, some lncRNAs have been shown to regulate the expression of genes involved in AD pathology, such as the beta-amyloid precursor protein (APP) and the tau protein. For example, the lncRNA named MALAT1 has been shown to regulate the expression of APP and to be involved in the formation of beta-amyloid plaques, a hallmark of AD.\nOverall, these findings suggest that dysregulated lncRNAs may play a role in the development and progression of AD, and that targeting lncRNAs may be a promising therapeutic strategy for AD.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Long non-coding RNAs (lncRNAs) are a class of non-protein-coding RNAs longer than 200 nucleotides.\n2. Several studies have reported altered expression levels of lncRNAs in Alzheimer's disease (AD) brain tissue and cell models.\n3. One study found that the expression of lncRNA named NEAT1 was decreased in the brains of AD patients.\n4. A study found that the lncRNA named H19 was increased in AD brain tissue, and when overexpressed in mouse models it led to increased levels of beta-amyloid and phosphorylated tau.\n5. Some lncRNAs, for example, the lncRNA named MALAT1, have been shown to regulate the expression of genes involved in AD pathology, such as the beta-amyloid precursor protein (APP).",
    "vicuna-13b_fact": [
      "Long non-coding RNAs (lncRNAs) are a class of non-protein-coding RNAs longer than 200 nucleotides.",
      "Several studies have reported altered expression levels of lncRNAs in Alzheimer's disease (AD) brain tissue and cell models.",
      "One study found that the expression of lncRNA named NEAT1 was decreased in the brains of AD patients.",
      "A study found that the lncRNA named H19 was increased in AD brain tissue, and when overexpressed in mouse models it led to increased levels of beta-amyloid and phosphorylated tau.",
      "Some lncRNAs, for example, the lncRNA named MALAT1, have been shown to regulate the expression of genes involved in AD pathology, such as the beta-amyloid precursor protein (APP)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1469,
    "user_query": "What is known about type D personality trait in cancer patients?",
    "vicuna-13b_response": "Type D personality is a term used to describe individuals who have a high level of distress and a low level of social support. Research has shown that individuals with a Type D personality are more likely to experience anxiety, depression, and other psychological symptoms.\nIn cancer patients, Type D personality has been associated with poorer outcomes, such as increased anxiety, depression, and fatigue, as well as lower quality of life and poorer overall survival. Additionally, individuals with a Type D personality in cancer have been found to have a higher level of perceived stress, which can negatively impact their physical and emotional well-being.\nIt is important to note that not all cancer patients with a Type D personality will experience negative outcomes, and that other factors, such as the type and stage of cancer, as well as the availability of social support, can also play a role in cancer outcomes.\nOverall, it is important for healthcare providers to be aware of the potential impact of Type D personality on cancer patients' outcomes, and to provide appropriate support and interventions to help manage psychological symptoms and improve overall well-being.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Type D personality describes individuals with a high level of distress and a low level of social support.\n2. Research shows that individuals with a Type D personality are more likely to experience anxiety, depression, and other psychological symptoms.\n3. In cancer patients, Type D personality has been linked with increased anxiety, depression, and fatigue, as well as lower quality of life and poorer survival.\n4. Individuals with a Type D personality in cancer have been found to have a higher level of perceived stress.\n5. Other factors, such as the type and stage of cancer, as well as the availability of social support, can also play a role in cancer outcomes.",
    "vicuna-13b_fact": [
      "Type D personality describes individuals with a high level of distress and a low level of social support.",
      "Research shows that individuals with a Type D personality are more likely to experience anxiety, depression, and other psychological symptoms.",
      "In cancer patients, Type D personality has been linked with increased anxiety, depression, and fatigue, as well as lower quality of life and poorer survival.",
      "Individuals with a Type D personality in cancer have been found to have a higher level of perceived stress.",
      "Other factors, such as the type and stage of cancer, as well as the availability of social support, can also play a role in cancer outcomes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1471,
    "user_query": "Which species may be used for the biotechnological production of itaconic acid?",
    "vicuna-13b_response": "Itaconic acid is a widely used intermediate chemical in the production of various polymers and other chemical products. Several microbial and fungal species have been identified as suitable for the biotechnological production of itaconic acid.\nOne of the most commonly used microorganisms for itaconic acid production is Aspergillus terreus. This fungus can produce itaconic acid through the degradation of cellulose-based materials, such as agricultural waste or wood chips. Other microorganisms that have been used for itaconic acid production include Penicillium roqueforti, Penicillium citrinum, and Rhizopus oryzae.\nIn recent years, research has also been conducted on the use of bacteria for itaconic acid production. For example, the bacterium Escherichia coli has been engineered to produce itaconic acid through the introduction of genes encoding enzymes involved in the citrate metabolic pathway. Other bacterial species that have been studied for itaconic acid production include Bacillus subtilis and Lactobacillus acidophilus.\nOverall, the choice of microorganism for itaconic acid production will depend on several factors, including the cost and availability of the organism, the efficiency of its metabolism, and the ease of scale-up of the production process.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Itaconic acid is a widely used intermediate chemical in the production of various polymers and other chemical products.\n2. The fungus Aspergillus terreus is commonly used for itaconic acid production.\n3. Aspergillus terreus can produce itaconic acid through the degradation of cellulose-based materials, like agricultural waste or wood chips. \n4. Other microorganisms that have been used for itaconic acid production include Penicillium roqueforti, Penicillium citrinum, and Rhizopus oryzae.\n5. The bacterium Escherichia coli has been engineered to produce itaconic acid through the introduction of genes encoding enzymes involved in the citrate metabolic pathway.",
    "vicuna-13b_fact": [
      "Itaconic acid is a widely used intermediate chemical in the production of various polymers and other chemical products.",
      "The fungus Aspergillus terreus is commonly used for itaconic acid production.",
      "Aspergillus terreus can produce itaconic acid through the degradation of cellulose-based materials, like agricultural waste or wood chips.",
      "Other microorganisms that have been used for itaconic acid production include Penicillium roqueforti, Penicillium citrinum, and Rhizopus oryzae.",
      "The bacterium Escherichia coli has been engineered to produce itaconic acid through the introduction of genes encoding enzymes involved in the citrate metabolic pathway."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1474,
    "user_query": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?",
    "vicuna-13b_response": "The methyl-directed mismatch repair (MMR) system in bacteria is composed of several proteins that work together to correct errors that occur during DNA replication. The key proteins in this system are:\n1. MutS protein: MutS is a homodimeric protein that recognizes and binds to mismatched base pairs in the DNA. MutS proteins are responsible for finding and marking the location of mismatched base pairs in the genome.\n2. MutL protein: MutL is a single-stranded DNA binding protein that interacts with MutS to form a complex known as the MutS-MutL complex. MutL helps to stabilize the MutS-MutL complex on the DNA, and it also plays a role in recruiting other proteins to the site of the mismatch.\n3. MutH protein: MutH is an endonuclease that cleaves the DNA at the site of the mismatch, creating a gap in the DNA strand. MutH is recruited to the site of the mismatch by the MutS-MutL complex.\n4. MutY protein: MutY is another endonuclease that is responsible for filling in the gap created by MutH. MutY seals the gap in the DNA strand, restoring the integrity of the genome.\n5. Exonuclease V (ExoV): ExoV is an exonuclease that degrades the single-stranded DNA that is generated by the cleavage of the mismatch by MutH. ExoV helps to remove the single-stranded DNA, which could otherwise lead to further errors in DNA replication.\nOverall, the MMR system is an important mechanism for maintaining the accuracy of DNA replication in bacteria. It ensures that any errors that occur during replication are corrected before they can lead to larger problems, such as the production of non-functional proteins or the accumulation of mutations in critical genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The methyl-directed mismatch repair (MMR) system in bacteria is composed of several proteins that correct errors during DNA replication.\n2. MutS protein recognizes and binds to mismatched base pairs in the DNA.\n3. MutL protein interacts with MutS to form a complex and plays a role in recruiting other proteins to the site of the mismatch.\n4. MutH is an endonuclease that cleaves the DNA at the site of the mismatch.\n5. MutY is another endonuclease responsible for filling in the gap created by MutH.\n6. Exonuclease V (ExoV) degrades the single-stranded DNA generated by the cleavage of the mismatch by MutH.",
    "vicuna-13b_fact": [
      "The methyl-directed mismatch repair (MMR) system in bacteria is composed of several proteins that correct errors during DNA replication.",
      "MutS protein recognizes and binds to mismatched base pairs in the DNA.",
      "MutL protein interacts with MutS to form a complex and plays a role in recruiting other proteins to the site of the mismatch.",
      "MutH is an endonuclease that cleaves the DNA at the site of the mismatch.",
      "MutY is another endonuclease responsible for filling in the gap created by MutH.",
      "Exonuclease V (ExoV) degrades the single-stranded DNA generated by the cleavage of the mismatch by MutH."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: MutY is a DNA glycosylase involved in base excision repair, not an endonuclease responsible for filling in DNA gaps created by MutH.\n6. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1476,
    "user_query": "Which is the vector of Louping ill virus?",
    "vicuna-13b_response": "The vector of Louping ill virus is the tick species Ixodes ricinus. This tick is commonly found in Europe, Asia, and North America and is the primary vector for several important tick-borne pathogens, including Louping ill virus. Louping ill virus is a member of the Flaviviridae family and is transmitted to cattle and other animals through the bite of infected ticks. The virus causes a disease known as Louping ill or \"tick-borne fever\" in cattle, which can lead to significant economic losses in affected herds.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The vector of Louping ill virus is the tick species Ixodes ricinus.\n2. Ixodes ricinus is commonly found in Europe, Asia, and North America.\n3. Ixodes ricinus is the primary vector for several important tick-borne pathogens, including Louping ill virus.\n4. Louping ill virus is a member of the Flaviviridae family.\n5. The virus causes a disease known as Louping ill or \"tick-borne fever\" in cattle.",
    "vicuna-13b_fact": [
      "The vector of Louping ill virus is the tick species Ixodes ricinus.",
      "Ixodes ricinus is commonly found in Europe, Asia, and North America.",
      "Ixodes ricinus is the primary vector for several important tick-borne pathogens, including Louping ill virus.",
      "Louping ill virus is a member of the Flaviviridae family.",
      "The virus causes a disease known as Louping ill or \"tick-borne fever\" in cattle."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The virus causes a disease known as Louping ill in sheep and red grouse, not in cattle.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "vicuna-13b_response": "Yes, the HuR protein is known to regulate the splicing process in cells. Splicing is a process by which the introns (non-coding sequences) are removed from the messenger RNA (mRNA) molecule, resulting in a mature mRNA that can be translated into a protein. The HuR protein is a RNA-binding protein that binds to the untranslated regions of mRNA molecules and regulates their stability and translation.\nHuR has been shown to play a role in the regulation of alternative splicing, a process by which different versions of a gene can be expressed in different cells or under different conditions. HuR can either enhance or repress the inclusion of specific exons in the mRNA molecule, depending on the cellular context and the stage of the cell cycle.\nOverall, the regulation of splicing by the HuR protein is important for proper gene expression and cellular function, and dysregulation of HuR has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. HuR protein regulates the splicing process in cells.\n2. Splicing is a process by which the introns are removed from the mRNA molecule, resulting in a mature mRNA that can be translated into a protein.\n3. HuR protein is a RNA-binding protein that binds to the untranslated regions of mRNA molecules and regulates their stability and translation.\n4. HuR protein plays a role in the regulation of alternative splicing, a process by which different versions of a gene can be expressed in different cells or under different conditions.\n5. Dysregulation of HuR has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact": [
      "HuR protein regulates the splicing process in cells.",
      "Splicing is a process by which the introns are removed from the mRNA molecule, resulting in a mature mRNA that can be translated into a protein.",
      "HuR protein is a RNA-binding protein that binds to the untranslated regions of mRNA molecules and regulates their stability and translation.",
      "HuR protein plays a role in the regulation of alternative splicing, a process by which different versions of a gene can be expressed in different cells or under different conditions.",
      "Dysregulation of HuR has been implicated in various diseases, including cancer and neurodegenerative disorders."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: HuR protein does not regulate the splicing process in cells. It is involved in the regulation of mRNA stability and translation. \n2. TRUE\n3. TRUE\n4. FALSE [correction]: HuR protein does not play a role in the regulation of alternative splicing, it regulates the stability and translation of mRNA. \n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1478,
    "user_query": "Is Titin the largest single protein molecule found in Nature?",
    "vicuna-13b_response": "No, titin is not the largest single protein molecule found in nature. Titin is a protein that is composed of multiple domains, each of which is a separate protein molecule. While titin is the largest known protein in terms of its total mass, it is not a single continuous protein molecule.\nThe largest single protein molecule found in nature is likely to be a protein called ferritin, which is found in many organisms, including bacteria, yeast, and animals. Ferritin is a protein that stores and releases iron, and it is composed of up to 24 subunits, each of which is a separate protein molecule. The total mass of ferritin subunits can be much larger than that of titin, with some ferritin subunits weighing over 200 kDa.\nAnother example of a large single protein molecule is the protein called legumain, which is found in certain bacteria and fungi. Legumain is a metalloprotease, which is an enzyme that cuts other proteins, and it is composed of a single polypeptide chain that is over 600 amino acids long.\nIt is worth noting that the size of a protein molecule is not always the most important factor in its function. Proteins can perform a wide range of functions, and their size and structure are often optimized for those functions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Titin is not the largest single protein molecule found in nature.\n2. Titin is composed of multiple domains, each a separate protein molecule.\n3. Ferritin is considered the largest single protein molecule found in nature.\n4. Ferritin, found in many organisms, stores and releases iron and is composed of up to 24 subunits.\n5. Legumain is another large single protein molecule and is a metalloprotease composed of a single polypeptide chain that is over 600 amino acids long.",
    "vicuna-13b_fact": [
      "Titin is not the largest single protein molecule found in nature.",
      "Titin is composed of multiple domains, each a separate protein molecule.",
      "Ferritin is considered the largest single protein molecule found in nature.",
      "Ferritin, found in many organisms, stores and releases iron and is composed of up to 24 subunits.",
      "Legumain is another large single protein molecule and is a metalloprotease composed of a single polypeptide chain that is over 600 amino acids long."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Titin is the largest single protein molecule found in nature.\n2. FALSE [correction]: Titin is composed of multiple domains, each a separate part of the same protein molecule, not separate protein molecules.\n3. FALSE [correction]: Titin, not Ferritin, is considered the largest single protein molecule found in nature.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1481,
    "user_query": "What is the the Menzerath-Altmann law?",
    "vicuna-13b_response": "The Menzerath-Altmann law is a principle in linguistics that states that the length of words in a language is subject to a power-law distribution. This means that the frequency of words of a certain length follows a mathematical pattern in which shorter words are more common than longer words, but the difference between the frequencies of shorter and longer words decreases as the length of the words increases.\nThe law was first proposed by the German linguists Paul Menzerath and Karl-Heinz Altmann in 1961, based on their analysis of the frequency of words in German. They found that the distribution of word lengths in German followed a power-law distribution, with shorter words being more common than longer words. This pattern has since been observed in many other languages as well.\nThe Menzerath-Altmann law has important implications for the study of language and communication. It suggests that the length of words in a language is not random, but follows a mathematical pattern that reflects the way in which words are used in language. This pattern can be used to study the structure of language and the way in which words are processed by speakers of a language.\nIn addition, the Menzerath-Altmann law has been applied in other fields, such as economics and social science, to study the distribution of various phenomena, such as wealth or power, which follow a similar power-law distribution.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Menzerath-Altmann law is a principle in linguistics.\n2. The law states that the frequency of words of a certain length follows a power-law distribution, where shorter words are more common than longer words.\n3. Paul Menzerath and Karl-Heinz Altmann first proposed the Menzerath-Altmann law in 1961.\n4. Menzerath and Altmann based this principle on their analysis of the frequency of words in German.\n5. The Menzerath-Altmann law has been utilized to study the distribution of various phenomena in other fields such as economics and social science.",
    "vicuna-13b_fact": [
      "The Menzerath-Altmann law is a principle in linguistics.",
      "The law states that the frequency of words of a certain length follows a power-law distribution, where shorter words are more common than longer words.",
      "Paul Menzerath and Karl-Heinz Altmann first proposed the Menzerath-Altmann law in 1961.",
      "Menzerath and Altmann based this principle on their analysis of the frequency of words in German.",
      "The Menzerath-Altmann law has been utilized to study the distribution of various phenomena in other fields such as economics and social science."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Menzerath-Altmann law states that the larger the linguistic construct, the shorter its constituents.\n3. UNKNOWN\n4. FALSE [correction]: The Menzerath-Altmann law is not particularly based on the frequency of words in German, but is applicable across languages.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 1482,
    "user_query": "Which receptor(s) recognize lysosomal hydrolases in trans-Golgi network (TGN)?",
    "vicuna-13b_response": "Lysosomal hydrolases are recognized by receptors in the trans-Golgi network (TGN) through a process called receptor-mediated endocytosis. The specific receptor responsible for recognizing lysosomal hydrolases in the TGN is the mannose 6-phosphate receptor (MPR).\nThe MPR is a type II transmembrane protein that is expressed on the surface of TGN and endosomal membranes. It has a high affinity for lysosomal hydrolases that contain a mannose 6-phosphate (Man-6-P) residue on their surface. Man-6-P is a sugar residue that is added to lysosomal hydrolases in the late Golgi apparatus, which targets them for transport to the TGN.\nOnce the lysosomal hydrolases are recognized by the MPR, they are internalized through a process of endocytosis, where the receptor and the hydrolase are transported to the endosome. The endosome then fuses with the lysosome, and the hydrolase is released into the lysosomal lumen where it can perform its hydrolytic function.\nOverall, the recognition of lysosomal hydrolases by the MPR in the TGN is a critical step in the proper targeting and delivery of these enzymes to the lysosome, where they play a crucial role in maintaining cellular homeostasis by breaking down and recycling cellular debris.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The mannose 6-phosphate receptor (MPR) is the specific receptor in the trans-Golgi network (TGN) that recognizes lysosomal hydrolases.\n2. MPR is a type II transmembrane protein that is expressed on the surface of TGN and endosomal membranes.\n3. MPR has a high affinity for lysosomal hydrolases that contain a mannose 6-phosphate (Man-6-P) residue on their surface.\n4. After lysosomal hydrolases are recognized by the MPR, they are internalized through a process known as endocytosis.\n5. The recognition of lysosomal hydrolases by the MPR in the TGN plays a critical role in the proper targeting and delivery of these enzymes to the lysosome.",
    "vicuna-13b_fact": [
      "The mannose 6-phosphate receptor (MPR) is the specific receptor in the trans-Golgi network (TGN) that recognizes lysosomal hydrolases.",
      "MPR is a type II transmembrane protein that is expressed on the surface of TGN and endosomal membranes.",
      "MPR has a high affinity for lysosomal hydrolases that contain a mannose 6-phosphate (Man-6-P) residue on their surface.",
      "After lysosomal hydrolases are recognized by the MPR, they are internalized through a process known as endocytosis.",
      "The recognition of lysosomal hydrolases by the MPR in the TGN plays a critical role in the proper targeting and delivery of these enzymes to the lysosome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "vicuna-13b_response": "Prothymosin alpha is a protein that is expressed in many tissues, including the brain, and has been shown to have a variety of functions. One of the known functions of the prothymosin alpha c-terminal peptide is its ability to regulate the activity of certain ion channels, including the NMDA receptor. The NMDA receptor is a type of ion channel that is involved in the transmission of signals between neurons and plays a role in the development and maintenance of synapses, the connections between neurons.\nThe prothymosin alpha c-terminal peptide has been shown to modulate the activity of the NMDA receptor by interacting with a specific region of the receptor called the GluN2B subunit. This interaction can either enhance or inhibit the activity of the NMDA receptor, depending on the specific context in which it occurs.\nIn addition to its effects on ion channels, the prothymosin alpha c-terminal peptide has also been shown to have effects on the activity of certain neurotransmitter receptors, including the dopamine D2 receptor. The prothymosin alpha c-terminal peptide can bind to the D2 receptor and modulate its activity, leading to changes in the levels of dopamine in the brain and potentially affecting mood and behavior.\nOverall, the prothymosin alpha c-terminal peptide plays an important role in the regulation of various aspects of brain function, including the activity of ion channels and neurotransmitter receptors. Further research is needed to fully understand the mechanisms by which the prothymosin alpha c-terminal peptide exerts its effects and to determine its potential as a therapeutic target for a variety of neurological disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Prothymosin alpha is a protein expressed in many tissues, including the brain.\n2. The prothymosin alpha c-terminal peptide has the ability to regulate the activity of certain ion channels, such as the NMDA receptor.\n3. The NMDA receptor is involved in the transmission of signals between neurons and plays a role in the development and maintenance of synapses.\n4. Prothymosin alpha c-terminal peptide has shown to modulate the activity of the dopamine D2 receptor.\n5. The modulation of the dopamine D2 receptor by the prothymosin alpha c-terminal peptide can lead to changes in the levels of dopamine in the brain and could potentially affect mood and behavior.",
    "vicuna-13b_fact": [
      "Prothymosin alpha is a protein expressed in many tissues, including the brain.",
      "The prothymosin alpha c-terminal peptide has the ability to regulate the activity of certain ion channels, such as the NMDA receptor.",
      "The NMDA receptor is involved in the transmission of signals between neurons and plays a role in the development and maintenance of synapses.",
      "Prothymosin alpha c-terminal peptide has shown to modulate the activity of the dopamine D2 receptor.",
      "The modulation of the dopamine D2 receptor by the prothymosin alpha c-terminal peptide can lead to changes in the levels of dopamine in the brain and could potentially affect mood and behavior."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1494,
    "user_query": "What is the role of the Ada O6-alkylguanine alkyltransferase in bacteria?",
    "vicuna-13b_response": "Ada O6-alkylguanine alkyltransferase, also known as AAGT, is an enzyme that plays a role in the DNA repair process in bacteria. Specifically, it is responsible for the removal of alkyl groups from the O6 position of guanine residues in DNA. This process is important for maintaining the integrity of the genetic material, as alkylation of guanine can lead to mutations and other DNA damage.\nThe AAGT enzyme recognizes and binds to alkylated guanine residues in DNA, and then transfers an alkyl group from the O6 position of the guanine to another molecule, effectively removing the damaged base from the DNA strand. This process is known as alkyltransferase activity.\nIn addition to its role in DNA repair, AAGT may also play a role in the regulation of gene expression and other cellular processes in bacteria. However, the exact mechanisms and functions of AAGT are still the subject of ongoing research and are not fully understood.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ada O6-alkylguanine alkyltransferase, also known as AAGT, is an enzyme present in bacteria.\n2. AAGT plays a role in the DNA repair process in bacteria.\n3. It is responsible for the removal of alkyl groups from the O6 position of guanine residues in DNA.\n4. AAGT enzyme recognizes and binds to alkylated guanine residues in DNA and then transfers an alkyl group from the O6 position of the guanine to another molecule.\n5. AAGT may also play a role in the regulation of gene expression and other cellular processes in bacteria.",
    "vicuna-13b_fact": [
      "Ada O6-alkylguanine alkyltransferase, also known as AAGT, is an enzyme present in bacteria.",
      "AAGT plays a role in the DNA repair process in bacteria.",
      "It is responsible for the removal of alkyl groups from the O6 position of guanine residues in DNA.",
      "AAGT enzyme recognizes and binds to alkylated guanine residues in DNA and then transfers an alkyl group from the O6 position of the guanine to another molecule.",
      "AAGT may also play a role in the regulation of gene expression and other cellular processes in bacteria."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1503,
    "user_query": "Which is the clinical meaning of the presence of delayed enhancement in patients with hypertrophic cardiomyopathy?",
    "vicuna-13b_response": "Hypertrophic cardiomyopathy (HCM) is a genetic disorder that affects the heart muscle, characterized by thickening of the heart muscle, particularly in the left ventricle. Delayed enhancement (DE) is a magnetic resonance imaging (MRI) technique that can detect areas of increased blood flow and metabolic activity in the heart. The presence of DE in patients with HCM may indicate a more severe form of the disease, as well as an increased risk of heart failure and other complications. It may also suggest the presence of myocardial scar tissue, which can lead to abnormal electrical signals that can cause arrhythmias. Therefore, the presence of DE in patients with HCM may have important clinical implications for their management and prognosis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hypertrophic cardiomyopathy (HCM) is a genetic disorder that affects the heart muscle.\n2. HCM is characterized by thickening of the heart muscle, particularly in the left ventricle.\n3. Delayed enhancement (DE) is a magnetic resonance imaging (MRI) technique that can detect areas of increased blood flow and metabolic activity in the heart.\n4. The presence of DE in patients with HCM may indicate a more severe form of the disease.\n5. The presence of DE may suggest the presence of myocardial scar tissue, which can lead to abnormal electrical signals that can cause arrhythmias.",
    "vicuna-13b_fact": [
      "Hypertrophic cardiomyopathy (HCM) is a genetic disorder that affects the heart muscle.",
      "HCM is characterized by thickening of the heart muscle, particularly in the left ventricle.",
      "Delayed enhancement (DE) is a magnetic resonance imaging (MRI) technique that can detect areas of increased blood flow and metabolic activity in the heart.",
      "The presence of DE in patients with HCM may indicate a more severe form of the disease.",
      "The presence of DE may suggest the presence of myocardial scar tissue, which can lead to abnormal electrical signals that can cause arrhythmias."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Delayed enhancement (DE) is a magnetic resonance imaging (MRI) technique that can detect areas of scar tissue in the heart.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1509,
    "user_query": "Alpha-spectrin and beta-spectrin subunits form parallel or antiparallel heterodimers?",
    "vicuna-13b_response": "Alpha-spectrin and beta-spectrin are two subunits that form a heterodimer, which is a type of protein complex composed of two different subunits. The alpha-spectrin and beta-spectrin subunits can form either parallel or antiparallel heterodimers, depending on the specific context in which they are studied.\nIn a parallel heterodimer, the two subunits are arranged in a head-to-head or tail-to-tail configuration, with their N-terminal or C-terminal regions facing each other. In an antiparallel heterodimer, the two subunits are arranged in a head-to-tail or tail-to-head configuration, with their N-terminal or C-terminal regions facing away from each other.\nThe specific arrangement of the alpha-spectrin and beta-spectrin subunits in a heterodimer can have important functional implications. For example, in some contexts, parallel heterodimers may be more stable or have higher affinity for certain ligands, while antiparallel heterodimers may be more dynamic or have different signaling properties.\nOverall, the specific arrangement of the alpha-spectrin and beta-spectrin subunits in a heterodimer can be influenced by a variety of factors, including the amino acid sequence of the subunits, the presence of post-translational modifications, and the presence of other proteins or ligands that interact with the heterodimer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Alpha-spectrin and beta-spectrin are two subunits that form a heterodimer.\n2. A heterodimer is a type of protein complex composed of two different subunits.\n3. The alpha-spectrin and beta-spectrin subunits can form either parallel or antiparallel heterodimers.\n4. In a parallel heterodimer, the two subunits are arranged in a head-to-head or tail-to-tail configuration, with their N-terminal or C-terminal regions facing each other.\n5. In an antiparallel heterodimer, the two subunits are arranged in a head-to-tail or tail-to-head configuration, with their N-terminal or C-terminal regions facing away from each other.",
    "vicuna-13b_fact": [
      "Alpha-spectrin and beta-spectrin are two subunits that form a heterodimer.",
      "A heterodimer is a type of protein complex composed of two different subunits.",
      "The alpha-spectrin and beta-spectrin subunits can form either parallel or antiparallel heterodimers.",
      "In a parallel heterodimer, the two subunits are arranged in a head-to-head or tail-to-tail configuration, with their N-terminal or C-terminal regions facing each other.",
      "In an antiparallel heterodimer, the two subunits are arranged in a head-to-tail or tail-to-head configuration, with their N-terminal or C-terminal regions facing away from each other."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.\n4. FALSE [correction]: In a parallel heterodimer, the two subunits are arranged in a head-to-head or tail-to-tail configuration, but the N-termini and C-termini of the same subunit do not face each other.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1510,
    "user_query": "Is gastro esophageal reflux related to burning mouth syndrome?",
    "vicuna-13b_response": "Gastroesophageal reflux (GER) and burning mouth syndrome (BMS) are two separate conditions that can have some similar symptoms, but they are caused by different factors and have different treatments.\nGER occurs when stomach acid and other contents flow back up into the esophagus, causing symptoms such as heartburn, regurgitation, and difficulty swallowing. This condition is often associated with a weak lower esophageal sphincter (LES) muscle that fails to keep the stomach's contents from flowing back up into the esophagus.\nBMS, on the other hand, is a condition characterized by chronic or recurrent burning or pain in the mouth without any visible signs of dental or medical problems. The cause of BMS is not well understood, but it is thought to be related to nerve damage or abnormalities in the brain or spinal cord that affect the sensation of pain in the mouth.\nWhile some people with GER may experience symptoms such as heartburn or regurgitation that can affect the mouth, BMS is not directly related to GER. However, some people with BMS may experience relief from their symptoms by using acid-suppressing medications that are commonly used to treat GERD.\nIt is important to note that if you are experiencing any symptoms, it is best to consult with a healthcare professional to determine the underlying cause and appropriate treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Gastroesophageal reflux (GER) occurs when stomach acid and other contents flow back up into the esophagus.\n2. GER is often associated with a weak lower esophageal sphincter (LES) muscle that fails to keep the stomach's contents from flowing back up into the esophagus.\n3. Burning mouth syndrome (BMS) is a condition characterized by chronic or recurrent burning or pain in the mouth without any visible signs of dental or medical problems.\n4. The cause of BMS is thought to be related to nerve damage or abnormalities in the brain or spinal cord that affect the sensation of pain in the mouth.\n5. Some people with BMS may experience relief from their symptoms by using acid-suppressing medications that are commonly used to treat GERD.",
    "vicuna-13b_fact": [
      "Gastroesophageal reflux (GER) occurs when stomach acid and other contents flow back up into the esophagus.",
      "GER is often associated with a weak lower esophageal sphincter (LES) muscle that fails to keep the stomach's contents from flowing back up into the esophagus.",
      "Burning mouth syndrome (BMS) is a condition characterized by chronic or recurrent burning or pain in the mouth without any visible signs of dental or medical problems.",
      "The cause of BMS is thought to be related to nerve damage or abnormalities in the brain or spinal cord that affect the sensation of pain in the mouth.",
      "Some people with BMS may experience relief from their symptoms by using acid-suppressing medications that are commonly used to treat GERD."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1511,
    "user_query": "Which is the protein (antigen) targeted by anti-Vel antibodies in the Vel blood group?",
    "vicuna-13b_response": "The Vel blood group is a type of blood group system that is determined by the presence or absence of a specific sugar molecule called N-acetyl-D-galactosamine (GalNAc) on the surface of red blood cells. The Vel blood group is also known as the \"Jka\" blood group.\nThe Vel blood group is important in transfusion medicine because some individuals who have the Vel(a) blood type may develop an immune response to transfusions of red blood cells that are typed as Vel(b) or Vel(o). This is because the antibodies produced in response to the presence of GalNAc on the surface of Vel(b) and Vel(o) red blood cells can cross-react with the ABO blood group antigens, which are also present on the surface of red blood cells.\nThe specific protein that is targeted by anti-Vel antibodies is called the ABO blood group antigen. The ABO blood group antigens are a group of carbohydrate molecules that are expressed on the surface of red blood cells and are responsible for the ABO blood group system. The ABO blood group antigens are composed of two different types of sugars: N-acetyl-D-galactosamine (GalNAc) and N-acetyl-D-glucosamine (GlcNAc).\nIndividuals who have anti-Vel antibodies in their blood are said to have the \"Vel(b)\" or \"Vel(o)\" blood type, depending on the specific type of antibodies they produce. These individuals are at risk of developing a transfusion reaction if they receive transfusions of red blood cells that are typed as Vel(a), because the anti-Vel antibodies will recognize and bind to the ABO blood group antigens on the surface of the red blood cells, leading to the destruction of the transfused red blood cells and the release of inflammatory mediators.\nIn conclusion, the protein targeted by anti-Vel antibodies is the ABO blood group antigen, which is a carbohydrate molecule expressed on the surface of red blood cells. The Vel blood group is important in transfusion medicine because some individuals who have the Vel",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Vel blood group is determined by the presence or absence of a specific sugar molecule called N-acetyl-D-galactosamine (GalNAc) on the surface of red blood cells.\n2. The Vel blood group is also known as the \"Jka\" blood group.\n3. The specific protein that is targeted by anti-Vel antibodies is called the ABO blood group antigen.\n4. The ABO blood group antigens are composed of two different types of sugars: N-acetyl-D-galactosamine (GalNAc) and N-acetyl-D-glucosamine (GlcNAc).\n5. Individuals who have anti-Vel antibodies in their blood are said to have the \"Vel(b)\" or \"Vel(o)\" blood type, depending on the specific type of antibodies they produce.",
    "vicuna-13b_fact": [
      "The Vel blood group is determined by the presence or absence of a specific sugar molecule called N-acetyl-D-galactosamine (GalNAc) on the surface of red blood cells.",
      "The Vel blood group is also known as the \"Jka\" blood group.",
      "The specific protein that is targeted by anti-Vel antibodies is called the ABO blood group antigen.",
      "The ABO blood group antigens are composed of two different types of sugars: N-acetyl-D-galactosamine (GalNAc) and N-acetyl-D-glucosamine (GlcNAc).",
      "Individuals who have anti-Vel antibodies in their blood are said to have the \"Vel(b)\" or \"Vel(o)\" blood type, depending on the specific type of antibodies they produce."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Vel blood group is determined by the presence or absence of a specific protein called small integral membrane protein 1 (SMIM1) on the surface of red blood cells, not N-acetyl-D-galactosamine (GalNAc). \n2. FALSE [correction]: The Vel blood group is not known as the \"Jka\" blood group. Jka is an antigen in a different blood group system known as the Kidd blood group system.\n3. FALSE [correction]: The specific protein targeted by anti-Vel antibodies is SMIM1, not the ABO blood group antigen.\n4. TRUE\n5. FALSE [correction]: Individuals who lack the SMIM1 protein (and thus the Vel antigen) on their red blood cells are said to have 'Vel negative' blood type. Their blood can contain anti-Vel antibodies, but they aren't referred to as \"Vel(b)\" or \"Vel(o)\".",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "vicuna-13b_response": "Cystatin C is a protein that is involved in regulating the activity of other proteins, known as cysteine proteases. It is a potent inhibitor of a variety of proteases, including the papain-like cysteine proteases, such as cathepsin B, C, and L, and the chymotrypsin-like cysteine proteases, such as elastase and plasmin. Cystatin C is a key player in the regulation of proteolytic activity in various physiological and pathological processes, including inflammation, fibrosis, and cancer.\nIn terms of its role in human cystatin C fibrillization, it is important to note that cystatin C is a large, hydrophilic protein that is composed of three identical chains of 110 amino acids. It has a unique, highly conserved structure that includes a tightly folded core region and a more flexible, disordered C-terminal tail. This structure is thought to play a key role in the aggregation of cystatin C into amyloid fibrils, which is a hallmark of a number of protein misfolding diseases, including Alzheimer's disease, Parkinson's disease, and prion diseases.\nSeveral studies have suggested that the C-terminal tail of cystatin C is particularly important in the formation of amyloid fibrils. For example, mutations in the C-terminal tail of cystatin C have been shown to increase its propensity to form amyloid fibrils, and to enhance its aggregation behavior in vitro. Additionally, the C-terminal tail of cystatin C has been shown to interact with the core region of the protein, and to play a key role in the formation of stable, cross-beta structure in amyloid fibrils.\nOverall, while there are several peptides that play a role in human cystatin C fibrillization, the C-terminal tail of the protein is thought to be particularly important in this process.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cystatin C is a protein that regulates the activity of other proteins, known as cysteine proteases.\n2. Cystatin C is composed of three identical chains of 110 amino acids.\n3. Cystatin C has a unique, highly conserved structure that includes a tightly folded core region and a more flexible, disordered C-terminal tail.\n4. Aggregation of cystatin C into amyloid fibrils is a hallmark of a number of protein misfolding diseases, including Alzheimer's disease, Parkinson's disease, and prion diseases.\n5. The C-terminal tail of cystatin C is thought to play a particularly important role in the formation of amyloid fibrils.",
    "vicuna-13b_fact": [
      "Cystatin C is a protein that regulates the activity of other proteins, known as cysteine proteases.",
      "Cystatin C is composed of three identical chains of 110 amino acids.",
      "Cystatin C has a unique, highly conserved structure that includes a tightly folded core region and a more flexible, disordered C-terminal tail.",
      "Aggregation of cystatin C into amyloid fibrils is a hallmark of a number of protein misfolding diseases, including Alzheimer's disease, Parkinson's disease, and prion diseases.",
      "The C-terminal tail of cystatin C is thought to play a particularly important role in the formation of amyloid fibrils."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Cystatin C is composed of a single chain of 120 amino acids.\n3. TRUE\n4. FALSE [correction]: Aggregation of cystatin C into amyloid fibrils is a hallmark of a disease called hereditary cystatin C amyloid angiopathy.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1518,
    "user_query": "What is the use of MammaPrint and Oncotype DX?",
    "vicuna-13b_response": "MammaPrint and Oncotype DX are both gene expression tests that are used to help determine the risk of recurrence of breast cancer in women who have been treated for early-stage breast cancer. These tests are designed to help doctors make more informed decisions about the need for additional treatment, such as chemotherapy, in women who have been diagnosed with breast cancer.\nMammaPrint is a multi-gene expression test that analyzes the activity of a panel of genes in breast cancer tissue to provide a risk score that indicates the likelihood of distant recurrence of breast cancer. The test is performed on a sample of the patient's tumor tissue and results are typically available within a few weeks.\nOncotype DX is a multi-gene expression test that analyzes the activity of a panel of genes in breast cancer tissue to provide a risk score that indicates the likelihood of recurrence of breast cancer and the likelihood of benefit from chemotherapy. The test is performed on a sample of the patient's tumor tissue and results are typically available within a few weeks.\nIt's important to note that these tests are not diagnostic tests, but rather prognostic tests, which means they can provide information about the likely course of the disease, but cannot definitively diagnose a specific condition.\nIt's important to discuss the results of these tests with your doctor and consider them in the context of your overall health, medical history, and other factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MammaPrint and Oncotype DX are gene expression tests used to determine the risk of recurrence of breast cancer in women treated for early-stage breast cancer.\n2. These tests are designed to assist doctors in deciding about the need for additional treatment, for example, chemotherapy, in women diagnosed with breast cancer.\n3. MammaPrint analyzes the activity of a panel of genes in breast cancer tissue to provide a risk score indicating the likelihood of distant recurrence of breast cancer.\n4. Oncotype DX analyzes the activity of a panel of genes in breast cancer tissue to provide a risk score indicating the likelihood of recurrence and the benefit from chemotherapy.\n5. MammaPrint and Oncotype DX are prognostic tests, not diagnostic tests, meaning they can provide information about the likely course of the disease, but cannot definitively diagnose a specific condition.",
    "vicuna-13b_fact": [
      "MammaPrint and Oncotype DX are gene expression tests used to determine the risk of recurrence of breast cancer in women treated for early-stage breast cancer.",
      "These tests are designed to assist doctors in deciding about the need for additional treatment, for example, chemotherapy, in women diagnosed with breast cancer.",
      "MammaPrint analyzes the activity of a panel of genes in breast cancer tissue to provide a risk score indicating the likelihood of distant recurrence of breast cancer.",
      "Oncotype DX analyzes the activity of a panel of genes in breast cancer tissue to provide a risk score indicating the likelihood of recurrence and the benefit from chemotherapy.",
      "MammaPrint and Oncotype DX are prognostic tests, not diagnostic tests, meaning they can provide information about the likely course of the disease, but cannot definitively diagnose a specific condition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1520,
    "user_query": "Is there any data to suggest that TRH (thyrotropin releasing hormone) administration can improve symptom severity of amyotrophic lateral sclerosis patients?",
    "vicuna-13b_response": "Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord. There is currently no cure for ALS, and treatment options are limited to symptom management.\nThyrotropin releasing hormone (TRH) is a hormone that stimulates the production and release of thyroid-stimulating hormone (TSH) from the pituitary gland. TRH has been studied for its potential to improve symptoms in ALS patients, but the results have been mixed.\nSome studies have suggested that TRH administration may improve muscle strength and function in ALS patients, while others have found no significant benefit. A small pilot study published in the journal Neurology in 2018 found that TRH treatment was associated with improved muscle strength and reduced muscle weakness in ALS patients, but the study was not large enough to definitively prove the effectiveness of TRH.\nMore research is needed to fully understand the potential benefits of TRH in ALS patients. While TRH may be a promising treatment option, it is important to note that it is not currently approved by the FDA for the treatment of ALS. ALS patients should always consult with their healthcare provider before trying any new treatments or supplements.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord.\n2. There is currently no cure for ALS, and treatment options are limited to symptom management.\n3. Thyrotropin releasing hormone (TRH) stimulates the production and release of thyroid-stimulating hormone (TSH) from the pituitary gland. \n4. A pilot study published in the journal Neurology in 2018 found that TRH treatment was associated with improved muscle strength and reduced muscle weakness in ALS patients.\n5. As of the time this document was written, TRH is not currently approved by the FDA for the treatment of ALS.",
    "vicuna-13b_fact": [
      "Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord.",
      "There is currently no cure for ALS, and treatment options are limited to symptom management.",
      "Thyrotropin releasing hormone (TRH) stimulates the production and release of thyroid-stimulating hormone (TSH) from the pituitary gland.",
      "A pilot study published in the journal Neurology in 2018 found that TRH treatment was associated with improved muscle strength and reduced muscle weakness in ALS patients.",
      "As of the time this document was written, TRH is not currently approved by the FDA for the treatment of ALS."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1524,
    "user_query": "What is the gold standard treatment for Iatrogenic male incontinence?",
    "vicuna-13b_response": "Iatrogenic male incontinence refers to urinary incontinence that is caused by medical treatment or surgery. The gold standard treatment for iatrogenic male incontinence is a type of surgery called a sling procedure.\nA sling procedure involves placing a sling or mesh material under the urethra to help support it and prevent urine leakage. There are several types of sling procedures, including the transobturator method and the retropubic method.\nDuring the procedure, a surgeon will make a small incision in the lower abdomen and insert a catheter to help drain urine from the bladder. The surgeon will then insert the sling material through the incision and secure it in place. The procedure typically takes about an hour to complete and is performed under general anesthesia.\nAfter the procedure, patients may experience some discomfort and swelling, but this typically subsides within a few days. Patients may also experience some urinary frequency or urgency, but these symptoms usually improve over time.\nIt's important to note that not all patients are candidates for sling procedures. Patients with certain medical conditions, such as a history of infection or bleeding disorders, may not be good candidates for this type of surgery. It's important to discuss the risks and benefits of sling procedures with a urologist to determine the best course of treatment for each individual patient.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Iatrogenic male incontinence refers to urinary incontinence that is caused by medical treatment or surgery.\n2. The gold standard treatment for iatrogenic male incontinence is a type of surgery called a sling procedure.\n3. A sling procedure involves placing a sling or mesh material under the urethra to help support it and prevent urine leakage.\n4. During the procedure, a surgeon will make a small incision in the lower abdomen and insert a catheter to help drain urine from the bladder. The surgeon will then insert the sling material through the incision and secure it in place.\n5. Not all patients are candidates for sling procedures. For instance, those with certain medical conditions, such as a history of infection or bleeding disorders, may not be considered good candidates for this type of surgery.",
    "vicuna-13b_fact": [
      "Iatrogenic male incontinence refers to urinary incontinence that is caused by medical treatment or surgery.",
      "The gold standard treatment for iatrogenic male incontinence is a type of surgery called a sling procedure.",
      "A sling procedure involves placing a sling or mesh material under the urethra to help support it and prevent urine leakage.",
      "During the procedure, a surgeon will make a small incision in the lower abdomen and insert a catheter to help drain urine from the bladder. The surgeon will then insert the sling material through the incision and secure it in place.",
      "Not all patients are candidates for sling procedures. For instance, those with certain medical conditions, such as a history of infection or bleeding disorders, may not be considered good candidates for this type of surgery."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The gold standard treatment for iatrogenic male incontinence is a type of surgery called artificial urinary sphincter implantation. The sling procedure is another common treatment.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1525,
    "user_query": "Which is the main CHEK2 genetic variant, thought to be involved in familial breast cancer?",
    "vicuna-13b_response": "The main CHEK2 genetic variant thought to be involved in familial breast cancer is the 1100delC variant. This variant is a deletion in the CHEK2 gene that results in a truncated protein product. The 1100delC variant has been shown to be associated with an increased risk of breast cancer, particularly in individuals with a family history of the disease. It is also associated with an increased risk of ovarian cancer. Other CHEK2 variants have also been identified as being associated with an increased risk of breast cancer, but the 1100delC variant is the most well-established and widely studied.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The main CHEK2 genetic variant thought to be involved in familial breast cancer is the 1100delC variant.\n2. The 1100delC variant is a deletion in the CHEK2 gene that results in a truncated protein product. \n3. The 1100delC variant has been shown to be associated with an increased risk of breast cancer. \n4. The 1100delC variant is associated with an increased risk of ovarian cancer.\n5. Other CHEK2 variants have also been associated with an increased risk of breast cancer.",
    "vicuna-13b_fact": [
      "The main CHEK2 genetic variant thought to be involved in familial breast cancer is the 1100delC variant.",
      "The 1100delC variant is a deletion in the CHEK2 gene that results in a truncated protein product.",
      "The 1100delC variant has been shown to be associated with an increased risk of breast cancer.",
      "The 1100delC variant is associated with an increased risk of ovarian cancer.",
      "Other CHEK2 variants have also been associated with an increased risk of breast cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1535,
    "user_query": "Are immune cells affected in Amyotrophic Lateral Sclerosis?",
    "vicuna-13b_response": "Yes, immune cells are known to be involved in the progression of Amyotrophic Lateral Sclerosis (ALS). Specifically, a type of immune cell called T cells have been found to play a role in the destruction of motor neurons, which are the cells that are affected in ALS.\nIn ALS, there is an abnormal immune response in the spinal cord and brain, which leads to the activation of T cells and the release of toxic substances that damage motor neurons. This immune response is thought to be triggered by a combination of genetic and environmental factors.\nThere is ongoing research into the role of immune cells in ALS, and there are several immunotherapy approaches that are being studied as potential treatments for the disease. These approaches aim to modulate the immune response in order to reduce the damage to motor neurons and slow the progression of ALS.\nOverall, while ALS is primarily a neurodegenerative disease, there is evidence to suggest that immune cells play a role in its progression, and targeting these cells may be a promising approach to treating the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Immune cells are known to be involved in the progression of Amyotrophic Lateral Sclerosis (ALS).\n2. In ALS, a type of immune cell called T cells play a role in the destruction of motor neurons.\n3. There is an abnormal immune response in the spinal cord and brain in ALS, resulting in the activation of T cells and the release of toxic substances.\n4. The abnormal immune response in ALS is thought to be triggered by a combination of genetic and environmental factors.\n5. Several immunotherapy approaches, aiming to modulate the immune response to slow down ALS progression, are under research.",
    "vicuna-13b_fact": [
      "Immune cells are known to be involved in the progression of Amyotrophic Lateral Sclerosis (ALS).",
      "In ALS, a type of immune cell called T cells play a role in the destruction of motor neurons.",
      "There is an abnormal immune response in the spinal cord and brain in ALS, resulting in the activation of T cells and the release of toxic substances.",
      "The abnormal immune response in ALS is thought to be triggered by a combination of genetic and environmental factors.",
      "Several immunotherapy approaches, aiming to modulate the immune response to slow down ALS progression, are under research."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1537,
    "user_query": "What is the mechanism of action of eprotirome?",
    "vicuna-13b_response": "Eprotirome is a synthetic retinoid that is used to treat various skin conditions, including acne and psoriasis. The mechanism of action of eprotirome is not fully understood, but it is believed to involve the regulation of cell growth and differentiation.\nRetinoids are a class of compounds that are derived from vitamin A. They play an important role in the development and differentiation of cells, including skin cells. Eprotirome is a synthetic retinoid that is structurally related to vitamin A.\nWhen applied to the skin, eprotirome is believed to work by regulating the growth and differentiation of skin cells. It is thought to inhibit the production of skin cells, which can help to reduce the appearance of acne and psoriasis.\nEprotirome may also have anti-inflammatory effects, which can help to reduce redness and swelling associated with acne and psoriasis.\nOverall, the mechanism of action of eprotirome is complex and not fully understood. However, it is believed to involve the regulation of cell growth and differentiation, as well as anti-inflammatory effects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Eprotirome is a synthetic retinoid used to treat skin conditions like acne and psoriasis.\n2. The mechanism of action of eprotirome is associated with cellular growth and differentiation, however, it is yet not fully understood.\n3. Retinoids are a group of compounds derived from vitamin A and they play a crucial role in the development and differentiation of cells.\n4. Eprotirome is known to possibly reduce the production of skin cells, aiding in the treatment of acne and psoriasis.\n5. Eprotirome may possess anti-inflammatory properties which can help reduce redness and swelling associated with acne and psoriasis.",
    "vicuna-13b_fact": [
      "Eprotirome is a synthetic retinoid used to treat skin conditions like acne and psoriasis.",
      "The mechanism of action of eprotirome is associated with cellular growth and differentiation, however, it is yet not fully understood.",
      "Retinoids are a group of compounds derived from vitamin A and they play a crucial role in the development and differentiation of cells.",
      "Eprotirome is known to possibly reduce the production of skin cells, aiding in the treatment of acne and psoriasis.",
      "Eprotirome may possess anti-inflammatory properties which can help reduce redness and swelling associated with acne and psoriasis."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Eprotirome is a thyroid hormone analog that has been studied for the treatment of hyperlipidemia.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Eprotirome is studied for its effects on lipid metabolism in hyperlipidemic patients, not for reducing the production of skin cells.\n5. FALSE [correction]: While anti-inflammatory properties are seen in some retinoids, eprotirome's potential properties for reducing redness and swelling associated with skin conditions such as acne and psoriasis are not established or studied.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1541,
    "user_query": "What is GDF10?",
    "vicuna-13b_response": "GDF10 (Growth Differentiation Factor 10) is a protein that plays a role in cell growth and differentiation. It is a member of the TGF-β superfamily of proteins, which are involved in regulating cellular proliferation and differentiation.\nGDF10 is expressed in many tissues, including the heart, skeletal muscle, and pancreas, and it has been shown to play a role in the development and maintenance of these tissues. In the heart, GDF10 is expressed in cardiac muscle cells and is involved in the regulation of cardiac muscle growth and differentiation. In skeletal muscle, GDF10 is involved in the regulation of muscle cell proliferation and differentiation.\nGDF10 has also been shown to play a role in the development of diabetes. Studies have shown that individuals with mutations in the GDF10 gene are more likely to develop type 2 diabetes. Additionally, GDF10 has been shown to play a role in the regulation of insulin secretion from pancreatic beta cells.\nOverall, GDF10 is an important protein that plays a role in cell growth and differentiation, and its dysregulation has been implicated in the development of certain diseases such as diabetes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GDF10 is a protein that plays a role in cell growth and differentiation.\n2. GDF10 is a member of the TGF-β superfamily of proteins.\n3. GDF10 is expressed in many tissues, including the heart, skeletal muscle, and pancreas.\n4. Individuals with mutations in the GDF10 gene are more likely to develop type 2 diabetes.\n5. GDF10 is involved in the regulation of insulin secretion from pancreatic beta cells.",
    "vicuna-13b_fact": [
      "GDF10 is a protein that plays a role in cell growth and differentiation.",
      "GDF10 is a member of the TGF-β superfamily of proteins.",
      "GDF10 is expressed in many tissues, including the heart, skeletal muscle, and pancreas.",
      "Individuals with mutations in the GDF10 gene are more likely to develop type 2 diabetes.",
      "GDF10 is involved in the regulation of insulin secretion from pancreatic beta cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1552,
    "user_query": "Which genetic defects are observed in Prader-Willi syndrome?",
    "vicuna-13b_response": "Prader-Willi syndrome is a genetic disorder that is caused by a lack of expression of certain genes in the 15th chromosome. This lack of expression leads to a variety of physical and mental characteristics, including:\n1. Low muscle tone, which can lead to poor muscle strength and weakness\n2. Poor growth and development before birth\n3. Difficulty feeding and swallowing as an infant\n4. Small hands and feet\n5. A narrowing of the nostrils and mouth\n6. Low blood sugar levels\n7. Delayed puberty\n8. Ongoing food seeking behavior\n9. Increased risk of obesity\n10. Learning difficulties\n11. Behavioral problems\n12. Short stature\n13. Differences in the structure of the skull\n14. Differences in the shape and size of the eyes\n15. Hearing loss\nIt is important to note that the severity of these symptoms can vary from person to person, and that not all individuals with Prader-Willi syndrome will have all of these characteristics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Prader-Willi syndrome is a genetic disorder caused by a lack of expression of certain genes in the 15th chromosome.\n2. This disorder leads to physical and mental characteristics such as low muscle tone, small hands and feet, and low blood sugar levels.\n3. Symptoms of Prader-Willi syndrome also include delayed puberty, increased risk of obesity, and behavioral problems.\n4. Differences in the structure of the skull and the shape and size of the eyes are also associated with Prader-Willi syndrome.\n5. Not all individuals with Prader-Willi syndrome will have all of these characteristics.",
    "vicuna-13b_fact": [
      "Prader-Willi syndrome is a genetic disorder caused by a lack of expression of certain genes in the 15th chromosome.",
      "This disorder leads to physical and mental characteristics such as low muscle tone, small hands and feet, and low blood sugar levels.",
      "Symptoms of Prader-Willi syndrome also include delayed puberty, increased risk of obesity, and behavioral problems.",
      "Differences in the structure of the skull and the shape and size of the eyes are also associated with Prader-Willi syndrome.",
      "Not all individuals with Prader-Willi syndrome will have all of these characteristics."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1555,
    "user_query": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?",
    "vicuna-13b_response": "There are several state-of-the-art computational tools available for the prediction of gene fusion events. Some of the most popular ones are:\n1. FusionMap: It is a computational tool that uses a machine learning approach to predict gene fusion events in cancer genomics data. It uses a combination of sequence and expression data to identify gene fusions and has been shown to be highly accurate in detecting gene fusions in various cancer types.\n2. FusionPrior: It is a computational tool that uses a statistical approach to predict gene fusion events. It uses a Bayesian framework to model the probability of gene fusion events and has been shown to be highly accurate in detecting gene fusions in various cancer types.\n3. FusionFinder: It is a computational tool that uses a combination of sequence and expression data to predict gene fusion events. It uses a combination of machine learning and statistical methods to identify gene fusions and has been shown to be highly accurate in detecting gene fusions in various cancer types.\n4. FusionMiner: It is a computational tool that uses a machine learning approach to predict gene fusion events. It uses a combination of sequence and expression data to identify gene fusions and has been shown to be highly accurate in detecting gene fusions in various cancer types.\n5. GFusion: It is a computational tool that uses a combination of sequence and expression data to predict gene fusion events. It uses a combination of machine learning and statistical methods to identify gene fusions and has been shown to be highly accurate in detecting gene fusions in various cancer types.\nThese are some of the most popular computational tools for the prediction of gene fusion events, but there are many other tools available as well, each with its own strengths and weaknesses. It is important to choose the right tool for the right job, depending on the specific requirements and characteristics of the data being analyzed.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. FusionMap is a computational tool that uses a machine learning approach to predict gene fusion events in cancer genomics data.\n2. FusionPrior is a computational tool that uses a statistical approach to predict gene fusion events.\n3. FusionFinder is a computational tool that uses a combination of sequence and expression data to predict gene fusion events.\n4. FusionMiner is a computational tool that uses a machine learning approach to predict gene fusion events.\n5. GFusion is a computational tool that uses a combination of sequence and expression data to predict gene fusion events.",
    "vicuna-13b_fact": [
      "FusionMap is a computational tool that uses a machine learning approach to predict gene fusion events in cancer genomics data.",
      "FusionPrior is a computational tool that uses a statistical approach to predict gene fusion events.",
      "FusionFinder is a computational tool that uses a combination of sequence and expression data to predict gene fusion events.",
      "FusionMiner is a computational tool that uses a machine learning approach to predict gene fusion events.",
      "GFusion is a computational tool that uses a combination of sequence and expression data to predict gene fusion events."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1559,
    "user_query": "Are the proteins Erbin (LAP2) and Merlin cooperating?",
    "vicuna-13b_response": "Erbin (LAP2) and Merlin are two different proteins that have been shown to interact with each other in certain cellular contexts. Erbin (LAP2) is a protein that plays a role in cell adhesion and cytoskeletal organization, while Merlin is a protein that acts as a tumor suppressor and is involved in regulating cell growth and differentiation.\nIn some studies, it has been shown that Erbin (LAP2) and Merlin can cooperate to regulate cellular processes such as cell migration and adhesion. For example, Erbin (LAP2) has been shown to interact with Merlin and modulate its activity, leading to the regulation of cellular adhesion and migration.\nHowever, it is important to note that the interaction between Erbin (LAP2) and Merlin is not always necessary for cellular processes, and the specific context and conditions of the cell can affect the outcome of their interaction. Additionally, the interaction between these two proteins can also be affected by various factors such as mutations or changes in expression levels, which can lead to the development of diseases such as cancer.\nOverall, while Erbin (LAP2) and Merlin can interact with each other in certain cellular contexts, their specific relationship and the extent to which they cooperate will depend on the specific conditions and context of the cell.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Erbin (LAP2) and Merlin are two different proteins that can interact with each other.\n2. Erbin (LAP2) is a protein that plays a role in cell adhesion and cytoskeletal organization.\n3. Merlin is a protein that acts as a tumor suppressor and is involved in regulating cell growth and differentiation.\n4. In some studies, Erbin (LAP2) and Merlin have been shown to regulate cellular processes such as cell migration and adhesion.\n5. The interaction between Erbin (LAP2) and Merlin can be affected by factors such as mutations or changes in protein expression levels.",
    "vicuna-13b_fact": [
      "Erbin (LAP2) and Merlin are two different proteins that can interact with each other.",
      "Erbin (LAP2) is a protein that plays a role in cell adhesion and cytoskeletal organization.",
      "Merlin is a protein that acts as a tumor suppressor and is involved in regulating cell growth and differentiation.",
      "In some studies, Erbin (LAP2) and Merlin have been shown to regulate cellular processes such as cell migration and adhesion.",
      "The interaction between Erbin (LAP2) and Merlin can be affected by factors such as mutations or changes in protein expression levels."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Erbin is a protein that plays a role in receptor localization and signal transduction. It's not directly involved in cell adhesion and cytoskeletal organization.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1568,
    "user_query": "Which deficiency is the cause of restless leg syndrome",
    "vicuna-13b_response": "Restless leg syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations such as crawling, tingling, or burning. The exact cause of RLS is not well understood, but research suggests that it may be related to a deficiency in dopamine, a neurotransmitter that helps regulate movement.\nDopamine is a key player in the brain's reward system, and it is also involved in regulating movement. In people with RLS, there may be a deficiency in dopamine, which can lead to the uncomfortable sensations and urges to move that characterize the condition.\nOther factors that may contribute to the development of RLS include genetics, changes in the brain, and certain medical conditions such as peripheral artery disease, diabetes, and kidney disease.\nIt is important to note that RLS can be managed with various treatments, including medications, lifestyle changes, and relaxation techniques. If you are experiencing symptoms of RLS, it is important to speak with a healthcare provider for proper diagnosis and treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Restless leg syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move the legs.\n2. Research suggests that RLS may be related to a deficiency in dopamine.\n3. Dopamine is a neurotransmitter that helps regulate movement.\n4. Genetics, changes in the brain, and certain medical conditions such as peripheral artery disease, diabetes, and kidney disease may contribute to the development of RLS.\n5. RLS can be managed with various treatments, including medications, lifestyle changes, and relaxation techniques.",
    "vicuna-13b_fact": [
      "Restless leg syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move the legs.",
      "Research suggests that RLS may be related to a deficiency in dopamine.",
      "Dopamine is a neurotransmitter that helps regulate movement.",
      "Genetics, changes in the brain, and certain medical conditions such as peripheral artery disease, diabetes, and kidney disease may contribute to the development of RLS.",
      "RLS can be managed with various treatments, including medications, lifestyle changes, and relaxation techniques."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1572,
    "user_query": "What is the role of eteplirsen in DMD patients?",
    "vicuna-13b_response": "Eteplirsen is a drug that is used to treat patients with Duchenne muscular dystrophy (DMD). DMD is a genetic disorder that affects muscle strength and function, and it is caused by a lack of dystrophin, a protein that helps keep muscle cells intact. Eteplirsen is an exon skipping drug, which means it helps the body to skip over certain parts of the dystrophin gene that are not working properly, in order to produce a functional dystrophin protein.\nEteplirsen is specifically approved for use in patients with DMD who have a specific genetic mutation called \"exon 51.\" This mutation is responsible for skipping over a large portion of the dystrophin gene, resulting in a lack of functional dystrophin protein. By skipping over this exon, eteplirsen helps the body to produce a shorter, but still functional, dystrophin protein.\nEteplirsen is given via intravenous infusion, and the treatment course typically lasts several weeks. The drug has been shown to improve muscle function and slow the progression of DMD in clinical trials. However, it is important to note that the benefits of eteplirsen may vary from patient to patient, and it is not a cure for DMD.\nIt is important to note that Eteplirsen is not available in all countries and it is not approved for use in all patients with DMD, it is only approved for patients with specific genetic mutation \"exon 51\" and it should only be used under the guidance of a qualified healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Eteplirsen is used to treat Duchenne muscular dystrophy (DMD).\n2. DMD is a genetic disorder caused by a lack of dystrophin, a protein that helps keep muscle cells intact.\n3. Eteplirsen is a drug that helps the body skip over certain parts of the dystrophin gene that are not working properly, in order to produce a functional dystrophin protein.\n4. Eteplirsen is specifically approved for use in DMD patients with a specific genetic mutation called \"exon 51.\"\n5. Treatment with Eteplirsen is administered via intravenous infusion and typically lasts several weeks.",
    "vicuna-13b_fact": [
      "Eteplirsen is used to treat Duchenne muscular dystrophy (DMD).",
      "DMD is a genetic disorder caused by a lack of dystrophin, a protein that helps keep muscle cells intact.",
      "Eteplirsen is a drug that helps the body skip over certain parts of the dystrophin gene that are not working properly, in order to produce a functional dystrophin protein.",
      "Eteplirsen is specifically approved for use in DMD patients with a specific genetic mutation called \"exon 51.\"",
      "Treatment with Eteplirsen is administered via intravenous infusion and typically lasts several weeks."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Treatment with Eteplirsen is administered via intravenous infusion but treatment is typically ongoing and not limited to just several weeks.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1573,
    "user_query": "Describe clinical presentation of Parkinsonism with dementia of Guadeloupe syndrome.",
    "vicuna-13b_response": "Parkinsonism with dementia of Guadeloupe syndrome (PDG) is a rare neurodegenerative disorder that is characterized by a combination of Parkinson's disease symptoms, such as tremors, stiffness, and difficulty with movement, along with dementia, which is a decline in cognitive abilities such as memory and thinking.\nThe clinical presentation of PDG can vary, but it typically involves the following symptoms:\n1. Motor symptoms: These include tremors, stiffness, and difficulty with movement, which are typical of Parkinson's disease. The tremors may affect the hands, arms, legs, and jaw, and may worsen with activity and improve with rest.\n2. Cognitive symptoms: People with PDG may experience dementia, which can include memory loss, difficulty with language, and changes in judgment and decision-making.\n3. Other symptoms: Other symptoms that may be present in PDG include changes in mood, such as depression or anxiety, and sleep disturbances, such as insomnia.\nIt is important to note that the symptoms of PDG can vary from person to person, and the severity of the symptoms can also vary. Some people with PDG may have mild symptoms, while others may have more severe symptoms.\nThere is currently no cure for PDG, but treatment can help to manage the symptoms. Medications, such as levodopa, can help to control the motor symptoms of Parkinson's disease, and cholinesterase inhibitors can help to improve cognitive function. Other treatments, such as physical therapy and occupational therapy, can also help to manage the symptoms of PDG.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Parkinsonism with dementia of Guadeloupe syndrome is a rare neurodegenerative disorder.\n2. Parkinsonism with dementia of Guadeloupe syndrome is characterized by a combination of Parkinson's symptoms and dementia.\n3. Motor symptoms of Parkinsonism with dementia of Guadeloupe syndrome may include tremors, stiffness, and difficulty with movement.\n4. Cognitive symptoms may include memory loss, difficulty with language, and changes in judgment and decision-making.\n5. There is currently no cure for Parkinsonism with dementia of Guadeloupe syndrome, but treatment can help manage the symptoms.",
    "vicuna-13b_fact": [
      "Parkinsonism with dementia of Guadeloupe syndrome is a rare neurodegenerative disorder.",
      "Parkinsonism with dementia of Guadeloupe syndrome is characterized by a combination of Parkinson's symptoms and dementia.",
      "Motor symptoms of Parkinsonism with dementia of Guadeloupe syndrome may include tremors, stiffness, and difficulty with movement.",
      "Cognitive symptoms may include memory loss, difficulty with language, and changes in judgment and decision-making.",
      "There is currently no cure for Parkinsonism with dementia of Guadeloupe syndrome, but treatment can help manage the symptoms."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1α increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "vicuna-13b_response": "Yes, the concentration of protein HIF-1α has been shown to increase after the administration of the cytoprotective prodrug \"amifostine\" (ethyol). Amifostine is a cytoprotective agent that has been used in cancer treatment to protect normal cells from the toxic effects of chemotherapy and radiation. It is also being studied for its potential to protect against ischemia-reperfusion injury, which is a type of tissue damage that can occur when blood flow is restored to an area after a period of ischemia (reduced blood flow).\nOne of the mechanisms by which amifostine exerts its cytoprotective effects is through the activation of the hypoxia-inducible factor (HIF) signaling pathway. HIF is a transcription factor that regulates the expression of genes that help cells to adapt to low oxygen levels. Amifostine has been shown to increase the expression and activity of HIF-1α, a subunit of HIF, in cells. This increase in HIF-1α activity can lead to the expression of genes that promote cell survival and protect against oxidative stress and inflammation.\nIn conclusion, the administration of amifostine has been shown to increase the concentration of protein HIF-1α, which plays a crucial role in the cytoprotective effects of the drug.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The concentration of protein HIF-1α increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol).\n2. Amifostine is a cytoprotective agent used in cancer treatment to protect normal cells from the toxic effects of chemotherapy and radiation.\n3. Amifostine is also being studied for its potential to protect against ischemia-reperfusion injury.\n4. Amifostine increases the expression and activity of HIF-1α, a subunit of the hypoxia-inducible factor (HIF).\n5. Increase in HIF-1α activity can lead to the expression of genes that promote cell survival and protect against oxidative stress and inflammation.",
    "vicuna-13b_fact": [
      "The concentration of protein HIF-1α increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol).",
      "Amifostine is a cytoprotective agent used in cancer treatment to protect normal cells from the toxic effects of chemotherapy and radiation.",
      "Amifostine is also being studied for its potential to protect against ischemia-reperfusion injury.",
      "Amifostine increases the expression and activity of HIF-1α, a subunit of the hypoxia-inducible factor (HIF).",
      "Increase in HIF-1α activity can lead to the expression of genes that promote cell survival and protect against oxidative stress and inflammation."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1578,
    "user_query": "Which are the main histone modifications associated with enhancers?",
    "vicuna-13b_response": "Enhancers are regions of DNA that are associated with the transcriptional activation of nearby genes. Histone modifications are covalent chemical modifications to the histone proteins that package DNA into chromatin. There are several histone modifications that are associated with enhancers, including:\n1. H3K4me1 (histone H3 lysine 4 monomethylation): This modification is associated with transcriptional activation and is often found at the edges of enhancers.\n2. H3K4me3 (histone H3 lysine 4 trimethylation): This modification is also associated with transcriptional activation and is often found at the center of enhancers.\n3. H3K27me3 (histone H3 lysine 27 trimethylation): This modification is associated with transcriptional repression and is often found at the edges of enhancers.\n4. H3K36me3 (histone H3 lysine 36 trimethylation): This modification is associated with transcriptional repression and is often found at the centers of enhancers.\nIt's important to note that these modifications are not exclusive to enhancers and can also be found in other regions of the genome. Additionally, the presence of a particular histone modification does not necessarily indicate that a region is an enhancer, but it can be a clue for further investigation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Enhancers are regions of DNA that are associated with the transcriptional activation of nearby genes.\n2. Histone modifications are covalent chemical modifications to the histone proteins that package DNA into chromatin.\n3. Modification H3K4me1 is associated with transcriptional activation and is often found at the edges of enhancers.\n4. Modification H3K27me3 is linked with transcriptional repression and is often found at the edges of enhancers.\n5. The presence of a particular histone modification does not necessarily indicate that a region is an enhancer.",
    "vicuna-13b_fact": [
      "Enhancers are regions of DNA that are associated with the transcriptional activation of nearby genes.",
      "Histone modifications are covalent chemical modifications to the histone proteins that package DNA into chromatin.",
      "Modification H3K4me1 is associated with transcriptional activation and is often found at the edges of enhancers.",
      "Modification H3K27me3 is linked with transcriptional repression and is often found at the edges of enhancers.",
      "The presence of a particular histone modification does not necessarily indicate that a region is an enhancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Modification H3K27me3 is linked with transcriptional repression and is often found at promoter regions, not enhancers.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1586,
    "user_query": "What is the principle of ATAC (Assay for Transposase-Accessible Chromatin) technique?",
    "vicuna-13b_response": "ATAC (Assay for Transposase-Accessible Chromatin) is a technique used to identify and analyze the chromatin accessibility landscape of a genome. The principle of the ATAC technique is based on the use of a transposase enzyme to access and digest chromatin, which is then analyzed by next-generation sequencing to identify the accessible chromatin regions.\nThe ATAC technique involves the following steps:\n1. Chromatin isolation: The first step is to isolate chromatin from cells or tissues of interest.\n2. Transposase treatment: The isolated chromatin is then treated with a transposase enzyme, such as Tn5 or MuDR, which cuts the chromatin DNA at specific recognition sites.\n3. Chromatin digestion: The transposase-treated chromatin is then digested with a combination of restriction enzymes that recognize the transposase-generated breaks. This results in the generation of small chromatin fragments.\n4. Sequencing: The resulting chromatin fragments are then subjected to next-generation sequencing, which allows for the identification of the accessible chromatin regions.\n5. Analysis: The data generated from the sequencing is then analyzed to identify the accessible chromatin regions and to determine the chromatin accessibility landscape of the genome.\nThe ATAC technique provides a high-resolution map of the chromatin accessibility landscape, which can be used to identify regulatory elements, such as transcription factor binding sites, and to study the epigenetic regulation of gene expression. The ATAC technique has been widely used in various research applications, including the study of gene regulation, epigenetics, and cancer biology.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Assay for Transposase-Accessible Chromatin (ATAC) technique is used to analyze the chromatin accessibility landscape of a genome.\n2. The ATAC uses a transposase enzyme to access and digest chromatin.\n3. Chromatin fragments generated by ATAC are analyzed by next-generation sequencing to identify the accessible chromatin regions.\n4. The ATAC technique can be used to identify regulatory elements and study the epigenetic regulation of gene expression.\n5. The ATAC technique has been used in the study of gene regulation, epigenetics, and cancer biology.",
    "vicuna-13b_fact": [
      "The Assay for Transposase-Accessible Chromatin (ATAC) technique is used to analyze the chromatin accessibility landscape of a genome.",
      "The ATAC uses a transposase enzyme to access and digest chromatin.",
      "Chromatin fragments generated by ATAC are analyzed by next-generation sequencing to identify the accessible chromatin regions.",
      "The ATAC technique can be used to identify regulatory elements and study the epigenetic regulation of gene expression.",
      "The ATAC technique has been used in the study of gene regulation, epigenetics, and cancer biology."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1587,
    "user_query": "Which are the main NMD factors in Saccharomyces cerevisiae?",
    "vicuna-13b_response": "NMD (nonsense-mediated decay) is a cellular process that degrades mRNAs containing premature stop codons or other mutations that disrupt the normal translation of the mRNA into protein. In the yeast Saccharomyces cerevisiae, several factors play important roles in NMD:\n1. Upf complex: The Upf complex is a multi-subunit complex that recognizes and targets mRNAs for NMD. The Upf complex consists of three subunits: Upf1, Upf2, and Upf3. Upf1 is the catalytic subunit that cleaves the mRNA, while Upf2 and Upf3 help to recognize the target mRNAs.\n2. Smg5 and Smg6: Smg5 and Smg6 are two proteins that are required for the recognition of mRNAs by the Upf complex. Smg5 and Smg6 form a complex that interacts with the Upf complex and helps to recruit it to the target mRNAs.\n3. Hrp1: Hrp1 is a protein that is required for the recognition of mRNAs with premature stop codons. Hrp1 interacts with the Upf complex and helps to recruit it to the target mRNAs.\n4. Lsm proteins: Lsm proteins are a family of proteins that are involved in the recognition and degradation of mRNAs by the NMD pathway. Lsm proteins interact with the Upf complex and help to recruit it to the target mRNAs.\nOverall, these factors work together to recognize and degrade mRNAs containing premature stop codons or other mutations that disrupt the normal translation of the mRNA into protein.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nonsense-mediated decay is a cellular process that degrades mRNAs containing premature stop codons or other mutations that disrupt normal translation.\n2. In the yeast Saccharomyces cerevisiae, the Upf complex plays a crucial role in NMD. This complex is composed of three subunits: Upf1, Upf2, and Upf3.\n3. In Saccharomyces cerevisiae, Smg5 and Smg6 are two proteins that are needed for the recognition of mRNAs by the Upf complex.\n4. Hrp1 is a protein in Saccharomyces cerevisiae that is required for the recognition of mRNAs with premature stop codons. \n5. Lsm proteins are a family of proteins in Saccharomyces cerevisiae that are involved in the recognition and degradation of mRNAs by the NMD pathway.",
    "vicuna-13b_fact": [
      "Nonsense-mediated decay is a cellular process that degrades mRNAs containing premature stop codons or other mutations that disrupt normal translation.",
      "In the yeast Saccharomyces cerevisiae, the Upf complex plays a crucial role in NMD. This complex is composed of three subunits: Upf1, Upf2, and Upf3.",
      "In Saccharomyces cerevisiae, Smg5 and Smg6 are two proteins that are needed for the recognition of mRNAs by the Upf complex.",
      "Hrp1 is a protein in Saccharomyces cerevisiae that is required for the recognition of mRNAs with premature stop codons.",
      "Lsm proteins are a family of proteins in Saccharomyces cerevisiae that are involved in the recognition and degradation of mRNAs by the NMD pathway."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "vicuna-13b_response": "Set7 is a histone methyltransferase enzyme that deposits methyl groups on histone H3 at position K4, also known as H3K4me. This modification is often referred to as \"Set7 modification\" or \"H3K4me1\". Set7 is involved in various cellular processes, including transcriptional regulation, DNA repair, and chromosome segregation. The Set7 enzyme is recruited to specific target genes through interactions with other proteins, such as the transcription factor YY1, and is thought to play a role in the regulation of gene expression. In addition to H3K4me, Set7 has also been shown to deposit methyl groups on histone H4 at position K16, also known as H4K16me, although this is less well characterized.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Set7 is a histone methyltransferase enzyme.\n2. Set7 deposits methyl groups on histone H3 at position K4.\n3. The modification by Set7 on H3K4 is often referred to as \"Set7 modification\" or \"H3K4me1\".\n4. Set7 is involved in various cellular processes, including transcriptional regulation, DNA repair, and chromosome segregation.\n5. Set7 has been shown to deposit methyl groups on histone H4 at position K16, also known as H4K16me.",
    "vicuna-13b_fact": [
      "Set7 is a histone methyltransferase enzyme.",
      "Set7 deposits methyl groups on histone H3 at position K4.",
      "The modification by Set7 on H3K4 is often referred to as \"Set7 modification\" or \"H3K4me1\".",
      "Set7 is involved in various cellular processes, including transcriptional regulation, DNA repair, and chromosome segregation.",
      "Set7 has been shown to deposit methyl groups on histone H4 at position K16, also known as H4K16me."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Set7 does not deposit methyl groups on histone H4 at position K16, it acts on histone H3.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1593,
    "user_query": "Which factors are considered in the ABCD2 score?",
    "vicuna-13b_response": "The ABCD2 score is a clinical decision tool used to assess the risk of stroke or transient ischemic attack (TIA) in patients with acute stroke symptoms. The score is based on five clinical variables that can be easily obtained from the patient's medical history and physical examination. The variables considered in the ABCD2 score are:\nA: Age (1 point for each decade of life)\nB: Blood pressure (1 point for each 10 mmHg increase in systolic blood pressure or each 5 mmHg increase in diastolic blood pressure)\nC: Clinical features of the stroke (1 point for each of the following: speech difficulty, arm weakness, facial weakness, and visual disturbance)\nD: Time from onset of symptoms to evaluation (1 point for each hour)\n2: Presence of diabetes mellitus (1 point)\nThe ABCD2 score ranges from 0 to 14, with higher scores indicating a higher risk of stroke or TIA. The score is used to help guide clinical decision-making, such as whether to perform a computed tomography (CT) scan or to initiate thrombolytic therapy. However, it is important to note that the ABCD2 score is not a diagnostic tool and should not be used as the sole basis for determining the need for imaging or treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The ABCD2 score is a tool used to assess the risk of stroke or transient ischemic attack in patients with acute stroke symptoms.\n2. The ABCD2 score is based on five clinical variables obtained from the patient's medical history and physical examination.\n3. The variables considered in the ABCD2 score include age, blood pressure, clinical features of the stroke, time from onset of symptoms to evaluation, and presence of diabetes mellitus.\n4. The ABCD2 score ranges from 0 to 14, with higher scores indicating a higher risk of stroke or TIA.\n5. The ABCD2 score is used to help guide clinical decision-making, such as whether to perform a computed tomography (CT) scan or to initiate thrombolytic therapy.",
    "vicuna-13b_fact": [
      "The ABCD2 score is a tool used to assess the risk of stroke or transient ischemic attack in patients with acute stroke symptoms.",
      "The ABCD2 score is based on five clinical variables obtained from the patient's medical history and physical examination.",
      "The variables considered in the ABCD2 score include age, blood pressure, clinical features of the stroke, time from onset of symptoms to evaluation, and presence of diabetes mellitus.",
      "The ABCD2 score ranges from 0 to 14, with higher scores indicating a higher risk of stroke or TIA.",
      "The ABCD2 score is used to help guide clinical decision-making, such as whether to perform a computed tomography (CT) scan or to initiate thrombolytic therapy."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The ABCD2 score ranges from 0 to 7, with higher scores indicating a higher risk of stroke or TIA.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1594,
    "user_query": "Is Tuberous Sclerosis a genetic disease?",
    "vicuna-13b_response": "Yes, Tuberous Sclerosis is a genetic disease. It is caused by a mutation in one of the genes that control the growth and development of cells in the body. The mutation can occur spontaneously or can be inherited from a parent who has the disease.\nTuberous Sclerosis is a rare genetic disorder that affects the skin, brain, and other organs. It is characterized by the growth of benign tumors, called hamartomas, in various parts of the body. These tumors can cause a variety of symptoms, depending on the location in the body.\nThe symptoms of Tuberous Sclerosis can vary widely, but they usually include benign skin lesions, such as facial angiofibromas, which are small, red, raised bumps on the face. Other common symptoms include seizures, developmental delay, and skin pigmentation changes.\nThere is no cure for Tuberous Sclerosis, but treatment can help manage the symptoms. Treatment options may include medication to control seizures, surgery to remove tumors, and skin treatments to improve appearance.\nIt is important for individuals with Tuberous Sclerosis to receive regular medical care to manage their condition and prevent complications. They should also be aware of the potential risks of passing the genetic mutation on to their children.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tuberous Sclerosis is a genetic disease. \n2. Tuberous Sclerosis is characterized by the growth of benign tumors, called hamartomas, in various parts of the body. \n3. Symptoms of Tuberous Sclerosis can include seizures, developmental delay, skin pigmentation changes, and benign skin lesions such as facial angiofibromas. \n4. There is no cure for Tuberous Sclerosis, but there are various treatment options available to manage symptoms. \n5. Individuals with Tuberous Sclerosis can potentially pass the disease to their children.",
    "vicuna-13b_fact": [
      "Tuberous Sclerosis is a genetic disease.",
      "Tuberous Sclerosis is characterized by the growth of benign tumors, called hamartomas, in various parts of the body.",
      "Symptoms of Tuberous Sclerosis can include seizures, developmental delay, skin pigmentation changes, and benign skin lesions such as facial angiofibromas.",
      "There is no cure for Tuberous Sclerosis, but there are various treatment options available to manage symptoms.",
      "Individuals with Tuberous Sclerosis can potentially pass the disease to their children."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1598,
    "user_query": "What type of DNA repair pathways is initiated by AlkA glycosylase?",
    "vicuna-13b_response": "AlkA glycosylase is an enzyme that is involved in the DNA repair pathway known as nucleotide excision repair (NER). NER is a process that removes damaged or incorrectly paired nucleotides from the DNA molecule and replaces them with correct nucleotides. AlkA glycosylase is responsible for recognizing and removing a specific type of damaged nucleotide called an alkylated base. Alkylated bases are formed when a molecule called a alkylating agent attaches to the DNA molecule and damages the base pair. AlkA glycosylase is specific for removing alkylated bases, it is not involved in other DNA repair pathways.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. AlkA glycosylase is an enzyme involved in the nucleotide excision repair (NER) DNA repair pathway.\n2. The nucleotide excision repair process removes damaged or incorrectly paired nucleotides from the DNA molecule and replaces them with correct ones.\n3. AlkA glycosylase is responsible for recognizing and removing a specific type of damaged nucleotide called an alkylated base.\n4. Alkylated bases are formed when a molecule called an alkylating agent attaches to and damages the DNA molecule's base pair.\n5. AlkA glycosylase is specific for removing alkylated bases and is not involved in other DNA repair pathways.",
    "vicuna-13b_fact": [
      "AlkA glycosylase is an enzyme involved in the nucleotide excision repair (NER) DNA repair pathway.",
      "The nucleotide excision repair process removes damaged or incorrectly paired nucleotides from the DNA molecule and replaces them with correct ones.",
      "AlkA glycosylase is responsible for recognizing and removing a specific type of damaged nucleotide called an alkylated base.",
      "Alkylated bases are formed when a molecule called an alkylating agent attaches to and damages the DNA molecule's base pair.",
      "AlkA glycosylase is specific for removing alkylated bases and is not involved in other DNA repair pathways."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: AlkA glycosylase is an enzyme involved in the base excision repair (BER) DNA repair pathway, not the nucleotide excision repair (NER) pathway.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While AlkA glycosylase primarily removes alkylated bases, it may also be involved in other DNA repair pathways.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1605,
    "user_query": "What is the mechanism of cementogenesis in pulp regeneration?",
    "vicuna-13b_response": "Cementogenesis is the process by which a hard tissue, such as bone, is formed. In the context of pulp regeneration, cementogenesis refers to the formation of cementum, which is a hard tissue that covers the roots of teeth.\nThe mechanism of cementogenesis in pulp regeneration involves several steps:\n1. Inflammation: In response to injury or infection, the pulp tissue becomes inflamed, which triggers the body's natural healing response.\n2. Formation of a provisional matrix: The inflammatory response attracts cells called fibroblasts to the site of injury. These cells produce a provisional matrix, which is a temporary scaffolding material made of collagen and other proteins.\n3. Differentiation of pulp cells: As the provisional matrix matures, the pulp cells in the inflamed pulp tissue undergo differentiation. This means that they specialize and become more specific types of cells, such as odontoblasts, which are responsible for forming cementum.\n4. Secretion of cementum: The differentiated pulp cells secrete cementum, which is a hard, non-mineralized tissue that covers the roots of the teeth. Cementum is made up of collagen fibers and proteoglycans, which give it its hard, durable properties.\n5. Maturation of the cementum: As the cementum continues to be secreted and accumulates on the root surface, it undergoes maturation. This process involves the formation of tight junctions between the cementum fibers, which helps to secure the cementum to the tooth surface.\nOverall, the mechanism of cementogenesis in pulp regeneration is a complex process that involves inflammation, cell differentiation, and tissue remodeling. The end result is the formation of a hard, durable tissue called cementum, which helps to protect the roots of the teeth and maintain the integrity of the tooth structure.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cementogenesis refers to the formation of cementum, a hard tissue that covers the roots of teeth.\n2. The mechanism of cementogenesis in pulp regeneration involves an inflammatory response to injury or infection in the pulp tissue.\n3. Fibroblasts are attracted to the injury site during inflammation and produce a provisional matrix made of collagen and other proteins.\n4. As the provisional matrix matures, pulp cells undergo differentiation to become more specific types of cells, such as odontoblasts.\n5. The differentiated pulp cells secrete cementum, a hard, non-mineralized tissue made up of collagen fibers and proteoglycans.\n6. The maturation of cementum involves the formation of tight junctions between the cementum fibers, which secures the cementum to the tooth surface.",
    "vicuna-13b_fact": [
      "Cementogenesis refers to the formation of cementum, a hard tissue that covers the roots of teeth.",
      "The mechanism of cementogenesis in pulp regeneration involves an inflammatory response to injury or infection in the pulp tissue.",
      "Fibroblasts are attracted to the injury site during inflammation and produce a provisional matrix made of collagen and other proteins.",
      "As the provisional matrix matures, pulp cells undergo differentiation to become more specific types of cells, such as odontoblasts.",
      "The differentiated pulp cells secrete cementum, a hard, non-mineralized tissue made up of collagen fibers and proteoglycans.",
      "The maturation of cementum involves the formation of tight junctions between the cementum fibers, which secures the cementum to the tooth surface."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The differentiated pulp cells secrete cementum, a hard, mineralized tissue made up of collagen fibers and proteoglycans.\n6. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1606,
    "user_query": "What are the reported adverse effects of gabapentin used in children?",
    "vicuna-13b_response": "Gabapentin is an antiepileptic drug that is commonly used in the treatment of epilepsy and other neurological conditions in adults and children. However, its use in children is limited due to the potential for serious adverse effects.\nThe reported adverse effects of gabapentin in children include:\n1. Somnolence: Gabapentin has been associated with a significant increase in the risk of somnolence, which can lead to falls, injuries, and other complications.\n2. Dizziness: Gabapentin can cause dizziness, which can increase the risk of falls and other accidents.\n3. Fatigue: Gabapentin can cause fatigue, which can affect a child's ability to concentrate and perform daily activities.\n4. Nausea and vomiting: Gabapentin can cause nausea and vomiting, which can lead to dehydration and other complications.\n5. Diarrhea: Gabapentin can cause diarrhea, which can lead to dehydration and other complications.\n6. Rash: Gabapentin can cause a rash, which can be a sign of an allergic reaction or other adverse effects.\n7. Drowsiness: Gabapentin can cause drowsiness, which can affect a child's ability to concentrate and perform daily activities.\n8. Agitation: Gabapentin can cause agitation, which can lead to aggressive behavior and other complications.\n9. Confusion: Gabapentin can cause confusion, which can affect a child's ability to understand and respond to instructions.\n10. Hallucinations: Gabapentin can cause hallucinations, which can lead to delusional thinking and other complications.\nIt is important to note that the safety and efficacy of gabapentin in children have not been established, and its use in this population is generally not recommended. Therefore, it is important to follow the advice of a healthcare professional when using this medication in children.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Gabapentin is an antiepileptic drug used in the treatment of epilepsy and other neurological conditions.\n2. The use of gabapentin in children can lead to somnolence.\n3. Dizziness is a reported adverse effect of gabapentin in children.\n4. Gabapentin, when used in children, can cause fatigue.\n5. The use of gabapentin can lead to nausea and vomiting in children.",
    "vicuna-13b_fact": [
      "Gabapentin is an antiepileptic drug used in the treatment of epilepsy and other neurological conditions.",
      "The use of gabapentin in children can lead to somnolence.",
      "Dizziness is a reported adverse effect of gabapentin in children.",
      "Gabapentin, when used in children, can cause fatigue.",
      "The use of gabapentin can lead to nausea and vomiting in children."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1617,
    "user_query": "What are the skeletal muscle satellite cells?",
    "vicuna-13b_response": "Skeletal muscle satellite cells are a type of stem cell that reside between the muscle fibers in the skeletal muscle tissue. They are responsible for the repair and regeneration of muscle tissue. These cells are capable of differentiating into muscle cells, and they play a crucial role in muscle growth and recovery after injury.\nSkeletal muscle satellite cells are also known as muscle stem cells or muscle precursor cells. They are found in the muscle tissue of all vertebrates, and they are particularly abundant in skeletal muscles such as the quadriceps, biceps, and triceps.\nThe function of skeletal muscle satellite cells is to maintain and repair the muscle tissue. When a muscle is injured, the satellite cells will divide and differentiate into new muscle cells to repair the damage. They also play a role in muscle growth and hypertrophy, the process by which muscles become larger and stronger.\nSkeletal muscle satellite cells are important for maintaining muscle health throughout life, and they have been the focus of research in the field of regenerative medicine. Studies have shown that these cells can be used to generate muscle tissue in the laboratory, and they have potential therapeutic applications for the treatment of muscle diseases such as muscular dystrophy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Skeletal muscle satellite cells reside between the muscle fibers in the skeletal muscle tissue.\n2. Skeletal muscle satellite cells are responsible for the repair and regeneration of muscle tissue.\n3. These cells are capable of differentiating into muscle cells.\n4. Skeletal muscle satellite cells are found in the muscle tissue of all vertebrates.\n5. Studies indicate that these cells can be used to generate muscle tissue in the laboratory.",
    "vicuna-13b_fact": [
      "Skeletal muscle satellite cells reside between the muscle fibers in the skeletal muscle tissue.",
      "Skeletal muscle satellite cells are responsible for the repair and regeneration of muscle tissue.",
      "These cells are capable of differentiating into muscle cells.",
      "Skeletal muscle satellite cells are found in the muscle tissue of all vertebrates.",
      "Studies indicate that these cells can be used to generate muscle tissue in the laboratory."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1618,
    "user_query": "What is the role of neurogranin in Alzheimer's disease patients?",
    "vicuna-13b_response": "Neurogranin is a protein that is expressed in the brain and is involved in various cellular processes, including synaptic transmission and regulation of the cytoskeleton. In Alzheimer's disease, neurogranin has been implicated in the pathogenesis of the disease.\nStudies have shown that neurogranin levels are decreased in the brains of Alzheimer's disease patients, and that this decrease may be associated with the formation of amyloid plaques and neurofibrillary tangles, which are hallmark features of the disease. Additionally, neurogranin has been shown to interact with beta-amyloid peptides, which are thought to play a role in the development of Alzheimer's disease.\nFurthermore, neurogranin has been suggested as a potential therapeutic target for Alzheimer's disease. For example, increasing neurogranin levels in the brain has been shown to improve cognitive function in animal models of the disease. Additionally, neurogranin has been shown to have anti-inflammatory and anti-apoptotic effects, which may be beneficial in the treatment of Alzheimer's disease.\nOverall, while more research is needed to fully understand the role of neurogranin in Alzheimer's disease, it appears that it may play a role in the pathogenesis of the disease and may be a potential therapeutic target for the treatment of Alzheimer's disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Neurogranin is a protein expressed in the brain.\n2. It is involved in various cellular processes including synaptic transmission and regulation of the cytoskeleton.\n3. Decreased neurogranin levels are observed in the brains of Alzheimer's disease patients.\n4. Neurogranin interacts with beta-amyloid peptides which are thought to play a role in the development of Alzheimer's disease.\n5. neurogranin has been suggested as a potential therapeutic target for Alzheimer's disease.",
    "vicuna-13b_fact": [
      "Neurogranin is a protein expressed in the brain.",
      "It is involved in various cellular processes including synaptic transmission and regulation of the cytoskeleton.",
      "Decreased neurogranin levels are observed in the brains of Alzheimer's disease patients.",
      "Neurogranin interacts with beta-amyloid peptides which are thought to play a role in the development of Alzheimer's disease.",
      "neurogranin has been suggested as a potential therapeutic target for Alzheimer's disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Neurogranin does not interact directly with beta-amyloid peptides, but decreased Neurogranin levels are observed in the brains of Alzheimer's disease patients, potentially due to the effects of increased beta-amyloid peptides.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1619,
    "user_query": "Does triiodothyronine play a regulatory role in insulin secretion from pancreas?",
    "vicuna-13b_response": "Yes, triiodothyronine (T3) plays a regulatory role in insulin secretion from the pancreas. T3 is a hormone produced by the thyroid gland that is involved in many physiological processes, including metabolism and growth.\nIn the pancreas, T3 stimulates the secretion of insulin, a hormone that regulates blood sugar levels by promoting the storage of glucose in cells. T3 receptors are present on the pancreatic beta cells that produce insulin, and T3 binds to these receptors to stimulate the production and secretion of insulin.\nStudies have shown that T3 deficiency, such as in cases of hypothyroidism, can lead to decreased insulin secretion and increased risk of developing diabetes. Conversely, excessive T3 levels, such as in cases of hyperthyroidism, can lead to increased insulin secretion and decreased blood sugar levels.\nOverall, T3 plays a crucial role in regulating insulin secretion from the pancreas and maintaining proper blood sugar levels.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Triiodothyronine (T3) plays a regulatory role in insulin secretion from the pancreas.\n2. T3 is a hormone produced by the thyroid gland.\n3. In the pancreas, T3 stimulates the secretion of insulin.\n4. T3 receptors are present on the pancreatic beta cells that produce insulin.\n5. T3 deficiency can lead to decreased insulin secretion and increased risk of developing diabetes.",
    "vicuna-13b_fact": [
      "Triiodothyronine (T3) plays a regulatory role in insulin secretion from the pancreas.",
      "T3 is a hormone produced by the thyroid gland.",
      "In the pancreas, T3 stimulates the secretion of insulin.",
      "T3 receptors are present on the pancreatic beta cells that produce insulin.",
      "T3 deficiency can lead to decreased insulin secretion and increased risk of developing diabetes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "vicuna-13b_response": "Hepcidin is a small peptide hormone that plays a crucial role in regulating iron homeostasis in the body. It has a total of four disulfide bridges, which are essential for its stability and function. These disulfide bridges are formed between the following pairs of cysteine residues: Cys1-Cys3, Cys2-Cys4, Cys1-Cys5, and Cys3-Cys6. The presence of these disulfide bridges is necessary for hepcidin to bind to its receptor, ferroportin, and inhibit iron uptake in cells. Mutations in the disulfide bridges of hepcidin can lead to defects in iron regulation and can result in iron overload disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hepcidin is a small peptide hormone that plays a crucial role in regulating iron homeostasis in the body.\n2. Hepcidin has a total of four disulfide bridges.\n3. These disulfide bridges in Hepcidin are formed between the following pairs of cysteine residues: Cys1-Cys3, Cys2-Cys4, Cys1-Cys5, and Cys3-Cys6.\n4. The presence of these disulfide bridges is necessary for hepcidin to bind to its receptor, ferroportin, and inhibit iron uptake in cells.\n5. Mutations in the disulfide bridges of hepcidin can lead to defects in iron regulation and can result in iron overload disorders.",
    "vicuna-13b_fact": [
      "Hepcidin is a small peptide hormone that plays a crucial role in regulating iron homeostasis in the body.",
      "Hepcidin has a total of four disulfide bridges.",
      "These disulfide bridges in Hepcidin are formed between the following pairs of cysteine residues: Cys1-Cys3, Cys2-Cys4, Cys1-Cys5, and Cys3-Cys6.",
      "The presence of these disulfide bridges is necessary for hepcidin to bind to its receptor, ferroportin, and inhibit iron uptake in cells.",
      "Mutations in the disulfide bridges of hepcidin can lead to defects in iron regulation and can result in iron overload disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hepcidin has a total of eight cysteines forming four disulfide bridges.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1622,
    "user_query": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?",
    "vicuna-13b_response": "Intramolecular phosphorylation refers to the process of adding a phosphate group to a protein molecule, which can alter its activity and function. In the case of human Chk2, a protein involved in cell cycle control, several intramolecular phosphorylation sites have been identified as important regulators of its activity.\nOne of the major intramolecular phosphorylation sites of human Chk2 is Ser317, which is phosphorylated by the CDK-activating kinase (CAK) during the G1 phase of the cell cycle. This phosphorylation event promotes the activity of Chk2, which in turn activates the CDK inhibitor p21Cip1, thereby inhibiting the progression of the cell cycle.\nAnother important intramolecular phosphorylation site of human Chk2 is Thr68, which is phosphorylated by the kinase activity of Chk2 itself during the S phase of the cell cycle. This phosphorylation event promotes the interaction of Chk2 with the anaphase-promoting complex/cyclosome (APC/C), leading to the degradation of Chk2 and the progression of the cell cycle.\nIn addition to these two major intramolecular phosphorylation sites, other sites on human Chk2 have also been shown to play a role in cell cycle control, including Ser296, Ser365, and Ser380. However, the exact roles of these sites in the regulation of Chk2 activity and cell cycle progression are still being actively studied and are not as well understood as the roles of Ser317 and Thr68.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Intramolecular phosphorylation refers to the process of adding a phosphate group to a protein molecule, altering its activity and function.\n2. A major intramolecular phosphorylation site of human Chk2 is Ser317, which is phosphorylated by the CDK-activating kinase (CAK) during the G1 phase.\n3. Phosphorylation at Ser317 promotes the activity of Chk2 and activates the CDK inhibitor p21Cip1, inhibiting the progression of the cell cycle.\n4. Another intramolecular phosphorylation site of human Chk2 is Thr68, which is phosphorylated by Chk2 itself during the S phase of the cell cycle.\n5. Other sites on human Chk2 that are involved in cell cycle control, include Ser296, Ser365, and Ser380.",
    "vicuna-13b_fact": [
      "Intramolecular phosphorylation refers to the process of adding a phosphate group to a protein molecule, altering its activity and function.",
      "A major intramolecular phosphorylation site of human Chk2 is Ser317, which is phosphorylated by the CDK-activating kinase (CAK) during the G1 phase.",
      "Phosphorylation at Ser317 promotes the activity of Chk2 and activates the CDK inhibitor p21Cip1, inhibiting the progression of the cell cycle.",
      "Another intramolecular phosphorylation site of human Chk2 is Thr68, which is phosphorylated by Chk2 itself during the S phase of the cell cycle.",
      "Other sites on human Chk2 that are involved in cell cycle control, include Ser296, Ser365, and Ser380."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1630,
    "user_query": "Which extra thyroid tissues have thyrotropin (TSH) receptors?",
    "vicuna-13b_response": "Thyrotropin (TSH) receptors are found not only on thyroid tissue, but also on extra-thyroid tissues such as the pituitary gland, hypothalamus, and peripheral tissues.\nIn the pituitary gland, TSH receptors are found on the thyroid-stimulating hormone (TSH) producing cells, which are responsible for producing TSH. This allows for negative feedback regulation of TSH production, as TSH binds to its receptors on the pituitary gland to inhibit TSH production.\nIn the hypothalamus, TSH receptors are found on the cells that produce thyroid-stimulating hormone-releasing hormone (TRH), which stimulates the production and release of TSH from the pituitary gland.\nIn peripheral tissues, TSH receptors are found on a variety of tissues including skeletal muscle, heart, kidney, and liver. The presence of TSH receptors on these tissues suggests that TSH may play a role in regulating metabolism and growth in these tissues, in addition to its well-known role in regulating thyroid function.\nIt is important to note that the presence of TSH receptors on extra-thyroid tissues does not necessarily indicate that these tissues are capable of producing TSH or that they are involved in the regulation of thyroid function. Rather, TSH receptors are found on a variety of tissues as a result of evolutionary conservation of the TSH receptor gene, and may have functions unrelated to thyroid hormone regulation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Thyrotropin (TSH) receptors are found on thyroid tissue, the pituitary gland, hypothalamus, and peripheral tissues.\n2. In the pituitary gland, TSH receptors are found on the thyroid-stimulating hormone producing cells, and play a part in the regulation of TSH production.\n3. In the hypothalamus, TSH receptors are found on the cells that produce thyroid-stimulating hormone-releasing hormone (TRH).\n4. In peripheral tissues, TSH receptors are found on a variety of tissues including skeletal muscle, heart, kidney, and liver.\n5. The presence of TSH receptors on extra-thyroid tissues does not necessarily indicate that these tissues are capable of producing TSH or that they are involved in the regulation of thyroid function.",
    "vicuna-13b_fact": [
      "Thyrotropin (TSH) receptors are found on thyroid tissue, the pituitary gland, hypothalamus, and peripheral tissues.",
      "In the pituitary gland, TSH receptors are found on the thyroid-stimulating hormone producing cells, and play a part in the regulation of TSH production.",
      "In the hypothalamus, TSH receptors are found on the cells that produce thyroid-stimulating hormone-releasing hormone (TRH).",
      "In peripheral tissues, TSH receptors are found on a variety of tissues including skeletal muscle, heart, kidney, and liver.",
      "The presence of TSH receptors on extra-thyroid tissues does not necessarily indicate that these tissues are capable of producing TSH or that they are involved in the regulation of thyroid function."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: In the hypothalamus, thyrotropin-releasing hormone (TRH) is produced, which regulates the release of TSH from the pituitary gland. TSH receptors are not found on the hypothalamus.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1631,
    "user_query": "Which histone modifications distinguish between promoters and enhancers?",
    "vicuna-13b_response": "Histone modifications are chemical modifications to the histone proteins that make up the nucleosome, the basic unit of chromatin. These modifications can have a significant impact on the accessibility of the DNA to the transcriptional machinery and the overall transcriptional activity of a gene. There are several histone modifications that are important for distinguishing between promoters and enhancers.\nPromoters are regions of DNA that are involved in the initiation of transcription. They are typically characterized by the presence of the RNA polymerase enzyme and the synthesis of mRNA. Promoters are often marked by the presence of specific histone modifications, such as histone H3 lysine 4 (H3K4) methylation and histone H3 lysine 27 (H3K27) methylation. These modifications are thought to help recruit the RNA polymerase enzyme to the promoter and facilitate the initiation of transcription.\nEnhancers, on the other hand, are regions of DNA that are involved in the regulation of gene expression and can increase the transcriptional activity of a gene. Enhancers are often located far from the gene they regulate and are typically marked by the presence of specific histone modifications, such as histone H3 lysine 18 (H3K18) methylation, histone H3 lysine 26 (H3K26) methylation, and histone H3 lysine 4 trimethylation (H3K4me3). These modifications are thought to help recruit transcriptional coactivators to the enhancer and increase the transcriptional activity of the gene.\nIn summary, histone modifications such as H3K4 methylation, H3K27 methylation, H3K18 methylation, H3K26 methylation, and H3K4me3 are important for distinguishing between promoters and enhancers. The presence of these modifications can help recruit transcriptional machinery to the appropriate regions of DNA and regulate the transcriptional activity of genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Histone modifications are chemical modifications to the histone proteins that make up the nucleosome, the basic unit of chromatin.\n2. Promoters, regions of DNA involved in the initiation of transcription, are often marked by specific histone modifications like histone H3 lysine 4 (H3K4) methylation and histone H3 lysine 27 (H3K27) methylation. \n3. The modifications at promoters are thought to help recruit the RNA polymerase enzyme to the promoter and facilitate the initiation of transcription.\n4. Enhancers, regions of DNA involved in the regulation of gene expression, are characterized by histone modifications such as histone H3 lysine 18 (H3K18) methylation, histone H3 lysine 26 (H3K26) methylation, and histone H3 lysine 4 trimethylation (H3K4me3).\n5. The specific histone modifications at enhancers are believed to help recruit transcriptional coactivators to the enhancer and increase the transcriptional activity of the gene.",
    "vicuna-13b_fact": [
      "Histone modifications are chemical modifications to the histone proteins that make up the nucleosome, the basic unit of chromatin.",
      "Promoters, regions of DNA involved in the initiation of transcription, are often marked by specific histone modifications like histone H3 lysine 4 (H3K4) methylation and histone H3 lysine 27 (H3K27) methylation.",
      "The modifications at promoters are thought to help recruit the RNA polymerase enzyme to the promoter and facilitate the initiation of transcription.",
      "Enhancers, regions of DNA involved in the regulation of gene expression, are characterized by histone modifications such as histone H3 lysine 18 (H3K18) methylation, histone H3 lysine 26 (H3K26) methylation, and histone H3 lysine 4 trimethylation (H3K4me3).",
      "The specific histone modifications at enhancers are believed to help recruit transcriptional coactivators to the enhancer and increase the transcriptional activity of the gene."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Enhancers, regions of DNA involved in the regulation of gene expression, are typically characterized by histone modifications such as histone H3 lysine 4 monomethylation (H3K4me1) and histone H3 lysine 27 acetylation (H3K27ac).\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1632,
    "user_query": "Where is the metaxin complex localized?",
    "vicuna-13b_response": "The metaxin complex is a protein complex that plays a role in regulating the activity of the aryl hydrocarbon receptor (AhR), a transcription factor that is involved in the response to environmental toxins. The metaxin complex is composed of three proteins: Metaxin 1, Metaxin 2, and AIP (Aryl Hydrocarbon Receptor Interacting Protein).\nThe Metaxin complex is localized in the cytoplasm of cells, where it interacts with the AhR and regulates its activity by controlling its stability and transport to the nucleus. The Metaxin complex also interacts with other proteins, such as the Cullin-3-based E3 ubiquitin ligase complex, which is involved in the degradation of the AhR.\nIn summary, the Metaxin complex is a protein complex that is localized in the cytoplasm of cells and plays a role in regulating the activity of the aryl hydrocarbon receptor (AhR) by controlling its stability and transport to the nucleus.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The metaxin complex is a protein complex that regulates the activity of the aryl hydrocarbon receptor (AhR).\n2. The metaxin complex is composed of three proteins: Metaxin 1, Metaxin 2, and AIP (Aryl Hydrocarbon Receptor Interacting Protein).\n3. The Metaxin complex is localized in the cytoplasm of cells.\n4. The Metaxin complex interacts with the AhR and regulates its activity by controlling its stability and transport to the nucleus.\n5. The Metaxin complex interacts with the Cullin-3-based E3 ubiquitin ligase complex, which is involved in the degradation of the AhR.",
    "vicuna-13b_fact": [
      "The metaxin complex is a protein complex that regulates the activity of the aryl hydrocarbon receptor (AhR).",
      "The metaxin complex is composed of three proteins: Metaxin 1, Metaxin 2, and AIP (Aryl Hydrocarbon Receptor Interacting Protein).",
      "The Metaxin complex is localized in the cytoplasm of cells.",
      "The Metaxin complex interacts with the AhR and regulates its activity by controlling its stability and transport to the nucleus.",
      "The Metaxin complex interacts with the Cullin-3-based E3 ubiquitin ligase complex, which is involved in the degradation of the AhR."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1633,
    "user_query": "What are the major classes of retrotransposons active in the human genome?",
    "vicuna-13b_response": "Retrotransposons are a class of mobile genetic elements that can move within the genome and can cause genomic instability. There are two major classes of retrotransposons active in the human genome: long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs).\n1. Long Interspersed Nuclear Elements (LINEs): LINEs are the largest class of retrotransposons in the human genome and are typically 1-2 kilobases in size. They are found in the non-coding regions of the genome and are thought to have evolved from a group of ancient transposable elements. LINEs can be further divided into three subclasses based on their sequence characteristics: L1, L2, and L3.\n2. Short Interspersed Nuclear Elements (SINEs): SINEs are smaller than LINEs, typically ranging from 50-200 base pairs in length. They are found in the non-coding regions of the genome and are thought to have evolved from a group of ancient transposable elements. SINEs can be further divided into two subclasses based on their sequence characteristics: S1 and S2.\nBoth LINEs and SINEs have been active in the human genome throughout evolution, and their activity has contributed to the evolution of the human genome. However, their activity can also cause genomic instability and contribute to the development of diseases such as cancer. Therefore, the regulation of retrotransposon activity is an important area of research in genomics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Retrotransposons are a class of mobile genetic elements that can move within the genome.\n2. There are two major classes of retrotransposons active in the human genome: long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs).\n3. LINEs are the largest class of retrotransposons in the human genome, typically 1-2 kilobases in size, and found in the non-coding regions of the genome.\n4. SINEs are smaller than LINEs, typically ranging from 50-200 base pairs in length, and found in the non-coding regions of the genome.\n5. Both LINEs and SINEs activity contribute to the evolution of the human genome and can cause genomic instability.",
    "vicuna-13b_fact": [
      "Retrotransposons are a class of mobile genetic elements that can move within the genome.",
      "There are two major classes of retrotransposons active in the human genome: long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs).",
      "LINEs are the largest class of retrotransposons in the human genome, typically 1-2 kilobases in size, and found in the non-coding regions of the genome.",
      "SINEs are smaller than LINEs, typically ranging from 50-200 base pairs in length, and found in the non-coding regions of the genome.",
      "Both LINEs and SINEs activity contribute to the evolution of the human genome and can cause genomic instability."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: LINEs are the largest class of retrotransposons in the human genome, but they typically are 6-8 kilobases in size.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1634,
    "user_query": "Which are the clinical characteristics of Diamond-Blackfan anemia?",
    "vicuna-13b_response": "Diamond-Blackfan anemia (DBA) is a rare congenital anemia characterized by a triad of congenital heart disease, growth retardation, and a macrocytic anemia. The clinical characteristics of DBA include:\n1. Anemia: DBA is characterized by a macrocytic anemia with a low hemoglobin level and a large red blood cell size.\n2. Congenital heart disease: Approximately 50% of individuals with DBA have some form of congenital heart disease, which can include patent ductus arteriosus, atrial septal defect, and ventricular septal defect.\n3. Growth retardation: Many individuals with DBA have growth retardation and may be small for their age.\n4. Other features: Some individuals with DBA may have other features such as a large spleen, low blood pressure, and a pale skin color.\nIt is important to note that not all individuals with DBA will have all of these features, and the severity of the anemia and other symptoms can vary widely. A diagnosis of DBA is typically made based on a combination of clinical findings, laboratory tests, and genetic testing.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Diamond-Blackfan anemia (DBA) is a rare congenital anemia.\n2. DBA is characterized by a triad of congenital heart disease, growth retardation, and a macrocytic anemia.\n3. Approximately 50% of individuals with DBA have some form of congenital heart disease.\n4. Many individuals with DBA experience growth retardation.\n5. A diagnosis of DBA is typically made based on a combination of clinical findings, laboratory tests, and genetic testing.",
    "vicuna-13b_fact": [
      "Diamond-Blackfan anemia (DBA) is a rare congenital anemia.",
      "DBA is characterized by a triad of congenital heart disease, growth retardation, and a macrocytic anemia.",
      "Approximately 50% of individuals with DBA have some form of congenital heart disease.",
      "Many individuals with DBA experience growth retardation.",
      "A diagnosis of DBA is typically made based on a combination of clinical findings, laboratory tests, and genetic testing."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: DBA is characterized by a failure of the bone marrow to produce red blood cells, leading to anemia.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1638,
    "user_query": "Which is the receptor for the immunosuppressive drug cyclosporin A (CsA)?",
    "vicuna-13b_response": "The receptor for the immunosuppressive drug cyclosporin A (CsA) is the cyclophilin-cyclosporin complex. Cyclosporin A is a cyclic peptide that binds to cyclophilin, a protein found in the endoplasmic reticulum, and forms a complex that inhibits the activity of calcineurin, an enzyme involved in the immune response. The binding of cyclosporin A to cyclophilin-cyclosporin complex results in inhibition of T-cell activation and proliferation, making it an effective immunosuppressive drug for the prevention of organ rejection in transplantation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The receptor for the drug cyclosporin A (CsA) is the cyclophilin-cyclosporin complex.\n2. Cyclosporin A is a cyclic peptide.\n3. Cyclosporin A binds to a protein in the endoplasmic reticulum known as cyclophilin to form a complex.\n4. This complex inhibits the enzyme calcineurin, which is involved in the immune response.\n5. The inhibition of T-cell activation and proliferation by cyclosporin A can help prevent organ rejection in transplantation.",
    "vicuna-13b_fact": [
      "The receptor for the drug cyclosporin A (CsA) is the cyclophilin-cyclosporin complex.",
      "Cyclosporin A is a cyclic peptide.",
      "Cyclosporin A binds to a protein in the endoplasmic reticulum known as cyclophilin to form a complex.",
      "This complex inhibits the enzyme calcineurin, which is involved in the immune response.",
      "The inhibition of T-cell activation and proliferation by cyclosporin A can help prevent organ rejection in transplantation."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The drug cyclosporin A (CsA) binds to the protein cyclophilin to form the cyclosporin-cyclophilin complex, which is not the receptor but the active form of the drug.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1642,
    "user_query": "In which types of DNA repair is the UvrAB complex involved?",
    "vicuna-13b_response": "The UvrAB complex is involved in several types of DNA repair, including:\n1. DNA damage recognition: The UvrA and UvrB proteins form a complex that recognizes damaged DNA and recruits other repair proteins to the site of damage.\n2. Nucleotide excision repair (NER): The UvrAB complex is responsible for removing damaged nucleotides from the DNA strand, a process known as nucleotide excision repair (NER). This process is essential for repairing DNA damage caused by UV light, chemicals, and other mutagens.\n3. Base excision repair (BER): The UvrAB complex is also involved in base excision repair (BER), a process that removes damaged or incorrect base pairs from the DNA strand.\n4. DNA mismatch repair: The UvrAB complex is involved in DNA mismatch repair, which corrects mismatched base pairs that have been improperly paired during DNA replication.\nOverall, the UvrAB complex plays a critical role in maintaining the integrity of the genome by repairing DNA damage and ensuring accurate DNA replication.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The UvrAB complex is involved in DNA damage recognition.\n2. The UvrAB complex participates in the process of nucleotide excision repair (NER).\n3. The UvrAB complex is used for base excision repair (BER).\n4. The UvrAB complex is involved in DNA mismatch repair.\n5. The UvrAB complex plays a role in maintaining the integrity of the genome by repairing DNA damage and ensuring accurate DNA replication.",
    "vicuna-13b_fact": [
      "The UvrAB complex is involved in DNA damage recognition.",
      "The UvrAB complex participates in the process of nucleotide excision repair (NER).",
      "The UvrAB complex is used for base excision repair (BER).",
      "The UvrAB complex is involved in DNA mismatch repair.",
      "The UvrAB complex plays a role in maintaining the integrity of the genome by repairing DNA damage and ensuring accurate DNA replication."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The UvrAB complex is not used for base excision repair (BER), it is involved in nucleotide excision repair.\n4. FALSE [correction]: The UvrAB complex is not involved in DNA mismatch repair, it is involved in nucleotide excision repair.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "vicuna-13b_response": "Localization of a protein refers to its distribution and location within a cell or organism. The localization of a protein can be crucial for its function, as it determines where the protein can interact with other molecules and carry out its intended role.\nThe localization of the protein encoded by the gene DNAJC11 has not been extensively studied, and there is limited information available on this topic. However, based on the function of similar proteins, it is possible that DNAJC11 may be localized to the cytoplasm or endoplasmic reticulum (ER).\nDNAJC11 is a member of the heat shock protein (HSP) family, which are proteins that play a role in protein folding and transport. HSPs are known to be localized to the cytoplasm and ER, where they assist in the proper folding and transport of proteins. It is therefore possible that DNAJC11 is also localized to these areas.\nHowever, further research is needed to confirm the localization of DNAJC11 and to understand its specific function in the cell.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Localization of a protein refers to its distribution and location within a cell or organism.\n2. The localization of the protein can be crucial for its function.\n3. The protein encoded by the gene DNAJC11 is a member of the heat shock protein (HSP) family.\n4. HSPs play a role in protein folding and transport.\n5. HSPs are known to be localized to the cytoplasm and ER.",
    "vicuna-13b_fact": [
      "Localization of a protein refers to its distribution and location within a cell or organism.",
      "The localization of the protein can be crucial for its function.",
      "The protein encoded by the gene DNAJC11 is a member of the heat shock protein (HSP) family.",
      "HSPs play a role in protein folding and transport.",
      "HSPs are known to be localized to the cytoplasm and ER."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1646,
    "user_query": "Which hormone abnormalities are characteristic to Pendred syndrome?",
    "vicuna-13b_response": "Pendred syndrome is a rare genetic disorder that is characterized by a variety of symptoms, including hearing loss, thyroid and parathyroid gland abnormalities, and adrenal insufficiency. The hormone abnormalities that are characteristic of Pendred syndrome include:\n1. Hypothyroidism: Pendred syndrome is characterized by a congenital hypothyroidism, which is a condition in which the thyroid gland does not produce enough thyroid hormones. This is due to an inherited mutation in the THRB gene, which is responsible for the production of the thyroid hormone receptor beta.\n2. Hyperparathyroidism: Pendred syndrome is also characterized by hyperparathyroidism, which is a condition in which the parathyroid gland produces too much parathyroid hormone. This is due to an inherited mutation in the PRAD1 gene, which is responsible for the production of the parathyroid hormone 1 receptor.\n3. Adrenal insufficiency: Pendred syndrome is also characterized by a deficiency in the production of adrenal hormones, particularly cortisol and aldosterone. This is due to an inherited mutation in the CYP21A2 gene, which is responsible for the production of the enzyme 21-hydroxylase.\nIt's important to note that not all individuals with Pendred syndrome will have all of these hormone abnormalities, and the severity of the hormone abnormalities can vary from person to person. A diagnosis of Pendred syndrome is typically made through a combination of clinical evaluation, genetic testing, and other diagnostic tests.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pendred syndrome is a rare genetic disorder characterized by hearing loss, thyroid and parathyroid gland abnormalities, and adrenal insufficiency.\n2. Pendred syndrome is characterized by a congenital hypothyroidism due to an inherited mutation in the THRB gene.\n3. Hyperparathyroidism is also a characteristic of Pendred syndrome due to an inherited mutation in the PRAD1 gene.\n4. In people with Pendred syndrome, there is typically a deficiency in the production of adrenal hormones, particularly cortisol and aldosterone due to an inherited mutation in the CYP21A2 gene.\n5. A diagnosis of Pendred syndrome is typically made through a combination of clinical evaluation, genetic testing, and other diagnostic tests.",
    "vicuna-13b_fact": [
      "Pendred syndrome is a rare genetic disorder characterized by hearing loss, thyroid and parathyroid gland abnormalities, and adrenal insufficiency.",
      "Pendred syndrome is characterized by a congenital hypothyroidism due to an inherited mutation in the THRB gene.",
      "Hyperparathyroidism is also a characteristic of Pendred syndrome due to an inherited mutation in the PRAD1 gene.",
      "In people with Pendred syndrome, there is typically a deficiency in the production of adrenal hormones, particularly cortisol and aldosterone due to an inherited mutation in the CYP21A2 gene.",
      "A diagnosis of Pendred syndrome is typically made through a combination of clinical evaluation, genetic testing, and other diagnostic tests."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Pendred syndrome is a rare genetic disorder characterized by hearing loss and thyroid gland abnormalities, not adrenal insufficiency.\n2. FALSE [correction]: Pendred syndrome is characterized by congenital hearing loss and thyroid disease due to an inherited mutation in the SLC26A4 gene, not the THRB gene.\n3. FALSE [correction]: Hyperparathyroidism is not a characteristic of Pendred syndrome attributed to the PRAD1 gene. Pendred syndrome primarily affects the inner ear and thyroid.\n4. FALSE [correction]: People with Pendred syndrome typically do not have a deficiency in the production of adrenal hormones due to the CYP21A2 gene. The syndrome primarily affects hearing and thyroid function.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1647,
    "user_query": "What is the mode of inheritance of  long QT  Jervell and Lange-Nielsen syndrome?",
    "vicuna-13b_response": "Long QT syndrome is a condition that affects the electrical activity of the heart. It is caused by abnormalities in the genes that control the movement of sodium and potassium ions within the heart cells. The mode of inheritance of long QT syndrome is complex and can be either autosomal dominant or recessive.\nAutosomal dominant inheritance means that a person has a 50% chance of inheriting the condition from an affected parent. The gene that causes the condition is located on one of the non-sex chromosomes (autosomes), and a person who inherits the gene from one parent will usually develop the condition.\nAutosomal recessive inheritance means that a person has a 25% chance of inheriting the condition from each affected parent. The gene that causes the condition is located on one of the non-sex chromosomes, and a person who inherits the gene from both parents will usually develop the condition.\nIt's important to note that the inheritance of long QT syndrome is not always straightforward, and there may be cases where the mode of inheritance is not clear. Additionally, there may be cases where the condition is caused by spontaneous mutations in the genes, rather than inherited from parents.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Long QT syndrome is a condition that affects the electrical activity of the heart.\n2. The condition is caused by abnormalities in the genes that control the movement of sodium and potassium ions within the heart cells.\n3. The mode of inheritance of long QT syndrome can be either autosomal dominant or autosomal recessive.\n4. Autosomal dominant inheritance means that a person has a 50% chance of inheriting the condition from an affected parent, and they will usually develop the condition if they inherit the gene from one parent.\n5. Autosomal recessive inheritance means that a person has a 25% chance of inheriting the condition from each affected parent, and they will usually develop the condition if they inherit the gene from both parents.",
    "vicuna-13b_fact": [
      "Long QT syndrome is a condition that affects the electrical activity of the heart.",
      "The condition is caused by abnormalities in the genes that control the movement of sodium and potassium ions within the heart cells.",
      "The mode of inheritance of long QT syndrome can be either autosomal dominant or autosomal recessive.",
      "Autosomal dominant inheritance means that a person has a 50% chance of inheriting the condition from an affected parent, and they will usually develop the condition if they inherit the gene from one parent.",
      "Autosomal recessive inheritance means that a person has a 25% chance of inheriting the condition from each affected parent, and they will usually develop the condition if they inherit the gene from both parents."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1648,
    "user_query": "List programs suitable for protein docking",
    "vicuna-13b_response": "Protein docking is a computational method used to predict the binding of a protein to a ligand (small molecule or peptide). Here are some programs that are suitable for protein docking:\n1. Autodock: Autodock is a popular protein docking program that uses an optimization algorithm to search for the best orientation and position of a ligand in a protein binding site. It can also perform molecular dynamics simulations to further refine the docked poses.\n2. GROMACS: GROMACS is a molecular dynamics simulation package that can be used for protein docking. It includes a built-in protein docking algorithm called GROMOS, which can be used to predict the binding of small molecules to proteins.\n3. Rosetta: Rosetta is a comprehensive computational biology software suite that includes a protein docking algorithm called FlexX. FlexX can be used to predict the binding of small molecules and peptides to proteins, and it can also perform molecular dynamics simulations to refine the docked poses.\n4. PyMOL: PyMOL is a molecular visualization program that can be used for protein docking. It includes a built-in protein docking algorithm called Genetic Algorithm for Ligand Docking (GALD), which can be used to predict the binding of small molecules to proteins.\n5. DOCK: DOCK is a protein docking program that uses a physics-based approach to predict the binding of small molecules to proteins. It can also perform molecular dynamics simulations to refine the docked poses.\nThese programs are widely used in the field of computational biology and drug discovery, and they can be used to predict the binding of small molecules to proteins, which is important for understanding the mechanism of action of drugs and developing new drugs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Autodock is a protein docking program that uses an optimization algorithm to search for the best orientation and position of a ligand in a protein binding site.\n2. GROMACS is a molecular dynamics simulation package that can be used for protein docking and it includes a built-in protein docking algorithm called GROMOS.\n3. Rosetta is a comprehensive computational biology software suite that includes a protein docking algorithm called FlexX.\n4. PyMOL is a molecular visualization program that can be used for protein docking and includes a built-in protein docking algorithm called Genetic Algorithm for Ligand Docking (GALD).\n5. DOCK is a protein docking program that uses a physics-based approach to predict the binding of small molecules to proteins.",
    "vicuna-13b_fact": [
      "Autodock is a protein docking program that uses an optimization algorithm to search for the best orientation and position of a ligand in a protein binding site.",
      "GROMACS is a molecular dynamics simulation package that can be used for protein docking and it includes a built-in protein docking algorithm called GROMOS.",
      "Rosetta is a comprehensive computational biology software suite that includes a protein docking algorithm called FlexX.",
      "PyMOL is a molecular visualization program that can be used for protein docking and includes a built-in protein docking algorithm called Genetic Algorithm for Ligand Docking (GALD).",
      "DOCK is a protein docking program that uses a physics-based approach to predict the binding of small molecules to proteins."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: GROMACS is a molecular dynamics simulation package but it doesn't include a built-in protein docking algorithm called GROMOS.\n3. FALSE [correction]: Rosetta is a comprehensive computational biology software suite, but it's protein docking algorithm is not called FlexX.\n4. FALSE [correction]: PyMOL is a molecular visualization program, but it does not include a built-in protein docking algorithm called Genetic Algorithm for Ligand Docking (GALD).\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1649,
    "user_query": "Which genes have been found mutated in Gray platelet syndrome patients?",
    "vicuna-13b_response": "Gray platelet syndrome (GPS) is a rare genetic disorder characterized by the presence of large, immature platelets (thrombocytosis) and a tendency to form blood clots (thrombosis). The genetic basis of GPS is not well understood, but several genes have been identified as potential causes of the disorder.\nOne of the genes that has been found to be mutated in GPS patients is the MYH9 gene, which encodes for a protein involved in the production of fibrin, a protein that plays a key role in blood clotting. Mutations in the MYH9 gene have been shown to cause GPS-like thrombocytosis and thrombosis in animal models.\nAnother gene that has been associated with GPS is the ADAMTS13 gene, which encodes for a protein involved in the regulation of von Willebrand factor, a protein that plays a key role in blood clotting. Mutations in the ADAMTS13 gene have been shown to cause GPS-like thrombocytosis and thrombosis in animal models.\nIt is important to note that these are not the only genes that have been found to be mutated in GPS patients, and further research is needed to fully understand the genetic basis of this disorder.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. Gray platelet syndrome (GPS) is a genetic disorder characterized by large, immature platelets (thrombocytosis) and a tendency to form blood clots (thrombosis).\n2. MYH9 is one of the genes that has been found to be mutated in GPS patients.\n3. MYH9 gene encodes for a protein involved in the production of fibrin, which plays a key role in blood clotting.\n4. ADAMTS13 is another gene associated with GPS, its mutations have been shown to cause GPS-like thrombocytosis and thrombosis in animal models.\n5. ADAMTS13 gene encodes for a protein involved in the regulation of von Willebrand factor, which plays a key role in blood clotting.",
    "vicuna-13b_fact": [
      "Gray platelet syndrome (GPS) is a genetic disorder characterized by large, immature platelets (thrombocytosis) and a tendency to form blood clots (thrombosis).",
      "MYH9 is one of the genes that has been found to be mutated in GPS patients.",
      "MYH9 gene encodes for a protein involved in the production of fibrin, which plays a key role in blood clotting.",
      "ADAMTS13 is another gene associated with GPS, its mutations have been shown to cause GPS-like thrombocytosis and thrombosis in animal models.",
      "ADAMTS13 gene encodes for a protein involved in the regulation of von Willebrand factor, which plays a key role in blood clotting."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Gray platelet syndrome (GPS) is a genetic disorder characterized by large, pale, abnormally low number of platelets (thrombocytopenia), not thrombocytosis, and a tendency to form blood clots (thrombosis).\n2. FALSE [correction]: MYH9 is mutated in MYH9-related disease not in Gray platelet syndrome. GPS is often caused by mutations in the NBEAL2 gene.\n3. FALSE [correction]: MYH9 gene encodes for a nonmuscle myosin IIa, which is involved in cell movement and maintenance of cell shape, not in the production of fibrin.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1652,
    "user_query": "Is cardiac magnetic resonance imaging indicated in the pre-participation screening of athletes?",
    "vicuna-13b_response": "Cardiac magnetic resonance imaging (CMRI) is a non-invasive imaging technique that uses magnetic fields and radio waves to produce detailed images of the heart. It is a valuable tool for the evaluation of cardiac function, structure, and perfusion in athletes.\nThe pre-participation screening of athletes aims to identify any underlying cardiovascular conditions that may put them at risk of sudden cardiac death during sports activities. CMRI is one of the imaging modalities that can be used in the pre-participation screening of athletes.\nThe indications for CMRI in the pre-participation screening of athletes include:\n1. History of cardiovascular disease: Athletes with a history of cardiovascular disease, such as hypertrophic cardiomyopathy, dilated cardiomyopathy, or coronary artery disease, may require CMRI to assess their cardiac function and risk of exercise-induced cardiac events.\n2. Family history of sudden cardiac death: Athletes with a family history of sudden cardiac death may require CMRI to evaluate their risk of inheriting cardiovascular conditions that may put them at risk of sudden cardiac death during sports activities.\n3. Signs or symptoms of cardiovascular disease: Athletes who present with signs or symptoms of cardiovascular disease, such as chest pain, shortness of breath, or palpitations, may require CMRI to evaluate the presence of any underlying cardiovascular conditions.\n4. Age: Athletes who are older than 35 years may require CMRI as part of their pre-participation screening, as the risk of cardiovascular disease increases with age.\nIn conclusion, CMRI is an important tool in the pre-participation screening of athletes, and it may be indicated in certain circumstances, such as a history of cardiovascular disease, a family history of sudden cardiac death, signs or symptoms of cardiovascular disease, or age. However, the decision to use CMRI in pre-participation screening should be made on an individual basis, taking into account the specific needs and risks of each athlete.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cardiac magnetic resonance imaging (CMRI) is a non-invasive imaging technique that uses magnetic fields and radio waves to produce detailed images of the heart.\n2. The pre-participation screening of athletes aims to identify any underlying cardiovascular conditions.\n3. CMRI can be used in the pre-participation screening of athletes.\n4. Athletes with a history of cardiovascular disease may require CMRI to assess their cardiac function and risk of exercise-induced cardiac events.\n5. Athletes who are older than 35 years may require CMRI as part of their pre-participation screening.",
    "vicuna-13b_fact": [
      "Cardiac magnetic resonance imaging (CMRI) is a non-invasive imaging technique that uses magnetic fields and radio waves to produce detailed images of the heart.",
      "The pre-participation screening of athletes aims to identify any underlying cardiovascular conditions.",
      "CMRI can be used in the pre-participation screening of athletes.",
      "Athletes with a history of cardiovascular disease may require CMRI to assess their cardiac function and risk of exercise-induced cardiac events.",
      "Athletes who are older than 35 years may require CMRI as part of their pre-participation screening."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1654,
    "user_query": "What is the function of the MTH1 enzyme in cancer cells?",
    "vicuna-13b_response": "MTH1 (8-oxoguanine DNA glycosylase) is an enzyme that plays a role in the repair of oxidative DNA damage. It is involved in the removal of 8-oxoguanine, a product of oxidative stress, from the DNA. In cancer cells, MTH1 has been shown to be involved in the repair of DNA damage caused by chemotherapy and radiation, which can contribute to the development of drug resistance. Additionally, MTH1 has been shown to be involved in the regulation of cell cycle progression and apoptosis (programmed cell death) in cancer cells. Inhibition of MTH1 has been proposed as a potential strategy for cancer therapy, as it could increase the efficacy of chemotherapy and radiation therapy by increasing the amount of DNA damage in cancer cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MTH1 is an enzyme that plays a role in the repair of oxidative DNA damage.\n2. MTH1 is involved in the removal of 8-oxoguanine from the DNA.\n3. In cancer cells, MTH1 has been shown to be involved in the repair of DNA damage caused by chemotherapy and radiation.\n4. MTH1 has been shown to be involved in the regulation of cell cycle progression and apoptosis in cancer cells.\n5. The inhibition of MTH1 has been proposed as a potential strategy for cancer therapy.",
    "vicuna-13b_fact": [
      "MTH1 is an enzyme that plays a role in the repair of oxidative DNA damage.",
      "MTH1 is involved in the removal of 8-oxoguanine from the DNA.",
      "In cancer cells, MTH1 has been shown to be involved in the repair of DNA damage caused by chemotherapy and radiation.",
      "MTH1 has been shown to be involved in the regulation of cell cycle progression and apoptosis in cancer cells.",
      "The inhibition of MTH1 has been proposed as a potential strategy for cancer therapy."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: MTH1 is involved in the prevention of incorporation of 8-oxoguanine into the DNA, not its removal.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "vicuna-13b_response": "Ultraconserved elements (UCEs) are DNA sequences that are highly conserved across multiple species and are thought to play important roles in maintaining genome stability and function. Copy number variants (CNVs) are DNA alterations that involve changes in the number of copies of a particular gene or genomic region.\nSeveral studies have reported that UCEs are depleted among CNVs. For example, a study published in the journal Nature Genetics in 2011 found that UCEs are significantly underrepresented in regions with CNVs, compared to non-CNV regions. This suggests that UCEs may be more susceptible to disruption by CNVs, which could have important implications for genome stability and function.\nAnother study published in the journal Genome Research in 2012 found that UCEs are more likely to be affected by CNVs in regions that are associated with disease, such as those involved in cancer. This suggests that UCEs may play important roles in the development and progression of disease, and that disruptions to UCEs may contribute to disease pathology.\nOverall, while the evidence is not conclusive, there is some suggestion that UCEs may be depleted among CNVs, and that this could have important implications for genome stability and function, as well as disease pathology. Further research is needed to fully understand the relationship between UCEs and CNVs, and to determine the functional and clinical significance of these DNA alterations.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ultraconserved elements (UCEs) are DNA sequences that are highly conserved across multiple species.\n2. Copy number variants (CNVs) are DNA alterations that involve changes in the number of copies of a particular gene or genomic region.\n3. A study published in the journal Nature Genetics in 2011 found that UCEs are significantly underrepresented in regions with CNVs.\n4. A study published in the journal Genome Research in 2012 found that UCEs are more likely to be affected by CNVs in regions that are associated with disease.\n5. The alteration of UCEs may be associated with the development and progression of diseases, such as cancer.",
    "vicuna-13b_fact": [
      "Ultraconserved elements (UCEs) are DNA sequences that are highly conserved across multiple species.",
      "Copy number variants (CNVs) are DNA alterations that involve changes in the number of copies of a particular gene or genomic region.",
      "A study published in the journal Nature Genetics in 2011 found that UCEs are significantly underrepresented in regions with CNVs.",
      "A study published in the journal Genome Research in 2012 found that UCEs are more likely to be affected by CNVs in regions that are associated with disease.",
      "The alteration of UCEs may be associated with the development and progression of diseases, such as cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1660,
    "user_query": "Which population has a high frequency of the HLA-B*1502 allele?",
    "vicuna-13b_response": "The HLA-B*1502 allele is a genetic variation that is associated with an increased risk of developing certain autoimmune diseases, such as rheumatoid arthritis. The frequency of this allele varies among different populations.\nAccording to research, the highest frequency of the HLA-B*1502 allele is found in populations of African origin, including individuals of West African, Central African, and South African descent. Studies have shown that the frequency of this allele is particularly high in populations of African ancestry, with some studies reporting frequencies as high as 20-30% in certain populations.\nIn contrast, the frequency of the HLA-B*1502 allele is lower in populations of European ancestry, with studies reporting frequencies of around 5-10%. The frequency of this allele is also lower in populations of Asian and Native American ancestry, with frequencies ranging from 1-5%.\nIt's important to note that the frequency of the HLA-B*1502 allele can vary depending on the specific population and the geographic region within a population. Additionally, the presence of this allele does not necessarily mean that an individual will develop an autoimmune disease, as other genetic and environmental factors also play a role in disease susceptibility.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The HLA-B*1502 allele is associated with an increased risk of developing certain autoimmune diseases, such as rheumatoid arthritis.\n2. The frequency of the HLA-B*1502 allele varies among different populations.\n3. The highest frequency of the HLA-B*1502 allele is found in populations of African origin, including individuals of West African, Central African, and South African descent.\n4. The frequency of the HLA-B*1502 allele is lower in populations of European ancestry. \n5. The frequency of the HLA-B*1502 allele can vary depending on the specific population and the geographic region within a population.",
    "vicuna-13b_fact": [
      "The HLA-B*1502 allele is associated with an increased risk of developing certain autoimmune diseases, such as rheumatoid arthritis.",
      "The frequency of the HLA-B*1502 allele varies among different populations.",
      "The highest frequency of the HLA-B*1502 allele is found in populations of African origin, including individuals of West African, Central African, and South African descent.",
      "The frequency of the HLA-B*1502 allele is lower in populations of European ancestry.",
      "The frequency of the HLA-B*1502 allele can vary depending on the specific population and the geographic region within a population."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The HLA-B*1502 allele is associated with an increased risk of developing severe skin reactions to certain medications, not autoimmune diseases such as rheumatoid arthritis.\n2. TRUE\n3. FALSE [correction]: The highest frequency of the HLA-B*1502 allele is found in populations of Southeast Asian, particularly Han Chinese, Thai and Malaysian descent.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1663,
    "user_query": "What is the role of the Tsix gene during X chromosome inactivation?",
    "vicuna-13b_response": "The Tsix gene is a key regulator of X chromosome inactivation in female mammals, including humans. X chromosome inactivation is a process that occurs in female cells during embryonic development, where one of the two X chromosomes is randomly inactivated. This ensures that each cell has a single active X chromosome, avoiding the potential negative effects of having two active X chromosomes.\nThe Tsix gene is located on the X chromosome and encodes a transcription factor that is expressed in cells undergoing X chromosome inactivation. The Tsix protein binds to specific sequences in the DNA and recruits other proteins that help to silence the expression of genes on the inactivated X chromosome. This helps to ensure that only one X chromosome is active in each cell.\nMutations in the Tsix gene have been associated with a variety of developmental and neurological disorders in females, including X-linked mental retardation and Rett syndrome. These disorders are thought to result from abnormal X chromosome inactivation, leading to the expression of genes on both X chromosomes in some cells.\nOverall, the Tsix gene plays a crucial role in regulating X chromosome inactivation and ensuring that each cell has a single active X chromosome. Dysfunction of the Tsix gene can lead to a variety of developmental and neurological disorders in females.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Tsix gene is a key regulator of X chromosome inactivation in female mammals, including humans.\n2. X chromosome inactivation is a process that occurs in female cells during embryonic development, where one of the two X chromosomes is randomly inactivated.\n3. The Tsix gene is located on the X chromosome and encodes a transcription factor that is expressed in cells undergoing X chromosome inactivation.\n4. Mutations in the Tsix gene have been associated with a variety of developmental and neurological disorders in females, including X-linked mental retardation and Rett syndrome.\n5. Dysfunction of the Tsix gene can lead to a variety of developmental and neurological disorders in females.",
    "vicuna-13b_fact": [
      "The Tsix gene is a key regulator of X chromosome inactivation in female mammals, including humans.",
      "X chromosome inactivation is a process that occurs in female cells during embryonic development, where one of the two X chromosomes is randomly inactivated.",
      "The Tsix gene is located on the X chromosome and encodes a transcription factor that is expressed in cells undergoing X chromosome inactivation.",
      "Mutations in the Tsix gene have been associated with a variety of developmental and neurological disorders in females, including X-linked mental retardation and Rett syndrome.",
      "Dysfunction of the Tsix gene can lead to a variety of developmental and neurological disorders in females."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Tsix gene is located on the X chromosome and encodes a non-coding RNA that plays a crucial role in the process of X chromosome inactivation.\n4. FALSE [correction]: Mutations in the Tsix gene have not been directly associated with neurological disorders in females, but rather, X chromosome inactivation irregularities leading to a skewed outcome can potentially link to disorders like Rett syndrome.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "vicuna-13b_response": "The Haspin kinase is a protein that plays a role in regulating the progression of mitosis, which is the process by which a cell divides into two daughter cells. The substrate of the Haspin kinase during mitosis is not yet clear, as it is still an area of active research. However, it is known that the Haspin kinase is involved in the regulation of the anaphase-promoting complex/cyclosome (APC/C), which is a complex that plays a critical role in the progression of mitosis by promoting the degradation of proteins that are necessary for the progression of the cell cycle.\nIt is thought that the Haspin kinase may act as a regulator of the APC/C, either by activating it or by inhibiting its activity. The Haspin kinase may also play a role in the regulation of other proteins that are involved in the progression of mitosis, such as the polo-like kinase 1 (PLK1).\nOverall, the substrate of the Haspin kinase during mitosis is still not well understood, but it is clear that this protein plays a critical role in the regulation of the progression of mitosis. Further research is needed to fully understand the role of the Haspin kinase in this process.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Haspin kinase is a protein that plays a role in regulating the progression of mitosis.\n2. The substrate of the Haspin kinase during mitosis is still an area of active research.\n3. The Haspin kinase is involved in the regulation of the anaphase-promoting complex/cyclosome (APC/C).\n4. The APC/C plays a critical role in the progression of mitosis by promoting the degradation of proteins.\n5. The Haspin kinase may also regulate other proteins that are involved in the progression of mitosis, such as the polo-like kinase 1 (PLK1).",
    "vicuna-13b_fact": [
      "The Haspin kinase is a protein that plays a role in regulating the progression of mitosis.",
      "The substrate of the Haspin kinase during mitosis is still an area of active research.",
      "The Haspin kinase is involved in the regulation of the anaphase-promoting complex/cyclosome (APC/C).",
      "The APC/C plays a critical role in the progression of mitosis by promoting the degradation of proteins.",
      "The Haspin kinase may also regulate other proteins that are involved in the progression of mitosis, such as the polo-like kinase 1 (PLK1)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Haspin kinase is not typically involved in the regulation of the anaphase-promoting complex/cyclosome (APC/C). It is involved in the regulation of histone H3 phosphorylation.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1668,
    "user_query": "What is the advantage of neutral loss detection in phosphoproteomics?",
    "vicuna-13b_response": "Neutral loss detection in phosphoproteomics refers to the detection of phosphorylation sites in proteins that have not been modified by the addition or removal of a specific group of atoms, such as phosphate groups. This type of detection is important because it allows researchers to identify and quantify the various modifications that occur to proteins, which can provide important information about the function and regulation of these proteins.\nOne advantage of neutral loss detection in phosphoproteomics is that it can help to identify and quantify the levels of specific phosphorylation sites in a sample, even if these sites have not been modified by a specific type of modification. This can be useful in cases where the specific modification of interest is not present in the sample, or where the sample is complex and it is difficult to detect the specific modification.\nAnother advantage of neutral loss detection is that it can help to improve the accuracy and sensitivity of phosphoproteomics experiments. By detecting neutral losses, researchers can identify and remove background noise in the data, which can improve the overall quality of the data and make it easier to identify and quantify specific phosphorylation sites.\nOverall, neutral loss detection in phosphoproteomics is an important tool for identifying and quantifying the various modifications that occur to proteins, and can help to improve the accuracy and sensitivity of phosphoproteomics experiments.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Neutral loss detection in phosphoproteomics refers to the detection of phosphorylation sites in proteins that have not been modified by the addition or removal of a specific group of atoms.\n2. Neutral loss detection allows researchers to identify and quantify the various modifications that occur to proteins.\n3. Neutral loss detection can help to identify and quantify the levels of specific phosphorylation sites in a sample, even if these sites have not been specifically modified.\n4. By detecting neutral losses, researchers can identify and remove background noise in the data, which can improve the overall quality of the data.\n5. Neutral loss detection in phosphoproteomics is an important tool for identifying and quantifying the various modifications that occur to proteins.",
    "vicuna-13b_fact": [
      "Neutral loss detection in phosphoproteomics refers to the detection of phosphorylation sites in proteins that have not been modified by the addition or removal of a specific group of atoms.",
      "Neutral loss detection allows researchers to identify and quantify the various modifications that occur to proteins.",
      "Neutral loss detection can help to identify and quantify the levels of specific phosphorylation sites in a sample, even if these sites have not been specifically modified.",
      "By detecting neutral losses, researchers can identify and remove background noise in the data, which can improve the overall quality of the data.",
      "Neutral loss detection in phosphoproteomics is an important tool for identifying and quantifying the various modifications that occur to proteins."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Neutral loss detection in phosphoproteomics refers to the detection of phosphorylation sites in proteins that have been modified by the addition or removal of a specific group of atoms.\n2. TRUE\n3. FALSE [correction]: Neutral loss detection can help to identify and quantify the levels of specific phosphorylation sites in a sample, whether or not these sites have been specifically modified.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1672,
    "user_query": "Which cyclin- dependent kinase inhibitor is regulated by Bmi-1?",
    "vicuna-13b_response": "Bmi-1 is a protein that is involved in regulating cell growth and division. It is a member of the polycomb group (PcG) of proteins, which are involved in maintaining the repressed state of certain genes during development.\nBmi-1 has been shown to regulate the activity of several cyclin-dependent kinase inhibitors (CDKIs), including p21Cip1, p27Kip1, and p57Kip2. These CDKIs help to regulate the progression of the cell cycle by inhibiting the activity of cyclin-dependent kinases (CDKs), which are enzymes that phosphorylate and activate other proteins involved in cell division.\nIn particular, Bmi-1 has been shown to promote the degradation of p27Kip1, which is a CDKI that is involved in inhibiting the G1 phase of the cell cycle. This leads to the activation of CDKs and the progression of the cell cycle. Bmi-1 also promotes the degradation of p57Kip2, which is another CDKI that is involved in inhibiting the G1 phase of the cell cycle.\nOverall, Bmi-1 is involved in regulating the activity of several CDKIs, including p21Cip1, p27Kip1, and p57Kip2, which help to regulate the progression of the cell cycle.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Bmi-1 is a protein involved in regulating cell growth and division.\n2. Bmi-1 is a member of the polycomb group of proteins.\n3. Bmi-1 regulates the activity of several cyclin-dependent kinase inhibitors (CDKIs), including p21Cip1, p27Kip1, and p57Kip2.\n4. Bmi-1 promotes the degradation of p27Kip1 and p57Kip2, both of which are CDKIs that inhibit the G1 phase of the cell cycle.\n5. CDKIs help to regulate the progression of the cell cycle by inhibiting the activity of cyclin-dependent kinases (CDKs).",
    "vicuna-13b_fact": [
      "Bmi-1 is a protein involved in regulating cell growth and division.",
      "Bmi-1 is a member of the polycomb group of proteins.",
      "Bmi-1 regulates the activity of several cyclin-dependent kinase inhibitors (CDKIs), including p21Cip1, p27Kip1, and p57Kip2.",
      "Bmi-1 promotes the degradation of p27Kip1 and p57Kip2, both of which are CDKIs that inhibit the G1 phase of the cell cycle.",
      "CDKIs help to regulate the progression of the cell cycle by inhibiting the activity of cyclin-dependent kinases (CDKs)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Bmi-1 does not promote the degradation of p27Kip1 and p57Kip2, but it represses the transcription of these CDKIs, which leads to the promotion of cell cycle progression.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1675,
    "user_query": "List inhibtors targeting the mitochondrial permeability transition pore.",
    "vicuna-13b_response": "The mitochondrial permeability transition pore (MPTP) is a channel in the mitochondrial outer membrane that regulates the exchange of molecules between the cytosol and the mitochondrial matrix. Inhibitors of the MPTP are compounds that block the opening of the pore, which can have a variety of effects on cellular metabolism and function. Here are some examples of inhibitors that target the MPTP:\n1. Cyclosporine A: This is an immunosuppressant drug that is commonly used in organ transplantation. It has been shown to block the MPTP and prevent the release of cytochrome c from mitochondria, which can prevent apoptosis (programmed cell death).\n2. Mitochondrial permeability transition pore blockers: These are small molecule compounds that can bind to the MPTP and block its opening. Examples include cyclosporine, tamoxifen, and rapamycin.\n3. Antioxidants: Antioxidants such as melatonin, vitamin E, and glutathione have been shown to block the MPTP and prevent the release of cytochrome c, which can prevent apoptosis.\n4. Mitochondrial uncouplers: These are compounds that disrupt the function of the electron transport chain in mitochondria, which can reduce the production of reactive oxygen species (ROS) and prevent the opening of the MPTP. Examples include carbonyl cyanide m-chlorophenylhydrazone (CCCP) and 3-nitropropionic acid.\n5. Mitochondrial-targeted peptides: Peptides that target the MPTP can be used to regulate mitochondrial function. Examples include the mitochondrial-derived peptide (MDP) and the mitochondrial-targeted antioxidant peptide (MTAP).\nOverall, inhibitors of the MPTP can have a wide range of effects on cellular metabolism and function, and can be used to prevent apoptosis, reduce oxidative stress, and regulate mitochondrial function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The mitochondrial permeability transition pore (MPTP) is a channel in the mitochondrial outer membrane that regulates the exchange of molecules between the cytosol and the mitochondrial matrix.\n2. Inhibitors of the MPTP are compounds that block the opening of the pore.\n3. Cyclosporine A is an immune suppressant drug that can prevent apoptosis by blocking the MPTP and preventing the release of cytochrome c from mitochondria.\n4. Mitochondrial permeability transition pore blockers, such as cyclosporine, tamoxifen, and rapamycin, can bind to the MPTP and block its opening.\n5. Antioxidants like melatonin, vitamin E, and glutathione can prevent apoptosis by blocking the MPTP and preventing the release of cytochrome c.",
    "vicuna-13b_fact": [
      "The mitochondrial permeability transition pore (MPTP) is a channel in the mitochondrial outer membrane that regulates the exchange of molecules between the cytosol and the mitochondrial matrix.",
      "Inhibitors of the MPTP are compounds that block the opening of the pore.",
      "Cyclosporine A is an immune suppressant drug that can prevent apoptosis by blocking the MPTP and preventing the release of cytochrome c from mitochondria.",
      "Mitochondrial permeability transition pore blockers, such as cyclosporine, tamoxifen, and rapamycin, can bind to the MPTP and block its opening.",
      "Antioxidants like melatonin, vitamin E, and glutathione can prevent apoptosis by blocking the MPTP and preventing the release of cytochrome c."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The mitochondrial permeability transition pore (MPTP) is a channel that is believed to exist in the inner membrane, not the outer membrane, that regulates the exchange of molecules between the cytosol and the mitochondrial matrix.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1678,
    "user_query": "Which is the process that Conserved noncoding elements mostly regulate?",
    "vicuna-13b_response": "Conserved noncoding elements (CNEs) are DNA sequences that are present in multiple species and are not involved in coding for proteins. CNEs have been shown to play important roles in regulating gene expression, and they can act as binding sites for transcription factors and other regulatory proteins.\nThere are several types of CNEs, including enhancers, promoters, and silencers. Enhancers are CNEs that increase the expression of a nearby gene, while promoters are CNEs that initiate transcription of a gene. Silencers are CNEs that repress the expression of a nearby gene.\nCNEs can regulate a variety of cellular processes, including cell differentiation, development, and response to environmental cues. They are also involved in the regulation of gene expression in response to DNA damage and other stress responses.\nOverall, the process that CNEs mostly regulate is gene expression, by controlling the initiation and regulation of transcription of nearby genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Conserved noncoding elements (CNEs) are DNA sequences that are present in multiple species and are not involved in coding for proteins.\n2. CNEs play roles in regulating gene expression and can act as binding sites for transcription factors and other regulatory proteins.\n3. Enhancers, promoters, and silencers are different types of CNEs.\n4. CNEs can regulate a variety of cellular processes, including cell differentiation, development, and response to environmental cues.\n5. The process that CNEs mostly regulate is gene expression, by controlling the initiation and regulation of transcription of nearby genes.",
    "vicuna-13b_fact": [
      "Conserved noncoding elements (CNEs) are DNA sequences that are present in multiple species and are not involved in coding for proteins.",
      "CNEs play roles in regulating gene expression and can act as binding sites for transcription factors and other regulatory proteins.",
      "Enhancers, promoters, and silencers are different types of CNEs.",
      "CNEs can regulate a variety of cellular processes, including cell differentiation, development, and response to environmental cues.",
      "The process that CNEs mostly regulate is gene expression, by controlling the initiation and regulation of transcription of nearby genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1689,
    "user_query": "Is Achondroplasia associated with hearing loss?",
    "vicuna-13b_response": "Achondroplasia is a genetic disorder that affects bone growth and development. It is the most common form of short-limbed dwarfism, and is characterized by short stature, disproportionately short arms and legs, and normal-sized trunk and head. Hearing loss is not a common feature of achondroplasia, but it can occur in some individuals with the condition.\nStudies have shown that individuals with achondroplasia have an increased risk of developing hearing loss, particularly in the form of sensorineural hearing loss. This type of hearing loss is caused by damage to the inner ear or the nerve pathways that transmit sound to the brain. The exact prevalence of hearing loss in individuals with achondroplasia is not known, but it is estimated to be around 10-20%.\nThere are several factors that may contribute to the development of hearing loss in individuals with achondroplasia. One possible factor is the presence of craniofacial abnormalities, such as a small or abnormally shaped head, which can affect the development of the inner ear. Additionally, some studies have suggested that the underlying genetic mutations that cause achondroplasia may also affect the development of the auditory system.\nIt is important for individuals with achondroplasia to undergo regular hearing tests to detect any hearing loss early on and to receive appropriate treatment. Hearing aids or cochlear implants may be recommended to improve hearing in individuals with hearing loss associated with achondroplasia.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Achondroplasia is a genetic disorder that affects bone growth and development.\n2. Achondroplasia is the most common form of short-limbed dwarfism. \n3. Individuals with achondroplasia have an increased risk of developing hearing loss, especially sensorineural hearing loss.\n4. The prevalence of hearing loss in individuals with achondroplasia is estimated to be around 10-20%.\n5. Hearing aids or cochlear implants may be recommended to improve hearing in individuals with hearing loss associated with achondroplasia.",
    "vicuna-13b_fact": [
      "Achondroplasia is a genetic disorder that affects bone growth and development.",
      "Achondroplasia is the most common form of short-limbed dwarfism.",
      "Individuals with achondroplasia have an increased risk of developing hearing loss, especially sensorineural hearing loss.",
      "The prevalence of hearing loss in individuals with achondroplasia is estimated to be around 10-20%.",
      "Hearing aids or cochlear implants may be recommended to improve hearing in individuals with hearing loss associated with achondroplasia."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1691,
    "user_query": "Is STAT3 transcription factor regulated by mTORC1?",
    "vicuna-13b_response": "Yes, STAT3 transcription factor is regulated by mTORC1. mTORC1 is a complex of two distinct regulatory proteins, mTOR and rapamycin-insensitive companion of mTOR (Rictor). mTORC1 is a key regulator of cell growth, proliferation, and metabolism, and it is activated in response to various stimuli, such as growth factors and nutrients.\nOne of the downstream targets of mTORC1 is the STAT3 transcription factor. STAT3 is a transcription factor that is activated by tyrosine phosphorylation in response to various cytokines and growth factors. Once activated, STAT3 dimerizes with other STAT proteins and translocates to the nucleus, where it regulates the expression of target genes involved in cell proliferation, differentiation, and survival.\nmTORC1 phosphorylates and activates the S6K1 protein, which in turn, phosphorylates and activates the ribosomal protein S6. This leads to the activation of the ULK1 complex, which promotes the formation of the mTORC1 complex on the lysosomal surface. Once assembled, mTORC1 phosphorylates and activates the ribosomal protein S6, which promotes protein synthesis and cell growth. Additionally, mTORC1 inhibits autophagy by inhibiting the ULK1 complex, which is required for the formation of the mTORC1 complex.\nIn conclusion, STAT3 transcription factor is regulated by mTORC1, which is a complex of two distinct regulatory proteins, mTOR and Rictor. mTORC1 is a key regulator of cell growth, proliferation, and metabolism, and it activates the STAT3 transcription factor, which regulates the expression of target genes involved in cell proliferation, differentiation, and survival.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. STAT3 transcription factor is regulated by mTORC1.\n2. mTORC1 is a complex of two distinct regulatory proteins, mTOR and rapamycin-insensitive companion of mTOR (Rictor).\n3. mTORC1 is a key regulator of cell growth, proliferation, and metabolism, and is activated in response to various stimuli.\n4. One of the downstream targets of mTORC1 is the STAT3 transcription factor.\n5. mTORC1 phosphorylates and activates the S6K1 protein, which in turn phosphorylates and activates the ribosomal protein S6.",
    "vicuna-13b_fact": [
      "STAT3 transcription factor is regulated by mTORC1.",
      "mTORC1 is a complex of two distinct regulatory proteins, mTOR and rapamycin-insensitive companion of mTOR (Rictor).",
      "mTORC1 is a key regulator of cell growth, proliferation, and metabolism, and is activated in response to various stimuli.",
      "One of the downstream targets of mTORC1 is the STAT3 transcription factor.",
      "mTORC1 phosphorylates and activates the S6K1 protein, which in turn phosphorylates and activates the ribosomal protein S6."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: mTORC1 is a complex that includes the protein mTOR and other components, such as Raptor, but not Rictor which is a part of mTORC2.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1693,
    "user_query": "List components of the CRSP/Med complex.",
    "vicuna-13b_response": "The CRSP/Med complex is a group of proteins that play a role in regulating the activity of the heat shock factor (HSF), which is a transcription factor that is activated in response to heat shock. The components of the CRSP/Med complex include:\n1. HSP70: A heat shock protein that is involved in protein folding and is a substrate for the HSF.\n2. HSP23: A heat shock protein that is involved in protein folding and is a substrate for the HSF.\n3. HSP90: A heat shock protein that is involved in protein folding and is a substrate for the HSF.\n4. HSP105: A heat shock protein that is involved in protein folding and is a substrate for the HSF.\n5. HSP110: A heat shock protein that is involved in protein folding and is a substrate for the HSF.\n6. HSP115: A heat shock protein that is involved in protein folding and is a substrate for the HSF.\n7. HSP115BP1: A protein that interacts with HSP115 and modulates its activity.\n8. HSP115BP2: A protein that interacts with HSP115 and modulates its activity.\nThe CRSP/Med complex plays a role in regulating the activity of the HSF by binding to and inhibiting the activity of the HSF. This complex is involved in the regulation of protein folding and the response to heat shock.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The CRSP/Med complex is a group of proteins that regulate the activity of the heat shock factor (HSF).\n2. HSP70, HSP23, HSP90, HSP105, HSP110, and HSP115 are components of the CRSP/Med complex.\n3. HSP115BP1 and HSP115BP2 are proteins that interact with HSP115 and regulate its activity.\n4. The CRSP/Med complex regulates the activity of the HSF by binding to and inhibiting the HSF.\n5. The CRSP/Med complex is involved in the regulation of protein folding and the response to heat shock.",
    "vicuna-13b_fact": [
      "The CRSP/Med complex is a group of proteins that regulate the activity of the heat shock factor (HSF).",
      "HSP70, HSP23, HSP90, HSP105, HSP110, and HSP115 are components of the CRSP/Med complex.",
      "HSP115BP1 and HSP115BP2 are proteins that interact with HSP115 and regulate its activity.",
      "The CRSP/Med complex regulates the activity of the HSF by binding to and inhibiting the HSF.",
      "The CRSP/Med complex is involved in the regulation of protein folding and the response to heat shock."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "vicuna-13b_response": "Viroids are non-cellular, single-stranded RNA viruses that replicate through a rolling-circle mechanism. This mechanism involves the annealing of complementary strands of RNA, followed by the synthesis of a new strand by a viral RNA-dependent RNA polymerase. The new strand is then used as a template for the synthesis of more virus particles. The rolling-circle mechanism allows for the efficient replication of viroids, as it does not require the synthesis of a new strand of DNA or RNA, and it allows for the production of multiple copies of the virus in a short amount of time.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Viroids are non-cellular, single-stranded RNA viruses.\n2. Viroids replicate through a rolling-circle mechanism.\n3. The rolling-circle mechanism of replication involves the annealing of complementary strands of RNA.\n4. In the rolling-circle mechanism, a new strand is synthesized by a viral RNA-dependent RNA polymerase.\n5. The rolling-circle mechanism allows for the efficient replication of viroids and does not require the synthesis of a new strand of DNA or RNA.",
    "vicuna-13b_fact": [
      "Viroids are non-cellular, single-stranded RNA viruses.",
      "Viroids replicate through a rolling-circle mechanism.",
      "The rolling-circle mechanism of replication involves the annealing of complementary strands of RNA.",
      "In the rolling-circle mechanism, a new strand is synthesized by a viral RNA-dependent RNA polymerase.",
      "The rolling-circle mechanism allows for the efficient replication of viroids and does not require the synthesis of a new strand of DNA or RNA."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Viroids are non-cellular, single-stranded RNA molecules, not viruses.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: In the rolling-circle mechanism, a new strand is synthesized by a host RNA-dependent RNA polymerase, not a viral one. \n5. FALSE [correction]: The rolling-circle mechanism allows for the efficient replication of viroids and does require the synthesis of a new strand of RNA.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1698,
    "user_query": "Mutation of which gene is associated with McLeod syndrome?",
    "vicuna-13b_response": "McLeod syndrome is a rare genetic disorder that is caused by a mutation in the PTPRD gene. This gene provides instructions for making a protein called PTPRD, which is involved in the regulation of cell growth and division. Mutations in the PTPRD gene can disrupt the normal function of PTPRD, leading to the development of McLeod syndrome.\nMcLeod syndrome is characterized by a variety of physical features, including short stature, a triangular face with a pointed chin, low-set ears, and a broad nasal bridge. Other symptoms of the condition can include developmental delays, intellectual disability, and problems with the eyes, such as cataracts and glaucoma.\nThe PTPRD gene is located on the X chromosome, which is one of the two sex chromosomes. McLeod syndrome is inherited in an X-linked recessive pattern, which means that the mutation in the gene is located on the X chromosome and that it only affects males, who have only one X chromosome. Females, who have two X chromosomes, are typically carriers of the mutation and may be affected with the condition, but the severity of their symptoms can vary.\nThere is no cure for McLeod syndrome, but treatment is focused on managing the symptoms of the condition. This may include physical therapy, occupational therapy, and speech therapy to help improve physical and cognitive abilities, as well as medical interventions to address specific symptoms, such as cataract surgery or glaucoma treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. McLeod syndrome is caused by a mutation in the PTPRD gene.\n2. The PTPRD gene provides instructions for making a protein involved in the regulation of cell growth and division.\n3. The PTPRD gene is located on the X chromosome.\n4. McLeod syndrome is inherited in an X-linked recessive pattern, which means it primarily affects males.\n5. There is no cure for McLeod syndrome, but treatment is focused on managing the symptoms of the condition.",
    "vicuna-13b_fact": [
      "McLeod syndrome is caused by a mutation in the PTPRD gene.",
      "The PTPRD gene provides instructions for making a protein involved in the regulation of cell growth and division.",
      "The PTPRD gene is located on the X chromosome.",
      "McLeod syndrome is inherited in an X-linked recessive pattern, which means it primarily affects males.",
      "There is no cure for McLeod syndrome, but treatment is focused on managing the symptoms of the condition."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: McLeod syndrome is caused by a mutation in the XK gene.\n2. TRUE\n3. FALSE [correction]: The XK gene, which when mutated causes McLeod syndrome, is located on the X chromosome.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1699,
    "user_query": "Is RIP1 (RIP-1) part of the necrosome?",
    "vicuna-13b_response": "RIP1 (also known as RIP-1) is a key regulator of programmed cell death, or apoptosis. It is a member of the RIP family of proteins, which includes RIP2 and RIP3. RIP1 is involved in the activation of caspases, which are enzymes that play a central role in the process of apoptosis.\nThe necrosome is a multi-protein complex that plays a role in the regulation of programmed cell death. It is composed of several key components, including RIP1, RIP2, and RIP3, as well as other proteins such as caspases, cytochrome c, and ATP. The necrosome is involved in the activation of caspases and the initiation of apoptosis.\nTherefore, while RIP1 is a key regulator of programmed cell death and is involved in the activation of caspases, it is not part of the necrosome itself. Instead, it is a component of the larger apoptotic signaling pathway that involves the necrosome and other proteins.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. RIP1 (RIP-1) is a key regulator of programmed cell death, or apoptosis.\n2. RIP1 is a member of the RIP family of proteins, which includes RIP2 and RIP3.\n3. RIP1 is involved in the activation of caspases, enzymes that play a central role in the process of apoptosis.\n4. The necrosome is a multi-protein complex that plays a role in the regulation of programmed cell death.\n5. The necrosome is composed of several key components, including RIP1, RIP2, and RIP3, as well as other proteins such as caspases, cytochrome c, and ATP.",
    "vicuna-13b_fact": [
      "RIP1 (RIP-1) is a key regulator of programmed cell death, or apoptosis.",
      "RIP1 is a member of the RIP family of proteins, which includes RIP2 and RIP3.",
      "RIP1 is involved in the activation of caspases, enzymes that play a central role in the process of apoptosis.",
      "The necrosome is a multi-protein complex that plays a role in the regulation of programmed cell death.",
      "The necrosome is composed of several key components, including RIP1, RIP2, and RIP3, as well as other proteins such as caspases, cytochrome c, and ATP."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The necrosome is composed of RIP1, RIP3, and MLKL. It does not necessarily include RIP2, caspases, cytochrome c, or ATP.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1700,
    "user_query": "Which is the molecular target of the immunosuppressant drug Rapamycin?",
    "vicuna-13b_response": "The molecular target of the immunosuppressant drug Rapamycin is the mammalian target of rapamycin (mTOR). mTOR is a serine/threonine kinase that is a key regulator of cell growth, proliferation, and survival. Rapamycin binds to and inhibits the activity of mTOR, thereby inhibiting cell proliferation and suppressing the immune system. Rapamycin is used as an immunosuppressant drug in organ transplantation to prevent the rejection of transplanted organs by the immune system. It is also being studied as a potential treatment for a variety of diseases, including cancer, aging, and certain inherited diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The molecular target of the immunosuppressant drug Rapamycin is the mammalian target of rapamycin (mTOR).\n2. mTOR is a key regulator of cell growth, proliferation, and survival.\n3. Rapamycin binds to and inhibits the activity of mTOR.\n4. Rapamycin is used in organ transplantation to prevent the rejection of transplanted organs by the immune system.\n5. Rapamycin is being studied as a potential treatment for a variety of diseases, including cancer, aging, and certain inherited diseases.",
    "vicuna-13b_fact": [
      "The molecular target of the immunosuppressant drug Rapamycin is the mammalian target of rapamycin (mTOR).",
      "mTOR is a key regulator of cell growth, proliferation, and survival.",
      "Rapamycin binds to and inhibits the activity of mTOR.",
      "Rapamycin is used in organ transplantation to prevent the rejection of transplanted organs by the immune system.",
      "Rapamycin is being studied as a potential treatment for a variety of diseases, including cancer, aging, and certain inherited diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1702,
    "user_query": "PBT2 has been tested for which disorder?",
    "vicuna-13b_response": "PBT2 (Pimavanserin) is a medication that has been approved for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It is a serotonin inverse agonist and antagonist (SIAA) that acts on serotonin 2A receptors in the brain. PBT2 has been studied in clinical trials for the treatment of Parkinson's disease psychosis, and it has been shown to be effective in reducing the frequency and severity of hallucinations and delusions in patients with this condition. PBT2 is taken orally as a tablet, and it is usually taken twice a day. It is important to note that PBT2 is not approved for use in treating other disorders, and it should only be used as directed by a healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PBT2 (Pimavanserin) has been approved for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.\n2. PBT2 is a serotonin inverse agonist and antagonist (SIAA) that acts on serotonin 2A receptors in the brain.\n3. PBT2 has been tested in clinical trials for the treatment of Parkinson's disease psychosis.\n4. PBT2 has been shown to reduce the frequency and severity of hallucinations and delusions in patients with Parkinson's disease psychosis.\n5. PBT2 is taken orally as a tablet, usually twice a day.",
    "vicuna-13b_fact": [
      "PBT2 (Pimavanserin) has been approved for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.",
      "PBT2 is a serotonin inverse agonist and antagonist (SIAA) that acts on serotonin 2A receptors in the brain.",
      "PBT2 has been tested in clinical trials for the treatment of Parkinson's disease psychosis.",
      "PBT2 has been shown to reduce the frequency and severity of hallucinations and delusions in patients with Parkinson's disease psychosis.",
      "PBT2 is taken orally as a tablet, usually twice a day."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Nuplazid (Pimavanserin), not PBT2, has been approved for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.\n2. FALSE [correction]: Pimavanserin is a serotonin inverse agonist and antagonist (SIAA) that acts on serotonin 2A receptors in the brain. PBT2 has different pharmacological properties.\n3. UNKNOWN (The statement doesn't specify which drug, Pimavanserin or PBT2, has been tested in clinical trials for the treatment of Parkinson's disease psychosis.)\n4. UNKNOWN (The statement doesn't specify which drug, Pimavanserin or PBT2, shown to reduce the frequency and severity of hallucinations and delusions in patients with Parkinson's disease psychosis.)\n5. UNKNOWN (The statement doesn't specify which drug, Pimavanserin or PBT2, is taken orally as a tablet, usually twice a day.)",
    "vicuna-13b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1704,
    "user_query": "How does long-range epigenetic silencing (LRES) occur?",
    "vicuna-13b_response": "Long-range epigenetic silencing (LRES) is a process by which a segment of DNA is silenced, or turned off, despite being far away from the regulatory elements that typically control gene expression. This process is thought to play a role in the development of certain diseases, such as cancer.\nLRES occurs when a chromatin structure called a \"chromatin loop\" forms between two distant regulatory elements, such as promoters or enhancers. This loop brings the regulatory elements into close proximity, allowing them to interact and silence the target gene. The target gene is typically located in the middle of the loop, and is silenced by the interaction of the regulatory elements.\nLRES can also occur through the formation of \"chromatin bridges,\" which are structures that connect two different regions of the genome, allowing them to interact and regulate each other's expression.\nOverall, LRES is a complex process that involves the interaction of multiple regulatory elements and the manipulation of chromatin structure. It is an important area of research, as a better understanding of LRES could lead to new ways to treat diseases that are caused by abnormal gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Long-range epigenetic silencing (LRES) is a process by which a segment of DNA is silenced, despite being far from the regulatory elements that typically control gene expression.\n2. LRES is thought to play a role in the development of certain diseases, like cancer.\n3. The process involves the formation of a \"chromatin loop\" between two distant regulatory elements, allowing them to interact and silence the target gene.\n4. LRES can occur through the formation of \"chromatin bridges,\" which connect two different regions of the genome.\n5. Understanding LRES could potentially lead to new ways to treat diseases caused by abnormal gene expression.",
    "vicuna-13b_fact": [
      "Long-range epigenetic silencing (LRES) is a process by which a segment of DNA is silenced, despite being far from the regulatory elements that typically control gene expression.",
      "LRES is thought to play a role in the development of certain diseases, like cancer.",
      "The process involves the formation of a \"chromatin loop\" between two distant regulatory elements, allowing them to interact and silence the target gene.",
      "LRES can occur through the formation of \"chromatin bridges,\" which connect two different regions of the genome.",
      "Understanding LRES could potentially lead to new ways to treat diseases caused by abnormal gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The process does not involve the formation of a \"chromatin loop\" between two distant regulatory elements. Instead, it involves modifications to histone proteins and DNA itself in a specific region of the genome.\n4. FALSE [correction]: LRES does not occur through the formation of \"chromatin bridges.\" It involves epigenetic changes that silence the genes over a large region.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1706,
    "user_query": "Can RNAPolII function as an RNA-dependent RNA-polymerase?",
    "vicuna-13b_response": "Yes, RNAPolII can function as an RNA-dependent RNA-polymerase. RNAPolII is a type of RNA polymerase enzyme that is responsible for transcribing DNA into RNA in eukaryotic cells. It is composed of several subunits and has a specific binding site for the initiator nucleotide dATP.\nRNAPolII can also function as an RNA-dependent RNA-polymerase by transcribing RNA templates, rather than DNA templates. This process is known as transcriptional activation and is regulated by various factors, including transcription factors and small molecules.\nIn some cases, RNAPolII can also act as a reverse transcriptase, which is an enzyme that synthesizes DNA from RNA templates. This process is important in the replication of some viruses, such as retroviruses.\nOverall, RNAPolII is a versatile enzyme that can function in a variety of transcriptional processes, including transcriptional activation, reverse transcription, and RNA-dependent RNA-polymerase activity.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. RNAPolII is a type of RNA polymerase enzyme that is responsible for transcribing DNA into RNA in eukaryotic cells.\n2. RNAPolII is composed of several subunits.\n3. RNAPolII has a specific binding site for the initiator nucleotide dATP.\n4. RNAPolII can function as an RNA-dependent RNA-polymerase by transcribing RNA templates.\n5. RNAPolII can also act as a reverse transcriptase, synthesizing DNA from RNA templates.",
    "vicuna-13b_fact": [
      "RNAPolII is a type of RNA polymerase enzyme that is responsible for transcribing DNA into RNA in eukaryotic cells.",
      "RNAPolII is composed of several subunits.",
      "RNAPolII has a specific binding site for the initiator nucleotide dATP.",
      "RNAPolII can function as an RNA-dependent RNA-polymerase by transcribing RNA templates.",
      "RNAPolII can also act as a reverse transcriptase, synthesizing DNA from RNA templates."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: RNAPolII has no specific binding site for the initiator nucleotide dATP; instead, it uses ATP, GTP, CTP, and UTP as substrate nucleotides for RNA synthesis.\n4. FALSE [correction]: RNAPolII cannot function as an RNA-dependent RNA-polymerase, it transcribes DNA templates into RNA.\n5. FALSE [correction]: RNAPolII cannot act as a reverse transcriptase, it is not able to synthesize DNA from RNA templates.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1708,
    "user_query": "List sclerostin interaction partners.",
    "vicuna-13b_response": "Sclerostin is a protein that plays a key role in regulating bone growth and remodeling. It is a negative regulator of the Wnt signaling pathway, which is a key pathway involved in the development and maintenance of bone. Sclerostin interacts with several other proteins to regulate its function. Here are some of the known interaction partners of sclerostin:\n1. Wnt proteins: Sclerostin binds to Wnt proteins, which are involved in the regulation of bone growth and remodeling. This interaction inhibits the Wnt signaling pathway and prevents the formation of bone.\n2. Frizzled proteins: Sclerostin interacts with Frizzled proteins, which are G protein-coupled receptors that are involved in the Wnt signaling pathway. This interaction enhances the inhibitory effect of sclerostin on bone growth.\n3. LRP5 and LRP6: Sclerostin interacts with LRP5 and LRP6, which are receptors for Wnt proteins. This interaction promotes the internalization and degradation of Wnt proteins, thereby inhibiting the Wnt signaling pathway and bone growth.\n4. Beta-catenin: Sclerostin binds to beta-catenin, which is a key component of the Wnt signaling pathway. This interaction inhibits the translocation of beta-catenin to the nucleus, which is necessary for the activation of Wnt target genes involved in bone growth and remodeling.\n5. Kallikrein-related peptidases (KLKs): Sclerostin interacts with KLKs, which are enzymes involved in the processing and activation of Wnt proteins. This interaction enhances the inhibitory effect of sclerostin on bone growth by promoting the degradation of Wnt proteins.\nOverall, sclerostin interacts with several proteins to regulate its function in bone growth and remodeling. These interactions help to fine-tune the activity of the Wnt signaling pathway and ensure that bone growth and remodeling are properly regulated.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Sclerostin is a protein that plays a key role in regulating bone growth and remodeling.\n2. Sclerostin is a negative regulator of the Wnt signaling pathway.\n3. Sclerostin binds to Wnt proteins to inhibit the Wnt signaling pathway and prevent bone formation.\n4. Sclerostin interacts with Frizzled proteins, LRP5 and LRP6, and beta-catenin, all involved in the Wnt signaling pathway.\n5. Sclerostin also interacts with Kallikrein-related peptidases (KLKs) to promote the degradation of Wnt proteins.",
    "vicuna-13b_fact": [
      "Sclerostin is a protein that plays a key role in regulating bone growth and remodeling.",
      "Sclerostin is a negative regulator of the Wnt signaling pathway.",
      "Sclerostin binds to Wnt proteins to inhibit the Wnt signaling pathway and prevent bone formation.",
      "Sclerostin interacts with Frizzled proteins, LRP5 and LRP6, and beta-catenin, all involved in the Wnt signaling pathway.",
      "Sclerostin also interacts with Kallikrein-related peptidases (KLKs) to promote the degradation of Wnt proteins."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1711,
    "user_query": "Which are currently available software tools for detecting rare codon clusters in coding sequences?",
    "vicuna-13b_response": "There are several software tools available for detecting rare codon clusters in coding sequences, including:\n1. CodonTools: This tool is a web-based application that provides a user-friendly interface for analyzing codon usage in DNA sequences. It allows users to identify rare codon clusters and provides information on the frequency and distribution of codons in the sequence.\n2. CodonCounters: This tool is a command-line program that can be used to analyze codon usage in DNA sequences. It allows users to identify rare codon clusters and provides information on the frequency and distribution of codons in the sequence.\n3. CodonW: This tool is a software package that can be used to analyze codon usage in DNA sequences. It allows users to identify rare codon clusters and provides information on the frequency and distribution of codons in the sequence.\n4. CodonAnalyzer: This tool is a web-based application that provides a user-friendly interface for analyzing codon usage in DNA sequences. It allows users to identify rare codon clusters and provides information on the frequency and distribution of codons in the sequence.\n5. CodonDistributionAnalyzer: This tool is a command-line program that can be used to analyze codon usage in DNA sequences. It allows users to identify rare codon clusters and provides information on the frequency and distribution of codons in the sequence.\nThese are some of the commonly used software tools for detecting rare codon clusters in coding sequences. However, it is important to note that the choice of tool may depend on the specific requirements and preferences of the user.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CodonTools is a web-based application for detecting rare codon clusters in coding sequences.\n2. CodonCounters is a command-line program that analyzes codon usage in DNA sequences.\n3. CodonW is a software package used to analyze codon usage in DNA sequences.\n4. CodonAnalyzer is a web-based application that analyzes codon usage in DNA sequences.\n5. CodonDistributionAnalyzer is a command-line program that analyzes codon usage in DNA sequences.",
    "vicuna-13b_fact": [
      "CodonTools is a web-based application for detecting rare codon clusters in coding sequences.",
      "CodonCounters is a command-line program that analyzes codon usage in DNA sequences.",
      "CodonW is a software package used to analyze codon usage in DNA sequences.",
      "CodonAnalyzer is a web-based application that analyzes codon usage in DNA sequences.",
      "CodonDistributionAnalyzer is a command-line program that analyzes codon usage in DNA sequences."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1714,
    "user_query": "Where does CTCF colocalize with cohesin?",
    "vicuna-13b_response": "CTCF (CCCTC-binding factor) is a transcriptional repressor that plays a role in regulating the 3D organization of chromatin in the nucleus. Cohesin is a complex of proteins that helps to hold sister chromatids together during the process of DNA replication.\nStudies have shown that CTCF can colocalize with cohesin at specific regions of the genome, including the pericentromeric regions of chromosomes, where the cohesin complex helps to maintain the integrity of the chromosomes during mitosis. CTCF can also bind to the cohesin complex at the regulatory regions of genes, where it can help to repress transcription.\nIn addition, CTCF has been shown to interact with the cohesin complex through its N-terminal domain, which contains a CCCTC-binding motif. This interaction can help to recruit CTCF to specific regions of the genome where cohesin is active, and can also help to regulate the activity of the cohesin complex.\nOverall, the colocalization of CTCF and cohesin suggests that these two proteins may play a role in coordinating the 3D organization of chromatin and the regulation of gene expression in the nucleus.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CTCF (CCCTC-binding factor) is a transcriptional repressor that regulates the 3D organization of chromatin in the nucleus.\n2. Cohesin is a complex of proteins that helps to hold sister chromatids together during DNA replication.\n3. CTCF can colocalize with cohesin at specific regions of the genome, including the pericentromeric regions of chromosomes.\n4. CTCF can also bind to the cohesin complex at the regulatory regions of genes, where it can help to repress transcription.\n5. CTCF can interact with the cohesin complex through its N-terminal domain, which contains a CCCTC-binding motif.",
    "vicuna-13b_fact": [
      "CTCF (CCCTC-binding factor) is a transcriptional repressor that regulates the 3D organization of chromatin in the nucleus.",
      "Cohesin is a complex of proteins that helps to hold sister chromatids together during DNA replication.",
      "CTCF can colocalize with cohesin at specific regions of the genome, including the pericentromeric regions of chromosomes.",
      "CTCF can also bind to the cohesin complex at the regulatory regions of genes, where it can help to repress transcription.",
      "CTCF can interact with the cohesin complex through its N-terminal domain, which contains a CCCTC-binding motif."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1715,
    "user_query": "Name triad of Wernicke encephalopathy.",
    "vicuna-13b_response": "Wernicke-Korsakoff syndrome is a neuropsychiatric disorder caused by a deficiency of thiamine (vitamin B1). It is characterized by a triad of symptoms: confusion, memory loss, and oculomotor abnormalities. The confusion is usually severe and is often accompanied by disorientation, agitation, and delirium. The memory loss is typically irreversible and affects both short-term and long-term memory. The oculomotor abnormalities include a tendency for the eyes to move abnormally (nystagmus) and a lack of coordination between the eyes (stereopsia). Wernicke-Korsakoff syndrome is most commonly seen in alcoholics and other individuals who have a chronic deficiency of thiamine due to poor diet or other medical conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Wernicke-Korsakoff syndrome is a neuropsychiatric disorder caused by a deficiency of thiamine (vitamin B1).\n2. Wernicke-Korsakoff syndrome is characterized by confusion, memory loss, and oculomotor abnormalities.\n3. The memory loss associated with Wernicke-Korsakoff syndrome typically affects both short-term and long-term memory and is often irreversible.\n4. Oculomotor abnormalities in Wernicke-Korsakoff syndrome include a tendency for the eyes to move abnormally and a lack of coordination between the eyes.\n5. Wernicke-Korsakoff syndrome is most commonly seen in alcoholics and other individuals with a chronic deficiency of thiamine.",
    "vicuna-13b_fact": [
      "Wernicke-Korsakoff syndrome is a neuropsychiatric disorder caused by a deficiency of thiamine (vitamin B1).",
      "Wernicke-Korsakoff syndrome is characterized by confusion, memory loss, and oculomotor abnormalities.",
      "The memory loss associated with Wernicke-Korsakoff syndrome typically affects both short-term and long-term memory and is often irreversible.",
      "Oculomotor abnormalities in Wernicke-Korsakoff syndrome include a tendency for the eyes to move abnormally and a lack of coordination between the eyes.",
      "Wernicke-Korsakoff syndrome is most commonly seen in alcoholics and other individuals with a chronic deficiency of thiamine."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1718,
    "user_query": "How many and which are the different isoforms for the ryanodine receptor?",
    "vicuna-13b_response": "The ryanodine receptor (RyR) is a type of calcium channel found in the sarcoplasmic reticulum (SR) of muscle cells. There are three main isoforms of the RyR: RyR1, RyR2, and RyR3.\n1. RyR1: This is the most widely studied isoform and is found in skeletal muscle, heart, and other tissues. RyR1 is responsible for the release of calcium from the SR and plays a key role in muscle contraction.\n2. RyR2: This isoform is found in the brain and is involved in the regulation of neurotransmitter release.\n3. RyR3: This isoform is found in the SR of smooth muscle cells and plays a role in the regulation of smooth muscle contraction.\nIn addition to these three main isoforms, there are also several smaller isoforms of the RyR that have been identified, including RyR4, RyR5, and RyR6. However, these isoforms are less well understood and their functions are not as well characterized as those of RyR1, RyR2, and RyR3.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The ryanodine receptor (RyR) is a type of calcium channel found in the sarcoplasmic reticulum (SR) of muscle cells.\n2. There are three main isoforms of the RyR: RyR1, RyR2, and RyR3.\n3. The RyR1 isoform is found in skeletal muscle, heart, and other tissues.\n4. The RyR2 isoform is found in the brain and is involved in the regulation of neurotransmitter release.\n5. The RyR3 isoform is found in the SR of smooth muscle cells.",
    "vicuna-13b_fact": [
      "The ryanodine receptor (RyR) is a type of calcium channel found in the sarcoplasmic reticulum (SR) of muscle cells.",
      "There are three main isoforms of the RyR: RyR1, RyR2, and RyR3.",
      "The RyR1 isoform is found in skeletal muscle, heart, and other tissues.",
      "The RyR2 isoform is found in the brain and is involved in the regulation of neurotransmitter release.",
      "The RyR3 isoform is found in the SR of smooth muscle cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The RyR2 isoform is primarily found in cardiac muscle and is involved in the regulation of cardiac muscle contraction.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "vicuna-13b_response": "Fibronectin is a protein that is involved in a variety of biological processes, including cell adhesion and migration. In the context of Duchenne muscular dystrophy (DMD), fibronectin has been studied as a potential biomarker for the disease.\nDMD is a genetic disorder that affects muscle function and results from mutations in the dystrophin gene. Dystrophin is a protein that is important for maintaining the integrity of muscle cells and protecting them from damage. In DMD, the lack of dystrophin leads to progressive muscle degeneration and weakness.\nFibronectin has been found to be elevated in the blood of individuals with DMD, and this has led to its consideration as a potential biomarker for the disease. However, the exact relationship between fibronectin levels and the severity of DMD is not well understood, and more research is needed to determine the utility of fibronectin as a diagnostic biomarker for the disease.\nIn summary, while fibronectin has been studied as a potential biomarker for DMD, its utility as a diagnostic tool is still being evaluated and more research is needed to fully understand its role in the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fibronectin is a protein that is involved in cell adhesion and migration.\n2. Duchenne muscular dystrophy (DMD) is a genetic disorder that affects muscle function and results from mutations in the dystrophin gene.\n3. Dystrophin is a protein that is important for maintaining the integrity of muscle cells and protecting them from damage.\n4. Fibronectin has been found to be elevated in the blood of individuals with DMD.\n5. The relationship between fibronectin levels and the severity of DMD is not well understood.",
    "vicuna-13b_fact": [
      "Fibronectin is a protein that is involved in cell adhesion and migration.",
      "Duchenne muscular dystrophy (DMD) is a genetic disorder that affects muscle function and results from mutations in the dystrophin gene.",
      "Dystrophin is a protein that is important for maintaining the integrity of muscle cells and protecting them from damage.",
      "Fibronectin has been found to be elevated in the blood of individuals with DMD.",
      "The relationship between fibronectin levels and the severity of DMD is not well understood."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1732,
    "user_query": "What is the association between number of pregnancies and rheumatoid arthritis",
    "vicuna-13b_response": "There is some evidence to suggest that there may be an association between the number of pregnancies a woman has and her risk of developing rheumatoid arthritis (RA).\nStudies have shown that women who have had more than two pregnancies may be at a higher risk of developing RA compared to those who have had fewer pregnancies or no pregnancies. This may be due to the hormonal changes that occur during pregnancy, which can affect the immune system and increase the risk of autoimmune diseases like RA.\nHowever, it's important to note that the relationship between pregnancies and RA is not fully understood and more research is needed to confirm the association and determine the underlying mechanisms. Additionally, it's important to remember that the risk of developing RA is still relatively low, even in women who have had multiple pregnancies.\nOverall, while there may be an association between the number of pregnancies and RA, it is not a definitive risk factor and other factors such as genetics, environment, and lifestyle also play a role in the development of the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Research suggests an association between the number of pregnancies a woman has and her risk of developing rheumatoid arthritis (RA).\n2. Studies have shown that women who have had more than two pregnancies may be at a higher risk of developing RA.\n3. The hormonal changes that occur during pregnancy can affect the immune system and increase the risk of autoimmune diseases like RA.\n4. The relationship between pregnancies and RA is not fully understood and more research is needed to confirm this association.\n5. Other factors such as genetics, environment, and lifestyle also play a role in the development of RA.",
    "vicuna-13b_fact": [
      "Research suggests an association between the number of pregnancies a woman has and her risk of developing rheumatoid arthritis (RA).",
      "Studies have shown that women who have had more than two pregnancies may be at a higher risk of developing RA.",
      "The hormonal changes that occur during pregnancy can affect the immune system and increase the risk of autoimmune diseases like RA.",
      "The relationship between pregnancies and RA is not fully understood and more research is needed to confirm this association.",
      "Other factors such as genetics, environment, and lifestyle also play a role in the development of RA."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1737,
    "user_query": "Can we use prodrug amifostine to protect healthy cell during chemotherapy?",
    "vicuna-13b_response": "Yes, amifostine is a prodrug that can be used to protect healthy cells during chemotherapy. It is also known as WR-2721 or FT-207. Amifostine is a cytoprotectant, which means it can protect healthy cells from the toxic effects of chemotherapy.\nAmifostine works by converting to the active compound FT-205 in the body, which then binds to purine nucleosides and inhibits the activity of enzymes involved in DNA synthesis. This leads to a reduction in cell proliferation and a decrease in the toxicity of chemotherapy drugs to healthy cells.\nAmifostine has been used in clinical trials for the prevention of chemotherapy-induced toxicity in normal tissues, such as the gastrointestinal tract, lung, and bone marrow. It has also been studied for its potential to protect against the toxicity of radiation therapy.\nHowever, it is important to note that the use of amifostine in clinical practice is still limited, and more research is needed to fully understand its efficacy and safety. Additionally, the specific dosage and administration of amifostine used during chemotherapy can vary depending on the type of chemotherapy and the patient's medical history.\nIt is always recommended to consult with a healthcare professional for the most up-to-date information and advice on the use of amifostine or any other medication during chemotherapy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Amifostine is a prodrug that can be used to protect healthy cells during chemotherapy.\n2. Amifostine is also known as WR-2721 or FT-207.\n3. In the body, amifostine converts to the active compound FT-205, which binds to purine nucleosides and inhibits the activity of enzymes involved in DNA synthesis.\n4. Amifostine has been used in clinical trials for the prevention of chemotherapy-induced toxicity in normal tissues, such as the gastrointestinal tract, lung, and bone marrow.\n5. The specific dosage and administration of amifostine used during chemotherapy can vary depending on the type of chemotherapy and the patient's medical history.",
    "vicuna-13b_fact": [
      "Amifostine is a prodrug that can be used to protect healthy cells during chemotherapy.",
      "Amifostine is also known as WR-2721 or FT-207.",
      "In the body, amifostine converts to the active compound FT-205, which binds to purine nucleosides and inhibits the activity of enzymes involved in DNA synthesis.",
      "Amifostine has been used in clinical trials for the prevention of chemotherapy-induced toxicity in normal tissues, such as the gastrointestinal tract, lung, and bone marrow.",
      "The specific dosage and administration of amifostine used during chemotherapy can vary depending on the type of chemotherapy and the patient's medical history."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: In the body, amifostine converts to the active compound WR-1065, which helps to protect cells from the harmful effects of chemotherapy.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1738,
    "user_query": "Which is the main difference between Alu and B1 repeats?",
    "vicuna-13b_response": "Alu and B1 repeats are both types of repetitive DNA sequences that are found in the genome of many organisms, including humans. However, there are some key differences between these two types of repeats.\nAlu repeats are a type of short, dispersed repeat that is found in the genome of many primates, including humans. They are thought to have originated from the insertion of transposable elements, which are DNA sequences that can move around the genome. Alu repeats are typically around 300 base pairs long and are found in introns (non-coding regions of the genome) and exons (coding regions of the genome). They are also rich in the nucleotide G+C, which is unusual for a transposable element. Alu repeats have been shown to be involved in a variety of biological processes, including gene regulation and the development of certain diseases.\nB1 repeats, on the other hand, are a type of long, simple repeat that is found in the genome of many organisms, including humans. They are thought to have originated from the amplification of a short, repetitive sequence. B1 repeats are typically around 100-200 base pairs long and are found in introns. They are also rich in the nucleotide A+T, which is unusual for a simple repeat. B1 repeats have been shown to be involved in the regulation of gene expression and the development of certain diseases, including cancer.\nIn summary, the main difference between Alu and B1 repeats is their length and composition. Alu repeats are typically shorter and rich in G+C, while B1 repeats are longer and rich in A+T. Additionally, Alu repeats are found in both introns and exons, while B1 repeats are found only in introns.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Alu and B1 repeats are both types of repetitive DNA sequences found in the genome of many organisms, including humans.\n2. Alu repeats are a type of short, dispersed repeat that is found in the genome of many primates, including humans.\n3. B1 repeats are a type of long, simple repeat that is found in the genome of many organisms.\n4. The main difference between Alu and B1 repeats is their length and composition: Alu repeats are shorter and rich in G+C, while B1 repeats are longer and rich in A+T.\n5. Alu repeats are found in both introns and exons, while B1 repeats are found only in introns.",
    "vicuna-13b_fact": [
      "Alu and B1 repeats are both types of repetitive DNA sequences found in the genome of many organisms, including humans.",
      "Alu repeats are a type of short, dispersed repeat that is found in the genome of many primates, including humans.",
      "B1 repeats are a type of long, simple repeat that is found in the genome of many organisms.",
      "The main difference between Alu and B1 repeats is their length and composition: Alu repeats are shorter and rich in G+C, while B1 repeats are longer and rich in A+T.",
      "Alu repeats are found in both introns and exons, while B1 repeats are found only in introns."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: B1 repeats are also a type of short, interspersed element found in the genome of many organisms.\n4. FALSE [correction]: The main difference between Alu and B1 repeats is not their length and composition, but rather the organisms where they are predominantly found. Alu repeats are found in primates (including humans) while B1 repeats are found in mice.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1740,
    "user_query": "What is the frequency of mutations induced spontaneously through Ethylnitrosourea (ENU) mutagenesis?",
    "vicuna-13b_response": "ENU (Ethyl Nitrosourea) is a mutagen that can induce point mutations, insertions, and deletions in DNA. The frequency of mutations induced by ENU mutagenesis can vary depending on the specific conditions used for the mutagenesis, such as the concentration of ENU and the length of exposure to the mutagen. In general, the frequency of mutations can be increased by using higher concentrations of ENU or by exposing cells to the mutagen for longer periods of time. The frequency of mutations can also be influenced by the type of cell or organism used for the mutagenesis, with some cells or organisms being more susceptible to mutagenesis than others. In addition, the specific type of mutation induced by ENU can also affect the frequency of mutations, with some types of mutations occurring more frequently than others. Overall, the frequency of mutations induced by ENU mutagenesis can vary widely, and it is important to carefully optimize the conditions used for the mutagenesis in order to obtain a high frequency of the desired type of mutation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ENU (Ethyl Nitrosourea) is a mutagen that can induce point mutations, insertions, and deletions in DNA.\n2. The frequency of mutations induced by ENU mutagenesis can vary depending on the specific conditions used for the mutagenesis.\n3. The frequency of mutations can be increased by using higher concentrations of ENU or by exposing cells to the mutagen for longer periods of time.\n4. The type of cell or organism used for the mutagenesis can influence the frequency of mutations.\n5. The specific type of mutation induced by ENU can also affect the frequency of mutations.",
    "vicuna-13b_fact": [
      "ENU (Ethyl Nitrosourea) is a mutagen that can induce point mutations, insertions, and deletions in DNA.",
      "The frequency of mutations induced by ENU mutagenesis can vary depending on the specific conditions used for the mutagenesis.",
      "The frequency of mutations can be increased by using higher concentrations of ENU or by exposing cells to the mutagen for longer periods of time.",
      "The type of cell or organism used for the mutagenesis can influence the frequency of mutations.",
      "The specific type of mutation induced by ENU can also affect the frequency of mutations."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The specific type of mutation induced by ENU is determined by its mechanism of action, it does not influence the frequency of mutations.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1758,
    "user_query": "Has Glucose-6-phosphate dehydrogenase (G6PD) deficiency an X-linked inheritance?",
    "vicuna-13b_response": "Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic condition that affects the body's ability to produce a protein called G6PD, which is involved in the metabolism of glucose. G6PD deficiency is a common genetic disorder, particularly in people of African, Southeast Asian, and Mediterranean descent.\nThe inheritance pattern of G6PD deficiency is not X-linked, but rather follows a complex pattern of inheritance. G6PD is located on chromosome X, but the gene that encodes for it is not linked to any specific disease or disorder. The deficiency can be caused by mutations in the G6PD gene, which can be inherited from either parent.\nG6PD deficiency is a recessive genetic disorder, meaning that an individual must inherit two copies of the gene (one from each parent) to develop the condition. If an individual has one normal copy of the G6PD gene and one copy with a mutation, they are a carrier of the disorder and may not show any symptoms. However, if they have two copies of the mutated gene, they will develop G6PD deficiency.\nIn summary, G6PD deficiency is not an X-linked inheritance disorder, but rather follows a complex pattern of inheritance. It is a recessive genetic disorder that can be caused by mutations in the G6PD gene and is more common in people of certain ethnic backgrounds.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic condition that affects the body's ability to produce a protein called G6PD.\n2. G6PD deficiency is a common genetic disorder, particularly in people of African, Southeast Asian, and Mediterranean descent.\n3. The gene for G6PD is located on chromosome X.\n4. G6PD deficiency is a recessive genetic disorder, meaning that an individual must inherit two copies of the gene to develop the condition.\n5. Individuals with one normal copy of the G6PD gene and one copy with a mutation are carriers of the disorder.",
    "vicuna-13b_fact": [
      "Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic condition that affects the body's ability to produce a protein called G6PD.",
      "G6PD deficiency is a common genetic disorder, particularly in people of African, Southeast Asian, and Mediterranean descent.",
      "The gene for G6PD is located on chromosome X.",
      "G6PD deficiency is a recessive genetic disorder, meaning that an individual must inherit two copies of the gene to develop the condition.",
      "Individuals with one normal copy of the G6PD gene and one copy with a mutation are carriers of the disorder."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: G6PD deficiency is an X-linked genetic disorder, which means males only need one copy of the gene to develop the condition, while females need two copies.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1760,
    "user_query": "Which mutated genes are associated with the Tourette's syndrome?",
    "vicuna-13b_response": "Tourette's syndrome is a neurodevelopmental disorder characterized by the presence of motor and vocal tics. The exact cause of Tourette's syndrome is not known, but research has identified several genetic mutations that are associated with an increased risk of developing the condition.\nOne of the most well-known genetic mutations associated with Tourette's syndrome is a deletion on chromosome 16p13.3, which has been found to occur in about 50% of individuals with the condition. This deletion involves the removal of a segment of DNA that contains the gene for the protein tyrosine phosphatase-like protein Tourette's syndrome 1 (TSG1).\nAnother genetic mutation associated with Tourette's syndrome is a variation in the gene for the neurotransmitter dopamine, specifically a single nucleotide polymorphism (SNP) in the dopamine transporter gene (SLC6A3). This variation has been found to be more common in individuals with Tourette's syndrome than in the general population.\nAdditionally, several other genes have been identified as potential risk factors for Tourette's syndrome, including the gene for the protein parkin (PARK2), the gene for the protein glutamic acid decarboxylase (GAD1), and the gene for the protein elongation factor-1 alpha (EF1A).\nIt's important to note that while genetics plays a role in the development of Tourette's syndrome, the condition is not solely determined by genetics. Environmental and other factors are also thought to contribute to the development of the condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tourette's syndrome is a neurodevelopmental disorder characterized by the presence of motor and vocal tics.\n2. One well-known genetic mutation associated with Tourette's syndrome is a deletion on chromosome 16p13.3.\n3. This deletion involves the removal of a segment of DNA that contains the gene for the protein tyrosine phosphatase-like protein Tourette's syndrome 1 (TSG1).\n4. Another genetic mutation associated with Tourette's syndrome is a variation in the dopamine transporter gene (SLC6A3).\n5. Some other genes identified as potential risk factors for Tourette's syndrome are the gene for the protein parkin (PARK2), the gene for the protein glutamic acid decarboxylase (GAD1), and the gene for the protein elongation factor-1 alpha (EF1A).",
    "vicuna-13b_fact": [
      "Tourette's syndrome is a neurodevelopmental disorder characterized by the presence of motor and vocal tics.",
      "One well-known genetic mutation associated with Tourette's syndrome is a deletion on chromosome 16p13.3.",
      "This deletion involves the removal of a segment of DNA that contains the gene for the protein tyrosine phosphatase-like protein Tourette's syndrome 1 (TSG1).",
      "Another genetic mutation associated with Tourette's syndrome is a variation in the dopamine transporter gene (SLC6A3).",
      "Some other genes identified as potential risk factors for Tourette's syndrome are the gene for the protein parkin (PARK2), the gene for the protein glutamic acid decarboxylase (GAD1), and the gene for the protein elongation factor-1 alpha (EF1A)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "vicuna-13b_response": "The DeepBlue epigenomic data server is a comprehensive database of epigenomic data from a variety of organisms and experimental conditions. Some of the major epigenome projects that are contained in the DeepBlue database include:\n1. The Roadmap Epigenomics Project: This project is a comprehensive study of the epigenomes of over 100 different cell types from human, mouse, and rat. The data is available for browsing and download on the DeepBlue website.\n2. The ENCODE Project: This project is a large-scale effort to characterize the functional elements in the human genome, including the epigenome. The data from the ENCODE project is available on the DeepBlue website, and includes information on chromatin accessibility, DNA methylation, and histone modifications.\n3. The Epigenome Atlas Project: This project is a collaborative effort to generate and analyze epigenomic data from a variety of organisms, including human, mouse, and fruit fly. The data from the Epigenome Atlas Project is available on the DeepBlue website, and includes information on chromatin accessibility, DNA methylation, and histone modifications.\n4. The Single Cell Epigenomics Project: This project is a comprehensive study of the epigenomes of individual cells, including both normal and disease cells. The data from the Single Cell Epigenomics Project is available on the DeepBlue website, and includes information on chromatin accessibility, DNA methylation, and histone modifications.\nThese are just a few examples of the major epigenome projects that are contained in the DeepBlue epigenomic data server. The database is constantly being updated with new data, so it is a valuable resource for researchers in the field of epigenetics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The DeepBlue epigenomic data server contains data from the Roadmap Epigenomics Project.\n2. Data from the ENCODE Project is available on the DeepBlue website.\n3. The Epigenome Atlas Project data, which includes a variety of organisms, is contained in the DeepBlue database.\n4. The DeepBlue database includes data from the Single Cell Epigenomics Project.\n5. The DeepBlue epigenomic data server is constantly being updated with new data.",
    "vicuna-13b_fact": [
      "The DeepBlue epigenomic data server contains data from the Roadmap Epigenomics Project.",
      "Data from the ENCODE Project is available on the DeepBlue website.",
      "The Epigenome Atlas Project data, which includes a variety of organisms, is contained in the DeepBlue database.",
      "The DeepBlue database includes data from the Single Cell Epigenomics Project.",
      "The DeepBlue epigenomic data server is constantly being updated with new data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Epigenome Atlas Project data, which includes a variety of human tissues, is contained in the DeepBlue database.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1765,
    "user_query": "Is the toxin produced by Clostridium botulinum always deadly?",
    "vicuna-13b_response": "The toxin produced by Clostridium botulinum is one of the most potent toxins known, and it can cause a severe and potentially life-threatening condition called botulism. However, not all cases of botulism are fatal.\nBotulism is a foodborne illness caused by the ingestion of food or drink that contains the toxin produced by C. botulinum. The toxin works by blocking the release of acetylcholine, a neurotransmitter that is essential for muscle function. This can cause muscle weakness and paralysis, which can lead to difficulty swallowing, breathing, and other serious complications.\nThe severity of botulism depends on the amount of toxin ingested and the age and health of the individual. In general, botulism is more common in infants and young children, who may not have fully developed immune systems and are more susceptible to the toxin. In these cases, botulism can be life-threatening and requires prompt medical treatment.\nIn adults, botulism is generally less severe and can be treated with antitoxins and supportive care. However, even in these cases, botulism can still cause significant illness and may require hospitalization.\nIt is important to note that while not all cases of botulism are fatal, it is still a serious condition that requires prompt medical attention. If you suspect that you or someone you know may have botulism, it is important to seek medical care immediately.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The toxin produced by Clostridium botulinum can cause botulism.\n2. Botulism is a foodborne illness caused by the ingestion of food or drink that contains the toxin produced by C. botulinum.\n3. The toxin produced by Clostridium botulinum works by blocking the release of acetylcholine, a neurotransmitter essential for muscle function.\n4. The severity of botulism depends on the amount of toxin ingested and the age and health of the individual.\n5. Botulism is more common in infants and young children and can be life-threatening.",
    "vicuna-13b_fact": [
      "The toxin produced by Clostridium botulinum can cause botulism.",
      "Botulism is a foodborne illness caused by the ingestion of food or drink that contains the toxin produced by C. botulinum.",
      "The toxin produced by Clostridium botulinum works by blocking the release of acetylcholine, a neurotransmitter essential for muscle function.",
      "The severity of botulism depends on the amount of toxin ingested and the age and health of the individual.",
      "Botulism is more common in infants and young children and can be life-threatening."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1771,
    "user_query": "Describe mechanism of action of Eteplirsen?",
    "vicuna-13b_response": "Eteplirsen is an experimental drug that is being developed to treat Duchenne muscular dystrophy (DMD), a genetic disorder that affects muscle strength and mobility. The mechanism of action of eteplirsen is based on its ability to bind to and stabilize dystrophin, a protein that is missing or defective in individuals with DMD.\nDystrophin is a crucial protein that helps maintain the integrity of muscle cells and protect them from damage. In individuals with DMD, the lack of dystrophin leads to progressive muscle degeneration and weakness. Eteplirsen is designed to restore the production of dystrophin in muscle cells by using a small molecule to bind to and stabilize the dystrophin protein.\nEteplirsen is administered via intravenous infusion and works by targeting the underlying genetic cause of DMD. The drug is designed to bind to the messenger RNA (mRNA) that carries the instructions for making dystrophin. By binding to this mRNA, eteplirsen prevents the body from eliminating it, leading to an increase in the production of dystrophin.\nThe increased production of dystrophin in muscle cells can help improve muscle function and slow the progression of DMD. Eteplirsen has shown promising results in clinical trials and is currently under review by regulatory authorities for potential approval.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Eteplirsen is an experimental drug being developed to treat Duchenne muscular dystrophy (DMD).\n2. Eteplirsen works by binding to and stabilizing dystrophin, which is missing or defective in individuals with DMD.\n3. Dystrophin is a protein that helps maintain the integrity of muscle cells and protect them from damage.\n4. Eteplirsen is administered via intravenous infusion.\n5. Eteplirsen targets the underlying genetic cause of DMD by binding to the mRNA that carries the instructions for making dystrophin.",
    "vicuna-13b_fact": [
      "Eteplirsen is an experimental drug being developed to treat Duchenne muscular dystrophy (DMD).",
      "Eteplirsen works by binding to and stabilizing dystrophin, which is missing or defective in individuals with DMD.",
      "Dystrophin is a protein that helps maintain the integrity of muscle cells and protect them from damage.",
      "Eteplirsen is administered via intravenous infusion.",
      "Eteplirsen targets the underlying genetic cause of DMD by binding to the mRNA that carries the instructions for making dystrophin."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Eteplirsen is not an experimental drug, it is an approved drug to treat Duchenne muscular dystrophy (DMD).\n2. FALSE [correction]: Eteplirsen works by binding to the messenger RNA (mRNA) sequence and enabling dystrophin protein production, which is often missing or defective in individuals with DMD.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1777,
    "user_query": "Which gene-defect causes the Vel-blood type?",
    "vicuna-13b_response": "The Vel blood type is not a recognized blood type in the medical community. It is possible that you may be referring to a fictional or mythical blood type, or a blood type that is not widely recognized or studied.\nIf you have any further information or context about the Vel blood type, please let me know and I will do my best to provide an answer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Vel blood type is not a recognized blood type in the medical community.",
    "vicuna-13b_fact": [
      "The Vel blood type is not a recognized blood type in the medical community."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Vel blood type is a rare blood type that is recognized by the medical community.",
    "vicuna-13b_judge": [
      "false"
    ]
  },
  {
    "id": 1782,
    "user_query": "What are the exonic splice enhancers?",
    "vicuna-13b_response": "Exonic splice enhancers are specific DNA sequences that are located within the coding region of a gene and that function to increase the efficiency of splicing of the gene's mRNA. These enhancers can be identified by their ability to stimulate the splicing of a reporter gene construct in a transient transfection assay, and they are thought to function by recruiting the U1 small nuclear ribonucleoprotein (U1 snRNP) to the splice site. Exonic splice enhancers are important for the proper expression of genes, and mutations in these sequences can lead to splicing defects and disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Exonic splice enhancers are specific DNA sequences that are located within the coding region of a gene.\n2. Exonic splice enhancers function to increase the efficiency of splicing of the gene's mRNA.\n3. These enhancers can be identified by their ability to stimulate the splicing of a reporter gene construct in a transient transfection assay.\n4. Exonic splice enhancers are thought to function by recruiting the U1 small nuclear ribonucleoprotein (U1 snRNP) to the splice site.\n5. Mutations in exonic splice enhancer sequences can lead to splicing defects and disease.",
    "vicuna-13b_fact": [
      "Exonic splice enhancers are specific DNA sequences that are located within the coding region of a gene.",
      "Exonic splice enhancers function to increase the efficiency of splicing of the gene's mRNA.",
      "These enhancers can be identified by their ability to stimulate the splicing of a reporter gene construct in a transient transfection assay.",
      "Exonic splice enhancers are thought to function by recruiting the U1 small nuclear ribonucleoprotein (U1 snRNP) to the splice site.",
      "Mutations in exonic splice enhancer sequences can lead to splicing defects and disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Exonic splice enhancers are thought to function by recruiting splicing factors, not specifically the U1 small nuclear ribonucleoprotein (U1 snRNP), to the splice site.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1784,
    "user_query": "What is Neisseria adhesin A?",
    "vicuna-13b_response": "Neisseria adhesin A (NadA) is a protein found on the surface of the bacterium Neisseria meningitidis, which is a causative agent of meningococcal disease. NadA is a key factor in the bacterium's ability to colonize and infect human hosts.\nNadA is a surface protein that is expressed by the bacterium and is involved in the attachment of the bacterium to human cells. It is a major virulence factor that plays a role in the initiation of infection by allowing the bacterium to adhere to and invade human cells. NadA is also involved in the formation of biofilms, which are communities of bacteria that are embedded in a matrix of extracellular polymeric substances and are resistant to antibiotics and host defenses.\nNadA has been studied extensively as a potential vaccine candidate for meningococcal disease, and several vaccines have been developed that use NadA as an antigen. These vaccines have shown promising results in clinical trials and are currently being evaluated for their efficacy and safety.\nOverall, NadA is an important factor in the pathogenesis of meningococcal disease and is a promising target for the development of vaccines and other therapeutic strategies to prevent and treat this disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Neisseria adhesin A (NadA) is a protein found on the surface of the bacterium Neisseria meningitidis.\n2. Neisseria meningitidis is a causative agent of meningococcal disease.\n3. NadA plays a role in the initiation of infection by allowing the bacterium to adhere to and invade human cells.\n4. NadA is involved in the formation of biofilms, which are communities of bacteria that are resistant to antibiotics and host defenses.\n5. Several vaccines using NadA as an antigen have been developed and are currently being evaluated for their efficacy and safety in preventing meningococcal disease.",
    "vicuna-13b_fact": [
      "Neisseria adhesin A (NadA) is a protein found on the surface of the bacterium Neisseria meningitidis.",
      "Neisseria meningitidis is a causative agent of meningococcal disease.",
      "NadA plays a role in the initiation of infection by allowing the bacterium to adhere to and invade human cells.",
      "NadA is involved in the formation of biofilms, which are communities of bacteria that are resistant to antibiotics and host defenses.",
      "Several vaccines using NadA as an antigen have been developed and are currently being evaluated for their efficacy and safety in preventing meningococcal disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1785,
    "user_query": "Which R package is used for the detection of chromosomal abnormalities from microarray data?",
    "vicuna-13b_response": "The R package \"affy\" is commonly used for the detection of chromosomal abnormalities from microarray data. This package provides a set of functions for the analysis of Affymetrix GeneChip data, including the detection of copy number variations (CNVs) which can indicate chromosomal abnormalities. Other packages such as \"limma\" and \"edgeR\" can also be used for the analysis of microarray data and detection of chromosomal abnormalities.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The R package \"affy\" is commonly used for the detection of chromosomal abnormalities from microarray data.\n2. The \"affy\" package provides a set of functions for the analysis of Affymetrix GeneChip data.\n3. The \"affy\" package can help detect copy number variations (CNVs) which can indicate chromosomal abnormalities.\n4. The \"limma\" and \"edgeR\" are other R packages that can be used for the analysis of microarray data and detection of chromosomal abnormalities.",
    "vicuna-13b_fact": [
      "The R package \"affy\" is commonly used for the detection of chromosomal abnormalities from microarray data.",
      "The \"affy\" package provides a set of functions for the analysis of Affymetrix GeneChip data.",
      "The \"affy\" package can help detect copy number variations (CNVs) which can indicate chromosomal abnormalities.",
      "The \"limma\" and \"edgeR\" are other R packages that can be used for the analysis of microarray data and detection of chromosomal abnormalities."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The R package \"affy\" is commonly used for the analysis of Affymetrix GeneChip data, not specifically for the detection of chromosomal abnormalities.\n2. TRUE\n3. FALSE [correction]: The \"affy\" package is not specifically designed to detect copy number variations (CNVs). However, the detection of CNVs can be a part of the processing and analysis of microarray data.\n4. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "vicuna-13b_response": "A self-organizing map (SOM) is a type of neural network that can be used to map high-dimensional input data to a lower-dimensional representation. In the context of analyzing codon usage in molecular biology, SOMs can be used to identify groups of codons that are functionally equivalent, despite differences in their nucleotide sequence. This can be useful for understanding how cells translate genetic information into proteins, and for identifying potential targets for genetic engineering and synthetic biology applications. Some tools that employ SOMs for analyzing synonymous codon usage include the CodonUsage tool, which is part of the Bioinformatics Toolbox in MATLAB, and the CodonW tool, which is a standalone software package for analyzing codon usage in protein-coding genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Self-organizing map (SOM) is a type of neural network used to map high-dimensional input data to a lower-dimensional representation.\n2. Self-organizing maps can be used to analyze codon usage in molecular biology.\n3. SOMs assist in identifying groups of codons that are functionally equivalent, despite differences in their nucleotide sequences.\n4. The CodonUsage tool, part of the Bioinformatics Toolbox in MATLAB, employs self-organizing maps for analyzing synonymous codon usage.\n5. The CodonW tool, a standalone software package, employs self-organizing maps for analyzing codon usage in protein-coding genes.",
    "vicuna-13b_fact": [
      "Self-organizing map (SOM) is a type of neural network used to map high-dimensional input data to a lower-dimensional representation.",
      "Self-organizing maps can be used to analyze codon usage in molecular biology.",
      "SOMs assist in identifying groups of codons that are functionally equivalent, despite differences in their nucleotide sequences.",
      "The CodonUsage tool, part of the Bioinformatics Toolbox in MATLAB, employs self-organizing maps for analyzing synonymous codon usage.",
      "The CodonW tool, a standalone software package, employs self-organizing maps for analyzing codon usage in protein-coding genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "vicuna-13b_response": "MINDY-1 is a type of neural network architecture that is designed for natural language processing tasks. It stands for Multi-layer Intent Detection and You-detection, and it is a deep learning model that is capable of understanding the intent behind a given text and identifying the person who wrote it.\nThe MINDY-1 architecture is composed of several layers, including a convolutional layer, a bidirectional layer, and a fully connected layer. The convolutional layer is used to extract features from the input text, while the bidirectional layer is used to capture the context and dependencies between words. The fully connected layer is responsible for making predictions about the intent and author of the text.\nThe MINDY-1 model was trained on a large dataset of text samples and is capable of accurately identifying the intent and author of new, unseen text. It has been used for a variety of natural language processing tasks, including sentiment analysis, named entity recognition, and text classification.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MINDY-1 is a type of neural network architecture.\n2. MINDY-1 is designed for natural language processing tasks.\n3. The MINDY-1 architecture is composed of several layers, including a convolutional layer, a bidirectional layer, and a fully connected layer. \n4. MINDY-1 was trained on a large dataset of text samples.\n5. MINDY-1 has been used for a variety of natural language processing tasks, including sentiment analysis, named entity recognition, and text classification.",
    "vicuna-13b_fact": [
      "MINDY-1 is a type of neural network architecture.",
      "MINDY-1 is designed for natural language processing tasks.",
      "The MINDY-1 architecture is composed of several layers, including a convolutional layer, a bidirectional layer, and a fully connected layer.",
      "MINDY-1 was trained on a large dataset of text samples.",
      "MINDY-1 has been used for a variety of natural language processing tasks, including sentiment analysis, named entity recognition, and text classification."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1805,
    "user_query": "What is BioCreative?",
    "vicuna-13b_response": "BioCreative is a community-driven, open-source platform for biotechnology. It is a collaborative effort to promote the development and responsible use of biotechnology, and to provide resources and support for researchers, entrepreneurs, and innovators in the field.\nBioCreative aims to make biotechnology more accessible and affordable, and to encourage the creation of new biotechnology applications and products. The platform provides a range of tools and resources, including a marketplace for biotech products and services, a community forum for discussion and collaboration, and a database of biotech research and information.\nBioCreative also promotes the responsible use of biotechnology, and encourages researchers and innovators to consider the ethical and societal implications of their work. The platform provides resources and support for the development of responsible and ethical biotechnology practices, and works to educate the public about the potential benefits and risks of biotechnology.\nOverall, BioCreative is a valuable resource for anyone interested in biotechnology, and aims to promote the development of innovative and responsible biotechnology solutions for the benefit of society.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BioCreative is a community-driven, open-source platform for biotechnology.\n2. The platform provides a marketplace for biotech products and services, a community forum for discussion and collaboration, and a database of biotech research and information.\n3. BioCreative promotes the responsible use of biotechnology and the consideration of the ethical and societal implications of biotech work.\n4. BioCreative provides resources and support for the development of responsible and ethical biotechnology practices.\n5. BioCreative works to educate the public about the potential benefits and risks of biotechnology.",
    "vicuna-13b_fact": [
      "BioCreative is a community-driven, open-source platform for biotechnology.",
      "The platform provides a marketplace for biotech products and services, a community forum for discussion and collaboration, and a database of biotech research and information.",
      "BioCreative promotes the responsible use of biotechnology and the consideration of the ethical and societal implications of biotech work.",
      "BioCreative provides resources and support for the development of responsible and ethical biotechnology practices.",
      "BioCreative works to educate the public about the potential benefits and risks of biotechnology."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: BioCreative is a community-wide effort for the evaluation of text mining and information extraction systems applied to the biological domain.\n2. FALSE [correction]: BioCreative does not provide a marketplace for biotech products and services, or community forum for discussion and collaboration. They do however help in the extraction of biotechnology related research information from texts.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1808,
    "user_query": "What type of mutation is causing the industrial melanism phenotype in peppered moths?",
    "vicuna-13b_response": "The industrial melanism phenotype in peppered moths is caused by a mutation in the BMP4 gene. This gene encodes for a protein that plays a role in the development of the embryo, including the development of pigmentation. The mutation in the BMP4 gene leads to an overproduction of melanin, resulting in the dark coloration of the moth's wings. This mutation has been selected for in peppered moths due to the increased camouflage it provides in industrial environments.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The industrial melanism phenotype in peppered moths is caused by a mutation in the BMP4 gene.\n2. The BMP4 gene encodes for a protein that plays a role in the development of the embryo, including the development of pigmentation.\n3. The mutation in the BMP4 gene leads to an overproduction of melanin.\n4. Overproduction of melanin causes the dark coloration of the moth's wings.\n5. This mutation provides increased camouflage in industrial environments, hence it's selected for in peppered moths.",
    "vicuna-13b_fact": [
      "The industrial melanism phenotype in peppered moths is caused by a mutation in the BMP4 gene.",
      "The BMP4 gene encodes for a protein that plays a role in the development of the embryo, including the development of pigmentation.",
      "The mutation in the BMP4 gene leads to an overproduction of melanin.",
      "Overproduction of melanin causes the dark coloration of the moth's wings.",
      "This mutation provides increased camouflage in industrial environments, hence it's selected for in peppered moths."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The industrial melanism phenotype in peppered moths is caused by a mutation in the cortex gene, not the BMP4 gene.\n2. TRUE\n3. FALSE [correction]: The mutation in the cortex gene leads to a change in the distribution of melanin, not necessarily an overproduction.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "vicuna-13b_response": "There are several software packages available for the analysis of conserved genomic loci. Some of the popular ones are:\n1. Conserved Elements in Regulatory Networks (CERN): It is a web-based tool that identifies conserved non-coding elements (CNEs) in the genomic regions surrounding a gene of interest. It can also predict the potential regulatory functions of these CNEs based on their evolutionary conservation and functional annotations.\n2. PhyloBayes: It is a software package that can be used to identify conserved genomic regions based on their evolutionary history. It uses Bayesian methods to infer the evolutionary history of multiple genomes and identifies regions that are conserved across different species.\n3. Genomic Regions Enriched in Annotation (GREAT): It is a web-based tool that can be used to identify genomic regions that are enriched in functional annotations, such as transcription factor binding sites or regulatory motifs. It can also identify conserved regions based on their evolutionary conservation.\n4. Regulatory Genomic Units (RGUs): It is a software package that can be used to identify regulatory elements in the genome, including enhancers, promoters, and silencers. It can also identify conserved RGUs across different species.\n5. Genome-wide Identification of Functional Elements Using Comparative Genomics (GIFEST): It is a software package that can be used to identify functional elements in the genome based on their evolutionary conservation. It can identify conserved regions, regulatory motifs, and other functional elements.\nThese are just a few examples of the software packages available for the analysis of conserved genomic loci. The choice of software depends on the specific research question and the type of data being analyzed.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Conserved Elements in Regulatory Networks (CERN) is a software that identifies conserved non-coding elements in the genomic regions surrounding a gene of interest.\n2. PhyloBayes is a software package used to identify conserved genomic regions based on evolutionary history using Bayesian methods.\n3. Genomic Regions Enriched in Annotation (GREAT) is a web-based tool used to identify genomic regions that are enriched in functional annotations.\n4. Regulatory Genomic Units (RGUs) is a software package that identifies regulatory elements in the genome, including enhancers, promoters, and silencers.\n5. Genome-wide Identification of Functional Elements Using Comparative Genomics (GIFEST) is used to identify functional elements in the genome based on their evolutionary conservation.",
    "vicuna-13b_fact": [
      "Conserved Elements in Regulatory Networks (CERN) is a software that identifies conserved non-coding elements in the genomic regions surrounding a gene of interest.",
      "PhyloBayes is a software package used to identify conserved genomic regions based on evolutionary history using Bayesian methods.",
      "Genomic Regions Enriched in Annotation (GREAT) is a web-based tool used to identify genomic regions that are enriched in functional annotations.",
      "Regulatory Genomic Units (RGUs) is a software package that identifies regulatory elements in the genome, including enhancers, promoters, and silencers.",
      "Genome-wide Identification of Functional Elements Using Comparative Genomics (GIFEST) is used to identify functional elements in the genome based on their evolutionary conservation."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1812,
    "user_query": "What is Eteplirsen (Exondys 51)?",
    "vicuna-13b_response": "Eteplirsen, also known by its brand name Exondys 51, is a medication that is used to treat patients with Duchenne muscular dystrophy (DMD). DMD is a genetic disorder that affects muscle strength and function, and it is caused by a lack of dystrophin, a protein that helps keep muscle cells intact.\nEteplirsen is a type of medication called an exon-skipping therapy. It works by helping the body to skip over a certain exon in the dystrophin gene, which allows the body to still produce a functional version of the dystrophin protein. This can help to slow the progression of DMD and improve muscle function in patients.\nEteplirsen is administered via intravenous infusion, and it is typically given once a week. The medication is available in the United States and several other countries, but it is not currently available in all countries.\nIt is important to note that Eteplirsen is only approved for the treatment of DMD in patients who have a specific genetic mutation, and it is not effective for all patients with DMD. Additionally, the medication can have side effects, and it is important for patients to discuss the potential benefits and risks of treatment with their healthcare provider before starting therapy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Eteplirsen, also known by its brand name Exondys 51, is used to treat Duchenne muscular dystrophy (DMD).\n2. DMD is a genetic disorder that affects muscle strength and function.\n3. Eteplirsen is an exon-skipping therapy.\n4. Eteplirsen is administered via intravenous infusion, typically once a week.\n5. Eteplirsen is available in the United States and several other countries, but not in all countries.",
    "vicuna-13b_fact": [
      "Eteplirsen, also known by its brand name Exondys 51, is used to treat Duchenne muscular dystrophy (DMD).",
      "DMD is a genetic disorder that affects muscle strength and function.",
      "Eteplirsen is an exon-skipping therapy.",
      "Eteplirsen is administered via intravenous infusion, typically once a week.",
      "Eteplirsen is available in the United States and several other countries, but not in all countries."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1813,
    "user_query": "What are the SINEUPs?",
    "vicuna-13b_response": "SINEUPs are a type of non-uniformly spaced time series data, which is commonly used in signal processing and time series analysis. The name \"SINEUP\" stands for \"Sine Wave with Equally Spaced Undulation Periods\".\nA SINEUP is a time series that consists of a sine wave with a fixed frequency, but with an undulation period that is not uniform. The undulation period is the time interval between successive local maxima or minima of the sine wave. In a SINEUP, the undulation period is constant and equal to the reciprocal of the number of data points in the time series.\nSINEUPs are often used as a benchmark signal for testing and evaluating the performance of signal processing and time series analysis algorithms. They are also used in various applications, such as in the analysis of physiological signals, speech signals, and other types of time series data.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SINEUPs are a type of non-uniformly spaced time series data used in signal processing and time series analysis.\n2. The name \"SINEUP\" stands for \"Sine Wave with Equally Spaced Undulation Periods\".\n3. A SINEUP consists of a sine wave with a fixed frequency and an undulation period that is not uniform.\n4. The undulation period in a SINEUP is constant and equal to the reciprocal of the number of data points in the time series.\n5. SINEUPs are commonly used in the analysis of physiological signals, speech signals, and other types of time series data.",
    "vicuna-13b_fact": [
      "SINEUPs are a type of non-uniformly spaced time series data used in signal processing and time series analysis.",
      "The name \"SINEUP\" stands for \"Sine Wave with Equally Spaced Undulation Periods\".",
      "A SINEUP consists of a sine wave with a fixed frequency and an undulation period that is not uniform.",
      "The undulation period in a SINEUP is constant and equal to the reciprocal of the number of data points in the time series.",
      "SINEUPs are commonly used in the analysis of physiological signals, speech signals, and other types of time series data."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1815,
    "user_query": "What is the mechanism of action of raxibacumab?",
    "vicuna-13b_response": "Raxibacumab is an intravenous (IV) monoclonal antibody drug that is used to treat a variety of inflammatory conditions, including ankylosing spondylitis, a type of arthritis that affects the spine. The mechanism of action of raxibacumab is not fully understood, but it is believed to involve the inhibition of a protein called tumor necrosis factor (TNF).\nTNF is a cytokine, which is a type of protein that plays a role in the immune response. It is involved in the inflammatory response and has been implicated in the development of a number of chronic inflammatory conditions, including ankylosing spondylitis. Raxibacumab binds to TNF and neutralizes it, which reduces the inflammatory response and helps to alleviate the symptoms of ankylosing spondylitis.\nRaxibacumab is typically given as an IV infusion, and the dosage and frequency of administration will depend on the specific condition being treated and the individual patient's needs. It is important to follow the instructions provided by your healthcare provider when receiving raxibacumab treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Raxibacumab is an intravenous monoclonal antibody drug.\n2. Raxibacumab is used to treat ankylosing spondylitis, a type of arthritis that affects the spine.\n3. The mechanism of action of raxibacumab includes the inhibition of a protein called tumor necrosis factor (TNF).\n4. TNF is a cytokine that plays a role in the immune response and is involved in the inflammatory response.\n5. Raxibacumab is typically given as an IV infusion, and the dosage and frequency of administration will depend on the specific condition being treated and the individual patient's needs.",
    "vicuna-13b_fact": [
      "Raxibacumab is an intravenous monoclonal antibody drug.",
      "Raxibacumab is used to treat ankylosing spondylitis, a type of arthritis that affects the spine.",
      "The mechanism of action of raxibacumab includes the inhibition of a protein called tumor necrosis factor (TNF).",
      "TNF is a cytokine that plays a role in the immune response and is involved in the inflammatory response.",
      "Raxibacumab is typically given as an IV infusion, and the dosage and frequency of administration will depend on the specific condition being treated and the individual patient's needs."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Raxibacumab is used to treat inhalational anthrax, not ankylosing spondylitis.\n3. FALSE [correction]: The mechanism of action of raxibacumab involves binding to the protective antigen component of the anthrax toxin to prevent the toxin from entering cells, not the inhibition of TNF.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1817,
    "user_query": "Is SUMOylation a post-translational modification in eukaryotes?",
    "vicuna-13b_response": "Yes, SUMOylation (short for Small Ubiquitin-like Modifier) is a post-translational modification in eukaryotes.\nSUMOylation is a process in which a small ubiquitin-like protein called SUMO is covalently attached to other proteins. This modification can alter the localization, stability, and activity of the target protein, and is involved in a wide range of cellular processes such as DNA repair, protein degradation, and gene expression regulation.\nThe SUMOylation process occurs in the cytoplasm and involves the action of a group of enzymes called SUMO ligases, which recognize and bind to specific regions of target proteins, and then add SUMO moieties to them. The target proteins can then be recognized by other proteins that bind to the SUMO moiety, leading to changes in their function.\nSUMOylation is a reversible process, and the target protein can be deSUMOylated by specific deSUMOylases, which remove the SUMO moiety from the target protein.\nOverall, SUMOylation is an important post-translational modification in eukaryotes, and plays a crucial role in regulating various cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SUMOylation is a post-translational modification in eukaryotes.\n2. The SUMOylation process involves the covalent attachment of a small ubiquitin-like protein called SUMO to other proteins. \n3. SUMOylation can alter the localization, stability, and activity of the target protein.\n4. The SUMOylation process involves a group of enzymes called SUMO ligases.\n5. SUMOylation is a reversible process that can be reversed by specific deSUMOylases.",
    "vicuna-13b_fact": [
      "SUMOylation is a post-translational modification in eukaryotes.",
      "The SUMOylation process involves the covalent attachment of a small ubiquitin-like protein called SUMO to other proteins.",
      "SUMOylation can alter the localization, stability, and activity of the target protein.",
      "The SUMOylation process involves a group of enzymes called SUMO ligases.",
      "SUMOylation is a reversible process that can be reversed by specific deSUMOylases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1823,
    "user_query": "Is Annexin V an apoptotic marker?",
    "vicuna-13b_response": "Yes, Annexin V is an apoptotic marker. It is a protein that is expressed on the surface of cells undergoing apoptosis (programmed cell death). When Annexin V binds to phosphatidylserine, which is a component of the cell membrane that is exposed during apoptosis, it helps to identify cells that are undergoing this process.\nAnnexin V is commonly used in scientific research to identify and quantify cells that are undergoing apoptosis. It can be used in a variety of techniques, such as flow cytometry, to measure the levels of Annexin V expression on cells. This information can be used to better understand the mechanisms of apoptosis, as well as to identify potential therapeutic targets for a variety of diseases.\nIn summary, Annexin V is an important apoptotic marker that is widely used in scientific research to identify and study the process of programmed cell death.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Annexin V is an apoptotic marker.\n2. Annexin V is a protein that is found on the surface of cells undergoing apoptosis.\n3. Annexin V binds to phosphatidylserine, a component of the cell membrane exposed during apoptosis.\n4. Annexin V is used in scientific research to identify and quantify cells undergoing apoptosis.\n5. Annexin V expression on cells can be measured using a variety of techniques, such as flow cytometry.",
    "vicuna-13b_fact": [
      "Annexin V is an apoptotic marker.",
      "Annexin V is a protein that is found on the surface of cells undergoing apoptosis.",
      "Annexin V binds to phosphatidylserine, a component of the cell membrane exposed during apoptosis.",
      "Annexin V is used in scientific research to identify and quantify cells undergoing apoptosis.",
      "Annexin V expression on cells can be measured using a variety of techniques, such as flow cytometry."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1825,
    "user_query": "What are PD-1 inhibitors?",
    "vicuna-13b_response": "PD-1 (Programmed Death-1) inhibitors are a type of cancer immunotherapy that work by blocking the PD-1 protein on T cells, which helps to enhance the immune system's ability to recognize and attack cancer cells. PD-1 is a receptor that is expressed on the surface of T cells, and it helps to regulate the immune response by preventing T cells from attacking healthy cells. However, cancer cells can exploit this mechanism by expressing PD-1 ligands, which bind to PD-1 and inhibit T cell activation.\nPD-1 inhibitors are monoclonal antibodies that bind to the PD-1 protein and block its interaction with PD-1 ligands, thereby releasing the brakes on the immune system and allowing T cells to attack cancer cells. PD-1 inhibitors have been approved for the treatment of several types of cancer, including melanoma, non-small cell lung cancer, and renal cell carcinoma.\nSome examples of PD-1 inhibitors include pembrolizumab (Keytruda), nivolumab (Opdivo), and durvalumab (Imfinzi). These drugs have shown significant clinical benefits for patients with advanced cancer, and they are often used in combination with other immunotherapies or chemotherapies to improve treatment outcomes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PD-1 inhibitors are a type of cancer immunotherapy.\n2. PD-1 inhibitors work by blocking the PD-1 protein, enhancing the immune system's ability to recognize and attack cancer cells.\n3. PD-1 inhibitors are monoclonal antibodies that counteract the PD-1 ligands, enabling T cells to attack cancer cells.\n4. PD-1 inhibitors have been approved for the treatment of several types of cancer, including melanoma, non-small cell lung cancer, and renal cell carcinoma.\n5. Examples of PD-1 inhibitors include pembrolizumab (Keytruda), nivolumab (Opdivo), and durvalumab (Imfinzi).",
    "vicuna-13b_fact": [
      "PD-1 inhibitors are a type of cancer immunotherapy.",
      "PD-1 inhibitors work by blocking the PD-1 protein, enhancing the immune system's ability to recognize and attack cancer cells.",
      "PD-1 inhibitors are monoclonal antibodies that counteract the PD-1 ligands, enabling T cells to attack cancer cells.",
      "PD-1 inhibitors have been approved for the treatment of several types of cancer, including melanoma, non-small cell lung cancer, and renal cell carcinoma.",
      "Examples of PD-1 inhibitors include pembrolizumab (Keytruda), nivolumab (Opdivo), and durvalumab (Imfinzi)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Examples of PD-1 inhibitors include pembrolizumab (Keytruda), nivolumab (Opdivo), but durvalumab (Imfinzi) is a PD-L1 inhibitor, not a PD-1 inhibitor.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1828,
    "user_query": "Is Migalastat used for treatment of Fabry Disease?",
    "vicuna-13b_response": "Yes, Migalastat is used for the treatment of Fabry disease. Fabry disease is an inherited disorder caused by a deficiency of the enzyme alpha-galactosidase A, which leads to the accumulation of a specific type of fat molecule called globotriaosylceramide (GL-3) in various cells and tissues of the body. Migalastat is a phosphate donor that helps to stabilize the body's natural alpha-galactosidase A enzyme, which in turn helps to reduce the accumulation of GL-3 in cells and tissues.\nMigalastat is used in combination with another medication called ERT (enzyme replacement therapy) to treat Fabry disease. ERT is a treatment that involves the infusion of a missing enzyme into the body to help replace the missing enzyme. Migalastat works by stabilizing the body's own enzyme, which helps to reduce the amount of GL-3 that is accumulating in the body. By using both ERT and Migalastat, patients with Fabry disease can experience improved symptoms and a better quality of life.\nIt is important to note that Migalastat is only used in patients with Fabry disease who have a specific genetic mutation called GLA-deficient. It is also important to note that Migalastat is not a cure for Fabry disease, and patients will need to continue to receive treatment with ERT and other medications to manage their symptoms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Migalastat is used for the treatment of Fabry disease. \n2. Fabry disease is an inherited disorder caused by a deficiency of the enzyme alpha-galactosidase A.\n3. This disease leads to the accumulation of a specific type of fat molecule called globotriaosylceramide (GL-3) in various cells and tissues of the body.\n4. Migalastat is used in combination with another medication called ERT (enzyme replacement therapy) to treat Fabry disease.\n5. Migalastat is only used in patients with Fabry disease who have a specific genetic mutation called GLA-deficient.",
    "vicuna-13b_fact": [
      "Migalastat is used for the treatment of Fabry disease.",
      "Fabry disease is an inherited disorder caused by a deficiency of the enzyme alpha-galactosidase A.",
      "This disease leads to the accumulation of a specific type of fat molecule called globotriaosylceramide (GL-3) in various cells and tissues of the body.",
      "Migalastat is used in combination with another medication called ERT (enzyme replacement therapy) to treat Fabry disease.",
      "Migalastat is only used in patients with Fabry disease who have a specific genetic mutation called GLA-deficient."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Migalastat is not usually used in combination with ERT. It is an alternative to enzyme replacement therapy for certain patients.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1829,
    "user_query": "Where are Paneth cells located?",
    "vicuna-13b_response": "Paneth cells are located in the crypts of the small intestine. The small intestine is a long, narrow tube that connects the stomach to the large intestine. It is the main part of the digestive system where nutrients from food are absorbed into the bloodstream. The crypts of the small intestine are small, finger-like projections that project into the lumen (the inner space) of the small intestine. Paneth cells are found in the base of these crypts.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Paneth cells are located in the crypts of the small intestine.\n2. The small intestine is a long, narrow tube that connects the stomach to the large intestine.\n3. The small intestine is the main part of the digestive system where nutrients from food are absorbed into the bloodstream.\n4. The crypts of the small intestine are small, finger-like projections that project into the lumen of the small intestine.\n5. Paneth cells are found in the base of these crypts of the small intestine.",
    "vicuna-13b_fact": [
      "Paneth cells are located in the crypts of the small intestine.",
      "The small intestine is a long, narrow tube that connects the stomach to the large intestine.",
      "The small intestine is the main part of the digestive system where nutrients from food are absorbed into the bloodstream.",
      "The crypts of the small intestine are small, finger-like projections that project into the lumen of the small intestine.",
      "Paneth cells are found in the base of these crypts of the small intestine."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The crypts of the small intestine are tubular invaginations of the epithelium, not finger-like projections. The finger-like projections are called villi.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1832,
    "user_query": "Which pipelines are used for analyzing data from ChIP-nexus experiments?",
    "vicuna-13b_response": "ChIP-nexus experiments are used to study the interactions between proteins and DNA. The data from these experiments is typically analyzed using a variety of bioinformatics tools and pipelines. Some of the commonly used pipelines for analyzing data from ChIP-nexus experiments include:\n1. Bowtie: Bowtie is a popular tool for aligning sequencing reads to a reference genome. It can be used to align ChIP-seq reads to a reference genome and identify the specific locations where a protein of interest is binding to the DNA.\n2. HISAT: HISAT is a tool for aligning sequencing reads to a reference genome using a hash table. It can be used to align ChIP-seq reads to a reference genome and identify the specific locations where a protein of interest is binding to the DNA.\n3. MACS: MACS is a tool for identifying and quantifying chromatin interactions. It can be used to analyze ChIP-seq data and identify the specific locations where a protein of interest is binding to the DNA.\n4. STAR: STAR is a tool for aligning sequencing reads to a reference genome. It can be used to align ChIP-seq reads to a reference genome and identify the specific locations where a protein of interest is binding to the DNA.\n5. Subread: Subread is a tool for aligning sequencing reads to a reference genome. It can be used to align ChIP-seq reads to a reference genome and identify the specific locations where a protein of interest is binding to the DNA.\n6. GATK: GATK is a suite of tools for analyzing next-generation sequencing data. It includes tools for aligning reads, marking duplicates, and performing base quality score recalibration. It can be used to analyze ChIP-seq data and identify the specific locations where a protein of interest is binding to the DNA.\nThese are some of the commonly used pipelines for analyzing data from ChIP-nexus experiments, but there are many other tools and pipelines available depending on the specific requirements of the experiment and the type of data generated.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ChIP-nexus experiments are used to study the interactions between proteins and DNA.\n2. Bowtie is a bioinformatics tool used for aligning sequencing reads to a reference genome.\n3. HISAT is another tool for aligning sequencing reads to a reference genome using a hash table.\n4. MACS is a tool for identifying and quantifying chromatin interactions.\n5. STAR is a bioinformatics tool for aligning sequencing reads to a reference genome.\n6. GATK is a suite of tools for analyzing next-generation sequencing data, including aligning reads, marking duplicates, and performing base quality score recalibration.",
    "vicuna-13b_fact": [
      "ChIP-nexus experiments are used to study the interactions between proteins and DNA.",
      "Bowtie is a bioinformatics tool used for aligning sequencing reads to a reference genome.",
      "HISAT is another tool for aligning sequencing reads to a reference genome using a hash table.",
      "MACS is a tool for identifying and quantifying chromatin interactions.",
      "STAR is a bioinformatics tool for aligning sequencing reads to a reference genome.",
      "GATK is a suite of tools for analyzing next-generation sequencing data, including aligning reads, marking duplicates, and performing base quality score recalibration."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: MACS is a tool for identifying and quantifying peak regions in ChIP-Seq experiments, not chromatin interactions.\n5. TRUE\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1833,
    "user_query": "What do statins do?",
    "vicuna-13b_response": "Statins are a type of medication that is used to lower cholesterol levels in the blood. They work by inhibiting an enzyme in the liver that is involved in the production of cholesterol. The main goal of using statins is to reduce the risk of cardiovascular disease, such as heart attack and stroke, by lowering the levels of low-density lipoprotein (LDL) cholesterol in the blood.\nStatins are often prescribed for people who have high cholesterol levels or who have already developed cardiovascular disease. They are also sometimes used in conjunction with other medications and lifestyle changes, such as diet and exercise, to help manage high cholesterol levels.\nIt is important to note that statins can have side effects, although most people tolerate them well. Common side effects may include headache, muscle pain, and nausea. It is important to talk to your doctor if you experience any side effects while taking statins.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Statins are a type of medication used to lower cholesterol levels in the blood.\n2. The main goal of using statins is to reduce the risk of cardiovascular disease.\n3. Statins work by inhibiting an enzyme in the liver that is involved in the production of cholesterol.\n4. Statins are often prescribed for people who have high cholesterol levels or who have already developed cardiovascular disease.\n5. Common side effects of statins may include headache, muscle pain, and nausea.",
    "vicuna-13b_fact": [
      "Statins are a type of medication used to lower cholesterol levels in the blood.",
      "The main goal of using statins is to reduce the risk of cardiovascular disease.",
      "Statins work by inhibiting an enzyme in the liver that is involved in the production of cholesterol.",
      "Statins are often prescribed for people who have high cholesterol levels or who have already developed cardiovascular disease.",
      "Common side effects of statins may include headache, muscle pain, and nausea."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1835,
    "user_query": "Do statins cause diabetes?",
    "vicuna-13b_response": "Statins are a type of medication that is commonly used to lower cholesterol levels in the blood. There has been some concern that statins may increase the risk of developing type 2 diabetes, but the evidence on this topic is mixed and not entirely clear.\nSome studies have suggested that statins may increase the risk of developing type 2 diabetes, particularly in individuals who have other risk factors for the condition, such as obesity or a family history of diabetes. However, other studies have found no increased risk of diabetes associated with statin use.\nIt is important to note that the overall risk of developing type 2 diabetes with statin use is relatively low, and the benefits of using statins to lower cholesterol levels and reduce the risk of heart disease and stroke generally outweigh the potential risks.\nIf you are taking statins and have concerns about your risk of developing diabetes, it is important to speak with your healthcare provider. They can help you understand your individual risk and make any necessary adjustments to your treatment plan.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Statins are a type of medication used to lower cholesterol levels in the blood.\n2. Some studies suggest that statins may increase the risk of developing type 2 diabetes, especially in individuals with other risk factors such as obesity or a family history of diabetes.\n3. Other studies have found no increased risk of diabetes associated with statin use.\n4. The overall risk of developing type 2 diabetes with statin use is relatively low.\n5. The benefits of using statins to lower cholesterol levels and reduce the risk of heart disease and stroke generally outweigh the potential risks.",
    "vicuna-13b_fact": [
      "Statins are a type of medication used to lower cholesterol levels in the blood.",
      "Some studies suggest that statins may increase the risk of developing type 2 diabetes, especially in individuals with other risk factors such as obesity or a family history of diabetes.",
      "Other studies have found no increased risk of diabetes associated with statin use.",
      "The overall risk of developing type 2 diabetes with statin use is relatively low.",
      "The benefits of using statins to lower cholesterol levels and reduce the risk of heart disease and stroke generally outweigh the potential risks."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1841,
    "user_query": "What is the composition of the gamma-secretase complex?",
    "vicuna-13b_response": "The gamma-secretase complex is a multi-subunit protein complex that plays a critical role in the processing and cleavage of the beta-amyloid precursor protein (APP) and the Notch receptor. The gamma-secretase complex consists of four subunits: APH-1, APH-2, nicastrin, and presenilin-1 (PSEN-1).\nAPH-1 and APH-2 are two transmembrane proteins that form the core of the gamma-secretase complex and are responsible for the cleavage of APP and Notch. Nicastrin is an essential component of the complex that helps to stabilize the APH-1 and APH-2 subunits and regulate their activity. Presenilin-1 (PSEN-1) is a key component of the gamma-secretase complex that contains a proteolytic active site and is responsible for the cleavage of APP and Notch.\nThe gamma-secretase complex is involved in several important cellular processes, including the regulation of cell growth and differentiation, and the processing and cleavage of key signaling molecules. Dysregulation of the gamma-secretase complex has been implicated in a number of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The gamma-secretase complex plays a critical role in the processing and cleavage of the beta-amyloid precursor protein (APP) and the Notch receptor.\n2. The gamma-secretase complex includes four subunits: APH-1, APH-2, nicastrin, and presenilin-1 (PSEN-1).\n3. APH-1 and APH-2 are transmembrane proteins that form the core of the gamma-secretase complex.\n4. Nicastrin is part of the gamma-secretase complex and helps to stabilize the APH-1 and APH-2 subunits.\n5. Dysregulation of the gamma-secretase complex has been implicated in neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.",
    "vicuna-13b_fact": [
      "The gamma-secretase complex plays a critical role in the processing and cleavage of the beta-amyloid precursor protein (APP) and the Notch receptor.",
      "The gamma-secretase complex includes four subunits: APH-1, APH-2, nicastrin, and presenilin-1 (PSEN-1).",
      "APH-1 and APH-2 are transmembrane proteins that form the core of the gamma-secretase complex.",
      "Nicastrin is part of the gamma-secretase complex and helps to stabilize the APH-1 and APH-2 subunits.",
      "Dysregulation of the gamma-secretase complex has been implicated in neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The gamma-secretase complex includes four subunits: Presenilin, Nicastrin, APH-1, and PEN-2.\n3. FALSE [correction]: APH-1 is a transmembrane protein that forms the core of the gamma-secretase complex, along with presenilin, nicastrin, and PEN-2. There is no APH-2 in the gamma-secretase complex.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1844,
    "user_query": "What is the role of the UBC9 enzyme in the protein sumoylation pathway?",
    "vicuna-13b_response": "UBC9 (Ubiquitin-conjugating enzyme E2) is an enzyme that plays a critical role in the protein sumoylation pathway, which is a post-translational modification process that involves the attachment of a small protein called sumoylation to target proteins.\nThe UBC9 enzyme is responsible for the transfer of a ubiquitin molecule to a target protein, which is the first step in the sumoylation process. The UBC9 enzyme recognizes the target protein and conjugates a ubiquitin molecule to it, which then recruits other enzymes that are involved in the sumoylation process.\nThe sumoylation pathway is involved in a wide range of cellular processes, including regulation of protein stability, localization, and activity. The sumoylation of proteins can either enhance or repress their activity, depending on the specific protein and the sumoylation status of its target site.\nMutations in the UBC9 gene have been linked to a variety of human diseases, including cancer, neurodegenerative disorders, and immune disorders, highlighting the importance of the UBC9 enzyme in maintaining proper cellular function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. UBC9 (Ubiquitin-conjugating enzyme E2) plays a crucial role in the sumoylation pathway, a post-translational modification process.\n2. Ubiquitin-conjugating enzyme E2 is responsible for the transfer of a ubiquitin molecule to a target protein.\n3. The sumoylation pathway regulates protein stability, localization, and activity.\n4. Sumoylation of proteins can either enhance or repress their activity.\n5. Mutations in the UBC9 gene have been linked to various human diseases such as cancer, neurodegenerative disorders, and immune disorders.",
    "vicuna-13b_fact": [
      "UBC9 (Ubiquitin-conjugating enzyme E2) plays a crucial role in the sumoylation pathway, a post-translational modification process.",
      "Ubiquitin-conjugating enzyme E2 is responsible for the transfer of a ubiquitin molecule to a target protein.",
      "The sumoylation pathway regulates protein stability, localization, and activity.",
      "Sumoylation of proteins can either enhance or repress their activity.",
      "Mutations in the UBC9 gene have been linked to various human diseases such as cancer, neurodegenerative disorders, and immune disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1849,
    "user_query": "What is the role of cohesins at the IFNG locus?",
    "vicuna-13b_response": "Cohesins are a type of protein complex that plays a crucial role in maintaining the integrity of chromosomes during cell division. The IFNG locus, which stands for Interferon Gamma (IFNG) locus, is a region on chromosome 4 that contains the gene for the IFNG protein.\nCohesins are involved in the regulation of gene expression and are essential for the proper segregation of chromosomes during cell division. They are also involved in the maintenance of chromosome structure and the prevention of chromosome fragmentation.\nIn the IFNG locus, cohesins are thought to play a role in the regulation of the IFNG gene, which is involved in the immune response to viral infections. Specifically, cohesins are thought to help maintain the integrity of the IFNG locus during cell division, ensuring that the gene is accurately passed on to daughter cells.\nOverall, the role of cohesins at the IFNG locus is to help maintain the integrity of the chromosome and ensure the proper expression and segregation of the IFNG gene during cell division.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cohesins are a type of protein complex that plays a role in maintaining the integrity of chromosomes during cell division.\n2. The IFNG locus is a region on chromosome 4 that contains the gene for the IFNG protein.\n3. Cohesins play a vital role in the regulation of gene expression.\n4. Cohesins are also involved in the maintenance of chromosome structure and the prevention of chromosome fragmentation.\n5. At the IFNG locus, cohesins help ensure the accurate segregation and timely expression of the IFNG gene during cell division.",
    "vicuna-13b_fact": [
      "Cohesins are a type of protein complex that plays a role in maintaining the integrity of chromosomes during cell division.",
      "The IFNG locus is a region on chromosome 4 that contains the gene for the IFNG protein.",
      "Cohesins play a vital role in the regulation of gene expression.",
      "Cohesins are also involved in the maintenance of chromosome structure and the prevention of chromosome fragmentation.",
      "At the IFNG locus, cohesins help ensure the accurate segregation and timely expression of the IFNG gene during cell division."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1853,
    "user_query": "Could hypophosphatemic rickets cause craniosynostosis?",
    "vicuna-13b_response": "Hypophosphatemic rickets is a rare genetic disorder that affects the development and growth of bones, caused by a deficiency of vitamin D, calcium, or phosphorus. Craniosynostosis, on the other hand, is a condition in which the bones in the skull fuse together too early, which can cause problems with the shape and development of the skull and the brain.\nThere is some evidence to suggest that hypophosphatemic rickets may be associated with an increased risk of craniosynostosis. Studies have shown that children with hypophosphatemic rickets have an increased frequency of craniosynostosis compared to children without the disorder. However, the exact relationship between the two conditions is not well understood, and more research is needed to determine the nature of this association.\nIt is important to note that craniosynostosis can also be caused by other genetic disorders, as well as by environmental factors such as premature closure of the cranial sutures due to trauma or infection. Therefore, if a child is diagnosed with hypophosphatemic rickets, it is important to closely monitor their skull development and seek medical advice if any signs of craniosynostosis are observed. Early detection and treatment of craniosynostosis can help to prevent complications and improve outcomes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hypophosphatemic rickets is a genetic disorder that impacts the development and growth of bones due to a deficiency of vitamin D, calcium, or phosphorus.\n2. Craniosynostosis is a condition where the skull bones fuse too early.\n3. Studies suggest that there is an increased risk of craniosynostosis in children with hypophosphatemic rickets.\n4. Several factors, including other genetic disorders and environmental factors such as trauma or infection, can cause craniosynostosis.\n5. Early detection and treatment of craniosynostosis can help to prevent complications and improve outcomes.",
    "vicuna-13b_fact": [
      "Hypophosphatemic rickets is a genetic disorder that impacts the development and growth of bones due to a deficiency of vitamin D, calcium, or phosphorus.",
      "Craniosynostosis is a condition where the skull bones fuse too early.",
      "Studies suggest that there is an increased risk of craniosynostosis in children with hypophosphatemic rickets.",
      "Several factors, including other genetic disorders and environmental factors such as trauma or infection, can cause craniosynostosis.",
      "Early detection and treatment of craniosynostosis can help to prevent complications and improve outcomes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1854,
    "user_query": "Is vortioxetine effective for treatment of depression?",
    "vicuna-13b_response": "Vortioxetine is a medication that is approved for the treatment of depression. It is a serotonin modulator and stimulator (SMART) medication, which means it acts on multiple targets in the brain, including serotonin receptors and transporters, to enhance the overall action of serotonin.\nVortioxetine has been shown to be effective in the treatment of depression, with studies showing that it can reduce symptoms of depression, such as sadness, hopelessness, and loss of interest in activities, compared to placebo. It has also been shown to be effective in treating refractory depression, which is depression that does not respond to other treatments.\nVortioxetine is generally well-tolerated, but like all medications, it can cause side effects. The most common side effects of vortioxetine include nausea, headache, and fatigue. It is important to discuss the potential benefits and risks of vortioxetine with a healthcare professional before starting treatment.\nIt is important to note that while vortioxetine can be effective in treating depression, it is not a first-line treatment and should only be used under the guidance of a healthcare professional. Other treatments, such as psychotherapy and selective serotonin reuptake inhibitors (SSRIs), should be considered first.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Vortioxetine is approved for the treatment of depression.\n2. Vortioxetine is a serotonin modulator and stimulator (SMART) medication.\n3. Studies have shown vortioxetine can reduce symptoms of depression compared to placebo.\n4. Vortioxetine has also been shown to be effective in treating refractory depression.\n5. The common side effects of vortioxetine include nausea, headache, and fatigue.",
    "vicuna-13b_fact": [
      "Vortioxetine is approved for the treatment of depression.",
      "Vortioxetine is a serotonin modulator and stimulator (SMART) medication.",
      "Studies have shown vortioxetine can reduce symptoms of depression compared to placebo.",
      "Vortioxetine has also been shown to be effective in treating refractory depression.",
      "The common side effects of vortioxetine include nausea, headache, and fatigue."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE \n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1859,
    "user_query": "Where do the Schwann cells and melanocytes originate from?",
    "vicuna-13b_response": "Schwann cells and melanocytes are two distinct cell types that play important roles in the development and maintenance of the nervous system and the skin, respectively.\nSchwann cells are a type of glial cell that form a myelin sheath around the axons of neurons in the peripheral nervous system. They originate from neural crest cells, which are a group of cells that give rise to many different cell types in the developing embryo, including the nervous system. During development, neural crest cells migrate to the peripheral nervous system and differentiate into Schwann cells.\nMelanocytes, on the other hand, are cells that produce the pigment melanin, which gives skin, hair, and eyes their color. They originate from the neural crest cells as well. During development, neural crest cells migrate to the skin and differentiate into melanocytes.\nIn summary, both Schwann cells and melanocytes originate from neural crest cells, which are a group of cells that give rise to many different cell types in the developing embryo.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Schwann cells, a type of glial cell, form a myelin sheath around the axons of neurons in the peripheral nervous system.\n2. Schwann cells originate from neural crest cells.\n3. Melanocytes are cells that produce the pigment melanin, which gives skin, hair, and eyes their color.\n4. Melanocytes originate from the neural crest cells.\n5. Both Schwann cells and melanocytes originate from neural crest cells, which are a group of cells that give rise to many different cell types in the developing embryo.",
    "vicuna-13b_fact": [
      "Schwann cells, a type of glial cell, form a myelin sheath around the axons of neurons in the peripheral nervous system.",
      "Schwann cells originate from neural crest cells.",
      "Melanocytes are cells that produce the pigment melanin, which gives skin, hair, and eyes their color.",
      "Melanocytes originate from the neural crest cells.",
      "Both Schwann cells and melanocytes originate from neural crest cells, which are a group of cells that give rise to many different cell types in the developing embryo."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "vicuna-13b_response": "PIEZO2 is a gene that is associated with several diseases, including:\n1. Piezo2-related primary ciliary dyskinesia (PKD): PKD is a rare genetic disorder that affects the function of cilia, which are small, hair-like structures that line the airways and help to clear mucus and debris from the lungs. Mutations in the PIEZO2 gene have been identified as a cause of PKD.\n2. Autosomal recessive lymphoedema (ARL): ARL is a genetic disorder that affects the development and function of the lymphatic system, which helps to regulate fluid balance in the body. Mutations in the PIEZO2 gene have been identified as a cause of ARL.\n3. Joubert syndrome: Joubert syndrome is a rare genetic disorder that affects the development of the brain and the cilia. Mutations in the PIEZO2 gene have been identified as a cause of Joubert syndrome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The PIEZO2 gene is associated with several diseases including Piezo2-related primary ciliary dyskinesia, autosomal recessive lymphoedema and Joubert syndrome.\n2. Piezo2-related primary ciliary dyskinesia is a rare genetic disorder that affects the function of cilia.\n3. Mutations in the PIEZO2 gene have been identified as a cause of Piezo2-related primary ciliary dyskinesia.\n4. Autosomal recessive lymphoedema is a disorder that affects the development and function of the lymphatic system.\n5. Mutations in the PIEZO2 gene have been identified as a cause of Joubert syndrome.",
    "vicuna-13b_fact": [
      "The PIEZO2 gene is associated with several diseases including Piezo2-related primary ciliary dyskinesia, autosomal recessive lymphoedema and Joubert syndrome.",
      "Piezo2-related primary ciliary dyskinesia is a rare genetic disorder that affects the function of cilia.",
      "Mutations in the PIEZO2 gene have been identified as a cause of Piezo2-related primary ciliary dyskinesia.",
      "Autosomal recessive lymphoedema is a disorder that affects the development and function of the lymphatic system.",
      "Mutations in the PIEZO2 gene have been identified as a cause of Joubert syndrome."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Primary ciliary dyskinesia is a rare genetic disorder that affects the function of cilia. Piezo2-related is not typically used to describe it.\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1862,
    "user_query": "Where is the protein slitrk1 localized?",
    "vicuna-13b_response": "SLTN (slit-like transmembrane protein 1) also known as SLTN (slit-like transmembrane protein 1) or SLTN (slit-like transmembrane protein 1) is a protein that is expressed in various tissues in the human body, including the brain, heart, pancreas, and intestine. It is a transmembrane protein that is localized in the endoplasmic reticulum and Golgi apparatus. It is involved in various cellular processes such as protein trafficking, cell signaling, and apoptosis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SLTN, also known as slit-like transmembrane protein 1, is a protein expressed in various tissues in the human body.\n2. This protein is found in the brain, heart, pancreas, and intestine.\n3. SLTN is a transmembrane protein.\n4. SLTN is localized in the endoplasmic reticulum and Golgi apparatus.\n5. This protein is involved in protein trafficking, cell signaling, and apoptosis.",
    "vicuna-13b_fact": [
      "SLTN, also known as slit-like transmembrane protein 1, is a protein expressed in various tissues in the human body.",
      "This protein is found in the brain, heart, pancreas, and intestine.",
      "SLTN is a transmembrane protein.",
      "SLTN is localized in the endoplasmic reticulum and Golgi apparatus.",
      "This protein is involved in protein trafficking, cell signaling, and apoptosis."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1863,
    "user_query": "Describe clinical manifestation of the Harlequin syndrome.",
    "vicuna-13b_response": "The Harlequin syndrome is a rare but serious condition that is characterized by a distinctive skin rash, fever, and joint pain. The rash is typically red and raised, and is usually accompanied by blisters. The rash usually appears on the face, neck, and upper torso, and can spread to other parts of the body.\nIn addition to the skin symptoms, people with the Harlequin syndrome often experience fever, chills, and joint pain. The joint pain is usually severe and can affect any part of the body, including the hands, feet, and knees. The fever can be high and can last for several days.\nThe Harlequin syndrome is caused by an adverse reaction to a type of medication called a tumor necrosis factor (TNF) inhibitor. These medications are commonly used to treat conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease.\nIf you experience any of the symptoms of the Harlequin syndrome, it is important to seek medical attention immediately. Early diagnosis and treatment can help to prevent serious complications, such as sepsis and organ failure. Treatment typically involves discontinuing the offending medication and providing supportive care, such as intravenous fluids and antibiotics, as needed.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Harlequin syndrome is a rare condition characterized by a distinctive skin rash, fever, and joint pain.\n2. The rash in Harlequin syndrome usually appears on the face, neck, and upper torso and can spread to other body parts.\n3. Those with Harlequin syndrome often experience fever, chills, and joint pain that can affect any part of the body.\n4. Harlequin syndrome is caused by an adverse reaction to tumor necrosis factor (TNF) inhibitor medications.\n5. Treatment for Harlequin syndrome usually requires discontinuing the offending medication and providing supportive care like intravenous fluids and antibiotics.",
    "vicuna-13b_fact": [
      "Harlequin syndrome is a rare condition characterized by a distinctive skin rash, fever, and joint pain.",
      "The rash in Harlequin syndrome usually appears on the face, neck, and upper torso and can spread to other body parts.",
      "Those with Harlequin syndrome often experience fever, chills, and joint pain that can affect any part of the body.",
      "Harlequin syndrome is caused by an adverse reaction to tumor necrosis factor (TNF) inhibitor medications.",
      "Treatment for Harlequin syndrome usually requires discontinuing the offending medication and providing supportive care like intravenous fluids and antibiotics."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Harlequin syndrome is a rare condition characterized by unilateral decreased sweating and flushing due to damage to the autonomic nervous system. It is not typically associated with fever or joint pain.\n2. FALSE [corification]: The characteristic sign of Harlequin syndrome is half of the face, or one side of the body, flushing and sweating while the other half does not. It is not a rash.\n3. FALSE [corification]: Harlequin syndrome does not typically involve fever, chills, or joint pain. It primarily involves changes in the skin's appearance (flushing and sweating) on one side of the body.\n4. UNKNOWN\n5. FALSE [correction]: Treatment for Harlequin syndrome may involve managing symptoms and treating underlying conditions when possible. It does not require stopping a medication because it is not typically caused by medication. Treatment could also involve surgical intervention in some cases.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1864,
    "user_query": "What is the role of the constitutive photomorphogenesis 9 signalosome (CSN)?",
    "vicuna-13b_response": "The constitutive photomorphogenesis 9 (CSN) signalosome is a complex signaling pathway found in plants that plays a crucial role in regulating the plant's response to light. The CSN pathway is activated in response to light and promotes the accumulation of phytochromobilin, a chromophore that acts as a ligand for the phytochrome protein. This interaction activates a series of downstream signaling events that ultimately lead to the regulation of a variety of plant processes, including seed germination, stem elongation, and the regulation of the circadian clock. The CSN pathway is also involved in the regulation of the plant's response to other environmental stimuli, such as temperature and water availability. Overall, the CSN signalosome plays a critical role in regulating the plant's growth and development in response to environmental cues.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The constitutive photomorphogenesis 9 (CSN) signalosome is found in plants.\n2. The CSN signalosome plays a role in regulating the plant's response to light.\n3. The activation of the CSN pathway promotes the accumulation of phytochromobilin.\n4. The CSN pathway is involved in the regulation of several plant processes, including seed germination, stem elongation, and the circadian clock.\n5. Apart from light, the CSN pathway also regulates the plant's response to temperature and water availability.",
    "vicuna-13b_fact": [
      "The constitutive photomorphogenesis 9 (CSN) signalosome is found in plants.",
      "The CSN signalosome plays a role in regulating the plant's response to light.",
      "The activation of the CSN pathway promotes the accumulation of phytochromobilin.",
      "The CSN pathway is involved in the regulation of several plant processes, including seed germination, stem elongation, and the circadian clock.",
      "Apart from light, the CSN pathway also regulates the plant's response to temperature and water availability."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The activation of the phytochrome pathway, not the CSN pathway, promotes the accumulation of phytochromobilin.\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "vicuna-13b_response": "ERAP1-ERAP2 dimerization is a process that occurs in the endoplasmic reticulum (ER) of cells. The ER is a network of membranes that is responsible for many cellular functions, including protein synthesis and folding.\nERAP1 and ERAP2 are two proteins that are involved in the transport of proteins from the ER to the Golgi apparatus, which is another organelle responsible for protein processing and packaging. When ERAP1 and ERAP2 dimerize, they form a complex that can bind to and transport certain proteins from the ER to the Golgi apparatus.\nThis process is important for maintaining the proper functioning of the ER and Golgi apparatus, as well as for ensuring that proteins are transported to the correct locations within the cell. Dysfunction in ERAP1-ERAP2 dimerization has been linked to a number of diseases, including neurodegenerative disorders and cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ERAP1-ERAP2 dimerization is a process that occurs in the endoplasmic reticulum (ER) of cells.\n2. The ER is responsible for many cellular functions, including protein synthesis and folding.\n3. ERAP1 and ERAP2 are proteins involved in the transport of proteins from the ER to the Golgi apparatus.\n4. ERAP1-ERAP2 dimerization is necessary for the correct transport of proteins within the cell.\n5. Dysfunction in ERAP1-ERAP2 dimerization has been linked to diseases, including neurodegenerative disorders and cancer.",
    "vicuna-13b_fact": [
      "ERAP1-ERAP2 dimerization is a process that occurs in the endoplasmic reticulum (ER) of cells.",
      "The ER is responsible for many cellular functions, including protein synthesis and folding.",
      "ERAP1 and ERAP2 are proteins involved in the transport of proteins from the ER to the Golgi apparatus.",
      "ERAP1-ERAP2 dimerization is necessary for the correct transport of proteins within the cell.",
      "Dysfunction in ERAP1-ERAP2 dimerization has been linked to diseases, including neurodegenerative disorders and cancer."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: ERAP1 and ERAP2 are enzymes involved in the trimming of peptides in the endoplasmic reticulum, not in the transport of proteins from the ER to the Golgi apparatus.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1868,
    "user_query": "What is plantar fasciitis",
    "vicuna-13b_response": "Plantar fasciitis is a common condition that affects the bottom of the foot. It is caused by inflammation of the plantar fascia, a thick band of tissue that runs along the bottom of the foot and connects the heel bone to the toes.\nThe main symptom of plantar fasciitis is pain on the bottom of the foot, near the heel. This pain is usually worse in the morning and after sitting or standing for long periods of time. The pain may also worsen after activities that put strain on the foot, such as running or prolonged walking.\nOther symptoms of plantar fasciitis may include:\n* Stiffness in the bottom of the foot\n* Difficulty bending the toes\n* Pain that radiates up the leg\nPlantar fasciitis can be caused by a variety of factors, including:\n* Excessive pronation (rolling in) of the foot\n* High arches or flat feet\n* Tight calf muscles\n* Excessive weight or obesity\n* Aging\nTreatment for plantar fasciitis typically includes rest, ice, and physical therapy exercises to stretch and strengthen the foot and ankle. In some cases, medication or orthotics (shoe inserts) may be prescribed to help alleviate pain and inflammation. In rare cases, surgery may be necessary to release the plantar fascia or remove a heel spur.\nIt's important to see a doctor if you are experiencing persistent pain on the bottom of your foot, as plantar fasciitis can be mistaken for other conditions such as a heel spur or bone fracture.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Plantar fasciitis is a condition that affects the bottom of the foot.\n2. Plantar fasciitis is caused by inflammation of the plantar fascia, a band of tissue that connects the heel bone to the toes.\n3. The main symptom of plantar fasciitis is pain on the bottom of the foot, near the heel.\n4. Some factors that can cause plantar fasciitis include excessive pronation of the foot, high arches or flat feet, tight calf muscles, excessive weight, and aging.\n5. Treatment for plantar fasciitis can include rest, ice, physical therapy, medication, orthotics, and in rare cases, surgery.",
    "vicuna-13b_fact": [
      "Plantar fasciitis is a condition that affects the bottom of the foot.",
      "Plantar fasciitis is caused by inflammation of the plantar fascia, a band of tissue that connects the heel bone to the toes.",
      "The main symptom of plantar fasciitis is pain on the bottom of the foot, near the heel.",
      "Some factors that can cause plantar fasciitis include excessive pronation of the foot, high arches or flat feet, tight calf muscles, excessive weight, and aging.",
      "Treatment for plantar fasciitis can include rest, ice, physical therapy, medication, orthotics, and in rare cases, surgery."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1869,
    "user_query": "Which is the enzymatic activity of OTULIN?",
    "vicuna-13b_response": "Otulin is a protein that is involved in several cellular processes, including cell growth and differentiation, and is expressed in various tissues, including the brain, heart, and pancreas.\nOne of the enzymatic activities of Otulin is its function as a protein tyrosine phosphatase (PTP), which is an enzyme that dephosphorylates protein tyrosine residues. Otulin PTP has been shown to play a role in regulating cellular signaling pathways, including those involved in the development and differentiation of neurons, and in the regulation of cell growth and proliferation.\nIn addition to its PTP activity, Otulin has also been shown to have other enzymatic activities, including its ability to act as a GTPase activating protein (GAP) for small GTPases such as Rap1 and Rac1, which are involved in regulating cellular signaling pathways.\nOverall, the enzymatic activities of Otulin are involved in regulating various cellular processes, including cell growth and differentiation, cell signaling, and neuronal development.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Otulin is a protein that is involved in cell growth and differentiation.\n2. Otulin is expressed in various tissues, including the brain, heart, and pancreas.\n3. Otulin functions as a protein tyrosine phosphatase (PTP), an enzyme that dephosphorylates protein tyrosine residues.\n4. Otulin PTP plays a role in regulating cellular signaling pathways, including those involved in neuron development and differentiation, as well as cell growth and proliferation.\n5. Otulin can act as a GTPase activating protein (GAP) for small GTPases such as Rap1 and Rac1.",
    "vicuna-13b_fact": [
      "Otulin is a protein that is involved in cell growth and differentiation.",
      "Otulin is expressed in various tissues, including the brain, heart, and pancreas.",
      "Otulin functions as a protein tyrosine phosphatase (PTP), an enzyme that dephosphorylates protein tyrosine residues.",
      "Otulin PTP plays a role in regulating cellular signaling pathways, including those involved in neuron development and differentiation, as well as cell growth and proliferation.",
      "Otulin can act as a GTPase activating protein (GAP) for small GTPases such as Rap1 and Rac1."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Otulin function as a deubiquitinase, an enzyme that removes ubiquitin molecules from proteins, not a protein tyrosine phosphatase (PTP).\n4. FALSE [correction]: Otulin deubiquitinase plays a role in regulating cellular signaling pathways, performed through the modification of proteins by ubiquitin, not a protein tyrosine phosphatase (PTP).\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1874,
    "user_query": "Is there an association between Muenke Syndrome and FGFR3 gene mutation?",
    "vicuna-13b_response": "Muenke syndrome is a rare genetic disorder that is characterized by a specific pattern of physical features, including craniofacial abnormalities, limb abnormalities, and growth delays. FGFR3 (fibroblast growth factor receptor 3) gene mutation is a genetic mutation that can cause various developmental disorders, including skeletal abnormalities and growth delays.\nThere is some evidence to suggest that FGFR3 gene mutation may be associated with Muenke syndrome. Studies have identified mutations in the FGFR3 gene in individuals with Muenke syndrome, and it is thought that these mutations may be responsible for the characteristic physical features of the disorder. However, more research is needed to fully understand the relationship between FGFR3 gene mutation and Muenke syndrome.\nIt is important to note that Muenke syndrome is a rare disorder, and the majority of cases are not associated with FGFR3 gene mutation. The diagnosis of Muenke syndrome is made based on a combination of clinical features, genetic testing, and other diagnostic tools. If you or a loved one has been diagnosed with Muenke syndrome or you are concerned about this condition, it is important to speak with a healthcare provider for proper diagnosis and treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Muenke syndrome is a rare genetic disorder characterized by a specific pattern of physical features, including craniofacial abnormalities, limb abnormalities, and growth delays.\n2. FGFR3 gene mutation is a genetic mutation that can cause various developmental disorders, including skeletal abnormalities and growth delays.\n3. Some studies have found a link between FGFR3 gene mutation and Muenke syndrome.\n4. Most cases of Muenke syndrome are not associated with FGFR3 gene mutation.\n5. The diagnosis of Muenke syndrome is made based on a combination of clinical features, genetic testing, and other diagnostic tools.",
    "vicuna-13b_fact": [
      "Muenke syndrome is a rare genetic disorder characterized by a specific pattern of physical features, including craniofacial abnormalities, limb abnormalities, and growth delays.",
      "FGFR3 gene mutation is a genetic mutation that can cause various developmental disorders, including skeletal abnormalities and growth delays.",
      "Some studies have found a link between FGFR3 gene mutation and Muenke syndrome.",
      "Most cases of Muenke syndrome are not associated with FGFR3 gene mutation.",
      "The diagnosis of Muenke syndrome is made based on a combination of clinical features, genetic testing, and other diagnostic tools."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Most cases of Muenke syndrome are caused by an FGFR3 gene mutation.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1875,
    "user_query": "Which R package is used for visualization of linear and circular karyotypes?",
    "vicuna-13b_response": "The R package \"karyoPlot\" is commonly used for the visualization of both linear and circular karyotypes. It provides a user-friendly interface for the creation of karyotype plots, which are commonly used in cytogenetics to represent the chromosomes of an organism. The package allows for the customization of the appearance of the karyotype plot, including the ability to add labels, colors, and other features to the chromosomes. Additionally, the package includes functions for the creation of other types of cytogenetic plots, such as G-banded karyotypes and fluorescence in situ hybridization (FISH) images.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The \"karyoPlot\" is an R package used for the visualization of both linear and circular karyotypes.\n2. This package is commonly used in cytogenetics to represent the chromosomes of an organism.\n3. The \"karyoPlot\" package provides a user-friendly interface for the creation of karyotype plots.\n4. The \"karyoPlot\" package allows for the customization of the appearance of the karyotype plot.\n5. The package includes functions for the creation of other types of cytogenetic plots, such as G-banded karyotypes and fluorescence in situ hybridization (FISH) images.",
    "vicuna-13b_fact": [
      "The \"karyoPlot\" is an R package used for the visualization of both linear and circular karyotypes.",
      "This package is commonly used in cytogenetics to represent the chromosomes of an organism.",
      "The \"karyoPlot\" package provides a user-friendly interface for the creation of karyotype plots.",
      "The \"karyoPlot\" package allows for the customization of the appearance of the karyotype plot.",
      "The package includes functions for the creation of other types of cytogenetic plots, such as G-banded karyotypes and fluorescence in situ hybridization (FISH) images."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The \"karyoploteR\" is an R package used for the visualization of both linear and circular karyotypes.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The \"karyoploteR\" package primarily focuses on creating customizable karyotype plots. It does not directly support the creation of G-banded karyotypes or fluorescence in situ hybridization (FISH) images.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1882,
    "user_query": "What is Bartter syndrome?",
    "vicuna-13b_response": "Bartter syndrome is a rare genetic disorder that affects the kidneys. It is characterized by the presence of high levels of potassium in the blood (hyperkalemia), low levels of sodium (hyponatremia), and low levels of calcium (hypocalcemia). These abnormal levels of electrolytes can lead to a variety of symptoms, including muscle weakness, fatigue, and abnormal heart rhythms.\nBartter syndrome is caused by mutations in certain genes that are involved in the regulation of electrolyte levels in the body. It is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder.\nThere is no cure for Bartter syndrome, but treatment can help manage symptoms and prevent complications. This may include medications to control electrolyte levels, dietary changes, and other supportive measures. It is important for individuals with Bartter syndrome to receive ongoing medical care from a team of healthcare providers who can help manage their condition and prevent complications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Bartter syndrome is a rare genetic disorder that affects the kidneys.\n2. The syndrome is characterized by high levels of potassium, low levels of sodium, and low levels of calcium in the blood.\n3. Bartter syndrome is caused by mutations in certain genes involved in the regulation of electrolyte levels.\n4. The disorder is inherited in an autosomal recessive pattern, which means a person must inherit two copies of the mutated gene to develop the disorder.\n5. There is currently no cure for Bartter syndrome, but symptoms can be managed with treatment.",
    "vicuna-13b_fact": [
      "Bartter syndrome is a rare genetic disorder that affects the kidneys.",
      "The syndrome is characterized by high levels of potassium, low levels of sodium, and low levels of calcium in the blood.",
      "Bartter syndrome is caused by mutations in certain genes involved in the regulation of electrolyte levels.",
      "The disorder is inherited in an autosomal recessive pattern, which means a person must inherit two copies of the mutated gene to develop the disorder.",
      "There is currently no cure for Bartter syndrome, but symptoms can be managed with treatment."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Bartter syndrome is characterized by low levels of potassium, not high, and high levels of calcium and sodium in the blood.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1884,
    "user_query": "List RNA modifications databases",
    "vicuna-13b_response": "There are several databases that list RNA modifications:\n1. The RNA Modification Database (RMD): RMD is a comprehensive database that provides information on RNA modifications found in different organisms. It includes information on the modification sites, chemical nature of the modifications, and the functional implications of these modifications.\n2. The ModMine database: ModMine is a database that provides information on RNA modifications found in different organisms. It includes information on the modification sites, chemical nature of the modifications, and the functional implications of these modifications.\n3. The Rfam database: Rfam is a database that provides information on RNA families and their modifications. It includes information on the modification sites, chemical nature of the modifications, and the functional implications of these modifications.\n4. The UniMod database: UniMod is a database that provides information on RNA modifications found in different organisms. It includes information on the modification sites, chemical nature of the modifications, and the functional implications of these modifications.\n5. The Modification Atlas: The Modification Atlas is a database that provides information on RNA modifications found in different organisms. It includes information on the modification sites, chemical nature of the modifications, and the functional implications of these modifications.\nThese databases can be useful resources for researchers and scientists interested in studying RNA modifications and their functional implications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The RNA Modification Database (RMD) provides information on RNA modifications found in different organisms.\n2. The ModMine database provides information on RNA modifications found in different organisms.\n3. Rfam is a database that provides information on RNA families and their modifications.\n4. The UniMod database provides information on RNA modifications found in different organisms.\n5. The Modification Atlas is a database that provides information on RNA modifications found in different organisms.",
    "vicuna-13b_fact": [
      "The RNA Modification Database (RMD) provides information on RNA modifications found in different organisms.",
      "The ModMine database provides information on RNA modifications found in different organisms.",
      "Rfam is a database that provides information on RNA families and their modifications.",
      "The UniMod database provides information on RNA modifications found in different organisms.",
      "The Modification Atlas is a database that provides information on RNA modifications found in different organisms."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The ModMine database provides information on the functional elements of modENCODE datasets and other related modENCODE resources.\n3. TRUE\n4. FALSE [correction]: The UniMod database provides information on protein modifications for mass spectrometry.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1888,
    "user_query": "What gene is mutated in Sickle Cell Anemia?",
    "vicuna-13b_response": "Sickle Cell Anemia is a genetic disorder that is caused by a mutation in the hemoglobin gene. Specifically, the mutation involves a change in the amino acid sequence of the hemoglobin protein, which is responsible for carrying oxygen to cells throughout the body.\nThe normal hemoglobin protein is composed of two alpha and two beta chains, which are encoded by the HBA and HBB genes, respectively. In individuals with sickle cell anemia, the HBB gene is mutated, resulting in the production of abnormal hemoglobin protein that is unable to function properly.\nThe specific mutation that causes sickle cell anemia is a single nucleotide change in the HBB gene, which results in the substitution of the amino acid glutamic acid for valine at position 6 in the hemoglobin protein. This mutation leads to the formation of abnormal red blood cells that are shaped like crescents or sickles, which can cause a variety of symptoms, including anemia, jaundice, and episodes of severe pain.\nOverall, the mutation in the hemoglobin gene is the underlying cause of sickle cell anemia, and genetic testing can be used to diagnose this disorder.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Sickle Cell Anemia is a genetic disorder caused by a mutation in the hemoglobin gene.\n2. The normal hemoglobin protein is composed of two alpha and two beta chains, which are encoded by the HBA and HBB genes, respectively.\n3. In individuals with sickle cell anemia, the HBB gene is mutated.\n4. The specific mutation that causes sickle cell anemia is a single nucleotide change in the HBB gene. \n5. This mutation leads to the formation of abnormal red blood cells that are shaped like crescents or sickles.",
    "vicuna-13b_fact": [
      "Sickle Cell Anemia is a genetic disorder caused by a mutation in the hemoglobin gene.",
      "The normal hemoglobin protein is composed of two alpha and two beta chains, which are encoded by the HBA and HBB genes, respectively.",
      "In individuals with sickle cell anemia, the HBB gene is mutated.",
      "The specific mutation that causes sickle cell anemia is a single nucleotide change in the HBB gene.",
      "This mutation leads to the formation of abnormal red blood cells that are shaped like crescents or sickles."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1889,
    "user_query": "What is the function of the Indian hedgehog protein in chondrocytes?",
    "vicuna-13b_response": "The Indian hedgehog (IHH) protein is a key regulator of chondrocyte differentiation and growth during skeletal development. Chondrocytes are the cells responsible for the production of cartilage, which is a key component of joints and other connective tissues.\nIHH is a member of the hedgehog family of proteins, which are involved in a variety of developmental processes. IHH is produced by chondrocytes and acts as a signaling molecule to regulate the differentiation and proliferation of chondrocytes.\nIn particular, IHH promotes the expression of genes involved in cartilage matrix synthesis and inhibits the expression of genes involved in chondrocyte hypertrophy, which is the process of cell growth and differentiation that occurs during skeletal maturation.\nIHH also plays a role in the regulation of bone growth and development, and mutations in the IHH gene have been linked to several skeletal disorders, including brachydactyly, a condition characterized by short fingers and toes.\nOverall, the function of the Indian hedgehog protein in chondrocytes is to regulate the differentiation and growth of these cells during skeletal development, and its dysregulation can lead to a range of skeletal disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Indian hedgehog (IHH) protein is a regulator of chondrocyte differentiation and growth during skeletal development.\n2. Chondrocytes are responsible for the production of cartilage, a component of joints and other connective tissues.\n3. IHH is a member of the hedgehog family of proteins, which participate in numerous developmental processes.\n4. IHH promotes the expression of genes involved in cartilage matrix synthesis and inhibits genes involved in chondrocyte hypertrophy.\n5. Mutations in the IHH gene have been associated with various skeletal disorders, including brachydactyly.",
    "vicuna-13b_fact": [
      "The Indian hedgehog (IHH) protein is a regulator of chondrocyte differentiation and growth during skeletal development.",
      "Chondrocytes are responsible for the production of cartilage, a component of joints and other connective tissues.",
      "IHH is a member of the hedgehog family of proteins, which participate in numerous developmental processes.",
      "IHH promotes the expression of genes involved in cartilage matrix synthesis and inhibits genes involved in chondrocyte hypertrophy.",
      "Mutations in the IHH gene have been associated with various skeletal disorders, including brachydactyly."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "vicuna-13b_response": "R-spondin 1 and noggin are two proteins that are involved in various cellular processes in the body. In the non-damaged gallbladder, R-spondin 1 and noggin play important roles in the development and function of the gallbladder.\nR-spondin 1 is a protein that is expressed in the gallbladder and other tissues, and it has been shown to play a role in the development of the gallbladder and bile ducts. R-spondin 1 is involved in the regulation of cell proliferation and differentiation, and it has been shown to be important for the normal function of the gallbladder.\nNoggin, on the other hand, is a protein that is involved in the regulation of cellular differentiation and proliferation. In the gallbladder, noggin is involved in the development and function of the epithelial cells that line the gallbladder. Noggin is also involved in the regulation of the activity of other proteins that are important for gallbladder function.\nIn summary, R-spondin 1 and noggin play important roles in the development and function of the gallbladder. They are involved in the regulation of cellular processes, including proliferation, differentiation, and the activity of other proteins that are important for gallbladder function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. R-spondin 1 and noggin are two proteins involved in various cellular processes in the body.\n2. R-spondin 1 is expressed in the gallbladder and other tissues.\n3. R-spondin 1 plays a role in the development of the gallbladder and bile ducts.\n4. Noggin is a protein that is involved in the regulation of cellular differentiation and proliferation.\n5. Noggin is involved in the development and function of the epithelial cells that line the gallbladder.",
    "vicuna-13b_fact": [
      "R-spondin 1 and noggin are two proteins involved in various cellular processes in the body.",
      "R-spondin 1 is expressed in the gallbladder and other tissues.",
      "R-spondin 1 plays a role in the development of the gallbladder and bile ducts.",
      "Noggin is a protein that is involved in the regulation of cellular differentiation and proliferation.",
      "Noggin is involved in the development and function of the epithelial cells that line the gallbladder."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1897,
    "user_query": "Which is the genome browser database for DNA shape annotations?",
    "vicuna-13b_response": "There are several genome browser databases that provide DNA shape annotations, including:\n1. The University of California, Santa Cruz (UCSC) Genome Browser: This browser provides a variety of DNA sequence and gene expression data, as well as visualization tools for DNA alignments and genome-wide chromatin accessibility data.\n2. The Ensembl Genome Browser: This browser provides a variety of DNA sequence and gene expression data, as well as tools for comparing multiple genomes and identifying regulatory elements.\n3. The Genome Browser at the Broad Institute of MIT and Harvard: This browser provides access to a variety of DNA sequence and gene expression data, as well as tools for analyzing genome-wide chromatin accessibility data and identifying regulatory elements.\n4. The National Center for Biotechnology Information (NCBI) Genome Browser: This browser provides access to a variety of DNA sequence and gene expression data, as well as tools for comparing multiple genomes and identifying regulatory elements.\n5. The European Bioinformatics Institute (EBI) Genome Browser: This browser provides access to a variety of DNA sequence and gene expression data, as well as tools for analyzing genome-wide chromatin accessibility data and identifying regulatory elements.\nIt is worth noting that these are just a few examples of the many genome browser databases that provide DNA shape annotations, and the choice of which one to use will depend on the specific needs of the user.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The University of California, Santa Cruz (UCSC) Genome Browser provides DNA sequence and gene expression data.\n2. The Ensembl Genome Browser provides DNA sequence and gene expression data.\n3. The Genome Browser at the Broad Institute of MIT and Harvard provides access to DNA sequence and gene expression data.\n4. The National Center for Biotechnology Information (NCBI) Genome Browser provides DNA sequence and gene expression data.\n5. The European Bioinformatics Institute (EBI) Genome Browser provides access to a variety of DNA sequence and gene expression data.",
    "vicuna-13b_fact": [
      "The University of California, Santa Cruz (UCSC) Genome Browser provides DNA sequence and gene expression data.",
      "The Ensembl Genome Browser provides DNA sequence and gene expression data.",
      "The Genome Browser at the Broad Institute of MIT and Harvard provides access to DNA sequence and gene expression data.",
      "The National Center for Biotechnology Information (NCBI) Genome Browser provides DNA sequence and gene expression data.",
      "The European Bioinformatics Institute (EBI) Genome Browser provides access to a variety of DNA sequence and gene expression data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The National Center for Biotechnology Information (NCBI) offers a database called GenBank, not a Genome Browser, for access to DNA sequence and gene expression data.\n5. FALSE [correction]: The European Bioinformatics Institute (EBI) offers various databases (not specifically a Genome Browser) for access to a variety of DNA sequence and gene expression data, one of which is Ensembl.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1903,
    "user_query": "Where is the respirasome located?",
    "vicuna-13b_response": "The respirasome is a complex structure that is found in the mitochondria of some bacteria. It is responsible for generating energy for the cell through a process called respiration. The respirasome is composed of several different components, including the cytochrome bc1 complex, which is located in the inner mitochondrial membrane, and the ATP synthase, which is located in the outer mitochondrial membrane. The respirasome is an important structure for the survival of the bacteria, as it provides the energy needed for the cell to carry out its various functions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The respirasome is found in the mitochondria of some bacteria.\n2. The respirasome is responsible for generating energy for the cell through a process called respiration.\n3. The respirasome is composed of several different components, including the cytochrome bc1 complex and the ATP synthase.\n4. The cytochrome bc1 complex is located in the inner mitochondrial membrane of the respirasome.\n5. The ATP synthase is located in the outer mitochondrial membrane of the respirasome.",
    "vicuna-13b_fact": [
      "The respirasome is found in the mitochondria of some bacteria.",
      "The respirasome is responsible for generating energy for the cell through a process called respiration.",
      "The respirasome is composed of several different components, including the cytochrome bc1 complex and the ATP synthase.",
      "The cytochrome bc1 complex is located in the inner mitochondrial membrane of the respirasome.",
      "The ATP synthase is located in the outer mitochondrial membrane of the respirasome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The respirasome is found in the mitochondria of eukaryotic cells, not bacteria.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The ATP synthase is located in the inner mitochondrial membrane of the respirasome.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1906,
    "user_query": "What kind of analyses are performed with the software tool \"unipept\"",
    "vicuna-13b_response": "unipept is a software tool used for peptide sequencing analysis. It is commonly used to determine the sequence of peptides from tandem mass spectrometry (MS/MS) data. The tool can also be used to identify post-translational modifications (PTMs) on the peptides.\nThe analysis performed by unipept typically involves the following steps:\n1. Peptide sequencing: The tool matches the MS/MS spectra to a database of known peptides, identifying the sequence of the peptide that best matches the observed fragmentation pattern.\n2. PTM identification: unipept can also identify PTMs on the peptides, such as phosphorylation, acetylation, or glycylation, by comparing the observed fragmentation patterns to a database of known PTMs.\n3. Peptide identification: unipept can also identify the peptide that produced a particular set of MS/MS spectra, even if the sequence of the peptide is not already known. This is done by matching the observed fragmentation pattern to a database of known peptides.\n4. Quantification: unipept can also be used to quantify the relative abundance of different peptides in a sample, by comparing the intensities of the MS/MS spectra to a database of known peptide sequences and their corresponding abundances.\nOverall, unipept is a powerful tool for analyzing complex peptide mixtures, and it is widely used in proteomics research to identify and quantify proteins and their modifications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Unipept is a software tool used for peptide sequencing analysis.\n2. Unipept is used to determine the sequence of peptides from tandem mass spectrometry (MS/MS) data.\n3. The tool can be used to identify post-translational modifications (PTMs) on peptides.\n4. The software can identify the peptide that produced a particular set of MS/MS spectra.\n5. Unipept can be used to quantify the relative abundance of different peptides in a sample.",
    "vicuna-13b_fact": [
      "Unipept is a software tool used for peptide sequencing analysis.",
      "Unipept is used to determine the sequence of peptides from tandem mass spectrometry (MS/MS) data.",
      "The tool can be used to identify post-translational modifications (PTMs) on peptides.",
      "The software can identify the peptide that produced a particular set of MS/MS spectra.",
      "Unipept can be used to quantify the relative abundance of different peptides in a sample."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Unipept is not specifically designed to identify post-translational modifications (PTMs) on peptides. It is used for taxonomic profiling and functional annotation of metaproteomic samples.\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1907,
    "user_query": "What is the role of gamma-secreatase complex in Alzheimer's Disease?",
    "vicuna-13b_response": "Gamma-secretase complex is a protein complex that plays a role in the production of beta-amyloid peptides, which are a hallmark of Alzheimer's disease. The gamma-secretase complex is responsible for cleaving the amyloid precursor protein (APP) into smaller peptides, including beta-amyloid peptides.\nBeta-amyloid peptides are thought to play a role in the development of Alzheimer's disease. High levels of beta-amyloid peptides are found in the brains of individuals with Alzheimer's disease, and it is believed that these peptides contribute to the formation of amyloid plaques, a hallmark of the disease.\nIn recent years, there has been a lot of interest in the gamma-secretase complex as a potential target for the development of treatments for Alzheimer's disease. Inhibiting the gamma-secretase complex has been shown to reduce the production of beta-amyloid peptides and amyloid plaques in animal models of the disease. Clinical trials of gamma-secretase inhibitors are currently underway, and it is hoped that these treatments may be effective in slowing the progression of Alzheimer's disease.\nHowever, it is important to note that the role of the gamma-secretase complex in Alzheimer's disease is still an area of active research, and much more work is needed to fully understand its role in the disease and to develop effective treatments.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The gamma-secretase complex is a protein complex that plays a role in the production of beta-amyloid peptides.\n2. Beta-amyloid peptides are associated with Alzheimer's disease.\n3. The gamma-secretase complex cleaves the amyloid precursor protein (APP) into smaller peptides, including beta-amyloid peptides.\n4. High levels of beta-amyloid peptides are found in the brains of individuals with Alzheimer's disease.\n5. Clinical trials of gamma-secretase inhibitors, which have shown to reduce the production of beta-amyloid peptides and amyloid plaques in animal models, are currently underway.",
    "vicuna-13b_fact": [
      "The gamma-secretase complex is a protein complex that plays a role in the production of beta-amyloid peptides.",
      "Beta-amyloid peptides are associated with Alzheimer's disease.",
      "The gamma-secretase complex cleaves the amyloid precursor protein (APP) into smaller peptides, including beta-amyloid peptides.",
      "High levels of beta-amyloid peptides are found in the brains of individuals with Alzheimer's disease.",
      "Clinical trials of gamma-secretase inhibitors, which have shown to reduce the production of beta-amyloid peptides and amyloid plaques in animal models, are currently underway."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1912,
    "user_query": "List peptide fragmentations methods in mass spectrometry",
    "vicuna-13b_response": "Peptide fragmentation methods in mass spectrometry are techniques used to break down large peptide molecules into smaller, more manageable fragments for analysis. Some common methods include:\n1. Electron capture dissociation (ECD): This method uses electrons to ionize and fragment peptides. It is particularly useful for identifying aromatic and sulfur-containing residues.\n2. High-energy collision dissociation (HCD): This method uses high-energy collisions between ions and neutral molecules to fragment peptides. It is particularly useful for identifying peptide bonds and side-chain functional groups.\n3. Electron transfer dissociation (ETD): This method uses electrons to transfer from a peptide ion to a neutral molecule, leading to fragmentation. It is particularly useful for identifying proline and other nitrogen-containing residues.\n4. Infrared multiphoton dissociation (IRMPD): This method uses infrared radiation to fragment peptides. It is particularly useful for identifying side-chain functional groups and aromatic residues.\n5. Ultraviolet photodissociation (UVPD): This method uses ultraviolet radiation to fragment peptides. It is particularly useful for identifying aromatic and sulfur-containing residues.\n6. Matrix-assisted laser desorption/ionization (MALDI): This method uses a matrix to absorb the laser energy and generate ions, which are then fragmented in a mass spectrometer. It is particularly useful for analyzing large peptides and proteins.\n7. Electrospray ionization (ESI): This method uses a charged spray to generate ions from a sample, which are then analyzed in a mass spectrometer. It is particularly useful for analyzing small peptides and molecules.\n8. Fast atom bombardment (FAB): This method uses a fast beam of atoms to ionize and fragment peptides. It is particularly useful for analyzing large peptides and proteins.\nThese are some of the most commonly used peptide fragmentation methods in mass spectrometry, and the choice of method depends on the specific needs of the experiment and the properties of the peptide being analyzed.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Electron capture dissociation (ECD) is a peptide fragmentation method in mass spectrometry used to identify aromatic and sulfur-containing residues.\n2. High-energy collision dissociation (HCD) uses high-energy collisions between ions and neutral molecules to fragment peptides.\n3. Electron transfer dissociation (ETD) is another method that uses electrons to transfer from a peptide ion to a neutral molecule, leading to fragmentation. \n4. Infrared multiphoton dissociation (IRMPD) uses infrared radiation to fragment peptides.\n5. Ultraviolet photodissociation (UVPD) is a peptide fragmentation method in mass spectrometry used to identify aromatic and sulfur-containing residues.",
    "vicuna-13b_fact": [
      "Electron capture dissociation (ECD) is a peptide fragmentation method in mass spectrometry used to identify aromatic and sulfur-containing residues.",
      "High-energy collision dissociation (HCD) uses high-energy collisions between ions and neutral molecules to fragment peptides.",
      "Electron transfer dissociation (ETD) is another method that uses electrons to transfer from a peptide ion to a neutral molecule, leading to fragmentation.",
      "Infrared multiphoton dissociation (IRMPD) uses infrared radiation to fragment peptides.",
      "Ultraviolet photodissociation (UVPD) is a peptide fragmentation method in mass spectrometry used to identify aromatic and sulfur-containing residues."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Electron capture dissociation (ECD) is a method in mass spectrometry used to cleave peptide bonds and identify post-translational modifications. \n2. TRUE\n3. FALSE [correction]: Electron transfer dissociation (ETD) is a method in which an electron is transferred from a radical anion to a peptide cation, leading to fragmentation.\n4. TRUE\n5. FALSE [correction]: Ultraviolet photodissociation (UVPD) is a peptide fragmentation method in mass spectrometry that uses ultraviolet light to induce fragmentation.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1915,
    "user_query": "Which infection can be prevented with Dapivirine?",
    "vicuna-13b_response": "Dapivirine is an antiretroviral drug used to treat HIV infection. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and works by blocking the activity of the virus's reverse transcriptase enzyme, which is necessary for viral replication. Dapivirine is not effective in preventing infections, but it can help to slow the progression of HIV infection and reduce the risk of developing AIDS-related illnesses. It is often used in combination with other antiretroviral drugs as part of HIV treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dapivirine is an antiretroviral drug used to treat HIV infection.\n2. Dapivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI).\n3. Dapivirine works by blocking the activity of the virus's reverse transcriptase enzyme.\n4. Dapivirine can slow the progression of HIV infection and reduce the risk of developing AIDS-related illnesses.\n5. Dapivirine is often used in combination with other antiretroviral drugs as part of HIV treatment.",
    "vicuna-13b_fact": [
      "Dapivirine is an antiretroviral drug used to treat HIV infection.",
      "Dapivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI).",
      "Dapivirine works by blocking the activity of the virus's reverse transcriptase enzyme.",
      "Dapivirine can slow the progression of HIV infection and reduce the risk of developing AIDS-related illnesses.",
      "Dapivirine is often used in combination with other antiretroviral drugs as part of HIV treatment."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1917,
    "user_query": "Is there a role for gamma knife in treatment of Obsessive-Compulsive Disorder?",
    "vicuna-13b_response": "Gamma knife is a type of stereotactic radiosurgery that uses high-dose radiation to target and destroy abnormal cells in the brain. While it has been used to treat a variety of brain disorders, including brain tumors and vascular malformations, its role in the treatment of Obsessive-Compulsive Disorder (OCD) is limited.\nOCD is a mental health disorder characterized by persistent, uncontrollable thoughts, feelings, and behaviors that interfere with daily life. It is not a brain disorder, but rather a disorder of the brain's reward system.\nWhile there is no cure for OCD, there are several effective treatments available, including medications and behavioral therapy. In some cases, surgery may be recommended for individuals with OCD who have not responded to other treatments.\nOne type of surgery that has been used to treat OCD is called deep brain stimulation (DBS). DBS involves implanting a device in the brain that delivers electrical impulses to targeted areas to disrupt abnormal brain activity.\nGamma knife is not typically used to treat OCD because it is not a brain disorder and because DBS has been shown to be more effective in treating OCD. However, in some cases, gamma knife may be used to treat certain types of movement disorders, such as dystonia, that can occur in individuals with OCD.\nIn summary, while gamma knife has a limited role in the treatment of OCD, other treatments, such as medications and behavioral therapy, are more commonly used to manage the symptoms of this disorder. In cases where these treatments are not effective, surgery, such as DBS, may be considered.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Gamma knife is a type of stereotactic radiosurgery that uses high-dose radiation to target and destroy abnormal cells in the brain.\n2. Obsessive-Compulsive Disorder (OCD) is a mental health disorder characterized by persistent, uncontrollable thoughts, feelings, and behaviors that interfere with daily life. \n3. There is no cure for OCD, but there are several treatments available, including medications and behavioral therapy.\n4. One type of surgery used to treat OCD is deep brain stimulation (DBS).\n5. Gamma knife is not typically used to treat OCD because DBS has been shown to be more effective in treating the disorder.",
    "vicuna-13b_fact": [
      "Gamma knife is a type of stereotactic radiosurgery that uses high-dose radiation to target and destroy abnormal cells in the brain.",
      "Obsessive-Compulsive Disorder (OCD) is a mental health disorder characterized by persistent, uncontrollable thoughts, feelings, and behaviors that interfere with daily life.",
      "There is no cure for OCD, but there are several treatments available, including medications and behavioral therapy.",
      "One type of surgery used to treat OCD is deep brain stimulation (DBS).",
      "Gamma knife is not typically used to treat OCD because DBS has been shown to be more effective in treating the disorder."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Gamma knife is not typically used to treat OCD, not necessarily because DBS is more effective, but because it is not traditionally used in psychiatric disorders treatment. Gamma Knife surgery is typically used to treat conditions such as brain tumors, arteriovenous malformations, and trigeminal neuralgia.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1918,
    "user_query": "What is the mechanism of action of the biguanide class of diabetes drugs?",
    "vicuna-13b_response": "The biguanide class of diabetes drugs, which includes metformin, works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and adipose tissue.\nSpecifically, metformin decreases glucose production by inhibiting the liver's glucose-producing enzyme, glucose-6-phosphatase. This enzyme is responsible for converting glucose-1-phosphate into glucose, which is then released into the bloodstream. By inhibiting this enzyme, metformin reduces the amount of glucose produced by the liver.\nIn addition, metformin increases insulin sensitivity by activating the AMP-activated protein kinase (AMPK) pathway in muscle and adipose tissue. AMPK is an energy sensor that is activated when the energy level of the cell drops, such as when glucose levels are low. When AMPK is activated, it triggers a number of downstream effects that improve insulin sensitivity, including increasing glucose uptake and inhibiting glucose production.\nOverall, the biguanide class of diabetes drugs works by targeting both the liver and muscle/adipose tissue to improve glucose control in the body.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The biguanide class of diabetes drugs, which includes metformin, works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and adipose tissue.\n2. Metformin decreases glucose production by inhibiting the liver's glucose-producing enzyme, glucose-6-phosphatase.\n3. Glucose-6-phosphatase is responsible for converting glucose-1-phosphate into glucose.\n4. Metformin increases insulin sensitivity by activating the AMP-activated protein kinase (AMPK) pathway in muscle and adipose tissue.\n5. When activated, AMPK triggers a number of downstream effects that improve insulin sensitivity, including increasing glucose uptake and inhibiting glucose production.",
    "vicuna-13b_fact": [
      "The biguanide class of diabetes drugs, which includes metformin, works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and adipose tissue.",
      "Metformin decreases glucose production by inhibiting the liver's glucose-producing enzyme, glucose-6-phosphatase.",
      "Glucose-6-phosphatase is responsible for converting glucose-1-phosphate into glucose.",
      "Metformin increases insulin sensitivity by activating the AMP-activated protein kinase (AMPK) pathway in muscle and adipose tissue.",
      "When activated, AMPK triggers a number of downstream effects that improve insulin sensitivity, including increasing glucose uptake and inhibiting glucose production."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Metformin decreases glucose production by inhibiting the liver's process of gluconeogenesis, not specifically the enzyme glucose-6-phosphatase.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1919,
    "user_query": "Where is the proteasome located?",
    "vicuna-13b_response": "The proteasome is a large intracellular protein complex that is found in all eukaryotic cells. It is responsible for regulating the balance of proteins within the cell by breaking down unnecessary or damaged proteins and recycling their amino acids.\nThe proteasome is composed of several different subunits, including a catalytic core complex and several regulatory subunits. The catalytic core complex is responsible for the actual proteolytic activity, or breakdown of proteins, while the regulatory subunits help to control the activity of the proteasome.\nThe proteasome is located in the cytoplasm of cells, as well as in the endoplasmic reticulum and the Golgi apparatus. It is also found in the mitochondria and the endoplasmic reticulum of some cells. The proteasome is a dynamic structure that is constantly moving and changing, and it is involved in a wide range of cellular processes, including protein folding, transport, and degradation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The proteasome is a large intracellular protein complex found in all eukaryotic cells.\n2. The proteasome regulates the balance of proteins within the cell by breaking down unnecessary or damaged proteins and recycling their amino acids.\n3. The proteasome is composed of a catalytic core complex and several regulatory subunits.\n4. The proteasome is located in the cytoplasm, the endoplasmic reticulum, the Golgi apparatus, and in the mitochondria of some cells.\n5. The proteasome is involved in a wide range of cellular processes, including protein folding, transport, and degradation.",
    "vicuna-13b_fact": [
      "The proteasome is a large intracellular protein complex found in all eukaryotic cells.",
      "The proteasome regulates the balance of proteins within the cell by breaking down unnecessary or damaged proteins and recycling their amino acids.",
      "The proteasome is composed of a catalytic core complex and several regulatory subunits.",
      "The proteasome is located in the cytoplasm, the endoplasmic reticulum, the Golgi apparatus, and in the mitochondria of some cells.",
      "The proteasome is involved in a wide range of cellular processes, including protein folding, transport, and degradation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1923,
    "user_query": "List available circular RNA prediction tools.",
    "vicuna-13b_response": "Circular RNA (circRNA) prediction tools are software programs that use computational methods to identify and predict the existence of circRNAs in a given RNA sequencing (RNA-seq) dataset. Here are some available circular RNA prediction tools:\n1. CircRNA (<https://www.circrna.org/>): CircRNA is a web-based tool that predicts circRNAs from RNA-seq data using a combination of machine learning and rule-based methods. It can also predict the expression levels of circRNAs and their potential functions.\n2. CIRCexplorer (<https://www.circularity.com/circlexplorer/>): CIRCexplorer is a desktop application that predicts circRNAs from RNA-seq data using a combination of machine learning and rule-based methods. It can also visualize the predicted circRNAs and their potential functions.\n3. RNAfold (<https://rna.bio.ku.dk/RNAfold.html>): RNAfold is a web-based tool that predicts the formation of RNA structures, including circRNAs, from RNA sequence data. It can also predict the thermodynamic stability of RNA structures.\n4. RNA3D (<https://rna3d.dcode.org/>): RNA3D is a web-based tool that predicts the three-dimensional structures of RNA molecules, including circRNAs, from RNA sequence data. It can also predict the binding affinity of RNA molecules to other molecules.\n5. HISAT2 (<https://www.ebi.ac.uk/tools/hisat2>): HISAT2 is a command-line tool that can be used to identify and align RNA-seq data to a reference genome. It can also be used to identify circRNAs by aligning the RNA-seq data to a reference transcriptome.\n6. STAR (<https://www.ncbi.nlm.nih.gov/star/>): STAR is a command-line tool that can be used to align RNA-seq data to a reference genome. It can also be used to identify circRNAs by aligning the RNA-seq data to a reference transcriptome.\n7. TopHat",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Circular RNA (circRNA) prediction tools use computational methods to identify and predict the existence of circRNAs in an RNA sequencing (RNA-seq) dataset.\n2. CircRNA is a web-based tool that predicts circRNAs from RNA-seq data.\n3. CIRCexplorer is a desktop application that predicts circRNAs from RNA-seq data.\n4. RNAfold is a web-based tool that predicts the formation of RNA structures, including circRNAs, from RNA sequence data.\n5. HISAT2 is a command-line tool that can be used to identify and align RNA-seq data to a reference genome. \n6. STAR is a command-line tool that can be used to align RNA-seq data to a reference genome.",
    "vicuna-13b_fact": [
      "Circular RNA (circRNA) prediction tools use computational methods to identify and predict the existence of circRNAs in an RNA sequencing (RNA-seq) dataset.",
      "CircRNA is a web-based tool that predicts circRNAs from RNA-seq data.",
      "CIRCexplorer is a desktop application that predicts circRNAs from RNA-seq data.",
      "RNAfold is a web-based tool that predicts the formation of RNA structures, including circRNAs, from RNA sequence data.",
      "HISAT2 is a command-line tool that can be used to identify and align RNA-seq data to a reference genome.",
      "STAR is a command-line tool that can be used to align RNA-seq data to a reference genome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: CircRNA is not a web-based tool. There are multiple tools that can predict circRNAs from RNA-seq data.\n3. TRUE\n4. FALSE [correction]: RNAfold is a tool that predicts the secondary structure of a single stranded RNA or DNA sequence. It doesn't specifically predict circRNAs. \n5. TRUE\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1924,
    "user_query": "Which disease is treated with Nusinersen?",
    "vicuna-13b_response": "Nusinersen is a medication that is used to treat a rare genetic disorder called spinal muscular atrophy (SMA). SMA is a progressive neurodegenerative disorder that affects the motor neurons in the spinal cord and brainstem, leading to muscle weakness and atrophy. Nusinersen is an antisense oligonucleotide, which means it is a type of medication that works by targeting the messenger RNA (mRNA) of the survival motor neuron (SMN1) gene. By doing so, it helps to increase the production of a protein called survival motor neuron (SMN), which is essential for the survival of motor neurons. Nusinersen is administered through a spinal injection and is approved for use in patients with SMA types 1, 2, and 3.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nusinersen is used to treat spinal muscular atrophy (SMA).\n2. Spinal muscular atrophy is a progressive neurodegenerative disorder that affects the motor neurons in the spinal cord and brainstem.\n3. Nusinersen is an antisense oligonucleotide.\n4. Nusinersen works by targeting the messenger RNA (mRNA) of the survival motor neuron (SMN1) gene.\n5. Nusinersen is administered through a spinal injection and is approved for use in patients with SMA types 1, 2, and 3.",
    "vicuna-13b_fact": [
      "Nusinersen is used to treat spinal muscular atrophy (SMA).",
      "Spinal muscular atrophy is a progressive neurodegenerative disorder that affects the motor neurons in the spinal cord and brainstem.",
      "Nusinersen is an antisense oligonucleotide.",
      "Nusinersen works by targeting the messenger RNA (mRNA) of the survival motor neuron (SMN1) gene.",
      "Nusinersen is administered through a spinal injection and is approved for use in patients with SMA types 1, 2, and 3."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Nusinersen works by targeting the messenger RNA (mRNA) of the survival motor neuron (SMN2) gene.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1925,
    "user_query": "Which disease the London mutation involved in?",
    "vicuna-13b_response": "The London mutation refers to a specific genetic mutation that is associated with a condition called Bloom syndrome. Bloom syndrome is a rare genetic disorder that affects approximately 1 in 250,000 people worldwide.\nThe London mutation is one of several mutations that can cause Bloom syndrome. It is named after the London Hospital, where the condition was first described in 1954. The London mutation is located on the ninth chromosome and involves a deletion of a specific sequence of DNA bases.\nPeople with Bloom syndrome are at increased risk of developing certain cancers, particularly cancer of the colon and cervix. They are also at increased risk of developing other health problems, such as gastrointestinal problems, hearing loss, and a higher risk of infections.\nThere is no cure for Bloom syndrome, and treatment is focused on managing symptoms and reducing the risk of complications. People with Bloom syndrome should receive regular medical care and monitoring to help manage their condition and prevent complications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The London mutation is associated with Bloom syndrome.\n2. Bloom syndrome is a rare genetic disorder that affects approximately 1 in 250,000 people worldwide.\n3. The London mutation is one of several mutations that can cause Bloom syndrome.\n4. People with Bloom syndrome are at increased risk of developing certain cancers, particularly cancer of the colon and cervix.\n5. There is no cure for Bloom syndrome, and treatment is focused on managing symptoms and reducing the risk of complications.",
    "vicuna-13b_fact": [
      "The London mutation is associated with Bloom syndrome.",
      "Bloom syndrome is a rare genetic disorder that affects approximately 1 in 250,000 people worldwide.",
      "The London mutation is one of several mutations that can cause Bloom syndrome.",
      "People with Bloom syndrome are at increased risk of developing certain cancers, particularly cancer of the colon and cervix.",
      "There is no cure for Bloom syndrome, and treatment is focused on managing symptoms and reducing the risk of complications."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: People with Bloom syndrome are at increased risk of developing various types of cancer, including leukemia and cancers of the breast, ovary, gastrointestinal tract and skin. The specific mention of colon and cervical cancer is not accurate.\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 1930,
    "user_query": "Viliuisk encephalomyelitis is diagnosed in which geographical area?",
    "vicuna-13b_response": "Viliuisk encephalomyelitis is a rare disease that has been reported primarily in the former Soviet Union countries, such as Lithuania, Latvia, and Estonia. It is caused by a virus called Borrelia viliuiskensis, which is transmitted to humans through the bite of infected ticks. The disease primarily affects the central nervous system and can cause a range of symptoms, including fever, headache, fatigue, and muscle weakness. It can also cause neurological complications such as meningitis, encephalitis, and myelitis.\nDiagnosis of Viliuisk encephalomyelitis can be challenging, as the symptoms are similar to those of other tick-borne diseases. The diagnosis is typically made based on a combination of clinical presentation, laboratory tests, and epidemiological data. Serological tests, such as enzyme-linked immunosorbent assay (ELISA) and Western blot, can be used to detect antibodies against B. viliuiskensis in the blood. PCR (polymerase chain reaction) can also be used to detect the virus in the blood or cerebrospinal fluid.\nThere is no specific treatment for Viliuisk encephalomyelitis, and the management of the disease is largely supportive. Antibiotics, such as doxycycline and rifampin, can be used to treat the tick-borne disease, but they are not effective against the virus itself. Patients with severe symptoms may require hospitalization and intensive care. Prevention measures include using tick repellents, wearing protective clothing, and avoiding tick-endemic areas.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Viliuisk encephalomyelitis has been primarily reported in the former Soviet Union countries like Lithuania, Latvia, and Estonia.\n2. The disease is caused by a virus called Borrelia viliuiskensis, which is transmitted to humans through the bite of infected ticks.\n3. Diagnosis of Viliuisk encephalomyelitis includes clinical presentation, laboratory tests, and epidemiological data.\n4. Tests like ELISA and Western blot can be used to detect antibodies against B. viliuiskensis in the blood and PCR can detect the virus in the blood or cerebrospinal fluid.\n5. Antibiotics, such as doxycycline and rifampin, can be used to treat the tick-borne disease, but they are not effective against the virus itself.",
    "vicuna-13b_fact": [
      "Viliuisk encephalomyelitis has been primarily reported in the former Soviet Union countries like Lithuania, Latvia, and Estonia.",
      "The disease is caused by a virus called Borrelia viliuiskensis, which is transmitted to humans through the bite of infected ticks.",
      "Diagnosis of Viliuisk encephalomyelitis includes clinical presentation, laboratory tests, and epidemiological data.",
      "Tests like ELISA and Western blot can be used to detect antibodies against B. viliuiskensis in the blood and PCR can detect the virus in the blood or cerebrospinal fluid.",
      "Antibiotics, such as doxycycline and rifampin, can be used to treat the tick-borne disease, but they are not effective against the virus itself."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Viliuisk encephalomyelitis has been primarily reported in East Siberia, not in former Soviet Union countries like Lithuania, Latvia, and Estonia.\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1934,
    "user_query": "What makes telomerase a good drug target?",
    "vicuna-13b_response": "Telomerase is an enzyme that is responsible for maintaining the length of telomeres, which are the protective endcaps of chromosomes. Telomeres are gradually shortened as cells divide, and when they become too short, cells can no longer divide and undergo senescence, which is a state of irreversible cell growth arrest. This is thought to play a role in the aging process and the development of age-related diseases.\nTelomerase is unique among enzymes in that it has the ability to extend telomeres by adding TTAGGG repeats to their ends. This allows cells to maintain their telomere length and continue to divide, which is why telomerase is considered a potential drug target for a variety of diseases.\nOne of the main reasons that telomerase is a good drug target is that it is active in many types of cancer, including cancer stem cells. Cancer stem cells are a subpopulation of cells within a tumor that have the ability to self-renew and give rise to all of the different cell types within the tumor. By targeting telomerase in these cells, it may be possible to inhibit their proliferation and the growth of the tumor.\nIn addition to its role in cancer, telomerase is also active in many other types of cells, including immune cells and stem cells. This makes it a potential target for a variety of diseases, including autoimmune diseases and degenerative diseases.\nOverall, telomerase is a good drug target because it has a specific and unique role in cell biology, and its inhibition has the potential to have a wide range of therapeutic effects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Telomerase is an enzyme that is responsible for maintaining the length of telomeres.\n2. Telomeres are gradually shortened as cells divide, and when they become too short, cells undergo senescence.\n3. Telomerase has the ability to extend telomeres by adding TTAGGG repeats to their ends, allowing cells to maintain their telomere length.\n4. Telomerase is active in many types of cancer, including cancer stem cells.\n5. Telomerase is also active in other types of cells, such as immune cells and stem cells.",
    "vicuna-13b_fact": [
      "Telomerase is an enzyme that is responsible for maintaining the length of telomeres.",
      "Telomeres are gradually shortened as cells divide, and when they become too short, cells undergo senescence.",
      "Telomerase has the ability to extend telomeres by adding TTAGGG repeats to their ends, allowing cells to maintain their telomere length.",
      "Telomerase is active in many types of cancer, including cancer stem cells.",
      "Telomerase is also active in other types of cells, such as immune cells and stem cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "vicuna-13b_response": "NADPH oxidase 5, also known as NOX5, is a complex enzyme that generates reactive oxygen species (ROS) in response to various stimuli. While NOX5 can function as a homodimer, it also requires the presence of specific subunits for full activity.\nThe NOX5 enzyme consists of four subunits: p22phox, p40phox, p47phox, and p67phox. The first three subunits, p22phox, p40phox, and p47phox, are essential for the assembly and function of NOX5. The p22phox subunit contains the flavin adenine dinucleotide (FAD) binding site, while the p40phox and p47phox subunits contribute to the cytochrome b558 domain. The p67phox subunit, also known as RAC2, is not essential for NOX5 function but can modulate its activity.\nMutations in any of the NOX5 subunits can lead to altered enzymatic activity or dysfunction, and some of these mutations have been associated with human diseases such as chronic granulomatous disease (CGD) and age-related macular degeneration (AMD).\nIn summary, while NOX5 can function as a homodimer, it requires the presence of specific subunits for full activity. The p22phox, p40phox, and p47phox subunits are essential for NOX5 assembly and function, while the p67phox subunit can modulate its activity.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. NADPH oxidase 5, also known as NOX5, generates reactive oxygen species (ROS) in response to various stimuli.\n2. NOX5 can function as a homodimer, but also requires specific subunits for full activity.\n3. The NOX5 enzyme consists of four subunits: p22phox, p40phox, p47phox, and p67phox. \n4. Mutations in any of the NOX5 subunits can lead to altered enzymatic activity or dysfunction. \n5. Some mutations in NOX5 subunits have been associated with human diseases such as chronic granulomatous disease (CGD) and age-related macular degeneration (AMD).",
    "vicuna-13b_fact": [
      "NADPH oxidase 5, also known as NOX5, generates reactive oxygen species (ROS) in response to various stimuli.",
      "NOX5 can function as a homodimer, but also requires specific subunits for full activity.",
      "The NOX5 enzyme consists of four subunits: p22phox, p40phox, p47phox, and p67phox.",
      "Mutations in any of the NOX5 subunits can lead to altered enzymatic activity or dysfunction.",
      "Some mutations in NOX5 subunits have been associated with human diseases such as chronic granulomatous disease (CGD) and age-related macular degeneration (AMD)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: NOX5 does not require specific subunits to function and can function as a monomer.\n3. FALSE [correction]: The NOX5 enzyme does not consist of these subunits. It is the other NOX enzymes (e.g., NOX2) that have these four subunits.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1940,
    "user_query": "What is the doRiNA database?",
    "vicuna-13b_response": "The doRiNA (Disease Relationship Network Analysis) database is a comprehensive resource for exploring the complex network of relationships between diseases and other biological entities such as genes, drugs, and proteins. It was created by researchers at the University of California, San Diego, and was first made available in 2019.\nThe doRiNA database contains information on over 2,500 diseases and over 15,000 biological entities, including both human and model organism data. The database is built on a graph-based representation of the relationships between diseases and other biological entities, with each disease and entity represented as a node in the graph. The edges between nodes represent the relationships between diseases and other biological entities, such as whether a gene is associated with a particular disease or whether a drug is used to treat a particular condition.\nThe doRiNA database is designed to be user-friendly and accessible to researchers of all levels of expertise. It includes a range of tools for exploring the data, including search functions, visualization tools, and network analysis tools. The database is also regularly updated with new data and features, making it a valuable resource for researchers in the fields of genomics, systems biology, and personalized medicine.\nOverall, the doRiNA database is an important resource for researchers seeking to understand the complex network of relationships between diseases and other biological entities, and to identify potential new targets for disease treatment and prevention.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The doRiNA database is a resource for exploring relationships between diseases and other biological entities such as genes, drugs, and proteins.\n2. The doRiNA database was created by researchers at the University of California, San Diego.\n3. The doRiNA database was first made available in 2019.\n4. The database contains information on over 2,500 diseases and over 15,000 biological entities.\n5. The doRiNA database includes tools for exploring the data, such as search functions, visualization tools, and network analysis tools.",
    "vicuna-13b_fact": [
      "The doRiNA database is a resource for exploring relationships between diseases and other biological entities such as genes, drugs, and proteins.",
      "The doRiNA database was created by researchers at the University of California, San Diego.",
      "The doRiNA database was first made available in 2019.",
      "The database contains information on over 2,500 diseases and over 15,000 biological entities.",
      "The doRiNA database includes tools for exploring the data, such as search functions, visualization tools, and network analysis tools."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1942,
    "user_query": "Is pseudouridine a RNA modification?",
    "vicuna-13b_response": "Yes, pseudouridine is a type of RNA modification. It is a common modification found in RNA molecules, particularly in ribosomal RNA and transfer RNA, where it can play a role in protein synthesis and other cellular processes.\nPseudouridine is formed by the conversion of uridine residues to pseudouridine residues through the action of specific enzymes called ribonucleosyltransferases (RNTs). This modification involves the transfer of a molecule of ribose from uridine to the N-1 position of adenosine, resulting in the formation of a 2',3'-cyclophosphate group at the N-1 position of adenosine.\nPseudouridine can affect the stability, folding, and function of RNA molecules, and its levels can be regulated by various factors, including cellular stress, developmental stage, and environmental cues. The study of RNA modifications, including pseudouridine, is an active area of research, with implications for understanding cellular processes, disease pathogenesis, and potential therapeutic targets.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pseudouridine is a type of RNA modification.\n2. Pseudouridine is commonly found in ribosomal RNA and transfer RNA.\n3. Pseudouridine can play a role in protein synthesis and other cellular processes.\n4. Pseudouridine is formed by the conversion of uridine residues to pseudouridine residues through the action of specific enzymes called ribonucleosyltransferases (RNTs).\n5. The study of RNA modifications, including pseudouridine, is an active area of research.",
    "vicuna-13b_fact": [
      "Pseudouridine is a type of RNA modification.",
      "Pseudouridine is commonly found in ribosomal RNA and transfer RNA.",
      "Pseudouridine can play a role in protein synthesis and other cellular processes.",
      "Pseudouridine is formed by the conversion of uridine residues to pseudouridine residues through the action of specific enzymes called ribonucleosyltransferases (RNTs).",
      "The study of RNA modifications, including pseudouridine, is an active area of research."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Pseudouridine is formed by the conversion of uridine residues to pseudouridine residues through the action of specific enzymes called Pseudouridine Synthases.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1943,
    "user_query": "What does the human ABCC gene  product do?",
    "vicuna-13b_response": "The human ABCC gene encodes for the ABC transporter protein known as the multidrug resistance protein 1 (MRP1). MRP1 is a membrane-bound protein that plays an important role in the transport of a variety of substances across the cell membrane, including xenobiotics (foreign compounds) and lipids.\nMRP1 is expressed in many tissues, including the liver, intestine, and kidney, and it is involved in the elimination of a wide range of compounds from the body, including drugs, toxins, and metabolites. MRP1 is also involved in the regulation of cellular Ca2+ levels and has been implicated in a number of cellular processes, including cell proliferation, differentiation, and apoptosis (programmed cell death).\nMutations in the ABCC gene have been associated with a number of human diseases, including cancer, neurological disorders, and inherited metabolic disorders. Dysfunction of MRP1 has also been implicated in a number of drug-related side effects and toxicities.\nOverall, the human ABCC gene product plays a critical role in the transport and elimination of a variety of substances from the body, and its dysfunction has been linked to a number of human diseases and drug-related side effects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The human ABCC gene encodes for the ABC transporter protein, also known as the multidrug resistance protein 1 (MRP1).\n2. MRP1 is involved in the transport of a variety of substances across the cell membrane, including xenobiotics and lipids.\n3. MRP1 is expressed in many tissues, including the liver, intestine, and kidney.\n4. MRP1 is involved in the elimination of a wide range of compounds from the body, including drugs, toxins, and metabolites.\n5. Mutations in the ABCC gene have been associated with a number of human diseases, including cancer, neurological disorders, and inherited metabolic disorders.",
    "vicuna-13b_fact": [
      "The human ABCC gene encodes for the ABC transporter protein, also known as the multidrug resistance protein 1 (MRP1).",
      "MRP1 is involved in the transport of a variety of substances across the cell membrane, including xenobiotics and lipids.",
      "MRP1 is expressed in many tissues, including the liver, intestine, and kidney.",
      "MRP1 is involved in the elimination of a wide range of compounds from the body, including drugs, toxins, and metabolites.",
      "Mutations in the ABCC gene have been associated with a number of human diseases, including cancer, neurological disorders, and inherited metabolic disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "vicuna-13b_response": "Furin and hepcidin are both proteases, which are enzymes that break down other proteins. Furin is a type of protease that is involved in the processing of many different proteins, including the precursor of hepcidin.\nHepcidin is a small peptide hormone that is involved in regulating iron metabolism in the body. It is produced by the liver and released into the bloodstream, where it binds to and inhibits the activity of the iron transport protein transferrin. This causes the liver to release stored iron into the bloodstream, where it can be used by other tissues.\nThe connection between furin and hepcidin is that furin is involved in the processing of the precursor protein that is converted into hepcidin. Specifically, furin cleaves the precursor protein at a specific site, releasing the mature hepcidin peptide. This processing step is necessary for the proper functioning of hepcidin and its regulation of iron metabolism in the body.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Furin and hepcidin are both proteases.\n2. Furin is involved in the processing of many different proteins, including the precursor of hepcidin.\n3. Hepcidin is a small peptide hormone that regulates iron metabolism in the body.\n4. Hepcidin is produced by the liver and inhibits the activity of the iron transport protein transferrin.\n5. The connection between furin and hepcidin is that furin cleaves the precursor protein at a specific site, releasing the mature hepcidin peptide.",
    "vicuna-13b_fact": [
      "Furin and hepcidin are both proteases.",
      "Furin is involved in the processing of many different proteins, including the precursor of hepcidin.",
      "Hepcidin is a small peptide hormone that regulates iron metabolism in the body.",
      "Hepcidin is produced by the liver and inhibits the activity of the iron transport protein transferrin.",
      "The connection between furin and hepcidin is that furin cleaves the precursor protein at a specific site, releasing the mature hepcidin peptide."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Furin is a protease, but hepcidin is not. Hepcidin is a small peptide hormone that regulates iron metabolism in the body.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Hepcidin is produced by the liver and inhibits the activity of the iron transport protein ferroportin, not transferrin.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1951,
    "user_query": "What is the incidence of new cases of X-linked adrenoleukodystrophy (ALD) in Australian and New Zealand in the late 1990's?",
    "vicuna-13b_response": "X-linked adrenoleukodystrophy (ALD) is a rare genetic disorder that affects the metabolism of fatty acids. It is caused by a deficiency in the enzyme adrenoleukodystrophy protein (ALDP), which is involved in the breakdown of very long chain fatty acids.\nThe incidence of new cases of X-linked adrenoleukodystrophy (ALD) in Australian and New Zealand in the late 1990's is not readily available. However, it is estimated that the incidence of ALD is approximately 1 in 18,000 live male births.\nIt is important to note that this is an estimate and the actual incidence may vary. Also, it is worth mentioning that ALD is more common in boys than in girls, as it is X-linked recessive disorder, meaning that the gene is located on the X chromosome and that the disorder only affects boys because they only have one X chromosome, while girls have two X chromosomes.\nIt is also worth noting that the availability of newborn screening programs for ALD has improved over the years, which allows for early detection and treatment of the disorder. This can help to prevent the severe neurological symptoms associated with the disorder.\nIt is important to note that the information provided here is general and should not be used as a substitute for professional medical advice. If you have any concerns about X-linked adrenoleukodystrophy (ALD) or any other medical condition, it is best to consult a qualified healthcare provider.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. X-linked adrenoleukodystrophy (ALD) is a rare genetic disorder that affects the metabolism of fatty acids.\n2. ALD is caused by a deficiency in the enzyme adrenoleukodystrophy protein (ALDP).\n3. This enzyme is involved in the breakdown of very long chain fatty acids.\n4. It is estimated that the incidence of ALD is approximately 1 in 18,000 live male births.\n5. ALD is more common in boys than in girls, as it is an X-linked recessive disorder.",
    "vicuna-13b_fact": [
      "X-linked adrenoleukodystrophy (ALD) is a rare genetic disorder that affects the metabolism of fatty acids.",
      "ALD is caused by a deficiency in the enzyme adrenoleukodystrophy protein (ALDP).",
      "This enzyme is involved in the breakdown of very long chain fatty acids.",
      "It is estimated that the incidence of ALD is approximately 1 in 18,000 live male births.",
      "ALD is more common in boys than in girls, as it is an X-linked recessive disorder."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1952,
    "user_query": "Can telomere length shortening be reversed by telomerase?",
    "vicuna-13b_response": "Telomere length shortening is a natural process that occurs as we age, but it can also be caused by factors such as stress, inflammation, and poor lifestyle choices. Telomerase is an enzyme that can slow down or even reverse telomere shortening by adding DNA repeats to the ends of chromosomes.\nTelomerase is active in most cells throughout our lives, but its activity decreases as we age. This is one reason why telomeres shorten over time and why cells can no longer divide as efficiently. However, some cells, such as stem cells, have high levels of telomerase activity, which allows them to maintain their telomere length and continue to divide.\nStudies have shown that telomerase can slow down or even reverse telomere shortening in some cells and tissues. For example, in a study published in the journal Nature Medicine, researchers found that telomerase activity was higher in people with longer telomeres, suggesting that telomerase may be able to slow down telomere shortening.\nIn addition, some lifestyle factors, such as regular exercise, a healthy diet, and stress management, have been shown to increase telomerase activity and slow down telomere shortening.\nOverall, while telomere shortening is a natural process that cannot be completely reversed, telomerase activity can slow down the process and potentially even reverse it in some cases. However, more research is needed to fully understand the role of telomerase in telomere maintenance and its potential as a therapeutic target for age-related diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Telomere length shortening is a natural process that occurs as we age.\n2. Telomerase can slow down or even reverse telomere shortening by adding DNA repeats to the ends of chromosomes.\n3. Telomerase activity decreases as we age.\n4. Some cells, such as stem cells, have high levels of telomerase activity, which allows them to maintain their telomere length and continue to divide.\n5. Some lifestyle factors, like regular exercise, a healthy diet, and stress management, have been shown to increase telomerase activity and slow down telomere shortening.",
    "vicuna-13b_fact": [
      "Telomere length shortening is a natural process that occurs as we age.",
      "Telomerase can slow down or even reverse telomere shortening by adding DNA repeats to the ends of chromosomes.",
      "Telomerase activity decreases as we age.",
      "Some cells, such as stem cells, have high levels of telomerase activity, which allows them to maintain their telomere length and continue to divide.",
      "Some lifestyle factors, like regular exercise, a healthy diet, and stress management, have been shown to increase telomerase activity and slow down telomere shortening."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1953,
    "user_query": "Is ABCE1 involved in ribosomal recycling?",
    "vicuna-13b_response": "I'm sorry, but I'm not sure what you mean by \"ABCE1.\" Could you please provide more context or clarify your question?",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 1955,
    "user_query": "Does oculocutaneous albinism show an autosomal recessive inheritance?",
    "vicuna-13b_response": "Oculocutaneous albinism (OCA) is a genetic disorder that affects the production of melanin, a pigment that gives color to the skin, hair, and eyes. OCA can be inherited in different ways, including autosomal recessive inheritance.\nAutosomal recessive inheritance means that the gene for the disorder is located on one of the non-sex chromosomes (autosomes) and that two copies of the gene, one inherited from each parent, are necessary to develop the disorder. An individual who inherits one normal gene and one gene for the disorder from their parents is a carrier of the disorder and will not show symptoms, but can pass the gene on to their children.\nOCA is inherited in this way, and it is estimated that about 90% of cases are inherited through autosomal recessive inheritance. This means that an individual who has a parent with OCA has a 25% chance of inheriting the disorder, a 25% chance of being a carrier, and a 50% chance of inheriting two normal genes and being unaffected.\nIt's important to note that there are other forms of albinism that are inherited in different ways, such as X-linked recessive inheritance and dominant inheritance.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Oculocutaneous albinism (OCA) is a genetic disorder that affects the production of melanin.\n2. OCA can be inherited through autosomal recessive inheritance.\n3. Autosomal recessive inheritance means that the gene for the disorder is located on one of the non-sex chromosomes and two copies of the gene, one from each parent, are needed to develop the disorder.\n4. Approximately 90% of OCA cases are inherited through autosomal recessive inheritance.\n5. There are other forms of albinism that are inherited in different ways, such as X-linked recessive inheritance and dominant inheritance.",
    "vicuna-13b_fact": [
      "Oculocutaneous albinism (OCA) is a genetic disorder that affects the production of melanin.",
      "OCA can be inherited through autosomal recessive inheritance.",
      "Autosomal recessive inheritance means that the gene for the disorder is located on one of the non-sex chromosomes and two copies of the gene, one from each parent, are needed to develop the disorder.",
      "Approximately 90% of OCA cases are inherited through autosomal recessive inheritance.",
      "There are other forms of albinism that are inherited in different ways, such as X-linked recessive inheritance and dominant inheritance."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "vicuna-13b_response": "The largest metabolic gene cluster in yeast is the glycolytic pathway, which is responsible for the breakdown of glucose into carbon dioxide and ethanol. This pathway involves a series of enzymatic reactions that convert glucose into pyruvate, which is then converted into ethanol and carbon dioxide through the fermentation process. The glycolytic pathway is essential for the survival of yeast, as it provides the energy required for cell growth and reproduction.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The largest metabolic gene cluster in yeast is the glycolytic pathway.\n2. The glycolytic pathway in yeast is responsible for the breakdown of glucose into carbon dioxide and ethanol.\n3. This pathway involves enzymatic reactions that convert glucose into pyruvate, which is then converted into ethanol and carbon dioxide.\n4. The glycolytic pathway is essential for the survival of yeast, providing the energy required for cell growth and reproduction.",
    "vicuna-13b_fact": [
      "The largest metabolic gene cluster in yeast is the glycolytic pathway.",
      "The glycolytic pathway in yeast is responsible for the breakdown of glucose into carbon dioxide and ethanol.",
      "This pathway involves enzymatic reactions that convert glucose into pyruvate, which is then converted into ethanol and carbon dioxide.",
      "The glycolytic pathway is essential for the survival of yeast, providing the energy required for cell growth and reproduction."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1958,
    "user_query": "Which ApoE isoform is associated with atherosclerosis and Alzheimer's disease?",
    "vicuna-13b_response": "ApoE (apolipoprotein E) is a protein that plays a critical role in lipid metabolism and transport. There are several isoforms of ApoE, including ApoE2, ApoE3, and ApoE4.\nApoE4 is the isoform that has been most strongly associated with an increased risk of both atherosclerosis and Alzheimer's disease. ApoE4 is a risk factor for both of these conditions, and it is also a biomarker for these diseases.\nApoE4 is thought to increase the risk of atherosclerosis by promoting the uptake of cholesterol and other lipids by macrophages, which are immune cells that play a role in the development of atherosclerotic plaques. ApoE4 is also thought to contribute to the development of Alzheimer's disease by promoting the formation of amyloid-beta plaques, which are a hallmark of the disease.\nOverall, ApoE4 is the isoform most strongly associated with atherosclerosis and Alzheimer's disease, and it is an important biomarker for these conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ApoE is a protein that plays a critical role in lipid metabolism and transport.\n2. There are several isoforms of ApoE, including ApoE2, ApoE3, and ApoE4.\n3. The ApoE4 isoform is strongly associated with an increased risk of atherosclerosis and Alzheimer's disease.\n4. ApoE4 is a risk factor and biomarker for both atherosclerosis and Alzheimer's disease.\n5. ApoE4 is thought to increase the risk of atherosclerosis by promoting the uptake of cholesterol and other lipids by macrophages.",
    "vicuna-13b_fact": [
      "ApoE is a protein that plays a critical role in lipid metabolism and transport.",
      "There are several isoforms of ApoE, including ApoE2, ApoE3, and ApoE4.",
      "The ApoE4 isoform is strongly associated with an increased risk of atherosclerosis and Alzheimer's disease.",
      "ApoE4 is a risk factor and biomarker for both atherosclerosis and Alzheimer's disease.",
      "ApoE4 is thought to increase the risk of atherosclerosis by promoting the uptake of cholesterol and other lipids by macrophages."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1960,
    "user_query": "What organism causes woolsorter's disease",
    "vicuna-13b_response": "Woolsorter's disease is caused by the bacterium Corynebacterium anthropi. It is a rare but serious infection that primarily affects sheep and goats, although it can also affect other animals and humans. The bacteria infect the skin and cause lesions, which can lead to hair loss and other skin problems. If left untreated, the infection can spread to the bloodstream and cause more severe illness. Treatment typically involves antibiotics and supportive care, such as wound care and fluid therapy. Prevention measures include vaccination and good hygiene practices in animal husbandry and wool processing.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Woolsorter's disease is caused by the bacterium Corynebacterium anthropi.\n2. Woolsorter's disease primarily affects sheep and goats but can also affect other animals and humans.\n3. Corynebacterium anthropi infects the skin and causes lesions that can lead to hair loss and other skin problems.\n4. If left untreated, the infection can spread to the bloodstream and cause more severe illness.\n5. Treatment for woolsorter's disease typically involves antibiotics and supportive care such as wound care and fluid therapy.",
    "vicuna-13b_fact": [
      "Woolsorter's disease is caused by the bacterium Corynebacterium anthropi.",
      "Woolsorter's disease primarily affects sheep and goats but can also affect other animals and humans.",
      "Corynebacterium anthropi infects the skin and causes lesions that can lead to hair loss and other skin problems.",
      "If left untreated, the infection can spread to the bloodstream and cause more severe illness.",
      "Treatment for woolsorter's disease typically involves antibiotics and supportive care such as wound care and fluid therapy."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Woolsorter's disease is caused by the bacterium Bacillus anthracis.\n2. TRUE\n3. FALSE [correction]: Corynebacterium anthropi is a bacterium that can infect humans, often causing skin infections. Bacillus anthracis, the cause of Woolsorter's disease, infects through spores and cause lesions that can lead to sepsis in severe cases.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1963,
    "user_query": "Which protein complexes recognize centromeric (CEN) DNA in yeast?",
    "vicuna-13b_response": "In yeast, several protein complexes have been identified that recognize centromeric (CEN) DNA. These complexes include:\n1. Cdc48/Hsl1/Hsl7 complex: This complex is composed of the Cdc48/Hsl1/Hsl7 proteins and is responsible for the recognition and degradation of CEN DNA.\n2. Sgo1/Sgo2/Sgo3 complex: This complex is composed of the Sgo1/Sgo2/Sgo3 proteins and is involved in the recognition and protection of CEN DNA.\n3. Ndc10/Ndc80 complex: This complex is composed of the Ndc10/Ndc80 proteins and is involved in the recognition and assembly of the mitotic spindle around the CEN DNA.\n4. Cenp-A/Cenp-C/Cenp-I complex: This complex is composed of the Cenp-A/Cenp-C/Cenp-I proteins and is involved in the recognition and assembly of the kinetochore, which is responsible for the attachment of the mitotic spindle to the CEN DNA.\nOverall, these protein complexes play important roles in the recognition and regulation of CEN DNA in yeast, and their dysfunction can lead to abnormal cell division and other cellular defects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. In yeast, the Cdc48/Hsl1/Hsl7 complex is responsible for the recognition and degradation of centromeric (CEN) DNA. \n2. The Sgo1/Sgo2/Sgo3 complex in yeast is involved in the recognition and protection of CEN DNA. \n3. The Ndc10/Ndc80 complex in yeast is involved in the recognition and assembly of the mitotic spindle around the CEN DNA. \n4. The Cenp-A/Cenp-C/Cenp-I complex in yeast is involved in the recognition and assembly of the kinetochore, which is responsible for the attachment of the mitotic spindle to the CEN DNA. \n5. Dysfunctions in these yeast protein complexes can lead to abnormal cell division and other cellular defects.",
    "vicuna-13b_fact": [
      "In yeast, the Cdc48/Hsl1/Hsl7 complex is responsible for the recognition and degradation of centromeric (CEN) DNA.",
      "The Sgo1/Sgo2/Sgo3 complex in yeast is involved in the recognition and protection of CEN DNA.",
      "The Ndc10/Ndc80 complex in yeast is involved in the recognition and assembly of the mitotic spindle around the CEN DNA.",
      "The Cenp-A/Cenp-C/Cenp-I complex in yeast is involved in the recognition and assembly of the kinetochore, which is responsible for the attachment of the mitotic spindle to the CEN DNA.",
      "Dysfunctions in these yeast protein complexes can lead to abnormal cell division and other cellular defects."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. FALSE [correction]: The Cenp-A/Cenp-C/Cenp-I complex is not present in yeast. The equivalent complex in yeast is the Ctf19/Mcm21/Okp1 complex which is involved in the recognition and assembly of the kinetochore.\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1966,
    "user_query": "What is the function of yeast Clr4 on chromatin?",
    "vicuna-13b_response": "Yeast Clr4 is a chromatin-associated protein that plays a role in regulating the structure and function of chromatin. Chromatin is the complex of DNA, RNA, and proteins that makes up the chromosomes in the nucleus of a cell.\nClr4 is a member of the SWI/SNF chromatin-remodeling complex, which is responsible for altering the structure of chromatin to make it more accessible to the transcriptional machinery. Specifically, Clr4 helps to remove nucleosomes, which are the basic building blocks of chromatin, from the DNA. This process, known as chromatin remodeling, helps to make the DNA more accessible to the enzymes that are responsible for transcribing the genetic information into RNA.\nIn addition to its role in chromatin remodeling, Clr4 also plays a role in regulating the activity of transcription factors, which are proteins that bind to specific sequences of DNA and control the expression of genes. Clr4 helps to recruit transcription factors to specific regions of the genome, and it may also help to regulate the activity of these factors once they are bound to the DNA.\nOverall, the function of yeast Clr4 on chromatin is to regulate the structure and accessibility of the chromatin, and to help control the expression of genes by recruiting and regulating the activity of transcription factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Yeast Clr4 is a chromatin-associated protein that regulates the structure and function of chromatin.\n2. Clr4 is a member of the SWI/SNF chromatin-remodeling complex.\n3. The Clr4 protein helps to remove nucleosomes from the DNA, a process known as chromatin remodeling.\n4. Besides in chromatin remodeling, Clr4 also plays a role in regulating the activity of transcription factors.\n5. Clr4 helps to recruit transcription factors to specific regions of the genome.",
    "vicuna-13b_fact": [
      "Yeast Clr4 is a chromatin-associated protein that regulates the structure and function of chromatin.",
      "Clr4 is a member of the SWI/SNF chromatin-remodeling complex.",
      "The Clr4 protein helps to remove nucleosomes from the DNA, a process known as chromatin remodeling.",
      "Besides in chromatin remodeling, Clr4 also plays a role in regulating the activity of transcription factors.",
      "Clr4 helps to recruit transcription factors to specific regions of the genome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Clr4 is not a member of the SWI/SNF chromatin-remodeling complex. It is a part of the CLR-C (Cryptic Loci Regulator Complex).\n3. FALSE [correction]: The Clr4 protein helps to add methyl groups to histones, a process known as histone methylation, which leads to chromatin compaction, not its remodeling.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "vicuna-13b_response": "Long non-coding RNA (lncRNA) is a type of RNA that is longer than 200 nucleotides in length and does not code for proteins. One example of an lncRNA is called LINC (Liver-Enriched Transcript 1, LncRNA) which is also known as LIMT (Liver-Enriched Motif-Containing).\nThe role of LIMT lncRNA is not yet fully understood, but studies have suggested that it plays an important role in regulating gene expression. LIMT lncRNA is specifically expressed in the liver and other tissues, and it has been shown to interact with microRNAs, which are small non-coding RNAs that play a role in regulating gene expression by binding to messenger RNAs (mRNAs) and preventing their translation into proteins.\nOne study found that LIMT lncRNA can act as a sponge for microRNAs, binding to them and preventing them from binding to their target mRNAs. This suggests that LIMT lncRNA may play a role in regulating the expression of specific genes by controlling the levels of microRNAs.\nAdditionally, LIMT lncRNA has been shown to be involved in the regulation of cell proliferation and differentiation, and it has been suggested that it may play a role in the development of liver cancer.\nOverall, the role of LIMT lncRNA is still an active area of research, and more studies are needed to fully understand its function and the specific mechanisms by which it regulates gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Long non-coding RNA (lncRNA) is a type of RNA that is longer than 200 nucleotides in length and does not code for proteins.\n2. LINC (Liver-Enriched Transcript 1, LncRNA) is also known as LIMT (Liver-Enriched Motif-Containing).\n3. LIMT lncRNA has been suggested to play a role in regulating gene expression.\n4. A study found that LIMT lncRNA can act as a sponge for microRNAs, binding to them and preventing them from binding to their target mRNAs.\n5. LIMT lncRNA has been implicated in the regulation of cell proliferation and differentiation and has been suggested that it may play a role in the development of liver cancer.",
    "vicuna-13b_fact": [
      "Long non-coding RNA (lncRNA) is a type of RNA that is longer than 200 nucleotides in length and does not code for proteins.",
      "LINC (Liver-Enriched Transcript 1, LncRNA) is also known as LIMT (Liver-Enriched Motif-Containing).",
      "LIMT lncRNA has been suggested to play a role in regulating gene expression.",
      "A study found that LIMT lncRNA can act as a sponge for microRNAs, binding to them and preventing them from binding to their target mRNAs.",
      "LIMT lncRNA has been implicated in the regulation of cell proliferation and differentiation and has been suggested that it may play a role in the development of liver cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1969,
    "user_query": "What are Kupffer cells and what is their role?",
    "vicuna-13b_response": "Kupffer cells, also known as liver macrophages, are a type of white blood cell that plays a crucial role in the immune system. They are primarily found in the liver and are responsible for phagocytosing (engulfing and destroying) pathogens, dead cells, and other foreign substances that enter the liver.\nKupffer cells are part of the mononuclear phagocyte system (MPS), which also includes other types of immune cells such as monocytes and dendritic cells. They are derived from monocytes, which are precursor cells that differentiate into macrophages and other immune cells.\nIn addition to their role in immune defense, Kupffer cells also play a role in the clearance of cholesterol from the bloodstream and in the regulation of the immune response. They can produce cytokines and other signaling molecules that help coordinate the immune response and regulate the activity of other immune cells.\nOverall, Kupffer cells are important components of the immune system and play a crucial role in protecting the liver from infection and damage.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Kupffer cells, also known as liver macrophages, are a type of white blood cell.\n2. Kupffer cells play a crucial role in the immune system.\n3. These cells are primarily found in the liver and are responsible for engulfing and destroying pathogens, dead cells, and other foreign substances that enter the liver.\n4. Kupffer cells are part of the mononuclear phagocyte system which includes other types of immune cells such as monocytes and dendritic cells.\n5. In addition to their role in immune defense, Kupffer cells also assist in the clearance of cholesterol from the bloodstream and in the regulation of the immune response.",
    "vicuna-13b_fact": [
      "Kupffer cells, also known as liver macrophages, are a type of white blood cell.",
      "Kupffer cells play a crucial role in the immune system.",
      "These cells are primarily found in the liver and are responsible for engulfing and destroying pathogens, dead cells, and other foreign substances that enter the liver.",
      "Kupffer cells are part of the mononuclear phagocyte system which includes other types of immune cells such as monocytes and dendritic cells.",
      "In addition to their role in immune defense, Kupffer cells also assist in the clearance of cholesterol from the bloodstream and in the regulation of the immune response."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1971,
    "user_query": "Is golimumab effective for ulcerative colitis?",
    "vicuna-13b_response": "Golimumab is a medication that is approved for the treatment of several autoimmune diseases, including ulcerative colitis. Ulcerative colitis is a chronic inflammatory bowel disease that affects the colon and rectum, and golimumab is a biologic drug that works by targeting a specific protein involved in the immune response.\nStudies have shown that golimumab is effective in treating ulcerative colitis, particularly in patients who have not responded to other treatments. In clinical trials, golimumab has been shown to reduce symptoms, improve bowel movement frequency, and decrease the risk of disease flare-ups in patients with ulcerative colitis.\nIt's important to note that golimumab is not a cure for ulcerative colitis, and it may not work for everyone. Additionally, golimumab can have serious side effects, so it's important to discuss the potential benefits and risks with a healthcare provider before starting treatment.\nOverall, golimumab can be an effective treatment option for patients with ulcerative colitis who have not responded to other treatments, but it's important to work with a healthcare provider to determine if it's the right treatment option for an individual case.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Golimumab is a medication approved for the treatment of several autoimmune diseases, including ulcerative colitis.\n2. Ulcerative colitis is a chronic inflammatory bowel disease that affects the colon and rectum.\n3. Studies have shown that golimumab is effective in treating ulcerative colitis, particularly in patients who have not responded to other treatments.\n4. In clinical trials, golimumab has been shown to reduce symptoms and decrease the risk of disease flare-ups in patients with ulcerative colitis.\n5. Golimumab is not a cure for ulcerative colitis and it may not work for everyone.",
    "vicuna-13b_fact": [
      "Golimumab is a medication approved for the treatment of several autoimmune diseases, including ulcerative colitis.",
      "Ulcerative colitis is a chronic inflammatory bowel disease that affects the colon and rectum.",
      "Studies have shown that golimumab is effective in treating ulcerative colitis, particularly in patients who have not responded to other treatments.",
      "In clinical trials, golimumab has been shown to reduce symptoms and decrease the risk of disease flare-ups in patients with ulcerative colitis.",
      "Golimumab is not a cure for ulcerative colitis and it may not work for everyone."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1976,
    "user_query": "What is the aim of the TRAP assay?",
    "vicuna-13b_response": "The TRAP (Transcriptional Regulatory Assay by Proteomics) assay is a laboratory technique used to identify proteins that bind to specific DNA sequences and regulate gene expression. The aim of the TRAP assay is to identify the proteins that interact with a particular DNA sequence, which can provide insight into how gene expression is regulated.\nThe TRAP assay works by using a protein-DNA binding assay to identify proteins that bind to a specific DNA sequence. The assay typically involves the following steps:\n1. Crosslinking: Proteins and DNA are crosslinked together in the sample.\n2. Sonication: The sample is sonicated to shear the DNA into smaller fragments.\n3. Immunoprecipitation: The protein-DNA complexes are captured using an antibody that recognizes the protein of interest.\n4. Mass spectrometry: The captured protein-DNA complexes are identified using mass spectrometry, which detects the mass-to-charge ratio of the proteins and DNA fragments.\n5. Data analysis: The data generated from mass spectrometry is analyzed to identify the proteins that bind to the specific DNA sequence.\nThe TRAP assay is a powerful tool for identifying proteins that regulate gene expression and understanding how genes are controlled. By identifying the proteins that bind to specific DNA sequences, researchers can gain insight into the mechanisms of gene regulation and potentially identify new targets for therapeutic intervention.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The TRAP assay is used to identify proteins that bind to specific DNA sequences and regulate gene expression.\n2. In the TRAP assay, proteins and DNA are crosslinked together in the sample.\n3. The TRAP assay uses sonication to shear the DNA into smaller fragments.\n4. The TRAP assay uses immunoprecipitation to capture the protein-DNA complexes.\n5. The captured protein-DNA complexes are identified using mass spectrometry in the TRAP assay.",
    "vicuna-13b_fact": [
      "The TRAP assay is used to identify proteins that bind to specific DNA sequences and regulate gene expression.",
      "In the TRAP assay, proteins and DNA are crosslinked together in the sample.",
      "The TRAP assay uses sonication to shear the DNA into smaller fragments.",
      "The TRAP assay uses immunoprecipitation to capture the protein-DNA complexes.",
      "The captured protein-DNA complexes are identified using mass spectrometry in the TRAP assay."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The TRAP assay is used to identify and quantitatively assess telomerase activity, not to identify proteins that bind to specific DNA sequences and regulate gene expression.\n2. FALSE [correction]: In the TRAP assay, telomerase adds telomeric repeats to the 3' end of substrate primers, not crosslinked with DNA in the sample.\n3. FALSE [correction]: The TRAP assay does not use sonication to shear the DNA into smaller fragments.\n4. FALSE [correction]: The TRAP assay does not use immunoprecipitation to capture the protein-DNA complexes.\n5. FALSE [correction]: Identified telomerase-extended products in TRAP assays are usually determined by PCR, not by mass spectrometry.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1979,
    "user_query": "Which disease is associated with mutations in SLC40A1 gene?",
    "vicuna-13b_response": "A disease associated with mutations in the SLC40A1 gene is Hirschsprung's disease (HD).\nHirschsprung's disease is a congenital disorder of the enteric nervous system that affects the colon. It is characterized by a lack of proper innervation of the colon, leading to constipation and abdominal pain. The disease is caused by mutations in the SLC40A1 gene, which encodes for the protein called \"Rabphilin-3A.\" Rabphilin-3A is involved in the transport of neurotransmitters in the nervous system, and mutations in the SLC40A1 gene lead to a deficiency of Rabphilin-3A, resulting in the symptoms of Hirschsprung's disease.\nHirschsprung's disease is a rare disorder, affecting approximately 1 in every 5,000 to 10,000 newborns. It is usually diagnosed in the first few months of life, and the symptoms can vary in severity. The diagnosis of Hirschsprung's disease is typically made through a combination of physical examination, imaging studies, and rectal biopsy. Treatment options include surgical intervention to remove the affected segment of the colon and anastomosis with the normal colon.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hirschsprung's disease is associated with mutations in the SLC40A1 gene.\n2. Hirschsprung's disease is a congenital disorder of the enteric nervous system that affects the colon.\n3. The SLC40A1 gene encodes for the protein \"Rabphilin-3A,\" which plays a role in the transport of neurotransmitters in the nervous system.\n4. Hirschsprung's disease affects approximately 1 in every 5,000 to 10,000 newborns.\n5. Diagnosis of Hirschsprung's disease is typically made through a combination of physical examination, imaging studies, and rectal biopsy.",
    "vicuna-13b_fact": [
      "Hirschsprung's disease is associated with mutations in the SLC40A1 gene.",
      "Hirschsprung's disease is a congenital disorder of the enteric nervous system that affects the colon.",
      "The SLC40A1 gene encodes for the protein \"Rabphilin-3A,\" which plays a role in the transport of neurotransmitters in the nervous system.",
      "Hirschsprung's disease affects approximately 1 in every 5,000 to 10,000 newborns.",
      "Diagnosis of Hirschsprung's disease is typically made through a combination of physical examination, imaging studies, and rectal biopsy."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Hirschsprung's disease is associated with mutations in several genes, but SLC40A1 is not one of them. The most commonly associated genes are RET and EDNRB.\n2. TRUE\n3. FALSE [correction]: The SLC40A1 gene encodes for the protein \"Ferroportin,\" which is involved in iron transport, not \"Rabphilin-3A.\"\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1982,
    "user_query": "Is lenvatinib effective for renal cell carcinoma?",
    "vicuna-13b_response": "Lenvatinib is a targeted therapy drug that is approved for the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer. It is specifically approved for use in patients with advanced RCC who have received prior anti-angiogenic therapy (such as sorafenib).\nLenvatinib works by targeting multiple receptors that are involved in the growth and survival of cancer cells, including the vascular endothelial growth factor (VEGF) receptor, the fibroblast growth factor receptor (FGFR), and the platelet-derived growth factor receptor (PDGFR). By inhibiting these receptors, lenvatinib can slow down or stop the growth and spread of cancer cells.\nClinical trials have shown that lenvatinib can benefit some patients with advanced RCC. In a phase III clinical trial, lenvatinib was shown to improve progression-free survival (PFS) compared to placebo in patients with advanced RCC who had received prior anti-angiogenic therapy. The most common side effects of lenvatinib include fatigue, diarrhea, and hypertension.\nIt's important to note that not all patients will respond to lenvatinib, and that other treatments may be more appropriate for some patients. Therefore, it's important to discuss treatment options with a healthcare provider.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Lenvatinib is a targeted therapy drug approved for the treatment of advanced renal cell carcinoma (RCC).\n2. Lenvatinib is specifically approved for RCC patients who have previously received anti-angiogenic therapy.\n3. Lenvatinib works by targeting multiple receptors, including the VEGF receptor, the FGFR, and the PDGFR.\n4. Clinical trials have shown that lenvatinib can benefit some patients with advanced RCC by improving progression-free survival.\n5. The most common side effects of lenvatinib include fatigue, diarrhea, and hypertension.",
    "vicuna-13b_fact": [
      "Lenvatinib is a targeted therapy drug approved for the treatment of advanced renal cell carcinoma (RCC).",
      "Lenvatinib is specifically approved for RCC patients who have previously received anti-angiogenic therapy.",
      "Lenvatinib works by targeting multiple receptors, including the VEGF receptor, the FGFR, and the PDGFR.",
      "Clinical trials have shown that lenvatinib can benefit some patients with advanced RCC by improving progression-free survival.",
      "The most common side effects of lenvatinib include fatigue, diarrhea, and hypertension."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "vicuna-13b_response": "The R/Bioconductor package that is commonly used for performing SNP enrichment analysis is \"Sleuth.\"",
    "vicuna-13b_fact_raw": "The factual statement is:\n1. The \"Sleuth\" is a commonly used R/Bioconductor package for performing SNP enrichment analysis.",
    "vicuna-13b_fact": [
      "The \"Sleuth\" is a commonly used R/Bioconductor package for performing SNP enrichment analysis."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The \"Sleuth\" is a commonly used R/Bioconductor package for performing RNA-seq data analysis, not SNP enrichment analysis.",
    "vicuna-13b_judge": [
      "false"
    ]
  },
  {
    "id": 1988,
    "user_query": "Describe crowned dens syndrome.",
    "vicuna-13b_response": "Crowned dens syndrome is a rare genetic disorder that affects the development of bones and teeth. It is characterized by the presence of dens invaginatus, which is a conical or tubular dental anomaly that protrudes into the pulp chamber of the tooth. This can lead to pain, infection, and inflammation of the tooth, as well as damage to the surrounding tissue.\nIndividuals with crowned dens syndrome often have abnormalities in the formation of the teeth, including missing or malformed enamel, dentin, and cementum. They may also have other dental abnormalities, such as peg-shaped teeth, which can lead to difficulty with eating and speaking.\nIn addition to dental abnormalities, individuals with crowned dens syndrome may also have other physical abnormalities, such as short stature, a small head, and a narrow face. They may also have developmental delays and intellectual disability.\nThere is no cure for crowned dens syndrome, but treatment can help manage the symptoms and prevent complications. This may include dental treatment, such as the removal of affected teeth and the placement of dental implants, as well as medical treatment for any associated conditions. It is important for individuals with crowned dens syndrome to receive regular dental care to prevent further dental problems and maintain good oral health.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Crowned dens syndrome is a rare genetic disorder that affects the development of bones and teeth.\n2. Crowned dens syndrome is characterized by the presence of dens invaginatus, which is a dental anomaly that protrudes into the pulp chamber of the tooth.\n3. Individuals with crowned dens syndrome often have abnormalities in the formation of the teeth, including missing or malformed enamel, dentin, and cementum.\n4. Apart from dental abnormalities, individuals with crowned dens syndrome may also have physical abnormalities, such as short stature, a small head, and a narrow face. They may also have developmental delays and intellectual disability.\n5. There is no cure for crowned dens syndrome, but its symptoms can be managed with treatment, which may include dental treatment and medical treatment for any associated conditions.",
    "vicuna-13b_fact": [
      "Crowned dens syndrome is a rare genetic disorder that affects the development of bones and teeth.",
      "Crowned dens syndrome is characterized by the presence of dens invaginatus, which is a dental anomaly that protrudes into the pulp chamber of the tooth.",
      "Individuals with crowned dens syndrome often have abnormalities in the formation of the teeth, including missing or malformed enamel, dentin, and cementum.",
      "Apart from dental abnormalities, individuals with crowned dens syndrome may also have physical abnormalities, such as short stature, a small head, and a narrow face. They may also have developmental delays and intellectual disability.",
      "There is no cure for crowned dens syndrome, but its symptoms can be managed with treatment, which may include dental treatment and medical treatment for any associated conditions."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Crowned dens syndrome is a condition characterized by calcification around the odontoid process, causing neck pain and stiffness, not a genetic disorder that affects bone and teeth development.\n2. FALSE [correction]: Crowned dens syndrome is characterized by the presence of calcium deposits around the dens, not dens invaginatus which is a dental anomaly. \n3. FALSE [correction]: Crowned dens syndrome is not associated with abnormalities in dental formation like missing or malformed enamel, dentin, and cementum. \n4. FALSE [correction]: Crowned dens syndrome doesn't cause physical abnormalities such as shorter stature, smaller head, or narrower face. Nor does it cause developmental delays or intellectual disability. It mostly causes neck pain and stiffness, elevated inflammatory markers, and sometimes fever.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1989,
    "user_query": "Does CRISPR inversion of CTCF sites alter genome topology?",
    "vicuna-13b_response": "CRISPR inversion of CTCF sites can indeed alter genome topology, as CTCF (CCCTC-binding factor) is a transcription factor that plays a crucial role in regulating the 3D organization of chromatin in the nucleus. CTCF binds to specific DNA sequences and acts as a \"architect\" to shape the chromatin structure, which in turn regulates gene expression.\nWhen CRISPR is used to invert CTCF sites, it can disrupt the normal binding of CTCF to its target sites, leading to changes in the chromatin structure and the spatial organization of the genome. This can result in changes in gene expression, as well as other downstream effects on cellular behavior.\nIt is important to note that the specific effects of CRISPR inversion of CTCF sites will depend on the context of the genome, the specific CTCF sites targeted, and the cell type being studied. However, in general, CRISPR inversion of CTCF sites can be expected to have a significant impact on genome topology and the regulation of gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CRISPR inversion of CTCF sites can alter genome topology.\n2. CTCF (CCCTC-binding factor) is a transcription factor that plays a crucial role in regulating the 3D organization of chromatin in the nucleus.\n3. CTCF binds to specific DNA sequences and shapes the chromatin structure, which regulates gene expression.\n4. When CRISPR is used to invert CTCF sites, it can disrupt the normal binding of CTCF to its target sites, leading to changes in the chromatin structure and the spatial organization of the genome.\n5. The specific effects of CRISPR inversion of CTCF sites depend on the context of the genome, the targeted CTCF sites, and the cell type being studied.",
    "vicuna-13b_fact": [
      "CRISPR inversion of CTCF sites can alter genome topology.",
      "CTCF (CCCTC-binding factor) is a transcription factor that plays a crucial role in regulating the 3D organization of chromatin in the nucleus.",
      "CTCF binds to specific DNA sequences and shapes the chromatin structure, which regulates gene expression.",
      "When CRISPR is used to invert CTCF sites, it can disrupt the normal binding of CTCF to its target sites, leading to changes in the chromatin structure and the spatial organization of the genome.",
      "The specific effects of CRISPR inversion of CTCF sites depend on the context of the genome, the targeted CTCF sites, and the cell type being studied."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1999,
    "user_query": "What is Mondor's disease?",
    "vicuna-13b_response": "Mondor's disease is a rare autoimmune disorder that affects the skin and joints. It is characterized by the formation of red, scaly patches on the skin (psoriasis) and inflammation of the joints (arthritis). The condition is named after French dermatologist Jean-Baptiste Mondor who first described it in 1867.\nMondor's disease typically affects middle-aged women and is more common in people with a family history of autoimmune disorders. The exact cause of the disease is not known, but it is thought to be related to an overactive immune system that mistakenly attacks healthy cells and tissues in the skin and joints.\nThe symptoms of Mondor's disease can vary from person to person, but they typically include:\n* Red, scaly patches on the skin, usually on the lower legs and feet\n* Inflammation and pain in the joints, particularly in the fingers and toes\n* Swollen and painful joints\n* Stiffness and difficulty moving the affected joints\n* Skin lesions that may ooze or crust over\nDiagnosis of Mondor's disease is typically made through a combination of physical examination, medical history, and laboratory tests. Treatment options include topical creams and ointments to manage the skin symptoms, as well as nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain in the joints. In severe cases, corticosteroids or immunosuppressive drugs may be prescribed to manage the symptoms.\nIt is important for people with Mondor's disease to follow their treatment plan closely and to seek medical attention if their symptoms worsen or if they experience any new symptoms. With proper treatment, most people with Mondor's disease are able to manage their symptoms and lead active, normal lives.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mondor's disease is an autoimmune disorder that affects the skin and joints. \n2. The condition is named after French dermatologist Jean-Baptiste Mondor who first described it in 1867.\n3. Symptoms of Mondor's disease include red, scaly patches on the skin, inflammation and pain in the joints, swollen and painful joints, and skin lesions that may ooze or crust over.\n4. Diagnosis of Mondor's disease is typically made through physical examination, medical history, and laboratory tests.\n5. Treatment options for Mondor's disease include topical creams and ointments, nonsteroidal anti-inflammatory drugs, corticosteroids, or immunosuppressive drugs.",
    "vicuna-13b_fact": [
      "Mondor's disease is an autoimmune disorder that affects the skin and joints.",
      "The condition is named after French dermatologist Jean-Baptiste Mondor who first described it in 1867.",
      "Symptoms of Mondor's disease include red, scaly patches on the skin, inflammation and pain in the joints, swollen and painful joints, and skin lesions that may ooze or crust over.",
      "Diagnosis of Mondor's disease is typically made through physical examination, medical history, and laboratory tests.",
      "Treatment options for Mondor's disease include topical creams and ointments, nonsteroidal anti-inflammatory drugs, corticosteroids, or immunosuppressive drugs."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mondor's disease is a rare condition that involves superficial veins usually in the breasts/chest wall or antecubital fossa.\n2. TRUE\n3. FALSE [correction]: Symptoms of Mondor's disease include pain, a cord-like structure on the body (usually near the breast), and skin redness over the affected vein.\n4. TRUE\n5. FALSE [correction]: Treatment options for Mondor's disease are usually pain relievers and warm compression. It often resolves itself without treatment.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2000,
    "user_query": "List metalloenzyme inhibitors.",
    "vicuna-13b_response": "Metalloenzyme inhibitors are a class of drugs that target enzymes that contain metal ions as a critical component of their active site. These enzymes are involved in a variety of biological processes, including cell signaling, DNA repair, and metabolism. Inhibition of metalloenzymes can lead to a variety of therapeutic effects, including the treatment of cancer, neurodegenerative diseases, and bacterial infections.\nHere are some examples of metalloenzyme inhibitors:\n1. Cisplatin: Cisplatin is a platinum-based drug that is used to treat a variety of solid tumors, including ovarian, testicular, and lung cancer. It inhibits a variety of metalloenzymes, including DNA repair enzymes and transcription factors.\n2. Carboplatin: Carboplatin is another platinum-based drug that is used to treat cancer. It is less toxic than cisplatin and is often used as a replacement therapy in patients who have developed resistance to cisplatin.\n3. Raloxifene: Raloxifene is a selective estrogen receptor modulator (SERM) that is used to treat and prevent osteoporosis in postmenopausal women. It inhibits metalloenzymes involved in estrogen signaling, including the estrogen receptor.\n4. Ferroquine: Ferroquine is an iron chelator that is used to treat iron overload disorders, such as hemochromatosis. It inhibits the ferroportin metalloenzyme, which is responsible for exporting iron from cells.\n5. Alkylating agents: Alkylating agents are a class of drugs that are used to treat cancer. They inhibit a variety of metalloenzymes involved in DNA repair and cell division.\nThese are just a few examples of metalloenzyme inhibitors. There are many other drugs that target metalloenzymes, and new ones are continually being developed and researched.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Metalloenzyme inhibitors are a class of drugs that target enzymes that contain metal ions as a critical component of their active site.\n2. Cisplatin is a platinum-based drug used to treat solid tumors, including ovarian, testicular, and lung cancer.\n3. Carboplatin is another platinum-based drug used to treat cancer and is often utilized as a replacement therapy in patients who have developed resistance to cisplatin.\n4. Raloxifene is a selective estrogen receptor modulator (SERM) used to treat and prevent osteoporosis in postmenopausal women.\n5. Ferroquine is an iron chelator used to treat iron overload disorders, such as hemochromatosis.",
    "vicuna-13b_fact": [
      "Metalloenzyme inhibitors are a class of drugs that target enzymes that contain metal ions as a critical component of their active site.",
      "Cisplatin is a platinum-based drug used to treat solid tumors, including ovarian, testicular, and lung cancer.",
      "Carboplatin is another platinum-based drug used to treat cancer and is often utilized as a replacement therapy in patients who have developed resistance to cisplatin.",
      "Raloxifene is a selective estrogen receptor modulator (SERM) used to treat and prevent osteoporosis in postmenopausal women.",
      "Ferroquine is an iron chelator used to treat iron overload disorders, such as hemochromatosis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Ferroquine is an antimalarial drug, not used to treat iron overload disorders. Deferasirox is an example of an iron chelator used in the treatment of iron overload disorders.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2007,
    "user_query": "Is the mouse Sry gene locus free of repetitive sequences?",
    "vicuna-13b_response": "The mouse Sry gene locus is not completely free of repetitive sequences. The Sry gene is located on the Y chromosome of mice and is responsible for initiating the process of male sex determination during embryonic development.\nWhile the Sry gene itself is not surrounded by repetitive sequences, there are several repetitive sequences located in the vicinity of the Sry gene. These repetitive sequences are thought to play a role in the regulation of Sry expression and the proper functioning of the male sex determination pathway.\nOne of the repetitive sequences located near the Sry gene is the Sry-box transcription factor (SOX9) gene, which is essential for male sex determination in mice. The SOX9 gene is located approximately 200 kilobases downstream of the Sry gene and is regulated by Sry through a negative feedback loop.\nIn addition to SOX9, there are several other repetitive sequences in the vicinity of the Sry gene, including satellite repeats and transposable elements. These repetitive sequences can affect the expression and regulation of the Sry gene, as well as the overall functioning of the male sex determination pathway.\nOverall, while the Sry gene locus itself is not completely surrounded by repetitive sequences, there are several repetitive sequences located in the vicinity of the gene that play important roles in its regulation and function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The mouse Sry gene locus is not completely free of repetitive sequences.\n2. The Sry gene is located on the Y chromosome of mice.\n3. The Sry gene is responsible for initiating the process of male sex determination during embryonic development.\n4. The Sry-box transcription factor (SOX9) gene is located approximately 200 kilobases downstream of the Sry gene.\n5. There are several other repetitive sequences near the Sry gene, including satellite repeats and transposable elements.",
    "vicuna-13b_fact": [
      "The mouse Sry gene locus is not completely free of repetitive sequences.",
      "The Sry gene is located on the Y chromosome of mice.",
      "The Sry gene is responsible for initiating the process of male sex determination during embryonic development.",
      "The Sry-box transcription factor (SOX9) gene is located approximately 200 kilobases downstream of the Sry gene.",
      "There are several other repetitive sequences near the Sry gene, including satellite repeats and transposable elements."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2011,
    "user_query": "Which mutated enzyme is responsible for oculocutaneous 1 (OCA1)-type albinism?",
    "vicuna-13b_response": "Oculocutaneous 1 (OCA1)-type albinism is a genetic disorder that results from mutations in the TYR gene, which is responsible for the production of the enzyme tyrosinase. Tyrosinase is an enzyme that plays a critical role in the production of melanin, a pigment that gives color to the skin, hair, and eyes. Mutations in the TYR gene can lead to a reduction or complete absence of melanin production, resulting in the characteristic features of OCA1-type albinism, which include white skin, hair, and eyes, as well as vision problems. It is important to note that there are other types of albinism that can be caused by mutations in different genes, and each type can have different symptoms and characteristics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Oculocutaneous 1 (OCA1)-type albinism is a genetic disorder caused by mutations in the TYR gene.\n2. The TYR gene is responsible for the production of the enzyme tyrosinase.\n3. Tyrosinase plays a critical role in the production of melanin.\n4. Mutations in the TYR gene can lead to a reduction or complete absence of melanin production.\n5. Characteristics of OCA1-type albinism include white skin, hair, and eyes, as well as vision problems.",
    "vicuna-13b_fact": [
      "Oculocutaneous 1 (OCA1)-type albinism is a genetic disorder caused by mutations in the TYR gene.",
      "The TYR gene is responsible for the production of the enzyme tyrosinase.",
      "Tyrosinase plays a critical role in the production of melanin.",
      "Mutations in the TYR gene can lead to a reduction or complete absence of melanin production.",
      "Characteristics of OCA1-type albinism include white skin, hair, and eyes, as well as vision problems."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2014,
    "user_query": "Which protein mediates the replacement of H2A by H2A.Z in the yeast Saccharomyces cerevisiae?",
    "vicuna-13b_response": "In the yeast Saccharomyces cerevisiae, the protein that mediates the replacement of H2A by H2A.Z is the histone deacetylase complex, also known as the NuRD complex. This complex is composed of several subunits, including the histone deacetylase HDACs, the ATPase Spt16, and the transcription factor Mll. The NuRD complex is responsible for regulating the expression of genes, and it does so by modifying the chromatin structure of the genes it regulates. Specifically, the NuRD complex can replace the histone H2A with the histone variant H2A.Z, which is involved in the compaction of chromatin and the repression of transcription. The NuRD complex is also involved in other processes, such as the regulation of DNA repair and the maintenance of genome stability.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The NuRD complex in yeast Saccharomyces cerevisiae mediates the replacement of H2A by H2A.Z.\n2. The NuRD complex consists of several subunits, including histone deacetylase HDACs, the ATPase Spt16, and the transcription factor Mll.\n3. This complex regulates the expression of genes by modifying the chromatin structure of the genes it regulates.\n4. The NuRD complex can replace the histone H2A with the histone variant H2A.Z.\n5. The NuRD complex is involved in the regulation of DNA repair and the maintenance of genome stability.",
    "vicuna-13b_fact": [
      "The NuRD complex in yeast Saccharomyces cerevisiae mediates the replacement of H2A by H2A.Z.",
      "The NuRD complex consists of several subunits, including histone deacetylase HDACs, the ATPase Spt16, and the transcription factor Mll.",
      "This complex regulates the expression of genes by modifying the chromatin structure of the genes it regulates.",
      "The NuRD complex can replace the histone H2A with the histone variant H2A.Z.",
      "The NuRD complex is involved in the regulation of DNA repair and the maintenance of genome stability."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The SWR1 complex in Saccharomyces cerevisiae mediates the replacement of H2A by H2A.Z, not the NuRD complex.\n2. FALSE [correction]: The NuRD complex consists of several subunits, including histone deacetylase HDACs, MTA family proteins, and the RbAp46/RbAp48 proteins.\n3. TRUE\n4. FALSE [correction]: The SWR1 complex, not the NuRD complex, can replace the histone H2A with the histone variant H2A.Z.\n5. TRUE.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "vicuna-13b_response": "Radial glial cells are a type of neural stem cell that give rise to various types of neural cells, including ependymal cells, during development. The process of radial glial cell specification into ependymal cells is a complex process that involves a number of key players.\nOne of the key transcription factors involved in radial glial cell specification is the Sox2 gene. Sox2 is a transcription factor that is expressed in radial glial cells and is required for their maintenance and differentiation into ependymal cells.\nAnother key player in radial glial cell specification is the Wt1 gene. Wt1 is a transcription factor that is expressed in radial glial cells and is required for their differentiation into ependymal cells.\nAdditionally, the Notch signaling pathway plays a crucial role in radial glial cell specification. The Notch pathway is involved in cell-cell communication and regulates the differentiation of radial glial cells into ependymal cells.\nOverall, the process of radial glial cell specification into ependymal cells is a complex process that involves the interplay of multiple genetic and signaling pathways.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Radial glial cells are a type of neural stem cell that give rise to various types of neural cells, including ependymal cells.\n2. The Sox2 gene is a transcription factor expressed in radial glial cells and is required for their maintenance and differentiation into ependymal cells.\n3. The Wt1 gene is a transcription factor that is expressed in radial glial cells and is needed for their differentiation into ependymal cells.\n4. The Notch signaling pathway plays a role in the differentiation of radial glial cells into ependymal cells.\n5. The process of radial glial cell specification into ependymal cells involves the interplay of multiple genetic and signaling pathways.",
    "vicuna-13b_fact": [
      "Radial glial cells are a type of neural stem cell that give rise to various types of neural cells, including ependymal cells.",
      "The Sox2 gene is a transcription factor expressed in radial glial cells and is required for their maintenance and differentiation into ependymal cells.",
      "The Wt1 gene is a transcription factor that is expressed in radial glial cells and is needed for their differentiation into ependymal cells.",
      "The Notch signaling pathway plays a role in the differentiation of radial glial cells into ependymal cells.",
      "The process of radial glial cell specification into ependymal cells involves the interplay of multiple genetic and signaling pathways."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2018,
    "user_query": "What fruit causes Jamaican vomiting sickness?",
    "vicuna-13b_response": "The fruit that is commonly associated with Jamaican vomiting sickness is the Ackee fruit. Ackee is a type of tropical fruit that is native to West Africa, but is also commonly grown in Jamaica. It is characterized by its bright red or yellow flesh and its distinctive, pungent smell.\nJamaican vomiting sickness, also known as Jamaican sickness or Jamaican vomiting disease, is a type of food poisoning that is caused by the consumption of unripe or improperly prepared ackee fruit. The fruit contains a toxin called hypoglycin A, which can cause vomiting, dizziness, and in severe cases, coma or death.\nThe toxin is found in the unripe fruit and the arils (the edible part of the fruit), and the risk of poisoning is highest when the fruit is eaten before it is fully ripe. The ripe fruit is safe to eat, and the toxin is destroyed by cooking or processing the fruit.\nSymptoms of Jamaican vomiting sickness typically appear within 24 to 48 hours after eating the contaminated fruit and can include vomiting, abdominal pain, dizziness, and weakness. In severe cases, the condition can lead to hypoglycemia (low blood sugar), which can cause seizures, coma, and even death.\nTo avoid Jamaican vomiting sickness, it is important to only eat ripe ackee fruit, and to thoroughly cook or process any unripe or underripe fruit before consuming it. It is also important to handle the fruit properly, as the toxin can be absorbed through the skin.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The fruit associated with Jamaican vomiting sickness is the Ackee fruit.\n2. Ackee is a tropical fruit native to West Africa that is also commonly grown in Jamaica.\n3. Jamaican vomiting sickness is a type of food poisoning caused by the consumption of unripe or improperly prepared ackee fruit.\n4. The ackee fruit contains a toxin called hypoglycin A, which can cause symptoms such as vomiting, dizziness, and, in severe cases, coma or death.\n5. To avoid Jamaican vomiting sickness, it is recommended to only eat ripe ackee fruit and to thoroughly cook or process any unripe or underripe fruit before consuming it.",
    "vicuna-13b_fact": [
      "The fruit associated with Jamaican vomiting sickness is the Ackee fruit.",
      "Ackee is a tropical fruit native to West Africa that is also commonly grown in Jamaica.",
      "Jamaican vomiting sickness is a type of food poisoning caused by the consumption of unripe or improperly prepared ackee fruit.",
      "The ackee fruit contains a toxin called hypoglycin A, which can cause symptoms such as vomiting, dizziness, and, in severe cases, coma or death.",
      "To avoid Jamaican vomiting sickness, it is recommended to only eat ripe ackee fruit and to thoroughly cook or process any unripe or underripe fruit before consuming it."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2022,
    "user_query": "What are Degrons?",
    "vicuna-13b_response": "Degron is a term used in molecular biology to refer to a protein that promotes the degradation of other proteins. Degrons are typically found in the cytoplasm of cells and are responsible for targeting specific proteins for degradation by the cell's proteasome.\nThe process of protein degradation is an important mechanism for regulating protein levels in cells. When a protein is no longer needed, it can be targeted for degradation by the proteasome, which breaks it down into smaller peptides that can be recycled and reused. Degrons play a key role in this process by recognizing and binding to specific proteins, leading to their degradation by the proteasome.\nDegrons are typically small proteins that contain a specific sequence of amino acids that allows them to recognize and bind to their target proteins. Once bound, the degron recruits the proteasome to the target protein, leading to its degradation.\nDegrons have important roles in a variety of cellular processes, including regulation of the cell cycle, apoptosis (programmed cell death), and response to stress. Dysregulation of degron function has been implicated in a number of diseases, including cancer and neurodegenerative disorders.\nOverall, degrons are an important component of the cell's protein degradation machinery, playing a critical role in regulating protein levels and ensuring proper cellular function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Degrons are proteins that promote the degradation of other proteins. \n2. They are typically found in the cytoplasm of cells.\n3. Degrons target specific proteins for degradation by the cell's proteasome.\n4. Once bound to a protein, the degron recruits the proteasome leading to the protein's degradation.\n5. Degrons play important roles in regulation of the cell cycle, apoptosis, and cellular response to stress. Dysregulation of degron function has been implicated in diseases such as cancer and neurodegenerative disorders.",
    "vicuna-13b_fact": [
      "Degrons are proteins that promote the degradation of other proteins.",
      "They are typically found in the cytoplasm of cells.",
      "Degrons target specific proteins for degradation by the cell's proteasome.",
      "Once bound to a protein, the degron recruits the proteasome leading to the protein's degradation.",
      "Degrons play important roles in regulation of the cell cycle, apoptosis, and cellular response to stress. Dysregulation of degron function has been implicated in diseases such as cancer and neurodegenerative disorders."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Degrons are not proteins, but specific sequences within a protein that target it for degradation.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2023,
    "user_query": "Which disease is associated with mutated Sox2?",
    "vicuna-13b_response": "Mutated Sox2 is associated with the development of a group of disorders known as the Rett syndrome. Rett syndrome is a rare genetic disorder that affects mostly girls and is characterized by a wide range of symptoms, including developmental delay, loss of purposeful hand use, seizures, and difficulty with walking and coordination. The symptoms of Rett syndrome typically begin to appear after the first year of life, and the severity of the disorder can vary widely.\nMutations in the SOX2 gene, which provides instructions for making a protein called SOX2, have been identified as the cause of Rett syndrome. The SOX2 protein plays a critical role in the development of the brain and other tissues, and it is necessary for the proper formation and function of nerve cells (neurons) and other cells. Mutations in the SOX2 gene can disrupt the normal function of the SOX2 protein, leading to the characteristic features of Rett syndrome.\nIt is important to note that while mutated Sox2 is associated with Rett syndrome, there are other genetic and environmental factors that can also contribute to the development of this disorder.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mutated Sox2 is associated with the development of a group of disorders known as the Rett syndrome.\n2. Rett syndrome is a rare genetic disorder that affects mostly girls.\n3. Symptoms of Rett syndrome typically begin to appear after the first year of life.\n4. The SOX2 gene provides instructions for making a protein called SOX2.\n5. Mutations in the SOX2 gene can disrupt the normal function of the SOX2 protein, leading to the characteristic features of Rett syndrome.",
    "vicuna-13b_fact": [
      "Mutated Sox2 is associated with the development of a group of disorders known as the Rett syndrome.",
      "Rett syndrome is a rare genetic disorder that affects mostly girls.",
      "Symptoms of Rett syndrome typically begin to appear after the first year of life.",
      "The SOX2 gene provides instructions for making a protein called SOX2.",
      "Mutations in the SOX2 gene can disrupt the normal function of the SOX2 protein, leading to the characteristic features of Rett syndrome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mutated MECP2, not Sox2, is associated with the development of Rett syndrome.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Mutations in the MECP2 gene, not the SOX2 gene, can disrupt normal functions leading to the characteristic features of Rett syndrome.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2024,
    "user_query": "Is the enzyme EPRS phosphorylated?",
    "vicuna-13b_response": "The enzyme EPRS (5-enolpyruvylshikimate-3-phosphate synthase) is not known to be phosphorylated.\nEPRS is an enzyme involved in the shikimate pathway, a metabolic pathway found in plants, fungi, and bacteria that is responsible for the synthesis of aromatic amino acids and other aromatic compounds. The enzyme catalyzes the conversion of 5-enolpyruvylshikimate-3-phosphate (EPSP) to shikimate-3-phosphate (S3P), using the cofactor pyridoxal 5'-phosphate (PLP).\nPhosphorylation is a process in which a phosphate group is added to a molecule, typically a protein or a small molecule, by the action of a kinase enzyme. While many enzymes are known to be phosphorylated, EPRS is not one of them.\nIt is important to note that the presence or absence of phosphorylation is an important aspect of the function and regulation of many enzymes, and can have a significant impact on their activity and stability. In the case of EPRS, its function is regulated by other mechanisms, such as allosteric regulation by substrates and products, and post-translational modifications such as glycosylation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. EPRS (5-enolpyruvylshikimate-3-phosphate synthase) is an enzyme involved in the shikimate pathway.\n2. The shikimate pathway is a metabolic pathway found in plants, fungi, and bacteria.\n3. The enzyme EPRS catalyzes the conversion of 5-enolpyruvylshikimate-3-phosphate (EPSP) to shikimate-3-phosphate (S3P), using the cofactor pyridoxal 5'-phosphate (PLP).\n4. EPRS is not known to be phosphorylated.\n5. Phosphorylation is a process in which a phosphate group is added to a molecule by the action of a kinase enzyme.",
    "vicuna-13b_fact": [
      "EPRS (5-enolpyruvylshikimate-3-phosphate synthase) is an enzyme involved in the shikimate pathway.",
      "The shikimate pathway is a metabolic pathway found in plants, fungi, and bacteria.",
      "The enzyme EPRS catalyzes the conversion of 5-enolpyruvylshikimate-3-phosphate (EPSP) to shikimate-3-phosphate (S3P), using the cofactor pyridoxal 5'-phosphate (PLP).",
      "EPRS is not known to be phosphorylated.",
      "Phosphorylation is a process in which a phosphate group is added to a molecule by the action of a kinase enzyme."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The enzyme EPSPS catalyzes the conversion of shikimate-3-phosphate and phosphoenolpyruvate to 5-enolpyruvylshikimate-3-phosphate and inorganic phosphate.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2038,
    "user_query": "Which disease(s) are caused by HEX A deficiency?",
    "vicuna-13b_response": "HEX A is a protein that is involved in the regulation of many cellular processes, including the immune response, cell growth and division, and the response to DNA damage. HEX A deficiency can lead to a variety of health problems, including immune disorders, developmental disorders, and cancer.\nSpecifically, HEX A deficiency has been linked to the development of certain types of leukemia, a cancer of the blood cells. HEX A is involved in the regulation of cell growth and division, and its deficiency can lead to the uncontrolled growth and division of blood cells, which can result in the development of leukemia.\nAdditionally, HEX A deficiency has been associated with an increased risk of other types of cancer, including lymphoma and solid tumors. The exact mechanisms by which HEX A deficiency contributes to the development of cancer are not fully understood, but it is thought to involve the regulation of cell growth and division, as well as the response to DNA damage.\nOverall, while HEX A deficiency can contribute to a variety of health problems, its most well-known association is with the development of leukemia and other types of cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. HEX A is a protein that regulates many cellular processes.\n2. Deficiency in HEX A can lead to immune disorders, developmental disorders, and cancer.\n3. HEX A deficiency can contribute to the development of leukemia.\n4. An increased risk of lymphoma and solid tumors has been linked to HEX A deficiency.\n5. The role of HEX A involves both the regulation of cell growth and division, and the response to DNA damage.",
    "vicuna-13b_fact": [
      "HEX A is a protein that regulates many cellular processes.",
      "Deficiency in HEX A can lead to immune disorders, developmental disorders, and cancer.",
      "HEX A deficiency can contribute to the development of leukemia.",
      "An increased risk of lymphoma and solid tumors has been linked to HEX A deficiency.",
      "The role of HEX A involves both the regulation of cell growth and division, and the response to DNA damage."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2046,
    "user_query": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?",
    "vicuna-13b_response": "The JASPAR 2016 open-access database is a comprehensive collection of transcription factor binding profiles derived from a variety of experimental and computational methods. The database contains information on transcription factor binding to DNA in a variety of cell types and tissues, and is a valuable resource for researchers in the fields of genomics and systems biology.\nThe JASPAR 2016 database includes a number of additions and updates compared to previous versions of the database. Some of the key additions and updates include:\n1. Expanded coverage: The JASPAR 2016 database includes a significant expansion of the number of samples and transcription factors covered compared to previous versions of the database. This expanded coverage provides researchers with a more comprehensive view of transcription factor binding in different cell types and tissues.\n2. Improved data quality: The JASPAR 2016 database includes a number of improvements to the quality of the data, including the use of more stringent filtering criteria to remove poor-quality data and the inclusion of more detailed information about the experimental and computational methods used to derive the binding profiles.\n3. New data types: The JASPAR 2016 database includes a number of new data types, including ChIP-seq and DNase-seq data, which provide more detailed information about the binding of transcription factors to the genome.\n4. Enhanced data visualization: The JASPAR 2016 database includes a number of new data visualization tools, including interactive plots and heatmaps, which allow researchers to explore the binding profiles in more detail.\nOverall, the JASPAR 2016 database represents a significant update and expansion of the previous version of the database, providing researchers with a more comprehensive and reliable resource for studying transcription factor binding to DNA.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The JASPAR 2016 database is a collection of transcription factor binding profiles derived from experimental and computational methods.\n2. The JASPAR 2016 database expanded the number of samples and transcription factors covered compared to previous versions of the database.\n3. The JASPAR 2016 database includes improvements to data quality, including the use of stringent filtering criteria and the inclusion of more detailed methodological information.\n4. The JASPAR 2016 database includes new data types like ChIP-seq and DNase-seq.\n5. The JASPAR 2016 database provides enhanced data visualization tools for researchers including interactive plots and heatmaps.",
    "vicuna-13b_fact": [
      "The JASPAR 2016 database is a collection of transcription factor binding profiles derived from experimental and computational methods.",
      "The JASPAR 2016 database expanded the number of samples and transcription factors covered compared to previous versions of the database.",
      "The JASPAR 2016 database includes improvements to data quality, including the use of stringent filtering criteria and the inclusion of more detailed methodological information.",
      "The JASPAR 2016 database includes new data types like ChIP-seq and DNase-seq.",
      "The JASPAR 2016 database provides enhanced data visualization tools for researchers including interactive plots and heatmaps."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2047,
    "user_query": "What is the function of the protein tafazzin?",
    "vicuna-13b_response": "Tafazzin is a protein that plays a critical role in regulating the activity of other proteins in cells. It is also known as TAF15 or TAF150, and it is a component of the general transcription factor TFIID, which is involved in the initiation of transcription, the process by which cells produce new copies of their genetic material.\nTafazzin helps to recruit other proteins to the promoter region of a gene, where transcription begins. It also helps to hold the transcription complex together and to facilitate the interaction between the transcription factor TBP (TATA-box binding protein) and the DNA template.\nMutations in the TAFazzin gene have been linked to several human diseases, including some forms of cancer, and researchers are studying the protein as a potential target for therapeutic interventions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tafazzin is a protein that regulates the activity of other proteins in cells.\n2. Tafazzin is also known as TAF15 or TAF150.\n3. Tafazzin is a component of the general transcription factor TFIID, which is involved in the initiation of transcription.\n4. Tafazzin helps to recruit other proteins to the promoter region of a gene, where transcription begins.\n5. Mutations in the Tafazzin gene have been linked to several human diseases, including some forms of cancer.",
    "vicuna-13b_fact": [
      "Tafazzin is a protein that regulates the activity of other proteins in cells.",
      "Tafazzin is also known as TAF15 or TAF150.",
      "Tafazzin is a component of the general transcription factor TFIID, which is involved in the initiation of transcription.",
      "Tafazzin helps to recruit other proteins to the promoter region of a gene, where transcription begins.",
      "Mutations in the Tafazzin gene have been linked to several human diseases, including some forms of cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Tafazzin is not referred to as TAF15 or TAF150. They are different proteins.\n3. FALSE [correction]: Tafazzin is not a component of the general transcription factor TFIID. It is involved in the remodeling of cardiolipin, a lipid in the mitochondria.\n4. FALSE [correction]: Tafazzin is not involved in the recruitment of proteins to the promoter region of a gene. It is involved in remodeling of cardiolipin.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2051,
    "user_query": "Where is base J found in the genome of Leishmania tarentolae?",
    "vicuna-13b_response": "Leishmania tarentolae is a protozoan parasite that causes leishmaniasis, a disease that affects humans and animals. The genome of Leishmania tarentolae has been sequenced and the location of base J in the genome has been identified.\nBase J is a unique feature of the Leishmania genome and is found in the subtelomeric regions of all Leishmania species. These regions are rich in repetitive DNA sequences and are thought to play a role in the maintenance of genome stability and the regulation of gene expression.\nIn Leishmania tarentolae, base J is located in the subtelomeric regions on all four chromosomes. The presence of base J in these regions is thought to be important for the survival and replication of the parasite within its host.\nIt is important to note that the location of base J in the genome of Leishmania tarentolae may be subject to variation depending on the specific strain or isolate of the parasite.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Leishmania tarentolae is a protozoan parasite that causes leishmaniasis.\n2. The genome of Leishmania tarentolae has been sequenced.\n3. Base J is found in the subtelomeric regions of all Leishmania species.\n4. Base J is located in the subtelomeric regions on all four chromosomes of Leishmania tarentolae.\n5. The location of base J in the genome of Leishmania tarentolae might vary depending on the specific strain or isolate of the parasite.",
    "vicuna-13b_fact": [
      "Leishmania tarentolae is a protozoan parasite that causes leishmaniasis.",
      "The genome of Leishmania tarentolae has been sequenced.",
      "Base J is found in the subtelomeric regions of all Leishmania species.",
      "Base J is located in the subtelomeric regions on all four chromosomes of Leishmania tarentolae.",
      "The location of base J in the genome of Leishmania tarentolae might vary depending on the specific strain or isolate of the parasite."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Leishmania tarentolae is a protozoan parasite, but it is not known to cause leishmaniasis.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Leishmania tarentolae has 36 chromosomes rather than four. Hence, the statement is wrong. \n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2052,
    "user_query": "Which tool is available for predicting regulatory interactions from ChIP-seq data?",
    "vicuna-13b_response": "There are several tools available for predicting regulatory interactions from ChIP-seq data. Some of the popular ones are:\n1. PAR-CLIP: PAR-CLIP (Prediction of Transcriptional Regulatory Interactions from ChIP-seq Data) is a computational tool that predicts transcriptional regulatory interactions from ChIP-seq data. It uses a combination of machine learning algorithms and statistical methods to identify binding sites and predict regulatory interactions.\n2. HOMER: HOMER (Host-Mediated Expression Regulation) is a computational tool that predicts transcription factor binding sites and regulatory interactions from ChIP-seq data. It uses a combination of machine learning algorithms and statistical methods to identify binding sites and predict regulatory interactions.\n3. ChIP-Seq-Regulatory-Element-Finder (ChIP-SREF): ChIP-SREF is a computational tool that predicts regulatory interactions from ChIP-seq data. It uses a combination of machine learning algorithms and statistical methods to identify binding sites and predict regulatory interactions.\n4. ChIP-Seq-Regulatory-Network-Inference (ChIP-Net): ChIP-Net is a computational tool that predicts regulatory interactions from ChIP-seq data. It uses a combination of machine learning algorithms and statistical methods to identify binding sites and predict regulatory interactions.\n5. ChIP-Seq-Regulatory-Element-Predictor (ChIP-SERP): ChIP-SERP is a computational tool that predicts regulatory interactions from ChIP-seq data. It uses a combination of machine learning algorithms and statistical methods to identify binding sites and predict regulatory interactions.\nThese tools can help researchers to better understand the regulatory interactions in a cell, and can aid in the identification of potential therapeutic targets.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PAR-CLIP is a computational tool that predicts transcriptional regulatory interactions from ChIP-seq data.\n2. HOMER is a computational tool that predicts transcription factor binding sites and regulatory interactions from ChIP-seq data.\n3. ChIP-Seq-Regulatory-Element-Finder (ChIP-SREF) is a computational tool that predicts regulatory interactions from ChIP-seq data.\n4. ChIP-Seq-Regulatory-Network-Inference (ChIP-Net) is a computational tool that predicts regulatory interactions from ChIP-seq data.\n5. ChIP-Seq-Regulatory-Element-Predictor (ChIP-SERP) is a computational tool that predicts regulatory interactions from ChIP-seq data.",
    "vicuna-13b_fact": [
      "PAR-CLIP is a computational tool that predicts transcriptional regulatory interactions from ChIP-seq data.",
      "HOMER is a computational tool that predicts transcription factor binding sites and regulatory interactions from ChIP-seq data.",
      "ChIP-Seq-Regulatory-Element-Finder (ChIP-SREF) is a computational tool that predicts regulatory interactions from ChIP-seq data.",
      "ChIP-Seq-Regulatory-Network-Inference (ChIP-Net) is a computational tool that predicts regulatory interactions from ChIP-seq data.",
      "ChIP-Seq-Regulatory-Element-Predictor (ChIP-SERP) is a computational tool that predicts regulatory interactions from ChIP-seq data."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: PAR-CLIP is a method used to identify the binding sites of RNA-binding proteins at a genome-wide scale, not predicting transcriptional regulatory interactions from ChIP-seq data.\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2053,
    "user_query": "Where are the unipolar brush cells localized?",
    "vicuna-13b_response": "Unipolar brush cells are a type of sensory cell found in the vestibular system of the inner ear. They are located in the semicircular canals, which are three fluid-filled channels in the inner ear that help detect changes in the position and movement of the head.\nUnipolar brush cells are specialized sensory cells that are responsible for detecting the movement of fluid within the semicircular canals. They have long, hair-like extensions called cilia that are lined with sensory receptors. When the fluid in the semicircular canals moves, the cilia of the unipolar brush cells bend, causing the sensory receptors to detect the movement and send signals to the brain.\nThe unipolar brush cells are named because they have a single cilium, unlike other types of sensory cells in the inner ear that have multiple cilia. They are important for maintaining balance and stability, and damage to these cells can lead to vertigo, dizziness, and balance problems.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Unipolar brush cells are a type of sensory cell found in the vestibular system of the inner ear.\n2. They are located in the semicircular canals in the inner ear.\n3. Unipolar brush cells are responsible for detecting the movement of fluid within the semicircular canals.\n4. Unipolar brush cells have a single cilium.\n5. Damage to unipolar brush cells can lead to vertigo, dizziness, and balance problems.",
    "vicuna-13b_fact": [
      "Unipolar brush cells are a type of sensory cell found in the vestibular system of the inner ear.",
      "They are located in the semicircular canals in the inner ear.",
      "Unipolar brush cells are responsible for detecting the movement of fluid within the semicircular canals.",
      "Unipolar brush cells have a single cilium.",
      "Damage to unipolar brush cells can lead to vertigo, dizziness, and balance problems."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Unipolar brush cells are a type of neuron found in the cerebellar cortex and the granular layer of the dorsal cochlear nucleus, not in the vestibular system of the inner ear.\n2. FALSE [correction]: They are located in the cerebellar cortex and the granular layer of the dorsal cochlear nucleus, not in the semicircular canals in the inner ear.\n3. FALSE [correction]: Hair cells, not unipolar brush cells, are responsible for detecting the movement of fluid within the semicircular canals.\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2054,
    "user_query": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?",
    "vicuna-13b_response": "Diffuse Intrinsic Pontine Glioma (DIPG) is a type of brain tumor that affects the pons, a part of the brainstem. While DIPG is a rare tumor, it is highly aggressive and often difficult to treat.\nThere have been several driver mutations identified in DIPG, including:\n1. Histone H3 lysine 27 trimethylation (H3K27me3) - This is a epigenetic modification that is often found to be decreased in DIPG, and it has been shown to play a role in the development and progression of the tumor.\n2. PDGFRA - This is a receptor tyrosine kinase that has been found to be frequently mutated in DIPG. The mutations in this gene lead to the activation of the receptor, which can promote the growth and survival of the tumor cells.\n3. IDH1 and IDH2 - These are enzymes that are involved in the metabolism of lipids. Mutations in these genes have been found to be common in DIPG, and they can lead to the production of abnormal metabolites that can promote the growth and survival of the tumor cells.\n4. TP53 - This is a tumor suppressor gene that plays a role in maintaining the stability of the genome. Mutations in this gene have been found to be common in DIPG, and they can lead to the development of the tumor.\n5. NF1 - This is a tumor suppressor gene that plays a role in the regulation of cell growth and differentiation. Mutations in this gene have been found to be common in DIPG, and they can lead to the development of the tumor.\nOverall, these driver mutations have been identified as key players in the development and progression of DIPG, and they are the focus of ongoing research aimed at developing new and more effective treatments for this aggressive and often lethal brain tumor.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Diffuse Intrinsic Pontine Glioma (DIPG) is a type of brain tumor that affects the pons.\n2. DIPG is a rare but highly aggressive tumor, and it is often difficult to treat.\n3. The H3K27me3 mutation, an epigenetic modification, plays a role in the development and progression of DIPG.\n4. PDGFRA, a receptor tyrosine kinase, is frequently mutated in DIPG, and this promotes the growth and survival of the tumor cells.\n5. Mutations in enzymes IDH1 and IDH2 have been found to be common in DIPG, leading to the production of abnormal metabolites that promote the growth and survival of the tumor cells.\n6. TP53 and NF1 are tumor suppressor genes that, when mutated, can lead to the development of DIPG.",
    "vicuna-13b_fact": [
      "Diffuse Intrinsic Pontine Glioma (DIPG) is a type of brain tumor that affects the pons.",
      "DIPG is a rare but highly aggressive tumor, and it is often difficult to treat.",
      "The H3K27me3 mutation, an epigenetic modification, plays a role in the development and progression of DIPG.",
      "PDGFRA, a receptor tyrosine kinase, is frequently mutated in DIPG, and this promotes the growth and survival of the tumor cells.",
      "Mutations in enzymes IDH1 and IDH2 have been found to be common in DIPG, leading to the production of abnormal metabolites that promote the growth and survival of the tumor cells.",
      "TP53 and NF1 are tumor suppressor genes that, when mutated, can lead to the development of DIPG."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Mutations in enzymes IDH1 and IDH2 are not common in DIPG, they are more frequently associated with adult gliomas.\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2059,
    "user_query": "What is the enzymatic activity of PARL?",
    "vicuna-13b_response": "PARL (Peroxisome Proliferator-Activated Receptor-Lambda) is a nuclear receptor that plays a role in regulating gene expression and cellular metabolism. One of the key functions of PARL is its ability to regulate enzymatic activity.\nPARL can act as a transcription factor, meaning it can bind to specific DNA sequences and regulate the expression of target genes. One of the genes that PARL can regulate is the gene for an enzyme called 15-lipoxygenase (15-LO). 15-LO is an enzyme involved in the production of leukotrienes, which are pro-inflammatory molecules that play a role in the immune response and the development of certain diseases.\nBy binding to the 15-LO gene and regulating its expression, PARL can influence the enzymatic activity of 15-LO and thereby affect the production of leukotrienes. PARL can also regulate the expression of other genes involved in the metabolism of lipids and other molecules, which can impact enzymatic activity and overall cellular function.\nOverall, the enzymatic activity of PARL is regulated through its ability to bind to specific DNA sequences and regulate the expression of target genes, including those involved in enzymatic activity.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PARL (Peroxisome Proliferator-Activated Receptor-Lambda) is a nuclear receptor.\n2. PARL regulates gene expression and cellular metabolism.\n3. PARL can act as a transcription factor by binding to specific DNA sequences. \n4. PARL can regulate the gene for an enzyme called 15-lipoxygenase (15-LO). \n5. 15-LO is involved in the production of leukotrienes, pro-inflammatory molecules that play a role in the immune response and the development of certain diseases.",
    "vicuna-13b_fact": [
      "PARL (Peroxisome Proliferator-Activated Receptor-Lambda) is a nuclear receptor.",
      "PARL regulates gene expression and cellular metabolism.",
      "PARL can act as a transcription factor by binding to specific DNA sequences.",
      "PARL can regulate the gene for an enzyme called 15-lipoxygenase (15-LO).",
      "15-LO is involved in the production of leukotrienes, pro-inflammatory molecules that play a role in the immune response and the development of certain diseases."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: PARL (Presenilins Associated Rhomboid-Like) is a mitochondrial protein, not a nuclear receptor.\n2. UNKNOWN\n3. FALSE [correction]: As a mitochondrial protein, PARL does not act as a transcription factor by binding to specific DNA sequences. Transcription factors are typically found in the cell's nucleus.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2064,
    "user_query": "What is the mechanism of action of verubecestat?",
    "vicuna-13b_response": "Verubecestat is an oral small molecule inhibitor of the proteasome, which is an enzyme complex responsible for protein degradation in cells. The mechanism of action of verubecestat is to inhibit the activity of the proteasome, leading to the accumulation of proteins that are normally degraded by this enzyme. This can result in the inhibition of cell proliferation and the induction of cell death, particularly in cancer cells. Verubecestat has been studied as a potential treatment for various types of cancer, and it is thought to be particularly effective against cancer cells that are resistant to other types of cancer therapies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Verubecestat is an oral small molecule inhibitor of the proteasome.\n2. The proteasome is an enzyme complex responsible for protein degradation in cells.\n3. Verubecestat works by inhibiting the activity of the proteasome.\n4. This inhibition leads to the accumulation of proteins that are normally degraded by this enzyme.\n5. Verubecestat has been studied as a potential treatment for various types of cancer.",
    "vicuna-13b_fact": [
      "Verubecestat is an oral small molecule inhibitor of the proteasome.",
      "The proteasome is an enzyme complex responsible for protein degradation in cells.",
      "Verubecestat works by inhibiting the activity of the proteasome.",
      "This inhibition leads to the accumulation of proteins that are normally degraded by this enzyme.",
      "Verubecestat has been studied as a potential treatment for various types of cancer."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Verubecestat is an oral small molecule inhibitor of the Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1), not the proteasome.\n2. TRUE\n3. FALSE [correction]: Verubecestat works by inhibiting the activity of BACE1, not the proteasome.\n4. TRUE\n5. FALSE [correction]: Verubecestat has been studied as a potential treatment for Alzheimer's disease, not various types of cancer.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "vicuna-13b_response": "Triple negative gliomas are a type of brain tumor that are characterized by the absence of three key molecular markers: EGFR (epidermal growth factor receptor), P53 (tumor suppressor protein), and ER (estrogen receptor). These markers are often used to classify and diagnose different types of brain tumors, and their absence in triple negative gliomas distinguishes them from other types of gliomas.\nTriple negative gliomas are typically classified as grade III or IV astrocytomas, which are malignant brain tumors that arise from astrocyte cells. These tumors are highly aggressive and have a poor prognosis, with a median survival time of less than 1 year.\nIn addition to the absence of these key molecular markers, triple negative gliomas may also be characterized by other features, such as their location in the brain, their size and shape, and the presence of certain genetic mutations. For example, they are often found in the brain's hemispheres, and they can be large and difficult to remove surgically. They may also harbor mutations in genes such as IDH1 and IDH2, which are involved in the metabolism of the amino acid tryptophan.\nOverall, triple negative gliomas are a rare and aggressive type of brain tumor that are characterized by the absence of key molecular markers and other features such as their location, size, and genetic mutations.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Triple negative gliomas are a type of brain tumor characterized by the absence of EGFR, P53, and ER molecular markers.\n2. These markers (EGFR, P53, and ER) are often used to classify and diagnose different types of brain tumors.\n3. Triple negative gliomas are typically classified as grade III or IV astrocytomas.\n4. Grade III or IV astrocytomas are malignant brain tumors that arise from astrocyte cells.\n5. Triple negative gliomas often harbor mutations in genes such as IDH1 and IDH2, which are involved in the metabolism of the amino acid tryptophan.",
    "vicuna-13b_fact": [
      "Triple negative gliomas are a type of brain tumor characterized by the absence of EGFR, P53, and ER molecular markers.",
      "These markers (EGFR, P53, and ER) are often used to classify and diagnose different types of brain tumors.",
      "Triple negative gliomas are typically classified as grade III or IV astrocytomas.",
      "Grade III or IV astrocytomas are malignant brain tumors that arise from astrocyte cells.",
      "Triple negative gliomas often harbor mutations in genes such as IDH1 and IDH2, which are involved in the metabolism of the amino acid tryptophan."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. TRUE \n5. FALSE [correction]: Triple negative gliomas often harbor mutations in genes such as IDH1 and IDH2, which are involved in the metabolism of the molecule isocitrate, not tryptophan.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 2068,
    "user_query": "What is the function of gasdermin D?",
    "vicuna-13b_response": "Gasdermin D is a protein that plays a critical role in programmed cell death, also known as apoptosis. It is a member of the gasdermin family of proteins, which are involved in various cellular processes, including inflammation and cell death.\nGasdermin D is expressed in many different cell types and is involved in the regulation of various cellular functions. It has been shown to play a role in the regulation of autophagy, a process in which cells break down and recycle their own proteins and organelles. Gasdermin D has also been implicated in the regulation of inflammation and the immune response.\nOne of the most well-known functions of Gasdermin D is its role in the regulation of apoptosis. Gasdermin D is a key player in the process of pyroptosis, a type of programmed cell death that is characterized by the release of cytoplasmic contents and the activation of the immune system. Gasdermin D is activated in response to cellular stress, and its activation leads to the formation of a large pore in the cell membrane, which results in the release of cytoplasmic contents and the activation of the immune system.\nOverall, Gasdermin D is a critical regulator of various cellular processes, including autophagy, inflammation, and programmed cell death. Its dysregulation has been implicated in a variety of diseases, including cancer, neurodegenerative disorders, and inflammatory diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Gasdermin D is a protein that plays a role in programmed cell death or apoptosis.\n2. Gasdermin D is a member of the gasdermin family of proteins, which are involved in cellular processes such as inflammation and cell death.\n3. It has been shown that Gasdermin D plays a role in the regulation of autophagy.\n4. Gasdermin D is a key player in the process of pyroptosis.\n5. Dysfunction of Gasdermin D has been associated with various diseases, including cancer, neurodegenerative disorders, and inflammatory diseases.",
    "vicuna-13b_fact": [
      "Gasdermin D is a protein that plays a role in programmed cell death or apoptosis.",
      "Gasdermin D is a member of the gasdermin family of proteins, which are involved in cellular processes such as inflammation and cell death.",
      "It has been shown that Gasdermin D plays a role in the regulation of autophagy.",
      "Gasdermin D is a key player in the process of pyroptosis.",
      "Dysfunction of Gasdermin D has been associated with various diseases, including cancer, neurodegenerative disorders, and inflammatory diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "vicuna-13b_response": "TOPAZ1 is a software program developed by the United States government as part of the country's nuclear weapons program. It was used to simulate the behavior of nuclear explosions in various scenarios, including detonations above and below ground, as well as in different atmospheric conditions. The program was developed in the 1950s and was used for many years by the U.S. Department of Energy and its predecessor agencies. It was declassified in the 1990s and is now used for academic research and other non-nuclear purposes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TOPAZ1 is a software program that was developed by the United States government.\n2. The software was part of the United States' nuclear weapons program.\n3. TOPAZ1 was used to simulate the behavior of nuclear explosions in various scenarios.\n4. The program was developed in the 1950s.\n5. TOPAZ1 was declassified in the 1990s and is now used for academic research and other non-nuclear purposes.",
    "vicuna-13b_fact": [
      "TOPAZ1 is a software program that was developed by the United States government.",
      "The software was part of the United States' nuclear weapons program.",
      "TOPAZ1 was used to simulate the behavior of nuclear explosions in various scenarios.",
      "The program was developed in the 1950s.",
      "TOPAZ1 was declassified in the 1990s and is now used for academic research and other non-nuclear purposes."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2070,
    "user_query": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?",
    "vicuna-13b_response": "Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme that is present in red blood cells and helps to protect them from damage. G6PD deficiency occurs when the body does not have enough of this enzyme, which can lead to a condition called hemolytic anemia.\nThe symptoms of G6PD deficiency can vary depending on the severity of the deficiency and the presence of other underlying health conditions. Some common symptoms of G6PD deficiency include:\n1. Jaundice: This is a yellowing of the skin and eyes that is caused by an excess of bilirubin in the blood. Bilirubin is a substance that is produced when red blood cells break down.\n2. Fatigue: Many people with G6PD deficiency experience fatigue, weakness, and muscle cramps.\n3. Shortness of breath: G6PD deficiency can cause the body to produce more free radicals, which can damage the red blood cells and lead to shortness of breath.\n4. Headaches: Headaches are a common symptom of G6PD deficiency, and they can be caused by the buildup of toxins in the blood.\n5. Pale skin: G6PD deficiency can cause the skin to appear pale or yellowish due to the presence of excess bilirubin in the blood.\n6. Rapid heartbeat: The buildup of toxins in the blood can cause the heart to beat more rapidly.\n7. Dizziness: Some people with G6PD deficiency may experience dizziness or lightheadedness.\nIf you are experiencing any of these symptoms, it is important to speak with a healthcare provider for proper diagnosis and treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme present in red blood cells that helps protect them from damage.\n2. G6PD deficiency can lead to a condition called hemolytic anemia.\n3. Common symptoms of G6PD deficiency include jaundice, fatigue, shortness of breath, headaches, pale skin, rapid heartbeat, and dizziness.\n4. Jaundice, a symptom of G6PD deficiency, is a yellowing of the skin and eyes caused by an excess of bilirubin in the blood.\n5. G6PD deficiency can cause the body to produce more free radicals, damaging the red blood cells and causing shortness of breath.",
    "vicuna-13b_fact": [
      "Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme present in red blood cells that helps protect them from damage.",
      "G6PD deficiency can lead to a condition called hemolytic anemia.",
      "Common symptoms of G6PD deficiency include jaundice, fatigue, shortness of breath, headaches, pale skin, rapid heartbeat, and dizziness.",
      "Jaundice, a symptom of G6PD deficiency, is a yellowing of the skin and eyes caused by an excess of bilirubin in the blood.",
      "G6PD deficiency can cause the body to produce more free radicals, damaging the red blood cells and causing shortness of breath."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2071,
    "user_query": "Has the gorilla genome been determined?",
    "vicuna-13b_response": "Yes, the gorilla genome has been determined. The genome of the eastern gorilla (Gorilla beringei) was first sequenced in 2012, and the genome of the mountain gorilla (Gorilla beringei beringei) was sequenced in 2016. These sequences were generated using DNA samples from wild-caught gorillas, and the resulting genomes were compared to the human genome to better understand the evolutionary relationships between humans and great apes.\nThe gorilla genome is larger than the human genome, with approximately 3 billion base pairs of DNA. The sequence contains a high degree of similarity to the human genome, but also contains many unique features that are specific to gorillas. For example, the gorilla genome contains more genes related to smell and taste than the human genome, which is thought to reflect the important role of these senses in the behavior and ecology of gorillas.\nThe determination of the gorilla genome has provided valuable insights into the evolutionary history of the great apes, and has also been used to study a variety of biological processes, including disease susceptibility, cognitive development, and behavior.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The genome of the eastern gorilla (Gorilla beringei) was first sequenced in 2012.\n2. The genome of the mountain gorilla (Gorilla beringei beringei) was sequenced in 2016.\n3. The sequences were generated using DNA samples from wild-caught gorillas.\n4. The gorilla genome is larger than the human genome, with approximately 3 billion base pairs of DNA.\n5. The gorilla genome contains more genes related to smell and taste than the human genome.",
    "vicuna-13b_fact": [
      "The genome of the eastern gorilla (Gorilla beringei) was first sequenced in 2012.",
      "The genome of the mountain gorilla (Gorilla beringei beringei) was sequenced in 2016.",
      "The sequences were generated using DNA samples from wild-caught gorillas.",
      "The gorilla genome is larger than the human genome, with approximately 3 billion base pairs of DNA.",
      "The gorilla genome contains more genes related to smell and taste than the human genome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: The gorilla genome is slightly smaller than the human genome, with approximately 2.9 billion base pairs of DNA.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2073,
    "user_query": "Are mutations in the C9orf72  gene associated with macular degeneration?",
    "vicuna-13b_response": "Yes, mutations in the C9orf72 gene have been associated with macular degeneration. C9orf72 is a gene that provides instructions for making a protein that is involved in the regulation of gene expression and other cellular processes. Mutations in the C9orf72 gene have been identified as a cause of both familial and sporadic forms of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disorder that affects muscle strength and mobility.\nRecent studies have also found that mutations in the C9orf72 gene may be associated with an increased risk of developing age-related macular degeneration (AMD), which is a leading cause of vision loss in older adults. Specifically, a study published in the journal Nature Genetics in 2017 found that mutations in the C9orf72 gene were associated with an increased risk of developing both early- and late-stage AMD.\nThe exact mechanism by which C9orf72 mutations contribute to the development of AMD is not fully understood, but it is thought to involve the accumulation of toxic proteins in the retina, which is the light-sensitive tissue at the back of the eye. Further research is needed to better understand the relationship between C9orf72 mutations and AMD, and to develop effective treatments for this sight-threatening condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The C9orf72 gene provides instructions for making a protein that is involved in the regulation of gene expression and other cellular processes.\n2. Mutations in the C9orf72 gene have been identified as a cause of both familial and sporadic forms of amyotrophic lateral sclerosis.\n3. Recent studies have found that mutations in the C9orf72 gene may be associated with an increased risk of developing age-related macular degeneration.\n4. A study published in the journal Nature Genetics in 2017 found that mutations in the C9orf72 gene were associated with an increased risk of developing both early- and late-stage AMD.\n5. It is thought that the development of AMD involves the accumulation of toxic proteins in the retina due to mutations in the C9orf72 gene.",
    "vicuna-13b_fact": [
      "The C9orf72 gene provides instructions for making a protein that is involved in the regulation of gene expression and other cellular processes.",
      "Mutations in the C9orf72 gene have been identified as a cause of both familial and sporadic forms of amyotrophic lateral sclerosis.",
      "Recent studies have found that mutations in the C9orf72 gene may be associated with an increased risk of developing age-related macular degeneration.",
      "A study published in the journal Nature Genetics in 2017 found that mutations in the C9orf72 gene were associated with an increased risk of developing both early- and late-stage AMD.",
      "It is thought that the development of AMD involves the accumulation of toxic proteins in the retina due to mutations in the C9orf72 gene."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "vicuna-13b_response": "The expression of GATA-1 isoforms is controlled by several genes, including GATA1, GATA2, and GATA3. These genes are part of the GATA transcription factor family, which plays a crucial role in the development and differentiation of various cell types.\nGATA1 is the founding member of the GATA family and is expressed in a variety of tissues, including the heart, kidney, and liver. Mutations in the GATA1 gene have been linked to several human diseases, including congenital heart defects and anemia.\nGATA2 is expressed in the developing heart and is essential for the development of the cardiac conduction system. Mutations in the GATA2 gene have been associated with the development of heart block, a condition in which the electrical signals that control the heartbeat are disrupted.\nGATA3 is expressed in the developing lung and is essential for the development of the pulmonary circulation. Mutations in the GATA3 gene have been linked to the development of pulmonary hypertension, a condition in which the blood pressure in the lungs is elevated.\nOverall, the expression of GATA-1 isoforms is controlled by multiple genes, and dysregulation of these genes can lead to a variety of human diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GATA-1 isoforms expression is controlled by several genes, including GATA1, GATA2, and GATA3.\n2. Mutations in the GATA1 gene have been linked to several human diseases, including congenital heart defects and anemia.\n3. GATA2 gene is essential for the development of the cardiac conduction system.\n4. Mutations in the GATA2 gene have been associated with the development of heart block.\n5. Mutations in the GATA3 gene have been linked to the development of pulmonary hypertension.",
    "vicuna-13b_fact": [
      "GATA-1 isoforms expression is controlled by several genes, including GATA1, GATA2, and GATA3.",
      "Mutations in the GATA1 gene have been linked to several human diseases, including congenital heart defects and anemia.",
      "GATA2 gene is essential for the development of the cardiac conduction system.",
      "Mutations in the GATA2 gene have been associated with the development of heart block.",
      "Mutations in the GATA3 gene have been linked to the development of pulmonary hypertension."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: GATA-1 isoforms expression is controlled by the GATA1 gene.\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "vicuna-13b_response": "MIRA-seq (Multiplexed Ion Beam Recognition of Antigens by Sequencing) is a multiplexed sequencing-based assay used to detect and identify antibodies in a sample. It is a highly sensitive and specific method for detecting and measuring the presence of antibodies in a sample, such as blood.\nThe assay works by using a multiplexed ion beam to fragment antibodies in the sample, which are then sequenced to identify the specific antibodies present. This allows for the detection and quantification of a wide range of antibodies in a single sample, with high sensitivity and specificity.\nMIRA-seq has a wide range of applications in the field of immunology, including the detection and measurement of antibodies in disease diagnosis, monitoring of immune responses, and the study of immune system disorders. It is a powerful tool for understanding the immune system and its role in disease, and has the potential to revolutionize the way we diagnose and treat immune-related diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MIRA-seq stands for Multiplexed Ion Beam Recognition of Antigens by Sequencing.\n2. MIRA-seq is used to detect and identify antibodies in a sample.\n3. The MIRA-seq method includes the use of a multiplexed ion beam to fragment antibodies in the sample, which are then sequenced to identify the specific antibodies present.\n4. MIRA-seq can be used in the field of immunology for disease diagnosis, monitoring of immune responses, and the study of immune system disorders.\n5. MIRA-seq allows for the detection and quantification of a wide range of antibodies in a single sample.",
    "vicuna-13b_fact": [
      "MIRA-seq stands for Multiplexed Ion Beam Recognition of Antigens by Sequencing.",
      "MIRA-seq is used to detect and identify antibodies in a sample.",
      "The MIRA-seq method includes the use of a multiplexed ion beam to fragment antibodies in the sample, which are then sequenced to identify the specific antibodies present.",
      "MIRA-seq can be used in the field of immunology for disease diagnosis, monitoring of immune responses, and the study of immune system disorders.",
      "MIRA-seq allows for the detection and quantification of a wide range of antibodies in a single sample."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: MIRA-seq stands for Methylated CpG Island Recovery Assay-Sequencing.\n2. FALSE [correction]: MIRA-seq is used to examine DNA methylation patterns in a sample.\n3. FALSE [correction]: The MIRA-seq method includes the use of the MIRA protein to bind to methylated DNA regions, which are then sequenced to identify these methylated regions.\n4. TRUE\n5. FALSE [correction]: MIRA-seq allows for the detection and quantification of methylated DNA regions in a single sample.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2077,
    "user_query": "How does Ssu72 mediate gene looping?",
    "vicuna-13b_response": "Ssu72 is a transcription factor that plays a critical role in regulating gene expression in eukaryotic cells. One of the ways in which Ssu72 mediates gene expression is through a process known as gene looping, which involves the physical interaction between regulatory elements located in different regions of a chromosome.\nGene looping occurs when proteins, such as transcription factors, bind to specific sequences in the DNA and create a looped structure that brings distant regulatory elements into close proximity. This allows for the formation of complex regulatory interactions between different genes and gene promoters, which can have a significant impact on gene expression.\nSsu72 is known to play a role in mediating gene looping by binding to specific sequences in the DNA and recruiting other proteins to form a looped structure. This can bring regulatory elements into close proximity, leading to the coordinated regulation of multiple genes.\nSsu72 has been shown to play a role in a variety of biological processes, including cell cycle progression, cell growth and differentiation, and response to stress. Dysregulation of Ssu72 has been implicated in a number of diseases, including cancer, and it is the subject of ongoing research in the field of epigenetics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ssu72 is a transcription factor that plays a critical role in regulating gene expression in eukaryotic cells.\n2. Ssu72 mediates gene expression through a process known as gene looping, which involves the physical interaction between regulatory elements located in different regions of a chromosome.\n3. Gene looping occurs when proteins bind to specific sequences in the DNA to create a looped structure.\n4. Ssu72 mediates gene looping by binding to specific sequences in the DNA and recruiting other proteins to form a looped structure.\n5. Dysregulation of Ssu72 has been implicated in a number of diseases, including cancer.",
    "vicuna-13b_fact": [
      "Ssu72 is a transcription factor that plays a critical role in regulating gene expression in eukaryotic cells.",
      "Ssu72 mediates gene expression through a process known as gene looping, which involves the physical interaction between regulatory elements located in different regions of a chromosome.",
      "Gene looping occurs when proteins bind to specific sequences in the DNA to create a looped structure.",
      "Ssu72 mediates gene looping by binding to specific sequences in the DNA and recruiting other proteins to form a looped structure.",
      "Dysregulation of Ssu72 has been implicated in a number of diseases, including cancer."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Ssu72 is not a transcription factor, it is a phosphatase that plays a critical role in regulating gene expression in eukaryotic cells.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2081,
    "user_query": "What is the Glasgow Coma score?",
    "vicuna-13b_response": "The Glasgow Coma Scale (GCS) is a scoring system used to assess the level of consciousness in patients with acute brain injury. It is a widely used tool in emergency departments, intensive care units, and other medical settings to evaluate the severity of brain injury and determine the need for further treatment.\nThe GCS is based on a patient's eye opening, verbal response, and motor response. The score ranges from 3 to 15, with a lower score indicating a more severe brain injury. A score of 3 indicates deep coma, while a score of 15 indicates normal consciousness.\nThe GCS is used by healthcare professionals to assess the level of consciousness in patients with acute brain injury. It is important to note that the GCS is not a diagnostic tool, but rather a way to assess the severity of brain injury and determine the need for further treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Glasgow Coma Scale (GCS) is used to assess the level of consciousness in patients with acute brain injury.\n2. The GCS is widely used in emergency departments, intensive care units, and other medical settings.\n3. The GCS evaluates severity of brain injury and helps determine the need for further treatment.\n4. The Glasgow Coma Scale is based on a patient's eye opening, verbal response, and motor response.\n5. The GCS score ranges from 3 to 15, with a lower score indicating a more severe brain injury.",
    "vicuna-13b_fact": [
      "The Glasgow Coma Scale (GCS) is used to assess the level of consciousness in patients with acute brain injury.",
      "The GCS is widely used in emergency departments, intensive care units, and other medical settings.",
      "The GCS evaluates severity of brain injury and helps determine the need for further treatment.",
      "The Glasgow Coma Scale is based on a patient's eye opening, verbal response, and motor response.",
      "The GCS score ranges from 3 to 15, with a lower score indicating a more severe brain injury."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2083,
    "user_query": "Which is the main cause of the Patau syndrome?",
    "vicuna-13b_response": "Patau syndrome, also known as Trisomy 13, is a genetic disorder caused by the presence of an extra copy of chromosome 13. This extra genetic material affects the development of the fetus and results in a variety of physical and intellectual disabilities. The main cause of Patau syndrome is meiotic nondisjunction, which is a error in the process of cell division that occurs during the formation of gametes (eggs and sperm). This error results in the fertilization of an egg and sperm cell with an extra copy of chromosome 13, which then forms a zygote with the extra genetic material. Patau syndrome is not caused by anything the parents did or did not do during pregnancy. It is a random genetic occurrence.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Patau syndrome, also known as Trisomy 13, is a genetic disorder caused by an extra copy of chromosome 13.\n2. The extra genetic material from chromosome 13 affects the development of the fetus and results in physical and intellectual disabilities.\n3. The main cause of Patau syndrome is meiotic nondisjunction, an error in the process of cell division during the formation of gametes.\n4. Meiotic nondisjunction results in the fertilization of an egg and sperm cell with an extra copy of chromosome 13.\n5. Patau syndrome is not caused by anything the parents did or did not do during pregnancy.",
    "vicuna-13b_fact": [
      "Patau syndrome, also known as Trisomy 13, is a genetic disorder caused by an extra copy of chromosome 13.",
      "The extra genetic material from chromosome 13 affects the development of the fetus and results in physical and intellectual disabilities.",
      "The main cause of Patau syndrome is meiotic nondisjunction, an error in the process of cell division during the formation of gametes.",
      "Meiotic nondisjunction results in the fertilization of an egg and sperm cell with an extra copy of chromosome 13.",
      "Patau syndrome is not caused by anything the parents did or did not do during pregnancy."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2085,
    "user_query": "Is Musclin a secretory peptide?",
    "vicuna-13b_response": "I'm sorry, but I am not familiar with the term \"Musclin.\" It is possible that \"Musclin\" is a specific peptide or protein that has secretory properties, but without more information, I cannot provide a definitive answer.\nSecretory peptides are a class of peptides that are synthesized and secreted by cells. They can perform a variety of functions, such as signaling, enzyme activation, and regulation of cellular processes. Examples of secretory peptides include hormones, neurotransmitters, and enzymes.\nIf you have any additional information about \"Musclin,\" please let me know and I will do my best to provide a more informed answer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. Musclin may be a specific peptide or protein that has secretory properties.\n2. Secretory peptides are synthesized and secreted by cells.\n3. Secretory peptides can perform functions like signaling, enzyme activation, and regulation of cellular processes.\n4. Examples of secretory peptides include hormones, neurotransmitters, and enzymes.",
    "vicuna-13b_fact": [
      "Musclin may be a specific peptide or protein that has secretory properties.",
      "Secretory peptides are synthesized and secreted by cells.",
      "Secretory peptides can perform functions like signaling, enzyme activation, and regulation of cellular processes.",
      "Examples of secretory peptides include hormones, neurotransmitters, and enzymes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2091,
    "user_query": "What happens to H2AX upon DNA bouble strand breaks?",
    "vicuna-13b_response": "When a double strand break (DSB) occurs in DNA, the H2AX protein undergoes a series of modifications that help to signal the presence of the DSB to the rest of the cell. These modifications include the formation of phosphorylated histone H2AX (gamma-H2AX) on serine 139, which is a hallmark of DSBs.\nThe gamma-H2AX modification is thought to create a binding site for repair factors, which are recruited to the site of the DSB to facilitate repair. In addition, the gamma-H2AX modification is also thought to play a role in the regulation of the DNA damage response, which is a series of cellular pathways that are activated in response to DNA damage.\nOverall, the modification of H2AX in response to DSBs plays a crucial role in the cell's response to DNA damage, and is an important part of the cell's mechanism for maintaining the integrity of its genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. When a double strand break occurs in DNA, the H2AX protein undergoes a series of modifications.\n2. These modifications include the formation of phosphorylated histone H2AX (gamma-H2AX) on serine 139.\n3. The gamma-H2AX modification creates a binding site for repair factors to the site of the DSB to facilitate repair.\n4. Gamma-H2AX modification plays a role in the regulation of the DNA damage response.\n5. The modification of H2AX in response to DSBs plays a crucial role in the cell's response to DNA damage.",
    "vicuna-13b_fact": [
      "When a double strand break occurs in DNA, the H2AX protein undergoes a series of modifications.",
      "These modifications include the formation of phosphorylated histone H2AX (gamma-H2AX) on serine 139.",
      "The gamma-H2AX modification creates a binding site for repair factors to the site of the DSB to facilitate repair.",
      "Gamma-H2AX modification plays a role in the regulation of the DNA damage response.",
      "The modification of H2AX in response to DSBs plays a crucial role in the cell's response to DNA damage."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2095,
    "user_query": "What is the inheritance of Barth syndrome?",
    "vicuna-13b_response": "Barth syndrome is a rare genetic disorder that is inherited in an X-linked recessive pattern. This means that the gene that causes the disorder is located on the X chromosome and that it only affects males, as they only have one X chromosome. Females, who have two X chromosomes, are typically carriers of the disorder and may show mild symptoms.\nBarth syndrome is caused by a deficiency in the enzyme 3-methylglutaconic acid synthase, which is involved in the metabolism of certain amino acids. This deficiency leads to the accumulation of 3-methylglutaconic acid in the body, which can cause a variety of symptoms, including growth delay, intellectual disability, and skeletal abnormalities.\nThe inheritance of Barth syndrome is X-linked recessive, which means that the gene that causes the disorder is located on the X chromosome.\nBarth syndrome is inherited in an X-linked recessive pattern, which means that the gene that causes the disorder is located on the X chromosome and that it only affects males, as they only have one X chromosome. Females, who have two X chromosomes, are typically carriers of the disorder and may show mild symptoms.\nIt is important to note that genetic disorders are complex and that the inheritance of a disorder can be influenced by various factors, including the presence of modifier genes and environmental factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Barth syndrome is a genetic disorder that is inherited in an X-linked recessive pattern.\n2. The disorder only affects males because they have only one X chromosome.\n3. Females, having two X chromosomes, are typically carriers of Barth syndrome and may show mild symptoms.\n4. Barth syndrome is caused by a deficiency in the enzyme 3-methylglutaconic acid synthase, which is involved in the metabolism of certain amino acids.\n5. The deficiency in the enzyme leads to the accumulation of 3-methylglutaconic acid in the body, causing symptoms like growth delay, intellectual disability, and skeletal abnormalities.",
    "vicuna-13b_fact": [
      "Barth syndrome is a genetic disorder that is inherited in an X-linked recessive pattern.",
      "The disorder only affects males because they have only one X chromosome.",
      "Females, having two X chromosomes, are typically carriers of Barth syndrome and may show mild symptoms.",
      "Barth syndrome is caused by a deficiency in the enzyme 3-methylglutaconic acid synthase, which is involved in the metabolism of certain amino acids.",
      "The deficiency in the enzyme leads to the accumulation of 3-methylglutaconic acid in the body, causing symptoms like growth delay, intellectual disability, and skeletal abnormalities."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Barth syndrome is caused by a mutation in the TAZ gene, which instructs the body to produce tafazzin, a protein that plays a critical role in the normal function of mitochondria.\n5. FALSE [correction]: Barth syndrome is characterized by weakened heart muscle (cardiomyopathy), skeletal muscle weakness, an unusually large number of infections due to neutropenia (a reduction in the number of white blood cells termed neutrophils), and growth delay. The disorder does not directly result from the buildup of 3-methylglutaconic acid in the body.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2096,
    "user_query": "Is Cryptococcus neoformans a frequent cause of isolated skin infections in immunocompromised individuals",
    "vicuna-13b_response": "Cryptococcus neoformans is a type of fungus that can cause a variety of infections, including skin infections. It is a common cause of fungal infections in immunocompromised individuals, such as those with AIDS or those who have undergone organ transplants.\nHowever, the frequency of isolated skin infections caused by C. neoformans in immunocompromised individuals can vary depending on the population being studied and the specific location of the infection. In some studies, the incidence of skin infections caused by C. neoformans in immunocompromised individuals has been reported to be as high as 20-30% of all infections.\nIt is important to note that C. neoformans can also cause more severe infections, such as meningitis and pulmonary infections, in immunocompromised individuals. Therefore, it is important for individuals who are immunocompromised to be aware of the signs and symptoms of C. neoformans infections and to seek medical attention if they suspect they may have been infected.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cryptococcus neoformans is a type of fungus that can cause a variety of infections, including skin infections.\n2. Cryptococcus neoformans is a common cause of fungal infections in immunocompromised individuals.\n3. The frequency of isolated skin infections caused by Cryptococcus neoformans in immunocompromised individuals can reach 20-30% of all infections according to some studies.\n4. Cryptococcus neoformans can cause more severe infections, such as meningitis and pulmonary infections, in immunocompromised individuals.\n5. Immunocompromised individuals should be aware of the signs and symptoms of Cryptococcus neoformans infections.",
    "vicuna-13b_fact": [
      "Cryptococcus neoformans is a type of fungus that can cause a variety of infections, including skin infections.",
      "Cryptococcus neoformans is a common cause of fungal infections in immunocompromised individuals.",
      "The frequency of isolated skin infections caused by Cryptococcus neoformans in immunocompromised individuals can reach 20-30% of all infections according to some studies.",
      "Cryptococcus neoformans can cause more severe infections, such as meningitis and pulmonary infections, in immunocompromised individuals.",
      "Immunocompromised individuals should be aware of the signs and symptoms of Cryptococcus neoformans infections."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE \n3. UNKNOWN\n4. TRUE \n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2098,
    "user_query": "What are sirtuins?",
    "vicuna-13b_response": "Sirtuins are a class of NAD+-dependent deacetylases that play a critical role in regulating a wide range of biological processes, including aging, metabolism, inflammation, and stress response. They are also known as class III histone deacetylases (HDACs) and are found in all eukaryotic organisms.\nSirtuins are involved in the regulation of gene expression, DNA repair, and apoptosis (programmed cell death). They are also involved in the regulation of inflammation and oxidative stress, which are key contributors to the aging process.\nSirtuins have been the subject of intense research in recent years due to their potential as a target for the development of anti-aging and anti-inflammatory therapies. Some studies have suggested that sirtuin activators may have beneficial effects on various diseases, including cancer, diabetes, and neurodegenerative disorders.\nOverall, sirtuins are important regulators of cellular processes and have been the subject of intense research due to their potential as a target for the development of new therapies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Sirtuins are a class of NAD+-dependent deacetylases.\n2. Sirtuins play a role in regulating diverse biological processes such as aging, metabolism, inflammation, and stress response.\n3. Sirtuins are also known as class III histone deacetylases (HDACs) and are found in all eukaryotic organisms.\n4. Sirtuins are involved in the regulation of gene expression, DNA repair, and apoptosis.\n5. Recent research has been focusing on sirtuins as a potential target for the development of anti-aging and anti-inflammatory therapies.",
    "vicuna-13b_fact": [
      "Sirtuins are a class of NAD+-dependent deacetylases.",
      "Sirtuins play a role in regulating diverse biological processes such as aging, metabolism, inflammation, and stress response.",
      "Sirtuins are also known as class III histone deacetylases (HDACs) and are found in all eukaryotic organisms.",
      "Sirtuins are involved in the regulation of gene expression, DNA repair, and apoptosis.",
      "Recent research has been focusing on sirtuins as a potential target for the development of anti-aging and anti-inflammatory therapies."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2100,
    "user_query": "Which technique led to the elucidation of the role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C?",
    "vicuna-13b_response": "The technique that led to the elucidation of the role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C is gene editing. Gene editing is a technique that allows scientists to make precise changes to the DNA of an organism. In this case, researchers used a technique called CRISPR/Cas9 gene editing to knock out the HOXD10 gene in lymphatic endothelial cells. By doing this, they were able to study the effects of the loss of HOXD10 on the cells' responses to VEGF-C, a protein that plays a key role in the development and function of the lymphatic system. Through this technique, researchers were able to determine that HOXD10 plays a critical role in regulating lymphatic endothelial responses to VEGF-C and that its loss can lead to abnormal lymphatic vessel formation and function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C was elucidated through gene editing.\n2. Researchers used CRISPR/Cas9 gene editing to knock out the HOXD10 gene in lymphatic endothelial cells.\n3. VEGF-C is a protein that plays a key role in the development and function of the lymphatic system.\n4. The loss of HOXD10 can lead to abnormal lymphatic vessel formation and function.\n5. Researchers determined that HOXD10 plays a critical role in regulating lymphatic endothelial responses to VEGF-C.",
    "vicuna-13b_fact": [
      "The role of HOXD10 in regulating lymphatic endothelial responses to VEGF-C was elucidated through gene editing.",
      "Researchers used CRISPR/Cas9 gene editing to knock out the HOXD10 gene in lymphatic endothelial cells.",
      "VEGF-C is a protein that plays a key role in the development and function of the lymphatic system.",
      "The loss of HOXD10 can lead to abnormal lymphatic vessel formation and function.",
      "Researchers determined that HOXD10 plays a critical role in regulating lymphatic endothelial responses to VEGF-C."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2101,
    "user_query": "Is Obeticholic Acid used for treatment of Primary Biliary Cholangitis?",
    "vicuna-13b_response": "Yes, Obeticholic Acid (OCA) is used for the treatment of Primary Biliary Cholangitis (PBC), a chronic autoimmune liver disease. OCA is a farnesoid X receptor (FXR) agonist, which means it activates the FXR receptor in the liver and bile ducts to improve the flow of bile and reduce inflammation.\nOCA is approved by the U.S. Food and Drug Administration (FDA) for the treatment of PBC in adults. The drug is taken orally and works by reducing the production of bile in the liver, which can help reduce inflammation and slow the progression of the disease.\nClinical trials have shown that OCA can improve liver function, reduce symptoms, and slow the progression of PBC. However, it is important to note that OCA may not be effective for everyone with PBC, and it is not a cure for the disease.\nIt is important to discuss the potential benefits and risks of OCA with a healthcare provider before starting treatment, especially if you have any underlying medical conditions or are taking other medications. Regular monitoring of liver function and other health markers may be necessary while taking OCA.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Obeticholic Acid (OCA) is used for the treatment of Primary Biliary Cholangitis (PBC).\n2. Obeticholic Acid is a farnesoid X receptor (FXR) agonist.\n3. The U.S. Food and Drug Administration (FDA) has approved OCA for the treatment of PBC in adults.\n4. OCA can improve liver function, reduce symptoms, and slow the progression of PBC, as shown in clinical trials.\n5. Regular monitoring of liver function and other health markers may be necessary while taking OCA.",
    "vicuna-13b_fact": [
      "Obeticholic Acid (OCA) is used for the treatment of Primary Biliary Cholangitis (PBC).",
      "Obeticholic Acid is a farnesoid X receptor (FXR) agonist.",
      "The U.S. Food and Drug Administration (FDA) has approved OCA for the treatment of PBC in adults.",
      "OCA can improve liver function, reduce symptoms, and slow the progression of PBC, as shown in clinical trials.",
      "Regular monitoring of liver function and other health markers may be necessary while taking OCA."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2102,
    "user_query": "What alternate indication has Vanoxerine been repositioned for?",
    "vicuna-13b_response": "Vanoxerine is a drug that was originally developed and marketed for the treatment of obesity, but it was withdrawn from the market due to safety concerns. However, recent research has suggested that vanoxerine may have potential therapeutic benefits for treating other conditions, such as Huntington's disease and other neurodegenerative disorders.\nHuntington's disease is a genetic disorder that affects the brain and causes a range of symptoms, including movement problems, emotional changes, and cognitive decline. There is currently no cure for Huntington's disease, and existing treatments only provide limited symptomatic relief.\nVanoxerine has been repositioned for the treatment of Huntington's disease based on its potential to protect brain cells from damage and promote their survival. Studies in animal models of Huntington's disease have shown that vanoxerine can reduce the amount of damage to brain cells and improve motor function.\nWhile vanoxerine has shown promise in preclinical studies, it is important to note that it has not yet been approved by regulatory authorities for the treatment of Huntington's disease. Further research is needed to confirm its safety and efficacy in human patients before it can be considered for approval.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Vanoxerine was originally developed and marketed for the treatment of obesity.\n2. The drug Vanoxerine was withdrawn from the market due to safety concerns.\n3. Recent research suggests that Vanoxerine may have potential therapeutic benefits for Huntington's disease.\n4. Huntington's disease is a genetic disorder that affects the brain and currently has no cure.\n5. Vanoxerine has not yet been approved by regulatory authorities for the treatment of Huntington's disease.",
    "vicuna-13b_fact": [
      "Vanoxerine was originally developed and marketed for the treatment of obesity.",
      "The drug Vanoxerine was withdrawn from the market due to safety concerns.",
      "Recent research suggests that Vanoxerine may have potential therapeutic benefits for Huntington's disease.",
      "Huntington's disease is a genetic disorder that affects the brain and currently has no cure.",
      "Vanoxerine has not yet been approved by regulatory authorities for the treatment of Huntington's disease."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2105,
    "user_query": "Does the word ovine refers to goats?",
    "vicuna-13b_response": "Yes, the word \"ovine\" does refer to goats. \"Ovine\" is an adjective that is used to describe animals that belong to the family Bovidae, which includes goats, sheep, and cattle. The word \"ovine\" comes from the Latin word \"ovinus,\" which means \"relating to a sheep.\" So, if you're looking for a word to describe goats specifically, \"ovine\" is a good choice.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The word \"ovine\" refers to animals that belong to the family Bovidae.\n2. The family Bovidae includes goats, sheep, and cattle.\n3. \"Ovine\" is an adjective.\n4. The word \"ovine\" is derived from the Latin word \"ovinus\".\n5. \"Ovinus\" means \"relating to a sheep.\"",
    "vicuna-13b_fact": [
      "The word \"ovine\" refers to animals that belong to the family Bovidae.",
      "The family Bovidae includes goats, sheep, and cattle.",
      "\"Ovine\" is an adjective.",
      "The word \"ovine\" is derived from the Latin word \"ovinus\".",
      "\"Ovinus\" means \"relating to a sheep.\""
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The word \"ovine\" refers to animals that are sheep or related to sheep.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "vicuna-13b_response": "ARCALYST (also known as raloxifene) is a medication that is primarily used to treat and prevent osteoporosis in postmenopausal women. It is also sometimes used to reduce the risk of breast cancer in women with a high risk of developing this disease.\nARCALYST works by binding to estrogen receptors in the body, which helps to maintain bone density and prevent bone loss. It also has anti-estrogenic effects on the uterus and breasts, which may help to reduce the risk of certain types of cancer.\nARCALYST is taken orally as a tablet, and the dosage and duration of treatment will depend on the specific condition being treated. It is important to follow your doctor's instructions carefully when taking ARCALYST, as it may interact with certain medications and may have side effects.\nIt is important to note that ARCALYST is not suitable for everyone, and it is important to speak to your doctor before starting treatment to determine if it is the right medication for you.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ARCALYST, also known as raloxifene, is primarily used to treat and prevent osteoporosis in postmenopausal women.\n2. ARCALYST is sometimes used to reduce the risk of breast cancer in women with a high risk of developing this disease.\n3. The medication works by binding to estrogen receptors in the body to maintain bone density and prevent bone loss.\n4. ARCALYST is taken orally as a tablet, and the dosage and duration of treatment depend on the specific condition being treated.\n5. ARCALYST may interact with certain medications and may have side effects.",
    "vicuna-13b_fact": [
      "ARCALYST, also known as raloxifene, is primarily used to treat and prevent osteoporosis in postmenopausal women.",
      "ARCALYST is sometimes used to reduce the risk of breast cancer in women with a high risk of developing this disease.",
      "The medication works by binding to estrogen receptors in the body to maintain bone density and prevent bone loss.",
      "ARCALYST is taken orally as a tablet, and the dosage and duration of treatment depend on the specific condition being treated.",
      "ARCALYST may interact with certain medications and may have side effects."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: ARCALYST, also known as rilonacept, is primarily used to treat certain types of periodic fever syndromes.\n2. FALSE [correction]: ARCALYST is not used to reduce the risk of breast cancer in women. It is primarily used for the treatment of periodic fever syndromes.\n3. FALSE [correction]: ARCALYST works by inhibiting the action of certain proteins in the body that cause inflammation.\n4. FALSE [correction]: ARCALYST is taken by subcutaneous injection, typically once per week.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2114,
    "user_query": "Where is the TAZ (G4.5) is located in humans?",
    "vicuna-13b_response": "The Thyroid-stimulating hormone (TSH) receptor autoantibody (TAAb) also known as G4.5, is an autoantibody that is directed against the thyroid-stimulating hormone (TSH) receptor. The TSH receptor is a protein that is found on the surface of cells in the thyroid gland and in other tissues, such as the brain, heart, and bones. The TSH receptor is responsible for responding to TSH, which is a hormone produced by the pituitary gland that regulates the production and release of the hormones thyroxine (T4) and triiodothyronine (T3) by the thyroid gland.\nIn individuals with Graves' disease, an autoimmune disorder that leads to hyperthyroidism, the immune system produces TAAb which can bind to the TSH receptor and stimulate the production of T3 and T4, leading to hyperthyroidism. The presence of TAAb in the blood is used as a diagnostic marker for Graves' disease.\nIt is important to note that the location of TAAb is not specific to the thyroid gland, it can be found in other tissues as well, as mentioned before.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Thyroid-stimulating hormone (TSH) receptor autoantibody (TAAb), also known as G4.5, is an autoantibody directed against the TSH receptor.\n2. The TSH receptor is located on the surface of cells in the thyroid gland and in other tissues, such as the brain, heart, and bones.\n3. TSH receptor is responsible for responding to TSH, a hormone produced by the pituitary gland.\n4. In Graves' disease, the immune system produces TAAb which can bind to the TSH receptor and stimulate the production of T3 and T4.\n5. The presence of TAAb in the blood is used as a diagnostic marker for Graves' disease.",
    "vicuna-13b_fact": [
      "The Thyroid-stimulating hormone (TSH) receptor autoantibody (TAAb), also known as G4.5, is an autoantibody directed against the TSH receptor.",
      "The TSH receptor is located on the surface of cells in the thyroid gland and in other tissues, such as the brain, heart, and bones.",
      "TSH receptor is responsible for responding to TSH, a hormone produced by the pituitary gland.",
      "In Graves' disease, the immune system produces TAAb which can bind to the TSH receptor and stimulate the production of T3 and T4.",
      "The presence of TAAb in the blood is used as a diagnostic marker for Graves' disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2115,
    "user_query": "What do nerve-associated peripheral glial progenitors give rise to?",
    "vicuna-13b_response": "Nerve-associated peripheral glial progenitors (NG2 cells) are a type of glial cell that give rise to Schwann cells. Schwann cells are the glial cells that form the myelin sheath surrounding neurons in the peripheral nervous system (PNS). The NG2 cells are a type of glial cell that are closely associated with nerves in the PNS and are responsible for the formation and maintenance of the myelin sheath. They are also involved in the repair and regeneration of nerves in the PNS.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nerve-associated peripheral glial progenitors (NG2 cells) give rise to Schwann cells.\n2. Schwann cells form the myelin sheath surrounding neurons in the peripheral nervous system.\n3. NG2 cells are a type of glial cell that are closely associated with nerves in the peripheral nervous system.\n4. NG2 cells are responsible for the formation and maintenance of the myelin sheath.\n5. NG2 cells are involved in the repair and regeneration of nerves in the peripheral nervous system.",
    "vicuna-13b_fact": [
      "Nerve-associated peripheral glial progenitors (NG2 cells) give rise to Schwann cells.",
      "Schwann cells form the myelin sheath surrounding neurons in the peripheral nervous system.",
      "NG2 cells are a type of glial cell that are closely associated with nerves in the peripheral nervous system.",
      "NG2 cells are responsible for the formation and maintenance of the myelin sheath.",
      "NG2 cells are involved in the repair and regeneration of nerves in the peripheral nervous system."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Nerve-associated peripheral glial progenitors (NG2 cells) do not give rise to Schwann cells. They are two distinct types of glial cells.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Schwann cells, not NG2 cells, are responsible for the formation and maintenance of the myelin sheath.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2117,
    "user_query": "Is Lennox-Gastaut Syndrome usually diagnosed in older adults?",
    "vicuna-13b_response": "Lennox-Gastaut Syndrome (LGS) is a rare and severe form of epilepsy that typically occurs in childhood, but can also occur in adults. It is characterized by multiple types of seizures, including tonic-clonic seizures, atonic seizures, and myoclonic seizures. LGS is often associated with developmental delay, intellectual disability, and other neurological abnormalities.\nWhile LGS can occur in adults, it is more commonly diagnosed in children. The age of onset of LGS can vary widely, with some individuals diagnosed in infancy, and others not diagnosed until later in life. It is not uncommon for adults to be diagnosed with LGS after years of experiencing unexplained seizures or other neurological symptoms.\nIf you suspect that you or someone you know may have LGS, it is important to consult a neurologist or other healthcare provider for a proper diagnosis and treatment. Early and appropriate treatment can greatly improve outcomes for individuals with LGS.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Lennox-Gastaut Syndrome (LGS) is a rare and severe form of epilepsy that typically occurs in childhood, but can also occur in adults.\n2. LGS is characterized by multiple types of seizures, including tonic-clonic seizures, atonic seizures, and myoclonic seizures.\n3. LGS is often associated with developmental delay, intellectual disability, and other neurological abnormalities.\n4. The age of onset of LGS can vary widely, with some individuals diagnosed in infancy, and others not diagnosed until later in life.\n5. Early and appropriate treatment can greatly improve outcomes for individuals with LGS.",
    "vicuna-13b_fact": [
      "Lennox-Gastaut Syndrome (LGS) is a rare and severe form of epilepsy that typically occurs in childhood, but can also occur in adults.",
      "LGS is characterized by multiple types of seizures, including tonic-clonic seizures, atonic seizures, and myoclonic seizures.",
      "LGS is often associated with developmental delay, intellectual disability, and other neurological abnormalities.",
      "The age of onset of LGS can vary widely, with some individuals diagnosed in infancy, and others not diagnosed until later in life.",
      "Early and appropriate treatment can greatly improve outcomes for individuals with LGS."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2119,
    "user_query": "Describe ATR-16 syndrome.",
    "vicuna-13b_response": "ATR-16 syndrome is a rare genetic disorder that is caused by a mutation in the ATR gene on chromosome 16. This disorder is characterized by a variety of physical and developmental abnormalities, including short stature, a small head (microcephaly), a flat face with a broad nose and low-set ears, and abnormalities of the fingers and toes (digital anomalies). Individuals with ATR-16 syndrome may also have intellectual disability, seizures, and other medical problems. The severity of the symptoms can vary widely, and some individuals with ATR-16 syndrome may have mild symptoms while others may have more severe symptoms. There is no cure for ATR-16 syndrome, and treatment is focused on managing the symptoms and providing supportive care.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ATR-16 syndrome is a rare genetic disorder caused by a mutation in the ATR gene on chromosome 16.\n2. The disorder is characterized by physical and developmental abnormalities such as short stature, a small head, a flat face with a broad nose and low-set ears, and abnormalities of the fingers and toes.\n3. Individuals with ATR-16 syndrome may also have intellectual disability and seizures.\n4. The symptoms of ATR-16 syndrome can vary in severity.\n5. There is currently no cure for ATR-16 syndrome, and treatment is focused on managing the symptoms and providing supportive care.",
    "vicuna-13b_fact": [
      "ATR-16 syndrome is a rare genetic disorder caused by a mutation in the ATR gene on chromosome 16.",
      "The disorder is characterized by physical and developmental abnormalities such as short stature, a small head, a flat face with a broad nose and low-set ears, and abnormalities of the fingers and toes.",
      "Individuals with ATR-16 syndrome may also have intellectual disability and seizures.",
      "The symptoms of ATR-16 syndrome can vary in severity.",
      "There is currently no cure for ATR-16 syndrome, and treatment is focused on managing the symptoms and providing supportive care."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: ATR-16 syndrome is a rare genetic disorder caused by a deletion in the short arm of chromosome 16.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2120,
    "user_query": "What is the results of inactivated ANGPLT3?",
    "vicuna-13b_response": "Activated partial thromboplastin time (aPTT) is a blood test that measures the time it takes for a blood sample to clot. Inactivated ANGPTL3 is a protein that is used to inhibit the activity of ANGPTL3, which is a protein that can inhibit the clotting process. The results of inactivated ANGPTL3 would depend on the specific context in which it is being used and the individual's specific medical condition.\nIn general, inactivated ANGPTL3 is used to study the coagulation cascade, which is the series of chemical reactions that occur in the blood to form a clot. Inactivated ANGPTL3 is used to assess the function of the coagulation cascade and to detect any abnormalities or dysfunction in the clotting process.\nThe results of inactivated ANGPTL3 may be used to diagnose bleeding disorders, such as hemophilia, or to monitor the effectiveness of anticoagulant therapy, such as heparin or warfarin. In some cases, inactivated ANGPTL3 may be used to monitor the progression of a disease or to evaluate the effectiveness of a treatment plan.\nIt is important to note that the results of inactivated ANGPTL3 should be interpreted in the context of the individual's medical history, symptoms, and other diagnostic tests. It is best to discuss the results of this test with a healthcare professional who can provide a more complete interpretation and explanation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Activated partial thromboplastin time (aPTT) is a blood test that measures the time it takes for a blood sample to clot.\n2. Inactivated ANGPTL3 is a protein that is used to inhibit the activity of ANGPTL3.\n3. ANGPTL3 is a protein that can inhibit the clotting process.\n4. Inactivated ANGPTL3 is used to study the coagulation cascade.\n5. The results of inactivated ANGPTL3 may be used to diagnose bleeding disorders, such as hemophilia, or to monitor the effectiveness of anticoagulant therapy.",
    "vicuna-13b_fact": [
      "Activated partial thromboplastin time (aPTT) is a blood test that measures the time it takes for a blood sample to clot.",
      "Inactivated ANGPTL3 is a protein that is used to inhibit the activity of ANGPTL3.",
      "ANGPTL3 is a protein that can inhibit the clotting process.",
      "Inactivated ANGPTL3 is used to study the coagulation cascade.",
      "The results of inactivated ANGPTL3 may be used to diagnose bleeding disorders, such as hemophilia, or to monitor the effectiveness of anticoagulant therapy."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: ANGPTL3 inhibitors, not inactivated ANGPTL3, are used to inhibit the activity of ANGPTL3.\n3. FALSE [correction]: ANGPTL3 is a protein that can inhibit the process of lipoprotein lipase and endothelial lipase, not the clotting process.\n4. UNKNOWN\n5. FALSE [correction]: The tests of ANGPTL3 levels, not inactivated ANGPTL3, may be used to diagnose lipid disorders. aPTT can be used for diagnosing bleeding disorders, such as hemophilia, or to monitor the effectiveness of anticoagulant therapy.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2127,
    "user_query": "Which deep learning-based algorithms are used for enhancer prediction?",
    "vicuna-13b_response": "Deep learning-based algorithms are increasingly being used for enhancer prediction in genomics. Some of the commonly used algorithms are:\n1. DeepSEA: DeepSEA is a deep learning-based algorithm that uses a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs) to predict enhancers. It was developed by the Grossman lab at the Broad Institute of MIT and Harvard.\n2. DNN-seq: DNN-seq is a deep learning-based algorithm that uses a combination of CNNs and long short-term memory (LSTM) networks to predict enhancers. It was developed by the Jaitly lab at the University of California, San Diego.\n3. DeepBind: DeepBind is a deep learning-based algorithm that uses a combination of CNNs and RNNs to predict transcription factor binding sites and enhancers. It was developed by the Hakeem lab at the University of Toronto.\n4. Evolve: Evolve is a deep learning-based algorithm that uses a combination of CNNs and RNNs to predict enhancers. It was developed by the Morris lab at the University of Edinburgh.\nThese algorithms have been shown to outperform traditional computational methods for enhancer prediction, and are increasingly being used in genomics research.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Deep learning-based algorithms are being used for enhancer prediction in genomics.\n2. DeepSEA is a deep learning-based algorithm that was developed by the Grossman lab at the Broad Institute of MIT and Harvard.\n3. DNN-seq is a deep learning-based algorithm that was developed by the Jaitly lab at the University of California, San Diego.\n4. DeepBind is a deep learning-based algorithm that was developed by the Hakeem lab at the University of Toronto.\n5. Evolve is a deep learning-based algorithm that was developed by the Morris lab at the University of Edinburgh.",
    "vicuna-13b_fact": [
      "Deep learning-based algorithms are being used for enhancer prediction in genomics.",
      "DeepSEA is a deep learning-based algorithm that was developed by the Grossman lab at the Broad Institute of MIT and Harvard.",
      "DNN-seq is a deep learning-based algorithm that was developed by the Jaitly lab at the University of California, San Diego.",
      "DeepBind is a deep learning-based algorithm that was developed by the Hakeem lab at the University of Toronto.",
      "Evolve is a deep learning-based algorithm that was developed by the Morris lab at the University of Edinburgh."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: DeepSEA is a deep learning-based algorithm that was developed by the Zhou and Troyanskaya labs at Princeton University.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2128,
    "user_query": "Is Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin?",
    "vicuna-13b_response": "Yes, Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin. Beta-Thalassemia is a genetic disorder that affects the production of hemoglobin in the body. Hemoglobin is a protein in red blood cells that carries oxygen from the lungs to the body's tissues and carbon dioxide from the tissues to the lungs.\nThe genetic mutation that causes Beta-Thalassemia affects the gene that codes for the alpha globin chain of hemoglobin. The alpha globin chain is one of the two chains that make up the hemoglobin protein. In Beta-Thalassemia, the mutation results in reduced or absent production of the alpha globin chain, leading to abnormal levels of hemoglobin in the blood.\nThere are several types of Beta-Thalassemia, ranging from mild to severe, depending on the severity of the symptoms and the amount of hemoglobin produced by the body. The most severe forms of Beta-Thalassemia can lead to anemia, jaundice, and other health problems, and may require regular blood transfusions and other medical treatments.\nIn summary, Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin, leading to reduced or absent production of the alpha globin chain and abnormal levels of hemoglobin in the blood.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin.\n2. Beta-Thalassemia is a genetic disorder that affects the production of hemoglobin in the body.\n3. The mutation in Beta-Thalassemia results in reduced or absent production of the alpha globin chain.\n4. This leads to abnormal levels of hemoglobin in the blood.\n5. The most severe forms of Beta-Thalassemia can lead to anemia, jaundice, and other health problems, and may require regular blood transfusions and other medical treatments.",
    "vicuna-13b_fact": [
      "Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for alpha globin.",
      "Beta-Thalassemia is a genetic disorder that affects the production of hemoglobin in the body.",
      "The mutation in Beta-Thalassemia results in reduced or absent production of the alpha globin chain.",
      "This leads to abnormal levels of hemoglobin in the blood.",
      "The most severe forms of Beta-Thalassemia can lead to anemia, jaundice, and other health problems, and may require regular blood transfusions and other medical treatments."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Beta-Thalassemia is associated with a mutation or deletion of the gene that codes for beta globin.\n2. TRUE\n3. FALSE [correction]: The mutation in Beta-Thalassemia results in reduced or absent production of the beta globin chain.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2132,
    "user_query": "What is the mechanism of action of Romosozumab?",
    "vicuna-13b_response": "Romosozumab is a monoclonal antibody that is used to treat osteoporosis. It works by targeting and inhibiting the activity of the protein known as sclerostin, which is responsible for regulating the activity of osteoclasts, cells that are responsible for breaking down bone tissue. By inhibiting sclerostin, romosozumab promotes the formation of new bone tissue, thereby increasing bone density and reducing the risk of fractures. It is administered as an intravenous injection and is typically used in patients who have been diagnosed with postmenopausal osteoporosis or who have a high risk of fractures due to other conditions such as cancer or chronic use of corticosteroids.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Romosozumab is a monoclonal antibody used to treat osteoporosis.\n2. The drug works by targeting and inhibiting the protein known as sclerostin.\n3. Sclerostin is responsible for the activity of osteoclasts, which are cells that break down bone tissue.\n4. The inhibition of sclerostin by romosozumab can increase bone density and decrease the risk of fractures.\n5. Romosozumab is administered as an intravenous injection.",
    "vicuna-13b_fact": [
      "Romosozumab is a monoclonal antibody used to treat osteoporosis.",
      "The drug works by targeting and inhibiting the protein known as sclerostin.",
      "Sclerostin is responsible for the activity of osteoclasts, which are cells that break down bone tissue.",
      "The inhibition of sclerostin by romosozumab can increase bone density and decrease the risk of fractures.",
      "Romosozumab is administered as an intravenous injection."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Sclerostin is responsible for inhibition of osteoblasts, which are cells that build up bone tissue.\n4. TRUE\n5. FALSE [correction]: Romosozumab is administered as a subcutaneous injection.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2134,
    "user_query": "What is the function of the Mis18 protein?",
    "vicuna-13b_response": "The function of the Mis18 protein is not well understood. It is a protein that is involved in meiosis, which is a type of cell division that occurs in the reproductive cells of plants and animals. Meiosis is necessary for sexual reproduction, as it leads to the formation of haploid cells, which contain half the number of chromosomes as the original diploid cells.\nMis18 is a protein that is found in the plant Arabidopsis thaliana, and it has been shown to be involved in the meiosis I stage of meiosis. Meiosis I is the first stage of meiosis, during which the DNA is replicated and the chromosomes are duplicated. It is thought that the Mis18 protein may play a role in the replication of the DNA or the separation of the duplicated chromosomes.\nAdditionally, some studies have suggested that the Mis18 protein may be involved in the regulation of meiosis, as it has been shown to interact with other proteins that are known to be involved in the regulation of meiosis. However, the exact mechanism by which the Mis18 protein regulates meiosis is not well understood.\nOverall, the function of the Mis18 protein is not well understood, but it is clear that it plays a role in the process of meiosis in the plant Arabidopsis thaliana. Further research is needed to fully understand the function of the Mis18 protein and its role in meiosis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Mis18 protein is involved in meiosis, a type of cell division that occurs in reproductive cells.\n2. Meiosis is necessary for sexual reproduction, as it leads to the formation of haploid cells, which contain half the number of chromosomes as the original diploid cells.\n3. In the plant Arabidopsis thaliana, Mis18 is involved in the meiosis I stage of meiosis.\n4. Some studies suggest that the Mis18 protein may interact with other proteins involved in the regulation of meiosis.\n5. The exact mechanism by which the Mis18 protein regulates meiosis is not well understood.",
    "vicuna-13b_fact": [
      "The Mis18 protein is involved in meiosis, a type of cell division that occurs in reproductive cells.",
      "Meiosis is necessary for sexual reproduction, as it leads to the formation of haploid cells, which contain half the number of chromosomes as the original diploid cells.",
      "In the plant Arabidopsis thaliana, Mis18 is involved in the meiosis I stage of meiosis.",
      "Some studies suggest that the Mis18 protein may interact with other proteins involved in the regulation of meiosis.",
      "The exact mechanism by which the Mis18 protein regulates meiosis is not well understood."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2135,
    "user_query": "Are hepadnaviral minichromosomes free of nucleosomes?",
    "vicuna-13b_response": "Hepadnaviral minichromosomes are small, circular DNA elements that are present in some viruses, such as the hepatitis B virus. These minichromosomes are unique in that they are not associated with histone proteins, which are typically found in the nucleus of a cell and are responsible for compacting chromosomal DNA into a condensed form called chromatin.\nIn contrast to chromatin, which is heavily compacted and regulated by histone proteins, hepadnaviral minichromosomes are relatively unstructured and are not associated with nucleosomes, which are the basic units of chromatin structure. Instead, the minichromosomes are thought to be protected by a protein capsid, which surrounds the DNA and helps to maintain its stability and integrity.\nOverall, the lack of nucleosome association and the relatively unstructured nature of hepadnaviral minichromosomes suggests that these elements have a unique mechanism for DNA packaging and regulation, which is distinct from the mechanisms used by chromatin in the nucleus of a cell.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hepadnaviral minichromosomes are small, circular DNA elements that are present in some viruses, including the hepatitis B virus.\n2. Hepadnaviral minichromosomes are not associated with histone proteins.\n3. Histone proteins are typically found in the nucleus of a cell and are responsible for compacting chromosomal DNA into a condensed form called chromatin.\n4. The minichromosomes are not associated with nucleosomes, which are the basic units of chromatin structure.\n5. Instead, the minichromosomes are thought to be protected by a protein capsid, which surrounds the DNA and helps to maintain its stability and integrity.",
    "vicuna-13b_fact": [
      "Hepadnaviral minichromosomes are small, circular DNA elements that are present in some viruses, including the hepatitis B virus.",
      "Hepadnaviral minichromosomes are not associated with histone proteins.",
      "Histone proteins are typically found in the nucleus of a cell and are responsible for compacting chromosomal DNA into a condensed form called chromatin.",
      "The minichromosomes are not associated with nucleosomes, which are the basic units of chromatin structure.",
      "Instead, the minichromosomes are thought to be protected by a protein capsid, which surrounds the DNA and helps to maintain its stability and integrity."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hepadnaviral minichromosomes are associated with histone proteins.\n3. TRUE\n4. FALSE [correction]: The minichromosomes are associated with nucleosomes, which are the basic units of chromatin structure.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2136,
    "user_query": "Is Cri Du Chat associated with an expansion of a repeat with in the gene found on chromosome 5?",
    "vicuna-13b_response": "Cri Du Chat syndrome is a genetic disorder that is caused by a deletion of a portion of the 5p chromosome. This deletion typically involves the deletion of a segment of DNA that includes the gene known as SLC22A1, which is responsible for the production of a protein called the organic cation transporter 1 (OCT1). OCT1 is involved in the transport of certain molecules across the blood-brain barrier, and it is thought to play a role in the development of the brain and other organs.\nThe expansion of a repeat within a gene can sometimes lead to the production of abnormal proteins, which can cause problems with the function of the gene. In the case of the SLC22A1 gene, an expansion of a repeat within the gene has been associated with an increased risk of developing Cri Du Chat syndrome. However, it is important to note that not all individuals with an expansion of this repeat will develop the syndrome, and that other genetic and environmental factors may also play a role in the development of the condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cri Du Chat syndrome is a genetic disorder caused by a deletion of a portion of the 5p chromosome.\n2. The deletion typically involves the SLC22A1 gene.\n3. The SLC22A1 gene is responsible for the production of a protein called the organic cation transporter 1 (OCT1).\n4. OCT1 is involved in the transport of certain molecules across the blood-brain barrier and can affect the development of the brain and other organs.\n5. An expansion of a repeat within the SLC22A1 gene has been associated with an increased risk of developing Cri Du Chat syndrome.",
    "vicuna-13b_fact": [
      "Cri Du Chat syndrome is a genetic disorder caused by a deletion of a portion of the 5p chromosome.",
      "The deletion typically involves the SLC22A1 gene.",
      "The SLC22A1 gene is responsible for the production of a protein called the organic cation transporter 1 (OCT1).",
      "OCT1 is involved in the transport of certain molecules across the blood-brain barrier and can affect the development of the brain and other organs.",
      "An expansion of a repeat within the SLC22A1 gene has been associated with an increased risk of developing Cri Du Chat syndrome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The deletion typically involves the CTNND2 gene, not the SLC22A1 gene.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: An expansion of a repeat within the SLC22A1 gene has not been associated with an increased risk of developing Cri Du Chat syndrome. The syndrome is caused by a deletion of a portion of chromosome 5.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2141,
    "user_query": "Is osteocrin expressed exclusively in the bone?",
    "vicuna-13b_response": "Osteocrin is a protein that is primarily expressed in bone cells, specifically in osteoblasts and osteocytes. Osteoblasts are bone-forming cells that are responsible for the production of bone matrix and mineralization, while osteocytes are mature bone cells that are involved in the regulation of bone remodeling.\nWhile osteocrin is primarily expressed in bone, it is also expressed in other tissues, such as the heart, kidney, and pancreas. However, its expression in these tissues is much lower compared to bone.\nIt is important to note that while osteocrin is primarily associated with bone biology, its expression in other tissues suggests that it may play a role in other physiological processes as well. Further research is needed to fully understand the function and role of osteocrin in these tissues.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Osteocrin is a protein that is primarily expressed in bone cells.\n2. Osteocrin is specifically expressed in osteoblasts and osteocytes.\n3. Osteoblasts are bone-forming cells that are responsible for the production of bone matrix and mineralization.\n4. Osteocytes are mature bone cells that are involved in the regulation of bone remodeling.\n5. Osteocrin is also expressed in other tissues, such as the heart, kidney, and pancreas.",
    "vicuna-13b_fact": [
      "Osteocrin is a protein that is primarily expressed in bone cells.",
      "Osteocrin is specifically expressed in osteoblasts and osteocytes.",
      "Osteoblasts are bone-forming cells that are responsible for the production of bone matrix and mineralization.",
      "Osteocytes are mature bone cells that are involved in the regulation of bone remodeling.",
      "Osteocrin is also expressed in other tissues, such as the heart, kidney, and pancreas."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2142,
    "user_query": "What is  Achondroplasia?",
    "vicuna-13b_response": "Achondroplasia is the most common form of short-limbed dwarfism, a genetic disorder that affects the development of cartilage and bone. It is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, which plays a role in regulating bone growth.\nPeople with achondroplasia have shorter than average arms and legs, a normal-sized torso, and normal intelligence. They may also have characteristic physical features such as a \"normal\"-sized head, a flat face with a prominent forehead, and a normal-sized or larger hands and feet.\nThe symptoms of achondroplasia can vary in severity, and some people with the condition may experience mild to moderate physical disabilities. Common problems associated with the condition include joint pain and stiffness, spinal curvature (scoliosis), and limited range of motion in the joints.\nThere is no cure for achondroplasia, but treatment can help manage symptoms and improve quality of life. This may include physical therapy, bracing, and surgery to correct spinal curvature or other joint problems. People with achondroplasia can lead full and active lives with the right support and accommodations.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Achondroplasia is the most common form of short-limbed dwarfism.\n2. Achondroplasia is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.\n3. People with achondroplasia have shorter than average arms and legs, a normal-sized torso, and normal intelligence.\n4. Common problems associated with achondroplasia include joint pain and stiffness, spinal curvature (scoliosis), and limited range of motion in the joints.\n5. There is no cure for achondroplasia, but treatment options such as physical therapy, bracing, and surgery can help manage symptoms and improve quality of life.",
    "vicuna-13b_fact": [
      "Achondroplasia is the most common form of short-limbed dwarfism.",
      "Achondroplasia is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.",
      "People with achondroplasia have shorter than average arms and legs, a normal-sized torso, and normal intelligence.",
      "Common problems associated with achondroplasia include joint pain and stiffness, spinal curvature (scoliosis), and limited range of motion in the joints.",
      "There is no cure for achondroplasia, but treatment options such as physical therapy, bracing, and surgery can help manage symptoms and improve quality of life."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2156,
    "user_query": "Do circRNAs remain untranslated?",
    "vicuna-13b_response": "Circular RNAs (circRNAs) are a type of non-coding RNA that are generated by the back-transcription of protein-coding genes. Unlike most other RNA molecules, circRNAs are not translated into proteins, but instead, they can perform various functions in the cell, such as acting as miRNA sponges, regulating gene expression, and participating in RNA-protein complexes.\nCircRNAs are generated by the reverse transcription of messenger RNA (mRNA) into DNA, followed by the integration of the DNA into the host genome. This process is called retrotransposition. Once integrated into the genome, the circRNA can be transcribed into a double-stranded RNA (dsRNA) molecule, which can act as a miRNA sponge, blocking the activity of miRNAs that would otherwise target the protein-coding gene.\nIn summary, circRNAs are not translated into proteins, but instead, they can perform various functions in the cell, such as acting as miRNA sponges, regulating gene expression, and participating in RNA-protein complexes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Circular RNAs (circRNAs) are a type of non-coding RNA.\n2. CircRNAs are generated by the back-transcription of protein-coding genes.\n3. Unlike most other RNA molecules, circRNAs are not translated into proteins.\n4. CircRNAs can perform various functions in the cell, such as acting as miRNA sponges, regulating gene expression, and participating in RNA-protein complexes.\n5. CircRNAs are generated by the reverse transcription of messenger RNA (mRNA) into DNA, followed by the integration of the DNA into the host genome, a process called retrotransposition.",
    "vicuna-13b_fact": [
      "Circular RNAs (circRNAs) are a type of non-coding RNA.",
      "CircRNAs are generated by the back-transcription of protein-coding genes.",
      "Unlike most other RNA molecules, circRNAs are not translated into proteins.",
      "CircRNAs can perform various functions in the cell, such as acting as miRNA sponges, regulating gene expression, and participating in RNA-protein complexes.",
      "CircRNAs are generated by the reverse transcription of messenger RNA (mRNA) into DNA, followed by the integration of the DNA into the host genome, a process called retrotransposition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: CircRNAs are not generated by retrotransposition. Instead, they are typically formed when the spliceosome back-splices a downstream splice donor to an upstream splice acceptor. This produces a covalently closed continuous loop.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2158,
    "user_query": "What is Uhl's anomaly?",
    "vicuna-13b_response": "Uhl's anomaly is a rare congenital disorder that affects the development of the kidneys. It is characterized by the presence of a large cyst on one side of the kidney, which can cause the kidney to become enlarged and twisted. This can lead to obstruction of the urinary tract and can cause problems with urination, such as recurrent urinary tract infections.\nUhl's anomaly is typically diagnosed in infancy or early childhood, and it is often detected incidentally during an imaging study done for another reason. The treatment for Uhl's anomaly depends on the severity of the condition, and may include surgery to remove the cyst or to correct any obstruction of the urinary tract. In some cases, a kidney transplant may be necessary.\nIt is important for individuals with Uhl's anomaly to receive ongoing monitoring and care from a pediatric nephrologist or a urologist to ensure that their kidney function is not affected and to manage any complications that may arise.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Uhl's anomaly is a rare congenital disorder that affects the development of the kidneys.\n2. The condition is characterized by the presence of a large cyst on one side of the kidney.\n3. Uhl's anomaly can lead to obstruction of the urinary tract and can cause recurrent urinary tract infections.\n4. Uhl's anomaly is typically diagnosed in infancy or early childhood, often incidentally during an imaging study done for another reason.\n5. The treatment for Uhl's anomaly may include surgery or, in some cases, a kidney transplant.",
    "vicuna-13b_fact": [
      "Uhl's anomaly is a rare congenital disorder that affects the development of the kidneys.",
      "The condition is characterized by the presence of a large cyst on one side of the kidney.",
      "Uhl's anomaly can lead to obstruction of the urinary tract and can cause recurrent urinary tract infections.",
      "Uhl's anomaly is typically diagnosed in infancy or early childhood, often incidentally during an imaging study done for another reason.",
      "The treatment for Uhl's anomaly may include surgery or, in some cases, a kidney transplant."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Uhl's anomaly is a rare congenital disorder that primarily affects the development of the heart, specifically the right ventricular myocardium.\n2. FALSE [correction]: Uhl's anomaly is not characterized by the presence of a large cyst on one side of the kidney, but by an almost complete absence of the myocardium of the right ventricle of the heart.\n3. FALSE [correction]: Uhl's anomaly does not lead to obstruction of the urinary tract or recurrent urinary tract infections, but it can lead to heart failure or arrhythmias.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2159,
    "user_query": "Is autophagy the process where bacteria ingest viral particles?",
    "vicuna-13b_response": "Autophagy is a process in which a cell digests its own proteins and organelles, breaking them down into amino acids and other molecules that can be recycled and reused by the cell. It is a normal, regulated process that occurs in most cells in the body, and it plays a role in maintaining cellular homeostasis and preventing the accumulation of damaged or unnecessary cellular components.\nAutophagy is not the process where bacteria ingest viral particles. Bacteria can take up and internalize extracellular viral particles through a variety of mechanisms, including phagocytosis, endocytosis, and conjugation. These processes involve the engulfment of viral particles by the bacterial cell, which then either destroy the viral particles or use them for their own benefit.\nIn summary, autophagy is a process in which a cell digests its own proteins and organelles, while bacteria take up and internalize extracellular viral particles through different mechanisms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Autophagy is a process in which a cell digests its own proteins and organelles.\n2. Autophagy is a regulated process that occurs in most cells in the body.\n3. Autophagy plays a role in maintaining cellular homeostasis and preventing the accumulation of damaged or unnecessary cellular components.\n4. Bacteria can take up and internalize extracellular viral particles through a variety of mechanisms, including phagocytosis, endocytosis, and conjugation.\n5. Autophagy is not the process where bacteria ingest viral particles.",
    "vicuna-13b_fact": [
      "Autophagy is a process in which a cell digests its own proteins and organelles.",
      "Autophagy is a regulated process that occurs in most cells in the body.",
      "Autophagy plays a role in maintaining cellular homeostasis and preventing the accumulation of damaged or unnecessary cellular components.",
      "Bacteria can take up and internalize extracellular viral particles through a variety of mechanisms, including phagocytosis, endocytosis, and conjugation.",
      "Autophagy is not the process where bacteria ingest viral particles."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2161,
    "user_query": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?",
    "vicuna-13b_response": "The pre-replication complex (pre-RC) in eukaryotes is a multi-protein complex that assembles on the chromosome before DNA replication begins. The pre-RC is responsible for recruiting and organizing the proteins and enzymes necessary for DNA replication. The components of the pre-RC can vary depending on the organism, but some of the key components include:\n1. Origin recognition complex (ORC): ORC is a six-protein complex that recognizes and binds to specific sequences in the DNA called origins. Origins are the sites where replication initiates.\n2. Cdc6: Cdc6 is a protein that helps to recruit and activate the other proteins in the pre-RC.\n3. Cdt1: Cdt1 is a protein that helps to recruit and activate the other proteins in the pre-RC.\n4. Cdc45: Cdc45 is a protein that helps to recruit and activate the other proteins in the pre-RC.\n5. Cdc48: Cdc48 is a protein that helps to recruit and activate the other proteins in the pre-RC.\n6. Cdc37: Cdc37 is a protein that helps to recruit and activate the other proteins in the pre-RC.\n7. Cdt2: Cdt2 is a protein that helps to recruit and activate the other proteins in the pre-RC.\n8. Cdc46: Cdc46 is a protein that helps to recruit and activate the other proteins in the pre-RC.\nThese are some of the key components of the pre-RC in eukaryotes, but it's important to note that the composition of the pre-RC can vary between different organisms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The pre-replication complex (pre-RC) in eukaryotes assembles on the chromosome before DNA replication begins.\n2. The pre-RC is responsible for recruiting and organizing the proteins and enzymes necessary for DNA replication.\n3. The Origin Recognition Complex (ORC) is a component of the pre-RC and it recognizes and binds to specific sequences in the DNA called origins.\n4. Cdc6, Cdt1, Cdc45, Cdc48, Cdc37, Cdt2, and Cdc46 are proteins that help to recruit and activate other proteins in the pre-RC.\n5. The composition of the pre-RC can vary between different organisms.",
    "vicuna-13b_fact": [
      "The pre-replication complex (pre-RC) in eukaryotes assembles on the chromosome before DNA replication begins.",
      "The pre-RC is responsible for recruiting and organizing the proteins and enzymes necessary for DNA replication.",
      "The Origin Recognition Complex (ORC) is a component of the pre-RC and it recognizes and binds to specific sequences in the DNA called origins.",
      "Cdc6, Cdt1, Cdc45, Cdc48, Cdc37, Cdt2, and Cdc46 are proteins that help to recruit and activate other proteins in the pre-RC.",
      "The composition of the pre-RC can vary between different organisms."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Cdc6, Cdt1, and members of the MCM complex are proteins that help to recruit and activate other proteins in the pre-RC. Cdc45, Cdc48, Cdc37, Cdt2, and Cdc46 are not typically described as part of this process.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2162,
    "user_query": "What is the inheritance of hypophosphatemic rickets?",
    "vicuna-13b_response": "Hypophosphatemic rickets is a genetic disorder that is inherited in an autosomal recessive pattern. This means that an individual must inherit two copies of the gene mutation, one from each parent, in order to develop the disorder. If an individual has only one copy of the gene mutation, they are a carrier of the disorder and will not develop the disorder but can pass it on to their offspring. The gene mutation that causes hypophosphatemic rickets is located on the PHEX gene, which is responsible for regulating the production and reabsorption of phosphate in the body.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hypophosphatemic rickets is a genetic disorder.\n2. Hypophosphatemic rickets is inherited in an autosomal recessive pattern.\n3. An individual must inherit two copies of the gene mutation, one from each parent, in order to develop hypophosphatemic rickets.\n4. An individual with one copy of the gene mutation is a carrier of the disorder.\n5. The gene mutation that causes hypophosphatemic rickets is located on the PHEX gene.",
    "vicuna-13b_fact": [
      "Hypophosphatemic rickets is a genetic disorder.",
      "Hypophosphatemic rickets is inherited in an autosomal recessive pattern.",
      "An individual must inherit two copies of the gene mutation, one from each parent, in order to develop hypophosphatemic rickets.",
      "An individual with one copy of the gene mutation is a carrier of the disorder.",
      "The gene mutation that causes hypophosphatemic rickets is located on the PHEX gene."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hypophosphatemic rickets is often inherited in an X-linked dominant pattern.\n3. FALSE [correction]: For X-linked dominant disorders like hypophosphatemic rickets, an individual only needs to inherit one copy of the gene mutation, usually from their mother.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2167,
    "user_query": "Which server is used for generating modes of pseudo components of DNA, RNA and protein sequences?",
    "vicuna-13b_response": "The server used for generating modes of pseudo components of DNA, RNA, and protein sequences is called the \"Pseudo Component Generation Server\". This server is a computational tool that uses algorithms and machine learning techniques to predict the secondary structure of RNA and protein sequences based on their DNA sequences. The generated modes of pseudo components can be used for various applications in bioinformatics, such as the design of RNA and protein molecules with specific functions, the prediction of protein-DNA binding sites, and the analysis of gene regulation. The Pseudo Component Generation Server is a powerful tool that can help researchers better understand the mechanisms of gene expression and the function of RNA and protein molecules.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The \"Pseudo Component Generation Server\" is used for generating modes of pseudo components of DNA, RNA, and protein sequences.\n2. The server utilises algorithms and machine learning techniques to predict the secondary structure of RNA and protein sequences based on their DNA sequences. \n3. The generated modes of pseudo components can be used for various applications in bioinformatics.\n4. These applications can include the design of RNA and protein molecules with specific functions, the prediction of protein-DNA binding sites, and the analysis of gene regulation.\n5. The server can assist researchers in understanding the mechanisms of gene expression and the function of RNA and protein molecules.",
    "vicuna-13b_fact": [
      "The \"Pseudo Component Generation Server\" is used for generating modes of pseudo components of DNA, RNA, and protein sequences.",
      "The server utilises algorithms and machine learning techniques to predict the secondary structure of RNA and protein sequences based on their DNA sequences.",
      "The generated modes of pseudo components can be used for various applications in bioinformatics.",
      "These applications can include the design of RNA and protein molecules with specific functions, the prediction of protein-DNA binding sites, and the analysis of gene regulation.",
      "The server can assist researchers in understanding the mechanisms of gene expression and the function of RNA and protein molecules."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2169,
    "user_query": "Which class of genes are mutated in Diamond Blackfan Anemia patients?",
    "vicuna-13b_response": "Diamond Blackfan Anemia (DBA) is a congenital anemia characterized by a reduced number of red blood cells, and it is caused by mutations in the gene encoding the transcription factor KLF1. DBA is a rare disorder that affects approximately 1 in 10,000 newborns.\nKLF1 is a member of the Krüppel-like factor (KLF) family of transcription factors, which play important roles in regulating the expression of genes involved in hematopoiesis, or blood cell formation. Mutations in the KLF1 gene lead to a reduction in the production of red blood cells, resulting in anemia.\nThe specific class of genes that are mutated in DBA patients is the transcription factor genes. Transcription factors are proteins that bind to specific sequences of DNA and regulate the expression of genes. KLF1 is a transcription factor that plays a critical role in the development and differentiation of hematopoietic stem cells, which give rise to all the different types of blood cells.\nMutations in the KLF1 gene result in a reduction in the expression of genes involved in red blood cell production, leading to the characteristic anemia of DBA. The mutations can be either inherited or de novo, and they can occur in different parts of the KLF1 gene, leading to different clinical presentations and severity of the disease.\nOverall, the class of genes that are mutated in DBA patients is the transcription factor genes, specifically the gene encoding the transcription factor KLF1. Mutations in this gene lead to a reduction in the production of red blood cells, resulting in the characteristic anemia of DBA.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Diamond Blackfan Anemia is characterized by a reduced number of red blood cells. \n2. Diamond Blackfan Anemia is caused by mutations in the gene encoding the transcription factor KLF1. \n3. KLF1 is a member of the Krüppel-like factor family of transcription factors. \n4. Mutations in the KLF1 gene result in a reduction in the production of red blood cells, causing anemia in DBA patients.\n5. The class of genes that are mutated in DBA patients is termed as the transcription factor genes, specifically the gene encoding for transcription factor KLF1.",
    "vicuna-13b_fact": [
      "Diamond Blackfan Anemia is characterized by a reduced number of red blood cells.",
      "Diamond Blackfan Anemia is caused by mutations in the gene encoding the transcription factor KLF1.",
      "KLF1 is a member of the Krüppel-like factor family of transcription factors.",
      "Mutations in the KLF1 gene result in a reduction in the production of red blood cells, causing anemia in DBA patients.",
      "The class of genes that are mutated in DBA patients is termed as the transcription factor genes, specifically the gene encoding for transcription factor KLF1."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Diamond Blackfan Anemia (DBA) is typically caused by mutations in the ribosomal protein genes, not KLF1.\n3. TRUE\n4. FALSE [correction]: While mutations in the KLF1 gene can cause anemia, they are not typically associated with Diamond Blackfan Anemia. DBA is generally caused by mutations in the ribosomal protein genes.\n5. FALSE [correction]: DBA is usually caused by mutations in the ribosomal protein genes, not in the transcription factor KLF1 gene.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "vicuna-13b_response": "Robertsonian translocation is a type of chromosomal abnormality that occurs when a part of one chromosome breaks off and attaches to another chromosome. There are several human acrocentric chromosomes that are involved in Robertsonian translocation, including:\n1. Chromosome 1: The most common acrocentric chromosome involved in Robertsonian translocation is chromosome 1, which makes up about 8% of all translocations.\n2. Chromosome 9: Chromosome 9 is the second most common acrocentric chromosome involved in Robertsonian translocation, making up about 7% of all translocations.\n3. Chromosome 21: Chromosome 21 is involved in about 5% of all Robertsonian translocations.\n4. Chromosome 13: Chromosome 13 is involved in about 4% of all Robertsonian translocations.\n5. Chromosome 15: Chromosome 15 is involved in about 3% of all Robertsonian translocations.\nIt is important to note that Robertsonian translocation can occur with any acrocentric chromosome, but the ones listed above are the most commonly involved.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Robertsonian translocation is a type of chromosomal abnormality that occurs when a part of one chromosome breaks off and attaches to another chromosome. \n2. Chromosome 1 is the most common acrocentric chromosome involved in Robertsonian translocation.\n3. Chromosome 9 is the second most common acrocentric chromosome involved in Robertsonian translocation.\n4. Chromosome 21 is involved in about 5% of all Robertsonian translocations.\n5. Chromosome 13 is involved in about 4% of all Robertsonian translocations.",
    "vicuna-13b_fact": [
      "Robertsonian translocation is a type of chromosomal abnormality that occurs when a part of one chromosome breaks off and attaches to another chromosome.",
      "Chromosome 1 is the most common acrocentric chromosome involved in Robertsonian translocation.",
      "Chromosome 9 is the second most common acrocentric chromosome involved in Robertsonian translocation.",
      "Chromosome 21 is involved in about 5% of all Robertsonian translocations.",
      "Chromosome 13 is involved in about 4% of all Robertsonian translocations."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Robertsonian translocation is a type of chromosomal abnormality where two whole chromosomes fuse at the centromere.\n2. FALSE [correction]: Chromosome 21 is the most common acrocentric chromosome involved in Robertsonian translocation.\n3. TRUE\n4. FALSE [correction]: Chromosome 21 is involved in about 75% of all Robertsonian translocations.\n5. FALSE [correction]: Chromosome 13 is involved in about 20% of all Robertsonian translocations.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2171,
    "user_query": "Is tirilazad effective for treatment of aneurysmal subarachnoid haemorrhage?",
    "vicuna-13b_response": "Tirilazad is a medication that is used to treat aneurysmal subarachnoid hemorrhage (aSAH), which is a type of stroke caused by bleeding into the subarachnoid space, a fluid-filled area between the brain and the membranes that cover the spinal cord. Tirilazad is a vasodilator, which means it widens blood vessels, and it is thought to work by reducing the pressure on the aneurysm and improving blood flow to the brain.\nThere is some evidence that tirilazad may be effective in the treatment of aSAH. A study published in the journal Stroke found that patients who received tirilazad in addition to standard treatments for aSAH had a lower rate of death and disability compared to those who did not receive tirilazad. However, more research is needed to fully understand the benefits and risks of tirilazad for the treatment of aSAH.\nIt is important to note that the use of tirilazad for the treatment of aSAH is not universally accepted and its use may vary depending on the hospital and the physician. The decision to use tirilazad for the treatment of aSAH should be made on a case-by-case basis, taking into account the specific needs and medical history of the patient.\nIt is also important to note that the treatment of aSAH is a complex and multidisciplinary process that requires close monitoring and management by a team of healthcare professionals. The treatment options and the outcome of the treatment will depend on the patient's condition, the size and location of the aneurysm, and other factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tirilazad is a medication used to treat aneurysmal subarachnoid hemorrhage (aSAH).\n2. Tirilazad is a vasodilator, meaning it widens blood vessels.\n3. A study published in the journal Stroke found that patients who received tirilazad had a lower rate of death and disability compared to those who did not receive tirilazad.\n4. The use of tirilazad for the treatment of aSAH is not universally accepted and its use may vary depending on the hospital and the physician.\n5. The treatment of aSAH requires close monitoring and management by a team of healthcare professionals.",
    "vicuna-13b_fact": [
      "Tirilazad is a medication used to treat aneurysmal subarachnoid hemorrhage (aSAH).",
      "Tirilazad is a vasodilator, meaning it widens blood vessels.",
      "A study published in the journal Stroke found that patients who received tirilazad had a lower rate of death and disability compared to those who did not receive tirilazad.",
      "The use of tirilazad for the treatment of aSAH is not universally accepted and its use may vary depending on the hospital and the physician.",
      "The treatment of aSAH requires close monitoring and management by a team of healthcare professionals."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Tirilazad is not a vasodilator. It is an antioxidant which inhibits lipid peroxidation.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2175,
    "user_query": "List viral vectors used in gene therapy.",
    "vicuna-13b_response": "Viral vectors are used in gene therapy to deliver genetic material into cells. Here are some commonly used viral vectors in gene therapy:\n1. Adeno-associated virus (AAV): AAV is a small, single-stranded DNA virus that infects humans and other animals. It has a wide host range and can be easily manipulated to carry therapeutic genes. AAV vectors are often used for gene therapy because they are relatively safe and can be administered in low doses.\n2. Retroviruses: Retroviruses are RNA viruses that infect humans and other animals. They can be modified to carry therapeutic genes and can be used to treat a variety of genetic disorders. However, retroviruses can cause insertional mutagenesis, which is the insertion of viral DNA into the host genome, leading to unintended consequences.\n3. Lentiviruses: Lentiviruses are RNA viruses that infect humans and other animals. They are similar to retroviruses but have a longer latency period, which allows for more efficient gene transfer. Lentiviral vectors are often used for gene therapy because they can be used to treat a variety of genetic disorders and can be easily modified to carry therapeutic genes.\n4. Herpesviruses: Herpesviruses are DNA viruses that infect humans and other animals. They can be modified to carry therapeutic genes and can be used to treat a variety of genetic disorders. However, herpesviruses can cause reactivation of the virus, which can lead to unintended consequences.\n5. Oncoretroviruses: Oncoretroviruses are a type of retrovirus that can cause cancer. They can be modified to carry therapeutic genes and can be used to treat genetic disorders that cause cancer.\nOverall, viral vectors are a powerful tool in gene therapy and have been used to treat a variety of genetic disorders. However, they can also cause unintended consequences, and their use must be carefully monitored and regulated.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Adeno-associated virus (AAV) is a small, single-stranded DNA virus that infects humans and other animals, often used in gene therapy.\n2. Retroviruses are RNA viruses used in gene therapy that can cause insertional mutagenesis, the insertion of viral DNA into the host genome.\n3. Lentiviruses are RNA viruses used in gene therapy, similar to retroviruses but with a longer latency period.\n4. Herpesviruses are DNA viruses that infect humans and other animals, can be modified for gene therapy use and can cause reactivation of the virus.\n5. Oncoretroviruses are a type of retrovirus that can cause cancer and can be modified for gene treatment of genetic disorders that cause cancer.",
    "vicuna-13b_fact": [
      "Adeno-associated virus (AAV) is a small, single-stranded DNA virus that infects humans and other animals, often used in gene therapy.",
      "Retroviruses are RNA viruses used in gene therapy that can cause insertional mutagenesis, the insertion of viral DNA into the host genome.",
      "Lentiviruses are RNA viruses used in gene therapy, similar to retroviruses but with a longer latency period.",
      "Herpesviruses are DNA viruses that infect humans and other animals, can be modified for gene therapy use and can cause reactivation of the virus.",
      "Oncoretroviruses are a type of retrovirus that can cause cancer and can be modified for gene treatment of genetic disorders that cause cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2178,
    "user_query": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura).",
    "vicuna-13b_response": "The Moschcowitz syndrome, also known as thrombotic thrombocytopenic purpura (TTP), is a rare blood disorder characterized by the formation of blood clots in small blood vessels throughout the body. The classical symptoms of TTP include:\n1. Hemolytic anemia: This is a condition in which there is an excessive breakdown of red blood cells, leading to anemia, jaundice, and dark urine.\n2. Thrombocytopenia: This is a condition in which there is a low count of platelets in the blood, leading to easy bruising and bleeding.\n3. Neurological symptoms: TTP can cause ischemia (reduced blood flow) to the brain, leading to headaches, confusion, and in severe cases, stroke or seizures.\n4. Renal symptoms: TTP can cause ischemia to the kidneys, leading to decreased kidney function and, in severe cases, kidney failure.\n5. Skin lesions: TTP can cause small blood clots to form under the skin, leading to purple or red bruises (purpura) on the skin.\n6. Fever: TTP can cause a high fever, which can be accompanied by chills and sweats.\nIt is important to note that TTP is a serious and potentially life-threatening condition that requires prompt medical attention. If you are experiencing any of these symptoms, it is important to seek medical care immediately.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Moschcowitz syndrome, also known as thrombotic thrombocytopenic purpura (TTP), is a rare blood disorder characterized by the formation of blood clots in small blood vessels throughout the body.\n2. Hemolytic anemia, a condition with excessive breakdown of red blood cells, is a symptom of Moschcowitz syndrome.\n3. Thrombocytopenia, a condition where the count of platelets in the blood is low, is a symptom of Moschcowitz syndrome.\n4. Neurological symptoms like headaches, confusion, stroke, or seizures can occur due to TTP causing ischemia to the brain.\n5. TTP can cause ischemia to the kidneys, leading to decreased kidney function and potentially kidney failure.",
    "vicuna-13b_fact": [
      "Moschcowitz syndrome, also known as thrombotic thrombocytopenic purpura (TTP), is a rare blood disorder characterized by the formation of blood clots in small blood vessels throughout the body.",
      "Hemolytic anemia, a condition with excessive breakdown of red blood cells, is a symptom of Moschcowitz syndrome.",
      "Thrombocytopenia, a condition where the count of platelets in the blood is low, is a symptom of Moschcowitz syndrome.",
      "Neurological symptoms like headaches, confusion, stroke, or seizures can occur due to TTP causing ischemia to the brain.",
      "TTP can cause ischemia to the kidneys, leading to decreased kidney function and potentially kidney failure."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2181,
    "user_query": "Which is the major RNA editing enzyme in Drosophila melanogaster?",
    "vicuna-13b_response": "The major RNA editing enzyme in Drosophila melanogaster is called \"RNA-dependent RNA polymerase\" (RdRP). RdRP is an enzyme that can edit the transcripts of genes by adding or removing nucleotides, leading to the production of different versions of the same RNA molecule. This process is called RNA editing, and it plays a crucial role in the regulation of gene expression in Drosophila melanogaster. RdRP is responsible for most of the RNA editing events that occur in this organism, and it is a key factor in the development and function of the fly's nervous system.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The major RNA editing enzyme in Drosophila melanogaster is called \"RNA-dependent RNA polymerase\" (RdRP).\n2. RdRP is an enzyme that can edit the transcripts of genes by adding or removing nucleotides.\n3. This process of editing by RdRP is known as RNA editing.\n4. RNA editing plays a crucial role in the regulation of gene expression in Drosophila melanogaster.\n5. RdRP is a key factor in the development and function of the fly's nervous system.",
    "vicuna-13b_fact": [
      "The major RNA editing enzyme in Drosophila melanogaster is called \"RNA-dependent RNA polymerase\" (RdRP).",
      "RdRP is an enzyme that can edit the transcripts of genes by adding or removing nucleotides.",
      "This process of editing by RdRP is known as RNA editing.",
      "RNA editing plays a crucial role in the regulation of gene expression in Drosophila melanogaster.",
      "RdRP is a key factor in the development and function of the fly's nervous system."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The major RNA editing enzyme in Drosophila melanogaster is called \"Adenosine Deaminases Acting on RNA\"(ADAR).\n2. FALSE [correction]: RdRP is an enzyme that synthesizes RNA from an RNA template, not edit the transcripts of genes by adding or removing nucleotides.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2182,
    "user_query": "What is the CEGA catalog?",
    "vicuna-13b_response": "The CEGA (Council of European Geological Surveys) catalog is a database of geological maps and related information, maintained by the Council of European Geological Surveys (CEGA). CEGA is an organization that brings together the national geological surveys of Europe to promote cooperation and coordination in the field of geological mapping and research.\nThe CEGA catalog contains information on geological maps and related data from across Europe, including information on the geology, mineral resources, and geohazards of the region. The database is intended to provide a centralized resource for geological information that can be used by policymakers, industry, and the scientific community.\nThe CEGA catalog is a valuable resource for those interested in the geology of Europe, and can be used to access information on a wide range of topics, including the distribution of different rock types, the location of mineral deposits, and the potential for geohazards such as earthquakes and landslides. The database is regularly updated, and new information is added as it becomes available.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The CEGA (Council of European Geological Surveys) catalog is a database of geological maps and related information.\n2. The CEGA catalog is maintained by the Council of European Geological Surveys.\n3. The catalog includes information on the geology, mineral resources, and geohazards of Europe.\n4. The CEGA catalog is intended as a resource for policymakers, industry, and the scientific community.\n5. The CEGA catalog is regularly updated with new information.",
    "vicuna-13b_fact": [
      "The CEGA (Council of European Geological Surveys) catalog is a database of geological maps and related information.",
      "The CEGA catalog is maintained by the Council of European Geological Surveys.",
      "The catalog includes information on the geology, mineral resources, and geohazards of Europe.",
      "The CEGA catalog is intended as a resource for policymakers, industry, and the scientific community.",
      "The CEGA catalog is regularly updated with new information."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2183,
    "user_query": "Which protein is associated with hyperemesis gravidarum during pregrancy?",
    "vicuna-13b_response": "Hyperemesis gravidarum is a severe form of morning sickness that affects some women during pregnancy. It is characterized by persistent vomiting, dehydration, and electrolyte imbalances. One of the proteins that has been associated with hyperemesis gravidarum is human chorionic gonadotropin (hCG).\nhCG is a hormone produced by the placenta during pregnancy. It is often used in pregnancy tests to detect the presence of pregnancy. Studies have shown that women with hyperemesis gravidarum have higher levels of hCG in their blood compared to women who do not have this condition. It is thought that hCG may play a role in the development of hyperemesis gravidarum by stimulating the production of gastrin, a hormone that can increase stomach acid production.\nHowever, it is important to note that the exact cause of hyperemesis gravidarum is not fully understood and more research is needed to determine the role of hCG and other proteins in the development of this condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hyperemesis gravidarum is a severe form of morning sickness that affects some women during pregnancy.\n2. Hyperemesis gravidarum is characterized by persistent vomiting, dehydration, and electrolyte imbalances.\n3. Human chorionic gonadotropin (hCG) is a protein associated with hyperemesis gravidarum.\n4. hCG is a hormone produced by the placenta during pregnancy and is often used to detect pregnancy.\n5. Women with hyperemesis gravidarum typically have higher levels of hCG in their blood compared to women who do not have this condition.",
    "vicuna-13b_fact": [
      "Hyperemesis gravidarum is a severe form of morning sickness that affects some women during pregnancy.",
      "Hyperemesis gravidarum is characterized by persistent vomiting, dehydration, and electrolyte imbalances.",
      "Human chorionic gonadotropin (hCG) is a protein associated with hyperemesis gravidarum.",
      "hCG is a hormone produced by the placenta during pregnancy and is often used to detect pregnancy.",
      "Women with hyperemesis gravidarum typically have higher levels of hCG in their blood compared to women who do not have this condition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2187,
    "user_query": "Is edema a symptom of nephrotic syndrome?",
    "vicuna-13b_response": "Yes, edema is a common symptom of nephrotic syndrome. Edema is the swelling or puffiness of the skin, usually in the feet and ankles, caused by the accumulation of fluid in the body's tissues. In nephrotic syndrome, the kidneys are unable to filter waste and excess fluids from the blood, leading to the retention of fluids in the body. This can cause edema, as well as other symptoms such as fatigue, weakness, and weight gain. If you are experiencing edema, it is important to speak with a healthcare provider to determine the underlying cause and receive appropriate treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. Edema is a common symptom of nephrotic syndrome.\n2. Edema is the swelling or puffiness of the skin, usually in the feet and ankles, caused by the accumulation of fluid in the body's tissues.\n3. In nephrotic syndrome, the kidneys are unable to filter waste and excess fluids from the blood.\n4. The retention of fluids in the body due to nephrotic syndrome can cause symptoms such as fatigue, weakness, and weight gain.\n5. It is important to speak with a healthcare provider if experiencing edema.",
    "vicuna-13b_fact": [
      "Edema is a common symptom of nephrotic syndrome.",
      "Edema is the swelling or puffiness of the skin, usually in the feet and ankles, caused by the accumulation of fluid in the body's tissues.",
      "In nephrotic syndrome, the kidneys are unable to filter waste and excess fluids from the blood.",
      "The retention of fluids in the body due to nephrotic syndrome can cause symptoms such as fatigue, weakness, and weight gain.",
      "It is important to speak with a healthcare provider if experiencing edema."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2195,
    "user_query": "Borden classification is used for which disease?",
    "vicuna-13b_response": "The Borden classification is used for the classification of leukemia, a type of cancer that affects the blood and bone marrow. It is a system that is used to classify leukemia based on the type of white blood cell that is affected, as well as the degree of differentiation of the cancer cells. The Borden classification system is commonly used in conjunction with other systems, such as the FAB classification, to provide a more complete picture of the leukemia and to help guide treatment decisions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Borden classification is used for the classification of leukemia.\n2. Leukemia is a type of cancer that affects the blood and bone marrow.\n3. The Borden classification system classifies leukemia based on the type of white blood cell that is affected and the degree of differentiation of the cancer cells.\n4. The Borden classification system is often used in conjunction with the FAB classification. \n5. The Borden classification system is used to help guide treatment decisions for leukemia.",
    "vicuna-13b_fact": [
      "The Borden classification is used for the classification of leukemia.",
      "Leukemia is a type of cancer that affects the blood and bone marrow.",
      "The Borden classification system classifies leukemia based on the type of white blood cell that is affected and the degree of differentiation of the cancer cells.",
      "The Borden classification system is often used in conjunction with the FAB classification.",
      "The Borden classification system is used to help guide treatment decisions for leukemia."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Borden classification is not used for the classification of leukemia, but rather for orbital fractures. The French-American-British (FAB) Classification and the World Health Organization (WHO) classification are commonly used for leukemia.\n2. TRUE\n3. FALSE [correction]: The mentioned classification system for leukemia is the WHO or FAB classification system, not Borden. They classify leukemia based on the type of white blood cell affected and the cell development stage.\n4. FALSE [correction]: The Borden classification system is not used for leukemia, so it is incorrect to assert that it's used in conjunction with the FAB classification. The FAB and WHO classifications are commonly used in the field of leukemia.\n5. FALSE [correction]: The Borden classification system is not used to guide treatment decisions for leukemia, instead, the FAB and WHO classifications are.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2198,
    "user_query": "What is the function of mTOR?",
    "vicuna-13b_response": "mTOR (mechanistic target of rapamycin) is a serine/threonine kinase that plays a key role in regulating cell growth, proliferation, and metabolism. It is a downstream target of the TOR (target of rapamycin) signaling pathway, which is activated in response to nutrient availability and growth factors.\nmTOR exists in two distinct complexes: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). mTORC1 is composed of mTOR, regulatory-associated protein of mTOR (Raptor), mammalian lethal with SEC13 protein 8 (mLST8), and other regulatory proteins. mTORC2 is composed of mTOR, rapamycin-insensitive companion of mTOR (Rictor), stress-activated protein kinase-interacting protein 1 (SIN1), mLST8, and other regulatory proteins.\nmTORC1 is a central regulator of cell growth and metabolism, and its activity is tightly controlled by various signaling pathways. When mTORC1 is activated, it phosphorylates and activates several downstream targets, including the ribosomal protein S6 kinase 1 (S6K1) and eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1), which promote protein synthesis and cell growth. Additionally, mTORC1 inhibits the tumor suppressor protein S6K2, which promotes cell survival.\nmTORC2 regulates cell survival, cytoskeletal organization, and metabolism. It is activated by rapamycin, an immunosuppressant drug that inhibits mTORC1. Rapamycin also inhibits mTORC2 by binding to and inhibiting the activity of mTOR.\nOverall, the mTOR pathway plays a crucial role in regulating cellular homeostasis and is implicated in various diseases, including cancer, metabolic disorders, and kidney diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. mTOR is a serine/threonine kinase that regulates cell growth, proliferation, and metabolism.\n2. mTOR is a downstream target of the TOR signaling pathway, which is activated in response to nutrient availability and growth factors.\n3. mTOR exists in two distinct complexes: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2).\n4. mTORC1 is a central regulator of cell growth and metabolism, and it phosphorylates and activates several downstream targets, including the ribosomal protein S6 kinase 1 (S6K1) and eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1).\n5. mTOR pathway plays a crucial role in regulating cellular homeostasis and is implicated in various diseases, including cancer, metabolic disorders, and kidney diseases.",
    "vicuna-13b_fact": [
      "mTOR is a serine/threonine kinase that regulates cell growth, proliferation, and metabolism.",
      "mTOR is a downstream target of the TOR signaling pathway, which is activated in response to nutrient availability and growth factors.",
      "mTOR exists in two distinct complexes: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2).",
      "mTORC1 is a central regulator of cell growth and metabolism, and it phosphorylates and activates several downstream targets, including the ribosomal protein S6 kinase 1 (S6K1) and eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1).",
      "mTOR pathway plays a crucial role in regulating cellular homeostasis and is implicated in various diseases, including cancer, metabolic disorders, and kidney diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: mTOR is an upstream, not a downstream, target of the TOR signaling pathway, which is activated in response to nutrient availability and growth factors.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2203,
    "user_query": "List cardinal features of the Triple A syndrome.",
    "vicuna-13b_response": "The Triple A syndrome refers to a set of symptoms that are associated with Alzheimer's disease, atherosclerosis, and age-related macular degeneration. These three conditions are among the most common causes of death and disability in older adults.\nHere are some of the cardinal features of the Triple A syndrome:\n1. Alzheimer's disease: Alzheimer's disease is a neurodegenerative disorder that is characterized by progressive memory loss, decline in cognitive function, and changes in behavior and personality.\n2. Atherosclerosis: Atherosclerosis is a condition in which the arteries become narrowed or blocked by a build-up of plaque, made up of cholesterol, fat, and other substances. This can lead to heart disease, stroke, and other complications.\n3. Age-related macular degeneration: Age-related macular degeneration (AMD) is a condition that affects the center of the retina, leading to progressive loss of vision. It is the leading cause of blindness in older adults.\nOverall, the Triple A syndrome is a complex and multifaceted condition that is associated with significant morbidity and mortality. While there is currently no cure for these conditions, there are many treatments and interventions that can help to manage symptoms and improve quality of life.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Triple A syndrome refers to a set of symptoms associated with Alzheimer's disease, atherosclerosis, and age-related macular degeneration.\n2. Alzheimer's disease is a neurodegenerative disorder characterized by progressive memory loss, decline in cognitive function, and changes in behavior and personality.\n3. Atherosclerosis is a condition where arteries become narrowed or blocked by a build-up of plaque, leading to heart disease, stroke, and other complications.\n4. Age-related macular degeneration affects the center of the retina, resulting in progressive vision loss.\n5. Triple A syndrome is associated with significant morbidity and mortality.",
    "vicuna-13b_fact": [
      "The Triple A syndrome refers to a set of symptoms associated with Alzheimer's disease, atherosclerosis, and age-related macular degeneration.",
      "Alzheimer's disease is a neurodegenerative disorder characterized by progressive memory loss, decline in cognitive function, and changes in behavior and personality.",
      "Atherosclerosis is a condition where arteries become narrowed or blocked by a build-up of plaque, leading to heart disease, stroke, and other complications.",
      "Age-related macular degeneration affects the center of the retina, resulting in progressive vision loss.",
      "Triple A syndrome is associated with significant morbidity and mortality."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Triple A syndrome refers to a rare inherited disorder characterized by adrenal insufficiency, achalasia of the esophagus, and alacrima.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2205,
    "user_query": "Does the Abelson-related gene (ARG) gene encode for a serine kinase?",
    "vicuna-13b_response": "The Abelson-related gene (ARG) is a gene that encodes for a non-receptor tyrosine kinase, also known as the Abelson kinase. The ARG gene is located on the long arm of chromosome X and is composed of 19 exons. The protein product of the ARG gene, called Abelson kinase, is a tyrosine kinase that plays a role in cell growth and differentiation. It is involved in the regulation of the actin cytoskeleton and is essential for the formation of filopodia, which are small, finger-like protrusions that extend from the cell membrane. The Abelson kinase is also involved in the regulation of the cell cycle and has been shown to be necessary for the progression of cells from the G1 phase to the S phase of the cell cycle. It is also involved in the regulation of the JAK-STAT signaling pathway, which is important for the development and function of immune cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Abelson-related gene (ARG) encodes for a non-receptor tyrosine kinase, known as the Abelson kinase.\n2. The ARG gene is located on the long arm of chromosome X and is composed of 19 exons.\n3. The protein product of the ARG gene, Abelson kinase, plays a role in cell growth and differentiation.\n4. Abelson kinase is necessary for the formation of filopodia, which are small, finger-like protrusions that extend from the cell membrane.\n5. Abelson kinase has been shown to be necessary for the progression of cells from the G1 phase to the S phase of the cell cycle.",
    "vicuna-13b_fact": [
      "The Abelson-related gene (ARG) encodes for a non-receptor tyrosine kinase, known as the Abelson kinase.",
      "The ARG gene is located on the long arm of chromosome X and is composed of 19 exons.",
      "The protein product of the ARG gene, Abelson kinase, plays a role in cell growth and differentiation.",
      "Abelson kinase is necessary for the formation of filopodia, which are small, finger-like protrusions that extend from the cell membrane.",
      "Abelson kinase has been shown to be necessary for the progression of cells from the G1 phase to the S phase of the cell cycle."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The ARG gene is located on the long arm of chromosome 1 and is composed of 13 exons.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2207,
    "user_query": "Is Prochlorococcus the most abundant photosynthetic organism?",
    "vicuna-13b_response": "Prochlorococcus is a type of cyanobacteria that is known for its ability to perform photosynthesis, and it is one of the most abundant photosynthetic organisms in the ocean. However, it is not the most abundant photosynthetic organism overall, as there are other types of photosynthetic organisms, such as algae and plants, that are more abundant on land.\nProchlorococcus is a small, marine cyanobacteria that is known for its ability to thrive in a wide range of ocean environments, from the surface waters to the deep sea. It is a key player in the marine food web, and is responsible for a significant portion of the ocean's primary productivity.\nProchlorococcus is able to perform photosynthesis using a variety of different pigments, including chlorophyll a and b, as well as other accessory pigments. This allows it to adapt to a wide range of different light conditions, and to survive in a variety of different habitats.\nOverall, while Prochlorococcus is an important and abundant photosynthetic organism in the ocean, it is not the most abundant photosynthetic organism overall. That honor is held by other types of photosynthetic organisms, such as algae and plants, which are more abundant on land.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Prochlorococcus is a type of cyanobacteria that is known for performing photosynthesis.\n2. Prochlorococcus is one of the most abundant photosynthetic organisms in the ocean but not the most abundant overall.\n3. Prochlorococcus is a small, marine cyanobacteria that thrives in a wide range of ocean environments.\n4. Prochlorococcus is responsible for a significant portion of the ocean's primary productivity.\n5. Prochlorococcus is able to perform photosynthesis using a variety of different pigments, including chlorophyll a and b, as well as other accessory pigments.",
    "vicuna-13b_fact": [
      "Prochlorococcus is a type of cyanobacteria that is known for performing photosynthesis.",
      "Prochlorococcus is one of the most abundant photosynthetic organisms in the ocean but not the most abundant overall.",
      "Prochlorococcus is a small, marine cyanobacteria that thrives in a wide range of ocean environments.",
      "Prochlorococcus is responsible for a significant portion of the ocean's primary productivity.",
      "Prochlorococcus is able to perform photosynthesis using a variety of different pigments, including chlorophyll a and b, as well as other accessory pigments."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Prochlorococcus is able to perform photosynthesis using different pigments, but not chlorophyll b. It mainly uses chlorophyll a and divinyl-chlorophyll a and b.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2208,
    "user_query": "List 3 features of IRVAN syndrome.",
    "vicuna-13b_response": "IRVAN syndrome is a rare genetic disorder that affects the development of the brain and other parts of the body. Here are three features of IRVAN syndrome:\n1. Intellectual disability: People with IRVAN syndrome often have intellectual disability, which is a condition that affects a person's ability to learn and understand new things. This can range from mild to severe intellectual disability.\n2. Developmental delay: People with IRVAN syndrome may experience developmental delay, which means that they may take longer than usual to reach certain milestones in their development, such as crawling, walking, and talking.\n3. Facial features: People with IRVAN syndrome may have distinctive facial features, including a flat face with a broad forehead, a small jaw, and a flat nose with a broad bridge. They may also have low-set ears and a small chin.\nIt's important to note that these are just three features of IRVAN syndrome, and there may be other symptoms and characteristics associated with the condition as well. If you or someone you know has been diagnosed with IRVAN syndrome, it's important to work closely with a healthcare provider to manage the condition and ensure the best possible quality of life.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. IRVAN syndrome is a rare genetic disorder that affects the development of the brain and other parts of the body.\n2. Intellectual disability, ranging from mild to severe, is a feature of IRVAN syndrome.\n3. Developmental delay is another feature of IRVAN syndrome.\n4. Distinctive facial features, including a flat face with a broad forehead, a small jaw, and a flat nose with a broad bridge, along with low-set ears and a small chin, are also characteristics of IRVAN syndrome.\n5. Management of IRVAN syndrome requires close cooperation with a healthcare provider.",
    "vicuna-13b_fact": [
      "IRVAN syndrome is a rare genetic disorder that affects the development of the brain and other parts of the body.",
      "Intellectual disability, ranging from mild to severe, is a feature of IRVAN syndrome.",
      "Developmental delay is another feature of IRVAN syndrome.",
      "Distinctive facial features, including a flat face with a broad forehead, a small jaw, and a flat nose with a broad bridge, along with low-set ears and a small chin, are also characteristics of IRVAN syndrome.",
      "Management of IRVAN syndrome requires close cooperation with a healthcare provider."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2211,
    "user_query": "List active ingredients of the Stribild polypill.",
    "vicuna-13b_response": "Stribild is a fixed-dose combination pill that contains four active ingredients:\n1. Elvitegravir: This is a integrase inhibitor drug used for treating HIV infection.\n2. Cobicistat: This is a pharmacokinetic enhancer drug used to increase the concentration of other HIV drugs in the body.\n3. Emtricitabine: This is a nucleoside reverse transcriptase inhibitor (NRTI) drug used for treating HIV infection.\n4. Tenofovir alafenamide (TAF): This is a nucleotide reverse transcriptase inhibitor (NRTI) drug used for treating HIV infection.\nIt is important to note that Stribild is only approved for use in adults with HIV-1 infection and should only be used under the guidance of a healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Stribild is a fixed-dose combination pill that contains four active ingredients.\n2. Elvitegravir, an active ingredient in Stribild, is an integrase inhibitor drug used for treating HIV infection.\n3. Cobicistat, an active ingredient in Stribild, is a pharmacokinetic enhancer drug used to increase the concentration of other HIV drugs in the body.\n4. Emtricitabine, an active ingredient in Stribild, is a nucleoside reverse transcriptase inhibitor (NRTI) drug used for treating HIV infection.\n5. Tenofovir alafenamide (TAF), an active ingredient in Stribild, is a nucleotide reverse transcriptase inhibitor (NRTI) drug used for treating HIV infection.",
    "vicuna-13b_fact": [
      "Stribild is a fixed-dose combination pill that contains four active ingredients.",
      "Elvitegravir, an active ingredient in Stribild, is an integrase inhibitor drug used for treating HIV infection.",
      "Cobicistat, an active ingredient in Stribild, is a pharmacokinetic enhancer drug used to increase the concentration of other HIV drugs in the body.",
      "Emtricitabine, an active ingredient in Stribild, is a nucleoside reverse transcriptase inhibitor (NRTI) drug used for treating HIV infection.",
      "Tenofovir alafenamide (TAF), an active ingredient in Stribild, is a nucleotide reverse transcriptase inhibitor (NRTI) drug used for treating HIV infection."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Tenofovir disoproxil fumarate (TDF), not Tenofovir alafenamide (TAF), is an active ingredient in Stribild and is a nucleotide reverse transcriptase inhibitor (NRTI) drug used for treating HIV infection.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2215,
    "user_query": "Does the histone chaperone ASF1 interact with histones H1/H2?",
    "vicuna-13b_response": "ASF1 is a histone chaperone that plays a role in the assembly and disassembly of nucleosome structures. It has been shown to interact with a variety of histones, including H1 and H2, but the specifics of these interactions are not well understood.\nHistone H1 and histone H2 are two of the five main types of histones found in chromatin. Histone H1 is a small histone that is involved in the compaction of chromatin and the regulation of gene expression, while histone H2 is a histone that is involved in the formation of nucleosome structures.\nThere have been some studies that suggest that ASF1 may interact with histones H1 and H2, but the evidence for these interactions is not conclusive. For example, one study found that ASF1 interacts with histone H1 and histone H2 in yeast, while another study found that ASF1 interacts with histone H2 but not histone H1 in mammalian cells.\nOverall, while there is some evidence to suggest that ASF1 may interact with histones H1 and H2, the specifics of these interactions are not well understood and further research is needed to confirm these interactions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ASF1 is a histone chaperone that plays a role in the assembly and disassembly of nucleosome structures.\n2. Histone H1 and histone H2 are two of the five main types of histones found in chromatin.\n3. Histone H1 is involved in the compaction of chromatin and the regulation of gene expression.\n4. Histone H2 is involved in the formation of nucleosome structures.\n5. There have been some studies that suggest that ASF1 may interact with histones H1 and H2.",
    "vicuna-13b_fact": [
      "ASF1 is a histone chaperone that plays a role in the assembly and disassembly of nucleosome structures.",
      "Histone H1 and histone H2 are two of the five main types of histones found in chromatin.",
      "Histone H1 is involved in the compaction of chromatin and the regulation of gene expression.",
      "Histone H2 is involved in the formation of nucleosome structures.",
      "There have been some studies that suggest that ASF1 may interact with histones H1 and H2."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Histone H2A, H2B, H3 and H4 are the main types of histones found in chromatin. Histone H1 is a linker histone.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2218,
    "user_query": "How many times is CLAST faster than BLAST?",
    "vicuna-13b_response": "CLAST and BLAST are both popular bioinformatics tools used for comparing biological sequences. The number of times CLAST is faster than BLAST depends on various factors such as the size of the sequence database, the length of the query sequence, the type of database search (e.g. exact match, mismatch penalty, etc.), and the computational resources available.\nIn general, CLAST is faster than BLAST for short query sequences because it uses a suffix array data structure to perform database searches, which is more efficient for small queries. However, for longer query sequences, BLAST may be faster as it uses a more powerful algorithm that can handle longer queries.\nIt is also worth noting that there are many different versions of BLAST and CLAST, each with their own performance characteristics. Therefore, the relative performance of CLAST and BLAST can vary depending on the specific tools and parameters used.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CLAST and BLAST are bioinformatics tools used for comparing biological sequences.\n2. The speed of CLAST and BLAST depends on factors such as the size of the sequence database, the length of the query sequence, the type of database search, and computational resources available.\n3. CLAST is generally faster than BLAST for short query sequences due to its use of a suffix array data structure.\n4. For long query sequences, BLAST may be faster as it uses a powerful algorithm that can handle longer queries.\n5. There are many different versions of BLAST and CLAST, each with their own performance characteristics.",
    "vicuna-13b_fact": [
      "CLAST and BLAST are bioinformatics tools used for comparing biological sequences.",
      "The speed of CLAST and BLAST depends on factors such as the size of the sequence database, the length of the query sequence, the type of database search, and computational resources available.",
      "CLAST is generally faster than BLAST for short query sequences due to its use of a suffix array data structure.",
      "For long query sequences, BLAST may be faster as it uses a powerful algorithm that can handle longer queries.",
      "There are many different versions of BLAST and CLAST, each with their own performance characteristics."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2221,
    "user_query": "Which tool is used for the identification of recurrent variants in noncoding regions?",
    "vicuna-13b_response": "There are several tools that can be used for the identification of recurrent variants in noncoding regions. Some of the commonly used tools are:\n1. Breakpoint software: Breakpoint is a bioinformatics tool that can be used to identify the breakpoints of structural variants, including deletions and duplications, in genomic regions. It can also be used to identify the genes and functional elements that are disrupted by these structural variants.\n2. Sensible genomics: Sensible genomics is a web-based tool that can be used to identify recurrent variants in noncoding regions. It uses a combination of statistical analysis and machine learning algorithms to identify the most likely causal variants in a given dataset.\n3. GATK: The Genome Analysis Toolkit (GATK) is a widely used bioinformatics tool that can be used for the analysis of genomic data. It includes several tools that can be used for the identification of recurrent variants in noncoding regions, including the HaplotypeCaller, which can be used to identify the genotypes of variants in a given dataset, and the VariantEval tool, which can be used to evaluate the potential impact of variants on gene function.\n4. DeepVariant: DeepVariant is a bioinformatics tool that can be used to analyze genomic sequencing data and identify rare and low-frequency variants. It uses a deep learning approach to detect variants that may be missed by traditional methods, and can be used to identify recurrent variants in noncoding regions.\nThese are just a few examples of the tools that can be used for the identification of recurrent variants in noncoding regions. The choice of tool will depend on the specific needs of the research question and the available resources.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Breakpoint is a bioinformatics tool that can identify the breakpoints of structural variants in genomic regions.\n2. Sensible genomics is a web-based tool that can identify recurrent variants in noncoding regions.\n3. The Genome Analysis Toolkit (GATK) is a widely used bioinformatics tool for the analysis of genomic data.\n4. The HaplotypeCaller and the VariantEval tool are part of GATK and can be used for the identification of recurrent variants in noncoding regions.\n5. DeepVariant is a bioinformatics tool that can analyze genomic sequencing data and identify rare and low-frequency variants.",
    "vicuna-13b_fact": [
      "Breakpoint is a bioinformatics tool that can identify the breakpoints of structural variants in genomic regions.",
      "Sensible genomics is a web-based tool that can identify recurrent variants in noncoding regions.",
      "The Genome Analysis Toolkit (GATK) is a widely used bioinformatics tool for the analysis of genomic data.",
      "The HaplotypeCaller and the VariantEval tool are part of GATK and can be used for the identification of recurrent variants in noncoding regions.",
      "DeepVariant is a bioinformatics tool that can analyze genomic sequencing data and identify rare and low-frequency variants."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. FALSE [correction]: The HaplotypeCaller and the VariantEval tool are part of GATK and can be used for variant discovery and genotyping.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2222,
    "user_query": "What body parts are also known as phalanges?",
    "vicuna-13b_response": "The phalanges are the bones of the fingers and toes in the human body. There are 14 phalanges in each hand and foot, with three phalanges in each finger and toe. The phalanges are categorized as the distal, middle, and proximal phalanges. The distal phalanges are the bones closest to the nail, the middle phalanges are the bones in the middle of the finger or toe, and the proximal phalanges are the bones closest to the body.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Phalanges are the bones of the fingers and toes in the human body.\n2. There are 14 phalanges in each hand and foot.\n3. There are three phalanges in each finger and toe.\n4. The phalanges are categorized as the distal, middle, and proximal phalanges.\n5. Distal phalanges are the bones closest to the nail, middle phalanges are the bones in the middle of the finger or toe, and proximal phalanges are the bones closest to the body.",
    "vicuna-13b_fact": [
      "Phalanges are the bones of the fingers and toes in the human body.",
      "There are 14 phalanges in each hand and foot.",
      "There are three phalanges in each finger and toe.",
      "The phalanges are categorized as the distal, middle, and proximal phalanges.",
      "Distal phalanges are the bones closest to the nail, middle phalanges are the bones in the middle of the finger or toe, and proximal phalanges are the bones closest to the body."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There are three phalanges in each finger, but only two in the thumb and each toe.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2223,
    "user_query": "Are selenium supplements recommended for prostate cancer prevention?",
    "vicuna-13b_response": "Selenium is a mineral that is essential for good health, and it is found in small amounts in many foods, especially in brazil nuts, tuna, and eggs. Selenium supplements are available and some people take them to boost their selenium intake.\nThere is some evidence that selenium may help to prevent prostate cancer, but the evidence is not conclusive. Some studies have suggested that higher selenium levels may be associated with a lower risk of prostate cancer, while others have found no link.\nThe National Cancer Institute (NCI) states that \"Selenium supplements have not been proven to prevent prostate cancer, and it is not clear if taking selenium supplements would be safe for men who have had prostate cancer or are at risk of developing it.\"\nIt is important to note that selenium supplements should not be used as a substitute for proven methods of prostate cancer prevention, such as regular screenings and a healthy lifestyle. If you are considering taking selenium supplements, it is important to talk to your doctor first, especially if you have a history of prostate cancer or other health conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Selenium is a mineral that is found in small amounts in many foods.\n2. Some studies suggest that higher selenium levels may be associated with a lower risk of prostate cancer, while others have found no link.\n3. The National Cancer Institute states that selenium supplements have not been proven to prevent prostate cancer.\n4. Selenium supplements should not be used as a substitute for proven methods of prostate cancer prevention, such as regular screenings and a healthy lifestyle.\n5. If considering taking selenium supplements, it is important to consult a doctor first, especially if there is a history of prostate cancer or other health conditions.",
    "vicuna-13b_fact": [
      "Selenium is a mineral that is found in small amounts in many foods.",
      "Some studies suggest that higher selenium levels may be associated with a lower risk of prostate cancer, while others have found no link.",
      "The National Cancer Institute states that selenium supplements have not been proven to prevent prostate cancer.",
      "Selenium supplements should not be used as a substitute for proven methods of prostate cancer prevention, such as regular screenings and a healthy lifestyle.",
      "If considering taking selenium supplements, it is important to consult a doctor first, especially if there is a history of prostate cancer or other health conditions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2227,
    "user_query": "Is Downs syndrome associated with decreased risk of leukemia?",
    "vicuna-13b_response": "Down syndrome is a genetic condition that occurs when there is an extra copy of chromosome 21. It is not directly associated with a decreased risk of leukemia. In fact, individuals with Down syndrome have an increased risk of developing certain types of leukemia, specifically acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).\nThe risk of developing leukemia in individuals with Down syndrome is estimated to be about 1 in 20, which is much higher than the general population, where the risk is about 1 in 5000. The reason for this increased risk is not fully understood, but it is thought to be related to the abnormal chromosomal structure and the resulting changes in the development and function of blood cells.\nIt is important to note that not all individuals with Down syndrome will develop leukemia, and not all cases of leukemia in individuals with Down syndrome are related to the genetic condition. However, it is important for individuals with Down syndrome to be closely monitored for the development of leukemia, as early detection and treatment can improve outcomes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Down syndrome is a genetic condition that occurs when there is an extra copy of chromosome 21.\n2. Individuals with Down syndrome have an increased risk of developing certain types of leukemia, specifically acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).\n3. The risk of developing leukemia in individuals with Down syndrome is estimated to be about 1 in 20.\n4. The risk of developing leukemia in the general population is estimated to be about 1 in 5000.\n5. It is possible for individuals with Down syndrome to not develop leukemia.",
    "vicuna-13b_fact": [
      "Down syndrome is a genetic condition that occurs when there is an extra copy of chromosome 21.",
      "Individuals with Down syndrome have an increased risk of developing certain types of leukemia, specifically acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).",
      "The risk of developing leukemia in individuals with Down syndrome is estimated to be about 1 in 20.",
      "The risk of developing leukemia in the general population is estimated to be about 1 in 5000.",
      "It is possible for individuals with Down syndrome to not develop leukemia."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2230,
    "user_query": "Hy's law measures failure for what organ?",
    "vicuna-13b_response": "Hy's law, also known as the \"Law of the Hammer,\" is a principle in emergency medicine that states that the number of patients who present to an emergency department is inversely proportional to the number of available beds. In other words, as the number of beds in an emergency department decreases, the number of patients seeking treatment in that department will increase.\nHy's law is named after Dr. Gordon Hy, an emergency physician who first described the phenomenon in the 1980s. The law is often used to illustrate the concept of emergency department overcrowding, which can lead to delays in treatment and increased risk of medical errors.\nHy's law applies to the organ of the body that is responsible for regulating the circulatory system, which is the heart. The heart is responsible for pumping blood throughout the body, and any disruption in its function can have serious consequences. Emergency departments are designed to provide prompt treatment for patients with acute medical conditions, including those affecting the heart and circulatory system. When emergency departments become overcrowded, as described by Hy's law, patients may experience delays in receiving the care they need, which can have serious consequences for their overall health and well-being.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hy's law, also known as the \"Law of the Hammer,\" is a principle used in emergency medicine.\n2. The principle states that the number of patients who present to an emergency department is inversely proportional to the number of available beds.\n3. Hy's law is named after Dr. Gordon Hy, an emergency physician who first described the phenomenon in the 1980s.\n4. Hy's law is often used to illustrate the concept of emergency department overcrowding.\n5. Hy's law applies to the organ of the body that is responsible for regulating the circulatory system, which is the heart.",
    "vicuna-13b_fact": [
      "Hy's law, also known as the \"Law of the Hammer,\" is a principle used in emergency medicine.",
      "The principle states that the number of patients who present to an emergency department is inversely proportional to the number of available beds.",
      "Hy's law is named after Dr. Gordon Hy, an emergency physician who first described the phenomenon in the 1980s.",
      "Hy's law is often used to illustrate the concept of emergency department overcrowding.",
      "Hy's law applies to the organ of the body that is responsible for regulating the circulatory system, which is the heart."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Hy's law is not known as the \"Law of the Hammer,\" and it is not a principle used in emergency medicine. It is actually a clinical-rule in pharmacology to detect drug-induced liver injury.\n2. FALSE [correction]: Hy's law does not state anything about patient presentation in relation to available beds. Hy's Law is instead about predicting drug-induced liver injury.\n3. UNKNOWN\n4. FALSE [correction]: Hy's law is not used to illustrate the concept of emergency department overcrowding. It's used in clinical trials for detecting drug-induced liver injury.\n5. FALSE [correction]: Hy's law does not apply to the organ of the body that is responsible for regulating the circulatory system, i.e., the heart. It relates to drug-induced liver injury.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "vicuna-13b_response": "There are several R packages that can be used for the identification of pediatric brain tumors. Some of the most commonly used packages include:\n1. \"brain\\_metadata\" - This package provides a set of functions for extracting and analyzing metadata from brain tumor imaging studies, including magnetic resonance imaging (MRI) and computed tomography (CT) scans.\n2. \"rpart\" - This package provides a set of functions for performing recursive partitioning, which is a technique used to classify objects into a set of mutually exclusive classes. Recursive partitioning can be used to identify patterns and relationships in brain tumor data, which can aid in the diagnosis and treatment of pediatric brain tumors.\n3. \"survival\" - This package provides a set of functions for analyzing survival data, which is often used in the study of brain tumors. Survival analysis can be used to estimate the probability of survival for patients with brain tumors, as well as to identify factors that are associated with improved survival.\n4. \"limma\" - This package provides a set of functions for performing linear modeling of microarray data, which can be used to identify genes that are associated with the development of brain tumors in pediatric patients.\nOverall, these packages can be used in combination with other tools and techniques to identify and diagnose pediatric brain tumors. It is important to note that the accuracy of any diagnostic tool depends on the quality and quantity of the available data, as well as the expertise of the person using the tool.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The \"brain\\_metadata\" R package can be used for extracting and analyzing metadata from brain tumor imaging studies.\n2. \"rpart\" is an R package that provides functions for performing recursive partitioning and can be used with brain tumor data.\n3. The \"survival\" R package is used for analyzing survival data.\n4. The \"limma\" R package is used for performing linear modeling of microarray data, which can identify genes associated with the development of brain tumors in pediatric patients.\n5. The accuracy of these diagnostic tools depends on the quality and quantity of the available data, and the expertise of the person using the tool.",
    "vicuna-13b_fact": [
      "The \"brain\\_metadata\" R package can be used for extracting and analyzing metadata from brain tumor imaging studies.",
      "\"rpart\" is an R package that provides functions for performing recursive partitioning and can be used with brain tumor data.",
      "The \"survival\" R package is used for analyzing survival data.",
      "The \"limma\" R package is used for performing linear modeling of microarray data, which can identify genes associated with the development of brain tumors in pediatric patients.",
      "The accuracy of these diagnostic tools depends on the quality and quantity of the available data, and the expertise of the person using the tool."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2243,
    "user_query": "Which factors drive replisome disassembly during DNA replication termination and mitosis?",
    "vicuna-13b_response": "During DNA replication termination and mitosis, the replisome disassembles due to several factors. These factors include:\n1. Completion of DNA replication: Once the replication of the DNA is complete, the replisome disassembles.\n2. Changes in the chromatin structure: During mitosis, the chromatin structure undergoes significant changes, which lead to the disassembly of the replisome.\n3. Changes in the level of cyclin-dependent kinase inhibitors: During mitosis, the level of cyclin-dependent kinase inhibitors increases, which leads to the inactivation of the cyclin-dependent kinases that drive the replisome.\n4. Changes in the level of cyclin-dependent kinase activators: During mitosis, the level of cyclin-dependent kinase activators increases, which leads to the activation of the cyclin-dependent kinases that drive the replisome.\n5. Changes in the level of checkpoint proteins: During mitosis, the level of checkpoint proteins increases, which helps to ensure that the replisome disassembles only when the DNA replication is complete.\nOverall, the disassembly of the replisome during DNA replication termination and mitosis is a complex process that is regulated by multiple factors. These factors work together to ensure that the replisome disassembles at the appropriate time and in the appropriate way.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The replisome disassembles after the completion of DNA replication.\n2. Changes in the chromatin structure during mitosis leads to the disassembly of the replisome.\n3. During mitosis, the level of cyclin-dependent kinase inhibitors increases.\n4. During mitosis, there's an increase in the level of cyclin-dependent kinase activators.\n5. In mitosis, the level of checkpoint proteins increases, which ensures the replisome disassembles when the DNA replication is complete.",
    "vicuna-13b_fact": [
      "The replisome disassembles after the completion of DNA replication.",
      "Changes in the chromatin structure during mitosis leads to the disassembly of the replisome.",
      "During mitosis, the level of cyclin-dependent kinase inhibitors increases.",
      "During mitosis, there's an increase in the level of cyclin-dependent kinase activators.",
      "In mitosis, the level of checkpoint proteins increases, which ensures the replisome disassembles when the DNA replication is complete."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2244,
    "user_query": "Does RNA polymerase II have RNA cleavage activity?",
    "vicuna-13b_response": "RNA polymerase II (RNA Pol II) is a key enzyme responsible for transcribing DNA into RNA in eukaryotic cells. While RNA Pol II plays a crucial role in gene expression, it does not have RNA cleavage activity.\nRNA cleavage refers to the process of cutting RNA molecules into smaller pieces. In contrast, RNA polymerase II's function is to synthesize new RNA molecules by adding nucleotides to the template DNA.\nRNA cleavage is typically carried out by different enzymes, such as ribonucleases (RNases), which are specialized proteins that recognize and cleave specific sequences in RNA molecules. In contrast, RNA polymerase II recognizes and binds to specific DNA sequences called promoters, which serve as the starting point for transcription.\nTherefore, while RNA polymerase II is a crucial enzyme for gene expression, it does not have RNA cleavage activity. Instead, RNA cleavage is carried out by different enzymes that recognize and cleave specific RNA molecules.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. RNA polymerase II (RNA Pol II) is an enzyme responsible for transcribing DNA into RNA in eukaryotic cells.\n2. RNA polymerase II does not have RNA cleavage activity.\n3. RNA cleavage is the process of cutting RNA molecules into smaller pieces.\n4. RNA cleavage is typically carried out by enzymes such as ribonucleases (RNases).\n5. RNA polymerase II recognizes and binds to specific DNA sequences called promoters.",
    "vicuna-13b_fact": [
      "RNA polymerase II (RNA Pol II) is an enzyme responsible for transcribing DNA into RNA in eukaryotic cells.",
      "RNA polymerase II does not have RNA cleavage activity.",
      "RNA cleavage is the process of cutting RNA molecules into smaller pieces.",
      "RNA cleavage is typically carried out by enzymes such as ribonucleases (RNases).",
      "RNA polymerase II recognizes and binds to specific DNA sequences called promoters."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2245,
    "user_query": "Is there a sequence bias in MNase digestion patterns?",
    "vicuna-13b_response": "MNase (Micrococcal Nuclease) is an enzyme that digests DNA by breaking the phosphodiester bonds between nucleotides. The digestion pattern of MNase is influenced by the sequence of the DNA template, and this can lead to a bias in the digestion pattern.\nThere are two main types of MNase digestion patterns: random and biased. In a random digestion pattern, the enzyme cuts the DNA randomly, without any preference for specific sequences. In a biased digestion pattern, the enzyme prefers to cut the DNA in certain regions, leading to a non-random distribution of cuts.\nThe bias in MNase digestion patterns is influenced by several factors, including the presence of certain sequences in the DNA template, the concentration of the enzyme, and the temperature and pH conditions of the digestion. For example, MNase is known to preferentially cut the DNA in regions with a high concentration of G/C nucleotides, and this can lead to a bias in the digestion pattern.\nOverall, the presence of a bias in MNase digestion patterns can have important implications for downstream applications, such as DNA sequencing and genotyping. It is important to carefully optimize the conditions for MNase digestion to minimize any bias in the digestion pattern and ensure accurate results.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MNase (Micrococcal Nuclease) is an enzyme that digests DNA by breaking phosphodiester bonds between nucleotides.\n2. The digestion pattern of MNase is influenced by the sequence of the DNA template.\n3. There are two main types of MNase digestion patterns: random and biased.\n4. The bias in MNase digestion patterns is influenced by several factors, including the presence of certain sequences in the DNA template, the concentration of the enzyme, and the temperature and pH conditions of the digestion.\n5. MNase is known to preferentially cut the DNA in regions with a high concentration of G/C nucleotides.",
    "vicuna-13b_fact": [
      "MNase (Micrococcal Nuclease) is an enzyme that digests DNA by breaking phosphodiester bonds between nucleotides.",
      "The digestion pattern of MNase is influenced by the sequence of the DNA template.",
      "There are two main types of MNase digestion patterns: random and biased.",
      "The bias in MNase digestion patterns is influenced by several factors, including the presence of certain sequences in the DNA template, the concentration of the enzyme, and the temperature and pH conditions of the digestion.",
      "MNase is known to preferentially cut the DNA in regions with a high concentration of G/C nucleotides."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The digestion pattern of MNase is influenced by the structure of the DNA, notably the compactness of the chromatin, not the sequence of the DNA template.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "vicuna-13b_response": "NEMO (Nuclear Factor of Activated T-Cells, also known as NF-AT) is a transcription factor that plays a role in regulating the expression of genes involved in immune cell function. It is not a zinc finger protein, but it does contain a zinc finger domain, which is a structural motif that is involved in protein-DNA interactions and is found in many transcription factors. The zinc finger domain of NEMO is involved in its binding to specific DNA sequences and regulation of gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. NEMO is also known as Nuclear Factor of Activated T-Cells or NF-AT.\n2. NEMO is a transcription factor that plays a role in regulating the expression of genes involved in immune cell function.\n3. NEMO is not a zinc finger protein.\n4. NEMO does contain a zinc finger domain.\n5. The zinc finger domain of NEMO is involved in its binding to specific DNA sequences and regulation of gene expression.",
    "vicuna-13b_fact": [
      "NEMO is also known as Nuclear Factor of Activated T-Cells or NF-AT.",
      "NEMO is a transcription factor that plays a role in regulating the expression of genes involved in immune cell function.",
      "NEMO is not a zinc finger protein.",
      "NEMO does contain a zinc finger domain.",
      "The zinc finger domain of NEMO is involved in its binding to specific DNA sequences and regulation of gene expression."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: NEMO, an acronym for NF-kappa-B essential modulator, is not also known as Nuclear Factor of Activated T-Cells or NF-AT. NF-AT is a separate protein.\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: NEMO does not contain a zinc-finger domain.\n5. FALSE [correction]: Since NEMO does not contain a zinc finger domain, it does not use such a domain for binding to specific DNA sequences and regulation of gene expression.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "vicuna-13b_response": "TFIIS (Transcription Factor IIS) is a protein that plays a role in the regulation of gene expression by controlling the initiation of transcription. It is not directly involved in the positioning of nucleosomes.\nNucleosomes are the basic units of chromatin, consisting of a DNA molecule wrapped around a histone protein core. The positioning of nucleosomes along the DNA sequence is regulated by various factors, including transcription factors, chromatin-modifying enzymes, and the DNA sequence itself.\nWhile TFIIS is not directly involved in nucleosome positioning, it is known to interact with other proteins that are involved in this process. For example, TFIIS has been shown to interact with the chromatin-modifying enzyme, ISWI (Imitation Switch/Whi5-like histone-binding protein), which is involved in the positioning of nucleosomes and other chromatin structures. Additionally, TFIIS has been shown to interact with the transcription factor, TFIIE, which is involved in the initiation of transcription and can affect nucleosome positioning by controlling the access of other transcription factors to the DNA template.\nIn summary, while TFIIS is not directly involved in nucleosome positioning, it is involved in the regulation of gene expression and can interact with other proteins that are involved in this process.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TFIIS (Transcription Factor IIS) is a protein that plays a role in the regulation of gene expression by controlling the initiation of transcription.\n2. TFIIS is not directly involved in the positioning of nucleosomes.\n3. Nucleosomes are the basic units of chromatin, consisting of a DNA molecule wrapped around a histone protein core.\n4. TFIIS has been shown to interact with the chromatin-modifying enzyme, ISWI.\n5. TFIIS has been shown to interact with the transcription factor, TFIIE.",
    "vicuna-13b_fact": [
      "TFIIS (Transcription Factor IIS) is a protein that plays a role in the regulation of gene expression by controlling the initiation of transcription.",
      "TFIIS is not directly involved in the positioning of nucleosomes.",
      "Nucleosomes are the basic units of chromatin, consisting of a DNA molecule wrapped around a histone protein core.",
      "TFIIS has been shown to interact with the chromatin-modifying enzyme, ISWI.",
      "TFIIS has been shown to interact with the transcription factor, TFIIE."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2250,
    "user_query": "What is metaSPAdes?",
    "vicuna-13b_response": "MetaSPAdes is a software tool that is used for analyzing and comparing the performance of different machine learning models. It is a web-based platform that provides a user-friendly interface for evaluating the performance of machine learning models using various metrics and visualization tools.\nMetaSPAdes allows users to compare the performance of different models on the same dataset, which can be useful for selecting the best model for a particular task. It provides a range of performance metrics, including accuracy, precision, recall, F1 score, and area under the receiver operating characteristic (ROC) curve.\nIn addition to these metrics, MetaSPAdes also provides a range of visualization tools that can help users understand the performance of their models. These tools include confusion matrices, ROC curves, and precision-recall curves, which can provide insights into how well the models are performing on different subsets of the data.\nOverall, MetaSPAdes is a powerful tool for evaluating and comparing the performance of machine learning models, and can be useful for researchers, practitioners, and students in the field of machine learning.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MetaSPAdes is a software tool used for analyzing and comparing the performance of different machine learning models.\n2. MetaSPAdes is a web-based platform.\n3. The platform provides various metrics for evaluating the performance of machine learning models such as accuracy, precision, recall, F1 score, and area under the ROC curve.\n4. Visualization tools provided by MetaSPAdes include confusion matrices, ROC curves, and precision-recall curves.\n5. MetaSPAdes allows users to compare the performance of different models on the same dataset.",
    "vicuna-13b_fact": [
      "MetaSPAdes is a software tool used for analyzing and comparing the performance of different machine learning models.",
      "MetaSPAdes is a web-based platform.",
      "The platform provides various metrics for evaluating the performance of machine learning models such as accuracy, precision, recall, F1 score, and area under the ROC curve.",
      "Visualization tools provided by MetaSPAdes include confusion matrices, ROC curves, and precision-recall curves.",
      "MetaSPAdes allows users to compare the performance of different models on the same dataset."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: MetaSPAdes is a software tool used for genome assembly from metagenomic data.\n2. FALSE [correction]: MetaSPAdes is not a web-based platform, it is a software tool.\n3. FALSE [correction]: MetaSPAdes does not provide metrics for evaluating the performance of machine learning models as it is not a machine learning tool.\n4. FALSE [correction]: MetaSPAdes does not provide visualization tools for confusion matrices, ROC curves, and precision-recall curves as it is not a machine learning tool.\n5. FALSE [correction]: MetaSPAdes does not allow users to compare the performance of different models on the same dataset, as it is focused on metagenomic data assembly.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2257,
    "user_query": "What is the difference between ganglion mother cells (GMC) and intermediate neural precursor cells (INP) in Drosophila?",
    "vicuna-13b_response": "Ganglion mother cells (GMCs) and intermediate neural precursor cells (INPs) are two types of neural precursor cells that play important roles in the development of the nervous system in Drosophila.\nGMCs are a specific type of neural stem cell that give rise to all of the neurons in the peripheral nervous system of Drosophila. They are characterized by their expression of the transcription factor \"NeuroD\" and are responsible for the generation of a diverse array of neuronal cell types.\nINPs, on the other hand, are a more general category of neural precursor cells that give rise to a variety of different neural cell types, including neurons and glial cells. INPs are characterized by their expression of the transcription factor \"Early Neural Fate Maker\" (ENFM) and are involved in the development of the central nervous system as well as the peripheral nervous system.\nIn summary, GMCs are a specific type of neural stem cell that give rise to all of the neurons in the peripheral nervous system, while INPs are a more general category of neural precursor cells that give rise to a variety of different neural cell types.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ganglion mother cells (GMCs) and intermediate neural precursor cells (INPs) are types of neural precursor cells in Drosophila.\n2. GMCs give rise to all of the neurons in the peripheral nervous system of Drosophila.\n3. GMCs are marked by the expression of the transcription factor \"NeuroD\".\n4. INPs give rise to a variety of different neural cell types, including neurons and glial cells.\n5. INPs express the transcription factor \"Early Neural Fate Maker\" (ENFM) and partake in the development of both the central and peripheral nervous system.",
    "vicuna-13b_fact": [
      "Ganglion mother cells (GMCs) and intermediate neural precursor cells (INPs) are types of neural precursor cells in Drosophila.",
      "GMCs give rise to all of the neurons in the peripheral nervous system of Drosophila.",
      "GMCs are marked by the expression of the transcription factor \"NeuroD\".",
      "INPs give rise to a variety of different neural cell types, including neurons and glial cells.",
      "INPs express the transcription factor \"Early Neural Fate Maker\" (ENFM) and partake in the development of both the central and peripheral nervous system."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: GMCs give rise only to neurons and glial cells of the central nervous system of Drosophila.\n3. UNKNOWN \n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "vicuna-13b_response": "The origins of replication close to yeast centromeres can fire either early or late during the cell cycle, depending on the specific conditions and the genetic background of the yeast strain.\nIn general, the firing of origins of replication is regulated by a complex network of signaling pathways and checkpoint mechanisms that ensure proper chromosome segregation and prevent aneuploidy. In yeast, the decision to initiate DNA replication at a specific origin is influenced by a variety of factors, including the availability of replication proteins, the level of cyclin-dependent kinase activity, and the presence of specific transcription factors.\nIn some cases, origins of replication close to yeast centromeres may fire early in the cell cycle, when the levels of cyclin-dependent kinase activity are high and the checkpoint mechanisms are less active. This can lead to the initiation of DNA replication before the proper assembly of the replication fork, which can result in errors and potentially lead to aneuploidy.\nIn other cases, origins of replication close to yeast centromeres may fire late in the cell cycle, when the levels of cyclin-dependent kinase activity are low and the checkpoint mechanisms are more active. This can lead to the initiation of DNA replication after the proper assembly of the replication fork, which can result in more accurate and efficient DNA replication.\nOverall, the firing of origins of replication close to yeast centromeres is a complex process that is influenced by a variety of factors, and the specific timing of replication initiation can vary depending on the genetic background and the specific conditions of the yeast strain.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The origins of replication close to yeast centromeres can fire either early or late during the cell cycle.\n2. The firing of origins of replication is regulated by signaling pathways and checkpoint mechanisms.\n3. In yeast, initiating DNA replication at a specific origin is influenced by the availability of replication proteins, the level of cyclin-dependent kinase activity, and the presence of specific transcription factors.\n4. Origins of replication close to yeast centromeres may fire early when the levels of cyclin-dependent kinase activity are high and the checkpoint mechanisms are less active.\n5. Origins of replication close to yeast centromeres may fire late when the levels of cyclin-dependent kinase activity are low and the checkpoint mechanisms are more active.",
    "vicuna-13b_fact": [
      "The origins of replication close to yeast centromeres can fire either early or late during the cell cycle.",
      "The firing of origins of replication is regulated by signaling pathways and checkpoint mechanisms.",
      "In yeast, initiating DNA replication at a specific origin is influenced by the availability of replication proteins, the level of cyclin-dependent kinase activity, and the presence of specific transcription factors.",
      "Origins of replication close to yeast centromeres may fire early when the levels of cyclin-dependent kinase activity are high and the checkpoint mechanisms are less active.",
      "Origins of replication close to yeast centromeres may fire late when the levels of cyclin-dependent kinase activity are low and the checkpoint mechanisms are more active."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "vicuna-13b_response": "GA-sequences are a type of non-coding RNA that play important roles in gene regulation in mammalian cells. Some of the properties of mammalian GA-sequences include:\n1. Structure: GA-sequences are typically around 200 nucleotides in length and contain a single stem-loop structure.\n2. Localization: GA-sequences are typically found in the 3' untranslated region (3' UTR) of mRNA molecules and can act as microRNA (miRNA) precursors.\n3. Function: GA-sequences can act as miRNA precursors, which means they can be processed by the cell's miRNA biogenesis machinery to produce mature miRNA molecules that can regulate gene expression.\n4. Diversity: There are many different GA-sequence variants in mammalian cells, which can be generated through a process called alternative processing.\n5. Regulation: The expression and processing of GA-sequences can be regulated by a variety of factors, including cell type, developmental stage, and environmental cues.\nOverall, GA-sequences are important regulators of gene expression in mammalian cells and play a role in a wide range of biological processes, including development, differentiation, and disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GA-sequences are a type of non-coding RNA that play roles in gene regulation in mammalian cells.\n2. GA-sequences are typically around 200 nucleotides in length and contain a single stem-loop structure.\n3. GA-sequences are typically found in the 3' untranslated region (3' UTR) of mRNA molecules and can act as microRNA (miRNA) precursors.\n4. GA-sequences can be processed by the cell's miRNA biogenesis machinery to produce mature miRNA molecules that can regulate gene expression.\n5. There are many different GA-sequence variants in mammalian cells, which can be generated through a process called alternative processing.",
    "vicuna-13b_fact": [
      "GA-sequences are a type of non-coding RNA that play roles in gene regulation in mammalian cells.",
      "GA-sequences are typically around 200 nucleotides in length and contain a single stem-loop structure.",
      "GA-sequences are typically found in the 3' untranslated region (3' UTR) of mRNA molecules and can act as microRNA (miRNA) precursors.",
      "GA-sequences can be processed by the cell's miRNA biogenesis machinery to produce mature miRNA molecules that can regulate gene expression.",
      "There are many different GA-sequence variants in mammalian cells, which can be generated through a process called alternative processing."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2272,
    "user_query": "What is the origin of XUT transcripts in yeast?",
    "vicuna-13b_response": "XUT transcripts are a type of non-coding RNA molecule found in the yeast Saccharomyces cerevisiae. The origin of XUT transcripts in yeast is not well understood, but they are thought to be generated through a process called \"alternative splicing\" of the XUT1 gene.\nAlternative splicing is a mechanism by which a single gene can produce multiple RNA transcripts by using different combinations of exons (the coding regions of a gene) and introns (non-coding regions of a gene). In the case of XUT1, the gene produces two different transcripts, one of which is a functional protein, while the other is a non-coding RNA molecule known as XUT1-AS.\nThe XUT1-AS transcript is generated through the use of alternative splicing sites in the XUT1 gene, which allow for the inclusion or exclusion of specific exons in the final RNA transcript. The XUT1-AS transcript is not translated into a protein, but instead functions as a non-coding RNA molecule with unknown functions.\nIt is thought that the XUT1 gene may play a role in the regulation of gene expression in yeast, but the specific functions of XUT1 and XUT1-AS are not well understood. Further research is needed to fully understand the origin and function of XUT transcripts in yeast.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. XUT transcripts are a type of non-coding RNA molecule found in the yeast Saccharomyces cerevisiae.\n2. The origin of XUT transcripts in yeast is thought to be generated through a process called \"alternative splicing\" of the XUT1 gene.\n3. Alternative splicing is a mechanism by which a single gene can produce multiple RNA transcripts by using different combinations of exons and introns.\n4. The XUT1 gene produces two different transcripts, one of which is a functional protein, while the other is a non-coding RNA molecule known as XUT1-AS.\n5. The XUT1-AS transcript is not translated into a protein, but instead functions as a non-coding RNA molecule with unknown functions.",
    "vicuna-13b_fact": [
      "XUT transcripts are a type of non-coding RNA molecule found in the yeast Saccharomyces cerevisiae.",
      "The origin of XUT transcripts in yeast is thought to be generated through a process called \"alternative splicing\" of the XUT1 gene.",
      "Alternative splicing is a mechanism by which a single gene can produce multiple RNA transcripts by using different combinations of exons and introns.",
      "The XUT1 gene produces two different transcripts, one of which is a functional protein, while the other is a non-coding RNA molecule known as XUT1-AS.",
      "The XUT1-AS transcript is not translated into a protein, but instead functions as a non-coding RNA molecule with unknown functions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2274,
    "user_query": "Is autophagy modulated in a circadian fashion?",
    "vicuna-13b_response": "Autophagy is a cellular process that involves the degradation and recycling of damaged or unnecessary cellular components. The process of autophagy is regulated by a complex network of signaling pathways, and it has been shown to be modulated in a circadian fashion in some cell types.\nCircadian rhythms are natural biological processes that occur in many organisms, including humans, and involve the regulation of physiological and behavioral processes over a 24-hour period. In recent years, there has been growing evidence to suggest that autophagy is also regulated in a circadian fashion.\nStudies in various cell types, including liver, muscle, and neurons, have shown that autophagy is regulated by the circadian clock, with autophagy being highest during the active phase of the circadian cycle and lowest during the resting phase. This circadian regulation of autophagy has been shown to be important for maintaining proper cellular function and preventing the accumulation of damaged or unnecessary cellular components.\nIn addition, there is also evidence to suggest that disruptions to the circadian regulation of autophagy can contribute to the development of various diseases, including metabolic disorders and neurodegenerative diseases.\nOverall, while more research is needed to fully understand the mechanisms underlying the circadian regulation of autophagy, it is clear that this process is important for maintaining proper cellular function and preventing disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Autophagy is a cellular process that involves the degradation and recycling of damaged or unnecessary cellular components.\n2. Autophagy is regulated by a complex network of signaling pathways.\n3. Studies have shown that autophagy is modulated in a circadian fashion in some cell types like liver, muscle, and neurons.\n4. Autophagy is at its highest during the active phase of the circadian cycle and lowest during the resting phase.\n5. Disruptions to the circadian regulation of autophagy can contribute to the development of various diseases, including metabolic disorders and neurodegenerative diseases.",
    "vicuna-13b_fact": [
      "Autophagy is a cellular process that involves the degradation and recycling of damaged or unnecessary cellular components.",
      "Autophagy is regulated by a complex network of signaling pathways.",
      "Studies have shown that autophagy is modulated in a circadian fashion in some cell types like liver, muscle, and neurons.",
      "Autophagy is at its highest during the active phase of the circadian cycle and lowest during the resting phase.",
      "Disruptions to the circadian regulation of autophagy can contribute to the development of various diseases, including metabolic disorders and neurodegenerative diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2275,
    "user_query": "Is Drk essential for anesthesia-resistant memory (ARM) in Drosophila?",
    "vicuna-13b_response": "Drk (Dark) is a gene that encodes for a protein called Drk protein in Drosophila. Drk is involved in various biological processes such as regulation of sleep, circadian rhythm, and neurotransmitter release.\nIn Drosophila, the ARM phenotype is characterized by an increased sensitivity to anesthesia and a reduced response to light. Studies have shown that mutations in the Drk gene can result in a reduction of ARM phenotype, suggesting that Drk is essential for the development of ARM in Drosophila.\nAdditionally, Drk has been shown to regulate the expression of genes involved in the GABAergic neurotransmitter system, which is known to play a role in anesthesia resistance.\nIn summary, Drk is an essential gene for the development of anesthesia-resistant memory in Drosophila, and its function is related to the regulation of sleep, circadian rhythm, and neurotransmitter release.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Drk is a gene in Drosophila that encodes for a protein called Drk protein.\n2. Drk is involved in various biological processes such as regulation of sleep, circadian rhythm, and neurotransmitter release.\n3. Studies have shown that mutations in the Drk gene can result in a reduction of the anesthesia-resistant memory (ARM) phenotype in Drosophila.\n4. Drk has been shown to regulate the expression of genes involved in the GABAergic neurotransmitter system.\n5. The GABAergic neurotransmitter system plays a role in anesthesia resistance.",
    "vicuna-13b_fact": [
      "Drk is a gene in Drosophila that encodes for a protein called Drk protein.",
      "Drk is involved in various biological processes such as regulation of sleep, circadian rhythm, and neurotransmitter release.",
      "Studies have shown that mutations in the Drk gene can result in a reduction of the anesthesia-resistant memory (ARM) phenotype in Drosophila.",
      "Drk has been shown to regulate the expression of genes involved in the GABAergic neurotransmitter system.",
      "The GABAergic neurotransmitter system plays a role in anesthesia resistance."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2284,
    "user_query": "Has IVIG been tested in clinical trials for the treatment of Alzheimer's disease?",
    "vicuna-13b_response": "Yes, IVIG (intravenous immunoglobulin) has been tested in clinical trials for the treatment of Alzheimer's disease. Several small clinical trials have been conducted to evaluate the safety and efficacy of IVIG in patients with Alzheimer's disease, and some of these trials have shown promising results.\nFor example, a small pilot study published in the Journal of Alzheimer's Disease in 2012 found that IVIG treatment was associated with improvements in cognitive function and reductions in beta-amyloid plaques in patients with mild to moderate Alzheimer's disease. Another small trial published in the Journal of Neurology, Neurosurgery, and Psychiatry in 2016 found that IVIG treatment was associated with improvements in cognition and function in patients with Alzheimer's disease.\nHowever, it is important to note that these trials were small and had various limitations, and larger, more rigorous clinical trials are needed to confirm the efficacy and safety of IVIG for the treatment of Alzheimer's disease. Additionally, the exact mechanism of action of IVIG in Alzheimer's disease is not fully understood, and more research is needed to determine how IVIG may impact the progression of the disease.\nOverall, while there is some promising evidence for the use of IVIG in the treatment of Alzheimer's disease, further research is needed to fully understand its potential benefits and risks.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. IVIG (intravenous immunoglobulin) has been tested in clinical trials for the treatment of Alzheimer's disease.\n2. Several small clinical trials have been conducted to evaluate the safety and efficacy of IVIG in patients with Alzheimer's disease.\n3. A pilot study published in the Journal of Alzheimer's Disease in 2012 reported that IVIG treatment led to improvements in cognitive function and reductions in beta-amyloid plaques in patients with mild to moderate Alzheimer's disease.\n4. A trial published in the Journal of Neurology, Neurosurgery, and Psychiatry in 2016 found that IVIG treatment improved cognition and function in patients with Alzheimer's disease.\n5. The exact mechanism of action of IVIG in Alzheimer's disease is still not fully understood.",
    "vicuna-13b_fact": [
      "IVIG (intravenous immunoglobulin) has been tested in clinical trials for the treatment of Alzheimer's disease.",
      "Several small clinical trials have been conducted to evaluate the safety and efficacy of IVIG in patients with Alzheimer's disease.",
      "A pilot study published in the Journal of Alzheimer's Disease in 2012 reported that IVIG treatment led to improvements in cognitive function and reductions in beta-amyloid plaques in patients with mild to moderate Alzheimer's disease.",
      "A trial published in the Journal of Neurology, Neurosurgery, and Psychiatry in 2016 found that IVIG treatment improved cognition and function in patients with Alzheimer's disease.",
      "The exact mechanism of action of IVIG in Alzheimer's disease is still not fully understood."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2285,
    "user_query": "Which type of urinary incontinence is diagnosed with the Q tip test?",
    "vicuna-13b_response": "The Q tip test is a diagnostic test used to evaluate stress incontinence, which is a type of urinary incontinence that occurs when there is a weakness or instability of the muscles and ligaments that support the bladder and urethra. During the test, a Q-tip is inserted into the vagina and pressure is applied to the urethra while the patient is lying down and then standing up. The test is used to assess the strength of the muscles that help to hold the bladder in place.\nThe Q-tip test is a simple, non-invasive test that can be performed in a doctor's office or clinic. It is usually performed after other diagnostic tests such as a urine test and a physical examination. The test is usually performed in women who are experiencing stress incontinence, which is a common type of urinary incontinence that occurs when there is a weakness or instability of the muscles and ligaments that support the bladder and urethra.\nIt is important to note that the Q-tip test is not a definitive test for stress incontinence and other tests such as urethral pressure profilometry (UPP) or cystometry may be needed to confirm the diagnosis.\nIn summary, the Q tip test is used to diagnose stress incontinence, which is a type of urinary incontinence that occurs when there is a weakness or instability of the muscles and ligaments that support the bladder and urethra. The test is a simple, non-invasive test that can be performed in a doctor's office or clinic and it is usually performed after other diagnostic tests such as a urine test and a physical examination.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Q-tip test is a diagnostic test used to evaluate stress incontinence.\n2. Stress incontinence is a type of urinary incontinence that occurs when there is a weakness or instability of the muscles and ligaments that support the bladder and urethra.\n3. During the Q-tip test, a Q-tip is inserted into the vagina and pressure is applied to the urethra while the patient is lying down and then standing up.\n4. The Q-tip test is a simple, non-invasive test that can be performed in a doctor's office or clinic.\n5. The Q-tip test is usually performed after other diagnostic tests such as a urine test and a physical examination.",
    "vicuna-13b_fact": [
      "The Q-tip test is a diagnostic test used to evaluate stress incontinence.",
      "Stress incontinence is a type of urinary incontinence that occurs when there is a weakness or instability of the muscles and ligaments that support the bladder and urethra.",
      "During the Q-tip test, a Q-tip is inserted into the vagina and pressure is applied to the urethra while the patient is lying down and then standing up.",
      "The Q-tip test is a simple, non-invasive test that can be performed in a doctor's office or clinic.",
      "The Q-tip test is usually performed after other diagnostic tests such as a urine test and a physical examination."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: During the Q-tip test, a Q-tip is inserted into the urethra and the angle of the Q-tip is measured while the patient is lying down and then standing up.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2295,
    "user_query": "Which are the main manifestations of Ohdo syndrome?",
    "vicuna-13b_response": "Ohdo syndrome is a rare genetic disorder that is characterized by a variety of symptoms. The main manifestations of Ohdo syndrome include:\n1. Intellectual disability: People with Ohdo syndrome often have a mild to moderate intellectual disability, which can range from borderline intelligence to severe mental retardation.\n2. Facial features: People with Ohdo syndrome may have distinctive facial features, including a flat face with a broad forehead, a small chin, and a prominent nose.\n3. Skeletal abnormalities: Ohdo syndrome can cause a range of skeletal abnormalities, including short stature, a broad pelvis, and a deformity of the spine called kyphoscoliosis.\n4. Heart defects: Some people with Ohdo syndrome may have heart defects, such as a hole in the heart or an abnormal connection between the heart and the lung arteries.\n5. Kidney problems: People with Ohdo syndrome may have kidney problems, such as small kidneys or a condition called nephrotic syndrome, which causes the kidneys to leak protein.\n6. Other symptoms: Ohdo syndrome can also cause a range of other symptoms, including hearing loss, vision problems, and gastrointestinal problems.\nIt's important to note that not everyone with Ohdo syndrome will have all of these symptoms, and the severity of the symptoms can vary from person to person. If you have concerns about Ohdo syndrome or think you may be affected, it's important to speak with a healthcare provider for a proper diagnosis and treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ohdo syndrome is a rare genetic disorder.\n2. Intellectual disability is a main manifestation of Ohdo syndrome.\n3. Distinctive facial features can be a symptom of Ohdo syndrome.\n4. Ohdo syndrome can cause skeletal abnormalities.\n5. Some people with Ohdo syndrome may have heart defects and kidney problems.\n6. Symptoms of Ohdo syndrome can also include hearing loss, vision problems, and gastrointestinal problems.",
    "vicuna-13b_fact": [
      "Ohdo syndrome is a rare genetic disorder.",
      "Intellectual disability is a main manifestation of Ohdo syndrome.",
      "Distinctive facial features can be a symptom of Ohdo syndrome.",
      "Ohdo syndrome can cause skeletal abnormalities.",
      "Some people with Ohdo syndrome may have heart defects and kidney problems.",
      "Symptoms of Ohdo syndrome can also include hearing loss, vision problems, and gastrointestinal problems."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2296,
    "user_query": "Which algorithm is used by the UCSC Genome Browser?",
    "vicuna-13b_response": "The UCSC Genome Browser uses a number of algorithms to visualize and analyze genomic data. Some of the key algorithms used by the UCSC Genome Browser include:\n1. BLAT (BLAST-like alignment tool): BLAT is a fast and efficient algorithm for aligning large sets of sequences against a reference genome. It is used by the UCSC Genome Browser to align genomic sequences to the reference genome and to identify the locations of genes, transcripts, and other features on the genome.\n2. BWA (Burrows-Wheeler Alignment): BWA is a fast and efficient algorithm for aligning sequences against a reference genome. It is used by the UCSC Genome Browser to align genomic sequences to the reference genome and to identify the locations of genes, transcripts, and other features on the genome.\n3. GSNAP (Genomic Short-read Nucleotide Alignment Program): GSNAP is a fast and efficient algorithm for aligning short-read sequences against a reference genome. It is used by the UCSC Genome Browser to align genomic sequences to the reference genome and to identify the locations of genes, transcripts, and other features on the genome.\n4. SAMtools: SAMtools is a set of tools for aligning, sorting, and marking up genomic sequences. It is used by the UCSC Genome Browser to perform a variety of tasks, including aligning genomic sequences to the reference genome, identifying the locations of genes, transcripts, and other features on the genome, and generating summary statistics about the genomic data.\nOverall, the UCSC Genome Browser uses a variety of algorithms to visualize and analyze genomic data, including BLAT, BWA, GSNAP, and SAMtools. These algorithms are designed to be fast and efficient, allowing the UCSC Genome Browser to handle large amounts of data and provide users with a powerful tool for exploring the genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The UCSC Genome Browser uses a variety of algorithms to visualize and analyze genomic data.\n2. One of the algorithms used by the UCSC Genome Browser is BLAT (BLAST-like alignment tool), which is used for aligning large sets of sequences against a reference genome.\n3. The UCSC Genome Browser also uses BWA (Burrows-Wheeler Alignment) for aligning sequences against a reference genome.\n4. GSNAP (Genomic Short-read Nucleotide Alignment Program) is another algorithm used by the UCSC Genome Browser for aligning short-read sequences against a reference genome.\n5. The UCSC Genome Browser uses SAMtools, a set of tools for aligning, sorting, and marking up genomic sequences.",
    "vicuna-13b_fact": [
      "The UCSC Genome Browser uses a variety of algorithms to visualize and analyze genomic data.",
      "One of the algorithms used by the UCSC Genome Browser is BLAT (BLAST-like alignment tool), which is used for aligning large sets of sequences against a reference genome.",
      "The UCSC Genome Browser also uses BWA (Burrows-Wheeler Alignment) for aligning sequences against a reference genome.",
      "GSNAP (Genomic Short-read Nucleotide Alignment Program) is another algorithm used by the UCSC Genome Browser for aligning short-read sequences against a reference genome.",
      "The UCSC Genome Browser uses SAMtools, a set of tools for aligning, sorting, and marking up genomic sequences."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The UCSC Genome Browser does not use BWA (Burrows-Wheeler Alignment). BWA is a software package for mapping low-divergent sequences against a large reference genome.\n4. FALSE [correction]: The UCSC Genome Browser does not use GSNAP (Genomic Short-read Nucleotide Alignment Program). GSNAP is a separate genome sequence alignment software.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2298,
    "user_query": "Which gene is the paralog of yeast UPC2?",
    "vicuna-13b_response": "The paralog of yeast UPC2 is unknown. UPC2 is a gene that is specific to the yeast Saccharomyces cerevisiae and does not have a paralog in this organism.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The paralog of yeast UPC2 is unknown.\n2. UPC2 is a gene that is specific to the yeast Saccharomyces cerevisiae.\n3. UPC2 does not have a paralog in Saccharomyces cerevisiae.",
    "vicuna-13b_fact": [
      "The paralog of yeast UPC2 is unknown.",
      "UPC2 is a gene that is specific to the yeast Saccharomyces cerevisiae.",
      "UPC2 does not have a paralog in Saccharomyces cerevisiae."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: UPC2 does have a paralog in Saccharomyces cerevisiae, it is Ecm22.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 2299,
    "user_query": "Where is the enzyme PM20D1 localized?",
    "vicuna-13b_response": "PM20D1 is an enzyme that is involved in the biosynthesis of the amino acid phenylalanine. It is localized in the cytosol of bacteria, where it catalyzes the conversion of L-tyrosine to L-phenylalanine. PM20D1 is a member of the phenylalanine ammonia-lyase family of enzymes, which are involved in the degradation or biosynthesis of aromatic amino acids.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PM20D1 is an enzyme involved in the biosynthesis of the amino acid phenylalanine.\n2. PM20D1 is localized in the cytosol of bacteria.\n3. PM20D1 catalyzes the conversion of L-tyrosine to L-phenylalanine.\n4. PM20D1 is a member of the phenylalanine ammonia-lyase family of enzymes.\n5. The phenylalanine ammonia-lyase family of enzymes are involved in the degradation or biosynthesis of aromatic amino acids.",
    "vicuna-13b_fact": [
      "PM20D1 is an enzyme involved in the biosynthesis of the amino acid phenylalanine.",
      "PM20D1 is localized in the cytosol of bacteria.",
      "PM20D1 catalyzes the conversion of L-tyrosine to L-phenylalanine.",
      "PM20D1 is a member of the phenylalanine ammonia-lyase family of enzymes.",
      "The phenylalanine ammonia-lyase family of enzymes are involved in the degradation or biosynthesis of aromatic amino acids."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2301,
    "user_query": "How does increased GDF15 affect body weight?",
    "vicuna-13b_response": "GDF15 (Growth Differentiation Factor 15) is a protein that is involved in various biological processes, including bone growth and development, inflammation, and metabolism. Recent studies have suggested that GDF15 may also play a role in regulating body weight.\nIncreased levels of GDF15 have been associated with an increased risk of obesity and metabolic disorders, such as type 2 diabetes. This suggests that GDF15 may contribute to the development of these conditions by affecting energy balance and metabolism.\nOne potential mechanism by which GDF15 may affect body weight is by regulating the production and release of energy-containing molecules, such as glucose and fatty acids. GDF15 may also affect the body's ability to store and use these energy molecules, leading to changes in body weight.\nAdditionally, GDF15 may affect appetite and food intake, potentially leading to an increased caloric intake and weight gain. However, the exact mechanisms by which GDF15 affects body weight are not fully understood and are the subject of ongoing research.\nOverall, while the role of GDF15 in regulating body weight is still being studied, there is evidence to suggest that increased levels of this protein may contribute to the development of obesity and related metabolic disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GDF15 (Growth Differentiation Factor 15) is a protein that is involved in various biological processes, including bone growth and development, inflammation, and metabolism.\n2. Recent studies have suggested that GDF15 may play a role in regulating body weight.\n3. Increased levels of GDF15 have been associated with an increased risk of obesity and metabolic disorders, such as type 2 diabetes.\n4. One potential mechanism by which GDF15 may affect body weight is by regulating the production and release of energy-containing molecules.\n5. GDF15 may affect appetite and food intake.",
    "vicuna-13b_fact": [
      "GDF15 (Growth Differentiation Factor 15) is a protein that is involved in various biological processes, including bone growth and development, inflammation, and metabolism.",
      "Recent studies have suggested that GDF15 may play a role in regulating body weight.",
      "Increased levels of GDF15 have been associated with an increased risk of obesity and metabolic disorders, such as type 2 diabetes.",
      "One potential mechanism by which GDF15 may affect body weight is by regulating the production and release of energy-containing molecules.",
      "GDF15 may affect appetite and food intake."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Increased levels of GDF15 have been associated with weight loss and various diseases, not an increase in obesity.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "vicuna-13b_response": "RNA cleavage activity is not a function of RNA polymerase II subunits. RNA cleavage is typically carried out by enzymes such as RNases, which are responsible for cleaving RNA molecules. RNA polymerase II is an enzyme that is responsible for transcribing DNA into RNA. It is composed of several subunits, including a large catalytic subunit (Pol II) and several regulatory subunits. The regulatory subunits play a role in controlling the activity of Pol II and the specific genes that are transcribed. However, they do not have RNA cleavage activity.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. RNA cleavage activity is not a function of RNA polymerase II subunits. \n2. RNA cleavage is typically carried out by enzymes such as RNases.\n3. RNA polymerase II is an enzyme that is responsible for transcribing DNA into RNA.\n4. RNA polymerase II is composed of several subunits, including a large catalytic subunit (Pol II) and several regulatory subunits.\n5. The regulatory subunits of RNA polymerase II play a role in controlling the activity of Pol II and the specific genes that are transcribed.",
    "vicuna-13b_fact": [
      "RNA cleavage activity is not a function of RNA polymerase II subunits.",
      "RNA cleavage is typically carried out by enzymes such as RNases.",
      "RNA polymerase II is an enzyme that is responsible for transcribing DNA into RNA.",
      "RNA polymerase II is composed of several subunits, including a large catalytic subunit (Pol II) and several regulatory subunits.",
      "The regulatory subunits of RNA polymerase II play a role in controlling the activity of Pol II and the specific genes that are transcribed."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2306,
    "user_query": "How many PML isoforms exist in the human genome?",
    "vicuna-13b_response": "PML (Promyelocytic Leukemia) is a single-stranded RNA virus that infects plants. It does not exist in the human genome. Therefore, there are no PML isoforms in the human genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PML (Promyelocytic Leukemia) is a single-stranded RNA virus.\n2. PML infects plants.\n3. PML does not exist in the human genome.\n4. There are no PML isoforms in the human genome.",
    "vicuna-13b_fact": [
      "PML (Promyelocytic Leukemia) is a single-stranded RNA virus.",
      "PML infects plants.",
      "PML does not exist in the human genome.",
      "There are no PML isoforms in the human genome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: PML (Promyelocytic Leukemia) is not a single-stranded RNA virus. It is a gene that produces a protein involved in many cellular processes such as cell growth and division or the response to stress.\n2. FALSE [correction]: PML does not infect plants. It is associated with humans and related to Promyelocytic Leukemia.\n3. FALSE [correction]: PML does exist in the human genome. It is a gene situated on chromosome 15q24.\n4. FALSE [correction]: There are various isoforms of PML in the human genome, which are created through alternative splicing.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2312,
    "user_query": "Which tendons are affected in the Dequervain's tenosynovitis?",
    "vicuna-13b_response": "Dequervain's tenosynovitis is a condition that affects the tendons and synovial sheaths in the hand. Specifically, it affects the tendons of the thumb and index finger, which are located in the palm side of the hand. The tendons in question are the tendons of the abductor pollicis brevis and the tendons of the extensor pollicis brevis. These tendons work together to allow the thumb to move and grip objects. Inflammation and swelling of the tendons and synovial sheaths can cause pain and difficulty moving the thumb.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dequervain's tenosynovitis is a condition that affects the tendons and synovial sheaths in the hand.\n2. Dequervain's tenosynovitis specifically affects the tendons of the thumb and index finger.\n3. The tendons affected by Dequervain's tenosynovitis are the tendons of the abductor pollicis brevis and the extensor pollicis brevis.\n4. The abductor pollicis brevis and extensor pollicis brevis tendons work together to allow the thumb to move and grip objects.\n5. Inflammation and swelling of the tendons and synovial sheaths in Dequervain's tenosynovitis can cause pain and difficulty moving the thumb.",
    "vicuna-13b_fact": [
      "Dequervain's tenosynovitis is a condition that affects the tendons and synovial sheaths in the hand.",
      "Dequervain's tenosynovitis specifically affects the tendons of the thumb and index finger.",
      "The tendons affected by Dequervain's tenosynovitis are the tendons of the abductor pollicis brevis and the extensor pollicis brevis.",
      "The abductor pollicis brevis and extensor pollicis brevis tendons work together to allow the thumb to move and grip objects.",
      "Inflammation and swelling of the tendons and synovial sheaths in Dequervain's tenosynovitis can cause pain and difficulty moving the thumb."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Dequervain's tenosynovitis specifically affects the tendons of the thumb and the wrist, not the index finger.\n3. FALSE [correction]: The tendons affected by Dequervain's tenosynovitis are the tendons of the abductor pollicis longus and the extensor pollicis brevis.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2314,
    "user_query": "What does davunetide do to microtubules?",
    "vicuna-13b_response": "Davunetide is a synthetic peptide that is known to affect the dynamics of microtubules. It is composed of 31 amino acids and is structurally related to the microtubule-binding domain of the protein tyrosine kinase receptor c-Abl.\nDavunetide has been shown to inhibit the growth of microtubules in a dose-dependent manner, and it can also induce the depolymerization of preformed microtubules. This effect is thought to be due to the ability of davunetide to bind to microtubules and disrupt their dynamics.\nIn addition to its effects on microtubules, davunetide has also been shown to have anti-proliferative and pro-apoptotic effects on cancer cells, making it a potential therapeutic agent for the treatment of cancer. However, further research is needed to fully understand the mechanisms by which davunetide exerts its effects and to determine its potential as a therapeutic agent.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Davunetide is a synthetic peptide that affects the dynamics of microtubules.\n2. Davunetide is composed of 31 amino acids.\n3. Davunetide is structurally related to the microtubule-binding domain of the protein tyrosine kinase receptor c-Abl.\n4. Davunetide can inhibit the growth of microtubules and induced the depolymerization of preformed microtubules.\n5. Davunetide has shown anti-proliferative and pro-apoptotic effects on cancer cells.",
    "vicuna-13b_fact": [
      "Davunetide is a synthetic peptide that affects the dynamics of microtubules.",
      "Davunetide is composed of 31 amino acids.",
      "Davunetide is structurally related to the microtubule-binding domain of the protein tyrosine kinase receptor c-Abl.",
      "Davunetide can inhibit the growth of microtubules and induced the depolymerization of preformed microtubules.",
      "Davunetide has shown anti-proliferative and pro-apoptotic effects on cancer cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Davunetide is composed of eight amino acids.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2317,
    "user_query": "Which proteins are controlling sterol metabolism in S. cerevisiae?",
    "vicuna-13b_response": "In the yeast Saccharomyces cerevisiae, several proteins are involved in controlling sterol metabolism. These include:\n1. SREBP (Sterol Regulatory Element-Binding Protein) transcription factors, which regulate the expression of genes involved in sterol biosynthesis and uptake.\n2. HMG-CoA reductase, an enzyme involved in the production of mevalonate, a key intermediate in cholesterol biosynthesis.\n3. 3-hydroxy-3-methylglutaryl-CoA synthase, an enzyme involved in the production of mevalonate from acetyl-CoA.\n4. Cholesterol ester transfer protein (CETP), which facilitates the transfer of cholesterol from high-density lipoproteins to apolipoprotein B-100 for secretion.\n5. Cytochrome P450 enzymes, which are involved in the conversion of cholesterol to bile acids and other steroids.\n6. Sterol uptake transporters, such as the sterol-binding protein Stp2, which facilitate the uptake of cholesterol from the extracellular environment.\nThese proteins work together to regulate sterol metabolism in S. cerevisiae, ensuring that the yeast has sufficient levels of sterols for membrane synthesis and other essential functions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. In the yeast Saccharomyces cerevisiae, several proteins control sterol metabolism.\n2. SREBP transcription factors regulate the expression of genes involved in sterol biosynthesis and uptake in Saccharomyces cerevisiae.\n3. HMG-CoA reductase is involved in the production of mevalonate and contributes to sterol metabolism in Saccharomyces cerevisiae.\n4. 3-hydroxy-3-methylglutaryl-CoA synthase is involved in the production of mevalonate from acetyl-CoA.\n5. Sterol uptake transporters, such as the sterol-binding protein Stp2, facilitate the uptake of cholesterol from the extracellular environment in Saccharomyces cerevisiae. \n6. Cytochrome P450 enzymes contribute to sterol metabolism in Saccharomyces cerevisiae by converting cholesterol to bile acids and other steroids.",
    "vicuna-13b_fact": [
      "In the yeast Saccharomyces cerevisiae, several proteins control sterol metabolism.",
      "SREBP transcription factors regulate the expression of genes involved in sterol biosynthesis and uptake in Saccharomyces cerevisiae.",
      "HMG-CoA reductase is involved in the production of mevalonate and contributes to sterol metabolism in Saccharomyces cerevisiae.",
      "3-hydroxy-3-methylglutaryl-CoA synthase is involved in the production of mevalonate from acetyl-CoA.",
      "Sterol uptake transporters, such as the sterol-binding protein Stp2, facilitate the uptake of cholesterol from the extracellular environment in Saccharomyces cerevisiae.",
      "Cytochrome P450 enzymes contribute to sterol metabolism in Saccharomyces cerevisiae by converting cholesterol to bile acids and other steroids."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: SREBP transcription factors regulate the expression of genes involved in sterol biosynthesis and uptake in mammals, not in Saccharomyces cerevisiae.\n3. TRUE\n4. TRUE\n5. TRUE\n6. FALSE [correction]: Cytochrome P450 enzymes contribute to sterol metabolism in Saccharomyces cerevisiae by catalyzing the demethylation of sterols, not by converting cholesterol to bile acids and other steroids.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2318,
    "user_query": "Which enzymes are responsible for base J creation in Trypanosoma brucei?",
    "vicuna-13b_response": "Trypanosoma brucei is a parasitic protozoan that causes African trypanosomiasis or sleeping sickness in humans and nagana in animals. The parasite has a complex life cycle involving two main hosts, the tsetse fly (Glossina species) and a mammalian host (e.g., humans, cattle, or other animals). The parasite's genome is composed of a single circular chromosome that contains a unique set of genes involved in various biological processes, including the creation of base J.\nBase J is a unique nucleobase that is present in the trypanosome genome but not in the genomes of other organisms. Its presence is essential for the parasite's survival, and its biosynthesis is tightly regulated. The biosynthesis of base J involves several enzymes, including:\n1. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH): This enzyme is involved in the initial step of the glycolytic pathway, which provides the precursor for base J biosynthesis.\n2. 5-hydroxy-4-methyl-2-oxoglutarate synthase (HMG-CoA synthase): This enzyme is involved in the synthesis of 5-hydroxy-4-methyl-2-oxoglutarate (HMG-CoA), which is a precursor for base J biosynthesis.\n3. Dihydroorotate dehydrogenase (DHODH): This enzyme is involved in the conversion of dihydroorotate to orotate, which is a crucial step in the biosynthesis of base J.\n4. Orotidine 5'-phosphate decarboxylase (OPDC): This enzyme is involved in the conversion of orotidine 5'-phosphate (orotidine-5-phosphate, or pre-base J) to base J.\nThese enzymes work together in a sequential manner to produce base J, which is essential for the survival and replication of Trypanosoma brucei. Understanding the biosynthesis",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Trypanosoma brucei is a parasitic protozoan that causes African trypanosomiasis or sleeping sickness in humans and nagana in animals.\n2. Base J is a unique nucleobase that is present in the trypanosome genome but not in the genomes of other organisms.\n3. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is involved in the initial step of the glycolytic pathway, which provides the precursor for base J biosynthesis.\n4. 5-hydroxy-4-methyl-2-oxoglutarate synthase is involved in the synthesis of 5-hydroxy-4-methyl-2-oxoglutarate, a precursor for base J biosynthesis.\n5. Dihydroorotate dehydrogenase (DHODH) and Orotidine 5'-phosphate decarboxylase (OPDC) are involved in the biosynthesis of base J in Trypanosoma brucei.",
    "vicuna-13b_fact": [
      "Trypanosoma brucei is a parasitic protozoan that causes African trypanosomiasis or sleeping sickness in humans and nagana in animals.",
      "Base J is a unique nucleobase that is present in the trypanosome genome but not in the genomes of other organisms.",
      "Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is involved in the initial step of the glycolytic pathway, which provides the precursor for base J biosynthesis.",
      "5-hydroxy-4-methyl-2-oxoglutarate synthase is involved in the synthesis of 5-hydroxy-4-methyl-2-oxoglutarate, a precursor for base J biosynthesis.",
      "Dihydroorotate dehydrogenase (DHODH) and Orotidine 5'-phosphate decarboxylase (OPDC) are involved in the biosynthesis of base J in Trypanosoma brucei."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is involved in the glycolytic pathway, but it does not provide the precursor for base J biosynthesis.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "vicuna-13b_response": "Ohdo syndrome is a rare genetic disorder that is caused by mutations in the SLC25A20 gene. This gene provides instructions for making a protein that is involved in the transport of zinc and other metals across cell membranes.\nMutations in the SLC25A20 gene can lead to reduced zinc transport, which can cause a range of symptoms, including intellectual disability, developmental delay, and movement difficulties. The severity of these symptoms can vary widely, depending on the specific mutation and the presence of other genetic factors.\nOhdo syndrome is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) to develop the disorder. Carriers of one copy of the mutated gene do not typically have any symptoms, but they can pass the mutation on to their children.\nDiagnosis of Ohdo syndrome is typically based on a combination of clinical features, genetic testing, and other medical tests. There is currently no cure for Ohdo syndrome, but treatment is focused on managing symptoms and providing supportive care. This may include physical therapy, occupational therapy, and other interventions to help individuals with the disorder reach their full potential.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ohdo syndrome is a rare genetic disorder that is caused by mutations in the SLC25A20 gene.\n2. This gene provides instructions for making a protein that is involved in the transport of zinc and other metals across cell membranes.\n3. Ohdo syndrome is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene to develop the disorder.\n4. Diagnosis of Ohdo syndrome is typically based on a combination of clinical features, genetic testing, and other medical tests.\n5. There is currently no cure for Ohdo syndrome, but treatment is focused on managing symptoms and providing supportive care.",
    "vicuna-13b_fact": [
      "Ohdo syndrome is a rare genetic disorder that is caused by mutations in the SLC25A20 gene.",
      "This gene provides instructions for making a protein that is involved in the transport of zinc and other metals across cell membranes.",
      "Ohdo syndrome is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene to develop the disorder.",
      "Diagnosis of Ohdo syndrome is typically based on a combination of clinical features, genetic testing, and other medical tests.",
      "There is currently no cure for Ohdo syndrome, but treatment is focused on managing symptoms and providing supportive care."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Ohdo syndrome is a rare genetic disorder that is caused by mutations in the MED12 gene.\n2. FALSE [correction]: The SLC25A20 gene provides instructions for making a protein that play a crucial role in the breakdown of lipids (fats) for energy. It is not involved in the transport of zinc and other metals across cell membranes.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2326,
    "user_query": "How may CTCF mediate splicing?",
    "vicuna-13b_response": "CTCF (CCCTC-binding factor) is a transcription factor that plays a critical role in regulating gene expression by controlling the access of RNA polymerase to chromatin. CTCF can also regulate splicing by binding to specific sequences in the introns of target genes and recruiting splicing factors to these regions.\nThere are several ways in which CTCF can mediate splicing:\n1. CTCF can act as a transcriptional repressor by binding to the promoter regions of splicing factors, such as SRSF1 (serine-arginine-rich splicing factor 1), and inhibiting their transcription. This can lead to a decrease in the levels of splicing factors, which can in turn reduce the efficiency of splicing.\n2. CTCF can act as a transcriptional activator by binding to the promoter regions of splicing factors and enhancing their transcription. This can lead to an increase in the levels of splicing factors, which can increase the efficiency of splicing.\n3. CTCF can act as a splicing activator by binding to specific sequences in the introns of target genes and recruiting splicing factors to these regions. This can enhance the efficiency of splicing and promote the inclusion of specific exons in the final mRNA product.\n4. CTCF can act as a splicing repressor by binding to specific sequences in the introns of target genes and recruiting splicing factors that promote exon skipping or alternative splicing.\nOverall, CTCF plays a critical role in regulating splicing by controlling the access of splicing factors to specific regions in the introns of target genes. By modulating the levels and activity of splicing factors, CTCF can regulate the efficiency of splicing and promote the inclusion or exclusion of specific exons in the final mRNA product.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CTCF (CCCTC-binding factor) is a transcription factor that regulates gene expression by controlling the access of RNA polymerase to chromatin.\n2. CTCF can mediate splicing by binding to specific sequences in the introns of target genes and recruiting splicing factors to these regions.\n3. CTCF can act as a transcriptional repressor by binding to the promoter regions of splicing factors, such as SRSF1, and inhibiting their transcription.\n4. CTCF can act as a transcriptional activator by binding to the promoter regions of splicing factors and enhancing their transcription.\n5. CTCF can act as a splicing activator or repressor by binding to specific sequences in the introns of target genes and recruiting splicing factors that either promote or repress the efficiency of splicing.",
    "vicuna-13b_fact": [
      "CTCF (CCCTC-binding factor) is a transcription factor that regulates gene expression by controlling the access of RNA polymerase to chromatin.",
      "CTCF can mediate splicing by binding to specific sequences in the introns of target genes and recruiting splicing factors to these regions.",
      "CTCF can act as a transcriptional repressor by binding to the promoter regions of splicing factors, such as SRSF1, and inhibiting their transcription.",
      "CTCF can act as a transcriptional activator by binding to the promoter regions of splicing factors and enhancing their transcription.",
      "CTCF can act as a splicing activator or repressor by binding to specific sequences in the introns of target genes and recruiting splicing factors that either promote or repress the efficiency of splicing."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2329,
    "user_query": "What is the function of the TFIIS transcriptional factor (Dst1) in yeast?",
    "vicuna-13b_response": "TFIIS, also known as Dst1, is a transcriptional factor that plays a critical role in regulating gene expression in the yeast Saccharomyces cerevisiae. TFIIS is a DNA-binding protein that recognizes specific sequences in the promoter regions of genes and recruits the RNA polymerase II transcription complex to initiate transcription.\nTFIIS is involved in the regulation of a wide range of genes, including those involved in metabolism, stress response, and cell cycle progression. It has been shown to regulate the expression of genes involved in stress response pathways, such as the heat shock response and the oxidative stress response, by binding to specific DNA sequences in their promoters.\nIn addition to its role in transcriptional regulation, TFIIS also plays a role in DNA repair and recombination. It has been shown to interact with the Rad52 protein, which is involved in the repair of double-stranded DNA breaks, and to be required for the proper repair of chromosomal damage.\nOverall, TFIIS plays a crucial role in the regulation of gene expression in yeast, and its dysfunction has been linked to a variety of cellular processes, including stress response, DNA repair, and cell cycle progression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TFIIS, also known as Dst1, is a transcriptional factor in the yeast Saccharomyces cerevisiae.\n2. TFIIS is a DNA-binding protein and initiates transcription by recognizing sequences in the promoter regions of genes and recruiting RNA polymerase II transcription complex.\n3. TFIIS regulates a wide range of genes, including those involved in metabolism, stress response, and cell cycle progression.\n4. TFIIS regulates the expression of genes in stress response pathways such as the heat shock response and the oxidative stress response.\n5. Besides its role in transcriptional regulation, TFIIS also plays a part in DNA repair and recombination, and works with the Rad52 protein in the repair of double-stranded DNA breaks.",
    "vicuna-13b_fact": [
      "TFIIS, also known as Dst1, is a transcriptional factor in the yeast Saccharomyces cerevisiae.",
      "TFIIS is a DNA-binding protein and initiates transcription by recognizing sequences in the promoter regions of genes and recruiting RNA polymerase II transcription complex.",
      "TFIIS regulates a wide range of genes, including those involved in metabolism, stress response, and cell cycle progression.",
      "TFIIS regulates the expression of genes in stress response pathways such as the heat shock response and the oxidative stress response.",
      "Besides its role in transcriptional regulation, TFIIS also plays a part in DNA repair and recombination, and works with the Rad52 protein in the repair of double-stranded DNA breaks."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: While TFIIS does bind to DNA and plays a role in transcription initiation, it does not itself recognize sequences in the promoter regions of genes. Rather, it helps RNA polymerase II to overcome transcriptional arrest.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: TFIIS does not directly participate in DNA repair and recombination. The transcription machinery, in general, may have roles in these processes, but the role of TFIIS is primarily in aiding RNA polymerase II during transcription.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "vicuna-13b_response": "There are several R/Bioconductor packages that are commonly used for the analysis of psychiatric disease genes. Some of the most popular ones include:\n1. PsychArray: This package provides a set of functions for the analysis of gene expression data in psychiatric diseases. It includes functions for quality control, normalization, and differential expression analysis.\n2. BrainArray: This package provides a set of functions for the analysis of gene expression data in brain tissue. It includes functions for quality control, normalization, and differential expression analysis, and it is specifically designed for brain-related studies.\n3. PsychTranscriptomics: This package provides a set of functions for the analysis of transcriptomics data in psychiatric diseases. It includes functions for quality control, normalization, and differential expression analysis, and it also allows for the analysis of alternative splicing and gene fusion events.\n4. BrainTranscriptomics: This package provides a set of functions for the analysis of transcriptomics data in brain tissue. It includes functions for quality control, normalization, and differential expression analysis, and it is specifically designed for brain-related studies.\n5. RvDREAM: This package provides a set of functions for the analysis of ChIP-seq and DNase-seq data in brain tissue. It includes functions for quality control, peak calling, and peak annotation, and it is specifically designed for brain-related studies.\nIt's worth noting that these packages are not exclusive to psychiatric disease analysis, they can be used for other types of studies as well, but they have been developed with the specific aim of analyzing psychiatric disease genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PsychArray is an R/Bioconductor package designed for the analysis of gene expression data in psychiatric diseases.\n2. BrainArray is an R/Bioconductor package intended for the analysis of gene expression data in brain tissue.\n3. PsychTranscriptomics is an R/Bioconductor package designed to analyze transcriptomics data in psychiatric diseases, including the analysis of alternative splicing and gene fusion events.\n4. BrainTranscriptomics is an R/Bioconductor package for the analysis of transcriptomics data in brain tissue.\n5. RvDREAM is an R/Bioconductor package for the analysis of ChIP-seq and DNase-seq data in brain tissue, with features for quality control, peak calling, and peak annotation.",
    "vicuna-13b_fact": [
      "PsychArray is an R/Bioconductor package designed for the analysis of gene expression data in psychiatric diseases.",
      "BrainArray is an R/Bioconductor package intended for the analysis of gene expression data in brain tissue.",
      "PsychTranscriptomics is an R/Bioconductor package designed to analyze transcriptomics data in psychiatric diseases, including the analysis of alternative splicing and gene fusion events.",
      "BrainTranscriptomics is an R/Bioconductor package for the analysis of transcriptomics data in brain tissue.",
      "RvDREAM is an R/Bioconductor package for the analysis of ChIP-seq and DNase-seq data in brain tissue, with features for quality control, peak calling, and peak annotation."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2335,
    "user_query": "What is the function of the gene MDA5?",
    "vicuna-13b_response": "MDA5 (melanoma differentiation-associated gene 5) is a gene that encodes a protein called a GTPase-activating protein (GAP). GAPs play a role in regulating the activity of GTPases, which are enzymes that catalyze the conversion of GTP to GDP, a process that is important for many cellular processes such as signal transduction and vesicle trafficking.\nMDA5 has been shown to play a role in the immune response and inflammation. Specifically, MDA5 has been shown to be involved in the recognition and clearance of intracellular pathogens such as viruses and bacteria. MDA5 has also been shown to be involved in the regulation of the NLRP3 inflammasome, a complex that plays a key role in the innate immune response.\nIn addition, MDA5 has been implicated in the development and progression of certain types of cancer, including melanoma. Studies have suggested that increased expression of MDA5 may be associated with poor prognosis in melanoma patients.\nOverall, the function of the MDA5 gene is to encode a protein that plays a role in regulating the activity of GTPases and is involved in the immune response, inflammation, and cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MDA5 is the melanoma differentiation-associated gene 5.\n2. MDA5 encodes a protein called a GTPase-activating protein (GAP).\n3. GTPase-activating proteins play a role in regulating the activity of GTPases.\n4. MDA5 plays a role in the immune response, inflammation, and the regulation of the NLRP3 inflammasome.\n5. MDA5 has been implicated in the development and progression of certain types of cancer, including melanoma.",
    "vicuna-13b_fact": [
      "MDA5 is the melanoma differentiation-associated gene 5.",
      "MDA5 encodes a protein called a GTPase-activating protein (GAP).",
      "GTPase-activating proteins play a role in regulating the activity of GTPases.",
      "MDA5 plays a role in the immune response, inflammation, and the regulation of the NLRP3 inflammasome.",
      "MDA5 has been implicated in the development and progression of certain types of cancer, including melanoma."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: MDA5 encodes a protein that acts as a sensor for viral double-stranded RNA in the innate immune response, not a GTPase-activating protein (GAP).\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2336,
    "user_query": "Which is the conserved motif of DEAD box proteins?",
    "vicuna-13b_response": "The conserved motif of DEAD box proteins is the \"DEAD\" box, which is a conserved sequence of amino acids found in the N-terminal region of these proteins. The DEAD box is composed of 4 conserved amino acids ( Asp, Glu, Asp, and Asn) and is involved in the recognition and binding of RNA molecules. DEAD box proteins are RNA-binding proteins that play important roles in various cellular processes, such as mRNA transport, translation, and turnover. They are found in all eukaryotes and some bacteria and are named based on the conserved DEAD box motif.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The conserved motif of DEAD box proteins is the \"DEAD\" box.\n2. The DEAD box is a conserved sequence of amino acids located in the N-terminal region of DEAD box proteins.\n3. The DEAD box is composed of 4 conserved amino acids: Asp, Glu, Asp, and Asn.\n4. DEAD box proteins play important roles in various cellular processes such as mRNA transport, translation, and turnover.\n5. DEAD box proteins are found in all eukaryotes and some bacteria.",
    "vicuna-13b_fact": [
      "The conserved motif of DEAD box proteins is the \"DEAD\" box.",
      "The DEAD box is a conserved sequence of amino acids located in the N-terminal region of DEAD box proteins.",
      "The DEAD box is composed of 4 conserved amino acids: Asp, Glu, Asp, and Asn.",
      "DEAD box proteins play important roles in various cellular processes such as mRNA transport, translation, and turnover.",
      "DEAD box proteins are found in all eukaryotes and some bacteria."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The DEAD box is composed of 4 conserved amino acids: Asp (D), Glu (E), Ala (A), and Asp (D).\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2338,
    "user_query": "Describe GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types)",
    "vicuna-13b_response": "GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types) is a bioinformatics tool that uses genome-wide association studies (GWAS) data to predict the potential cell types and diseases that are associated with a given set of genetic variants. GARLIC uses a machine learning approach to analyze GWAS data and identify patterns of association between genetic variants and different cell types and diseases.\nGARLIC can be used to identify potential disease biomarkers and to better understand the underlying biological mechanisms of disease. It can also be used to identify potential drug targets and to predict the efficacy of different drugs for treating a given disease.\nGARLIC is a powerful tool for analyzing GWAS data and can be used to generate hypotheses about the potential cell types and diseases that are associated with a given set of genetic variants. It is a valuable resource for researchers in the fields of bioinformatics, genomics, and disease biology.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types) is a bioinformatics tool.\n2. GARLIC uses genome-wide association studies (GWAS) data.\n3. GARLIC employs a machine learning approach to analyze GWAS data.\n4. GARLIC can be used to identify potential disease biomarkers and to understand biological mechanisms of disease.\n5. GARLIC can also be used to identify potential drug targets and to predict the efficacy of different drugs for a certain disease.",
    "vicuna-13b_fact": [
      "GARLIC (GWAS-based Prediction Toolkit for Connecting Diseases and Cell Types) is a bioinformatics tool.",
      "GARLIC uses genome-wide association studies (GWAS) data.",
      "GARLIC employs a machine learning approach to analyze GWAS data.",
      "GARLIC can be used to identify potential disease biomarkers and to understand biological mechanisms of disease.",
      "GARLIC can also be used to identify potential drug targets and to predict the efficacy of different drugs for a certain disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2345,
    "user_query": "What is the function of yeast TERRA RNAs?",
    "vicuna-13b_response": "TERRA (Transcribed Epitranscripts Regulating Alternative splicing) RNAs are a type of non-coding RNA that play a critical role in regulating alternative splicing in yeast. Alternative splicing is a process by which a single gene can produce multiple different mRNA transcripts, each with a unique combination of exons and introns. This process allows for greater flexibility and complexity in gene expression, as it allows the same gene to produce multiple different proteins.\nTERRA RNAs bind to the splice sites of target genes and act as a barrier to the splicing machinery, preventing the inclusion of certain exons in the final mRNA transcript. This can lead to the production of different mRNA isoforms, each with a unique combination of exons and introns. TERRA RNAs can also recruit other proteins to the splice site, which can further regulate the splicing process.\nIn addition to their role in regulating alternative splicing, TERRA RNAs have also been shown to play a role in other cellular processes, such as transcriptional regulation and RNA transport.\nOverall, the function of TERRA RNAs is to regulate the alternative splicing of target genes, leading to the production of different mRNA isoforms and potentially contributing to the regulation of other cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TERRA (Transcribed Epitranscripts Regulating Alternative splicing) RNAs are a type of non-coding RNA.\n2. TERRA RNAs play a critical role in regulating alternative splicing in yeast.\n3. TERRA RNAs can bind to the splice sites of target genes and act as a barrier to the splicing machinery.\n4. TERRA RNAs can recruit other proteins to the splice site, which can further regulate the splicing process.\n5. TERRA RNAs also play a role in other cellular processes, such as transcriptional regulation and RNA transport.",
    "vicuna-13b_fact": [
      "TERRA (Transcribed Epitranscripts Regulating Alternative splicing) RNAs are a type of non-coding RNA.",
      "TERRA RNAs play a critical role in regulating alternative splicing in yeast.",
      "TERRA RNAs can bind to the splice sites of target genes and act as a barrier to the splicing machinery.",
      "TERRA RNAs can recruit other proteins to the splice site, which can further regulate the splicing process.",
      "TERRA RNAs also play a role in other cellular processes, such as transcriptional regulation and RNA transport."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2347,
    "user_query": "Do bacteria from the genus Morexella cause respiratory infections?",
    "vicuna-13b_response": "Yes, some species of the bacterial genus Moraxella are known to cause respiratory infections. Moraxella catarrhalis and Moraxella osloensis are two species that are commonly associated with respiratory tract infections, such as bronchitis and pneumonia. These bacteria can also cause ear infections and infections of the sinuses.\nMoraxella bacteria are typically spread from person to person through respiratory droplets that are produced when an infected person talks, coughs, or sneezes. They can also be spread by touching contaminated surfaces and then touching the face.\nSymptoms of a respiratory infection caused by Moraxella bacteria can include cough, fever, chest pain, and difficulty breathing. Treatment typically involves antibiotics, which can help to clear the infection and reduce symptoms. Prevention measures include washing hands frequently, covering the mouth and nose when coughing or sneezing, and avoiding close contact with people who are sick.\nIt's important to note that not all respiratory infections are caused by Moraxella bacteria, and other bacteria and viruses can also cause similar symptoms. If you are experiencing symptoms of a respiratory infection, it's important to see a healthcare provider for a proper diagnosis and treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Some species of the bacterial genus Moraxella are known to cause respiratory infections.\n2. Moraxella catarrhalis and Moraxella osloensis are commonly associated with respiratory tract infections, such as bronchitis and pneumonia.\n3. Moraxella bacteria can also cause ear infections and infections of the sinuses.\n4. Moraxella bacteria are spread from person to person through respiratory droplets or touching contaminated surfaces and then touching the face.\n5. Treatment for a respiratory infection caused by Moraxella bacteria typically involves antibiotics.",
    "vicuna-13b_fact": [
      "Some species of the bacterial genus Moraxella are known to cause respiratory infections.",
      "Moraxella catarrhalis and Moraxella osloensis are commonly associated with respiratory tract infections, such as bronchitis and pneumonia.",
      "Moraxella bacteria can also cause ear infections and infections of the sinuses.",
      "Moraxella bacteria are spread from person to person through respiratory droplets or touching contaminated surfaces and then touching the face.",
      "Treatment for a respiratory infection caused by Moraxella bacteria typically involves antibiotics."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2349,
    "user_query": "Do chromatin features predict genes associated with eQTLs?",
    "vicuna-13b_response": "Chromatin features, such as chromatin accessibility, histone modifications, and DNA methylation, have been shown to play a role in regulating gene expression and can be used to predict genes associated with eQTLs (expression quantitative trait loci).\nSeveral studies have used chromatin features to identify eQTLs by analyzing the correlation between chromatin accessibility or histone modifications at a specific locus and the expression of nearby genes. For example, a study published in the journal Nature Genetics in 2017 used chromatin accessibility data from over 1,000 human samples to identify eQTLs associated with a range of traits, including blood pressure and body mass index. The authors found that chromatin accessibility at a specific locus was highly correlated with the expression of nearby genes, and that this correlation was even stronger for eQTLs associated with traits.\nAnother study published in the journal Cell in 2019 used a combination of chromatin accessibility data and gene expression data to identify eQTLs associated with schizophrenia. The authors found that chromatin accessibility at specific loci was highly correlated with the expression of nearby genes, and that this correlation was even stronger for eQTLs associated with schizophrenia.\nIn summary, chromatin features can be used to predict genes associated with eQTLs by analyzing the correlation between chromatin accessibility or histone modifications at a specific locus and the expression of nearby genes. Several studies have used this approach to identify eQTLs associated with a range of traits and diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Chromatin features such as chromatin accessibility, histone modifications, and DNA methylation can be used to predict genes associated with eQTLs.\n2. Numerous studies have used chromatin features to identify eQTLs by analyzing the correlation between chromatin accessibility or histone modifications at a specific locus and the expression of nearby genes.\n3. A study published in Nature Genetics in 2017 used chromatin accessibility data from over 1,000 human samples to identify eQTLs.\n4. This study in Nature Genetics found that chromatin accessibility at a specific locus was highly correlated with the expression of nearby genes, particularly for eQTLs associated with traits like blood pressure and body mass index.\n5. Another study published in Cell in 2019, used a combination of chromatin accessibility data and gene expression data to identify eQTLs linked with schizophrenia and confirmed the high correlation between chromatin accessibility and expression of nearby genes.",
    "vicuna-13b_fact": [
      "Chromatin features such as chromatin accessibility, histone modifications, and DNA methylation can be used to predict genes associated with eQTLs.",
      "Numerous studies have used chromatin features to identify eQTLs by analyzing the correlation between chromatin accessibility or histone modifications at a specific locus and the expression of nearby genes.",
      "A study published in Nature Genetics in 2017 used chromatin accessibility data from over 1,000 human samples to identify eQTLs.",
      "This study in Nature Genetics found that chromatin accessibility at a specific locus was highly correlated with the expression of nearby genes, particularly for eQTLs associated with traits like blood pressure and body mass index.",
      "Another study published in Cell in 2019, used a combination of chromatin accessibility data and gene expression data to identify eQTLs linked with schizophrenia and confirmed the high correlation between chromatin accessibility and expression of nearby genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2350,
    "user_query": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta",
    "vicuna-13b_response": "Osteogenesis imperfecta (OI) is a genetic disorder that affects the development and function of bones and cartilage. There are several types of OI, including the autosomal recessive form, which is caused by mutations in six genes: COL1A1, COL1A2, COL3A1, COL3A2, LAMB3, and ITGB3. These genes provide instructions for making proteins that are important for the structure and function of bone and cartilage. Mutations in these genes can lead to weak bones and other characteristic features of OI, such as easy bruising, bone deformities, and vision problems.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Osteogenesis imperfecta is a genetic disorder that affects the development and function of bones and cartilage.\n2. There is an autosomal recessive form of Osteogenesis imperfecta.\n3. The autosomal recessive form of Osteogenesis imperfecta is caused by mutations in six genes: COL1A1, COL1A2, COL3A1, COL3A2, LAMB3, and ITGB3.\n4. The mentioned genes provide instructions for making proteins that are important for the structure and function of bone and cartilage.\n5. Mutations in these genes can lead to weak bones and other characteristic features of Osteogenesis imperfecta, such as easy bruising, bone deformities, and vision problems.",
    "vicuna-13b_fact": [
      "Osteogenesis imperfecta is a genetic disorder that affects the development and function of bones and cartilage.",
      "There is an autosomal recessive form of Osteogenesis imperfecta.",
      "The autosomal recessive form of Osteogenesis imperfecta is caused by mutations in six genes: COL1A1, COL1A2, COL3A1, COL3A2, LAMB3, and ITGB3.",
      "The mentioned genes provide instructions for making proteins that are important for the structure and function of bone and cartilage.",
      "Mutations in these genes can lead to weak bones and other characteristic features of Osteogenesis imperfecta, such as easy bruising, bone deformities, and vision problems."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The autosomal recessive form of Osteogenesis imperfecta is caused by mutations in genes like CRTAP, LEPRE1, PPIB, SERPINH1, not COL1A1, COL1A2, COL3A1, COL3A2, LAMB3, and ITGB3.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2354,
    "user_query": "What is the mode of action of teriparatide?",
    "vicuna-13b_response": "Teriparatide is a synthetic form of the hormone parathyroid hormone (PTH) that is used to treat osteoporosis. The mode of action of teriparatide is to stimulate bone formation and increase bone density.\nTeriparatide works by binding to receptors for PTH on bone cells, called osteoblasts. This stimulates the production of proteins that are necessary for bone growth and development, such as collagen and osteopontin. Teriparatide also increases the activity of osteoclasts, which are cells that break down old bone tissue and release minerals that are necessary for bone formation.\nBy stimulating bone formation and increasing bone density, teriparatide can help to reduce the risk of fractures in people with osteoporosis. Teriparatide is typically administered via injection, and the dosage and duration of treatment will depend on the individual patient's needs and response to the medication.\nIt is important to note that teriparatide should only be used under the guidance of a healthcare professional, as it can have side effects and may not be appropriate for everyone.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Teriparatide is a synthetic form of the hormone parathyroid hormone (PTH).\n2. Teriparatide is used to treat osteoporosis.\n3. The mode of action of teriparatide is to stimulate bone formation and increase bone density.\n4. Teriparatide works by binding to receptors for PTH on bone cells, called osteoblasts, stimulating the production of proteins necessary for bone growth and development.\n5. Teriparatide is typically administered via injection.",
    "vicuna-13b_fact": [
      "Teriparatide is a synthetic form of the hormone parathyroid hormone (PTH).",
      "Teriparatide is used to treat osteoporosis.",
      "The mode of action of teriparatide is to stimulate bone formation and increase bone density.",
      "Teriparatide works by binding to receptors for PTH on bone cells, called osteoblasts, stimulating the production of proteins necessary for bone growth and development.",
      "Teriparatide is typically administered via injection."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2355,
    "user_query": "What is the Strelka workflow?",
    "vicuna-13b_response": "The Strelka workflow is a visual representation of the steps involved in completing a design project. It is a tool used by designers to plan and organize their work, and to communicate the design process to clients or stakeholders.\nThe Strelka workflow typically includes the following steps:\n1. Discovery: This is the research phase of the project, where the designer gathers information about the project, the target audience, and the goals of the project.\n2. Concept: In this phase, the designer develops initial concepts and ideas for the project.\n3. Development: The designer refines and develops the chosen concept, creating detailed designs and specifications.\n4. Production: This is the implementation phase, where the designer works with developers to bring the design to life.\n5. Testing: The designer tests the final product to ensure that it meets the goals of the project and is user-friendly.\n6. Launch: The designer launches the final product and communicates the results to stakeholders.\nThe Strelka workflow is a flexible tool that can be adapted to the specific needs of each project. It is a useful tool for designers to plan and organize their work, and to communicate the design process to clients or stakeholders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Strelka workflow is a tool used by designers to plan and organize their work.\n2. The Strelka workflow is used to communicate the design process to clients or stakeholders.\n3. The Strelka workflow includes the steps Discovery, Concept, Development, Production, Testing, and Launch.\n4. In the Discovery phase of the Strelka workflow, a designer gathers information about the project, the target audience, and the goals of the project.\n5. The Strelka workflow can be adapted according to the specific needs of each project.",
    "vicuna-13b_fact": [
      "The Strelka workflow is a tool used by designers to plan and organize their work.",
      "The Strelka workflow is used to communicate the design process to clients or stakeholders.",
      "The Strelka workflow includes the steps Discovery, Concept, Development, Production, Testing, and Launch.",
      "In the Discovery phase of the Strelka workflow, a designer gathers information about the project, the target audience, and the goals of the project.",
      "The Strelka workflow can be adapted according to the specific needs of each project."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2359,
    "user_query": "Describe mechanism of action of Ozanimod.",
    "vicuna-13b_response": "Ozanimod is an oral, selective immunomodulator and sphingosine-1-phosphate (S1P) receptor modulator that is approved for the treatment of relapsing multiple sclerosis (MS). Its mechanism of action involves the following steps:\n1. Ozanimod is taken up by cells of the mononuclear phagocyte system (MPS), including macrophages and dendritic cells, through a process called endocytosis.\n2. Once inside the cell, ozanimod is converted to its active metabolite, RPC1063, by the enzyme CYP450.\n3. RPC1063 then binds to and activates S1P receptors 1 (S1PR1) on the surface of immune cells, including T cells, B cells, and natural killer (NK) cells.\n4. This activation of S1PR1 leads to the inhibition of cellular migration and the reduction of lymphocyte egress from lymphoid organs, resulting in a reduction of lymphocyte numbers in the peripheral blood.\n5. Additionally, ozanimod has been shown to modulate the activity of microglia, the resident immune cells of the central nervous system (CNS), which play a key role in the pathology of MS.\n6. By modulating the activity of these immune cells, ozanimod has been shown to reduce the inflammatory response in the CNS, which is thought to be a key factor in the pathology of MS.\nOverall, the mechanism of action of ozanimod involves the modulation of immune cell activity and the reduction of inflammation in the CNS, which makes it an effective treatment for relapsing MS.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ozanimod is an oral, selective immunomodulator and sphingosine-1-phosphate (S1P) receptor modulator that is approved for the treatment of relapsing multiple sclerosis (MS).\n2. Ozanimod is taken up by cells of the mononuclear phagocyte system (MPS), including macrophages and dendritic cells, through a process called endocytosis.\n3. Inside the cell, ozanimod is converted to its active metabolite, RPC1063, by the enzyme CYP450.\n4. RPC1063 binds to and activates S1P receptors 1 (S1PR1) on the surface of immune cells.\n5. Ozanimod reduces the inflammatory response in the CNS, which is thought to be a key factor in the pathology of MS.",
    "vicuna-13b_fact": [
      "Ozanimod is an oral, selective immunomodulator and sphingosine-1-phosphate (S1P) receptor modulator that is approved for the treatment of relapsing multiple sclerosis (MS).",
      "Ozanimod is taken up by cells of the mononuclear phagocyte system (MPS), including macrophages and dendritic cells, through a process called endocytosis.",
      "Inside the cell, ozanimod is converted to its active metabolite, RPC1063, by the enzyme CYP450.",
      "RPC1063 binds to and activates S1P receptors 1 (S1PR1) on the surface of immune cells.",
      "Ozanimod reduces the inflammatory response in the CNS, which is thought to be a key factor in the pathology of MS."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "vicuna-13b_response": "Swirl sign is a radiologic finding that is commonly seen in patients with intracerebral hemorrhage (ICH), which is a type of stroke caused by bleeding into the brain tissue. It is also known as a \"rice-grain\" sign or a \"floret sign\".\nThe swirl sign is caused by the presence of small, round, hyperdense areas (called \"rice grains\") within the hemorrhage. These small, round lesions are formed by the coagulation of blood within the brain tissue, and they are typically seen in the setting of ICH due to hypertension or other vascular conditions.\nThe swirl sign is often seen on CT scans of the brain, and it is a useful indicator of the presence and extent of ICH. It is important to note that the swirl sign is not specific to ICH and can also be seen in other types of brain injury or inflammation.\nIn summary, the swirl sign is a radiologic finding that is commonly seen in patients with intracerebral hemorrhage, and it is caused by the presence of small, round, hyperdense areas within the hemorrhage. It is a useful indicator of the presence and extent of ICH, and it is often seen on CT scans of the brain.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Swirl sign is a radiologic finding that is commonly seen in patients with intracerebral hemorrhage (ICH).\n2. Intracerebral hemorrhage is a type of stroke caused by bleeding into the brain tissue.\n3. The swirl sign is caused by the presence of small, round, hyperdense areas within the hemorrhage.\n4. The swirl sign is often seen on CT scans of the brain.\n5. The swirl sign is a useful indicator of the presence and extent of intracerebral hemorrhage.",
    "vicuna-13b_fact": [
      "Swirl sign is a radiologic finding that is commonly seen in patients with intracerebral hemorrhage (ICH).",
      "Intracerebral hemorrhage is a type of stroke caused by bleeding into the brain tissue.",
      "The swirl sign is caused by the presence of small, round, hyperdense areas within the hemorrhage.",
      "The swirl sign is often seen on CT scans of the brain.",
      "The swirl sign is a useful indicator of the presence and extent of intracerebral hemorrhage."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Swirl sign is not commonly seen in patients with intracerebral hemorrhage (ICH). It's seen in patients with epidural hematomas.\n2. TRUE\n3. FALSE [correction]: The swirl sign is not characterized by the presence of small, round, hyperdense areas within the hemorrhage. It's seen as a heterogeneous mixture of hyperdense (blood clots) and hypodense (unclotted blood) areas within the hematoma.\n4. TRUE\n5. FALSE [correction]: The swirl sign is not a useful indicator of the presence and extent of intracerebral hemorrhage but it can indicate active bleeding in a hematoma or worsening condition.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2361,
    "user_query": "What is Morgellons disease?",
    "vicuna-13b_response": "Morgellons disease is a rare and controversial condition characterized by the presence of lesions, crawling sensations, and other unusual symptoms. It is not recognized as a distinct medical condition by most health authorities, including the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH).\nThe symptoms of Morgellons disease can vary widely, but typically include the presence of lesions or sores on the skin, as well as crawling or biting sensations under the skin. Some people with Morgellons disease also report experiencing fatigue, changes in mood or cognitive function, and other unusual symptoms.\nThe cause of Morgellons disease is not well understood, and there is ongoing debate among medical professionals about whether it is a real medical condition or a psychiatric disorder. Some research suggests that Morgellons disease may be associated with Lyme disease or other tick-borne infections, while other studies have suggested that it may be related to stress or other psychological factors.\nThere is currently no cure for Morgellons disease, and treatment is typically focused on managing symptoms and improving quality of life. This may include antibiotics to treat any underlying infections, as well as medications to address symptoms such as anxiety or depression. It is important for anyone experiencing symptoms of Morgellons disease to speak with a healthcare provider for proper diagnosis and treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Morgellons disease is characterized by the presence of lesions, crawling sensations, and other unusual symptoms.\n2. The Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) do not recognize Morgellons disease as a distinct medical condition.\n3. Some research suggests that Morgellons disease may be associated with Lyme disease or other tick-borne infections.\n4. Some studies suggest that Morgellons disease may be related to stress or other psychological factors.\n5. There is currently no cure for Morgellons disease, and treatment is typically focused on managing symptoms and improving quality of life.",
    "vicuna-13b_fact": [
      "Morgellons disease is characterized by the presence of lesions, crawling sensations, and other unusual symptoms.",
      "The Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) do not recognize Morgellons disease as a distinct medical condition.",
      "Some research suggests that Morgellons disease may be associated with Lyme disease or other tick-borne infections.",
      "Some studies suggest that Morgellons disease may be related to stress or other psychological factors.",
      "There is currently no cure for Morgellons disease, and treatment is typically focused on managing symptoms and improving quality of life."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2363,
    "user_query": "What is the asosciation between the eustachian tube and the palatine muscle of the uvula?",
    "vicuna-13b_response": "The eustachian tube and the palatine muscle of the uvula are both structures located in the ear and are closely related in terms of their function and anatomy.\nThe eustachian tube is a small tube that connects the middle ear to the back of the nose and throat. It is responsible for maintaining the proper pressure in the middle ear and for facilitating the movement of mucus and other fluids in the ear.\nThe palatine muscle of the uvula is a muscle located in the back of the mouth, near the uvula. This muscle helps to control the movement of the uvula and is important for various functions such as speech and swallowing.\nThe eustachian tube and the palatine muscle of the uvula are connected in that they both play a role in the function of the middle ear. The eustachian tube helps to equalize the pressure in the middle ear and the palatine muscle of the uvula helps to facilitate the movement of mucus and other fluids in the ear.\nIn conclusion, the eustachian tube and the palatine muscle of the uvula are closely related structures that work together to maintain the proper function of the middle ear.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The eustachian tube is a small tube that connects the middle ear to the back of the nose and throat.\n2. The eustachian tube is responsible for maintaining the proper pressure in the middle ear and for facilitating the movement of mucus and other fluids in the ear.\n3. The palatine muscle of the uvula is a muscle located in the back of the mouth, near the uvula.\n4. This muscle helps to control the movement of the uvula and is important for various functions such as speech and swallowing.\n5. The eustachian tube and the palatine muscle of the uvula both play a role in the function of the middle ear.",
    "vicuna-13b_fact": [
      "The eustachian tube is a small tube that connects the middle ear to the back of the nose and throat.",
      "The eustachian tube is responsible for maintaining the proper pressure in the middle ear and for facilitating the movement of mucus and other fluids in the ear.",
      "The palatine muscle of the uvula is a muscle located in the back of the mouth, near the uvula.",
      "This muscle helps to control the movement of the uvula and is important for various functions such as speech and swallowing.",
      "The eustachian tube and the palatine muscle of the uvula both play a role in the function of the middle ear."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While the eustachian tube plays a role in the function of the middle ear, the palatine muscle of the uvula is primarily involved with functions such as speech and swallowing but not in the functioning of the middle ear.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2366,
    "user_query": "Which virus can be diagnosed with the monospot test?",
    "vicuna-13b_response": "The monospot test is a diagnostic test used to detect the presence of certain viral infections, including measles and mumps. The test is a serological test, which means it measures the level of antibodies in the blood that are specific to a particular virus. The monospot test is typically used to diagnose measles, but it can also be used to diagnose mumps, as well as other viral infections such as rubella and roseola. However, it's important to note that the monospot test is not a definitive test for these viral infections, and a positive result should be confirmed with other diagnostic tests.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The monospot test is used to detect the presence of certain viral infections, including measles and mumps.\n2. The monospot test is a serological test.\n3. This test measures the level of antibodies in the blood that are specific to a particular virus.\n4. The monospot test can be used to diagnose measles, mumps, rubella, and roseola.\n5. A positive result from the monospot test should be confirmed with other diagnostic tests.",
    "vicuna-13b_fact": [
      "The monospot test is used to detect the presence of certain viral infections, including measles and mumps.",
      "The monospot test is a serological test.",
      "This test measures the level of antibodies in the blood that are specific to a particular virus.",
      "The monospot test can be used to diagnose measles, mumps, rubella, and roseola.",
      "A positive result from the monospot test should be confirmed with other diagnostic tests."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The monospot test is used to detect the presence of Epstein-Barr virus (EBV), the cause of infectious mononucleosis, not measles and mumps.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The monospot test is used to diagnose infectious mononucleosis, not measles, mumps, rubella or roseola.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2376,
    "user_query": "What is the most common histological diagnosis of \"butterfly glioma\"?",
    "vicuna-13b_response": "Butterfly glioma is a type of brain tumor that is characterized by its unique butterfly-shaped appearance on imaging studies. The most common histological diagnosis of butterfly glioma is diffuse intrinsic pontine glioma (DIPG).\nDIPG is a type of glioma that arises from the brainstem, specifically the pons. It is a highly aggressive and malignant tumor that is difficult to treat due to its location and the difficulty of accessing it surgically. DIPG is the most common tumor that arises in the brainstem in children, and it is often diagnosed in children between the ages of 5 and 10.\nButterfly glioma is a subtype of DIPG that is characterized by its unique butterfly-shaped appearance on imaging studies, such as MRI. This appearance is due to the tumor's location in the brainstem and its ability to spread across the midline of the brain.\nIt is important to note that the diagnosis of butterfly glioma should be confirmed by a pathologist through histological examination of the tumor tissue. This typically involves examining the tumor under a microscope to determine the type of cells that are present and the degree of differentiation of the tumor.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Butterfly glioma is a type of brain tumor characterized by its butterfly-shaped appearance on imaging studies.\n2. The most common histological diagnosis of butterfly glioma is diffuse intrinsic pontine glioma (DIPG).\n3. DIPG is a highly aggressive, malignant brainstem tumor that is difficult to treat.\n4. DIPG is the most common tumor that arises in the brainstem in children, often diagnosed between the ages of 5 and 10.\n5. The diagnosis of butterfly glioma is typically confirmed by a pathologist through histological examination of the tumor tissue.",
    "vicuna-13b_fact": [
      "Butterfly glioma is a type of brain tumor characterized by its butterfly-shaped appearance on imaging studies.",
      "The most common histological diagnosis of butterfly glioma is diffuse intrinsic pontine glioma (DIPG).",
      "DIPG is a highly aggressive, malignant brainstem tumor that is difficult to treat.",
      "DIPG is the most common tumor that arises in the brainstem in children, often diagnosed between the ages of 5 and 10.",
      "The diagnosis of butterfly glioma is typically confirmed by a pathologist through histological examination of the tumor tissue."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The most common histological diagnosis of butterfly glioma is Glioblastoma Multiforme (GBM).\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2377,
    "user_query": "Which chromosomes are implicated in the Emanuel syndrome?",
    "vicuna-13b_response": "Emanuel syndrome is a rare genetic disorder that is caused by mutations in the SLC22A3 gene, which is located on chromosome X. The SLC22A3 gene provides instructions for making a protein called the organic cation transporter 1 (OCT1), which is involved in the transport of certain molecules across the cell membrane.\nMutations in the SLC22A3 gene can lead to a variety of symptoms, including developmental delay, intellectual disability, hypotonia (floppiness), and distinctive facial features. The severity of these symptoms can vary widely, and some individuals with Emanuel syndrome may have mild or no intellectual disability.\nEmanuel syndrome is inherited in an X-linked recessive pattern, which means that the mutated gene is located on the X chromosome and that affected individuals are typically male. Female carriers of the mutated gene are generally not affected, as they have a second, normal copy of the SLC22A3 gene on their other X chromosome.\nOverall, the chromosome implicated in Emanuel syndrome is X.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Emanuel syndrome is a rare genetic disorder caused by mutations in the SLC22A3 gene.\n2. The SLC22A3 gene is located on chromosome X.\n3. The SLC22A3 gene provides instructions for making a protein called the organic cation transporter 1 (OCT1).\n4. Emanuel syndrome is inherited in an X-linked recessive pattern.\n5. Female carriers of the mutated gene are generally not affected, as they have a second, normal copy of the SLC22A3 gene on their other X chromosome.",
    "vicuna-13b_fact": [
      "Emanuel syndrome is a rare genetic disorder caused by mutations in the SLC22A3 gene.",
      "The SLC22A3 gene is located on chromosome X.",
      "The SLC22A3 gene provides instructions for making a protein called the organic cation transporter 1 (OCT1).",
      "Emanuel syndrome is inherited in an X-linked recessive pattern.",
      "Female carriers of the mutated gene are generally not affected, as they have a second, normal copy of the SLC22A3 gene on their other X chromosome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Emanuel syndrome is a rare genetic disorder caused by having extra genetic material from chromosome 11 and 22.\n2. FALSE [correction]: The SLC22A3 gene is located on chromosome 6.\n3. TRUE\n4. FALSE [correction]: Emanuel syndrome is not inherited in an X-linked recessive pattern, it is a result of a chromosomal translocation specifically involving chromosomes 11 and 22.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2379,
    "user_query": "Are loop domains preserved upon cohesin loss?",
    "vicuna-13b_response": "Cohesin is a protein complex that plays a crucial role in maintaining the integrity of chromosomes during cell division. Loss of cohesin can lead to aneuploidy, which is a condition in which there is an abnormal number of chromosomes in the cells.\nIn terms of loop domains, cohesin is known to regulate the formation and maintenance of loop domains in the chromatin structure. Loop domains are regions of DNA that are looped out from the chromatin fiber and are thought to play a role in the regulation of gene expression.\nUpon cohesin loss, it is possible that the loop domains may be disrupted or altered in their organization. This could have a significant impact on the regulation of gene expression and cell behavior. However, the exact effects of cohesin loss on loop domains are still the subject of ongoing research and are not fully understood.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cohesin is a protein complex that plays a crucial role in maintaining the integrity of chromosomes during cell division.\n2. Loss of cohesin can lead to aneuploidy, a condition with an abnormal number of chromosomes in the cells.\n3. Cohesin is known to regulate the formation and maintenance of loop domains in the chromatin structure.\n4. Loop domains are regions of DNA that are looped out from the chromatin fiber and they play a role in the regulation of gene expression.\n5. Upon cohesin loss, the loop domains may be disrupted or altered in their organization.",
    "vicuna-13b_fact": [
      "Cohesin is a protein complex that plays a crucial role in maintaining the integrity of chromosomes during cell division.",
      "Loss of cohesin can lead to aneuploidy, a condition with an abnormal number of chromosomes in the cells.",
      "Cohesin is known to regulate the formation and maintenance of loop domains in the chromatin structure.",
      "Loop domains are regions of DNA that are looped out from the chromatin fiber and they play a role in the regulation of gene expression.",
      "Upon cohesin loss, the loop domains may be disrupted or altered in their organization."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2380,
    "user_query": "Which workflow in Bioconductor has been developed for accessing human RNA-seq samples?",
    "vicuna-13b_response": "There are several workflows in Bioconductor that can be used for analyzing human RNA-seq data. One popular workflow is the \"Sleuth\" package, which is designed specifically for the analysis of RNA-seq data from human samples. Sleuth provides a suite of tools for quality control, feature extraction, and differential expression analysis of RNA-seq data.\nTo start, you would first need to install the Sleuth package in Bioconductor. Once installed, you can load the data into Sleuth using the `sleuth_prep()` function, which will parse the input fastq files and generate a `sleuth_prep.csv` file containing information about the samples.\nNext, you can use the `sleuth_prep()` function to generate a `sleuth_prep.csv` file containing information about the samples. This file can be used to generate a `sleuth.table` object, which contains information about the samples and the aligned reads.\nOnce you have the `sleuth.table` object, you can use the `sleuth_analysis()` function to start the analysis workflow. This function will perform quality control on the data, extract features (e.g. counts, fragments per kilobase exon per million, etc.), and perform differential expression analysis. The output of the `sleuth_analysis()` function is a `sleuth.results` object, which contains the results of the analysis.\nOverall, the Sleuth package provides a powerful and flexible workflow for analyzing human RNA-seq data, and is a popular choice among Bioconductor users.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The \"Sleuth\" package in Bioconductor is used for analyzing human RNA-seq data.\n2. The Sleuth package provides tools for quality control, feature extraction, and differential expression analysis of RNA-seq data.\n3. The 'sleuth_prep()' is a function in the Sleuth package that parses input fastq files and generates a 'sleuth_prep.csv' file.\n4. The 'sleuth_analysis()' function in the Sleuth package performs quality control on the data, extracts features and performs differential expression analysis.\n5. The output of the 'sleuth_analysis()' function is a 'sleuth.results' object, which contains the results of the analysis.",
    "vicuna-13b_fact": [
      "The \"Sleuth\" package in Bioconductor is used for analyzing human RNA-seq data.",
      "The Sleuth package provides tools for quality control, feature extraction, and differential expression analysis of RNA-seq data.",
      "The 'sleuth_prep()' is a function in the Sleuth package that parses input fastq files and generates a 'sleuth_prep.csv' file.",
      "The 'sleuth_analysis()' function in the Sleuth package performs quality control on the data, extracts features and performs differential expression analysis.",
      "The output of the 'sleuth_analysis()' function is a 'sleuth.results' object, which contains the results of the analysis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The 'sleuth_prep()' function in the Sleuth package reads in kallisto results, not input fastq files, and it doesn't generate a 'sleuth_prep.csv' file.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2387,
    "user_query": "List polyubiquitin binding proteins involved in NF-kappaB signaling.",
    "vicuna-13b_response": "Polyubiquitin binding proteins (PUBs) play a crucial role in regulating the NF-κB signaling pathway by controlling the degradation of the inhibitory proteins that bind to NF-κB and the activation of the NF-κB transcription factor. Here are some of the PUBs involved in NF-κB signaling:\n1. C-terminal binding proteins (CTBPs): CTBPs are PUBs that bind to the C-terminal of the NF-κB inhibitory proteins, such as IκBα and IκBβ, and promote their degradation by the proteasome. CTBPs also interact with other transcription factors, including AP-1 and STATs, and regulate their activity.\n2. HSP70-interacting proteins (HIPs): HIPs are PUBs that interact with the heat shock protein 70 (HSP70) and regulate the folding and degradation of HSP70-bound proteins, including NF-κB. HIPs also interact with the proteasome and promote the degradation of NF-κB inhibitory proteins.\n3. Ubiquitin-conjugating enzymes (Ubcs): Ubcs are enzymes that catalyze the formation of ubiquitin conjugates, including polyubiquitin chains that target proteins for degradation by the proteasome. Ubcs play a crucial role in regulating the activity of NF-κB by controlling the degradation of NF-κB inhibitory proteins.\n4. Ubiquitin-specific proteases (USPs): USPs are enzymes that cleave ubiquitin conjugates and regulate the degradation of target proteins. USPs play a crucial role in regulating the activity of NF-κB by controlling the degradation of NF-κB inhibitory proteins.\nOverall, PUBs play a crucial role in regulating the NF-κB signaling pathway by controlling the degradation of the inhibitory proteins that bind to NF-κB and the activation",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Polyubiquitin binding proteins (PUBs) regulate the NF-κB signaling pathway by controlling the degradation of inhibitory proteins that bind to NF-κB and the activation of the NF-κB transcription factor.\n2. C-terminal binding proteins (CTBPs) are PUBs that bind to the C-terminal of the NF-κB inhibitory proteins and promote their degradation by the proteasome.\n3. HSP70-interacting proteins (HIPs) are PUBs that interact with the heat shock protein 70 (HSP70) and regulate the folding and degradation of HSP70-bound proteins, including NF-κB.\n4. Ubiquitin-conjugating enzymes (Ubcs) are enzymes that catalyze the formation of ubiquitin conjugates, including polyubiquitin chains that target proteins for degradation by the proteasome.\n5. Ubiquitin-specific proteases (USPs) are enzymes that cleave ubiquitin conjugates and regulate the degradation of target proteins.",
    "vicuna-13b_fact": [
      "Polyubiquitin binding proteins (PUBs) regulate the NF-κB signaling pathway by controlling the degradation of inhibitory proteins that bind to NF-κB and the activation of the NF-κB transcription factor.",
      "C-terminal binding proteins (CTBPs) are PUBs that bind to the C-terminal of the NF-κB inhibitory proteins and promote their degradation by the proteasome.",
      "HSP70-interacting proteins (HIPs) are PUBs that interact with the heat shock protein 70 (HSP70) and regulate the folding and degradation of HSP70-bound proteins, including NF-κB.",
      "Ubiquitin-conjugating enzymes (Ubcs) are enzymes that catalyze the formation of ubiquitin conjugates, including polyubiquitin chains that target proteins for degradation by the proteasome.",
      "Ubiquitin-specific proteases (USPs) are enzymes that cleave ubiquitin conjugates and regulate the degradation of target proteins."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2388,
    "user_query": "What are the prednisone side effects in DMD patients?",
    "vicuna-13b_response": "Prednisone is a corticosteroid medication that is commonly used to treat a variety of conditions, including muscle weakness and inflammation. In patients with Duchenne muscular dystrophy (DMD), prednisone may be used to help manage muscle weakness and inflammation associated with the condition.\nHowever, prednisone can also have a number of side effects, some of which can be serious. These side effects may include:\n1. Weight gain: Prednisone can cause weight gain, which can be particularly problematic in patients with DMD, who are already at risk for obesity.\n2. Acne: Prednisone can cause acne, particularly on the face, neck, and chest.\n3. Mood changes: Prednisone can cause mood changes, including irritability, depression, and anxiety.\n4. Sleep disturbances: Prednisone can cause sleep disturbances, including insomnia and nightmares.\n5. Gastrointestinal problems: Prednisone can cause gastrointestinal problems, including nausea, vomiting, and stomach pain.\n6. Skin thinning: Prednisone can cause skin thinning, which can lead to easy bruising and increased risk of infection.\n7. Osteoporosis: Long-term use of prednisone can lead to osteoporosis, which can increase the risk of fractures.\n8. Cataracts: Long-term use of prednisone can increase the risk of developing cataracts.\n9. Glaucoma: Long-term use of prednisone can increase the risk of developing glaucoma.\nIt is important to note that not all patients will experience these side effects, and the severity of side effects can vary from person to person. It is important to discuss the potential benefits and risks of prednisone therapy with a healthcare provider, who can help determine whether this treatment is appropriate for a particular patient with DMD.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Prednisone is a corticosteroid medication used to treat conditions such as muscle weakness and inflammation.\n2. Prednisone may be used to manage muscle weakness and inflammation in Duchenne muscular dystrophy (DMD) patients.\n3. Side effects of Prednisone can include weight gain, acne, mood changes, sleep disturbances, and gastrointestinal problems.\n4. Long-term use of Prednisone may lead to osteoporosis, cataracts, and glaucoma.\n5. The severity of Prednisone side effects can vary from person to person.",
    "vicuna-13b_fact": [
      "Prednisone is a corticosteroid medication used to treat conditions such as muscle weakness and inflammation.",
      "Prednisone may be used to manage muscle weakness and inflammation in Duchenne muscular dystrophy (DMD) patients.",
      "Side effects of Prednisone can include weight gain, acne, mood changes, sleep disturbances, and gastrointestinal problems.",
      "Long-term use of Prednisone may lead to osteoporosis, cataracts, and glaucoma.",
      "The severity of Prednisone side effects can vary from person to person."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "vicuna-13b_response": "ROF1 is a transcription factor that is involved in regulating the response of Arabidopsis thaliana to various environmental stresses, including drought, salt, and cold. The expression of ROF1 is induced in response to these stresses, and it plays a role in the activation of genes that are involved in stress response pathways.\nSeveral studies have identified different factors that can induce the expression of ROF1 in Arabidopsis. For example, exposure to high levels of salt or mannitol can induce ROF1 expression, as can exposure to low temperatures or high light intensity. Additionally, ROF1 expression can be induced by certain hormones, such as abscisic acid or ethylene.\nIn general, the induction of ROF1 expression is thought to be mediated by a combination of environmental signals and intracellular signaling pathways. For example, ROF1 expression may be induced by the activation of specific transcription factors, such as DREB1 or HSF, which are known to be involved in regulating stress response pathways in Arabidopsis. Additionally, the activity of ROF1 itself may be regulated by post-translational modifications, such as phosphorylation or acetylation, which can affect its ability to bind to DNA and regulate gene expression.\nOverall, the induction of ROF1 expression in Arabidopsis is a complex process that is influenced by a variety of environmental and intracellular signals, and it is likely that the specific mechanisms involved in ROF1 induction will vary depending on the specific stress conditions being experienced by the plant.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ROF1 is a transcription factor that is involved in regulating the response of Arabidopsis thaliana to various environmental stresses, including drought, salt, and cold.\n2. The expression of ROF1 in Arabidopsis can be induced by exposure to high levels of salt or mannitol, low temperatures, or high light intensity.\n3. ROF1 expression can also be induced by certain hormones, such as abscisic acid or ethylene.\n4. The expression of ROF1 can be induced by the activation of specific transcription factors, such as DREB1 or HSF.\n5. The activity of ROF1 may be regulated by post-translational modifications, such as phosphorylation or acetylation.",
    "vicuna-13b_fact": [
      "ROF1 is a transcription factor that is involved in regulating the response of Arabidopsis thaliana to various environmental stresses, including drought, salt, and cold.",
      "The expression of ROF1 in Arabidopsis can be induced by exposure to high levels of salt or mannitol, low temperatures, or high light intensity.",
      "ROF1 expression can also be induced by certain hormones, such as abscisic acid or ethylene.",
      "The expression of ROF1 can be induced by the activation of specific transcription factors, such as DREB1 or HSF.",
      "The activity of ROF1 may be regulated by post-translational modifications, such as phosphorylation or acetylation."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2393,
    "user_query": "What is the preferred orientation of CTCF binding sites for chromatin looping?",
    "vicuna-13b_response": "The preferred orientation of CTCF (CCCTC-binding factor) binding sites for chromatin looping is bidirectional. CTCF is a transcription factor that plays a crucial role in regulating chromatin structure and gene expression. It binds to the DNA in a specific sequence-dependent manner and acts as a bridge to bring distant regulatory elements into close proximity, thereby facilitating the formation of chromatin loops.\nThe binding of CTCF to its target sites on the DNA is thought to be bidirectional, meaning that it can bind to the DNA in both directions, either from the 5' to 3' end or from the 3' to 5' end. This bidirectional binding is important for the formation of stable chromatin loops, as it allows for the formation of a continuous loop structure that is not disrupted by the direction of transcription.\nIn addition, the bidirectional binding of CTCF also allows for the regulation of gene expression by controlling the access of other transcription factors to their target sites. By bringing regulatory elements into close proximity, CTCF can facilitate the interaction between transcription factors and their target genes, thereby modulating their expression.\nOverall, the bidirectional orientation of CTCF binding sites is crucial for the formation of stable chromatin loops and the regulation of gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The preferred orientation of CTCF binding sites for chromatin looping is bidirectional.\n2. CTCF is a transcription factor that plays a crucial role in regulating chromatin structure and gene expression.\n3. CTCF binds to the DNA in a specific sequence-dependent manner.\n4. The bidirectional binding of CTCF is important for the formation of stable chromatin loops.\n5. The bidirectional binding of CTCF helps regulate gene expression by controlling the access of other transcription factors to their target sites.",
    "vicuna-13b_fact": [
      "The preferred orientation of CTCF binding sites for chromatin looping is bidirectional.",
      "CTCF is a transcription factor that plays a crucial role in regulating chromatin structure and gene expression.",
      "CTCF binds to the DNA in a specific sequence-dependent manner.",
      "The bidirectional binding of CTCF is important for the formation of stable chromatin loops.",
      "The bidirectional binding of CTCF helps regulate gene expression by controlling the access of other transcription factors to their target sites."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "vicuna-13b_response": "The most common cause of hereditary renal amyloidosis is the accumulation of the protein transthyretin (TTR) in the kidneys. TTR is a protein that is produced in the liver and transported to the kidneys, where it is normally eliminated in the urine. In hereditary renal amyloidosis, there is a mutation in the TTR gene that causes the protein to misfold and accumulate in the kidneys, leading to the formation of amyloid fibrils. These fibrils can cause damage to the kidneys and lead to progressive kidney failure. Other proteins can also cause hereditary renal amyloidosis, but TTR is the most common.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The most common cause of hereditary renal amyloidosis is the accumulation of the protein transthyretin (TTR) in the kidneys.\n2. TTR is a protein that is produced in the liver and is usually transported to the kidneys to be eliminated in the urine.\n3. In cases of hereditary renal amyloidosis with TTR, there is a mutation in the TTR gene causing the protein to misfold and accumulate in the kidneys.\n4. The accumulation of amyloid fibrils can damage the kidneys and lead to progressive kidney failure.\n5. Other proteins besides TTR can cause hereditary renal amyloidosis.",
    "vicuna-13b_fact": [
      "The most common cause of hereditary renal amyloidosis is the accumulation of the protein transthyretin (TTR) in the kidneys.",
      "TTR is a protein that is produced in the liver and is usually transported to the kidneys to be eliminated in the urine.",
      "In cases of hereditary renal amyloidosis with TTR, there is a mutation in the TTR gene causing the protein to misfold and accumulate in the kidneys.",
      "The accumulation of amyloid fibrils can damage the kidneys and lead to progressive kidney failure.",
      "Other proteins besides TTR can cause hereditary renal amyloidosis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Transthyretin (TTR) is a protein that is produced in the liver, it is not usually transported to the kidneys to be eliminated in the urine.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2401,
    "user_query": "Where do centromeres locate according to the Rabl orientation of eukaryotic nuclei?",
    "vicuna-13b_response": "Centromeres are regions of the chromosome where the sister chromatids are held together by a protein structure called the kinetochore. In eukaryotic cells, the Rabl orientation refers to the orientation of the mitotic spindle relative to the nuclear envelope.\nIn prokaryotic cells, the centromere is located in the middle of the chromosome, and the sister chromatids are held together by a protein structure called the centromere. In eukaryotic cells, the centromeres are located at the ends of the chromosomes, and the sister chromatids are held together by the kinetochore.\nThe Rabl orientation is important for proper chromosome segregation during cell division. When the mitotic spindle is aligned with the Rabl orientation, it ensures that the sister chromatids are pulled apart in opposite directions, resulting in accurate segregation of the chromosomes.\nIn summary, centromeres are located at the ends of eukaryotic chromosomes, and the Rabl orientation is important for proper segregation of the sister chromatids during cell division.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Centromeres are regions of the chromosome where the sister chromatids are held together by a protein structure called the kinetochore.\n2. The Rabl orientation refers to the orientation of the mitotic spindle relative to the nuclear envelope in eukaryotic cells.\n3. In prokaryotic cells, the centromere is located in the middle of the chromosome.\n4. In eukaryotic cells, the centromeres are located at the ends of the chromosomes.\n5. The Rabl orientation is important for proper chromosome segregation during cell division.",
    "vicuna-13b_fact": [
      "Centromeres are regions of the chromosome where the sister chromatids are held together by a protein structure called the kinetochore.",
      "The Rabl orientation refers to the orientation of the mitotic spindle relative to the nuclear envelope in eukaryotic cells.",
      "In prokaryotic cells, the centromere is located in the middle of the chromosome.",
      "In eukaryotic cells, the centromeres are located at the ends of the chromosomes.",
      "The Rabl orientation is important for proper chromosome segregation during cell division."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Prokaryotic cells do not have a centromere as they lack the typical chromosome structure found in eukaryotic cells. Instead, they have a singular circular DNA molecule.\n4. FALSE [correction]: In eukaryotic cells, the centromeres are not necessarily located at the ends of the chromosomes. Their position can vary and that determines the shape of the chromosome.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2404,
    "user_query": "What is the mode of action of the drug Prolia?",
    "vicuna-13b_response": "Prolia (denosumab) is a medication that is used to treat a variety of conditions related to bone health, including osteoporosis, bone loss due to cancer, and fractures caused by low bone density.\nThe mode of action of Prolia is to target and inhibit the activity of osteoclasts, which are cells responsible for breaking down bone tissue. In this way, Prolia helps to reduce bone loss and increase bone density.\nProlia works by binding to a protein called the RANKL protein, which is essential for the survival and activity of osteoclasts. By inhibiting the activity of RANKL, Prolia reduces the number of osteoclasts and the amount of bone that is broken down, leading to an increase in bone density and a decrease in the risk of fractures.\nProlia is administered as an injection under the skin, and the dosage and frequency of administration depend on the condition being treated and the individual patient's needs. It is important to follow the instructions provided by your healthcare provider when using Prolia to ensure that you receive the maximum benefit from the medication.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Prolia (denosumab) is used to treat conditions related to bone health, including osteoporosis, bone loss due to cancer, and fractures caused by low bone density.\n2. The mode of action of Prolia is to target and inhibit the activity of osteoclasts, cells responsible for breaking down bone tissue.\n3. Prolia works by binding to a protein called the RANKL protein, which is involved in the survival and activity of osteoclasts.\n4. By inhibiting the activity of RANKL, Prolia reduces the number of osteoclasts and the amount of bone that is broken down.\n5. Prolia is administered as an injection under the skin, and the dosage and frequency depend on the condition being treated and the individual patient's needs.",
    "vicuna-13b_fact": [
      "Prolia (denosumab) is used to treat conditions related to bone health, including osteoporosis, bone loss due to cancer, and fractures caused by low bone density.",
      "The mode of action of Prolia is to target and inhibit the activity of osteoclasts, cells responsible for breaking down bone tissue.",
      "Prolia works by binding to a protein called the RANKL protein, which is involved in the survival and activity of osteoclasts.",
      "By inhibiting the activity of RANKL, Prolia reduces the number of osteoclasts and the amount of bone that is broken down.",
      "Prolia is administered as an injection under the skin, and the dosage and frequency depend on the condition being treated and the individual patient's needs."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "vicuna-13b_response": "Yes, the proteome of mice hippocampus has been analyzed. The hippocampus is a structure in the brain that plays a key role in memory and spatial navigation, and it is an important region to study in the context of neuroscience and brain disease.\nSeveral proteomic studies have been conducted on the hippocampus of mice, using techniques such as 2D gel electrophoresis, mass spectrometry, and other advanced proteomics tools. These studies have identified a large number of proteins that are expressed in the hippocampus, including structural proteins, enzymes, transport proteins, and signaling molecules.\nFor example, a study published in the journal \"Proteomics\" in 2012 used 2D gel electrophoresis and mass spectrometry to identify 462 proteins in the hippocampus of mice. Another study published in the journal \"Journal of Neuroscience\" in 2015 used a combination of 2D gel electrophoresis and liquid chromatography-tandem mass spectrometry to identify 1,325 proteins in the hippocampus of mice.\nThese studies have provided valuable insights into the proteins that are involved in various brain functions, such as learning and memory, and have also helped to identify potential targets for the development of new treatments for brain diseases. However, it is important to note that these studies are still ongoing, and there is still much to be learned about the proteome of the mouse hippocampus.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The proteome of mice hippocampus has been analyzed.\n2. The hippocampus is a structure in the brain that plays a key role in memory and spatial navigation.\n3. Several proteomic studies have been conducted on the hippocampus of mice, using techniques such as 2D gel electrophoresis, mass spectrometry, and other advanced proteomics tools.\n4. A study published in the journal \"Proteomics\" in 2012 identified 462 proteins in the hippocampus of mice.\n5. Another study published in the journal \"Journal of Neuroscience\" in 2015 identified 1,325 proteins in the hippocampus of mice.",
    "vicuna-13b_fact": [
      "The proteome of mice hippocampus has been analyzed.",
      "The hippocampus is a structure in the brain that plays a key role in memory and spatial navigation.",
      "Several proteomic studies have been conducted on the hippocampus of mice, using techniques such as 2D gel electrophoresis, mass spectrometry, and other advanced proteomics tools.",
      "A study published in the journal \"Proteomics\" in 2012 identified 462 proteins in the hippocampus of mice.",
      "Another study published in the journal \"Journal of Neuroscience\" in 2015 identified 1,325 proteins in the hippocampus of mice."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "vicuna-13b_response": "Mouse chromosomes are not acrocentric. Acrocentric chromosomes are those in which the centromere is located at the tip of the chromosome. Mouse chromosomes have a different type of centromere organization, called \"pericentromeric heterochromatin,\" which is located closer to the center of the chromosome.\nIn mice, the X and Y chromosomes are acrocentric, while the other chromosomes are metacentric or submetacentric. The X and Y chromosomes have a unique structure, with a large amount of heterochromatin at their tips, which is why they are considered acrocentric.\nIt's worth noting that the chromosome structure and organization can vary between different species, and even between different individuals of the same species.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mouse chromosomes are not acrocentric.\n2. Acrocentric chromosomes are those in which the centromere is located at the tip of the chromosome.\n3. Mouse chromosomes have an organization called \"pericentromeric heterochromatin,\" which is located closer to the center of the chromosome.\n4. In mice, the X and Y chromosomes are acrocentric.\n5. The chromosome structure and organization can vary between different species and even between different individuals of the same species.",
    "vicuna-13b_fact": [
      "Mouse chromosomes are not acrocentric.",
      "Acrocentric chromosomes are those in which the centromere is located at the tip of the chromosome.",
      "Mouse chromosomes have an organization called \"pericentromeric heterochromatin,\" which is located closer to the center of the chromosome.",
      "In mice, the X and Y chromosomes are acrocentric.",
      "The chromosome structure and organization can vary between different species and even between different individuals of the same species."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mouse chromosomes are predominantly acrocentric.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2414,
    "user_query": "Which disease risk can be estimated with the Stop-Bang questionnaire?",
    "vicuna-13b_response": "The Stop-Bang questionnaire is a tool used to assess the risk of obstructive sleep apnea (OSA), which is a sleep disorder characterized by pauses in breathing during sleep. The questionnaire consists of six questions that assess the symptoms of OSA, such as snoring, pauses in breathing, and daytime sleepiness. The Stop-Bang questionnaire is a simple and easy-to-use tool that can help identify individuals who may be at risk for OSA.\nThe six questions in the Stop-Bang questionnaire are:\n1. Do you snore loudly?\n2. Do you feel tired or sleepy during the day?\n3. Do you have difficulty staying awake while driving or reading?\n4. Do you have a history of high blood pressure?\n5. Do you have a history of heart disease or stroke?\n6. Do you have a large neck size (17 inches or greater in men, 16 inches or greater in women)?\nBased on the answers to these questions, a score is assigned to each individual, with a higher score indicating a higher risk of OSA. The Stop-Bang questionnaire has been shown to be a reliable and valid tool for identifying individuals at risk for OSA, and it can be used as a screening tool in clinical settings or as a self-assessment tool for individuals who suspect they may have OSA.\nIt is important to note that the Stop-Bang questionnaire is not a diagnostic tool and should not be used to diagnose OSA. A diagnosis of OSA should be made by a healthcare professional who has evaluated the individual's symptoms and has conducted a comprehensive sleep evaluation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Stop-Bang questionnaire is used to assess the risk of obstructive sleep apnea.\n2. Obstructive sleep apnea is a sleep disorder characterized by pauses in breathing during sleep.\n3. The Stop-Bang questionnaire consists of six questions that assess symptoms such as snoring, pauses in breathing, and daytime sleepiness.\n4. The Stop-Bang questionnaire assigns a score based on the answers to its questions, with a higher score indicating a higher risk of obstructive sleep apnea.\n5. The Stop-Bang questionnaire is not a diagnostic tool and should not be used to diagnose obstructive sleep apnea.",
    "vicuna-13b_fact": [
      "The Stop-Bang questionnaire is used to assess the risk of obstructive sleep apnea.",
      "Obstructive sleep apnea is a sleep disorder characterized by pauses in breathing during sleep.",
      "The Stop-Bang questionnaire consists of six questions that assess symptoms such as snoring, pauses in breathing, and daytime sleepiness.",
      "The Stop-Bang questionnaire assigns a score based on the answers to its questions, with a higher score indicating a higher risk of obstructive sleep apnea.",
      "The Stop-Bang questionnaire is not a diagnostic tool and should not be used to diagnose obstructive sleep apnea."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Stop-Bang questionnaire consists of eight questions that assess symptoms such as snoring, pauses in breathing, and daytime sleepiness.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2415,
    "user_query": "List indications for palivizumab for treatment of RSV-induced bronchiolitis.",
    "vicuna-13b_response": "Palivizumab is a monoclonal antibody used for the prevention of respiratory syncytial virus (RSV) infection in high-risk infants and young children. It is also used for the treatment of RSV-induced bronchiolitis in certain cases.\nIndications for palivizumab treatment for RSV-induced bronchiolitis include:\n1. Severely ill infants and young children who require hospitalization due to RSV infection.\n2. Infants and young children with chronic lung disease, including bronchopulmonary dysplasia, who are at high risk for severe RSV infection.\n3. Infants and young children with congenital heart disease, including those with cyanotic heart disease, who are at high risk for severe RSV infection.\n4. Infants and young children who have had a previous severe RSV infection or who have a family history of severe RSV infection.\n5. Premature infants who were born at less than 29 weeks gestational age and who have a history of respiratory distress syndrome (RDS) or who are at high risk for RSV-related hospitalization.\nIt is important to note that palivizumab is not a substitute for antibiotics, and antibiotics should be used to treat any concurrent bacterial infections. The use of palivizumab should be based on the clinical judgment of a healthcare provider and the individual needs of the patient.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Palivizumab is a monoclonal antibody used for the prevention of respiratory syncytial virus (RSV) infection in high-risk infants and young children.\n2. Palivizumab is also used for the treatment of RSV-induced bronchiolitis in certain cases.\n3. Indications for palivizumab treatment can include severely ill, hospitalized infants and young children due to RSV infection.\n4. Infants and young children with chronic lung disease, including bronchopulmonary dysplasia, who are at high risk for severe RSV infection can be treated with palivizumab.\n5. Infants and young children who have had a previous severe RSV infection or who have a family history of severe RSV infection may also be treated with palivizumab.",
    "vicuna-13b_fact": [
      "Palivizumab is a monoclonal antibody used for the prevention of respiratory syncytial virus (RSV) infection in high-risk infants and young children.",
      "Palivizumab is also used for the treatment of RSV-induced bronchiolitis in certain cases.",
      "Indications for palivizumab treatment can include severely ill, hospitalized infants and young children due to RSV infection.",
      "Infants and young children with chronic lung disease, including bronchopulmonary dysplasia, who are at high risk for severe RSV infection can be treated with palivizumab.",
      "Infants and young children who have had a previous severe RSV infection or who have a family history of severe RSV infection may also be treated with palivizumab."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Palivizumab is used for the prevention, not the treatment of RSV-induced bronchiolitis in high-risk infants and young children.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "vicuna-13b_response": "One siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer is called \"Onpattro\" (patisiran). Onpattro is a targeted therapy that uses RNA interference (RNAi) technology to inhibit the production of a protein called \"hematopoietic growth factor receptor 2\" (CD47), which is expressed on the surface of many types of cancer cells, including pancreatic cancer cells. By inhibiting CD47, Onpattro can help to enhance the immune system's ability to recognize and attack cancer cells.\nOnpattro is administered intravenously and has been studied in several clinical trials for the treatment of pancreatic cancer, including a phase 1b/2 clinical trial (NCT02822612) and a phase 3 clinical trial (NCT03003075). The results of these trials have shown that Onpattro can be effective in treating pancreatic cancer, with some patients experiencing significant reductions in tumor size and improvements in overall survival.\nIt's important to note that while Onpattro has shown promise in clinical trials, it is not yet approved by the FDA for the treatment of pancreatic cancer, and more research is needed to fully understand its safety and efficacy in this context.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Onpattro is an siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer.\n2. Onpattro uses RNA interference technology to inhibit the production of the protein CD47.\n3. CD47 is expressed on the surface of many types of cancer cells, including pancreatic cancer cells.\n4. Onpattro has been studied in a phase 1b/2 clinical trial (NCT02822612) and a phase 3 clinical trial (NCT03003075) for the treatment of pancreatic cancer.\n5. Onpattro is not yet approved by the FDA for the treatment of pancreatic cancer.",
    "vicuna-13b_fact": [
      "Onpattro is an siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer.",
      "Onpattro uses RNA interference technology to inhibit the production of the protein CD47.",
      "CD47 is expressed on the surface of many types of cancer cells, including pancreatic cancer cells.",
      "Onpattro has been studied in a phase 1b/2 clinical trial (NCT02822612) and a phase 3 clinical trial (NCT03003075) for the treatment of pancreatic cancer.",
      "Onpattro is not yet approved by the FDA for the treatment of pancreatic cancer."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Onpattro (patisiran) is an siRNA-based drug that is approved for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR), not pancreatic cancer.\n2. FALSE [correction]: Onpattro uses RNA interference technology to inhibit the production of the protein transthyretin (TTR), not CD47.\n3. TRUE\n4. FALSE [correction]: Onpattro has been studied in clinical trials for hATTR, not pancreatic cancer. The specific trial identifiers provided do not appear to be linked to studies of Onpattro for the treatment of pancreatic cancer.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "vicuna-13b_response": "The HPG pore, also known as the hypothalamic-pituitary-gonadal (HPG) axis, is a complex network of endocrine glands and tissues that work together to regulate various physiological processes in the body, including growth and development, reproduction, and stress response.\nThe hypothalamus is a small region of the brain that serves as the central control center for many of the body's autonomic functions, such as body temperature, hunger, and thirst. The pituitary gland, located at the base of the brain, is a small endocrine gland that plays a critical role in regulating various bodily functions through the production of hormones.\nThe gonads, which are the reproductive organs that produce gametes (testes in males, ovaries in females), are also part of the HPG axis. The HPG axis works by releasing various hormones that regulate the production and release of other hormones, creating a complex feedback loop that helps maintain homeostasis in the body.\nOverall, the HPG pore is a vital part of the endocrine system that plays a critical role in regulating many aspects of the body's physiology.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The HPG pore, also known as the hypothalamic-pituitary-gonadal (HPG) axis, is a complex network of endocrine glands and tissues.\n2. The HPG axis regulates various physiological processes in the body, including growth and development, reproduction, and stress response.\n3. The hypothalamus is a small region of the brain that serves as the central control center for many of the body's autonomic functions.\n4. The pituitary gland is a small endocrine gland that is located at the base of the brain and regulates various bodily functions through the production of hormones.\n5. The gonads, which produce gametes (testes in males, ovaries in females), are also part of the HPG axis.",
    "vicuna-13b_fact": [
      "The HPG pore, also known as the hypothalamic-pituitary-gonadal (HPG) axis, is a complex network of endocrine glands and tissues.",
      "The HPG axis regulates various physiological processes in the body, including growth and development, reproduction, and stress response.",
      "The hypothalamus is a small region of the brain that serves as the central control center for many of the body's autonomic functions.",
      "The pituitary gland is a small endocrine gland that is located at the base of the brain and regulates various bodily functions through the production of hormones.",
      "The gonads, which produce gametes (testes in males, ovaries in females), are also part of the HPG axis."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The HPG axis, also known as the hypothalamic-pituitary-gonadal axis, is a complex network of endocrine glands and tissues, not a pore.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2422,
    "user_query": "Which R/Bioconductor package has been developed for cancer subtype identification?",
    "vicuna-13b_response": "There are several R/Bioconductor packages that can be used for cancer subtype identification. Some of the most popular ones are:\n1. PAM50: This package is based on the PAM50 gene expression profile signature, which is a widely used classification system for breast cancer subtypes. PAM50 can be used to classify breast cancer samples into five different subtypes: Luminal A, Luminal B, HER2-enriched, Basal-like, and Normal-like.\n2. WGCNA: This package is used for identifying cancer subtypes based on gene expression data. It uses a weighted gene co-expression network analysis (WGCNA) approach to identify groups of genes that are co-expressed and enriched for specific functions or biological processes.\n3. CIBERSORT: This package is used for identifying cancer subtypes based on gene expression data. It uses a machine learning-based approach to classify samples into different subtypes based on their gene expression profiles.\n4. MAS5: This package is used for identifying cancer subtypes based on gene expression data. It uses a normalization and summarization method to identify differentially expressed genes between different subtypes.\n5. TCGA-RNAseq-V2: This package is based on the TCGA (The Cancer Genome Atlas) project and provides a comprehensive analysis of RNA sequencing data for multiple cancer types. It includes data from over 20,000 patient samples and can be used to identify cancer subtypes based on gene expression data.\nThese are just a few examples of the many R/Bioconductor packages that can be used for cancer subtype identification. The choice of package will depend on the specific needs of the user and the type of data they are working with.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The PAM50 R/Bioconductor package can be used to classify breast cancer samples into five different subtypes.\n2. The WGCNA R/Bioconductor package uses a gene co-expression network analysis approach to identify cancer subtypes.\n3. The CIBERSORT R/Bioconductor package uses a machine learning-based approach to classify samples into different subtypes based on their gene expression profiles.\n4. The MAS5 R/Bioconductor package uses a normalization and summarization method to identify differentially expressed genes between different subtypes.\n5. The TCGA-RNAseq-V2 package is based on the TCGA project and provides a comprehensive analysis of RNA sequencing data for multiple cancer types.",
    "vicuna-13b_fact": [
      "The PAM50 R/Bioconductor package can be used to classify breast cancer samples into five different subtypes.",
      "The WGCNA R/Bioconductor package uses a gene co-expression network analysis approach to identify cancer subtypes.",
      "The CIBERSORT R/Bioconductor package uses a machine learning-based approach to classify samples into different subtypes based on their gene expression profiles.",
      "The MAS5 R/Bioconductor package uses a normalization and summarization method to identify differentially expressed genes between different subtypes.",
      "The TCGA-RNAseq-V2 package is based on the TCGA project and provides a comprehensive analysis of RNA sequencing data for multiple cancer types."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2423,
    "user_query": "Is Solanezumab effective for Alzheimer's Disease?",
    "vicuna-13b_response": "Solanezumab is a monoclonal antibody that is being studied for its potential to slow the progression of Alzheimer's disease. It is designed to bind to beta-amyloid protein, a toxic substance that accumulates in the brains of people with Alzheimer's disease and is thought to play a role in the destruction of brain cells.\nClinical trials have shown that solanezumab can reduce the amount of beta-amyloid protein in the brain and slow the decline of cognitive abilities in people with mild to moderate Alzheimer's disease. However, the drug has not been approved by the FDA for use in the treatment of Alzheimer's disease, and more research is needed to fully understand its effectiveness and safety.\nIt's important to note that there is no cure for Alzheimer's disease, and current treatments can only slow the progression of the disease. Solanezumab is one of several potential treatments that are being studied for their potential to slow the progression of Alzheimer's disease, and it is important for people with Alzheimer's disease to work with their healthcare providers to determine the best course of treatment for their individual needs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Solanezumab is a monoclonal antibody being studied for its potential to slow the progression of Alzheimer's disease.\n2. This drug is designed to bind to beta-amyloid protein, which accumulates in the brains of people with Alzheimer's disease.\n3. Clinical trials have shown that solanezumab can reduce the amount of beta-amyloid protein in the brain and slow the decline of cognitive abilities in people with mild to moderate Alzheimer's disease.\n4. The FDA has not approved Solanezumab for the treatment of Alzheimer's disease.\n5. There is currently no cure for Alzheimer's disease, only treatments that can slow its progression.",
    "vicuna-13b_fact": [
      "Solanezumab is a monoclonal antibody being studied for its potential to slow the progression of Alzheimer's disease.",
      "This drug is designed to bind to beta-amyloid protein, which accumulates in the brains of people with Alzheimer's disease.",
      "Clinical trials have shown that solanezumab can reduce the amount of beta-amyloid protein in the brain and slow the decline of cognitive abilities in people with mild to moderate Alzheimer's disease.",
      "The FDA has not approved Solanezumab for the treatment of Alzheimer's disease.",
      "There is currently no cure for Alzheimer's disease, only treatments that can slow its progression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Clinical trials have not definitively shown that solanezumab can reduce the amount of beta-amyloid protein in the brain and slow the decline of cognitive abilities in people with mild to moderate Alzheimer's disease.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2424,
    "user_query": "Are organisms in the genus Morexella associated with sepsis?",
    "vicuna-13b_response": "Organisms in the genus Moraxella are bacteria that are commonly found on the skin and mucous membranes of humans and animals. While some species of Moraxella can cause infections, they are generally not associated with sepsis.\nSepsis is a serious and potentially life-threatening condition that occurs when the body's response to an infection causes inflammation throughout the body. Sepsis can be caused by a variety of bacteria, viruses, fungi, and other microorganisms, and it can lead to severe complications such as septic shock, multiple organ failure, and death.\nSome species of Moraxella, such as Moraxella catarrhalis and Moraxella lacunata, have been associated with certain types of infections, such as respiratory tract infections and skin infections. However, these infections are generally not severe enough to lead to sepsis.\nIt's important to note that while Moraxella species are generally not associated with sepsis, they can still cause infections in individuals with compromised immune systems or other underlying health conditions. If you have concerns about a Moraxella infection or sepsis, it's important to seek medical attention from a qualified healthcare provider.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Organisms in the genus Moraxella are bacteria that are commonly found on the skin and mucous membranes of humans and animals.\n2. Sepsis occurs when the body's response to an infection causes inflammation throughout the body.\n3. Sepsis can be caused by a variety of bacteria, viruses, fungi, and other microorganisms.\n4. Some species of Moraxella, such as Moraxella catarrhalis and Moraxella lacunata, have been associated with certain types of infections, such as respiratory tract infections and skin infections.\n5. Infections caused by Moraxella species are generally not severe enough to lead to sepsis.",
    "vicuna-13b_fact": [
      "Organisms in the genus Moraxella are bacteria that are commonly found on the skin and mucous membranes of humans and animals.",
      "Sepsis occurs when the body's response to an infection causes inflammation throughout the body.",
      "Sepsis can be caused by a variety of bacteria, viruses, fungi, and other microorganisms.",
      "Some species of Moraxella, such as Moraxella catarrhalis and Moraxella lacunata, have been associated with certain types of infections, such as respiratory tract infections and skin infections.",
      "Infections caused by Moraxella species are generally not severe enough to lead to sepsis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Infections caused by Moraxella species can be severe and may potentially lead to sepsis.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2427,
    "user_query": "Which R/bioconductor package has been developed to aid in epigenomic analysis?",
    "vicuna-13b_response": "The R/Bioconductor package that is commonly used for epigenomic analysis is called \"Bisulfite Conversion and Sequencing (BSeq).\" BSeq is a comprehensive tool for the analysis of bisulfite-treated DNA sequencing data, which is commonly used to study DNA methylation. BSeq provides a suite of functions for the processing, quality control, and analysis of bisulfite-converted DNA sequencing data, including the calculation of methylation levels, the identification of differentially methylated regions, and the construction of methylation profiles. BSeq is highly customizable and can be used in conjunction with other R/Bioconductor packages for more advanced analyses.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The R/Bioconductor package used for epigenomic analysis is \"Bisulfite Conversion and Sequencing (BSeq).\"\n2. BSeq is a tool for the analysis of bisulfite-treated DNA sequencing data.\n3. BSeq assists in studying DNA methylation.\n4. BSeq provides a suite of functions for processing, quality control, and analysis of bisulfite-converted DNA sequencing data.\n5. BSeq can be used along with other R/Bioconductor packages for advanced analyses.",
    "vicuna-13b_fact": [
      "The R/Bioconductor package used for epigenomic analysis is \"Bisulfite Conversion and Sequencing (BSeq).\"",
      "BSeq is a tool for the analysis of bisulfite-treated DNA sequencing data.",
      "BSeq assists in studying DNA methylation.",
      "BSeq provides a suite of functions for processing, quality control, and analysis of bisulfite-converted DNA sequencing data.",
      "BSeq can be used along with other R/Bioconductor packages for advanced analyses."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2431,
    "user_query": "What is miravirsen?",
    "vicuna-13b_response": "Miravirsen is a medication that is used to treat a type of skin cancer called cutaneous T-cell lymphoma (CTCL). It is a targeted therapy that works by inhibiting the activity of a protein called the cyclin-dependent kinase 4 (CDK4) protein, which is involved in the growth and division of cancer cells. Miravirsen is administered as an intravenous infusion and is given in combination with a chemotherapy drug called temsirolimus.\nMiravirsen was approved by the U.S. Food and Drug Administration (FDA) in 2020 for the treatment of adult patients with CTCL who have received at least one prior systemic therapy. It is important to note that miravirsen should only be used under the supervision of a healthcare provider who is experienced in the use of cancer medications.\nIt is important to remember that miravirsen may cause side effects, and it is important to discuss the potential benefits and risks of treatment with a healthcare provider before starting therapy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Miravirsen is a medication used to treat cutaneous T-cell lymphoma (CTCL).\n2. Miravirsen works by inhibiting the activity of the cyclin-dependent kinase 4 (CDK4) protein.\n3. Miravirsen is administered as an intravenous infusion and is combined with a chemotherapy drug called temsirolimus.\n4. The U.S. Food and Drug Administration (FDA) approved Miravirsen in 2020 for the treatment of adult patients with CTCL who have received at least one prior systemic therapy.\n5. Miravirsen should only be used under the supervision of a healthcare provider who is experienced in the use of cancer medications.",
    "vicuna-13b_fact": [
      "Miravirsen is a medication used to treat cutaneous T-cell lymphoma (CTCL).",
      "Miravirsen works by inhibiting the activity of the cyclin-dependent kinase 4 (CDK4) protein.",
      "Miravirsen is administered as an intravenous infusion and is combined with a chemotherapy drug called temsirolimus.",
      "The U.S. Food and Drug Administration (FDA) approved Miravirsen in 2020 for the treatment of adult patients with CTCL who have received at least one prior systemic therapy.",
      "Miravirsen should only be used under the supervision of a healthcare provider who is experienced in the use of cancer medications."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2435,
    "user_query": "Which are the main transcriptional activators of circadian oscillations?",
    "vicuna-13b_response": "The main transcriptional activators of circadian oscillations are the CLOCK-CYCLE (CLK-CYC) and the NPAS2-Cryptochrome (NPAS2-CRY) complexes.\nThe CLK-CYC complex is composed of the proteins CLOCK and CYCLE, which form a heterodimer that activates the transcription of genes involved in the circadian clock. This complex acts as a transcriptional activator by binding to specific DNA sequences, known as E-boxes, in the promoter regions of target genes. The CLK-CYC complex regulates the expression of genes involved in the negative feedback loop that drives the circadian oscillator.\nThe NPAS2-CRY complex is composed of the proteins NPAS2 and Cryptochrome, which form a heterodimer that activates the transcription of genes involved in the circadian clock. This complex acts as a transcriptional activator by binding to specific DNA sequences, known as CACGTG boxes, in the promoter regions of target genes. The NPAS2-CRY complex regulates the expression of genes involved in the positive feedback loop that drives the circadian oscillator.\nIn summary, the CLK-CYC and NPAS2-CRY complexes are the main transcriptional activators of circadian oscillations by regulating the expression of genes involved in the negative and positive feedback loops of the circadian clock.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The main transcriptional activators of circadian oscillations are the CLOCK-CYCLE (CLK-CYC) and the NPAS2-Cryptochrome (NPAS2-CRY) complexes.\n2. The CLK-CYC complex is composed of the proteins CLOCK and CYCLE.\n3. The CLK-CYC complex activates the transcription of genes involved in the circadian clock by binding to specific DNA sequences, known as E-boxes, in the promoter regions of target genes.\n4. The NPAS2-CRY complex is composed of the proteins NPAS2 and Cryptochrome.\n5. The NPAS2-CRY complex activates the transcription of genes involved in the circadian clock by binding to specific DNA sequences, known as CACGTG boxes, in the promoter regions of target genes.",
    "vicuna-13b_fact": [
      "The main transcriptional activators of circadian oscillations are the CLOCK-CYCLE (CLK-CYC) and the NPAS2-Cryptochrome (NPAS2-CRY) complexes.",
      "The CLK-CYC complex is composed of the proteins CLOCK and CYCLE.",
      "The CLK-CYC complex activates the transcription of genes involved in the circadian clock by binding to specific DNA sequences, known as E-boxes, in the promoter regions of target genes.",
      "The NPAS2-CRY complex is composed of the proteins NPAS2 and Cryptochrome.",
      "The NPAS2-CRY complex activates the transcription of genes involved in the circadian clock by binding to specific DNA sequences, known as CACGTG boxes, in the promoter regions of target genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The NPAS2-CRY complex represses the transcription of genes involved in the circadian clock by binding to specific DNA sequences, known as E-boxes, in the promoter regions of target genes.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2449,
    "user_query": "Is cilengitide effective for treatment of glioblastoma?",
    "vicuna-13b_response": "Glioblastoma is a type of brain cancer that is difficult to treat, and there is currently a high unmet medical need for more effective treatments. Cilengitide is a drug that has been studied for the treatment of glioblastoma, but its effectiveness is still being evaluated.\nCilengitide is a peptide drug that targets the integrin alphaVbeta3, which is involved in the development and progression of cancer. Studies have shown that cilengitide can inhibit the growth and survival of glioblastoma cells in vitro and in animal models.\nClinical trials have been conducted to evaluate the safety and efficacy of cilengitide in patients with glioblastoma. The results of these trials have been mixed, with some studies showing a benefit from cilengitide treatment and others showing no benefit or even harm.\nOne of the main challenges with using cilengitide for the treatment of glioblastoma is its poor pharmacokinetics, which makes it difficult to achieve therapeutic concentrations in the brain. Additionally, the drug has a short half-life, which limits its efficacy.\nOverall, while cilengitide has shown some promise in the treatment of glioblastoma, its effectiveness is still being evaluated and more research is needed to determine its potential as a treatment option. Other treatments, such as surgery, radiation therapy, and chemotherapy, are currently the standard of care for glioblastoma.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Glioblastoma is a type of brain cancer.\n2. Cilengitide is a drug that has been studied for the treatment of glioblastoma.\n3. Cilengitide is a peptide drug that targets the integrin alphaVbeta3.\n4. Clinical trials have been conducted to evaluate the safety and efficacy of cilengitide in patients with glioblastoma. \n5. Currently, surgery, radiation therapy, and chemotherapy are the standard of care for glioblastoma.",
    "vicuna-13b_fact": [
      "Glioblastoma is a type of brain cancer.",
      "Cilengitide is a drug that has been studied for the treatment of glioblastoma.",
      "Cilengitide is a peptide drug that targets the integrin alphaVbeta3.",
      "Clinical trials have been conducted to evaluate the safety and efficacy of cilengitide in patients with glioblastoma.",
      "Currently, surgery, radiation therapy, and chemotherapy are the standard of care for glioblastoma."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2453,
    "user_query": "What is TCGA2BED?",
    "vicuna-13b_response": "TCGA2BED is a tool that converts The Cancer Genome Atlas (TCGA) gene expression data into the BED format. TCGA is a comprehensive genomic characterization project that has generated large-scale gene expression data sets for a variety of cancer types. The data is typically presented in the BED format, which is a tab-delimited file format that specifies the genomic coordinates of a region of interest and the corresponding gene expression values.\nTCGA2BED is a useful tool for researchers who want to analyze TCGA data using tools that are compatible with the BED format. The tool converts TCGA data into BED format, making it easier to use with a variety of downstream analysis tools. TCGA2BED can also perform some basic data quality checks on the converted data, such as checking for missing values and flagging potential outliers.\nOverall, TCGA2BED is a useful tool for researchers who want to analyze TCGA gene expression data in the BED format. It can help to streamline the data analysis process and make it easier to use the data with a variety of downstream tools.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TCGA2BED is a tool that converts The Cancer Genome Atlas (TCGA) gene expression data into the BED format.\n2. The Cancer Genome Atlas is a comprehensive genomic characterization project.\n3. TCGA has generated large-scale gene expression data sets for various cancer types.\n4. The data from TCGA is typically presented in the BED format which specifies the genomic coordinates of a region of interest and the corresponding gene expression values.\n5. TCGA2BED can perform basic data quality checks on the converted data, including checking for missing values and flagging potential outliers.",
    "vicuna-13b_fact": [
      "TCGA2BED is a tool that converts The Cancer Genome Atlas (TCGA) gene expression data into the BED format.",
      "The Cancer Genome Atlas is a comprehensive genomic characterization project.",
      "TCGA has generated large-scale gene expression data sets for various cancer types.",
      "The data from TCGA is typically presented in the BED format which specifies the genomic coordinates of a region of interest and the corresponding gene expression values.",
      "TCGA2BED can perform basic data quality checks on the converted data, including checking for missing values and flagging potential outliers."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The data from TCGA is not typically presented in the BED format. The BED format is just one of many ways that genomic data can be formatted, depending on the needs of the analysis.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2455,
    "user_query": "Is LDB1-mediated enhancer looping dependent on cohesin?",
    "vicuna-13b_response": "LDB1 (Liver-enriched transcription factor 1) is a transcription factor that plays a role in regulating gene expression during embryonic development. It has been shown to be involved in the regulation of enhancer looping, which is the process by which an enhancer element located far from its target gene is able to interact with the gene and regulate its expression.\nCohesin is a complex of proteins that is involved in maintaining the integrity of chromosomes during mitosis. It has been suggested that cohesin may also play a role in enhancer looping, but the exact nature of this relationship is not yet fully understood.\nSome studies have suggested that LDB1-mediated enhancer looping is dependent on cohesin, while others have found that it is not. For example, one study found that LDB1 was able to recruit cohesin to enhancer elements and that this was necessary for enhancer looping, while another study found that cohesin was not required for LDB1-mediated enhancer looping.\nOverall, it appears that the relationship between LDB1-mediated enhancer looping and cohesin is complex and not fully understood. Further research is needed to clarify this relationship and to fully understand the mechanisms underlying enhancer looping.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. LDB1 is a transcription factor that plays a role in regulating gene expression during embryonic development.\n2. LDB1 has been shown to be involved in the regulation of enhancer looping.\n3. Cohesin maintains the integrity of chromosomes during mitosis.\n4. It has been suggested that cohesin may also play a role in enhancer looping.\n5. Some studies have suggested that LDB1-mediated enhancer looping is dependent on cohesin, while others have found that it is not.",
    "vicuna-13b_fact": [
      "LDB1 is a transcription factor that plays a role in regulating gene expression during embryonic development.",
      "LDB1 has been shown to be involved in the regulation of enhancer looping.",
      "Cohesin maintains the integrity of chromosomes during mitosis.",
      "It has been suggested that cohesin may also play a role in enhancer looping.",
      "Some studies have suggested that LDB1-mediated enhancer looping is dependent on cohesin, while others have found that it is not."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2456,
    "user_query": "Describe nursemaid's elbow injury.",
    "vicuna-13b_response": "Nursemaid's elbow, also known as radial head subluxation, is a common injury that occurs in young children. It typically occurs when a child's arm is pulled or twisted in a certain way, causing the elbow to bend in an abnormal position and the radial head, which is a bone at the end of the arm bone (radius), to partially dislocate from the elbow joint.\nSymptoms of nursemaid's elbow include pain, swelling, and difficulty moving the arm or bending the elbow. The child may also cry or refuse to use the affected arm. In some cases, there may be a visible deformity or bump on the elbow.\nNursemaid's elbow is most commonly seen in children between the ages of 1 and 3 years old, and it is more common in boys than in girls. It is often the result of rough play or accidental trauma, such as when a caregiver lifts a child by the arm or pulls on it too hard.\nTreatment for nursemaid's elbow typically involves immobilizing the arm in a sling or splint for a period of time to allow the bone to heal. This is usually followed by physical therapy to help regain strength and range of motion in the arm. In some cases, surgery may be necessary to repair the damaged bone or realign the elbow joint.\nPrevention of nursemaid's elbow can be achieved by being careful when lifting or playing with children, avoiding activities that could cause the arm to bend or twist in an abnormal way, and encouraging children to play in a safe and supervised environment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nursemaid's elbow, also known as radial head subluxation, is a common injury in young children.\n2. Symptoms of nursemaid's elbow include pain, swelling, difficulty moving the arm or bending the elbow, and in some cases, a visible deformity or bump on the elbow.\n3. Nursemaid's elbow is most commonly seen in children between the ages of 1 and 3 years old, and it is more common in boys than in girls.\n4. The treatment of nursemaid's elbow typically includes immobilizing the arm, physical therapy, and sometimes surgery.\n5. Prevention of nursemaid's elbow involves careful handling of children, avoiding activities that could cause the arm to bend or twist abnormally, and encouraging safe play in a supervised environment.",
    "vicuna-13b_fact": [
      "Nursemaid's elbow, also known as radial head subluxation, is a common injury in young children.",
      "Symptoms of nursemaid's elbow include pain, swelling, difficulty moving the arm or bending the elbow, and in some cases, a visible deformity or bump on the elbow.",
      "Nursemaid's elbow is most commonly seen in children between the ages of 1 and 3 years old, and it is more common in boys than in girls.",
      "The treatment of nursemaid's elbow typically includes immobilizing the arm, physical therapy, and sometimes surgery.",
      "Prevention of nursemaid's elbow involves careful handling of children, avoiding activities that could cause the arm to bend or twist abnormally, and encouraging safe play in a supervised environment."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Nursemaid's elbow is most commonly seen in children between the ages of 1 and 5 years old. Its prevalence in boys and girls is about the same.\n4. FALSE [correction]: The treatment of nursemaid's elbow usually involves a simple maneuver performed by a healthcare professional to pop the radial head back into place, it rarely requires immobilization, physical therapy, or surgery.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2458,
    "user_query": "What is mechanism of action of Benralizumab?",
    "vicuna-13b_response": "Benralizumab is an injectable medication that is used to treat severe asthma and chronic obstructive pulmonary disease (COPD). The mechanism of action of benralizumab is not fully understood, but it is believed to involve the suppression of inflammation and the reduction of the activity of certain immune cells, including eosinophils and T cells.\nBenralizumab works by binding to a protein called the interleukin-5 receptor alpha chain (IL-5Rα), which is found on the surface of eosinophils and T cells. By binding to this protein, benralizumab inhibits the activation and proliferation of these immune cells, which helps to reduce inflammation and improve symptoms of asthma and COPD.\nIn addition to its effects on eosinophils and T cells, benralizumab has also been shown to reduce the production of certain inflammatory molecules, including interleukin-4 (IL-4), interleukin-5 (IL-5), and granulocyte-macrophage colony-stimulating factor (GM-CSF). These molecules play a role in the recruitment and activation of immune cells, including eosinophils and T cells, and by reducing their production, benralizumab helps to reduce inflammation and improve symptoms of asthma and COPD.\nOverall, the mechanism of action of benralizumab involves the suppression of inflammation and the reduction of the activity of certain immune cells, which helps to improve symptoms of asthma and COPD.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Benralizumab is an injectable medication used to treat severe asthma and chronic obstructive pulmonary disease (COPD).\n2. The mechanism of action of benralizumab involves the suppression of inflammation and reduction of the activity of certain immune cells, including eosinophils and T cells.\n3. Benralizumab works by binding to a protein called the interleukin-5 receptor alpha chain (IL-5Rα).\n4. By binding to the IL-5Rα protein, benralizumab inhibits the activation and proliferation of certain immune cells. \n5. Benralizumab has been shown to reduce the production of certain inflammatory molecules, including interleukin-4 (IL-4), interleukin-5 (IL-5), and granulocyte-macrophage colony-stimulating factor (GM-CSF).",
    "vicuna-13b_fact": [
      "Benralizumab is an injectable medication used to treat severe asthma and chronic obstructive pulmonary disease (COPD).",
      "The mechanism of action of benralizumab involves the suppression of inflammation and reduction of the activity of certain immune cells, including eosinophils and T cells.",
      "Benralizumab works by binding to a protein called the interleukin-5 receptor alpha chain (IL-5Rα).",
      "By binding to the IL-5Rα protein, benralizumab inhibits the activation and proliferation of certain immune cells.",
      "Benralizumab has been shown to reduce the production of certain inflammatory molecules, including interleukin-4 (IL-4), interleukin-5 (IL-5), and granulocyte-macrophage colony-stimulating factor (GM-CSF)."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Benralizumab is an injectable medication used to treat severe asthma, but not chronic obstructive pulmonary disease (COPD).\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Benralizumab has been shown to reduce the production of certain inflammatory molecules, but specifically, it does not reduce interleukin-4 (IL-4) or granulocyte-macrophage colony-stimulating factor (GM-CSF), it mainly targets interleukin-5 (IL-5) to decrease the survival and function of eosinophils.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2459,
    "user_query": "Is there any link between ERCC1-XPF and cohesin?",
    "vicuna-13b_response": "Yes, there is a link between ERCC1-XPF and cohesin. ERCC1-XPF is a complex that plays a role in the regulation of DNA repair and recombination. Cohesin is a complex of proteins that is involved in the maintenance of chromosome structure and the regulation of gene expression.\nStudies have shown that ERCC1-XPF can interact with cohesin and that this interaction is important for the proper functioning of ERCC1-XPF in DNA repair and recombination. Additionally, cohesin has been shown to be involved in the regulation of ERCC1-XPF activity, suggesting that there is a complex interplay between these two proteins.\nOverall, the link between ERCC1-XPF and cohesin is an important one, and further research is needed to fully understand the mechanisms underlying their interaction and how this interaction contributes to the regulation of DNA repair and gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ERCC1-XPF is a complex that plays a role in the regulation of DNA repair and recombination.\n2. Cohesin is a complex of proteins that is involved in the maintenance of chromosome structure and the regulation of gene expression.\n3. Studies have shown that ERCC1-XPF can interact with cohesin and that this interaction is important for the proper functioning of ERCC1-XPF in DNA repair and recombination.\n4. Cohesin has been shown to be involved in the regulation of ERCC1-XPF activity.\n5. The link between ERCC1-XPF and cohesin contributes to the regulation of DNA repair and gene expression.",
    "vicuna-13b_fact": [
      "ERCC1-XPF is a complex that plays a role in the regulation of DNA repair and recombination.",
      "Cohesin is a complex of proteins that is involved in the maintenance of chromosome structure and the regulation of gene expression.",
      "Studies have shown that ERCC1-XPF can interact with cohesin and that this interaction is important for the proper functioning of ERCC1-XPF in DNA repair and recombination.",
      "Cohesin has been shown to be involved in the regulation of ERCC1-XPF activity.",
      "The link between ERCC1-XPF and cohesin contributes to the regulation of DNA repair and gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2461,
    "user_query": "Does Evolocumab improve cognitive function?",
    "vicuna-13b_response": "Evolocumab is a monoclonal antibody used to lower low-density lipoprotein (LDL) cholesterol levels in the blood. It is not typically used to treat cognitive impairment or improve cognitive function. Evolocumab works by inhibiting the protein receptor that is responsible for removing LDL cholesterol from the blood, thereby increasing the amount of LDL cholesterol that is removed from the blood.\nWhile LDL cholesterol is an important risk factor for cardiovascular disease, which can lead to cognitive decline, there is no evidence to suggest that evolocumab specifically improves cognitive function. Cognitive function is a complex process that is influenced by many factors, including genetics, lifestyle, and medical conditions. If you have concerns about your cognitive function, it is important to speak with a healthcare professional who can assess your overall health and provide appropriate recommendations.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Evolocumab is a monoclonal antibody used to lower low-density lipoprotein (LDL) cholesterol levels in the blood.\n2. Evolocumab works by inhibiting the protein receptor responsible for removing LDL cholesterol from the blood, hence increasing the amount of LDL cholesterol that is removed.\n3. LDL cholesterol is a risk factor for cardiovascular disease.\n4. There is no evidence to suggest that evolocumab specifically improves cognitive function.\n5. Cognitive function is influenced by many factors, including genetics, lifestyle, and medical conditions.",
    "vicuna-13b_fact": [
      "Evolocumab is a monoclonal antibody used to lower low-density lipoprotein (LDL) cholesterol levels in the blood.",
      "Evolocumab works by inhibiting the protein receptor responsible for removing LDL cholesterol from the blood, hence increasing the amount of LDL cholesterol that is removed.",
      "LDL cholesterol is a risk factor for cardiovascular disease.",
      "There is no evidence to suggest that evolocumab specifically improves cognitive function.",
      "Cognitive function is influenced by many factors, including genetics, lifestyle, and medical conditions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Evolocumab works by inhibiting the protein PCSK9, which would typically reduce the number of receptors that remove LDL cholesterol from the blood, hence increasing the amount of LDL cholesterol that is removed.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2462,
    "user_query": "Can radius fracture cause carpal tunnel syndrome?",
    "vicuna-13b_response": "Radius fracture can cause carpal tunnel syndrome in some cases. The carpal tunnel is a narrow passageway in the wrist that contains the median nerve and several tendons. When the radius bone is fractured, it can cause swelling and inflammation in the carpal tunnel, which can put pressure on the median nerve. This pressure can cause symptoms of carpal tunnel syndrome, such as pain, numbness, tingling, and weakness in the hand and wrist.\nIn some cases, a radius fracture may heal improperly, leading to a condition called \"malunion.\" Malunion can cause a change in the position or shape of the bone, which can further compress the median nerve and cause carpal tunnel syndrome.\nIt is important to seek medical attention if you experience symptoms of carpal tunnel syndrome, especially if you have a history of radius fracture. Your doctor can perform a physical examination and diagnostic tests, such as an electromyogram (EMG), to determine the cause of your symptoms and develop an appropriate treatment plan. Treatment options for carpal tunnel syndrome may include rest, ice, compression, and elevation of the affected hand, as well as medications, physical therapy, or even surgery in severe cases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Radius fracture can cause carpal tunnel syndrome.\n2. The carpal tunnel is a narrow passageway in the wrist that contains the median nerve and several tendons.\n3. A radius fracture may heal improperly, leading to a condition called \"malunion.\"\n4. In the event of \"malunion\", the median nerve can be further compressed causing carpal tunnel syndrome.\n5. Treatment options for carpal tunnel syndrome may include rest, ice, compression, and elevation of the affected hand, medications, physical therapy, or surgery in severe cases.",
    "vicuna-13b_fact": [
      "Radius fracture can cause carpal tunnel syndrome.",
      "The carpal tunnel is a narrow passageway in the wrist that contains the median nerve and several tendons.",
      "A radius fracture may heal improperly, leading to a condition called \"malunion.\"",
      "In the event of \"malunion\", the median nerve can be further compressed causing carpal tunnel syndrome.",
      "Treatment options for carpal tunnel syndrome may include rest, ice, compression, and elevation of the affected hand, medications, physical therapy, or surgery in severe cases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2464,
    "user_query": "Is Marfan syndrome associated with chordal rupture?",
    "vicuna-13b_response": "Marfan syndrome is a genetic disorder that affects the connective tissue. It is characterized by tall stature, thin fingers, and aortic root dilatation. Chordal rupture is a condition in which the chordae tendineae, which are the tendons that connect the heart valve leaflets to the muscle of the heart, rupture.\nThere is some evidence to suggest that Marfan syndrome may be associated with an increased risk of chordal rupture. Marfan syndrome is a disorder of the connective tissue, and the connective tissue in the heart may be affected in people with this condition. This can lead to weakening of the heart valve, which can increase the risk of chordal rupture.\nHowever, it is important to note that chordal rupture is a rare condition, and the majority of people with Marfan syndrome will not develop this condition. Additionally, there are other risk factors for chordal rupture, such as age, hypertension, and certain medications, and it is important to consider these factors as well.\nIf you have Marfan syndrome and are concerned about your risk of chordal rupture, it is important to speak with your doctor. They can help you understand your risk and discuss any necessary precautions or treatments.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Marfan syndrome is a genetic disorder that affects the connective tissue.\n2. Marfan syndrome is characterized by tall stature, thin fingers, and aortic root dilatation.\n3. Chordal rupture is a condition in which the chordae tendineae, the tendons that connect the heart valve leaflets to the muscle of the heart, rupture.\n4. There is some evidence to suggest that Marfan syndrome may be associated with an increased risk of chordal rupture.\n5. Chordal rupture is a rare condition, and the majority of people with Marfan syndrome will not develop this condition.",
    "vicuna-13b_fact": [
      "Marfan syndrome is a genetic disorder that affects the connective tissue.",
      "Marfan syndrome is characterized by tall stature, thin fingers, and aortic root dilatation.",
      "Chordal rupture is a condition in which the chordae tendineae, the tendons that connect the heart valve leaflets to the muscle of the heart, rupture.",
      "There is some evidence to suggest that Marfan syndrome may be associated with an increased risk of chordal rupture.",
      "Chordal rupture is a rare condition, and the majority of people with Marfan syndrome will not develop this condition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2465,
    "user_query": "What is the mechanism of action of Fremanezumab?",
    "vicuna-13b_response": "Fremanezumab is a monoclonal antibody that is used to treat multiple sclerosis. The mechanism of action of fremanezumab is not fully understood, but it is believed to involve the inhibition of the action of the calcitonin gene-related peptide (CGRP) receptor.\nCGRP is a neuropeptide that is involved in the regulation of blood flow, and it is also known to play a role in the pathophysiology of migraines and other pain conditions. Fremanezumab binds to the CGRP receptor and blocks the action of CGRP, which results in the inhibition of pain signaling.\nIn the treatment of multiple sclerosis, it is thought that the inhibition of CGRP signaling by fremanezumab may also have an effect on the immune system and the inflammatory response, which contributes to the disease process.\nOverall, the exact mechanism of action of fremanezumab is not fully understood, but it is believed to involve the inhibition of CGRP signaling and the modulation of the immune system and inflammatory response.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fremanezumab is a monoclonal antibody.\n2. Fremanezumab is used to treat multiple sclerosis.\n3. The mechanism of action of fremanezumab involves the inhibition of the action of the calcitonin gene-related peptide (CGRP) receptor.\n4. CGRP is a neuropeptide that is involved in the regulation of blood flow.\n5. CGRP is known to play a role in the pathophysiology of migraines and other pain conditions.",
    "vicuna-13b_fact": [
      "Fremanezumab is a monoclonal antibody.",
      "Fremanezumab is used to treat multiple sclerosis.",
      "The mechanism of action of fremanezumab involves the inhibition of the action of the calcitonin gene-related peptide (CGRP) receptor.",
      "CGRP is a neuropeptide that is involved in the regulation of blood flow.",
      "CGRP is known to play a role in the pathophysiology of migraines and other pain conditions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Fremanezumab is used to prevent migraines, not to treat multiple sclerosis.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "vicuna-13b_response": "The 959 Nematode Genomes initiative is a large-scale research project aimed at sequencing and analyzing the genomes of 959 species of nematodes, which are a type of roundworm. The project is a collaboration between researchers from around the world and is being funded by the National Science Foundation in the United States.\nThe goal of the project is to gain a better understanding of the biology and evolution of nematodes, which are among the most diverse and abundant organisms on Earth. By sequencing the genomes of such a large number of nematode species, researchers hope to identify genetic changes that have occurred over time and to study the ways in which these changes have influenced the evolution of the organisms.\nIn addition to providing insights into the biology and evolution of nematodes, the 959 Nematode Genomes initiative is also expected to have broader implications for the field of genomics and the study of other organisms. By providing a large and diverse dataset of genomic information, researchers will be able to develop new tools and techniques for analyzing genetic data and studying the evolution of complex organisms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The 959 Nematode Genomes initiative is a research project aimed at sequencing and analyzing the genomes of 959 species of nematodes.\n2. The project is a collaboration between researchers from around the world.\n3. Funding for the 959 Nematode Genomes initiative is provided by the National Science Foundation in the United States.\n4. The goal of the project is to better understand the biology and evolution of nematodes.\n5. As part of the project's broader implications, it aims to contribute to the field of genomics and the study of other organisms by providing a large dataset of genomic information.",
    "vicuna-13b_fact": [
      "The 959 Nematode Genomes initiative is a research project aimed at sequencing and analyzing the genomes of 959 species of nematodes.",
      "The project is a collaboration between researchers from around the world.",
      "Funding for the 959 Nematode Genomes initiative is provided by the National Science Foundation in the United States.",
      "The goal of the project is to better understand the biology and evolution of nematodes.",
      "As part of the project's broader implications, it aims to contribute to the field of genomics and the study of other organisms by providing a large dataset of genomic information."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2475,
    "user_query": "What is the drug target(s) for Belsomra?",
    "vicuna-13b_response": "Belsomra (also known as Suvorexant) is a medication that is used to treat insomnia, or difficulty falling asleep and staying asleep. It is a prescription medication that is taken as a tablet, usually just before bedtime.\nThe drug target for Belsomra is a protein in the brain called orexin. Orexin is involved in regulating the sleep-wake cycle, and it is believed to play a role in the development of insomnia. Belsomra works by blocking the action of orexin, which helps to promote sleep.\nIt is important to note that Belsomra is only intended for use as a short-term treatment for insomnia, and it should not be used for longer than 12 weeks at a time. If you have insomnia and are considering taking Belsomra, it is important to talk to your doctor about the potential benefits and risks of the medication, and to discuss any other treatment options that may be appropriate for you.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Belsomra, also known as Suvorexant, is a medication used to treat insomnia.\n2. Belsomra is a prescription medication that is taken as a tablet.\n3. The drug target for Belsomra is a protein in the brain called orexin.\n4. Orexin is involved in regulating the sleep-wake cycle and is believed to play a role in the development of insomnia.\n5. Belsomra is only intended for use as a short-term treatment for insomnia, and should not be used for longer than 12 weeks at a time.",
    "vicuna-13b_fact": [
      "Belsomra, also known as Suvorexant, is a medication used to treat insomnia.",
      "Belsomra is a prescription medication that is taken as a tablet.",
      "The drug target for Belsomra is a protein in the brain called orexin.",
      "Orexin is involved in regulating the sleep-wake cycle and is believed to play a role in the development of insomnia.",
      "Belsomra is only intended for use as a short-term treatment for insomnia, and should not be used for longer than 12 weeks at a time."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2476,
    "user_query": "Can canagliflozin cause euglycemic diabetic ketoacidosis?",
    "vicuna-13b_response": "Canagliflozin is a type 2 diabetes medication that is commonly known by the brand name Invokana. It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which means it helps the body remove excess glucose from the bloodstream by preventing the reabsorption of glucose in the kidneys.\nEuglycemic diabetic ketoacidosis (EDKA) is a rare but potentially serious complication that can occur in people with diabetes, particularly those who are taking insulin or insulin secretagogues such as sulfonylureas. It is characterized by high levels of ketones (acids) in the blood, low blood sugar (hypoglycemia), and an increased pH level (metabolic acidosis).\nWhile canagliflozin is not an insulin secretagogue, it is possible for it to cause EDKA in some cases. However, this is rare, and it is more commonly associated with other diabetes medications such as sulfonylureas.\nThe exact mechanism by which canagliflozin may cause EDKA is not well understood, but it is thought to be related to the drug's effect on insulin secretion and glucose metabolism. In some cases, canagliflozin may cause a decrease in insulin secretion, leading to an increase in ketone production and the development of EDKA.\nIf you are taking canagliflozin and experience symptoms of EDKA such as nausea, vomiting, abdominal pain, confusion, or unusual fatigue, it is important to seek medical attention immediately. Your healthcare provider may need to adjust your diabetes treatment plan or prescribe another medication to help prevent further episodes of EDKA.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Canagliflozin is a type 2 diabetes medication known by the brand name Invokana.\n2. Canagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.\n3. Euglycemic diabetic ketoacidosis (EDKA) is characterized by high levels of ketones in the blood, low blood sugar, and an increased pH level.\n4. It is possible, although rare, for canagliflozin to cause EDKA.\n5. If symptoms of EDKA occur while taking canagliflozin, it is important to seek medical attention immediately.",
    "vicuna-13b_fact": [
      "Canagliflozin is a type 2 diabetes medication known by the brand name Invokana.",
      "Canagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.",
      "Euglycemic diabetic ketoacidosis (EDKA) is characterized by high levels of ketones in the blood, low blood sugar, and an increased pH level.",
      "It is possible, although rare, for canagliflozin to cause EDKA.",
      "If symptoms of EDKA occur while taking canagliflozin, it is important to seek medical attention immediately."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Euglycemic diabetic ketoacidosis (EDKA) is characterized by high levels of ketones in the blood, normal or slightly elevated blood sugar, and a decreased pH level.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2478,
    "user_query": "Is there an association between Klinefelter syndrome and breast cancer?",
    "vicuna-13b_response": "Klinefelter syndrome is a genetic condition that affects males and females differently. It is caused by an extra X chromosome in males, resulting in XXY chromosomes instead of the typical XY. Breast cancer, on the other hand, is a cancer that affects the breast tissue in females.\nThere is no direct association between Klinefelter syndrome and breast cancer. However, individuals with Klinefelter syndrome may have an increased risk of certain types of cancer, including breast cancer. This may be due to the presence of extra X chromosomes, which can affect hormone levels and the development and function of certain organs.\nAdditionally, individuals with Klinefelter syndrome may have a higher risk of developing certain types of breast cancer due to the presence of higher levels of estrogen, which can promote the growth of breast cancer cells.\nIt is important to note that the risk of breast cancer in individuals with Klinefelter syndrome is still relatively low, and not all individuals with the condition will develop breast cancer. However, it is important for individuals with Klinefelter syndrome to be aware of their risk and to undergo regular screenings and check-ups to detect any signs of breast cancer early.\nIn summary, there is no direct association between Klinefelter syndrome and breast cancer, but individuals with Klinefelter syndrome may have an increased risk of certain types of cancer, including breast cancer due to the presence of extra X chromosomes and higher levels of estrogen.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Klinefelter syndrome is a genetic condition caused by an extra X chromosome in males, resulting in XXY chromosomes.\n2. There is no direct association between Klinefelter syndrome and breast cancer.\n3. Individuals with Klinefelter syndrome may have an increased risk of certain types of cancer, including breast cancer.\n4. The risk of breast cancer in individuals with Klinefelter syndrome is still relatively low.\n5. Individuals with Klinefelter syndrome may have a higher risk of breast cancer due to the presence of higher levels of estrogen.",
    "vicuna-13b_fact": [
      "Klinefelter syndrome is a genetic condition caused by an extra X chromosome in males, resulting in XXY chromosomes.",
      "There is no direct association between Klinefelter syndrome and breast cancer.",
      "Individuals with Klinefelter syndrome may have an increased risk of certain types of cancer, including breast cancer.",
      "The risk of breast cancer in individuals with Klinefelter syndrome is still relatively low.",
      "Individuals with Klinefelter syndrome may have a higher risk of breast cancer due to the presence of higher levels of estrogen."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: There is a direct association between Klinefelter syndrome and an increased risk of breast cancer. \n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2479,
    "user_query": "Which R packages have been developed for the discovery of mutational signatures in cancer?",
    "vicuna-13b_response": "There are several R packages that have been developed for the discovery of mutational signatures in cancer. Some of the most popular ones are:\n1. soma: This package is designed for the analysis of somatic mutation patterns in cancer. It provides a range of tools for identifying mutational signatures, including mutation spectrum analysis, somatic mutation rates, and mutational landscape analysis.\n2. mutation: This package is designed for the analysis of mutation data in cancer. It provides a range of tools for identifying mutational signatures, including mutation frequency analysis, mutation pattern analysis, and mutational landscape analysis.\n3. mutect: This package is designed for the analysis of somatic mutation data in cancer. It provides a range of tools for identifying mutational signatures, including mutation frequency analysis, mutation pattern analysis, and mutational landscape analysis.\n4. ngsplot: This package is designed for the visualization and analysis of next-generation sequencing data. It provides a range of tools for identifying mutational signatures, including mutation frequency analysis, mutation pattern analysis, and mutational landscape analysis.\n5. DGEList: This package is designed for the analysis of digital gene expression data. It provides a range of tools for identifying mutational signatures, including mutation frequency analysis, mutation pattern analysis, and mutational landscape analysis.\nThese packages are widely used in the field of cancer research and have been cited in many academic papers.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The 'soma' R package has been developed for the analysis of somatic mutation patterns in cancer.\n2. The 'mutation' R package is designed for the analysis of mutation data in cancer.\n3. The 'mutect' R package is designed for the analysis of somatic mutation data in cancer.\n4. The 'ngsplot' R package is designed for the visualization and analysis of next-generation sequencing data.\n5. The 'DGEList' R package is designed for the analysis of digital gene expression data in cancer.",
    "vicuna-13b_fact": [
      "The 'soma' R package has been developed for the analysis of somatic mutation patterns in cancer.",
      "The 'mutation' R package is designed for the analysis of mutation data in cancer.",
      "The 'mutect' R package is designed for the analysis of somatic mutation data in cancer.",
      "The 'ngsplot' R package is designed for the visualization and analysis of next-generation sequencing data.",
      "The 'DGEList' R package is designed for the analysis of digital gene expression data in cancer."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: The 'DGEList' is not an R package but an object in the 'edgeR' R package designed for the analysis of differential gene expression data in cancer.",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 2484,
    "user_query": "Which data simulator is available for CLIP-SEQ experiments?",
    "vicuna-13b_response": "There are several data simulators available for CLIP-SEQ experiments, including:\n1. SynthSim: A Python package that generates synthetic CLIP-SEQ data. It can simulate various experimental conditions, such as different sequencing depths, read lengths, and base quality distributions.\n2. SeqSim: A tool that generates synthetic CLIP-SEQ data in FASTA format. It can simulate various read lengths, base qualities, and sequencing depths.\n3. SeqGen: A tool that generates synthetic CLIP-SEQ data in FASTA format. It can simulate various read lengths, base qualities, and sequencing depths.\n4. ClipSim: A tool that generates synthetic CLIP-SEQ data in FASTA format. It can simulate various read lengths, base qualities, and sequencing depths.\n5. SeqPilot: A tool that generates synthetic CLIP-SEQ data in FASTA format. It can simulate various read lengths, base qualities, and sequencing depths.\n6. SeqAnnotator: A tool that generates synthetic CLIP-SEQ data in FASTA format. It can simulate various read lengths, base qualities, and sequencing depths.\n7. SeqAssembler: A tool that generates synthetic CLIP-SEQ data in FASTA format. It can simulate various read lengths, base qualities, and sequencing depths.\n8. SeqMatch: A tool that generates synthetic CLIP-SEQ data in FASTA format. It can simulate various read lengths, base qualities, and sequencing depths.\nIt's important to note that the choice of simulator will depend on the specific requirements of the experiment and the type of data being generated.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SynthSim is a Python package that generates synthetic CLIP-SEQ data.\n2. SeqSim is a tool that generates synthetic CLIP-SEQ data in FASTA format.\n3. SeqGen is a tool that generates synthetic CLIP-SEQ data in FASTA format.\n4. ClipSim is a tool generates synthetic CLIP-SEQ data in FASTA format.\n5. SeqPilot is a tool that generates synthetic CLIP-SEQ data in FASTA format.",
    "vicuna-13b_fact": [
      "SynthSim is a Python package that generates synthetic CLIP-SEQ data.",
      "SeqSim is a tool that generates synthetic CLIP-SEQ data in FASTA format.",
      "SeqGen is a tool that generates synthetic CLIP-SEQ data in FASTA format.",
      "ClipSim is a tool generates synthetic CLIP-SEQ data in FASTA format.",
      "SeqPilot is a tool that generates synthetic CLIP-SEQ data in FASTA format."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2487,
    "user_query": "Is there any role of Dlx1 and Dlx2 transcription factors in cortical interneurons?",
    "vicuna-13b_response": "Yes, Dlx1 and Dlx2 transcription factors play important roles in the development and function of cortical interneurons.\nDlx1 and Dlx2 are members of the Distal-less homeobox (Dlx) family of transcription factors, which are known to regulate the development of various tissues and cell types. In the developing brain, Dlx1 and Dlx2 are expressed in specific subpopulations of neurons, including cortical interneurons.\nStudies have shown that Dlx1 and Dlx2 are essential for the development and differentiation of cortical interneurons. For example, mutations in Dlx1 or Dlx2 have been shown to result in abnormal development and function of cortical interneurons, leading to various neurological disorders.\nIn addition to their role in development, Dlx1 and Dlx2 are also involved in the function of cortical interneurons. For example, Dlx1 and Dlx2 have been shown to regulate the expression of genes involved in the regulation of neuronal activity, such as ion channels and synaptic receptors.\nOverall, the role of Dlx1 and Dlx2 in cortical interneurons is complex and multifaceted, and further research is needed to fully understand their function and the mechanisms by which they regulate the development and function of these important neurons.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dlx1 and Dlx2 transcription factors play key roles in the development and function of cortical interneurons.\n2. Dlx1 and Dlx2 are part of the Distal-less homeobox (Dlx) family of transcription factors.\n3. The Dlx family of transcription factors is known to regulate the development of various tissues and cell types.\n4. Dlx1 and Dlx2 are essential for the development and differentiation of cortical interneurons.\n5. Mutations in Dlx1 or Dlx2 can result in abnormal development and function of cortical interneurons, leading to various neurological disorders.",
    "vicuna-13b_fact": [
      "Dlx1 and Dlx2 transcription factors play key roles in the development and function of cortical interneurons.",
      "Dlx1 and Dlx2 are part of the Distal-less homeobox (Dlx) family of transcription factors.",
      "The Dlx family of transcription factors is known to regulate the development of various tissues and cell types.",
      "Dlx1 and Dlx2 are essential for the development and differentiation of cortical interneurons.",
      "Mutations in Dlx1 or Dlx2 can result in abnormal development and function of cortical interneurons, leading to various neurological disorders."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2489,
    "user_query": "What is SMiLE-seq?",
    "vicuna-13b_response": "SMiLE-seq is a next-generation sequencing (NGS) library preparation method that is designed to improve the sequencing of highly fragmented DNA samples, such as those obtained from formalin-fixed, paraffin-embedded (FFPE) tissues.\nThe acronym SMiLE stands for \"Selective Multiplexed Integrated Linear Amplification\". The method involves multiple rounds of PCR amplification, where the primers are designed to selectively amplify the fragmented DNA fragments, followed by a selective sequencing library preparation step that enriches for the desired fragments.\nSMiLE-seq is a highly multiplexed method, meaning that it can simultaneously amplify and sequence thousands of DNA fragments in a single reaction. This allows for the efficient generation of sequencing libraries from highly complex and fragmented DNA samples, such as those obtained from FFPE tissues.\nSMiLE-seq has been shown to improve the sequencing of highly fragmented DNA samples, such as those obtained from FFPE tissues, by increasing the amount of DNA that is sequenced and reducing the amount of noise in the sequencing data. It has been used in a variety of applications, including cancer research, where it has been used to study the genomics of tumors and to identify somatic mutations that are associated with cancer development and progression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SMiLE-seq is a next-generation sequencing library preparation method.\n2. SMiLE stands for \"Selective Multiplexed Integrated Linear Amplification\".\n3. The method of SMiLE-seq involves multiple rounds of PCR amplification.\n4. SMiLE-seq can simultaneously amplify and sequence thousands of DNA fragments in a single reaction.\n5. SMiLE-seq has been used in various applications, including cancer research.",
    "vicuna-13b_fact": [
      "SMiLE-seq is a next-generation sequencing library preparation method.",
      "SMiLE stands for \"Selective Multiplexed Integrated Linear Amplification\".",
      "The method of SMiLE-seq involves multiple rounds of PCR amplification.",
      "SMiLE-seq can simultaneously amplify and sequence thousands of DNA fragments in a single reaction.",
      "SMiLE-seq has been used in various applications, including cancer research."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2493,
    "user_query": "Describe JACUSA",
    "vicuna-13b_response": "JACUSA stands for Joint Architecture for Unmanned Systems Software (JACUSA). It is an open-source software architecture designed for developing unmanned systems, such as drones, autonomous vehicles, and robots. JACUSA provides a modular and extensible framework for building complex unmanned systems, enabling developers to create custom solutions that meet their specific needs.\nThe JACUSA architecture is based on a set of standard interfaces and protocols, which ensure interoperability between different components and subsystems. It includes a set of software modules that handle various functions, such as communication, navigation, perception, and control. JACUSA also supports hardware abstraction, which allows developers to use different hardware platforms without having to modify the software components.\nJACUSA is designed to be scalable, flexible, and adaptable to different types of unmanned systems. It can be used for developing both ground and aerial vehicles, and it supports a wide range of operating systems, such as Linux, Windows, and RTX.\nJACUSA is maintained by the JACUSA Consortium, which includes leading companies and research institutions in the field of unmanned systems. The consortium regularly releases new versions of the architecture, which include new features, improvements, and bug fixes.\nOverall, JACUSA is a powerful and flexible software architecture that enables developers to build complex unmanned systems with ease. Its standardized interfaces and protocols ensure interoperability between different components, and its scalability and adaptability make it suitable for a wide range of applications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. JACUSA stands for Joint Architecture for Unmanned Systems Software.\n2. JACUSA is an open-source software architecture designed for developing unmanned systems.\n3. The JACUSA architecture is based on a set of standard interfaces and protocols.\n4. JACUSA supports a wide range of operating systems, such as Linux, Windows, and RTX.\n5. JACUSA is maintained by the JACUSA Consortium, which includes leading companies and research institutions in the field of unmanned systems.",
    "vicuna-13b_fact": [
      "JACUSA stands for Joint Architecture for Unmanned Systems Software.",
      "JACUSA is an open-source software architecture designed for developing unmanned systems.",
      "The JACUSA architecture is based on a set of standard interfaces and protocols.",
      "JACUSA supports a wide range of operating systems, such as Linux, Windows, and RTX.",
      "JACUSA is maintained by the JACUSA Consortium, which includes leading companies and research institutions in the field of unmanned systems."
    ],
    "vicuna-13b_judge_raw": "UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2507,
    "user_query": "CURB65 score is used for stratification of which disease?",
    "vicuna-13b_response": "CURB65 is a scoring system used to predict the risk of death in patients with acute respiratory distress syndrome (ARDS). The CURB65 score is calculated based on six clinical variables: age, urea level, respiratory rate, blood pressure, the number of organ failures (renal, hepatic, coagulation), and the Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score. The CURB65 score is used to stratify patients with ARDS into low, medium, and high risk groups for in-hospital mortality. The score is used to help guide clinical decision-making, such as the appropriate level of care and the use of aggressive interventions, for patients with ARDS.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CURB65 is a scoring system used to predict the risk of death in patients with acute respiratory distress syndrome (ARDS).\n2. The CURB65 score is calculated based on six clinical variables: age, urea level, respiratory rate, blood pressure, the number of organ failures, and the SOFA score.\n3. The CURB65 score is used to stratify patients with ARDS into low, medium, and high risk groups for in-hospital mortality.\n4. The CURB65 score is used to help guide clinical decision-making for patients with ARDS.\n5. The CURB65 score can influence the appropriate level of care and the use of aggressive interventions for patients with ARDS.",
    "vicuna-13b_fact": [
      "CURB65 is a scoring system used to predict the risk of death in patients with acute respiratory distress syndrome (ARDS).",
      "The CURB65 score is calculated based on six clinical variables: age, urea level, respiratory rate, blood pressure, the number of organ failures, and the SOFA score.",
      "The CURB65 score is used to stratify patients with ARDS into low, medium, and high risk groups for in-hospital mortality.",
      "The CURB65 score is used to help guide clinical decision-making for patients with ARDS.",
      "The CURB65 score can influence the appropriate level of care and the use of aggressive interventions for patients with ARDS."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: CURB65 is a clinical prediction rule that has been validated for predicting mortality in community-acquired pneumonia, not acute respiratory distress syndrome (ARDS).\n2. FALSE [correction]: The CURB65 score is calculated based on five clinical variables: Confusion, Uremia, Respiratory rate, Blood pressure, and age 65 or older. \n3. FALSE [correction]: The CURB65 score is used to stratify patients with community-acquired pneumonia into low, medium, and high risk groups for in-hospital mortality, not for patients with ARDS.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2509,
    "user_query": "Is creatinine assessment included in the MELD score?",
    "vicuna-13b_response": "No, creatinine assessment is not included in the MELD score. The MELD score is a measure of liver function and is calculated based on the serum bilirubin, serum albumin, and INR (international normalized ratio) values. Creatinine is a waste product that is generated by muscle metabolism and is typically measured in the blood to assess kidney function. The two values are not directly related, and therefore, creatinine is not included in the MELD score.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Creatinine assessment is not included in the MELD score.\n2. The MELD score is a measure of liver function.\n3. The MELD score is calculated based on the serum bilirubin, serum albumin, and INR (international normalized ratio) values.\n4. Creatinine is a waste product that is generated by muscle metabolism.\n5. Creatinine is typically measured in the blood to assess kidney function.",
    "vicuna-13b_fact": [
      "Creatinine assessment is not included in the MELD score.",
      "The MELD score is a measure of liver function.",
      "The MELD score is calculated based on the serum bilirubin, serum albumin, and INR (international normalized ratio) values.",
      "Creatinine is a waste product that is generated by muscle metabolism.",
      "Creatinine is typically measured in the blood to assess kidney function."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Creatinine assessment is included in the MELD score.\n2. TRUE\n3. FALSE [correction]: The MELD score is calculated based on the serum bilirubin, creatinine, and INR (international normalized ratio) values.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2516,
    "user_query": "What cellular process are okazaki fragments associated with?",
    "vicuna-13b_response": "Okazaki fragments are associated with the process of DNA replication. During DNA replication, the cell synthesizes a new strand of DNA by adding nucleotides to the template strand. Okazaki fragments are the short, single-stranded regions of DNA that are formed during the early stages of DNA replication. They are named after the Japanese scientist Dr. Motoo Okazaki, who first described this process in the 1960s.\nThe synthesis of a new strand of DNA during replication starts at a specific point on the template strand called the origin of replication. An enzyme called helicase unwinds the double helix and separates the two strands. Another enzyme called primase adds short RNA primers to the template strand, which provide a starting point for the synthesis of the new strand.\nOnce the primers are in place, an enzyme called polymerase synthesizes the new strand by adding nucleotides to the template strand. Nucleotides are the building blocks of DNA, and they are composed of a sugar, a phosphate group, and a nitrogenous base. There are four nitrogenous bases in DNA: adenine (A), guanine (G), cytosine (C), and thymine (T). The sequence of these bases determines the genetic information encoded in the DNA.\nAs polymerase synthesizes the new strand, it forms short, single-stranded regions called Okazaki fragments. These fragments are eventually linked together to form a continuous strand of DNA. The process of DNA replication is essential for the continuation of life, as it allows cells to divide and grow, and it is also involved in the repair of damaged DNA.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Okazaki fragments are associated with the process of DNA replication.\n2. Okazaki fragments were named after the Japanese scientist Dr. Motoo Okazaki.\n3. Dr. Motoo Okazaki first described the process of their creation in the 1960s.\n4. During DNA replication, Okazaki fragments are the short, single-stranded regions of DNA that are formed.\n5. These fragments are eventually linked together to form a continuous strand of DNA.",
    "vicuna-13b_fact": [
      "Okazaki fragments are associated with the process of DNA replication.",
      "Okazaki fragments were named after the Japanese scientist Dr. Motoo Okazaki.",
      "Dr. Motoo Okazaki first described the process of their creation in the 1960s.",
      "During DNA replication, Okazaki fragments are the short, single-stranded regions of DNA that are formed.",
      "These fragments are eventually linked together to form a continuous strand of DNA."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [Correction]: During DNA replication, Okazaki fragments are the short, double-stranded regions of DNA that are formed.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2518,
    "user_query": "Clue cells are characteristics to which causative bacteria of vaginitis?",
    "vicuna-13b_response": "Clue cells are characteristic of bacterial vaginosis, which is a condition caused by an imbalance of bacteria in the vagina. The bacteria that are typically associated with bacterial vaginosis are Gardnerella vaginalis, Mobiluncus species, and Mycoplasma hominis. These bacteria can cause an overgrowth in the vagina, leading to symptoms such as vaginal discharge with a \"fishy\" odor, itching, and burning during urination. Bacterial vaginosis can be treated with antibiotics, and it's important to seek medical attention if you suspect that you have the condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Clue cells are characteristic of bacterial vaginosis.\n2. Bacterial vaginosis is a condition caused by an imbalance of bacteria in the vagina. \n3. The bacteria associated with bacterial vaginosis are Gardnerella vaginalis, Mobiluncus species, and Mycoplasma hominis.\n4. Symptoms of bacterial vaginosis can include vaginal discharge with a \"fishy\" odor, itching, and burning during urination.\n5. Bacterial vaginosis can be treated with antibiotics.",
    "vicuna-13b_fact": [
      "Clue cells are characteristic of bacterial vaginosis.",
      "Bacterial vaginosis is a condition caused by an imbalance of bacteria in the vagina.",
      "The bacteria associated with bacterial vaginosis are Gardnerella vaginalis, Mobiluncus species, and Mycoplasma hominis.",
      "Symptoms of bacterial vaginosis can include vaginal discharge with a \"fishy\" odor, itching, and burning during urination.",
      "Bacterial vaginosis can be treated with antibiotics."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2519,
    "user_query": "What is included in the fourth generation HIV test?",
    "vicuna-13b_response": "The fourth generation HIV test, also known as the \"combination\" or \"multitarget\" assay, is a type of HIV test that uses a combination of different technologies to detect the presence of HIV in the body. These tests typically use both antibody and nucleic acid (DNA or RNA) testing methods to detect the virus.\nThe fourth generation tests are considered to be more accurate than earlier generation tests because they can detect HIV earlier in infection, and they can also detect the virus in people who have not yet developed antibodies to HIV.\nThe fourth generation tests include:\n* The Alere Determine HIV-1/2 Ag/Ab Combo test\n* The OraQuick HIV-1/2 test\n* The Clearview HIV-1/2 test\n* The Aptima HIV-1/2 test\n* The Multispot HIV-1/2 test\nThese tests are all FDA approved and are considered to be highly accurate when used according to the manufacturer's instructions. It's important to note that these tests are not 100% accurate and false positive results can occur. It's important to get a confirmatory test if the result is positive.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The fourth generation HIV test uses a combination of antibody and nucleic acid testing methods to detect HIV.\n2. Fourth generation HIV tests can detect HIV earlier in infection and also detect the virus in people who have not yet developed antibodies.\n3. The Alere Determine HIV-1/2 Ag/Ab Combo test, the OraQuick HIV-1/2 test, the Clearview HIV-1/2 test, the Aptima HIV-1/2 test, and the Multispot HIV-1/2 test are all fourth generation tests.\n4. All the aforementioned tests are FDA approved.\n5. False positive results can occur with these tests, necessitating a confirmatory test if the result is positive.",
    "vicuna-13b_fact": [
      "The fourth generation HIV test uses a combination of antibody and nucleic acid testing methods to detect HIV.",
      "Fourth generation HIV tests can detect HIV earlier in infection and also detect the virus in people who have not yet developed antibodies.",
      "The Alere Determine HIV-1/2 Ag/Ab Combo test, the OraQuick HIV-1/2 test, the Clearview HIV-1/2 test, the Aptima HIV-1/2 test, and the Multispot HIV-1/2 test are all fourth generation tests.",
      "All the aforementioned tests are FDA approved.",
      "False positive results can occur with these tests, necessitating a confirmatory test if the result is positive."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Alere Determine HIV-1/2 Ag/Ab Combo test is a fourth generation test, but the OraQuick HIV-1/2 test, the Clearview HIV-1/2 test, and the Multispot HIV-1/2 test are third generation tests and the Aptima HIV-1 Test is a qualitative nucleic acid amplification tests (NAATs).\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2520,
    "user_query": "Which disease is diagnosed using the Finkelstein's test?",
    "vicuna-13b_response": "Finkelstein's test is used to diagnose the presence of a cervical rib, which is a congenital abnormality that occurs when an extra rib is present in the neck. The test is performed by applying gentle pressure to the affected area while the patient is in a lateral position, and observing for any pain or discomfort. The presence of a cervical rib can also be confirmed through imaging studies such as X-ray or MRI.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Finkelstein's test is used to diagnose the presence of a cervical rib.\n2. A cervical rib is a congenital abnormality that occurs when an extra rib is present in the neck.\n3. The Finkelstein's test is performed by applying gentle pressure to the affected area while the patient is in a lateral position.\n4. The presence of a cervical rib can be confirmed through imaging studies such as X-ray or MRI.\n5. The presence of pain or discomfort in the affected area indicates the presence of a cervical rib during the Finkelstein's test.",
    "vicuna-13b_fact": [
      "Finkelstein's test is used to diagnose the presence of a cervical rib.",
      "A cervical rib is a congenital abnormality that occurs when an extra rib is present in the neck.",
      "The Finkelstein's test is performed by applying gentle pressure to the affected area while the patient is in a lateral position.",
      "The presence of a cervical rib can be confirmed through imaging studies such as X-ray or MRI.",
      "The presence of pain or discomfort in the affected area indicates the presence of a cervical rib during the Finkelstein's test."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Finkelstein's test is used to diagnose De Quervain's tenosynovitis, not the presence of a cervical rib.\n2. TRUE\n3. FALSE [correction]: Finkelstein's test is performed by having the patient make a fist with the thumb tucked inside the fingers, then the wrist is bent in the direction of the little finger.\n4. TRUE\n5. FALSE [correction]: The presence of pain or discomfort during Finkelstein's test may indicate De Quervain's tenosynovitis. Pain or discomfort caused by a cervical rib can be felt in the neck, shoulder, and arm, but it's not diagnosed with the Finkelstein's test.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2521,
    "user_query": "For which type of cancer can uc.189 be used as a potential prognostic biomarker?",
    "vicuna-13b_response": "UC.189 is a potential prognostic biomarker for colorectal cancer. Colorectal cancer is a type of cancer that affects the colon or rectum, which are the long, tube-like structures in the digestive system. UC.189 is a protein that is produced by a gene called KLK12, and it has been found to be involved in the development and progression of colorectal cancer. Studies have shown that higher levels of UC.189 in the blood may be associated with a poorer prognosis for patients with colorectal cancer, which means that it may be useful as a biomarker for predicting the outcome of the disease. However, more research is needed to confirm these findings and to understand the exact role of UC.189 in colorectal cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. UC.189 is a potential prognostic biomarker for colorectal cancer.\n2. Colorectal cancer affects the colon or rectum. \n3. UC.189 is a protein produced by a gene called KLK12.\n4. This protein has been found to be involved in the progression of colorectal cancer.\n5. Higher levels of UC.189 in the blood may correlate with a poorer prognosis for patients with colorectal cancer.",
    "vicuna-13b_fact": [
      "UC.189 is a potential prognostic biomarker for colorectal cancer.",
      "Colorectal cancer affects the colon or rectum.",
      "UC.189 is a protein produced by a gene called KLK12.",
      "This protein has been found to be involved in the progression of colorectal cancer.",
      "Higher levels of UC.189 in the blood may correlate with a poorer prognosis for patients with colorectal cancer."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2525,
    "user_query": "Which package in Bioconductor has been developed with the aim to analyze differential DNA loops from sequencing data?",
    "vicuna-13b_response": "The Bioconductor package that has been developed with the aim to analyze differential DNA loops from sequencing data is \"DifferentialDNALoop.\"\nDifferentialDNALoop is a Bioconductor package that is designed to detect and analyze differential DNA loops in sequencing data. It is specifically designed to work with single-cell or single-nucleus sequencing data, and it can be used to identify loops that are differentially enriched between different cell states or conditions.\nThe package uses a computational model that simulates the formation of DNA loops, and it can detect loops based on their size, shape, and orientation. It also includes several statistical tests that can be used to determine the significance of the loops that are detected.\nOverall, DifferentialDNALoop is a powerful tool for analyzing differential DNA loops in sequencing data, and it can be used to gain insights into the mechanisms that regulate gene expression in different cell states or conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Bioconductor package developed to analyze differential DNA loops from sequencing data is \"DifferentialDNALoop.\"\n2. DifferentialDNALoop is designed to work with single-cell or single-nucleus sequencing data.\n3. The DifferentialDNALoop package can identify loops that are differentially enriched between different cell states or conditions.\n4. This package uses a computational model that simulates the formation of DNA loops.\n5. DifferentialDNALoop includes several statistical tests that can be used to determine the significance of the loops that are detected.",
    "vicuna-13b_fact": [
      "The Bioconductor package developed to analyze differential DNA loops from sequencing data is \"DifferentialDNALoop.\"",
      "DifferentialDNALoop is designed to work with single-cell or single-nucleus sequencing data.",
      "The DifferentialDNALoop package can identify loops that are differentially enriched between different cell states or conditions.",
      "This package uses a computational model that simulates the formation of DNA loops.",
      "DifferentialDNALoop includes several statistical tests that can be used to determine the significance of the loops that are detected."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2526,
    "user_query": "Which disease can be diagnosed with the \"probe to bone\" test?",
    "vicuna-13b_response": "The \"probe to bone\" test is a diagnostic test used to detect bone diseases such as osteoporosis. This test involves using a device called a bone densitometer to measure the density of bone in a specific area of the body, typically the hip, spine, or heel. The test is usually done using X-rays or ultrasound, and it can detect changes in bone density that may indicate the presence of conditions such as osteoporosis, fractures, or tumors.\nOsteoporosis is a condition in which the bones become weak and brittle, leading to an increased risk of fractures. The \"probe to bone\" test can be used to diagnose osteoporosis and monitor its progression over time. Other conditions that can be diagnosed using this test include Paget's disease, which causes abnormal bone growth, and bone tumors.\nIt's important to note that the \"probe to bone\" test is not a diagnostic test for all diseases, and it should only be performed by a qualified healthcare professional in a medical setting. If you have concerns about your bone health or are experiencing symptoms such as pain or weakness, it's important to speak with a healthcare provider to determine the appropriate diagnostic tests and treatment options.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The \"probe to bone\" test is used to detect bone diseases such as osteoporosis.\n2. The test involves using a bone densitometer to measure the density of bone in a specific area of the body.\n3. The \"probe to bone\" test can be done using X-rays or ultrasound.\n4. Osteoporosis, fractures, or tumors can be indicated by changes in bone density that the test can detect.\n5. The \"probe to bone\" test can also diagnose Paget's disease and bone tumors.",
    "vicuna-13b_fact": [
      "The \"probe to bone\" test is used to detect bone diseases such as osteoporosis.",
      "The test involves using a bone densitometer to measure the density of bone in a specific area of the body.",
      "The \"probe to bone\" test can be done using X-rays or ultrasound.",
      "Osteoporosis, fractures, or tumors can be indicated by changes in bone density that the test can detect.",
      "The \"probe to bone\" test can also diagnose Paget's disease and bone tumors."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The \"probe to bone\" test is used to detect infection in wounds or ulcers, not necessarily to detect bone diseases such as osteoporosis.\n2. FALSE [correction]: The \"probe to bone\" test does not involve using a bone densitometer. It is a clinical examination that involves using a sterile probe to touch the surface of the bone.\n3. FALSE [correction]: The \"probe to bone\" test is not done using X-rays or ultrasound. It is a physical examination.\n4. FALSE [correction]: The \"probe to bone\" test is not designed to detect changes in bone density; it's a measure for assessing infection, not osteoporosis, fractures, or tumors.\n5. FALSE [correction]: The \"probe to bone\" test is not typically used to diagnose Paget's disease or bone tumors. It is used primarily to detect serious infection in wounds or ulcers.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2527,
    "user_query": "Can doxycycline cause photosensitivity?",
    "vicuna-13b_response": "Yes, doxycycline can cause photosensitivity. Doxycycline is a tetracycline antibiotic that is known to cause skin reactions, including photosensitivity. This means that the skin may become more sensitive to sunlight and other sources of UV radiation, which can lead to sunburn, skin redness, and other skin problems.\nPhotosensitivity can occur as a side effect of doxycycline, especially when the drug is taken for an extended period of time or in high doses. It is more likely to occur in people who have a history of sun sensitivity or who are taking other medications that increase the risk of photosensitivity.\nIf you are taking doxycycline and experience photosensitivity, it is important to protect your skin from sunlight and other sources of UV radiation. This may include wearing protective clothing, using sunscreen, and avoiding sun exposure during peak hours. If your symptoms are severe or do not improve, you should speak with your healthcare provider for further guidance.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Doxycycline is a tetracycline antibiotic.\n2. Doxycycline can cause skin reactions, including photosensitivity.\n3. Photosensitivity from doxycycline is more likely to occur in people who have a history of sun sensitivity or who are taking other medications that increase the risk of photosensitivity.\n4. Extended use or high doses of doxycycline can increase the risk of photosensitivity.\n5. Protection methods from the effects of photosensitivity can include wearing protective clothing, using sunscreen, and avoiding sun exposure during peak hours.",
    "vicuna-13b_fact": [
      "Doxycycline is a tetracycline antibiotic.",
      "Doxycycline can cause skin reactions, including photosensitivity.",
      "Photosensitivity from doxycycline is more likely to occur in people who have a history of sun sensitivity or who are taking other medications that increase the risk of photosensitivity.",
      "Extended use or high doses of doxycycline can increase the risk of photosensitivity.",
      "Protection methods from the effects of photosensitivity can include wearing protective clothing, using sunscreen, and avoiding sun exposure during peak hours."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2530,
    "user_query": "What is the normal body temperature in dogs?",
    "vicuna-13b_response": "The normal body temperature in dogs is typically around 101 to 102.5 degrees Fahrenheit (38.3 to 39.2 degrees Celsius). However, it's important to note that a dog's normal body temperature can vary slightly depending on a number of factors, including their age, size, and overall health.\nIn general, a dog's normal body temperature is slightly higher than a human's normal body temperature, which is typically around 98.6 degrees Fahrenheit (37 degrees Celsius). This is because dogs are warmer-blooded animals than humans, which means they have a higher metabolism and a higher body temperature.\nIt's also worth noting that a dog's normal body temperature can be affected by a number of factors, including their environment, activity level, and overall health. For example, a dog who is exposed to cold temperatures or who is suffering from a fever may have a lower than normal body temperature, while a dog who is overheated or who is suffering from a heatstroke may have a higher than normal body temperature.\nIf you're concerned about your dog's body temperature, it's always best to consult with a veterinarian. They can help determine your dog's normal body temperature and provide guidance on how to manage any issues related to their temperature.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The normal body temperature in dogs is typically around 101 to 102.5 degrees Fahrenheit (38.3 to 39.2 degrees Celsius).\n2. A dog's normal body temperature can vary slightly depending on factors such as their age, size, and overall health.\n3. A dog's normal body temperature is slightly higher than a human's normal body temperature, which is typically around 98.6 degrees Fahrenheit (37 degrees Celsius).\n4. Dogs have a higher body temperature than humans due to a higher metabolism.\n5. A dog's normal body temperature can be affected by factors including their environment, activity level, and overall health.",
    "vicuna-13b_fact": [
      "The normal body temperature in dogs is typically around 101 to 102.5 degrees Fahrenheit (38.3 to 39.2 degrees Celsius).",
      "A dog's normal body temperature can vary slightly depending on factors such as their age, size, and overall health.",
      "A dog's normal body temperature is slightly higher than a human's normal body temperature, which is typically around 98.6 degrees Fahrenheit (37 degrees Celsius).",
      "Dogs have a higher body temperature than humans due to a higher metabolism.",
      "A dog's normal body temperature can be affected by factors including their environment, activity level, and overall health."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2532,
    "user_query": "In quadruped mammals, what bones make up the stifle?",
    "vicuna-13b_response": "The stifle, also known as the knee, is a joint in the leg of quadruped mammals that connects the thigh bone (femur) to the shin bone (tibia). The bones that make up the stifle in quadruped mammals include:\n1. Femur: The femur is the thigh bone and is the upper bone in the stifle joint.\n2. Tibia: The tibia is the shin bone and is the lower bone in the stifle joint.\n3. Patella: The patella is a small bone located in the front of the knee, and it helps to protect the knee joint and improve its mobility.\n4. Fibula: The fibula is the smaller of the two bones in the lower leg, and it runs parallel to the tibia. It is also a part of the stifle joint.\n5. Tarsals: The tarsals are a group of seven bones in the foot that form the ankle joint. They are not directly involved in the stifle joint, but they are part of the leg bones that attach to the stifle joint.\nOverall, the stifle joint in quadruped mammals is a complex joint that is made up of several bones, including the femur, tibia, patella, fibula, and tarsals. These bones work together to provide stability and mobility to the leg and help the animal to move efficiently.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The stifle in quadruped mammals connects the thigh bone (femur) to the shin bone (tibia).\n2. The femur is the thigh bone and forms a part of the stifle joint.\n3. The tibia is the shin bone and forms the lower part of the stifle joint.\n4. The patella, a small bone located in front of the knee, helps protect the knee joint and improve its mobility. \n5. The stifle joint of quadruped mammals includes the fibula, a bone that runs parallel to the tibia.",
    "vicuna-13b_fact": [
      "The stifle in quadruped mammals connects the thigh bone (femur) to the shin bone (tibia).",
      "The femur is the thigh bone and forms a part of the stifle joint.",
      "The tibia is the shin bone and forms the lower part of the stifle joint.",
      "The patella, a small bone located in front of the knee, helps protect the knee joint and improve its mobility.",
      "The stifle joint of quadruped mammals includes the fibula, a bone that runs parallel to the tibia."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The stifle joint of quadruped mammals does not usually include the fibula. The main bones forming the stifle joint are the femur, tibia, and patella.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2535,
    "user_query": "Which tool exists for microsatellite (SSR) loci detection and primer design?",
    "vicuna-13b_response": "There are several tools available for microsatellite (SSR) loci detection and primer design, including:\n1. PrimerQuest: a web-based tool for primer design that includes a module for SSR primer design.\n2. SSRIT: a standalone software tool for SSR primer design that can also be used for SSR marker development and genotyping.\n3. ARDRA: a software tool for SSR analysis that includes primer design, marker development, and genotyping.\n4. POPGENE: a software tool for SSR analysis that includes primer design, marker development, and genotyping.\n5. FP-SSR: a software tool for SSR analysis that includes primer design, marker development, and genotyping.\n6. SSR-Marker: a software tool for SSR analysis that includes primer design, marker development, and genotyping.\n7. SSR-View: a software tool for SSR analysis that includes primer design, marker development, and genotyping.\n8. SSR-Analyzer: a software tool for SSR analysis that includes primer design, marker development, and genotyping.\nThese are some of the most commonly used tools for SSR primer design and analysis, but there may be others available as well. It's important to note that the choice of tool will depend on the specific requirements of the user and the type of data they are working with.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PrimerQuest is a web-based tool for primer design that includes a module for SSR primer design.\n2. SSRIT is a standalone software tool for SSR primer design that can also be used for SSR marker development and genotyping.\n3. ARDRA is a software tool for SSR analysis that includes primer design, marker development, and genotyping.\n4. POPGENE is a software tool for SSR analysis that includes primer design, marker development, and genotyping.\n5. FP-SSR is a software tool for SSR analysis that includes primer design, marker development, and genotyping.",
    "vicuna-13b_fact": [
      "PrimerQuest is a web-based tool for primer design that includes a module for SSR primer design.",
      "SSRIT is a standalone software tool for SSR primer design that can also be used for SSR marker development and genotyping.",
      "ARDRA is a software tool for SSR analysis that includes primer design, marker development, and genotyping.",
      "POPGENE is a software tool for SSR analysis that includes primer design, marker development, and genotyping.",
      "FP-SSR is a software tool for SSR analysis that includes primer design, marker development, and genotyping."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: ARDRA is a procedure for analyzing bacterial/fungal diversity, it doesn't concern with SSR analysis or primer design.\n4. FALSE [correction]: POPGENE is a software for the analysis of genetic variation among and within populations, it doesn't concern with SSR analysis or primer design.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2544,
    "user_query": "What is the preDIVA clinical trial?",
    "vicuna-13b_response": "The preDIVA clinical trial is a phase 3 clinical trial that is evaluating the safety and efficacy of a vaginal ring containing dapivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), for the prevention of HIV in women. The trial is being conducted by the International Partnership for Microbicides (IPM) and is taking place in four African countries: South Africa, Uganda, Tanzania, and Zimbabwe.\nThe preDIVA trial is a follow-up to the ASPIRE trial, which also evaluated the safety and efficacy of the dapivirine vaginal ring and found that it was effective in reducing the risk of HIV infection in women by approximately 30%. The preDIVA trial is designed to confirm the effectiveness of the dapivirine ring and to gather additional information about its use in the real-world setting.\nThe preDIVA trial is a double-blind, placebo-controlled trial, which means that neither the participants nor the researchers know which participants are receiving the active drug or a placebo. The trial is expected to enroll approximately 2,000 women who are at high risk of HIV infection and will follow them for up to two years.\nThe results of the preDIVA trial are eagerly awaited, as they will provide important information about the potential of the dapivirine ring as a tool for HIV prevention in women. If the trial confirms the effectiveness of the dapivirine ring, it could become an important addition to the HIV prevention toolkit, particularly in settings where women are at high risk of infection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The preDIVA clinical trial is a phase 3 trial evaluating the safety and efficacy of a vaginal ring containing dapivirine for the prevention of HIV in women.\n2. The preDIVA clinical trial is being conducted by the International Partnership for Microbicides (IPM).\n3. The trial is taking place in South Africa, Uganda, Tanzania, and Zimbabwe.\n4. The preDIVA trial is designed to confirm the effectiveness of the dapivirine ring and is a double-blind, placebo-controlled trial.\n5. The trial plans to enroll approximately 2,000 women who are at high risk of HIV infection and will follow them for up to two years.",
    "vicuna-13b_fact": [
      "The preDIVA clinical trial is a phase 3 trial evaluating the safety and efficacy of a vaginal ring containing dapivirine for the prevention of HIV in women.",
      "The preDIVA clinical trial is being conducted by the International Partnership for Microbicides (IPM).",
      "The trial is taking place in South Africa, Uganda, Tanzania, and Zimbabwe.",
      "The preDIVA trial is designed to confirm the effectiveness of the dapivirine ring and is a double-blind, placebo-controlled trial.",
      "The trial plans to enroll approximately 2,000 women who are at high risk of HIV infection and will follow them for up to two years."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2548,
    "user_query": "Milwaukee protocol was tested for treatment of which disease?",
    "vicuna-13b_response": "The Milwaukee protocol is a treatment protocol for a rare genetic disorder called MPS I, also known as Hurler syndrome. MPS I is a lysosomal storage disorder caused by a deficiency of the enzyme alpha-L-iduronidase, which is necessary for the breakdown of a complex carbohydrate called glycosaminoglycan (GAG). The accumulation of GAG in the lysosomes leads to progressive damage to various organs and tissues in the body, including the heart, bones, and joints.\nThe Milwaukee protocol involves enzyme replacement therapy (ERT), which involves administering the missing enzyme to the patient. The treatment is given intravenously, usually once or twice a week, and the dosage is adjusted based on the patient's weight and response to the treatment. The protocol is named after the Medical College of Wisconsin, where the treatment was first developed in the 1990s.\nThe Milwaukee protocol has been shown to be effective in improving the symptoms of MPS I, including reducing the accumulation of GAG in the lysosomes, improving cardiac function, and increasing mobility and flexibility. However, the treatment is expensive and requires frequent hospital visits, which can be challenging for patients and their families.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Milwaukee protocol is a treatment protocol for the genetic disorder MPS I, also known as Hurler syndrome.\n2. MPS I is a lysosomal storage disorder caused by a deficiency of the enzyme alpha-L-iduronidase.\n3. The Milwaukee protocol involves enzyme replacement therapy (ERT), which involves administering the missing enzyme to the patient.\n4. The Milwaukee protocol was first developed in the Medical College of Wisconsin in the 1990s.\n5. The Milwaukee protocol treatment needs to be administered intravenously, usually once or twice a week.",
    "vicuna-13b_fact": [
      "The Milwaukee protocol is a treatment protocol for the genetic disorder MPS I, also known as Hurler syndrome.",
      "MPS I is a lysosomal storage disorder caused by a deficiency of the enzyme alpha-L-iduronidase.",
      "The Milwaukee protocol involves enzyme replacement therapy (ERT), which involves administering the missing enzyme to the patient.",
      "The Milwaukee protocol was first developed in the Medical College of Wisconsin in the 1990s.",
      "The Milwaukee protocol treatment needs to be administered intravenously, usually once or twice a week."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Milwaukee protocol is not a treatment for MPS I, but a treatment protocol for rabies.\n2. TRUE\n3. FALSE [correction]: The Milwaukee protocol involves inducing coma and administration of antiviral drugs, not enzyme replacement therapy. \n4. TRUE\n5. FALSE [correction]: The Milwaukee protocol involves inducing coma and administering antiviral drugs; it does not involve weekly intravenous administrations.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2552,
    "user_query": "Is the consumption of chocolate associated with an increase in cardiovascular disease?",
    "vicuna-13b_response": "The relationship between chocolate consumption and cardiovascular disease is complex and has been the subject of much research. While it is true that chocolate contains sugar and fat, which can contribute to an increased risk of cardiovascular disease when consumed in excess, there is also evidence to suggest that moderate chocolate consumption may actually have some health benefits.\nOne study published in the journal \"Circulation\" found that moderate chocolate consumption was associated with a lower risk of cardiovascular disease, including a lower risk of stroke and lower systolic blood pressure. Another study published in the \"Journal of the American College of Cardiology\" found that consuming chocolate in moderation was associated with a lower risk of developing heart failure.\nHowever, it is important to note that these studies were conducted on relatively small sample sizes and more research is needed to fully understand the relationship between chocolate consumption and cardiovascular disease. Additionally, it is important to keep in mind that chocolate consumption should still be kept within moderate levels, as excessive consumption can lead to an increased risk of cardiovascular disease.\nIn conclusion, the relationship between chocolate consumption and cardiovascular disease is complex and depends on the amount of chocolate consumed. While moderate chocolate consumption may have some health benefits, it is still important to maintain a balanced diet and to consume chocolate in moderation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Chocolate contains sugar and fat, that can increase the risk of cardiovascular disease when consumed in excess.\n2. A study published in the journal \"Circulation\" found that moderate chocolate consumption was associated with a lower risk of cardiovascular disease, including a lower risk of stroke and lower systolic blood pressure.\n3. Another study published in the \"Journal of the American College of Cardiology\" found that consuming chocolate in moderation was associated with a lower risk of developing heart failure.\n4. These studies on chocolate consumption and cardiovascular disease were conducted on relatively small sample sizes.\n5. Excessive consumption of chocolate can lead to an increased risk of cardiovascular disease.",
    "vicuna-13b_fact": [
      "Chocolate contains sugar and fat, that can increase the risk of cardiovascular disease when consumed in excess.",
      "A study published in the journal \"Circulation\" found that moderate chocolate consumption was associated with a lower risk of cardiovascular disease, including a lower risk of stroke and lower systolic blood pressure.",
      "Another study published in the \"Journal of the American College of Cardiology\" found that consuming chocolate in moderation was associated with a lower risk of developing heart failure.",
      "These studies on chocolate consumption and cardiovascular disease were conducted on relatively small sample sizes.",
      "Excessive consumption of chocolate can lead to an increased risk of cardiovascular disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2553,
    "user_query": "What is the association of circular RNA to breast cancer?",
    "vicuna-13b_response": "Circular RNA (circRNA) is a type of non-coding RNA that is involved in various cellular processes, including gene expression regulation. Recent studies have suggested that circRNA may play a role in the development and progression of breast cancer.\nOne study found that circRNA levels were altered in breast cancer tissues compared to normal breast tissues. Additionally, circRNA was found to be involved in the regulation of genes that are important for breast cancer cell proliferation and survival.\nAnother study found that a specific circRNA, called circRNA-CAR1, was highly expressed in breast cancer cells and was associated with poor patient outcomes. CircRNA-CAR1 was found to regulate the expression of genes involved in cell growth and survival, suggesting that it may be a potential therapeutic target for breast cancer.\nOverall, while more research is needed to fully understand the role of circRNA in breast cancer, studies so far suggest that circRNA may be involved in the regulation of genes that are important for breast cancer development and progression, and that specific circRNAs may be potential biomarkers or therapeutic targets for the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Circular RNA (circRNA) is a type of non-coding RNA involved in gene expression regulation. \n2. Recent studies suggest that circRNA plays a role in the development and progression of breast cancer.\n3. One study found that circRNA levels were altered in breast cancer tissues compared to normal breast tissues.\n4. A study found a specific circRNA called circRNA-CAR1, was highly expressed in breast cancer cells and was associated with poor patient outcomes. \n5. CircRNA may be involved in the regulation of genes that are important for breast cancer development and progression.",
    "vicuna-13b_fact": [
      "Circular RNA (circRNA) is a type of non-coding RNA involved in gene expression regulation.",
      "Recent studies suggest that circRNA plays a role in the development and progression of breast cancer.",
      "One study found that circRNA levels were altered in breast cancer tissues compared to normal breast tissues.",
      "A study found a specific circRNA called circRNA-CAR1, was highly expressed in breast cancer cells and was associated with poor patient outcomes.",
      "CircRNA may be involved in the regulation of genes that are important for breast cancer development and progression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "vicuna-13b_response": "The \"nipy\" package is a popular R package for analyzing Non-invasive prenatal testing (NIPT) data. It provides functions for processing NIPT data, including calling variants, estimating fraction of cells, and calculating metrics such as cell-free DNA (cfDNA) and percent fetal DNA. The package also includes functions for visualizing NIPT data, including scatter plots and heatmaps. Additionally, there are other packages such as \"nipst\" and \"prenet\" that can be used for NIPT data analysis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The \"nipy\" package is an R package used for analyzing Non-invasive prenatal testing (NIPT) data.\n2. The \"nipy\" package provides functions for processing NIPT data.\n3. The \"nipy\" package has functionalities such as calling variants, estimating fraction of cells, and calculating metrics such as cell-free DNA (cfDNA) and percent fetal DNA.\n4. The \"nipy\" package includes functions for visualizing NIPT data.\n5. Other packages such as \"nipst\" and \"prenet\" can also be used for NIPT data analysis.",
    "vicuna-13b_fact": [
      "The \"nipy\" package is an R package used for analyzing Non-invasive prenatal testing (NIPT) data.",
      "The \"nipy\" package provides functions for processing NIPT data.",
      "The \"nipy\" package has functionalities such as calling variants, estimating fraction of cells, and calculating metrics such as cell-free DNA (cfDNA) and percent fetal DNA.",
      "The \"nipy\" package includes functions for visualizing NIPT data.",
      "Other packages such as \"nipst\" and \"prenet\" can also be used for NIPT data analysis."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The \"nipy\" package is a Python package used for analysis of the structure of brain images, not for Non-invasive prenatal testing (NIPT) data. \n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2558,
    "user_query": "Is the gene CDKN2A nevogenic?",
    "vicuna-13b_response": "CDKN2A is a gene that encodes a protein called p16INK4a, which is a cyclin-dependent kinase inhibitor. This protein plays a critical role in regulating the cell cycle by inhibiting the activity of cyclin-dependent kinases, which are enzymes that phosphorylate and activate other proteins involved in cell cycle progression.\nThe expression of p16INK4a is often decreased in various types of cancer, and it has been suggested that this may contribute to the development and progression of these tumors. In addition, p16INK4a has been shown to have a role in regulating cellular senescence, which is a state of irreversible cell growth arrest that can prevent the development of cancer.\nTherefore, while CDKN2A is not necessarily a \"nevogenic\" gene in the sense that it is involved in the formation of new blood vessels, it does play a role in regulating cell cycle progression and may have implications for the development and progression of cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CDKN2A is a gene that encodes a protein called p16INK4a.\n2. p16INK4a is a cyclin-dependent kinase inhibitor.\n3. This protein plays a crucial role in regulating the cell cycle by inhibiting the activity of cyclin-dependent kinases.\n4. The expression of p16INK4a is often decreased in various types of cancer.\n5. p16INK4a has a role in regulating cellular senescence, a state of irreversible cell growth arrest that can prevent the development of cancer.",
    "vicuna-13b_fact": [
      "CDKN2A is a gene that encodes a protein called p16INK4a.",
      "p16INK4a is a cyclin-dependent kinase inhibitor.",
      "This protein plays a crucial role in regulating the cell cycle by inhibiting the activity of cyclin-dependent kinases.",
      "The expression of p16INK4a is often decreased in various types of cancer.",
      "p16INK4a has a role in regulating cellular senescence, a state of irreversible cell growth arrest that can prevent the development of cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The expression of p16INK4a is often increased in various types of cancer.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2559,
    "user_query": "Are there ways of joint Bayesian inference of risk variants?",
    "vicuna-13b_response": "Yes, there are ways of joint Bayesian inference of risk variants. Joint Bayesian inference refers to the simultaneous estimation of the effects of multiple genetic variants on a disease or trait of interest. This can be done using a Bayesian hierarchical model, which models the relationship between the genetic variants and the disease or trait using a multivariate normal distribution. The Bayesian hierarchical model allows for the estimation of the effects of each genetic variant, as well as the estimation of the relationship between the effects of different genetic variants. Joint Bayesian inference can be used in genome-wide association studies (GWAS) to identify the most important genetic variants for a disease or trait, and to understand the interactions between different genetic variants.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Joint Bayesian inference refers to the simultaneous estimation of the effects of multiple genetic variants on a disease or trait.\n2. Bayesian inference can be done using a Bayesian hierarchical model.\n3. The Bayesian hierarchical model models the relationship between the genetic variants and the disease or trait using a multivariate normal distribution.\n4. The Bayesian hierarchical model allows for the estimation of the effects of each genetic variant.\n5. Joint Bayesian inference can be used in genome-wide association studies to identify important genetic variants for a disease or trait.",
    "vicuna-13b_fact": [
      "Joint Bayesian inference refers to the simultaneous estimation of the effects of multiple genetic variants on a disease or trait.",
      "Bayesian inference can be done using a Bayesian hierarchical model.",
      "The Bayesian hierarchical model models the relationship between the genetic variants and the disease or trait using a multivariate normal distribution.",
      "The Bayesian hierarchical model allows for the estimation of the effects of each genetic variant.",
      "Joint Bayesian inference can be used in genome-wide association studies to identify important genetic variants for a disease or trait."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbach’s syndrome.",
    "vicuna-13b_response": "Achenbach's syndrome is a rare congenital disorder characterized by the association of a cranial nerve palsy (usually of the third, fourth, or sixth cranial nerve) with a limb deformity, most commonly a congenital talipes equinovarus (clubfoot) or a congenital hip dislocation. The condition is named after the German pediatrician Franz Achenbach, who first described it in 1914.\nThe exact cause of Achenbach's syndrome is not known, but it is thought to be due to a developmental abnormality of the brain or spinal cord. The cranial nerve palsy is usually present at birth or within the first few months of life, and the limb deformity may be apparent at birth or become apparent later in infancy or early childhood.\nThe clinical features of Achenbach's syndrome include a cranial nerve palsy (usually of the third, fourth, or sixth cranial nerve) resulting in weakness or paralysis of the muscles of the face, arm, or leg on the affected side. The limb deformity may be mild or severe, and may be unilateral (affecting one limb) or bilateral (affecting both limbs).\nDiagnosis of Achenbach's syndrome is typically made through a combination of physical examination, medical imaging (such as MRI), and genetic testing. Treatment of Achenbach's syndrome is typically focused on managing the symptoms of the condition, and may include physical therapy, orthotic devices, or surgery to correct the limb deformity. In some cases, medications may be prescribed to manage the symptoms of the cranial nerve palsy.\nIt is important to note that Achenbach's syndrome is a rare condition, and the prognosis for individuals with the condition can vary widely depending on the severity of the cranial nerve palsy and limb deformity, as well as the response to treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Achenbach's syndrome is a rare congenital disorder often associated with a cranial nerve palsy and a limb deformity.\n2. The condition is named after the German pediatrician Franz Achenbach, who first described it in 1914.\n3. The cranial nerve palsy in Achenbach's syndrome is usually present at birth or within the first few months of life.\n4. Diagnosis of Achenbach's syndrome is typically made through physical examination, medical imaging, and genetic testing.\n5. Treatment of Achenbach's syndrome may include physical therapy, orthotic devices, surgery or medications.",
    "vicuna-13b_fact": [
      "Achenbach's syndrome is a rare congenital disorder often associated with a cranial nerve palsy and a limb deformity.",
      "The condition is named after the German pediatrician Franz Achenbach, who first described it in 1914.",
      "The cranial nerve palsy in Achenbach's syndrome is usually present at birth or within the first few months of life.",
      "Diagnosis of Achenbach's syndrome is typically made through physical examination, medical imaging, and genetic testing.",
      "Treatment of Achenbach's syndrome may include physical therapy, orthotic devices, surgery or medications."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Achenbach's syndrome is a rare condition that causes sudden temporary episodes of pain, bruising, and swelling in the fingers.\n2. TRUE\n3. FALSE [correction]: Achenbach's syndrome is not associated with cranial nerve palsy, but sudden episodes of hand and finger pain.\n4. FALSE [correction]: Diagnosis of Achenbach's syndrome is typically made by patient history and clinical examination.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2561,
    "user_query": "Has intepirdine been evaluated in clinical trials? (November 2017)",
    "vicuna-13b_response": "As of November 2017, intrapridine (also known as GBR-12909) had not yet been evaluated in clinical trials. It is an experimental drug that was being developed by GlaxoSmithKline for the treatment of various neurological disorders, including depression and anxiety. However, further research and clinical trials were needed to determine its safety and efficacy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. As of November 2017, intrapridine had not yet been evaluated in clinical trials.\n2. Intrapridine is also known as GBR-12909.\n3. Intrapridine was being developed by GlaxoSmithKline.\n4. The intended use for intrapridine is for the treatment of various neurological disorders, including depression and anxiety. \n5. Further research and clinical trials were needed to determine the safety and efficacy of intrapridine.",
    "vicuna-13b_fact": [
      "As of November 2017, intrapridine had not yet been evaluated in clinical trials.",
      "Intrapridine is also known as GBR-12909.",
      "Intrapridine was being developed by GlaxoSmithKline.",
      "The intended use for intrapridine is for the treatment of various neurological disorders, including depression and anxiety.",
      "Further research and clinical trials were needed to determine the safety and efficacy of intrapridine."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Intrapridine is also known as RVT-101.\n3. FALSE [correction]: Intrapridine was being developed by Axovant Sciences.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2565,
    "user_query": "Does armodafinil improve fatigue of glioma patients?",
    "vicuna-13b_response": "Armodafinil is a medication that is commonly used to treat conditions such as narcolepsy, sleep apnea, and shift work sleep disorder. It is a central nervous system stimulant that works by increasing the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine.\nThere have been some studies that have looked at the use of armodafinil in glioma patients, which are individuals with a type of brain cancer called glioma. The results of these studies have been mixed, and more research is needed to fully understand the potential benefits and risks of using armodafinil in this population.\nOne study published in the journal Neuro-Oncology found that armodafinil was associated with a significant reduction in fatigue in glioma patients, with the majority of patients reporting an improvement in their symptoms. However, another study published in the journal Cancer found that armodafinil did not significantly improve fatigue in patients with glioma.\nIt is important to note that the use of armodafinil in glioma patients is still considered experimental, and more research is needed to fully understand its potential benefits and risks. Additionally, the use of any medication in patients with cancer should be carefully monitored by a healthcare professional, as some medications may interact with chemotherapy or other treatments.\nIn conclusion, while there is some evidence to suggest that armodafinil may improve fatigue in glioma patients, more research is needed to fully understand its potential benefits and risks in this population. As with any medication, the use of armodafinil in glioma patients should be carefully monitored by a healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Armodafinil is a medication used to treat narcolepsy, sleep apnea, and shift work sleep disorder.\n2. Armodafinil works by increasing the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine.\n3. A study published in the journal Neuro-Oncology found that armodafinil was associated with a significant reduction in fatigue in glioma patients.\n4. Another study published in the journal Cancer found that armodafinil did not significantly improve fatigue in patients with glioma.\n5. The use of armodafinil in glioma patients is still considered experimental.",
    "vicuna-13b_fact": [
      "Armodafinil is a medication used to treat narcolepsy, sleep apnea, and shift work sleep disorder.",
      "Armodafinil works by increasing the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine.",
      "A study published in the journal Neuro-Oncology found that armodafinil was associated with a significant reduction in fatigue in glioma patients.",
      "Another study published in the journal Cancer found that armodafinil did not significantly improve fatigue in patients with glioma.",
      "The use of armodafinil in glioma patients is still considered experimental."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2566,
    "user_query": "What is the role of tankyrases in response to Double Strand Breaks (DSBs)?",
    "vicuna-13b_response": "Tankyrases are a family of enzymes that are involved in the regulation of telomere length and telomerase activity. They are also involved in the response to Double Strand Breaks (DSBs), which are DNA breaks that occur when both strands of a chromosome are broken.\nWhen a DSB occurs, the tankyrases are activated and they can either stimulate or inhibit the repair process, depending on the specific circumstances. In general, tankyrases can help to recruit repair factors to the site of the DSB, and they can also help to protect the telomeres from being damaged during the repair process.\nIn some cases, tankyrases can also help to promote the formation of a DNA double-strand break-induced replication fork stalling and/or DNA damage response (DDR) signaling, which can lead to the activation of checkpoint kinases and the initiation of DNA repair processes.\nOverall, the role of tankyrases in response to DSBs is complex and multifaceted, and it is still an area of active research. However, it is clear that tankyrases play an important role in regulating the response to DNA damage and in promoting the repair of DSBs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tankyrases are a family of enzymes that regulate telomere length and telomerase activity.\n2. Tankyrases are involved in the response to Double Strand Breaks (DSBs), which are DNA breaks that occur when both strands of a chromosome are broken.\n3. Tankyrases can help to recruit repair factors to the site of the DSB and protect the telomeres from being damaged during the repair process.\n4. In some cases, tankyrases can promote the formation of a DNA double-strand break-induced replication fork stalling and/or DNA damage response (DDR) signaling.\n5. Tankyrases role in response to DSBs leads to the activation of checkpoint kinases and the initiation of DNA repair processes.",
    "vicuna-13b_fact": [
      "Tankyrases are a family of enzymes that regulate telomere length and telomerase activity.",
      "Tankyrases are involved in the response to Double Strand Breaks (DSBs), which are DNA breaks that occur when both strands of a chromosome are broken.",
      "Tankyrases can help to recruit repair factors to the site of the DSB and protect the telomeres from being damaged during the repair process.",
      "In some cases, tankyrases can promote the formation of a DNA double-strand break-induced replication fork stalling and/or DNA damage response (DDR) signaling.",
      "Tankyrases role in response to DSBs leads to the activation of checkpoint kinases and the initiation of DNA repair processes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2569,
    "user_query": "Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?",
    "vicuna-13b_response": "There are several methods available for whole-genome identification of pathogenic regulatory variants in Mendelian diseases. Some of the commonly used methods are:\n1. Whole-exome sequencing (WES): This method involves sequencing all the exons in the genome, which are the regions that code for proteins. This approach allows for the identification of both coding and non-coding variants that may be associated with a Mendelian disease.\n2. Targeted sequencing: This method involves sequencing specific regions of the genome that are known to be associated with a particular Mendelian disease. This approach can be more cost-effective than whole-genome sequencing and may be used to focus on specific genes or regions of interest.\n3. Chromosomal microarray analysis (CMA): This method involves analyzing the copy number variation of all chromosomes in the genome. This approach can identify both deletions and duplications of genetic material that may be associated with a Mendelian disease.\n4. Genome-wide association studies (GWAS): This method involves analyzing the genotypes of individuals with a Mendelian disease and comparing them to unaffected individuals. This approach can identify common variants in the genome that are associated with an increased risk of developing the disease.\n5. Deep sequencing of candidate genes: This method involves sequencing all the exons and intron-exon boundaries of genes that have been identified as being associated with a Mendelian disease. This approach can identify both coding and non-coding variants that may be associated with the disease.\nIt is important to note that the choice of method will depend on the specific Mendelian disease, the availability of genetic data, and the resources available for analysis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Whole-exome sequencing (WES) is a method for whole-genome identification of pathogenic regulatory variants in Mendelian diseases, which involves sequencing all the exons in the genome.\n2. Targeted sequencing is another method which involves sequencing specific regions of the genome that are known to be associated with a particular Mendelian disease.\n3. Chromosomal microarray analysis (CMA) involves analyzing the copy number variation of all chromosomes in the genome.\n4. Genome-wide association studies (GWAS) involve analyzing the genotypes of individuals with a Mendelian disease and comparing them to unaffected individuals.\n5. Deep sequencing of candidate genes involves sequencing all the exons and intron-exon boundaries of genes that have been identified as being associated with a Mendelian disease.",
    "vicuna-13b_fact": [
      "Whole-exome sequencing (WES) is a method for whole-genome identification of pathogenic regulatory variants in Mendelian diseases, which involves sequencing all the exons in the genome.",
      "Targeted sequencing is another method which involves sequencing specific regions of the genome that are known to be associated with a particular Mendelian disease.",
      "Chromosomal microarray analysis (CMA) involves analyzing the copy number variation of all chromosomes in the genome.",
      "Genome-wide association studies (GWAS) involve analyzing the genotypes of individuals with a Mendelian disease and comparing them to unaffected individuals.",
      "Deep sequencing of candidate genes involves sequencing all the exons and intron-exon boundaries of genes that have been identified as being associated with a Mendelian disease."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Whole-exome sequencing (WES) is a method for selective identification of genetic variants in all exons, not the whole-genome.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Genome-wide association studies (GWAS) involve analyzing the genotypes of a large number of individuals to identify genetic variations associated with a particular disease, not specifically Mendelian diseases.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2576,
    "user_query": "Which algorithm has been proposed for efficient storage of WGS variant calls?",
    "vicuna-13b_response": "There are several algorithms that have been proposed for efficient storage of WGS (Whole Genome Sequence) variant calls. Some of the commonly used algorithms are:\n1. BCFtools: BCFtools is a widely used tool for storing and manipulating variant call format (VCF) files. It provides a number of features for working with VCF files, including filtering, sorting, and indexing.\n2. Samtools: Samtools is a popular tool for working with BAM (Binary Alignment Map) files, which are commonly used to store WGS data. It provides a number of features for working with BAM files, including sorting, indexing, and filtering.\n3. GATK: The Genome Analysis Toolkit (GATK) is a widely used tool for analyzing WGS data. It provides a number of tools for working with VCF files, including sorting, indexing, and filtering.\n4. VCFtools: VCFtools is a tool for manipulating VCF files, including filtering, sorting, and indexing. It is designed to be fast and efficient, making it well-suited for working with large VCF files.\n5. BWA: BWA (Burrows-Wheeler Aligner) is a popular tool for aligning DNA sequences. It is often used as part of a pipeline for analyzing WGS data, and can be used to sort and index VCF files.\nThese algorithms are designed to be efficient and scalable, making them well-suited for storing and manipulating large amounts of WGS variant call data.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BCFtools is a tool used for storing and manipulating variant call format (VCF) files.\n2. Samtools is a tool for working with BAM (Binary Alignment Map) files, which are used to store WGS data.\n3. The Genome Analysis Toolkit (GATK) is used for analyzing WGS data and it works with VCF files.\n4. VCFtools is a tool for manipulating VCF files, and is designed to be fast and efficient for working with large VCF files.\n5. BWA (Burrows-Wheeler Aligner) is a tool used for aligning DNA sequences and it is often used as part of a pipeline for analyzing WGS data.",
    "vicuna-13b_fact": [
      "BCFtools is a tool used for storing and manipulating variant call format (VCF) files.",
      "Samtools is a tool for working with BAM (Binary Alignment Map) files, which are used to store WGS data.",
      "The Genome Analysis Toolkit (GATK) is used for analyzing WGS data and it works with VCF files.",
      "VCFtools is a tool for manipulating VCF files, and is designed to be fast and efficient for working with large VCF files.",
      "BWA (Burrows-Wheeler Aligner) is a tool used for aligning DNA sequences and it is often used as part of a pipeline for analyzing WGS data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2577,
    "user_query": "Is Citrobacter rodentium pathogenic?",
    "vicuna-13b_response": "Citrobacter rodentium is a gram-negative bacteria that is commonly found in the intestines of mice and rats. While it is not typically considered a pathogenic organism, meaning it does not typically cause disease in healthy individuals, it can cause infections in immunocompromised individuals, such as those with AIDS or those receiving chemotherapy. Additionally, it has been associated with outbreaks of diarrhea in humans, particularly in settings such as nursing homes and hospitals. In these cases, the bacteria may be transmitted through contaminated food or water. It is also known to cause infections in other animals such as dogs and cats.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Citrobacter rodentium is a gram-negative bacteria found in the intestines of mice and rats.\n2. Citrobacter rodentium can cause infections in immunocompromised individuals.\n3. Citrobacter rodentium has been associated with outbreaks of diarrhea in humans.\n4. The bacteria can be transmitted through contaminated food or water.\n5. Citrobacter rodentium is known to cause infections in other animals such as dogs and cats.",
    "vicuna-13b_fact": [
      "Citrobacter rodentium is a gram-negative bacteria found in the intestines of mice and rats.",
      "Citrobacter rodentium can cause infections in immunocompromised individuals.",
      "Citrobacter rodentium has been associated with outbreaks of diarrhea in humans.",
      "The bacteria can be transmitted through contaminated food or water.",
      "Citrobacter rodentium is known to cause infections in other animals such as dogs and cats."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Citrobacter rodentium primarily infects mice and rats and has not been associated with outbreaks of diarrhea in humans. \n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2578,
    "user_query": "List two human monoclonal antibodies against Clostridium difficile toxins.",
    "vicuna-13b_response": "There are several human monoclonal antibodies available against Clostridium difficile toxins. Here are two examples:\n1. Clostridium difficile Toxin A and B Immune Globulin (Human) - This is a preparation of human immunoglobulin that contains antibodies against both C. difficile toxins A and B. It is indicated for the prevention and treatment of C. difficile-associated diarrhea.\n2. Bezlotoxumab (Invanz) - This is a monoclonal antibody that specifically targets C. difficile toxin B. It is indicated for the prevention of C. difficile-associated diarrhea in adult patients who are at high risk for C. difficile infection. It is given as an intravenous infusion and should be used in combination with oral vancomycin.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Clostridium difficile Toxin A and B Immune Globulin (Human) is a preparation of human immunoglobulin that contains antibodies against C. difficile toxins A and B.\n2. Clostridium difficile Toxin A and B Immune Globulin is indicated for the prevention and treatment of C. difficile-associated diarrhea.\n3. Bezlotoxumab (Invanz) is a monoclonal antibody that specifically targets C. difficile toxin B.\n4. Bezlotoxumab (Invanz) is indicated for the prevention of C. difficile-associated diarrhea in adult patients who are at high risk for C. difficile infection.\n5. Bezlotoxumab (Invanz) is given as an intravenous infusion and should be used in combination with oral vancomycin.",
    "vicuna-13b_fact": [
      "Clostridium difficile Toxin A and B Immune Globulin (Human) is a preparation of human immunoglobulin that contains antibodies against C. difficile toxins A and B.",
      "Clostridium difficile Toxin A and B Immune Globulin is indicated for the prevention and treatment of C. difficile-associated diarrhea.",
      "Bezlotoxumab (Invanz) is a monoclonal antibody that specifically targets C. difficile toxin B.",
      "Bezlotoxumab (Invanz) is indicated for the prevention of C. difficile-associated diarrhea in adult patients who are at high risk for C. difficile infection.",
      "Bezlotoxumab (Invanz) is given as an intravenous infusion and should be used in combination with oral vancomycin."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Bezlotoxumab (Zinplava) is a monoclonal antibody that specifically targets C. difficile toxin B.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2579,
    "user_query": "List ribosomal biogenesis proteins.",
    "vicuna-13b_response": "Ribosomes are complex molecular machines that play a crucial role in protein synthesis in all living organisms. The biogenesis of ribosomes involves the synthesis and assembly of ribosomal RNA (rRNA) and ribosomal proteins (RPs) into functional ribosomes. Here are some key proteins involved in ribosomal biogenesis:\n1. RNA polymerase: This enzyme is responsible for transcribing DNA into RNA, including the ribosomal RNA genes.\n2. RNA ligase: This enzyme is involved in the capping and polyadenylation of ribosomal RNA.\n3. RNA helicases: These enzymes unwind RNA and help with the folding and transport of ribosomal RNA.\n4. RPs: These proteins are essential components of ribosomes and are involved in various stages of ribosome biogenesis, including transcription, processing, and assembly.\n5. Ribosome-sized particles (RBs): These are precursor particles that are involved in the early stages of ribosome assembly.\n6. Small subunit processome: This complex is involved in the processing and assembly of the small subunit of ribosomes.\n7. Large subunit processome: This complex is involved in the processing and assembly of the large subunit of ribosomes.\nOverall, ribosomal biogenesis is a complex process that requires the coordinated action of many different proteins and enzymes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ribosomes play a crucial role in protein synthesis in all living organisms.\n2. The biogenesis of ribosomes involves the synthesis and assembly of ribosomal RNA (rRNA) and ribosomal proteins (RPs) into functional ribosomes.\n3. RNA polymerase, a key protein involved in ribosomal biogenesis, is responsible for transcribing DNA into RNA, including the ribosomal RNA genes.\n4. Small and Large subunit processomes are involved in the processing and assembly of the small and large subunit of ribosomes respectively.\n5. Ribosomal biogenesis requires the coordinated action of many different proteins and enzymes.",
    "vicuna-13b_fact": [
      "Ribosomes play a crucial role in protein synthesis in all living organisms.",
      "The biogenesis of ribosomes involves the synthesis and assembly of ribosomal RNA (rRNA) and ribosomal proteins (RPs) into functional ribosomes.",
      "RNA polymerase, a key protein involved in ribosomal biogenesis, is responsible for transcribing DNA into RNA, including the ribosomal RNA genes.",
      "Small and Large subunit processomes are involved in the processing and assembly of the small and large subunit of ribosomes respectively.",
      "Ribosomal biogenesis requires the coordinated action of many different proteins and enzymes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "vicuna-13b_response": "There are several algorithms that can be used for the detection of long repeat expansions, including:\n1. Longest Common Subsequence (LCS) algorithm: This algorithm is used to find the longest sequence of consecutive characters that are common to two or more strings. In the context of detecting long repeat expansions, the LCS algorithm can be used to identify the presence of long repeat sequences in a genome.\n2. Smith-Waterman algorithm: This algorithm is a dynamic programming algorithm that is commonly used for comparing biological sequences. It can be used to identify the presence of long repeat sequences in a genome by comparing the sequence to a known reference sequence.\n3. Repeat-induced polymerase chain reaction (RIP-PCR): This is a PCR-based method that can be used to amplify and detect long repeat sequences in a genome. RIP-PCR is based on the fact that repeat sequences can act as templates for the polymerase chain reaction, leading to the amplification of the repeat sequence.\n4. Next-generation sequencing (NGS) technologies: NGS technologies, such as whole-genome sequencing, can be used to identify long repeat expansions directly from the genome sequence. NGS technologies allow for the simultaneous detection of multiple repeat sequences, making them a powerful tool for the study of repeat disorders.\nOverall, the choice of algorithm will depend on the specific needs of the research question and the available resources.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Longest Common Subsequence (LCS) algorithm is used to find the longest sequence of consecutive characters that are common to two or more strings.\n2. The Smith-Waterman algorithm is a dynamic programming algorithm used for comparing biological sequences.\n3. Repeat-induced polymerase chain reaction (RIP-PCR) is a PCR-based method that can be used to amplify and detect long repeat sequences in a genome.\n4. Next-generation sequencing (NGS) technologies, like whole-genome sequencing, can be used to identify long repeat expansions directly from the genome sequence.\n5. The choice of algorithm for the detection of long repeat expansions will depend on the specific research question and available resources.",
    "vicuna-13b_fact": [
      "The Longest Common Subsequence (LCS) algorithm is used to find the longest sequence of consecutive characters that are common to two or more strings.",
      "The Smith-Waterman algorithm is a dynamic programming algorithm used for comparing biological sequences.",
      "Repeat-induced polymerase chain reaction (RIP-PCR) is a PCR-based method that can be used to amplify and detect long repeat sequences in a genome.",
      "Next-generation sequencing (NGS) technologies, like whole-genome sequencing, can be used to identify long repeat expansions directly from the genome sequence.",
      "The choice of algorithm for the detection of long repeat expansions will depend on the specific research question and available resources."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Longest Common Subsequence (LCS) algorithm is used to find the longest sequence of characters that are common to two or more strings, not necessarily consecutive.\n2. TRUE\n3. FALSE [correction]: Repeat-induced point mutation (RIP) is a mechanism that introduces mutations specifically into repeated DNA sequences during the sexual cycle, not a PCR-based method.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "vicuna-13b_response": "Neuroligin-3 is a protein that is expressed on the surface of neurons and plays a role in synaptic transmission. It has been implicated in the development and progression of certain types of brain tumors, specifically glioblastoma and medulloblastoma.\nGlioblastoma is a highly aggressive and malignant brain tumor that arises from astrocytes, a type of glial cell. Studies have shown that high levels of neuroligin-3 are associated with a poor prognosis in patients with glioblastoma. Increased expression of neuroligin-3 has been linked to increased cell proliferation, migration, and invasion, all of which are characteristics of cancer cells.\nMedulloblastoma is a type of brain tumor that arises from embryonic cells in the cerebellum. Studies have also shown that neuroligin-3 is expressed in medulloblastoma cells and that high levels of neuroligin-3 are associated with a poor prognosis in patients with this type of brain tumor.\nIt is important to note that while neuroligin-3 has been implicated in the development and progression of certain types of brain tumors, it is not the only factor that contributes to the development and progression of these tumors. Other genetic and environmental factors also play a role.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Neuroligin-3 is a protein expressed on the surface of neurons.\n2. Neuroligin-3 plays a role in synaptic transmission.\n3. Glioblastoma is a type of brain tumor that arises from astrocytes and its development and progression have been linked to neuroligin-3.\n4. High levels of neuroligin-3 are associated with poor prognosis in patients with glioblastoma.\n5. Medulloblastoma is a type of brain tumor that arises from embryonic cells in the cerebellum and it's also connected to neuroligin-3 expression.",
    "vicuna-13b_fact": [
      "Neuroligin-3 is a protein expressed on the surface of neurons.",
      "Neuroligin-3 plays a role in synaptic transmission.",
      "Glioblastoma is a type of brain tumor that arises from astrocytes and its development and progression have been linked to neuroligin-3.",
      "High levels of neuroligin-3 are associated with poor prognosis in patients with glioblastoma.",
      "Medulloblastoma is a type of brain tumor that arises from embryonic cells in the cerebellum and it's also connected to neuroligin-3 expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "vicuna-13b_response": "Gas vesicles are small, hollow, gas-filled structures that are found in certain types of aquatic plants and animals, such as blue-green algae, dinoflagellates, and some species of fish. The size of gas vesicles can vary depending on the species, but they are typically very small, ranging in size from a few micrometers to a few hundred micrometers in diameter.\nIn general, gas vesicles are much smaller than the cells that contain them, and they are used by the organism to float in the water or to adjust its buoyancy. The size and shape of the gas vesicles can also vary depending on the function they serve in the organism. For example, some gas vesicles may be larger and more spherical in shape, while others may be smaller and more elongated.\nOverall, the size of gas vesicles is an important characteristic of the organism that produces them, and it can be used to help identify different species and to understand their ecological role in the aquatic environment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Gas vesicles are small, hollow, gas-filled structures found in some aquatic plants and animals.\n2. Gas vesicles are found in blue-green algae, dinoflagellates, and some species of fish.\n3. The size of gas vesicles varies depending on the species, ranging from a few micrometers to a few hundred micrometers in diameter.\n4. Gas vesicles are generally smaller than the cells that contain them.\n5. The size and shape of the gas vesicles vary depending on the function they serve in the organism.",
    "vicuna-13b_fact": [
      "Gas vesicles are small, hollow, gas-filled structures found in some aquatic plants and animals.",
      "Gas vesicles are found in blue-green algae, dinoflagellates, and some species of fish.",
      "The size of gas vesicles varies depending on the species, ranging from a few micrometers to a few hundred micrometers in diameter.",
      "Gas vesicles are generally smaller than the cells that contain them.",
      "The size and shape of the gas vesicles vary depending on the function they serve in the organism."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Gas vesicles are small, rigid, gas-filled structures found in some bacteria and archaea.\n2. FALSE [correction]: Gas vesicles are found in bacteria, archaea, and cyanobacteria (also known as blue-green algae), not dinoflagellates or fish.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2588,
    "user_query": "Are osteoclasts specialized in bone degradation?",
    "vicuna-13b_response": "Yes, osteoclasts are specialized cells that are responsible for bone degradation. They are the primary cells involved in the process of bone remodeling, which is the continuous cycle of bone formation and bone resorption.\nOsteoclasts are multinucleated cells that are derived from monocytes, which are a type of white blood cell. They are responsible for breaking down old bone tissue and releasing the minerals that make up bone, such as calcium and phosphorus, into the bloodstream. This process is necessary for maintaining the proper balance of minerals in the body and for the growth and repair of bones.\nThe process of bone resorption is tightly regulated, and it is carefully balanced with the process of bone formation to ensure that the bones remain healthy and strong. When osteoclasts are active, they digest the minerals in bone and release them into the bloodstream. At the same time, osteoblasts, which are cells that are responsible for bone formation, use the minerals in the bloodstream to build new bone tissue.\nIn summary, osteoclasts are specialized cells that are responsible for bone degradation, which is a necessary process for maintaining the proper balance of minerals in the body and for the growth and repair of bones.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. Osteoclasts are specialized cells that are responsible for bone degradation.\n2. They are primary cells involved in the process of bone remodeling. \n3. The function of osteoclasts is necessary for maintaining the proper balance of minerals in the body and for the growth and repair of bones.\n4. Osteoclasts are derived from monocytes, a type of white blood cell.\n5. When active, osteoclasts digest the minerals in bone and release them into the bloodstream.",
    "vicuna-13b_fact": [
      "Osteoclasts are specialized cells that are responsible for bone degradation.",
      "They are primary cells involved in the process of bone remodeling.",
      "The function of osteoclasts is necessary for maintaining the proper balance of minerals in the body and for the growth and repair of bones.",
      "Osteoclasts are derived from monocytes, a type of white blood cell.",
      "When active, osteoclasts digest the minerals in bone and release them into the bloodstream."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "vicuna-13b_response": "BET (bromodomain and extraterminal) proteins are a family of transcription factors that play a critical role in regulating gene expression in response to environmental cues. There are three main members of the BET family: BRD2, BRD3, and BRD4.\nBRD2 is a ubiquitously expressed protein that is involved in the regulation of many different genes. It has been shown to play a role in the development of hematopoietic cells, and mutations in BRD2 have been linked to the development of certain types of leukemia.\nBRD3 is a protein that is primarily expressed in the brain, and it has been shown to play a role in the regulation of neuronal differentiation and survival. Mutations in BRD3 have been linked to the development of certain types of brain tumors.\nBRD4 is a protein that is expressed in many different tissues, and it has been shown to play a role in the regulation of cell proliferation and differentiation. Mutations in BRD4 have been linked to the development of certain types of cancer, including acute myeloid leukemia and myelodysplastic syndromes.\nOverall, BET proteins are important regulators of gene expression, and dysregulation of BET proteins has been linked to the development of a variety of diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BET proteins are a family of transcription factors that regulate gene expression in response to environmental cues.\n2. The BET family primarily includes three members: BRD2, BRD3, and BRD4.\n3. Mutations in BRD2 have been linked to the development of certain types of leukemia.\n4. BRD3 has been shown to play a role in the regulation of neuronal differentiation and survival and its mutations have been linked to certain types of brain tumors.\n5. BRD4 is involved in the regulation of cell proliferation and differentiation, and mutations in this protein have been associated with certain types of cancer, including acute myeloid leukemia and myelodysplastic syndromes.",
    "vicuna-13b_fact": [
      "BET proteins are a family of transcription factors that regulate gene expression in response to environmental cues.",
      "The BET family primarily includes three members: BRD2, BRD3, and BRD4.",
      "Mutations in BRD2 have been linked to the development of certain types of leukemia.",
      "BRD3 has been shown to play a role in the regulation of neuronal differentiation and survival and its mutations have been linked to certain types of brain tumors.",
      "BRD4 is involved in the regulation of cell proliferation and differentiation, and mutations in this protein have been associated with certain types of cancer, including acute myeloid leukemia and myelodysplastic syndromes."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: BET proteins are a family of proteins that recognized acetylated histones, not transcription factors per se. They influence gene expression in response to environmental cues.\n2. FALSE [correction]: The BET family primarily includes four members: BRD2, BRD3, BRD4, and BRDT.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2593,
    "user_query": "How does neuronal activity affect neuroligin-3?",
    "vicuna-13b_response": "Neuronal activity can affect neuroligin-3 through several mechanisms.\nFirst, it is known that neuronal activity can regulate the expression and synthesis of neuroligin-3 in the brain. For example, studies have shown that increased neuronal activity can lead to an increase in the expression of neuroligin-3 in certain brain regions.\nSecond, neuronal activity can also affect the trafficking and localization of neuroligin-3 in the brain. It is thought that during periods of high neuronal activity, there may be an increased demand for neuroligin-3 to form synapses with postsynaptic cells. This can lead to an increased transport of neuroligin-3 to the cell surface, where it can interact with its binding partners and form synapses.\nThird, neuronal activity can also affect the stability and degradation of neuroligin-3. It has been shown that increased neuronal activity can lead to an increased stability of neuroligin-3, which can prevent its degradation and help maintain its levels in the brain.\nOverall, neuronal activity can affect neuroligin-3 through multiple mechanisms, including regulating its expression, trafficking, and stability, and these effects can play a role in the formation and maintenance of synapses in the brain.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Neuronal activity can regulate the expression and synthesis of neuroligin-3 in the brain.\n2. Increased neuronal activity can lead to an increase in the expression of neuroligin-3 in certain brain regions.\n3. Neuronal activity can affect the trafficking and localization of neuroligin-3 in the brain.\n4. Increased neuronal activity may lead to increased transport of neuroligin-3 to the cell surface for synapse formation.\n5. Neuronal activity can affect the stability and degradation of neuroligin-3, with increased activity leading to increased stability.",
    "vicuna-13b_fact": [
      "Neuronal activity can regulate the expression and synthesis of neuroligin-3 in the brain.",
      "Increased neuronal activity can lead to an increase in the expression of neuroligin-3 in certain brain regions.",
      "Neuronal activity can affect the trafficking and localization of neuroligin-3 in the brain.",
      "Increased neuronal activity may lead to increased transport of neuroligin-3 to the cell surface for synapse formation.",
      "Neuronal activity can affect the stability and degradation of neuroligin-3, with increased activity leading to increased stability."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2596,
    "user_query": "What is PARP inhibitor (PARPi) resistance?",
    "vicuna-13b_response": "PARP inhibitors (PARPi) are a class of drugs that target the enzyme poly(ADP-ribose) polymerase (PARP), which is involved in DNA repair and cell survival. PARPi are used in cancer therapy as they can cause DNA damage and increase the sensitivity of cancer cells to chemotherapy and radiation therapy. However, some cancer cells can become resistant to PARPi treatment, which can limit the effectiveness of the therapy.\nPARPi resistance can occur through several mechanisms, including:\n1. Gene mutations: Some cancer cells may have mutations in the PARP gene that make them resistant to PARPi.\n2. Overexpression of PARP: Some cancer cells may have higher levels of PARP than normal cells, which can protect them from the toxic effects of PARPi.\n3. Altered DNA repair: Cancer cells may have altered DNA repair mechanisms that allow them to repair the DNA damage caused by PARPi, thus reducing their sensitivity to the drug.\n4. Increased PARP activity: Cancer cells may have increased PARP activity, which can protect them from the toxic effects of PARPi.\nUnderstanding the mechanisms of PARPi resistance is important for developing new strategies to overcome resistance and improve the effectiveness of PARPi-based therapies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PARP inhibitors (PARPi) are a class of drugs that target the enzyme poly(ADP-ribose) polymerase (PARP), which is involved in DNA repair and cell survival.\n2. PARPi are used in cancer therapy as they can cause DNA damage and increase the sensitivity of cancer cells to chemotherapy and radiation therapy.\n3. Some cancer cells can become resistant to PARPi treatment, which can limit the effectiveness of the therapy.\n4. PARPi resistance in cancer cells can occur through gene mutations, overexpression of PARP, altered DNA repair and increased PARP activity.\n5. Understanding the mechanisms of PARPi resistance is considered important for developing new strategies to overcome resistance and improve the effectiveness of PARPi-based therapies.",
    "vicuna-13b_fact": [
      "PARP inhibitors (PARPi) are a class of drugs that target the enzyme poly(ADP-ribose) polymerase (PARP), which is involved in DNA repair and cell survival.",
      "PARPi are used in cancer therapy as they can cause DNA damage and increase the sensitivity of cancer cells to chemotherapy and radiation therapy.",
      "Some cancer cells can become resistant to PARPi treatment, which can limit the effectiveness of the therapy.",
      "PARPi resistance in cancer cells can occur through gene mutations, overexpression of PARP, altered DNA repair and increased PARP activity.",
      "Understanding the mechanisms of PARPi resistance is considered important for developing new strategies to overcome resistance and improve the effectiveness of PARPi-based therapies."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2597,
    "user_query": "What is the association of the protein RAB10 and Alzheimers disease?",
    "vicuna-13b_response": "RAB10 (Ras-related protein 10) is a small GTPase protein that plays a role in regulating intracellular membrane traffic. It has been implicated in the development of Alzheimer's disease (AD).\nStudies have shown that RAB10 levels are decreased in the brains of AD patients and that this decrease may contribute to the formation of amyloid plaques, a hallmark of the disease. Additionally, RAB10 has been shown to regulate the trafficking of the amyloid precursor protein (APP), which is cleaved to form the beta-amyloid peptides that make up the amyloid plaques.\nFurthermore, RAB10 has been shown to regulate the activity of the protein kinase C (PKC) delta, which is involved in the processing of APP and the formation of beta-amyloid peptides. Additionally, RAB10 has been shown to regulate the activity of the GTPase-activating protein (GAP) for RAC1, which is involved in the regulation of the actin cytoskeleton and the formation of dendritic spines, which are important for neuronal function.\nOverall, the association of RAB10 with Alzheimer's disease is complex and multi-faceted, and further research is needed to fully understand its role in the disease. However, studies suggest that RAB10 may play a role in the regulation of intracellular membrane traffic, the processing of APP, and the formation of beta-amyloid plaques, and that its decreased levels may contribute to the development of AD.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. RAB10 (Ras-related protein 10) is a small GTPase protein that helps regulate intracellular membrane traffic.\n2. RAB10 levels are often decreased in the brains of Alzheimer's disease patients.\n3. This decrease in RAB10 levels may contribute to the formation of amyloid plaques, a characteristic of Alzheimer's disease.\n4. RAB10 has been shown to regulate the trafficking of the amyloid precursor protein (APP), which forms beta-amyloid peptides that constitute amyloid plaques.\n5. RAB10 regulates the activity of protein kinase C (PKC) delta and the GTPase-activating protein (GAP) for RAC1, both implicated in Alzheimer's disease.",
    "vicuna-13b_fact": [
      "RAB10 (Ras-related protein 10) is a small GTPase protein that helps regulate intracellular membrane traffic.",
      "RAB10 levels are often decreased in the brains of Alzheimer's disease patients.",
      "This decrease in RAB10 levels may contribute to the formation of amyloid plaques, a characteristic of Alzheimer's disease.",
      "RAB10 has been shown to regulate the trafficking of the amyloid precursor protein (APP), which forms beta-amyloid peptides that constitute amyloid plaques.",
      "RAB10 regulates the activity of protein kinase C (PKC) delta and the GTPase-activating protein (GAP) for RAC1, both implicated in Alzheimer's disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2599,
    "user_query": "A bite from the Lone Star Tick Amblyomma americanum, can cause the victim to become allergic to red meat, yes or no?",
    "vicuna-13b_response": "Yes, a bite from the Lone Star Tick Amblyomma americanum can cause the victim to become allergic to red meat.\nThe Lone Star Tick is known to transmit a variety of diseases, including Ehrlichiosis and Anaplasmosis, which are tick-borne illnesses that can cause fever, headache, and fatigue. In addition, the saliva of the Lone Star Tick contains a protein called alpha-gal, which can cause an immune response in some people, leading to an allergy to red meat. This condition is known as alpha-gal syndrome or red meat allergy.\nThe allergy to red meat can range from mild symptoms such as hives and itching, to severe symptoms including anaphylaxis, which can be life-threatening. The allergy can persist for years after the initial bite, and there is no known cure.\nIt's important to note that not everyone who is bitten by a Lone Star Tick will develop an allergy to red meat, but it's a possibility. If you have been bitten by a Lone Star Tick and experience symptoms such as hives, itching, or swelling, it's important to seek medical attention.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A bite from the Lone Star Tick Amblyomma americanum can cause the victim to become allergic to red meat.\n2. The Lone Star Tick can transmit diseases such as Ehrlichiosis and Anaplasmosis.\n3. The saliva of the Lone Star Tick contains a protein called alpha-gal, which can cause an immune response in some people, leading to an allergy to red meat.\n4. The allergy to red meat caused by the Lone Star Tick, known as alpha-gal syndrome or red meat allergy, can range from mild to severe symptoms.\n5. This allergy can persist for years after the initial bite and there is no known cure.",
    "vicuna-13b_fact": [
      "A bite from the Lone Star Tick Amblyomma americanum can cause the victim to become allergic to red meat.",
      "The Lone Star Tick can transmit diseases such as Ehrlichiosis and Anaplasmosis.",
      "The saliva of the Lone Star Tick contains a protein called alpha-gal, which can cause an immune response in some people, leading to an allergy to red meat.",
      "The allergy to red meat caused by the Lone Star Tick, known as alpha-gal syndrome or red meat allergy, can range from mild to severe symptoms.",
      "This allergy can persist for years after the initial bite and there is no known cure."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2600,
    "user_query": "What are pQTLs?",
    "vicuna-13b_response": "pQTLs, or protein quantitative trait loci, are genetic regions that are associated with variation in protein levels or activity. These regions can affect the expression or regulation of a gene, leading to differences in the amount of protein produced. pQTLs can be identified through the analysis of genetic data, such as genome-wide association studies (GWAS) or transcriptomic data, and can be used to better understand the underlying biology of complex traits and diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. pQTLs stand for protein quantitative trait loci.\n2. pQTLs are genetic regions associated with variation in protein levels or activity.\n3. These regions can affect the expression or regulation of a gene.\n4. Differences in the amount of protein produced can result from pQTLs.\n5. pQTLs can be identified through the analysis of genetic data, such as genome-wide association studies (GWAS) or transcriptomic data.",
    "vicuna-13b_fact": [
      "pQTLs stand for protein quantitative trait loci.",
      "pQTLs are genetic regions associated with variation in protein levels or activity.",
      "These regions can affect the expression or regulation of a gene.",
      "Differences in the amount of protein produced can result from pQTLs.",
      "pQTLs can be identified through the analysis of genetic data, such as genome-wide association studies (GWAS) or transcriptomic data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2603,
    "user_query": "What is the \"protein inference problem\"?",
    "vicuna-13b_response": "The protein inference problem is a computational problem in bioinformatics that involves predicting the three-dimensional structure of a protein from its amino acid sequence. Proteins are complex biomolecules that perform a wide range of functions in living organisms, and their structure is critical to their function. The amino acid sequence of a protein determines its chemical properties and interactions with other molecules, but it does not provide enough information to determine its three-dimensional structure.\nThe protein inference problem involves using computational methods to predict the three-dimensional structure of a protein based on its amino acid sequence. This problem is challenging because proteins can adopt a wide range of structures, and the process of protein folding is complex and not fully understood. In addition, the number of possible protein structures is vast, and the search space for finding the correct structure is large.\nVarious computational methods have been developed to address the protein inference problem, including molecular dynamics simulations, Monte Carlo simulations, and evolutionary algorithms. These methods use a combination of physics-based models, statistical mechanics, and machine learning techniques to predict the three-dimensional structure of a protein.\nThe protein inference problem is important for understanding protein function, designing drugs that target specific proteins, and developing new therapies for diseases caused by protein misfolding or aggregation. Accurate prediction of protein structure is also critical for the design of biotechnology products, such as enzymes and antibodies, and for the development of new materials with unique properties.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The protein inference problem is a computational problem in bioinformatics that involves predicting the three-dimensional structure of a protein from its amino acid sequence.\n2. The amino acid sequence of a protein determines its chemical properties and interactions with other molecules.\n3. Various computational methods have been developed to address the protein inference problem, including molecular dynamics simulations, Monte Carlo simulations, and evolutionary algorithms.\n4. The protein inference problem is important for understanding protein function, designing drugs that target specific proteins, and developing new therapies for diseases caused by protein misfolding or aggregation.\n5. Accurate prediction of protein structure is critical for the design of biotechnology products, such as enzymes and antibodies, and for the development of new materials with unique properties.",
    "vicuna-13b_fact": [
      "The protein inference problem is a computational problem in bioinformatics that involves predicting the three-dimensional structure of a protein from its amino acid sequence.",
      "The amino acid sequence of a protein determines its chemical properties and interactions with other molecules.",
      "Various computational methods have been developed to address the protein inference problem, including molecular dynamics simulations, Monte Carlo simulations, and evolutionary algorithms.",
      "The protein inference problem is important for understanding protein function, designing drugs that target specific proteins, and developing new therapies for diseases caused by protein misfolding or aggregation.",
      "Accurate prediction of protein structure is critical for the design of biotechnology products, such as enzymes and antibodies, and for the development of new materials with unique properties."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The protein inference problem is a computational problem in bioinformatics that involves predicting the presence and abundance of proteins from data obtained in a mass spectrometry experiment.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2604,
    "user_query": "What is the link between lithium use during pregnancy and Ebstein anomaly?",
    "vicuna-13b_response": "Lithium is a medication commonly used to treat bipolar disorder and other mental health conditions. While lithium is generally considered safe for use during pregnancy, there is some evidence to suggest that it may be associated with an increased risk of Ebstein anomaly in the developing fetus.\nEbstein anomaly is a rare congenital heart defect that affects the tricuspid valve, which is located in the heart between the right atrium and the right ventricle. With Ebstein anomaly, the tricuspid valve does not develop properly, which can lead to problems with blood flow and oxygenation of the body.\nSeveral studies have suggested that lithium use during pregnancy may be associated with an increased risk of Ebstein anomaly. For example, a study published in the American Journal of Medical Genetics in 2011 found that women who took lithium during pregnancy were more likely to have a child with Ebstein anomaly than women who did not take lithium.\nHowever, it is important to note that the link between lithium use and Ebstein anomaly is not well understood, and more research is needed to fully understand the potential risks. Additionally, the overall risk of Ebstein anomaly is still relatively low, and the benefits of lithium treatment for bipolar disorder and other mental health conditions may outweigh the potential risks for many women.\nWomen who are pregnant or planning to become pregnant and are taking lithium should talk to their healthcare provider about the potential risks and benefits of the medication, and whether it is appropriate for them to continue taking it.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Lithium is a medication commonly used to treat bipolar disorder and other mental health conditions.\n2. There is some evidence to suggest that lithium use may be associated with an increased risk of Ebstein anomaly in the developing fetus.\n3. Ebstein anomaly is a rare congenital heart defect that affects the tricuspid valve.\n4. A study published in the American Journal of Medical Genetics in 2011 found that women who took lithium during pregnancy were more likely to have a child with Ebstein anomaly than women who did not take lithium.\n5. The overall risk of Ebstein anomaly, while possibly increased by lithium use, is still relatively low.",
    "vicuna-13b_fact": [
      "Lithium is a medication commonly used to treat bipolar disorder and other mental health conditions.",
      "There is some evidence to suggest that lithium use may be associated with an increased risk of Ebstein anomaly in the developing fetus.",
      "Ebstein anomaly is a rare congenital heart defect that affects the tricuspid valve.",
      "A study published in the American Journal of Medical Genetics in 2011 found that women who took lithium during pregnancy were more likely to have a child with Ebstein anomaly than women who did not take lithium.",
      "The overall risk of Ebstein anomaly, while possibly increased by lithium use, is still relatively low."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2605,
    "user_query": "Does verubecestat activate BACE?",
    "vicuna-13b_response": "Verubecestat is a drug that is being developed to treat Alzheimer's disease. It is a small molecule inhibitor of beta-site amyloid precursor protein (APP) cleaving enzyme (BACE1), which is an enzyme that plays a role in the production of beta-amyloid peptides, a hallmark of Alzheimer's disease.\nBACE1 is responsible for cleaving APP, a large transmembrane protein, into smaller peptides, including beta-amyloid peptides. Beta-amyloid peptides are thought to play a role in the development of Alzheimer's disease, and reducing their production has been suggested as a potential therapeutic strategy for treating the disease.\nVerubecestat is a potent and selective inhibitor of BACE1, and it has been shown to reduce beta-amyloid peptide levels in the brain in preclinical studies. While verubecestat has shown promise in early clinical trials, it is important to note that the development of new drugs for Alzheimer's disease is a complex and ongoing process, and it is still uncertain whether verubecestat will ultimately be effective in treating the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Verubecestat is a drug being developed to treat Alzheimer's disease.\n2. Verubecestat is a small molecule inhibitor of beta-site amyloid precursor protein cleaving enzyme (BACE1).\n3. BACE1 plays a role in the production of beta-amyloid peptides, which are connected to Alzheimer's disease.\n4. Verubecestat can reduce beta-amyloid peptide levels in the brain as per preclinical studies.\n5. The development of new drugs for Alzheimer's disease, including verubecestat, is a complex and ongoing process.",
    "vicuna-13b_fact": [
      "Verubecestat is a drug being developed to treat Alzheimer's disease.",
      "Verubecestat is a small molecule inhibitor of beta-site amyloid precursor protein cleaving enzyme (BACE1).",
      "BACE1 plays a role in the production of beta-amyloid peptides, which are connected to Alzheimer's disease.",
      "Verubecestat can reduce beta-amyloid peptide levels in the brain as per preclinical studies.",
      "The development of new drugs for Alzheimer's disease, including verubecestat, is a complex and ongoing process."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2607,
    "user_query": "What is emicizumab?",
    "vicuna-13b_response": "Emicizumab is a monoclonal antibody drug that is used to treat hemophilia A, a genetic disorder that causes abnormal bleeding due to a deficiency in factor VIII, a clotting protein. Emicizumab is designed to bind to and inhibit the activity of factor IX, which is a protein that plays a role in blood clotting.\nEmicizumab is given as an intravenous infusion and is administered once or twice weekly. It is approved for use in adults and children with hemophilia A, and it has been shown to be effective in reducing the frequency and severity of bleeding episodes.\nEmicizumab is a relatively new treatment option for hemophilia A and has been shown to be effective in reducing the risk of bleeding complications in patients with the disorder. It is important for individuals with hemophilia A to work closely with their healthcare provider to determine the most appropriate treatment plan for their specific needs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Emicizumab is a monoclonal antibody drug used to treat hemophilia A.\n2. Hemophilia A is a genetic disorder causing abnormal bleeding due to a deficiency in factor VIII, a clotting protein.\n3. Emicizumab is designed to inhibit the activity of factor IX, a protein involved in blood clotting.\n4. Emicizumab is approved for use in both adults and children with hemophilia A.\n5. Emicizumab has been shown to reduce the frequency and severity of bleeding episodes in patients with hemophilia A.",
    "vicuna-13b_fact": [
      "Emicizumab is a monoclonal antibody drug used to treat hemophilia A.",
      "Hemophilia A is a genetic disorder causing abnormal bleeding due to a deficiency in factor VIII, a clotting protein.",
      "Emicizumab is designed to inhibit the activity of factor IX, a protein involved in blood clotting.",
      "Emicizumab is approved for use in both adults and children with hemophilia A.",
      "Emicizumab has been shown to reduce the frequency and severity of bleeding episodes in patients with hemophilia A."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Emicizumab is designed to bridge the deficiency in factor VIII, a protein involved in blood clotting. It does not inhibit the activity of factor IX.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2608,
    "user_query": "What illness is transmitted by the Lone Star Tick, Amblyomma americanum?",
    "vicuna-13b_response": "The Lone Star Tick, Amblyomma americanum, is known to transmit several illnesses, including:\n1. Ehrlichiosis: This is a bacterial infection caused by the bacteria Ehrlichia, which is transmitted to humans through the bite of the Lone Star Tick. The most common symptoms include fever, headache, and fatigue, and the illness can range from mild to severe.\n2. Heartland Disease: This is another name for the tick-borne illness caused by the bacteria Ehrlichia, which is transmitted by the Lone Star Tick. The symptoms are similar to Ehrlichiosis, but the infection can be more severe in some cases.\n3. Tularemia: This is a bacterial infection caused by the bacteria Francisella tularensis, which can be transmitted to humans through the bite of the Lone Star Tick. The most common symptoms include fever, chills, and headache, and the illness can range from mild to severe.\n4. Southern Tick-Associated Rash Illness (STARI): This is a tick-borne illness that is caused by an unknown bacteria, and it is often mistaken for other tick-borne illnesses such as Ehrlichiosis or Lyme disease. The symptoms include a rash, fever, and fatigue, and the illness is typically mild.\nIt's important to note that the Lone Star Tick is also known to transmit other illnesses, such as Tick-Borne Relapsing Fever (TBRF) and Babesiosis, but these are less common. If you believe you have been bitten by a Lone Star Tick or have symptoms of a tick-borne illness, it's important to seek medical attention.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Lone Star Tick, Amblyomma americanum, transmits several illnesses.\n2. Ehrlichiosis is a bacterial infection caused by the bacteria Ehrlichia, transmitted through the bite of the Lone Star Tick.\n3. Heartland Disease is another illness caused by the bacteria Ehrlichia and transmitted by the Lone Star Tick.\n4. Tularemia is a bacterial infection caused by the bacteria Francisella tularensis, which can be transmitted through the bite of the Lone Star Tick.\n5. Southern Tick-Associated Rash Illness (STARI) is a tick-borne illness caused by an unknown bacteria and transmitted by the Lone Star Tick.",
    "vicuna-13b_fact": [
      "The Lone Star Tick, Amblyomma americanum, transmits several illnesses.",
      "Ehrlichiosis is a bacterial infection caused by the bacteria Ehrlichia, transmitted through the bite of the Lone Star Tick.",
      "Heartland Disease is another illness caused by the bacteria Ehrlichia and transmitted by the Lone Star Tick.",
      "Tularemia is a bacterial infection caused by the bacteria Francisella tularensis, which can be transmitted through the bite of the Lone Star Tick.",
      "Southern Tick-Associated Rash Illness (STARI) is a tick-borne illness caused by an unknown bacteria and transmitted by the Lone Star Tick."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Heartland Disease is caused by the Phlebovirus and transmitted by the Lone Star Tick, not the bacteria Ehrlichia.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "vicuna-13b_response": "There are several algorithms that have been developed for prediction of protein subcellular localization using deep learning. Some of the popular ones are:\n1. DeepLoc: This algorithm uses a deep convolutional neural network (CNN) to predict the subcellular localization of proteins based on their amino acid sequences. The CNN is trained on a large dataset of protein sequences and their corresponding subcellular localization labels.\n2. LocNet: This algorithm is a fully convolutional network that is designed to predict the subcellular localization of proteins. It uses a combination of convolutional and fully connected layers to extract features from the protein sequences and then uses these features to make predictions.\n3. ProtTrans: This algorithm uses a multi-task learning approach to predict both the subcellular localization and the protein's function. It uses a combination of convolutional and recurrent neural networks to extract features from the protein sequences and then uses these features to make predictions.\n4. DeepPLoc: This algorithm uses a deep belief network (DBN) to predict the subcellular localization of proteins. It uses a hierarchical architecture that consists of multiple layers of DBNs to learn the complex patterns in the protein sequences.\nThese algorithms have been shown to achieve high accuracy in predicting the subcellular localization of proteins, and they have become popular in the field of protein bioinformatics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. DeepLoc is an algorithm that uses a deep convolutional neural network to predict the subcellular localization of proteins based on their amino acid sequences.\n2. LocNet is a fully convolutional network designed to predict the subcellular localization of proteins using a combination of convolutional and fully connected layers.\n3. ProtTrans uses a multi-task learning approach to predict both the subcellular localization and the protein's function.\n4. DeepPLoc uses a deep belief network to predict the subcellular localization of proteins and has a hierarchical architecture that consists of multiple layers of DBNs.\n5. These algorithms have been shown to achieve high accuracy in predicting the subcellular localization of proteins.",
    "vicuna-13b_fact": [
      "DeepLoc is an algorithm that uses a deep convolutional neural network to predict the subcellular localization of proteins based on their amino acid sequences.",
      "LocNet is a fully convolutional network designed to predict the subcellular localization of proteins using a combination of convolutional and fully connected layers.",
      "ProtTrans uses a multi-task learning approach to predict both the subcellular localization and the protein's function.",
      "DeepPLoc uses a deep belief network to predict the subcellular localization of proteins and has a hierarchical architecture that consists of multiple layers of DBNs.",
      "These algorithms have been shown to achieve high accuracy in predicting the subcellular localization of proteins."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2614,
    "user_query": "What is included in the Mentzer index?",
    "vicuna-13b_response": "The Mentzer index is a measure of the degree of competition in a market. It is used to evaluate the attractiveness of a market for a particular product or service. The index is based on five key factors:\n1. Market size: The size of the market is an important factor in determining the level of competition. A larger market generally indicates a higher level of competition.\n2. Market growth rate: The rate at which the market is growing can also impact the level of competition. A rapidly growing market may indicate a more competitive environment.\n3. Market share of leading competitors: The share of the market held by the leading competitors is another important factor in determining the level of competition. A highly concentrated market, with a small number of leading competitors, may indicate a lower level of competition.\n4. Number of competitors: The number of competitors in the market can also impact the level of competition. A market with a large number of competitors may indicate a more competitive environment.\n5. Barriers to entry: The ease with which new competitors can enter the market can also impact the level of competition. A market with low barriers to entry may indicate a more competitive environment.\nThe Mentzer index is calculated by assigning a weight to each of the five factors and then multiplying the weighted factors together. The weights can be adjusted to reflect the relative importance of each factor in a particular market. The resulting index can be used to compare the level of competition in different markets or to evaluate the attractiveness of a market for a particular product or service.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Mentzer index is a measure of the degree of competition in a market.\n2. Market size, market growth rate, market share of leading competitors, number of competitors, and barriers to entry are the five key factors in the Mentzer index.\n3. A larger market size generally indicates a higher level of competition.\n4. A market with a large number of competitors indicates a more competitive environment.\n5. The Mentzer index is calculated by assigning a weight to each of the five factors and then multiplying the weighted factors together.",
    "vicuna-13b_fact": [
      "The Mentzer index is a measure of the degree of competition in a market.",
      "Market size, market growth rate, market share of leading competitors, number of competitors, and barriers to entry are the five key factors in the Mentzer index.",
      "A larger market size generally indicates a higher level of competition.",
      "A market with a large number of competitors indicates a more competitive environment.",
      "The Mentzer index is calculated by assigning a weight to each of the five factors and then multiplying the weighted factors together."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2615,
    "user_query": "Which disease is treated with Fexinidazole?",
    "vicuna-13b_response": "Fexinidazole is a medication used to treat a variety of parasitic infections, including giardiasis, amebiasis, and trichomoniasis. It is an anti-parasitic medication that works by interfering with the parasite's ability to produce energy, leading to its death. Fexinidazole is usually taken orally, and the duration of treatment depends on the specific infection being treated. It is important to follow the instructions provided by a healthcare professional when taking Fexinidazole.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fexinidazole is a medication used to treat parasitic infections.\n2. Fexinidazole can be used to treat giardiasis, amebiasis, and trichomoniasis.\n3. Fexinidazole works by interfering with the parasite's ability to produce energy.\n4. Fexinidazole is usually taken orally.\n5. The duration of treatment with Fexinidazole depends on the specific infection being treated.",
    "vicuna-13b_fact": [
      "Fexinidazole is a medication used to treat parasitic infections.",
      "Fexinidazole can be used to treat giardiasis, amebiasis, and trichomoniasis.",
      "Fexinidazole works by interfering with the parasite's ability to produce energy.",
      "Fexinidazole is usually taken orally.",
      "The duration of treatment with Fexinidazole depends on the specific infection being treated."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Fexinidazole can be used to treat African trypanosomiasis (sleeping sickness) and visceral leishmaniasis.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2620,
    "user_query": "Is DNA polymerase θ involved in DNA repair?",
    "vicuna-13b_response": "Yes, DNA polymerase θ is involved in DNA repair. It is an enzyme that plays a crucial role in the process of DNA replication, which is essential for the repair of damaged DNA.\nDNA replication is the process by which a cell makes an exact copy of its DNA before cell division. During DNA replication, an enzyme called polymerase synthesizes new DNA strands by adding nucleotides to the template strands. DNA polymerase θ is one of the enzymes that participates in this process.\nIn addition to its role in DNA replication, DNA polymerase θ is also involved in DNA repair. When DNA is damaged, the cell needs to repair the damage in order to maintain the integrity of its genetic material. One way that cells repair DNA damage is through a process called nucleotide excision repair (NER). During NER, the damaged nucleotides are removed from the DNA strand, and the gap is filled in by adding new nucleotides. DNA polymerase θ plays a role in this process by synthesizing the new nucleotides that are added to the DNA strand.\nOverall, DNA polymerase θ is an important enzyme that plays a role in both DNA replication and DNA repair. Its ability to synthesize new DNA strands during replication makes it a valuable tool in the study of DNA structure and function. Its role in DNA repair suggests that it may also be a potential target for the development of therapies to treat diseases caused by DNA damage.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. DNA polymerase θ is involved in DNA repair.\n2. DNA polymerase θ is an enzyme that participates in the process of DNA replication.\n3. During DNA replication, polymerase synthesizes new DNA strands by adding nucleotides to the template strands.\n4. DNA polymerase θ also plays a role in nucleotide excision repair (NER), a process that repairs DNA damage by removing damaged nucleotides and filling the gap with new ones.\n5. DNA polymerase θ may be a potential target for the development of therapies to treat diseases caused by DNA damage.",
    "vicuna-13b_fact": [
      "DNA polymerase θ is involved in DNA repair.",
      "DNA polymerase θ is an enzyme that participates in the process of DNA replication.",
      "During DNA replication, polymerase synthesizes new DNA strands by adding nucleotides to the template strands.",
      "DNA polymerase θ also plays a role in nucleotide excision repair (NER), a process that repairs DNA damage by removing damaged nucleotides and filling the gap with new ones.",
      "DNA polymerase θ may be a potential target for the development of therapies to treat diseases caused by DNA damage."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: DNA polymerase θ does not participate in nucleotide excision repair (NER), but is involved in a process known as translesion synthesis, where it synthesizes DNA over a damaged region, and in double-strand break repair.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2623,
    "user_query": "Which algorithms are used for compression of SAM files?",
    "vicuna-13b_response": "SAM (Science and Medicine) files are typically compressed using lossless compression algorithms, which allow for the original data to be exactly reconstructed from the compressed file. Some common algorithms used for compressing SAM files include:\n1. Gzip: This is a widely-used open-source algorithm that is supported by many platforms and programs. It is a good choice for compressing SAM files that contain text or other types of data that have a lot of repeating patterns.\n2. Bzip2: This is another open-source algorithm that is similar to Gzip, but it is generally more effective at compressing data with less repeating patterns. It is often used for compressing SAM files that contain binary data or other types of data that have a lot of variable patterns.\n3. LZ77 and LZ78: These are two different variants of the Lempel-Ziv algorithm, which is a family of algorithms that are commonly used for compressing data with repeating patterns. LZ77 is more effective at compressing data with long repeating patterns, while LZ78 is more effective at compressing data with short repeating patterns.\n4. TAR: This is a file format that is used for compressing and archiving multiple files into a single file. TAR files can contain SAM files, and they can be compressed using any of the algorithms listed above.\nOverall, the choice of algorithm will depend on the specific characteristics of the SAM file being compressed and the desired level of compression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SAM (Science and Medicine) files are typically compressed using lossless compression algorithms.\n2. Gzip is an open-source algorithm used for compressing SAM files that contain text or other types of data that have a lot of repeating patterns.\n3. Bzip2, another open-source algorithm, is often used for compressing SAM files that contain binary data or other types of data that have a lot of variable patterns.\n4. LZ77 and LZ78 are two different variants of the Lempel-Ziv algorithm used for compressing data with repeating patterns.\n5. TAR is a file format that is used for compressing and archiving multiple files into a single file which can contain SAM files.",
    "vicuna-13b_fact": [
      "SAM (Science and Medicine) files are typically compressed using lossless compression algorithms.",
      "Gzip is an open-source algorithm used for compressing SAM files that contain text or other types of data that have a lot of repeating patterns.",
      "Bzip2, another open-source algorithm, is often used for compressing SAM files that contain binary data or other types of data that have a lot of variable patterns.",
      "LZ77 and LZ78 are two different variants of the Lempel-Ziv algorithm used for compressing data with repeating patterns.",
      "TAR is a file format that is used for compressing and archiving multiple files into a single file which can contain SAM files."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2629,
    "user_query": "What drug cures hepatitis C?",
    "vicuna-13b_response": "The drug that cures hepatitis C is called Sovaldi (sov-AL-dee). It is a prescription medication that is used to treat chronic hepatitis C infection. Sovaldi is a antiviral drug that works by reducing the amount of hepatitis C virus in the body. It is usually taken in combination with other antiviral drugs, such as ribavirin, for best results. Sovaldi is taken as a pill and is usually taken for 12 weeks. It is important to note that Sovaldi does not cure hepatitis C, but it can help to eliminate the virus from the body. It is important to consult with a doctor to determine the best course of treatment for hepatitis C.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The drug called Sovaldi is used to treat chronic hepatitis C infection.\n2. Sovaldi is a type of antiviral medication.\n3. Sovaldi works by reducing the amount of the hepatitis C virus in the body.\n4. This drug is typically taken in combination with other antiviral drugs such as ribavirin. \n5. The typical duration Sovaldi is taken for is 12 weeks.",
    "vicuna-13b_fact": [
      "The drug called Sovaldi is used to treat chronic hepatitis C infection.",
      "Sovaldi is a type of antiviral medication.",
      "Sovaldi works by reducing the amount of the hepatitis C virus in the body.",
      "This drug is typically taken in combination with other antiviral drugs such as ribavirin.",
      "The typical duration Sovaldi is taken for is 12 weeks."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2632,
    "user_query": "What can be predicted with the Wells criteria?",
    "vicuna-13b_response": "The Wells criteria is a set of guidelines used to determine the likelihood of a patient developing venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). The criteria were developed by Dr. John Wells, a clinical epidemiologist at McMaster University in Hamilton, Ontario, Canada.\nThe Wells criteria consist of eight factors that are used to assess the risk of VTE. These factors are:\n1. Age over 70 years\n2. Female sex\n3. Previous VTE or proximal DVT\n4. Active cancer or recent cancer treatment\n5. Immobility, defined as inability to walk or limited mobility\n6. Surgery or trauma in the past 4 weeks\n7. Oral contraceptive use or hormone replacement therapy\n8. Factor V Leiden or prothrombin G20210A mutation\nEach factor is assigned a score based on its presence or absence, with a higher score indicating a higher risk of VTE. The scores for each factor are then added together to give an overall score, which is used to determine the patient's risk of VTE.\nThe Wells criteria have been validated in several studies and have been shown to be effective in predicting the risk of VTE in patients. However, they are not perfect and may not accurately predict the risk of VTE in all patients. Therefore, clinical judgment and other factors, such as the patient's medical history and physical examination, should also be considered when assessing the risk of VTE.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Wells criteria is used to determine the likelihood of a patient developing venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE).\n2. The Wells criteria were developed by Dr. John Wells, a clinical epidemiologist at McMaster University in Hamilton, Ontario, Canada.\n3. The Wells criteria consist of eight factors that are used to assess the risk of VTE.\n4. Each factor in the Wells criteria is assigned a score based on its presence or absence, with a higher score indicating a higher risk of VTE.\n5. The Wells criteria have been validated in several studies and have been shown to be effective in predicting the risk of VTE in patients.",
    "vicuna-13b_fact": [
      "The Wells criteria is used to determine the likelihood of a patient developing venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE).",
      "The Wells criteria were developed by Dr. John Wells, a clinical epidemiologist at McMaster University in Hamilton, Ontario, Canada.",
      "The Wells criteria consist of eight factors that are used to assess the risk of VTE.",
      "Each factor in the Wells criteria is assigned a score based on its presence or absence, with a higher score indicating a higher risk of VTE.",
      "The Wells criteria have been validated in several studies and have been shown to be effective in predicting the risk of VTE in patients."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "vicuna-13b_response": "MULTOVL is a programming language that is designed to be easy to learn and use, while also being powerful and flexible. It is a high-level language, which means that it allows developers to write code in a more natural and intuitive way, without having to worry about the low-level details of how the code is executed.\nOne of the key features of MULTOVL is its support for multiple inheritance. This means that a class can inherit properties and methods from multiple other classes, rather than just one. This allows for more flexible and reusable code, as well as the ability to create more complex and hierarchical structures.\nMULTOVL also supports polymorphism, which allows objects of different classes to be treated as if they were the same type. This makes it easier to write code that can work with different types of objects in a consistent way.\nOverall, MULTOVL is a powerful and versatile programming language that is well-suited for a wide range of applications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MULTOVL is a programming language.\n2. MULTOVL is designed to be easy to learn and use. \n3. MULTOVL supports multiple inheritance. \n4. MULTOVL supports polymorphism.\n5. MULTOVL is a high-level language, allowing developers to code without worrying about low-level execution details.",
    "vicuna-13b_fact": [
      "MULTOVL is a programming language.",
      "MULTOVL is designed to be easy to learn and use.",
      "MULTOVL supports multiple inheritance.",
      "MULTOVL supports polymorphism.",
      "MULTOVL is a high-level language, allowing developers to code without worrying about low-level execution details."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2646,
    "user_query": "What is break induced replication?",
    "vicuna-13b_response": "Break-induced replication (BIR) is a mechanism used in computer systems to ensure data consistency in distributed environments. It is a type of replication that is used to maintain consistency between multiple copies of data in different locations.\nWhen a write operation is performed on a primary node, the change is propagated to all secondary nodes in the system. However, if a node fails or becomes disconnected from the network, the secondary nodes may become inconsistent with the primary node. This is where BIR comes in.\nBIR works by periodically \"breaking\" the connection between the primary node and the secondary nodes. This causes the secondary nodes to initiate a replication process to synchronize their data with the primary node. By periodically breaking the connection, BIR ensures that the secondary nodes are always up-to-date with the latest changes made to the data on the primary node.\nBIR is commonly used in distributed databases, cloud computing, and other distributed systems where data consistency is critical. It is an effective way to ensure that data remains consistent across multiple nodes, even in the face of network failures, node failures, or other disruptions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Break-induced replication (BIR) is a mechanism used in computer systems to ensure data consistency in distributed environments.\n2. BIR is a type of replication that is used to maintain consistency between multiple copies of data in different locations.\n3. When a write operation is performed on a primary node, the change is propagated to all secondary nodes in the system.\n4. BIR works by periodically \"breaking\" the connection between the primary node and the secondary nodes.\n5. BIR is commonly used in distributed databases, cloud computing, and other distributed systems where data consistency is critical.",
    "vicuna-13b_fact": [
      "Break-induced replication (BIR) is a mechanism used in computer systems to ensure data consistency in distributed environments.",
      "BIR is a type of replication that is used to maintain consistency between multiple copies of data in different locations.",
      "When a write operation is performed on a primary node, the change is propagated to all secondary nodes in the system.",
      "BIR works by periodically \"breaking\" the connection between the primary node and the secondary nodes.",
      "BIR is commonly used in distributed databases, cloud computing, and other distributed systems where data consistency is critical."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Break-induced replication (BIR) is a mechanism in molecular biology that is used for repairing damaged DNA, not for ensuring data consistency in computer systems.\n2. FALSE [correction]: BIR is a DNA repair process that occurs in cells, not a replication process used for data consistency in various locations.  \n3. FALSE [correction]: This statement describes replicated databases in computer systems, but it is not related to BIR which is a biological process.\n4. FALSE [correction]: BIR does not work by \"breaking\" connections in computational terms; rather, it repairs broken DNA strands in biological cells.\n5. FALSE [correction]: BIR is associated with biological processes, particularly DNA replication and repair, not with distributed databases or cloud computing.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2652,
    "user_query": "Name 4 circular RNA molecules associated with carcinogenesis.",
    "vicuna-13b_response": "Circular RNA (circRNA) molecules are a type of non-coding RNA that can play important roles in various biological processes, including carcinogenesis. Here are four examples of circRNA molecules associated with carcinogenesis:\n1. circRNA_101287: This circRNA molecule has been shown to be upregulated in various types of cancer, including breast, lung, and colorectal cancer. It has been suggested to act as a sponge for microRNA molecules that normally suppress tumor growth, and its upregulation may contribute to the development and progression of cancer.\n2. circRNA_0000077: This circRNA molecule has been shown to be downregulated in various types of cancer, including lung and colorectal cancer. It has been suggested to act as a tumor suppressor, and its downregulation may contribute to the development and progression of cancer.\n3. circRNA\\_0000083: This circRNA molecule has been shown to be upregulated in various types of cancer, including breast, lung, and colorectal cancer. It has been suggested to act as an oncogene, promoting the growth and survival of cancer cells.\n4. circRNA\\_0000173: This circRNA molecule has been shown to be downregulated in various types of cancer, including lung and colorectal cancer. It has been suggested to act as a tumor suppressor, and its downregulation may contribute to the development and progression of cancer.\nIt is important to note that these are just a few examples of circRNA molecules associated with carcinogenesis, and there are likely many more that have yet to be discovered. Additionally, the role of circRNA molecules in carcinogenesis is complex and multifaceted, and further research is needed to fully understand their contributions to cancer development and progression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Circular RNA molecules are a type of non-coding RNA that can play important roles in carcinogenesis.\n2. CircRNA_101287 has been shown to be upregulated in breast, lung, and colorectal cancer.\n3. CircRNA_0000077 has been shown to be downregulated in lung and colorectal cancer.\n4. CircRNA_0000083 has been shown to be upregulated in various types of cancer, including breast, lung, and colorectal cancer.\n5. CircRNA_0000173 has been shown to be downregulated in lung and colorectal cancer.",
    "vicuna-13b_fact": [
      "Circular RNA molecules are a type of non-coding RNA that can play important roles in carcinogenesis.",
      "CircRNA_101287 has been shown to be upregulated in breast, lung, and colorectal cancer.",
      "CircRNA_0000077 has been shown to be downregulated in lung and colorectal cancer.",
      "CircRNA_0000083 has been shown to be upregulated in various types of cancer, including breast, lung, and colorectal cancer.",
      "CircRNA_0000173 has been shown to be downregulated in lung and colorectal cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2653,
    "user_query": "Which is the enzymatic activity of nardilysin?",
    "vicuna-13b_response": "Nardilysin is a protease enzyme that is involved in the degradation of proteins in the endoplasmic reticulum (ER). It is a member of the thiol-protease family of enzymes, which are characterized by the presence of a free thiol group in their active site.\nNardilysin is involved in the degradation of misfolded or damaged proteins in the ER, and it plays a role in maintaining the proper functioning of the ER. It is also involved in the clearance of protein aggregates, which can accumulate in the ER and disrupt normal cellular function.\nIn addition to its role in protein degradation, nardilysin has also been shown to have anti-inflammatory and anti-fibrotic effects, and it may be a potential therapeutic target for the treatment of a variety of diseases, including neurodegenerative disorders and cardiovascular disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nardilysin is a protease enzyme.\n2. Nardilysin is involved in the degradation of proteins in the endoplasmic reticulum (ER).\n3. Nardilysin plays a role in maintaining the proper functioning of the ER.\n4. Nardilysin is involved in the clearance of protein aggregates.\n5. Beyond protein degradation, nardilysin has anti-inflammatory and anti-fibrotic effects.",
    "vicuna-13b_fact": [
      "Nardilysin is a protease enzyme.",
      "Nardilysin is involved in the degradation of proteins in the endoplasmic reticulum (ER).",
      "Nardilysin plays a role in maintaining the proper functioning of the ER.",
      "Nardilysin is involved in the clearance of protein aggregates.",
      "Beyond protein degradation, nardilysin has anti-inflammatory and anti-fibrotic effects."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2654,
    "user_query": "The Mantoux test detects what latent infection/disease?",
    "vicuna-13b_response": "The Mantoux test is a diagnostic test used to detect tuberculosis (TB) infection. It is a skin test that involves injecting a small amount of a purified protein derivative (PPD) into the skin of the forearm. The test measures the body's immune response to the PPD and is used to determine if the person has been infected with TB in the past or is currently infected. The test is also known as the tuberculin test.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Mantoux test is a diagnostic test used to detect tuberculosis (TB) infection.\n2. The Mantoux test involves injecting a small amount of a purified protein derivative (PPD) into the skin of the forearm.\n3. The test measures the body's immune response to the PPD.\n4. The Mantoux test determines if the person has been infected with TB in the past or is currently infected.\n5. The Mantoux test is also known as the tuberculin test.",
    "vicuna-13b_fact": [
      "The Mantoux test is a diagnostic test used to detect tuberculosis (TB) infection.",
      "The Mantoux test involves injecting a small amount of a purified protein derivative (PPD) into the skin of the forearm.",
      "The test measures the body's immune response to the PPD.",
      "The Mantoux test determines if the person has been infected with TB in the past or is currently infected.",
      "The Mantoux test is also known as the tuberculin test."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2657,
    "user_query": "Are AAV vectors considered for the treatment of retinal dystrophies?",
    "vicuna-13b_response": "Yes, AAV (Adeno-associated virus) vectors are being considered for the treatment of retinal dystrophies. AAV vectors are a type of gene therapy that involves using a harmless virus to deliver a healthy copy of a gene to cells in the body. In the case of retinal dystrophies, the goal is to deliver a healthy copy of a gene that is responsible for producing a protein that is necessary for the proper functioning of the retina.\nThere have been several clinical trials using AAV vectors for the treatment of retinal dystrophies, with promising results. For example, a phase 1/2 clinical trial of an AAV-based gene therapy for treating inherited retinal diseases, such as retinitis pigmentosa, showed significant improvements in visual function in patients.\nHowever, it's important to note that while AAV-based gene therapy holds promise for the treatment of retinal dystrophies, it is still an experimental approach and more research is needed to fully understand its safety and efficacy. Additionally, the cost of AAV-based gene therapy is currently very high, which may limit its accessibility to some patients.\nIn summary, AAV vectors are being considered for the treatment of retinal dystrophies, with promising results from clinical trials. However, more research is needed to fully understand its safety and efficacy, and the cost of AAV-based gene therapy is currently very high.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. AAV (Adeno-associated virus) vectors are being considered for the treatment of retinal dystrophies.\n2. AAV vectors are a type of gene therapy that involves using a harmless virus to deliver a healthy copy of a gene to cells in the body.\n3. There have been several clinical trials using AAV vectors for the treatment of retinal dystrophies.\n4. A phase 1/2 clinical trial of an AAV-based gene therapy for treating inherited retinal diseases, such as retinitis pigmentosa, showed significant improvements in visual function in patients.\n5. The cost of AAV-based gene therapy is currently very high.",
    "vicuna-13b_fact": [
      "AAV (Adeno-associated virus) vectors are being considered for the treatment of retinal dystrophies.",
      "AAV vectors are a type of gene therapy that involves using a harmless virus to deliver a healthy copy of a gene to cells in the body.",
      "There have been several clinical trials using AAV vectors for the treatment of retinal dystrophies.",
      "A phase 1/2 clinical trial of an AAV-based gene therapy for treating inherited retinal diseases, such as retinitis pigmentosa, showed significant improvements in visual function in patients.",
      "The cost of AAV-based gene therapy is currently very high."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "vicuna-13b_response": "GDF15, also known as growth differentiation factor 15, is a protein that has been studied in the context of metformin treatment for type 2 diabetes. Metformin is a widely used oral medication for the treatment of type 2 diabetes, and it works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and fat tissue.\nSeveral studies have suggested that GDF15 may be a potential biomarker for the effectiveness of metformin treatment in patients with type 2 diabetes. GDF15 levels have been shown to decrease in response to metformin treatment, and this decrease has been associated with improvements in glycemic control and insulin sensitivity.\nHowever, more research is needed to fully understand the role of GDF15 as a biomarker for metformin treatment. It is also important to note that other biomarkers, such as HbA1c and fasting plasma glucose, are more widely used and established as markers of glycemic control in patients with type 2 diabetes.\nIn conclusion, while GDF15 may have potential as a biomarker for metformin treatment in patients with type 2 diabetes, further research is needed to fully understand its role and to establish its clinical utility.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GDF15, also known as growth differentiation factor 15, is a protein that has been studied in the context of metformin treatment for type 2 diabetes.\n2. Metformin is an oral medication for the treatment of type 2 diabetes which works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and fat tissue.\n3. Several studies have suggested that GDF15 may be a potential biomarker for the effectiveness of metformin treatment in patients with type 2 diabetes.\n4. GDF15 levels have been observed to decrease in response to metformin treatment, and this decrease has been associated with improvements in glycemic control and insulin sensitivity.\n5. Other biomarkers, like HbA1c and fasting plasma glucose, are more widely used and established as markers of glycemic control in patients with type 2 diabetes.",
    "vicuna-13b_fact": [
      "GDF15, also known as growth differentiation factor 15, is a protein that has been studied in the context of metformin treatment for type 2 diabetes.",
      "Metformin is an oral medication for the treatment of type 2 diabetes which works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and fat tissue.",
      "Several studies have suggested that GDF15 may be a potential biomarker for the effectiveness of metformin treatment in patients with type 2 diabetes.",
      "GDF15 levels have been observed to decrease in response to metformin treatment, and this decrease has been associated with improvements in glycemic control and insulin sensitivity.",
      "Other biomarkers, like HbA1c and fasting plasma glucose, are more widely used and established as markers of glycemic control in patients with type 2 diabetes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2662,
    "user_query": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
    "vicuna-13b_response": "Oncogene-induced DNA replication stress can inhibit genomic instability in some cases. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. When oncogenes are activated, they can cause an increase in the rate of cell division, leading to genomic instability.\nDNA replication stress occurs when the cell's DNA replication machinery is unable to keep up with the demand for DNA replication caused by oncogene activation. This can lead to an accumulation of unreplicated or incorrectly replicated DNA, which can cause genomic instability.\nHowever, oncogene-induced DNA replication stress can also lead to the activation of DNA damage response pathways, which can help to prevent genomic instability. For example, the ATM and ATR kinases are activated by DNA replication stress and can trigger a response that helps to maintain the integrity of the genome.\nIn addition, oncogene-induced DNA replication stress can also lead to the activation of checkpoint pathways, which can help to prevent the propagation of damaged or mutated DNA. For example, the CHK2 pathway is activated by DNA replication stress and can help to prevent the propagation of damaged or mutated DNA.\nOverall, oncogene-induced DNA replication stress can both inhibit and promote genomic instability, depending on the specific circumstances and the response of the cell.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels.\n2. Oncogene activation can cause an increase in the rate of cell division, leading to genomic instability.\n3. Oncogene-induced DNA replication stress can lead to the activation of DNA damage response pathways, which can help to prevent genomic instability.\n4. ATM and ATR kinases can be activated by DNA replication stress and can trigger a response that helps to maintain the integrity of the genome.\n5. Oncogene-induced DNA replication stress can also lead to the activation of checkpoint pathways, like the CHK2 pathway, which can help to prevent the propagation of damaged or mutated DNA.",
    "vicuna-13b_fact": [
      "Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels.",
      "Oncogene activation can cause an increase in the rate of cell division, leading to genomic instability.",
      "Oncogene-induced DNA replication stress can lead to the activation of DNA damage response pathways, which can help to prevent genomic instability.",
      "ATM and ATR kinases can be activated by DNA replication stress and can trigger a response that helps to maintain the integrity of the genome.",
      "Oncogene-induced DNA replication stress can also lead to the activation of checkpoint pathways, like the CHK2 pathway, which can help to prevent the propagation of damaged or mutated DNA."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "vicuna-13b_response": "Recursive splicing is a process in which a splicing event occurs within a previously spliced intron. It is a form of alternative splicing, which is a process in which a single gene can produce multiple mRNA isoforms by using different combinations of exons.\nRecursive splicing can occur in both long and short introns, but it is more common in short introns. This is because short introns have a lower energy state, which makes them more susceptible to splicing events. Additionally, short introns are more likely to be included in the splicing machinery's search for a splice site, as they are more accessible to the splicing factors.\nRecursive splicing can also occur in introns that are too short to be spliced out, this is called intron retention. This process can be regulated by different factors such as the presence of specific proteins or RNA elements in the intron.\nIt's important to note that the length of the intron is not the only factor that determines whether recursive splicing will occur, other factors such as the presence of specific proteins or RNA elements in the intron, the presence of specific miRNA, and the chromatin structure can also regulate recursive splicing.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Recursive splicing is a process in which a splicing event occurs within a previously spliced intron. \n2. In recursive splicing, a single gene can produce multiple mRNA isoforms by using different combinations of exons.\n3. Recursive splicing is more common in short introns because they have a lower energy state, making them more susceptible to splicing events.\n4. Intron retention occurs when introns that are too short to be spliced out undergo recursive splicing.\n5. The occurrence of recursive splicing is not only determined by the length of the intron, but also other factors such as the presence of specific proteins or RNA elements, the presence of specific miRNA, and the chromatin structure.",
    "vicuna-13b_fact": [
      "Recursive splicing is a process in which a splicing event occurs within a previously spliced intron.",
      "In recursive splicing, a single gene can produce multiple mRNA isoforms by using different combinations of exons.",
      "Recursive splicing is more common in short introns because they have a lower energy state, making them more susceptible to splicing events.",
      "Intron retention occurs when introns that are too short to be spliced out undergo recursive splicing.",
      "The occurrence of recursive splicing is not only determined by the length of the intron, but also other factors such as the presence of specific proteins or RNA elements, the presence of specific miRNA, and the chromatin structure."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Recursive splicing is more common in long introns due to their complex structure, not because of a lower energy state or susceptibility to splicing events.\n4. FALSE [correction]: Intron retention is a form of alternative splicing where the intron is not removed. It does not involve recursive splicing.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2667,
    "user_query": "Is transcription of eRNA bidirectional?",
    "vicuna-13b_response": "Transcription of eRNA can be bidirectional, meaning that it can occur in both directions along the strand of the RNA molecule. This is different from traditional transcription, where the DNA template is used to generate a single RNA molecule in a unidirectional process.\nIn eRNA transcription, the RNA polymerase enzyme can move in both directions along the RNA template, allowing for the synthesis of RNA molecules in both directions. This bidirectional transcription can result in the production of complementary RNA strands, each with a different 5' end, or it can result in the synthesis of RNA molecules with overlapping sequences.\nBidirectional transcription of eRNA has important implications for gene expression regulation and RNA processing, as it allows for the generation of multiple RNA molecules from a single RNA template. These RNA molecules can then be processed in different ways, such as by splicing, editing, or transport, to generate the final RNA products.\nOverall, the bidirectional nature of eRNA transcription adds a level of complexity to the regulation of gene expression and RNA processing, and further research is needed to fully understand the mechanisms and consequences of this process.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Transcription of eRNA can be bidirectional, meaning that it can occur in both directions along the strand of the RNA molecule.\n2. In bidirectional eRNA transcription, the RNA polymerase enzyme can move in both directions along the RNA template.\n3. Bidirectional transcription can result in the production of complementary RNA strands, each with a different 5' end, or it can result in the synthesis of RNA molecules with overlapping sequences.\n4. The process of bidirectional eRNA transcription has implications for gene expression regulation and RNA processing.\n5. Bidirectional eRNA transcription allows for the generation of multiple RNA molecules from a single RNA template.",
    "vicuna-13b_fact": [
      "Transcription of eRNA can be bidirectional, meaning that it can occur in both directions along the strand of the RNA molecule.",
      "In bidirectional eRNA transcription, the RNA polymerase enzyme can move in both directions along the RNA template.",
      "Bidirectional transcription can result in the production of complementary RNA strands, each with a different 5' end, or it can result in the synthesis of RNA molecules with overlapping sequences.",
      "The process of bidirectional eRNA transcription has implications for gene expression regulation and RNA processing.",
      "Bidirectional eRNA transcription allows for the generation of multiple RNA molecules from a single RNA template."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: In bidirectional eRNA transcription, the RNA polymerase enzyme can move in both directions along the DNA template.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2668,
    "user_query": "Is the protein pelota a ribosomal rescue factor?",
    "vicuna-13b_response": "Pelota is a protein that is involved in the regulation of ribosome biogenesis in eukaryotic cells. It is a component of the small ribosomal subunit and plays a role in the assembly and maturation of ribosomes.\nRibosomal rescue factors are proteins that are involved in the repair and maintenance of ribosomes. They help to ensure that ribosomes are properly assembled and functioning correctly.\nWhile pelota is involved in the regulation of ribosome biogenesis, it is not considered to be a ribosomal rescue factor. Instead, it is thought to play a role in the assembly and maturation of ribosomes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pelota is a protein involved in the regulation of ribosome biogenesis in eukaryotic cells.\n2. Pelota is a component of the small ribosomal subunit.\n3. Pelota plays a role in the assembly and maturation of ribosomes.\n4. Ribosomal rescue factors are proteins that are involved in the repair and maintenance of ribosomes.\n5. Pelota is not considered to be a ribosomal rescue factor.",
    "vicuna-13b_fact": [
      "Pelota is a protein involved in the regulation of ribosome biogenesis in eukaryotic cells.",
      "Pelota is a component of the small ribosomal subunit.",
      "Pelota plays a role in the assembly and maturation of ribosomes.",
      "Ribosomal rescue factors are proteins that are involved in the repair and maintenance of ribosomes.",
      "Pelota is not considered to be a ribosomal rescue factor."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Pelota is considered to be a ribosomal rescue factor.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2671,
    "user_query": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
    "vicuna-13b_response": "Yes, a mutation in the ZIKV's membrane protein prM has been implicated in the microcephaly observed in new-born infants.\nZIKV (Zika virus) is a flavivirus that can cause a mild illness in adults, but can have severe consequences for unborn babies and new-born infants, including microcephaly, which is a condition where the baby's head is smaller than expected.\nStudies have shown that a specific mutation in the prM protein of the ZIKV can affect the virus's ability to infect and replicate in brain cells, leading to the development of microcephaly. This mutation is thought to have emerged in the Americas in 2015, and it has been associated with the large outbreaks of microcephaly that occurred in Brazil and other countries in the region.\nIt's important to note that while the prM mutation is one of the factors that have been linked to microcephaly in new-born infants, it is not the only one. Other factors such as the timing of infection during pregnancy, the mother's immune status, and the presence of other infections, are also thought to play a role in the development of microcephaly.\nOverall, the discovery of the prM mutation has helped to shed light on the mechanisms of ZIKV-associated microcephaly, and it has also highlighted the importance of continued research to better understand the virus and its effects on human health.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A mutation in the ZIKV's membrane protein prM has been linked to the microcephaly observed in new-born infants.\n2. ZIKV (Zika virus) is a flavivirus that can cause a mild illness in adults but can have severe consequences for unborn babies and new-born infants, such as microcephaly.\n3. The prM protein of ZIKV mutation affects the virus's ability to infect and replicate in brain cells, leading to microcephaly.\n4. The prM mutation is thought to have emerged in the Americas in 2015 and has been associated with large outbreaks of microcephaly in Brazil and other countries in the region.\n5. Factors such as the timing of infection during pregnancy, the mother's immune status, and the presence of other infections, also play a role in the development of microcephaly.",
    "vicuna-13b_fact": [
      "A mutation in the ZIKV's membrane protein prM has been linked to the microcephaly observed in new-born infants.",
      "ZIKV (Zika virus) is a flavivirus that can cause a mild illness in adults but can have severe consequences for unborn babies and new-born infants, such as microcephaly.",
      "The prM protein of ZIKV mutation affects the virus's ability to infect and replicate in brain cells, leading to microcephaly.",
      "The prM mutation is thought to have emerged in the Americas in 2015 and has been associated with large outbreaks of microcephaly in Brazil and other countries in the region.",
      "Factors such as the timing of infection during pregnancy, the mother's immune status, and the presence of other infections, also play a role in the development of microcephaly."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2673,
    "user_query": "What is the basis of the Sp3 procedure used in proteomics?",
    "vicuna-13b_response": "The SPECTRUM PREP 3 (Sp3) procedure is a method used in proteomics to prepare samples for mass spectrometry analysis. The Sp3 procedure is based on the use of strong cation exchange (SCX) chromatography, which separates proteins based on their charge and hydrophobicity.\nThe Sp3 procedure involves the following steps:\n1. Sample preparation: The first step in the Sp3 procedure is to prepare the sample for chromatography. This involves reducing the sample to a powder and then suspending it in a buffer containing a chaotropic agent, such as guanidine hydrochloride, to denature and unfold the proteins.\n2. Ion exchange chromatography: The sample is then loaded onto a SCX column and eluted with a gradient of increasing salt concentration. The proteins are separated based on their charge and hydrophobicity, with hydrophobic proteins eluting at the beginning of the gradient and charged proteins eluting at the end of the gradient.\n3. Fraction collection: The eluted proteins are collected in small fractions, and each fraction is analyzed by mass spectrometry to identify the proteins present.\n4. Peptide identification: The mass spectrometry data is used to identify the proteins present in each fraction by matching the mass-to-charge ratios of the peptides to a database of known proteins.\nThe Sp3 procedure is a widely used method in proteomics because it allows for the separation and identification of a large number of proteins in a single sample. It is particularly useful for the analysis of complex biological samples, such as tissue extracts or cell cultures, where many proteins are present and need to be separated and identified.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The SPECTRUM PREP 3 (Sp3) procedure is utilized in proteomics to prepare samples for mass spectrometry analysis.\n2. The Sp3 procedure is based on the use of strong cation exchange (SCX) chromatography.\n3. SCX chromatography separates proteins based on their charge and hydrophobicity.\n4. The Sp3 procedure involves steps like sample preparation, ion exchange chromatography, fraction collection, and peptide identification.\n5. The Sp3 procedure is particularly useful for the analysis of complex biological samples, such as tissue extracts or cell cultures.",
    "vicuna-13b_fact": [
      "The SPECTRUM PREP 3 (Sp3) procedure is utilized in proteomics to prepare samples for mass spectrometry analysis.",
      "The Sp3 procedure is based on the use of strong cation exchange (SCX) chromatography.",
      "SCX chromatography separates proteins based on their charge and hydrophobicity.",
      "The Sp3 procedure involves steps like sample preparation, ion exchange chromatography, fraction collection, and peptide identification.",
      "The Sp3 procedure is particularly useful for the analysis of complex biological samples, such as tissue extracts or cell cultures."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Sp3 procedure is based on the use of paramagnetic beads.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2678,
    "user_query": "What is ATAC-seq?",
    "vicuna-13b_response": "ATAC-seq (Assay for Transposase-Accessible Chromatin using Sequencing) is a method used to study the accessibility of chromatin, which is the complex of DNA, RNA, and proteins that makes up the chromosomes in the nucleus of a cell. ATAC-seq is a type of sequencing-based technique that uses a transposase enzyme to digest the chromatin into small fragments, which are then sequenced to identify the areas of the genome that are accessible to the transposase.\nThe method involves the following steps:\n1. Crosslinking: The cells are first crosslinked to stabilize the chromatin structure.\n2. Digestion: The chromatin is then digested with the transposase, which cuts the DNA at specific sequences.\n3. Sequencing: The resulting fragments are then sequenced to identify the areas of the genome that are accessible to the transposase.\n4. Analysis: The data is then analyzed to identify the specific sequences that are associated with the transposase and to determine the accessibility of different regions of the genome.\nATAC-seq is a powerful tool for studying the epigenetic regulation of gene expression and has been used to identify the binding sites of transcription factors and other regulatory proteins on the genome. It can also be used to study the effects of different conditions, such as disease or drug treatment, on chromatin accessibility.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ATAC-seq (Assay for Transposase-Accessible Chromatin using Sequencing) is used to study the accessibility of chromatin.\n2. The complex of DNA, RNA, and proteins that makes up the chromosomes in the nucleus of a cell is called chromatin.\n3. ATAC-seq uses a transposase enzyme to digest the chromatin into small fragments.\n4. ATAC-seq has been used to identify the binding sites of transcription factors and other regulatory proteins on the genome.\n5. ATAC-seq can be used to study the effects of different conditions, such as disease or drug treatment, on chromatin accessibility.",
    "vicuna-13b_fact": [
      "ATAC-seq (Assay for Transposase-Accessible Chromatin using Sequencing) is used to study the accessibility of chromatin.",
      "The complex of DNA, RNA, and proteins that makes up the chromosomes in the nucleus of a cell is called chromatin.",
      "ATAC-seq uses a transposase enzyme to digest the chromatin into small fragments.",
      "ATAC-seq has been used to identify the binding sites of transcription factors and other regulatory proteins on the genome.",
      "ATAC-seq can be used to study the effects of different conditions, such as disease or drug treatment, on chromatin accessibility."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "vicuna-13b_response": "The TALE-iD method is a systematic approach to identifying potential ecological risks associated with the use of engineered nanomaterials (ENMs) in various applications. The acronym TALE-iD stands for \"Target-Organism-Affected-Life-cycle-Stage-Endpoint-Individual-Dose,\" which describes the key components of the method.\nThe TALE-iD method is used to evaluate the potential ecological risks of ENMs by considering the interactions between the ENMs and various components of the environment, including living organisms, their life cycle stages, and the various endpoints that may be affected. The method is designed to be used in the early stages of ENM development, to help identify potential risks and inform the design of safer and more sustainable ENMs.\nThe TALE-iD method involves a systematic process of identifying the potential target organisms and life cycle stages that may be affected by the ENMs, as well as the endpoints that may be affected, such as reproductive success, survival, or behavior. The method also considers the individual dose of the ENMs, which is the amount of ENMs that may be taken up by an individual organism or cell.\nOverall, the TALE-iD method is a valuable tool for identifying potential ecological risks associated with the use of ENMs, and can help inform the development of safer and more sustainable ENMs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The TALE-iD method is used to identify potential ecological risks associated with the use of engineered nanomaterials (ENMs).\n2. The acronym TALE-iD stands for \"Target-Organism-Affected-Life-cycle-Stage-Endpoint-Individual-Dose.\"\n3. This method involves a systematic process of identifying potential target organisms and life cycle stages that may be affected by the ENMs.\n4. Endpoints like reproductive success, survival, or behavior are considered in the TALE-iD method.\n5. The individual dose of the ENMs, which is the amount of ENMs that may be taken up by an individual organism or cell, is also taken into account in this method.",
    "vicuna-13b_fact": [
      "The TALE-iD method is used to identify potential ecological risks associated with the use of engineered nanomaterials (ENMs).",
      "The acronym TALE-iD stands for \"Target-Organism-Affected-Life-cycle-Stage-Endpoint-Individual-Dose.\"",
      "This method involves a systematic process of identifying potential target organisms and life cycle stages that may be affected by the ENMs.",
      "Endpoints like reproductive success, survival, or behavior are considered in the TALE-iD method.",
      "The individual dose of the ENMs, which is the amount of ENMs that may be taken up by an individual organism or cell, is also taken into account in this method."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2681,
    "user_query": "What is the function of penicillinase, also known as beta lactamase?",
    "vicuna-13b_response": "Penicillinase, also known as beta-lactamase, is an enzyme that breaks down the beta-lactam ring of penicillin-type antibiotics. This makes the antibiotic less effective or ineffective in treating infections caused by bacteria that produce the enzyme. Penicillinase is produced by certain bacteria, such as Streptococcus pneumoniae and Haemophilus influenzae, as a defense mechanism against the antibiotic. The enzyme is also sometimes found in other organisms, such as fungi and viruses, although its function in these organisms is different. In general, the function of penicillinase is to degrade the beta-lactam antibiotics, making them less effective in fighting bacterial infections.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Penicillinase, also known as beta-lactamase, is an enzyme that breaks down the beta-lactam ring of penicillin-type antibiotics.\n2. By degrading the beta-lactam ring, the enzyme can make the antibiotic less effective or ineffective.\n3. Certain bacteria like Streptococcus pneumoniae and Haemophilus influenzae produce penicillinase.\n4. The function of penicillinase is to degrade the beta-lactam antibiotics, making them less effective in fighting bacterial infections.\n5. Penicillinase can be found in other organisms, such as fungi and viruses, but its function in these organisms is different.",
    "vicuna-13b_fact": [
      "Penicillinase, also known as beta-lactamase, is an enzyme that breaks down the beta-lactam ring of penicillin-type antibiotics.",
      "By degrading the beta-lactam ring, the enzyme can make the antibiotic less effective or ineffective.",
      "Certain bacteria like Streptococcus pneumoniae and Haemophilus influenzae produce penicillinase.",
      "The function of penicillinase is to degrade the beta-lactam antibiotics, making them less effective in fighting bacterial infections.",
      "Penicillinase can be found in other organisms, such as fungi and viruses, but its function in these organisms is different."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Penicillinase can be found in other organisms like certain bacteria and fungi. However, it is not found in viruses. Its function is largely the same in these organisms; it degrades penicillin-type antibiotics, making them less effective.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2684,
    "user_query": "What is the dardarin protein?",
    "vicuna-13b_response": "The dardarin protein is a type of protein that is found in certain species of plants, including the tomato. It is a member of the family of proteins known as lectins, which are proteins that bind to specific carbohydrates or sugars.\nThe dardarin protein is thought to play a role in plant defense mechanisms, as it can bind to and inhibit the activity of certain enzymes that are involved in the growth and development of pathogens, such as bacteria and fungi. It may also play a role in the plant's response to environmental stressors, such as drought or high temperatures.\nIn addition to its potential role in plant defense, the dardarin protein has also been studied for its potential health benefits for humans. Some research suggests that it may have antioxidant and anti-inflammatory properties, and may be able to help protect against certain types of cancer and other diseases. However, more research is needed to fully understand the potential health benefits of the dardarin protein and to determine its safety and efficacy for use in humans.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The dardarin protein is found in certain species of plants, including the tomato.\n2. It is a member of the family of proteins known as lectins.\n3. Dardarin protein is thought to play a role in plant defense mechanisms, binding to and inhibiting certain enzymes that are involved in the growth and development of pathogens, such as bacteria and fungi.\n4. The dardarin protein may also play a role in the plant's response to environmental stressors, such as drought or high temperatures.\n5. Some research suggests that the dardarin protein may have antioxidant and anti-inflammatory properties, and may be able to help protect against certain types of cancer and other diseases.",
    "vicuna-13b_fact": [
      "The dardarin protein is found in certain species of plants, including the tomato.",
      "It is a member of the family of proteins known as lectins.",
      "Dardarin protein is thought to play a role in plant defense mechanisms, binding to and inhibiting certain enzymes that are involved in the growth and development of pathogens, such as bacteria and fungi.",
      "The dardarin protein may also play a role in the plant's response to environmental stressors, such as drought or high temperatures.",
      "Some research suggests that the dardarin protein may have antioxidant and anti-inflammatory properties, and may be able to help protect against certain types of cancer and other diseases."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The dardarin protein is not found in plants, including the tomato. It is linked to Parkinson's disease in humans.\n2. FALSE [correction]: It is not a member of the family of proteins known as lectins.\n3. FALSE [correction]: Dardarin protein is not thought to play a role in plant defense mechanisms.\n4. FALSE [correction]: The dardarin protein does not play a role in the plant's response to environmental stressors, such as drought or high temperatures.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2685,
    "user_query": "In which syndrome is the RPS19 gene most frequently mutated?",
    "vicuna-13b_response": "The RPS19 gene is most frequently mutated in the 5q- Syndrome.\n5q- Syndrome is a genetic disorder that is caused by a deletion of the q arm of chromosome 5, which results in the loss of several genes including the RPS19 gene. This deletion is usually spontaneous and occurs during embryonic development. The RPS19 gene provides instructions for making a protein called ribosomal protein S19, which is a component of the ribosome, a structure that plays a critical role in protein synthesis.\nIndividuals with 5q- Syndrome typically have intellectual disability, short stature, and a characteristic facial appearance. They may also have heart defects, kidney problems, and other physical abnormalities. The severity of the condition varies, and some individuals may have mild symptoms, while others may have more severe symptoms.\nThe RPS19 gene mutation is responsible for approximately 50% of cases of 5q- Syndrome. Other genes that are located on the q arm of chromosome 5 can also be affected by the deletion, and these genes can also contribute to the symptoms of the condition. There is no cure for 5q- Syndrome, and treatment is focused on managing the symptoms of the condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The RPS19 gene is most frequently mutated in the 5q- Syndrome.\n2. 5q- Syndrome is caused by a deletion of the q arm of chromosome 5, causing a loss of several genes including the RPS19 gene.\n3. The RPS19 gene provides instructions for making a protein called ribosomal protein S19, which contributes to protein synthesis.\n4. The RPS19 gene mutation is responsible for approximately 50% of cases of 5q- Syndrome.\n5. There is no cure for 5q- Syndrome, and treatment focuses on managing the symptoms of the condition.",
    "vicuna-13b_fact": [
      "The RPS19 gene is most frequently mutated in the 5q- Syndrome.",
      "5q- Syndrome is caused by a deletion of the q arm of chromosome 5, causing a loss of several genes including the RPS19 gene.",
      "The RPS19 gene provides instructions for making a protein called ribosomal protein S19, which contributes to protein synthesis.",
      "The RPS19 gene mutation is responsible for approximately 50% of cases of 5q- Syndrome.",
      "There is no cure for 5q- Syndrome, and treatment focuses on managing the symptoms of the condition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2686,
    "user_query": "What type of sequences do enhancers evolve from?",
    "vicuna-13b_response": "Enhancers are cis-acting elements that are involved in the regulation of gene expression. They are typically located in the vicinity of a gene and can increase the transcription of that gene. Enhancers can be either natural or synthetic, and they can be derived from different sources.\nNatural enhancers are typically derived from transposable elements, which are DNA sequences that can move around the genome. Over time, the transposable elements can become inserted into the regulatory regions of genes and can take on a new function as an enhancer. This process is called \"enhancement\" and it is a way in which the genome can adapt to new functions.\nSynthetic enhancers, on the other hand, are typically designed by scientists in the lab and are used to increase the expression of a specific gene of interest. These synthetic enhancers are often based on the sequence of natural enhancers and are designed to work in a similar way.\nIn summary, enhancers can evolve from different sources, including transposable elements and synthetic designs. They are important regulatory elements that play a key role in controlling gene expression and are the focus of much research in the field of genomics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Enhancers are cis-acting elements involved in regulating gene expression.\n2. Enhancers are typically located in the vicinity of a gene and can increase its transcription.\n3. Natural enhancers usually derive from transposable elements.\n4. Transposable elements can move around the genome and get inserted into the regulatory regions of genes, potentially becoming enhancers.\n5. Synthetic enhancers are typically designed by scientists in labs to increase the expression of specific genes.",
    "vicuna-13b_fact": [
      "Enhancers are cis-acting elements involved in regulating gene expression.",
      "Enhancers are typically located in the vicinity of a gene and can increase its transcription.",
      "Natural enhancers usually derive from transposable elements.",
      "Transposable elements can move around the genome and get inserted into the regulatory regions of genes, potentially becoming enhancers.",
      "Synthetic enhancers are typically designed by scientists in labs to increase the expression of specific genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2687,
    "user_query": "What nerve is involved in carpal tunnel syndrome?",
    "vicuna-13b_response": "Carpal tunnel syndrome is a condition that affects the median nerve, which runs from the forearm to the hand. The median nerve passes through the carpal tunnel, a narrow passageway in the wrist, and controls the movement and sensation in the thumb, index finger, middle finger, and half of the ring finger.\nCarpal tunnel syndrome occurs when the pressure on the median nerve increases, which can be caused by a variety of factors such as repetitive hand movements, wrist injuries, arthritis, and certain medical conditions like diabetes or hypothyroidism. This increased pressure can cause the nerve to become inflamed and irritated, leading to symptoms such as pain, numbness, tingling, and weakness in the hand and wrist.\nTreatment for carpal tunnel syndrome may include rest, ice, physical therapy, medications, and in some cases, surgery. It's important to seek medical attention if you experience persistent symptoms of carpal tunnel syndrome, as untreated cases can lead to permanent nerve damage.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Carpal tunnel syndrome affects the median nerve.\n2. The median nerve controls the movement and sensation in the thumb, index finger, middle finger, and half of the ring finger.\n3. Carpal tunnel syndrome can be caused by factors such as repetitive hand movements, wrist injuries, arthritis, and certain medical conditions like diabetes or hypothyroidism.\n4. Treatment for carpal tunnel syndrome may include rest, ice, physical therapy, medications, and in some cases, surgery.\n5. Untreated cases of carpal tunnel syndrome can lead to permanent nerve damage.",
    "vicuna-13b_fact": [
      "Carpal tunnel syndrome affects the median nerve.",
      "The median nerve controls the movement and sensation in the thumb, index finger, middle finger, and half of the ring finger.",
      "Carpal tunnel syndrome can be caused by factors such as repetitive hand movements, wrist injuries, arthritis, and certain medical conditions like diabetes or hypothyroidism.",
      "Treatment for carpal tunnel syndrome may include rest, ice, physical therapy, medications, and in some cases, surgery.",
      "Untreated cases of carpal tunnel syndrome can lead to permanent nerve damage."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2689,
    "user_query": "Please list 3 diseases treated with Valtrex(valacyclovir)",
    "vicuna-13b_response": "Valtrex (valacyclovir) is an antiviral medication that is primarily used to treat infections caused by certain types of viruses, including herpes viruses. Here are three diseases that can be treated with Valtrex:\n1. Herpes zoster (shingles): Valtrex can be used to treat herpes zoster, which is caused by the reactivation of the varicella-zoster virus. This virus causes chickenpox and can also cause shingles, a painful rash that typically occurs on one side of the body.\n2. Herpes simplex virus (HSV) infections: Valtrex can be used to treat infections caused by HSV, which can cause cold sores or genital herpes.\n3. Cold sores: Valtrex can be used to treat cold sores, which are caused by HSV. Cold sores are small, painful blisters that typically appear on the lips or around the mouth.\nIt's important to note that Valtrex is not a cure for these diseases, but it can help to reduce the severity and duration of the symptoms. It is also important to note that Valtrex should only be used to treat infections caused by certain types of viruses, and it should not be used to treat infections caused by other types of viruses or bacteria. If you have any questions about whether Valtrex is appropriate for your specific condition, you should consult a healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Valtrex (valacyclovir) is an antiviral medication.\n2. Valtrex can be used to treat herpes zoster, also known as shingles.\n3. Valtrex can be used to treat infections caused by Herpes Simplex Virus, which can cause cold sores or genital herpes.\n4. Valtrex can be used to treat cold sores which appear on the lips or around the mouth.\n5. Valtrex should not be used to treat infections caused by types of viruses or bacteria other than certain herpes viruses.",
    "vicuna-13b_fact": [
      "Valtrex (valacyclovir) is an antiviral medication.",
      "Valtrex can be used to treat herpes zoster, also known as shingles.",
      "Valtrex can be used to treat infections caused by Herpes Simplex Virus, which can cause cold sores or genital herpes.",
      "Valtrex can be used to treat cold sores which appear on the lips or around the mouth.",
      "Valtrex should not be used to treat infections caused by types of viruses or bacteria other than certain herpes viruses."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2690,
    "user_query": "Which olfactory gene senses androsterone?",
    "vicuna-13b_response": "Androsterone is a steroid hormone that is produced by the testes, ovaries, and adrenal glands. It is a precursor to the production of other steroid hormones, such as testosterone and estradiol.\nThe olfactory system is responsible for the sense of smell, and it is composed of the olfactory receptors, which are located in the nasal cavity. These receptors are responsible for detecting different odors and transmitting this information to the brain.\nThere are several olfactory genes that are involved in the detection of androsterone. One of these genes is the olfactory receptor gene ORL1, which is expressed in the olfactory epithelium and is responsible for detecting androsterone.\nIn conclusion, the olfactory gene that senses androsterone is ORL1.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Androsterone is a steroid hormone that is produced by the testes, ovaries, and adrenal glands.\n2. Androsterone is a precursor to the production of steroid hormones like testosterone and estradiol.\n3. The olfactory system, situated in the nasal cavity, is responsible for the sense of smell.\n4. Among the olfactory genes involved in the detection of androsterone is the olfactory receptor gene ORL1.\n5. The olfactory gene ORL1 is responsible for detecting androsterone.",
    "vicuna-13b_fact": [
      "Androsterone is a steroid hormone that is produced by the testes, ovaries, and adrenal glands.",
      "Androsterone is a precursor to the production of steroid hormones like testosterone and estradiol.",
      "The olfactory system, situated in the nasal cavity, is responsible for the sense of smell.",
      "Among the olfactory genes involved in the detection of androsterone is the olfactory receptor gene ORL1.",
      "The olfactory gene ORL1 is responsible for detecting androsterone."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2699,
    "user_query": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
    "vicuna-13b_response": "The human monoamine oxidase A (MAOA) gene has been associated with several personality traits, including aggression, impulsivity, and risk-taking behavior. Studies have found that individuals with certain variants of the MAOA gene may be more likely to engage in these types of behaviors, although the relationship is complex and influenced by environmental and genetic factors. Additionally, the MAOA gene has also been linked to regulation of emotions, stress response, and other traits. However, it's important to note that the relationship between the MAOA gene and personality traits is still an area of active research and the findings are not yet fully understood.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The human monoamine oxidase A (MAOA) gene has been associated with several personality traits, including aggression, impulsivity, and risk-taking behavior.\n2. Certain variants of the MAOA gene may make individuals more likely to engage in behaviors such as aggression, impulsivity, and risk-taking.\n3. The MAOA gene has been linked to regulation of emotions, stress response, and other traits.\n4. The relationship between the MAOA gene and personality traits is influenced by environmental and genetic factors.\n5. The relationship between the MAOA gene and personality traits is an area of active research.",
    "vicuna-13b_fact": [
      "The human monoamine oxidase A (MAOA) gene has been associated with several personality traits, including aggression, impulsivity, and risk-taking behavior.",
      "Certain variants of the MAOA gene may make individuals more likely to engage in behaviors such as aggression, impulsivity, and risk-taking.",
      "The MAOA gene has been linked to regulation of emotions, stress response, and other traits.",
      "The relationship between the MAOA gene and personality traits is influenced by environmental and genetic factors.",
      "The relationship between the MAOA gene and personality traits is an area of active research."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2702,
    "user_query": "Which human gene encode for DNA polymerase θ?",
    "vicuna-13b_response": "The gene that encodes for DNA polymerase θ is POLQ. It is located on chromosome X and consists of 18 exons. DNA polymerase θ is an essential enzyme involved in DNA replication and repair, and it plays a crucial role in maintaining genome stability. Mutations in the POLQ gene have been associated with various human diseases, including cancer and neurological disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The POLQ gene encodes for DNA polymerase θ.\n2. The POLQ gene is located on chromosome X.\n3. The POLQ gene consists of 18 exons.\n4. DNA polymerase θ is involved in DNA replication and repair.\n5. Mutations in the POLQ gene have been associated with human diseases including cancer and neurological disorders.",
    "vicuna-13b_fact": [
      "The POLQ gene encodes for DNA polymerase θ.",
      "The POLQ gene is located on chromosome X.",
      "The POLQ gene consists of 18 exons.",
      "DNA polymerase θ is involved in DNA replication and repair.",
      "Mutations in the POLQ gene have been associated with human diseases including cancer and neurological disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The POLQ gene is located on chromosome 3.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2705,
    "user_query": "Which are the two main bacterial phyla in human gut?",
    "vicuna-13b_response": "The two main bacterial phyla in the human gut are Firmicutes and Bacteroidetes. These two phyla are responsible for the majority of the gut's bacterial diversity and play a crucial role in maintaining a healthy gut microbiome. They are also important for the breakdown and absorption of nutrients in the gut.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The two main bacterial phyla in the human gut are Firmicutes and Bacteroidetes.\n2. Firmicutes and Bacteroidetes are responsible for the majority of the gut's bacterial diversity.\n3. Firmicutes and Bacteroidetes play a crucial role in maintaining a healthy gut microbiome.\n4. Firmicutes and Bacteroidetes are important for the breakdown and absorption of nutrients in the gut.",
    "vicuna-13b_fact": [
      "The two main bacterial phyla in the human gut are Firmicutes and Bacteroidetes.",
      "Firmicutes and Bacteroidetes are responsible for the majority of the gut's bacterial diversity.",
      "Firmicutes and Bacteroidetes play a crucial role in maintaining a healthy gut microbiome.",
      "Firmicutes and Bacteroidetes are important for the breakdown and absorption of nutrients in the gut."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: While Firmicutes and Bacteroidetes are the most abundant phyla in the human gut, they do not account for the majority of the gut's bacterial diversity, as there are many other less abundant but still important phyla.\n3. TRUE\n4. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2710,
    "user_query": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
    "vicuna-13b_response": "Cytochrome p450 CYP3A is an enzyme that is involved in the metabolism of drugs and other xenobiotics. It is often induced by certain compounds, including rifampicin, which is an antibiotic used to treat tuberculosis. CYP3A is also induced by some drugs used to treat viral infections, such as HIV and hepatitis C. These drugs include protease inhibitors, non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase inhibitors, which are used in combination therapy to treat HIV. Induction of CYP3A by these drugs can affect the metabolism and clearance of other drugs, leading to potential drug interactions and altered therapeutic effects. Therefore, it is important to monitor the induction of CYP3A by antiviral drugs and to consider the potential drug interactions when prescribing these medications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cytochrome p450 CYP3A is an enzyme involved in the metabolism of drugs and other xenobiotics.\n2. CYP3A is induced by certain compounds, including the antibiotic rifampicin.\n3. Rifampicin is used to treat tuberculosis.\n4. CYP3A is also induced by some drugs used to treat viral infections such as HIV and hepatitis C.\n5. Protease inhibitors, non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase inhibitors, which induce CYP3A, are used in combination therapy to treat HIV.",
    "vicuna-13b_fact": [
      "Cytochrome p450 CYP3A is an enzyme involved in the metabolism of drugs and other xenobiotics.",
      "CYP3A is induced by certain compounds, including the antibiotic rifampicin.",
      "Rifampicin is used to treat tuberculosis.",
      "CYP3A is also induced by some drugs used to treat viral infections such as HIV and hepatitis C.",
      "Protease inhibitors, non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase inhibitors, which induce CYP3A, are used in combination therapy to treat HIV."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Protease inhibitors, non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase inhibitors, which are metabolized by CYP3A, are used in combination therapy to treat HIV. They do not typically induce CYP3A; instead, they are the substrates of this enzyme.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2712,
    "user_query": "Where is the EpCam protein mainly located?",
    "vicuna-13b_response": "The EpCam protein, also known as Epithelial Cell Adhesion Molecule (EpCAM), is mainly located on the surface of epithelial cells. Epithelial cells are a type of cell that forms the lining of various organs and glands in the body, such as the skin, lungs, digestive system, and reproductive system.\nEpCAM is a type of cell adhesion molecule, which means it helps to anchor epithelial cells together and maintain the integrity of the epithelial tissue. EpCAM is also involved in the regulation of cell growth and differentiation, and it has been implicated in the development of various types of cancer.\nIn addition to being expressed on the surface of epithelial cells, EpCAM is also found in other tissues and cells, such as the placenta, pancreas, and some types of cancer cells. However, its main location is on the surface of epithelial cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The EpCam protein is also known as Epithelial Cell Adhesion Molecule (EpCAM).\n2. EpCAM is mainly located on the surface of epithelial cells.\n3. Epithelial cells form the lining of various organs and glands in the body, such as the skin, lungs, digestive system, and reproductive system.\n4. EpCAM is a type of cell adhesion molecule and is involved in the regulation of cell growth and differentiation.\n5. Besides epithelial cells, EpCAM is also found in other tissues and cells, such as the placenta, pancreas, and some types of cancer cells.",
    "vicuna-13b_fact": [
      "The EpCam protein is also known as Epithelial Cell Adhesion Molecule (EpCAM).",
      "EpCAM is mainly located on the surface of epithelial cells.",
      "Epithelial cells form the lining of various organs and glands in the body, such as the skin, lungs, digestive system, and reproductive system.",
      "EpCAM is a type of cell adhesion molecule and is involved in the regulation of cell growth and differentiation.",
      "Besides epithelial cells, EpCAM is also found in other tissues and cells, such as the placenta, pancreas, and some types of cancer cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2719,
    "user_query": "What is the clathrin triskelia structure?",
    "vicuna-13b_response": "The clathrin triskelia structure is a type of protein complex that plays a crucial role in the process of endocytosis, which is the process by which cells take in molecules and substances from their surroundings. The clathrin triskelia structure is composed of three identical units, or triskelia, which are arranged in a triangular shape. Each triskelion is composed of three polypeptide chains, which are encoded by the clathrin heavy chain gene. The clathrin triskelia structure is responsible for the formation of coated pits, which are invaginations of the plasma membrane that are involved in the process of endocytosis. The clathrin triskelia structure also plays a role in the transport of proteins and other molecules along the cytoskeleton, and it has been implicated in a number of cellular processes, including cell adhesion, signal transduction, and intracellular trafficking.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The clathrin triskelia structure is a type of protein complex that plays a role in the process of endocytosis.\n2. The clathrin triskelia structure is composed of three identical units, or triskelia.\n3. Each triskelion in the clathrin triskelia structure is composed of three polypeptide chains.\n4. These polypeptide chains are encoded by the clathrin heavy chain gene.\n5. The clathrin triskelia structure is responsible for the formation of coated pits, which are involved in the process of endocytosis.",
    "vicuna-13b_fact": [
      "The clathrin triskelia structure is a type of protein complex that plays a role in the process of endocytosis.",
      "The clathrin triskelia structure is composed of three identical units, or triskelia.",
      "Each triskelion in the clathrin triskelia structure is composed of three polypeptide chains.",
      "These polypeptide chains are encoded by the clathrin heavy chain gene.",
      "The clathrin triskelia structure is responsible for the formation of coated pits, which are involved in the process of endocytosis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2721,
    "user_query": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
    "vicuna-13b_response": "Yes, Brucella abortus is a bacterium that is known to cause brucillosis, which can lead to spontaneous abortions in humans. Brucillosis is a zoonotic disease, meaning it is transmitted from animals to humans, and is caused by the bacterium Brucella abortus or Brucella melitensis.\nBrucella abortus is a highly infectious bacterium that can affect a wide range of animals, including cattle, sheep, goats, and deer. When a pregnant woman is infected with Brucella abortus, the bacteria can cause an abortion or stillbirth. The bacteria can also cause fever, chills, and muscle pain in humans.\nBrucella abortus is a serious disease that can have severe consequences for both animals and humans. It is important to take steps to prevent infection, such as practicing good hygiene, avoiding contact with infected animals, and vaccinating animals against the disease. If you have any concerns about brucillosis or think you may have been exposed to the bacteria, it is important to seek medical attention immediately.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Brucella abortus is a bacterium that causes brucillosis.\n2. Brucillosis can lead to spontaneous abortions in humans.\n3. Brucillosis is a zoonotic disease, meaning it transmits from animals to humans.\n4. Brucella abortus can affect a wide range of animals, including cattle, sheep, goats, and deer.\n5. Brucella abortus can cause symptoms like fever, chills, and muscle pain in humans.",
    "vicuna-13b_fact": [
      "Brucella abortus is a bacterium that causes brucillosis.",
      "Brucillosis can lead to spontaneous abortions in humans.",
      "Brucillosis is a zoonotic disease, meaning it transmits from animals to humans.",
      "Brucella abortus can affect a wide range of animals, including cattle, sheep, goats, and deer.",
      "Brucella abortus can cause symptoms like fever, chills, and muscle pain in humans."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Brucillosis can lead to spontaneous abortions in livestock, not humans. In humans, it can cause a range of symptoms such as fever, chills, and muscle pain.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2722,
    "user_query": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
    "vicuna-13b_response": "It is estimated that the DNA of modern humans (Homo sapiens) contains approximately 2% to 4% Neanderthal DNA. This indicates that Neanderthals and modern humans interbred in the past, and that Neanderthal genes have been passed down to present-day humans. This interbreeding is thought to have occurred during the time when modern humans were migrating out of Africa and encountering Neanderthals in Europe and Asia. The presence of Neanderthal DNA in modern humans is one of the ways in which scientists have been able to study the evolutionary history of our species.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The DNA of modern humans (Homo sapiens) contains approximately 2% to 4% Neanderthal DNA.\n2. Neanderthals and modern humans interbred in the past.\n3. Neanderthal genes have been passed down to present-day humans.\n4. The interbreeding between Neanderthals and modern humans is thought to have occurred during the time when modern humans were migrating out of Africa.\n5. The presence of Neanderthal DNA in modern humans has been used by scientists to study the evolutionary history of our species.",
    "vicuna-13b_fact": [
      "The DNA of modern humans (Homo sapiens) contains approximately 2% to 4% Neanderthal DNA.",
      "Neanderthals and modern humans interbred in the past.",
      "Neanderthal genes have been passed down to present-day humans.",
      "The interbreeding between Neanderthals and modern humans is thought to have occurred during the time when modern humans were migrating out of Africa.",
      "The presence of Neanderthal DNA in modern humans has been used by scientists to study the evolutionary history of our species."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2723,
    "user_query": "What is Dupuytren's contracture?",
    "vicuna-13b_response": "Dupuytren's contracture is a condition that affects the hands and fingers. It is characterized by the thickening and shortening of the connective tissue in the palm of the hand, which can cause the fingers to bend towards the palm and make it difficult to straighten them. This condition is also known as \"Viking's disease\" or \"the nodule\". It is caused by a genetic predisposition and is more common in people of Northern European descent. Dupuytren's contracture can be treated with medication, physical therapy, or surgery, depending on the severity of the condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dupuytren's contracture is a condition that affects the hands and fingers.\n2. It is caused by the thickening and shortening of the connective tissue in the palm of the hand.\n3. Dupuytren's contracture can cause the fingers to bend towards the palm and make it difficult to straighten them.\n4. This condition is also known as \"Viking's disease\" or \"the nodule\".\n5. Dupuytren's contracture can be treated with medication, physical therapy, or surgery, depending on the severity.",
    "vicuna-13b_fact": [
      "Dupuytren's contracture is a condition that affects the hands and fingers.",
      "It is caused by the thickening and shortening of the connective tissue in the palm of the hand.",
      "Dupuytren's contracture can cause the fingers to bend towards the palm and make it difficult to straighten them.",
      "This condition is also known as \"Viking's disease\" or \"the nodule\".",
      "Dupuytren's contracture can be treated with medication, physical therapy, or surgery, depending on the severity."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Dupuytren's contracture is also known as \"Viking's disease\" or \"Celtic hand\".\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2728,
    "user_query": "Are human enhancers or promoters evolving faster?",
    "vicuna-13b_response": "As an AI language model, I do not have access to the latest research or data on the evolution of human enhancers or promoters. However, I can provide some general information on these terms.\nHuman enhancers are genetic elements that regulate gene expression, which means they control when and how much a gene is expressed. Enhancers can be thought of as \"on switches\" that turn on the expression of a gene. They are often located far from the gene they regulate and can act over long distances.\nHuman promoters, on the other hand, are the regions of DNA where the transcription of a gene begins. They are located near the start of a gene and are responsible for recruiting the transcriptional machinery that reads the genetic code and converts it into a functional product, such as a protein.\nBoth enhancers and promoters play important roles in gene regulation and are essential for the proper functioning of the genome. However, the evolution of these elements is likely to be complex and influenced by many factors, including natural selection, genetic drift, and mutation.\nWithout more specific information, it is difficult to say whether human enhancers or promoters are evolving faster. However, it is likely that both types of genetic elements are evolving continuously through the process of natural selection, as they play important roles in the survival and reproduction of individuals and populations.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Human enhancers are genetic elements that regulate gene expression.\n2. Enhancers can act as \"on switches\" that control when and how much a gene is expressed and can often operate over long distances.\n3. Human promoters are regions of DNA where the transcription of a gene begins.\n4. Promoters are located near the start of a gene and recruit the transcriptional machinery that reads the genetic code and converts it into a functional product, such as a protein.\n5. Both enhancers and promoters play key roles in gene regulation and are essential for the proper functioning of the genome.",
    "vicuna-13b_fact": [
      "Human enhancers are genetic elements that regulate gene expression.",
      "Enhancers can act as \"on switches\" that control when and how much a gene is expressed and can often operate over long distances.",
      "Human promoters are regions of DNA where the transcription of a gene begins.",
      "Promoters are located near the start of a gene and recruit the transcriptional machinery that reads the genetic code and converts it into a functional product, such as a protein.",
      "Both enhancers and promoters play key roles in gene regulation and are essential for the proper functioning of the genome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2729,
    "user_query": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
    "vicuna-13b_response": "As of November 2017, the three antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, are:\n1. Andexanet alfa: This is an antidote for factor Xa inhibitors, such as apixaban, rivaroxaban, and edoxaban. It works by binding to these drugs and neutralizing their anticoagulant effect.\n2. Praxbind: This is also an antidote for factor Xa inhibitors, such as apixaban and rivaroxaban. It works by binding to these drugs and reversing their anticoagulant effect.\n3. Idraparinux: This is an antidote for the factor Xa inhibitor, rivaroxaban. It works by binding to rivaroxaban and reversing its anticoagulant effect.\nIt is important to note that the use of these antidotes should be carefully monitored by a healthcare professional, as they can also have adverse effects and may not be appropriate in all situations.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. As of November 2017, Andexanet alfa, Praxbind, and Idraparinux are antidotes for anticoagulant drugs, including factor Xa inhibitors.\n2. Andexanet alfa is an antidote for factor Xa inhibitors such as apixaban, rivaroxaban, and edoxaban.\n3. Praxbind is an antidote for factor Xa inhibitors such as apixaban and rivaroxaban.\n4. Idraparinux is an antidote for the factor Xa inhibitor, rivaroxaban.\n5. The use of these antidotes should be carefully monitored by a healthcare professional due to potential adverse effects.",
    "vicuna-13b_fact": [
      "As of November 2017, Andexanet alfa, Praxbind, and Idraparinux are antidotes for anticoagulant drugs, including factor Xa inhibitors.",
      "Andexanet alfa is an antidote for factor Xa inhibitors such as apixaban, rivaroxaban, and edoxaban.",
      "Praxbind is an antidote for factor Xa inhibitors such as apixaban and rivaroxaban.",
      "Idraparinux is an antidote for the factor Xa inhibitor, rivaroxaban.",
      "The use of these antidotes should be carefully monitored by a healthcare professional due to potential adverse effects."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Praxbind is an antidote for direct and indirect Thrombin inhibitors such as Dabigatran. It is not an antidote for factor Xa inhibitors.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2730,
    "user_query": "Which genes are associated with Epidermolysis Bullosa Simplex?",
    "vicuna-13b_response": "Epidermolysis bullosa simplex (EBS) is a genetic disorder that affects the skin and mucous membranes. It is a form of epidermolysis bullosa, which is a group of inherited disorders that cause the skin to be very fragile and prone to blistering and scarring.\nEBS is caused by mutations in the LAMB3 gene, which is responsible for the production of laminin-332, a protein that is important for the structure and function of the skin. The LAMB3 gene is located on the long (q) arm of chromosome 3 at position 21.1.\nMutations in the LAMB3 gene lead to a deficiency of laminin-332, which results in the characteristic symptoms of EBS, including fragile skin, mucous membrane ulcerations, and scarring. There are several subtypes of EBS, which are classified based on the severity of the symptoms and the age of onset.\nIn summary, the gene associated with Epidermolysis Bullosa Simplex is LAMB3.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Epidermolysis bullosa simplex (EBS) is a genetic disorder that affects the skin and mucous membranes.\n2. EBS is caused by mutations in the LAMB3 gene.\n3. The LAMB3 gene is responsible for the production of laminin-332.\n4. The LAMB3 gene is located on the long (q) arm of chromosome 3 at position 21.1.\n5. Mutations in the LAMB3 gene lead to a deficiency of laminin-332, which results in the symptoms of EBS.",
    "vicuna-13b_fact": [
      "Epidermolysis bullosa simplex (EBS) is a genetic disorder that affects the skin and mucous membranes.",
      "EBS is caused by mutations in the LAMB3 gene.",
      "The LAMB3 gene is responsible for the production of laminin-332.",
      "The LAMB3 gene is located on the long (q) arm of chromosome 3 at position 21.1.",
      "Mutations in the LAMB3 gene lead to a deficiency of laminin-332, which results in the symptoms of EBS."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2738,
    "user_query": "What part of the body is affected by mesotheliomia?",
    "vicuna-13b_response": "Mesothelioma is a type of cancer that affects the lining of the body's internal organs, specifically the pleura (the lining surrounding the lungs), the peritoneum (the lining surrounding the abdominal cavity), the pericardium (the lining surrounding the heart), and the tunica vaginalis (the lining of the testis in men). It is caused by exposure to asbestos and other forms of mineral dust.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mesothelioma is a type of cancer that affects the lining of the body's internal organs.\n2. The pleura, which is the lining surrounding the lungs, can be affected by mesothelioma.\n3. The peritoneum, which is the lining surrounding the abdominal cavity, can be affected by mesothelioma.\n4. The pericardium, the lining surrounding the heart, can be affected by mesothelioma.\n5. Mesothelioma can affect the tunica vaginalis, which is the lining of the testis in men.",
    "vicuna-13b_fact": [
      "Mesothelioma is a type of cancer that affects the lining of the body's internal organs.",
      "The pleura, which is the lining surrounding the lungs, can be affected by mesothelioma.",
      "The peritoneum, which is the lining surrounding the abdominal cavity, can be affected by mesothelioma.",
      "The pericardium, the lining surrounding the heart, can be affected by mesothelioma.",
      "Mesothelioma can affect the tunica vaginalis, which is the lining of the testis in men."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2741,
    "user_query": "What is PNPPP?",
    "vicuna-13b_response": "PNPPP stands for \"Phenyl Nitrone Phosphate Phosphoric Triester\", which is a type of chemical compound. It is a synthetic organic compound that is used in various industrial applications, such as in the production of dyes, pigments, and other chemicals.\nPNPPP is a colorless liquid that is soluble in water and other organic solvents. It is a highly reactive compound that undergoes a variety of chemical reactions, including esterification, nitration, and phosphorylation.\nPNPPP is typically synthesized by reacting phenyl chloride with sodium nitrite in the presence of a strong acid catalyst, such as sulfuric acid. The resulting compound is then treated with a phosphorus triester, such as triethyl phosphite, to form the final PNPPP product.\nOverall, PNPPP is an important chemical intermediate that is used in a variety of industrial applications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PNPPP stands for \"Phenyl Nitrone Phosphate Phosphoric Triester\".\n2. PNPPP is a synthetic organic compound used in various industrial applications.\n3. PNPPP is soluble in water and other organic solvents.\n4. The synthesis of PNPPP involves reacting phenyl chloride with sodium nitrite in the presence of a strong acid catalyst.\n5. After forming, PNPPP is treated with a phosphorus triester, such as triethyl phosphite, to form the final product.",
    "vicuna-13b_fact": [
      "PNPPP stands for \"Phenyl Nitrone Phosphate Phosphoric Triester\".",
      "PNPPP is a synthetic organic compound used in various industrial applications.",
      "PNPPP is soluble in water and other organic solvents.",
      "The synthesis of PNPPP involves reacting phenyl chloride with sodium nitrite in the presence of a strong acid catalyst.",
      "After forming, PNPPP is treated with a phosphorus triester, such as triethyl phosphite, to form the final product."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2746,
    "user_query": "Which genomic positions are preferentially selected for transposon insertion?",
    "vicuna-13b_response": "Transposons are mobile genetic elements that can move around the genome and insert themselves into new locations. The genomic positions that are preferentially selected for transposon insertion can vary depending on the specific transposon and the host organism. However, there are some general patterns that have been observed.\nIn general, transposons tend to preferentially insert into regions of the genome that are highly conserved across different species, such as protein-coding regions and regulatory elements. This is because these regions are more likely to be essential for the function of the organism, and therefore are less likely to be disrupted by a transposon insertion.\nTransposons can also be biased towards certain types of sequences, such as AT-rich regions or regions with a particular chromatin structure. Additionally, transposons may be more likely to insert into regions that are already occupied by other mobile elements, such as other transposons or transcriptional regulators.\nOverall, the specific genomic positions that are preferentially selected for transposon insertion can vary depending on the transposon and the host organism, but there are some general patterns that have been observed.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Transposons are mobile genetic elements that can move around the genome and insert themselves into new locations.\n2. The genomic positions that transposons prefer for insertion can vary depending on the specific transposon and the host organism.\n3. Transposons tend to preferentially insert into regions of the genome that are highly conserved across different species, such as protein-coding regions and regulatory elements.\n4. Transposons can be biased towards certain types of sequences, such as AT-rich regions or regions with a particular chromatin structure.\n5. Transposons may be more likely to insert into regions that are already occupied by other mobile elements, such as other transposons or transcriptional regulators.",
    "vicuna-13b_fact": [
      "Transposons are mobile genetic elements that can move around the genome and insert themselves into new locations.",
      "The genomic positions that transposons prefer for insertion can vary depending on the specific transposon and the host organism.",
      "Transposons tend to preferentially insert into regions of the genome that are highly conserved across different species, such as protein-coding regions and regulatory elements.",
      "Transposons can be biased towards certain types of sequences, such as AT-rich regions or regions with a particular chromatin structure.",
      "Transposons may be more likely to insert into regions that are already occupied by other mobile elements, such as other transposons or transcriptional regulators."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Transposons do not preferentially insert into highly conserved regions such as protein-coding regions and regulatory elements due to the potential negative impact on host fitness. They are more likely to insert into areas that will cause less detrimental effects to the gene function.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "vicuna-13b_response": "One popular Lisp framework for image processing is called \"CL-PNG\". CL-PNG is a Common Lisp library for working with PNG (Portable Network Graphics) images. It provides a simple and efficient way to read, manipulate, and write PNG images in Lisp. The library supports all the features of the PNG format, including transparency, gamma correction, and interlacing.\nCL-PNG is just one example of a Lisp framework for image processing. There are many other Lisp libraries and frameworks available for image processing, including CL-GD (for working with GIF images), CL-JPEG (for working with JPEG images), and CL-GIF (for working with animated GIF images).\nTo use CL-PNG or any other Lisp image processing library, you will need to have a working installation of a Common Lisp compiler or interpreter. You can then load the library into your Lisp program and use its functions to process images.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CL-PNG is a Common Lisp library for working with PNG images.\n2. The CL-PNG library supports all the features of the PNG format, including transparency, gamma correction, and interlacing.\n3. There are other Lisp libraries for image processing such as CL-GD, CL-JPEG, and CL-GIF.\n4. You need a working installation of a Common Lisp compiler or interpreter to use CL-PNG or any other Lisp image processing library.\n5. CL-PNG provides a way to read, manipulate, and write PNG images in Lisp.",
    "vicuna-13b_fact": [
      "CL-PNG is a Common Lisp library for working with PNG images.",
      "The CL-PNG library supports all the features of the PNG format, including transparency, gamma correction, and interlacing.",
      "There are other Lisp libraries for image processing such as CL-GD, CL-JPEG, and CL-GIF.",
      "You need a working installation of a Common Lisp compiler or interpreter to use CL-PNG or any other Lisp image processing library.",
      "CL-PNG provides a way to read, manipulate, and write PNG images in Lisp."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2751,
    "user_query": "List four features of the WHIM syndrome.",
    "vicuna-13b_response": "WHIM (Wiskott-Aldrich Immunodeficiency Syndrome) is a rare genetic disorder that affects the immune system. Here are four features of WHIM syndrome:\n1. Recurrent infections: People with WHIM syndrome have a reduced ability to fight off infections, due to a lack of functional B cells and plasma cells. This can lead to recurrent infections, particularly in the respiratory tract, gastrointestinal tract, and skin.\n2. Thrombocytopenia: WHIM syndrome is characterized by low levels of platelets (thrombocytopenia), which can lead to easy bruising and bleeding.\n3. Immunodeficiency: WHIM syndrome is a primary immunodeficiency disorder, meaning that it is caused by a genetic defect in the immune system. This defect leads to a reduced ability to fight off infections and respond to vaccines.\n4. Lymphoproliferative disease: People with WHIM syndrome are at an increased risk of developing lymphoproliferative diseases, such as lymphoma. This is due to the abnormal proliferation of lymphocytes, a type of white blood cell that plays a key role in the immune response.\nOverall, WHIM syndrome is a rare but serious immunodeficiency disorder that requires close monitoring and management to prevent serious infections and other complications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. WHIM syndrome is a disorder that impacts the immune system.\n2. People with WHIM syndrome have an increased risk of developing recurrent infections due to a lack of functional B cells and plasma cells.\n3. WHIM patients are known to suffer from thrombocytopenia, characterized by low platelet levels.\n4. As a primary immunodeficiency disorder, WHIM syndrome is caused by a genetic defect in the immune system.\n5. WHIM syndrome increases the risk of developing lymphoproliferative diseases, such as lymphoma.",
    "vicuna-13b_fact": [
      "WHIM syndrome is a disorder that impacts the immune system.",
      "People with WHIM syndrome have an increased risk of developing recurrent infections due to a lack of functional B cells and plasma cells.",
      "WHIM patients are known to suffer from thrombocytopenia, characterized by low platelet levels.",
      "As a primary immunodeficiency disorder, WHIM syndrome is caused by a genetic defect in the immune system.",
      "WHIM syndrome increases the risk of developing lymphoproliferative diseases, such as lymphoma."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: WHIM patients do not typically suffer from thrombocytopenia, which is characterized by low platelet levels. They do, however, have low white blood cell counts.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2753,
    "user_query": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?",
    "vicuna-13b_response": "It is not uncommon for infants who are exposed to furry pets, such as dogs and cats, to have an enriched gut microbiome with certain bacteria species. Some of the bacteria that may be enriched in the gut microbiome of infants following exposure to furry pets include:\n1. Clostridioides difficile (C. difficile): C. difficile is a gram-positive, spore-forming bacteria that can cause diarrhea and colitis in infants and adults. It is often associated with antibiotic use and can be transmitted from pets to humans through contact with contaminated surfaces or direct contact with the pet.\n2. Staphylococcus aureus: Staphylococcus aureus is a gram-positive bacteria that can cause skin infections, abscesses, and sepsis in infants. It is commonly found on the skin and fur of pets and can be transmitted to humans through direct contact with the pet or contaminated surfaces.\n3. Escherichia coli: E. coli is a gram-negative bacteria that is a normal inhabitant of the gut microbiome in infants and adults. However, some strains of E. coli can cause diarrhea, urinary tract infections, and sepsis in infants. Pet exposure can increase the risk of infection with certain strains of E. coli.\n4. Klebsiella pneumoniae: Klebsiella pneumoniae is a gram-negative bacteria that can cause pneumonia, urinary tract infections, and sepsis in infants. It is commonly found on the skin and fur of pets and can be transmitted to humans through direct contact with the pet or contaminated surfaces.\nIt is important to note that while exposure to furry pets can increase the risk of certain bacterial infections in infants, not all infants who are exposed to pets will develop these infections. Additionally, the gut microbiome of infants is constantly changing and developing, so exposure to pets may not have a lasting impact on the overall composition of the gut microbiome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Infants who are exposed to furry pets can have an enriched gut microbiome with certain bacteria species.\n2. Clostridioides difficile, a gram-positive, spore-forming bacteria, can be transmitted from pets to humans and might cause diarrhea and colitis in infants and adults.\n3. Staphylococcus aureus is a gram-positive bacteria that can cause skin infections, abscesses, and sepsis in infants, and can be transmitted to humans from pets.\n4. Escherichia coli is a gram-negative bacteria that is a normal inhabitant of the gut microbiome in infants and adults, but some strains can cause health issues.\n5. Klebsiella pneumoniae is a gram-negative bacteria that can cause various infections in infants and can be transmitted to humans through pets.",
    "vicuna-13b_fact": [
      "Infants who are exposed to furry pets can have an enriched gut microbiome with certain bacteria species.",
      "Clostridioides difficile, a gram-positive, spore-forming bacteria, can be transmitted from pets to humans and might cause diarrhea and colitis in infants and adults.",
      "Staphylococcus aureus is a gram-positive bacteria that can cause skin infections, abscesses, and sepsis in infants, and can be transmitted to humans from pets.",
      "Escherichia coli is a gram-negative bacteria that is a normal inhabitant of the gut microbiome in infants and adults, but some strains can cause health issues.",
      "Klebsiella pneumoniae is a gram-negative bacteria that can cause various infections in infants and can be transmitted to humans through pets."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Klebsiella pneumoniae is a gram-negative bacteria that can cause various infections in adults and infants, but there's no conclusive research suggesting it can be transmitted to humans through pets.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2755,
    "user_query": "Is Baloxavir effective for influenza?",
    "vicuna-13b_response": "Baloxavir is an antiviral medication that is effective in treating influenza, also known as the flu. It is a type of medication called a neuraminidase inhibitor, which works by blocking the activity of an enzyme called neuraminidase that is produced by the influenza virus. By blocking this enzyme, baloxavir can help to reduce the spread of the virus within the body and shorten the duration of flu symptoms.\nBaloxavir was approved by the U.S. Food and Drug Administration (FDA) in 2018 for the treatment of influenza in adults and children aged 12 years and older. It is taken as a single dose by mouth and is recommended for use within the first 48 hours of developing flu symptoms.\nStudies have shown that baloxavir can reduce the severity of flu symptoms and the duration of illness by about a day compared to placebo. It can also reduce the risk of developing complications from the flu, such as pneumonia and hospitalization.\nIt's important to note that baloxavir is not a substitute for getting a flu vaccine. The flu vaccine is the best way to prevent the flu and is recommended for everyone 6 months and older.\nIt's also important to note that baloxavir is not effective against other viral illnesses such as the common cold, and it's important to consult a doctor to diagnose the illness before starting any treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Baloxavir is an antiviral medication used to treat influenza.\n2. Baloxavir is a neuraminidase inhibitor which can help to reduce the spread of the influenza virus within the body.\n3. The U.S. Food and Drug Administration approved Baloxavir in 2018 for the treatment of influenza in adults and children aged 12 years and older.\n4. Studies show that baloxavir can reduce the severity of flu symptoms and the duration of illness by approximately one day compared to a placebo.\n5. While effective against influenza, baloxavir is not effective against other viral illnesses such as the common cold.",
    "vicuna-13b_fact": [
      "Baloxavir is an antiviral medication used to treat influenza.",
      "Baloxavir is a neuraminidase inhibitor which can help to reduce the spread of the influenza virus within the body.",
      "The U.S. Food and Drug Administration approved Baloxavir in 2018 for the treatment of influenza in adults and children aged 12 years and older.",
      "Studies show that baloxavir can reduce the severity of flu symptoms and the duration of illness by approximately one day compared to a placebo.",
      "While effective against influenza, baloxavir is not effective against other viral illnesses such as the common cold."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Baloxavir is not a neuraminidase inhibitor but an endonuclease inhibitor which prevents the virus from multiplying.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "vicuna-13b_response": "Whole genome duplication (WGD) events are known to have occurred in the evolutionary history of many eukaryotic species, including Saccharomyces cerevisiae, the baker's yeast. WGD events result in the duplication of an entire genome, leading to the creation of multiple copies of each gene. The exact number of genes in S. cerevisiae that are the result of an ancient WGD event is not well established, but it is estimated to be around 50-100 genes. These genes are thought to be responsible for a variety of functions, including the regulation of gene expression, DNA repair, and the maintenance of chromosome stability.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Whole genome duplication (WGD) events have occurred in the evolutionary history of many eukaryotic species, including Saccharomyces cerevisiae.\n2. WGD events result in the duplication of an entire genome, creating multiple copies of each gene.\n3. The exact number of genes in S. cerevisiae that are a result of an ancient WGD event is not well established.\n4. It's estimated that around 50-100 genes in S. cerevisiae are the result of an ancient WGD event.\n5. These duplicated genes in S. cerevisiae are thought to be responsible for functions such as the regulation of gene expression, DNA repair, and the maintenance of chromosome stability.",
    "vicuna-13b_fact": [
      "Whole genome duplication (WGD) events have occurred in the evolutionary history of many eukaryotic species, including Saccharomyces cerevisiae.",
      "WGD events result in the duplication of an entire genome, creating multiple copies of each gene.",
      "The exact number of genes in S. cerevisiae that are a result of an ancient WGD event is not well established.",
      "It's estimated that around 50-100 genes in S. cerevisiae are the result of an ancient WGD event.",
      "These duplicated genes in S. cerevisiae are thought to be responsible for functions such as the regulation of gene expression, DNA repair, and the maintenance of chromosome stability."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor β (Esrrb)?",
    "vicuna-13b_response": "Estrogen-related receptor β (Esrrb) is a transcription factor that binds to specific DNA sequences to regulate gene expression. Esrrb is known to bind to a variety of estrogen response elements (EREs) in the promoter regions of target genes, and plays a role in the regulation of cell proliferation, differentiation, and apoptosis.\nIn terms of which complex is bound by Esrrb, it is not clear if Esrrb binds to a specific complex or if it interacts with multiple complexes. However, Esrrb has been shown to interact with other transcription factors, such as AP-1, Sp1, and NF-κB, and these interactions can modulate its transcriptional activity. Additionally, Esrrb has been shown to interact with coactivators and corepressors, such as p300 and HDAC1, which can affect its ability to bind to DNA and regulate gene expression.\nOverall, while Esrrb is known to bind to specific DNA sequences, it is not clear if it is specifically bound to a particular complex.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Estrogen-related receptor β (Esrrb) is a transcription factor.\n2. Esrrb binds to specific DNA sequences to regulate gene expression.\n3. Esrrb binds to a variety of estrogen response elements (EREs) in the promoter regions of target genes.\n4. Esrrb interacts with other transcription factors, such as AP-1, Sp1, and NF-κB.\n5. Esrrb interacts with coactivators and corepressors, such as p300 and HDAC1.",
    "vicuna-13b_fact": [
      "Estrogen-related receptor β (Esrrb) is a transcription factor.",
      "Esrrb binds to specific DNA sequences to regulate gene expression.",
      "Esrrb binds to a variety of estrogen response elements (EREs) in the promoter regions of target genes.",
      "Esrrb interacts with other transcription factors, such as AP-1, Sp1, and NF-κB.",
      "Esrrb interacts with coactivators and corepressors, such as p300 and HDAC1."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Estrogen-related receptor β (Esrrb) does not bind to estrogen response elements (EREs), but to ERR response elements.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2773,
    "user_query": "Which database associates human noncoding SNPs with their three-dimensional interacting genes?",
    "vicuna-13b_response": "There are several databases that associate human noncoding SNPs with their three-dimensional interacting genes. Some examples include:\n1. The Encyclopedia of DNA Elements (ENCODE) database: This database is a comprehensive catalog of functional elements in the human genome, including noncoding SNPs and their associated genes.\n2. The Single Nucleotide Polymorphism (SNP) database: This database contains information on SNPs and their associated genes, including functional annotations and disease associations.\n3. The Human Gene Network Database (HGND): This database is a comprehensive resource for human gene interactions, including noncoding SNPs and their associated genes.\n4. The Gene Ontology (GO) database: This database provides functional annotations for genes, including information on their associated noncoding SNPs and their three-dimensional interacting genes.\n5. The Database of Interacting Proteins (DIP): This database contains information on protein-protein interactions, including those involving noncoding SNPs and their associated genes.\nIt's important to note that these databases are constantly evolving and updating, so it's always a good idea to check for the most recent information.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Encyclopedia of DNA Elements (ENCODE) database is a catalog of functional elements in the human genome, including noncoding SNPs and their associated genes.\n2. The Single Nucleotide Polymorphism (SNP) database contains information on SNPs and their associated genes.\n3. The Human Gene Network Database (HGND) is a resource for human gene interactions, including noncoding SNPs and their associated genes.\n4. The Gene Ontology (GO) database provides functional annotations for genes, including information on their associated noncoding SNPs.\n5. The Database of Interacting Proteins (DIP) contains information on protein-protein interactions.",
    "vicuna-13b_fact": [
      "The Encyclopedia of DNA Elements (ENCODE) database is a catalog of functional elements in the human genome, including noncoding SNPs and their associated genes.",
      "The Single Nucleotide Polymorphism (SNP) database contains information on SNPs and their associated genes.",
      "The Human Gene Network Database (HGND) is a resource for human gene interactions, including noncoding SNPs and their associated genes.",
      "The Gene Ontology (GO) database provides functional annotations for genes, including information on their associated noncoding SNPs.",
      "The Database of Interacting Proteins (DIP) contains information on protein-protein interactions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There is no known resource named the Human Gene Network Database (HGND). However, databases like the Human Protein Reference Database (HPRD) provide information on human gene interactions.\n4. FALSE [correction]: The Gene Ontology (GO) database provides functional annotations for genes, but not specific information on their associated noncoding SNPs.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2778,
    "user_query": "What is the role of fucokinase?",
    "vicuna-13b_response": "Fucokinase is an enzyme that plays a critical role in the regulation of glycoprotein biosynthesis. It is involved in the initiation step of glycoprotein biosynthesis, which is the addition of the first sugar molecule to a growing glycoprotein.\nFucokinase catalyzes the conversion of fucose, a type of sugar, to a fucose-1-phosphate, which is the first step in the formation of the complex carbohydrate side chains known as glycans. This enzyme is essential for the proper formation of glycans, which are important for the structure and function of many proteins and lipids in the body.\nFucokinase is found in the endoplasmic reticulum and Golgi apparatus of cells, and it is activated by calcium ions. It is also regulated by phosphorylation, which can inhibit its activity.\nMutations in the fucokinase gene have been linked to several diseases, including congenital disorders of glycosylation and fucosidosis, which are rare inherited disorders that affect the biosynthesis of glycans.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fucokinase is an enzyme that plays a role in the regulation of glycoprotein biosynthesis.\n2. Fucokinase catalyzes the conversion of fucose to fucose-1-phosphate.\n3. This enzyme is essential for the formation of glycans, which are important for the structure and function of many proteins and lipids in the body.\n4. Fucokinase can be found in the endoplasmic reticulum and Golgi apparatus of cells and is activated by calcium ions.\n5. Mutations in the fucokinase gene have been linked to congenital disorders of glycosylation and fucosidosis.",
    "vicuna-13b_fact": [
      "Fucokinase is an enzyme that plays a role in the regulation of glycoprotein biosynthesis.",
      "Fucokinase catalyzes the conversion of fucose to fucose-1-phosphate.",
      "This enzyme is essential for the formation of glycans, which are important for the structure and function of many proteins and lipids in the body.",
      "Fucokinase can be found in the endoplasmic reticulum and Golgi apparatus of cells and is activated by calcium ions.",
      "Mutations in the fucokinase gene have been linked to congenital disorders of glycosylation and fucosidosis."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Fucokinase is an enzyme that plays a role in the metabolism of fucose.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: Mutations in the fucokinase gene have not been directly linked to congenital disorders of glycosylation and fucosidosis. These disorders are generally caused by defects in other enzymes involved in the metabolism of fucose.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2785,
    "user_query": "Are whole-genome duplications more divergent than small-scale duplications in yeast?",
    "vicuna-13b_response": "Whole-genome duplications (WGDs) and small-scale duplications (SSDs) are two different types of genetic events that can occur in organisms, including yeast. WGDs involve the duplication of an entire genome, while SSDs involve the duplication of only a portion of the genome.\nStudies have shown that WGDs can lead to more divergent outcomes compared to SSDs in yeast. This is because WGDs result in the duplication of all genes in the genome, which can lead to changes in gene expression, protein function, and genome structure. These changes can result in the evolution of new functions and the diversification of the organism.\nIn contrast, SSDs typically involve the duplication of a smaller subset of genes, and the effects on gene expression and protein function are generally less dramatic than those of WGDs. However, SSDs can still play a role in the evolution of new functions and the diversification of the organism.\nOverall, both WGDs and SSDs can lead to divergent outcomes in yeast, but WGDs tend to have a more significant impact on the genome and the organism as a whole.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Whole-genome duplications (WGDs) involve the duplication of an entire genome.\n2. Small-scale duplications (SSDs) involve the duplication of only a portion of the genome.\n3. Studies have shown that WGDs can lead to more divergent outcomes compared to SSDs in yeast.\n4. WGDs can result in changes in gene expression, protein function, and genome structure.\n5. Both WGDs and SSDs can play a role in the diversification of the organism.",
    "vicuna-13b_fact": [
      "Whole-genome duplications (WGDs) involve the duplication of an entire genome.",
      "Small-scale duplications (SSDs) involve the duplication of only a portion of the genome.",
      "Studies have shown that WGDs can lead to more divergent outcomes compared to SSDs in yeast.",
      "WGDs can result in changes in gene expression, protein function, and genome structure.",
      "Both WGDs and SSDs can play a role in the diversification of the organism."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2791,
    "user_query": "Is erythropoietin effective for treatment of amyotrophic lateral sclerosis?",
    "vicuna-13b_response": "Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells in the body. It has been studied as a potential treatment for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.\nSome studies have suggested that EPO may have potential benefits for ALS patients. For example, a small clinical trial conducted in 2015 found that EPO treatment was associated with improved muscle strength and reduced muscle wasting in ALS patients. However, the study was relatively small and more research is needed to confirm these findings.\nAnother study published in 2020 found that EPO treatment improved motor function and increased the lifespan of ALS mice. The study suggested that EPO may work by reducing inflammation and promoting the survival of motor neurons, which are the nerve cells that are affected in ALS.\nDespite these promising findings, the use of EPO for ALS treatment is still in the experimental stage, and more research is needed to fully understand its potential benefits and risks. Currently, there are no approved medications that can slow the progression of ALS, and more research is needed to develop effective treatments for this devastating disease.\nIn conclusion, while some studies suggest that EPO may have potential benefits for ALS patients, more research is needed to fully understand its effects and determine whether it is an effective treatment for ALS.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells in the body.\n2. EPO has been studied as a potential treatment for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.\n3. A small clinical trial conducted in 2015 found that EPO treatment was associated with improved muscle strength and reduced muscle wasting in ALS patients.\n4. A study in 2020 found that EPO treatment improved motor function and increased the lifespan of ALS mice.\n5. Currently, there are no approved medications that can slow the progression of ALS.",
    "vicuna-13b_fact": [
      "Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells in the body.",
      "EPO has been studied as a potential treatment for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.",
      "A small clinical trial conducted in 2015 found that EPO treatment was associated with improved muscle strength and reduced muscle wasting in ALS patients.",
      "A study in 2020 found that EPO treatment improved motor function and increased the lifespan of ALS mice.",
      "Currently, there are no approved medications that can slow the progression of ALS."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [Correction]: There are approved medications like Riluzole and Edaravone that can slow the progression of ALS albeit modestly.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2795,
    "user_query": "Is chlorotoxin a peptide?",
    "vicuna-13b_response": "Yes, chlorotoxin is a peptide. It is a small, naturally occurring peptide that is produced by the bacterium Pseudomonas aeruginosa. Chlorotoxin is composed of 33 amino acids and has been shown to have a range of biological activities, including the ability to bind to and inhibit a variety of ion channels, as well as to induce the production of reactive oxygen species (ROS) in certain cell types. Chlorotoxin has also been studied as a potential therapeutic agent for a variety of diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Chlorotoxin is a peptide.\n2. Chlorotoxin is produced by the bacterium Pseudomonas aeruginosa.\n3. Chlorotoxin is composed of 33 amino acids.\n4. Chlorotoxin has the ability to bind to and inhibit a variety of ion channels.\n5. Chlorotoxin has potential as a therapeutic agent for diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact": [
      "Chlorotoxin is a peptide.",
      "Chlorotoxin is produced by the bacterium Pseudomonas aeruginosa.",
      "Chlorotoxin is composed of 33 amino acids.",
      "Chlorotoxin has the ability to bind to and inhibit a variety of ion channels.",
      "Chlorotoxin has potential as a therapeutic agent for diseases, including cancer and neurodegenerative disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Chlorotoxin is produced by the deathstalker scorpion, not Pseudomonas aeruginosa.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2797,
    "user_query": "Is selenocysteine an aminoacid?",
    "vicuna-13b_response": "Selenocysteine (Sec) is not a standard amino acid found in proteins. It is a derivative of the amino acid cysteine, with the addition of a selenium atom in its place. Selenocysteine is not present in proteins naturally, but it can be artificially introduced into proteins through site-directed mutagenesis or other methods. It has been shown to have important functions in some organisms, such as in the formation of antioxidant enzymes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Selenocysteine (Sec) is not a standard amino acid found in proteins.\n2. Selenocysteine is a derivative of the amino acid cysteine.\n3. Selenocysteine has a selenium atom in place of cysteine.\n4. Selenocysteine is not naturally present in proteins.\n5. Selenocysteine can be artificially introduced into proteins through site-directed mutagenesis or other methods.",
    "vicuna-13b_fact": [
      "Selenocysteine (Sec) is not a standard amino acid found in proteins.",
      "Selenocysteine is a derivative of the amino acid cysteine.",
      "Selenocysteine has a selenium atom in place of cysteine.",
      "Selenocysteine is not naturally present in proteins.",
      "Selenocysteine can be artificially introduced into proteins through site-directed mutagenesis or other methods."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Selenocysteine (Sec) is a standard amino acid found in proteins.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Selenocysteine is naturally present in many proteins.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2812,
    "user_query": "Which is the basis of the ATAC-Seq protocol?",
    "vicuna-13b_response": "ATAC-Seq (Assay for Transposase-Accessible Chromatin using Sequencing) is a protocol used to study the accessibility of chromatin to transcription factors and other proteins that bind to DNA. The protocol is based on the use of a transposase, such as Tn5, to create breaks in the DNA at specific sites in the genome. These breaks create \"transposon-induced chromosomal breaks\" (TICs) that can be used to identify the regions of the genome that are accessible to the transposase.\nThe ATAC-Seq protocol involves several steps:\n1. Chromatin is isolated from cells and fragmented into small pieces.\n2. The transposase is added to the chromatin, and it creates breaks at specific sites in the genome.\n3. The broken ends of the DNA are repaired by a process called \"transformation-associated recombination\" (TAR), which generates small circular DNA molecules called \"TARs\" that contain the information about the accessibility of the chromatin at the site of the break.\n4. The TARs are purified and sequenced using next-generation sequencing technologies.\n5. The data is analyzed to identify the regions of the genome that are accessible to the transposase, and thus the regions that are likely to be bound by transcription factors or other proteins.\nThe ATAC-Seq protocol provides a powerful tool for studying the epigenetic regulation of gene expression by providing information about the accessibility of chromatin to proteins that regulate transcription. It has been used to study a wide range of biological processes, including cell differentiation, development, and disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ATAC-Seq is a protocol used to study the accessibility of chromatin to transcription factors and other proteins that bind to DNA.\n2. The ATAC-Seq protocol is based on the use of a transposase, such as Tn5.\n3. ATAC-Seq involves the isolation and fragmentation of chromatin, addition of the transposase, repairing of the DNA ends, purification and sequencing of the TARs. \n4. The ATAC-Seq protocol can provide information about the accessibility of chromatin to proteins that regulate transcription.\n5. ATAC-Seq has been used to study various biological processes, including cell differentiation, development, and disease.",
    "vicuna-13b_fact": [
      "ATAC-Seq is a protocol used to study the accessibility of chromatin to transcription factors and other proteins that bind to DNA.",
      "The ATAC-Seq protocol is based on the use of a transposase, such as Tn5.",
      "ATAC-Seq involves the isolation and fragmentation of chromatin, addition of the transposase, repairing of the DNA ends, purification and sequencing of the TARs.",
      "The ATAC-Seq protocol can provide information about the accessibility of chromatin to proteins that regulate transcription.",
      "ATAC-Seq has been used to study various biological processes, including cell differentiation, development, and disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: ATAC-Seq involves the use of a transposase to fragment the chromatin into accessible and inaccessible regions, thereby negating the need for separate steps for isolation and fragmentation of chromatin.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2813,
    "user_query": "What is vcfanno?",
    "vicuna-13b_response": "VCFANNO is a tool for annotating and analyzing variant call format (VCF) files. It is a command-line tool that can be used to perform various tasks such as filtering variants based on their quality or frequency, calculating statistics on the variants, and annotating the variants with information from external databases. VCFANNO is designed to be used in conjunction with other tools in the ANNOOTMATE suite, which are used for annotating and analyzing genomic data. VCFANNO is a useful tool for researchers who work with genomic data and need to analyze and interpret the variants present in their data.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. VCFANNO is a tool for annotating and analyzing variant call format (VCF) files.\n2. VCFANNO is a command-line tool.\n3. VCFANNO can be used to filter variants based on their quality or frequency.\n4. VCFANNO can calculate statistics on the variants and annotate them with information from external databases.\n5. VCFANNO is to be used with other tools in the ANNOOTMATE suite for annotating and analyzing genomic data.",
    "vicuna-13b_fact": [
      "VCFANNO is a tool for annotating and analyzing variant call format (VCF) files.",
      "VCFANNO is a command-line tool.",
      "VCFANNO can be used to filter variants based on their quality or frequency.",
      "VCFANNO can calculate statistics on the variants and annotate them with information from external databases.",
      "VCFANNO is to be used with other tools in the ANNOOTMATE suite for annotating and analyzing genomic data."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2816,
    "user_query": "What are the \"Ohnologs\"?",
    "vicuna-13b_response": "Ohnologs are a type of cell that are found in the thymus gland. They are also known as \"thymic epithelial cells\" and play a crucial role in the development and maturation of T cells, which are a type of immune cell that play a central role in the immune system.\nOhnologs are responsible for providing the necessary signals and nutrients to T cells as they develop in the thymus. They also help to eliminate T cells that are not able to mature properly, ensuring that only functional T cells are released into the bloodstream.\nOhnologs are named after the German physician Paul Ohnen, who first described them in the 1920s. They are also sometimes referred to as \"thymic stromal cells\" or \"thymic epithelial progenitor cells.\"",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ohnologs are a type of cell that are found in the thymus gland.\n2. Ohnologs are also known as \"thymic epithelial cells\".\n3. Ohnologs play a crucial role in the development and maturation of T cells.\n4. Ohnologs are responsible for providing the necessary signals and nutrients to T cells as they develop in the thymus.\n5. Ohnologs are named after the German physician Paul Ohnen, who first described them in the 1920s.",
    "vicuna-13b_fact": [
      "Ohnologs are a type of cell that are found in the thymus gland.",
      "Ohnologs are also known as \"thymic epithelial cells\".",
      "Ohnologs play a crucial role in the development and maturation of T cells.",
      "Ohnologs are responsible for providing the necessary signals and nutrients to T cells as they develop in the thymus.",
      "Ohnologs are named after the German physician Paul Ohnen, who first described them in the 1920s."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Ohnologs are not a type of cell. They are pairs of genes originating from a whole genome duplication event.\n2. FALSE [correction]: Ohnologs are not known as \"thymic epithelial cells\". They are a type of gene.\n3. FALSE [correction]: Ohnologs do not play a role in the development and maturation of T cells. They are genes, not cells.\n4. FALSE [correction]: Ohnologs are not responsible for providing the necessary signals and nutrients to T cells. This is a function of thymic epithelial cells, not ohnologs.\n5. FALSE [correction]: Ohnologs are named after the Japanese geneticist Susumu Ohno, who first proposed the concept.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2818,
    "user_query": "Describe OligoSTORM",
    "vicuna-13b_response": "OligoSTORM is a high-throughput single-cell analysis platform that enables the study of gene expression in individual cells. It is based on the use of oligonucleotide barcodes, which are unique molecular identifiers that can be used to track the expression of individual genes in a single cell.\nThe OligoSTORM platform consists of two main components: the OligoSTORM primer pair and the OligoSTORM probe. The OligoSTORM primer pair is used to amplify a specific gene of interest in a single cell, while the OligoSTORM probe is used to detect the presence of the amplified gene in the same cell.\nThe OligoSTORM platform allows for the analysis of gene expression in individual cells with high sensitivity and specificity. This is achieved by using a combination of PCR and next-generation sequencing technologies to detect and quantify the expression of individual genes in each cell.\nOligoSTORM can be used in a variety of applications, including the study of cellular heterogeneity, the analysis of gene expression in rare cell populations, and the detection of gene expression changes in individual cells over time.\nOverall, OligoSTORM is a powerful tool for the study of single-cell gene expression and has the potential to provide valuable insights into the complex biology of individual cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. OligoSTORM is a high-throughput single-cell analysis platform that enables the study of gene expression in individual cells.\n2. It is based on the use of oligonucleotide barcodes.\n3. The OligoSTORM platform consists of the OligoSTORM primer pair and the OligoSTORM probe.\n4. OligoSTORM achieves the analysis of gene expression in individual cells with high sensitivity and specificity by using a combination of PCR and next-generation sequencing technologies.\n5. OligoSTORM can be used in the study of cellular heterogeneity, the analysis of gene expression in rare cell populations, and the detection of gene expression changes in individual cells over time.",
    "vicuna-13b_fact": [
      "OligoSTORM is a high-throughput single-cell analysis platform that enables the study of gene expression in individual cells.",
      "It is based on the use of oligonucleotide barcodes.",
      "The OligoSTORM platform consists of the OligoSTORM primer pair and the OligoSTORM probe.",
      "OligoSTORM achieves the analysis of gene expression in individual cells with high sensitivity and specificity by using a combination of PCR and next-generation sequencing technologies.",
      "OligoSTORM can be used in the study of cellular heterogeneity, the analysis of gene expression in rare cell populations, and the detection of gene expression changes in individual cells over time."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2825,
    "user_query": "What forms part of the senescence associated secretory phenotype, or SASP?",
    "vicuna-13b_response": "The senescence associated secretory phenotype (SASP) is a set of secretory molecules that are produced by senescent cells. Senescence is a state of cellular dysfunction that occurs when cells are no longer able to divide and replicate. SASP is a response to cellular senescence that involves the production and secretion of a variety of molecules, including cytokines, growth factors, and enzymes. These molecules can have a range of effects on surrounding cells and tissues, including inflammation, tissue damage, and the promotion of fibrosis. Some of the key components of the SASP include interleukin-1 (IL-1), IL-6, tumor necrosis factor (TNF), and the protease-activated receptor 1 (PAR-1).",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The senescence associated secretory phenotype (SASP) is a set of secretory molecules that are produced by senescent cells.\n2. Senescence is a state of cellular dysfunction that happens when cells are no longer able to divide and replicate.\n3. SASP involves the production and secretion of a variety of molecules, including cytokines, growth factors, and enzymes.\n4. Molecules produced by SASP can have effects on surrounding cells and tissues, including causing inflammation, tissue damage, and the promotion of fibrosis.\n5. Key components of the SASP include interleukin-1 (IL-1), IL-6, tumor necrosis factor (TNF), and the protease-activated receptor 1 (PAR-1).",
    "vicuna-13b_fact": [
      "The senescence associated secretory phenotype (SASP) is a set of secretory molecules that are produced by senescent cells.",
      "Senescence is a state of cellular dysfunction that happens when cells are no longer able to divide and replicate.",
      "SASP involves the production and secretion of a variety of molecules, including cytokines, growth factors, and enzymes.",
      "Molecules produced by SASP can have effects on surrounding cells and tissues, including causing inflammation, tissue damage, and the promotion of fibrosis.",
      "Key components of the SASP include interleukin-1 (IL-1), IL-6, tumor necrosis factor (TNF), and the protease-activated receptor 1 (PAR-1)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Senescence is a state of cellular arrest where cells are no longer able to divide and replicate, not necessarily a state of cellular dysfunction.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2826,
    "user_query": "How many pseudogenes are contained in the C. elegans genome?",
    "vicuna-13b_response": "A pseudogene is a region of DNA that resembles a gene but does not encode a functional product. The exact number of pseudogenes in the C. elegans genome is not well established, as new ones are continually being discovered and others are being deemed non-functional. However, it is estimated that there are several thousand pseudogenes in the C. elegans genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A pseudogene is a region of DNA that resembles a gene but does not encode a functional product.\n2. The exact number of pseudogenes in the C. elegans genome is not well established.\n3. New pseudogenes are continually being discovered in the C. elegans genome.\n4. Pseudogenes are occasionally deemed non-functional in the C. elegans genome.\n5. It is estimated that there are several thousand pseudogenes in the C. elegans genome.",
    "vicuna-13b_fact": [
      "A pseudogene is a region of DNA that resembles a gene but does not encode a functional product.",
      "The exact number of pseudogenes in the C. elegans genome is not well established.",
      "New pseudogenes are continually being discovered in the C. elegans genome.",
      "Pseudogenes are occasionally deemed non-functional in the C. elegans genome.",
      "It is estimated that there are several thousand pseudogenes in the C. elegans genome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2827,
    "user_query": "What is a Aquaporin channel?",
    "vicuna-13b_response": "Aquaporin channels are a type of protein found in the membranes of cells that facilitate the transport of water and other small solutes across the cell membrane. They are important for maintaining the proper hydration and osmotic balance of cells, and play a critical role in a variety of physiological processes, including the regulation of blood pressure and the transport of nutrients and waste products across cell membranes. Aquaporin channels are also of interest in the field of biotechnology, as they can be used to improve the efficiency of water transport in crops and other plants, and as a potential target for the development of new drugs and therapies for a variety of diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Aquaporin channels are a type of protein found in the membranes of cells.\n2. Aquaporin channels facilitate the transport of water and other small solutes across the cell membrane.\n3. These channels are important for maintaining the proper hydration and osmotic balance of cells.\n4. Aquaporin channels play a role in the regulation of blood pressure and the transport of nutrients and waste products across cell membranes.\n5. They are also of interest in biotechnology, for improving the efficiency of water transport in crops and other plants and as a potential target for the development of new drugs and therapies.",
    "vicuna-13b_fact": [
      "Aquaporin channels are a type of protein found in the membranes of cells.",
      "Aquaporin channels facilitate the transport of water and other small solutes across the cell membrane.",
      "These channels are important for maintaining the proper hydration and osmotic balance of cells.",
      "Aquaporin channels play a role in the regulation of blood pressure and the transport of nutrients and waste products across cell membranes.",
      "They are also of interest in biotechnology, for improving the efficiency of water transport in crops and other plants and as a potential target for the development of new drugs and therapies."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2832,
    "user_query": "Is durvalumab used for lung cancer treatment?",
    "vicuna-13b_response": "Yes, durvalumab is a monoclonal antibody drug that is used for the treatment of certain types of lung cancer. It is specifically approved for the treatment of non-small cell lung cancer (NSCLC) in patients who have had no prior treatment or have had limited treatment. Durvalumab works by targeting a protein called programmed cell death protein 1 (PD-1), which is involved in the immune system's response to cancer. By blocking the PD-1 protein, durvalumab can help to enhance the immune system's ability to recognize and attack cancer cells. Durvalumab is typically given intravenously and is usually administered in a healthcare setting by a trained medical professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Durvalumab is used for the treatment of certain types of lung cancer.\n2. Durvalumab is specifically approved for the treatment of non-small cell lung cancer (NSCLC) for patients who have had no or limited prior treatment.\n3. Durvalumab targets a protein called programmed cell death protein 1 (PD-1).\n4. By blocking the PD-1 protein, durvalumab can enhance the immune system's ability to recognize and attack cancer cells.\n5. Durvalumab is typically given intravenously by a trained medical professional.",
    "vicuna-13b_fact": [
      "Durvalumab is used for the treatment of certain types of lung cancer.",
      "Durvalumab is specifically approved for the treatment of non-small cell lung cancer (NSCLC) for patients who have had no or limited prior treatment.",
      "Durvalumab targets a protein called programmed cell death protein 1 (PD-1).",
      "By blocking the PD-1 protein, durvalumab can enhance the immune system's ability to recognize and attack cancer cells.",
      "Durvalumab is typically given intravenously by a trained medical professional."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Durvalumab targets a protein called programmed death-ligand 1 (PD-L1), not programmed cell death protein 1 (PD-1).\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2836,
    "user_query": "Describe information obtained by immunophenotyping.",
    "vicuna-13b_response": "Immunophenotyping is a technique used to analyze the characteristics of cells in a sample, particularly the cells of the immune system. This technique involves the use of antibodies that bind to specific proteins or markers on the surface of cells, followed by the detection and quantification of these cells using flow cytometry or other techniques.\nImmunophenotyping can provide a wealth of information about the cells in a sample, including their type, maturity, activation status, and proliferative activity. For example, immunophenotyping can be used to identify different types of T cells, B cells, and natural killer cells, as well as to distinguish between different subtypes of these cells based on the expression of specific surface markers.\nIn addition to providing information about the cells in a sample, immunophenotyping can also be used to assess the functional activity of these cells. For example, immunophenotyping can be used to measure the expression of activation markers on T cells, which can provide information about the cellular activation status of these cells.\nOverall, immunophenotyping is a powerful tool that can provide valuable information about the cells of the immune system, and can be used in a variety of research and clinical settings to study immune function and disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Immunophenotyping is a technique used to analyze the characteristics of cells in a sample.\n2. This technique involves the use of antibodies that bind to specific proteins or markers on the surface of cells.\n3. The cells are then detected and quantified using techniques like flow cytometry.\n4. Immunophenotyping can provide information about a cell's type, maturity, activation status, and proliferative activity.\n5. Immunophenotyping can be used to measure the expression of activation markers on T cells.",
    "vicuna-13b_fact": [
      "Immunophenotyping is a technique used to analyze the characteristics of cells in a sample.",
      "This technique involves the use of antibodies that bind to specific proteins or markers on the surface of cells.",
      "The cells are then detected and quantified using techniques like flow cytometry.",
      "Immunophenotyping can provide information about a cell's type, maturity, activation status, and proliferative activity.",
      "Immunophenotyping can be used to measure the expression of activation markers on T cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2837,
    "user_query": "What is the mechanism of action of Emicizumab?",
    "vicuna-13b_response": "Emicizumab is an intravenous medication that is used to treat hemophilia A, a genetic disorder that affects blood clotting. The mechanism of action of emicizumab is that it is a bispecific monoclonal antibody that binds to both factor VIII and factor IX, two proteins that are important for blood clotting. By binding to these proteins, emicizumab helps to increase the levels of factor VIII and factor IX in the blood, which in turn helps to improve blood clotting. This can help to reduce the frequency and severity of bleeding episodes in people with hemophilia A. Emicizumab is given as an intravenous infusion, and the dosing and frequency of administration will depend on the individual patient's needs and response to treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. Emicizumab is an intravenous medication used to treat hemophilia A.\n2. Hemophilia A is a genetic disorder that affects blood clotting.\n3. Emicizumab is a bispecific monoclonal antibody that binds to both factor VIII and factor IX.\n4. The drug helps to increase the levels of factor VIII and factor IX in the blood.\n5. Emicizumab is given as an intravenous infusion.",
    "vicuna-13b_fact": [
      "Emicizumab is an intravenous medication used to treat hemophilia A.",
      "Hemophilia A is a genetic disorder that affects blood clotting.",
      "Emicizumab is a bispecific monoclonal antibody that binds to both factor VIII and factor IX.",
      "The drug helps to increase the levels of factor VIII and factor IX in the blood.",
      "Emicizumab is given as an intravenous infusion."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Emicizumab is a subcutaneous, not intravenous, medication used to treat hemophilia A.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Emicizumab bridges factor IXa and factor X, mimicking the effect of the missing factor VIII in patients with hemophilia A. It does not increase levels of factor VIII and IX in the blood.\n5. FALSE [correction]: Emicizumab is given as a subcutaneous injection, not an intravenous infusion.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2841,
    "user_query": "What is the function of GFRAL?",
    "vicuna-13b_response": "GFRAL stands for Glomerular Filtration Rate-Associated Ligand. It is a protein that plays a role in regulating the kidney's glomerular filtration rate (GFR), which is a measure of the kidney's function. GFRAL is produced by cells in the glomeruli, which are the structures in the kidney that filter blood. It binds to a receptor called the GFR-associated protein (GFRAP), which is found on the surface of cells in the glomeruli. This binding activates a signaling pathway that regulates the production of a protein called podocan, which is important for maintaining the structure of the glomeruli and the filtration function of the kidney.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GFRAL stands for Glomerular Filtration Rate-Associated Ligand.\n2. GFRAL is a protein that is involved in regulating the kidney's glomerular filtration rate (GFR).\n3. GFRAL is produced by cells in the glomeruli of the kidney.\n4. GFRAL binds to the GFR-associated protein (GFRAP) found on the surface of cells in the glomeruli.\n5. This binding process activates a pathway that regulates the production of podocan, which maintains the structure of the glomeruli and the filtration function of the kidney.",
    "vicuna-13b_fact": [
      "GFRAL stands for Glomerular Filtration Rate-Associated Ligand.",
      "GFRAL is a protein that is involved in regulating the kidney's glomerular filtration rate (GFR).",
      "GFRAL is produced by cells in the glomeruli of the kidney.",
      "GFRAL binds to the GFR-associated protein (GFRAP) found on the surface of cells in the glomeruli.",
      "This binding process activates a pathway that regulates the production of podocan, which maintains the structure of the glomeruli and the filtration function of the kidney."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: GFRAL is a protein involved in regulation of body's energy balance and not the kidney's glomerular filtration rate (GFR).\n3. TRUE\n4. FALSE [correction]: GFRAL binds to the growth differentiation factor 15 (GDF15) and not the GFR-associated protein (GFRAP).\n5. FALSE [correction]: This binding process activates a pathway that regulates body's energy expenditure and food intake, not the production of podocan.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "vicuna-13b_response": "ZCCHC17 is a protein that plays a critical role in regulating the activity of other proteins in the body. Specifically, it is a chaperone protein, which helps to fold and assemble other proteins into their proper, functional forms.\nChaperone proteins are important because they help to ensure that proteins are properly folded and assembled, which is critical for their function. If proteins are not properly folded and assembled, they can become misfolded and aggregate, leading to harmful effects on the body.\nZCCHC17 is a member of the heat shock protein (HSP) family, which are proteins that are expressed in response to stress or other adverse conditions in the body. HSPs help to protect cells from damage and promote the proper folding and assembly of proteins.\nOverall, the role of ZCCHC17 is to help regulate the activity of other proteins in the body, ensuring that they are properly folded and assembled into their functional forms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ZCCHC17 is a protein that regulates the activity of other proteins in the body.\n2. ZCCHC17 is a chaperone protein.\n3. Chaperone proteins help to fold and assemble other proteins into their proper, functional forms.\n4. ZCCHC17 belongs to the heat shock protein (HSP) family.\n5. Heat shock proteins are expressed in response to stress or other adverse conditions in the body.",
    "vicuna-13b_fact": [
      "ZCCHC17 is a protein that regulates the activity of other proteins in the body.",
      "ZCCHC17 is a chaperone protein.",
      "Chaperone proteins help to fold and assemble other proteins into their proper, functional forms.",
      "ZCCHC17 belongs to the heat shock protein (HSP) family.",
      "Heat shock proteins are expressed in response to stress or other adverse conditions in the body."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2844,
    "user_query": "Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?",
    "vicuna-13b_response": "Epidural anesthesia is a type of pain management technique that is commonly used during labor to relieve pain and anxiety. It involves the injection of a local anesthetic into the epidural space of the spine, which numbs the lower half of the body.\nThere is some evidence to suggest that the use of epidural anesthesia during labor may have an effect on the Apgar score of the infant. The Apgar score is a measure of the infant's health and well-being at birth, and it is based on several factors, including heart rate, breathing, muscle tone, and color.\nSome studies have suggested that the use of epidural anesthesia during labor may be associated with a slightly lower Apgar score in the newborn. However, it is important to note that the overall impact of epidural anesthesia on the Apgar score is small, and the vast majority of newborns who receive epidural anesthesia during labor have normal Apgar scores.\nIt is also important to note that the decision to use epidural anesthesia during labor is a personal one that should be made in consultation with a healthcare provider. While there may be some potential risks associated with the use of epidural anesthesia, it can also provide significant pain relief and other benefits for the mother during labor and delivery. Ultimately, the decision to use epidural anesthesia should be based on the individual needs and preferences of the mother and her healthcare provider.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Epidural anesthesia is a type of pain management technique used during labor.\n2. Epidural anesthesia involves the injection of a local anesthetic into the epidural space of the spine, which numbs the lower half of the body.\n3. The Apgar score is a measure of the infant's health and well-being at birth, based on several factors, including heart rate, breathing, muscle tone, and color.\n4. Some studies suggest that the use of epidural anesthesia during labor may be associated with a slightly lower Apgar score in the newborn.\n5. The decision to use epidural anesthesia during labor should be made in consultation with a healthcare provider.",
    "vicuna-13b_fact": [
      "Epidural anesthesia is a type of pain management technique used during labor.",
      "Epidural anesthesia involves the injection of a local anesthetic into the epidural space of the spine, which numbs the lower half of the body.",
      "The Apgar score is a measure of the infant's health and well-being at birth, based on several factors, including heart rate, breathing, muscle tone, and color.",
      "Some studies suggest that the use of epidural anesthesia during labor may be associated with a slightly lower Apgar score in the newborn.",
      "The decision to use epidural anesthesia during labor should be made in consultation with a healthcare provider."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2846,
    "user_query": "Is phospholipid hydroperoxide glutathione peroxidase a selenoprotein?",
    "vicuna-13b_response": "Phospholipid hydroperoxide glutathione peroxidase (PHGPx) is a type of enzyme that plays a role in protecting cells against oxidative stress. It is a selenoprotein, which means that it contains the trace element selenium in its amino acid sequence. Selenoproteins are a group of enzymes that are involved in various biological processes, including the regulation of oxidative stress and the detoxification of harmful compounds.\nPHGPx is a selenoprotein that is involved in the detoxification of lipid peroxides, which are byproducts of oxidative stress. It is thought to play a role in protecting cells against oxidative damage and may be involved in the prevention of various diseases, including cancer and cardiovascular disease.\nOverall, PHGPx is a selenoprotein that plays an important role in protecting cells against oxidative stress and may be involved in the prevention of various diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Phospholipid hydroperoxide glutathione peroxidase (PHGPx) is a selenoprotein.\n2. PHGPx contains the trace element selenium in its amino acid sequence.\n3. Selenoproteins are a group of enzymes involved in various biological processes.\n4. PHGPx is involved in the detoxification of lipid peroxides, which are byproducts of oxidative stress.\n5. PHGPx is believed to play a role in protecting cells against oxidative damage.",
    "vicuna-13b_fact": [
      "Phospholipid hydroperoxide glutathione peroxidase (PHGPx) is a selenoprotein.",
      "PHGPx contains the trace element selenium in its amino acid sequence.",
      "Selenoproteins are a group of enzymes involved in various biological processes.",
      "PHGPx is involved in the detoxification of lipid peroxides, which are byproducts of oxidative stress.",
      "PHGPx is believed to play a role in protecting cells against oxidative damage."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2851,
    "user_query": "Is TIAM1 favoring tumor progression in colorectal cancer (CRC)?",
    "vicuna-13b_response": "TIAM1 (Transcriptional Intermediary Activating Factor 1) is a transcription factor that has been shown to play a role in the progression of certain types of cancer, including colorectal cancer (CRC). Research has suggested that TIAM1 may promote the growth and survival of CRC cells, and that it may also inhibit the differentiation of these cells.\nSome studies have found that high levels of TIAM1 are associated with poor prognosis in patients with CRC, while others have found that TIAM1 may be a potential therapeutic target for the treatment of CRC. However, more research is needed to fully understand the role of TIAM1 in the progression of CRC and to determine whether targeting TIAM1 could be an effective treatment strategy.\nOverall, while TIAM1 may play a role in the progression of CRC, it is important to note that the relationship between TIAM1 and CRC is complex and multifaceted, and further research is needed to fully understand its role in this disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TIAM1 is a transcription factor that plays a role in the progression of certain types of cancer, including colorectal cancer (CRC).\n2. Research suggests that TIAM1 may promote the growth and survival of CRC cells.\n3. Some studies have found that high levels of TIAM1 are associated with poor prognosis in patients with CRC.\n4. Some studies consider TIAM1 as a potential therapeutic target for the treatment of CRC.\n5. The relationship between TIAM1 and CRC is complex and multifaceted.",
    "vicuna-13b_fact": [
      "TIAM1 is a transcription factor that plays a role in the progression of certain types of cancer, including colorectal cancer (CRC).",
      "Research suggests that TIAM1 may promote the growth and survival of CRC cells.",
      "Some studies have found that high levels of TIAM1 are associated with poor prognosis in patients with CRC.",
      "Some studies consider TIAM1 as a potential therapeutic target for the treatment of CRC.",
      "The relationship between TIAM1 and CRC is complex and multifaceted."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: TIAM1 is not a transcription factor, but rather a guanine nucleotide exchange factor (GEF) that plays a role in the progression of certain types of cancer, including colorectal cancer (CRC).\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2854,
    "user_query": "Is pacritinib effective for treatment of myelofibrosis?",
    "vicuna-13b_response": "Pacritinib is a medication that is approved for the treatment of myelofibrosis, a type of myeloproliferative neoplasm (MPN). It is a small molecule inhibitor of the kinase enzyme JAK2, which is involved in the signaling pathways that regulate the proliferation and differentiation of hematopoietic cells.\nClinical trials have shown that pacritinib can significantly reduce symptoms and improve overall survival in patients with myelofibrosis. In a phase 3 clinical trial, pacritinib was shown to reduce spleen size and improve anemia, fatigue, and constitutional symptoms in patients with myelofibrosis. Additionally, pacritinib has been shown to be effective in reducing the risk of disease progression and improving overall survival in patients with advanced myelofibrosis.\nIt is important to note that pacritinib is not without side effects, and it can cause serious adverse events such as thrombocytopenia, anemia, and diarrhea. Therefore, the use of pacritinib should be carefully considered on an individual basis, taking into account the patient's medical history and current health status.\nIn conclusion, pacritinib is an effective treatment option for patients with myelofibrosis, and it can significantly reduce symptoms and improve overall survival. However, the use of pacritinib should be carefully considered on an individual basis, taking into account the patient's medical history and current health status.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pacritinib is a medication approved for the treatment of myelofibrosis, a type of myeloproliferative neoplasm (MPN).\n2. Pacritinib is a small molecule inhibitor of the kinase enzyme JAK2.\n3. Clinical trials have shown that pacritinib can significantly reduce symptoms and improve overall survival in patients with myelofibrosis.\n4. In a phase 3 clinical trial, pacritinib was shown to reduce spleen size and improve anemia, fatigue, and constitutional symptoms in patients with myelofibrosis.\n5. Pacritinib can cause serious adverse events such as thrombocytopenia, anemia, and diarrhea.",
    "vicuna-13b_fact": [
      "Pacritinib is a medication approved for the treatment of myelofibrosis, a type of myeloproliferative neoplasm (MPN).",
      "Pacritinib is a small molecule inhibitor of the kinase enzyme JAK2.",
      "Clinical trials have shown that pacritinib can significantly reduce symptoms and improve overall survival in patients with myelofibrosis.",
      "In a phase 3 clinical trial, pacritinib was shown to reduce spleen size and improve anemia, fatigue, and constitutional symptoms in patients with myelofibrosis.",
      "Pacritinib can cause serious adverse events such as thrombocytopenia, anemia, and diarrhea."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Pacritinib is an experimental medication and is not currently approved for the treatment of myelofibrosis, a type of myeloproliferative neoplasm (MPN).\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "vicuna-13b_response": "The nuclear pore basket in human cells is formed by a complex of proteins known as nuclear pore complex (NPC) proteins. The NPC is a large macromolecular structure that spans the nuclear envelope and forms the nuclear pore. It is composed of multiple copies of different NPC proteins, which are arranged in a specific order to form a filamentous structure that extends across the nuclear envelope.\nThere are several different types of NPC proteins that are involved in forming the nuclear pore basket in human cells. These include:\n1. Nup1-100: These are the most abundant NPC proteins and form the core of the nuclear pore basket. They are responsible for the formation of the central channel of the nuclear pore, which is the pathway for the movement of molecules between the cytoplasm and the nucleus.\n2. Nup11-16: These NPC proteins are involved in the formation of the nuclear pore basket and help to anchor the NPC to the nuclear envelope.\n3. Nup17-18: These NPC proteins are involved in the formation of the nuclear pore basket and are thought to play a role in the regulation of nuclear transport.\n4. Nup21-20: These NPC proteins are involved in the formation of the nuclear pore basket and are thought to play a role in the regulation of nuclear transport.\nOverall, the nuclear pore basket is a complex structure that is formed by multiple copies of different NPC proteins, and it plays a critical role in regulating the movement of molecules between the cytoplasm and the nucleus in human cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The nuclear pore basket in human cells is formed by a complex of proteins known as nuclear pore complex (NPC) proteins.\n2. The NPC is a large macromolecular structure that spans the nuclear envelope and forms the nuclear pore.\n3. The NPC is composed of multiple copies of different NPC proteins, which are arranged in a specific order to form a filamentous structure that extends across the nuclear envelope.\n4. The nuclear pore basket is involved in regulating the movement of molecules between the cytoplasm and the nucleus in human cells.\n5. The most abundant NPC proteins are Nup1-100, and they form the core of the nuclear pore basket and the central channel of the nuclear pore.",
    "vicuna-13b_fact": [
      "The nuclear pore basket in human cells is formed by a complex of proteins known as nuclear pore complex (NPC) proteins.",
      "The NPC is a large macromolecular structure that spans the nuclear envelope and forms the nuclear pore.",
      "The NPC is composed of multiple copies of different NPC proteins, which are arranged in a specific order to form a filamentous structure that extends across the nuclear envelope.",
      "The nuclear pore basket is involved in regulating the movement of molecules between the cytoplasm and the nucleus in human cells.",
      "The most abundant NPC proteins are Nup1-100, and they form the core of the nuclear pore basket and the central channel of the nuclear pore."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2862,
    "user_query": "Does lucatumumab bind to CD140?",
    "vicuna-13b_response": "Yes, lucatumumab is a monoclonal antibody that binds to CD140, also known as CD140 or activating transcription factor 3 (ATF3). It is a type of TNF superfamily member that is expressed on the surface of activated T cells and natural killer cells. Lucatumumab is being investigated as a potential treatment for a variety of autoimmune diseases, including rheumatoid arthritis and lupus.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Lucatumumab is a monoclonal antibody.\n2. Lucatumumab binds to CD140, also known as activating transcription factor 3 (ATF3).\n3. CD140 is a type of TNF superfamily member that is expressed on the surface of activated T cells and natural killer cells.\n4. Lucatumumab is being investigated as a potential treatment for a variety of autoimmune diseases.\n5. Some of the autoimmune diseases for which Lucatumumab is being investigated as a treatment include rheumatoid arthritis and lupus.",
    "vicuna-13b_fact": [
      "Lucatumumab is a monoclonal antibody.",
      "Lucatumumab binds to CD140, also known as activating transcription factor 3 (ATF3).",
      "CD140 is a type of TNF superfamily member that is expressed on the surface of activated T cells and natural killer cells.",
      "Lucatumumab is being investigated as a potential treatment for a variety of autoimmune diseases.",
      "Some of the autoimmune diseases for which Lucatumumab is being investigated as a treatment include rheumatoid arthritis and lupus."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Lucatumumab binds to CD40, not CD140. \n3. FALSE [correction]: CD140 is a tyrosine kinase receptor for PDGF (Platelet-Derived Growth Factor), it isn't a TNF superfamily member. CD40, the target of Lucatumumab, is a TNF superfamily member expressed on B cells, dendritic cells, and macrophages.\n4. FALSE [correction]: Lucatumumab is being investigated as a potential treatment for certain types of cancer, not autoimmune diseases.\n5. FALSE [correction]: Lucatumumab isn't being investigated as a treatment for autoimmune diseases such as rheumatoid arthritis and lupus, but is being investigated for the treatment of cancers, such as non-Hodgkin's lymphoma and multiple myeloma.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2872,
    "user_query": "Which molecule is targeted by Olaratumab?",
    "vicuna-13b_response": "Olaratumab is a monoclonal antibody that targets the protein called CD19, which is found on the surface of some types of cancer cells, including B-cell lymphomas and leukemias.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Olaratumab is a monoclonal antibody.\n2. Olaratumab targets the protein called CD19.\n3. CD19 is found on the surface of some types of cancer cells.\n4. B-cell lymphomas and leukemias are among the cancer types where CD19 is found on the cell surface.",
    "vicuna-13b_fact": [
      "Olaratumab is a monoclonal antibody.",
      "Olaratumab targets the protein called CD19.",
      "CD19 is found on the surface of some types of cancer cells.",
      "B-cell lymphomas and leukemias are among the cancer types where CD19 is found on the cell surface."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Olaratumab targets the protein called platelet-derived growth factor receptor alpha (PDGFRA), not CD19.\n3. TRUE\n4. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2874,
    "user_query": "Are phagosomal proteins ubiquitinated?",
    "vicuna-13b_response": "Phagosomes are specialized organelles that engulf and digest foreign particles, bacteria, and other debris in the cytoplasm. Phagosomal proteins play a crucial role in the process of phagocytosis, which is the process by which cells engulf and internalize foreign particles.\nUbiquitination is a post-translational modification that involves the attachment of a small protein called ubiquitin to target proteins. This modification can regulate protein function, stability, and localization.\nIn general, phagosomal proteins are not ubiquitinated. However, there are some exceptions. For example, some studies have shown that certain phagosomal proteins, such as Rab7 and LAMP-1, can be ubiquitinated in response to certain stimuli. Ubiquitination of these proteins can regulate their function and influence the dynamics of phagosome formation and maturation.\nOverall, while phagosomal proteins are not typically ubiquitinated, there is some evidence to suggest that this modification can occur under certain conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Phagosomes are specialized organelles that engulf and digest foreign particles, bacteria, and other debris in the cytoplasm.\n2. Phagosomal proteins play a role in phagocytosis, a process by which cells engulf and internalize foreign particles.\n3. Ubiquitination is a post-translational modification that involves the attachment of a protein called ubiquitin to target proteins.\n4. Some studies have shown that certain phagosomal proteins, such as Rab7 and LAMP-1, can be ubiquitinated in response to certain stimuli.\n5. While phagosomal proteins are not typically ubiquitinated, there is evidence to suggest that this modification can occur under certain conditions.",
    "vicuna-13b_fact": [
      "Phagosomes are specialized organelles that engulf and digest foreign particles, bacteria, and other debris in the cytoplasm.",
      "Phagosomal proteins play a role in phagocytosis, a process by which cells engulf and internalize foreign particles.",
      "Ubiquitination is a post-translational modification that involves the attachment of a protein called ubiquitin to target proteins.",
      "Some studies have shown that certain phagosomal proteins, such as Rab7 and LAMP-1, can be ubiquitinated in response to certain stimuli.",
      "While phagosomal proteins are not typically ubiquitinated, there is evidence to suggest that this modification can occur under certain conditions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While phagosomal proteins are not ubiquitinated, some specific proteins such as Rab7 and LAMP-1 can indeed be ubiquitinated in response to certain stimuli.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2876,
    "user_query": "Does tremelimumab improve survival of mesothelioma patients?",
    "vicuna-13b_response": "Tremelimumab is a monoclonal antibody drug that is being studied for its potential to treat mesothelioma, a rare and aggressive form of cancer that affects the lining of the lungs, chest wall, and abdominal cavity. While some early studies have shown promise, the overall evidence on the effectiveness of tremelimumab for mesothelioma treatment is still limited and inconclusive.\nOne of the main challenges with mesothelioma is that it is often diagnosed at a late stage, when treatment options are limited and the prognosis is poor. As a result, there is a significant need for more effective and innovative treatments for this disease.\nTremelimumab is a promising candidate for mesothelioma treatment because it targets a specific protein called CD137, which is involved in the immune system's response to cancer. By blocking this protein, tremelimumab may help to stimulate the immune system to attack cancer cells more effectively.\nThere have been several clinical trials of tremelimumab for mesothelioma, with mixed results. Some studies have shown that tremelimumab can help to extend survival in mesothelioma patients, while others have not. For example, a phase 2 clinical trial of tremelimumab in patients with mesothelioma found that the drug was associated with a median survival of 11.7 months, which was longer than expected based on historical controls. However, a subsequent phase 3 clinical trial of tremelimumab in mesothelioma patients did not show a statistically significant improvement in overall survival compared to standard of care treatment.\nOverall, while there is some evidence to suggest that tremelimumab may be effective in treating mesothelioma, the evidence is still limited and inconclusive. Further research is needed to fully understand the potential benefits and risks of this drug for mesothelioma treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tremelimumab is a monoclonal antibody drug that is being studied for its potential to treat mesothelioma.\n2. Mesothelioma is a rare and aggressive form of cancer that affects the lining of the lungs, chest wall, and abdominal cavity.\n3. Tremelimumab targets a specific protein called CD137, which is involved in the immune system's response to cancer.\n4. A phase 2 clinical trial of tremelimumab in patients with mesothelioma found that the drug was associated with a median survival of 11.7 months.\n5. A phase 3 clinical trial of tremelimumab in mesothelioma patients did not show a statistically significant improvement in overall survival compared to standard of care treatment.",
    "vicuna-13b_fact": [
      "Tremelimumab is a monoclonal antibody drug that is being studied for its potential to treat mesothelioma.",
      "Mesothelioma is a rare and aggressive form of cancer that affects the lining of the lungs, chest wall, and abdominal cavity.",
      "Tremelimumab targets a specific protein called CD137, which is involved in the immune system's response to cancer.",
      "A phase 2 clinical trial of tremelimumab in patients with mesothelioma found that the drug was associated with a median survival of 11.7 months.",
      "A phase 3 clinical trial of tremelimumab in mesothelioma patients did not show a statistically significant improvement in overall survival compared to standard of care treatment."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Tremelimumab targets a specific protein called CTLA-4, which is involved in the immune system's response to cancer.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2878,
    "user_query": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?",
    "vicuna-13b_response": "The TAM family of receptor tyrosine kinases (RTKs) includes three membrane proteins: TAM1, TAM2, and TAM3. These proteins are also known as Tyro3, Axl, and Mer (TAM) receptors. They are expressed on the surface of cells and play important roles in cellular signaling, cell growth and differentiation, and cell survival. The TAM family of RTKs is involved in a variety of diseases, including cancer, and is an active area of research in the field of oncology.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The TAM family of receptor tyrosine kinases (RTKs) includes three membrane proteins: TAM1, TAM2, and TAM3.\n2. The proteins in the TAM family of RTKs are also known as Tyro3, Axl, and Mer receptors.\n3. These receptors are expressed on the surface of cells.\n4. TAM family of RTKs plays crucial roles in cellular signaling, cell growth and differentiation, and cell survival.\n5. TAM family of RTKs is related to a variety of diseases, including cancer.",
    "vicuna-13b_fact": [
      "The TAM family of receptor tyrosine kinases (RTKs) includes three membrane proteins: TAM1, TAM2, and TAM3.",
      "The proteins in the TAM family of RTKs are also known as Tyro3, Axl, and Mer receptors.",
      "These receptors are expressed on the surface of cells.",
      "TAM family of RTKs plays crucial roles in cellular signaling, cell growth and differentiation, and cell survival.",
      "TAM family of RTKs is related to a variety of diseases, including cancer."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The TAM family of receptor tyrosine kinases (RTKs) includes three membrane proteins: Tyro3, Axl, and Mer.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2880,
    "user_query": "What is CPX351?",
    "vicuna-13b_response": "I'm sorry, but I don't have any information on a specific \"CPX351.\" Can you provide any additional context or details that might help me understand what you're asking about?",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 2881,
    "user_query": "Is collagen the most abundant human protein?",
    "vicuna-13b_response": "Collagen is one of the most abundant proteins in the human body, but it is not the most abundant. That honor is held by albumins, which are a family of proteins that are found in many tissues and fluids in the body. Albumins are responsible for maintaining the osmotic pressure and pH balance of the blood, and they also play a role in transporting and storing a variety of substances in the body.\nCollagen, on the other hand, is the main protein component of connective tissue, which provides support and structure to the body. It is found in the skin, bones, tendons, and ligaments, among other places. While collagen is an important protein in the body, it is not as ubiquitous as albumins.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Collagen is one of the most abundant proteins in the human body.\n2. The most abundant protein in the human body is albumin.\n3. Albumins are found in many tissues and fluids in the body.\n4. Albumins are responsible for maintaining the osmotic pressure and pH balance of the blood, as well as transporting and storing a variety of substances.\n5. Collagen is the main protein component of connective tissue, found in the skin, bones, tendons, and ligaments.",
    "vicuna-13b_fact": [
      "Collagen is one of the most abundant proteins in the human body.",
      "The most abundant protein in the human body is albumin.",
      "Albumins are found in many tissues and fluids in the body.",
      "Albumins are responsible for maintaining the osmotic pressure and pH balance of the blood, as well as transporting and storing a variety of substances.",
      "Collagen is the main protein component of connective tissue, found in the skin, bones, tendons, and ligaments."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The most abundant protein in the human body is collagen.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2886,
    "user_query": "What is the role of the Leucosporidium ice-binding protein",
    "vicuna-13b_response": "Leucosporidium is a type of fungus that can be found in soil and on plant surfaces. The Leucosporidium fungus is known for its ability to form ice crystals on its surface, which can help protect it from freezing temperatures and drying out.\nThe Leucosporidium fungus produces an ice-binding protein called LsIBP, which is responsible for binding ice crystals to the surface of the fungus. The LsIBP protein is made up of a series of repeating units, each of which contains a hydrophobic core and a hydrophilic \"tail\" that is capable of binding to ice.\nThe LsIBP protein is able to bind to ice crystals at low temperatures, which helps to protect the fungus from damage caused by freezing. The protein is also able to bind to water, which helps to keep the fungus moist and prevent it from drying out.\nIn addition to its role in protecting the fungus from freezing and drying, the LsIBP protein has also been shown to have potential applications in agriculture and food preservation. For example, the protein has been used as a natural additive in ice cream to help prevent ice crystal formation and improve texture.\nOverall, the Leucosporidium ice-binding protein plays an important role in protecting the fungus from freezing and drying, and has potential applications in agriculture and food preservation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Leucosporidium is a fungus that can be found in soil and on plant surfaces.\n2. The Leucosporidium fungus produces an ice-binding protein called LsIBP.\n3. The LsIBP protein is made up of repeating units, each of which contains a hydrophobic core and a hydrophilic \"tail\" that is capable of binding to ice.\n4. The LsIBP protein is able to bind to ice crystals at low temperatures and to water.\n5. The Leucosporidium ice-binding protein has been used as a natural additive in ice cream to prevent ice crystal formation and improve texture.",
    "vicuna-13b_fact": [
      "Leucosporidium is a fungus that can be found in soil and on plant surfaces.",
      "The Leucosporidium fungus produces an ice-binding protein called LsIBP.",
      "The LsIBP protein is made up of repeating units, each of which contains a hydrophobic core and a hydrophilic \"tail\" that is capable of binding to ice.",
      "The LsIBP protein is able to bind to ice crystals at low temperatures and to water.",
      "The Leucosporidium ice-binding protein has been used as a natural additive in ice cream to prevent ice crystal formation and improve texture."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2892,
    "user_query": "Name 3 diseases for which lucatumumab is being tested?",
    "vicuna-13b_response": "Lucatumumab is a monoclonal antibody drug that is being developed for the treatment of cancer. It is being tested for the treatment of several types of cancer, including:\n1. Multiple myeloma: Lucatumumab is being studied in clinical trials for the treatment of multiple myeloma, a type of blood cancer that affects the bone marrow and the immune system.\n2. Non-Hodgkin lymphoma: Lucatumumab is also being studied for the treatment of non-Hodgkin lymphoma, a type of blood cancer that affects the lymphatic system.\n3. Other types of cancer: In addition to multiple myeloma and non-Hodgkin lymphoma, lucatumumab is also being tested for the treatment of other types of cancer, including ovarian cancer, gastric cancer, and lung cancer.\nIt is important to note that while lucatumumab is being tested for the treatment of these diseases, it has not yet been approved by regulatory authorities for the treatment of any disease. Clinical trials are ongoing to evaluate the safety and efficacy of lucatumumab for the treatment of these and other conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Lucatumumab is a monoclonal antibody drug that is being developed for the treatment of cancer.\n2. Lucatumumab is being studied in clinical trials for the treatment of multiple myeloma.\n3. Lucatumumab is also being studied for the treatment of non-Hodgkin lymphoma. \n4. In addition to multiple myeloma and non-Hodgkin lymphoma, lucatumumab is being tested for the treatment of ovarian cancer, gastric cancer, and lung cancer. \n5. Lucatumumab has not yet been approved by regulatory authorities for the treatment of any disease.",
    "vicuna-13b_fact": [
      "Lucatumumab is a monoclonal antibody drug that is being developed for the treatment of cancer.",
      "Lucatumumab is being studied in clinical trials for the treatment of multiple myeloma.",
      "Lucatumumab is also being studied for the treatment of non-Hodgkin lymphoma.",
      "In addition to multiple myeloma and non-Hodgkin lymphoma, lucatumumab is being tested for the treatment of ovarian cancer, gastric cancer, and lung cancer.",
      "Lucatumumab has not yet been approved by regulatory authorities for the treatment of any disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2893,
    "user_query": "Which transcription factor binding site is contained in Alu repeats?",
    "vicuna-13b_response": "Alu repeats are a type of short, highly repeated sequence found in the human genome. They are composed of about 300 nucleotides and are dispersed throughout the genome, with an average distance of about 10 kb between adjacent Alu elements. Alu repeats have been shown to be important for the regulation of gene expression, and they are often found near the promoter regions of active genes.\nOne of the key features of Alu repeats is that they can act as binding sites for transcription factors. In particular, the Alu repeat sequence has been shown to be recognized by a number of different transcription factors, including the Sp1, AP-2, and NF-Y transcription factors. These transcription factors can bind to the Alu repeat sequence and regulate the expression of nearby genes.\nOverall, the presence of Alu repeats in the genome can help to regulate gene expression by providing binding sites for transcription factors, which can then modulate the expression of nearby genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Alu repeats are a type of short, highly repeated sequence found in the human genome.\n2. Alu repeats are composed of about 300 nucleotides.\n3. Alu repeats are dispersed throughout the genome, with an average distance of about 10 kb between adjacent Alu elements.\n4. Alu repeats can act as binding sites for transcription factors.\n5. The Alu repeat sequence has been shown to be recognized by the Sp1, AP-2, and NF-Y transcription factors.",
    "vicuna-13b_fact": [
      "Alu repeats are a type of short, highly repeated sequence found in the human genome.",
      "Alu repeats are composed of about 300 nucleotides.",
      "Alu repeats are dispersed throughout the genome, with an average distance of about 10 kb between adjacent Alu elements.",
      "Alu repeats can act as binding sites for transcription factors.",
      "The Alu repeat sequence has been shown to be recognized by the Sp1, AP-2, and NF-Y transcription factors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2894,
    "user_query": "What is ferroptosis?",
    "vicuna-13b_response": "Ferroptosis is a type of programmed cell death that occurs in response to oxidative stress. It is characterized by the formation of cellular ferrosoxines, which are small clusters of iron and oxygen that accumulate in the cytosol of cells. These clusters are toxic to cells and can cause damage to cellular machinery, leading to cell death. Ferroptosis is a regulated process that is involved in a variety of physiological and pathological processes, including inflammation, immune response, and cancer. It is also involved in the development of age-related diseases, such as neurodegenerative disorders. Ferroptosis can be triggered by a variety of factors, including oxidative stress, inflammation, and cellular stress. It is a complex process that is still being studied and understood, but it is thought to play a critical role in the regulation of cellular homeostasis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ferroptosis is a type of programmed cell death which occurs in response to oxidative stress.\n2. It involves the formation of cellular ferrosoxines.\n3. The clusters of iron and oxygen accumulation that characterize ferroptosis are toxic to cells and can cause damage to cellular machinery.\n4. Ferroptosis is involved in various physiological and pathological processes, including inflammation, immune response, and cancer.\n5. Ferroptosis is also associated with the development of age-related diseases such as neurodegenerative disorders.",
    "vicuna-13b_fact": [
      "Ferroptosis is a type of programmed cell death which occurs in response to oxidative stress.",
      "It involves the formation of cellular ferrosoxines.",
      "The clusters of iron and oxygen accumulation that characterize ferroptosis are toxic to cells and can cause damage to cellular machinery.",
      "Ferroptosis is involved in various physiological and pathological processes, including inflammation, immune response, and cancer.",
      "Ferroptosis is also associated with the development of age-related diseases such as neurodegenerative disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: It involves the accumulation of lethal lipid peroxides, not \"ferrosoxines\". \n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2896,
    "user_query": "Name 4 side effects of enasidenib",
    "vicuna-13b_response": "Enasidenib is a medication that is used to treat a type of blood cancer called acute myeloid leukemia (AML). It works by inhibiting a protein called mutated IDH2, which is present in some AML cells. Here are four potential side effects of enasidenib:\n1. Nausea: Enasidenib can cause nausea, which may be accompanied by vomiting, abdominal pain, or loss of appetite. Nausea is a common side effect of cancer medications and can be managed with anti-nausea medications.\n2. Fatigue: Enasidenib can cause fatigue, which is a feeling of tiredness or weakness that may not go away with rest. Fatigue is a common side effect of cancer medications and can be managed with rest, exercise, and supportive care.\n3. Diarrhea: Enasidenib can cause diarrhea, which may be accompanied by abdominal cramping, bloating, or vomiting. Diarrhea is a common side effect of cancer medications and can be managed with anti-diarrheal medications and hydration.\n4. Neutropenia: Enasidenib can cause a decrease in the number of neutrophils, which are a type of white blood cell that helps fight infections. This can put the patient at an increased risk of developing infections, which may be serious or life-threatening. Neutropenia is a common side effect of cancer medications and can be managed with supportive care, such as antibiotics and hydration.\nIt is important to note that not everyone who takes enasidenib will experience these side effects, and the severity of side effects may vary from person to person. It is important to discuss the potential side effects of enasidenib with a healthcare provider before starting treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Enasidenib is used to treat acute myeloid leukemia (AML).\n2. Enasidenib works by inhibiting a protein called mutated IDH2, present in some AML cells.\n3. Four potential side effects of enasidenib are nausea, fatigue, diarrhea, and neutropenia.\n4. Nausea caused by enasidenib may be accompanied by vomiting, abdominal pain, or loss of appetite.\n5. Enasidenib can cause a decrease in the number of neutrophils, putting the patient at an increased risk of developing infections.",
    "vicuna-13b_fact": [
      "Enasidenib is used to treat acute myeloid leukemia (AML).",
      "Enasidenib works by inhibiting a protein called mutated IDH2, present in some AML cells.",
      "Four potential side effects of enasidenib are nausea, fatigue, diarrhea, and neutropenia.",
      "Nausea caused by enasidenib may be accompanied by vomiting, abdominal pain, or loss of appetite.",
      "Enasidenib can cause a decrease in the number of neutrophils, putting the patient at an increased risk of developing infections."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2903,
    "user_query": "Should dacomitinib be used for treatment of glioblastoma patients?",
    "vicuna-13b_response": "Dacomitinib is a tyrosine kinase inhibitor that has been studied for the treatment of glioblastoma, a type of brain cancer. While it has shown some promise in clinical trials, it is not currently considered a first-line treatment for glioblastoma.\nIn a phase III clinical trial, dacomitinib was found to extend the median overall survival time of patients with glioblastoma compared to placebo, but the benefit was modest and came with significant side effects. Additionally, the overall response rate was low, with only a small percentage of patients experiencing a complete or partial response to treatment.\nGiven these results, dacomitinib is not typically recommended as a first-line treatment for glioblastoma. Instead, standard treatments such as surgery, radiation therapy, and temozolomide chemotherapy are typically used first. However, some patients may be candidates for clinical trials evaluating the use of dacomitinib or other targeted therapies for the treatment of glioblastoma.\nIt's important to note that treatment decisions for glioblastoma should be made in consultation with a healthcare provider who is knowledgeable about the latest research and treatment options.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dacomitinib is a tyrosine kinase inhibitor that has been studied for the treatment of glioblastoma.\n2. Dacomitinib extended the median overall survival time of patients with glioblastoma compared to placebo in a phase III clinical trial.\n3. The overall response rate to dacomitinib was low in the phase III trial, with only a small percentage of patients experiencing a complete or partial response.\n4. Dacomitinib is not typically recommended as a first-line treatment for glioblastoma.\n5. Standard treatments for glioblastoma include surgery, radiation therapy, and temozolomide chemotherapy.",
    "vicuna-13b_fact": [
      "Dacomitinib is a tyrosine kinase inhibitor that has been studied for the treatment of glioblastoma.",
      "Dacomitinib extended the median overall survival time of patients with glioblastoma compared to placebo in a phase III clinical trial.",
      "The overall response rate to dacomitinib was low in the phase III trial, with only a small percentage of patients experiencing a complete or partial response.",
      "Dacomitinib is not typically recommended as a first-line treatment for glioblastoma.",
      "Standard treatments for glioblastoma include surgery, radiation therapy, and temozolomide chemotherapy."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2906,
    "user_query": "What is the function of Plasminogen activator inhibitor 1?",
    "vicuna-13b_response": "Plasminogen activator inhibitor 1 (PAI-1) is a protein that plays a critical role in regulating the activity of plasminogen activators, which are enzymes that break down blood clots. PAI-1 is a potent inhibitor of plasminogen activators, and it helps to maintain the balance between clot formation and clot dissolution in the body.\nWhen a blood vessel is injured, platelets in the blood clump together to form a platelet plug, which initially helps to stop the bleeding. However, if the platelet plug becomes too large, it can cause blockages in the blood vessels, leading to heart attacks or strokes. To prevent this, the body produces plasminogen activators, which break down the platelet plug and help to maintain a healthy balance between clot formation and clot dissolution.\nPAI-1 inhibits the activity of plasminogen activators, which helps to prevent the breakdown of blood clots and maintain the balance between clot formation and clot dissolution. When the balance is maintained, the body can effectively respond to injuries and prevent the formation of dangerous blood clots.\nOverall, the function of PAI-1 is to regulate the activity of plasminogen activators and maintain the balance between clot formation and clot dissolution in the body.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Plasminogen activator inhibitor 1 (PAI-1) is a protein that regulates the activity of plasminogen activators.\n2. Plasminogen activators are enzymes that break down blood clots.\n3. PAI-1 helps to maintain a balance between clot formation and clot dissolution in the body.\n4. When a blood vessel is injured, platelets in the blood clump together to form a platelet plug.\n5. The function of PAI-1 is to regulate the activity of plasminogen activators and maintain the balance between clot formation and clot dissolution in the body.",
    "vicuna-13b_fact": [
      "Plasminogen activator inhibitor 1 (PAI-1) is a protein that regulates the activity of plasminogen activators.",
      "Plasminogen activators are enzymes that break down blood clots.",
      "PAI-1 helps to maintain a balance between clot formation and clot dissolution in the body.",
      "When a blood vessel is injured, platelets in the blood clump together to form a platelet plug.",
      "The function of PAI-1 is to regulate the activity of plasminogen activators and maintain the balance between clot formation and clot dissolution in the body."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2913,
    "user_query": "Endolymphatic hydrops is associated with Meniere’s disease. Please provide a summary of endoymphatic hydrops including the symptoms and affected body part.",
    "vicuna-13b_response": "Endolymphatic hydrops is a condition that affects the inner ear and is associated with Meniere's disease. It is characterized by the accumulation of fluid in the endolymphatic sac, which is located in the inner ear. This accumulation of fluid can cause a number of symptoms, including vertigo, tinnitus, hearing loss, and a feeling of fullness in the affected ear.\nThe affected body part is the inner ear, specifically the endolymphatic sac. The inner ear is responsible for balance and hearing, and the endolymphatic sac plays a role in the production and absorption of endolymph, a fluid that helps regulate the pressure in the inner ear.\nEndolymphatic hydrops can be diagnosed through a variety of tests, including hearing tests, balance tests, and imaging studies such as MRI or CT scans. Treatment options for endolymphatic hydrops include medications to control vertigo and tinnitus, surgery to drain the excess fluid, and lifestyle changes such as reducing salt intake and avoiding alcohol and tobacco.\nIt is important to note that endolymphatic hydrops is a serious condition that can lead to significant disability and loss of hearing if left untreated. If you are experiencing symptoms of endolymphatic hydrops, it is important to seek medical attention from an ear, nose, and throat specialist.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Endolymphatic hydrops is a condition that affects the inner ear.\n2. Endolymphatic hydrops is characterized by the accumulation of fluid in the endolymphatic sac, causing symptoms including vertigo, tinnitus, hearing loss, and a feeling of fullness in the ear.\n3. The body part affected by endolymphatic hydrops is the inner ear, particularly the endolymphatic sac.\n4. Endolymphatic hydrops can be diagnosed through hearing tests, balance tests, and imaging studies like MRI or CT scans.\n5. Treatment options for Endolymphatic hydrops include medications, surgery, and lifestyle changes such as reducing salt intake and avoiding alcohol and tobacco.",
    "vicuna-13b_fact": [
      "Endolymphatic hydrops is a condition that affects the inner ear.",
      "Endolymphatic hydrops is characterized by the accumulation of fluid in the endolymphatic sac, causing symptoms including vertigo, tinnitus, hearing loss, and a feeling of fullness in the ear.",
      "The body part affected by endolymphatic hydrops is the inner ear, particularly the endolymphatic sac.",
      "Endolymphatic hydrops can be diagnosed through hearing tests, balance tests, and imaging studies like MRI or CT scans.",
      "Treatment options for Endolymphatic hydrops include medications, surgery, and lifestyle changes such as reducing salt intake and avoiding alcohol and tobacco."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2916,
    "user_query": "Is there any role for HUWE1 in MYC signalling?",
    "vicuna-13b_response": "HUWE1 (also known as HUWE1-like protein 1) is a protein that has been shown to play a role in regulating cell growth and division. It is a member of the HUWE1 family of proteins, which are characterized by the presence of an N-terminal HUWE1-like domain and a C-terminal MYC-interacting domain.\nThere is some evidence to suggest that HUWE1 may play a role in MYC signalling, which is a pathway that regulates cell growth and division. MYC is a transcription factor that is involved in the regulation of many genes that are important for cell growth and proliferation. It has been shown to interact with HUWE1 and that this interaction is necessary for MYC-mediated transcriptional activation.\nAdditionally, HUWE1 has been shown to be involved in the regulation of the MYC protein levels by promoting its degradation. HUWE1 interacts with the anaphase-promoting complex/cyclosome (APC/C) and Cdc28, a key regulator of the cell cycle, to target MYC for degradation.\nOverall, while the exact role of HUWE1 in MYC signalling is not yet fully understood, there is evidence to suggest that it plays a role in regulating MYC-mediated transcriptional activation and in promoting MYC degradation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. HUWE1 is a protein that is part of the HUWE1 family of proteins.\n2. HUWE1 has an N-terminal HUWE1-like domain and a C-terminal MYC-interacting domain.\n3. MYC is a transcription factor involved in regulating genes related to cell growth and proliferation.\n4. HUWE1 has been shown to interact with MYC and this interaction is necessary for MYC-mediated transcriptional activation.\n5. HUWE1 has been involved in regulating MYC protein levels promoting its degradation.",
    "vicuna-13b_fact": [
      "HUWE1 is a protein that is part of the HUWE1 family of proteins.",
      "HUWE1 has an N-terminal HUWE1-like domain and a C-terminal MYC-interacting domain.",
      "MYC is a transcription factor involved in regulating genes related to cell growth and proliferation.",
      "HUWE1 has been shown to interact with MYC and this interaction is necessary for MYC-mediated transcriptional activation.",
      "HUWE1 has been involved in regulating MYC protein levels promoting its degradation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "vicuna-13b_response": "Gepotidacin is a type of topoisomerase inhibitor known as a pyrazole-containing topoisomerase inhibitor. Topoisomerase inhibitors are a class of antibiotics that target the enzymes responsible for regulating the topology of DNA, which is the way that the DNA molecule is organized and folded within a cell. Topoisomerase inhibitors are commonly used to treat bacterial infections, particularly those caused by Gram-positive bacteria. Gepotidacin is a newer antibiotic that has been shown to be effective against a wide range of bacterial pathogens, including those that are resistant to other types of antibiotics. It is currently in clinical trials for the treatment of various bacterial infections.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Gepotidacin is a pyrazole-containing topoisomerase inhibitor.\n2. Topoisomerase inhibitors are a class of antibiotics.\n3. Topoisomerase inhibitors aim at enzymes responsible for regulating the topology of DNA.\n4. Gepotidacin is effective against a wide range of bacterial pathogens, including drug-resistant ones.\n5. Gepotidacin is currently in clinical trials for the treatment of various bacterial infections.",
    "vicuna-13b_fact": [
      "Gepotidacin is a pyrazole-containing topoisomerase inhibitor.",
      "Topoisomerase inhibitors are a class of antibiotics.",
      "Topoisomerase inhibitors aim at enzymes responsible for regulating the topology of DNA.",
      "Gepotidacin is effective against a wide range of bacterial pathogens, including drug-resistant ones.",
      "Gepotidacin is currently in clinical trials for the treatment of various bacterial infections."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2941,
    "user_query": "Which disease is PGT121 used for?",
    "vicuna-13b_response": "PGT121 is a monoclonal antibody that is used to treat a disease called pemphigus vulgaris. Pemphigus vulgaris is a rare autoimmune disorder that causes blistering of the skin and mucous membranes. It occurs when the immune system mistakenly attacks the desmoglein-1 and -3 proteins, which are important for cell-to-cell adhesion in the skin. PGT121 works by targeting the pathogenic antibodies that are responsible for the attack on desmoglein-1 and -3 proteins, and helps to reduce the symptoms of pemphigus vulgaris.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PGT121 is a monoclonal antibody.\n2. PGT121 is used to treat pemphigus vulgaris.\n3. Pemphigus vulgaris is a rare autoimmune disorder that causes blistering of the skin and mucous membranes.\n4. In pemphigus vulgaris, the immune system mistakenly attacks desmoglein-1 and -3 proteins.\n5. PGT121 works by targeting the pathogenic antibodies that are responsible for the attack on desmoglein-1 and -3 proteins.",
    "vicuna-13b_fact": [
      "PGT121 is a monoclonal antibody.",
      "PGT121 is used to treat pemphigus vulgaris.",
      "Pemphigus vulgaris is a rare autoimmune disorder that causes blistering of the skin and mucous membranes.",
      "In pemphigus vulgaris, the immune system mistakenly attacks desmoglein-1 and -3 proteins.",
      "PGT121 works by targeting the pathogenic antibodies that are responsible for the attack on desmoglein-1 and -3 proteins."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: PGT121 is used for HIV treatment, not for pemphigus vulgaris.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: PGT121 works by binding to HIV and preventing it from entering cells, not by targeting the antibodies that attack desmoglein-1 and -3 proteins.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "vicuna-13b_response": "Canvas SPW (Single Page Web) is a web application that allows users to create and edit web pages using a simple, intuitive interface. It is designed to be easy to use for both beginners and experienced web developers.\nCanvas SPW allows users to create and edit web pages using a variety of tools, including a visual editor, a code editor, and a range of design and layout tools. Users can choose to work in the visual editor, which provides a WYSIWYG (What You See Is What You Get) interface for creating and editing web pages, or they can use the code editor to work directly with HTML, CSS, and JavaScript code.\nOne of the key features of Canvas SPW is its support for responsive design, which allows users to create web pages that are optimized for viewing on a range of devices, including smartphones, tablets, and desktop computers. Canvas SPW also includes a range of templates and themes that users can use to quickly create professional-looking web pages.\nIn addition to its core web page creation and editing tools, Canvas SPW also includes a range of other features, such as a file manager for uploading and organizing files, a project manager for managing multiple web pages and sites, and a range of integrations with other tools and services.\nOverall, Canvas SPW is a powerful and versatile web application that provides users with a wide range of tools and features for creating and editing web pages. Its intuitive interface and support for responsive design make it an excellent choice for both beginners and experienced web developers.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Canvas SPW (Single Page Web) is a web application that allows users to create and edit web pages.\n2. The application includes tools like a visual editor, a code editor, and design and layout tools.\n3. Canvas SPW has a feature that supports responsive design, optimizing web pages for different devices including smartphones, tablets, and desktop computers.\n4. Canvas SPW includes a file manager for uploading and organizing files and a project manager for managing multiple web pages and sites.\n5. It allows direct work with HTML, CSS, and JavaScript code using the code editor.",
    "vicuna-13b_fact": [
      "Canvas SPW (Single Page Web) is a web application that allows users to create and edit web pages.",
      "The application includes tools like a visual editor, a code editor, and design and layout tools.",
      "Canvas SPW has a feature that supports responsive design, optimizing web pages for different devices including smartphones, tablets, and desktop computers.",
      "Canvas SPW includes a file manager for uploading and organizing files and a project manager for managing multiple web pages and sites.",
      "It allows direct work with HTML, CSS, and JavaScript code using the code editor."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2950,
    "user_query": "Which algorithm has been developed for finding conserved non-coding elements (CNEs) in genomes?",
    "vicuna-13b_response": "There are several algorithms that have been developed for finding conserved non-coding elements (CNEs) in genomes. Some of the commonly used algorithms are:\n1. PhyloBayes: PhyloBayes is a Bayesian method that uses a combination of phylogenetic and statistical methods to identify conserved non-coding elements. It models the evolution of the genomic region and the conservation of the non-coding elements in different species.\n2. CpG-DNN: CpG-DNN is a deep learning-based algorithm that uses a convolutional neural network to identify conserved non-coding elements. It models the DNA methylation patterns in different species to identify the conserved non-coding elements.\n3. Hidden Markov Model (HMM): HMM is a statistical model that can be used to identify conserved non-coding elements. It models the evolution of the genomic region and the conservation of the non-coding elements in different species.\n4. MEME: MEME is a computational method that uses a combination of statistical and bioinformatic techniques to identify conserved non-coding elements. It models the conservation of the non-coding elements in different species and identifies the common motifs.\n5. Genomicus: Genomicus is a computational method that uses a combination of statistical and bioinformatic techniques to identify conserved non-coding elements. It models the conservation of the non-coding elements in different species and identifies the common motifs.\nThese algorithms have been used to identify CNEs in various genomes, including human, mouse, and fruit fly. They have been successful in identifying functional non-coding elements, such as enhancers, promoters, and insulators, and have helped in understanding the regulatory mechanisms of gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PhyloBayes is an algorithm used to identify conserved non-coding elements (CNEs) in genomes. It uses both phylogenetic and statistical methods and is used to model the evolution of genomic regions and the conservation of non-coding elements in different species. \n2. CpG-DNN is a deep learning-based algorithm used to identify conserved non-coding elements (CNEs) in genomes. It models the DNA methylation patterns in different species.\n3. The Hidden Markov Model (HMM) is a statistical model used to identify conserved non-coding elements (CNEs) in genomes. It models the evolution of the genomic region and conservation of the non-coding elements in different species.\n4. MEME is a computational method that uses a combination of statistical and bioinformatic techniques to identify conserved non-coding elements. It identifies common motifs in different species.\n5. Genomicus is a computational method that uses a combination of statistical and bioinformatic techniques to identify conserved non-coding elements. It identifies common motifs in different species.",
    "vicuna-13b_fact": [
      "PhyloBayes is an algorithm used to identify conserved non-coding elements (CNEs) in genomes. It uses both phylogenetic and statistical methods and is used to model the evolution of genomic regions and the conservation of non-coding elements in different species.",
      "CpG-DNN is a deep learning-based algorithm used to identify conserved non-coding elements (CNEs) in genomes. It models the DNA methylation patterns in different species.",
      "The Hidden Markov Model (HMM) is a statistical model used to identify conserved non-coding elements (CNEs) in genomes. It models the evolution of the genomic region and conservation of the non-coding elements in different species.",
      "MEME is a computational method that uses a combination of statistical and bioinformatic techniques to identify conserved non-coding elements. It identifies common motifs in different species.",
      "Genomicus is a computational method that uses a combination of statistical and bioinformatic techniques to identify conserved non-coding elements. It identifies common motifs in different species."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2953,
    "user_query": "Has ivosidenib been FDA approved for use against acute myeloid leukemia?",
    "vicuna-13b_response": "Yes, ivosidenib (trade name: Idhifa) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a specific genetic mutation called IDH1.\nThe FDA approved ivosidenib in 2019 based on clinical trial data that showed that the drug was effective in treating patients with this specific genetic mutation. The drug is intended for use in patients who have tried other treatments without success and is intended to be used in conjunction with a bone marrow transplant.\nIt's important to note that not all patients with AML will benefit from ivosidenib, and it is only approved for use in patients with the specific IDH1 mutation. Additionally, the drug can have significant side effects, so it's important to discuss the potential benefits and risks with a healthcare provider before starting treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ivosidenib (trade name: Idhifa) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a specific genetic mutation called IDH1.\n2. The FDA approved ivosidenib in 2019.\n3. Ivosidenib is intended for use in patients who have tried other treatments without success and is intended to be used in conjunction with a bone marrow transplant.\n4. Not all patients with AML will benefit from ivosidenib, as it is only approved for use in patients with the specific IDH1 mutation.\n5. Ivosidenib can have significant side effects.",
    "vicuna-13b_fact": [
      "Ivosidenib (trade name: Idhifa) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a specific genetic mutation called IDH1.",
      "The FDA approved ivosidenib in 2019.",
      "Ivosidenib is intended for use in patients who have tried other treatments without success and is intended to be used in conjunction with a bone marrow transplant.",
      "Not all patients with AML will benefit from ivosidenib, as it is only approved for use in patients with the specific IDH1 mutation.",
      "Ivosidenib can have significant side effects."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Ivosidenib (trade name: Tibsovo) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a specific genetic mutation called IDH1.\n2. FALSE [correction]: The FDA approved ivosidenib in 2018.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "vicuna-13b_response": "STING (Stimulator of Interferon Genes) is a critical sensor of the cGAS-cGAS sensor complex that detects intracellular DNA and triggers an interferon response. Inhibition of STING has been shown to be a promising strategy for treating viral infections and cancer. Here are some known STING agonists:\n1. Cyclic dinucleotides (CDNs): CDNs are small molecules that mimic the activity of viral DNA and activate STING. CDNs include the natural product cytidine-5'-triphosphate (cGMP) and synthetic analogs such as 2',3'-cGAMP and 2',6'-cGAMP.\n2. Synthetic STING agonists: Synthetic molecules that directly bind to STING and activate it have also been developed. Examples include compounds such as JQ1, MRT68111, and JNJ-752605.\n3. Endogenous STING agonists: Certain viruses and bacteria have evolved mechanisms to activate STING through the use of viral DNA sensors or bacterial toxins. For example, the herpesvirus US11 activates STING through its viral DNA sensor, while the bacterial toxin anthrax protective antigen activates STING through a different mechanism.\nOverall, STING agonists have shown promise as potential therapeutics for treating viral infections and cancer, and further research is ongoing to identify and develop new and more effective STING agonists.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. STING is a critical sensor of the cGAS-cGAS sensor complex that detects intracellular DNA and triggers an interferon response.\n2. Inhibition of STING is a strategy for treating viral infections and cancer.\n3. Cyclic dinucleotides (CDNs) are small molecules that mimic the activity of viral DNA and activate STING.\n4. Synthetic STING agonists such as JQ1, MRT68111, and JNJ-752605 directly bind to STING and activate it.\n5. Certain viruses and bacteria have evolved mechanisms to activate STING through the use of viral DNA sensors or bacterial toxins.",
    "vicuna-13b_fact": [
      "STING is a critical sensor of the cGAS-cGAS sensor complex that detects intracellular DNA and triggers an interferon response.",
      "Inhibition of STING is a strategy for treating viral infections and cancer.",
      "Cyclic dinucleotides (CDNs) are small molecules that mimic the activity of viral DNA and activate STING.",
      "Synthetic STING agonists such as JQ1, MRT68111, and JNJ-752605 directly bind to STING and activate it.",
      "Certain viruses and bacteria have evolved mechanisms to activate STING through the use of viral DNA sensors or bacterial toxins."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: cGAS is a sensor of the cGAS-STING sensor complex that detects intracellular DNA and triggers an interferon response, not STING.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Certain viruses and bacteria have evolved mechanisms to evade STING activation, not to activate it.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "vicuna-13b_response": "SLIC-CAGE (Spatially Localized Implicit Computational Assemblies for Geometric Engineering) is a computational framework for designing and optimizing the geometry of structures. It is a combination of two methods: SLIC (Spatially Localized Implicit Computation) and CAGE (Computational Assembly of Geometric Elements).\nSLIC is a method for solving partial differential equations (PDEs) that describe the behavior of materials in response to external loads. It does this by dividing the solution domain into small, non-overlapping elements, and solving for each element independently using the finite element method. The key innovation of SLIC is that it uses a sparse linear algebra solver to solve the system of equations, which makes it much more efficient than traditional finite element methods.\nCAGE is a method for designing the geometry of structures by optimizing a set of design variables that define the shape of the structure. It does this by using a optimization algorithm to find the configuration of the design variables that minimizes a cost function that reflects the desired behavior of the structure.\nThe combination of SLIC and CAGE in SLIC-CAGE allows for the efficient and accurate design and optimization of the geometry of structures. By using SLIC to solve the PDEs that describe the behavior of the structure, and CAGE to optimize the geometry, SLIC-CAGE can find the optimal shape of a structure that satisfies a set of design constraints and performance requirements. This can be used in a wide range of applications, such as in the design of bridges, buildings, and aircraft.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SLIC-CAGE (Spatially Localized Implicit Computational Assemblies for Geometric Engineering) is a computational framework for designing and optimizing the geometry of structures.\n2. SLIC-CAGE is a combination of two methods: Spatially Localized Implicit Computation (SLIC) and Computational Assembly of Geometric Elements (CAGE).\n3. SLIC method solves partial differential equations that describe the behavior of materials in response to external loads.\n4. SLIC uses a sparse linear algebra solver to solve the system of equations.\n5. CAGE method designs the geometry of structures by optimizing a set of design variables.",
    "vicuna-13b_fact": [
      "SLIC-CAGE (Spatially Localized Implicit Computational Assemblies for Geometric Engineering) is a computational framework for designing and optimizing the geometry of structures.",
      "SLIC-CAGE is a combination of two methods: Spatially Localized Implicit Computation (SLIC) and Computational Assembly of Geometric Elements (CAGE).",
      "SLIC method solves partial differential equations that describe the behavior of materials in response to external loads.",
      "SLIC uses a sparse linear algebra solver to solve the system of equations.",
      "CAGE method designs the geometry of structures by optimizing a set of design variables."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2967,
    "user_query": "What is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "vicuna-13b_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene. This gene provides instructions for making a protein called Bruton's tyrosine kinase, which plays a key role in the development and function of the immune system. Mutations in the BTK gene can lead to a reduction in the production of antibodies and an increased susceptibility to infections. CVID is a condition characterized by a reduced ability of the immune system to fight off infections, and it can also lead to the development of autoimmune disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene.\n2. The BTK gene provides instructions for making a protein called Bruton's tyrosine kinase.\n3. Bruton's tyrosine kinase plays a key role in the development and function of the immune system.\n4. Mutations in the BTK gene can lead to a reduction in the production of antibodies and an increased susceptibility to infections.\n5. CVID is a condition characterized by a reduced ability of the immune system to fight off infections and can also lead to the development of autoimmune disorders.",
    "vicuna-13b_fact": [
      "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene.",
      "The BTK gene provides instructions for making a protein called Bruton's tyrosine kinase.",
      "Bruton's tyrosine kinase plays a key role in the development and function of the immune system.",
      "Mutations in the BTK gene can lead to a reduction in the production of antibodies and an increased susceptibility to infections.",
      "CVID is a condition characterized by a reduced ability of the immune system to fight off infections and can also lead to the development of autoimmune disorders."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is not a mutation in the BTK gene but rather mutations in the genes ICOS, CD19, CD21, or CD81 among others.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2968,
    "user_query": "List two indications of Letermovir?",
    "vicuna-13b_response": "Letermovir is an antiviral medication used to treat conditions caused by various types of viruses. It is primarily used to treat cytomegalovirus (CMV) retinitis in people with AIDS.\nTwo indications of Letermovir are:\n1. Treatment of cytomegalovirus (CMV) retinitis in people with AIDS: Letermovir is used to treat CMV retinitis, a condition caused by the cytomegalovirus virus that affects the retina of the eye, in people with AIDS.\n2. Prophylaxis of cytomegalovirus (CMV) disease in transplant recipients: Letermovir is also used to prevent CMV disease in transplant recipients, including solid organ transplant recipients and stem cell transplant recipients. It is usually given in combination with other medications to reduce the risk of CMV infection and disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Letermovir is an antiviral medication used to treat conditions caused by various types of viruses.\n2. Letermovir is primarily used to treat cytomegalovirus (CMV) retinitis in people with AIDS.\n3. CMV retinitis, a condition that affects the retina of the eye, is caused by the cytomegalovirus virus.\n4. Letermovir is used to prevent CMV disease in transplant recipients, including solid organ transplant recipients and stem cell transplant recipients.\n5. Letermovir is usually given in combination with other medications to reduce the risk of CMV infection and disease.",
    "vicuna-13b_fact": [
      "Letermovir is an antiviral medication used to treat conditions caused by various types of viruses.",
      "Letermovir is primarily used to treat cytomegalovirus (CMV) retinitis in people with AIDS.",
      "CMV retinitis, a condition that affects the retina of the eye, is caused by the cytomegalovirus virus.",
      "Letermovir is used to prevent CMV disease in transplant recipients, including solid organ transplant recipients and stem cell transplant recipients.",
      "Letermovir is usually given in combination with other medications to reduce the risk of CMV infection and disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Letermovir is primarily used to prevent cytomegalovirus (CMV) infection in people who have received a donor stem cell transplant.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2969,
    "user_query": "What is achalasia?",
    "vicuna-13b_response": "Achalasia is a disorder of the esophagus, the tube that connects the mouth to the stomach. It is characterized by the loss of muscle tone in the esophagus, which makes it difficult to swallow food and liquids.\nIn achalasia, the muscles of the esophagus do not contract properly to move food towards the stomach. This can cause food to remain in the esophagus for a long time, leading to difficulty swallowing and regurgitation. In addition, the muscles of the lower esophageal sphincter (LES), which is the ring of muscle that separates the esophagus and stomach, do not relax properly, making it difficult for food and liquids to pass from the esophagus into the stomach.\nAchalasia can be caused by a variety of factors, including aging, infection, and degeneration of the nerve cells that control the muscles of the esophagus. It can also be inherited, and some people may have a genetic predisposition to the disorder.\nSymptoms of achalasia include difficulty swallowing, regurgitation, chest pain, and heartburn. Treatment options for achalasia include medications, surgery, and lifestyle changes. The goal of treatment is to improve the ability to swallow and to manage symptoms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. Achalasia is a disorder of the esophagus.\n2. In achalasia, the muscles of the esophagus do not contract properly to move food towards the stomach.\n3. The muscles of the lower esophageal sphincter (LES) in achalasia patients do not relax properly, making it difficult for food and liquids to pass into the stomach.\n4. Achalasia can be caused by a variety of factors, including aging, infection, and degeneration of the nerve cells that control the muscles of the esophagus.\n5. Treatment options for achalasia include medications, surgery, and lifestyle changes.",
    "vicuna-13b_fact": [
      "Achalasia is a disorder of the esophagus.",
      "In achalasia, the muscles of the esophagus do not contract properly to move food towards the stomach.",
      "The muscles of the lower esophageal sphincter (LES) in achalasia patients do not relax properly, making it difficult for food and liquids to pass into the stomach.",
      "Achalasia can be caused by a variety of factors, including aging, infection, and degeneration of the nerve cells that control the muscles of the esophagus.",
      "Treatment options for achalasia include medications, surgery, and lifestyle changes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Achalasia is not caused by aging or infection. It is generally believed to be caused by the degeneration of nerve cells in the esophagus, although the exact cause is still unclear.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2972,
    "user_query": "When is serum AFP used as marker?",
    "vicuna-13b_response": "AFP (alpha-fetoprotein) is a protein produced by the liver of a developing fetus. It is typically used as a marker for fetal health and development during pregnancy, as well as for certain types of cancer, such as liver cancer.\nIn pregnancy, AFP levels can be measured in the blood of the mother to monitor the health of the fetus and detect any potential problems, such as Down syndrome or other chromosomal abnormalities. AFP levels can also be used to detect gestational trophoblastic disease (GTD), a type of cancer that forms in the cells that would normally become the placenta.\nIn cancer, AFP can be used as a tumor marker, indicating the presence of cancer in the body. Elevated levels of AFP in the blood can indicate the presence of liver cancer, although it is not specific to this type of cancer and can also be elevated in other types of cancer, such as gastrointestinal and lung cancer.\nIt is important to note that the use of AFP as a marker for cancer is not always straightforward, as AFP levels can also be elevated in other conditions, such as cirrhosis of the liver, and may not always indicate the presence of cancer. Therefore, the use of AFP as a marker for cancer should always be interpreted in the context of other clinical findings and diagnostic tests.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Alpha-fetoprotein (AFP) is a protein produced by the liver of a developing fetus.\n2. AFP is used as a marker for fetal health and development during pregnancy.\n3. AFP levels can be measured in the blood of the mother to detect potential problems such as Down syndrome or other chromosomal abnormalities.\n4. AFP can be used as a tumor marker for certain types of cancer, including liver cancer.\n5. Elevated levels of AFP can also indicate the presence of other conditions, such as cirrhosis of the liver.",
    "vicuna-13b_fact": [
      "Alpha-fetoprotein (AFP) is a protein produced by the liver of a developing fetus.",
      "AFP is used as a marker for fetal health and development during pregnancy.",
      "AFP levels can be measured in the blood of the mother to detect potential problems such as Down syndrome or other chromosomal abnormalities.",
      "AFP can be used as a tumor marker for certain types of cancer, including liver cancer.",
      "Elevated levels of AFP can also indicate the presence of other conditions, such as cirrhosis of the liver."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "vicuna-13b_response": "LEM-3 stands for Lunar Exploration Module-3, which was a spacecraft designed by NASA to land on the Moon during the Apollo 15 mission in 1971. The primary role of LEM-3 was to transport astronauts and their equipment to the lunar surface and back to the command module in orbit around the Moon.\nThe LEM-3 was a two-stage spacecraft, consisting of a descent stage and an ascent stage. The descent stage was designed to land on the Moon and support the astronauts during their stay on the lunar surface. It had a landing gear system that allowed it to touch down on the Moon's surface and a rocket engine that enabled it to take off from the lunar surface and return to orbit.\nThe ascent stage, on the other hand, was designed to carry the astronauts back to the command module in orbit around the Moon. It had a rocket engine that propelled it upward and a cabin that housed the astronauts during their journey back to orbit.\nIn addition to its primary role, LEM-3 also served as a laboratory for the astronauts to conduct scientific experiments on the lunar surface. The spacecraft was equipped with various instruments and tools that allowed the astronauts to study the lunar environment, including the Moon's surface, rocks, and soil.\nOverall, the LEM-3 played a crucial role in the Apollo 15 mission, enabling the astronauts to successfully land on the Moon and conduct a range of scientific experiments on the lunar surface.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. LEM-3 stands for Lunar Exploration Module-3, a spacecraft designed by NASA for the Apollo 15 mission in 1971.\n2. The primary role of LEM-3 was to transport astronauts and their equipment to the lunar surface and back to the command module in orbit around the Moon.\n3. LEM-3 was a two-stage spacecraft, consisting of a descent stage and an ascent stage.\n4. The descent stage of LEM-3 was designed to land on the Moon and support the astronauts during their stay on the lunar surface.\n5. The ascent stage of LEM-3 was designed to carry the astronauts back to the command module in orbit around the Moon.",
    "vicuna-13b_fact": [
      "LEM-3 stands for Lunar Exploration Module-3, a spacecraft designed by NASA for the Apollo 15 mission in 1971.",
      "The primary role of LEM-3 was to transport astronauts and their equipment to the lunar surface and back to the command module in orbit around the Moon.",
      "LEM-3 was a two-stage spacecraft, consisting of a descent stage and an ascent stage.",
      "The descent stage of LEM-3 was designed to land on the Moon and support the astronauts during their stay on the lunar surface.",
      "The ascent stage of LEM-3 was designed to carry the astronauts back to the command module in orbit around the Moon."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: There's no record of a spacecraft named Lunar Exploration Module-3 (LEM-3) in the Apollo program. Apollo 15 used the Lunar Module-10, often referred as \"Falcon\".\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2981,
    "user_query": "What is the most common pediatric glioma?",
    "vicuna-13b_response": "The most common pediatric glioma is a type of brain tumor called a glioblastoma. Glioblastoma is a highly aggressive and malignant tumor that arises from glial cells, which are a type of supportive cell in the brain. These tumors are most commonly found in the cerebral hemispheres (the left and right sides of the brain) and are often difficult to completely remove surgically due to their infiltrative nature. Glioblastoma is the most common malignant primary brain tumor in children and adolescents, accounting for approximately 15-20% of all pediatric brain tumors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The most common pediatric glioma is glioblastoma.\n2. Glioblastoma is a highly aggressive and malignant tumor that arises from glial cells.\n3. Glial cells are a type of supportive cell in the brain.\n4. Glioblastomas are most commonly found in the cerebral hemispheres.\n5. Glioblastoma accounts for approximately 15-20% of all pediatric brain tumors.",
    "vicuna-13b_fact": [
      "The most common pediatric glioma is glioblastoma.",
      "Glioblastoma is a highly aggressive and malignant tumor that arises from glial cells.",
      "Glial cells are a type of supportive cell in the brain.",
      "Glioblastomas are most commonly found in the cerebral hemispheres.",
      "Glioblastoma accounts for approximately 15-20% of all pediatric brain tumors."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The most common pediatric glioma is pilocytic astrocytoma.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Glioblastoma accounts for approximately 3% of all pediatric brain tumors.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2983,
    "user_query": "List uniparental disomy (UPD) detection algorithms",
    "vicuna-13b_response": "Uniparental disomy (UPD) refers to the presence of two copies of the same chromosome in a genome, which can occur due to various genetic mechanisms such as meiotic non-disjunction, mitotic non-disjunction, or chromosomal translocation. Detection of UPD is important for various applications in genetics, genomics, and personalized medicine. Here are some commonly used UPD detection algorithms:\n1. B-allele frequency: This method is based on the principle that in a diploid genome, the frequency of the B-allele is higher than the A-allele. Therefore, if a SNP (single nucleotide polymorphism) in a genome has a B-allele frequency that is higher than expected, it is indicative of UPD.\n2. Multiplexed PCR: This method uses multiplexed PCR to amplify the target region from the genome, followed by capillary electrophoresis or sequencing to detect the presence of two copies of the same chromosome.\n3. Targeted sequencing: This method involves sequencing a targeted region of the genome that is known to be associated with UPD. The sequencing data is then analyzed to identify the presence of two copies of the same chromosome.\n4. Spectral karyotyping (SKY): This method uses fluorescence in situ hybridization (FISH) to detect the presence of two copies of the same chromosome. SKY is a high-throughput method that can analyze thousands of cells in parallel.\n5. Chromosomal microarray analysis (CMA): This method uses microarray technology to detect copy number variations in the genome, including UPD. CMA is a high-resolution method that can detect small deletions and duplications in the genome.\n6. Next-generation sequencing (NGS): This method involves sequencing the entire genome or exome of an individual, followed by analysis of the data to identify the presence of UPD. NGS is a high-throughput method that can detect copy number variations with high accuracy.\nOverall, the choice of UPD detection algorithm depends on the specific application, the size of the genome, the resolution required, and the available resources.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Uniparental disomy (UPD) refers to the presence of two copies of the same chromosome in a genome.\n2. UPD can occur due to meiotic non-disjunction, mitotic non-disjunction, or chromosomal translocation.\n3. B-allele frequency, multiplexed PCR, targeted sequencing, spectral karyotyping (SKY), chromosomal microarray analysis (CMA), and next-generation sequencing (NGS) are common UPD detection methods.\n4. B-allele frequency is based on the principle that in a diploid genome, the frequency of the B-allele is higher than the A-allele.\n5. Spectral karyotyping (SKY) uses fluorescence in situ hybridization (FISH) to detect the presence of two copies of the same chromosome.",
    "vicuna-13b_fact": [
      "Uniparental disomy (UPD) refers to the presence of two copies of the same chromosome in a genome.",
      "UPD can occur due to meiotic non-disjunction, mitotic non-disjunction, or chromosomal translocation.",
      "B-allele frequency, multiplexed PCR, targeted sequencing, spectral karyotyping (SKY), chromosomal microarray analysis (CMA), and next-generation sequencing (NGS) are common UPD detection methods.",
      "B-allele frequency is based on the principle that in a diploid genome, the frequency of the B-allele is higher than the A-allele.",
      "Spectral karyotyping (SKY) uses fluorescence in situ hybridization (FISH) to detect the presence of two copies of the same chromosome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: B-allele frequency is based on the principle that in a diploid genome, the frequency of the A-allele and B-allele can be the same or different, reflecting the genotype of each SNP.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2987,
    "user_query": "List major features of TEMPI Syndrome.",
    "vicuna-13b_response": "TEMPI (Transient Epileptic Muscle Paralysis in Infants) syndrome is a rare but serious condition that affects newborns and infants. It is characterized by episodes of muscle weakness or paralysis, often accompanied by fever, and can be caused by a variety of underlying medical conditions. The major features of TEMPI syndrome include:\n1. Episodes of muscle weakness or paralysis: The episodes of muscle weakness or paralysis that occur in TEMPI syndrome can range from mild to severe, and can affect any part of the body. They often occur suddenly and can last for several minutes to several hours.\n2. Fever: Many infants with TEMPI syndrome experience fever, which can be a sign of an underlying infection.\n3. Poor feeding: Infants with TEMPI syndrome may have difficulty feeding, due to weakness or paralysis of the muscles used for swallowing.\n4. Lack of response to stimuli: Infants with TEMPI syndrome may be unresponsive or have a decreased response to stimuli, such as loud noises or touch.\n5. Apnea: Some infants with TEMPI syndrome may experience apnea, which is a pause in breathing.\n6. Hypotonia: Infants with TEMPI syndrome may have low muscle tone, which can affect their ability to hold their head up, sit, or crawl.\n7. Seizures: In some cases, TEMPI syndrome can lead to seizures, which are abnormal electrical signals in the brain that can cause convulsions or other symptoms.\nIt is important to note that TEMPI syndrome is a serious condition that requires prompt medical attention. If you suspect that your child may have TEMPI syndrome, it is important to seek medical care immediately.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TEMPI syndrome affects newborns and infants.\n2. TEMPI syndrome is characterized by episodes of muscle weakness or paralysis, often accompanied by fever. \n3. Infants with TEMPI syndrome may experience difficulty feeding due to weakness or paralysis of the muscles used for swallowing.\n4. Some infants with TEMPI syndrome may display a lack of response to stimuli, such as loud noises or touch.\n5. Apnea, a pause in breathing, may be experienced by some infants with TEMPI syndrome.\n6. TEMPI syndrome can result in low muscle tone, which can affect the baby’s ability to hold their head up, sit, or crawl.\n7. Some cases of TEMPI syndrome can lead to seizures, which are abnormal electrical signals in the brain that can cause convulsions or other symptoms.",
    "vicuna-13b_fact": [
      "TEMPI syndrome affects newborns and infants.",
      "TEMPI syndrome is characterized by episodes of muscle weakness or paralysis, often accompanied by fever.",
      "Infants with TEMPI syndrome may experience difficulty feeding due to weakness or paralysis of the muscles used for swallowing.",
      "Some infants with TEMPI syndrome may display a lack of response to stimuli, such as loud noises or touch.",
      "Apnea, a pause in breathing, may be experienced by some infants with TEMPI syndrome.",
      "TEMPI syndrome can result in low muscle tone, which can affect the baby’s ability to hold their head up, sit, or crawl.",
      "Some cases of TEMPI syndrome can lead to seizures, which are abnormal electrical signals in the brain that can cause convulsions or other symptoms."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n6. UNKNOWN\n7. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2990,
    "user_query": "What is nyctinasty in plants?",
    "vicuna-13b_response": "Nyctinasty is a type of plant movement that occurs in response to changes in light intensity. It is also known as \"sleep movement\" or \"nocturnal movement.\"\nIn nyctinasty, plant parts such as leaves, stems, or petals move in a coordinated manner in response to changes in light levels, typically from darkness to light. This type of movement is triggered by the opening and closing of the stomata, which are small pores on the surface of leaves that allow for gas exchange.\nWhen the stomata are open, the plant takes in carbon dioxide and releases oxygen. As the light intensity increases, the stomata close, which causes the plant to release a hormone that triggers the nyctinastic movement. This movement helps the plant to adjust its position and optimize its exposure to light.\nNyctinasty is a common type of plant movement that occurs in many different plant species, including grasses, legumes, and cacti. It is an important adaptation that helps plants to survive and thrive in a variety of environments.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nyctinasty is a type of plant movement that occurs in response to changes in light intensity.\n2. In nyctinasty, plant parts such as leaves, stems, or petals move due to changes in light levels.\n3. This type of movement is triggered by the opening and closing of the stomata.\n4. When the stomata are open, the plant takes in carbon dioxide and releases oxygen.\n5. Nyctinasty is common in different plant species including grasses, legumes, and cacti.",
    "vicuna-13b_fact": [
      "Nyctinasty is a type of plant movement that occurs in response to changes in light intensity.",
      "In nyctinasty, plant parts such as leaves, stems, or petals move due to changes in light levels.",
      "This type of movement is triggered by the opening and closing of the stomata.",
      "When the stomata are open, the plant takes in carbon dioxide and releases oxygen.",
      "Nyctinasty is common in different plant species including grasses, legumes, and cacti."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: This type of movement is not triggered by the opening and closing of stomata, but by changes in turgor pressure within the plant cells.\n4. TRUE\n5. FALSE [correction]: Nyctinasty is common in certain plant species such as legumes and Oxalis species, but not specifically in grasses and cacti.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "vicuna-13b_response": "Here is a list of releases of `tmVar`, which is a package for managing temporary variables in Haskell:\n* `tmVar` version 1.0.0\n* `tmVar` version 1.1.0\n* `tmVar` version 1.2.0\n* `tmVar` version 1.2.1\n* `tmVar` version 1.2.2\n* `tmVar` version 1.2.3\n* `tmVar` version 1.2.4\n* `tmVar` version 1.2.5\n* `tmVar` version 1.2.6\n* `tmVar` version 1.2.7\n* `tmVar` version 1.2.8\n* `tmVar` version 1.2.9\n* `tmVar` version 1.2.10\n* `tmVar` version 1.2.11\n* `tmVar` version 1.2.12\n* `tmVar` version 1.2.13\n* `tmVar` version 1.2.14\n* `tmVar` version 1.2.15\n* `tmVar` version 1.2.16\n* `tmVar` version 1.2.17\n* `tmVar` version 1.2.18\n* `tmVar` version 1.2.19\n* `tmVar` version 1.2.20\n* `tmVar` version 1.2.21\n* `tmVar` version 1.2.22\n* `tmVar` version 1.2.23\n* `tmVar` version 1.2.24\n* `tmVar` version 1.2.25\n* `tmVar` version 1.2.26\n* `tmVar` version 1.2.27\n* `tmVar` version 1.2.28\n* `tmVar` version 1.2.29\n* `tmVar` version 1.2.30\n* `tmVar` version 1.2.31\n* `tmVar` version 1.2.32\n* `tmVar` version 1",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. `tmVar` is a package for managing temporary variables in Haskell.\n2. `tmVar` version 1.0.0 was released.\n3. `tmVar` version 1.1.0 was released.\n4. `tmVar` version 1.2.0 was released.\n5. `tmVar` version 1.2.1 was released.",
    "vicuna-13b_fact": [
      "`tmVar` is a package for managing temporary variables in Haskell.",
      "`tmVar` version 1.0.0 was released.",
      "`tmVar` version 1.1.0 was released.",
      "`tmVar` version 1.2.0 was released.",
      "`tmVar` version 1.2.1 was released."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: `TMVar` is a package for managing temporary variables in Haskell, not `tmVar`.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2993,
    "user_query": "Which deep learning algorithm has been developed for variant calling?",
    "vicuna-13b_response": "Deep learning algorithms have been used for various applications in genomics, including variant calling. One popular deep learning algorithm used for variant calling is called the DeepVariant algorithm.\nDeepVariant is a deep learning-based method for variant calling that was developed by researchers at the Broad Institute of MIT and Harvard. It uses a combination of deep learning and traditional genetic analysis techniques to identify variants in genomic data.\nThe DeepVariant algorithm is designed to be more accurate and sensitive than traditional variant calling methods, which rely on filtering and thresholding of raw sequencing data. It can identify variants that are difficult to detect using traditional methods, such as rare variants, low-frequency variants, and variants in heterogeneous populations.\nDeepVariant works by training a deep neural network on a dataset of known variants and non-variants, and then using this trained model to predict whether a given base call is a variant or not. The algorithm can also estimate the frequency, effect size, and functional impact of the variant.\nOverall, DeepVariant is a powerful tool for variant calling that has been used in a variety of applications, including the analysis of whole-genome sequencing data from individuals with Mendelian diseases, cancer, and other complex traits.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. DeepVariant is a deep learning-based method for variant calling developed by researchers at the Broad Institute of MIT and Harvard.\n2. DeepVariant combines deep learning and traditional genetic analysis techniques to identify variants in genomic data.\n3. The DeepVariant algorithm is intended to be more accurate and sensitive than traditional variant calling methods.\n4. DeepVariant trains a deep neural network on a dataset of known variants and non-variants to predict whether a given base call is a variant or not.\n5. The DeepVariant algorithm has been used in the analysis of whole-genome sequencing data from individuals with Mendelian diseases, cancer, and other complex traits.",
    "vicuna-13b_fact": [
      "DeepVariant is a deep learning-based method for variant calling developed by researchers at the Broad Institute of MIT and Harvard.",
      "DeepVariant combines deep learning and traditional genetic analysis techniques to identify variants in genomic data.",
      "The DeepVariant algorithm is intended to be more accurate and sensitive than traditional variant calling methods.",
      "DeepVariant trains a deep neural network on a dataset of known variants and non-variants to predict whether a given base call is a variant or not.",
      "The DeepVariant algorithm has been used in the analysis of whole-genome sequencing data from individuals with Mendelian diseases, cancer, and other complex traits."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: DeepVariant is a deep learning-based method for variant calling developed by researchers at Google Brain Team, Verily Life Sciences, and Google Cloud.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3000,
    "user_query": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III).",
    "vicuna-13b_response": "Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III), is a rare genetic disorder caused by the absence or malfunction of enzymes needed to break down long chains of sugar molecules called mucopolysaccharides. There are four main types of Sanfilippo syndrome, each caused by a deficiency of a different enzyme:\n1. Sanfilippo A syndrome: caused by a deficiency of the enzyme N-acetylgalactosamine-6-sulfatase.\n2. Sanfilippo B syndrome: caused by a deficiency of the enzyme N-acetylglucosamine-6-sulfatase.\n3. Sanfilippo C syndrome: caused by a deficiency of the enzyme N-acetylgalactosamine-4-sulfatase.\n4. Sanfilippo D syndrome: caused by a deficiency of the enzyme N-acetylglucosamine-4-sulfatase.\nEach of these types of Sanfilippo syndrome is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the gene (one from each parent) to develop the disorder.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III), is a rare genetic disorder that is caused by the absence or malfunction of enzymes needed to break down long chains of sugar molecules called mucopolysaccharides.\n2. Sanfilippo A syndrome is caused by a deficiency of the enzyme N-acetylgalactosamine-6-sulfatase.\n3. Sanfilippo B syndrome is caused by a deficiency of the enzyme N-acetylglucosamine-6-sulfatase.\n4. Sanfilippo C syndrome is caused by a deficiency of the enzyme N-acetylgalactosamine-4-sulfatase.\n5. Sanfilippo D syndrome is caused by a deficiency of the enzyme N-acetylglucosamine-4-sulfatase.",
    "vicuna-13b_fact": [
      "Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III), is a rare genetic disorder that is caused by the absence or malfunction of enzymes needed to break down long chains of sugar molecules called mucopolysaccharides.",
      "Sanfilippo A syndrome is caused by a deficiency of the enzyme N-acetylgalactosamine-6-sulfatase.",
      "Sanfilippo B syndrome is caused by a deficiency of the enzyme N-acetylglucosamine-6-sulfatase.",
      "Sanfilippo C syndrome is caused by a deficiency of the enzyme N-acetylgalactosamine-4-sulfatase.",
      "Sanfilippo D syndrome is caused by a deficiency of the enzyme N-acetylglucosamine-4-sulfatase."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Sanfilippo A syndrome is caused by a deficiency of the enzyme heparan N-sulfatase.\n3. TRUE\n4. FALSE [correction]: Sanfilippo C syndrome is caused by a deficiency of the enzyme acetyl-CoAlpha-glucosaminide acetyltransferase.\n5. FALSE [correction]: Sanfilippo D syndrome is caused by a deficiency of the enzyme N-acetylglucosamine 6-sulfatase.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3002,
    "user_query": "List clinical disorders or diseases where uc.189 is involved?",
    "vicuna-13b_response": "I'm sorry, but I am not aware of any clinical disorders or diseases where the term \"uc.189\" is commonly used or involved. It is possible that \"uc.189\" may be specific to a certain context or field, but without further information, I am unable to provide a more detailed answer.\nIf you have any additional information or context regarding \"uc.189,\" please let me know and I will do my best to assist you further.",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 3004,
    "user_query": "What is the role of metalloproteinase-17 (ADAM17) in NK cells?",
    "vicuna-13b_response": "Metalloproteinase-17 (ADAM17) is a protein that is expressed in a variety of cell types, including natural killer (NK) cells. ADAM17 is a member of the ADAM (A Disintegrin And Metalloproteinase) family of proteins, which are involved in cell adhesion, migration, and differentiation.\nIn NK cells, ADAM17 is involved in the regulation of cell activation and function. ADAM17 is expressed on the surface of NK cells and is involved in the processing and release of pro-inflammatory cytokines, such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α). This process is known as \"cytokine maturation\" and is important for the activation and proliferation of NK cells.\nIn addition, ADAM17 is also involved in the regulation of NK cell migration and homing. ADAM17 is expressed on the surface of NK cells and binds to specific proteins on the endothelial cells that line the blood vessels. This interaction is important for the migration of NK cells to the sites of infection or inflammation.\nOverall, ADAM17 plays an important role in the regulation of NK cell function and is a potential target for the development of new therapies for the treatment of diseases such as cancer and autoimmune disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Metalloproteinase-17 (ADAM17) is a protein expressed in various cell types, including natural killer (NK) cells.\n2. ADAM17 is a member of the ADAM (A Disintegrin And Metalloproteinase) family of proteins.\n3. In NK cells, ADAM17 is involved in the regulation of cell activation and function.\n4. ADAM17 plays a role in the cytokine maturation, which involves the processing and release of pro-inflammatory cytokines, such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α).\n5. ADAM17 also contributes to the regulation of NK cell migration and homing by binding to specific proteins on the endothelial cells that line the blood vessels.",
    "vicuna-13b_fact": [
      "Metalloproteinase-17 (ADAM17) is a protein expressed in various cell types, including natural killer (NK) cells.",
      "ADAM17 is a member of the ADAM (A Disintegrin And Metalloproteinase) family of proteins.",
      "In NK cells, ADAM17 is involved in the regulation of cell activation and function.",
      "ADAM17 plays a role in the cytokine maturation, which involves the processing and release of pro-inflammatory cytokines, such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α).",
      "ADAM17 also contributes to the regulation of NK cell migration and homing by binding to specific proteins on the endothelial cells that line the blood vessels."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: ADAM17 contributes to the regulation of NK cell migration and homing by cleaving and releasing cell surface proteins, not by directly binding to specific proteins on the endothelial cells that line the blood vessels.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3005,
    "user_query": "What is the triad of Melkersson-Rosenthal syndrome?",
    "vicuna-13b_response": "Melkersson-Rosenthal syndrome is a rare disorder characterized by the triad of recurrent herpes labialis (cold sores), fingertip pitting edema, and lymphedema of the face and neck. The exact cause of the syndrome is not known, but it is thought to be related to a defect in the immune system. The condition is typically diagnosed based on the presence of the characteristic symptoms and can be treated with antiviral medications to manage the herpes outbreaks and other symptoms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Melkersson-Rosenthal syndrome is a rare disorder.\n2. The triad of Melkersson-Rosenthal syndrome includes recurrent herpes labialis (cold sores), fingertip pitting edema, and lymphedema of the face and neck.\n3. The exact cause of Melkersson-Rosenthal syndrome is not known.\n4. Melkersson-Rosenthal syndrome is thought to be related to a defect in the immune system.\n5. The condition can be treated with antiviral medications to manage the herpes outbreaks and other symptoms.",
    "vicuna-13b_fact": [
      "Melkersson-Rosenthal syndrome is a rare disorder.",
      "The triad of Melkersson-Rosenthal syndrome includes recurrent herpes labialis (cold sores), fingertip pitting edema, and lymphedema of the face and neck.",
      "The exact cause of Melkersson-Rosenthal syndrome is not known.",
      "Melkersson-Rosenthal syndrome is thought to be related to a defect in the immune system.",
      "The condition can be treated with antiviral medications to manage the herpes outbreaks and other symptoms."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The triad of Melkersson-Rosenthal syndrome includes facial paralysis, swelling of the face and lips, and a fissured tongue.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The condition can be treated with corticosteroids to manage the swelling and other symptoms. Antiviral medications are not typically used as treatment.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3006,
    "user_query": "Is galcanezumab effective for treatment of migraine?",
    "vicuna-13b_response": "Galcanezumab is a medication that is approved for the prevention of migraines. It is a monoclonal antibody, which means it is a laboratory-made version of a protein that is produced by the body's immune system. Galcanezumab works by targeting a protein called calcitonin gene-related peptide (CGRP), which is involved in the transmission of pain signals in the body.\nStudies have shown that galcanezumab is effective in reducing the frequency and severity of migraines. In clinical trials, patients who received galcanezumab had fewer migraines and experienced fewer symptoms when they did have a migraine compared to those who received a placebo.\nGalcanezumab is given as an injection, either once a month or once every three months, depending on the specific treatment regimen. It is important to note that galcanezumab is not a cure for migraines and does not work for everyone. However, for people who experience frequent and severe migraines, galcanezumab can be an effective treatment option.\nIt is important to discuss the potential benefits and risks of galcanezumab with a healthcare provider to determine if it is an appropriate treatment option for an individual's specific needs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Galcanezumab is approved for the prevention of migraines.\n2. Galcanezumab is a monoclonal antibody.\n3. Studies have shown that galcanezumab is effective in reducing the frequency and severity of migraines.\n4. Galcanezumab is given as an injection, either once a month or once every three months.\n5. Galcanezumab is not a cure for migraines and does not work for everyone.",
    "vicuna-13b_fact": [
      "Galcanezumab is approved for the prevention of migraines.",
      "Galcanezumab is a monoclonal antibody.",
      "Studies have shown that galcanezumab is effective in reducing the frequency and severity of migraines.",
      "Galcanezumab is given as an injection, either once a month or once every three months.",
      "Galcanezumab is not a cure for migraines and does not work for everyone."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3011,
    "user_query": "Fecal transplantation is used to treat infection with what bacteria?",
    "vicuna-13b_response": "Fecal transplantation is a medical procedure that involves transplanting feces from a healthy donor into a recipient with the goal of restoring the normal balance of gut bacteria. This procedure is primarily used to treat infection with a type of bacteria called Clostridioides difficile, also known as C. difficile or C. diff.\nC. diff is a type of bacteria that can cause diarrhea and other gastrointestinal symptoms. It is often acquired in healthcare settings, such as hospitals or nursing homes, where antibiotics are frequently used to treat infections. Antibiotics can disrupt the normal balance of gut bacteria, allowing C. diff to overgrow and cause infection. C. diff infections can be difficult to treat and can lead to serious complications, such as colitis (inflammation of the colon) and sepsis (a life-threatening infection that can spread throughout the body).\nFecal transplantation works by introducing healthy gut bacteria into the recipient's gut, which can help to displace the C. diff bacteria and restore the normal balance of gut bacteria. The healthy gut bacteria are obtained from a donor who has a healthy gut and a diverse range of gut bacteria. The donor's feces are processed to remove any pathogens and then transplanted into the recipient through a process called colonoscopy or enema.\nFecal transplantation has been shown to be an effective treatment for C. diff infection, with a cure rate of up to 90% in some studies. However, it is important to note that this procedure is still considered experimental and is not widely available. Additionally, there are potential risks associated with fecal transplantation, such as infection with other bacteria or transmission of diseases through the donor's feces. Therefore, fecal transplantation should only be performed under the supervision of a qualified healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fecal transplantation is a medical procedure that involves transplanting feces from a healthy donor into a recipient to restore the normal balance of gut bacteria.\n2. Fecal transplantation is primarily used to treat infection with Clostridioides difficile, also known as C. difficile or C. diff.\n3. Clostridioides difficile is a type of bacteria that can cause diarrhea and other gastrointestinal symptoms.\n4. Fecal transplantation works by introducing healthy gut bacteria into the recipient's gut, which can help to displace the C. diff bacteria and restore the normal balance of gut bacteria.\n5. Fecal transplantation has been found to be an effective treatment for C. diff infection, with a cure rate of up to 90% in some studies.",
    "vicuna-13b_fact": [
      "Fecal transplantation is a medical procedure that involves transplanting feces from a healthy donor into a recipient to restore the normal balance of gut bacteria.",
      "Fecal transplantation is primarily used to treat infection with Clostridioides difficile, also known as C. difficile or C. diff.",
      "Clostridioides difficile is a type of bacteria that can cause diarrhea and other gastrointestinal symptoms.",
      "Fecal transplantation works by introducing healthy gut bacteria into the recipient's gut, which can help to displace the C. diff bacteria and restore the normal balance of gut bacteria.",
      "Fecal transplantation has been found to be an effective treatment for C. diff infection, with a cure rate of up to 90% in some studies."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3015,
    "user_query": "What are the CADD scores?",
    "vicuna-13b_response": "CADD (Childhood Autism Diagnostic Drill) is a tool used to help diagnose autism spectrum disorder (ASD) in children. It is a standardized, structured assessment that evaluates a child's communication, social interaction, and play skills. The CADD scores are based on the results of the assessment and are used to determine whether a child is likely to have ASD or if further evaluation is needed.\nThe CADD scores are comprised of three main components: Communication, Social Interaction, and Play. Each of these components is further divided into sub-domains, and the scores for each sub-domain are combined to give an overall CADD score.\nThe Communication domain assesses a child's ability to use and understand language, as well as their nonverbal communication skills. The Social Interaction domain looks at a child's ability to interact with others, including their ability to make friends and share interests. The Play domain evaluates a child's ability to engage in imaginative and creative play.\nThe CADD scores are used by healthcare professionals, such as psychologists or developmental pediatricians, to help diagnose ASD in children. A high CADD score may indicate that a child has ASD, while a low score may suggest that further evaluation is needed. However, it's important to note that the CADD is just one tool used in the diagnostic process and a diagnosis of ASD should be made by a qualified professional who has conducted a comprehensive evaluation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CADD stands for Childhood Autism Diagnostic Drill.\n2. CADD is a tool used to help diagnose autism spectrum disorder (ASD) in children.\n3. The CADD scores are comprised of three main components: Communication, Social Interaction, and Play.\n4. The CADD scores are used by healthcare professionals to help diagnose ASD in children.\n5. A diagnosis of ASD should be made by a qualified professional who has conducted a comprehensive evaluation.",
    "vicuna-13b_fact": [
      "CADD stands for Childhood Autism Diagnostic Drill.",
      "CADD is a tool used to help diagnose autism spectrum disorder (ASD) in children.",
      "The CADD scores are comprised of three main components: Communication, Social Interaction, and Play.",
      "The CADD scores are used by healthcare professionals to help diagnose ASD in children.",
      "A diagnosis of ASD should be made by a qualified professional who has conducted a comprehensive evaluation."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: CADD stands for Childhood Autism Diagnostic Descriptor.\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "vicuna-13b_response": "There are several databases of somatic mutations in normal cells, including:\n1. The Cancer Genome Atlas (TCGA) - a publicly available database that provides genomic and molecular characterization of a variety of cancer types, including somatic mutations in normal cells.\n2. The International Cancer Genome Consortium (ICGC) - a global collaboration that aims to perform comprehensive genomic analyses of a range of cancer types, including somatic mutations in normal cells.\n3. The Mutation Analysis in Non-small Cell Lung Cancer (Miracle) database - a resource that provides detailed information on somatic mutations in non-small cell lung cancer, including those that occur in normal cells.\n4. The Clinical Somatic Genome Project (CSGP) - a large-scale effort to analyze the genomes of patients with a range of somatic diseases, including those that involve normal cells.\nThese databases provide valuable resources for researchers and clinicians interested in understanding the genetic changes that occur in normal cells during the development of cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Cancer Genome Atlas (TCGA) is a publicly available database that provides genomic and molecular characterization of a variety of cancer types.\n2. The International Cancer Genome Consortium (ICGC) is a global collaboration that aims to perform comprehensive genomic analyses of a range of cancer types.\n3. The Mutation Analysis in Non-small Cell Lung Cancer (Miracle) database is a resource that provides information on somatic mutations in non-small cell lung cancer.\n4. The Clinical Somatic Genome Project (CSGP) is a project to analyze the genomes of patients with a range of somatic diseases.\n5. These databases provide resources for researchers and clinicians interested in understanding the genetic changes that occur in normal cells during the development of cancer.",
    "vicuna-13b_fact": [
      "The Cancer Genome Atlas (TCGA) is a publicly available database that provides genomic and molecular characterization of a variety of cancer types.",
      "The International Cancer Genome Consortium (ICGC) is a global collaboration that aims to perform comprehensive genomic analyses of a range of cancer types.",
      "The Mutation Analysis in Non-small Cell Lung Cancer (Miracle) database is a resource that provides information on somatic mutations in non-small cell lung cancer.",
      "The Clinical Somatic Genome Project (CSGP) is a project to analyze the genomes of patients with a range of somatic diseases.",
      "These databases provide resources for researchers and clinicians interested in understanding the genetic changes that occur in normal cells during the development of cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3023,
    "user_query": "What periodontal disease associated bacteria is also associated with Alzheimer's disease?",
    "vicuna-13b_response": "There is some evidence to suggest that periodontal disease associated bacteria may be associated with Alzheimer's disease. Porphyromonas gingivalis, a bacterium that is commonly found in the mouth and is associated with periodontal disease, has been found in the brains of individuals with Alzheimer's disease. Other studies have also suggested that periodontal disease may be a risk factor for the development of Alzheimer's disease. However, it is important to note that the relationship between periodontal disease and Alzheimer's disease is still being studied and more research is needed to fully understand the connection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Porphyromonas gingivalis is a bacterium associated with periodontal disease.\n2. Porphyromonas gingivalis has been found in the brains of individuals with Alzheimer's disease.\n3. Some studies have suggested that periodontal disease may be a risk factor for the development of Alzheimer's disease.\n4. The relationship between periodontal disease and Alzheimer's disease is still being studied.\n5. More research is needed to fully understand the connection between periodontal disease and Alzheimer's disease.",
    "vicuna-13b_fact": [
      "Porphyromonas gingivalis is a bacterium associated with periodontal disease.",
      "Porphyromonas gingivalis has been found in the brains of individuals with Alzheimer's disease.",
      "Some studies have suggested that periodontal disease may be a risk factor for the development of Alzheimer's disease.",
      "The relationship between periodontal disease and Alzheimer's disease is still being studied.",
      "More research is needed to fully understand the connection between periodontal disease and Alzheimer's disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3025,
    "user_query": "How does the Cholera toxin enter a cell?",
    "vicuna-13b_response": "The Cholera toxin is a major virulence factor produced by the bacterium Vibrio cholerae, which causes cholera. The toxin is a protein that is secreted by the bacteria and binds to specific receptors on the surface of epithelial cells that line the small intestine.\nOnce the toxin binds to the receptors, it activates a G protein-coupled receptor, which triggers an intracellular signaling cascade that leads to the activation of adenylate cyclase. This results in increased levels of cyclic AMP (cAMP) in the cell, which causes the secretion of large amounts of electrolytes and water into the intestinal lumen.\nThe increased fluid secretion leads to profuse, watery diarrhea, which is the hallmark symptom of cholera. The diarrhea is usually accompanied by abdominal cramps and vomiting, and can result in severe dehydration and electrolyte imbalances if left untreated.\nIn summary, the Cholera toxin enters epithelial cells in the small intestine by binding to specific receptors on the surface of the cells and activating an intracellular signaling cascade that leads to increased secretion of electrolytes and water. This results in the symptoms of cholera, which can be severe if left untreated.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Cholera toxin is a virulence factor produced by the bacterium Vibrio cholerae.\n2. The Cholera toxin binds to specific receptors on the surface of epithelial cells in the small intestine.\n3. Once the toxin binds to the receptors, it triggers an intracellular signaling cascade leading to the activation of adenylate cyclase.\n4. Activation of adenylate cyclase increases levels of cyclic AMP (cAMP) in the cell, causing the secretion of electrolytes and water into the intestinal lumen.\n5. This result of Cholera toxin binding and subsequent cellular events results in profuse diarrhea, a hallmark symptom of cholera.",
    "vicuna-13b_fact": [
      "The Cholera toxin is a virulence factor produced by the bacterium Vibrio cholerae.",
      "The Cholera toxin binds to specific receptors on the surface of epithelial cells in the small intestine.",
      "Once the toxin binds to the receptors, it triggers an intracellular signaling cascade leading to the activation of adenylate cyclase.",
      "Activation of adenylate cyclase increases levels of cyclic AMP (cAMP) in the cell, causing the secretion of electrolytes and water into the intestinal lumen.",
      "This result of Cholera toxin binding and subsequent cellular events results in profuse diarrhea, a hallmark symptom of cholera."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3027,
    "user_query": "Can mogamulizumab be used for the treatment of cutaneous T-cell lymphoma?",
    "vicuna-13b_response": "Mogamulizumab is a monoclonal antibody drug that is approved for the treatment of certain types of blood cancers, including myeloma and lymphoma. It is not specifically approved for the treatment of cutaneous T-cell lymphoma (CTCL), a type of non-Hodgkin lymphoma that affects T cells, a type of white blood cell that plays a central role in the immune system.\nHowever, mogamulizumab is being studied in clinical trials for the treatment of CTCL. These trials are investigating the safety and efficacy of mogamulizumab in patients with CTCL who have not responded to other treatments or who have experienced a relapse after treatment.\nIt is important to note that while mogamulizumab is not yet approved for the treatment of CTCL, it may be used \"off-label\" by healthcare providers if they determine that it is the best treatment option for a particular patient. Off-label use refers to the use of a medication for a condition or in a way that is not specifically approved by the FDA.\nIt is always important to discuss treatment options with a healthcare provider and to carefully consider the risks and benefits of any treatment before making a decision.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mogamulizumab is a monoclonal antibody drug approved for the treatment of certain types of blood cancers, including myeloma and lymphoma.\n2. Mogamulizumab is not specifically approved for the treatment of cutaneous T-cell lymphoma (CTCL).\n3. Mogamulizumab is being studied in clinical trials for the treatment of CTCL.\n4. Off-label use refers to the use of a medication for a condition or in a way that is not specifically approved by the FDA.\n5. Cutaneous T-cell lymphoma is a type of non-Hodgkin lymphoma that affects T cells, a type of white blood cell that plays a central role in the immune system.",
    "vicuna-13b_fact": [
      "Mogamulizumab is a monoclonal antibody drug approved for the treatment of certain types of blood cancers, including myeloma and lymphoma.",
      "Mogamulizumab is not specifically approved for the treatment of cutaneous T-cell lymphoma (CTCL).",
      "Mogamulizumab is being studied in clinical trials for the treatment of CTCL.",
      "Off-label use refers to the use of a medication for a condition or in a way that is not specifically approved by the FDA.",
      "Cutaneous T-cell lymphoma is a type of non-Hodgkin lymphoma that affects T cells, a type of white blood cell that plays a central role in the immune system."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mogamulizumab is a monoclonal antibody drug approved for the treatment of certain types of blood cancers, including T-cell lymphoma and adult T-cell leukemia-lymphoma (ATL).\n2. FALSE [correction]: Mogamulizumab IS specifically approved for the treatment of relapsed or refractory CTCL (cutaneous T-cell lymphoma).\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3028,
    "user_query": "Which enzymes are inhibited by Duvelisib?",
    "vicuna-13b_response": "Duvelisib is a phosphatidylinositol 3-kinase (PI3K) inhibitor that is used to treat certain types of cancer. It has been shown to inhibit a variety of PI3K enzymes, including PI3K-δ, PI3K-γ, and PI3K-β. Inhibition of these enzymes can lead to a variety of downstream effects, including the inhibition of cell proliferation and the induction of apoptosis (programmed cell death). Additionally, Duvelisib has been shown to inhibit the activity of the mTOR pathway, which is a signaling pathway that regulates cell growth and metabolism. Inhibition of mTOR activity can lead to inhibition of cell proliferation and the induction of apoptosis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Duvelisib is a phosphatidylinositol 3-kinase (PI3K) inhibitor.\n2. Duvelisib is used to treat certain types of cancer.\n3. Duvelisib inhibits a variety of PI3K enzymes, including PI3K-δ, PI3K-γ, and PI3K-β.\n4. Inhibition of these PI3K enzymes by Duvelisib can lead to inhibition of cell proliferation and induction of programmed cell death.\n5. Duvelisib has been shown to inhibit the activity of the mTOR pathway, which regulates cell growth and metabolism.",
    "vicuna-13b_fact": [
      "Duvelisib is a phosphatidylinositol 3-kinase (PI3K) inhibitor.",
      "Duvelisib is used to treat certain types of cancer.",
      "Duvelisib inhibits a variety of PI3K enzymes, including PI3K-δ, PI3K-γ, and PI3K-β.",
      "Inhibition of these PI3K enzymes by Duvelisib can lead to inhibition of cell proliferation and induction of programmed cell death.",
      "Duvelisib has been shown to inhibit the activity of the mTOR pathway, which regulates cell growth and metabolism."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3029,
    "user_query": "List search engines used in proteomics.",
    "vicuna-13b_response": "Proteomics is the study of proteins and their functions. Search engines are used to identify and quantify proteins in complex biological samples. Here are some commonly used search engines in proteomics:\n1. SEQUEST: SEQUEST is a search engine used for identifying and quantifying proteins in complex biological samples. It is a database search engine that uses a combination of peptide mass fingerprinting and tandem mass spectrometry to identify proteins.\n2. MASCOT: MASCOT is another search engine used for identifying and quantifying proteins in complex biological samples. It is a database search engine that uses a combination of peptide mass fingerprinting and tandem mass spectrometry to identify proteins.\n3. OMSSA: OMSSA is a search engine used for identifying and quantifying proteins in complex biological samples. It is a database search engine that uses a combination of peptide mass fingerprinting and tandem mass spectrometry to identify proteins.\n4. X!Tandem: X!Tandem is a search engine used for identifying and quantifying proteins in complex biological samples. It is a database search engine that uses a combination of peptide mass fingerprinting and tandem mass spectrometry to identify proteins.\n5. TOPP: TOPP is a search engine used for identifying and quantifying proteins in complex biological samples. It is a database search engine that uses a combination of peptide mass fingerprinting and tandem mass spectrometry to identify proteins.\nThese search engines are commonly used in proteomics to identify and quantify proteins in complex biological samples. They are powerful tools that help researchers gain insights into the functions of proteins and their role in various biological processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Proteomics is the study of proteins and their functions.\n2. SEQUEST is a search engine used in proteomics for identifying and quantifying proteins in complex biological samples.\n3. MASCOT is another search engine used in proteomics for identifying and quantifying proteins in complex biological samples.\n4. OMSSA is a search engine used in proteomics for identifying and quantifying proteins in complex biological samples.\n5. X!Tandem and TOPP are search engines used in proteomics for identifying and quantifying proteins in complex biological samples.",
    "vicuna-13b_fact": [
      "Proteomics is the study of proteins and their functions.",
      "SEQUEST is a search engine used in proteomics for identifying and quantifying proteins in complex biological samples.",
      "MASCOT is another search engine used in proteomics for identifying and quantifying proteins in complex biological samples.",
      "OMSSA is a search engine used in proteomics for identifying and quantifying proteins in complex biological samples.",
      "X!Tandem and TOPP are search engines used in proteomics for identifying and quantifying proteins in complex biological samples."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3035,
    "user_query": "Is Lasmiditan effective for migraine?",
    "vicuna-13b_response": "Lasmiditan is a medication that is approved by the FDA for the treatment of migraines. It is a serotonin (5-HT2A) receptor agonist, which means it works by activating certain receptors in the brain that are involved in pain signaling and blood vessel constriction.\nClinical trials have shown that lasmiditan is effective in reducing the severity and duration of migraine attacks when taken at the onset of symptoms. It is generally well-tolerated, but like all medications, it can cause side effects. The most common side effects of lasmiditan include nausea, dizziness, and fatigue.\nIt's important to note that not all migraines can be treated with lasmiditan, and it may not work for everyone. If you have migraines, it's important to work with your healthcare provider to find the most effective treatment plan for your individual needs. This may include trying different medications, lifestyle changes, or other therapies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Lasmiditan is a medication that is approved by the FDA for the treatment of migraines.\n2. Lasmiditan is a serotonin (5-HT2A) receptor agonist.\n3. Lasmiditan works by activating certain receptors in the brain that are involved in pain signaling and blood vessel constriction.\n4. Clinical trials have shown that lasmiditan is effective in reducing the severity and duration of migraine attacks.\n5. The most common side effects of lasmiditan include nausea, dizziness, and fatigue.",
    "vicuna-13b_fact": [
      "Lasmiditan is a medication that is approved by the FDA for the treatment of migraines.",
      "Lasmiditan is a serotonin (5-HT2A) receptor agonist.",
      "Lasmiditan works by activating certain receptors in the brain that are involved in pain signaling and blood vessel constriction.",
      "Clinical trials have shown that lasmiditan is effective in reducing the severity and duration of migraine attacks.",
      "The most common side effects of lasmiditan include nausea, dizziness, and fatigue."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "vicuna-13b_response": "Yes, there are several graph kernel libraries available that are implemented in Java. Some of the popular ones are:\n1. JUNG: JUNG (Java Universal Network/Graph) is a Java library for graph data structures and graph algorithms. It provides a wide range of graph algorithms, including PageRank, Breadth-First Search, Dijkstra's algorithm, and more.\n2. GraphX: GraphX is a distributed graph processing system for Apache Spark. It provides a set of graph algorithms and allows for efficient processing of large-scale graph data.\n3. GraphML Java: GraphML Java is a Java library for parsing and generating GraphML, a standard format for graph data. It provides a set of tools for working with GraphML files, including parsing, serialization, and visualization.\n4. Gephi: Gephi is a popular graph visualization tool that also provides a Java API for working with graph data. The API allows for custom visualizations and provides access to the graph's data and layout.\n5. NetworkX: NetworkX is a Python library for graph data structures and graph algorithms, but it also has a Java port called JNetworkX. It provides a wide range of graph algorithms and data structures, including directed and undirected graphs, weighted and unweighted graphs, and more.\nThese libraries provide a variety of tools and algorithms for working with graph data in Java, and can be used for tasks such as graph analysis, visualization, and processing.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. JUNG is a Java library for graph data structures and graph algorithms.\n2. GraphX is a distributed graph processing system for Apache Spark.\n3. GraphML Java is a Java library for parsing and generating GraphML, a standard format for graph data.\n4. Gephi is a graph visualization tool that also provides a Java API for working with graph data.\n5. NetworkX, a Python library for graph data structures and graph algorithms, has a Java port called JNetworkX.",
    "vicuna-13b_fact": [
      "JUNG is a Java library for graph data structures and graph algorithms.",
      "GraphX is a distributed graph processing system for Apache Spark.",
      "GraphML Java is a Java library for parsing and generating GraphML, a standard format for graph data.",
      "Gephi is a graph visualization tool that also provides a Java API for working with graph data.",
      "NetworkX, a Python library for graph data structures and graph algorithms, has a Java port called JNetworkX."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: NetworkX is a Python library for the creation, manipulation, and study of the structure of complex networks. There is no Java port called JNetworkX.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 3044,
    "user_query": "What is COG112?",
    "vicuna-13b_response": "I'm sorry, but I don't have any information about a specific \"COG112.\" Can you provide any additional context or details about what you are asking?",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "vicuna-13b_response": "SHERLOCKv2 is an advanced platform for automated threat intelligence and active defense. It integrates four key advances to provide comprehensive and effective cybersecurity capabilities. These advances are:\n1. Data Science: SHERLOCKv2 leverages data science techniques to provide advanced analytics and machine learning capabilities. This allows the platform to automatically detect and respond to threats in real-time, and to continuously learn and adapt to new threats and attack techniques.\n2. Automation: SHERLOCKv2 automates many of the tasks involved in threat intelligence and active defense, such as data collection, analysis, and response. This enables security teams to focus on higher-level tasks and strategic decision-making, while the platform handles the day-to-day operational tasks.\n3. Artificial Intelligence (AI): SHERLOCKv2 incorporates AI technologies such as natural language processing (NLP) and computer vision to provide advanced threat detection and response capabilities. For example, the platform can automatically analyze and interpret threat intelligence feeds, network traffic, and other data sources to identify potential threats and take appropriate action.\n4. Open Architecture: SHERLOCKv2 is built on an open architecture that allows it to integrate with other security tools and systems. This enables the platform to leverage existing security investments and to provide a seamless and integrated security solution that can meet the needs of organizations of all sizes and types.\nOverall, the integration of these four advances makes SHERLOCKv2 a powerful and effective platform for automated threat intelligence and active defense. It provides organizations with the advanced capabilities they need to detect and respond to threats quickly and effectively, and to stay ahead of the constantly evolving threat landscape.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SHERLOCKv2 integrates four major advances to enhance its cybersecurity capabilities. \n2. SHERLOCKv2 uses data science techniques for advanced analytics, machine learning capabilities and threat detection and response.\n3. Many tasks in threat intelligence and active defense, such as collection, analysis and response to data, are automated by SHERLOCKv2.\n4. Artificial Intelligence technologies like natural language processing (NLP) and computer vision are incorporated into SHERLOCKv2 for advanced threat detection and response.\n5. SHERLOCKv2 has an open architecture that enables it to integrate with other security tools and systems.",
    "vicuna-13b_fact": [
      "SHERLOCKv2 integrates four major advances to enhance its cybersecurity capabilities.",
      "SHERLOCKv2 uses data science techniques for advanced analytics, machine learning capabilities and threat detection and response.",
      "Many tasks in threat intelligence and active defense, such as collection, analysis and response to data, are automated by SHERLOCKv2.",
      "Artificial Intelligence technologies like natural language processing (NLP) and computer vision are incorporated into SHERLOCKv2 for advanced threat detection and response.",
      "SHERLOCKv2 has an open architecture that enables it to integrate with other security tools and systems."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3055,
    "user_query": "What is MOV10?",
    "vicuna-13b_response": "MOV10 is a data type in the x86 instruction set that represents a 16-bit immediate value. It is used in the instruction set to specify a constant value that is used in arithmetic or logical operations. The MOV10 instruction is used to move a 16-bit immediate value into a register.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MOV10 is a data type in the x86 instruction set.\n2. It represents a 16-bit immediate value.\n3. The MOV10 data type is used to specify a constant value in arithmetic or logical operations.\n4. The MOV10 instruction moves a 16-bit immediate value into a register.",
    "vicuna-13b_fact": [
      "MOV10 is a data type in the x86 instruction set.",
      "It represents a 16-bit immediate value.",
      "The MOV10 data type is used to specify a constant value in arithmetic or logical operations.",
      "The MOV10 instruction moves a 16-bit immediate value into a register."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: MOV10 is not a data type in the x86 instruction set, it is a gene involved in inhibiting the vif and replication of HIV-1 in human cells. \n2. FALSE [correction]: The statement is incorrect since MOV10 is not associated with instruction set.\n3. FALSE [correction]: MOV10 does not specify a constant value in arithmetic or logical operations as it is not a data type in the x86 instruction set.\n4. FALSE [correction]: There is no MOV10 instruction to move a 16-bit immediate value into a register in the x86 instruction set.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3057,
    "user_query": "Which cancer is associated with increased levels of Serum alpha fetoprotein (AFP) ?",
    "vicuna-13b_response": "Increased levels of Serum alpha fetoprotein (AFP) are associated with the presence of hepatocellular carcinoma (HCC), also known as liver cancer. AFP is a protein produced by the liver during fetal development and is usually present in low levels in adults. However, in the presence of HCC, the levels of AFP can become elevated. AFP can also be elevated in other types of cancer, such as germ cell tumors, but HCC is the most common cancer associated with elevated AFP levels.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Increased levels of Serum alpha fetoprotein (AFP) are associated with hepatocellular carcinoma (HCC), also known as liver cancer. \n2. AFP is a protein produced by the liver during fetal development.\n3. Serum alpha fetoprotein is usually present in low levels in adults.\n4. The presence of hepatocellular carcinoma (HCC) can cause the levels of AFP to become elevated.\n5. Other types of cancer, such as germ cell tumors, can also cause elevated AFP levels.",
    "vicuna-13b_fact": [
      "Increased levels of Serum alpha fetoprotein (AFP) are associated with hepatocellular carcinoma (HCC), also known as liver cancer.",
      "AFP is a protein produced by the liver during fetal development.",
      "Serum alpha fetoprotein is usually present in low levels in adults.",
      "The presence of hepatocellular carcinoma (HCC) can cause the levels of AFP to become elevated.",
      "Other types of cancer, such as germ cell tumors, can also cause elevated AFP levels."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3060,
    "user_query": "Does the interaction of MOV10 and RNASEH2 promote L1 retrotransposition?",
    "vicuna-13b_response": "MOV10 is a protein that plays a role in the process of L1 retrotransposition, which is the process by which a DNA sequence is inserted into a new location in the genome. RNASEH2 is a protein that is involved in the degradation of RNA. The interaction of these two proteins has been shown to promote L1 retrotransposition. This is because MOV10 helps to recruit RNASEH2 to the L1 retrotransposon, which in turn helps to degrade the RNA that is present in the region. This degradation of RNA helps to create a gap in the DNA, which is then filled by the L1 retrotransposon. This process is important for the maintenance and evolution of the genome, as it allows for the insertion of new DNA sequences into new locations in the genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MOV10 is a protein that plays a role in the process of L1 retrotransposition.\n2. RNASEH2 is a protein that is involved in the degradation of RNA.\n3. The interaction of MOV10 and RNASEH2 has been shown to promote L1 retrotransposition.\n4. MOV10 helps to recruit RNASEH2 to the L1 retrotransposon, which in turn helps to degrade the RNA that is present in the region.\n5. The degradation of RNA helps to create a gap in the DNA, which is then filled by the L1 retrotransposon.",
    "vicuna-13b_fact": [
      "MOV10 is a protein that plays a role in the process of L1 retrotransposition.",
      "RNASEH2 is a protein that is involved in the degradation of RNA.",
      "The interaction of MOV10 and RNASEH2 has been shown to promote L1 retrotransposition.",
      "MOV10 helps to recruit RNASEH2 to the L1 retrotransposon, which in turn helps to degrade the RNA that is present in the region.",
      "The degradation of RNA helps to create a gap in the DNA, which is then filled by the L1 retrotransposon."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: The degradation of RNA does not create a gap in the DNA. Instead, it helps in preventing the reverse transcription of the RNA into DNA, limiting the incorporation of L1 retrotransposon into the DNA sequence.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3063,
    "user_query": "List features of the Triple A syndrome.",
    "vicuna-13b_response": "The Triple A syndrome refers to a group of symptoms that are associated with Alzheimer's disease, atherosclerosis, and age-related macular degeneration. Here are some of the key features of the Triple A syndrome:\n1. Alzheimer's disease: Alzheimer's disease is a neurodegenerative disorder that is characterized by progressive memory loss, decline in cognitive abilities, and changes in behavior and personality.\n2. Atherosclerosis: Atherosclerosis is a condition in which the arteries become narrowed or blocked due to the buildup of plaque, a substance made up of fat, cholesterol, and other substances. This can lead to heart disease, stroke, and other health problems.\n3. Age-related macular degeneration: Age-related macular degeneration (AMD) is a condition that affects the macula, the part of the eye that provides sharp, central vision. It is a leading cause of blindness in older adults.\nOverall, the Triple A syndrome is a combination of conditions that are associated with aging and an increased risk of developing age-related chronic diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Triple A syndrome refers to symptoms associated with Alzheimer's disease, atherosclerosis, and age-related macular degeneration.\n2. Alzheimer's disease is a neurodegenerative disorder characterized by progressive memory loss, cognitive decline, and changes in behavior and personality.\n3. Atherosclerosis is a condition where arteries become narrowed or blocked due to plaque buildup, potentially leading to heart disease, stroke, and other health problems.\n4. Age-related macular degeneration affects the macula, providing sharp, central vision, and is a leading cause of blindness in older adults.\n5. The Triple A syndrome is associated with an increased risk of developing age-related chronic diseases.",
    "vicuna-13b_fact": [
      "The Triple A syndrome refers to symptoms associated with Alzheimer's disease, atherosclerosis, and age-related macular degeneration.",
      "Alzheimer's disease is a neurodegenerative disorder characterized by progressive memory loss, cognitive decline, and changes in behavior and personality.",
      "Atherosclerosis is a condition where arteries become narrowed or blocked due to plaque buildup, potentially leading to heart disease, stroke, and other health problems.",
      "Age-related macular degeneration affects the macula, providing sharp, central vision, and is a leading cause of blindness in older adults.",
      "The Triple A syndrome is associated with an increased risk of developing age-related chronic diseases."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Triple A syndrome refers to a rare genetic condition characterized by adrenal insufficiency, achalasia, and alacrima.\n2. TRUE\n3. TRUE\n4. TRUE \n5. FALSE [correction]: The Triple A syndrome is a rare genetic condition with symptoms like adrenal insufficiency, achalasia, and alacrima. It's not directly linked to an increased risk of age-related chronic diseases.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3065,
    "user_query": "Which protein is the Mitochondrial carrier homolog 2 (MTCH2) receptor for?",
    "vicuna-13b_response": "The Mitochondrial carrier homolog 2 (MTCH2) receptor is a protein that is involved in the transport of certain molecules across the mitochondrial membrane. Specifically, it is a member of the mitochondrial carrier family of proteins, which are involved in the transport of molecules such as amino acids, peptides, and lipids across the mitochondrial membrane. The MTCH2 receptor is thought to play a role in the regulation of mitochondrial metabolism and energy production.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Mitochondrial carrier homolog 2 (MTCH2) receptor is a protein.\n2. The MTCH2 receptor is involved in the transport of certain molecules across the mitochondrial membrane.\n3. The MTCH2 receptor is a member of the mitochondrial carrier family of proteins.\n4. Mitochondrial carrier proteins are involved in the transport of molecules such as amino acids, peptides, and lipids across the mitochondrial membrane.\n5. The MTCH2 receptor is thought to play a role in the regulation of mitochondrial metabolism and energy production.",
    "vicuna-13b_fact": [
      "The Mitochondrial carrier homolog 2 (MTCH2) receptor is a protein.",
      "The MTCH2 receptor is involved in the transport of certain molecules across the mitochondrial membrane.",
      "The MTCH2 receptor is a member of the mitochondrial carrier family of proteins.",
      "Mitochondrial carrier proteins are involved in the transport of molecules such as amino acids, peptides, and lipids across the mitochondrial membrane.",
      "The MTCH2 receptor is thought to play a role in the regulation of mitochondrial metabolism and energy production."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3066,
    "user_query": "What is PhenomeCentral?",
    "vicuna-13b_response": "PhenomeCentral is an open-source software platform that is designed to support the analysis and interpretation of phenotypic data in the context of personalized and precision medicine. It is a web-based platform that provides a user-friendly interface for the management, analysis, and visualization of phenotypic data, which refers to the physical characteristics or traits of an individual that can be observed or measured.\nPhenomeCentral is designed to support a range of different types of phenotypic data, including data on clinical measurements, imaging data, and other types of biomedical data. It provides a range of tools and features that enable users to manage and analyze their data, including tools for data import, data exploration, data analysis, and data visualization.\nOne of the key features of PhenomeCentral is its support for the analysis of complex traits, which are traits that are influenced by multiple genetic and environmental factors. The platform provides a range of tools and algorithms for the analysis of complex traits, including tools for genetic analysis, statistical analysis, and machine learning.\nOverall, PhenomeCentral is a powerful tool for the analysis and interpretation of phenotypic data in the context of personalized and precision medicine. It provides a user-friendly interface and a range of powerful tools and features that enable users to manage, analyze, and visualize their data in order to gain new insights into the underlying causes of disease and to develop more effective treatments.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PhenomeCentral is an open-source software platform.\n2. The platform is designed to support the analysis and interpretation of phenotypic data in the context of personalized and precision medicine.\n3. PhenomeCentral supports various types of phenotypic data, including clinical measurements, imaging data, and other types of biomedical data.\n4. One of the key features of PhenomeCentral is its support for the analysis of complex traits.\n5. PhenomeCentral provides tools for data import, data exploration, data analysis, and data visualization.",
    "vicuna-13b_fact": [
      "PhenomeCentral is an open-source software platform.",
      "The platform is designed to support the analysis and interpretation of phenotypic data in the context of personalized and precision medicine.",
      "PhenomeCentral supports various types of phenotypic data, including clinical measurements, imaging data, and other types of biomedical data.",
      "One of the key features of PhenomeCentral is its support for the analysis of complex traits.",
      "PhenomeCentral provides tools for data import, data exploration, data analysis, and data visualization."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3072,
    "user_query": "List sirtuin inhibitors.",
    "vicuna-13b_response": "Sirtuins are a class of NAD+-dependent deacetylases that play important roles in various cellular processes, including metabolism, inflammation, and aging. Inhibiting sirtuins has been shown to have potential therapeutic benefits in various diseases, including cancer, metabolic disorders, and neurodegenerative diseases. Here are some examples of sirtuin inhibitors:\n1. Exogenous NAD+ analogs: NAD+ analogs such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) can act as sirtuin inhibitors by competing with NAD+ for binding to sirtuins.\n2. Sir2 inhibitors: Sir2 is a well-known sirtuin that is involved in silencing chromosomal repeat regions and regulating gene expression. Sir2 inhibitors such as resveratrol, pterostilbene, and quercetin can bind to Sir2 and inhibit its activity, leading to increased expression of target genes.\n3. Sirtuin-specific inhibitors: Sirtuin-specific inhibitors such as sirtinib, EX-527, and MK-2206 are small molecule inhibitors that selectively target individual sirtuins. For example, sirtinib is a selective inhibitor of SIRT1, while EX-527 is a selective inhibitor of SIRT2.\n4. Histone deacetylase (HDAC) inhibitors: HDACs are enzymes that are responsible for removing acetyl groups from histone proteins, leading to chromatin compaction and gene silencing. HDAC inhibitors such as valproic acid, vorinostat, and romidepsin can inhibit HDAC activity and lead to histone hyperacetylation, which can in turn inhibit sirtuin activity.\nOverall, sirtuin inhibitors have shown promise in various preclinical and clinical studies, and further research is needed to fully understand their therapeutic potential and potential side effects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Sirtuins are a class of NAD+-dependent deacetylases that play important roles in various cellular processes including metabolism, inflammation, and aging.\n2. Inhibiting sirtuins has potential therapeutic benefits in various diseases like cancer, metabolic disorders, and neurodegenerative diseases.\n3. Exogenous NAD+ analogs such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) can act as sirtuin inhibitors.\n4. Sir2 inhibitors include compounds like resveratrol, pterostilbene, and quercetin.\n5. Sirtuin-specific inhibitors include sirtinib, EX-527, and MK-2206.",
    "vicuna-13b_fact": [
      "Sirtuins are a class of NAD+-dependent deacetylases that play important roles in various cellular processes including metabolism, inflammation, and aging.",
      "Inhibiting sirtuins has potential therapeutic benefits in various diseases like cancer, metabolic disorders, and neurodegenerative diseases.",
      "Exogenous NAD+ analogs such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) can act as sirtuin inhibitors.",
      "Sir2 inhibitors include compounds like resveratrol, pterostilbene, and quercetin.",
      "Sirtuin-specific inhibitors include sirtinib, EX-527, and MK-2206."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Activating, not inhibiting, sirtuins has potential therapeutic benefits in various diseases like cancer, metabolic disorders, and neurodegenerative diseases.\n3. FALSE [correction]: Exogenous NAD+ analogs such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) can act as sirtuin activators, not inhibitors.\n4. FALSE [correction]: Sir2 inhibitors include compounds like splitomicin, nicotinamide, and sirtinol. Resveratrol, pterostilbene, and quercetin are considered activators, not inhibitors.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3073,
    "user_query": "Is the NLM medical text indexer (MTI) still useful and relevant?",
    "vicuna-13b_response": "The NLM Medical Text Indexer (MTI) is a tool developed by the National Library of Medicine (NLM) to index and search the content of biomedical literature. It is still widely used and relevant in the field of biomedical informatics and text mining.\nOne of the main advantages of MTI is its ability to extract relevant information from biomedical literature, such as MeSH terms, and store it in a structured format. This information can then be used for various purposes, such as searching and retrieving relevant articles, analyzing trends in research, and identifying relationships between different pieces of information.\nAdditionally, MTI is constantly updated and maintained by the NLM, which ensures that it is up-to-date with the latest developments in biomedical research.\nHowever, it's worth noting that there are also other tools and methods available for text mining and information extraction, and the choice of tool depends on the specific use case and the requirements of the user.\nIn summary, the NLM Medical Text Indexer (MTI) is still a useful and relevant tool for biomedical informatics and text mining, as it allows for the extraction and organization of relevant information from biomedical literature.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The NLM Medical Text Indexer (MTI) is a tool developed by the National Library of Medicine (NLM).\n2. MTI is used to index and search the content of biomedical literature.\n3. One main advantage of MTI is its ability to extract information like MeSH terms from biomedical literature and store it in a structured format.\n4. The NLM constantly updates and maintains the MTI.\n5. The NLM Medical Text Indexer is used in the field of biomedical informatics and text mining.",
    "vicuna-13b_fact": [
      "The NLM Medical Text Indexer (MTI) is a tool developed by the National Library of Medicine (NLM).",
      "MTI is used to index and search the content of biomedical literature.",
      "One main advantage of MTI is its ability to extract information like MeSH terms from biomedical literature and store it in a structured format.",
      "The NLM constantly updates and maintains the MTI.",
      "The NLM Medical Text Indexer is used in the field of biomedical informatics and text mining."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3075,
    "user_query": "What antibiotic is currently used as the standard of care for Clostridium Difficile infection as of 2018",
    "vicuna-13b_response": "As of 2018, the standard of care for Clostridium difficile (C. diff) infection is generally metronidazole or vancomycin. Metronidazole is a nitroimidazole antibiotic that works by affecting the way the bacteria metabolizes food, while vancomycin is a glycopeptide antibiotic that works by inhibiting the bacteria's cell wall synthesis. However, it's important to note that treatment options may vary depending on the severity of the infection and other factors such as the patient's age, medical history, and other medications they are taking. It's always best to consult with a healthcare professional for the most appropriate treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Metronidazole and vancomycin are generally used as the standard of care for Clostridium difficile infection as of 2018.\n2. Metronidazole is a nitroimidazole antibiotic.\n3. Vancomycin is a glycopeptide antibiotic.\n4. Metronidazole works by affecting the way the bacteria metabolizes food.\n5. Vancomycin works by inhibiting the bacteria's cell wall synthesis.",
    "vicuna-13b_fact": [
      "Metronidazole and vancomycin are generally used as the standard of care for Clostridium difficile infection as of 2018.",
      "Metronidazole is a nitroimidazole antibiotic.",
      "Vancomycin is a glycopeptide antibiotic.",
      "Metronidazole works by affecting the way the bacteria metabolizes food.",
      "Vancomycin works by inhibiting the bacteria's cell wall synthesis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3077,
    "user_query": "Which features are evaluated with the CRAFFT screening test?",
    "vicuna-13b_response": "The CRAFFT screening test is used to evaluate a person's risk of alcohol and other drug (AOD) use disorders. The test assesses six key features that are associated with AOD use disorders:\n1. Craving: The test assesses the person's desire to use AOD and the strength of that desire.\n2. Readiness to change: The test assesses the person's willingness to change their AOD use behavior.\n3. Attitudes: The test assesses the person's attitudes towards AOD use and their perception of the harmful effects of AOD use.\n4. Family history: The test assesses the person's family history of AOD use and related problems.\n5. Functioning: The test assesses the person's ability to perform daily activities and responsibilities, such as work, school, and family obligations, while also considering their AOD use.\n6. Tolerance: The test assesses the person's need for increased amounts of AOD to achieve the same effects and their withdrawal symptoms when AOD use is stopped or reduced.\nThe CRAFFT screening test is a brief, simple, and effective tool for identifying individuals who may be at risk for AOD use disorders. It is used in a variety of settings, including primary care offices, emergency departments, and substance abuse treatment centers.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The CRAFFT screening test is used to evaluate a person's risk of alcohol and other drug (AOD) use disorders.\n2. The CRAFFT test assesses a person's desire to use AOD known as craving.\n3. The test evaluates the person's willingness to change their AOD use behavior, known as readiness to change.\n4. The test also evaluates the person's attitudes towards AOD use.\n5. The person's ability to perform daily activities and responsibilities, while also considering their AOD use is assessed as part of the test.\n6. The CRAFFT screening test is used in a variety of settings, including primary care offices, emergency departments, and substance abuse treatment centers.",
    "vicuna-13b_fact": [
      "The CRAFFT screening test is used to evaluate a person's risk of alcohol and other drug (AOD) use disorders.",
      "The CRAFFT test assesses a person's desire to use AOD known as craving.",
      "The test evaluates the person's willingness to change their AOD use behavior, known as readiness to change.",
      "The test also evaluates the person's attitudes towards AOD use.",
      "The person's ability to perform daily activities and responsibilities, while also considering their AOD use is assessed as part of the test.",
      "The CRAFFT screening test is used in a variety of settings, including primary care offices, emergency departments, and substance abuse treatment centers."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The CRAFFT test does not assess a person's desire to use AOD known as craving.\n3. FALSE [correction]: The CRAFFT test does not evaluate the person's willingness to change their AOD use behavior, known as readiness to change.\n4. FALSE [correction]: The CRAFFT test does not directly evaluate the person's attitudes towards AOD use.\n5. FALSE [correction]: The CRAFFT test does not assess the person's ability to perform daily activities and responsibilities while also considering their AOD use.\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "vicuna-13b_response": "The bartender algorithm is a heuristic search algorithm that is used to find the shortest path between two nodes in a graph. It is commonly used in artificial intelligence applications, such as in robotics and computer games, to find the optimal path between two points.\nThe algorithm works by simulating a bartender who is trying to minimize the distance that customers have to travel to reach their desired location. The bartender starts at the starting node and selects the closest unvisited neighbor. The bartender then moves to the selected neighbor and selects the closest unvisited neighbor again. This process continues until the bartender reaches the goal node.\nThe bartender algorithm uses a heuristic function to guide the search process. The heuristic function estimates the distance between the current node and the goal node. The bartender algorithm uses this heuristic function to determine which neighbor to select next, based on the estimated distance to the goal node.\nOne of the advantages of the bartender algorithm is that it is very efficient and can find the shortest path between two nodes in a graph. However, it is not guaranteed to find the optimal path, and there may be other algorithms that are better suited for certain types of problems.\nOverall, the bartender algorithm is a useful tool for finding the shortest path between two nodes in a graph, and it is commonly used in a variety of artificial intelligence applications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The bartender algorithm is a heuristic search algorithm used to find the shortest path between two nodes in a graph.\n2. This algorithm is commonly used in artificial intelligence applications such as robotics and computer games.\n3. The bartender algorithm works by starting at the initial node and selecting the closest unvisited neighbor.\n4. This algorithm uses a heuristic function to guide the search process, which estimates the distance between the current node and the goal node.\n5. The bartender algorithm is efficient in finding the shortest path between two nodes in a graph, but it is not guaranteed to find the optimal path.",
    "vicuna-13b_fact": [
      "The bartender algorithm is a heuristic search algorithm used to find the shortest path between two nodes in a graph.",
      "This algorithm is commonly used in artificial intelligence applications such as robotics and computer games.",
      "The bartender algorithm works by starting at the initial node and selecting the closest unvisited neighbor.",
      "This algorithm uses a heuristic function to guide the search process, which estimates the distance between the current node and the goal node.",
      "The bartender algorithm is efficient in finding the shortest path between two nodes in a graph, but it is not guaranteed to find the optimal path."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Dijkstra's algorithm is a heuristic search algorithm used to find the shortest path between two nodes in a graph, not the bartender algorithm.\n2. TRUE\n3. FALSE [correction]: This is a description of Dijkstra's algorithm, not the bartender algorithm.\n4. FALSE [correction]: The A* search algorithm uses a heuristic function to guide the search process, which estimates the distance between the current node and the goal node.\n5. FALSE [correction]: Dijkstra's or A* algorithms are efficient in finding the shortest path between two nodes in a graph and are guaranteed to find the optimal path, not the bartender algorithm.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3082,
    "user_query": "List two drugs that are included in the Akynzeo pill?",
    "vicuna-13b_response": "Akynzeo is a brand name medication that contains two active ingredients: fosnetupse (also known as netupitant) and palonosetron. Fosnetupse is a neurokinin-1 (NK-1) receptor antagonist, which means it works by blocking the action of certain chemicals in the body that contribute to nausea and vomiting. Palonosetron is a serotonin (5-HT3) receptor antagonist, which also works by blocking the action of certain chemicals in the body that contribute to nausea and vomiting. Together, these two drugs are used to prevent nausea and vomiting associated with cancer chemotherapy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Akynzeo is a brand name medication that contains two active ingredients: fosnetupitant and palonosetron.\n2. Fosnetupitant is a neurokinin-1 (NK-1) receptor antagonist.\n3. Fosnetupitant works by blocking the action of certain chemicals in the body that contribute to nausea and vomiting.\n4. Palonosetron is a serotonin (5-HT3) receptor antagonist.\n5. Akynzeo is used to prevent nausea and vomiting associated with cancer chemotherapy.",
    "vicuna-13b_fact": [
      "Akynzeo is a brand name medication that contains two active ingredients: fosnetupitant and palonosetron.",
      "Fosnetupitant is a neurokinin-1 (NK-1) receptor antagonist.",
      "Fosnetupitant works by blocking the action of certain chemicals in the body that contribute to nausea and vomiting.",
      "Palonosetron is a serotonin (5-HT3) receptor antagonist.",
      "Akynzeo is used to prevent nausea and vomiting associated with cancer chemotherapy."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3087,
    "user_query": "Safinamide is approved for treatment of which disease?",
    "vicuna-13b_response": "Safinamide is approved for the treatment of Parkinson's disease. It is a type of medication called a monoamine oxidase B inhibitor, which works by increasing the levels of certain neurotransmitters in the brain. Safinamide is typically used in combination with levodopa to help control the symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty with movement. It is important to note that safety and efficacy have not been established in children, and the drug should not be used in pregnant or breastfeeding women.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Safinamide is approved for the treatment of Parkinson's disease.\n2. Safinamide is a type of medication called a monoamine oxidase B inhibitor.\n3. Monoamine oxidase B inhibitors work by increasing the levels of certain neurotransmitters in the brain.\n4. Safinamide is typically used in combination with levodopa to help control the symptoms of Parkinson's disease.\n5. Safinamide's safety and efficacy have not been established in children, and it should not be used in pregnant or breastfeeding women.",
    "vicuna-13b_fact": [
      "Safinamide is approved for the treatment of Parkinson's disease.",
      "Safinamide is a type of medication called a monoamine oxidase B inhibitor.",
      "Monoamine oxidase B inhibitors work by increasing the levels of certain neurotransmitters in the brain.",
      "Safinamide is typically used in combination with levodopa to help control the symptoms of Parkinson's disease.",
      "Safinamide's safety and efficacy have not been established in children, and it should not be used in pregnant or breastfeeding women."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3091,
    "user_query": "What is the name of the Cas13 based diagnostic test for the Zika and dengue viruses?",
    "vicuna-13b_response": "The name of the Cas13-based diagnostic test for the Zika and dengue viruses is the \"Cas13-based assay for the detection of Zika and dengue viruses.\" This test utilizes the Cas13 enzyme, which is a CRISPR-associated protein, to detect the presence of the Zika and dengue viruses in a sample. The test works by targeting specific sequences of the viral RNA, and then the Cas13 enzyme cleaves the RNA, which results in the destruction of the virus. This test is still in the research phase and has not yet been widely used for diagnostic purposes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Cas13-based diagnostic test for the Zika and dengue viruses is named the \"Cas13-based assay for the detection of Zika and dengue viruses.\"\n2. The test uses the Cas13 enzyme to detect the presence of the Zika and dengue viruses in a sample.\n3. The Cas13 enzyme is a CRISPR-associated protein.\n4. The Cas13 enzyme works by targeting specific sequences of the viral RNA and then cleaving the RNA, which leads to the virus's destruction.\n5. The Cas13-based assay for the detection of Zika and dengue viruses is only in the research phase and is not widely used for diagnostic purposes.",
    "vicuna-13b_fact": [
      "The Cas13-based diagnostic test for the Zika and dengue viruses is named the \"Cas13-based assay for the detection of Zika and dengue viruses.\"",
      "The test uses the Cas13 enzyme to detect the presence of the Zika and dengue viruses in a sample.",
      "The Cas13 enzyme is a CRISPR-associated protein.",
      "The Cas13 enzyme works by targeting specific sequences of the viral RNA and then cleaving the RNA, which leads to the virus's destruction.",
      "The Cas13-based assay for the detection of Zika and dengue viruses is only in the research phase and is not widely used for diagnostic purposes."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3092,
    "user_query": "What are CRISPR-Cas12a proteins?",
    "vicuna-13b_response": "CRISPR-Cas12a is a bacterial immune system that has been adapted for use as a genetic engineering tool. It consists of two main components: a guide RNA (gRNA) and the Cas12a protein. The gRNA is designed to target a specific sequence of DNA, and the Cas12a protein is an enzyme that cuts the DNA at the targeted site. This allows for precise editing of genes, as the Cas12a protein can be used to delete or add specific sequences to the DNA. CRISPR-Cas12a has been used for a variety of applications, including disease treatment, crop improvement, and basic research.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CRISPR-Cas12a is a bacterial immune system adapted for use as a genetic engineering tool.\n2. The system consists of two main components: a guide RNA (gRNA) and the Cas12a protein.\n3. The gRNA is designed to target a specific sequence of DNA, and the Cas12a protein is an enzyme that cuts the DNA at the targeted site.\n4. CRISPR-Cas12a allows for precise editing of genes, as it can be used to delete or add specific sequences to the DNA.\n5. CRISPR-Cas12a has been used for a variety of applications including disease treatment, crop improvement, and basic research.",
    "vicuna-13b_fact": [
      "CRISPR-Cas12a is a bacterial immune system adapted for use as a genetic engineering tool.",
      "The system consists of two main components: a guide RNA (gRNA) and the Cas12a protein.",
      "The gRNA is designed to target a specific sequence of DNA, and the Cas12a protein is an enzyme that cuts the DNA at the targeted site.",
      "CRISPR-Cas12a allows for precise editing of genes, as it can be used to delete or add specific sequences to the DNA.",
      "CRISPR-Cas12a has been used for a variety of applications including disease treatment, crop improvement, and basic research."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3094,
    "user_query": "Can cardiospheres be produced from skin fibroblasts?",
    "vicuna-13b_response": "Cardiospheres are clusters of cardiac cells that can be used to repair damaged heart tissue. They can be produced from various sources of cardiac cells, including heart tissue, heart muscle cells (myocytes), and stem cells. However, it is also possible to produce cardiospheres from skin fibroblasts.\nFibroblasts are a type of cell that plays a key role in the extracellular matrix, a complex network of proteins and other molecules that provides support and structure to cells. Skin fibroblasts are found in the dermis, the layer of skin beneath the epidermis, and are responsible for producing collagen and other proteins that help to maintain the strength and elasticity of the skin.\nTo produce cardiospheres from skin fibroblasts, the fibroblasts must first be isolated from the skin and expanded in culture. This can be done using a variety of techniques, such as enzymatic digestion or mechanical dissociation. Once the fibroblasts are in culture, they can be induced to differentiate into cardiac cells using a variety of signaling molecules and growth factors. This process can be optimized to produce cardiospheres that are similar in composition and function to those produced from other sources of cardiac cells.\nIt is important to note that the use of skin fibroblasts to produce cardiospheres is still a relatively new and developing field, and more research is needed to optimize the process and ensure the safety and efficacy of these therapies. However, the use of skin fibroblasts as a source of cardiac cells has several potential advantages, including the availability of a large supply of cells, the ease of isolation and expansion in culture, and the potential to generate cells that are genetically matched to the patient, reducing the risk of immune rejection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cardiospheres are clusters of cardiac cells that can be used to repair damaged heart tissue.\n2. Cardiospheres can be produced from sources like heart tissue, heart muscle cells (myocytes), stem cells, and skin fibroblasts.\n3. Skin fibroblasts play a key role in the extracellular matrix which provides support and structure to cells.\n4. Fibroblasts, to produce cardiospheres, have to be isolated from the skin and expanded in culture and then induced to differentiate into cardiac cells.\n5. Use of skin fibroblasts to produce cardiospheres is a developing field that could reduce the risk of immune rejection due to potential to generate cells that are genetically matched to the patient.",
    "vicuna-13b_fact": [
      "Cardiospheres are clusters of cardiac cells that can be used to repair damaged heart tissue.",
      "Cardiospheres can be produced from sources like heart tissue, heart muscle cells (myocytes), stem cells, and skin fibroblasts.",
      "Skin fibroblasts play a key role in the extracellular matrix which provides support and structure to cells.",
      "Fibroblasts, to produce cardiospheres, have to be isolated from the skin and expanded in culture and then induced to differentiate into cardiac cells.",
      "Use of skin fibroblasts to produce cardiospheres is a developing field that could reduce the risk of immune rejection due to potential to generate cells that are genetically matched to the patient."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3095,
    "user_query": "What the chromsomal location of the gene that is deleted in Potocki-Shaffer syndrome?",
    "vicuna-13b_response": "Potocki-Shaffer syndrome is a rare genetic disorder that is caused by a deletion of a specific region on chromosome 15. The gene that is deleted in this disorder is called the WT1 gene, which is located on the long arm of chromosome 15 at position q15.1. The WT1 gene is responsible for the development and function of various organs and tissues in the body, including the kidneys, heart, and gonads. Deletions of the WT1 gene can result in a variety of symptoms, including kidney problems, heart defects, and genital abnormalities.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Potocki-Shaffer syndrome is caused by a deletion of a specific region on chromosome 15.\n2. The gene that is deleted in Potocki-Shaffer syndrome is the WT1 gene.\n3. The WT1 gene is located on the long arm of chromosome 15 at position q15.1.\n4. The WT1 gene is responsible for the development and function of various organs and tissues in the body, including the kidneys, heart, and gonads.\n5. Deletions of the WT1 gene can result in symptoms such as kidney problems, heart defects, and genital abnormalities.",
    "vicuna-13b_fact": [
      "Potocki-Shaffer syndrome is caused by a deletion of a specific region on chromosome 15.",
      "The gene that is deleted in Potocki-Shaffer syndrome is the WT1 gene.",
      "The WT1 gene is located on the long arm of chromosome 15 at position q15.1.",
      "The WT1 gene is responsible for the development and function of various organs and tissues in the body, including the kidneys, heart, and gonads.",
      "Deletions of the WT1 gene can result in symptoms such as kidney problems, heart defects, and genital abnormalities."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Potocki-Shaffer syndrome is caused by a deletion of a specific region on chromosome 11.\n2. FALSE [correction]: The gene that is deleted in Potocki-Shaffer syndrome is the PHF21A gene.\n3. FALSE [correction]: The WT1 gene is located on the short arm of chromosome 11 at position p13.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3099,
    "user_query": "List features of the DOOR syndrome.",
    "vicuna-13b_response": "DOOR syndrome is a rare genetic disorder that affects the development of the face, hands, and feet. The name DOOR is an acronym for the features that are typically present in individuals with this condition:\nD: Dysplasia of the oral region, which refers to abnormal development of the mouth and teeth\nO: Ocular hypertension or glaucoma, which is high pressure in the eyes\nO: Overlap of the fingers or toes (polydactyly)\nA: Apert syndrome, which is a condition that affects the development of the skull, face, and hands\nR: Radial ray syndrome, which affects the development of the bones in the hands and feet\nIndividuals with DOOR syndrome may also have other features, such as developmental delay, intellectual disability, and heart defects. The severity of the condition can vary widely, and the prognosis can depend on the specific features present and their severity.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. DOOR syndrome is a rare genetic disorder affecting development of the face, hands, and feet. \n2. Dysplasia of the oral region, ocular hypertension or glaucoma, overlap of the fingers or toes (polydactyly), Apert syndrome, and Radial ray syndrome are features present in individuals with DOOR syndrome. \n3. Individuals with DOOR syndrome may have developmental delay, intellectual disability, and heart defects. \n4. The severity of DOOR syndrome can vary widely. \n5. The prognosis of DOOR syndrome can depend on the specific features present and their severity.",
    "vicuna-13b_fact": [
      "DOOR syndrome is a rare genetic disorder affecting development of the face, hands, and feet.",
      "Dysplasia of the oral region, ocular hypertension or glaucoma, overlap of the fingers or toes (polydactyly), Apert syndrome, and Radial ray syndrome are features present in individuals with DOOR syndrome.",
      "Individuals with DOOR syndrome may have developmental delay, intellectual disability, and heart defects.",
      "The severity of DOOR syndrome can vary widely.",
      "The prognosis of DOOR syndrome can depend on the specific features present and their severity."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: DOOR syndrome stands for Deafness, Onychodystrophy, Osteodystrophy, mental Retardation. Dysplasia of the oral region, ocular hypertension or glaucoma, overlap of the fingers or toes (polydactyly), Apert syndrome, and Radial ray syndrome are not typically associated features.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "vicuna-13b_response": "There are several web-based pedigree editors available, including:\n1. GenoPro: A free, open-source, web-based genealogy software that allows users to create and edit family trees.\n2. MyHeritage: A paid web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n3. Ancestry: A paid web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n4. FamilySearch: A free, web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n5. Geni: A free, web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n6. WikiTree: A free, web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\nIt is important to note that the features and capabilities of these web-based pedigree editors may vary, and it is recommended to research and compare them before making a decision.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GenoPro is a free, open-source, web-based genealogy software.\n2. MyHeritage is a paid web-based genealogy software.\n3. Ancestry is a paid web-based genealogy software.\n4. FamilySearch is a free web-based genealogy software.\n5. Geni and WikiTree are free web-based genealogy softwares.",
    "vicuna-13b_fact": [
      "GenoPro is a free, open-source, web-based genealogy software.",
      "MyHeritage is a paid web-based genealogy software.",
      "Ancestry is a paid web-based genealogy software.",
      "FamilySearch is a free web-based genealogy software.",
      "Geni and WikiTree are free web-based genealogy softwares."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: GenoPro is a paid, genealogy software but it is not open-source nor web-based.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3101,
    "user_query": "What is the mechanism of action of Solriamfetol?",
    "vicuna-13b_response": "Solriamfetol is a medication that is used to treat excessive daytime sleepiness (EDS) and obstructive sleep apnea (OSA). It is a stimulant that works by increasing the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine. These neurotransmitters play a role in regulating arousal and alertness, and they help to increase brain activity and improve wakefulness.\nSolriamfetol is a prodrug, which means that it is converted into an active metabolite by enzymes in the body. The active metabolite is called (+)-N-[(1S)-1-(3,5-dichloro-2-oxo-1,2,4-oxadiazolidin-4-yl)-3-(2,4-dichlorophenyl)propanamide], which is also known as D-amphetamine. D-amphetamine has a similar mechanism of action to other stimulants, such as amphetamine and methylphenidate, and it works by increasing the levels of dopamine and norepinephrine in the brain.\nSolriamfetol is taken orally, and it is usually taken once or twice a day. It is usually prescribed for people who have EDS or OSA, and it is often used in combination with other treatments, such as lifestyle changes and continuous positive airway pressure (CPAP) therapy.\nIt is important to note that Solriamfetol is a controlled substance and it has the potential for abuse and dependence. It should only be used as directed by a healthcare professional and under close monitoring.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Solriamfetol is a medication used to treat excessive daytime sleepiness and obstructive sleep apnea.\n2. Solriamfetol works by increasing the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine.\n3. Solriamfetol is a prodrug and is converted into an active metabolite by enzymes in the body. \n4. The active metabolite of Solriamfetol is (+)-N-[(1S)-1-(3,5-dichloro-2-oxo-1,2,4-oxadiazolidin-4-yl)-3-(2,4-dichlorophenyl)propanamide], also known as D-amphetamine.\n5. Solriamfetol is taken orally, usually once or twice a day, and is often used in combination with other treatments.",
    "vicuna-13b_fact": [
      "Solriamfetol is a medication used to treat excessive daytime sleepiness and obstructive sleep apnea.",
      "Solriamfetol works by increasing the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine.",
      "Solriamfetol is a prodrug and is converted into an active metabolite by enzymes in the body.",
      "The active metabolite of Solriamfetol is (+)-N-[(1S)-1-(3,5-dichloro-2-oxo-1,2,4-oxadiazolidin-4-yl)-3-(2,4-dichlorophenyl)propanamide], also known as D-amphetamine.",
      "Solriamfetol is taken orally, usually once or twice a day, and is often used in combination with other treatments."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Solriamfetol is not a prodrug, it is active in its administered form.\n4. FALSE [correction]: The active metabolite of Solriamfetol is not D-amphetamine. Solriamfetol is not converted into another active compound in the body; it is active in its original form.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3102,
    "user_query": "What is the difference between the nuclease Cas13a and C2c2",
    "vicuna-13b_response": "Cas13a and C2c2 are both nucleases, which are enzymes that cut DNA or RNA molecules. However, there are some key differences between these two enzymes:\n1. Target recognition: Cas13a is a single-stranded DNA nuclease, meaning it recognizes and cuts one strand of DNA. In contrast, C2c2 is a double-stranded DNA nuclease, meaning it recognizes and cuts both strands of DNA.\n2. Cleavage site: Cas13a cleaves its target DNA molecule at a specific sequence called the PAM (protospacer adjacent motif). C2c2, on the other hand, does not require a specific sequence for cleavage and can cut DNA at any site.\n3. Specificity: Cas13a is highly specific and can only cleave a small subset of related DNA sequences. In contrast, C2c2 has a broader specificity and can cleave a wider range of DNA sequences.\n4. Mechanism: Cas13a and C2c2 have different mechanisms of cleavage. Cas13a uses a divalent cation (such as Mg2+) to stabilize the DNA helix and create a nick in the target molecule. C2c2, on the other hand, uses a different mechanism that involves bending and twisting the DNA molecule to create a cleavage site.\nOverall, while both Cas13a and C2c2 are nucleases that can cleave DNA, they have different target recognition mechanisms, cleavage sites, specificities, and mechanisms of action.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cas13a and C2c2 are both nucleases.\n2. Cas13a is a single-stranded DNA nuclease, while C2c2 is a double-stranded DNA nuclease.\n3. Cas13a cleaves its target DNA molecule at a specific sequence called the PAM (protospacer adjacent motif), while C2c2 does not require a specific sequence for cleavage.\n4. Cas13a is highly specific and can only cleave a small subset of related DNA sequences, while C2c2 has a broader specificity and can cleave a wider range of DNA sequences.\n5. Cas13a uses a divalent cation to stabilize the DNA helix and create a nick in the target molecule, while C2c2 uses a mechanism that involves bending and twisting the DNA molecule to create a cleavage site.",
    "vicuna-13b_fact": [
      "Cas13a and C2c2 are both nucleases.",
      "Cas13a is a single-stranded DNA nuclease, while C2c2 is a double-stranded DNA nuclease.",
      "Cas13a cleaves its target DNA molecule at a specific sequence called the PAM (protospacer adjacent motif), while C2c2 does not require a specific sequence for cleavage.",
      "Cas13a is highly specific and can only cleave a small subset of related DNA sequences, while C2c2 has a broader specificity and can cleave a wider range of DNA sequences.",
      "Cas13a uses a divalent cation to stabilize the DNA helix and create a nick in the target molecule, while C2c2 uses a mechanism that involves bending and twisting the DNA molecule to create a cleavage site."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Cas13a and C2c2 are not DNA nucleases, they are RNA nucleases.\n3. FALSE [correction]: Cas13a cleaves its target RNA molecule, not DNA, and unlike some other CRISPR enzymes, it does not require a PAM sequence. C2c2 also targets RNA, not DNA.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3103,
    "user_query": "Phlorotannin is extracted from what plant?",
    "vicuna-13b_response": "Phlorotannins are a type of polyphenolic compound that are found in a variety of plant species, including brown algae, such as kelp, and other seaweeds. They are also found in some land plants, such as in the bark of cinnamon trees. Phlorotannins are a complex mixture of compounds that can include different types of phenolic acids, such as ellagic acid, and different types of flavan-3-ols, such as catechins and procyanidins. They are known for their antioxidant and anti-inflammatory properties, and have been studied for their potential health benefits.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Phlorotannins are a type of polyphenolic compound.\n2. Phlorotannins are found in brown algae, such as kelp, and other seaweeds.\n3. Phlorotannins are also found in some land plants, including the bark of cinnamon trees.\n4. Phlorotannins are a complex mixture of compounds that can include different types of phenolic acids and flavan-3-ols.\n5. Phlorotannins are known for their antioxidant and anti-inflammatory properties.",
    "vicuna-13b_fact": [
      "Phlorotannins are a type of polyphenolic compound.",
      "Phlorotannins are found in brown algae, such as kelp, and other seaweeds.",
      "Phlorotannins are also found in some land plants, including the bark of cinnamon trees.",
      "Phlorotannins are a complex mixture of compounds that can include different types of phenolic acids and flavan-3-ols.",
      "Phlorotannins are known for their antioxidant and anti-inflammatory properties."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Phlorotannins are not found in land plants; they are exclusive to marine brown algae.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3104,
    "user_query": "Where are pannexins localized?",
    "vicuna-13b_response": "Pannexins are a family of gap junction proteins that are localized in the plasma membrane of cells. They form channels that allow the passage of ions and small molecules between cells, and play a role in various physiological processes such as cellular communication, metabolism, and inflammation.\nPannexins are expressed in many different cell types, including neurons, astrocytes, oligodendrocytes, and microglia, in the central nervous system. They are also expressed in various other tissues, such as the heart, kidney, and intestine.\nIn the central nervous system, pannexins have been implicated in various functions, including the regulation of neuronal excitability, the control of glial cell activity, and the modulation of neurotransmitter release. Mutations in pannexin genes have been linked to various neurological disorders, such as epilepsy, autism, and schizophrenia.\nOverall, pannexins are important components of cellular communication and play a role in a wide range of physiological processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pannexins are a family of gap junction proteins localized in the plasma membrane of cells.\n2. Pannexins form channels that allow the passage of ions and small molecules between cells.\n3. Pannexins are expressed in many different cell types in the central nervous system including neurons, astrocytes, oligodendrocytes, and microglia.\n4. Pannexins have been implicated in various functions in the central nervous system, including regulation of neuronal excitability, control of glial cell activity, and modulation of neurotransmitter release.\n5. Mutations in pannexin genes have been linked to various neurological disorders such as epilepsy, autism, and schizophrenia.",
    "vicuna-13b_fact": [
      "Pannexins are a family of gap junction proteins localized in the plasma membrane of cells.",
      "Pannexins form channels that allow the passage of ions and small molecules between cells.",
      "Pannexins are expressed in many different cell types in the central nervous system including neurons, astrocytes, oligodendrocytes, and microglia.",
      "Pannexins have been implicated in various functions in the central nervous system, including regulation of neuronal excitability, control of glial cell activity, and modulation of neurotransmitter release.",
      "Mutations in pannexin genes have been linked to various neurological disorders such as epilepsy, autism, and schizophrenia."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3105,
    "user_query": "What is the mechanism of action of cariprazine?",
    "vicuna-13b_response": "Cariprazine is an atypical antipsychotic medication that is used to treat schizophrenia and bipolar disorder. Its mechanism of action is not fully understood, but it is thought to involve a combination of dopamine D2 and serotonin 5-HT1A receptor antagonism.\nCariprazine binds to the dopamine D2 receptor, which is involved in the regulation of movement, emotion, and motivation. By blocking the activity of this receptor, cariprazine can help to reduce the symptoms of psychosis, such as hallucinations and delusions.\nIn addition to its effects on dopamine receptors, cariprazine is also thought to act on serotonin 5-HT1A receptors. These receptors are involved in the regulation of mood, anxiety, and aggression. By blocking the activity of these receptors, cariprazine may help to improve mood and reduce anxiety.\nOverall, the mechanism of action of cariprazine is complex and involves a combination of effects on different neurotransmitter systems. By understanding its mechanism of action, researchers can better understand how the medication works and how it may be used to treat different mental health conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cariprazine is an atypical antipsychotic medication.\n2. Cariprazine is used to treat schizophrenia and bipolar disorder.\n3. Cariprazine binds to the dopamine D2 receptor, which regulates movement, emotion, and motivation.\n4. Cariprazine is also thought to act on serotonin 5-HT1A receptors that regulate mood, anxiety, and aggression.\n5. The mechanism of action of cariprazine involves a combination of effects on different neurotransmitter systems.",
    "vicuna-13b_fact": [
      "Cariprazine is an atypical antipsychotic medication.",
      "Cariprazine is used to treat schizophrenia and bipolar disorder.",
      "Cariprazine binds to the dopamine D2 receptor, which regulates movement, emotion, and motivation.",
      "Cariprazine is also thought to act on serotonin 5-HT1A receptors that regulate mood, anxiety, and aggression.",
      "The mechanism of action of cariprazine involves a combination of effects on different neurotransmitter systems."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "vicuna-13b_response": "There are several curated databases that contain information on spider venom toxins. Some of the most well-known databases include:\n1. The Spider Venom Database (SVD): This database is maintained by the Australian Venom Research Unit and contains information on the venoms of spiders from around the world. It includes information on the toxins found in spider venom, their molecular structures, and their biological activities.\n2. The Toxin Database: This database is maintained by the National Center for Biotechnology Information (NCBI) and contains information on toxins from a variety of sources, including spider venom. It includes information on the molecular structures of toxins, their biological activities, and their taxonomic affiliations.\n3. The Venomous Animals Database: This database is maintained by the Venomous Animals Toxin Database (VATD) project and contains information on the venoms of a variety of animals, including spiders. It includes information on the toxins found in spider venom, their molecular structures, and their biological activities.\n4. The Spider Venomics Resource: This database is maintained by the University of California, Santa Cruz, and contains information on the transcriptomes of spiders and their venoms. It includes information on the genes and proteins involved in spider venom production, as well as the toxins themselves.\nThese databases are a great resource for researchers and others interested in spider venom toxins, and they provide a wealth of information on these fascinating molecules.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Spider Venom Database is maintained by the Australian Venom Research Unit.\n2. The Toxin Database is maintained by the National Center for Biotechnology Information.\n3. The Venomous Animals Database is maintained by the Venomous Animals Toxin Database project.\n4. The Spider Venomics Resource is maintained by the University of California, Santa Cruz.\n5. These databases provide information on toxins in spider venom, their molecular structures, and their biological activities.",
    "vicuna-13b_fact": [
      "The Spider Venom Database is maintained by the Australian Venom Research Unit.",
      "The Toxin Database is maintained by the National Center for Biotechnology Information.",
      "The Venomous Animals Database is maintained by the Venomous Animals Toxin Database project.",
      "The Spider Venomics Resource is maintained by the University of California, Santa Cruz.",
      "These databases provide information on toxins in spider venom, their molecular structures, and their biological activities."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3109,
    "user_query": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection",
    "vicuna-13b_response": "There are several antitoxin antibodies that have been approved by the FDA for reducing the recurrence of Clostridium difficile (C. diff) infection. Here are two examples:\n1. Clostridium difficile Infection (CDI) Antibodies: The FDA has approved several antibodies that target the toxins produced by C. diff, including:\n* Bevyxxan (celvapan) - This is a combination of two monoclonal antibodies (mAbs) that target two different toxins produced by C. diff. It is approved for the treatment of CDI in adults.\n* Recarbrio (imipenem/cilastatin) - This is a combination of an antibiotic and an antitoxin that targets the C. diff toxin A. It is approved for the treatment of CDI in adults and pediatric patients.\n2. Fidaxomicin: This is an antibiotic that targets the C. diff toxin B. It is approved for the treatment of CDI in adults. Fidaxomicin works by disrupting the ability of C. diff to produce the toxins that cause diarrhea and inflammation in the gut.\nIt's important to note that these treatments should only be used under the guidance of a healthcare professional, as they may have potential side effects and risks. Additionally, prevention measures such as proper hand hygiene, use of contact precautions, and optimizing the gut microbiome with probiotics can also help reduce the risk of C. diff recurrence.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Bevyxxan (celvapan) is a combination of two monoclonal antibodies that have been approved by the FDA for the treatment of CDI in adults.\n2. Bevyxxan (celvapan) targets two different toxins produced by C. diff.\n3. Recarbrio (imipenem/cilastatin) is a combination of an antibiotic and an antitoxin that targets the C. diff toxin A. It is approved by the FDA for the treatment of CDI in adults and pediatric patients.\n4. Fidaxomicin is an antibiotic that targets the C. diff toxin B and is approved by the FDA for the treatment of CDI in adults.\n5. Fidaxomicin works by disrupting the ability of C. diff to produce the toxins that cause diarrhea and inflammation in the gut.",
    "vicuna-13b_fact": [
      "Bevyxxan (celvapan) is a combination of two monoclonal antibodies that have been approved by the FDA for the treatment of CDI in adults.",
      "Bevyxxan (celvapan) targets two different toxins produced by C. diff.",
      "Recarbrio (imipenem/cilastatin) is a combination of an antibiotic and an antitoxin that targets the C. diff toxin A. It is approved by the FDA for the treatment of CDI in adults and pediatric patients.",
      "Fidaxomicin is an antibiotic that targets the C. diff toxin B and is approved by the FDA for the treatment of CDI in adults.",
      "Fidaxomicin works by disrupting the ability of C. diff to produce the toxins that cause diarrhea and inflammation in the gut."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Bevyxxan (celvapan) is a vaccine against the H1N1 influenza virus, not a treatment for CDI in adults.\n2. FALSE [correction]: Bevyxxan (celvapan) is targeted against the H1N1 influenza virus, not C. diff toxins.\n3. FALSE [correction]: Recarbrio (imipenem/cilastatin and relebactam) is a combination antibiotic used to treat bacterial infections, not specifically CDI. It does not target C. diff toxins. \n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "vicuna-13b_response": "Axitinib is a tyrosine kinase inhibitor (TKI) that has been studied in the treatment of various types of cancer, including pancreatic cancer. While Axitinib has shown some promise in the treatment of pancreatic cancer, its effectiveness in prolonging survival in patients with this disease has been mixed.\nA number of clinical trials have been conducted to evaluate the safety and efficacy of Axitinib in the treatment of pancreatic cancer. One of the most significant studies was a phase III clinical trial known as the \"AGILE\" trial, which involved over 800 patients with advanced pancreatic cancer. The results of this trial showed that Axitinib did not significantly improve overall survival compared to standard chemotherapy in patients with advanced pancreatic cancer.\nHowever, some smaller studies have suggested that Axitinib may benefit certain subgroups of pancreatic cancer patients. For example, a 2017 study published in the journal Cancer Research found that Axitinib may benefit patients with pancreatic cancer that has a specific genetic mutation known as CDH1. Additionally, a 2019 study published in the Journal of Clinical Oncology found that Axitinib may benefit patients with pancreatic cancer that has a high level of a protein called \"PD-L1\".\nIt is important to note that the use of Axitinib in the treatment of pancreatic cancer is still being studied, and more research is needed to fully understand its effectiveness in this context. Currently, Axitinib is not approved by the FDA for the treatment of pancreatic cancer.\nIn conclusion, while Axitinib has shown some promise in the treatment of pancreatic cancer, its effectiveness in prolonging survival in patients with this disease has been mixed. Further research is needed to fully understand the potential benefits and risks of Axitinib in the treatment of pancreatic cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Axitinib is a tyrosine kinase inhibitor (TKI) that has been studied in the treatment of various types of cancer, including pancreatic cancer. \n2. The results of the AGILE trial showed that Axitinib did not significantly improve overall survival compared to standard chemotherapy in patients with advanced pancreatic cancer.\n3. A 2017 study suggested that Axitinib may benefit patients with pancreatic cancer that has a specific genetic mutation known as CDH1.\n4. A 2019 study suggested that Axitinib may benefit patients with pancreatic cancer that has a high level of a protein called \"PD-L1\".\n5. Axitinib is not approved by the FDA for the treatment of pancreatic cancer.",
    "vicuna-13b_fact": [
      "Axitinib is a tyrosine kinase inhibitor (TKI) that has been studied in the treatment of various types of cancer, including pancreatic cancer.",
      "The results of the AGILE trial showed that Axitinib did not significantly improve overall survival compared to standard chemotherapy in patients with advanced pancreatic cancer.",
      "A 2017 study suggested that Axitinib may benefit patients with pancreatic cancer that has a specific genetic mutation known as CDH1.",
      "A 2019 study suggested that Axitinib may benefit patients with pancreatic cancer that has a high level of a protein called \"PD-L1\".",
      "Axitinib is not approved by the FDA for the treatment of pancreatic cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3116,
    "user_query": "What is CVT-301?",
    "vicuna-13b_response": "I'm sorry, but I don't have information on a specific \"CVT-301.\" Can you provide more context or details about what you are asking?",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 3118,
    "user_query": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019).",
    "vicuna-13b_response": "As of 2019, several siRNA drugs have entered phase 2-3 clinical trials. Here are some examples:\n1. Alnylam Pharmaceuticals' ALN-TTR: This drug is designed to treat transthyretin (TTR) amyloidosis, a rare genetic disease that causes progressive heart failure. ALN-TTR is in phase 3 clinical trials.\n2. Arrowhead Pharmaceuticals' ARO-LPA: This drug is designed to treat lipoprotein(a) (Lp(a)) hyperactivity, a genetic risk factor for cardiovascular disease. ARO-LPA is in phase 2b clinical trials.\n3. Dicerna Pharmaceuticals' DCR-PH1: This drug is designed to treat primary hyperoxaluria type 1 (PH1), a rare genetic disorder that causes kidney stones and other complications. DCR-PH1 is in phase 3 clinical trials.\n4. Exonics Therapeutics' EX-02: This drug is designed to treat cytosine arabinoside (Ara-C) resistance in acute myeloid leukemia (AML) patients. EX-02 is in phase 2b clinical trials.\n5. Ionis Pharmaceuticals' IONIS-TTR: This drug is designed to treat TTR amyloidosis, the same disease targeted by Alnylam's ALN-TTR. IONIS-TTR is in phase 3 clinical trials.\n6. Moderna Therapeutics' mRNA-1273: This drug is designed to treat cytomegalovirus (CMV) infection, a common viral infection that can cause serious complications in immunocompromised patients. mRNA-1273 is in phase 3 clinical trials.\n7. Regeneron Pharmaceuticals' REGN-LPI: This drug is designed to treat Lp(a) hyperactivity, the same target as Arrowhead's ARO-LPA. REGN-LPI is in phase 2b clinical trials.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Alnylam Pharmaceuticals' ALN-TTR, designed to treat transthyretin (TTR) amyloidosis, entered phase 3 clinical trials by 2019.\n2. Arrowhead Pharmaceuticals' ARO-LPA, designed to treat lipoprotein(a) (Lp(a)) hyperactivity, was in phase 2b clinical trials as of 2019.\n3. As of 2019, Dicerna Pharmaceuticals' DCR-PH1 had entered phase 3 clinical trials to treat primary hyperoxaluria type 1 (PH1).\n4. Exonics Therapeutics' EX-02, designed to treat cytosine arabinoside (Ara-C) resistance in acute myeloid leukemia (AML) patients, was in phase 2b clinical trials by 2019.\n5. By 2019, Moderna Therapeutics' mRNA-1273, designed to treat cytomegalovirus (CMV) infection, had entered phase 3 clinical trials.",
    "vicuna-13b_fact": [
      "Alnylam Pharmaceuticals' ALN-TTR, designed to treat transthyretin (TTR) amyloidosis, entered phase 3 clinical trials by 2019.",
      "Arrowhead Pharmaceuticals' ARO-LPA, designed to treat lipoprotein(a) (Lp(a)) hyperactivity, was in phase 2b clinical trials as of 2019.",
      "As of 2019, Dicerna Pharmaceuticals' DCR-PH1 had entered phase 3 clinical trials to treat primary hyperoxaluria type 1 (PH1).",
      "Exonics Therapeutics' EX-02, designed to treat cytosine arabinoside (Ara-C) resistance in acute myeloid leukemia (AML) patients, was in phase 2b clinical trials by 2019.",
      "By 2019, Moderna Therapeutics' mRNA-1273, designed to treat cytomegalovirus (CMV) infection, had entered phase 3 clinical trials."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3119,
    "user_query": "Where is fatty acid binding protein 2 expressed?",
    "vicuna-13b_response": "Fatty acid binding protein 2 (FABP2) is a protein that is expressed in various tissues and cells in the body. It is primarily expressed in the liver, but it is also found in other tissues such as the heart, kidney, pancreas, and intestine.\nFABP2 is involved in the transport and metabolism of fatty acids in the body. It binds to long-chain fatty acids and helps to facilitate their uptake by cells and their subsequent metabolism. FABP2 is also involved in the regulation of fatty acid metabolism and insulin sensitivity.\nOverall, FABP2 is an important protein that plays a critical role in the transport and metabolism of fatty acids in the body.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fatty acid binding protein 2 (FABP2) is a protein that is expressed in various tissues and cells in the body.\n2. FABP2 is primarily expressed in the liver.\n3. FABP2 is also found in the heart, kidney, pancreas, and intestine.\n4. FABP2 is involved in the transport and metabolism of fatty acids in the body. \n5. FABP2 binds to long-chain fatty acids and helps to facilitate their uptake by cells and their subsequent metabolism.",
    "vicuna-13b_fact": [
      "Fatty acid binding protein 2 (FABP2) is a protein that is expressed in various tissues and cells in the body.",
      "FABP2 is primarily expressed in the liver.",
      "FABP2 is also found in the heart, kidney, pancreas, and intestine.",
      "FABP2 is involved in the transport and metabolism of fatty acids in the body.",
      "FABP2 binds to long-chain fatty acids and helps to facilitate their uptake by cells and their subsequent metabolism."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: FABP2 is primarily expressed in the intestine.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3121,
    "user_query": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis",
    "vicuna-13b_response": "There are several computational tools that have been developed for alternative polyadenylation (APA) sites analysis. Some of them are:\n1. APAsite: APAsite is a computational tool that predicts APA sites in human and mouse transcriptomes using a machine learning approach. It uses a dataset of known APA sites and non-APA sites to train a classifier, which can then be used to predict APA sites in new transcriptomes.\n2. APAdb: APAdb is a database of APA sites in human and mouse transcriptomes. It provides a comprehensive resource for researchers to explore APA sites and their functional implications.\n3. PolyAdb: PolyAdb is a database of APA sites in Drosophila melanogaster transcriptomes. It provides a resource for researchers to explore APA sites and their functional implications in the fruit fly.\n4. APAtools: APAtools is a set of command-line tools for analyzing APA sites in transcriptomes. It provides a flexible and powerful way to explore APA sites and their functional implications.\n5. APAscan: APAscan is a web-based tool for predicting APA sites in human and mouse transcriptomes. It provides a user-friendly interface for researchers to explore APA sites and their functional implications.\nThese are some of the computational tools that have been developed for APA sites analysis. They provide a range of approaches and resources for researchers to explore this complex and dynamic aspect of gene regulation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. APAsite is a computational tool that predicts APA sites in human and mouse transcriptomes using a machine learning approach.\n2. APAdb is a database of APA sites in human and mouse transcriptomes.\n3. PolyAdb is a database of APA sites in Drosophila melanogaster transcriptomes.\n4. APAtools is a set of command-line tools for analyzing APA sites in transcriptomes.\n5. APAscan is a web-based tool for predicting APA sites in human and mouse transcriptomes.",
    "vicuna-13b_fact": [
      "APAsite is a computational tool that predicts APA sites in human and mouse transcriptomes using a machine learning approach.",
      "APAdb is a database of APA sites in human and mouse transcriptomes.",
      "PolyAdb is a database of APA sites in Drosophila melanogaster transcriptomes.",
      "APAtools is a set of command-line tools for analyzing APA sites in transcriptomes.",
      "APAscan is a web-based tool for predicting APA sites in human and mouse transcriptomes."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3124,
    "user_query": "Which curated data resources for ChIP-seq data are available?",
    "vicuna-13b_response": "There are several curated data resources for ChIP-seq data, including:\n1. The Encyclopedia of DNA Elements (ENCODE) ChIP-seq dataset: This is a large-scale public dataset generated by the ENCODE consortium, which includes ChIP-seq data for a variety of transcription factors and chromatin modifying enzymes across multiple cell types.\n2. The Gene Expression Omnibus (GEO) ChIP-seq dataset: This is a public database that archives and distributes functional genomics data, including ChIP-seq data, generated by researchers around the world.\n3. The ChIP-seq Tracking and Analysis (ChIP-seqTA) database: This is a curated database that provides access to high-quality ChIP-seq datasets, along with associated metadata and analysis tools.\n4. The ChIP-seq Data Analysis Center (ChIP-seq DAC): This is a resource that provides a variety of tools and resources for analyzing and visualizing ChIP-seq data, including a curated database of ChIP-seq datasets.\n5. The ChIP-seq Mapping and Analysis Server (ChIP-MAS): This is a web-based tool that provides a user-friendly interface for analyzing and visualizing ChIP-seq data, including the ability to compare multiple ChIP-seq datasets.\nThese resources provide a variety of options for accessing and analyzing ChIP-seq data, and are useful for researchers in the field of genomics and related fields.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Encyclopedia of DNA Elements (ENCODE) ChIP-seq dataset is a large-scale public dataset that includes ChIP-seq data for various transcription factors and chromatin modifying enzymes across multiple cell types.\n2. The Gene Expression Omnibus (GEO) ChIP-seq dataset is a public database that archives and distributes functional genomics data, including ChIP-seq data.\n3. The ChIP-seq Tracking and Analysis (ChIP-seqTA) database provides access to high-quality ChIP-seq datasets, also offering associated metadata and analysis tools.\n4. The ChIP-seq Data Analysis Center (ChIP-seq DAC) provides tools and resources for analyzing and visualizing ChIP-seq data, including a curated database of ChIP-seq datasets.\n5. The ChIP-seq Mapping and Analysis Server (ChIP-MAS) is a web-based tool that enables the comparison of multiple ChIP-seq datasets.",
    "vicuna-13b_fact": [
      "The Encyclopedia of DNA Elements (ENCODE) ChIP-seq dataset is a large-scale public dataset that includes ChIP-seq data for various transcription factors and chromatin modifying enzymes across multiple cell types.",
      "The Gene Expression Omnibus (GEO) ChIP-seq dataset is a public database that archives and distributes functional genomics data, including ChIP-seq data.",
      "The ChIP-seq Tracking and Analysis (ChIP-seqTA) database provides access to high-quality ChIP-seq datasets, also offering associated metadata and analysis tools.",
      "The ChIP-seq Data Analysis Center (ChIP-seq DAC) provides tools and resources for analyzing and visualizing ChIP-seq data, including a curated database of ChIP-seq datasets.",
      "The ChIP-seq Mapping and Analysis Server (ChIP-MAS) is a web-based tool that enables the comparison of multiple ChIP-seq datasets."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "vicuna-13b_response": "A pseudokinase is a protein that has some of the structural features of a kinase, but does not have the enzymatic activity of a kinase. In the human kinome, there are several hundred pseudokinases. The exact number can vary depending on the source and the specific definition of a pseudokinase used. However, it is estimated that there are around 300-500 pseudokinases in the human genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A pseudokinase is a protein that has some of the structural features of a kinase, but does not display the enzymatic activity of a kinase.\n2. There are several hundred pseudokinases in the human kinome. \n3. The exact count of pseudokinases can vary depending on the source and the specific definition used.\n4. It is estimated that there are around 300-500 pseudokinases in the human genome.",
    "vicuna-13b_fact": [
      "A pseudokinase is a protein that has some of the structural features of a kinase, but does not display the enzymatic activity of a kinase.",
      "There are several hundred pseudokinases in the human kinome.",
      "The exact count of pseudokinases can vary depending on the source and the specific definition used.",
      "It is estimated that there are around 300-500 pseudokinases in the human genome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3126,
    "user_query": "What is the mechanism of action of Inclisiran?",
    "vicuna-13b_response": "Inclisiran is an anti-atherosclerotic medication that is used to treat high cholesterol levels. The mechanism of action of Inclisiran is based on its ability to inhibit the activity of an enzyme called PCSK9, which is involved in the regulation of low-density lipoprotein (LDL) cholesterol levels.\nWhen PCSK9 is inhibited, it leads to an increase in the number of LDL receptors on the surface of liver cells, which results in an increased uptake of LDL cholesterol from the bloodstream. This, in turn, leads to a decrease in the levels of LDL cholesterol in the blood, which can help to prevent the formation of atherosclerotic plaques and reduce the risk of cardiovascular events such as heart attack and stroke.\nInclisiran is administered as an injection under the skin, and its effects can be seen within a few weeks of starting treatment. It is usually given in combination with other cholesterol-lowering medications, such as statins, to achieve optimal cholesterol-lowering effects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Inclisiran is an anti-atherosclerotic medication used to treat high cholesterol levels.\n2. The mechanism of action of Inclisiran is based on its ability to inhibit the activity of an enzyme called PCSK9, which is involved in the regulation of LDL cholesterol levels.\n3. When PCSK9 is inhibited by Inclisiran, the number of LDL receptors on the surface of liver cells increases, leading to an increased uptake of LDL cholesterol from the bloodstream.\n4. Inclisiran is administered as an injection under the skin.\n5. Inclisiran is usually given in combination with other cholesterol-lowering medications, such as statins.",
    "vicuna-13b_fact": [
      "Inclisiran is an anti-atherosclerotic medication used to treat high cholesterol levels.",
      "The mechanism of action of Inclisiran is based on its ability to inhibit the activity of an enzyme called PCSK9, which is involved in the regulation of LDL cholesterol levels.",
      "When PCSK9 is inhibited by Inclisiran, the number of LDL receptors on the surface of liver cells increases, leading to an increased uptake of LDL cholesterol from the bloodstream.",
      "Inclisiran is administered as an injection under the skin.",
      "Inclisiran is usually given in combination with other cholesterol-lowering medications, such as statins."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The mechanism of action of Inclisiran is based on its ability to inhibit the production of an enzyme called PCSK9, which is involved in the regulation of LDL cholesterol levels.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3127,
    "user_query": "Which tool has been developed for visualization of non-covalent contacts?",
    "vicuna-13b_response": "One tool that has been developed for the visualization of non-covalent contacts is called \"Contact Network Analysis\" (CNA). CNA is a computational tool that can be used to analyze the interactions between protein residues and small molecules, such as drugs or metabolites. It can help identify key residues involved in non-covalent interactions and can provide insights into the mechanism of drug binding and protein function. CNA can also be used to predict the effects of mutations on protein-ligand interactions and to design new drugs that target specific protein-ligand interactions. Other tools that can be used for the visualization of non-covalent contacts include molecular visualization software, such as PyMOL, and molecular modeling software, such as Rosetta.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. \"Contact Network Analysis\" (CNA) has been developed for the visualization of non-covalent contacts.\n2. CNA can be used to analyze the interactions between protein residues and small molecules such as drugs or metabolites.\n3. CNA can help identify key residues involved in non-covalent interactions.\n4. CNA can be used to predict the effects of mutations on protein-ligand interactions.\n5. Other tools for the visualization of non-covalent contacts include molecular visualization software such as PyMOL and molecular modeling software such as Rosetta.",
    "vicuna-13b_fact": [
      "\"Contact Network Analysis\" (CNA) has been developed for the visualization of non-covalent contacts.",
      "CNA can be used to analyze the interactions between protein residues and small molecules such as drugs or metabolites.",
      "CNA can help identify key residues involved in non-covalent interactions.",
      "CNA can be used to predict the effects of mutations on protein-ligand interactions.",
      "Other tools for the visualization of non-covalent contacts include molecular visualization software such as PyMOL and molecular modeling software such as Rosetta."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3130,
    "user_query": "Are apoE mimetics being considered as a treatment against Alzheimer's disease?",
    "vicuna-13b_response": "Yes, apoE mimetics are being considered as a potential treatment against Alzheimer's disease. ApoE mimetics are molecules that mimic the effects of apolipoprotein E (apoE), a protein that plays a role in transporting cholesterol and other lipids in the blood.\nStudies have shown that apoE mimetics can reduce the formation of amyloid plaques, a hallmark of Alzheimer's disease, in the brains of animals. Additionally, apoE mimetics have been shown to improve cognitive function in animal models of Alzheimer's disease.\nClinical trials of apoE mimetics are currently underway, and results from these trials will be important in determining the potential of these treatments for Alzheimer's disease. It is important to note that while apoE mimetics show promise, they are not a cure for Alzheimer's disease and more research is needed to fully understand their potential as a treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ApoE mimetics are being considered as a potential treatment against Alzheimer's disease.\n2. Apolipoprotein E (apoE) is a protein responsible for transporting cholesterol and other lipids in the blood.\n3. Studies have shown that apoE mimetics can reduce the formation of amyloid plaques, a hallmark of Alzheimer's disease, in the brains of animals.\n4. ApoE mimetics have been shown to improve cognitive function in animal models of Alzheimer's disease.\n5. Clinical trials of apoE mimetics are currently underway.",
    "vicuna-13b_fact": [
      "ApoE mimetics are being considered as a potential treatment against Alzheimer's disease.",
      "Apolipoprotein E (apoE) is a protein responsible for transporting cholesterol and other lipids in the blood.",
      "Studies have shown that apoE mimetics can reduce the formation of amyloid plaques, a hallmark of Alzheimer's disease, in the brains of animals.",
      "ApoE mimetics have been shown to improve cognitive function in animal models of Alzheimer's disease.",
      "Clinical trials of apoE mimetics are currently underway."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3135,
    "user_query": "What does Prevnar 13 consist of?",
    "vicuna-13b_response": "Prevnar 13 is a vaccine that is used to prevent infections caused by Streptococcus pneumoniae, a type of bacteria that can cause serious illnesses such as pneumonia, meningitis, and ear infections. It is given as an injection and contains 13 strains of the bacteria, including the 11 strains that are included in the pneumococcal conjugate vaccine (PCV13) and two additional strains that are not included in PCV13.\nThe vaccine works by stimulating the immune system to produce antibodies that can recognize and fight the bacteria. This helps to protect against infections caused by the bacteria. Prevnar 13 is typically given to children and adults who are at increased risk of pneumococcal infections, such as those with certain medical conditions or weakened immune systems.\nIt's important to note that Prevnar 13 does not protect against all types of pneumococcal infections, so it's important to follow the advice of a healthcare professional regarding the need for additional pneumococcal vaccines or other measures to prevent infection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Prevnar 13 is a vaccine used to prevent infections caused by Streptococcus pneumoniae.\n2. Streptococcus pneumoniae can cause serious illnesses such as pneumonia, meningitis, and ear infections.\n3. Prevnar 13 contains 13 strains of Streptococcus pneumoniae bacteria.\n4. The vaccine works by stimulating the immune system to produce antibodies that can recognize and fight the bacteria.\n5. Prevnar 13 does not protect against all types of pneumococcal infections.",
    "vicuna-13b_fact": [
      "Prevnar 13 is a vaccine used to prevent infections caused by Streptococcus pneumoniae.",
      "Streptococcus pneumoniae can cause serious illnesses such as pneumonia, meningitis, and ear infections.",
      "Prevnar 13 contains 13 strains of Streptococcus pneumoniae bacteria.",
      "The vaccine works by stimulating the immune system to produce antibodies that can recognize and fight the bacteria.",
      "Prevnar 13 does not protect against all types of pneumococcal infections."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3137,
    "user_query": "What is the cause of a STAG3 truncating variant?",
    "vicuna-13b_response": "STAG3 truncating variants are caused by a genetic mutation in the STAG3 gene. The STAG3 gene provides instructions for making a protein called STAG3, which is involved in the proper segregation of chromosomes during cell division. Truncating mutations in the STAG3 gene result in the production of a shorter, non-functional version of the STAG3 protein, which can lead to abnormalities in chromosome segregation and potentially lead to the development of cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. STAG3 truncating variants are caused by a genetic mutation in the STAG3 gene.\n2. The STAG3 gene provides instructions for making a protein called STAG3.\n3. This protein is involved in the proper segregation of chromosomes during cell division.\n4. Truncating mutations in the STAG3 gene result in the production of a shorter, non-functional version of the STAG3 protein.\n5. The non-functional version of the STAG3 protein can lead to abnormalities in chromosome segregation and potentially lead to the development of cancer.",
    "vicuna-13b_fact": [
      "STAG3 truncating variants are caused by a genetic mutation in the STAG3 gene.",
      "The STAG3 gene provides instructions for making a protein called STAG3.",
      "This protein is involved in the proper segregation of chromosomes during cell division.",
      "Truncating mutations in the STAG3 gene result in the production of a shorter, non-functional version of the STAG3 protein.",
      "The non-functional version of the STAG3 protein can lead to abnormalities in chromosome segregation and potentially lead to the development of cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3138,
    "user_query": "Which tools have been developed for computing split-networks?",
    "vicuna-13b_response": "Split-networks are a type of neural network architecture that consist of two separate sub-networks, often with different architectures, that are combined in some way to perform a specific task. There are several tools and frameworks available for computing split-networks, including:\n1. PyTorch: PyTorch is a popular open-source machine learning library that provides a wide range of tools and modules for building and training neural networks. PyTorch has built-in support for creating and manipulating split-networks, making it a popular choice for researchers and practitioners.\n2. TensorFlow: TensorFlow is another popular open-source machine learning library that provides a wide range of tools and modules for building and training neural networks. TensorFlow also has built-in support for creating and manipulating split-networks, making it a versatile choice for many applications.\n3. Keras: Keras is a high-level neural network API that runs on top of TensorFlow, allowing users to easily build and train neural networks. Keras provides a simple and intuitive interface for creating split-networks, making it a popular choice for researchers and practitioners who want to quickly prototype and test new ideas.\n4. Theano: Theano is a Python library for fast numerical computation that provides a flexible and efficient platform for building and training neural networks. Theano has built-in support for creating and manipulating split-networks, making it a popular choice for researchers who need to perform complex computations quickly.\n5. Caffe: Caffe is a deep learning framework that provides a simple and efficient platform for building and training neural networks. Caffe has built-in support for creating and manipulating split-networks, making it a popular choice for researchers and practitioners who need to quickly build and train neural networks for image classification and other tasks.\nThese are just a few examples of the many tools and frameworks available for computing split-networks. The choice of tool or framework will depend on the specific needs and goals of the user.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Split-networks are a type of neural network architecture that consist of two separate sub-networks.\n2. PyTorch is an open-source machine learning library with support for creating and manipulating split-networks.\n3. TensorFlow is an open-source machine learning library that supports creating and manipulating split-networks.\n4. Keras is a high-level neural network API that runs on top of TensorFlow, and it also supports creating split-networks.\n5. Theano is a Python library for fast numerical computation that supports building and training split-networks. \n6. Caffe is a deep learning framework that provides built-in support for creating and manipulating split-networks.",
    "vicuna-13b_fact": [
      "Split-networks are a type of neural network architecture that consist of two separate sub-networks.",
      "PyTorch is an open-source machine learning library with support for creating and manipulating split-networks.",
      "TensorFlow is an open-source machine learning library that supports creating and manipulating split-networks.",
      "Keras is a high-level neural network API that runs on top of TensorFlow, and it also supports creating split-networks.",
      "Theano is a Python library for fast numerical computation that supports building and training split-networks.",
      "Caffe is a deep learning framework that provides built-in support for creating and manipulating split-networks."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n6. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "vicuna-13b_response": "ApoE mimetics are molecules that mimic the activity of apolipoprotein E (ApoE), a protein that plays a critical role in lipid metabolism and transport. Here are three examples of ApoE mimetics:\n1. Mimetic peptides: Short peptides that mimic the structural and functional properties of ApoE have been developed. These peptides can bind to ApoE receptors and enhance the clearance of lipids from the bloodstream, reducing the risk of cardiovascular disease.\n2. Antibodies: Monoclonal antibodies that bind to ApoE and inhibit its activity have been developed. These antibodies can reduce the levels of ApoE in the bloodstream, leading to a decrease in the concentration of lipids and a lower risk of cardiovascular disease.\n3. Small molecules: Small molecules that mimic the activity of ApoE have been developed. These molecules can bind to ApoE receptors and enhance the clearance of lipids from the bloodstream, reducing the risk of cardiovascular disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Apolipoprotein E (ApoE) is a protein that plays a critical role in lipid metabolism and transport.\n2. Mimetic peptides that mimic ApoE's structural and functional properties have been developed.\n3. These mimetic peptides can bind to ApoE receptors and enhance the clearance of lipids from the bloodstream.\n4. Monoclonal antibodies that bind to ApoE and inhibit its activity have been developed.\n5. Small molecules that mimic the activity of ApoE have also been developed.",
    "vicuna-13b_fact": [
      "Apolipoprotein E (ApoE) is a protein that plays a critical role in lipid metabolism and transport.",
      "Mimetic peptides that mimic ApoE's structural and functional properties have been developed.",
      "These mimetic peptides can bind to ApoE receptors and enhance the clearance of lipids from the bloodstream.",
      "Monoclonal antibodies that bind to ApoE and inhibit its activity have been developed.",
      "Small molecules that mimic the activity of ApoE have also been developed."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "vicuna-13b_response": "SAMHD1 (Sterile alpha motif and HD-domain containing 1) is an enzyme that plays a role in regulating the replication of HIV and other viruses. There is evidence to suggest that there are sex differences in SAMHD1 activity.\nStudies have shown that SAMHD1 activity is higher in females compared to males. This suggests that females may be more resistant to HIV infection due to higher SAMHD1 activity. Additionally, some studies have found that SAMHD1 activity is higher in the female genital tract compared to the male genital tract, which may also contribute to the higher resistance to HIV infection in females.\nIt is important to note that these findings are not universal and more research is needed to fully understand the role of SAMHD1 in HIV infection and the potential sex differences in SAMHD1 activity.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SAMHD1 is an enzyme that regulates the replication of HIV and other viruses.\n2. There is evidence suggesting that there are sex differences in SAMHD1 activity.\n3. Studies have shown SAMHD1 activity to be higher in females than in males.\n4. Higher SAMHD1 activity is believed to make females more resistant to HIV infection.\n5. SAMHD1 activity has been found to be higher in the female genital tract compared to the male genital tract.",
    "vicuna-13b_fact": [
      "SAMHD1 is an enzyme that regulates the replication of HIV and other viruses.",
      "There is evidence suggesting that there are sex differences in SAMHD1 activity.",
      "Studies have shown SAMHD1 activity to be higher in females than in males.",
      "Higher SAMHD1 activity is believed to make females more resistant to HIV infection.",
      "SAMHD1 activity has been found to be higher in the female genital tract compared to the male genital tract."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3144,
    "user_query": "Is the protein Asporin related to disease?",
    "vicuna-13b_response": "Asporin is a protein that is involved in regulating the activity of other proteins in the body. It is not directly related to any specific disease, but it has been implicated in the development of certain diseases. For example, research has suggested that changes in the levels of asporin in the body may be associated with an increased risk of developing certain types of cancer, such as prostate cancer. However, more research is needed to fully understand the role of asporin in disease development and to determine whether it is a potential target for therapeutic intervention.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Asporin is a protein that regulates the activity of other proteins in the body.\n2. Asporin is not directly related to any specific disease.\n3. Research has suggested that changes in the levels of asporin may be associated with an increased risk of certain types of cancer, including prostate cancer.\n4. More research is needed to fully understand the role of asporin in disease development.\n5. Asporin is being considered as potential target for therapeutic intervention.",
    "vicuna-13b_fact": [
      "Asporin is a protein that regulates the activity of other proteins in the body.",
      "Asporin is not directly related to any specific disease.",
      "Research has suggested that changes in the levels of asporin may be associated with an increased risk of certain types of cancer, including prostate cancer.",
      "More research is needed to fully understand the role of asporin in disease development.",
      "Asporin is being considered as potential target for therapeutic intervention."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Asporin is directly related to certain diseases such as osteoarthritis and possibly other forms of cancer.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3147,
    "user_query": "Which cells secrete lactotransferrin?",
    "vicuna-13b_response": "Lactotransferrin is a glycoprotein that is secreted by cells in the mammary gland, specifically in the lining of the mammary ducts and in the alveoli. It is involved in the transport of iron and other metals in the milk, and also plays a role in protecting the milk from bacterial infections.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Lactotransferrin is a glycoprotein that is secreted by cells.\n2. Lactotransferrin is secreted by cells in the mammary gland.\n3. The mammary ducts and alveoli specifically secrete lactotransferrin.\n4. Lactotransferrin is involved in the transport of iron and other metals in the milk.\n5. Lactotransferrin plays a role in protecting the milk from bacterial infections.",
    "vicuna-13b_fact": [
      "Lactotransferrin is a glycoprotein that is secreted by cells.",
      "Lactotransferrin is secreted by cells in the mammary gland.",
      "The mammary ducts and alveoli specifically secrete lactotransferrin.",
      "Lactotransferrin is involved in the transport of iron and other metals in the milk.",
      "Lactotransferrin plays a role in protecting the milk from bacterial infections."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE \n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3150,
    "user_query": "What is the function of the protein Magt1?",
    "vicuna-13b_response": "Magt1 is a protein that plays a role in regulating the transport of magnesium ions (Mg2+) in cells. Magt1 is a member of the Transport Inhibitor Protein (TIP) family, which are proteins that regulate the function of ion channels and transporters.\nMagt1 is expressed in various tissues, including the heart, kidney, and intestine, and it is involved in the regulation of intracellular magnesium levels. Magt1 functions as a negative regulator of the magnesium transport channel, TRPM2, by binding to and inhibiting its activity. This results in a decrease in the influx of magnesium ions into cells, and an increase in the efflux of magnesium ions out of cells.\nMutations in the Magt1 gene have been associated with a form of hypomagnesemia (low magnesium levels) called familial hypomagnesemia with secondary hypocalcemia. This condition is characterized by low levels of both magnesium and calcium in the blood, and is caused by defects in the regulation of magnesium transport.\nOverall, the function of Magt1 is to regulate the transport of magnesium ions in cells, and mutations in the Magt1 gene can lead to disorders of magnesium metabolism.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Magt1 is a protein involved in regulating the transport of magnesium ions in cells.\n2. Magt1 is a member of the Transport Inhibitor Protein family.\n3. Magt1 functions as a negative regulator of the magnesium transport channel, TRPM2.\n4. Mutations in the Magt1 gene have been associated with a condition called familial hypomagnesemia with secondary hypocalcemia.\n5. Familial hypomagnesemia with secondary hypocalcemia is characterized by low levels of both magnesium and calcium in the blood.",
    "vicuna-13b_fact": [
      "Magt1 is a protein involved in regulating the transport of magnesium ions in cells.",
      "Magt1 is a member of the Transport Inhibitor Protein family.",
      "Magt1 functions as a negative regulator of the magnesium transport channel, TRPM2.",
      "Mutations in the Magt1 gene have been associated with a condition called familial hypomagnesemia with secondary hypocalcemia.",
      "Familial hypomagnesemia with secondary hypocalcemia is characterized by low levels of both magnesium and calcium in the blood."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3152,
    "user_query": "What is the function of the transcriptional co-activator p300?",
    "vicuna-13b_response": "The transcriptional co-activator p300, also known as E1A binding protein p300 (E1BP300), is a protein that plays a critical role in regulating gene expression. It is a member of the p300/CBP family of transcriptional co-activators, which are large proteins that can interact with a variety of transcription factors and other proteins to regulate the activity of genes.\nThe primary function of p300 is to enhance the activity of transcription factors by recruiting them to specific promoter regions of genes and helping to assemble the necessary pre-initiation complex. p300 can also modify transcription factors by adding acetyl groups to their lysine residues, which can enhance their transcriptional activity.\np300 is involved in a wide range of biological processes, including cell growth and differentiation, apoptosis (programmed cell death), and response to environmental stimuli. It has been shown to play a role in the development of several diseases, including cancer and neurodegenerative disorders.\nOverall, p300 is a critical regulator of gene expression that plays a crucial role in many biological processes and is involved in the development of a variety of diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The transcriptional co-activator p300, also known as E1A binding protein p300 (E1BP300), is a protein that plays a critical role in regulating gene expression.\n2. p300 is a member of the p300/CBP family of transcriptional co-activators, which interact with a variety of transcription factors and other proteins to regulate genes.\n3. The primary function of p300 is to enhance the activity of transcription factors by recruiting them to specific promoter regions of genes and assembling the necessary pre-initiation complex.\n4. p300 can modify transcription factors by adding acetyl groups to their lysine residues.\n5. p300 is involved in a wide range of biological processes, including cell growth and differentiation, apoptosis, response to environmental stimuli and is associated with the development of diseases like cancer and neurodegenerative disorders.",
    "vicuna-13b_fact": [
      "The transcriptional co-activator p300, also known as E1A binding protein p300 (E1BP300), is a protein that plays a critical role in regulating gene expression.",
      "p300 is a member of the p300/CBP family of transcriptional co-activators, which interact with a variety of transcription factors and other proteins to regulate genes.",
      "The primary function of p300 is to enhance the activity of transcription factors by recruiting them to specific promoter regions of genes and assembling the necessary pre-initiation complex.",
      "p300 can modify transcription factors by adding acetyl groups to their lysine residues.",
      "p300 is involved in a wide range of biological processes, including cell growth and differentiation, apoptosis, response to environmental stimuli and is associated with the development of diseases like cancer and neurodegenerative disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3158,
    "user_query": "What is a mitosome?",
    "vicuna-13b_response": "A mitosome is a type of organelle found in certain types of cells, such as blood cells and immune cells. It is responsible for the production and maintenance of the cell's cytoskeleton, which is a network of proteins that gives the cell its shape and helps it to move. The mitosome is also involved in the process of cell division, and helps to ensure that the cell divides properly and that the resulting daughter cells have the correct number of cytoskeletal components.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A mitosome is a type of organelle found in certain types of cells, such as blood cells and immune cells.\n2. The mitosome is responsible for the production and maintenance of the cell's cytoskeleton.\n3. The cell's cytoskeleton is a network of proteins that gives the cell its shape and helps it to move.\n4. The mitosome is also involved in the process of cell division.\n5. The mitosome helps to ensure that the cell divides properly and that the resulting daughter cells have the correct number of cytoskeletal components.",
    "vicuna-13b_fact": [
      "A mitosome is a type of organelle found in certain types of cells, such as blood cells and immune cells.",
      "The mitosome is responsible for the production and maintenance of the cell's cytoskeleton.",
      "The cell's cytoskeleton is a network of proteins that gives the cell its shape and helps it to move.",
      "The mitosome is also involved in the process of cell division.",
      "The mitosome helps to ensure that the cell divides properly and that the resulting daughter cells have the correct number of cytoskeletal components."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mitosomes are a type of organelle found in certain types of eukaryotic cells, but not typically in blood cells and immune cells.\n2. FALSE [correction]: The mitosome is not directly responsible for the production and maintenance of the cell's cytoskeleton. That is typically the job of other organelles such as the endoplasmic reticulum and Golgi apparatus.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3164,
    "user_query": "What is the effect of NFIA on astrocyte differentiation?",
    "vicuna-13b_response": "NFIA (Nuclear Factor I-A) is a transcription factor that plays a critical role in regulating the differentiation and function of astrocytes, which are a type of glial cell in the brain.\nAstrocytes are responsible for a variety of important functions, including maintaining the extracellular environment, regulating the levels of neurotransmitters, and providing support to neurons. The differentiation of astrocytes is a complex process that involves the coordinated expression of a variety of genes, and NFIA is one of the key transcription factors that regulates this process.\nStudies have shown that NFIA is essential for the differentiation of astrocytes from neural stem cells. NFIA promotes the expression of genes that are involved in the development of astrocytes, including the expression of glial fibrillary acidic protein (GFAP), a key protein involved in astrocyte function.\nIn addition, NFIA has been shown to play a role in regulating the response of astrocytes to injury and disease. For example, NFIA has been shown to be involved in the response of astrocytes to traumatic brain injury, where it promotes the expression of genes involved in the repair and regeneration of the brain.\nOverall, the effect of NFIA on astrocyte differentiation is to promote the development and function of astrocytes, and to regulate their response to injury and disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. NFIA (Nuclear Factor I-A) is a transcription factor.\n2. NFIA plays a critical role in regulating the differentiation and function of astrocytes.\n3. Astrocytes maintain the extracellular environment, regulate the levels of neurotransmitters, and provide support to neurons.\n4. The differentiation of astrocytes involves the coordinated expression of a variety of genes.\n5. NFIA promotes the expression of genes that are involved in the development of astrocytes.",
    "vicuna-13b_fact": [
      "NFIA (Nuclear Factor I-A) is a transcription factor.",
      "NFIA plays a critical role in regulating the differentiation and function of astrocytes.",
      "Astrocytes maintain the extracellular environment, regulate the levels of neurotransmitters, and provide support to neurons.",
      "The differentiation of astrocytes involves the coordinated expression of a variety of genes.",
      "NFIA promotes the expression of genes that are involved in the development of astrocytes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3165,
    "user_query": "What is the mode of action for Tocilizumab?",
    "vicuna-13b_response": "Tocilizumab is a monoclonal antibody that is used to treat a variety of autoimmune diseases, including rheumatoid arthritis, Castleman disease, and systemic lupus erythematosus (SLE). The mode of action of tocilizumab is not fully understood, but it is believed to involve the inhibition of certain immune cells, including T cells and B cells, which play a role in the autoimmune response.\nTocilizumab binds to and inhibits the activity of a protein called interleukin-6 (IL-6) receptor alpha chain, which is expressed on the surface of many different cell types, including immune cells. By inhibiting the IL-6 receptor, tocilizumab reduces the signaling of IL-6, which is a cytokine that plays a role in the activation and survival of immune cells.\nIn addition to its effects on immune cells, tocilizumab has been shown to reduce the production of certain pro-inflammatory cytokines, including TNF-alpha and IL-1 beta, which are involved in the pathogenesis of autoimmune diseases.\nOverall, the mode of action of tocilizumab is complex and involves the inhibition of multiple signaling pathways that are involved in the autoimmune response. By targeting these pathways, tocilizumab has been shown to be effective in reducing the symptoms of autoimmune diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tocilizumab is a monoclonal antibody used to treat a variety of autoimmune diseases, including rheumatoid arthritis, Castleman disease, and systemic lupus erythematosus (SLE).\n2. Tocilizumab is believed to inhibit certain immune cells, including T cells and B cells.\n3. Tocilizumab binds to and inhibits the activity of a protein called interleukin-6 (IL-6) receptor alpha chain.\n4. By inhibiting the IL-6 receptor, tocilizumab reduces the signaling of IL-6, a cytokine that plays a role in the activation and survival of immune cells.\n5. Tocilizumab reduces the production of certain pro-inflammatory cytokines, including TNF-alpha and IL-1 beta, which are involved in the pathogenesis of autoimmune diseases.",
    "vicuna-13b_fact": [
      "Tocilizumab is a monoclonal antibody used to treat a variety of autoimmune diseases, including rheumatoid arthritis, Castleman disease, and systemic lupus erythematosus (SLE).",
      "Tocilizumab is believed to inhibit certain immune cells, including T cells and B cells.",
      "Tocilizumab binds to and inhibits the activity of a protein called interleukin-6 (IL-6) receptor alpha chain.",
      "By inhibiting the IL-6 receptor, tocilizumab reduces the signaling of IL-6, a cytokine that plays a role in the activation and survival of immune cells.",
      "Tocilizumab reduces the production of certain pro-inflammatory cytokines, including TNF-alpha and IL-1 beta, which are involved in the pathogenesis of autoimmune diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Tocilizumab is believed to inhibit certain immune cells, including macrophages, not T cells and B cells.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Tocilizumab reduces the signaling of IL-6, which may indirectly reduce the production of certain pro-inflammatory cytokines, but it doesn't directly reduce the production of TNF-alpha and IL-1 beta.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3166,
    "user_query": "Where is the protein protamine 2 expressed?",
    "vicuna-13b_response": "Protamine 2 is a protein that is expressed in the testes, specifically in the spermatogonia cells. These cells are responsible for the production of sperm cells. Protamine 2 is involved in the regulation of the cell cycle and apoptosis, or programmed cell death, in these cells. It also plays a role in the differentiation of spermatogonia into Sertoli cells, which are important for the development and maturation of sperm.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Protamine 2 is a protein that is expressed in the testes.\n2. Protamine 2 is specifically expressed in the spermatogonia cells.\n3. Spermatogonia cells in the testes are responsible for the production of sperm cells.\n4. Protamine 2 is involved in the regulation of the cell cycle and apoptosis in spermatogonia cells.\n5. Protamine 2 plays a role in the differentiation of spermatogonia into Sertoli cells.",
    "vicuna-13b_fact": [
      "Protamine 2 is a protein that is expressed in the testes.",
      "Protamine 2 is specifically expressed in the spermatogonia cells.",
      "Spermatogonia cells in the testes are responsible for the production of sperm cells.",
      "Protamine 2 is involved in the regulation of the cell cycle and apoptosis in spermatogonia cells.",
      "Protamine 2 plays a role in the differentiation of spermatogonia into Sertoli cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Protamine 2 is specifically expressed in spermatids, not spermatogonia cells.\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: Spermatogonia differentiate into sperm cells, not Sertoli cells. Furthermore, Protamine 2 does not play a role in this process as its expression is seen in spermatids.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3174,
    "user_query": "Was stelara developed by Amgen?",
    "vicuna-13b_response": "Yes, Stelara (ustekinumab) is a medication developed by Amgen. It is a monoclonal antibody therapy used to treat a variety of autoimmune conditions, including psoriasis, psoriatic arthritis, and Crohn's disease. Stelara was approved by the U.S. Food and Drug Administration (FDA) in 2016 and has since become a widely used treatment option for patients with these conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Stelara (ustekinumab) is a medication developed by Amgen.\n2. Stelara is a monoclonal antibody therapy.\n3. Stelara is used to treat a variety of autoimmune conditions, including psoriasis, psoriatic arthritis, and Crohn's disease.\n4. Stelara was approved by the U.S. Food and Drug Administration (FDA) in 2016.\n5. Stelara has widely been used as a treatment option for autoimmune conditions since its approval.",
    "vicuna-13b_fact": [
      "Stelara (ustekinumab) is a medication developed by Amgen.",
      "Stelara is a monoclonal antibody therapy.",
      "Stelara is used to treat a variety of autoimmune conditions, including psoriasis, psoriatic arthritis, and Crohn's disease.",
      "Stelara was approved by the U.S. Food and Drug Administration (FDA) in 2016.",
      "Stelara has widely been used as a treatment option for autoimmune conditions since its approval."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Stelara (ustekinumab) is a medication developed by Janssen Biotech.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3178,
    "user_query": "What is the cause of Krabbe disease?",
    "vicuna-13b_response": "Krabbe disease is a rare, inherited disorder that affects the nervous system. It is caused by a deficiency of the enzyme galactocerebrosidase, which is responsible for breaking down a specific type of fat molecule found in the brain and other tissues.\nThis deficiency leads to the accumulation of these fat molecules, called galactosylceramides, in the brain and other organs, causing progressive damage to the nervous system. The exact cause of the enzyme deficiency is not known in most cases, but it is thought to be due to a genetic mutation or deletion of the gene that encodes for the enzyme.\nKrabbe disease is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the gene, one from each parent, in order to develop the disorder.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Krabbe disease is a rare, inherited disorder that affects the nervous system.\n2. Krabbe disease is caused by a deficiency of the enzyme galactocerebrosidase.\n3. The enzyme galactocerebrosidase is responsible for breaking down a specific type of fat molecule found in the brain and other tissues.\n4. The deficiency of the enzyme galactocerebrosidase leads to the accumulation of galactosylceramides in the brain and other organs, causing progressive damage to the nervous system.\n5. Krabbe disease is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the gene, one from each parent, in order to develop the disorder.",
    "vicuna-13b_fact": [
      "Krabbe disease is a rare, inherited disorder that affects the nervous system.",
      "Krabbe disease is caused by a deficiency of the enzyme galactocerebrosidase.",
      "The enzyme galactocerebrosidase is responsible for breaking down a specific type of fat molecule found in the brain and other tissues.",
      "The deficiency of the enzyme galactocerebrosidase leads to the accumulation of galactosylceramides in the brain and other organs, causing progressive damage to the nervous system.",
      "Krabbe disease is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the gene, one from each parent, in order to develop the disorder."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3182,
    "user_query": "What are the phenotypic features of the autosomal dominant, development disease, Noonans syndrome",
    "vicuna-13b_response": "Noonan syndrome is an autosomal dominant developmental disorder that is characterized by a variety of physical and developmental features. Some of the key phenotypic features of Noonan syndrome include:\n1. Short stature: Individuals with Noonan syndrome tend to be shorter than average, with an average height of around 5'2\".\n2. Dysmorphic facial features: Individuals with Noonan syndrome often have distinctive facial features, including a low hairline, a broad forehead, a small chin, and a depressed nasal bridge.\n3. Congenital heart defects: Approximately 50% of individuals with Noonan syndrome are born with congenital heart defects, which can range from mild to severe.\n4. Developmental delays: Many individuals with Noonan syndrome experience developmental delays, including delayed crawling, walking, and talking.\n5. Hypertelorism: Individuals with Noonan syndrome often have widely spaced eyes (hypertelorism) and a narrowing of the eye socket (orbit).\n6. Short, webbed neck: Individuals with Noonan syndrome may have a short, webbed neck, which can make it difficult for them to hold their head up.\n7. Low-set ears: Individuals with Noonan syndrome may have low-set ears that are rotated forward.\n8. Abnormalities of the fingers and toes: Some individuals with Noonan syndrome may have abnormalities of the fingers and toes, including webbing or extra digits.\nIt's important to note that not all individuals with Noonan syndrome will have all of these features, and the severity of the features can vary widely from person to person.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Noonan syndrome is an autosomal dominant developmental disorder.\n2. Individuals with Noonan syndrome tend to have an average height of around 5'2\".\n3. Approximately 50% of individuals with Noonan syndrome are born with congenital heart defects.\n4. Many individuals with Noonan syndrome experience developmental delays, including delayed crawling, walking, and talking.\n5. Some individuals with Noonan syndrome may have abnormalities of the fingers and toes, including webbing or extra digits.",
    "vicuna-13b_fact": [
      "Noonan syndrome is an autosomal dominant developmental disorder.",
      "Individuals with Noonan syndrome tend to have an average height of around 5'2\".",
      "Approximately 50% of individuals with Noonan syndrome are born with congenital heart defects.",
      "Many individuals with Noonan syndrome experience developmental delays, including delayed crawling, walking, and talking.",
      "Some individuals with Noonan syndrome may have abnormalities of the fingers and toes, including webbing or extra digits."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Individuals with Noonan syndrome tend to have a short stature, but the average height can vary widely based on many factors, including the individual's specific genetic makeup and overall health.  \n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3186,
    "user_query": "Are there any anti-amyloid antibody approved as drug for Alzheimer's disease treatment?",
    "vicuna-13b_response": "Yes, there are several anti-amyloid antibody drugs that have been approved for the treatment of Alzheimer's disease. These drugs work by targeting and removing amyloid-beta plaques, which are a hallmark of the disease.\nOne such drug is aducanumab, which was approved by the U.S. Food and Drug Administration (FDA) in March 2021. Another drug, gantenerumab, was approved in the European Union in 2020. Other anti-amyloid antibody drugs that are currently in development include crenezumab, BAN2401, and ABBV-951.\nIt's important to note that while these drugs have shown promise in clinical trials, they are not a cure for Alzheimer's disease and do not work for everyone. Additionally, these drugs can have significant side effects, so they must be carefully monitored by healthcare professionals.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Anti-amyloid antibody drugs have been approved for the treatment of Alzheimer's disease.\n2. These drugs work by targeting and removing amyloid-beta plaques.\n3. Aducanumab is an anti-amyloid antibody drug that was approved by the U.S. FDA in March 2021.\n4. Gantenerumab was approved as an Alzheimer's disease treatment in the European Union in 2020.\n5. Crenezumab, BAN2401, and ABBV-951 are other anti-amyloid antibody drugs that are currently in development.",
    "vicuna-13b_fact": [
      "Anti-amyloid antibody drugs have been approved for the treatment of Alzheimer's disease.",
      "These drugs work by targeting and removing amyloid-beta plaques.",
      "Aducanumab is an anti-amyloid antibody drug that was approved by the U.S. FDA in March 2021.",
      "Gantenerumab was approved as an Alzheimer's disease treatment in the European Union in 2020.",
      "Crenezumab, BAN2401, and ABBV-951 are other anti-amyloid antibody drugs that are currently in development."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Aducanumab is an anti-amyloid antibody drug that was approved by the U.S. FDA in June 2021.\n4. FALSE [correction]: As of now, Gantenerumab has not been approved as an Alzheimer's disease treatment in the European Union.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3192,
    "user_query": "List places in the body where somatostatin is produced.",
    "vicuna-13b_response": "Somatostatin is a hormone that is produced by the hypothalamus and the posterior pituitary gland in the body. It plays a crucial role in regulating the release of other hormones, including growth hormone, thyroid-stimulating hormone, and adrenocorticotropic hormone.\nThe following are the places in the body where somatostatin is produced:\n1. Hypothalamus: The hypothalamus is a part of the brain that plays a crucial role in regulating various bodily functions, including hunger, thirst, and body temperature. Somatostatin is produced by the hypothalamus and is released into the bloodstream.\n2. Posterior pituitary gland: The posterior pituitary gland is a small endocrine gland located at the base of the brain. It is responsible for producing and releasing several hormones, including somatostatin.\n3. Pancreas: Somatostatin is also produced by the pancreas, particularly by the delta cells located in the pancreatic islets. These cells produce and release somatostatin into the bloodstream, where it helps to regulate insulin secretion.\n4. Gastrointestinal tract: Somatostatin is also produced by the cells lining the small intestine. These cells produce and release somatostatin into the bloodstream, where it helps to regulate the release of digestive enzymes.\nOverall, somatostatin is produced by multiple tissues in the body, and its production and release are tightly regulated to maintain proper hormonal balance and homeostasis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Somatostatin is produced by the hypothalamus and the posterior pituitary gland.\n2. Somatostatin plays a role in regulating the release of other hormones, including growth hormone, thyroid-stimulating hormone, and adrenocorticotropic hormone.\n3. The posterior pituitary gland, located at the base of the brain, is a producer of somatostatin.\n4. Somatostatin is also produced by the pancreas, specifically by the delta cells located in the pancreatic islets.\n5. The cells lining the small intestine also produce somatostatin.",
    "vicuna-13b_fact": [
      "Somatostatin is produced by the hypothalamus and the posterior pituitary gland.",
      "Somatostatin plays a role in regulating the release of other hormones, including growth hormone, thyroid-stimulating hormone, and adrenocorticotropic hormone.",
      "The posterior pituitary gland, located at the base of the brain, is a producer of somatostatin.",
      "Somatostatin is also produced by the pancreas, specifically by the delta cells located in the pancreatic islets.",
      "The cells lining the small intestine also produce somatostatin."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Somatostatin is produced by the hypothalamus and the delta cells of the pancreas, not the posterior pituitary gland.\n2. TRUE\n3. FALSE [correction]: The posterior pituitary gland does not produce somatostatin. It produces hormones like oxytocin and vasopressin.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3195,
    "user_query": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?",
    "vicuna-13b_response": "Human breast milk contains several types of immunoglobulin heavy chain (IgH) containing antibodies that help protect the infant against infections and other harmful substances. The three main types of IgH antibodies found in human breast milk are:\n1. IgA: This is the most abundant type of antibody found in breast milk. It is secreted in large amounts by mammary glands and helps protect the infant against infections in the gut and respiratory tract.\n2. IgD: This is a type of IgH antibody that is found in low levels in breast milk. It is involved in the development and activation of B cells, which are important components of the immune system.\n3. IgE: This is a type of IgH antibody that is found in very low levels in breast milk. It plays a role in allergic reactions and helps protect against parasites such as worms.\nOverall, the presence of these IgH antibodies in breast milk helps provide the infant with important immune protection during the critical period of development.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Human breast milk contains several types of immunoglobulin heavy chain (IgH) containing antibodies.\n2. IgA is the most abundant type of antibody found in breast milk.\n3. IgD is a type of IgH antibody that is found in low levels in breast milk.\n4. IgE is a type of IgH antibody that is found in very low levels in breast milk.\n5. The presence of IgH antibodies in breast milk provides the infant with important immune protection during the period of development.",
    "vicuna-13b_fact": [
      "Human breast milk contains several types of immunoglobulin heavy chain (IgH) containing antibodies.",
      "IgA is the most abundant type of antibody found in breast milk.",
      "IgD is a type of IgH antibody that is found in low levels in breast milk.",
      "IgE is a type of IgH antibody that is found in very low levels in breast milk.",
      "The presence of IgH antibodies in breast milk provides the infant with important immune protection during the period of development."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3196,
    "user_query": "What is a exposome?",
    "vicuna-13b_response": "An exposome is a comprehensive measure of all the exposures an individual has experienced over their lifetime, including environmental, lifestyle, and occupational factors. It is a concept that takes into account the idea that an individual's health is not solely determined by their genetic makeup, but also by the exposures they have had to various substances and factors in their environment. The exposome is thought to play a role in the development of chronic diseases such as cancer, cardiovascular disease, and diabetes. It is a complex and dynamic concept that is still being studied and defined, but it has the potential to provide a more complete picture of an individual's health and disease risk.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. An exposome is a measure of all the exposures an individual experiences over their lifetime, including environmental, lifestyle, and occupational factors.\n2. The concept of exposome takes into account that an individual's health is influenced not only by their genetics, but also by their environmental exposures.\n3. The exposome is thought to play a role in the development of chronic diseases such as cancer, cardiovascular disease, and diabetes.\n4. The concept of the exposome is still being studied and defined.\n5. The exposome can potentially provide a more complete picture of an individual's health and disease risk.",
    "vicuna-13b_fact": [
      "An exposome is a measure of all the exposures an individual experiences over their lifetime, including environmental, lifestyle, and occupational factors.",
      "The concept of exposome takes into account that an individual's health is influenced not only by their genetics, but also by their environmental exposures.",
      "The exposome is thought to play a role in the development of chronic diseases such as cancer, cardiovascular disease, and diabetes.",
      "The concept of the exposome is still being studied and defined.",
      "The exposome can potentially provide a more complete picture of an individual's health and disease risk."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3202,
    "user_query": "Which gene therapy treatment is FDA approved for retinal dystrophy?",
    "vicuna-13b_response": "As of my knowledge cutoff date of September 2021, the FDA has approved one gene therapy treatment for retinal dystrophy, which is called Luxturna (voretigene neparvovec-rzyl).\nLuxturna is a one-time infusion of a genetically modified virus that contains a healthy copy of the gene that is responsible for the inherited retinal dystrophy. The virus is administered through an intravenous (IV) infusion, and it delivers the healthy gene to the cells in the retina that are responsible for vision.\nLuxturna was approved by the FDA in 2017 for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy, which is a rare inherited condition that causes progressive vision loss. It is the first gene therapy to be approved for the treatment of an inherited retinal disease, and it has been shown to significantly improve vision in patients with this condition.\nIt's important to note that since my knowledge cutoff, there may have been new developments or updates regarding gene therapy treatments for retinal dystrophy, and it's always best to consult with a healthcare professional for the most current and accurate information.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. As of September 2021, the FDA has approved one gene therapy treatment for retinal dystrophy, Luxturna (voretigene neparvovec-rzyl).\n2. Luxturna is a one-time infusion of a genetically modified virus that contains a healthy copy of a specific gene.\n3. The therapy is administered via an intravenous (IV) infusion which delivers the healthy gene to the retina cells responsible for vision.\n4. Luxturna was approved by the FDA in 2017 for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy.\n5. Luxturna is the first gene therapy to be approved for the treatment of an inherited retinal disease and has been shown to significantly improve vision in patients with this condition.",
    "vicuna-13b_fact": [
      "As of September 2021, the FDA has approved one gene therapy treatment for retinal dystrophy, Luxturna (voretigene neparvovec-rzyl).",
      "Luxturna is a one-time infusion of a genetically modified virus that contains a healthy copy of a specific gene.",
      "The therapy is administered via an intravenous (IV) infusion which delivers the healthy gene to the retina cells responsible for vision.",
      "Luxturna was approved by the FDA in 2017 for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy.",
      "Luxturna is the first gene therapy to be approved for the treatment of an inherited retinal disease and has been shown to significantly improve vision in patients with this condition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The therapy is administered via a subretinal injection which delivers the healthy gene to the retina cells responsible for vision.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "vicuna-13b_response": "RUNX2 is a transcription factor that plays a critical role in regulating the differentiation and development of various cell types, including astrocytes. While some studies have suggested that RUNX2 may inhibit astrocyte differentiation, other studies have shown that RUNX2 can promote astrocyte differentiation.\nOne study published in the journal \"Neurochemistry International\" in 2011 found that RUNX2 inhibited the differentiation of astrocytes in vitro by suppressing the expression of genes involved in the astrocyte phenotype. However, other studies have shown that RUNX2 can promote astrocyte differentiation by activating the expression of genes involved in astrocyte development.\nFor example, a study published in the journal \"Gene Expression Patterns\" in 2010 found that RUNX2 was required for the differentiation of astrocytes in the developing brain. The study showed that RUNX2 activated the expression of genes involved in the astrocyte phenotype and that this process was necessary for the proper development of astrocytes in the brain.\nOverall, the available evidence suggests that the effect of RUNX2 on astrocyte differentiation is complex and may depend on the specific context and developmental stage being studied. Further research is needed to fully understand the role of RUNX2 in regulating astrocyte differentiation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. RUNX2 is a transcription factor that plays a critical role in the differentiation and development of various cell types, including astrocytes.\n2. A study in Neurochemistry International in 2011 suggested that RUNX2 inhibited the differentiation of astrocytes.\n3. Some studies have indicated that RUNX2 can promote astrocyte differentiation.\n4. A study published in the journal \"Gene Expression Patterns\" in 2010 found that RUNX2 was required for the differentiation of astrocytes in the developing brain.\n5. The effect of RUNX2 on astrocyte differentiation may depend on the specific context and developmental stage being studied.",
    "vicuna-13b_fact": [
      "RUNX2 is a transcription factor that plays a critical role in the differentiation and development of various cell types, including astrocytes.",
      "A study in Neurochemistry International in 2011 suggested that RUNX2 inhibited the differentiation of astrocytes.",
      "Some studies have indicated that RUNX2 can promote astrocyte differentiation.",
      "A study published in the journal \"Gene Expression Patterns\" in 2010 found that RUNX2 was required for the differentiation of astrocytes in the developing brain.",
      "The effect of RUNX2 on astrocyte differentiation may depend on the specific context and developmental stage being studied."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "vicuna-13b_response": "The Cobb-Stainsby excision arthroplasty is a surgical procedure performed to treat osteoarthritis of the hip. During the procedure, the surgeon will make an incision over the hip joint and remove the damaged cartilage and bone. The damaged joint is then replaced with an artificial joint made of metal, plastic, or ceramic materials.\nThe specific location where the Cobb-Stainsby excision arthroplasty is performed will depend on the specific needs of the patient and the location of the damaged joint. The incision will typically be made over the hip joint, which is located in the upper part of the leg, just below the gluteal muscles. The surgeon will carefully dissect the tissue and muscles to access the hip joint and perform the procedure.\nAfter the procedure, the patient will typically spend several days in the hospital recovering and undergoing physical therapy. The recovery process can take several months, during which time the patient will need to follow specific instructions to ensure proper healing and prevent complications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Cobb-Stainsby excision arthroplasty is performed to treat osteoarthritis of the hip.\n2. During the Cobb-Stainsby excision arthroplasty, the damaged cartilage and bone are removed.\n3. The incision for the Cobb-Stainsby excision arthroplasty is typically made over the hip joint.\n4. The hip joint is located in the upper part of the leg, just below the gluteal muscles.\n5. The recovery process after the Cobb-Stainsby excision arthroplasty can take several months.",
    "vicuna-13b_fact": [
      "The Cobb-Stainsby excision arthroplasty is performed to treat osteoarthritis of the hip.",
      "During the Cobb-Stainsby excision arthroplasty, the damaged cartilage and bone are removed.",
      "The incision for the Cobb-Stainsby excision arthroplasty is typically made over the hip joint.",
      "The hip joint is located in the upper part of the leg, just below the gluteal muscles.",
      "The recovery process after the Cobb-Stainsby excision arthroplasty can take several months."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3213,
    "user_query": "What is a lipin 1 protein doing?",
    "vicuna-13b_response": "Lipin 1 is a protein that plays a critical role in regulating lipid metabolism in cells. It is a member of the lipin family of proteins, which are involved in the transport and storage of lipids in cells.\nLipin 1 is primarily found in the cytoplasm of cells, where it functions as a phosphatidate phosphatase enzyme. This enzyme helps to break down phosphatidate, a lipid molecule that is involved in the synthesis of other important lipids in the cell. By breaking down phosphatidate, lipin 1 helps to regulate the levels of this lipid in the cell, which in turn affects the overall metabolism of lipids in the cell.\nIn addition to its role in lipid metabolism, lipin 1 has also been shown to play a role in regulating the activity of other enzymes involved in lipid metabolism, such as acetyl-CoA carboxylase and fatty acid synthase. It does this by interacting with these enzymes and modulating their activity, which helps to regulate the overall balance of lipid synthesis and breakdown in the cell.\nOverall, the function of lipin 1 is to regulate the metabolism of lipids in cells by breaking down phosphatidate and modulating the activity of other enzymes involved in lipid metabolism. Dysregulation of lipin 1 has been implicated in a number of diseases, including metabolic disorders and cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Lipin 1 is a protein that regulates lipid metabolism in cells.\n2. It is a member of the lipin family of proteins, involved in the transport and storage of lipids in cells.\n3. Lipin 1 operates as a phosphatidate phosphatase enzyme in the cytoplasm of cells.\n4. This enzyme assists in breaking down phosphatidate, a lipid molecule involved in the synthesis of other important lipids in the cell.\n5. Dysregulation of lipin 1 has been implicated in a number of diseases, including metabolic disorders and cancer.",
    "vicuna-13b_fact": [
      "Lipin 1 is a protein that regulates lipid metabolism in cells.",
      "It is a member of the lipin family of proteins, involved in the transport and storage of lipids in cells.",
      "Lipin 1 operates as a phosphatidate phosphatase enzyme in the cytoplasm of cells.",
      "This enzyme assists in breaking down phosphatidate, a lipid molecule involved in the synthesis of other important lipids in the cell.",
      "Dysregulation of lipin 1 has been implicated in a number of diseases, including metabolic disorders and cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3215,
    "user_query": "What protein is recruited by Crumbs to regulate tracheal development?",
    "vicuna-13b_response": "Crumbs is a protein that plays a role in regulating tracheal development in Drosophila melanogaster, also known as the fruit fly. Specifically, Crumbs is recruited by the transmembrane protein Daughterless to regulate the expression of the gene that encodes the protein Spalt, which is also involved in tracheal development.\nIn Drosophila, the tracheal system is a network of tubes that functions as the respiratory system. The development of the tracheal system is a complex process that involves the coordination of cell proliferation, differentiation, and migration. Crumbs and Daughterless are two key proteins that regulate this process by controlling the expression of genes involved in tracheal development.\nCrumbs is a zinc finger protein that acts as a transcriptional repressor. It is recruited to the surface of cells by the transmembrane protein Daughterless, which is expressed in the tracheal precursor cells. Once recruited, Crumbs binds to specific DNA sequences and represses the expression of genes involved in tracheal development, including the gene that encodes the protein Spalt.\nSpalt is another key protein involved in tracheal development. It is expressed in the tracheal precursor cells and is required for the differentiation and elongation of the tracheal tubes. The recruitment of Crumbs by Daughterless to the surface of cells inhibits the expression of the Spalt gene, which in turn inhibits the differentiation and elongation of the tracheal tubes.\nOverall, the recruitment of Crumbs by Daughterless is a critical step in the regulation of tracheal development in Drosophila. By controlling the expression of genes involved in tracheal development, Crumbs and Daughterless help to coordinate the complex process of tracheal development and ensure the proper functioning of the respiratory system in the fly.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Crumbs is a protein that plays a role in regulating tracheal development in Drosophila melanogaster, or the fruit fly.\n2. The transmembrane protein Daughterless recruits Crumbs to regulate the expression of the gene that encodes the protein Spalt.\n3. Crumbs is a zinc finger protein that acts as a transcriptional repressor.\n4. Daughterless is expressed in the tracheal precursor cells.\n5. Spalt, which is also involved in tracheal development, is required for the differentiation and elongation of the tracheal tubes.",
    "vicuna-13b_fact": [
      "Crumbs is a protein that plays a role in regulating tracheal development in Drosophila melanogaster, or the fruit fly.",
      "The transmembrane protein Daughterless recruits Crumbs to regulate the expression of the gene that encodes the protein Spalt.",
      "Crumbs is a zinc finger protein that acts as a transcriptional repressor.",
      "Daughterless is expressed in the tracheal precursor cells.",
      "Spalt, which is also involved in tracheal development, is required for the differentiation and elongation of the tracheal tubes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: Crumbs is a transmembrane protein that plays a key role in cell polarity. \n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3223,
    "user_query": "Name three binding partners of cofilin 2.",
    "vicuna-13b_response": "Cofilin 2 is a protein that plays a role in regulating the actin cytoskeleton, and it has been shown to interact with several other proteins. Here are three examples of binding partners of cofilin 2:\n1. Actin: Cofilin 2 binds to actin filaments and regulates their dynamics by severing and re-forming actin filaments. This helps to promote the formation of filopodia and lamellipodia, which are important for cell motility and other processes.\n2. ADF/cofilin: Cofilin 2 is a member of the ADF/cofilin family of proteins, which includes ADF (actin depolymerizing factor) and other cofilin isoforms. Cofilin 2 binds to ADF/cofilin with high affinity and can activate it to depolymerize actin filaments.\n3. Calmodulin: Cofilin 2 has been shown to bind to calmodulin, a calcium-sensing protein that regulates a variety of downstream targets. This interaction may play a role in the regulation of cofilin 2 activity and the actin cytoskeleton in response to changes in calcium levels.\nIt's worth noting that these are just a few examples of binding partners of cofilin 2, and there may be others that have yet to be identified. Additionally, the specific binding partners of cofilin 2 can vary depending on the cellular context and the specific function that cofilin 2 is performing.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cofilin 2 is a protein that plays a role in regulating the actin cytoskeleton.\n2. Cofilin 2 binds to actin filaments and regulates their dynamics by severing and re-forming actin filaments.\n3. Cofilin 2 is a member of the ADF/cofilin family of proteins, which includes ADF (actin depolymerizing factor) and other cofilin isoforms.\n4. Cofilin 2 binds to ADF/cofilin with high affinity and can activate it to depolymerize actin filaments.\n5. Cofilin 2 has been shown to bind to calmodulin, a calcium-sensing protein that regulates a variety of downstream targets.",
    "vicuna-13b_fact": [
      "Cofilin 2 is a protein that plays a role in regulating the actin cytoskeleton.",
      "Cofilin 2 binds to actin filaments and regulates their dynamics by severing and re-forming actin filaments.",
      "Cofilin 2 is a member of the ADF/cofilin family of proteins, which includes ADF (actin depolymerizing factor) and other cofilin isoforms.",
      "Cofilin 2 binds to ADF/cofilin with high affinity and can activate it to depolymerize actin filaments.",
      "Cofilin 2 has been shown to bind to calmodulin, a calcium-sensing protein that regulates a variety of downstream targets."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Cofilin 2 doesn't bind to ADF/cofilin, but it does bind to actin filaments and regulates their dynamics.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3224,
    "user_query": "What is the function of GvpA?",
    "vicuna-13b_response": "GvpA is a protein that is involved in the regulation of gene expression in bacteria. It is a member of the Gvp family of proteins, which are involved in the regulation of transcription initiation in response to environmental signals.\nGvpA is a transcriptional regulator that binds to specific DNA sequences, known as gvpA boxes, which are found upstream of genes involved in amino acid metabolism and transport. By binding to these DNA sequences, GvpA activates the transcription of these genes, leading to the production of enzymes involved in amino acid metabolism and transport.\nIn addition to its role in the regulation of amino acid metabolism and transport, GvpA is also involved in the regulation of other processes in the cell, such as stress response and DNA repair.\nOverall, the function of GvpA is to regulate the expression of genes involved in amino acid metabolism and transport, as well as other processes in the cell, by binding to specific DNA sequences and activating transcription.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GvpA is a protein involved in the regulation of gene expression in bacteria. \n2. GvpA is a member of the Gvp family of proteins.\n3. GvpA functions as a transcriptional regulator that binds to specific DNA sequences called gvpA boxes.\n4. These DNA sequences are located upstream of genes involved in amino acid metabolism and transport.\n5. GvpA is also involved in the regulation of other cellular processes such as stress response and DNA repair.",
    "vicuna-13b_fact": [
      "GvpA is a protein involved in the regulation of gene expression in bacteria.",
      "GvpA is a member of the Gvp family of proteins.",
      "GvpA functions as a transcriptional regulator that binds to specific DNA sequences called gvpA boxes.",
      "These DNA sequences are located upstream of genes involved in amino acid metabolism and transport.",
      "GvpA is also involved in the regulation of other cellular processes such as stress response and DNA repair."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: GvpA is a protein involved in gas vesicle formation in bacteria, not in the regulation of gene expression.\n2. TRUE\n3. FALSE [correction]: GvpA does not function as a transcriptional regulator that binds to specific DNA sequences. Instead, it is a structural protein required for creating gas vesicles.\n4. FALSE [correction]: GvpA boxes are not related to amino acid metabolism and transport. GvpA and its related proteins are primarily associated with gas vesicle formation.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3225,
    "user_query": "What is a SMR based BCI?",
    "vicuna-13b_response": "A SMR (Sensorimotor Rhythm) based BCI (Brain-Computer Interface) is a type of BCI that uses the sensorimotor rhythm (SMR) as the main feature for brain-computer communication. The SMR is a neural signal that is associated with the preparation and execution of voluntary movements. It is typically recorded from electrodes placed on the scalp over the left central electrode (C3) and the right central electrode (C4) of the electroencephalography (EEG) and it is around 12-15 Hz.\nIn a SMR-based BCI, the user is typically asked to perform a motor task, such as moving their finger or hand, while their brain activity is recorded using EEG. The recorded SMR signal is then used to control the movement of a computer cursor or robotic arm. The BCI system uses various algorithms to decode the SMR signal and translate it into commands that can be used to control the computer or robot.\nSMR-based BCIs have several advantages over other types of BCIs, such as high-resolution control, good robustness to noise and interference, and the ability to operate in real-time. They have been used in various applications such as gaming, robotics, and rehabilitation.\nIt's important to note that SMR-based BCIs are still an active area of research and development, and there are many challenges that need to be overcome before they can be used in real-world applications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A SMR based BCI (Brain-Computer Interface) utilizes the sensorimotor rhythm as the main feature for brain-computer communication.\n2. The SMR is a neural signal associated with the preparation and execution of voluntary movements.\n3. The SMR signal is typically recorded from electrodes placed on the scalp over the left central electrode (C3) and the right central electrode (C4) of the electroencephalography (EEG) and it is around 12-15 Hz.\n4. A user of a SMR-based BCI is typically asked to perform a motor task, such as moving their finger or hand, while their brain activity is recorded.\n5. SMR-based BCIs have uses in various applications such as gaming, robotics, and rehabilitation.",
    "vicuna-13b_fact": [
      "A SMR based BCI (Brain-Computer Interface) utilizes the sensorimotor rhythm as the main feature for brain-computer communication.",
      "The SMR is a neural signal associated with the preparation and execution of voluntary movements.",
      "The SMR signal is typically recorded from electrodes placed on the scalp over the left central electrode (C3) and the right central electrode (C4) of the electroencephalography (EEG) and it is around 12-15 Hz.",
      "A user of a SMR-based BCI is typically asked to perform a motor task, such as moving their finger or hand, while their brain activity is recorded.",
      "SMR-based BCIs have uses in various applications such as gaming, robotics, and rehabilitation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3226,
    "user_query": "Is myc a tumour suppressor gene?",
    "vicuna-13b_response": "MYC is a proto-oncogene that is involved in cell growth and proliferation. It is often referred to as a \"tumor suppressor gene\" because it helps regulate the growth of cells and can prevent cancer from developing. However, when MYC is over-expressed or mutated, it can lead to uncontrolled cell growth and the development of cancer. Therefore, while MYC can act as a tumor suppressor, it is also known to be involved in oncogenesis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MYC is a proto-oncogene that is involved in cell growth and proliferation.\n2. MYC is often referred to as a \"tumor suppressor gene\" because it helps regulate the growth of cells.\n3. The MYC gene can prevent cancer from developing.\n4. When MYC is over-expressed or mutated, it can lead to uncontrolled cell growth and the development of cancer.\n5. MYC can act as a tumor suppressor and is also known to be involved in oncogenesis.",
    "vicuna-13b_fact": [
      "MYC is a proto-oncogene that is involved in cell growth and proliferation.",
      "MYC is often referred to as a \"tumor suppressor gene\" because it helps regulate the growth of cells.",
      "The MYC gene can prevent cancer from developing.",
      "When MYC is over-expressed or mutated, it can lead to uncontrolled cell growth and the development of cancer.",
      "MYC can act as a tumor suppressor and is also known to be involved in oncogenesis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: MYC is often referred to as an \"oncogene\" because it when it is dysregulated it can contribute to the growth of cells.\n3. FALSE [correction]: The MYC gene, when dysregulated or mutated, can contribute to the development of cancer, it does not prevent it.\n4. TRUE\n5. FALSE [correction]: MYC is an oncogene that may contribute to oncogenesis, it does not act as a tumor suppressor.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3227,
    "user_query": "Which syndrome is associated to SAMHD1 gene mutations?",
    "vicuna-13b_response": "SAMHD1 gene mutations are associated with a rare genetic disorder called \"SAMHD1 deficiency.\" This disorder is characterized by a deficiency in the SAMHD1 enzyme, which is involved in the regulation of the innate immune response.\nSAMHD1 deficiency has been linked to a variety of symptoms, including severe combined immunodeficiency (SCID), chronic mucocutaneous candidiasis (CMC), and autoinflammation. The symptoms of SAMHD1 deficiency can vary widely from person to person, and can range from mild to severe.\nIn particular, SAMHD1 deficiency is associated with a condition called \"chronic mucocutaneous candidiasis\" (CMC), which is a type of yeast infection that affects the skin and mucous membranes. CMC is caused by a deficiency in the SAMHD1 enzyme, which normally helps to regulate the immune response to Candida albicans, a type of yeast that is normally present on the skin and mucous membranes.\nSAMHD1 deficiency can also lead to a variety of other symptoms, including recurrent infections, inflammation, and autoimmune disorders. The exact symptoms and severity of SAMHD1 deficiency can vary widely from person to person, and can depend on a variety of factors, including the specific genetic mutation that is present.\nOverall, SAMHD1 gene mutations are associated with a rare genetic disorder called SAMHD1 deficiency, which is characterized by a deficiency in the SAMHD1 enzyme and is associated with a variety of symptoms, including chronic mucocutaneous candidiasis and autoinflammation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SAMHD1 gene mutations are associated with a disorder called \"SAMHD1 deficiency.\"\n2. SAMHD1 deficiency is a rare genetic disorder characterized by a deficiency in the SAMHD1 enzyme, which regulates the innate immune response.\n3. Symptoms of SAMHD1 deficiency can include severe combined immunodeficiency (SCID), chronic mucocutaneous candidiasis (CMC), and autoinflammation.\n4. Chronic mucocutaneous candidiasis (CMC), which affects the skin and mucous membranes, is associated with SAMHD1 deficiency.\n5. SAMHD1 deficiency can also lead to recurrent infections, inflammation, and autoimmune disorders.",
    "vicuna-13b_fact": [
      "SAMHD1 gene mutations are associated with a disorder called \"SAMHD1 deficiency.\"",
      "SAMHD1 deficiency is a rare genetic disorder characterized by a deficiency in the SAMHD1 enzyme, which regulates the innate immune response.",
      "Symptoms of SAMHD1 deficiency can include severe combined immunodeficiency (SCID), chronic mucocutaneous candidiasis (CMC), and autoinflammation.",
      "Chronic mucocutaneous candidiasis (CMC), which affects the skin and mucous membranes, is associated with SAMHD1 deficiency.",
      "SAMHD1 deficiency can also lead to recurrent infections, inflammation, and autoimmune disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3228,
    "user_query": "List proteins with RING domain.",
    "vicuna-13b_response": "A RING domain is a common protein domain found in a variety of proteins involved in cellular signaling and regulation. Here are some examples of proteins that contain a RING domain:\n1. Protein kinase A (PKA) - a serine/threonine protein kinase involved in a variety of cellular processes, including muscle contraction, glucose metabolism, and cell growth.\n2. Protein kinase C (PKC) - a family of serine/threonine protein kinases involved in cellular signaling and regulation, including the regulation of cell growth and differentiation.\n3. Cdc42 - a small GTPase involved in the regulation of cell growth and division, as well as the cytoskeleton.\n4. NEDD8 - a protein that regulates the activity of a variety of proteins, including the Cdc42 GTPase.\n5. Cullin - a family of proteins that form part of an E3 ubiquitin ligase complex, which targets proteins for degradation by the ubiquitin-proteasome pathway.\n6. RBX1 - a protein that plays a role in regulating the activity of the Cdc42 GTPase.\n7. SCFSIN1 - a protein that forms part of an E3 ubiquitin ligase complex involved in the regulation of cell growth and differentiation.\nThese are just a few examples of proteins that contain a RING domain. There are many other proteins that contain RING domains and are involved in a variety of cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A RING domain is a common protein domain found in a variety of proteins involved in cellular signaling and regulation.\n2. Protein kinase A (PKA) is a serine/threonine protein kinase involved in a variety of cellular processes, including muscle contraction, glucose metabolism, and cell growth.\n3. Protein kinase C (PKC) is a family of serine/threonine protein kinases involved in cellular signaling and regulation, including the regulation of cell growth and differentiation.\n4. Cdc42 is a small GTPase involved in the regulation of cell growth and division, as well as the cytoskeleton.\n5. NEDD8 is a protein that regulates the activity of a variety of proteins, including the Cdc42 GTPase.\n6. Cullin is a family of proteins that form part of an E3 ubiquitin ligase complex, which targets proteins for degradation by the ubiquitin-proteasome pathway.\n7. RBX1 is a protein that plays a role in regulating the activity of the Cdc42 GTPase.",
    "vicuna-13b_fact": [
      "A RING domain is a common protein domain found in a variety of proteins involved in cellular signaling and regulation.",
      "Protein kinase A (PKA) is a serine/threonine protein kinase involved in a variety of cellular processes, including muscle contraction, glucose metabolism, and cell growth.",
      "Protein kinase C (PKC) is a family of serine/threonine protein kinases involved in cellular signaling and regulation, including the regulation of cell growth and differentiation.",
      "Cdc42 is a small GTPase involved in the regulation of cell growth and division, as well as the cytoskeleton.",
      "NEDD8 is a protein that regulates the activity of a variety of proteins, including the Cdc42 GTPase.",
      "Cullin is a family of proteins that form part of an E3 ubiquitin ligase complex, which targets proteins for degradation by the ubiquitin-proteasome pathway.",
      "RBX1 is a protein that plays a role in regulating the activity of the Cdc42 GTPase."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE\n7. FALSE [correction]: RBX1 is a protein that forms part of an E3 ubiquitin ligase complex, not specifically regulating the activity of the Cdc42 GTPase.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3230,
    "user_query": "What is the results of mutations in the gene autoimmune regulator?",
    "vicuna-13b_response": "The autoimmune regulator (AIRE) gene is located on the X chromosome and encodes a transcription factor that plays a critical role in the regulation of the immune system. Mutations in the AIRE gene have been associated with a variety of autoimmune diseases, including autoimmune polyglandular syndrome (APS) and its subtypes, which are characterized by the presence of multiple autoimmune conditions affecting different endocrine glands.\nMutations in the AIRE gene can result in a loss of function, leading to a failure in the proper regulation of the immune system and the development of autoimmune diseases. The specific effects of AIRE mutations on the immune system and the development of autoimmune diseases can vary depending on the type and location of the mutation, as well as other genetic and environmental factors.\nOverall, mutations in the AIRE gene can have significant impacts on the function of the immune system and the development of autoimmune diseases, and further research is needed to fully understand the mechanisms underlying these effects and to develop effective treatments for these conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The autoimmune regulator (AIRE) gene is located on the X chromosome.\n2. The AIRE gene encodes a transcription factor that plays a critical role in the regulation of the immune system.\n3. Mutations in the AIRE gene have been associated with a variety of autoimmune diseases, including autoimmune polyglandular syndrome (APS) and its subtypes.\n4. Mutations in the AIRE gene can result in a loss of function, leading to a failure in the proper regulation of the immune system and the development of autoimmune diseases.\n5. The specific effects of AIRE mutations on the immune system and the development of autoimmune diseases can vary depending on the type and location of the mutation, as well as other genetic and environmental factors.",
    "vicuna-13b_fact": [
      "The autoimmune regulator (AIRE) gene is located on the X chromosome.",
      "The AIRE gene encodes a transcription factor that plays a critical role in the regulation of the immune system.",
      "Mutations in the AIRE gene have been associated with a variety of autoimmune diseases, including autoimmune polyglandular syndrome (APS) and its subtypes.",
      "Mutations in the AIRE gene can result in a loss of function, leading to a failure in the proper regulation of the immune system and the development of autoimmune diseases.",
      "The specific effects of AIRE mutations on the immune system and the development of autoimmune diseases can vary depending on the type and location of the mutation, as well as other genetic and environmental factors."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The autoimmune regulator (AIRE) gene is located on chromosome 21, not the X chromosome.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3232,
    "user_query": "Is subdural empyema a complication of sinusitis?",
    "vicuna-13b_response": "Subdural empyema is a rare but serious complication of sinusitis, which is an infection of the sinuses. It occurs when pus or other infectious material collects in the space between the dura mater, which is the outermost protective covering of the brain, and the brain itself.\nSinusitis can lead to subdural empyema when the infection spreads to the brain, usually through the cerebrospinal fluid (CSF) that surrounds the brain and spinal cord. This can occur if the sinus infection is severe or if it spreads to the brain through the bloodstream.\nSymptoms of subdural empyema can include headache, fever, confusion, and difficulty with balance or coordination. It is a medical emergency and requires prompt treatment with antibiotics and, in some cases, surgery to drain the infected fluid and relieve pressure on the brain.\nIf you have sinusitis and are experiencing any of these symptoms, it is important to seek medical attention immediately. Early diagnosis and treatment can help prevent the development of subdural empyema and other serious complications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Subdural empyema is a complication of sinusitis.\n2. Sinusitis is an infection of the sinuses that can lead to subdural empyema.\n3. Subdural empyema occurs when pus or other infectious material collects in the space between the dura mater and the brain.\n4. Symptoms of subdural empyema can include headache, fever, confusion, and difficulty with balance or coordination.\n5. Treatment for subdural empyema often involves antibiotics and, in some cases, surgery to drain the infected fluid and relieve pressure on the brain.",
    "vicuna-13b_fact": [
      "Subdural empyema is a complication of sinusitis.",
      "Sinusitis is an infection of the sinuses that can lead to subdural empyema.",
      "Subdural empyema occurs when pus or other infectious material collects in the space between the dura mater and the brain.",
      "Symptoms of subdural empyema can include headache, fever, confusion, and difficulty with balance or coordination.",
      "Treatment for subdural empyema often involves antibiotics and, in some cases, surgery to drain the infected fluid and relieve pressure on the brain."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3237,
    "user_query": "Is the crystal structure of Pim-1 available?",
    "vicuna-13b_response": "The crystal structure of Pim-1, also known as Pim-1 protein kinase, has been determined and published in scientific journals. Pim-1 is a serine/threonine kinase that plays a role in cell proliferation and survival, and it has been implicated in various cancers.\nThe crystal structure of Pim-1 has been solved by X-ray crystallography and reported in several research articles. One such article is \"Crystal structure of Pim-1 and its implications for regulation by phosphorylation\" by J. E. Conway et al., published in the journal Structure in 2002.\nThe crystal structure of Pim-1 is available in several protein databases, including the Protein Data Bank (PDB) and the Structural Genomics Consortium (SGC) database. The PDB entry for the crystal structure of Pim-1 is 1AIS, and the SGC entry is SGCPK109091001.\nThe crystal structure of Pim-1 is also available through various online resources, such as the RCSB PDB (Research Collaboratory for Structural Bioinformatics) and the PDBe (Protein Data Bank in Europe). These resources provide 3D visualization tools and other features to facilitate the study and analysis of the Pim-1 crystal structure.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The crystal structure of Pim-1, also known as Pim-1 protein kinase, has been determined and published in scientific journals.\n2. Pim-1 is a serine/threonine kinase that is implicated in various cancers.\n3. The crystal structure of Pim-1 has been solved by X-ray crystallography.\n4. The crystal structure of Pim-1 is available in the Protein Data Bank (PDB) and the Structural Genomics Consortium (SGC) database, with the PDB entry being 1AIS and the SGC entry being SGCPK109091001.\n5. Online resources like the RCSB PDB (Research Collaboratory for Structural Bioinformatics) and PDBe (Protein Data Bank in Europe) provide tools and features for the study and analysis of the Pim-1 crystal structure.",
    "vicuna-13b_fact": [
      "The crystal structure of Pim-1, also known as Pim-1 protein kinase, has been determined and published in scientific journals.",
      "Pim-1 is a serine/threonine kinase that is implicated in various cancers.",
      "The crystal structure of Pim-1 has been solved by X-ray crystallography.",
      "The crystal structure of Pim-1 is available in the Protein Data Bank (PDB) and the Structural Genomics Consortium (SGC) database, with the PDB entry being 1AIS and the SGC entry being SGCPK109091001.",
      "Online resources like the RCSB PDB (Research Collaboratory for Structural Bioinformatics) and PDBe (Protein Data Bank in Europe) provide tools and features for the study and analysis of the Pim-1 crystal structure."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3238,
    "user_query": "Do tumour-associated macrophages have a prognostic role in gliomas?",
    "vicuna-13b_response": "Tumor-associated macrophages (TAMs) are a type of immune cell that can be found in the tumor microenvironment of various types of cancer, including gliomas. TAMs are thought to play a role in the progression and growth of gliomas, as well as in the response to therapy.\nSeveral studies have suggested that the presence and activation state of TAMs may be associated with a poor prognosis in patients with gliomas. For example, a higher number of TAMs has been found to be associated with increased tumor grade and decreased survival in patients with glioblastoma, the most aggressive form of glioma. Additionally, TAMs have been shown to produce factors that can promote tumor growth and angiogenesis, as well as to inhibit the activity of other immune cells that could help to fight the tumor.\nHowever, other studies have also suggested that TAMs may play a more complex role in gliomas, and that their presence and activation state may not always be associated with a poor prognosis. For example, some studies have found that TAMs can also produce factors that can inhibit tumor growth and promote immune surveillance, and that their activation state may be influenced by the specific subtype of glioma and the patient's immune status.\nOverall, the role of TAMs in the prognosis of gliomas is still an area of active research, and more studies are needed to fully understand their contribution to the development and progression of this disease. However, the presence of TAMs in gliomas is thought to be a complex and multifaceted phenomenon that may be influenced by a variety of factors, including the specific subtype of glioma, the patient's immune status, and the effects of therapy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tumor-associated macrophages (TAMs) are a type of immune cell that can be found in the tumor microenvironment of various types of cancer, including gliomas.\n2. TAMs are thought to play a role in the progression and growth of gliomas, as well as in the response to therapy.\n3. Various studies suggest that a higher number of TAMs is associated with increased tumor grade and decreased survival in patients with glioblastoma, the most aggressive form of glioma.\n4. TAMs have been found to produce factors that can promote tumor growth and angiogenesis.\n5. Some studies have also found that TAMs can produce factors that inhibit tumor growth and promote immune surveillance.\n",
    "vicuna-13b_fact": [
      "Tumor-associated macrophages (TAMs) are a type of immune cell that can be found in the tumor microenvironment of various types of cancer, including gliomas.",
      "TAMs are thought to play a role in the progression and growth of gliomas, as well as in the response to therapy.",
      "Various studies suggest that a higher number of TAMs is associated with increased tumor grade and decreased survival in patients with glioblastoma, the most aggressive form of glioma.",
      "TAMs have been found to produce factors that can promote tumor growth and angiogenesis.",
      "Some studies have also found that TAMs can produce factors that inhibit tumor growth and promote immune surveillance."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "vicuna-13b_response": "Yes, over-expression of the Growth Regulation by Heterologous Ligand 2 (GRHL2) gene has been shown to lead to the development of an epithelial-to-mesenchymal transition (EMT) phenotype in certain cell types. EMT is a process by which epithelial cells, which typically form tight junctions and cover the surface of organs and glands, transform into mesenchymal cells, which are more mobile and have a more fibroblast-like appearance.\nGRHL2 is a transcription factor that plays a role in regulating the expression of genes involved in cell growth and differentiation. Over-expression of GRHL2 has been shown to promote the proliferation and survival of cells, and to inhibit their differentiation. In some cases, this can lead to the development of a more mesenchymal phenotype, including the loss of epithelial cell characteristics and the acquisition of mesenchymal cell characteristics.\nOver-expression of GRHL2 has been observed in a variety of cancer types, including breast cancer, gastric cancer, and lung cancer, and has been associated with poor prognosis and increased risk of metastasis. In addition, over-expression of GRHL2 has been shown to promote the development of resistance to chemotherapy in cancer cells.\nOverall, while the exact mechanisms by which GRHL2 over-expression leads to EMT are not fully understood, it is clear that this process plays a role in the development of certain cancer types and may contribute to the progression of cancer and the acquisition of drug resistance.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Growth Regulation by Heterologous Ligand 2 (GRHL2) over-expression can lead to the development of an epithelial-to-mesenchymal transition (EMT) phenotype in certain cell types.\n2. EMT is a process by which epithelial cells transform into mesenchymal cells.\n3. GRHL2 is a transcription factor that affects the expression of genes related to cell growth and differentiation.\n4. Over-expression of GRHL2 has been observed in various types of cancer, including breast, gastric, and lung cancer.\n5. Over-expression of GRHL2 can promote the development of resistance to chemotherapy in cancer cells.",
    "vicuna-13b_fact": [
      "Growth Regulation by Heterologous Ligand 2 (GRHL2) over-expression can lead to the development of an epithelial-to-mesenchymal transition (EMT) phenotype in certain cell types.",
      "EMT is a process by which epithelial cells transform into mesenchymal cells.",
      "GRHL2 is a transcription factor that affects the expression of genes related to cell growth and differentiation.",
      "Over-expression of GRHL2 has been observed in various types of cancer, including breast, gastric, and lung cancer.",
      "Over-expression of GRHL2 can promote the development of resistance to chemotherapy in cancer cells."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3245,
    "user_query": "Is the Fluzone intradermal and the Fluzone intradermal quadrivalent vaccine produced by different companies?",
    "vicuna-13b_response": "The Fluzone intradermal and the Fluzone intradermal quadrivalent vaccines are produced by the same company, Sanofi Pasteur.\nFluzone intradermal is a seasonal influenza vaccine that is administered by intradermal injection, which means it is given into the skin instead of the muscle. It is designed to provide protection against influenza virus strains that are expected to be prevalent in a given flu season.\nFluzone intradermal quadrivalent is a similar vaccine, but it is designed to protect against four different strains of influenza virus instead of three. It is also administered by intradermal injection.\nBoth vaccines are approved by the FDA and are recommended by the CDC for use in the United States.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Fluzone intradermal and the Fluzone intradermal quadrivalent vaccines are produced by Sanofi Pasteur.\n2. Fluzone intradermal is administered by intradermal injection.\n3. Fluzone intradermal provides protection against influenza virus strains expected to be prevalent in a given flu season.\n4. Fluzone intradermal quadrivalent is designed to protect against four different strains of influenza virus.\n5. Both vaccines are approved by the FDA and recommended by the CDC for use in the United States.",
    "vicuna-13b_fact": [
      "The Fluzone intradermal and the Fluzone intradermal quadrivalent vaccines are produced by Sanofi Pasteur.",
      "Fluzone intradermal is administered by intradermal injection.",
      "Fluzone intradermal provides protection against influenza virus strains expected to be prevalent in a given flu season.",
      "Fluzone intradermal quadrivalent is designed to protect against four different strains of influenza virus.",
      "Both vaccines are approved by the FDA and recommended by the CDC for use in the United States."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3251,
    "user_query": "List features of the Currarino triad.",
    "vicuna-13b_response": "The Currarino triad is a congenital condition that affects the spine and lower limbs. It is characterized by the following three features:\n1. Sacral agenesis: This is a condition where the sacrum, which is the triangular bone at the base of the spine, is missing or underdeveloped. This can lead to problems with the alignment of the spine and the ability to walk.\n2. Lumbar meningocele: This is a type of spinal tumor that is formed by the protrusion of the spinal cord through a sac that is not fully closed. It can cause nerve damage and weakness in the legs.\n3. Legg-Calve-Perthes disease: This is a condition that affects the hip joint, where the head of the thigh bone (femoral head) becomes deformed and causes pain and stiffness in the hip.\nThe Currarino triad is a rare condition that affects approximately 1 in 100,000 people. It is usually diagnosed in early childhood and can be treated with surgery, physical therapy, and other medical interventions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Currarino triad is a congenital condition that affects the spine and lower limbs.\n2. One feature of the Currarino triad is sacral agenesis, which can cause issues with spine alignment and the ability to walk.\n3. Another feature of the Currarino triad is lumbar meningocele, a type of spinal tumor.\n4. The third feature of the Currarino triad is Legg-Calve-Perthes disease, a condition that impacts the hip joint.\n5. The Currarino triad affects approximately 1 in 100,000 people.",
    "vicuna-13b_fact": [
      "The Currarino triad is a congenital condition that affects the spine and lower limbs.",
      "One feature of the Currarino triad is sacral agenesis, which can cause issues with spine alignment and the ability to walk.",
      "Another feature of the Currarino triad is lumbar meningocele, a type of spinal tumor.",
      "The third feature of the Currarino triad is Legg-Calve-Perthes disease, a condition that impacts the hip joint.",
      "The Currarino triad affects approximately 1 in 100,000 people."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Currarino triad is a congenital condition that primarily affects the tailbone, rectum and anus, not the spine and lower limbs. \n2. TRUE\n3. TRUE\n4. FALSE [correction]: The third feature of the Currarino triad is an anorectal malformation, not Legg-Calve-Perthes disease.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3253,
    "user_query": "What are invasomes",
    "vicuna-13b_response": "Invasomes are specialized membrane-bound organelles found in certain types of cells, such as immune cells, that play a critical role in the process of cell invasion. Invasomes are formed when a cell extends its plasma membrane to form a protrusion, called an invadopodium, which can penetrate into the extracellular matrix or basement membrane of a neighboring cell.\nOnce the invadopodium has breached the basement membrane, it can form a stable connection with the target cell, called a tight junction, which allows the immune cell to transfer its contents, including its cytosol and organelles, into the target cell. This process is called cell invasion or endocytosis.\nInvasomes are composed of several different components, including the plasma membrane, invadopodiums, and the cytoskeleton. They also require the coordinated action of several different signaling pathways and molecular machines, such as the Rho family of GTPases, to coordinate the formation and movement of the invadopodium.\nInvasomes play a critical role in a variety of biological processes, including immune cell function, tissue repair, and cancer progression. Dysregulation of invasome function has been implicated in a variety of diseases, including cancer, autoimmune disorders, and inflammatory diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Invasomes are specialized membrane-bound organelles found in certain cells, such as immune cells.\n2. Invasomes play a role in the process of cell invasion and are formed when a cell extends its plasma membrane to form a protrusion, called an invadopodium.\n3. An invadopodium can penetrate into the extracellular matrix or basement membrane of a neighboring cell.\n4. Invasomes are composed of several different components, including the plasma membrane, invadopodiums, and the cytoskeleton. \n5. Dysregulation of invasome function has been implicated in a variety of diseases, including cancer, autoimmune disorders, and inflammatory diseases.",
    "vicuna-13b_fact": [
      "Invasomes are specialized membrane-bound organelles found in certain cells, such as immune cells.",
      "Invasomes play a role in the process of cell invasion and are formed when a cell extends its plasma membrane to form a protrusion, called an invadopodium.",
      "An invadopodium can penetrate into the extracellular matrix or basement membrane of a neighboring cell.",
      "Invasomes are composed of several different components, including the plasma membrane, invadopodiums, and the cytoskeleton.",
      "Dysregulation of invasome function has been implicated in a variety of diseases, including cancer, autoimmune disorders, and inflammatory diseases."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Invasomes are not recognized as specialized membrane-bound organelles found in certain cells, such as immune cells.\n2. UNKNOWN\n3. TRUE\n4. FALSE [correction]: Since invasomes are not recognized as scientific terms, it's incorrect to say they are composed of the plasma membrane, invadopodia, and the cytoskeleton.\n5. FALSE [correction]: The statement is incorrect as invasomes are not recognized entities in cellular biology. The related invadopodia structure, however, does have implications in diseases such as cancer.",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "vicuna-13b_response": "T-UCRs, or Tumor-Upregulated Conserved Regulators, are genes that are upregulated (i.e., expressed at higher levels) in cancer cells compared to normal cells. Several T-UCRs have been implicated in the development and progression of lung cancer.\nOne example is the T-UCR known as TWIST1. TWIST1 is a transcription factor that has been shown to play a role in the development and progression of several types of cancer, including lung cancer. In lung cancer, TWIST1 is often upregulated and has been shown to promote the growth and survival of cancer cells.\nAnother example is the T-UCR known as FOXM1. FOXM1 is a transcription factor that has been shown to be involved in the regulation of cell proliferation and differentiation. In lung cancer, FOXM1 is often upregulated and has been shown to promote the growth and survival of cancer cells.\nIt is important to note that while T-UCRs have been implicated in the development and progression of lung cancer, they are not the only genes that are involved in this process. There are many other genes and pathways that are involved in the development and progression of lung cancer, and a better understanding of these pathways is needed in order to develop effective treatments for this disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. T-UCRs, or Tumor-Upregulated Conserved Regulators, are genes that are upregulated in cancer cells in comparison to normal cells. \n2. Several T-UCRs have been implicated in the development and progression of lung cancer.\n3. TWIST1 and FOXM1 are Tumor-Upregulated Conserved Regulators known to be implicated in lung cancer. \n4. TWIST1 is a transcription factor that plays a role in the development and progression of several types of cancer, including lung cancer.\n5. FOXM1 is a transcription factor involved in the regulation of cell proliferation and differentiation and is often upregulated in lung cancer.",
    "vicuna-13b_fact": [
      "T-UCRs, or Tumor-Upregulated Conserved Regulators, are genes that are upregulated in cancer cells in comparison to normal cells.",
      "Several T-UCRs have been implicated in the development and progression of lung cancer.",
      "TWIST1 and FOXM1 are Tumor-Upregulated Conserved Regulators known to be implicated in lung cancer.",
      "TWIST1 is a transcription factor that plays a role in the development and progression of several types of cancer, including lung cancer.",
      "FOXM1 is a transcription factor involved in the regulation of cell proliferation and differentiation and is often upregulated in lung cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: TWIST1 and FOXM1 are not Tumor-Upregulated Conserved Regulators; they are transcription factors.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3255,
    "user_query": "Can Daptacel be used instead of IPOL?",
    "vicuna-13b_response": "Daptacel and IPOL are both brands of vaccines that are used to protect against tetanus and diphtheria. Daptacel is a tetanus and diphtheria toxoids, acellular pertussis vaccine, while IPOL is a tetanus and diphtheria toxoids vaccine.\nBoth vaccines are used to provide protection against tetanus and diphtheria, but they contain different components. Daptacel also contains a component that protects against pertussis (whooping cough), while IPOL does not.\nBoth vaccines are generally safe and effective when used according to the recommended schedule. However, the decision of which vaccine to use depends on various factors such as the individual's age, health status, and previous vaccination history.\nIt is important to consult with a healthcare professional to determine which vaccine is appropriate for an individual's specific needs. They will take into account the individual's medical history, current health status, and any allergies or sensitivities to vaccine components.\nIn summary, Daptacel and IPOL are both effective vaccines that protect against tetanus and diphtheria, but they contain different components and may be used for different purposes. It is important to consult with a healthcare professional to determine which vaccine is appropriate for an individual's specific needs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Daptacel and IPOL are both brands of vaccines that are used to protect against tetanus and diphtheria.\n2. Daptacel is a tetanus and diphtheria toxoids, acellular pertussis vaccine.\n3. IPOL is a tetanus and diphtheria toxoids vaccine.\n4. Daptacel also contains a component that protects against pertussis (whooping cough), while IPOL does not.\n5. The decision of which vaccine to use depends on various factors such as the individual's age, health status, and previous vaccination history.",
    "vicuna-13b_fact": [
      "Daptacel and IPOL are both brands of vaccines that are used to protect against tetanus and diphtheria.",
      "Daptacel is a tetanus and diphtheria toxoids, acellular pertussis vaccine.",
      "IPOL is a tetanus and diphtheria toxoids vaccine.",
      "Daptacel also contains a component that protects against pertussis (whooping cough), while IPOL does not.",
      "The decision of which vaccine to use depends on various factors such as the individual's age, health status, and previous vaccination history."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Daptacel is a brand of vaccine used to protect against diphtheria, tetanus, and pertussis (whooping cough), while IPOL is a brand of vaccine used to protect against polio.\n2. TRUE\n3. FALSE [correction]: IPOL is a polio vaccine.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3256,
    "user_query": "Is ACE2 expressed on cell surfaces?",
    "vicuna-13b_response": "ACE2, or angiotensin-converting enzyme 2, is a protein that is primarily expressed in the lysosomes of cells, which are organelles responsible for degrading macromolecules and cellular debris. While ACE2 is not typically expressed on the cell surface, it has been shown to be secreted by some cell types, including immune cells such as dendritic cells and macrophages.\nIn these cell types, ACE2 has been shown to play a role in the processing and presentation of antigens to T cells, which are a type of immune cell involved in cell-mediated immunity. ACE2 can also interact with other proteins, such as the SARS-CoV-2 virus, which is the virus that causes COVID-19. This interaction can facilitate the entry of the virus into cells, and is thought to play a role in the pathogenesis of COVID-19.\nOverall, while ACE2 is not typically expressed on the cell surface, it can be secreted by certain cell types and play a role in immune function and virus entry.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ACE2, or angiotensin-converting enzyme 2, is a protein that is primarily expressed in the lysosomes of cells.\n2. Certain types of cells, including immune cells such as dendritic cells and macrophages, can secrete ACE2.\n3. ACE2 plays a role in the processing and presentation of antigens to T cells.\n4. The SARS-CoV-2 virus, which causes COVID-19, can interact with ACE2.\n5. This interaction between ACE2 and the SARS-CoV-2 virus can facilitate the entry of the virus into cells.",
    "vicuna-13b_fact": [
      "ACE2, or angiotensin-converting enzyme 2, is a protein that is primarily expressed in the lysosomes of cells.",
      "Certain types of cells, including immune cells such as dendritic cells and macrophages, can secrete ACE2.",
      "ACE2 plays a role in the processing and presentation of antigens to T cells.",
      "The SARS-CoV-2 virus, which causes COVID-19, can interact with ACE2.",
      "This interaction between ACE2 and the SARS-CoV-2 virus can facilitate the entry of the virus into cells."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: ACE2, or angiotensin-converting enzyme 2, is a protein that is primarily expressed on the surface of cells, particularly in the lungs, heart, arteries, and intestines.\n2. TRUE\n3. FALSE [correction]: ACE2 plays a significant role in heart function and the regulation of blood pressure, not in the processing and presentation of antigens to T cells.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3259,
    "user_query": "List the cancers that are associated with SBLA syndrome.",
    "vicuna-13b_response": "SBLA (Short Bowel Syndrome with Lactase Deficiency) is a rare genetic disorder that affects the digestive system. It is caused by a deficiency of the enzyme lactase, which is needed to break down lactose, a sugar found in milk and other dairy products.\nSBLA syndrome is associated with an increased risk of certain types of cancer, particularly lymphoma and gastrointestinal cancers such as colon cancer.\nThe exact link between SBLA syndrome and cancer is not fully understood, but it is thought to be related to the chronic inflammation and immune dysfunction that can occur as a result of the digestive problems associated with the disorder.\nIndividuals with SBLA syndrome should be closely monitored for the development of cancer, and may require additional screening, such as colonoscopies, to detect any early signs of cancer. It is important to discuss the risks and screening recommendations with a healthcare provider.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SBLA syndrome is a rare genetic disorder that affects the digestive system.\n2. SBLA syndrome is caused by a deficiency of the enzyme lactase.\n3. SBLA syndrome is associated with an increased risk of certain types of cancer, particularly lymphoma and gastrointestinal cancers such as colon cancer.\n4. The link between SBLA syndrome and cancer is thought to be related to the chronic inflammation and immune dysfunction that can occur as a result of the digestive problems associated with the disorder.\n5. Individuals with SBLA syndrome may require additional screening, for example, colonoscopies, to detect any early signs of cancer.",
    "vicuna-13b_fact": [
      "SBLA syndrome is a rare genetic disorder that affects the digestive system.",
      "SBLA syndrome is caused by a deficiency of the enzyme lactase.",
      "SBLA syndrome is associated with an increased risk of certain types of cancer, particularly lymphoma and gastrointestinal cancers such as colon cancer.",
      "The link between SBLA syndrome and cancer is thought to be related to the chronic inflammation and immune dysfunction that can occur as a result of the digestive problems associated with the disorder.",
      "Individuals with SBLA syndrome may require additional screening, for example, colonoscopies, to detect any early signs of cancer."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3266,
    "user_query": "Which lncRNAS are regulated by SAM68?",
    "vicuna-13b_response": "SAM68 (also known as SAM-68 or SAM-associated protein 68) is a protein that plays a role in regulating alternative splicing of messenger RNA (mRNA) in response to stress signals. It has been shown to regulate the expression of several long non-coding RNAs (lncRNAs) in response to different types of stress, such as heat shock, oxidative stress, and DNA damage.\nSome of the lncRNAs that have been reported to be regulated by SAM68 include:\n1. H19: SAM68 has been shown to bind to the H19 lncRNA and regulate its expression in response to heat shock.\n2. Xist: SAM68 has been shown to regulate the expression of the Xist lncRNA, which is involved in X chromosome inactivation.\n3. GAS5: SAM68 has been shown to regulate the expression of the GAS5 lncRNA, which is involved in the regulation of the p53 pathway.\n4. MEG3: SAM68 has been shown to regulate the expression of the MEG3 lncRNA, which is involved in the regulation of cell proliferation and differentiation.\n5. BC034658: SAM68 has been shown to regulate the expression of the BC034658 lncRNA, which is involved in the regulation of the NF-κB pathway.\nIt is important to note that this is not an exhaustive list, and more lncRNAs may be regulated by SAM68 as more research is conducted on this protein. Additionally, the specific lncRNAs regulated by SAM68 may vary depending on the type of stress and the cellular context in which the protein is active.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SAM68 is a protein that plays a role in regulating alternative splicing of messenger RNA (mRNA) in response to stress signals.\n2. SAM68 regulates the expression of several long non-coding RNAs (lncRNAs) in response to different types of stress, such as heat shock, oxidative stress, and DNA damage.\n3. SAM68 has been shown to bind to the H19 lncRNA and regulate its expression in response to heat shock.\n4. SAM68 has been shown to regulate the expression of the Xist lncRNA, which is involved in X chromosome inactivation.\n5. SAM68 has been shown to regulate the expression of the GAS5 lncRNA, which is involved in the regulation of the p53 pathway.",
    "vicuna-13b_fact": [
      "SAM68 is a protein that plays a role in regulating alternative splicing of messenger RNA (mRNA) in response to stress signals.",
      "SAM68 regulates the expression of several long non-coding RNAs (lncRNAs) in response to different types of stress, such as heat shock, oxidative stress, and DNA damage.",
      "SAM68 has been shown to bind to the H19 lncRNA and regulate its expression in response to heat shock.",
      "SAM68 has been shown to regulate the expression of the Xist lncRNA, which is involved in X chromosome inactivation.",
      "SAM68 has been shown to regulate the expression of the GAS5 lncRNA, which is involved in the regulation of the p53 pathway."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "vicuna-13b_response": "GPR151 (also known as G protein-coupled receptor 151) is a member of the G protein-coupled receptor (GPCR) family of membrane receptors. It is a seven transmembrane domain receptor and is thought to play a role in regulating various physiological processes, including glucose metabolism and inflammation.\nGPR151 has been found to be expressed in various tissues, including the pancreas, intestine, and adipose tissue. It has been shown to regulate glucose-stimulated insulin secretion in pancreatic beta cells and to play a role in regulating glucose uptake in adipose tissue.\nStudies have also suggested that GPR151 may be involved in the regulation of inflammation. For example, GPR151 has been shown to regulate the production of inflammatory cytokines in macrophages and to play a role in the regulation of the immune response.\nOverall, while much is still unknown about the function and regulation of GPR151, it is thought to play an important role in various physiological processes and may be a potential target for the development of new therapies for diseases such as diabetes and inflammation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GPR151, also known as G protein-coupled receptor 151, is a member of the G protein-coupled receptor family of membrane receptors.\n2. GPR151 is a seven transmembrane domain receptor.\n3. GPR151 has been found to be expressed in various tissues, including the pancreas, intestine, and adipose tissue.\n4. Studies have suggested that GPR151 may be involved in the regulation of inflammation.\n5. GPR151 has been shown to regulate glucose-stimulated insulin secretion in pancreatic beta cells.",
    "vicuna-13b_fact": [
      "GPR151, also known as G protein-coupled receptor 151, is a member of the G protein-coupled receptor family of membrane receptors.",
      "GPR151 is a seven transmembrane domain receptor.",
      "GPR151 has been found to be expressed in various tissues, including the pancreas, intestine, and adipose tissue.",
      "Studies have suggested that GPR151 may be involved in the regulation of inflammation.",
      "GPR151 has been shown to regulate glucose-stimulated insulin secretion in pancreatic beta cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3269,
    "user_query": "Is Li–Fraumeni syndrome a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development?",
    "vicuna-13b_response": "Yes, Li–Fraumeni syndrome (LFS) is a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development. LFS is caused by mutations in the TP53 gene, which is responsible for regulating cell growth and preventing the formation of tumors. People with LFS have a significantly increased risk of developing a variety of cancers, particularly sarcomas and brain tumors, at a young age. The condition is considered rare, with an estimated prevalence of 1 in 100,000 people. While the exact prevalence of LFS is not known, it is considered a rare disorder.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Li–Fraumeni syndrome is a hereditary disorder predisposing carriers to cancer development.\n2. The disorder is rare and is autosomal recessive.\n3. LFS is caused by mutations in the TP53 gene. \n4. The TP53 gene is responsible for regulating cell growth and preventing the formation of tumors.\n5. People with LFS have a significantly increased risk of developing a variety of cancers, particularly sarcomas, and brain tumors at a young age.",
    "vicuna-13b_fact": [
      "Li–Fraumeni syndrome is a hereditary disorder predisposing carriers to cancer development.",
      "The disorder is rare and is autosomal recessive.",
      "LFS is caused by mutations in the TP53 gene.",
      "The TP53 gene is responsible for regulating cell growth and preventing the formation of tumors.",
      "People with LFS have a significantly increased risk of developing a variety of cancers, particularly sarcomas, and brain tumors at a young age."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The disorder is rare and is autosomal dominant.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3271,
    "user_query": "Salzburg EEG criteria are used to diagnose which disorder?",
    "vicuna-13b_response": "The Salzburg EEG criteria are used to diagnose epilepsy, a neurological disorder characterized by seizures or convulsions. The criteria were developed by a group of experts at the University of Salzburg in Austria and are used to classify EEG patterns in patients with suspected epilepsy. The criteria include the presence of spikes, sharp waves, and other abnormal patterns on the EEG, as well as the frequency and distribution of these patterns. The criteria are used to help differentiate epilepsy from other conditions that can cause similar symptoms, such as syncope or psychogenic non-epileptic seizures.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Salzburg EEG criteria are used to diagnose epilepsy.\n2. Epilepsy is a neurological disorder characterized by seizures or convulsions.\n3. The criteria were developed by a group of experts at the University of Salzburg in Austria.\n4. The Salzburg EEG criteria are used to classify EEG patterns in patients with suspected epilepsy.\n5. The criteria are also used to differentiate epilepsy from other conditions that can cause similar symptoms such as syncope or psychogenic non-epileptic seizures.",
    "vicuna-13b_fact": [
      "The Salzburg EEG criteria are used to diagnose epilepsy.",
      "Epilepsy is a neurological disorder characterized by seizures or convulsions.",
      "The criteria were developed by a group of experts at the University of Salzburg in Austria.",
      "The Salzburg EEG criteria are used to classify EEG patterns in patients with suspected epilepsy.",
      "The criteria are also used to differentiate epilepsy from other conditions that can cause similar symptoms such as syncope or psychogenic non-epileptic seizures."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3272,
    "user_query": "List the components of the COMPASS complex",
    "vicuna-13b_response": "The COMPASS complex is a group of proteins that play a role in regulating the transcription of genes in eukaryotic cells. The components of the COMPASS complex include:\n1. SWI/SNF complex: This complex is composed of several subunits, including the brg1, brm, and snf5 genes. The SWI/SNF complex is responsible for remodeling chromatin structure, which allows for the access of transcription factors to the DNA and the initiation of transcription.\n2. ATP-dependent chromatin-remodeling factor: This complex is composed of several subunits, including the nascent ATP-dependent chromatin-remodeling factor, which is responsible for remodeling chromatin structure.\n3. Chromatin-modifying enzymes: These enzymes are responsible for modifying the chromatin structure, which can either activate or repress transcription.\n4. Transcription factors: These proteins bind to specific sequences of DNA and regulate the transcription of genes.\nOverall, the COMPASS complex is a complex regulatory system that plays a crucial role in the control of gene expression in eukaryotic cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The COMPASS complex is a group of proteins that regulate the transcription of genes in eukaryotic cells.\n2. The SWI/SNF complex is a component of the COMPASS complex.\n3. The SWI/SNF complex is composed of several subunits, including the brg1, brm, and snf5 genes.\n4. Another component of the COMPASS complex is the ATP-dependent chromatin-remodeling factor.\n5. The COMPASS complex also includes chromatin-modifying enzymes and transcription factors.",
    "vicuna-13b_fact": [
      "The COMPASS complex is a group of proteins that regulate the transcription of genes in eukaryotic cells.",
      "The SWI/SNF complex is a component of the COMPASS complex.",
      "The SWI/SNF complex is composed of several subunits, including the brg1, brm, and snf5 genes.",
      "Another component of the COMPASS complex is the ATP-dependent chromatin-remodeling factor.",
      "The COMPASS complex also includes chromatin-modifying enzymes and transcription factors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The SWI/SNF complex is not a component of the COMPASS complex. They are both separate protein complexes involved in chromatin remodeling.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3274,
    "user_query": "Central Vein Sign is characteristic to which disease?",
    "vicuna-13b_response": "The Central Vein Sign is a physical examination finding that is characteristic of certain diseases, particularly those that affect the liver and the biliary system. The Central Vein Sign is observed when the central venous pressure (CVP) is elevated, and the liver is not tender on palpation.\nThe Central Vein Sign is often seen in patients with cirrhosis of the liver, which is a chronic liver disease characterized by the replacement of normal liver tissue with scar tissue. This can be caused by a variety of factors, including chronic alcohol consumption, viral hepatitis, and other forms of liver damage.\nIn addition to cirrhosis, the Central Vein Sign may also be seen in patients with other liver and biliary system disorders, such as portal hypertension, biliary tract cancer, and pancreatic cancer.\nIt is important to note that the Central Vein Sign is just one of many physical examination findings that may be used to help diagnose and evaluate liver and biliary system disorders. A complete diagnostic workup may also include laboratory tests, imaging studies, and other diagnostic procedures.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Central Vein Sign is a physical examination finding characteristic of certain diseases that affect the liver and the biliary system.\n2. The Central Vein Sign is often seen in patients with cirrhosis of the liver.\n3. Cirrhosis of the liver is characterized by the replacement of normal liver tissue with scar tissue.\n4. The Central Vein Sign may also be seen in patients with portal hypertension, biliary tract cancer, and pancreatic cancer.\n5. The Central Vein Sign is just one examination finding that may be used to help diagnose and evaluate liver and biliary system disorders.",
    "vicuna-13b_fact": [
      "The Central Vein Sign is a physical examination finding characteristic of certain diseases that affect the liver and the biliary system.",
      "The Central Vein Sign is often seen in patients with cirrhosis of the liver.",
      "Cirrhosis of the liver is characterized by the replacement of normal liver tissue with scar tissue.",
      "The Central Vein Sign may also be seen in patients with portal hypertension, biliary tract cancer, and pancreatic cancer.",
      "The Central Vein Sign is just one examination finding that may be used to help diagnose and evaluate liver and biliary system disorders."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3284,
    "user_query": "Do de novo truncating mutations in WASF1 cause cancer?",
    "vicuna-13b_response": "De novo truncating mutations in WASF1, a gene that encodes a protein involved in regulating cell growth and division, have been identified in some cases of cancer. These mutations can lead to the production of a non-functional or dysfunctional WASF1 protein, which can contribute to the development and progression of cancer. However, it is important to note that not all cases of cancer are caused by de novo truncating mutations in WASF1, and other genetic and environmental factors are also known to contribute to the development of cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. WASF1 is a gene that encodes a protein involved in regulating cell growth and division.\n2. De novo truncating mutations in WASF1 have been identified in some cases of cancer.\n3. These mutations can lead to the production of a non-functional or dysfunctional WASF1 protein.\n4. This dysfunctional WASF1 protein can contribute to the development and progression of cancer.\n5. Not all cases of cancer are caused by de novo truncating mutations in WASF1.",
    "vicuna-13b_fact": [
      "WASF1 is a gene that encodes a protein involved in regulating cell growth and division.",
      "De novo truncating mutations in WASF1 have been identified in some cases of cancer.",
      "These mutations can lead to the production of a non-functional or dysfunctional WASF1 protein.",
      "This dysfunctional WASF1 protein can contribute to the development and progression of cancer.",
      "Not all cases of cancer are caused by de novo truncating mutations in WASF1."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "vicuna-13b_response": "The Fluzone intradermal quadrivalent vaccine is a vaccine that is used to protect against four different strains of the influenza virus. It contains attenuated live viruses, which means that the viruses have been weakened in order to stimulate an immune response without causing serious illness.\nThe four strains of the influenza virus that are included in the Fluzone intradermal quadrivalent vaccine are:\n* A/Brisbane/10/2019 (H1N1)\n* A/Kansas/14/2019 (H3N2)\n* B/Colorado/06/2017\n* B/Phuket/3073/2018\nIt is important to note that the viruses in the vaccine are attenuated, which means they are weakened and cannot cause serious illness. However, it is possible to experience side effects from the vaccine, such as pain, redness, or swelling at the injection site. It is also possible to experience mild symptoms, such as fever or fatigue, after receiving the vaccine. These side effects are generally mild and short-lived.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Fluzone intradermal quadrivalent vaccine is used to protect against four different strains of the influenza virus.\n2. The Fluzone vaccine contains attenuated live viruses, meaning the viruses are weakened to stimulate an immune response without causing serious illness.\n3. The four strains of the influenza virus included in the Fluzone intradermal quadrivalent vaccine are A/Brisbane/10/2019 (H1N1), A/Kansas/14/2019 (H3N2), B/Colorado/06/2017, and B/Phuket/3073/2018.\n4. It is possible to experience side effects from the Fluzone vaccine like pain, redness, or swelling at the injection site.\n5. Mild symptoms such as fever or fatigue can also be experienced after receiving the Fluzone vaccine.",
    "vicuna-13b_fact": [
      "The Fluzone intradermal quadrivalent vaccine is used to protect against four different strains of the influenza virus.",
      "The Fluzone vaccine contains attenuated live viruses, meaning the viruses are weakened to stimulate an immune response without causing serious illness.",
      "The four strains of the influenza virus included in the Fluzone intradermal quadrivalent vaccine are A/Brisbane/10/2019 (H1N1), A/Kansas/14/2019 (H3N2), B/Colorado/06/2017, and B/Phuket/3073/2018.",
      "It is possible to experience side effects from the Fluzone vaccine like pain, redness, or swelling at the injection site.",
      "Mild symptoms such as fever or fatigue can also be experienced after receiving the Fluzone vaccine."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Fluzone vaccine contains inactivated viruses, not attenuated live viruses.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3300,
    "user_query": "How is Slc22a3 imprinted?",
    "vicuna-13b_response": "SLC22A3 is imprinted, which means that the expression of this gene is influenced by the presence or absence of a specific epigenetic mark called a differentially methylated region (DMR). Imprinting occurs when a gene is expressed differently depending on the parental origin of the allele. In the case of SLC22A3, the gene is imprinted, which means that it is expressed only from the maternal allele, and this is due to the presence of a DMR in the promoter region of the gene that prevents the expression of the paternal allele. This imprinting is important for normal fetal development and function, and disruptions in imprinting have been associated with various diseases, including cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SLC22A3 is an imprinted gene.\n2. The expression of the SLC22A3 gene is influenced by differentially methylated regions (DMRs).\n3. The SLC22A3 is expressed only from the maternal allele.\n4. A DMR in the promoter region of the SLC22A3 gene prevents the expression of the paternal allele.\n5. Disruptions in imprinting have been associated with various diseases, including cancer.",
    "vicuna-13b_fact": [
      "SLC22A3 is an imprinted gene.",
      "The expression of the SLC22A3 gene is influenced by differentially methylated regions (DMRs).",
      "The SLC22A3 is expressed only from the maternal allele.",
      "A DMR in the promoter region of the SLC22A3 gene prevents the expression of the paternal allele.",
      "Disruptions in imprinting have been associated with various diseases, including cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3302,
    "user_query": "Is the tyrosine kinase BTK implicated in autoimmunity?",
    "vicuna-13b_response": "Yes, the tyrosine kinase BTK (Bruton's tyrosine kinase) is implicated in autoimmunity. BTK is a key signaling molecule in B cells, a type of immune cell that plays a central role in the adaptive immune system.\nIn autoimmune diseases, the immune system mistakenly attacks the body's own tissues and organs. BTK signaling has been shown to play a role in the regulation of B cell activation and differentiation, and dysregulation of BTK signaling has been implicated in the pathogenesis of several autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.\nIn rheumatoid arthritis, for example, BTK signaling has been shown to be involved in the activation and survival of autoreactive B cells, which are B cells that mistakenly recognize and attack the body's own tissues. Inhibition of BTK signaling has been shown to have therapeutic effects in animal models of rheumatoid arthritis, and BTK inhibitors are currently being studied as potential treatments for this and other autoimmune diseases.\nOverall, while BTK is not the only molecule involved in autoimmunity, its dysregulation has been implicated in the pathogenesis of several autoimmune diseases, and targeting BTK signaling with small molecule inhibitors has shown promise as a potential therapeutic approach for these diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The tyrosine kinase BTK (Bruton's tyrosine kinase) is implicated in autoimmunity.\n2. BTK is a key signaling molecule in B cells, a type of immune cell that plays a central role in the adaptive immune system.\n3. Dysregulation of BTK signaling has been implicated in the pathogenesis of several autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.\n4. In rheumatoid arthritis, BTK signaling has been shown to be involved in the activation and survival of autoreactive B cells.\n5. Inhibition of BTK signaling has been shown to have therapeutic effects in animal models of rheumatoid arthritis, and BTK inhibitors are currently being studied as potential treatments for autoimmune diseases.",
    "vicuna-13b_fact": [
      "The tyrosine kinase BTK (Bruton's tyrosine kinase) is implicated in autoimmunity.",
      "BTK is a key signaling molecule in B cells, a type of immune cell that plays a central role in the adaptive immune system.",
      "Dysregulation of BTK signaling has been implicated in the pathogenesis of several autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.",
      "In rheumatoid arthritis, BTK signaling has been shown to be involved in the activation and survival of autoreactive B cells.",
      "Inhibition of BTK signaling has been shown to have therapeutic effects in animal models of rheumatoid arthritis, and BTK inhibitors are currently being studied as potential treatments for autoimmune diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3303,
    "user_query": "What is the BioPlex network?",
    "vicuna-13b_response": "The BioPlex network is a decentralized platform that aims to facilitate the creation and management of digital assets, such as tokens, within the biotech and pharmaceutical industries. The platform utilizes blockchain technology to provide a secure and transparent environment for the creation and management of these assets.\nThe BioPlex network allows for the creation of smart contracts, which are self-executing contracts with the terms of the agreement between buyer and seller being directly written into lines of code. These smart contracts can be used to automate various processes within the biotech and pharmaceutical industries, such as the transfer of intellectual property rights or the distribution of royalties.\nIn addition to smart contracts, the BioPlex network also allows for the creation and management of digital assets, such as tokens. These tokens can be used as a means of payment or as a way to represent ownership or rights within the biotech and pharmaceutical industries.\nOverall, the BioPlex network aims to provide a decentralized and secure platform for the creation and management of digital assets within the biotech and pharmaceutical industries, enabling more efficient and transparent transactions and facilitating innovation in these sectors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The BioPlex network is a decentralized platform that facilitates creation and management of digital assets within the biotech and pharmaceutical industries.\n2. The BioPlex network utilizes blockchain technology.\n3. The BioPlex network allows for the creation of smart contracts.\n4. These smart contracts on the BioPlex network can automate various processes, such as the transfer of intellectual property rights or the distribution of royalties.\n5. The BioPlex network enables the creation and management of tokens which can be used as a means of payment or to represent ownership or rights.",
    "vicuna-13b_fact": [
      "The BioPlex network is a decentralized platform that facilitates creation and management of digital assets within the biotech and pharmaceutical industries.",
      "The BioPlex network utilizes blockchain technology.",
      "The BioPlex network allows for the creation of smart contracts.",
      "These smart contracts on the BioPlex network can automate various processes, such as the transfer of intellectual property rights or the distribution of royalties.",
      "The BioPlex network enables the creation and management of tokens which can be used as a means of payment or to represent ownership or rights."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3304,
    "user_query": "Which algorithm has been developed for detecting expansions of tandem repeats?",
    "vicuna-13b_response": "There are several algorithms that have been developed for detecting expansions of tandem repeats, including:\n1. The Tandem Repeat Finder (TRF) algorithm, which is a widely used algorithm for identifying tandem repeats in DNA sequences. TRF uses a sliding window approach to identify repeating patterns in the DNA sequence.\n2. The Repeat Mismatch Amplification (RMA) algorithm, which is a more recent algorithm that uses a probabilistic approach to detect expansions of tandem repeats. RMA is particularly useful for detecting small expansions of tandem repeats that may be difficult to detect using other algorithms.\n3. The Combinatorial Extension (CE) algorithm, which is a combinatorial approach to detecting tandem repeats. CE uses a dynamic programming approach to identify all possible extensions of a given tandem repeat.\n4. The Markov Chain Monte Carlo (MCMC) algorithm, which is a probabilistic algorithm that uses Markov chain methods to detect tandem repeats. MCMC is particularly useful for detecting large expansions of tandem repeats.\nOverall, the choice of algorithm will depend on the specific characteristics of the DNA sequence being analyzed, as well as the desired sensitivity and specificity of the analysis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Tandem Repeat Finder (TRF) algorithm is used for identifying tandem repeats in DNA sequences.\n2. TRF uses a sliding window approach to identify repeating patterns in the DNA sequence.\n3. The Repeat Mismatch Amplification (RMA) algorithm uses a probabilistic approach to detect expansions of tandem repeats.\n4. The Combinatorial Extension (CE) algorithm uses a dynamic programming approach to identify all possible extensions of a given tandem repeat.\n5. The Markov Chain Monte Carlo (MCMC) algorithm uses Markov chain methods to detect tandem repeats.",
    "vicuna-13b_fact": [
      "The Tandem Repeat Finder (TRF) algorithm is used for identifying tandem repeats in DNA sequences.",
      "TRF uses a sliding window approach to identify repeating patterns in the DNA sequence.",
      "The Repeat Mismatch Amplification (RMA) algorithm uses a probabilistic approach to detect expansions of tandem repeats.",
      "The Combinatorial Extension (CE) algorithm uses a dynamic programming approach to identify all possible extensions of a given tandem repeat.",
      "The Markov Chain Monte Carlo (MCMC) algorithm uses Markov chain methods to detect tandem repeats."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: The Markov Chain Monte Carlo (MCMC) algorithm is a class of algorithms for sampling from probability distributions based on constructing a Markov chain. It is not specifically used to detect tandem repeats.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3305,
    "user_query": "Which clotting factor is in the Andexxa?",
    "vicuna-13b_response": "Andexxa is a medication that is used to treat bleeding episodes in people with hemophilia who have developed inhibitors to factor VIII or IX. Andexxa contains a combination of recombinant coagulation factor VIIa and recombinant coagulation factor X.\nFactor VIIa is a clotting factor that is involved in the extrinsic pathway of blood clotting. It is a key enzyme in the process of converting prothrombin to thrombin, which is an important step in the formation of a blood clot. Factor X is another clotting factor that is involved in the intrinsic pathway of blood clotting. It works with factor VIIa to activate the blood clotting cascade and promote the formation of a clot.\nIn summary, Andexxa contains both factor VIIa and factor X, which are two important clotting factors that work together to promote blood clotting in people with hemophilia who have developed inhibitors to factor VIII or IX.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Andexxa is used to treat bleeding episodes in people with hemophilia who have developed inhibitors to factor VIII or IX.\n2. Andexxa contains a combination of recombinant coagulation factor VIIa and recombinant coagulation factor X.\n3. Factor VIIa is a clotting factor involved in the extrinsic pathway of blood clotting.\n4. Factor VIIa is responsible for converting prothrombin to thrombin during blood clotting.\n5. Factor X is a clotting factor involved in the intrinsic pathway of blood clotting and works with factor VIIa to activate the blood clotting cascade.",
    "vicuna-13b_fact": [
      "Andexxa is used to treat bleeding episodes in people with hemophilia who have developed inhibitors to factor VIII or IX.",
      "Andexxa contains a combination of recombinant coagulation factor VIIa and recombinant coagulation factor X.",
      "Factor VIIa is a clotting factor involved in the extrinsic pathway of blood clotting.",
      "Factor VIIa is responsible for converting prothrombin to thrombin during blood clotting.",
      "Factor X is a clotting factor involved in the intrinsic pathway of blood clotting and works with factor VIIa to activate the blood clotting cascade."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Andexxa is used to reverse the effects of anticoagulants like Apixaban and Rivaroxaban.\n2. FALSE [correction]: Andexxa contains a modified form of human factor Xa as its active ingredient.\n3. TRUE\n4. FALSE [correction]: Factor X is responsible for converting prothrombin to thrombin during blood clotting.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3315,
    "user_query": "What classes of drugs does Retapamulin belong to?",
    "vicuna-13b_response": "Retapamulin is an antibiotic drug that belongs to the class of medications known as pleuromutilins. It is used to treat certain types of bacterial infections, particularly those caused by gram-positive bacteria such as Streptococcus pneumoniae and Staphylococcus aureus. Retapamulin works by interfering with the ability of bacteria to produce a component of their cell walls, which is necessary for their growth and survival. This helps to prevent the spread of the infection and allows the body's immune system to fight off the invading bacteria.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Retapamulin is an antibiotic drug.\n2. Retapamulin belongs to the class of medications known as pleuromutilins.\n3. Retapamulin is used to treat certain types of bacterial infections, particularly those caused by gram-positive bacteria.\n4. Streptococcus pneumoniae and Staphylococcus aureus are types of gram-positive bacteria that can be treated by Retapamulin.\n5. Retapamulin works by interfering with the ability of bacteria to produce a component of their cell walls.",
    "vicuna-13b_fact": [
      "Retapamulin is an antibiotic drug.",
      "Retapamulin belongs to the class of medications known as pleuromutilins.",
      "Retapamulin is used to treat certain types of bacterial infections, particularly those caused by gram-positive bacteria.",
      "Streptococcus pneumoniae and Staphylococcus aureus are types of gram-positive bacteria that can be treated by Retapamulin.",
      "Retapamulin works by interfering with the ability of bacteria to produce a component of their cell walls."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Retapamulin works by inhibiting the synthesis of bacterial protein, not by interfering with the ability of bacteria to produce a component of their cell walls.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3322,
    "user_query": "Which T-UCR has been implicated in prostate cancer?",
    "vicuna-13b_response": "There are several T-UCRs (T-cell receptors) that have been implicated in the immune response to prostate cancer. One of the most well-known is the TCR gene called TP10, which is a T-cell receptor that recognizes an MHC class I molecule called HLA-A2. This TCR has been shown to be highly specific for prostate cancer and has been used as a biomarker for the disease. Other T-UCRs that have been implicated in the immune response to prostate cancer include TCRs such as TP21, TP24, and TP40. These TCRs are also specific for different MHC class I molecules and have been shown to be involved in the recognition and destruction of prostate cancer cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The T-UCRs that have been implicated in the immune response to prostate cancer include TP10, TP21, TP24, and TP40.\n2. The TCR gene called TP10 is a T-cell receptor that recognizes an MHC class I molecule called HLA-A2.\n3. TCR TP10 is highly specific for prostate cancer and has been used as a biomarker for the disease.\n4. TCRs such as TP21, TP24, and TP40 are specific for different MHC class I molecules.\n5. TCRs like TP21, TP24, and TP40 have been shown to be involved in the recognition and destruction of prostate cancer cells.",
    "vicuna-13b_fact": [
      "The T-UCRs that have been implicated in the immune response to prostate cancer include TP10, TP21, TP24, and TP40.",
      "The TCR gene called TP10 is a T-cell receptor that recognizes an MHC class I molecule called HLA-A2.",
      "TCR TP10 is highly specific for prostate cancer and has been used as a biomarker for the disease.",
      "TCRs such as TP21, TP24, and TP40 are specific for different MHC class I molecules.",
      "TCRs like TP21, TP24, and TP40 have been shown to be involved in the recognition and destruction of prostate cancer cells."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3325,
    "user_query": "Which company sells the drug Afrezza since 2015?",
    "vicuna-13b_response": "The company that sells the drug Afrezza since 2015 is called MannKind Corporation. Afrezza is an inhaled insulin therapy used to treat adults with type 1 or type 2 diabetes. It was approved by the U.S. Food and Drug Administration (FDA) in 2014 and launched in the United States in 2015. MannKind is a biopharmaceutical company that specializes in the development, manufacturing, and commercialization of medical products, including Afrezza.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MannKind Corporation has been selling the drug Afrezza since 2015.\n2. Afrezza is an inhaled insulin therapy used to treat adults with type 1 or type 2 diabetes.\n3. The U.S. Food and Drug Administration (FDA) approved Afrezza in 2014.\n4. Afrezza was launched in the United States in 2015.\n5. MannKind is a biopharmaceutical company that specializes in the development, manufacturing, and commercialization of medical products, including Afrezza.",
    "vicuna-13b_fact": [
      "MannKind Corporation has been selling the drug Afrezza since 2015.",
      "Afrezza is an inhaled insulin therapy used to treat adults with type 1 or type 2 diabetes.",
      "The U.S. Food and Drug Administration (FDA) approved Afrezza in 2014.",
      "Afrezza was launched in the United States in 2015.",
      "MannKind is a biopharmaceutical company that specializes in the development, manufacturing, and commercialization of medical products, including Afrezza."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3327,
    "user_query": "Does Uc.63+ promote sensitivity to treatment in prostate cancer?",
    "vicuna-13b_response": "Uc.63+ is a gene expression signature that has been identified as a potential biomarker for the prediction of response to radiation therapy in prostate cancer patients. The Uc.63+ signature is based on the expression of a set of genes that are associated with DNA repair and cell cycle progression, and it has been shown to be able to predict the likelihood of response to radiation therapy in prostate cancer patients with high accuracy.\nHowever, it is important to note that the Uc.63+ signature is not a treatment in and of itself, but rather a biomarker that can be used to predict the likelihood of response to a particular treatment, in this case, radiation therapy. The use of the Uc.63+ signature in clinical practice would involve analyzing the expression of the genes in the signature in a patient's tumor tissue, and using that information to inform the decision of whether or not to proceed with radiation therapy.\nIt is also important to note that while the Uc.63+ signature has been shown to be a promising biomarker for the prediction of response to radiation therapy in prostate cancer, it is not yet widely used in clinical practice, and further research is needed to validate its utility in the clinic.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Uc.63+ is a gene expression signature.\n2. Uc.63+ is identified as a potential biomarker for the prediction of response to radiation therapy in prostate cancer patients.\n3. The Uc.63+ signature is based on the expression of genes associated with DNA repair and cell cycle progression.\n4. Uc.63+ is not a treatment but a biomarker that predicts likelihood of response to radiation therapy.\n5. The Uc.63+ signature is not yet widely used in clinical practice.",
    "vicuna-13b_fact": [
      "Uc.63+ is a gene expression signature.",
      "Uc.63+ is identified as a potential biomarker for the prediction of response to radiation therapy in prostate cancer patients.",
      "The Uc.63+ signature is based on the expression of genes associated with DNA repair and cell cycle progression.",
      "Uc.63+ is not a treatment but a biomarker that predicts likelihood of response to radiation therapy.",
      "The Uc.63+ signature is not yet widely used in clinical practice."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3332,
    "user_query": "What is OAC CHV?",
    "vicuna-13b_response": "OAC CHV stands for the Ontario Autism Coordinating Committee's Community Hubs and Virtual Services. It is a program that provides support and resources to individuals with autism spectrum disorder (ASD) and their families across Ontario, Canada.\nThe program offers a range of services, including information and referral, community hubs, and virtual services. Community hubs are physical locations where individuals and families can access resources and support, while virtual services are online resources and support available to anyone with an internet connection.\nThe goal of OAC CHV is to improve access to care and support for individuals with ASD and their families, particularly those who live in rural and remote areas of the province. The program aims to provide a more coordinated and integrated approach to autism services, helping individuals and families navigate the complex system of care and support available in Ontario.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. OAC CHV stands for the Ontario Autism Coordinating Committee's Community Hubs and Virtual Services.\n2. The OAC CHV program provides support to individuals with autism spectrum disorder (ASD) and their families in Ontario, Canada.\n3. The OAC CHV program includes physical community hubs and online virtual services.\n4. The goal of OAC CHV is to improve access to care for individuals with ASD and their families, especially those in rural and remote areas of Ontario.\n5. The program aims to provide a more coordinated and integrated approach to autism services in Ontario.",
    "vicuna-13b_fact": [
      "OAC CHV stands for the Ontario Autism Coordinating Committee's Community Hubs and Virtual Services.",
      "The OAC CHV program provides support to individuals with autism spectrum disorder (ASD) and their families in Ontario, Canada.",
      "The OAC CHV program includes physical community hubs and online virtual services.",
      "The goal of OAC CHV is to improve access to care for individuals with ASD and their families, especially those in rural and remote areas of Ontario.",
      "The program aims to provide a more coordinated and integrated approach to autism services in Ontario."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3338,
    "user_query": "What does MVA85A stand for?",
    "vicuna-13b_response": "MVA85A is not a commonly recognized acronym or abbreviation. It is possible that it may have a specific meaning in a particular context or industry, but without more information, it is not possible to provide a definitive answer.",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 3339,
    "user_query": "Can MVA85A confer immunity against smallpox?",
    "vicuna-13b_response": "MVA85A is a modified vaccinia virus Ankara (MVA) that has been used in smallpox vaccination programs. It is a live, attenuated virus that is similar to the vaccinia virus, which is used in the traditional smallpox vaccine.\nMVA85A has been shown to be highly effective in inducing immunity against smallpox, and it has been used in several clinical trials to evaluate its safety and efficacy. Studies have shown that MVA85A can generate a strong immune response, including the production of antibodies and T cells, which are important for protecting against smallpox.\nIt is important to note that MVA85A is not the same as the traditional smallpox vaccine, which is made from a different virus (vaccinia). However, both vaccines work in a similar way, by exposing the body to a small, harmless piece of the virus, which triggers the immune system to produce antibodies and memory cells that can recognize and fight off the virus if it is encountered in the future.\nIn summary, MVA85A has been shown to be effective in conferring immunity against smallpox, and it has been used in smallpox vaccination programs as an alternative to the traditional smallpox vaccine.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MVA85A is a modified vaccinia virus Ankara (MVA) that has been used in smallpox vaccination programs.\n2. MVA85A has been shown to be effective in providing immunity against smallpox.\n3. MVA85A has been used in several clinical trials to evaluate its safety and effectiveness.\n4. The traditional smallpox vaccine is made with the vaccinia virus.\n5. MVA85A can generate a strong immune response, which includes the production of antibodies and T cells.",
    "vicuna-13b_fact": [
      "MVA85A is a modified vaccinia virus Ankara (MVA) that has been used in smallpox vaccination programs.",
      "MVA85A has been shown to be effective in providing immunity against smallpox.",
      "MVA85A has been used in several clinical trials to evaluate its safety and effectiveness.",
      "The traditional smallpox vaccine is made with the vaccinia virus.",
      "MVA85A can generate a strong immune response, which includes the production of antibodies and T cells."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: MVA85A is a modified vaccinia virus Ankara (MVA) that has been used in tuberculosis vaccine research, not smallpox vaccination programs.\n2. FALSE [correction]: MVA85A has not been shown to be effective in providing immunity against smallpox; it's being evaluated as a booster for BCG, the current tuberculosis vaccine.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3342,
    "user_query": "List cohesinopathies",
    "vicuna-13b_response": "Cohesinopathies are a group of rare genetic disorders that are caused by mutations in the genes that encode cohesin complex proteins. Cohesin is a complex of proteins that is involved in the regulation of gene expression and the maintenance of chromosome structure.\nThere are several types of cohesinopathies, including:\n1. Cornelia de Lange syndrome (CdLS): This is a rare genetic disorder that affects growth and development. It is characterized by a range of physical and intellectual disabilities, including limb abnormalities, facial features such as a small head, long eyelashes, and a downturned mouth, and gastrointestinal and genitourinary abnormalities. CdLS is caused by mutations in the NIPBL gene, which encodes a cohesin complex protein.\n2. Mental retardation-hypotonia-facial abnormality syndrome (MTHFS): This is a rare genetic disorder that affects growth and development. It is characterized by intellectual disability, hypotonia (muscle weakness), and facial abnormalities such as a broad forehead, a flat face, and an upward slant to the eyes. MTHFS is caused by mutations in the GTF2I gene, which encodes a cohesin complex protein.\n3. Subtelomeric disorders: These are a group of rare genetic disorders that affect the ends of chromosomes. They are characterized by abnormalities in the structure and function of the telomeres, which are the protective caps on the ends of chromosomes. Subtelomeric disorders are caused by mutations in genes that are involved in the maintenance of telomere structure and function, including the cohesin complex proteins.\nOverall, cohesinopathies are a diverse group of genetic disorders that are caused by mutations in the genes that encode cohesin complex proteins. These disorders can affect a wide range of physical and intellectual abilities, and can have a significant impact on the lives of those affected.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cohesinopathies are caused by mutations in the genes that encode cohesin complex proteins.\n2. Cornelia de Lange syndrome (CdLS) is a type of cohesinopathy caused by mutations in the NIPBL gene.\n3. Mental retardation-hypotonia-facial abnormality syndrome (MTHFS) is a cohesinopathy caused by mutations in the GTF2I gene.\n4. Subtelomeric disorders are a group of cohesinopathies that affect the ends of chromosomes.\n5. The cohesin complex is involved in the regulation of gene expression and the maintenance of chromosome structure.",
    "vicuna-13b_fact": [
      "Cohesinopathies are caused by mutations in the genes that encode cohesin complex proteins.",
      "Cornelia de Lange syndrome (CdLS) is a type of cohesinopathy caused by mutations in the NIPBL gene.",
      "Mental retardation-hypotonia-facial abnormality syndrome (MTHFS) is a cohesinopathy caused by mutations in the GTF2I gene.",
      "Subtelomeric disorders are a group of cohesinopathies that affect the ends of chromosomes.",
      "The cohesin complex is involved in the regulation of gene expression and the maintenance of chromosome structure."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Mental retardation-hypotonia-facial abnormality syndrome (MTHFS) is not classified as a cohesinopathy and is not caused by mutations in the GTF2I gene.\n4. FALSE [correction]: Subtelomeric disorders are not a group of cohesinopathies. They involve deletions or duplications in the regions at the ends of chromosomes, not mutations in the genes that encode the cohesin complex.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "vicuna-13b_response": "Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organs and systems in the body. There are several genetic factors that have been identified as contributing to the development of SLE, including variations in the TNFR2 gene.\nThe TNFR2 gene provides instructions for making a protein called tumor necrosis factor receptor superfamily member 2 (TNFRSF2), which is involved in the immune response and inflammation. Variations in the TNFR2 gene have been associated with an increased risk of developing SLE.\nSpecifically, a variation in the TNFR2 gene called the 196G>C polymorphism has been identified as a genetic risk factor for SLE. This variation is located in the promoter region of the TNFR2 gene and has been shown to affect the expression of the TNFRSF2 protein.\nIt is important to note that genetic variations are only one of many factors that can contribute to the development of SLE, and that other environmental and lifestyle factors are also thought to play a role in the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organs and systems in the body.\n2. The TNFR2 gene provides instructions for making a protein called tumor necrosis factor receptor superfamily member 2 (TNFRSF2).\n3. Variations in the TNFR2 gene have been associated with an increased risk of developing SLE.\n4. A specific variation in the TNFR2 gene, called the 196G>C polymorphism, is located in the promoter region of the gene.\n5. This 196G>C polymorphism in the TNFR2 gene has been shown to affect the expression of the TNFRSF2 protein.",
    "vicuna-13b_fact": [
      "Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organs and systems in the body.",
      "The TNFR2 gene provides instructions for making a protein called tumor necrosis factor receptor superfamily member 2 (TNFRSF2).",
      "Variations in the TNFR2 gene have been associated with an increased risk of developing SLE.",
      "A specific variation in the TNFR2 gene, called the 196G>C polymorphism, is located in the promoter region of the gene.",
      "This 196G>C polymorphism in the TNFR2 gene has been shown to affect the expression of the TNFRSF2 protein."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3348,
    "user_query": "Is Figitumumab effective for non-small cell lung cancer?",
    "vicuna-13b_response": "Figitumumab is a monoclonal antibody drug that is designed to target a specific protein called CD20, which is found on the surface of some types of cancer cells, including non-small cell lung cancer (NSCLC). CD20 is a protein that is involved in the growth and survival of cancer cells, and by targeting it with figitumumab, the drug can help to slow down or stop the growth and spread of cancer cells.\nThere have been several clinical trials conducted to evaluate the effectiveness of figitumumab in the treatment of NSCLC, and the results have been mixed. Some studies have shown that figitumumab can help to improve overall survival and progression-free survival in patients with advanced stages of NSCLC, while others have shown no significant benefit or even some side effects.\nFor example, a phase III clinical trial called \"IMPRESS\" was conducted on patients with previously untreated advanced stage IIB-IV NSCLC. The trial found that adding figitumumab to standard chemotherapy did not improve overall survival compared to chemotherapy alone. However, another phase III clinical trial called \"FLEX\" found that figitumumab in combination with paclitaxel improved progression-free survival in patients with advanced stage IIIB-IV NSCLC compared to paclitaxel alone.\nIt's worth noting that the effectiveness of figitumumab in the treatment of NSCLC can depend on various factors such as the patient's individual characteristics, the stage and severity of the cancer, and the specific treatment regimen used. Therefore, the decision to use figitumumab for the treatment of NSCLC should be made on a case-by-case basis, based on the advice of a qualified oncologist.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Figitumumab is a monoclonal antibody drug that targets a protein called CD20 found on some types of cancer cells, including non-small cell lung cancer.\n2. The IMPRESS phase III clinical trial found that adding figitumumab to standard chemotherapy did not improve overall survival for patients with advanced stage IIB-IV NSCLC.\n3. The FLEX phase III clinical trial found that figitumumab in combination with paclitaxel improved progression-free survival in patients with advanced stage IIIB-IV NSCLC.\n4. The effectiveness of figitumumab in treating NSCLC can depend on factors like patient characteristics, stage and severity of the cancer, and the specific treatment regimen used.\n5. Clinical trial results for figitumumab's effectiveness on NSCLC have been mixed, with some showing improved survival and others showing no significant benefit or side effects.",
    "vicuna-13b_fact": [
      "Figitumumab is a monoclonal antibody drug that targets a protein called CD20 found on some types of cancer cells, including non-small cell lung cancer.",
      "The IMPRESS phase III clinical trial found that adding figitumumab to standard chemotherapy did not improve overall survival for patients with advanced stage IIB-IV NSCLC.",
      "The FLEX phase III clinical trial found that figitumumab in combination with paclitaxel improved progression-free survival in patients with advanced stage IIIB-IV NSCLC.",
      "The effectiveness of figitumumab in treating NSCLC can depend on factors like patient characteristics, stage and severity of the cancer, and the specific treatment regimen used.",
      "Clinical trial results for figitumumab's effectiveness on NSCLC have been mixed, with some showing improved survival and others showing no significant benefit or side effects."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Figitumumab is a monoclonal antibody drug that targets the insulin-like growth factor-1 receptor (IGF-1R), not CD20.\n2. TRUE\n3. FALSE [correction]: There is no record of a FLEX phase III clinical trial associated with figitumumab. This statement may be misattributed or confused with cetuximab, another drug.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3349,
    "user_query": "The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?",
    "vicuna-13b_response": "Yes, the LINCS L1000 data set contains gene expression data for drug-treated human cells. The LINCS (Library of Integrated Network-based Cellular Signatures) L1000 dataset is a large-scale gene expression dataset that includes data from a variety of cell types and conditions, including drug-treated human cells. The dataset includes gene expression profiles for a wide range of cellular processes and disease states, and is widely used in the scientific community for the study of cellular behavior and the development of new therapies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The LINCS L1000 data set contains gene expression data for drug-treated human cells.\n2. The LINCS L1000 dataset includes data from a variety of cell types and conditions.\n3. This dataset includes gene expression profiles for a wide range of cellular processes and disease states. \n4. The LINCS L1000 dataset is used in the scientific community for the study of cellular behavior. \n5. The LINCS L1000 dataset also aids in the development of new therapies.",
    "vicuna-13b_fact": [
      "The LINCS L1000 data set contains gene expression data for drug-treated human cells.",
      "The LINCS L1000 dataset includes data from a variety of cell types and conditions.",
      "This dataset includes gene expression profiles for a wide range of cellular processes and disease states.",
      "The LINCS L1000 dataset is used in the scientific community for the study of cellular behavior.",
      "The LINCS L1000 dataset also aids in the development of new therapies."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3351,
    "user_query": "Which database exists that contains regulatory SNPs which affect predicted transcription factor binding site affinity?",
    "vicuna-13b_response": "One database that contains regulatory SNPs (single nucleotide polymorphisms) that affect predicted transcription factor binding site affinity is the Encyclopedia of DNA Elements (ENCODE) database. The ENCODE project is a scientific initiative that aims to identify and map all the functional elements in the human genome, including transcription factor binding sites. The database contains information on regulatory SNPs that affect the binding affinity of transcription factors to their target sites, as well as other types of functional variants that can affect gene expression. The data is derived from a variety of experimental and computational methods, including chromatin immunoprecipitation sequencing (ChIP-seq), DNA sequencing, and computational modeling. The ENCODE database is a valuable resource for researchers studying the regulatory mechanisms that control gene expression and for identifying potential targets for therapeutic intervention.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Encyclopedia of DNA Elements (ENCODE) database contains regulatory SNPs (single nucleotide polymorphisms) that affect predicted transcription factor binding site affinity.\n2. The ENCODE project aims to identify and map all the functional elements in the human genome, including transcription factor binding sites.\n3. The ENCODE database contains information on other types of functional variants that can affect gene expression.\n4. The data in the ENCODE database is derived from a variety of experimental and computational methods, including chromatin immunoprecipitation sequencing (ChIP-seq), DNA sequencing, and computational modeling.\n5. The ENCODE database is used as a resource for researchers studying regulatory mechanisms that control gene expression and identifying potential targets for therapeutic intervention.",
    "vicuna-13b_fact": [
      "The Encyclopedia of DNA Elements (ENCODE) database contains regulatory SNPs (single nucleotide polymorphisms) that affect predicted transcription factor binding site affinity.",
      "The ENCODE project aims to identify and map all the functional elements in the human genome, including transcription factor binding sites.",
      "The ENCODE database contains information on other types of functional variants that can affect gene expression.",
      "The data in the ENCODE database is derived from a variety of experimental and computational methods, including chromatin immunoprecipitation sequencing (ChIP-seq), DNA sequencing, and computational modeling.",
      "The ENCODE database is used as a resource for researchers studying regulatory mechanisms that control gene expression and identifying potential targets for therapeutic intervention."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3352,
    "user_query": "Which R package has been developed for MS-based label-free phosphoproteomics?",
    "vicuna-13b_response": "There are several R packages that have been developed for MS-based label-free phosphoproteomics. Some of the popular ones are:\n1. PhosphoRS: This package is designed for the analysis of MS-based label-free phosphoproteomics data. It provides tools for identifying and quantifying phosphorylation sites, as well as for comparing different samples and identifying changes in phosphorylation patterns over time.\n2. PhosphoPep: This package is designed for the analysis of MS-based label-free phosphoproteomics data, with a focus on phosphopeptide identification and quantification. It provides tools for analyzing large datasets and for identifying changes in phosphorylation patterns over time.\n3. MS-GF+: This package is a general-purpose tool for analyzing MS-based proteomics data. It provides tools for identifying and quantifying proteins and peptides, as well as for comparing different samples and identifying changes in protein expression over time.\n4. X!Tandem: This package is designed for the analysis of MS-based proteomics data, with a focus on the identification and quantification of proteins and peptides. It provides tools for analyzing large datasets and for identifying changes in protein expression over time.\nThese packages are widely used in the field of phosphoproteomics and have been published in various scientific journals.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PhosphoRS is an R package developed for the analysis of MS-based label-free phosphoproteomics data.\n2. PhosphoPep is an R package that focuses on phosphopeptide identification and quantification in MS-based label-free phosphoproteomics.\n3. MS-GF+ is an R package used for analyzing MS-based proteomics data.\n4. X!Tandem is an R package designed for the analysis of MS-based proteomics data, with a focus on the identification and quantification of proteins and peptides.\n5. These mentioned packages are used in the field of phosphoproteomics and have been published in various scientific journals.",
    "vicuna-13b_fact": [
      "PhosphoRS is an R package developed for the analysis of MS-based label-free phosphoproteomics data.",
      "PhosphoPep is an R package that focuses on phosphopeptide identification and quantification in MS-based label-free phosphoproteomics.",
      "MS-GF+ is an R package used for analyzing MS-based proteomics data.",
      "X!Tandem is an R package designed for the analysis of MS-based proteomics data, with a focus on the identification and quantification of proteins and peptides.",
      "These mentioned packages are used in the field of phosphoproteomics and have been published in various scientific journals."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3358,
    "user_query": "What is Soluvia?",
    "vicuna-13b_response": "I'm sorry, but I am not familiar with the term \"Soluvia.\" It is possible that it is a fictional or mythical place, or a name used in a work of fiction or fantasy. Can you provide any additional context or information that might help me understand what you are referring to?",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 3361,
    "user_query": "What is the main difference between nascent and mature chromatin?",
    "vicuna-13b_response": "Nascent chromatin is the newly synthesized DNA that has not yet been compacted into chromosomes. It is in a loose, unstructured form and contains a mixture of nucleotides, including adenine, guanine, cytosine, and thymine (A, G, C, and T).\nMature chromatin, on the other hand, is the compacted form of chromosomes that contains the DNA tightly wound around proteins called histones. The DNA in mature chromatin is in a more stable, less accessible form than in nascent chromatin.\nThe main difference between nascent and mature chromatin is their structure and the degree of compaction of the DNA. Nascent chromatin is in a loose, unstructured form, while mature chromatin is tightly wound around histone proteins and is more compact. Additionally, the DNA in nascent chromatin is not yet fully synthesized, while the DNA in mature chromatin is fully synthesized and has undergone the process of replication.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nascent chromatin is the newly synthesized DNA that has not yet been compacted into chromosomes.\n2. Nascent chromatin contains a mixture of nucleotides, including adenine, guanine, cytosine, and thymine (A, G, C, and T).\n3. Mature chromatin is the compacted form of chromosomes that contains the DNA tightly wound around proteins called histones.\n4. The DNA in mature chromatin is in a more stable, less accessible form than in nascent chromatin.\n5. The DNA in nascent chromatin is not yet fully synthesized, while the DNA in mature chromatin is fully synthesized and has undergone the process of replication.",
    "vicuna-13b_fact": [
      "Nascent chromatin is the newly synthesized DNA that has not yet been compacted into chromosomes.",
      "Nascent chromatin contains a mixture of nucleotides, including adenine, guanine, cytosine, and thymine (A, G, C, and T).",
      "Mature chromatin is the compacted form of chromosomes that contains the DNA tightly wound around proteins called histones.",
      "The DNA in mature chromatin is in a more stable, less accessible form than in nascent chromatin.",
      "The DNA in nascent chromatin is not yet fully synthesized, while the DNA in mature chromatin is fully synthesized and has undergone the process of replication."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The DNA in both nascent and mature chromatin is fully synthesized. The difference lies in the level of compaction and accessibility, not the synthesis or replication of the DNA.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3362,
    "user_query": "Is CTCF bound at nucleosome free regions?",
    "vicuna-13b_response": "CTCF (CCCTC-binding factor) is a transcription factor that plays a crucial role in the regulation of gene expression by controlling the access of other transcription factors to their target sites. CTCF is known to bind to the untranslated regions of mRNA and to specific DNA sequences, including insulators and enhancers.\nNucleosomes are the basic units of chromatin, consisting of a DNA molecule wrapped around a histone protein core. Nucleosome free regions are regions of DNA that are not associated with a nucleosome.\nThere is evidence that CTCF can bind to nucleosome free regions. For example, CTCF has been shown to bind to the promoter regions of some genes, which are typically nucleosome free. Additionally, CTCF has been shown to interact with the histone modifying enzyme, H3K4 methyltransferase, which is involved in the maintenance of nucleosome occupancy.\nHowever, it is also known that CTCF can bind to nucleosomes, and this binding can affect the positioning and activity of nucleosomes. For example, CTCF has been shown to recruit the histone-modifying enzyme, H3K9 methyltransferase, which can lead to the deposition of histone methylation marks on the tail of histone H3, and this can affect the compaction of chromatin and the access of other transcription factors to their target sites.\nIn summary, while CTCF can bind to nucleosome free regions, it is also known to bind to nucleosomes and affect their positioning and activity.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CTCF is a transcription factor that controls the access of other transcription factors to their target sites.\n2. CTCF binds to the untranslated regions of mRNA and specific DNA sequences, including insulators and enhancers.\n3. Nucleosomes are the basic units of chromatin, consisting of a DNA molecule wrapped around a histone protein core.\n4. There is evidence that CTCF can bind to nucleosome free regions.\n5. CTCF also binds to nucleosomes and this binding can affect the positioning and activity of nucleosomes.",
    "vicuna-13b_fact": [
      "CTCF is a transcription factor that controls the access of other transcription factors to their target sites.",
      "CTCF binds to the untranslated regions of mRNA and specific DNA sequences, including insulators and enhancers.",
      "Nucleosomes are the basic units of chromatin, consisting of a DNA molecule wrapped around a histone protein core.",
      "There is evidence that CTCF can bind to nucleosome free regions.",
      "CTCF also binds to nucleosomes and this binding can affect the positioning and activity of nucleosomes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: CTCF does not bind to mRNA untranslated regions, but binds to specific DNA sequences including insulators and enhancers.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3364,
    "user_query": "Is PRDM9 essential for meiosis?",
    "vicuna-13b_response": "PRDM9 (PR domain containing 9) is a protein that plays a crucial role in the regulation of meiosis, which is a type of cell division that occurs in the reproductive cells of plants and animals. PRDM9 is a transcription factor, which means it helps control the expression of other genes.\nStudies have shown that PRDM9 is essential for the proper progression of meiosis in plants, animals, and even fungi. In plants, PRDM9 is required for the proper timing of meiosis, the correct segregation of chromosomes, and the development of the haploid cells. In animals, PRDM9 is necessary for the initiation of meiosis and the proper segregation of chromosomes during meiosis.\nIn summary, PRDM9 is an essential protein for the regulation of meiosis in many organisms, and its loss can result in abnormal meiosis and infertility.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PRDM9 is a protein that aids in the regulation of meiosis, a type of cell division in the reproductive cells of plants and animals.\n2. PRDM9 functions as a transcription factor, meaning it helps control the gene expression.\n3. PRDM9 is essential for the proper progression of meiosis in plants, animals, and fungi.\n4. In plants, PRDM9 facilitates proper timing of meiosis, correct segregation of chromosomes, and development of haploid cells.\n5. In animals, PRDM9 is needed for the initiation of meiosis and the correct segregation of chromosomes during meiosis.",
    "vicuna-13b_fact": [
      "PRDM9 is a protein that aids in the regulation of meiosis, a type of cell division in the reproductive cells of plants and animals.",
      "PRDM9 functions as a transcription factor, meaning it helps control the gene expression.",
      "PRDM9 is essential for the proper progression of meiosis in plants, animals, and fungi.",
      "In plants, PRDM9 facilitates proper timing of meiosis, correct segregation of chromosomes, and development of haploid cells.",
      "In animals, PRDM9 is needed for the initiation of meiosis and the correct segregation of chromosomes during meiosis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: PRDM9 is essential for the proper progression of meiosis in mammals, not in plants and fungi.\n4. FALSE [correction]: PRDM9 is not known to play a role in meiosis in plants.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "vicuna-13b_response": "The Fxy gene is a gene that is responsible for the development of the mouse coat color. The Fxy gene is located on the X chromosome of the mouse, which is one of the two sex chromosomes in mice. The X chromosome is the larger of the two sex chromosomes and contains a large number of genes that are involved in various biological processes, including development, growth, and reproduction.\nThe Fxy gene is specifically located on the distal end of the X chromosome, which is the part of the chromosome that is closest to the centromere. The centromere is the point on the chromosome where the two arms of the chromosome are joined. The distal end of the X chromosome is also known as the Xp region.\nThe chromosomal position of a gene is important because it determines the location of the gene on the chromosome and can affect the expression of the gene. The Fxy gene is expressed in the coat cells of the mouse, and its expression is regulated by the surrounding environment and other genetic factors. The chromosomal position of the Fxy gene can affect its expression and can also affect the inheritance of the coat color trait in mice.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Fxy gene is responsible for the development of the mouse coat color.\n2. The Fxy gene is located on the X chromosome of the mouse.\n3. The X chromosome is one of the two sex chromosomes in mice and is the larger of the two.\n4. The Fxy gene is specifically located on the distal end of the X chromosome.\n5. The chromosomal position of a gene can affect its expression and can also affect the inheritance of traits in mice.",
    "vicuna-13b_fact": [
      "The Fxy gene is responsible for the development of the mouse coat color.",
      "The Fxy gene is located on the X chromosome of the mouse.",
      "The X chromosome is one of the two sex chromosomes in mice and is the larger of the two.",
      "The Fxy gene is specifically located on the distal end of the X chromosome.",
      "The chromosomal position of a gene can affect its expression and can also affect the inheritance of traits in mice."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3367,
    "user_query": "What does a PET (Positron Excitation Tomography) measure?",
    "vicuna-13b_response": "PET (Positron Emission Tomography) is a type of medical imaging that uses small amounts of radioactive material, called a tracer, to produce detailed, three-dimensional images of the body's internal structures and functions. PET scans can be used to detect and diagnose a variety of diseases, including cancer, heart disease, and neurological disorders.\nDuring a PET scan, a patient is injected with a small amount of a tracer, which is usually a sugar-based compound that is labeled with a radioactive isotope. The tracer is taken up by cells in the body and emits positrons, which are the opposite of electrons. These positrons travel a short distance and then collide with electrons, which results in the emission of gamma rays. A special camera called a PET scanner is used to detect these gamma rays and create detailed images of the body's internal structures and functions.\nPET scans are particularly useful for identifying the location and extent of cancerous tumors, as well as the presence of malignant cells in the body. They can also be used to monitor the effectiveness of cancer treatment and to detect the recurrence of cancer. In addition, PET scans can be used to evaluate the function of various organs and tissues in the body, such as the heart, brain, and liver.\nOverall, PET scans are a valuable tool for diagnosing and treating a wide range of diseases, and they are an important part of modern medical imaging.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PET (Positron Emission Tomography) uses small amounts of radioactive material to produce detailed images of the body's internal structures and functions.\n2. PET scans can detect and diagnose a variety of diseases, including cancer, heart disease, and neurological disorders.\n3. During a PET scan, a patient is injected with a sugar-based compound that is labeled with a radioactive isotope.\n4. PET scans are useful for identifying the location and extent of cancerous tumors, as well as the presence of malignant cells in the body.\n5. PET scans can be used to evaluate the function of various organs and tissues in the body, such as the heart, brain, and liver.",
    "vicuna-13b_fact": [
      "PET (Positron Emission Tomography) uses small amounts of radioactive material to produce detailed images of the body's internal structures and functions.",
      "PET scans can detect and diagnose a variety of diseases, including cancer, heart disease, and neurological disorders.",
      "During a PET scan, a patient is injected with a sugar-based compound that is labeled with a radioactive isotope.",
      "PET scans are useful for identifying the location and extent of cancerous tumors, as well as the presence of malignant cells in the body.",
      "PET scans can be used to evaluate the function of various organs and tissues in the body, such as the heart, brain, and liver."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3371,
    "user_query": "Does clinical trial data support the use of minocycline for amyotrophic lateral sclerosis?",
    "vicuna-13b_response": "Minocycline is an antibiotic that has been studied for its potential to treat amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.\nThere have been several clinical trials conducted to evaluate the safety and efficacy of minocycline for the treatment of ALS. While some studies have suggested that minocycline may have potential therapeutic benefits for ALS patients, the evidence is not conclusive and more research is needed to fully understand its effects.\nOne of the main challenges in studying the use of minocycline for ALS is that the disease is rare and the sample size of patients is small, which makes it difficult to conduct large-scale, randomized, controlled clinical trials. Additionally, the biological mechanisms underlying ALS are complex and not fully understood, which makes it challenging to design clinical trials that can accurately measure the effectiveness of a particular treatment.\nOverall, while there is some evidence to suggest that minocycline may have potential therapeutic benefits for ALS patients, more research is needed to fully understand its effects and to determine whether it is an effective treatment for ALS.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Minocycline is an antibiotic that has been studied for its potential to treat amyotrophic lateral sclerosis (ALS).\n2. Amyotrophic lateral sclerosis is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord.\n3. There have been several clinical trials conducted to evaluate the safety and efficacy of minocycline for the treatment of ALS.\n4. Some studies have suggested that minocycline may have potential therapeutic benefits for ALS patients.\n5. ALS is a rare disease which makes it difficult to conduct large-scale, randomized, controlled clinical trials.",
    "vicuna-13b_fact": [
      "Minocycline is an antibiotic that has been studied for its potential to treat amyotrophic lateral sclerosis (ALS).",
      "Amyotrophic lateral sclerosis is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord.",
      "There have been several clinical trials conducted to evaluate the safety and efficacy of minocycline for the treatment of ALS.",
      "Some studies have suggested that minocycline may have potential therapeutic benefits for ALS patients.",
      "ALS is a rare disease which makes it difficult to conduct large-scale, randomized, controlled clinical trials."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3374,
    "user_query": "What is the function of the ISW1 and CHD1 remodellers in yeast chromatin?",
    "vicuna-13b_response": "In yeast, the ISW1 and CHD1 remodellers are two different types of chromatin remodellers that play important roles in regulating chromatin structure and accessibility.\nThe ISW1 remodeller is a complex composed of several subunits, including SWR1, ISW1, and RSC. The ISW1 complex is responsible for removing histone H2A.Z from nucleosomes, leading to an increase in nucleosome mobility and accessibility to the underlying DNA. This complex is also involved in the regulation of gene expression, DNA repair, and meiosis.\nThe CHD1 remodeller, on the other hand, is a single-subunit complex that is responsible for depositing histone H3.3 onto nucleosomes, leading to an increase in nucleosome stability and a decrease in nucleosome mobility. The CHD1 complex is involved in the regulation of gene expression, DNA repair, and meiosis.\nIn summary, the ISW1 and CHD1 remodellers play opposite roles in regulating chromatin structure and accessibility in yeast. ISW1 promotes accessibility to the underlying DNA, while CHD1 promotes nucleosome stability and decreases accessibility. Both complexes are important for proper chromatin regulation and gene expression in yeast.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ISW1 and CHD1 are two different types of chromatin remodellers in yeast.\n2. The ISW1 complex in yeast is composed of several subunits, including SWR1, ISW1, and RSC.\n3. The ISW1 remodeller is responsible for removing histone H2A.Z from nucleosomes, promoting DNA accessibility and facilitating gene expression, DNA repair, and meiosis.\n4. The CHD1 remodeller is a single-subunit complex that deposits histone H3.3 onto nucleosomes, increasing nucleosome stability and decreasing their mobility.\n5. Both ISW1 and CHD1 complexes are significant for proper chromatin regulation and gene expression in yeast, but play opposing roles in regulating chromatin structure and accessibility.",
    "vicuna-13b_fact": [
      "ISW1 and CHD1 are two different types of chromatin remodellers in yeast.",
      "The ISW1 complex in yeast is composed of several subunits, including SWR1, ISW1, and RSC.",
      "The ISW1 remodeller is responsible for removing histone H2A.Z from nucleosomes, promoting DNA accessibility and facilitating gene expression, DNA repair, and meiosis.",
      "The CHD1 remodeller is a single-subunit complex that deposits histone H3.3 onto nucleosomes, increasing nucleosome stability and decreasing their mobility.",
      "Both ISW1 and CHD1 complexes are significant for proper chromatin regulation and gene expression in yeast, but play opposing roles in regulating chromatin structure and accessibility."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The ISW1 complex in yeast is composed of several subunits, but not SWR1 and RSC.\n3. FALSE [correction]: It's not the ISW1 remodeller but the SWR1 complex in yeast that is responsible for removing histone H2A.Z from nucleosomes, promoting DNA accessibility and facilitating gene expression, DNA repair, and meiosis.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3382,
    "user_query": "What is the difference between Daptacel and Pentacel?",
    "vicuna-13b_response": "Daptacel and Pentacel are both combination vaccines that are used to protect against infectious diseases in children. Daptacel is a vaccine that is used to protect against diphtheria, tetanus, and pertussis (whooping cough), while Pentacel is a vaccine that is used to protect against diphtheria, tetanus, and pertussis as well as polio. Both vaccines are given as a series of shots, typically starting in infancy and continuing through childhood. It is important to follow the vaccination schedule recommended by your healthcare provider to ensure that your child is fully protected against these serious diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Daptacel is a combination vaccine used to protect against diphtheria, tetanus, and pertussis (whooping cough).\n2. Pentacel is a combination vaccine used to protect against diphtheria, tetanus, pertussis, and polio.\n3. Both Daptacel and Pentacel are given in a series of shots.\n4. The shots of both Daptacel and Pentacel vaccines typically start from infancy and continue through childhood.\n5. It is recommended to follow the vaccination schedule given by the healthcare provider to ensure full protection against the diseases.",
    "vicuna-13b_fact": [
      "Daptacel is a combination vaccine used to protect against diphtheria, tetanus, and pertussis (whooping cough).",
      "Pentacel is a combination vaccine used to protect against diphtheria, tetanus, pertussis, and polio.",
      "Both Daptacel and Pentacel are given in a series of shots.",
      "The shots of both Daptacel and Pentacel vaccines typically start from infancy and continue through childhood.",
      "It is recommended to follow the vaccination schedule given by the healthcare provider to ensure full protection against the diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3389,
    "user_query": "What is herd immunity?",
    "vicuna-13b_response": "Herd immunity is a concept in epidemiology that describes the protection of a population from the spread of infectious diseases when a sufficient proportion of individuals in the population are immune to the disease, either through vaccination or natural infection. This means that even if an infectious individual enters the population, they will not be able to spread the disease to a large number of susceptible individuals because the majority of the population is immune.\nThe concept of herd immunity is important because it helps to control the spread of infectious diseases, even in populations where vaccination rates may be low. It is also important for individuals who may not be able to receive vaccinations due to medical reasons, such as those with compromised immune systems.\nHerd immunity is typically achieved when a certain proportion of the population is immune to a disease, and this proportion varies depending on the infectiousness of the disease and the effectiveness of the vaccine or natural infection. For example, for measles, herd immunity is typically considered to be around 90-95% for the vaccinated population and around 80-85% for the naturally infected population.\nIt's important to note that herd immunity is not a guarantee that an outbreak will not happen, but it greatly reduces the chances of an outbreak and makes it harder for the disease to spread. Additionally, it's important to keep in mind that vaccination rates are not the only factor that determines herd immunity, other factors such as the effectiveness of the vaccine, the infectiousness of the disease, and the population size also play a role.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Herd immunity is a concept in epidemiology that describes the protection of a population from the spread of infectious diseases when a sufficient proportion of individuals in the population are immune to the disease.\n2. Herd immunity can be achieved either through vaccination or natural infection.\n3. The concept of herd immunity helps to control the spread of infectious diseases, even in populations where vaccination rates may be low.\n4. The proportion of the population that needs to be immune to achieve herd immunity varies depending on the infectiousness of the disease and the effectiveness of the vaccine or natural infection.\n5. Despite herd immunity, vaccination rates, effectiveness of vaccines, the infectiousness of the disease, and the population size are also factors that play a role in disease control.",
    "vicuna-13b_fact": [
      "Herd immunity is a concept in epidemiology that describes the protection of a population from the spread of infectious diseases when a sufficient proportion of individuals in the population are immune to the disease.",
      "Herd immunity can be achieved either through vaccination or natural infection.",
      "The concept of herd immunity helps to control the spread of infectious diseases, even in populations where vaccination rates may be low.",
      "The proportion of the population that needs to be immune to achieve herd immunity varies depending on the infectiousness of the disease and the effectiveness of the vaccine or natural infection.",
      "Despite herd immunity, vaccination rates, effectiveness of vaccines, the infectiousness of the disease, and the population size are also factors that play a role in disease control."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3391,
    "user_query": "List the stages/types of Multiple Sclerosis.",
    "vicuna-13b_response": "Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), which is made up of the brain, spinal cord, and optic nerves. The disease causes the immune system to attack the myelin sheath, which is the protective covering that surrounds and insulates the nerve fibers in the CNS. This attack can cause a range of symptoms, including muscle weakness, fatigue, and cognitive impairment.\nThere are several different stages or types of MS, which are defined based on the pattern of symptoms and the degree of disability. These stages include:\n1. Relapsing-remitting MS (RRMS): This is the most common type of MS, characterized by episodes of symptoms (relapses) followed by periods of partial or complete recovery (remissions).\n2. Secondary progressive MS (SPMS): This type of MS is characterized by a gradual worsening of symptoms over time, without distinct relapses or remissions.\n3. Primary progressive MS (PPMS): This type of MS is characterized by a gradual worsening of symptoms from the onset of the disease, without distinct relapses or remissions.\n4. Benign MS: This type of MS is characterized by few or no symptoms, and a low risk of progression.\n5. Progressive relapsing MS (PRMS): This type of MS is characterized by a gradual worsening of symptoms over time, with occasional relapses.\nIt's important to note that these stages are not absolute, and some people may experience a mix of symptoms across different stages of the disease. Additionally, the progression of MS can vary greatly from person to person, and many people with MS are able to manage their symptoms effectively with treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system.\n2. The disease attacks the myelin sheath, the protective covering that surrounds and insulates the nerve fibers in the central nervous system.\n3. Relapsing-remitting MS (RRMS) is characterized by episodes of symptoms followed by periods of partial or complete recovery.\n4. Secondary progressive MS (SPMS) is characterized by a gradual worsening of symptoms over time, without distinct relapses or remissions.\n5. Progressive relapsing MS (PRMS) is characterized by a gradual worsening of symptoms over time, with occasional relapses.",
    "vicuna-13b_fact": [
      "Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system.",
      "The disease attacks the myelin sheath, the protective covering that surrounds and insulates the nerve fibers in the central nervous system.",
      "Relapsing-remitting MS (RRMS) is characterized by episodes of symptoms followed by periods of partial or complete recovery.",
      "Secondary progressive MS (SPMS) is characterized by a gradual worsening of symptoms over time, without distinct relapses or remissions.",
      "Progressive relapsing MS (PRMS) is characterized by a gradual worsening of symptoms over time, with occasional relapses."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3395,
    "user_query": "List Mcl-1 inhibitors.",
    "vicuna-13b_response": "McL-1 (Bcl-2-like protein 1) is a protein that plays a role in regulating programmed cell death (apoptosis) in cells. Inhibitors of McL-1 are a class of drugs that are being investigated as potential treatments for a variety of diseases, including cancer and neurodegenerative disorders. Here are some examples of McL-1 inhibitors:\n1. ABT-263 (navitoclax): ABT-263 is a small molecule inhibitor of McL-1 and Bcl-2 that is being studied in clinical trials for the treatment of various types of cancer, including chronic lymphocytic leukemia and non-Hodgkin lymphoma.\n2. GDC-0199 (formerly known as OGD-019): GDC-0199 is an oral small molecule inhibitor of McL-1 that is being studied in clinical trials for the treatment of multiple myeloma and other hematological malignancies.\n3. MK-2206 (formerly known as NVP-MC110): MK-2206 is a small molecule inhibitor of McL-1 that is being studied in clinical trials for the treatment of various types of cancer, including non-small cell lung cancer and glioblastoma.\n4. PF-03832147: PF-03832147 is a small molecule inhibitor of McL-1 that is being studied in clinical trials for the treatment of multiple myeloma and other hematological malignancies.\n5. S61045: S61045 is a small molecule inhibitor of McL-1 that is being studied in clinical trials for the treatment of various types of cancer, including ovarian cancer and non-small cell lung cancer.\nIt's important to note that while these compounds have shown promise in preclinical studies, they are still being evaluated in clinical trials and have not yet been approved by regulatory agencies for use in humans.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. McL-1, also known as Bcl-2-like protein 1, is a protein that regulates programmed cell death in cells.\n2. ABT-263, also known as navitoclax, is a small molecule inhibitor of McL-1 and Bcl-2.\n3. GDC-0199 is an oral small molecule inhibitor of McL-1.\n4. MK-2206 is a small molecule inhibitor of McL-1 that's being studied for the treatment of several types of cancer.\n5. S61045 is another small molecule inhibitor of McL-1 that's under investigation in clinical trials as a potential treatment for various cancers.",
    "vicuna-13b_fact": [
      "McL-1, also known as Bcl-2-like protein 1, is a protein that regulates programmed cell death in cells.",
      "ABT-263, also known as navitoclax, is a small molecule inhibitor of McL-1 and Bcl-2.",
      "GDC-0199 is an oral small molecule inhibitor of McL-1.",
      "MK-2206 is a small molecule inhibitor of McL-1 that's being studied for the treatment of several types of cancer.",
      "S61045 is another small molecule inhibitor of McL-1 that's under investigation in clinical trials as a potential treatment for various cancers."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: ABT-263, also known as navitoclax, is a small molecule inhibitor of Bcl-2, Bcl-xL and Bcl-w, but it does not inhibit McL-1.\n3. FALSE [correction]: GDC-0199, also known as Venetoclax, is an oral small molecule inhibitor of Bcl-2, not McL-1.\n4. FALSE [correction]: MK-2206 is a small molecule inhibitor of Akt, not McL-1 that's being studied for the treatment of several types of cancer.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3396,
    "user_query": "Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",
    "vicuna-13b_response": "No, autophagy is a process in which a cell digests its own contents and recycles the broken-down components. It is not related to the process of a virus obtaining nutrients from its host. Autophagy is a normal physiological process that occurs in all cells, and it helps to recycle and reuse cellular components, including proteins and organelles. It is also involved in the removal of damaged or unnecessary cellular components, and it can be triggered by various factors, including nutrient deprivation, stress, and disease. Autophagy is not specific to viruses, and it is not a process that involves the transfer of nutrients from the host to the virus.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Autophagy is a process in which a cell digests its own contents and recycles the broken-down components.\n2. Autophagy is a normal physiological process that occurs in all cells.\n3. Autophagy helps to recycle and reuse cellular components, including proteins and organelles.\n4. Autophagy is involved in the removal of damaged or unnecessary cellular components.\n5. Autophagy can be triggered by various factors, including nutrient deprivation, stress, and disease.",
    "vicuna-13b_fact": [
      "Autophagy is a process in which a cell digests its own contents and recycles the broken-down components.",
      "Autophagy is a normal physiological process that occurs in all cells.",
      "Autophagy helps to recycle and reuse cellular components, including proteins and organelles.",
      "Autophagy is involved in the removal of damaged or unnecessary cellular components.",
      "Autophagy can be triggered by various factors, including nutrient deprivation, stress, and disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "vicuna-13b_response": "Methyl-propyl-EDTA (MPE) sequencing is a method used to analyze the methylation status of DNA. The method is based on the ability of MPE to selectively bind to methylated DNA, allowing for the separation of methylated and unmethylated DNA.\nThe MPE-seq method involves treating DNA with MPE, which binds to methylated DNA, and then isolating the bound DNA. The bound DNA is then sequenced using next-generation sequencing technologies, allowing for the identification of methylated and unmethylated regions of the genome.\nThe basis of the MPE-seq method is the specific binding of MPE to methylated DNA, which is due to the presence of a methyl group on the cytosine residue in the DNA. MPE has a higher affinity for methylated DNA than for unmethylated DNA, allowing for the selective isolation of methylated DNA.\nOnce the methylated DNA is isolated, it can be sequenced using next-generation sequencing technologies, such as Illumina or PacBio, to identify the methylation status of each base in the genome. The resulting data can be used to generate methylation maps, which can be used to study the role of DNA methylation in various biological processes, such as gene regulation and disease.\nOverall, the MPE-seq method is a powerful tool for studying DNA methylation, and its basis lies in the specific binding of MPE to methylated DNA, which allows for the selective isolation and sequencing of methylated DNA.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Methyl-propyl-EDTA (MPE) sequencing is a technique used to analyze the methylation status of DNA.\n2. The MPE-seq method involves treating DNA with MPE which binds to methylated DNA and then isolating the bound DNA.\n3. The method is dependent on MPE's ability to selectively bind to methylated DNA due to the presence of a methyl group on the cytosine residue in the DNA.\n4. After isolation, the methylated DNA is sequenced using next-generation sequencing technologies, such as Illumina or PacBio.\n5. The data resulting from MPE-seq can be used to generate methylation maps, providing insights into processes such as gene regulation and disease.",
    "vicuna-13b_fact": [
      "Methyl-propyl-EDTA (MPE) sequencing is a technique used to analyze the methylation status of DNA.",
      "The MPE-seq method involves treating DNA with MPE which binds to methylated DNA and then isolating the bound DNA.",
      "The method is dependent on MPE's ability to selectively bind to methylated DNA due to the presence of a methyl group on the cytosine residue in the DNA.",
      "After isolation, the methylated DNA is sequenced using next-generation sequencing technologies, such as Illumina or PacBio.",
      "The data resulting from MPE-seq can be used to generate methylation maps, providing insights into processes such as gene regulation and disease."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3399,
    "user_query": "Does CXorf21 escape X chromosome inactivation?",
    "vicuna-13b_response": "CXorf21 is a gene that is located on the X chromosome and encodes for a protein called CXorf21. This protein is involved in the regulation of gene expression and has been shown to play a role in the process of X chromosome inactivation.\nX chromosome inactivation is a process that occurs in female mammals, where one of the two X chromosomes is randomly inactivated in order to ensure that the expression of genes on the X chromosome does not lead to too much gene dosage. This process is important for ensuring that the expression of genes on the X chromosome is balanced and that the development and function of female mammals is not affected by an excess of X-linked genes.\nCXorf21 has been shown to play a role in the regulation of X chromosome inactivation. Specifically, CXorf21 has been shown to be involved in the maintenance of the inactive state of the X chromosome, and it is thought to do this by binding to and inhibiting the activity of the protein Smyd2. Smyd2 is involved in the process of X chromosome inactivation, and it is thought to act as a repressor of X-linked gene expression. By binding to and inhibiting the activity of Smyd2, CXorf21 is thought to help maintain the inactive state of the X chromosome.\nIn summary, CXorf21 is a gene that is located on the X chromosome and encodes for a protein that is involved in the regulation of gene expression. CXorf21 has been shown to play a role in the process of X chromosome inactivation, and it is thought to do this by binding to and inhibiting the activity of the protein Smyd2. CXorf21 is important for maintaining the inactive state of the X chromosome and ensuring the proper regulation of X-linked gene expression in female mammals.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CXorf21 is a gene located on the X chromosome that encodes for a protein also known as CXorf21. \n2. The protein CXorf21 has a role in the regulation of gene expression. \n3. The process of X chromosome inactivation occurs in female mammals.\n4. CXorf21 has been shown to be involved in the maintenance of the inactive state of the X chromosome.\n5. The protein CXorf21 functions by binding to and inhibiting the activity of the protein Smyd2, which is involved in the process of X chromosome inactivation.",
    "vicuna-13b_fact": [
      "CXorf21 is a gene located on the X chromosome that encodes for a protein also known as CXorf21.",
      "The protein CXorf21 has a role in the regulation of gene expression.",
      "The process of X chromosome inactivation occurs in female mammals.",
      "CXorf21 has been shown to be involved in the maintenance of the inactive state of the X chromosome.",
      "The protein CXorf21 functions by binding to and inhibiting the activity of the protein Smyd2, which is involved in the process of X chromosome inactivation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "vicuna-13b_response": "GWAR (GNU Wget for Autonomous Robots) is a software system used for controlling and coordinating a swarm of robots. The programming language used for implementing GWAR can vary depending on the specific implementation and the preferences of the developers.\nHowever, in the case of the original GWAR implementation developed by the Robotics Institute at Carnegie Mellon University, the programming language used was Python. Python is a popular, high-level programming language that is well-suited for tasks such as coordinating complex systems and working with large amounts of data. Its ease of use and flexibility make it a popular choice for many applications, including robotics and machine learning.\nIn summary, the programming language used for implementing GWAR can vary, but in the case of the original implementation, Python was used.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GWAR stands for GNU Wget for Autonomous Robots.\n2. GWAR is a software system used for controlling and coordinating a swarm of robots.\n3. Python was used in the original implementation of GWAR by the Robotics Institute at Carnegie Mellon University.\n4. Python is a high-level programming language.\n5. Python is well-suited for tasks such as coordinating complex systems and working with large amounts of data.",
    "vicuna-13b_fact": [
      "GWAR stands for GNU Wget for Autonomous Robots.",
      "GWAR is a software system used for controlling and coordinating a swarm of robots.",
      "Python was used in the original implementation of GWAR by the Robotics Institute at Carnegie Mellon University.",
      "Python is a high-level programming language.",
      "Python is well-suited for tasks such as coordinating complex systems and working with large amounts of data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3401,
    "user_query": "Describe f-scLVM",
    "vicuna-13b_response": "f-scLVM (Fast Sparse Linear Vector Machine) is a type of Support Vector Machine (SVM) algorithm that is designed to handle large-scale datasets. It is an extension of the standard SVM algorithm, which is known for its ability to handle high-dimensional data with a large number of features.\nThe key difference between f-scLVM and other SVM algorithms is its use of a sparse representation of the input data. In f-scLVM, only a small subset of the input features are used to represent each data point, which helps to reduce the computational complexity of the algorithm. This is achieved by using a sparse coding technique, which encodes the input data as a sparse linear combination of a small number of basis functions.\nThe f-scLVM algorithm is designed to be fast and efficient, making it well-suited for large-scale classification tasks. It is particularly useful for datasets with a large number of features, as it can handle high-dimensional data without becoming computationally expensive.\nIn addition to its speed and efficiency, f-scLVM is also known for its accuracy and robustness. It has been shown to perform well on a wide range of classification tasks, and is often used in applications where fast and accurate classification is critical.\nOverall, f-scLVM is a powerful and effective SVM algorithm that is well-suited for large-scale classification tasks. Its use of a sparse representation of the input data makes it fast and efficient, while its accuracy and robustness make it a popular choice for many applications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. f-scLVM (Fast Sparse Linear Vector Machine) is a type of Support Vector Machine (SVM) algorithm designed for large-scale datasets.\n2. f-scLVM is an extension of the standard SVM algorithm.\n3. f-scLVM uses a sparse representation of the input data, utilizing only a small subset of the input features to represent each data point.\n4. f-scLVM is designed to be fast and efficient.\n5. f-scLVM has demonstrated strong performance on a variety of classification tasks and is utilized in applications that require rapid and accurate classification.",
    "vicuna-13b_fact": [
      "f-scLVM (Fast Sparse Linear Vector Machine) is a type of Support Vector Machine (SVM) algorithm designed for large-scale datasets.",
      "f-scLVM is an extension of the standard SVM algorithm.",
      "f-scLVM uses a sparse representation of the input data, utilizing only a small subset of the input features to represent each data point.",
      "f-scLVM is designed to be fast and efficient.",
      "f-scLVM has demonstrated strong performance on a variety of classification tasks and is utilized in applications that require rapid and accurate classification."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3403,
    "user_query": "How large is a lncRNAs?",
    "vicuna-13b_response": "lncRNAs, or long non-coding RNAs, are RNA molecules that are typically longer than 200 nucleotides in length and do not code for proteins. The size of lncRNAs can vary greatly, with some being only a few kilobases in length, while others can be hundreds or even thousands of kilobases long.\nIt's important to note that the size of lncRNAs can be influenced by various factors, such as the method used to measure their length, the presence of introns and exons, and the presence of repeat sequences. Additionally, some lncRNAs can be alternatively spliced, resulting in multiple isoforms with different lengths.\nOverall, the size of lncRNAs can vary greatly, and their length is not necessarily a reliable indicator of their function or importance. Instead, researchers often focus on the specific sequences and regions of lncRNAs that are involved in their function, as well as their interactions with other RNA and protein molecules.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. lncRNAs, or long non-coding RNAs, are RNA molecules that are typically longer than 200 nucleotides in length and do not code for proteins.\n2. The size of lncRNAs can vary greatly, from a few kilobases to hundreds or even thousands of kilobases long.\n3. The size of lncRNAs can be influenced by various factors, such as the method used to measure their length, the presence of introns and exons, and the presence of repeat sequences.\n4. Some lncRNAs can be alternatively spliced, resulting in multiple isoforms with different lengths.\n5. The specific sequences and regions of lncRNAs that are involved in their function, as well as their interactions with other RNA and protein molecules, are often the focus of researchers.",
    "vicuna-13b_fact": [
      "lncRNAs, or long non-coding RNAs, are RNA molecules that are typically longer than 200 nucleotides in length and do not code for proteins.",
      "The size of lncRNAs can vary greatly, from a few kilobases to hundreds or even thousands of kilobases long.",
      "The size of lncRNAs can be influenced by various factors, such as the method used to measure their length, the presence of introns and exons, and the presence of repeat sequences.",
      "Some lncRNAs can be alternatively spliced, resulting in multiple isoforms with different lengths.",
      "The specific sequences and regions of lncRNAs that are involved in their function, as well as their interactions with other RNA and protein molecules, are often the focus of researchers."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "vicuna-13b_response": "Xaliproden (also known as riluzole) is a medication that is commonly used to treat amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord. The main cause of ALS is not well understood, but it is thought to involve a combination of genetic and environmental factors.\nThere is some evidence to suggest that xaliproden may improve the prognosis of ALS. In clinical trials, xaliproden has been shown to slow the progression of ALS and improve survival in patients with the disease. However, the extent to which xaliproden improves prognosis in ALS is still being studied, and more research is needed to fully understand its effects.\nIt is important to note that the use of xaliproden in ALS is still considered experimental, and it is not yet approved by the FDA for the treatment of ALS. Additionally, the benefits of xaliproden in ALS may vary from person to person, and it is important to discuss the potential benefits and risks of this medication with a healthcare provider before starting treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Xaliproden, also known as riluzole, is a medication used to treat amyotrophic lateral sclerosis (ALS).\n2. ALS is a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord.\n3. Clinical trials have shown xaliproden to slow the progression of ALS and improve survival in patients with the disease.\n4. Xaliproden is currently not approved by the FDA for the treatment of ALS.\n5. The use of xaliproden in ALS is still considered experimental.",
    "vicuna-13b_fact": [
      "Xaliproden, also known as riluzole, is a medication used to treat amyotrophic lateral sclerosis (ALS).",
      "ALS is a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord.",
      "Clinical trials have shown xaliproden to slow the progression of ALS and improve survival in patients with the disease.",
      "Xaliproden is currently not approved by the FDA for the treatment of ALS.",
      "The use of xaliproden in ALS is still considered experimental."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Xaliproden and riluzole are two different medications. Riluzole is an approved medication for ALS, not xaliproden.\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3407,
    "user_query": "What is Telangiectasia?",
    "vicuna-13b_response": "Telangiectasia is a medical condition characterized by the formation of small, dilated blood vessels near the surface of the skin. These blood vessels are also known as \"spider veins\" because they often have a web-like appearance. Telangiectasia can affect any part of the body, but it is most commonly found on the face and legs.\nThe exact cause of telangiectasia is not known, but it is often associated with aging, sun damage, and certain medical conditions such as diabetes and circulatory problems. Telangiectasia can also be a side effect of certain medications, including blood thinners and corticosteroids.\nTelangiectasia is usually a cosmetic concern and does not typically require treatment. However, some people may choose to seek treatment for telangiectasia due to the appearance of the affected area. Treatment options for telangiectasia include sclerotherapy, laser therapy, and surgical excision.\nIt is important to note that telangiectasia is not the same as varicose veins, which are larger, more tortuous blood vessels that can cause aching, cramping, and other symptoms. If you have telangiectasia or suspect you may have varicose veins, it is important to consult with a healthcare provider for proper diagnosis and treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Telangiectasia is a medical condition characterized by the formation of small, dilated blood vessels near the surface of the skin.\n2. Telangiectasia can affect any part of the body, but is most commonly found on the face and legs.\n3. Causes of telangiectasia may include aging, sun damage, medical conditions such as diabetes and circulatory problems, and use of certain medications.\n4. Telangiectasia is usually a cosmetic concern and does not typically require treatment.\n5. Telangiectasia is different from varicose veins, which are larger and can cause aching, cramping, and other symptoms.",
    "vicuna-13b_fact": [
      "Telangiectasia is a medical condition characterized by the formation of small, dilated blood vessels near the surface of the skin.",
      "Telangiectasia can affect any part of the body, but is most commonly found on the face and legs.",
      "Causes of telangiectasia may include aging, sun damage, medical conditions such as diabetes and circulatory problems, and use of certain medications.",
      "Telangiectasia is usually a cosmetic concern and does not typically require treatment.",
      "Telangiectasia is different from varicose veins, which are larger and can cause aching, cramping, and other symptoms."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3409,
    "user_query": "Which tissues express the ACE2 protein?",
    "vicuna-13b_response": "The ACE2 (Angiotensin-Converting Enzyme 2) protein is expressed in various tissues in the human body, including the lungs, heart, kidneys, intestines, and the female reproductive system. It is primarily produced by cells in these tissues and is involved in regulating the renin-angiotensin-aldosterone system, which plays a critical role in blood pressure regulation and fluid balance.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The ACE2 protein is expressed in various tissues in the human body.\n2. The ACE2 protein is prevalent in the lungs, heart, kidneys, intestines, and the female reproductive system.\n3. The ACE2 protein is produced primarily by cells in these tissues.\n4. The ACE2 protein is involved in regulating the renin-angiotensin-aldosterone system.\n5. The renin-angiotensin-aldosterone system plays a critical role in blood pressure regulation and fluid balance.",
    "vicuna-13b_fact": [
      "The ACE2 protein is expressed in various tissues in the human body.",
      "The ACE2 protein is prevalent in the lungs, heart, kidneys, intestines, and the female reproductive system.",
      "The ACE2 protein is produced primarily by cells in these tissues.",
      "The ACE2 protein is involved in regulating the renin-angiotensin-aldosterone system.",
      "The renin-angiotensin-aldosterone system plays a critical role in blood pressure regulation and fluid balance."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "vicuna-13b_response": "The LiPS-A3S line is a transgenic line of plants that has been engineered to express a bacterial gene called nopaline synthase (NOS) under the control of a plant promoter. The NOS gene is inserted into the chloroplast genome of the plant, specifically into the large inverted repeat (LIT) region of chromosome 1.\nThe LiPS-A3S line was created by Agrobacterium-mediated transformation, which involves the introduction of a DNA construct into plant cells using the Agrobacterium tumefaciens bacterium as a vector. The DNA construct contains the NOS gene, which is driven by a plant promoter called the 35S promoter, and a selection marker gene called the bar gene, which confers resistance to the herbicide bialaphos.\nThe LiPS-A3S line is a useful tool for studying plant metabolism and for developing new strategies for crop improvement. It has been used to study the biosynthesis of secondary metabolites, such as flavonoids and alkaloids, and to develop new methods for the production of valuable compounds in plants.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The LiPS-A3S line is a transgenic line of plants.\n2. In the LiPS-A3S line, the NOS gene is inserted into the large inverted repeat (LIT) region of chromosome 1.\n3. The LiPS-A3S line was created by Agrobacterium-mediated transformation.\n4. The NOS gene in the LiPS-A3S line is driven by a plant promoter called the 35S promoter.\n5. The LiPS-A3S line contains a selection marker gene called the bar gene, which confers resistance to the herbicide bialaphos.",
    "vicuna-13b_fact": [
      "The LiPS-A3S line is a transgenic line of plants.",
      "In the LiPS-A3S line, the NOS gene is inserted into the large inverted repeat (LIT) region of chromosome 1.",
      "The LiPS-A3S line was created by Agrobacterium-mediated transformation.",
      "The NOS gene in the LiPS-A3S line is driven by a plant promoter called the 35S promoter.",
      "The LiPS-A3S line contains a selection marker gene called the bar gene, which confers resistance to the herbicide bialaphos."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3411,
    "user_query": "What is a J pouch?",
    "vicuna-13b_response": "A J pouch, also known as a loop pouch or a continuous loop pouch, is a type of pouch used in packaging. It is a continuous loop of film that is sealed on three sides, with an open top. The open top allows the contents of the pouch to be easily added or removed, and the continuous loop allows the pouch to be sealed tightly after the contents have been added or removed.\nJ pouches are commonly used for packaging dry goods such as cereal, rice, and beans. They are also used for packaging liquids, such as liquid soap or lotion. The pouches are made of flexible film, usually plastic, and are designed to be durable and resistant to leaks.\nJ pouches are a popular choice for packaging because they are easy to use and provide a convenient way to store and transport goods. They are also environmentally friendly, as they are lightweight and can be easily recycled.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A J pouch is a type of pouch used in packaging. \n2. J pouches are continuous loops of film that are sealed on three sides, with an open top for easy addition or removal of contents. \n3. Dry goods such as cereal, rice, beans, as well as liquids like soap and lotion, are commonly packaged in J pouches.\n4. J pouches are made from flexible films, often plastic, and are designed to resist leaks. \n5. J pouches are environmentally friendly choices for packaging because they are lightweight and easily recyclable.",
    "vicuna-13b_fact": [
      "A J pouch is a type of pouch used in packaging.",
      "J pouches are continuous loops of film that are sealed on three sides, with an open top for easy addition or removal of contents.",
      "Dry goods such as cereal, rice, beans, as well as liquids like soap and lotion, are commonly packaged in J pouches.",
      "J pouches are made from flexible films, often plastic, and are designed to resist leaks.",
      "J pouches are environmentally friendly choices for packaging because they are lightweight and easily recyclable."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: A J pouch is not a type of pouch used in packaging. It is a surgically created internal reservoir commonly used to replace the rectum after rectal surgery.\n2. FALSE [correction]: The description is incorrect because J pouches are not used for packaging goods. They serve as internal reservoirs constructed from a patient's small intestine.\n3. FALSE [correction]: J pouches are not used for packaging dry goods or liquids, they are typically associated with surgical procedures in humans.\n4. FALSE [correction]: Though the description of the material might be true for packaging pouches, the J-pouch is part of a surgical procedure, and so, this statement is false.\n5. FALSE [correction]: The statement is false because J pouches are not used for packaging; they are a type of intestinal reservoir created during surgery.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3412,
    "user_query": "What is the function of the protein encoded by the gene NKCC2?",
    "vicuna-13b_response": "NKCC2 (Neuronal K+-Cl- cotransporter 2) is a protein that is encoded by the gene NKCC2. It is a member of the solute carrier family 12 (SLC12) and is expressed primarily in the brain, specifically in neurons.\nThe main function of NKCC2 is to regulate the levels of potassium and chloride ions in neurons. It does this by transporting potassium ions into cells and chloride ions out of cells, thereby creating an environment that is favorable for neuronal activity. Specifically, NKCC2 functions as a cotransporter, meaning that it co-transports one ion (potassium) with another ion (chloride) in the opposite direction.\nIn addition to its role in regulating ionic gradients, NKCC2 has also been implicated in a number of other processes, including the regulation of cell volume, the modulation of neuronal excitability, and the protection of neurons against oxidative stress.\nMutations in the NKCC2 gene have been associated with a number of neurological disorders, including epilepsy, migraine, and neurodevelopmental disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. NKCC2 is a protein that is encoded by the gene NKCC2.\n2. The protein NKCC2 is a member of the solute carrier family 12 (SLC12).\n3. NKCC2 is primarily expressed in the brain, specifically in neurons.\n4. NKCC2 regulates the levels of potassium and chloride ions in neurons by transporting potassium ions into cells and chloride ions out of cells.\n5. Mutations in the NKCC2 gene have been associated with neurological disorders, including epilepsy, migraine, and neurodevelopmental disorders.",
    "vicuna-13b_fact": [
      "NKCC2 is a protein that is encoded by the gene NKCC2.",
      "The protein NKCC2 is a member of the solute carrier family 12 (SLC12).",
      "NKCC2 is primarily expressed in the brain, specifically in neurons.",
      "NKCC2 regulates the levels of potassium and chloride ions in neurons by transporting potassium ions into cells and chloride ions out of cells.",
      "Mutations in the NKCC2 gene have been associated with neurological disorders, including epilepsy, migraine, and neurodevelopmental disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: NKCC2 is primarily expressed in the kidneys, specifically in cells of the thick ascending limb of the Loop of Henle and in macula densa cells.\n4. FALSE [correction]: NKCC2 regulates the levels of sodium, potassium, and chloride ions in the cells by transporting these ions into the cells.\n5. FALSE [correction]: Mutations in the NKCC2 gene have been associated with a variety of diseases, most notably Bartter syndrome, which is characterized by a salt-losing nephropathy, rather than neurological disorders.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3414,
    "user_query": "Is the protein MCL-1 anti-apoptotic?",
    "vicuna-13b_response": "Yes, MCL-1 is an anti-apoptotic protein, which means it helps to prevent programmed cell death (apoptosis) in cells. MCL-1 is a member of the BCL-2 protein family, which is a group of proteins that regulate apoptosis.\nMCL-1 is expressed in many different types of cells and is involved in a variety of cellular processes, including cell growth, differentiation, and survival. MCL-1 functions by inhibiting the activity of pro-apoptotic BCL-2 proteins, such as BAX and BAK, which are involved in the process of mitochondrial outer membrane permeabilization (MOMP), a critical step in the execution of apoptosis.\nMCL-1 has been shown to play a role in the survival of cancer cells, making it an attractive target for cancer therapy. Inhibition of MCL-1 has been shown to induce apoptosis in cancer cells, suggesting that it may be a promising therapeutic strategy for the treatment of certain types of cancer.\nOverall, MCL-1 is an important anti-apoptotic protein that plays a critical role in regulating cell survival and death.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MCL-1 is an anti-apoptotic protein that helps to prevent programmed cell death (apoptosis) in cells.\n2. MCL-1 is a member of the BCL-2 protein family, which are proteins that regulate apoptosis.\n3. MCL-1 is expressed in many different types of cells and is involved in various cellular processes, including cell growth, differentiation, and survival.\n4. MCL-1 functions by inhibiting the activity of pro-apoptotic BCL-2 proteins, such as BAX and BAK.\n5. Inhibition of MCL-1 has been shown to induce apoptosis in cancer cells.",
    "vicuna-13b_fact": [
      "MCL-1 is an anti-apoptotic protein that helps to prevent programmed cell death (apoptosis) in cells.",
      "MCL-1 is a member of the BCL-2 protein family, which are proteins that regulate apoptosis.",
      "MCL-1 is expressed in many different types of cells and is involved in various cellular processes, including cell growth, differentiation, and survival.",
      "MCL-1 functions by inhibiting the activity of pro-apoptotic BCL-2 proteins, such as BAX and BAK.",
      "Inhibition of MCL-1 has been shown to induce apoptosis in cancer cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3417,
    "user_query": "Which disease is ZP-PTH used for?",
    "vicuna-13b_response": "ZP-PTH is a medication that is used to treat hypoparathyroidism, a condition in which the parathyroid gland does not produce enough parathyroid hormone (PTH). This can lead to low levels of calcium in the blood, which can cause a range of symptoms including bone pain, muscle weakness, and osteoporosis. ZP-PTH is a synthetic form of PTH that is given to patients to help increase their levels of PTH and improve their symptoms. It is typically prescribed for patients who have hypoparathyroidism that is not responsive to other treatments, such as dietary changes or calcium supplements.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ZP-PTH is a medication used to treat hypoparathyroidism.\n2. Hypoparathyroidism is a condition where the parathyroid gland does not produce enough parathyroid hormone.\n3. Hypoparathyroidism can lead to low levels of calcium in the blood.\n4. ZP-PTH is a synthetic form of PTH.\n5. ZP-PTH is typically prescribed for patients with hypoparathyroidism that is not responsive to other treatments.",
    "vicuna-13b_fact": [
      "ZP-PTH is a medication used to treat hypoparathyroidism.",
      "Hypoparathyroidism is a condition where the parathyroid gland does not produce enough parathyroid hormone.",
      "Hypoparathyroidism can lead to low levels of calcium in the blood.",
      "ZP-PTH is a synthetic form of PTH.",
      "ZP-PTH is typically prescribed for patients with hypoparathyroidism that is not responsive to other treatments."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3424,
    "user_query": "When was vaxchora first licensed by the FDA?",
    "vicuna-13b_response": "Vaxchora, also known as Adeno-associated virus type 2 (AAV2) vector-based vaccine, was first licensed by the U.S. Food and Drug Administration (FDA) in December 2020. The vaccine was approved for the prevention of disease caused by serogroup B meningococcus in individuals aged 10 years and older. The vaccine was developed by the biotechnology company, REGENXBIO.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Vaxchora was first licensed by the U.S. Food and Drug Administration (FDA) in December 2020.\n2. Vaxchora is also known as Adeno-associated virus type 2 (AAV2) vector-based vaccine.\n3. The vaccine was approved for the prevention of disease caused by serogroup B meningococcus in individuals aged 10 years and older.\n4. The vaccine was developed by the biotechnology company, REGENXBIO.",
    "vicuna-13b_fact": [
      "Vaxchora was first licensed by the U.S. Food and Drug Administration (FDA) in December 2020.",
      "Vaxchora is also known as Adeno-associated virus type 2 (AAV2) vector-based vaccine.",
      "The vaccine was approved for the prevention of disease caused by serogroup B meningococcus in individuals aged 10 years and older.",
      "The vaccine was developed by the biotechnology company, REGENXBIO."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Vaxchora was first licensed by the U.S. Food and Drug Administration (FDA) in 2016.\n2. FALSE [correction]: Vaxchora is a vaccine used to prevent cholera, not an AAV2 vector-based vaccine.\n3. FALSE [correction]: Vaxchora was approved for the prevention of cholera in adults aged 18-64 years, not for the prevention of disease caused by serogroup B meningococcus in individuals aged 10 years and older.\n4. FALSE [correction]: The vaccine was developed by PaxVax, now owned by Emergent BioSolutions, not REGENXBIO.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3427,
    "user_query": "Which type of distance is used in the R-package XenofilteR?",
    "vicuna-13b_response": "The R-package Xenofilter uses Euclidean distance for its spatial analysis. Euclidean distance is a common distance metric used in geographic information systems (GIS) and is calculated as the square root of the sum of the squared differences between the coordinates of two points. In other words, it is the straight-line distance between two points. Xenofilter uses this distance metric for its nearest neighbor and k-nearest neighbor imputation methods.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The R-package Xenofilter uses Euclidean distance for its spatial analysis.\n2. Euclidean distance is a common distance metric used in geographic information systems (GIS).\n3. Euclidean distance is calculated as the square root of the sum of the squared differences between the coordinates of two points.\n4. Euclidean distance measures the straight-line distance between two points.\n5. Xenofilter uses this distance metric for its nearest neighbor and k-nearest neighbor imputation methods.",
    "vicuna-13b_fact": [
      "The R-package Xenofilter uses Euclidean distance for its spatial analysis.",
      "Euclidean distance is a common distance metric used in geographic information systems (GIS).",
      "Euclidean distance is calculated as the square root of the sum of the squared differences between the coordinates of two points.",
      "Euclidean distance measures the straight-line distance between two points.",
      "Xenofilter uses this distance metric for its nearest neighbor and k-nearest neighbor imputation methods."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "vicuna-13b_response": "There are several tools that use deep learning to predict drug synergy. One example is the DeepSynergy tool, which was developed by researchers at the University of California, San Francisco. This tool uses a deep neural network to predict the synergistic interactions between drugs based on their molecular properties.\nAnother example is the DeepDrug tool, which was developed by researchers at the Massachusetts Institute of Technology. This tool uses a deep convolutional neural network to analyze images of cells and predict the synergistic interactions between drugs based on their effects on cellular processes.\nThere are also several commercial tools that use deep learning for drug discovery, such as the Paige.AI platform and the DrugSpace platform from IBM. These platforms use machine learning algorithms, including deep learning, to analyze large datasets of drug and disease information and identify potential drug candidates and drug combinations.\nIt's important to note that while deep learning has shown promise in predicting drug synergy, it is still a developing field and these tools are not yet widely adopted in the pharmaceutical industry. Additionally, these tools require large amounts of data and computational resources to train and run, and may not be accessible to all researchers.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. DeepSynergy, a tool that uses a deep neural network to predict drug synergy, was developed by researchers at the University of California, San Francisco.\n2. DeepDrug uses a deep convolutional neural network to analyze images of cells and predict drug interactions; it was developed by the Massachusetts Institute of Technology.\n3. Commercial platforms, like Paige.AI and DrugSpace from IBM, use machine learning algorithms, including deep learning, for drug discovery.\n4. Predicting drug synergy with deep learning requires large amounts of data and computational resources to train and run the tools.\n5. Deep learning for predicting drug synergy is a developing field and not yet widely adopted in the pharmaceutical industry.",
    "vicuna-13b_fact": [
      "DeepSynergy, a tool that uses a deep neural network to predict drug synergy, was developed by researchers at the University of California, San Francisco.",
      "DeepDrug uses a deep convolutional neural network to analyze images of cells and predict drug interactions; it was developed by the Massachusetts Institute of Technology.",
      "Commercial platforms, like Paige.AI and DrugSpace from IBM, use machine learning algorithms, including deep learning, for drug discovery.",
      "Predicting drug synergy with deep learning requires large amounts of data and computational resources to train and run the tools.",
      "Deep learning for predicting drug synergy is a developing field and not yet widely adopted in the pharmaceutical industry."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3431,
    "user_query": "Is ozanezumab effective for amyotrophic lateral sclerosis?",
    "vicuna-13b_response": "Ozanezumab is a monoclonal antibody that has been studied for its potential use in treating amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and wasting.\nThere have been several clinical trials of ozanezumab for the treatment of ALS, and the results have been mixed. Some studies have suggested that ozanezumab may slow the progression of ALS and improve symptoms, while others have found no significant benefit.\nOne of the main concerns with ozanezumab is its potential side effects, which can include inflammation and infusion reactions. Additionally, ozanezumab is a costly treatment, which may limit its availability and accessibility for patients with ALS.\nOverall, while ozanezumab has shown some promise in treating ALS, it is not currently considered a first-line treatment and more research is needed to fully understand its effectiveness and safety. Other treatments, such as riluzole, are currently recommended for the treatment of ALS.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ozanezumab is a monoclonal antibody.\n2. Ozanezumab has been studied for its potential use in treating amyotrophic lateral sclerosis (ALS).\n3. There have been mixed results from clinical trials of ozanezumab for the treatment of ALS.\n4. One main concern with ozanezumab is its potential side effects, including inflammation and infusion reactions.\n5. Ozanezumab is not considered a first-line treatment for ALS.",
    "vicuna-13b_fact": [
      "Ozanezumab is a monoclonal antibody.",
      "Ozanezumab has been studied for its potential use in treating amyotrophic lateral sclerosis (ALS).",
      "There have been mixed results from clinical trials of ozanezumab for the treatment of ALS.",
      "One main concern with ozanezumab is its potential side effects, including inflammation and infusion reactions.",
      "Ozanezumab is not considered a first-line treatment for ALS."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3432,
    "user_query": "Is Dexmecamylamine effective for depression?",
    "vicuna-13b_response": "Dexmecamylamine is a medication that is sometimes used to treat depression, but it is not a first-line treatment and is not widely used due to its potential for serious side effects. It is a stimulant drug that works by increasing the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine. These neurotransmitters play a role in regulating mood, energy levels, and arousal, and increasing their levels can help to improve symptoms of depression in some people.\nHowever, dexmecamylamine has a number of potential side effects, including anxiety, agitation, restlessness, and insomnia, which can make depression worse in some cases. It can also cause serious cardiovascular side effects, such as increased blood pressure and heart rate, and can lead to addiction and abuse.\nTherefore, dexmecamylamine is generally only used as a last resort in cases where other treatments have not been effective, and it should only be used under the close supervision of a healthcare professional. It is not recommended for people with a history of heart disease or other serious medical conditions.\nIt is important to note that depression is a complex condition that can be caused by a variety of factors, and there is no single treatment that works for everyone. If you are experiencing symptoms of depression, it is important to speak with a healthcare professional who can help you to determine the best course of treatment for your individual needs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dexmecamylamine is sometimes used to treat depression.\n2. Dexmecamylamine works by increasing the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine.\n3. These neurotransmitters play a role in regulating mood, energy levels, and arousal.\n4. Dexmecamylamine can cause side effects such as anxiety, agitation, restlessness, insomnia and serious cardiovascular issues.\n5. Dexmecamylamine is generally only used as a last resort in cases where other treatments have not been effective.",
    "vicuna-13b_fact": [
      "Dexmecamylamine is sometimes used to treat depression.",
      "Dexmecamylamine works by increasing the levels of certain neurotransmitters in the brain, including dopamine and norepinephrine.",
      "These neurotransmitters play a role in regulating mood, energy levels, and arousal.",
      "Dexmecamylamine can cause side effects such as anxiety, agitation, restlessness, insomnia and serious cardiovascular issues.",
      "Dexmecamylamine is generally only used as a last resort in cases where other treatments have not been effective."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "vicuna-13b_response": "There are several cloud-based platforms that have been developed for comparing GWAS (Genome-Wide Association Studies). Some of the popular ones are:\n1. Amazon Web Services (AWS): AWS offers a variety of cloud-based services, including Amazon Elastic Compute Cloud (EC2) and Amazon S3, which can be used for storing and analyzing large-scale GWAS data.\n2. Google Cloud Platform (GCP): GCP provides a variety of cloud-based services, including Google BigQuery and Google Cloud Storage, which can be used for managing and analyzing large-scale GWAS data.\n3. Microsoft Azure: Azure provides a variety of cloud-based services, including Azure Blob Storage and Azure Machine Learning, which can be used for storing and analyzing large-scale GWAS data.\n4. IBM Cloud: IBM Cloud provides a variety of cloud-based services, including IBM Cloud Object Storage and IBM Watson Studio, which can be used for managing and analyzing large-scale GWAS data.\nThese cloud-based platforms offer a range of tools and services that can be used for comparing GWAS, including data storage, data processing, data analysis, and data visualization. They also provide scalable infrastructure that can handle large-scale GWAS data, making it easier to compare GWAS across different populations and identify genetic variants that are associated with disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Amazon Web Services (AWS) offers Amazon Elastic Compute Cloud (EC2) and Amazon S3 for storing and analyzing large-scale GWAS data.\n2. Google Cloud Platform (GCP) provides services such as Google BigQuery and Google Cloud Storage for managing and analyzing large-scale GWAS data.\n3. Microsoft Azure provides Azure Blob Storage and Azure Machine Learning for storing and analyzing large-scale GWAS data.\n4. IBM Cloud provides IBM Cloud Object Storage and IBM Watson Studio for managing and analyzing large-scale GWAS data.\n5. Cloud-based platforms offer tools and services that can be used for comparing Genome-Wide Association Studies (GWAS), including data storage, data processing, data analysis, and data visualization.",
    "vicuna-13b_fact": [
      "Amazon Web Services (AWS) offers Amazon Elastic Compute Cloud (EC2) and Amazon S3 for storing and analyzing large-scale GWAS data.",
      "Google Cloud Platform (GCP) provides services such as Google BigQuery and Google Cloud Storage for managing and analyzing large-scale GWAS data.",
      "Microsoft Azure provides Azure Blob Storage and Azure Machine Learning for storing and analyzing large-scale GWAS data.",
      "IBM Cloud provides IBM Cloud Object Storage and IBM Watson Studio for managing and analyzing large-scale GWAS data.",
      "Cloud-based platforms offer tools and services that can be used for comparing Genome-Wide Association Studies (GWAS), including data storage, data processing, data analysis, and data visualization."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "vicuna-13b_response": "CMB305 is a monoclonal antibody drug that is currently being investigated for its potential to treat various types of cancer. While it has shown promise in early clinical trials for the treatment of some types of cancer, it has not yet been approved by regulatory authorities for use against sarcomas specifically.\nSarcomas are a rare type of cancer that can arise from various types of cells in the body, including bone, muscle, and connective tissue. They are relatively uncommon, accounting for less than 1% of all cancer cases.\nCMB305 is a bispecific antibody that targets the CD19 and CD3 molecules on the surface of cancer cells. It has been studied primarily in clinical trials for the treatment of B-cell malignancies, such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. While early results from these trials have been promising, more research is needed to determine the safety and efficacy of CMB305 for the treatment of sarcomas.\nIt is important to note that the development of new treatments for cancer is a complex and lengthy process that involves extensive research and clinical testing. While CMB305 has shown promise in early trials, it may not ultimately be effective or safe for the treatment of sarcomas. Further research is needed to determine the potential of CMB305 for the treatment of this rare and complex type of cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CMB305 is a monoclonal antibody drug currently being investigated for its potential against various types of cancer.\n2. CMB305 has not yet been approved by regulatory authorities for use against sarcomas.\n3. Sarcomas are a rare type of cancer accounting for less than 1% of all cancer cases.\n4. CMB305 targets the CD19 and CD3 molecules on the surface of cancer cells.\n5. CMB305 has been studied primarily in clinical trials for the treatment of B-cell malignancies, including non-Hodgkin lymphoma and chronic lymphocytic leukemia.",
    "vicuna-13b_fact": [
      "CMB305 is a monoclonal antibody drug currently being investigated for its potential against various types of cancer.",
      "CMB305 has not yet been approved by regulatory authorities for use against sarcomas.",
      "Sarcomas are a rare type of cancer accounting for less than 1% of all cancer cases.",
      "CMB305 targets the CD19 and CD3 molecules on the surface of cancer cells.",
      "CMB305 has been studied primarily in clinical trials for the treatment of B-cell malignancies, including non-Hodgkin lymphoma and chronic lymphocytic leukemia."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3435,
    "user_query": "What is Quadracel?",
    "vicuna-13b_response": "Quadracel is a brand name vaccine that is used to protect against four different types of bacteria: Haemophilus influenzae type b (Hib), diphtheria, tetanus, and pertussis (whooping cough). It is given as an injection and is typically given to children as part of their routine vaccination schedule. The vaccine works by stimulating the immune system to produce antibodies that can recognize and fight the bacteria that cause these diseases. It is important to get vaccinated with Quadracel to help protect yourself and others from serious and potentially life-threatening infections.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Quadracel is a brand name vaccine.\n2. Quadracel is used to protect against Haemophilus influenzae type b (Hib), diphtheria, tetanus, and pertussis (whooping cough).\n3. Quadracel is given as an injection.\n4. This vaccine is typically administered to children as part of their routine vaccination schedule.\n5. Quadracel works by stimulating the immune system to produce antibodies against these bacteria.",
    "vicuna-13b_fact": [
      "Quadracel is a brand name vaccine.",
      "Quadracel is used to protect against Haemophilus influenzae type b (Hib), diphtheria, tetanus, and pertussis (whooping cough).",
      "Quadracel is given as an injection.",
      "This vaccine is typically administered to children as part of their routine vaccination schedule.",
      "Quadracel works by stimulating the immune system to produce antibodies against these bacteria."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Quadracel is used to protect against diphtheria, tetanus, pertussis (whooping cough), and polio.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3436,
    "user_query": "What delivery system is used for the Fluzone Intradermal vaccine?",
    "vicuna-13b_response": "The Fluzone Intradermal vaccine is delivered using a microinjection system that involves the use of a needle to inject the vaccine into the skin. The needle is attached to a device that allows the vaccine to be delivered in a precise and controlled manner, ensuring that the correct dose is delivered and that the vaccine is given at the appropriate depth and location in the skin.\nThe microinjection system is designed to minimize discomfort and reduce the risk of side effects associated with traditional intramuscular injections. The vaccine is delivered into the skin in a series of tiny droplets, which helps to ensure that it is absorbed efficiently by the immune system.\nIt's important to note that the Fluzone Intradermal vaccine should only be administered by a healthcare professional who is trained in the use of the microinjection system and who can ensure that the vaccine is given safely and effectively.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Fluzone Intradermal vaccine is delivered using a microinjection system.\n2. The vaccine is injected into the skin using a needle that is attached to a device.\n3. This device allows the vaccine to be delivered in a precise and controlled manner.\n4. The microinjection system for the Fluzone Intradermal vaccine is designed to minimize discomfort and reduce side effects.\n5. The Fluzone Intradermal vaccine should only be administered by a healthcare professional trained in the use of the microinjection system.",
    "vicuna-13b_fact": [
      "The Fluzone Intradermal vaccine is delivered using a microinjection system.",
      "The vaccine is injected into the skin using a needle that is attached to a device.",
      "This device allows the vaccine to be delivered in a precise and controlled manner.",
      "The microinjection system for the Fluzone Intradermal vaccine is designed to minimize discomfort and reduce side effects.",
      "The Fluzone Intradermal vaccine should only be administered by a healthcare professional trained in the use of the microinjection system."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3450,
    "user_query": "How many genes belong to the KRAB-ZNF family in the human genome?",
    "vicuna-13b_response": "The KRAB-ZNF family is a group of genes that are characterized by the presence of a Krüppel-associated box (KRAB) DNA-binding motif and the presence of zinc finger domains. These genes play important roles in various biological processes, including development, differentiation, and cellular proliferation.\nAs of September 2021, the human genome contains 188 known KRAB-ZNF genes. However, it is important to note that this number may be subject to change as new genes are discovered and the accuracy of gene annotations improves. Additionally, some KRAB-ZNF genes may be pseudogenes, meaning they have undergone mutations that have rendered them non-functional.\nOverall, the KRAB-ZNF family is a large and diverse group of genes that play important roles in human biology. Further research is needed to fully understand the functions of these genes and their potential as therapeutic targets.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The KRAB-ZNF family is characterized by the presence of a Krüppel-associated box (KRAB) DNA-binding motif and zinc finger domains.\n2. KRAB-ZNF genes play important roles in development, differentiation, and cellular proliferation.\n3. As of September 2021, the human genome contains 188 known KRAB-ZNF genes.\n4. Some KRAB-ZNF genes may be pseudogenes, which have undergone mutations that have rendered them non-functional.\n5. The KRAB-ZNF family is a large and diverse group of genes in human biology.",
    "vicuna-13b_fact": [
      "The KRAB-ZNF family is characterized by the presence of a Krüppel-associated box (KRAB) DNA-binding motif and zinc finger domains.",
      "KRAB-ZNF genes play important roles in development, differentiation, and cellular proliferation.",
      "As of September 2021, the human genome contains 188 known KRAB-ZNF genes.",
      "Some KRAB-ZNF genes may be pseudogenes, which have undergone mutations that have rendered them non-functional.",
      "The KRAB-ZNF family is a large and diverse group of genes in human biology."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3453,
    "user_query": "What is characteristic to Fitz-Hugh–Curtis syndrome?",
    "vicuna-13b_response": "Fitz-Hugh–Curtis syndrome is a rare clinical entity characterized by acute inflammation of the pancreas (pancreatitis) and concurrent cholecystitis, which is inflammation of the gallbladder. It is most commonly seen in women of reproductive age and is often associated with pregnancy, particularly in the postpartum period. The exact cause of Fitz-Hugh–Curtis syndrome is not well understood, but it is thought to be related to a bacterial infection, most commonly with Escherichia coli.\nThe symptoms of Fitz-Hugh–Curtis syndrome can vary, but they typically include severe abdominal pain, nausea, vomiting, and fever. The pain is often located in the upper abdomen and may radiate to the back. Other symptoms may include tenderness when touching the abdomen, loss of appetite, and a feeling of fullness in the abdomen.\nDiagnosis of Fitz-Hugh–Curtis syndrome is typically made through a combination of physical examination, laboratory tests, and imaging studies. Physical examination may reveal tenderness in the upper abdomen, and laboratory tests may show elevated levels of liver enzymes and white blood cells. Imaging studies, such as ultrasound or CT scan, can confirm the presence of pancreatitis and cholecystitis.\nTreatment of Fitz-Hugh–Curtis syndrome typically involves hospitalization and supportive care, such as intravenous fluids and pain management. Antibiotics are often used to treat any underlying infection. In some cases, surgery may be necessary to remove the gallbladder (cholecystectomy) or to drain any abscesses that may have formed.\nPrognosis for Fitz-Hugh–Curtis syndrome is generally good with appropriate treatment, but it can be complicated by the development of complications such as abscesses, sepsis, or respiratory distress. Prevention of Fitz-Hugh–Curtis syndrome is not well established, but good hygiene practices and prompt treatment of any infections can help reduce the risk of developing this condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fitz-Hugh–Curtis syndrome is characterized by acute inflammation of the pancreas and concurrent cholecystitis.\n2. The syndrome is most commonly seen in women of reproductive age, often associated with pregnancy.\n3. Symptoms of Fitz-Hugh–Curtis syndrome typically include severe abdominal pain, nausea, vomiting, and fever.\n4. Diagnosis of Fitz-Hugh–Curtis syndrome is generally made through physical examination, laboratory tests, and imaging studies.\n5. Treatment of Fitz-Hugh–Curtis syndrome typically involves hospitalization and supportive care, and in some cases, surgery may be necessary.",
    "vicuna-13b_fact": [
      "Fitz-Hugh–Curtis syndrome is characterized by acute inflammation of the pancreas and concurrent cholecystitis.",
      "The syndrome is most commonly seen in women of reproductive age, often associated with pregnancy.",
      "Symptoms of Fitz-Hugh–Curtis syndrome typically include severe abdominal pain, nausea, vomiting, and fever.",
      "Diagnosis of Fitz-Hugh–Curtis syndrome is generally made through physical examination, laboratory tests, and imaging studies.",
      "Treatment of Fitz-Hugh–Curtis syndrome typically involves hospitalization and supportive care, and in some cases, surgery may be necessary."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Fitz-Hugh–Curtis syndrome is characterized by liver capsule inflammation and concurrent pelvic inflammatory disease, not inflammation of the pancreas and cholecystitis.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3454,
    "user_query": "What is the trade name of sildenafil?",
    "vicuna-13b_response": "The trade name of sildenafil is Viagra.",
    "vicuna-13b_fact_raw": "The factual statement is:\n1. The trade name of sildenafil is Viagra.",
    "vicuna-13b_fact": [
      "The trade name of sildenafil is Viagra."
    ],
    "vicuna-13b_judge_raw": "TRUE",
    "vicuna-13b_judge": [
      "true"
    ]
  },
  {
    "id": 3455,
    "user_query": "How large is the SARS-CoV  proteome?",
    "vicuna-13b_response": "The SARS-CoV  proteome refers to the complete set of proteins that are encoded by the SARS-CoV  genome. The SARS-CoV  genome is the genetic material of the virus, which consists of RNA. The size of the SARS-CoV  proteome can vary depending on the specific strain of the virus and the methods used to predict proteins.\nUsing bioinformatics tools and methods, researchers have predicted that the SARS-CoV  proteome contains over 200 proteins, including structural proteins, enzymes, and non-structural proteins. These proteins are involved in various cellular processes, such as cell adhesion, signal transduction, and protein synthesis.\nIt's important to note that not all of these predicted proteins have been experimentally verified, and some may not be functional or may have different functions than what is currently understood. Additionally, some proteins may be present in different forms or isoforms, which can affect their function and size.\nOverall, the size of the SARS-CoV  proteome is large and complex, and ongoing research is needed to better understand the functions of its proteins and how they contribute to the virulence and pathogenesis of the virus.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The SARS-CoV proteome refers to the complete set of proteins that are encoded by the SARS-CoV genome. \n2. The SARS-CoV genome is the genetic material of the virus, which consists of RNA.\n3. The size of the SARS-CoV proteome can vary depending on the specific strain of the virus and the methods used to predict proteins.\n4. Using bioinformatics tools and methods, researchers have predicted that the SARS-CoV proteome contains over 200 proteins.\n5. The proteins of the SARS-CoV genom are involved in various cellular processes, such as cell adhesion, signal transduction, and protein synthesis.",
    "vicuna-13b_fact": [
      "The SARS-CoV proteome refers to the complete set of proteins that are encoded by the SARS-CoV genome.",
      "The SARS-CoV genome is the genetic material of the virus, which consists of RNA.",
      "The size of the SARS-CoV proteome can vary depending on the specific strain of the virus and the methods used to predict proteins.",
      "Using bioinformatics tools and methods, researchers have predicted that the SARS-CoV proteome contains over 200 proteins.",
      "The proteins of the SARS-CoV genom are involved in various cellular processes, such as cell adhesion, signal transduction, and protein synthesis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Using bioinformatics tools and methods, researchers have predicted that the SARS-CoV-2 proteome contains about 29 proteins.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3460,
    "user_query": "Can radiotherapy cause radiation induced osteosarcoma?",
    "vicuna-13b_response": "Radiotherapy is a treatment that uses high-energy radiation to kill cancer cells or shrink tumors. While radiotherapy can be an effective treatment for many types of cancer, it can also have some potential side effects. One of these side effects is the development of a new type of cancer, known as radiation-induced cancer.\nRadiation-induced cancer can occur years after the initial treatment and can affect any part of the body that was exposed to radiation. Osteosarcoma is a type of bone cancer that can be caused by radiation exposure. It is a rare side effect of radiotherapy, but it can occur. The risk of developing osteosarcoma after radiotherapy depends on several factors, including the dose and duration of the radiation, the age of the patient at the time of treatment, and the specific area of the body that was exposed to radiation.\nIt is important to note that the risk of developing osteosarcoma after radiotherapy is still relatively low, and the benefits of radiotherapy for treating cancer are generally greater than the risks. However, it is important for patients to be aware of the potential side effects of radiotherapy and to discuss the risks and benefits of the treatment with their doctor. Regular follow-up appointments and imaging studies can help to detect any potential side effects early, and to manage them effectively.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Radiotherapy is a treatment that uses high-energy radiation to kill cancer cells or shrink tumors.\n2. One of the side effects of radiotherapy can be the development of a new type of cancer, known as radiation-induced cancer.\n3. Osteosarcoma, a type of bone cancer, can be caused by radiation exposure.\n4. The risk of developing osteosarcoma after radiotherapy depends on several factors, including the dose and duration of the radiation, the age of the patient at the time of treatment, and the specific area of the body that was exposed to radiation.\n5. Regular follow-up appointments and imaging studies can help to detect any potential side effects early, and to manage them effectively.",
    "vicuna-13b_fact": [
      "Radiotherapy is a treatment that uses high-energy radiation to kill cancer cells or shrink tumors.",
      "One of the side effects of radiotherapy can be the development of a new type of cancer, known as radiation-induced cancer.",
      "Osteosarcoma, a type of bone cancer, can be caused by radiation exposure.",
      "The risk of developing osteosarcoma after radiotherapy depends on several factors, including the dose and duration of the radiation, the age of the patient at the time of treatment, and the specific area of the body that was exposed to radiation.",
      "Regular follow-up appointments and imaging studies can help to detect any potential side effects early, and to manage them effectively."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "vicuna-13b_response": "The Saint's Triad is a concept in Christian theology that describes the threefold office of Christ: prophet, priest, and king. These three roles are seen as being united in one person, Jesus Christ. The manifestations of the Saint's Triad can be seen in various aspects of Christ's life and ministry, including his teachings, his sacrificial death, and his reign as King of kings and Lord of lords.\n1. Prophet: As a prophet, Christ is seen as the ultimate revealer of God's truth and will. He taught with authority and power, and his teachings continue to be a source of guidance and inspiration for Christians today.\n2. Priest: As a priest, Christ is seen as the mediator between God and humanity. He offered himself as a sacrifice for the sins of the world, and through his death and resurrection, he made it possible for people to be reconciled to God.\n3. King: As a king, Christ is seen as the ruler and sovereign over all creation. He reigns in glory and power, and one day he will return to establish his kingdom in its fullness.\nThe manifestations of the Saint's Triad can also be seen in the lives of the saints, who are seen as living examples of the Christian life. They embody the virtues and values of the Christian faith, and they serve as inspiration for others to follow in their footsteps.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Saint's Triad in Christian theology refers to the threefold office of Christ as a prophet, priest, and king.\n2. The three roles of the Saint's Triad are seen as being united in one person, Jesus Christ.\n3. Christ, as a prophet in the Saint's Triad, is seen as the ultimate revealer of God's truth and his teachings continue to guide Christians.\n4. Christ, as a priest in the Saint's Triad, is seen as the mediator between God and humanity and offered himself as a sacrifice for the sins of the world.\n5. Christ, as a king in the Saint's Triad, is considered the ruler and sovereign over all creation and will return to establish his kingdom in its fullness.",
    "vicuna-13b_fact": [
      "The Saint's Triad in Christian theology refers to the threefold office of Christ as a prophet, priest, and king.",
      "The three roles of the Saint's Triad are seen as being united in one person, Jesus Christ.",
      "Christ, as a prophet in the Saint's Triad, is seen as the ultimate revealer of God's truth and his teachings continue to guide Christians.",
      "Christ, as a priest in the Saint's Triad, is seen as the mediator between God and humanity and offered himself as a sacrifice for the sins of the world.",
      "Christ, as a king in the Saint's Triad, is considered the ruler and sovereign over all creation and will return to establish his kingdom in its fullness."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The term used in Christian theology is the \"Munus triplex,\" not the \"Saint's Triad,\" which refers to the threefold office of Christ as a prophet, priest, and king.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3463,
    "user_query": "Are male or female persons more prone to autoimmunity?",
    "vicuna-13b_response": "Autoimmunity occurs when the immune system mistakenly attacks the body's own tissues and organs. The likelihood of developing autoimmunity is not determined by gender, but rather by a combination of genetic and environmental factors.\nThat being said, some studies have suggested that women are more prone to certain types of autoimmune diseases than men. For example, women are more likely to develop autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis. However, this may be due to hormonal and other factors that are unique to women.\nIt is important to note that autoimmunity can affect anyone, regardless of gender. It is also important to recognize that there are many factors that can contribute to the development of autoimmunity, and that prevention and treatment strategies may differ depending on the specific type of autoimmune disease. If you have concerns about autoimmunity, it is important to speak with a healthcare provider for proper evaluation and guidance.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Autoimmunity occurs when the immune system mistakenly attacks the body's own tissues and organs.\n2. The likelihood of developing autoimmunity is determined by a combination of genetic and environmental factors.\n3. Some studies suggest that women are more prone to certain types of autoimmune diseases than men.\n4. Women are more likely to develop autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis.\n5. Autoimmunity can affect anyone, regardless of gender.",
    "vicuna-13b_fact": [
      "Autoimmunity occurs when the immune system mistakenly attacks the body's own tissues and organs.",
      "The likelihood of developing autoimmunity is determined by a combination of genetic and environmental factors.",
      "Some studies suggest that women are more prone to certain types of autoimmune diseases than men.",
      "Women are more likely to develop autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis.",
      "Autoimmunity can affect anyone, regardless of gender."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3469,
    "user_query": "What is Fuchs' Uveitis?",
    "vicuna-13b_response": "Fuchs' uveitis, also known as Fuchs' disease, is a chronic inflammatory eye disease that affects the middle layer of the eye, known as the uvea. The uvea is responsible for supplying blood to the retina and the choroid, a layer of blood vessels that provides nutrients to the retina.\nFuchs' uveitis is a progressive disease that can lead to vision loss and blindness if left untreated. The exact cause of Fuchs' uveitis is not known, but it is thought to be an autoimmune disorder, in which the body's immune system mistakenly attacks healthy cells and tissues in the eye.\nSymptoms of Fuchs' uveitis can include:\n* Floaters or spots in your vision\n* Blurred vision\n* Eye pain or discomfort\n* Sensitivity to light\n* Redness and inflammation in the eye\nIf you experience any of these symptoms, it is important to see an eye doctor for a proper diagnosis and treatment. Treatment options for Fuchs' uveitis include medications, such as corticosteroids, and surgery, such as a vitrectomy, which involves removing the vitreous humor, a gel-like substance in the eye, and replacing it with a saline solution.\nIt is important to note that Fuchs' uveitis is a chronic condition, and symptoms may recur even after successful treatment. Regular eye exams and follow-up care with an eye doctor are necessary to manage the condition and prevent vision loss.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fuchs' uveitis, also known as Fuchs' disease, is a chronic inflammatory eye disease that affects the uvea.\n2. The uvea is responsible for supplying blood to the retina and the choroid.\n3. Fuchs' uveitis is a progressive disease that can lead to vision loss and blindness if left untreated.\n4. Treatment options for Fuchs' uveitis include medications, such as corticosteroids, and surgery, such as a vitrectomy.\n5. Fuchs' uveitis is a chronic condition, and symptoms may recur even after successful treatment.",
    "vicuna-13b_fact": [
      "Fuchs' uveitis, also known as Fuchs' disease, is a chronic inflammatory eye disease that affects the uvea.",
      "The uvea is responsible for supplying blood to the retina and the choroid.",
      "Fuchs' uveitis is a progressive disease that can lead to vision loss and blindness if left untreated.",
      "Treatment options for Fuchs' uveitis include medications, such as corticosteroids, and surgery, such as a vitrectomy.",
      "Fuchs' uveitis is a chronic condition, and symptoms may recur even after successful treatment."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "vicuna-13b_response": "Overexpression of LY6K, also known as LY6K/KLH, is a protein that has been identified as a potential biomarker for non-small cell lung cancer (NSCLC). However, the relationship between LY6K overexpression and patient prognosis is not straightforward and may depend on various factors.\nSome studies have suggested that LY6K overexpression may be associated with a better prognosis for NSCLC patients. For example, a study published in the journal Clinical Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC. Another study published in the journal Cancer Research in 2018 also found that LY6K overexpression was associated with better prognosis in patients with NSCLC, particularly in those with squamous cell carcinoma subtype.\nHowever, other studies have reported conflicting results or have found no association between LY6K overexpression and patient prognosis. For example, a study published in the journal Lung Cancer in 2019 found that high levels of LY6K expression were not significantly associated with overall survival in NSCLC patients.\nIt is important to note that the relationship between LY6K overexpression and patient prognosis may be influenced by various factors, such as the stage and histology of the cancer, the patient's age and smoking history, and the presence of other biomarkers. Therefore, further research is needed to fully understand the role of LY6K in NSCLC and its potential as a biomarker for prognosis.\nIn conclusion, while some studies have suggested that overexpression of LY6K may be associated with a better prognosis for NSCLC patients, the relationship between LY6K and patient prognosis is not well established and may depend on various factors. Further research is needed to fully understand the role of LY6K in NSCLC and its potential as a biomarker for prognosis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. LY6K, also known as LY6K/KLH, is a protein that has been identified as a potential biomarker for non-small cell lung cancer.\n2. A study published in the journal Clinical Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.\n3. Another study published in the journal Cancer Research in 2018 also found that LY6K overexpression was associated with better prognosis in patients with NSCLC, particularly in those with squamous cell carcinoma subtype.\n4. A study published in the journal Lung Cancer in 2019 found that high levels of LY6K expression were not significantly associated with overall survival in NSCLC patients.\n5. The relationship between LY6K overexpression and patient prognosis may be influenced by various factors such as stage and histology of the cancer, patient's age and smoking history, and the presence of other biomarkers.",
    "vicuna-13b_fact": [
      "LY6K, also known as LY6K/KLH, is a protein that has been identified as a potential biomarker for non-small cell lung cancer.",
      "A study published in the journal Clinical Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.",
      "Another study published in the journal Cancer Research in 2018 also found that LY6K overexpression was associated with better prognosis in patients with NSCLC, particularly in those with squamous cell carcinoma subtype.",
      "A study published in the journal Lung Cancer in 2019 found that high levels of LY6K expression were not significantly associated with overall survival in NSCLC patients.",
      "The relationship between LY6K overexpression and patient prognosis may be influenced by various factors such as stage and histology of the cancer, patient's age and smoking history, and the presence of other biomarkers."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "vicuna-13b_response": "Cytokinesis is the final stage of cell division, where the cell physically splits into two daughter cells. During cytokinesis, several CDK (cyclin-dependent kinase) targets are dephosphorylated to facilitate the process of cell division. These targets include:\n1. Cdc28 - a CDK that is involved in the progression of the cell cycle in yeast. Cdc28 is dephosphorylated during cytokinesis, which allows it to enter a new cell cycle.\n2. Polo - a CDK that is involved in the regulation of mitosis in animals. Polo is dephosphorylated during cytokinesis, which allows it to activate the spindle assembly checkpoint and ensure that the cell has properly divided.\n3. Aurora B - a CDK that is involved in the regulation of mitosis in animals. Aurora B is dephosphorylated during cytokinesis, which allows it to activate the spindle assembly checkpoint and ensure that the cell has properly divided.\n4. Myt1 - a CDK that is involved in the regulation of mitosis in plants. Myt1 is dephosphorylated during cytokinesis, which allows it to activate the spindle assembly checkpoint and ensure that the cell has properly divided.\nOverall, the dephosphorylation of these CDK targets during cytokinesis plays a crucial role in the proper division of cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cdk targets are dephosphorylated during cytokinesis.\n2. Cdc28, a CDK target, is dephosphorylated during cytokinesis to facilitate the cell cycle progression in yeast.\n3. Polo, a CDK target, is dephosphorylated during cytokinesis which allows it to activate the spindle assembly checkpoint in animal mitosis.\n4. Aurora B, a CDK target, is dephosphorylated during cytokinesis, facilitating activation of the spindle assembly checkpoint in animal mitosis.\n5. Myt1, a CDK involved in plant mitosis, is dephosphorylated during cytokinesis to activate the spindle assembly checkpoint.",
    "vicuna-13b_fact": [
      "Cdk targets are dephosphorylated during cytokinesis.",
      "Cdc28, a CDK target, is dephosphorylated during cytokinesis to facilitate the cell cycle progression in yeast.",
      "Polo, a CDK target, is dephosphorylated during cytokinesis which allows it to activate the spindle assembly checkpoint in animal mitosis.",
      "Aurora B, a CDK target, is dephosphorylated during cytokinesis, facilitating activation of the spindle assembly checkpoint in animal mitosis.",
      "Myt1, a CDK involved in plant mitosis, is dephosphorylated during cytokinesis to activate the spindle assembly checkpoint."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3474,
    "user_query": "What is dystopia canthorum?",
    "vicuna-13b_response": "Dystopia canthorum is a term used to describe a hypothetical future society that is characterized by widespread suffering, oppression, and environmental degradation. The term is derived from the Greek words \"dystopia,\" meaning \"bad place,\" and \"canthorum,\" which refers to the hollows or depressions on the surface of the moon.\nThe concept of dystopia canthorum was first introduced by the philosopher and futurist Buckminster Fuller in the 1960s as a warning about the potential consequences of unchecked human population growth and environmental degradation. Fuller believed that if these trends continued, they would eventually lead to a world where the majority of people lived in poverty and misery, with limited access to resources and opportunities.\nIn a dystopia canthorum, the environment would be severely degraded, with pollution, deforestation, and climate change leading to widespread ecological collapse. The social and political systems would be characterized by inequality, oppression, and authoritarianism, with a small elite controlling the majority of resources and wealth.\nOverall, dystopia canthorum is a cautionary tale about the potential consequences of unchecked human activity and the need for sustainable and equitable societies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Dystopia canthorum is a term used to describe a future society characterized by widespread suffering, oppression, and environmental degradation.\n2. The term \"dystopia canthorum\" is derived from the Greek words \"dystopia,\" meaning \"bad place,\" and \"canthorum,\" which refers to the hollows or depressions on the surface of the moon.\n3. The term was introduced by Buckminster Fuller in the 1960s.\n4. Fuller was a philosopher and futurist.\n5. In a dystopia canthorum, the environment would be severely degraded, with pollution, deforestation, and climate change leading to widespread ecological collapse.",
    "vicuna-13b_fact": [
      "Dystopia canthorum is a term used to describe a future society characterized by widespread suffering, oppression, and environmental degradation.",
      "The term \"dystopia canthorum\" is derived from the Greek words \"dystopia,\" meaning \"bad place,\" and \"canthorum,\" which refers to the hollows or depressions on the surface of the moon.",
      "The term was introduced by Buckminster Fuller in the 1960s.",
      "Fuller was a philosopher and futurist.",
      "In a dystopia canthorum, the environment would be severely degraded, with pollution, deforestation, and climate change leading to widespread ecological collapse."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Dystopia canthorum is a medical term describing a specific facial feature related to disease, not a term for a future society.\n2. FALSE [correction]: The term \"dystopia canthorum\" is derived from the Greek words \"dys,\" meaning \"bad,\" and \"opos,\" meaning \"view.\" \"Canthorum\" refers to the corner of the eyes where the eyelids meet. It does not describe the surface of the moon.\n3. FALSE [correction]: The term was not coined by Buckminster Fuller. It is a medical term used in the field of genetics.\n4. TRUE\n5. UNKNOWN, as \"dystopia canthorum\" is a medical term and does not inherently define any specific future ecological conditions.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3476,
    "user_query": "What is Heterochromia Iridis?",
    "vicuna-13b_response": "Heterochromia iridis is a condition in which one iris (the colored part of the eye) is a different color from the other iris. This can be caused by a variety of factors, including genetics, injury, or disease. Heterochromia is a relatively uncommon condition, affecting an estimated 1 in 2,000 people worldwide.\nThere are two main types of heterochromia:\n1. Differential iris pigmentation: This type of heterochromia is caused by a difference in the amount of pigment in the iris. For example, one iris may be brown and the other blue or green.\n2. Iris heterochromia: This type of heterochromia is caused by a difference in the color of the iris tissue itself. For example, one iris may be blue and the other brown.\nHeterochromia can be a cosmetic concern for some people, but it is generally not a serious medical condition. However, it can be a sign of an underlying health problem, such as a thyroid disorder or a genetic condition. If you have heterochromia and are concerned about its impact on your vision or overall health, you should speak with an eye doctor or other healthcare provider.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Heterochromia iridis is a condition where one iris is a different color from the other iris.\n2. This condition can be caused by genetics, injury, or disease.\n3. Heterochromia affects an estimated 1 in 2,000 people worldwide.\n4. There are two main types of heterochromia: differential iris pigmentation and iris heterochromia.\n5. While generally not serious, heterochromia can be a sign of an underlying health problem, such as a thyroid disorder or a genetic condition.",
    "vicuna-13b_fact": [
      "Heterochromia iridis is a condition where one iris is a different color from the other iris.",
      "This condition can be caused by genetics, injury, or disease.",
      "Heterochromia affects an estimated 1 in 2,000 people worldwide.",
      "There are two main types of heterochromia: differential iris pigmentation and iris heterochromia.",
      "While generally not serious, heterochromia can be a sign of an underlying health problem, such as a thyroid disorder or a genetic condition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: There are two main types of heterochromia: complete, where one iris is a completely different color from the other; and partial, where part of one iris is a different color from the rest.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3483,
    "user_query": "Is Ubrogepant effective for migraine?",
    "vicuna-13b_response": "Ubrogepant is a medication that is used to treat migraines. It is a calcitonin gene-related peptide (CGRP) antagonist, which means it works by blocking the action of CGRP, a molecule that is involved in the pain and inflammation associated with migraines.\nUbrogepant has been shown to be effective in reducing the severity and duration of migraines. In clinical trials, it has been shown to be effective in treating both episodic migraines and chronic migraines.\nIt is important to note that Ubrogepant should be used as a part of a complete treatment plan for migraines, which may include other medications, lifestyle changes, and other therapies. It is also important to follow the instructions of a healthcare provider regarding the use of Ubrogepant and to report any side effects or concerns.\nIt is also important to note that Ubrogepant is not a preventive treatment for migraines, it is a treatment for acute migraines.\nIt is always recommended to consult a healthcare professional before taking any medication, including Ubrogepant. They will be able to provide more information on the safety and efficacy of the medication, as well as any potential interactions with other medications or medical conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ubrogepant is a medication used to treat migraines.\n2. Ubrogepant is a calcitonin gene-related peptide (CGRP) antagonist, meaning it works by blocking the action of CGRP.\n3. CGRP is a molecule involved in the pain and inflammation associated with migraines.\n4. In clinical trials, Ubrogepant has been shown to be effective in treating both episodic migraines and chronic migraines.\n5. Ubrogepant is not a preventive treatment for migraines, rather, it is a treatment for acute migraines.",
    "vicuna-13b_fact": [
      "Ubrogepant is a medication used to treat migraines.",
      "Ubrogepant is a calcitonin gene-related peptide (CGRP) antagonist, meaning it works by blocking the action of CGRP.",
      "CGRP is a molecule involved in the pain and inflammation associated with migraines.",
      "In clinical trials, Ubrogepant has been shown to be effective in treating both episodic migraines and chronic migraines.",
      "Ubrogepant is not a preventive treatment for migraines, rather, it is a treatment for acute migraines."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3485,
    "user_query": "What is the protein product of the gene GBA2?",
    "vicuna-13b_response": "The protein product of the gene GBA2 is beta-glucocerebrosidase. It is also known as GCase or glucocerebrosidase. Beta-glucocerebrosidase is an enzyme that plays a critical role in the breakdown and recycling of a specific type of fat called glucocerebroside. This enzyme is found primarily in the lysosomes, which are specialized organelles that play a key role in the degradation and recycling of cellular components. Mutations in the GBA2 gene have been linked to several lysosomal storage disorders, including Gaucher disease, which is the most common inherited lysosomal disorder.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The gene GBA2 produces the protein beta-glucocerebrosidase.\n2. Beta-glucocerebrosidase is also known as GCase or glucocerebrosidase.\n3. Beta-glucocerebrosidase plays a crucial role in the breakdown and recycling of glucocerebroside.\n4. The beta-glucocerebrosidase enzyme is primarily found in the lysosomes.\n5. Mutations in the GBA2 gene have been linked to several lysosomal storage disorders, including Gaucher disease.",
    "vicuna-13b_fact": [
      "The gene GBA2 produces the protein beta-glucocerebrosidase.",
      "Beta-glucocerebrosidase is also known as GCase or glucocerebrosidase.",
      "Beta-glucocerebrosidase plays a crucial role in the breakdown and recycling of glucocerebroside.",
      "The beta-glucocerebrosidase enzyme is primarily found in the lysosomes.",
      "Mutations in the GBA2 gene have been linked to several lysosomal storage disorders, including Gaucher disease."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The gene GBA, not GBA2, produces the protein beta-glucocerebrosidase.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Mutations in the GBA gene, not GBA2, have been linked to several lysosomal storage disorders, including Gaucher disease.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3498,
    "user_query": "Has ProSavin undergone phase IV clinical trials by 2018?",
    "vicuna-13b_response": "I could not find any information indicating that ProSavin underwent a phase IV clinical trial by 2018. Phase IV clinical trials are post-marketing studies that are conducted after a drug has been approved for use in the general population. These studies are designed to further evaluate the safety and effectiveness of the drug in real-world settings and to gather additional information about the drug's long-term effects.\nIt is possible that ProSavin may have undergone phase IV clinical trials after 2018, but I do not have access to information on all clinical trials that have taken place since that time. It is also possible that ProSavin was not approved for use in the general population by 2018, in which case it would not have undergone a phase IV clinical trial.\nI recommend consulting with a healthcare professional or conducting further research to obtain more information on the current status of ProSavin and its clinical trial history.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ProSavin did not undergo a phase IV clinical trial as of 2018 according to the available information.\n2. Phase IV clinical trials are post-marketing studies conducted after a drug has been approved for use in the general population.\n3. Phase IV studies are meant to evaluate the safety and effectiveness of the drug in real-world settings and gather additional information about its long-term effects.",
    "vicuna-13b_fact": [
      "ProSavin did not undergo a phase IV clinical trial as of 2018 according to the available information.",
      "Phase IV clinical trials are post-marketing studies conducted after a drug has been approved for use in the general population.",
      "Phase IV studies are meant to evaluate the safety and effectiveness of the drug in real-world settings and gather additional information about its long-term effects."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3502,
    "user_query": "What is ProSavin?",
    "vicuna-13b_response": "ProSavin is a medication that is used to treat type 2 diabetes. It is a synthetic version of a hormone called glucagon-like peptide-1 (GLP-1), which is naturally produced in the body. ProSavin helps to regulate blood sugar levels by stimulating the release of insulin from the pancreas and by inhibiting the release of glucagon, which is a hormone that raises blood sugar levels.\nProSavin is administered by injection and is typically given once or twice a day. It is usually used in combination with other diabetes medications, such as metformin, to achieve better blood sugar control. ProSavin is not suitable for treating type 1 diabetes or diabetic ketoacidosis.\nIt is important to note that ProSavin should not be used in people with severe kidney problems or who are allergic to any of the ingredients in the medication. It is also important to monitor blood sugar levels regularly while taking ProSavin, as it can cause low blood sugar (hypoglycemia) if the dose is too high or if the body becomes more sensitive to the medication over time.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ProSavin is a medication used to treat type 2 diabetes.\n2. ProSavin is a synthetic version of a hormone called glucagon-like peptide-1 (GLP-1).\n3. ProSavin helps regulate blood sugar levels by stimulating the release of insulin from the pancreas and inhibiting the release of glucagon.\n4. ProSavin is administered by injection and is typically given once or twice a day.\n5. ProSavin should not be used in people with severe kidney problems or who are allergic to any of the ingredients in the medication.",
    "vicuna-13b_fact": [
      "ProSavin is a medication used to treat type 2 diabetes.",
      "ProSavin is a synthetic version of a hormone called glucagon-like peptide-1 (GLP-1).",
      "ProSavin helps regulate blood sugar levels by stimulating the release of insulin from the pancreas and inhibiting the release of glucagon.",
      "ProSavin is administered by injection and is typically given once or twice a day.",
      "ProSavin should not be used in people with severe kidney problems or who are allergic to any of the ingredients in the medication."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: ProSavin is not a medication used to treat type 2 diabetes, but is a gene therapy drug used to treat Parkinson's disease.\n2. FALSE [correction]: ProSavin is not a synthetic version of a hormone. It is a gene therapy drug which uses a lentiviral vector to deliver three genes that are required for dopamine synthesis.\n3. FALSE [correction]: ProSavin does not regulate blood sugar levels. It is used to provide long-term effects and significantly reduce the motor disability in Parkinson's patients.\n4. FALSE [correction]: ProSavin is not administered by injection, but it is administered via a surgical procedure into the patient's brain.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3503,
    "user_query": "Are stretch enhancers transcribed more than super-enhancers?",
    "vicuna-13b_response": "Stretch enhancers and super-enhancers are both types of chromatin structures that are involved in regulating gene expression. However, the transcription of stretch enhancers and super-enhancers can vary depending on the specific context and cell type.\nStretch enhancers are defined as regions of chromatin that are associated with the transcription factor STRE, which is involved in the regulation of gene expression during development. Studies have shown that stretch enhancers can be transcribed at low levels in some cell types, but their transcription is generally thought to be low compared to other chromatin structures such as promoters and enhancers.\nSuper-enhancers, on the other hand, are defined as regions of chromatin that are associated with the transcription factor TFII-I, which is involved in the regulation of gene expression. Super-enhancers have been shown to be highly transcribed in many cell types, and they are often associated with the regulation of cell-specific gene expression programs.\nOverall, while both stretch enhancers and super-enhancers can be transcribed, the transcription of these chromatin structures can vary depending on the specific context and cell type.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Stretch enhancers and super-enhancers are types of chromatin structures that regulate gene expression.\n2. Stretch enhancers are associated with the transcription factor STRE.\n3. Stretch enhancers can be transcribed at low levels in some cell types.\n4. Super-enhancers are associated with the transcription factor TFII-I.\n5. Super-enhancers have been shown to be highly transcribed in many cell types.",
    "vicuna-13b_fact": [
      "Stretch enhancers and super-enhancers are types of chromatin structures that regulate gene expression.",
      "Stretch enhancers are associated with the transcription factor STRE.",
      "Stretch enhancers can be transcribed at low levels in some cell types.",
      "Super-enhancers are associated with the transcription factor TFII-I.",
      "Super-enhancers have been shown to be highly transcribed in many cell types."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Stretch enhancers are not typically associated with any specific transcription factor.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3507,
    "user_query": "Which diagnostic test is approved for coronavirus infection screening?",
    "vicuna-13b_response": "As of my knowledge cutoff date of September 2021, there were several diagnostic tests approved for coronavirus infection screening, including:\n1. PCR (polymerase chain reaction) test: This test detects the genetic material of the virus in a sample from the patient, such as a nasal swab or blood sample.\n2. Antigen detection test: This test detects the presence of the virus in a sample from the patient, such as a nasal swab or blood sample.\n3. Nucleic acid test (NAT): This test detects the genetic material of the virus in a sample from the patient, such as a nasal swab or blood sample.\n4. Rapid antigen test: This test is a quick, on-site test that can provide results in about 15 minutes. It detects the presence of the virus in a sample from the patient, such as a nasal swab or throat swab.\nIt's important to note that diagnostic testing for COVID-19 can be complex and may involve multiple tests. It's also important to get tested at a qualified healthcare facility and to follow the guidance of healthcare professionals.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. As of September 2021, several diagnostic tests were approved for coronavirus infection screening.\n2. The PCR (polymerase chain reaction) test is a type of test that detects the genetic material of the virus in a sample from the patient.\n3. An antigen detection test is used to detect the presence of the virus in a patient's sample.\n4. The nucleic acid test (NAT) also identifies the virus's genetic material in a patient's sample.\n5. Rapid antigen tests can provide results in approximately 15 minutes by identifying the virus in a sample from the patient.",
    "vicuna-13b_fact": [
      "As of September 2021, several diagnostic tests were approved for coronavirus infection screening.",
      "The PCR (polymerase chain reaction) test is a type of test that detects the genetic material of the virus in a sample from the patient.",
      "An antigen detection test is used to detect the presence of the virus in a patient's sample.",
      "The nucleic acid test (NAT) also identifies the virus's genetic material in a patient's sample.",
      "Rapid antigen tests can provide results in approximately 15 minutes by identifying the virus in a sample from the patient."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "vicuna-13b_response": "Xanamem is a drug that is used to treat acid reflux, also known as gastroesophageal reflux disease (GERD). It is a type of medication called a proton pump inhibitor (PPI), which works by reducing the amount of acid produced by the stomach. Xanamem is available in tablet form and is taken orally. It is usually taken once a day, with or without food. Xanamem is used to treat symptoms of acid reflux such as heartburn, regurgitation, and difficulty swallowing. It is also used to prevent acid reflux from occurring in the first place. Xanamem is available by prescription only and should only be taken under the guidance of a healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Xanamem is a drug that is used to treat acid reflux, also known as gastroesophageal reflux disease (GERD).\n2. Xanamem is a type of medication called a proton pump inhibitor (PPI).\n3. This drug works by reducing the amount of acid produced by the stomach.\n4. Xanamem is available in tablet form and is taken orally.\n5. Xanamem is available by prescription only and should be taken under the guidance of a healthcare professional.",
    "vicuna-13b_fact": [
      "Xanamem is a drug that is used to treat acid reflux, also known as gastroesophageal reflux disease (GERD).",
      "Xanamem is a type of medication called a proton pump inhibitor (PPI).",
      "This drug works by reducing the amount of acid produced by the stomach.",
      "Xanamem is available in tablet form and is taken orally.",
      "Xanamem is available by prescription only and should be taken under the guidance of a healthcare professional."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Xanamem is a drug originally developed for the treatment of Alzheimer's disease not gastroesophageal reflux disease (GERD).\n2. FALSE [correction]: Xanamem is not a proton pump inhibitor (PPI); it is designed to inhibit the production of cortisol in the brain. \n3. FALSE [correction]: Xanamem does not reduce the amount of acid produced by the stomach. It is meant to work by blocking the excess production of the stress hormone cortisol.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3509,
    "user_query": "Can nrf2 activation lead to resistance to radiotherapy?",
    "vicuna-13b_response": "Nrf2 is a transcription factor that plays a critical role in the cellular response to oxidative stress and inflammation. It is also involved in the regulation of detoxification and antioxidant pathways. Activation of Nrf2 has been shown to have a protective effect against radiation-induced damage in some studies.\nHowever, there is also evidence that Nrf2 activation can lead to resistance to radiotherapy in certain circumstances. For example, in cancer cells, Nrf2 activation can lead to increased DNA repair and decreased sensitivity to radiation-induced apoptosis. Additionally, Nrf2 can also regulate the expression of genes involved in angiogenesis, which can lead to the development of new blood vessels that can support tumor growth and survival.\nOverall, the effect of Nrf2 activation on radiotherapy sensitivity is complex and context-dependent. While Nrf2 activation may provide some protection against radiation-induced damage in normal cells, it can also lead to resistance in cancer cells. Further research is needed to fully understand the role of Nrf2 in radiotherapy and to develop strategies to target Nrf2 in cancer cells to improve the effectiveness of radiotherapy.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Nrf2 is a transcription factor that plays a role in the cellular response to oxidative stress and inflammation.\n2. Nrf2 regulates detoxification and antioxidant pathways.\n3. Activation of Nrf2 can provide some protection against radiation-induced damage.\n4. Research has shown that Nrf2 activation can lead to resistance to radiotherapy in some cancer cells.\n5. Nrf2 can regulate the expression of genes involved in angiogenesis.",
    "vicuna-13b_fact": [
      "Nrf2 is a transcription factor that plays a role in the cellular response to oxidative stress and inflammation.",
      "Nrf2 regulates detoxification and antioxidant pathways.",
      "Activation of Nrf2 can provide some protection against radiation-induced damage.",
      "Research has shown that Nrf2 activation can lead to resistance to radiotherapy in some cancer cells.",
      "Nrf2 can regulate the expression of genes involved in angiogenesis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3513,
    "user_query": "What is the role of Scc2/Nipbl?",
    "vicuna-13b_response": "Scc2/Nipbl is a complex that plays a crucial role in regulating the proper segregation of chromosomes during cell division. The Scc2/Nipbl complex is composed of two proteins: Scc2 and Nipbl.\nScc2 is a structural protein that forms a ring-shaped structure that binds to the centromere of the chromosome. The centromere is the region of the chromosome where the sister chromatids are joined together. Scc2 helps to anchor the chromosome to the mitotic spindle, which is the structure that pulls the chromosomes apart during cell division.\nNipbl, on the other hand, is a regulatory protein that helps to recruit the Scc2 complex to the chromosomes. Nipbl also helps to ensure that the Scc2 complex is properly positioned on the chromosome so that it can properly anchor the chromosome to the mitotic spindle.\nMutations in the Scc2/Nipbl complex can lead to abnormal chromosome segregation, which can result in aneuploidy, a condition in which the cells have an abnormal number of chromosomes. This can lead to a variety of developmental disorders and cancers.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Scc2/Nipbl is a complex that plays a crucial role in regulating the proper segregation of chromosomes during cell division.\n2. The Scc2/Nipbl complex is composed of two proteins: Scc2 and Nipbl.\n3. Scc2 forms a ring-shaped structure that binds to the centromere of the chromosome and helps anchor the chromosome to the mitotic spindle.\n4. Nipbl is a regulatory protein that recruits the Scc2 complex to the chromosomes and ensures it is properly positioned.\n5. Mutations in the Scc2/Nipbl complex can lead to abnormal chromosome segregation, aneuploidy, and potentially developmental disorders and cancers.",
    "vicuna-13b_fact": [
      "Scc2/Nipbl is a complex that plays a crucial role in regulating the proper segregation of chromosomes during cell division.",
      "The Scc2/Nipbl complex is composed of two proteins: Scc2 and Nipbl.",
      "Scc2 forms a ring-shaped structure that binds to the centromere of the chromosome and helps anchor the chromosome to the mitotic spindle.",
      "Nipbl is a regulatory protein that recruits the Scc2 complex to the chromosomes and ensures it is properly positioned.",
      "Mutations in the Scc2/Nipbl complex can lead to abnormal chromosome segregation, aneuploidy, and potentially developmental disorders and cancers."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Scc1, not Scc2, forms a part of a ring-shaped structure, called cohesin, that binds to the chromosomes.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3515,
    "user_query": "Can brain derived exosomes carry APP molecules?",
    "vicuna-13b_response": "Yes, brain-derived exosomes can carry APP (amyloid precursor protein) molecules. Exosomes are small vesicles that are released by cells and can carry various types of molecules, including proteins, lipids, and nucleic acids. APP is a protein that is expressed in the brain and is involved in the formation of amyloid plaques, a hallmark of Alzheimer's disease.\nSeveral studies have shown that exosomes can carry APP molecules and that these exosomes can be secreted by brain cells, including neurons and glial cells. For example, one study found that exosomes secreted by glial cells contained high levels of APP, and that these exosomes could transfer APP to neighboring cells.\nIt is thought that exosomes may play a role in the spread of Alzheimer's disease pathology throughout the brain, as they can carry APP molecules to other cells and potentially contribute to the formation of amyloid plaques. However, more research is needed to fully understand the role of exosomes in Alzheimer's disease and to develop potential therapeutic strategies that target exosomes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Brain-derived exosomes can carry APP (amyloid precursor protein) molecules.\n2. Exosomes are small vesicles released by cells which can carry proteins, lipids, and nucleic acids.\n3. APP is a protein that is expressed in the brain and involved in the formation of amyloid plaques.\n4. Several studies have shown that exosomes can carry APP molecules and these exosomes can be secreted by brain cells.\n5. Exosomes are thought to possibly play a role in the spread of Alzheimer's disease pathology throughout the brain.",
    "vicuna-13b_fact": [
      "Brain-derived exosomes can carry APP (amyloid precursor protein) molecules.",
      "Exosomes are small vesicles released by cells which can carry proteins, lipids, and nucleic acids.",
      "APP is a protein that is expressed in the brain and involved in the formation of amyloid plaques.",
      "Several studies have shown that exosomes can carry APP molecules and these exosomes can be secreted by brain cells.",
      "Exosomes are thought to possibly play a role in the spread of Alzheimer's disease pathology throughout the brain."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3517,
    "user_query": "Which are the main G1/S transcription factors in yeast?",
    "vicuna-13b_response": "In yeast, the main G1/S transcription factors are:\n1. SBF (Swi/Snf complex binding factor)\n2. MBF (Mbp1/Budding yeast transcription factor)\n3. CBF (CBF complex binding factor)\n4. RBF (Rapamycin-binding factor)\n5. SAGA (Swi/Snf-related adapter guanine nucleotide exchange factor)\nThese transcription factors play important roles in regulating the transition of yeast cells from the G1 phase to the S phase of the cell cycle. They control the expression of genes involved in cell cycle progression, DNA replication, and repair, among other processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. In yeast, the main G1/S transcription factors include SBF (Swi4/Swi6 cell cycle box binding factor), MBF (Mbp1/Swi6 complex), CBF (CBF complex binding factor), RBF (Rapamycin-binding factor), and SAGA (Spt-Ada-Gcn5-acetyltransferase).\n2. These transcription factors are crucial in regulating the transition of yeast cells from the G1 phase to the S phase of the cell cycle.\n3. SBF, MBF, RBF, CBF, and SAGA control the expression of genes involved in cell cycle progression, DNA replication, and repair.",
    "vicuna-13b_fact": [
      "In yeast, the main G1/S transcription factors include SBF (Swi4/Swi6 cell cycle box binding factor), MBF (Mbp1/Swi6 complex), CBF (CBF complex binding factor), RBF (Rapamycin-binding factor), and SAGA (Spt-Ada-Gcn5-acetyltransferase).",
      "These transcription factors are crucial in regulating the transition of yeast cells from the G1 phase to the S phase of the cell cycle.",
      "SBF, MBF, RBF, CBF, and SAGA control the expression of genes involved in cell cycle progression, DNA replication, and repair."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "vicuna-13b_response": "The Hof1-Cyk3 interaction is a protein-protein interaction that occurs in the yeast Saccharomyces cerevisiae. Hof1 is a transcription factor that regulates the expression of genes involved in stress response and metabolism, while Cyk3 is a cyclin-dependent kinase inhibitor that regulates the activity of cyclin-dependent kinases.\nThe Hof1-Cyk3 interaction plays a crucial role in regulating the stress response in yeast. When the cell is exposed to stress, Hof1 is activated and interacts with Cyk3 to inhibit the activity of cyclin-dependent kinases. This inhibition leads to the accumulation of the transcription factor Skn7, which then activates the expression of genes involved in the stress response.\nThe Hof1-Cyk3 interaction also plays a role in regulating metabolism in yeast. When the cell is exposed to nutrient limitation, Hof1-Cyk3 complex formation is induced, which leads to the activation of genes involved in glycolysis and other metabolic pathways.\nOverall, the Hof1-Cyk3 interaction is a critical regulatory mechanism in yeast that helps the cell respond to environmental stress and maintain metabolic homeostasis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Hof1-Cyk3 interaction is a protein-protein interaction that occurs in the yeast Saccharomyces cerevisiae.\n2. Hof1 is a transcription factor that regulates the expression of genes associated with stress response and metabolism.\n3. Cyk3 is a cyclin-dependent kinase inhibitor that regulates the activity of cyclin-dependent kinases.\n4. The Hof1-Cyk3 interaction is involved in regulating stress response and metabolism in Saccharomyces cerevisiae.\n5. When the yeast cell is exposed to nutrient limitation, the Hof1-Cyk3 interaction can trigger the activation of genes involved in glycolysis and other metabolic pathways.",
    "vicuna-13b_fact": [
      "The Hof1-Cyk3 interaction is a protein-protein interaction that occurs in the yeast Saccharomyces cerevisiae.",
      "Hof1 is a transcription factor that regulates the expression of genes associated with stress response and metabolism.",
      "Cyk3 is a cyclin-dependent kinase inhibitor that regulates the activity of cyclin-dependent kinases.",
      "The Hof1-Cyk3 interaction is involved in regulating stress response and metabolism in Saccharomyces cerevisiae.",
      "When the yeast cell is exposed to nutrient limitation, the Hof1-Cyk3 interaction can trigger the activation of genes involved in glycolysis and other metabolic pathways."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3523,
    "user_query": "Is SATB1 positioned close to AT-rich sequences?",
    "vicuna-13b_response": "SATB1 (Special AT-rich sequence-binding protein 1) is a transcription factor that plays a role in regulating the expression of genes involved in various cellular processes, including cell growth and differentiation. While SATB1 has been shown to bind to various DNA sequences, it is not specifically positioned close to AT-rich sequences.\nIn fact, SATB1 has been shown to bind to a wide range of DNA sequences, including both AT-rich and GC-rich sequences, as well as more complex DNA structures such as hairpins and cruciforms. The specific DNA sequences to which SATB1 binds depend on the context of the surrounding chromatin environment and the specific target gene that is being regulated.\nTherefore, while SATB1 may bind to AT-rich sequences in some contexts, it is not positioned specifically close to AT-rich sequences in general.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SATB1 (Special AT-rich sequence-binding protein 1) is a transcription factor.\n2. SATB1 plays a role in regulating the expression of genes involved in cell growth and differentiation.\n3. SATB1 has been shown to bind to various DNA sequences.\n4. SATB1 can bind to both AT-rich and GC-rich sequences, and more complex DNA structures such as hairpins and cruciforms.\n5. The specific DNA sequences to which SATB1 binds depend on the context of the surrounding chromatin environment and the specific target gene that is being regulated.",
    "vicuna-13b_fact": [
      "SATB1 (Special AT-rich sequence-binding protein 1) is a transcription factor.",
      "SATB1 plays a role in regulating the expression of genes involved in cell growth and differentiation.",
      "SATB1 has been shown to bind to various DNA sequences.",
      "SATB1 can bind to both AT-rich and GC-rich sequences, and more complex DNA structures such as hairpins and cruciforms.",
      "The specific DNA sequences to which SATB1 binds depend on the context of the surrounding chromatin environment and the specific target gene that is being regulated."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3526,
    "user_query": "What is known about PAI-1 in longevity in humans?",
    "vicuna-13b_response": "PAI-1, or plasminogen activator inhibitor-1, is a protein that plays a role in regulating the activity of plasmin, a protein that helps to break down blood clots. There is some evidence to suggest that PAI-1 may be involved in the aging process and may have an impact on longevity in humans.\nStudies have shown that higher levels of PAI-1 are associated with an increased risk of cardiovascular disease, which is a major cause of death and disability in older adults. Additionally, some research has suggested that PAI-1 may play a role in the development of certain types of cancer, which are also major causes of death in older adults.\nHowever, it is important to note that the relationship between PAI-1 and longevity is complex and not fully understood. Some studies have suggested that higher levels of PAI-1 may actually be protective against certain diseases, while others have found no association between PAI-1 and longevity.\nOverall, more research is needed to fully understand the role of PAI-1 in the aging process and its impact on longevity in humans.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PAI-1, or plasminogen activator inhibitor-1, is a protein that plays a role in regulating the activity of plasmin.\n2. Plasmin helps to break down blood clots.\n3. Higher levels of PAI-1 are associated with an increased risk of cardiovascular disease.\n4. PAI-1 may play a role in the development of certain types of cancer.\n5. The relationship between PAI-1 and longevity is complex and not fully understood.",
    "vicuna-13b_fact": [
      "PAI-1, or plasminogen activator inhibitor-1, is a protein that plays a role in regulating the activity of plasmin.",
      "Plasmin helps to break down blood clots.",
      "Higher levels of PAI-1 are associated with an increased risk of cardiovascular disease.",
      "PAI-1 may play a role in the development of certain types of cancer.",
      "The relationship between PAI-1 and longevity is complex and not fully understood."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3530,
    "user_query": "What bacteria is associated with Gastric cancer and peptic ulcers?",
    "vicuna-13b_response": "Helicobacter pylori (H. pylori) is a type of bacteria that is associated with gastric cancer and peptic ulcers. H. pylori is a gram-negative bacteria that colonizes the stomach and is found to be present in about 50% of cases of gastric cancer and 90% of cases of peptic ulcers. It is also a major risk factor for the development of gastric lymphoma and MALT lymphoma. Eradication of H. pylori has been shown to reduce the risk of gastric cancer and peptic ulcers.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Helicobacter pylori (H. pylori) is a type of bacteria that is associated with gastric cancer and peptic ulcers.\n2. H. pylori is a gram-negative bacteria that colonizes the stomach.\n3. H. pylori is found to be present in about 50% of cases of gastric cancer and 90% of cases of peptic ulcers.\n4. H. pylori is a major risk factor for the development of gastric lymphoma and MALT lymphoma.\n5. Eradication of H. pylori has been shown to reduce the risk of gastric cancer and peptic ulcers.",
    "vicuna-13b_fact": [
      "Helicobacter pylori (H. pylori) is a type of bacteria that is associated with gastric cancer and peptic ulcers.",
      "H. pylori is a gram-negative bacteria that colonizes the stomach.",
      "H. pylori is found to be present in about 50% of cases of gastric cancer and 90% of cases of peptic ulcers.",
      "H. pylori is a major risk factor for the development of gastric lymphoma and MALT lymphoma.",
      "Eradication of H. pylori has been shown to reduce the risk of gastric cancer and peptic ulcers."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The prevalence of H. pylori in cases of gastric cancer and peptic ulcers is a significant portion, but the exact percentages can vary among different studies and populations.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3532,
    "user_query": "What is the purpose of the 123 dihydrorhodamine assay?",
    "vicuna-13b_response": "The 123 dihydrorhodamine (DHR) assay is a method used to measure the antioxidant activity of a sample. It is a colorimetric assay that measures the ability of a sample to reduce 123 dihydrorhodamine, a fluorescent dye, to its non-fluorescent form. The assay is based on the reaction between the dye and hydrogen peroxide (H2O2), which generates singlet oxygen (1O2). The singlet oxygen reacts with the dye, causing it to lose its fluorescence. Antioxidants present in the sample can scavenge the singlet oxygen, preventing its reaction with the dye and preserving the fluorescence of the dye. By measuring the fluorescence of the dye, the antioxidant activity of the sample can be determined.\nThe 123 DHR assay is commonly used to evaluate the antioxidant activity of various samples, such as foods, beverages, and pharmaceuticals. It is also used to evaluate the efficacy of antioxidant compounds and to determine the antioxidant capacity of a sample. The assay is sensitive and specific, and can be used to measure the antioxidant activity of a wide range of samples. It is a useful tool for studying the role of antioxidants in various biological processes and for evaluating the antioxidant content of different samples.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The 123 dihydrorhodamine (DHR) assay is a method used to measure the antioxidant activity of a sample. \n2. This is a colorimetric assay that measures the ability of a sample to reduce 123 dihydrorhodamine, a fluorescent dye, to its non-fluorescent form. \n3. The assay is based on the reaction between the dye and hydrogen peroxide (H2O2), which generates singlet oxygen (1O2). \n4. The 123 DHR assay is used to evaluate the antioxidant activity of various samples, such as foods, beverages, and pharmaceuticals. \n5. The 123-DHR assay can be used to measure the antioxidant activity of a wide range of samples and is a useful tool for studying the role of antioxidants in various biological processes.",
    "vicuna-13b_fact": [
      "The 123 dihydrorhodamine (DHR) assay is a method used to measure the antioxidant activity of a sample.",
      "This is a colorimetric assay that measures the ability of a sample to reduce 123 dihydrorhodamine, a fluorescent dye, to its non-fluorescent form.",
      "The assay is based on the reaction between the dye and hydrogen peroxide (H2O2), which generates singlet oxygen (1O2).",
      "The 123 DHR assay is used to evaluate the antioxidant activity of various samples, such as foods, beverages, and pharmaceuticals.",
      "The 123-DHR assay can be used to measure the antioxidant activity of a wide range of samples and is a useful tool for studying the role of antioxidants in various biological processes."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3533,
    "user_query": "What is the mode of action of filgotinib?",
    "vicuna-13b_response": "Filgotinib is a drug that is used to treat autoimmune diseases such as rheumatoid arthritis. Its mode of action is by inhibiting the activity of a protein called JAK1 (Janus kinase 1), which is involved in the signaling pathways that regulate the activity of immune cells, including T cells and B cells. By inhibiting JAK1, filgotinib reduces the activity of these immune cells, which leads to a reduction in inflammation and other symptoms of autoimmune diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Filgotinib is used to treat autoimmune diseases such as rheumatoid arthritis.\n2. Filgotinib functions by inhibiting the activity of a protein called JAK1 (Janus kinase 1).\n3. JAK1 is involved in the signaling pathways that regulate the activity of immune cells.\n4. The cells regulated by JAK1 include T cells and B cells.\n5. By inhibiting JAK1, filgotinib reduces the inflammation and other symptoms of autoimmune diseases.",
    "vicuna-13b_fact": [
      "Filgotinib is used to treat autoimmune diseases such as rheumatoid arthritis.",
      "Filgotinib functions by inhibiting the activity of a protein called JAK1 (Janus kinase 1).",
      "JAK1 is involved in the signaling pathways that regulate the activity of immune cells.",
      "The cells regulated by JAK1 include T cells and B cells.",
      "By inhibiting JAK1, filgotinib reduces the inflammation and other symptoms of autoimmune diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3535,
    "user_query": "What is RiboTag profiling?",
    "vicuna-13b_response": "RiboTag profiling is a method used to study the translation and protein synthesis of ribosomes in cells. It involves the use of small molecule inhibitors called RiboTags, which are incorporated into newly synthesized proteins during translation. These inhibitors are designed to be cleaved by proteases, which releases a fluorescent or biotinylated tag that can be detected and visualized in the cell.\nThe RiboTag profiling method allows researchers to track the movement and activity of ribosomes in cells, as well as to identify the specific proteins being synthesized by these ribosomes. This information can be used to study the regulation of gene expression, protein synthesis, and the role of ribosomes in cellular processes.\nRiboTag profiling can be performed in a variety of cell types, including bacteria, yeast, and mammalian cells, and can be used to study both steady-state and dynamic processes in cells. The method has been widely used to study the effects of drugs and other small molecules on protein synthesis and ribosome function, as well as to study the role of ribosomes in cellular processes such as cell cycle progression and stress responses.\nOverall, RiboTag profiling is a powerful tool for studying the translation and protein synthesis of ribosomes in cells, and has provided valuable insights into the regulation of gene expression and cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. RiboTag profiling is a method used to study the translation and protein synthesis of ribosomes in cells.\n2. The method involves the use of small molecule inhibitors called RiboTags.\n3. The RiboTag profiling method allows researchers to track the movement and activity of ribosomes in cells.\n4. RiboTag profiling can be performed in a variety of cell types including bacteria, yeast, and mammalian cells.\n5. RiboTag profiling is used to study the effects of drugs and small molecules on protein synthesis and ribosome function.",
    "vicuna-13b_fact": [
      "RiboTag profiling is a method used to study the translation and protein synthesis of ribosomes in cells.",
      "The method involves the use of small molecule inhibitors called RiboTags.",
      "The RiboTag profiling method allows researchers to track the movement and activity of ribosomes in cells.",
      "RiboTag profiling can be performed in a variety of cell types including bacteria, yeast, and mammalian cells.",
      "RiboTag profiling is used to study the effects of drugs and small molecules on protein synthesis and ribosome function."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The method involves an allele expressing an epitope-tagged form of ribosomal protein L22, not small molecule inhibitors called RiboTags.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3537,
    "user_query": "What is foliglurax?",
    "vicuna-13b_response": "Foliglurax is a medication that is used to treat certain types of cancer. It is a chemotherapy drug that belongs to a class of medications called alkylating agents. Foliglurax is used to treat various types of cancer, including non-Hodgkin lymphoma, multiple myeloma, and ovarian cancer. It works by damaging the DNA of cancer cells, which prevents them from dividing and growing. Foliglurax is usually administered intravenously, and the dosage and frequency of treatment will depend on the specific type of cancer being treated and the individual patient's medical history. Common side effects of Foliglurax may include nausea, vomiting, and hair loss. It is important to follow the instructions of your healthcare provider regarding the use of Foliglurax.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Foliglurax is a medication used to treat certain types of cancer.\n2. Foliglurax is a chemotherapy drug that belongs to a class of medications called alkylating agents.\n3. Foliglurax is used to treat non-Hodgkin lymphoma, multiple myeloma, and ovarian cancer.\n4. Foliglurax works by damaging the DNA of cancer cells, which prevents them from dividing and growing.\n5. Common side effects of Foliglurax may include nausea, vomiting, and hair loss.",
    "vicuna-13b_fact": [
      "Foliglurax is a medication used to treat certain types of cancer.",
      "Foliglurax is a chemotherapy drug that belongs to a class of medications called alkylating agents.",
      "Foliglurax is used to treat non-Hodgkin lymphoma, multiple myeloma, and ovarian cancer.",
      "Foliglurax works by damaging the DNA of cancer cells, which prevents them from dividing and growing.",
      "Common side effects of Foliglurax may include nausea, vomiting, and hair loss."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3549,
    "user_query": "List symptoms of Allgrove syndrome.",
    "vicuna-13b_response": "Allgrove syndrome is a rare genetic disorder that affects the development of the kidneys and other organs. Some of the symptoms of Allgrove syndrome include:\n1. Renal Fibrosis: It is a condition in which the kidneys become scarred and stiff, leading to decreased kidney function.\n2. Hypoparathyroidism: It is a condition in which the parathyroid glands do not produce enough parathyroid hormone, which is essential for maintaining healthy bones and teeth.\n3. Hypocalcemia: It is a condition in which the body does not have enough calcium, which is essential for many functions in the body, including muscle contraction, nerve function, and blood clotting.\n4. Nephrocalcinosis: It is a condition in which there is abnormal deposit of calcium in the kidneys, which can lead to kidney damage.\n5. Hyperphosphatemia: It is a condition in which there is an abnormally high level of phosphorus in the blood.\n6. Chronic Kidney Disease: It is a condition in which the kidneys gradually lose their function over time, leading to kidney failure.\n7. Short stature: People with Allgrove syndrome tend to be shorter than average.\n8. Developmental delay: People with Allgrove syndrome may experience developmental delay, which is a term used to describe a delay in reaching certain milestones, such as crawling, walking, or talking.\nIt is important to note that not everyone with Allgrove syndrome will experience all of these symptoms, and the severity of the symptoms can vary from person to person. If you have any concerns about Allgrove syndrome or any of its symptoms, it is important to speak with a healthcare provider.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Allgrove syndrome is a rare genetic disorder that affects the development of the kidneys and other organs.\n2. Renal Fibrosis, a condition where the kidneys become scarred and stiff, leading to decreased kidney function, is a symptom of Allgrove syndrome.\n3. Hypoparathyroidism, a condition in which the parathyroid glands do not produce enough parathyroid hormone, is a symptom of Allgrove syndrome.\n4. Hypocalcemia, a condition in which the body does not have enough calcium, is a symptom of Allgrove syndrome.\n5. Nephrocalcinosis, a condition in which there is abnormal deposit of calcium in the kidneys, is a symptom of Allgrove syndrome.",
    "vicuna-13b_fact": [
      "Allgrove syndrome is a rare genetic disorder that affects the development of the kidneys and other organs.",
      "Renal Fibrosis, a condition where the kidneys become scarred and stiff, leading to decreased kidney function, is a symptom of Allgrove syndrome.",
      "Hypoparathyroidism, a condition in which the parathyroid glands do not produce enough parathyroid hormone, is a symptom of Allgrove syndrome.",
      "Hypocalcemia, a condition in which the body does not have enough calcium, is a symptom of Allgrove syndrome.",
      "Nephrocalcinosis, a condition in which there is abnormal deposit of calcium in the kidneys, is a symptom of Allgrove syndrome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Allgrove syndrome, also known as Triple A syndrome, is a rare genetic disorder that primarily affects the nervous system and adrenal glands, not the kidneys.\n2. FALSE [correction]: Renal Fibrosis is not a recognized symptom of Allgrove syndrome.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3551,
    "user_query": "How do the plasma concentrations of amantadine extended release and amantadine immediate release compare?",
    "vicuna-13b_response": "Amantadine extended release and amantadine immediate release are two different formulations of the same drug, amantadine. The extended release formulation is designed to release the drug slowly over an extended period of time, while the immediate release formulation releases the drug more quickly.\nThe plasma concentration of a drug is a measure of the amount of the drug present in the bloodstream. The plasma concentration of amantadine extended release and amantadine immediate release may differ due to the different release profiles of the two formulations. The extended release formulation will likely result in a lower peak plasma concentration and a longer duration of action compared to the immediate release formulation.\nIt is important to note that the plasma concentration of a drug can be influenced by a variety of factors, including the dose and frequency of administration, the patient's age, weight, and liver and kidney function, and any other medications the patient is taking. Therefore, the plasma concentration of amantadine extended release and amantadine immediate release may vary depending on these factors.\nIn conclusion, the plasma concentration of amantadine extended release and amantadine immediate release may differ due to the different release profiles of the two formulations. However, the actual plasma concentration will depend on various individual factors and cannot be determined without considering these factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Amantadine extended release and amantadine immediate release are two different formulations of the same drug.\n2. The extended release formulation is designed to release the drug slowly over an extended period of time.\n3. The immediate release formulation releases the drug more quickly.\n4. The plasma concentration of a drug is a measure of the amount of the drug present in the bloodstream.\n5. The plasma concentration of a drug can be influenced by a variety of factors, including the dose and frequency of administration, the patient's age, weight, liver and kidney function, and any other medications the patient is taking.",
    "vicuna-13b_fact": [
      "Amantadine extended release and amantadine immediate release are two different formulations of the same drug.",
      "The extended release formulation is designed to release the drug slowly over an extended period of time.",
      "The immediate release formulation releases the drug more quickly.",
      "The plasma concentration of a drug is a measure of the amount of the drug present in the bloodstream.",
      "The plasma concentration of a drug can be influenced by a variety of factors, including the dose and frequency of administration, the patient's age, weight, liver and kidney function, and any other medications the patient is taking."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3554,
    "user_query": "Which drugs are included in GI cocktail?",
    "vicuna-13b_response": "The GI cocktail is a combination of drugs used to treat gastrointestinal (GI) disorders. The specific drugs included in the GI cocktail may vary depending on the individual patient and their specific condition, but some common drugs that may be included in the GI cocktail include:\n1. Metoclopramide: This drug is used to treat GI disorders such as gastroparesis, which is a condition where the stomach muscles are weakened and the stomach cannot empty food properly.\n2. Domperidone: Similar to metoclopramide, domperidone is used to treat gastroparesis and other GI disorders.\n3. Loperamide: This drug is used to treat diarrhea by slowing down the movement of the intestines.\n4. Cimetidine: This drug is used to treat GI disorders such as heartburn, acid reflux, and stomach ulcers.\n5. Ranitidine: Similar to cimetidine, ranitidine is used to treat GI disorders such as heartburn, acid reflux, and stomach ulcers.\n6. Antibiotics: Depending on the specific GI disorder being treated, antibiotics may be included in the GI cocktail to help prevent or treat infections caused by bacteria.\nIt's important to note that the use of these drugs in the GI cocktail should only be done under the guidance of a healthcare professional, as they may have potential side effects and interactions with other medications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The GI cocktail is a combination of drugs used to treat gastrointestinal disorders.\n2. Metoclopramide is a drug used to treat gastrointestinal disorders such as gastroparesis.\n3. Domperidone is also used to treat gastrointestinal disorders like gastroparesis.\n4. Loperamide is a drug used to treat diarrhea.\n5. Cimetidine and ranitidine are both drugs used to treat heartburn, acid reflux, and stomach ulcers.\n6. The use of these drugs in the GI cocktail should be done under the guidance of a healthcare professional.",
    "vicuna-13b_fact": [
      "The GI cocktail is a combination of drugs used to treat gastrointestinal disorders.",
      "Metoclopramide is a drug used to treat gastrointestinal disorders such as gastroparesis.",
      "Domperidone is also used to treat gastrointestinal disorders like gastroparesis.",
      "Loperamide is a drug used to treat diarrhea.",
      "Cimetidine and ranitidine are both drugs used to treat heartburn, acid reflux, and stomach ulcers.",
      "The use of these drugs in the GI cocktail should be done under the guidance of a healthcare professional."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3555,
    "user_query": "Is AZD5153 active in prostate cancer?",
    "vicuna-13b_response": "AZD5153 is a drug that is being studied for its potential to treat prostate cancer. It is a type of drug called a \"PI3K delta inhibitor,\" which works by blocking a protein called PI3K delta that is involved in cell growth and survival.\nStudies have shown that AZD5153 may have activity against certain types of prostate cancer cells, particularly those that are resistant to other types of treatments. However, more research is needed to fully understand its effectiveness and safety in treating prostate cancer.\nIt's important to note that AZD5153 is not currently approved by the FDA for the treatment of prostate cancer, and clinical trials are ongoing to further evaluate its potential as a treatment for this disease. If you are interested in participating in a clinical trial for prostate cancer, it's important to speak with your doctor or a medical professional to determine if you may be eligible.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. AZD5153 is a drug being studied for its potential to treat prostate cancer.\n2. AZD5153 is a type of drug called a \"PI3K delta inhibitor\".\n3. PI3K delta inhibitor drugs work by blocking a protein called PI3K delta involved in cell growth and survival.\n4. AZD5153 is not currently approved by the FDA for the treatment of prostate cancer.\n5. Clinical trials on AZD5153 for treating prostate cancer are ongoing.",
    "vicuna-13b_fact": [
      "AZD5153 is a drug being studied for its potential to treat prostate cancer.",
      "AZD5153 is a type of drug called a \"PI3K delta inhibitor\".",
      "PI3K delta inhibitor drugs work by blocking a protein called PI3K delta involved in cell growth and survival.",
      "AZD5153 is not currently approved by the FDA for the treatment of prostate cancer.",
      "Clinical trials on AZD5153 for treating prostate cancer are ongoing."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: AZD5153 is a type of drug called a \"BET bromodomain inhibitor\".\n3. FALSE [correction]: BET bromodomain inhibitor drugs like AZD5153 work by interfering with the function of BET proteins, which are involved in gene expression.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3556,
    "user_query": "Is GRG5 involved only in late embryonic mouse development?",
    "vicuna-13b_response": "The protein GRG5 is involved in various cellular processes, including cell growth and differentiation, and has been studied in various organisms, including mice.\nIn mice, GRG5 has been shown to play a role in late embryonic development, specifically in the development of the central nervous system. Studies have shown that mice lacking GRG5 have abnormal brain development and do not survive past birth.\nHowever, it is important to note that the function of GRG5 may also vary in different organisms and tissues, and further research is needed to fully understand its role in cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The protein GRG5 is involved in cellular processes such as cell growth and differentiation.\n2. GRG5 plays a role in late embryonic development of mice.\n3. Specifically, GRG5 contributes to the development of the central nervous system in mice.\n4. Mice lacking GRG5 have abnormal brain development and do not survive past birth.\n5. The function of GRG5 may vary in different organisms and tissues.",
    "vicuna-13b_fact": [
      "The protein GRG5 is involved in cellular processes such as cell growth and differentiation.",
      "GRG5 plays a role in late embryonic development of mice.",
      "Specifically, GRG5 contributes to the development of the central nervous system in mice.",
      "Mice lacking GRG5 have abnormal brain development and do not survive past birth.",
      "The function of GRG5 may vary in different organisms and tissues."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3558,
    "user_query": "Describe the mechanism of action of a drug Elagolix.",
    "vicuna-13b_response": "Elagolix is a medication that is used to treat women with heavy menstrual bleeding. It works by blocking the action of a hormone called gonadotropin-releasing hormone (GnRH) in the body. GnRH is a hormone that stimulates the production of other hormones, including luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which play a role in the regulation of menstrual bleeding. By blocking the action of GnRH, Elagolix reduces the production of LH and FSH, which in turn reduces the amount of bleeding during menstruation. Elagolix is taken as a pill, and the effects of the medication can be seen within a few days of starting treatment. It is usually taken for a period of 6 to 12 months, depending on the individual patient's needs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Elagolix is a medication used to treat women with heavy menstrual bleeding.\n2. Elagolix works by blocking the action of gonadotropin-releasing hormone (GnRH) in the body.\n3. GnRH stimulates the production of other hormones, including luteinizing hormone (LH) and follicle-stimulating hormone (FSH).\n4. By blocking the action of GnRH, Elagolix reduces the production of LH and FSH, thereby reducing menstrual bleeding.\n5. Elagolix is usually taken for a period of 6 to 12 months, depending on the individual patient's needs.",
    "vicuna-13b_fact": [
      "Elagolix is a medication used to treat women with heavy menstrual bleeding.",
      "Elagolix works by blocking the action of gonadotropin-releasing hormone (GnRH) in the body.",
      "GnRH stimulates the production of other hormones, including luteinizing hormone (LH) and follicle-stimulating hormone (FSH).",
      "By blocking the action of GnRH, Elagolix reduces the production of LH and FSH, thereby reducing menstrual bleeding.",
      "Elagolix is usually taken for a period of 6 to 12 months, depending on the individual patient's needs."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Elagolix is a medication used to treat moderate to severe pain associated with endometriosis.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3567,
    "user_query": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?",
    "vicuna-13b_response": "CRISPR/Cas9 knockout screens are a commonly used tool in genetic research to study the function of genes. There are several algorithms that have been developed for analyzing the data generated from these screens. Here are a few examples:\n1. Deep learning algorithms: Deep learning algorithms, such as neural networks, can be used to analyze gene expression data generated from CRISPR/Cas9 knockout screens. These algorithms can identify patterns and relationships in the data, and can be used to predict the function of unknown genes.\n2. Machine learning algorithms: Machine learning algorithms, such as decision trees and support vector machines, can be used to analyze CRISPR/Cas9 knockout screens data and identify genes that are associated with specific phenotypes. These algorithms can also be used to identify potential drug targets.\n3. Clustering algorithms: Clustering algorithms, such as k-means clustering and hierarchical clustering, can be used to group genes based on their expression patterns in CRISPR/Cas9 knockout screens. This can help identify functional modules and pathways in the cell.\n4. Pathway analysis tools: Pathway analysis tools, such as Ingenuity Pathway Analysis and DAVID, can be used to analyze CRISPR/Cas9 knockout screens data and identify the pathways and biological processes that are affected by the knockout of a particular gene.\n5. Expression quantitative trait loci (eQTL) analysis: eQTL analysis can be used to analyze the relationship between gene expression and genetic variation in CRISPR/Cas9 knockout screens data. This can help identify genetic variants that are associated with changes in gene expression and can provide insights into the mechanisms underlying gene regulation.\nThese are just a few examples of the algorithms that can be used for analyzing CRISPR/Cas9 knockout screens data. The choice of algorithm will depend on the specific research question and the type of data that is available.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CRISPR/Cas9 knockout screens are used in genetic research to study the function of genes.\n2. Deep learning algorithms can be used to analyze gene expression data from CRISPR/Cas9 knockout screens.\n3. Machine learning algorithms, like decision trees and support vector machines, can be applied to identify genes associated with specific phenotypes in CRISPR/Cas9 knockout screens data.\n4. Clustering algorithms, such as k-means clustering and hierarchical clustering, are used to group genes based on their expression patterns in CRISPR/Cas9 knockout screens.\n5. Pathway analysis tools, including Ingenuity Pathway Analysis and DAVID, can be utilized to analyze CRISPR/Cas9 knockout screens data and identify affected pathways and biological processes.\n6. Expression quantitative trait loci (eQTL) analysis can be employed to analyze the relationship between gene expression and genetic variation in CRISPR/Cas9 knockout screens data.",
    "vicuna-13b_fact": [
      "CRISPR/Cas9 knockout screens are used in genetic research to study the function of genes.",
      "Deep learning algorithms can be used to analyze gene expression data from CRISPR/Cas9 knockout screens.",
      "Machine learning algorithms, like decision trees and support vector machines, can be applied to identify genes associated with specific phenotypes in CRISPR/Cas9 knockout screens data.",
      "Clustering algorithms, such as k-means clustering and hierarchical clustering, are used to group genes based on their expression patterns in CRISPR/Cas9 knockout screens.",
      "Pathway analysis tools, including Ingenuity Pathway Analysis and DAVID, can be utilized to analyze CRISPR/Cas9 knockout screens data and identify affected pathways and biological processes.",
      "Expression quantitative trait loci (eQTL) analysis can be employed to analyze the relationship between gene expression and genetic variation in CRISPR/Cas9 knockout screens data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. FALSE [correction]: Expression quantitative trait loci (eQTL) analysis is used to analyze the relationship between gene expression and genetic variation, but it isn't typically applied in the context of CRISPR/Cas9 knockout screens data.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3569,
    "user_query": "PDQ39 questionnaires is design for which disease?",
    "vicuna-13b_response": "PDQ39 questionnaires are designed to assess the severity of cancer-related symptoms in patients with cancer. The questionnaires are used to evaluate the symptoms and side effects of cancer and its treatment, and to track changes in symptoms over time. The PDQ39 questionnaires are a set of validated, standardized questionnaires that are widely used in cancer clinical trials and in routine cancer care to assess the severity of symptoms such as nausea, fatigue, pain, and breathlessness. The questionnaires are also used to evaluate the effectiveness of interventions to manage these symptoms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PDQ39 questionnaires are designed to assess the severity of cancer-related symptoms.\n2. PDQ39 questionnaires are used in cancer clinical trials.\n3. PDQ39 questionnaires are employed in routine cancer care.\n4. The PDQ39 questionnaires are standardized and validated.\n5. They are used to track changes in symptoms over time and assess the effectiveness of interventions.",
    "vicuna-13b_fact": [
      "PDQ39 questionnaires are designed to assess the severity of cancer-related symptoms.",
      "PDQ39 questionnaires are used in cancer clinical trials.",
      "PDQ39 questionnaires are employed in routine cancer care.",
      "The PDQ39 questionnaires are standardized and validated.",
      "They are used to track changes in symptoms over time and assess the effectiveness of interventions."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: PDQ39 questionnaires are designed to assess the quality of life of patients with Parkinson's disease.\n2. FALSE [correction]: PDQ39 questionnaires are not specifically used in cancer clinical trials, they are used for patients with Parkinson's disease.\n3. FALSE [correction]: PDQ39 questionnaires are not used in routine cancer care, but are used in routine care for patients with Parkinson's disease.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3570,
    "user_query": "Is palbociclib effective for glioblastoma?",
    "vicuna-13b_response": "Palbociclib is a targeted therapy drug that is primarily used to treat breast cancer. It is not typically used to treat glioblastoma, which is a type of brain cancer. While some research has been done on the use of palbociclib in treating other types of cancer, such as lung cancer and ovarian cancer, the results have been mixed and the drug is not currently approved for use in treating these cancers. It is important to note that glioblastoma is a highly aggressive and difficult-to-treat cancer, and there are currently limited treatment options available. It is always best to consult with a healthcare professional for the most up-to-date and accurate information on the use of any medication for a specific medical condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Palbociclib is a targeted therapy drug primarily used to treat breast cancer.\n2. Palbociclib is not typically used to treat glioblastoma, a type of brain cancer.\n3. Some research has been done on the use of palbociclib in treating other types of cancer.\n4. The results of using palbociclib to treat cancers such as lung and ovarian have been mixed.\n5. Palbociclib is not currently approved for use in treating lung cancer and ovarian cancer.",
    "vicuna-13b_fact": [
      "Palbociclib is a targeted therapy drug primarily used to treat breast cancer.",
      "Palbociclib is not typically used to treat glioblastoma, a type of brain cancer.",
      "Some research has been done on the use of palbociclib in treating other types of cancer.",
      "The results of using palbociclib to treat cancers such as lung and ovarian have been mixed.",
      "Palbociclib is not currently approved for use in treating lung cancer and ovarian cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3572,
    "user_query": "Does the Mcm2-Ctf4-Polα axis play a role in transfer of histones to leading strand DNA at the replication forks?",
    "vicuna-13b_response": "Yes, the Mcm2-Ctf4-Polα axis plays a crucial role in transferring histones to the leading strand DNA at the replication forks. The Mcm2-Ctf4-Polα complex is a key component of the replication fork, and it is responsible for unwinding the double helix and separating the two strands. During this process, the complex transfers histones to the leading strand DNA, which helps to compact the DNA and form the nucleosome structure.\nThe Mcm2-Ctf4-Polα complex is composed of several subunits, including Mcm2, Ctf4, and Polα. Mcm2 and Ctf4 are required for the assembly of the complex, while Polα is responsible for the polymerization activity that is necessary for DNA replication.\nThe transfer of histones to the leading strand DNA is a crucial step in the replication process, as it helps to stabilize the DNA and prevent it from rewinding. Without the proper transfer of histones, the replication fork would not be able to progress, and DNA replication would be impaired.\nIn summary, the Mcm2-Ctf4-Polα axis plays a crucial role in transferring histones to the leading strand DNA at the replication forks, which is necessary for the stability and progression of the replication fork.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Mcm2-Ctf4-Polα axis plays a role in transferring histones to the leading strand DNA at the replication forks.\n2. The Mcm2-Ctf4-Polα complex is a key component of the replication fork.\n3. The Mcm2-Ctf4-Polα complex is composed of several subunits, including Mcm2, Ctf4, and Polα.\n4. Mcm2 and Ctf4 are required for the assembly of the Mcm2-Ctf4-Polα complex.\n5. The transfer of histones to the leading strand DNA is a crucial step in the replication process.",
    "vicuna-13b_fact": [
      "The Mcm2-Ctf4-Polα axis plays a role in transferring histones to the leading strand DNA at the replication forks.",
      "The Mcm2-Ctf4-Polα complex is a key component of the replication fork.",
      "The Mcm2-Ctf4-Polα complex is composed of several subunits, including Mcm2, Ctf4, and Polα.",
      "Mcm2 and Ctf4 are required for the assembly of the Mcm2-Ctf4-Polα complex.",
      "The transfer of histones to the leading strand DNA is a crucial step in the replication process."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3574,
    "user_query": "Which gene is frequently involved in autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)?",
    "vicuna-13b_response": "Autosomal dominant adult-onset demyelinating leukodystrophy (ADLD) is a rare genetic disorder that affects the central nervous system. It is characterized by progressive damage to the myelin sheath, which surrounds and protects nerve fibers. The myelin sheath is essential for the proper functioning of the nervous system, and its damage can lead to a range of neurological symptoms, including difficulty with movement, coordination, and cognitive function.\nThere are several genes that have been identified as being frequently involved in ADLD. One of the most commonly implicated genes is the PLP1 gene, which is located on chromosome 1. This gene provides instructions for making a protein called proteolipid protein 1, which is an important component of the myelin sheath. Mutations in the PLP1 gene have been shown to cause ADLD, as well as other forms of leukodystrophy.\nOther genes that have been associated with ADLD include the MTMR14 gene, which is located on chromosome 16, and the ZFYVE26 gene, which is located on chromosome 19. These genes also provide instructions for proteins that are involved in the development and maintenance of the myelin sheath.\nIt is important to note that ADLD is a rare condition, and the specific gene involved in an individual case can vary. A diagnosis of ADLD is typically made through a combination of clinical evaluation, genetic testing, and other diagnostic procedures.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Autosomal dominant adult-onset demyelinating leukodystrophy (ADLD) is a rare genetic disorder that affects the central nervous system.\n2. The PLP1 gene, located on chromosome 1, is commonly implicated in ADLD. \n3. The PLP1 gene provides instructions for making a protein called proteolipid protein 1, which is an important component of the myelin sheath.\n4. Mutations in the PLP1 gene have been shown to cause ADLD.\n5. Other genes that have been associated with ADLD include the MTMR14 gene, located on chromosome 16, and the ZFYVE26 gene, located on chromosome 19.",
    "vicuna-13b_fact": [
      "Autosomal dominant adult-onset demyelinating leukodystrophy (ADLD) is a rare genetic disorder that affects the central nervous system.",
      "The PLP1 gene, located on chromosome 1, is commonly implicated in ADLD.",
      "The PLP1 gene provides instructions for making a protein called proteolipid protein 1, which is an important component of the myelin sheath.",
      "Mutations in the PLP1 gene have been shown to cause ADLD.",
      "Other genes that have been associated with ADLD include the MTMR14 gene, located on chromosome 16, and the ZFYVE26 gene, located on chromosome 19."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The LMNB1 gene, not the PLP1 gene, located on chromosome 5, is commonly implicated in ADLD.\n3. TRUE\n4. FALSE [correction]: Mutations in the LMNB1 gene, not the PLP1 gene, have been shown to cause ADLD.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3577,
    "user_query": "Which is the main epigenetic difference between poised and constitutive enhancers?",
    "vicuna-13b_response": "Poised enhancers and constitutive enhancers are two different types of regulatory elements that play important roles in controlling gene expression in cells. The main epigenetic difference between these two types of enhancers is the way in which they are activated and the timing of their activity.\nPoised enhancers are regulatory elements that are primed and ready to activate gene expression in response to specific signals or conditions. These enhancers are typically associated with open chromatin structure and have a low level of histone modification, such as histone H3 lysine 4 trimethylation (H3K4me3), which is a mark of active enhancers. Poised enhancers require additional signals or inputs to become activated and initiate gene expression.\nConstitutive enhancers, on the other hand, are regulatory elements that are constantly active and do not require additional signals or inputs to initiate gene expression. These enhancers are typically associated with a closed chromatin structure and have a high level of histone modification, such as H3K4me3, which is a mark of active enhancers. Constitutive enhancers are involved in maintaining the expression of certain genes under steady-state conditions and are not dependent on specific signals or inputs.\nIn summary, the main epigenetic difference between poised and constitutive enhancers is the timing of their activity. Poised enhancers are primed and ready to activate gene expression in response to specific signals or conditions, while constitutive enhancers are constantly active and do not require additional signals or inputs to initiate gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Poised enhancers are regulatory elements that are primed and ready to activate gene expression in response to specific signals or conditions.\n2. Poised enhancers are typically associated with open chromatin structure and have a low level of histone H3 lysine 4 trimethylation (H3K4me3).\n3. Constitutive enhancers are regulatory elements that are constantly active and do not require additional signals or inputs to initiate gene expression.\n4. Constitutive enhancers are typically associated with a closed chromatin structure and have a high level of histone modification, such as H3K4me3.\n5. The main epigenetic difference between poised and constitutive enhancers is the timing of their activity.",
    "vicuna-13b_fact": [
      "Poised enhancers are regulatory elements that are primed and ready to activate gene expression in response to specific signals or conditions.",
      "Poised enhancers are typically associated with open chromatin structure and have a low level of histone H3 lysine 4 trimethylation (H3K4me3).",
      "Constitutive enhancers are regulatory elements that are constantly active and do not require additional signals or inputs to initiate gene expression.",
      "Constitutive enhancers are typically associated with a closed chromatin structure and have a high level of histone modification, such as H3K4me3.",
      "The main epigenetic difference between poised and constitutive enhancers is the timing of their activity."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Constitutive enhancers are typically associated with an open chromatin structure and have a high level of histone modification, such as H3K4me3.\n5. FALSE [correction]: The main epigenetic difference between poised and constitutive enhancers is not just the timing of their activity, but also the specific molecular features including chromatin structure and histone modifications.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3586,
    "user_query": "What is gamma sterilization used for?",
    "vicuna-13b_response": "Gamma sterilization, also known as gamma radiation sterilization, is a form of sterilization that uses gamma rays to kill or inactivate microorganisms. This process is commonly used to sterilize medical instruments, equipment, and supplies, as well as food and other products that require a high level of sterilization.\nGamma sterilization is a highly effective method of sterilization, as it can penetrate deeply into materials and kill microorganisms that are resistant to other forms of sterilization. This makes it particularly useful for sterilizing items that are difficult to sterilize using other methods, such as heat or chemicals.\nIn addition to its use in medicine and food processing, gamma sterilization is also used in a variety of other industries, including pharmaceuticals, cosmetics, and electronics. It is often used to ensure the sterilization of critical components and equipment in these industries, as the use of contaminated or non-sterile materials can have serious consequences, such as the spread of disease or the failure of equipment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Gamma sterilization uses gamma rays to kill or inactivate microorganisms.\n2. Gamma sterilization is used to sterilize medical instruments, equipment, and supplies.\n3. This method of sterilization can penetrate deeply into materials and kill microorganisms that are resistant to other forms of sterilization.\n4. Gamma sterilization is used in the food processing, pharmaceuticals, cosmetics, and electronics industries.\n5. The use of contaminated or non-sterile materials can result in the spread of disease or equipment failure.",
    "vicuna-13b_fact": [
      "Gamma sterilization uses gamma rays to kill or inactivate microorganisms.",
      "Gamma sterilization is used to sterilize medical instruments, equipment, and supplies.",
      "This method of sterilization can penetrate deeply into materials and kill microorganisms that are resistant to other forms of sterilization.",
      "Gamma sterilization is used in the food processing, pharmaceuticals, cosmetics, and electronics industries.",
      "The use of contaminated or non-sterile materials can result in the spread of disease or equipment failure."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3589,
    "user_query": "What is the current regulation of eye lens radiation exposure?",
    "vicuna-13b_response": "The regulation of eye lens radiation exposure varies by country, but in general, most countries have set limits on the amount of radiation that can be emitted by medical X-ray equipment and other sources that may be harmful to the eyes.\nIn the United States, the Food and Drug Administration (FDA) is responsible for regulating medical X-ray equipment, including mammography equipment. The FDA has set limits on the amount of radiation that can be emitted by these devices, and requires manufacturers to ensure that their equipment meets these standards. The FDA also requires that mammography facilities follow certain guidelines to ensure the safety of patients, including limiting the amount of radiation exposure to the eye lens.\nThe International Commission on Radiological Protection (ICRP) also has recommendations for limiting radiation exposure to the eye lens. The ICRP recommends that the dose to the lens of the eye should be kept as low as reasonably achievable (ALARA) in all exposures, and that the dose to the skin of the eye should be limited to 500 microsieverts (μSv) per year.\nIt's important to note that while regulations exist to protect the public from excessive radiation exposure, it is still important for individuals to take steps to protect their own health, such as wearing protective eyewear during medical procedures that involve radiation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Most countries have set limits on the amount of radiation that can be emitted by medical X-ray equipment and other sources that may be harmful to the eyes.\n2. In the United States, the FDA is responsible for regulating medical X-ray equipment.\n3. The FDA requires manufacturers to ensure that their equipment meets the set radiation emission standards. \n4. The International Commission on Radiological Protection (ICRP) recommends that the dose to the lens of the eye should be kept as low as reasonably achievable (ALARA) in all exposures and that the dose to the skin of the eye should be limited to 500 microsieverts (μSv) per year.\n5. Despite regulations, individuals are recommended to protect their own health by wearing protective eyewear during medical procedures that involve radiation.",
    "vicuna-13b_fact": [
      "Most countries have set limits on the amount of radiation that can be emitted by medical X-ray equipment and other sources that may be harmful to the eyes.",
      "In the United States, the FDA is responsible for regulating medical X-ray equipment.",
      "The FDA requires manufacturers to ensure that their equipment meets the set radiation emission standards.",
      "The International Commission on Radiological Protection (ICRP) recommends that the dose to the lens of the eye should be kept as low as reasonably achievable (ALARA) in all exposures and that the dose to the skin of the eye should be limited to 500 microsieverts (μSv) per year.",
      "Despite regulations, individuals are recommended to protect their own health by wearing protective eyewear during medical procedures that involve radiation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3593,
    "user_query": "What is the cause of the disease Xeroderma Pigmentosum?",
    "vicuna-13b_response": "Xeroderma pigmentosum is a rare genetic disorder that affects the skin's ability to repair damage from ultraviolet (UV) light. It is caused by a deficiency in one of several enzymes involved in the nucleotide excision repair (NER) pathway, which is responsible for removing DNA damage caused by UV light.\nThe NER pathway is a complex process that involves several enzymes, including XPA, which is the enzyme deficient in xeroderma pigmentosum. XPA plays a critical role in recognizing and initiating the repair of UV-damaged DNA. When the NER pathway is impaired, UV-damaged DNA is not properly repaired, leading to the formation of mutations in the DNA.\nMutations in the XPA gene are the most common cause of xeroderma pigmentosum. These mutations can be inherited from one's parents or can occur spontaneously. There are several types of xeroderma pigmentosum, ranging from mild to severe, depending on the degree of enzyme deficiency.\nPeople with xeroderma pigmentosum are extremely sensitive to UV light and are at increased risk of developing skin cancer. They must avoid sunlight and other sources of UV light as much as possible, and use sunscreen and other protective measures when they cannot avoid UV exposure.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Xeroderma pigmentosum is a rare genetic disorder that affects the skin's ability to repair damage from ultraviolet (UV) light.\n2. The disorder is caused by a deficiency in one of several enzymes involved in the nucleotide excision repair (NER) pathway.\n3. The enzyme XPA, involved in the NER pathway, is deficient in xeroderma pigmentosum.\n4. Mutations in the XPA gene are the most common cause of xeroderma pigmentosum.\n5. People with xeroderma pigmentosum are extremely sensitive to UV light and are at increased risk of developing skin cancer.",
    "vicuna-13b_fact": [
      "Xeroderma pigmentosum is a rare genetic disorder that affects the skin's ability to repair damage from ultraviolet (UV) light.",
      "The disorder is caused by a deficiency in one of several enzymes involved in the nucleotide excision repair (NER) pathway.",
      "The enzyme XPA, involved in the NER pathway, is deficient in xeroderma pigmentosum.",
      "Mutations in the XPA gene are the most common cause of xeroderma pigmentosum.",
      "People with xeroderma pigmentosum are extremely sensitive to UV light and are at increased risk of developing skin cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Mutations in different genes related to the NER pathway, not only the XPA gene, can cause xeroderma pigmentosum. There is not one \"most common\" cause.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "vicuna-13b_response": "T-UCRs, or Tumor-Upregulated Conserved Regions, are genomic regions that are commonly altered in cancer cells. Several T-UCRs have been implicated in the development and progression of gastric cancer, a type of cancer that affects the stomach.\nOne of the most well-known T-UCRs in gastric cancer is the CDH1 gene, which codes for the E-cadherin protein. Loss of CDH1 expression has been shown to be a common event in gastric cancer and is associated with poor prognosis.\nAnother T-UCR that has been implicated in gastric cancer is the TP53 gene, which is a tumor suppressor gene that plays a crucial role in maintaining genomic stability. Mutations in TP53 have been identified in a significant percentage of gastric cancer cases and are associated with poor prognosis.\nAdditionally, the PIK3CA gene, which codes for a protein that regulates cell growth and survival, has also been implicated in gastric cancer. Mutations in PIK3CA have been identified in a subset of gastric cancer cases and are associated with poor prognosis.\nOverall, these T-UCRs are among the most commonly implicated in gastric cancer, and their alteration has been shown to play a role in the development and progression of this disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. T-UCRs, or Tumor-Upregulated Conserved Regions, are genomic regions commonly altered in cancer cells.\n2. Several T-UCRs have been implicated in the development and progression of gastric cancer.\n3. The CDH1 gene, another T-UCR, codes for the E-cadherin protein and its loss of expression has been shown to be a common event in gastric cancer.\n4. Mutations in the TP53 gene, a known T-UCR and tumor suppressor gene, have been identified in a significant percentage of gastric cancer cases.\n5. The PIK3CA gene codes for a protein that regulates cell growth and survival, and mutations in this gene have also been identified in a subset of gastric cancer cases.",
    "vicuna-13b_fact": [
      "T-UCRs, or Tumor-Upregulated Conserved Regions, are genomic regions commonly altered in cancer cells.",
      "Several T-UCRs have been implicated in the development and progression of gastric cancer.",
      "The CDH1 gene, another T-UCR, codes for the E-cadherin protein and its loss of expression has been shown to be a common event in gastric cancer.",
      "Mutations in the TP53 gene, a known T-UCR and tumor suppressor gene, have been identified in a significant percentage of gastric cancer cases.",
      "The PIK3CA gene codes for a protein that regulates cell growth and survival, and mutations in this gene have also been identified in a subset of gastric cancer cases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [Correction]: The CDH1 gene is not a T-UCR, but it does code for the E-cadherin protein and its loss of expression has been shown to be a common event in gastric cancer.\n4. FALSE [Correction]: The TP53 gene is not a T-UCR, but it is a tumor suppressor gene and mutations in it have been identified in a significant percentage of gastric cancer cases.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3600,
    "user_query": "Which de novo mutation in FGFR cause achondroplasia?",
    "vicuna-13b_response": "Achondroplasia is the most common form of short-limbed dwarfism and is caused by a de novo mutation in the fibroblast growth factor receptor 3 (FGFR3) gene. The mutation results in an altered protein product that is constitutively active, leading to abnormal cartilage growth and development. The specific mutation that causes achondroplasia is a deletion of the glutamic acid at position 531 in the FGFR3 protein, which results in the production of a truncated, constitutively active form of the receptor. This mutation is present in approximately 80% of individuals with achondroplasia.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Achondroplasia is caused by a de novo mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.\n2. The mutation in the FGFR3 gene results in an altered protein product.\n3. This altered protein product leads to abnormal cartilage growth and development.\n4. The specific mutation that causes achondroplasia occurs due to a deletion of the glutamic acid at position 531 in the FGFR3 protein.\n5. Approximately 80% of individuals with achondroplasia have this mutation.",
    "vicuna-13b_fact": [
      "Achondroplasia is caused by a de novo mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.",
      "The mutation in the FGFR3 gene results in an altered protein product.",
      "This altered protein product leads to abnormal cartilage growth and development.",
      "The specific mutation that causes achondroplasia occurs due to a deletion of the glutamic acid at position 531 in the FGFR3 protein.",
      "Approximately 80% of individuals with achondroplasia have this mutation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The specific mutation that causes achondroplasia occurs due to a change in the DNA code from guanine to adenine at position 1138 in the FGFR3 gene.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3601,
    "user_query": "List types of DNA lesions caused by UV light.",
    "vicuna-13b_response": "UV light can cause various types of DNA lesions, including:\n1. Cyclobutane pyrimidine dimers (CPDs): These are formed by the binding of two adjacent pyrimidine bases (C or T) across one strand of the DNA double helix. CPDs can disrupt the normal function of genes and are considered to be one of the most important types of DNA damage caused by UV light.\n2. Pyrimidine(6-4)pyrimidone photoproducts (6-4PPs): These are formed when two adjacent pyrimidine bases are flipped from one strand of the DNA helix to the other, resulting in a cross-link between the two bases. 6-4PPs can cause mutations and are thought to be involved in the development of skin cancer.\n3. Pyrimidine(2-2)pyrimidone photoproducts (2-2PPs): These are formed when two adjacent pyrimidine bases are flipped from one strand of the DNA helix to the other, resulting in a cross-link between the two bases. 2-2PPs can cause mutations and are thought to be involved in the development of skin cancer.\n4. N-glycolylation: This is a type of DNA damage caused by the attack of UV light on the N-glycosidic bond of a base pair. N-glycolylation can cause mutations and is thought to be involved in the development of skin cancer.\n5. O-methylation: This is a type of DNA damage caused by the attack of UV light on the O-methyl group of a base pair. O-methylation can cause mutations and is thought to be involved in the development of skin cancer.\n6. Formamidopyrimidine DNA glycolase (FPG) product: This is a type of DNA damage caused by the attack of UV light on the FPG enzyme, which is involved in the repair of cyclobutane pyrimidine dimers (CPDs). The FPG product can cause mutations and is thought to be involved in the development of skin cancer.\nOverall, these types of DNA lesions caused by UV light can lead to mut",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. UV light can cause a type of DNA lesion called Cyclobutane pyrimidine dimers (CPDs).\n2. Pyrimidine(6-4)pyrimidone photoproducts (6-4PPs) are a type of DNA lesion caused by UV light.\n3. Pyrimidine(2-2)pyrimidone photoproducts (2-2PPs) are a type of DNA lesion caused by UV light.\n4. N-glycolylation is a type of DNA damage caused by the attack of UV light.\n5. O-methylation is a type of DNA damage caused by the attack of UV light.",
    "vicuna-13b_fact": [
      "UV light can cause a type of DNA lesion called Cyclobutane pyrimidine dimers (CPDs).",
      "Pyrimidine(6-4)pyrimidone photoproducts (6-4PPs) are a type of DNA lesion caused by UV light.",
      "Pyrimidine(2-2)pyrimidone photoproducts (2-2PPs) are a type of DNA lesion caused by UV light.",
      "N-glycolylation is a type of DNA damage caused by the attack of UV light.",
      "O-methylation is a type of DNA damage caused by the attack of UV light."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There is no such DNA lesion as Pyrimidine(2-2)pyrimidone photoproducts (2-2PPs)\n4. FALSE [correction]: N-glycolylation is not a type of DNA damage caused by the attack of UV light. It's a process of protein modification.\n5. FALSE  [correction]: O-methylation is not a type of DNA damage caused by UV light. It refers to a process where a methyl group is added to the oxygen atom of a molecule.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3604,
    "user_query": "Which software are used for the detection of selective sweeps?",
    "vicuna-13b_response": "Selective sweeps are a key feature of genome evolution that can be studied by comparing the genetic variation in different populations or species. There are several software tools that can be used to detect selective sweeps, including:\n1. SweepFinder: This is a widely used software tool that can detect selective sweeps using a variety of statistical methods. SweepFinder can analyze single-nucleotide polymorphism (SNP) data and calculate the likelihood of a selective sweep based on the patterns of genetic variation in the data.\n2. SelectiveTrace: This is another software tool that can detect selective sweeps using a Bayesian approach. SelectiveTrace can analyze SNP data and infer the parameters of the selective sweep, such as the strength and direction of selection, as well as the time and location of the sweep.\n3. Fst: This is a software tool that can calculate the Fst statistic, which is a measure of the differentiation between populations. Fst can be used to identify regions of the genome that have undergone selective sweeps, as these regions will have higher levels of genetic differentiation between populations.\n4. iHS: This is a software tool that can detect selective sweeps by analyzing the patterns of linkage disequilibrium (LD) in the data. iHS can infer the parameters of the selective sweep, such as the strength and direction of selection, as well as the time and location of the sweep.\nOverall, these software tools can be used to detect selective sweeps and infer the parameters of the sweep, such as the strength and direction of selection, as well as the time and location of the sweep.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Selective sweeps can be studied by comparing the genetic variation in different populations or species.\n2. SweepFinder is a software tool that can detect selective sweeps using a variety of statistical methods and it can analyze single-nucleotide polymorphism (SNP) data.\n3. SelectiveTrace is a software tool that can detect selective sweeps using a Bayesian approach and it can analyze SNP data.\n4. Fst is a software tool that can calculate the Fst statistic, which is a measure of the differentiation between populations.\n5. iHS is a software tool that can detect selective sweeps by analyzing the patterns of linkage disequilibrium (LD) in the data.",
    "vicuna-13b_fact": [
      "Selective sweeps can be studied by comparing the genetic variation in different populations or species.",
      "SweepFinder is a software tool that can detect selective sweeps using a variety of statistical methods and it can analyze single-nucleotide polymorphism (SNP) data.",
      "SelectiveTrace is a software tool that can detect selective sweeps using a Bayesian approach and it can analyze SNP data.",
      "Fst is a software tool that can calculate the Fst statistic, which is a measure of the differentiation between populations.",
      "iHS is a software tool that can detect selective sweeps by analyzing the patterns of linkage disequilibrium (LD) in the data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3606,
    "user_query": "What is Amyand hernia?",
    "vicuna-13b_response": "Amyand hernia is a type of hernia that occurs in the groin area. It is named after the British surgeon William Amyand, who first described the condition in the 18th century.\nAmyand hernia occurs when the inguinal canal, which is a passageway that contains the spermatic cord in males and the round ligament in females, becomes weak or damaged. This can cause a portion of the abdominal cavity to protrude through the inguinal canal, creating a bulge or lump in the groin area.\nAmyand hernia can occur in both males and females, but it is more common in males. It is often seen in infants and children, but it can also occur in adults. In some cases, Amyand hernia can be asymptomatic and may not cause any problems. However, in other cases, it can cause discomfort, pain, or other complications.\nTreatment for Amyand hernia typically involves surgery to repair the weakened or damaged inguinal canal. The specific type of surgery used will depend on the severity of the hernia and the patient's individual needs. After surgery, most patients are able to return to their normal activities within a few weeks to a few months.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Amyand hernia is a type of hernia that occurs in the groin area.\n2. It is named after the British surgeon William Amyand, who first described the condition in the 18th century.\n3. Amyand hernia occurs when the inguinal canal becomes weak or damaged.\n4. Amyand hernia can occur in both males and females, but it is more common in males.\n5. Treatment for Amyand hernia typically involves surgery to repair the weakened or damaged inguinal canal.",
    "vicuna-13b_fact": [
      "Amyand hernia is a type of hernia that occurs in the groin area.",
      "It is named after the British surgeon William Amyand, who first described the condition in the 18th century.",
      "Amyand hernia occurs when the inguinal canal becomes weak or damaged.",
      "Amyand hernia can occur in both males and females, but it is more common in males.",
      "Treatment for Amyand hernia typically involves surgery to repair the weakened or damaged inguinal canal."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Amyand hernia occurs when the appendix becomes trapped in an inguinal hernia, not when the inguinal canal becomes weak or damaged.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "vicuna-13b_response": "The Lupus Severity Index (LSI) is a scoring system that is used to assess the severity of systemic lupus erythematosus (SLE), a chronic autoimmune disease that can affect many parts of the body, including the skin, joints, and organs such as the kidneys, heart, and lungs. The LSI is based on the presence of certain clinical features and laboratory abnormalities that are commonly seen in SLE.\nThe LSI is a simple, easy-to-use tool that can be used by healthcare providers to quickly assess the severity of lupus in a patient. It is based on a total score of 100 points, which can be divided into three categories:\n1. Organ involvement: This category includes points for the presence of active disease in any organ system, such as the skin, joints, kidneys, heart, lungs, and central nervous system.\n2. Activity: This category includes points for the level of activity of the disease, such as whether it is quiescent (inactive), mildly active, moderately active, or severely active.\n3. Chronicity: This category includes points for the duration of disease, such as whether it is new (less than 1 year), established (1-5 years), or long-standing (more than 5 years).\nThe LSI can be used to assess the severity of lupus at a single point in time, or it can be used to track changes in severity over time. It is important to note that the LSI is not specific to lupus and may not accurately reflect the severity of the disease in all patients. It should be used in conjunction with other clinical assessments and laboratory tests to determine the best course of treatment for each individual patient.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Lupus Severity Index (LSI) is a scoring system that is used to assess the severity of systemic lupus erythematosus (SLE).\n2. The LSI is based on the presence of certain clinical features and laboratory abnormalities.\n3. The LSI is a tool used by healthcare providers to quickly assess the severity of lupus in a patient and is based on a total score of 100 points. \n4. Three categories that the LSI score can be divided into are: organ involvement, activity of the disease, and the duration of the disease.\n5. The Lupus Severity Index can be used to track changes in lupus severity over time.",
    "vicuna-13b_fact": [
      "The Lupus Severity Index (LSI) is a scoring system that is used to assess the severity of systemic lupus erythematosus (SLE).",
      "The LSI is based on the presence of certain clinical features and laboratory abnormalities.",
      "The LSI is a tool used by healthcare providers to quickly assess the severity of lupus in a patient and is based on a total score of 100 points.",
      "Three categories that the LSI score can be divided into are: organ involvement, activity of the disease, and the duration of the disease.",
      "The Lupus Severity Index can be used to track changes in lupus severity over time."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3610,
    "user_query": "Is g-H2AX a marker for double strand breaks?",
    "vicuna-13b_response": "Yes, g-H2AX is a marker for double strand breaks (DSBs) in DNA.\ng-H2AX is a protein that is rapidly phosphorylated in response to DNA damage, including double strand breaks. The phosphorylation of g-H2AX is a key step in the DNA damage response and is used as a marker for DSBs. The presence of g-H2AX at a particular site in the genome is an indication that a DSB has occurred and that the cell has initiated repair processes to fix the damage.\nIn addition to its role as a marker for DSBs, g-H2AX is also involved in the recruitment of repair factors to the site of the damage, as well as in the regulation of the cell cycle in response to DNA damage.\nOverall, g-H2AX is a valuable tool for studying DNA damage and repair, and its presence at a particular site in the genome can provide important information about the nature and extent of DNA damage in a cell.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. g-H2AX is a marker for double strand breaks (DSBs) in DNA.\n2. g-H2AX is rapidly phosphorylated in response to DNA damage, including double strand breaks.\n3. The phosphorylation of g-H2AX is a key step in the DNA damage response.\n4. g-H2AX is involved in the recruitment of repair factors to the site of the DNA damage.\n5. g-H2AX plays a part in the regulation of the cell cycle in response to DNA damage.",
    "vicuna-13b_fact": [
      "g-H2AX is a marker for double strand breaks (DSBs) in DNA.",
      "g-H2AX is rapidly phosphorylated in response to DNA damage, including double strand breaks.",
      "The phosphorylation of g-H2AX is a key step in the DNA damage response.",
      "g-H2AX is involved in the recruitment of repair factors to the site of the DNA damage.",
      "g-H2AX plays a part in the regulation of the cell cycle in response to DNA damage."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3611,
    "user_query": "Which algorithm has been developed for finding conserved non-coding elements (CNEs)?",
    "vicuna-13b_response": "There are several algorithms that have been developed for finding conserved non-coding elements (CNEs). Some of the commonly used algorithms are:\n1. PhyloBayes: PhyloBayes is a Bayesian method that uses a combination of phylogenetic and statistical methods to identify conserved non-coding elements. It models the evolution of the genomic region and the functional elements within it, and uses Bayesian inference to estimate the posterior probabilities of the presence of functional elements in different regions of the genome.\n2. MEME: MEME (Modeling Expectation-Maximization for Motif Elicitation) is a computational method that uses a statistical model to identify conserved non-coding elements. It uses a hidden Markov model to model the distribution of the motifs in the genome and uses expectation-maximization to estimate the parameters of the model.\n3. Hidden Markov Model (HMM): Hidden Markov Model (HMM) is a statistical model that can be used to identify conserved non-coding elements. It models the sequence of the genome as a sequence of hidden states, and uses the observed sequence of the genome to estimate the probabilities of the hidden states.\n4. Gibbs Sampling: Gibbs Sampling is a computational method that can be used to identify conserved non-coding elements. It uses Markov Chain Monte Carlo (MCMC) methods to sample the posterior distribution of the parameters of the model, and uses the samples to estimate the probabilities of the conserved non-coding elements.\n5. BaySeq: BaySeq is a computational method that uses Bayesian methods to identify conserved non-coding elements. It models the evolution of the genomic region and the functional elements within it, and uses Bayesian inference to estimate the posterior probabilities of the presence of functional elements in different regions of the genome.\nThese are some of the commonly used algorithms for finding conserved non-coding elements, but there are many other algorithms that have been developed for this purpose as well.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PhyloBayes is a method that uses a combination of phylogenetic and statistical methods to identify conserved non-coding elements.\n2. MEME (Modeling Expectation-Maximization for Motif Elicitation) uses a hidden Markov model to model the distribution of motifs in the genome.\n3. Hidden Markov Model (HMM) is a statistical model used to identify conserved non-coding elements.\n4. Gibbs Sampling uses Markov Chain Monte Carlo (MCMC) methods to sample the posterior distribution of the parameters of the model.\n5. BaySeq is a computational method that uses Bayesian methods to identify conserved non-coding elements.",
    "vicuna-13b_fact": [
      "PhyloBayes is a method that uses a combination of phylogenetic and statistical methods to identify conserved non-coding elements.",
      "MEME (Modeling Expectation-Maximization for Motif Elicitation) uses a hidden Markov model to model the distribution of motifs in the genome.",
      "Hidden Markov Model (HMM) is a statistical model used to identify conserved non-coding elements.",
      "Gibbs Sampling uses Markov Chain Monte Carlo (MCMC) methods to sample the posterior distribution of the parameters of the model.",
      "BaySeq is a computational method that uses Bayesian methods to identify conserved non-coding elements."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3612,
    "user_query": "What type of antagonist is istradefylline?",
    "vicuna-13b_response": "Istradefylline is an antagonist of adenosine A2A receptors. It is a selective A2A receptor antagonist, which means that it specifically blocks the activity of the A2A subtype of adenosine receptors without affecting other types of adenosine receptors or other types of G protein-coupled receptors. Istradefylline has been studied for its potential therapeutic use in a variety of conditions, including Parkinson's disease, Alzheimer's disease, and depression, among others.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Istradefylline is an antagonist of adenosine A2A receptors.\n2. Istradefylline specifically blocks the activity of the A2A subtype of adenosine receptors without affecting other types of adenosine receptors.\n3. Istradefylline does not affect other types of G protein-coupled receptors.\n4. Istradefylline has been studied for its potential therapeutic use in several conditions including Parkinson's disease, Alzheimer's disease, and depression.",
    "vicuna-13b_fact": [
      "Istradefylline is an antagonist of adenosine A2A receptors.",
      "Istradefylline specifically blocks the activity of the A2A subtype of adenosine receptors without affecting other types of adenosine receptors.",
      "Istradefylline does not affect other types of G protein-coupled receptors.",
      "Istradefylline has been studied for its potential therapeutic use in several conditions including Parkinson's disease, Alzheimer's disease, and depression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "vicuna-13b_response": "ZSWIM6 is a gene that plays a role in the development and function of the brain, and mutations in this gene have been associated with several neurodevelopmental disorders.\nOne disorder that is caused by de novo mutations in ZSWIM6 is schizophrenia. Studies have found that individuals with schizophrenia are more likely to have de novo mutations in ZSWIM6 than individuals without the disorder.\nAnother disorder that may be caused by de novo mutations in ZSWIM6 is autism spectrum disorder (ASD). While the evidence is still inconclusive, some studies have suggested that de novo mutations in ZSWIM6 may contribute to the development of ASD in some individuals.\nIt is important to note that while mutations in ZSWIM6 have been associated with these disorders, the relationship between the gene and the disorders is complex and not fully understood. Further research is needed to determine the exact role of ZSWIM6 in the development and function of the brain, and to better understand the relationship between ZSWIM6 mutations and these disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ZSWIM6 is a gene that plays a role in brain development and function.\n2. Schizophrenia is a disorder known to be caused by de novo mutations in ZSWIM6.\n3. Individuals with schizophrenia are more likely to have de novo mutations in ZSWIM6.\n4. Autism spectrum disorder (ASD) may also be associated with de novo mutations in ZSWIM6. \n5. The relationship between ZSWIM6 mutations and related disorders such as schizophrenia and autism is not fully understood.",
    "vicuna-13b_fact": [
      "ZSWIM6 is a gene that plays a role in brain development and function.",
      "Schizophrenia is a disorder known to be caused by de novo mutations in ZSWIM6.",
      "Individuals with schizophrenia are more likely to have de novo mutations in ZSWIM6.",
      "Autism spectrum disorder (ASD) may also be associated with de novo mutations in ZSWIM6.",
      "The relationship between ZSWIM6 mutations and related disorders such as schizophrenia and autism is not fully understood."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3625,
    "user_query": "Which disease category is LB-100 mostly assessed for?",
    "vicuna-13b_response": "LB-100 is a laboratory test that measures the levels of various blood cells and proteins, including red blood cells, white blood cells, and platelets. It is used to help diagnose and monitor a variety of blood disorders and diseases, including anemia, infection, and bleeding disorders.\nSpecifically, LB-100 is often used to assess the levels of red blood cells, white blood cells, and platelets in the blood. Abnormal results on an LB-100 test can indicate the presence of a variety of diseases or conditions, including:\n1. Anemia: LB-100 can be used to diagnose anemia, which is a condition in which the body does not have enough healthy red blood cells to carry oxygen to the body's tissues.\n2. Infection: LB-100 can be used to help diagnose and monitor infections, as the test can show changes in the levels of white blood cells, which are the body's primary defense against infection.\n3. Bleeding disorders: LB-100 can be used to diagnose and monitor bleeding disorders, such as hemophilia, which are conditions in which the body has difficulty forming blood clots and stopping bleeding.\nOverall, LB-100 is a useful test for assessing the levels of various blood cells and proteins in the blood, and it can be used to diagnose and monitor a variety of blood disorders and diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. LB-100 is a laboratory test that measures the levels of various blood cells and proteins, including red blood cells, white blood cells, and platelets.\n2. LB-100 is used to diagnose and monitor a variety of blood disorders and diseases, including anemia, infection, and bleeding disorders.\n3. LB-100 can be used to diagnose anemia.\n4. LB-100 can help diagnose and monitor infections by showing changes in the levels of white blood cells.\n5. LB-100 can be used to diagnose and monitor bleeding disorders such as hemophilia.",
    "vicuna-13b_fact": [
      "LB-100 is a laboratory test that measures the levels of various blood cells and proteins, including red blood cells, white blood cells, and platelets.",
      "LB-100 is used to diagnose and monitor a variety of blood disorders and diseases, including anemia, infection, and bleeding disorders.",
      "LB-100 can be used to diagnose anemia.",
      "LB-100 can help diagnose and monitor infections by showing changes in the levels of white blood cells.",
      "LB-100 can be used to diagnose and monitor bleeding disorders such as hemophilia."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "vicuna-13b_response": "The Koos Classification is a system for classifying bacteria based on their cell wall composition. It is used primarily for the identification of bacteria in the laboratory. The classification system is based on the composition of the bacterial cell wall and divides bacteria into four main groups: A, B, C, and D.\nGroup A bacteria have a cell wall containing peptidoglycan and muramic acid. Group B bacteria have a cell wall containing peptidoglycan and lipids. Group C bacteria have a cell wall containing peptidoglycan and glycans. Group D bacteria have a cell wall containing only lipids.\nThe Koos Classification is useful for identifying bacteria, but it is not used to classify diseases. Diseases are classified based on the symptoms they cause and the underlying medical conditions that lead to those symptoms. For example, a disease like pneumonia can be classified based on the cause, such as bacterial, viral, or fungal, and the severity of the disease.\nIn summary, the Koos Classification is a system for classifying bacteria based on their cell wall composition, but it is not used to classify diseases. Diseases are classified based on the symptoms they cause and the underlying medical conditions that lead to those symptoms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Koos Classification is a system for classifying bacteria based on their cell wall composition.\n2. The Koos Classification system divides bacteria into four main groups: A, B, C, and D.\n3. Group A bacteria in Koos Classification have a cell wall containing peptidoglycan and muramic acid.\n4. Group B bacteria in Koos Classification have a cell wall containing peptidoglycan and lipids.\n5. The Koos Classification system is not used to classify diseases.",
    "vicuna-13b_fact": [
      "The Koos Classification is a system for classifying bacteria based on their cell wall composition.",
      "The Koos Classification system divides bacteria into four main groups: A, B, C, and D.",
      "Group A bacteria in Koos Classification have a cell wall containing peptidoglycan and muramic acid.",
      "Group B bacteria in Koos Classification have a cell wall containing peptidoglycan and lipids.",
      "The Koos Classification system is not used to classify diseases."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Koos Classification is a system for classifying pituitary adenomas based on their size and supra and parasellar extension.\n2. FALSE [correction]: The Koos Classification system divides pituitary adenomas into four stages: I, II, III, and IV.\n3. FALSE [correction]: The Koos Classification does not classify bacteria and has no information about Group A and its cell wall composition.\n4. FALSE [correction]: The Koos Classification does not classify bacteria and has no information about Group B and its cell wall composition.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "vicuna-13b_response": "AZD8601 is a drug that is being developed for the treatment of various diseases, including cancer. The in vivo effects of AZD8601 refer to its effects on living organisms, as opposed to in vitro effects, which are observed in laboratory conditions.\nThe in vivo effects of AZD8601 have been studied in various preclinical models, and some promising results have been observed. For example, AZD8601 has been shown to have anti-tumor effects in models of cancer, by inhibiting the activity of a protein called CDK12. In addition, AZD8601 has been shown to have immunomodulatory effects, which may help to enhance the effects of cancer immunotherapy.\nIt is important to note that the in vivo effects of AZD8601 may vary depending on the disease being targeted, the dose and schedule of administration, and other factors. Further research is needed to fully understand the in vivo effects of AZD8601 and to determine its potential as a treatment for various diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. AZD8601 is a drug that is being developed for the treatment of various diseases, including cancer.\n2. The in vivo effects of AZD8601 have been studied in various preclinical models.\n3. AZD8601 has shown to have anti-tumor effects in models of cancer.\n4. The drug, AZD8601, operates by inhibiting the activity of a protein called CDK12.\n5. AZD8601 has been shown to have immunomodulatory effects.",
    "vicuna-13b_fact": [
      "AZD8601 is a drug that is being developed for the treatment of various diseases, including cancer.",
      "The in vivo effects of AZD8601 have been studied in various preclinical models.",
      "AZD8601 has shown to have anti-tumor effects in models of cancer.",
      "The drug, AZD8601, operates by inhibiting the activity of a protein called CDK12.",
      "AZD8601 has been shown to have immunomodulatory effects."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3630,
    "user_query": "Which characteristics are used in the SLEDAI index for SLE patients?",
    "vicuna-13b_response": "The SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) is a scoring system used to measure the activity of systemic lupus erythematosus (SLE), an autoimmune disease that can affect many parts of the body. The SLEDAI index is based on the presence or absence of certain characteristics or \"domains\" that are commonly associated with SLE. These domains include:\n1. Fever: The presence of fever (a temperature of 100.4°F or higher) is a characteristic of active SLE.\n2. Joint pain and swelling: Pain and swelling in the joints are common symptoms of SLE and are used to assess disease activity.\n3. Rash: A rash, particularly on the face, is a characteristic of SLE and is used to assess disease activity.\n4. Photophobia: Photophobia (discomfort in bright light) is a symptom of SLE and is used to assess disease activity.\n5. Fatigue: Fatigue is a common symptom of SLE and is used to assess disease activity.\n6. Muscle pain: Muscle pain is a common symptom of SLE and is used to assess disease activity.\n7. Headaches: Headaches are a common symptom of SLE and are used to assess disease activity.\n8. Chest pain: Chest pain is a characteristic of active SLE and is used to assess disease activity.\n9. Heartburn: Heartburn is a symptom of SLE and is used to assess disease activity.\n10. Indigestion: Indigestion is a symptom of SLE and is used to assess disease activity.\n11. Nausea and vomiting: Nausea and vomiting are common symptoms of SLE and are used to assess disease activity.\n12. Abdominal pain: Abdominal pain is a symptom of SLE and is used to assess disease activity.\n13. Diarrhea: Diarrhea is a symptom of SLE and is used to assess disease activity.\n14. Constipation: Constipation is a symptom of SLE and is used to assess disease activity.\n15. Blood in the urine: The presence of blood in the urine (hematur",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) is a scoring system used to measure the activity of systemic lupus erythematosus (SLE).\n2. The SLEDAI index is based on the presence or absence of certain characteristics or \"domains\".\n3. Fever, joint pain and swelling, and rash are some of the characteristics used in the SLEDAI index.\n4. Photophobia, fatigue, and muscle pain are also included in the SLEDAI index.\n5. Symptoms like headaches, chest pain, heartburn, indigestion, nausea and vomiting, abdominal pain, diarrhea, constipation, and the presence of blood in the urine are also considered in the SLEDAI index.",
    "vicuna-13b_fact": [
      "The SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) is a scoring system used to measure the activity of systemic lupus erythematosus (SLE).",
      "The SLEDAI index is based on the presence or absence of certain characteristics or \"domains\".",
      "Fever, joint pain and swelling, and rash are some of the characteristics used in the SLEDAI index.",
      "Photophobia, fatigue, and muscle pain are also included in the SLEDAI index.",
      "Symptoms like headaches, chest pain, heartburn, indigestion, nausea and vomiting, abdominal pain, diarrhea, constipation, and the presence of blood in the urine are also considered in the SLEDAI index."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Photophobia, fatigue, and muscle pain are not included in the SLEDAI index.\n5. FALSE [correction]: Symptoms like headaches, chest pain, heartburn, indigestion, nausea and vomiting, abdominal pain, diarrhea, constipation, and the presence of blood in the urine are not considered in the SLEDAI index.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3632,
    "user_query": "Describe the mechanism of action of Luspatercept.",
    "vicuna-13b_response": "Luspatercept is a modified activin receptor type IIB fusion protein that is used to treat anemia in patients with beta-thalassemia and myelodysplastic syndromes. The mechanism of action of luspatercept is based on its ability to bind to activin receptor type IIB (ActRIIB) on the surface of stem cells in the bone marrow.\nWhen luspatercept binds to ActRIIB, it activates a signaling pathway that promotes the differentiation and maturation of erythroid precursor cells, leading to an increase in red blood cell production. Additionally, luspatercept also inhibits the activity of activin receptor type I (ActRII), which is involved in the differentiation of myeloid cells, allowing for a more balanced differentiation of hematopoietic cells.\nBy increasing the number of red blood cells, luspatercept can help to reduce the symptoms of anemia, such as fatigue, shortness of breath, and dizziness. Additionally, by promoting a more balanced differentiation of hematopoietic cells, luspatercept can help to improve the overall health and function of the bone marrow.\nIt's important to note that luspatercept is not a cure for beta-thalassemia or myelodysplastic syndromes, but it can help to manage the symptoms and improve the quality of life for patients with these conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Luspatercept is a modified activin receptor type IIB fusion protein.\n2. Luspatercept is used to treat anemia in patients with beta-thalassemia and myelodysplastic syndromes.\n3. Luspatercept operates by binding to activin receptor type IIB (ActRIIB) on the surface of stem cells in the bone marrow, stimulating red blood cell production.\n4. Luspatercept also inhibits the activity of activin receptor type I (ActRII) to allow for more balanced differentiation of hematopoietic cells.\n5. Luspatercept is not a cure for beta-thalassemia or myelodysplastic syndromes.",
    "vicuna-13b_fact": [
      "Luspatercept is a modified activin receptor type IIB fusion protein.",
      "Luspatercept is used to treat anemia in patients with beta-thalassemia and myelodysplastic syndromes.",
      "Luspatercept operates by binding to activin receptor type IIB (ActRIIB) on the surface of stem cells in the bone marrow, stimulating red blood cell production.",
      "Luspatercept also inhibits the activity of activin receptor type I (ActRII) to allow for more balanced differentiation of hematopoietic cells.",
      "Luspatercept is not a cure for beta-thalassemia or myelodysplastic syndromes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Luspatercept binds to select proteins in the TGF-beta superfamily to reduce Smad2/3 signalling, it doesn't inhibit the activity of ActRI.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3633,
    "user_query": "Which method has been developed for mapping of Transcription Start Sites (TSS) starting from nanograms of RNA?",
    "vicuna-13b_response": "There are several methods that have been developed for mapping of Transcription Start Sites (TSS) starting from nanograms of RNA. Some of the commonly used methods are:\n1. RNA ligase-mediated rapid amplification of cDNA ends (RLM-RACE): This method uses RNA ligase to create cDNA templates for PCR amplification, which allows for the detection of transcription start sites.\n2. Sanger sequencing: This method uses chain termination sequencing to determine the sequence of the transcribed region, which can be used to identify the transcription start site.\n3. 5' RNA sequencing: This method uses next-generation sequencing to determine the sequence of the 5' end of the transcribed region, which can be used to identify the transcription start site.\n4. Chromatin immunoprecipitation (ChIP) sequencing: This method uses chromatin immunoprecipitation to enrich for the transcribed region, followed by next-generation sequencing to determine the sequence of the transcribed region, which can be used to identify the transcription start site.\n5. Amplicon sequencing: This method uses PCR amplification of the transcribed region, followed by next-generation sequencing to determine the sequence of the amplified region, which can be used to identify the transcription start site.\nIt's worth noting that the choice of method will depend on the specific requirements of the experiment, such as the amount of RNA available, the complexity of the transcriptome, and the desired resolution of the mapping.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. RNA ligase-mediated rapid amplification of cDNA ends (RLM-RACE) is a method for mapping Transcription Start Sites (TSS) starting from nanograms of RNA.\n2. Sanger sequencing is another method used for mapping of Transcription Start Sites (TSS).\n3. 5' RNA sequencing is used to determine the sequence of the 5' end of the transcribed region to identify the transcription start site.\n4. Chromatin immunoprecipitation (ChIP) sequencing enriches for the transcribed region and uses next-generation sequencing to identify the transcription start site.\n5. Amplicon sequencing uses PCR amplification of the transcribed region, and next-generation sequencing to identify the transcription start site.",
    "vicuna-13b_fact": [
      "RNA ligase-mediated rapid amplification of cDNA ends (RLM-RACE) is a method for mapping Transcription Start Sites (TSS) starting from nanograms of RNA.",
      "Sanger sequencing is another method used for mapping of Transcription Start Sites (TSS).",
      "5' RNA sequencing is used to determine the sequence of the 5' end of the transcribed region to identify the transcription start site.",
      "Chromatin immunoprecipitation (ChIP) sequencing enriches for the transcribed region and uses next-generation sequencing to identify the transcription start site.",
      "Amplicon sequencing uses PCR amplification of the transcribed region, and next-generation sequencing to identify the transcription start site."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Sanger sequencing is a method of DNA sequencing, not specifically for mapping of Transcription Start Sites (TSS).\n3. TRUE\n4. FALSE [correction]: Chromatin immunoprecipitation (ChIP) sequencing is a method used to identify DNA-protein interaction sites in the genome, it doesn't directly identify the transcription start site.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3637,
    "user_query": "Which mRNAs are sequestered in stress granules?",
    "vicuna-13b_response": "Stress granules are dynamic ribonucleoprotein (RNP) structures that form in response to cellular stress, such as heat shock, oxidative stress, or viral infection. The mRNAs that are sequestered in stress granules are typically those that are involved in the stress response or those that are not immediately required for protein synthesis.\nSome of the mRNAs that have been identified in stress granules include:\n1. Hsp70 mRNA: Hsp70 proteins are involved in protein folding and are required for the proper folding of proteins that are denatured by stress.\n2. Hsp27 mRNA: Hsp27 proteins are involved in protein folding and are required for the proper folding of proteins that are denatured by stress.\n3. Hsp90 mRNA: Hsp90 proteins are involved in protein folding and are required for the proper folding of proteins that are denatured by stress.\n4. Hsp104 mRNA: Hsp104 proteins are involved in protein folding and are required for the proper folding of proteins that are denatured by stress.\n5. MHC class I mRNA: MHC class I proteins are involved in antigen presentation and are required for the proper folding of proteins that are denatured by stress.\n6. MHC class II mRNA: MHC class II proteins are involved in antigen presentation and are required for the proper folding of proteins that are denatured by stress.\n7. TAP mRNA: TAP proteins are involved in mRNA transport and are required for the proper folding of proteins that are denatured by stress.\n8. Tubulin mRNA: Tubulin proteins are involved in microtubule formation and are required for the proper folding of proteins that are denatured by stress.\nIt is important to note that the specific mRNAs sequestered in stress granules can vary depending on the type of stress and the cell type. Additionally, the sequestration of mRNAs in stress granules is a dynamic process, and the composition of stress granules can change over time in response to changing cellular conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Stress granules are dynamic ribonucleoprotein structures that form in response to cellular stress, such as heat shock, oxidative stress, or viral infection.\n2. Certain mRNAs that are sequestered in stress granules involve those not immediately required for protein synthesis.\n3.  Hsp70, Hsp27, Hsp90, Hsp104, MHC class I, MHC class II, TAP, and Tubulin mRNAs are identified in stress granules and are involved in various cellular functions.\n4. The specific mRNAs sequestered in stress granules can vary depending on the type of stress and the cell type.\n5. The composition of stress granules can change over time in response to changing cellular conditions.",
    "vicuna-13b_fact": [
      "Stress granules are dynamic ribonucleoprotein structures that form in response to cellular stress, such as heat shock, oxidative stress, or viral infection.",
      "Certain mRNAs that are sequestered in stress granules involve those not immediately required for protein synthesis.",
      "Hsp70, Hsp27, Hsp90, Hsp104, MHC class I, MHC class II, TAP, and Tubulin mRNAs are identified in stress granules and are involved in various cellular functions.",
      "The specific mRNAs sequestered in stress granules can vary depending on the type of stress and the cell type.",
      "The composition of stress granules can change over time in response to changing cellular conditions."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3638,
    "user_query": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?",
    "vicuna-13b_response": "PD-L1 (Programmed Death-Ligand 1) is a protein that is expressed on the surface of some cancer cells and is involved in inhibiting the immune system's ability to recognize and attack cancer cells. PD-L1 has been targeted with monoclonal antibodies, such as pembrolizumab and nivolumab, as a means of enhancing the immune system's ability to recognize and attack cancer cells. However, there are several problems associated with the use of PD-L1 as an immunotherapy biomarker.\nOne problem is that PD-L1 is not specific to cancer cells and is also expressed on normal cells, which can lead to side effects such as inflammation and autoimmune reactions. Additionally, some cancer cells may be resistant to PD-L1 blockade, which can limit the effectiveness of immunotherapy.\nAnother problem is that the expression of PD-L1 on cancer cells is not always correlated with the response to immunotherapy, which can make it difficult to predict which patients will benefit from treatment. Furthermore, PD-L1 expression can vary within a tumor, with some regions expressing high levels of PD-L1 and others expressing low levels, which can make it difficult to target the protein effectively.\nFinally, there can be issues with the measurement of PD-L1 expression, as different methods can yield different results, and some methods may not be as sensitive or specific as others. This can make it difficult to compare results across different studies and to interpret the significance of changes in PD-L1 expression over time.\nIn summary, the use of PD-L1 as an immunotherapy biomarker is associated with several challenges, including the potential for side effects, the lack of correlation between PD-L1 expression and response to treatment, variability in PD-L1 expression within a tumor, and issues with the measurement of PD-L1 expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PD-L1 (Programmed Death-Ligand 1) is a protein that is expressed on the surface of some cancer cells.\n2. PD-L1 has been targeted with monoclonal antibodies, such as pembrolizumab and nivolumab, as a means of enhancing the immune system's ability to recognize and attack cancer cells.\n3. PD-L1 is not specific to cancer cells and is also expressed on normal cells, which can lead to side effects such as inflammation and autoimmune reactions.\n4. The expression of PD-L1 on cancer cells is not always correlated with the response to immunotherapy.\n5. PD-L1 expression can vary within a tumor, with some regions expressing high levels of PD-L1 and others expressing low levels.",
    "vicuna-13b_fact": [
      "PD-L1 (Programmed Death-Ligand 1) is a protein that is expressed on the surface of some cancer cells.",
      "PD-L1 has been targeted with monoclonal antibodies, such as pembrolizumab and nivolumab, as a means of enhancing the immune system's ability to recognize and attack cancer cells.",
      "PD-L1 is not specific to cancer cells and is also expressed on normal cells, which can lead to side effects such as inflammation and autoimmune reactions.",
      "The expression of PD-L1 on cancer cells is not always correlated with the response to immunotherapy.",
      "PD-L1 expression can vary within a tumor, with some regions expressing high levels of PD-L1 and others expressing low levels."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3639,
    "user_query": "Is poliosis circumscripta another term for a white or unpigmented patch of hair or skin?",
    "vicuna-13b_response": "Poliosis circumscripta is a medical condition characterized by a patch of hair that is white or unpigmented. It is also sometimes referred to as \"poliosis\" or \"leukotrichia.\"\nPoliosis circumscripta is a type of alopecia, which is a hair loss condition. It is caused by a congenital (present at birth) disorder of the hair follicles, which results in the growth of hair that is white or unpigmented. The patch of hair that is affected is usually small, and it is usually located on the scalp.\nThe condition is usually diagnosed by a dermatologist or a pediatrician, and it is typically treated with minoxidil, a medication that is commonly used to treat hair loss. In some cases, the affected hair may be plucked or surgically removed.\nIt is important to note that poliosis circumscripta is a benign condition and it does not pose any health risks. However, it can be a source of embarrassment for some people, and they may choose to seek treatment to improve their appearance.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Poliosis circumscripta is a medical condition characterized by a patch of hair that is white or unpigmented.\n2. Poliosis circumscripta is sometimes referred to as \"poliosis\" or \"leukotrichia.\"\n3. Poliosis circumscripta is a type of alopecia, a hair loss condition.\n4. The condition is usually diagnosed by a dermatologist or a pediatrician, and it is typically treated with minoxidil.\n5. Poliosis circumscripta is a benign condition and it does not pose any health risks.",
    "vicuna-13b_fact": [
      "Poliosis circumscripta is a medical condition characterized by a patch of hair that is white or unpigmented.",
      "Poliosis circumscripta is sometimes referred to as \"poliosis\" or \"leukotrichia.\"",
      "Poliosis circumscripta is a type of alopecia, a hair loss condition.",
      "The condition is usually diagnosed by a dermatologist or a pediatrician, and it is typically treated with minoxidil.",
      "Poliosis circumscripta is a benign condition and it does not pose any health risks."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Poliosis circumscripta is not a type of alopecia, it is a condition that causes a patch of hair to turn white or unpigmented, but it does not cause hair loss.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "vicuna-13b_response": "SAHFS stands for Secure Hash Functions (SHA) with a Hash Value of 160 bits. These hash functions are used to create a unique fixed-length output, known as a hash value or digest, from an input of any size. The input can be any type of data, such as a message, file, or password.\nThere are several ways to create a SAHFS, but the most commonly used method is through the use of a cryptographic algorithm. This algorithm takes the input data and performs a series of mathematical operations on it, which results in the creation of the hash value. The specific algorithm used to create a SAHFS is defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.\nThe process of creating a SAHFS is generally considered to be one-way, meaning that it is computationally infeasible to recreate the original input data from the hash value. This makes SAHFS useful for a variety of purposes, such as verifying the integrity of data, authenticating the identity of a sender, and storing passwords securely.\nIn summary, SAHFS are created through the use of a cryptographic algorithm that takes an input of any size and produces a fixed-length output, known as a hash value or digest. This process is defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SAHFS stands for Secure Hash Functions (SHA) with a Hash Value of 160 bits.\n2. SAHFS produce a unique fixed-length output from an input of any size, known as a hash value or digest.\n3. SAHFS uses a cryptographic algorithm defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.\n4. The process of creating a SAHFS is generally considered to be one-way, making it computationally infeasible to recreate the original input from the hash value.\n5. SAHFS can be used for verifying data integrity, authenticating the identity of a sender, and storing passwords securely.",
    "vicuna-13b_fact": [
      "SAHFS stands for Secure Hash Functions (SHA) with a Hash Value of 160 bits.",
      "SAHFS produce a unique fixed-length output from an input of any size, known as a hash value or digest.",
      "SAHFS uses a cryptographic algorithm defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.",
      "The process of creating a SAHFS is generally considered to be one-way, making it computationally infeasible to recreate the original input from the hash value.",
      "SAHFS can be used for verifying data integrity, authenticating the identity of a sender, and storing passwords securely."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: SHA stands for Secure Hash Algorithm with a Hash Value of 160 bits.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3641,
    "user_query": "What is another name for AZD0530?",
    "vicuna-13b_response": "AZD0530 is also known as MK-8628.",
    "vicuna-13b_fact_raw": "The factual statement is: \n1. AZD0530 is also known as MK-8628.",
    "vicuna-13b_fact": [
      "AZD0530 is also known as MK-8628."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: AZD0530 is also known as Saracatinib, not MK-8628.",
    "vicuna-13b_judge": [
      "false"
    ]
  },
  {
    "id": 3647,
    "user_query": "What is the Match BAM to VCF method?",
    "vicuna-13b_response": "The Match BAM to VCF method is a tool used in genomics research to align BAM (Binary Alignment Map) files to a reference VCF (Variation Call Format) file. BAM files contain the alignment of DNA sequences to a reference genome, while VCF files contain information about the genetic variations found in a sample, such as single nucleotide polymorphisms (SNPs) and small insertions and deletions (indels).\nThe Match BAM to VCF method uses a set of rules to match the BAM alignments to the reference VCF variants. The method first identifies the overlapping regions between the BAM alignments and the reference VCF variants, and then uses a set of rules to determine which BAM alignments correspond to which VCF variants.\nThe rules used by the Match BAM to VCF method can be customized to suit the specific needs of a particular study. For example, the method can be configured to only consider alignments with a certain minimum quality score, or to only consider variants that are within a certain distance of the alignment.\nOverall, the Match BAM to VCF method is a useful tool for identifying the genetic variations that are present in a sample, and can be used to help understand the genetic basis of disease or other phenotypes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Match BAM to VCF method is a tool used in genomics research.\n2. BAM files contain the alignment of DNA sequences to a reference genome.\n3. VCF files contain information about the genetic variations found in a sample.\n4. The Match BAM to VCF method uses a set of rules to match the BAM alignments to the reference VCF variants.\n5. The rules used by the Match BAM to VCF method can be customized to suit the needs of a particular study.",
    "vicuna-13b_fact": [
      "The Match BAM to VCF method is a tool used in genomics research.",
      "BAM files contain the alignment of DNA sequences to a reference genome.",
      "VCF files contain information about the genetic variations found in a sample.",
      "The Match BAM to VCF method uses a set of rules to match the BAM alignments to the reference VCF variants.",
      "The rules used by the Match BAM to VCF method can be customized to suit the needs of a particular study."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3649,
    "user_query": "Is SATB1 expressed in thymocytes?",
    "vicuna-13b_response": "SATB1, also known as special AT-rich binding protein 1, is a transcription factor that plays a role in the development and differentiation of various cell types, including hematopoietic cells.\nThymocytes are a type of immune cell that develops from hematopoietic stem cells in the bone marrow and mature in the thymus. They are responsible for the development of T cells, a type of T cell that plays a central role in cell-mediated immunity.\nWhile SATB1 has been shown to be expressed in various hematopoietic cells, including T cells and B cells, there is limited information available on its expression in thymocytes specifically. However, it is likely that SATB1 is expressed in thymocytes, as it is a ubiquitously expressed transcription factor that regulates the expression of a wide range of genes involved in cell growth, differentiation, and survival.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SATB1, also known as special AT-rich binding protein 1, is a transcription factor that contributes to the development and differentiation of various cell types.\n2. Thymocytes are a type of immune cell that develops from hematopoietic stem cells in the bone marrow.\n3. Thymocytes are responsible for the development of T cells.\n4. SATB1 is known to be expressed in various hematopoietic cells, including T cells and B cells.\n5. SATB1 regulates the expression of a wide range of genes involved in cell growth, differentiation, and survival.",
    "vicuna-13b_fact": [
      "SATB1, also known as special AT-rich binding protein 1, is a transcription factor that contributes to the development and differentiation of various cell types.",
      "Thymocytes are a type of immune cell that develops from hematopoietic stem cells in the bone marrow.",
      "Thymocytes are responsible for the development of T cells.",
      "SATB1 is known to be expressed in various hematopoietic cells, including T cells and B cells.",
      "SATB1 regulates the expression of a wide range of genes involved in cell growth, differentiation, and survival."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Thymocytes are a type of immune cell that develops in the thymus, not the bone marrow.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3652,
    "user_query": "Describe Twiddler Syndrome.",
    "vicuna-13b_response": "Twiddler's syndrome is a condition that affects the thumbs and hands of individuals who excessively use their thumbs to type or text on mobile devices. It is also known as \"Blackberry thumb\" or \"Texting thumb.\"\nThe condition is caused by repetitive strain injury (RSI) to the thumb and wrist, which can lead to pain, swelling, and stiffness in the affected area. It is commonly seen in people who use their thumbs to type on small keypads for extended periods of time, such as those found on smartphones and other mobile devices.\nSymptoms of Twiddler's syndrome include pain and stiffness in the thumb and wrist, difficulty moving the thumb, and decreased grip strength. In severe cases, it can lead to decreased range of motion and even permanent damage to the affected area.\nTo prevent Twiddler's syndrome, it is recommended to take frequent breaks while using mobile devices, to use the proper grip while typing, and to stretch the affected area regularly. If you experience symptoms of Twiddler's syndrome, it is important to seek medical attention to prevent further damage and to develop an appropriate treatment plan.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Twiddler's syndrome affects the thumbs and hands of individuals who excessively use their thumbs to type or text on mobile devices.\n2. Twiddler's syndrome is also known as \"Blackberry thumb\" or \"Texting thumb.\"\n3. The condition is caused by repetitive strain injury (RSI) to the thumb and wrist, leading to pain, swelling, and stiffness in the affected area.\n4. Symptoms of Twiddler's syndrome include pain and stiffness in the thumb and wrist, difficulty moving the thumb, and decreased grip strength.\n5. To prevent Twiddler's syndrome, it is recommended to take frequent breaks while using mobile devices, use the proper grip while typing, and stretch the affected area regularly.",
    "vicuna-13b_fact": [
      "Twiddler's syndrome affects the thumbs and hands of individuals who excessively use their thumbs to type or text on mobile devices.",
      "Twiddler's syndrome is also known as \"Blackberry thumb\" or \"Texting thumb.\"",
      "The condition is caused by repetitive strain injury (RSI) to the thumb and wrist, leading to pain, swelling, and stiffness in the affected area.",
      "Symptoms of Twiddler's syndrome include pain and stiffness in the thumb and wrist, difficulty moving the thumb, and decreased grip strength.",
      "To prevent Twiddler's syndrome, it is recommended to take frequent breaks while using mobile devices, use the proper grip while typing, and stretch the affected area regularly."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [Correction]: Twiddler's syndrome is a condition that affects individuals with pacemaker or implantable cardioverter-defibrillator (ICD) devices, where the patient unintentionally or habitually manipulates the device, leading to lead displacement or device malfunction. It's not related to excessive thumb use on mobiles.\n2. FALSE [Correction]: \"Blackberry thumb\" or \"Texting thumb\" are colloquial names for a condition not known as Twiddler's syndrome but instead as De Quervain’s Tenosynovitis.\n3. FALSE [Correction]: Twiddler's syndrome is not caused by repetitive strain injury (RSI). It is associated with device manipulation in patients with pacemaker or ICD devices.\n4. FALSE [Correction]: Symptoms of Twiddler's syndrome are not related to pain or stiffness in thumb or wrist. It usually leads to symptoms like palpitations, syncope, or dyspnea due to malfunction of the pacemaker or ICD device.\n5. FALSE [Correction]: Prevention of Twiddler's syndrome involves correct surgical implantation of devices and patient education about not manipulating their implanted devices rather than taking breaks while using mobile devices or practicing proper grip while typing.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3654,
    "user_query": "What is iodine thyroid blocking?",
    "vicuna-13b_response": "Iodine thyroid blocking is a process in which the thyroid gland is prevented from absorbing iodine, a trace element necessary for the production of thyroid hormones. This can be achieved through the use of certain medications, such as iodine-containing contrast agents used in medical imaging, or through the use of iodine-blocking agents in the treatment of hyperthyroidism. The goal of iodine thyroid blocking is to either prevent the production of thyroid hormones or to inhibit the absorption of iodine by the thyroid gland, depending on the specific medical condition being treated.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Iodine thyroid blocking is a process which prevents the thyroid gland from absorbing iodine.\n2. Iodine is needed for the production of thyroid hormones.\n3. Iodine thyroid blocking can be achieved using certain medications, such as iodine-containing contrast agents used in medical imaging.\n4. Iodine-blocking agents can be used in the treatment of hyperthyroidism.\n5. The goal of iodine thyroid blocking is to inhibit the absorption of iodine by the thyroid gland or to prevent the production of thyroid hormones.",
    "vicuna-13b_fact": [
      "Iodine thyroid blocking is a process which prevents the thyroid gland from absorbing iodine.",
      "Iodine is needed for the production of thyroid hormones.",
      "Iodine thyroid blocking can be achieved using certain medications, such as iodine-containing contrast agents used in medical imaging.",
      "Iodine-blocking agents can be used in the treatment of hyperthyroidism.",
      "The goal of iodine thyroid blocking is to inhibit the absorption of iodine by the thyroid gland or to prevent the production of thyroid hormones."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Iodine thyroid blocking is a process which prevents the thyroid gland from absorbing radioactive iodine.\n2. TRUE\n3. FALSE [correction]: Iodine thyroid blocking can be achieved using certain medications, such as Potassium iodide.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3658,
    "user_query": "What is the mechanism of action of rogaratinib?",
    "vicuna-13b_response": "Rogaratinib is a tyrosine kinase inhibitor (TKI) that is used to treat certain types of cancer, including leukemia and lymphoma. The mechanism of action of rogaratinib is related to its ability to inhibit the activity of the c-Kit and PDGFR-β tyrosine kinases, which are involved in cell growth and survival.\nWhen rogaratinib binds to these kinases, it blocks their activity, which in turn inhibits the signaling pathways that promote cell proliferation and survival. This leads to the apoptosis (programmed cell death) of cancer cells, which can help to slow down or stop the growth and spread of the cancer.\nRogaratinib is typically administered orally as a tablet, and its dosage and schedule depend on the specific condition being treated, the patient's weight, and other factors. The most common side effects of rogaratinib include diarrhea, nausea, vomiting, and fatigue.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Rogaratinib is a tyrosine kinase inhibitor (TKI).\n2. Rogaratinib is used to treat certain types of cancer, including leukemia and lymphoma.\n3. Rogaratinib works by inhibiting the activity of the c-Kit and PDGFR-β tyrosine kinases, which are involved in cell growth and survival.\n4. By blocking the activity of these kinases, rogaratinib can trigger apoptosis (programmed cell death) of cancer cells.\n5. The most common side effects of rogaratinib include diarrhea, nausea, vomiting, and fatigue.",
    "vicuna-13b_fact": [
      "Rogaratinib is a tyrosine kinase inhibitor (TKI).",
      "Rogaratinib is used to treat certain types of cancer, including leukemia and lymphoma.",
      "Rogaratinib works by inhibiting the activity of the c-Kit and PDGFR-β tyrosine kinases, which are involved in cell growth and survival.",
      "By blocking the activity of these kinases, rogaratinib can trigger apoptosis (programmed cell death) of cancer cells.",
      "The most common side effects of rogaratinib include diarrhea, nausea, vomiting, and fatigue."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3661,
    "user_query": "List diseases that are caused by the Meningococcus B?",
    "vicuna-13b_response": "Meningococcus B is a type of bacteria that can cause a serious infection known as meningococcal disease. The most common symptoms of meningococcal disease are fever, headache, and a stiff neck. The infection can also cause other symptoms such as vomiting, diarrhea, and rash.\nMeningococcal disease can be caused by several different types of bacteria, including Meningococcus B. Some of the diseases that can be caused by Meningococcus B include:\n1. Meningitis: Inflammation of the membranes that surround the brain and spinal cord.\n2. Septicaemia: Blood poisoning caused by the spread of bacteria throughout the body.\n3. Pneumonia: Inflammation of the lungs.\nMeningococcal disease can be treated with antibiotics, but it is important to seek medical attention immediately if you suspect that you or someone you know may have the infection. Preventive vaccines are also available to protect against meningococcal disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Meningococcus B is a type of bacteria that can cause meningococcal disease.\n2. Meningitis, an inflammation of the membranes that surround the brain and spinal cord, can be caused by Meningococcus B.\n3. Septicaemia, or blood poisoning caused by the spread of bacteria throughout the body, can also be caused by Meningococcus B.\n4. Pneumonia, an inflammation of the lungs, can be the result of Meningococcus B.\n5. Preventive vaccines are available to protect against meningococcal disease.",
    "vicuna-13b_fact": [
      "Meningococcus B is a type of bacteria that can cause meningococcal disease.",
      "Meningitis, an inflammation of the membranes that surround the brain and spinal cord, can be caused by Meningococcus B.",
      "Septicaemia, or blood poisoning caused by the spread of bacteria throughout the body, can also be caused by Meningococcus B.",
      "Pneumonia, an inflammation of the lungs, can be the result of Meningococcus B.",
      "Preventive vaccines are available to protect against meningococcal disease."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Pneumonia, an inflammation of the lungs, is typically not caused by Meningococcus B but rather other types of bacteria, viruses, or fungi.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3664,
    "user_query": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved",
    "vicuna-13b_response": "TBC1 domain family member 16 (TBC1D16) is a protein that has been shown to play a role in regulating cell growth and division. Several studies have suggested that TBC1D16 may be involved in the development and progression of certain types of cancer.\nOne study published in the journal Cancer Research in 2013 found that high levels of TBC1D16 expression were associated with poor prognosis in patients with colorectal cancer. Another study published in the journal Cancer Research in 2016 found that TBC1D16 was overexpressed in a subset of breast cancer cases and that its expression was associated with poor outcomes.\nOther studies have suggested that TBC1D16 may be involved in the development and progression of other types of cancer, including lung cancer, ovarian cancer, and gastric cancer. However, more research is needed to fully understand the role of TBC1D16 in cancer and to determine whether targeting this protein with drugs or other therapeutic approaches could be an effective way to treat cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TBC1 domain family member 16 (TBC1D16) plays a role in regulating cell growth and division.\n2. High levels of TBC1D16 expression were associated with poor prognosis in patients with colorectal cancer, according to a 2013 study in the journal Cancer Research.\n3. TBC1D16 was found to be overexpressed in a subset of breast cancer cases, its expression was associated with poor outcomes as per a 2016 study published in the journal Cancer Research.\n4. Studies have suggested TBC1D16 may be involved in the development and progression of lung cancer, ovarian cancer, and gastric cancer.\n5. More research is needed to fully understand the role of TBC1D16 in cancer and to determine whether targeting this protein with drugs or other therapeutic approaches could be an effective way to treat cancer.",
    "vicuna-13b_fact": [
      "TBC1 domain family member 16 (TBC1D16) plays a role in regulating cell growth and division.",
      "High levels of TBC1D16 expression were associated with poor prognosis in patients with colorectal cancer, according to a 2013 study in the journal Cancer Research.",
      "TBC1D16 was found to be overexpressed in a subset of breast cancer cases, its expression was associated with poor outcomes as per a 2016 study published in the journal Cancer Research.",
      "Studies have suggested TBC1D16 may be involved in the development and progression of lung cancer, ovarian cancer, and gastric cancer.",
      "More research is needed to fully understand the role of TBC1D16 in cancer and to determine whether targeting this protein with drugs or other therapeutic approaches could be an effective way to treat cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3665,
    "user_query": "What does osanetant and talnetant have in common?",
    "vicuna-13b_response": "I'm sorry, but I'm not sure what you are referring to when you say \"osanetant\" and \"talnetant.\" Could you please provide more context or clarify your question?",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 3666,
    "user_query": "List SLC25A46-related pathologies",
    "vicuna-13b_response": "SLC25A46 is a gene that encodes a protein called Zinc transporter 7 (ZnT-7). This protein is involved in the regulation of zinc homeostasis in the body, which is essential for many cellular processes. Mutations in the SLC25A46 gene have been associated with several pathologies, including:\n1. Neurodevelopmental disorders: Mutations in SLC25A46 have been linked to a variety of neurodevelopmental disorders, including intellectual disability, autism spectrum disorder, and epilepsy.\n2. Cognitive impairment: Some studies have suggested that SLC25A46 mutations may be associated with cognitive impairment in older adults.\n3. Zinc deficiency: Mutations in SLC25A46 can lead to reduced levels of zinc in the body, which can cause a range of health problems, including growth retardation, skin lesions, and diarrhea.\n4. Neurodegenerative diseases: Some studies have suggested that SLC25A46 mutations may be associated with an increased risk of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.\n5. Cancer: While the exact role of SLC25A46 in cancer is not well understood, some studies have suggested that it may play a role in regulating cell growth and proliferation, and mutations in the gene may be associated with an increased risk of certain types of cancer.\nIt is important to note that while these associations have been identified, further research is needed to confirm the role of SLC25A46 in these pathologies and to fully understand the mechanisms by which mutations in the gene can lead to these health problems.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SLC25A46 is a gene that encodes a protein called Zinc transporter 7.\n2. This protein is involved in the regulation of zinc homeostasis in the body.\n3. Mutations in the SLC25A46 gene have been associated with several pathologies, including neurodevelopmental disorders, cognitive impairment, zinc deficiency, neurodegenerative diseases, and cancer.\n4. Mutations in SLC25A46 have been linked to neurodevelopmental disorders like intellectual disability, autism spectrum disorder, and epilepsy.\n5. Some studies suggest that mutations in SLC25A46 may be associated with cognitive impairment in older adults and an increased risk of neurodegenerative diseases and certain types of cancer.",
    "vicuna-13b_fact": [
      "SLC25A46 is a gene that encodes a protein called Zinc transporter 7.",
      "This protein is involved in the regulation of zinc homeostasis in the body.",
      "Mutations in the SLC25A46 gene have been associated with several pathologies, including neurodevelopmental disorders, cognitive impairment, zinc deficiency, neurodegenerative diseases, and cancer.",
      "Mutations in SLC25A46 have been linked to neurodevelopmental disorders like intellectual disability, autism spectrum disorder, and epilepsy.",
      "Some studies suggest that mutations in SLC25A46 may be associated with cognitive impairment in older adults and an increased risk of neurodegenerative diseases and certain types of cancer."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: SLC25A46 is a gene that encodes a protein involved in mitochondrial dynamics and function, not Zinc transporter 7.\n2. FALSE [correction]: The protein encoded by the SLC25A46 gene is not specifically involved in the regulation of zinc homeostasis in the body, rather, it is involved in the function and dynamics of mitochondria.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "vicuna-13b_response": "The PDZ domain is a protein domain found in the SATB1 (Special AT-rich binding protein 1) protein. The PDZ domain is a common protein interaction domain that is involved in the regulation of various cellular processes, including cell signaling, trafficking, and development.\nThe PDZ domain of SATB1 is involved in protein-protein interactions with other proteins, including receptors, ion channels, and scaffolding proteins. These interactions play a role in the regulation of cellular responses to various stimuli, including hormones, neurotransmitters, and growth factors.\nSATB1 is expressed in various tissues, including the brain, heart, and pancreas, and is involved in the regulation of cellular processes such as cell proliferation, differentiation, and survival. The PDZ domain of SATB1 is thought to play a role in these processes by mediating interactions with other proteins that regulate cellular signaling pathways.\nOverall, the function of the PDZ domain in SATB1 is to mediate protein-protein interactions that regulate cellular processes, including cell signaling, trafficking, and development.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The PDZ domain is a protein domain found in the SATB1 protein.\n2. The PDZ domain is involved in regulating various cellular processes such as cell signaling, trafficking, and development.\n3. The PDZ domain in SATB1 mediates protein-protein interactions with other proteins, including receptors, ion channels, and scaffolding proteins.\n4. SATB1 is expressed in various tissues, such as the brain, heart, and pancreas.\n5. SATB1 is involved in the regulation of cellular processes such as cell proliferation, differentiation, and survival.",
    "vicuna-13b_fact": [
      "The PDZ domain is a protein domain found in the SATB1 protein.",
      "The PDZ domain is involved in regulating various cellular processes such as cell signaling, trafficking, and development.",
      "The PDZ domain in SATB1 mediates protein-protein interactions with other proteins, including receptors, ion channels, and scaffolding proteins.",
      "SATB1 is expressed in various tissues, such as the brain, heart, and pancreas.",
      "SATB1 is involved in the regulation of cellular processes such as cell proliferation, differentiation, and survival."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3675,
    "user_query": "Which are the databases for intrinsic protein disorders?",
    "vicuna-13b_response": "There are several databases that are useful for identifying intrinsic protein disorders. Some of the most commonly used databases include:\n1. UniProt: UniProt is a comprehensive protein database that provides information on protein sequences, structures, functions, and disorders. It contains information on over 250,000 human and mouse proteins, as well as a large number of other organisms.\n2. OMIM: OMIM (Online Mendelian Inheritance in Man) is a database of human genetic disorders. It contains information on over 25,000 genes and disorders, and is a valuable resource for identifying genetic disorders that are caused by mutations in specific genes.\n3. DisGeNET: DisGeNET is a database of genetic disorders that is based on the OMIM database. It provides information on over 2,000 genetic disorders, and includes data on the underlying genetic causes of each disorder, as well as information on the associated phenotypes and other relevant information.\n4. ClinVar: ClinVar is a database of clinically relevant variants that is based on the OMIM database. It provides information on over 250,000 variants, including both pathogenic and benign variants, and is a valuable resource for identifying variants that may be associated with disease.\n5. Gene2Phenotype: Gene2Phenotype is a database that links genetic variations to their potential phenotypic effects. It provides information on over 100,000 genetic variations, and includes data on the associated phenotypes, as well as information on the underlying genetics and other relevant information.\nThese databases can be used together to identify intrinsic protein disorders, and to gain a better understanding of the underlying genetics and mechanisms of these disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. UniProt is a comprehensive protein database providing information on protein sequences, structures, functions, and disorders.\n2. OMIM is a database of human genetic disorders, providing information on over 25,000 genes and disorders.\n3. DisGeNET is a database providing information on over 2,000 genetic disorders, it is based on the OMIM database.\n4. ClinVar is a database of clinically relevant variants providing information on over 250,000 variants.\n5. Gene2Phenotype is a database that links genetic variations to their potential phenotypic effects, providing information on over 100,000 genetic variations.",
    "vicuna-13b_fact": [
      "UniProt is a comprehensive protein database providing information on protein sequences, structures, functions, and disorders.",
      "OMIM is a database of human genetic disorders, providing information on over 25,000 genes and disorders.",
      "DisGeNET is a database providing information on over 2,000 genetic disorders, it is based on the OMIM database.",
      "ClinVar is a database of clinically relevant variants providing information on over 250,000 variants.",
      "Gene2Phenotype is a database that links genetic variations to their potential phenotypic effects, providing information on over 100,000 genetic variations."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3676,
    "user_query": "List the 5 different human immunoglobulin heavy chains.",
    "vicuna-13b_response": "The five different human immunoglobulin heavy chains are:\n1. IgG (Immunoglobulin G)\n2. IgA (Immunoglobulin A)\n3. IgM (Immunoglobulin M)\n4. IgE (Immunoglobulin E)\n5. IgD (Immunoglobulin D)\nThese five types of immunoglobulins are classified based on their physical and chemical properties, and they play different roles in the immune system. For example, IgG is the most abundant immunoglobulin in the blood and lymph fluid, and it is responsible for neutralizing bacterial and viral infections. IgA is found in mucosal secretions and helps protect against infections in the respiratory and gastrointestinal tracts. IgM is the first type of immunoglobulin produced in response to a new infection, and it plays a key role in the early stages of an immune response. IgE is involved in the protection against parasites and is also responsible for the production of histamine in response to an allergic reaction. IgD is a type of immunoglobulin found on the surface of B cells and is involved in the process of B cell activation and differentiation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. There are five different human immunoglobulin heavy chains: IgG, IgA, IgM, IgE, IgD.\n2. IgG is the most abundant immunoglobulin in the blood and lymph fluid, and it is responsible for neutralizing bacterial and viral infections.\n3. IgA is found in mucosal secretions and helps protect against infections in the respiratory and gastrointestinal tracts.\n4. IgM is the first type of immunoglobulin produced in response to a new infection, and it plays a key role in the early stages of an immune response.\n5. IgE is involved in the protection against parasites and is also responsible for the production of histamine in response to an allergic reaction.\n6. IgD is a type of immunoglobulin found on the surface of B cells and is involved in the process of B cell activation and differentiation.",
    "vicuna-13b_fact": [
      "There are five different human immunoglobulin heavy chains: IgG, IgA, IgM, IgE, IgD.",
      "IgG is the most abundant immunoglobulin in the blood and lymph fluid, and it is responsible for neutralizing bacterial and viral infections.",
      "IgA is found in mucosal secretions and helps protect against infections in the respiratory and gastrointestinal tracts.",
      "IgM is the first type of immunoglobulin produced in response to a new infection, and it plays a key role in the early stages of an immune response.",
      "IgE is involved in the protection against parasites and is also responsible for the production of histamine in response to an allergic reaction.",
      "IgD is a type of immunoglobulin found on the surface of B cells and is involved in the process of B cell activation and differentiation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "vicuna-13b_response": "The BLISS technique is a method for improving sleep quality and reducing insomnia symptoms. It is an acronym that stands for:\nB - Bedtime routine: Establishing a consistent bedtime routine can help regulate the sleep-wake cycle and promote better sleep.\nL - Light exposure: Exposure to natural light during the day and dim red light in the evening can help regulate the sleep-wake cycle and improve sleep quality.\nI - Insomnia-specific exercises: Cognitive-behavioral therapy for insomnia (CBT-I) is a type of therapy that can help people with insomnia improve their sleep by changing negative thoughts and behaviors related to sleep.\nS - Sleep hygiene: Practicing good sleep hygiene, such as maintaining a dark, cool, and quiet sleep environment, can improve sleep quality.\nS - Sleep restriction: Limiting time in bed to the amount of time spent asleep can help increase the sleep drive and improve sleep quality.\nOverall, the BLISS technique is based on the principles of cognitive-behavioral therapy for insomnia (CBT-I) and emphasizes the importance of establishing a consistent bedtime routine, regulating light exposure, and practicing good sleep hygiene to improve sleep quality and reduce insomnia symptoms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The BLISS technique is a method for improving sleep quality and reducing insomnia symptoms.\n2. BLISS is an acronym that stands for Bedtime routine, Light exposure, Insomnia-specific exercises, Sleep hygiene, and Sleep restriction.\n3. Cognitive-behavioral therapy for insomnia (CBT-I) is a component of the BLISS technique.\n4. The BLISS technique emphasizes the importance of establishing a consistent bedtime routine, regulating light exposure, and practicing good sleep hygiene.\n5. One of the principles of the BLISS technique is limiting time in bed to the amount of time spent asleep.",
    "vicuna-13b_fact": [
      "The BLISS technique is a method for improving sleep quality and reducing insomnia symptoms.",
      "BLISS is an acronym that stands for Bedtime routine, Light exposure, Insomnia-specific exercises, Sleep hygiene, and Sleep restriction.",
      "Cognitive-behavioral therapy for insomnia (CBT-I) is a component of the BLISS technique.",
      "The BLISS technique emphasizes the importance of establishing a consistent bedtime routine, regulating light exposure, and practicing good sleep hygiene.",
      "One of the principles of the BLISS technique is limiting time in bed to the amount of time spent asleep."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: BLISS is an acronym that stands for Bedtime routine, Limiting behavior, Internal distractions, Sleep hygiene, and Stimulus control.\n3. FALSE [correction]: Cognitive-behavioral therapy for insomnia (CBT-I) is a separate method for managing insomnia, it is not a component of the BLISS technique.\n4. TRUE\n5. FALSE [correction]: One of the principles of the BLISS technique is controlling stimulus that can interfere with sleep, not limiting time in bed to the amount of time asleep.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "vicuna-13b_response": "NK3R (Neurokinin-3 receptor) is a G protein-coupled receptor that is involved in various physiological processes, including pain, inflammation, and gastrointestinal motility. Antagonists of NK3R can bind to the receptor and block its activation, leading to various therapeutic effects. Here are three examples of NK3R antagonists:\n1. Aprepitant: Aprepitant is a synthetic analogue of the natural neurotransmitter substance P, which is a potent antagonist of NK3R. Aprepitant is used as an antiemetic drug to prevent nausea and vomiting associated with chemotherapy. It is also being investigated for its potential use in treating other conditions, such as pain and inflammation.\n2. Emend: Emend (fosaprepitant) is a prodrug of aprepitant and is used to prevent nausea and vomiting associated with chemotherapy. It is a long-acting form of aprepitant and is administered as a single dose on the day of chemotherapy. Emend has been shown to have anti-inflammatory and analgesic effects in addition to its antiemetic effects.\n3. MK-8628: MK-8628 is a potent and selective NK3R antagonist that has been shown to have anti-inflammatory and analgesic effects in animal models. It has been proposed as a potential treatment for chronic pain conditions, such as fibromyalgia and neuropathic pain. MK-8628 is currently in preclinical development and has not yet been approved for use in humans.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Neurokinin-3 receptor (NK3R) is a G protein-coupled receptor involved in physiological processes such as pain, inflammation, and gastrointestinal motility.\n2. Aprepitant is a synthetic analogue of the natural neurotransmitter substance P and an antagonist of NK3R, used as an antiemetic drug to prevent feelings of sickness and vomiting associated with chemotherapy.\n3. Emend (fosaprepitant) is a prodrug of aprepitant used to prevent nausea and vomiting related to chemotherapy.\n4. Emend (fosaprepitant) has displayed anti-inflammatory and analgesic effects alongside its antiemetic qualities.\n5. MK-8628 is a potent and selective NK3R antagonist being developed to potentially treat chronic pain conditions like fibromyalgia and neuropathic pain, currently in preclinical development.",
    "vicuna-13b_fact": [
      "Neurokinin-3 receptor (NK3R) is a G protein-coupled receptor involved in physiological processes such as pain, inflammation, and gastrointestinal motility.",
      "Aprepitant is a synthetic analogue of the natural neurotransmitter substance P and an antagonist of NK3R, used as an antiemetic drug to prevent feelings of sickness and vomiting associated with chemotherapy.",
      "Emend (fosaprepitant) is a prodrug of aprepitant used to prevent nausea and vomiting related to chemotherapy.",
      "Emend (fosaprepitant) has displayed anti-inflammatory and analgesic effects alongside its antiemetic qualities.",
      "MK-8628 is a potent and selective NK3R antagonist being developed to potentially treat chronic pain conditions like fibromyalgia and neuropathic pain, currently in preclinical development."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Aprepitant is a synthetic substance, and it is an antagonist of the neurokinin-1 receptor (NK1R), not NK3R. It is used as an antiemetic drug to prevent feelings of sickness and vomiting associated with chemotherapy.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3682,
    "user_query": "Is indinavir effective for treatment of amyotrophic lateral sclerosis?",
    "vicuna-13b_response": "Indinavir is not currently approved or recommended for the treatment of amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and wasting. Indinavir is a protease inhibitor that is primarily used to treat HIV infection. While there is ongoing research into the potential therapeutic benefits of protease inhibitors for the treatment of ALS, there is currently no strong evidence to support the use of indinavir for this purpose. It is important to note that ALS is a complex and multifactorial disease, and effective treatment requires a comprehensive approach that addresses the underlying causes and symptoms of the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Indinavir is not currently approved or recommended for the treatment of amyotrophic lateral sclerosis (ALS).\n2. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.\n3. Indinavir is a protease inhibitor.\n4. Indinavir is primarily used to treat HIV infection.\n5. There is ongoing research into the potential therapeutic benefits of protease inhibitors for the treatment of ALS.",
    "vicuna-13b_fact": [
      "Indinavir is not currently approved or recommended for the treatment of amyotrophic lateral sclerosis (ALS).",
      "ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.",
      "Indinavir is a protease inhibitor.",
      "Indinavir is primarily used to treat HIV infection.",
      "There is ongoing research into the potential therapeutic benefits of protease inhibitors for the treatment of ALS."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3685,
    "user_query": "What is ORMD-0801?",
    "vicuna-13b_response": "I'm sorry, but I don't have any information about ORMD-0801. Can you provide any additional context or details about what you are looking for?",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 3686,
    "user_query": "Does saracatinib promote oncogenesis?",
    "vicuna-13b_response": "Saracatinib is a small molecule inhibitor that targets the tyrosine kinase enzyme, which is involved in cell growth and differentiation. It has been studied for its potential use in the treatment of various types of cancer, including leukemia and solid tumors.\nHowever, the use of saracatinib in cancer treatment is still in the experimental stages, and its effects on oncogenesis (the process of cancer development) are not yet fully understood. Some studies have suggested that saracatinib may have anti-tumor effects and can inhibit the growth and proliferation of cancer cells. However, other studies have also shown that saracatinib can promote oncogenesis in certain contexts, such as when it is used in combination with other cancer therapies.\nOverall, more research is needed to fully understand the effects of saracatinib on oncogenesis and its potential use in cancer treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Saracatinib is a small molecule inhibitor that targets the tyrosine kinase enzyme.\n2. The tyrosine kinase enzyme is involved in cell growth and differentiation.\n3. Saracatinib has been studied for its potential use in the treatment of various types of cancer.\n4. The use of saracatinib in cancer treatment is still in the experimental stages.\n5. Some studies have suggested that saracatinib may have anti-tumor effects and can inhibit the growth and proliferation of cancer cells.",
    "vicuna-13b_fact": [
      "Saracatinib is a small molecule inhibitor that targets the tyrosine kinase enzyme.",
      "The tyrosine kinase enzyme is involved in cell growth and differentiation.",
      "Saracatinib has been studied for its potential use in the treatment of various types of cancer.",
      "The use of saracatinib in cancer treatment is still in the experimental stages.",
      "Some studies have suggested that saracatinib may have anti-tumor effects and can inhibit the growth and proliferation of cancer cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3687,
    "user_query": "Is BCL11B involved in schizophrenia?",
    "vicuna-13b_response": "BCL11B is a gene that encodes a transcription factor involved in the regulation of neuronal development and function. There is some evidence to suggest that BCL11B may be involved in the development of schizophrenia, a mental illness characterized by symptoms such as delusions, hallucinations, and disorganized thinking.\nStudies have found that individuals with schizophrenia are more likely to have certain variations in the BCL11B gene, and that these variations may be associated with an increased risk of developing the disorder. However, it is important to note that the relationship between BCL11B and schizophrenia is still an area of active research, and more studies are needed to fully understand the role of this gene in the development of the disorder.\nAdditionally, it is important to note that schizophrenia is a complex disorder with many possible causes, including genetic, environmental, and neurobiological factors. Therefore, it is likely that the development of schizophrenia is influenced by a combination of genetic and environmental factors, and that the role of any single gene, including BCL11B, is likely to be complex and multifactorial.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BCL11B is a gene that encodes a transcription factor involved in the regulation of neuronal development and function.\n2. There's evidence suggesting BCL11B may have involvement in the development of schizophrenia.\n3. Studies have found that individuals with schizophrenia are more likely to have certain variations in the BCL11B gene.\n4. These variations in the BCL11B gene may be associated with an increased risk of developing schizophrenia.\n5. The development of schizophrenia is likely influenced by a combination of genetic and environmental factors.",
    "vicuna-13b_fact": [
      "BCL11B is a gene that encodes a transcription factor involved in the regulation of neuronal development and function.",
      "There's evidence suggesting BCL11B may have involvement in the development of schizophrenia.",
      "Studies have found that individuals with schizophrenia are more likely to have certain variations in the BCL11B gene.",
      "These variations in the BCL11B gene may be associated with an increased risk of developing schizophrenia.",
      "The development of schizophrenia is likely influenced by a combination of genetic and environmental factors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3690,
    "user_query": "What is a zoonotic virus?",
    "vicuna-13b_response": "A zoonotic virus is a virus that is transmitted from animals to humans. The word \"zoonotic\" comes from the Greek words \"zoon\" meaning \"animal\" and \"nosos\" meaning \"disease\". Zoonotic viruses can cause a wide range of diseases, from mild illnesses to severe and life-threatening conditions. These viruses can be transmitted through various routes, such as through direct contact with infected animals, consuming contaminated food or water, or being bitten by insects that have fed on infected animals. Examples of zoonotic viruses include influenza, Ebola, Marburg virus, Lassa fever, and rabies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A zoonotic virus is a virus that is transmitted from animals to humans.\n2. The term \"zoonotic\" comes from the Greek words \"zoon\" meaning \"animal\" and \"nosos\" meaning \"disease\".\n3. Zoonotic viruses can cause a wide range of diseases, from mild to severe life-threatening conditions.\n4. These viruses can be transmitted through direct contact with infected animals, consuming contaminated food or water, or being bitten by insects that have fed on infected animals.\n5. Examples of zoonotic viruses include influenza, Ebola, Marburg virus, Lassa fever, and rabies.",
    "vicuna-13b_fact": [
      "A zoonotic virus is a virus that is transmitted from animals to humans.",
      "The term \"zoonotic\" comes from the Greek words \"zoon\" meaning \"animal\" and \"nosos\" meaning \"disease\".",
      "Zoonotic viruses can cause a wide range of diseases, from mild to severe life-threatening conditions.",
      "These viruses can be transmitted through direct contact with infected animals, consuming contaminated food or water, or being bitten by insects that have fed on infected animals.",
      "Examples of zoonotic viruses include influenza, Ebola, Marburg virus, Lassa fever, and rabies."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "vicuna-13b_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is called \"drug X\". Unfortunately, I do not have any further information about this drug as my training data only goes up until 2021 and I don't have access to any confidential or proprietary information. However, I can tell you that ghrelin is a hormone that plays a role in regulating appetite and energy homeostasis in the body. Inverse agonists are a type of drug that bind to a receptor but do not activate it, instead they block the activation of the receptor.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Drug X is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.\n2. Ghrelin is a hormone that regulates appetite and energy homeostasis in the body.\n3. Inverse agonists are a type of drug that bind to a receptor but do not activate it, instead they block the activation of the receptor.",
    "vicuna-13b_fact": [
      "Drug X is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "Ghrelin is a hormone that regulates appetite and energy homeostasis in the body.",
      "Inverse agonists are a type of drug that bind to a receptor but do not activate it, instead they block the activation of the receptor."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "vicuna-13b_response": "Vaxchora is a cholera vaccine that is given as a single dose and is approved for the prevention of moderate to severe cholera in adults and children six years of age and older. The protective efficacy of Vaxchora against moderate to severe cholera has been demonstrated in clinical trials.\nIn a study conducted in Bangladesh, Vaxchora was found to be 85% effective in preventing moderate to severe cholera in adults and children six years of age and older. In another study conducted in Haiti, Vaxchora was found to be 90% effective in preventing moderate to severe cholera in adults and children six years of age and older.\nIt is important to note that the protective efficacy of a vaccine can vary depending on a number of factors, including the population being vaccinated, the strain of cholera being targeted, and the timing of vaccination relative to exposure to cholera.\nIt is also important to follow the vaccination schedule and advice of your healthcare professional for the best protection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Vaxchora is a cholera vaccine that is given as a single dose.\n2. Vaxchora is approved for the prevention of moderate to severe cholera in adults and children six years of age and older.\n3. In a study conducted in Bangladesh, Vaxchora was found to be 85% effective in preventing moderate to severe cholera in adults and children six years of age and older.\n4. In a study conducted in Haiti, Vaxchora was found to be 90% effective in preventing moderate to severe cholera in adults and children six years of age and older.\n5. The protective efficacy of a vaccine can vary depending on a number of factors, including the population being vaccinated, the strain of cholera being targeted, and the timing of vaccination relative to exposure to cholera.",
    "vicuna-13b_fact": [
      "Vaxchora is a cholera vaccine that is given as a single dose.",
      "Vaxchora is approved for the prevention of moderate to severe cholera in adults and children six years of age and older.",
      "In a study conducted in Bangladesh, Vaxchora was found to be 85% effective in preventing moderate to severe cholera in adults and children six years of age and older.",
      "In a study conducted in Haiti, Vaxchora was found to be 90% effective in preventing moderate to severe cholera in adults and children six years of age and older.",
      "The protective efficacy of a vaccine can vary depending on a number of factors, including the population being vaccinated, the strain of cholera being targeted, and the timing of vaccination relative to exposure to cholera."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Vaxchora is approved for the prevention of cholera in adults 18 through 64 years of age.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3694,
    "user_query": "What is minodixil approved for?",
    "vicuna-13b_response": "Minodixil is a medication that is approved for the treatment of acute exacerbations of chronic bronchitis and pneumonia in patients who are at risk of developing respiratory tract infections. It is a macrolide antibiotic that works by inhibiting the growth of bacteria. Minodixil is usually prescribed for patients who have been diagnosed with chronic bronchitis or pneumonia and are at risk of developing complications from respiratory tract infections. It is important to note that Minodixil should only be used as directed by a healthcare professional and should not be used to treat viral infections.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Minodixil is a medication approved for the treatment of acute exacerbations of chronic bronchitis and pneumonia.\n2. Minodixil is typical for patients at risk of developing respiratory tract infections.\n3. Minodixil is a macrolide antibiotic.\n4. This medication works by inhibiting the growth of bacteria.\n5. Minodixil cannot be used to treat viral infections.",
    "vicuna-13b_fact": [
      "Minodixil is a medication approved for the treatment of acute exacerbations of chronic bronchitis and pneumonia.",
      "Minodixil is typical for patients at risk of developing respiratory tract infections.",
      "Minodixil is a macrolide antibiotic.",
      "This medication works by inhibiting the growth of bacteria.",
      "Minodixil cannot be used to treat viral infections."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The statement is incorrect as there is no known medication called Minodixil.\n2. FALSE [correction]: Again, no drug named Minodixil is recorded for treating patients at risk of developing respiratory tract infections.\n3. FALSE [correction]: Minodixil doesn't exist, thus can't be classified as a macrolide antibiotic.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3697,
    "user_query": "Is SATB1 necessary for T-cell maturation?",
    "vicuna-13b_response": "SATB1, also known as special AT-rich sequence-binding protein 1, is a transcription factor that plays a role in regulating the expression of genes involved in various cellular processes, including immune cell development. T-cells, also known as T-lymphocytes, are a type of immune cell that plays a central role in cell-mediated immunity.\nSATB1 has been shown to be involved in the development and maturation of T-cells. Studies have shown that SATB1 is expressed in developing T-cells and that it is necessary for the differentiation of T-cells into mature, functional cells. SATB1 has been shown to regulate the expression of genes involved in T-cell development and to play a role in the activation and proliferation of T-cells.\nIn summary, SATB1 is necessary for T-cell maturation, as it plays a role in regulating the development and differentiation of T-cells into mature, functional cells, and is involved in the activation and proliferation of T-cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SATB1, also known as special AT-rich sequence-binding protein 1, is a transcription factor.\n2. SATB1 regulates the expression of genes involved in various cellular processes, including immune cell development.\n3. T-cells, also known as T-lymphocytes, play a central role in cell-mediated immunity.\n4. SATB1 has been shown to be involved in the development and maturation of T-cells.\n5. SATB1 is necessary for the differentiation of T-cells into mature, functional cells.",
    "vicuna-13b_fact": [
      "SATB1, also known as special AT-rich sequence-binding protein 1, is a transcription factor.",
      "SATB1 regulates the expression of genes involved in various cellular processes, including immune cell development.",
      "T-cells, also known as T-lymphocytes, play a central role in cell-mediated immunity.",
      "SATB1 has been shown to be involved in the development and maturation of T-cells.",
      "SATB1 is necessary for the differentiation of T-cells into mature, functional cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3700,
    "user_query": "What is the function of a viral peplomer?",
    "vicuna-13b_response": "A viral peplomer is a protein structure that is found on the surface of some viruses. The primary function of a viral peplomer is to help the virus to attach to and infect host cells.\nViruses are obligate intracellular parasites, meaning that they must enter a host cell in order to replicate and produce new virions (virus particles). The viral peplomer is a key component of the virion, and it plays a crucial role in the process of cell entry.\nThe viral peplomer is typically composed of a single protein molecule, and it is often heavily glycosylated (covered in sugar molecules). The glycosylation of the peplomer can help the virus to evade the host immune system and facilitate attachment to host cells.\nOnce the virion has bound to the host cell, the viral peplomer is often involved in the process of fusion, which allows the viral and host cell membranes to merge and allow the viral genetic material to enter the host cell.\nOverall, the viral peplomer is a critical structure for the survival and replication of the virus, and it plays a central role in the process of cell entry and infection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A viral peplomer is a protein structure found on the surface of some viruses.\n2. The function of a viral peplomer is to help the virus attach to and infect host cells.\n3. Viruses are obligate intracellular parasites, which means they need to enter a host cell to replicate and produce new virions.\n4. The viral peplomer is typically composed of a single protein molecule which is often heavily glycosylated.\n5. The glycosylation of the peplomer can help the virus evade the host immune system and facilitate attachment to host cells.",
    "vicuna-13b_fact": [
      "A viral peplomer is a protein structure found on the surface of some viruses.",
      "The function of a viral peplomer is to help the virus attach to and infect host cells.",
      "Viruses are obligate intracellular parasites, which means they need to enter a host cell to replicate and produce new virions.",
      "The viral peplomer is typically composed of a single protein molecule which is often heavily glycosylated.",
      "The glycosylation of the peplomer can help the virus evade the host immune system and facilitate attachment to host cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The viral peplomer is typically composed of multiple protein molecules which are often heavily glycosylated.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3704,
    "user_query": "Does radiotherapy for prostate cancer increase bladder cancer risk?",
    "vicuna-13b_response": "Radiotherapy, or radiation therapy, is a common treatment for prostate cancer. However, there is some evidence to suggest that radiotherapy for prostate cancer may increase the risk of developing bladder cancer in some patients.\nStudies have shown that men who have undergone radiotherapy for prostate cancer have a higher risk of developing bladder cancer compared to those who have not undergone radiotherapy. The risk of bladder cancer increases with the dose and duration of radiotherapy.\nThe exact mechanism by which radiotherapy increases the risk of bladder cancer is not fully understood. However, it is thought to be related to the radiation damage to the normal cells in the bladder, which can lead to the development of cancer over time.\nIt is important to note that the risk of developing bladder cancer after radiotherapy for prostate cancer is still relatively low. The overall incidence of bladder cancer in the general population is about 1 in 20,000, and the risk increases to about 1 in 1,000 for men who have undergone radiotherapy for prostate cancer.\nIt is also important to discuss the potential risks and benefits of radiotherapy with your doctor, as well as other treatment options, before making a decision about your treatment plan. Your doctor will consider your individual health status, the stage and grade of your cancer, and other factors to determine the best course of treatment for you.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Radiotherapy is a common treatment for prostate cancer.\n2. Some evidence suggests that radiotherapy for prostate cancer may increase the risk of developing bladder cancer.\n3. Studies show that men who have undergone radiotherapy for prostate cancer have a higher risk of developing bladder cancer compared to those who have not.\n4. The risk of bladder cancer increases with the dose and duration of radiotherapy.\n5. The incidence of bladder cancer in the general population is about 1 in 20,000, and the risk increases to about 1 in 1,000 for men who have undergone radiotherapy for prostate cancer.",
    "vicuna-13b_fact": [
      "Radiotherapy is a common treatment for prostate cancer.",
      "Some evidence suggests that radiotherapy for prostate cancer may increase the risk of developing bladder cancer.",
      "Studies show that men who have undergone radiotherapy for prostate cancer have a higher risk of developing bladder cancer compared to those who have not.",
      "The risk of bladder cancer increases with the dose and duration of radiotherapy.",
      "The incidence of bladder cancer in the general population is about 1 in 20,000, and the risk increases to about 1 in 1,000 for men who have undergone radiotherapy for prostate cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3705,
    "user_query": "What is ESN364?",
    "vicuna-13b_response": "I'm sorry, but I don't have information on ESN364. Can you provide more context or details about what you are looking for?",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 3707,
    "user_query": "Has MLE4901 been tested in phase III clinical trials?",
    "vicuna-13b_response": "MLE4901 is a drug that is being developed by Merck & Co., Inc. for the treatment of Alzheimer's disease. As of my knowledge cutoff date of September 2021, MLE4901 had completed phase II clinical trials and was in the process of conducting phase III clinical trials.\nPhase III clinical trials are the final stage of clinical trials before a drug can be approved for use by the general public. These trials involve large-scale studies of the drug in order to confirm its effectiveness and safety in a larger population and to compare its benefits and risks to those of currently available treatments.\nIt is important to note that clinical trials are ongoing and dynamic, and the status of a drug's clinical trial status can change over time. Therefore, it is possible that MLE4901 may have completed additional phase III clinical trials or may be in the process of conducting additional trials since my knowledge cutoff date.\nIt is also important to note that the results of clinical trials do not always guarantee that a drug will be approved for use by regulatory agencies such as the U.S. Food and Drug Administration (FDA). The FDA will review the results of the clinical trials, as well as other information about the drug, before making a decision about whether to approve the drug for use.\nIn summary, as of my knowledge cutoff date, MLE4901 had completed phase II clinical trials and was in the process of conducting phase III clinical trials. It is possible that additional phase III clinical trials have been conducted or are ongoing since my knowledge cutoff date, and it is also important to note that the results of clinical trials do not always guarantee that a drug will be approved for use by regulatory agencies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MLE4901 is a drug being developed by Merck & Co., Inc. for the treatment of Alzheimer's disease.\n2. As of September 2021, MLE4901 had completed phase II clinical trials and was in the process of conducting phase III clinical trials.\n3. Phase III clinical trials are the final stage of clinical trials before a drug can be approved for use by the general public.\n4. The status of a drug's clinical trial can change over time.\n5. The results of clinical trials do not always guarantee that a drug will be approved for use by regulatory agencies such as the U.S. Food and Drug Administration (FDA).",
    "vicuna-13b_fact": [
      "MLE4901 is a drug being developed by Merck & Co., Inc. for the treatment of Alzheimer's disease.",
      "As of September 2021, MLE4901 had completed phase II clinical trials and was in the process of conducting phase III clinical trials.",
      "Phase III clinical trials are the final stage of clinical trials before a drug can be approved for use by the general public.",
      "The status of a drug's clinical trial can change over time.",
      "The results of clinical trials do not always guarantee that a drug will be approved for use by regulatory agencies such as the U.S. Food and Drug Administration (FDA)."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3713,
    "user_query": "What is the interaction between WAPL and PDS5 proteins?",
    "vicuna-13b_response": "WAPL (Whey Acidic Protein L) and PDS5 (Proline-Rich Protein 5) are two proteins that have been shown to interact with each other in various studies.\nWAPL is a protein that is found in the milk of mammals and is known to play a role in the immune response and in the regulation of inflammation. PDS5, on the other hand, is a protein that is involved in the regulation of cell growth and division.\nStudies have shown that WAPL and PDS5 interact with each other in a complex called the WAPL-PDS5 complex. This complex is thought to play a role in the regulation of cell growth and division, and it may also be involved in the immune response.\nOverall, the interaction between WAPL and PDS5 is complex and multifaceted, and further research is needed to fully understand the role of this interaction in the body.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. WAPL and PDS5 are proteins that interact with each other.\n2. WAPL is found in the milk of mammals.\n3. WAPL plays a role in the immune response and in the regulation of inflammation.\n4. PDS5 is involved in the regulation of cell growth and division.\n5. WAPL and PDS5 interact in a complex called the WAPL-PDS5 complex which is thought to play a role in the regulation of cell growth and division and immune response.",
    "vicuna-13b_fact": [
      "WAPL and PDS5 are proteins that interact with each other.",
      "WAPL is found in the milk of mammals.",
      "WAPL plays a role in the immune response and in the regulation of inflammation.",
      "PDS5 is involved in the regulation of cell growth and division.",
      "WAPL and PDS5 interact in a complex called the WAPL-PDS5 complex which is thought to play a role in the regulation of cell growth and division and immune response."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "vicuna-13b_response": "The first cholera vaccine approved in the United States was the Vaxchora vaccine, which was approved by the Food and Drug Administration (FDA) in 2016. Vaxchora is a single-dose, oral cholera vaccine that is administered in a single dose and is designed to provide protection against cholera for up to six months. The Vaxchora vaccine was developed by PaxVax, a biotechnology company based in California.\nCholera is an acute diarrheal disease that is caused by infection with the bacterium Vibrio cholerae. It is spread through contaminated food or water and can cause severe dehydration and even death if left untreated. Cholera vaccines are an important tool in preventing the spread of cholera in endemic areas and in travelers to areas where cholera is common. The Vaxchora vaccine is the first cholera vaccine to be approved in the United States and it is an important step in the prevention and control of cholera.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Vaxchora vaccine was the first cholera vaccine approved in the United States.\n2. The Food and Drug Administration (FDA) approved the Vaxchora vaccine in 2016.\n3. Vaxchora is a single-dose, oral cholera vaccine designed to provide protection against cholera for up to six months.\n4. PaxVax, a biotechnology company based in California, developed the Vaxchora vaccine.\n5. Cholera, an acute diarrheal disease caused by infection with the bacterium Vibrio cholerae, can be prevented with vaccines like Vaxchora.",
    "vicuna-13b_fact": [
      "The Vaxchora vaccine was the first cholera vaccine approved in the United States.",
      "The Food and Drug Administration (FDA) approved the Vaxchora vaccine in 2016.",
      "Vaxchora is a single-dose, oral cholera vaccine designed to provide protection against cholera for up to six months.",
      "PaxVax, a biotechnology company based in California, developed the Vaxchora vaccine.",
      "Cholera, an acute diarrheal disease caused by infection with the bacterium Vibrio cholerae, can be prevented with vaccines like Vaxchora."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3718,
    "user_query": "Are there negative enhancers?",
    "vicuna-13b_response": "Yes, there are negative enhancers. An enhancer is a sequence of DNA that increases the transcription of a gene, but it is also possible for certain sequences to decrease the transcription of a gene, these are called negative enhancers.\nNegative enhancers work by binding to transcription factors that repress gene expression, preventing them from activating transcription. They can also recruit chromatin modifying enzymes that remove activating marks and add repressive marks on the target gene, further reducing its expression.\nNegative enhancers can play a role in regulating gene expression in response to different cellular conditions, such as in response to differentiation or developmental stages, or in response to environmental cues. They can also play a role in the regulation of cellular processes such as cell cycle progression, apoptosis, and differentiation.\nIt is important to note that the function of a negative enhancer can be context-dependent, and it can act as a positive enhancer in certain conditions or cell types. Additionally, the function of a negative enhancer can be regulated by other factors such as the binding of transcription factors or the presence of specific post-transcriptional modifications.\nIn summary, negative enhancers are sequences of DNA that decrease the transcription of a gene, they work by binding to transcription factors that repress gene expression, preventing them from activating transcription, recruiting chromatin modifying enzymes that remove activating marks and add repressive marks on the target gene, further reducing its expression. They play a role in regulating gene expression in response to different cellular conditions and can act as a context-dependent positive enhancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Negative enhancers are sequences of DNA that decrease the transcription of a gene.\n2. Negative enhancers work by binding to transcription factors that repress gene expression, preventing them from activating transcription.\n3. Negative enhancers can recruit chromatin modifying enzymes that remove activating marks and add repressive marks on the target gene.\n4. Negative enhancers play a role in the regulation of cellular processes such as cell cycle progression, apoptosis, and differentiation.\n5. The function of a negative enhancer can be context-dependent, and it can act as a positive enhancer in certain conditions or cell types.",
    "vicuna-13b_fact": [
      "Negative enhancers are sequences of DNA that decrease the transcription of a gene.",
      "Negative enhancers work by binding to transcription factors that repress gene expression, preventing them from activating transcription.",
      "Negative enhancers can recruit chromatin modifying enzymes that remove activating marks and add repressive marks on the target gene.",
      "Negative enhancers play a role in the regulation of cellular processes such as cell cycle progression, apoptosis, and differentiation.",
      "The function of a negative enhancer can be context-dependent, and it can act as a positive enhancer in certain conditions or cell types."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3719,
    "user_query": "What is the function of WAPL protein on cohesin?",
    "vicuna-13b_response": "WAPL (Wiskott-Aldrich syndrome protein like) is a protein that plays a role in regulating the activity of cohesin, a complex that is involved in maintaining the integrity of chromosomes during cell division. Cohesin is composed of several subunits, including SMC1, SMC3, and Rad21, and it forms a ring-shaped structure that surrounds the chromosomes and holds their sister chromatids together.\nWAPL protein is one of several proteins that regulate the activity of cohesin by controlling the ability of the cohesin complex to bind to DNA. Specifically, WAPL protein acts as a cohesin loader, helping to recruit cohesin to the DNA and maintain its attachment to the chromosomes during cell division.\nMutations in the WAPL gene have been linked to the development of certain types of cancer, as well as other diseases such as Wiskott-Aldrich syndrome, a disorder that affects the immune system. Understanding the function of WAPL protein and its role in regulating cohesin activity is important for gaining insights into the mechanisms that control chromosome stability and how these processes can go awry in disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. WAPL is a protein that regulates the activity of cohesin.\n2. Cohesin is a complex involved in maintaining the integrity of chromosomes during cell division.\n3. The cohesin complex is composed of several subunits, including SMC1, SMC3, and Rad21.\n4. WAPL protein acts as a cohesin loader, helping to recruit cohesin to the DNA and maintain its attachment to the chromosomes during cell division.\n5. Mutations in the WAPL gene have been linked to the development of certain types of cancer and Wiskott-Aldrich syndrome, a disorder that affects the immune system.",
    "vicuna-13b_fact": [
      "WAPL is a protein that regulates the activity of cohesin.",
      "Cohesin is a complex involved in maintaining the integrity of chromosomes during cell division.",
      "The cohesin complex is composed of several subunits, including SMC1, SMC3, and Rad21.",
      "WAPL protein acts as a cohesin loader, helping to recruit cohesin to the DNA and maintain its attachment to the chromosomes during cell division.",
      "Mutations in the WAPL gene have been linked to the development of certain types of cancer and Wiskott-Aldrich syndrome, a disorder that affects the immune system."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: WAPL protein doesn't act as a cohesin loader. It promotes the removal of cohesin from chromosomes, helping to release cohesin, not to recruit it to the DNA.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3728,
    "user_query": "Which cells mature in the human thymus?",
    "vicuna-13b_response": "The thymus is a gland located in the chest region of the human body that plays a crucial role in the development and maturation of the immune system. The thymus is responsible for the development and maturation of T cells, a type of immune cell that plays a central role in cell-mediated immunity.\nDuring fetal development, the thymus is composed of two lobes, which gradually fuse together to form a single organ. The thymus is at its peak size and activity during infancy and early childhood, after which it begins to atrophy and is replaced by fat tissue.\nT cells are produced in the thymus by immature T cells called T precursor cells. These T precursor cells undergo a process of maturation and selection in the thymus, during which they are tested for their ability to recognize and respond to specific antigens. T cells that are able to recognize and respond to antigens are allowed to mature and enter the circulation, while T cells that are unable to do so are eliminated through a process of apoptosis (programmed cell death).\nIn summary, the thymus is responsible for the development and maturation of T cells, a type of immune cell that plays a central role in cell-mediated immunity. T cells are produced in the thymus by immature T cells called T precursor cells, and undergo a process of maturation and selection in the thymus before entering the circulation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The thymus, located in the chest region, is responsible for the development and maturation of T cells.\n2. T cells play a central role in cell-mediated immunity.\n3. During fetal development, the thymus is composed of two lobes that fuse together to form a single organ.\n4. T cells are produced in the thymus by immature T cells called T precursor cells.\n5. T precursor cells undergo a process of maturation and selection in the thymus, during which they are tested for their ability to recognize and respond to specific antigens.",
    "vicuna-13b_fact": [
      "The thymus, located in the chest region, is responsible for the development and maturation of T cells.",
      "T cells play a central role in cell-mediated immunity.",
      "During fetal development, the thymus is composed of two lobes that fuse together to form a single organ.",
      "T cells are produced in the thymus by immature T cells called T precursor cells.",
      "T precursor cells undergo a process of maturation and selection in the thymus, during which they are tested for their ability to recognize and respond to specific antigens."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: During fetal development, the thymus is composed of two lobes that do not fuse together but function as one organ.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3729,
    "user_query": "What are the eRNA-producing centers (EPCs)?",
    "vicuna-13b_response": "eRNA-producing centers (EPCs) are specialized structures within cells that are responsible for producing small RNA molecules called endogenous RNA (eRNA). eRNA molecules are involved in a variety of cellular processes, including gene regulation, RNA interference, and mRNA splicing.\nThere are two main types of eRNA-producing centers:\n1. P-bodies: P-bodies are cytoplasmic structures that are involved in the regulation of gene expression by RNA interference. They are formed by the aggregation of messenger RNA (mRNA) and associated proteins, including the protein heterogeneous nuclear ribonucleoproteins (hnRNPs). P-bodies play a role in the degradation of mRNA molecules that are not needed for protein synthesis, and they also help to regulate the stability of mRNA molecules.\n2. Micropeptide-binding regions (MBRs): MBRs are regions of RNA that are capable of binding to small peptides or proteins. They are found in a variety of RNA molecules, including ribosomal RNA, transfer RNA, and small nuclear RNA (snRNA). MBRs play a role in the regulation of RNA processing and ribosome biogenesis.\nOverall, eRNA-producing centers are important for the regulation of gene expression and the maintenance of cellular homeostasis. Dysfunction in these structures has been linked to a variety of diseases, including neurodegenerative disorders and cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. eRNA-producing centers (EPCs) are specialized structures within cells that produce endogenous RNA (eRNA).\n2. Endogenous RNA molecules are involved in gene regulation, RNA interference, and mRNA splicing.\n3. One type of eRNA-producing center is P-bodies, which are cytoplasmic structures that regulate gene expression by RNA interference.\n4. Another type of eRNA-producing center is Micropeptide-binding regions (MBRs), which regulate RNA processing and ribosome biogenesis.\n5. Dysfunction in eRNA-producing centers has been linked to a variety of diseases, including neurodegenerative disorders and cancer.",
    "vicuna-13b_fact": [
      "eRNA-producing centers (EPCs) are specialized structures within cells that produce endogenous RNA (eRNA).",
      "Endogenous RNA molecules are involved in gene regulation, RNA interference, and mRNA splicing.",
      "One type of eRNA-producing center is P-bodies, which are cytoplasmic structures that regulate gene expression by RNA interference.",
      "Another type of eRNA-producing center is Micropeptide-binding regions (MBRs), which regulate RNA processing and ribosome biogenesis.",
      "Dysfunction in eRNA-producing centers has been linked to a variety of diseases, including neurodegenerative disorders and cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: P-bodies are not eRNA-producing centers, they are involved in processes such as mRNA decay and translation arrest.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3731,
    "user_query": "When was vivotif first licenced in Europe?",
    "vicuna-13b_response": "I'm sorry, but I don't have information about the specific product \"vivotif\" and its licensing in Europe. Can you provide more context or clarify the product you are referring to?",
    "vicuna-13b_fact_raw": "NO FACTS",
    "vicuna-13b_fact": [],
    "vicuna-13b_judge": []
  },
  {
    "id": 3735,
    "user_query": "Which molecules are inhibited by Gilteritinib?",
    "vicuna-13b_response": "Gilteritinib is a tyrosine kinase inhibitor that is used to treat various types of cancer, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The molecules that are inhibited by Gilteritinib are the receptor tyrosine kinases (RTKs), specifically the fibroblast growth factor receptors (FGFRs).\nGilteritinib specifically targets the FGFR1, FGFR2, and FGFR3 isoforms, which are commonly expressed in various types of hematological malignancies. By inhibiting these FGFRs, Gilteritinib can inhibit the proliferation and survival of cancer cells, leading to the inhibition of cancer growth and the induction of cell death.\nIn conclusion, Gilteritinib is a tyrosine kinase inhibitor that targets the fibroblast growth factor receptors (FGFRs), specifically FGFR1, FGFR2, and FGFR3 isoforms, which are commonly expressed in various types of hematological malignancies. By inhibiting these FGFRs, Gilteritinib can inhibit the proliferation and survival of cancer cells, leading to the inhibition of cancer growth and the induction of cell death.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Gilteritinib is a tyrosine kinase inhibitor.\n2. Gilteritinib is used to treat various types of cancer, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).\n3. Fibroblast growth factor receptors (FGFRs) are the molecules inhibited by Gilteritinib.\n4. Gilteritinib specifically targets the FGFR1, FGFR2, and FGFR3 isoforms.\n5. By inhibiting these FGFRs, Gilteritinib can inhibit the proliferation and survival of cancer cells, leading to the inhibition of cancer growth and the induction of cell death.",
    "vicuna-13b_fact": [
      "Gilteritinib is a tyrosine kinase inhibitor.",
      "Gilteritinib is used to treat various types of cancer, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).",
      "Fibroblast growth factor receptors (FGFRs) are the molecules inhibited by Gilteritinib.",
      "Gilteritinib specifically targets the FGFR1, FGFR2, and FGFR3 isoforms.",
      "By inhibiting these FGFRs, Gilteritinib can inhibit the proliferation and survival of cancer cells, leading to the inhibition of cancer growth and the induction of cell death."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Gilteritinib is used to treat acute myeloid leukemia (AML), not myelodysplastic syndromes (MDS).\n3. FALSE [correction]: Gilteritinib inhibits FMS-like tyrosine kinase 3 (FLT3) and AXL, not Fibroblast growth factor receptors (FGFRs).\n4. FALSE [correction]: Gilteritinib does not target FGFR1, FGFR2, and FGFR3 isoforms.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "vicuna-13b_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene. This gene provides instructions for making a protein called Bruton's tyrosine kinase, which plays a key role in the development and function of immune cells. Mutations in the BTK gene can lead to a reduction in the number of immune cells and an increased susceptibility to infections, which are characteristic of CVID. Other genetic causes of CVID include mutations in the IL-21R, CD40, and STAT3 genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene.\n2. The BTK gene provides instructions for making a protein called Bruton's tyrosine kinase.\n3. Bruton's tyrosine kinase plays a key role in the development and function of immune cells.\n4. Mutations in the BTK gene can lead to a reduction in the number of immune cells and an increased susceptibility to infections.\n5. Other genetic causes of CVID include mutations in the IL-21R, CD40, and STAT3 genes.",
    "vicuna-13b_fact": [
      "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene.",
      "The BTK gene provides instructions for making a protein called Bruton's tyrosine kinase.",
      "Bruton's tyrosine kinase plays a key role in the development and function of immune cells.",
      "Mutations in the BTK gene can lead to a reduction in the number of immune cells and an increased susceptibility to infections.",
      "Other genetic causes of CVID include mutations in the IL-21R, CD40, and STAT3 genes."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The most common genetic cause of common variable immunodeficiency (CVID) in Europeans is not a mutation in the BTK gene, but mutations in the TNFSF12-TNFSF13 and ICOS genes have been implicated.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3738,
    "user_query": "List 3 human diseases caused by  viruses in the family Paramyxoviridae.",
    "vicuna-13b_response": "1. Measles: Measles is a highly contagious viral disease caused by the measles virus, which belongs to the family Paramyxoviridae. It is characterized by a rash, fever, and respiratory symptoms.\n2. Mumps: Mumps is a viral disease caused by the mumps virus, which also belongs to the family Paramyxoviridae. It is characterized by swelling of the salivary glands and can lead to complications such as deafness and inflammation of the testicles in males.\n3. Rubella: Rubella, also known as German measles, is a viral disease caused by the rubella virus, which is also a member of the family Paramyxoviridae. It is characterized by a rash and can lead to serious complications such as birth defects if contracted by a pregnant woman.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Measles is a disease caused by the measles virus, which belongs to the family Paramyxoviridae.\n2. Mumps is a viral disease caused by the mumps virus, a member of the family Paramyxoviridae.\n3. Rubella, also known as German measles, is caused by the rubella virus, which belongs to the family Paramyxoviridae.\n4. The Measles virus is characterized by a rash, fever, and respiratory symptoms.\n5. In mumps, there can be complications such as deafness and inflammation of the testicles in males.",
    "vicuna-13b_fact": [
      "Measles is a disease caused by the measles virus, which belongs to the family Paramyxoviridae.",
      "Mumps is a viral disease caused by the mumps virus, a member of the family Paramyxoviridae.",
      "Rubella, also known as German measles, is caused by the rubella virus, which belongs to the family Paramyxoviridae.",
      "The Measles virus is characterized by a rash, fever, and respiratory symptoms.",
      "In mumps, there can be complications such as deafness and inflammation of the testicles in males."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Rubella, also known as German measles, is caused by the rubella virus, which belongs to the family Togaviridae.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3740,
    "user_query": "What is the target of a drug pidilizumab?",
    "vicuna-13b_response": "Pidilizumab is a monoclonal antibody drug that is used to treat certain types of cancer, including multiple myeloma and non-Hodgkin's lymphoma. The target of pidilizumab is a protein called CD28, which is a component of the immune system that plays a role in regulating T cell activation and survival. Pidilizumab binds to CD28 and blocks its activity, which can help to inhibit the growth and survival of cancer cells. Pidilizumab is typically given intravenously and is administered in a healthcare setting by a trained healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Pidilizumab is a monoclonal antibody drug.\n2. Pidilizumab is used to treat certain types of cancer, including multiple myeloma and non-Hodgkin's lymphoma.\n3. The target of pidilizumab is a protein called CD28.\n4. CD28 is a component of the immune system that plays a role in regulating T cell activation and survival.\n5. Pidilizumab is typically given intravenously and is administered in a healthcare setting by a trained healthcare professional.",
    "vicuna-13b_fact": [
      "Pidilizumab is a monoclonal antibody drug.",
      "Pidilizumab is used to treat certain types of cancer, including multiple myeloma and non-Hodgkin's lymphoma.",
      "The target of pidilizumab is a protein called CD28.",
      "CD28 is a component of the immune system that plays a role in regulating T cell activation and survival.",
      "Pidilizumab is typically given intravenously and is administered in a healthcare setting by a trained healthcare professional."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The target of pidilizumab is PD-1, not CD28.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3742,
    "user_query": "Han Wistar and Sprague Dawley are breeds of what laboratory animal?",
    "vicuna-13b_response": "Han Wistar and Sprague Dawley are breeds of laboratory rats. They are commonly used in scientific research due to their relatively stable genetics, high fertility, and ease of handling. Han Wistar rats are a strain of albino rats that were developed in the 19th century, while Sprague Dawley rats are a strain of brown rats that were developed in the early 20th century. Both strains are widely used in a variety of research fields, including toxicology, pharmacology, and behavioral studies.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Han Wistar and Sprague Dawley are breeds of laboratory rats.\n2. Han Wistar and Sprague Dawley rats are commonly used in scientific research due to their stable genetics, high fertility, and ease of handling.\n3. Han Wistar rats are a strain of albino rats that were developed in the 19th century.\n4. Sprague Dawley rats are a strain of brown rats that were developed in the early 20th century.\n5. Both strains of rats are widely used in various research fields, including toxicology, pharmacology, and behavioral studies.",
    "vicuna-13b_fact": [
      "Han Wistar and Sprague Dawley are breeds of laboratory rats.",
      "Han Wistar and Sprague Dawley rats are commonly used in scientific research due to their stable genetics, high fertility, and ease of handling.",
      "Han Wistar rats are a strain of albino rats that were developed in the 19th century.",
      "Sprague Dawley rats are a strain of brown rats that were developed in the early 20th century.",
      "Both strains of rats are widely used in various research fields, including toxicology, pharmacology, and behavioral studies."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Han Wistar rats are a strain of rats developed in the mid-20th century, not the 19th century.\n4. FALSE [correction]: Sprague Dawley rats are a strain of white, or albino rats, not brown rats, that were developed in the early 20th century.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  }
]